OBO_ID (LABEL):	UBERON_0000178 (blood)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2008_Nov_7_337_a2001	11/2008	S48-BMJ_2008_Nov_7_337_a2001	['recruited Pregnant women received three free Antenatal care checks, at which they were asked about Pregnancy complications and underwent a physical examination including Blood pressure and weight measurement.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'pregnant'), ('GO_0007567', 'parturition', 45, 'antenatal'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('UBERON_0000178', 'blood', 170, 'blood')]
BMJ_2008_Nov_7_337_a2001	11/2008	S65-BMJ_2008_Nov_7_337_a2001	['small for Gestational age babies were defined as those whose weight was below the 10th centile of the Gestational age-sex specific us reference for fetal growth.13\nmaternal haemoglobin concentration was measured in capillary Blood collected early in the third trimester (Gestation 28-32 weeks) from a subsample of 599 Pregnant women with a Birth outcome, who were consecutively enrolled from 6 july 2004 to 28 october 2005.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('GO_0007565', 'female pregnancy', 102, 'gestational'), ('UBERON_0000178', 'blood', 225, 'blood'), ('GO_0007565', 'female pregnancy', 271, 'gestation'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('GO_0007567', 'parturition', 340, 'birth')]
BMJ_2012_Aug_30_345_e5605	8/2012	S38-BMJ_2012_Aug_30_345_e5605	['at 28 weeks’ Gestation, repeat fasting Blood Glucose was measured and Glucose challenge testing one hour after a 50 g Glucose load was carried out.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('CHEBI_17234', 'glucose', 70, 'glucose'), ('CHEBI_17234', 'glucose', 118, 'glucose')]
BMJ_2012_Aug_30_345_e5605	8/2012	S72-BMJ_2012_Aug_30_345_e5605	['values are mean (sd) unless stated otherwiseoutcomeintervention group (n=372)control group (n=387)mean difference (95% ci)p valuebirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409no (%) Birth weight >4000 g189 (51)199 (51)—0.88length at Birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189head circumference at Birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95birthweight difference* from first Pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603fetal Abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89fetal anterior Abdominal Wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323fasting Glucose at 28 weeks (mmol/l)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/l)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088cord Blood Glucose (mmol/l)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second Pregnancy minus Birth weight in first Pregnancy.']	N/A	N/A	[('GO_0007567', 'parturition', 263, 'birth'), ('GO_0007567', 'parturition', 314, 'birth'), ('GO_0007567', 'parturition', 393, 'birth'), ('GO_0007565', 'female pregnancy', 558, 'pregnancy'), ('UBERON_0000916', 'abdomen', 716, 'abdominal'), ('UBERON_0003697', 'abdominal wall', 823, 'abdominal wall'), ('CHEBI_17234', 'glucose', 915, 'glucose'), ('CHEBI_27415', "(+-)-2-(4'-isobutylphenyl)propionitrile", 988, '198Glucose'), ('UBERON_0000178', 'blood', 1087, 'blood'), ('CHEBI_17234', 'glucose', 1093, 'glucose'), ('GO_0007567', 'parturition', 1463, 'Birth'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy'), ('GO_0007567', 'parturition', 1502, 'birth'), ('GO_0007565', 'female pregnancy', 1524, 'pregnancy')]
BMJ_2012_Aug_30_345_e5605	8/2012	S82-BMJ_2012_Aug_30_345_e5605	['an equal number of women in each arm had formal Glucose tolerance testing, and no significant difference existed in the incidence of Gestational diabetes according to either carpenter and coustan criteria (7 v 9) or the american diabetes association criteria (12 v 18).2328cord Blood Glucose was similar between the two groups (table 3).']	N/A	N/A	[('CHEBI_17234', 'glucose', 48, 'glucose'), ('GO_0007565', 'female pregnancy', 133, 'gestational'), ('UBERON_0000178', 'blood', 278, 'blood'), ('CHEBI_17234', 'glucose', 284, 'glucose')]
BMJ_2012_Jan_30_344_e184	1/2012	S71-BMJ_2012_Jan_30_344_e184	['concentrations of Docosahexaenoic Acid and Eicosapentaenoic Acid in the Plasma Phospholipids of Cord Blood from women in the N-3 Lcpufa group were greater than those for the control group (Docosahexaenoic Acid: median 7.5% v 6.2% total Phospholipid Fatty Acids, p<0.001; Eicosapentaenoic Acid: median 0.54% v 0.27% total Phospholipid Fatty Acids, p<0.001 based on a comparison of mean log transformed values).']	N/A	N/A	[('CHEBI_36003', 'decenoic acid', 18, 'docosahexaenoic acid'), ('CHEBI_36003', 'decenoic acid', 43, 'eicosapentaenoic acid'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_16247', 'phospholipid', 79, 'phospholipids'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood'), ('CHEBI_30256', 'thiocarbonyl group', 125, 'n-3'), ('CHEBI_63559', 'HBOA', 129, 'LCPUFA'), ('CHEBI_36003', 'decenoic acid', 189, 'docosahexaenoic acid'), ('CHEBI_16247', 'phospholipid', 236, 'phospholipid'), ('CHEBI_35366', 'fatty acid', 249, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 271, 'eicosapentaenoic acid'), ('CHEBI_16247', 'phospholipid', 321, 'phospholipid'), ('CHEBI_35366', 'fatty acid', 334, 'fatty acids')]
BMJ_2012_Jan_30_344_e184	1/2012	S72-BMJ_2012_Jan_30_344_e184	['the concentration of total n-3 lcpufa in the Cord Blood was higher in women in the N-3 lcpufa group (median 8.8% v 7.2% total Phospholipid Fatty Acids, p<0.001 based on a comparison of mean log transformed values), whereas the concentration of arachidonic acid in Cord Blood was lower in women in the n-3 lcpufa group compared with control (mean 14.6% v 16.4%, p<0.001 based on a comparison of means).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0000178', 'blood', 50, 'blood'), ('31', 'ACACA (human)', 83, 'n'), ('CHEBI_16247', 'phospholipid', 126, 'phospholipid'), ('CHEBI_35366', 'fatty acid', 139, 'fatty acids'), ('UBERON_0002240', 'spinal cord', 264, 'cord'), ('UBERON_0000178', 'blood', 269, 'blood')]
BMJ_2014_Feb_10_348_g1285	2/2014	S35-BMJ_2014_Feb_10_348_g1285	['prespecified secondary maternal outcomes included hypertension (systolic Blood pressure ≥140 mm hg and/or diastolic ≥90 mm hg on two occasions four or more hours apart) and pre-eclampsia27; Gestational diabetes (positive 75g Oral Glucose tolerance test result with fasting Blood Glucose ≥5.5 mmol/l or 2 hour ≥7.8 mmol/l)25; need for and length of antepartum hospital stay; antepartum haemorrhage requiring stay in hospital; preterm ruptured membranes before labour; term ruptured membranes before labour; chorioamnionitis requiring Antibiotics during labour; need for induction of labour; Antibiotic use during labour; caesarean section; Postpartum haemorrhage (>600 ml); Perineal trauma; wound infection; endometritis; Antibiotics Postpartum; Postpartum length of hospital stay; thromboembolic disease; and maternal death.']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood'), ('GO_0007565', 'female pregnancy', 190, 'gestational'), ('UBERON_0000165', 'mouth', 225, 'oral'), ('CHEBI_17234', 'glucose', 230, 'glucose'), ('UBERON_0000178', 'blood', 273, 'blood'), ('CHEBI_17234', 'glucose', 279, 'glucose'), ('CHEBI_33282', 'antibacterial agent', 533, 'antibiotics'), ('CHEBI_33282', 'antibacterial agent', 590, 'antibiotic'), ('GO_0007565', 'female pregnancy', 639, 'postpartum'), ('UBERON_0001977', 'blood serum', 673, 'perineal'), ('CHEBI_33282', 'antibacterial agent', 721, 'antibiotics'), ('GO_0007565', 'female pregnancy', 733, 'postpartum'), ('GO_0007565', 'female pregnancy', 745, 'postpartum')]
PMC1164414	5/2005	S27-PMC1164414	['controls (n = 379) consisted of Blood samples from healthy Blood donors (aged between 18–68 years), with no history of malignant neoplastic disease.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0000178', 'blood', 59, 'blood')]
PMC1164414	5/2005	S31-PMC1164414	['genotyping\ndna was extracted from Peripheral Blood or Bone Marrow samples by using the qiaamp dna Blood midi kit (qiagen gmbh, hilden, germany).']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 34, 'peripheral'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002371', 'bone marrow', 54, 'bone marrow'), ('UBERON_0000178', 'blood', 98, 'Blood')]
PMC1182379	6/2005	S33-PMC1182379	['Cmv is transmitted Person-to-Person via close non-sexual contact, sexual activity, breastfeeding, Blood transfusions, and Organ transplantation [12].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'CMV'), ('NCBITaxon_10088', 'Mus <genus>', 19, 'person'), ('NCBITaxon_10088', 'Mus <genus>', 29, 'person'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0000062', 'organ', 122, 'organ')]
PMC1184067	7/2005	S75-PMC1184067	["caption (table-wrap): table 3\n\njapanese family physicians' experiences in Preconception education during medical school and residency training (n = 268)n(%)smoking cessation191(71.3)testing for anemia172(64.2)Blood testing for rubella Antibody156(58.2)use of basal body temperature monitoring125(46.6)restricting Alcohol intake120(44.8)increasing calcium intake86(32.1)restricting Caffeine intake52(19.4)exercise during Pregnancy48(17.9)timing of Intercourse to maximize chances of Conception38(14.2)Folic Acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in table4."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 74, 'preconception'), ('UBERON_0000178', 'blood', 209, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 235, 'antibody156'), ('CHEBI_30879', 'alcohol', 313, 'alcohol'), ('CHEBI_27732', 'caffeine', 381, 'caffeine'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy48'), ('GO_0006954', 'inflammatory response', 447, 'intercourse'), ('GO_0007631', 'feeding behavior', 482, 'conception38'), ('CHEBI_30751', 'formic acid', 500, 'Folic acid'), ('GO_0007565', 'female pregnancy', 535, 'Preconception')]
PMC1184067	7/2005	S80-PMC1184067	['about two thirds of participants reported their willingness to provide preconception care about such topics as Calcium intake (70%), Blood testing for rubella Antibody (69%), and restricting Caffeine intake (64%).']	N/A	N/A	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('UBERON_0000178', 'blood', 133, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 159, 'antibody'), ('CHEBI_27732', 'caffeine', 191, 'caffeine')]
PMC1184067	7/2005	S127-PMC1184067	['list of abbreviations used\ncbc – complete Blood count\nfp/gps – family physicians and general practitioners\nIgg – Immunoglobulin g\njafm – japanese academy of family medicine\nmg – milligrams\nmhlw – ministry of health, labour and welfare\nob/gyn – obstetrics and gynecology\nrct – randomized controlled trial\nspss – statistical package for the social sciences\nwho – world health organization\nwk – week\n\ncompeting interests\nthe author(s) declare that they have no competing interests.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('GO_0071735', 'IgG immunoglobulin complex', 107, 'IgG'), ('GO_0019814', 'immunoglobulin complex', 113, 'immunoglobulin')]
PMC1280409	9/2005	S47-PMC1280409	['controls were selected from the cohort and matched to cases on the basis of several factors, including date of membership in the cohort, date of Birth, gender, timing of first maternal Blood draw, and the number of available Serum samples (for details seesusser et al.']	N/A	N/A	[('GO_0007567', 'parturition', 145, 'birth'), ('UBERON_0000178', 'blood', 185, 'blood'), ('UBERON_0001977', 'blood serum', 225, 'serum')]
PMC1280409	9/2005	S95-PMC1280409	['they have focused primarily on developmental outcomes such as attention, academic achievement, and Cognition, and have used maternal Blood draws or Postnatal measures in a variety of biologic media (pocock et al.']	N/A	N/A	[('GO_0050890', 'cognition', 99, 'cognition'), ('UBERON_0000178', 'blood', 133, 'blood'), ('GO_0007567', 'parturition', 148, 'postnatal')]
PMC1280409	9/2005	S127-PMC1280409	['the pds study has stored Sera, not whole Blood, containing the pb-Sequestering Erythrocytes required for direct measurements in small volumes.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'sera'), ('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0051235', 'maintenance of location', 66, 'sequestering'), ('CL_0000232', 'erythrocyte', 79, 'erythrocytes')]
PMC1281295	10/2005	S162-PMC1281295	['Cord Blood has been sampled in three studies.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC1281295	10/2005	S163-PMC1281295	['mount sinai center investigators collected Cord Blood for enzyme, lead, and Gene analyses.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 43, 'cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('SO_0000704', 'gene', 76, 'gene')]
PMC1281295	10/2005	S164-PMC1281295	['the mount sinai group relied on hospital staff for Cord Blood retrieval, with prenotification of impending Delivery and a note on the chart, with the result that 59% of the participants’ Cord Blood was obtained.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 51, 'cord'), ('UBERON_0000178', 'blood', 56, 'blood'), ('GO_0007567', 'parturition', 107, 'delivery'), ('UBERON_0002240', 'spinal cord', 187, 'cord'), ('UBERON_0000178', 'blood', 192, 'blood')]
PMC1281295	10/2005	S166-PMC1281295	['Umbilical Cord Blood was obtained by syringing the Blood into heparinized syringes at the point the Cord enters the Placenta.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0002240', 'spinal cord', 100, 'cord'), ('UBERON_0001987', 'placenta', 116, 'placenta')]
PMC1281295	10/2005	S167-PMC1281295	['to date, a Cord Blood sample has been obtained from 81% of the infants in the study.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 11, 'cord'), ('UBERON_0000178', 'blood', 16, 'blood')]
PMC1281295	10/2005	S203-PMC1281295	['several of the centers have also collected Blood samples from children Postnatally.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0007565', 'female pregnancy', 71, 'postnatally')]
PMC1281295	10/2005	S204-PMC1281295	['the columbia center has employed a pediatric phlebotomist to draw Blood when children came to the center for the developmental assessment.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood')]
PMC1281295	10/2005	S207-PMC1281295	['the berkeley center hired a pediatric phlebotomist to collect Blood for both state-required lead screening and the chamacos (center for health analysis of mothers and children of salinas) study, increasing the rate of Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000178', 'blood', 218, 'blood')]
PMC1281295	10/2005	S272-PMC1281295	['finally, there are no laboratory methods available for many common use agricultural or home Pesticides in Blood.']	N/A	N/A	[('CHEBI_35392', 'glucarate(1-)', 92, 'pesticides'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC1409785	1/2006	S55-PMC1409785	['with regard to common causes of nnj in our environment, only 25 (37.9%) chose all the three correct answers namely: Blood group disparity between mother and child, infection in the baby (sepsis), and prematurity.']	N/A	N/A	[('UBERON_0000178', 'blood', 116, 'blood')]
PMC1409785	1/2006	S58-PMC1409785	['on the question of effective treatment for nnj, 36 (54.5%) of the respondents mentioned both photo therapy and exchange Blood transfusion correctly while an additional 21 (31.8%) picked either of the two.']	N/A	N/A	[('UBERON_0000178', 'blood', 120, 'blood')]
PMC1409785	1/2006	S69-PMC1409785	['methods of prevention mentioned by them include proper Antenatal Care – 18 (43.9%) respondents, Blood group screening – 12 (29.3%), treatment of malaria in Pregnancy – 4 (9.8%), and adequate maternal nutrition in Pregnancy – 3 (7.3%).']	N/A	N/A	[('GO_0007608', 'sensory perception of smell', 55, 'antenatal care'), ('UBERON_0000178', 'blood', 96, 'blood'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy')]
PMC1448690	4/2006	S85-PMC1448690	['[29] compared Th Cell Proliferative Responses in Cord Blood samples from a cohort of 2000 births, according to Birth order, maternal smoking and maternal dietary intake.']	N/A	N/A	[('CL_0000545', 'T-helper 1 cell', 14, 'Th cell'), ('GO_0002517', 'T cell tolerance induction', 14, 'Th cell proliferative responses'), ('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007567', 'parturition', 111, 'birth')]
PMC1448690	4/2006	S387-PMC1448690	['during and after Viral infections (both Respiratory and enteric viral infections), Virus particles are shed in large numbers in Body Fluids including Blood, Faeces, Saliva and Nasal secretions.']	N/A	N/A	[('NCBITaxon_1', 'root', 17, 'viral'), ('UBERON_0001004', 'respiratory system', 40, 'respiratory'), ('NCBITaxon_1', 'root', 83, 'virus'), ('UBERON_0006314', 'bodily fluid', 128, 'body fluids'), ('UBERON_0000178', 'blood', 150, 'blood'), ('UBERON_0001988', 'feces', 157, 'faeces'), ('UBERON_0004339', 'vault of skull', 165, 'saliva'), ('UBERON_0000004', 'nose', 176, 'nasal')]
PMC1592148	7/2006	S62-PMC1592148	['acog, american college of obstetricians and gynecologists; aap, american academy of pediatrics; hp2010, healthy people 2010; fda, Food and Drug administration; epa, environmental protection agency; cdc, centers for disease control and prevention; iom, institute of medicine; nhlbi, national Heart, Lungs, and Blood institute; icsi, institute for clinical systems improvement; acs, american cancer society; ada, american diabetes association.']	N/A	N/A	[('CHEBI_33290', 'food', 130, 'Food'), ('CHEBI_23888', 'drug', 139, 'Drug'), ('UBERON_0000948', 'heart', 291, 'Heart'), ('UBERON_0002048', 'lung', 298, 'Lungs'), ('UBERON_0000178', 'blood', 309, 'Blood')]
PMC1592148	7/2006	S167-PMC1592148	['these include periodic height, weight and Blood pressure measurements, total skin examination, clinical Breast examination, pap smear and Bimanual Pelvic examination every 1 to 3 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0000310', 'breast', 104, 'breast'), ('UBERON_0006062', 'zygapophysis', 138, 'bimanual'), ('UBERON_0002108', 'small intestine', 147, 'pelvic')]
PMC1592148	7/2006	S243-PMC1592148	['in most women with Gestational hypertension, the Blood pressure will become normal during the first week Postpartum; for women with Preeclampsia the hypertension will take longer to resolve.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'gestational'), ('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007565', 'female pregnancy', 105, 'postpartum'), ('GO_0007128', 'meiotic prophase I', 132, 'preeclampsia')]
PMC1665416	11/2006	S89-PMC1665416	['details of the Blood sample collection for biomarker analysis have been reported (perera et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC1764147	12/2006	S47-PMC1764147	['data reported in the present study were collected using an extensive household interview addressing health conditions and health-related behaviors and a standardized physical examination including medical Blood and Urine tests, which were conducted in mobile examination centers.']	N/A	N/A	[('UBERON_0000178', 'blood', 205, 'blood'), ('UBERON_0001088', 'urine', 215, 'urine')]
PMC1764147	12/2006	S59-PMC1764147	['laboratory methods\nduring the physical examinations, whole Blood and spot Urine specimens were collected from participants, aliquoted, and stored cold (2–4°c) or frozen until shipment.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood'), ('UBERON_0001088', 'urine', 74, 'urine')]
PMC184457	8/2003	S20-PMC184457	['her Blood type was o positive.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC184457	8/2003	S47-PMC184457	["at 28 weeks' Gestation, the patient was readmitted to hospital for mild preeclampsia with a Blood pressure of 140/80."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC1852384	1/2007	S28-PMC1852384	['all patients were evaluated by an attending anesthesiologist before surgery.routine preoperative studies included: electrocardiogram, Chest x-ray, Gallbladder ultrasonography, Serum electrolytes, glucose, hba1c, calcium, albumin, Lipid profile, Liver function tests, complete Blood count, Platelets, prothrombin time, partial thromboplastin time, inr, and Urinalysis.']	N/A	N/A	[('UBERON_0001443', 'chest', 134, 'chest'), ('UBERON_0002110', 'gall bladder', 147, 'gallbladder'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_18059', 'lipid', 230, 'lipid'), ('UBERON_0002107', 'liver', 245, 'liver'), ('UBERON_0000178', 'blood', 276, 'blood'), ('CL_0000233', 'platelet', 289, 'platelets'), ('GO_0006281', 'DNA repair', 356, 'urinalysis')]
PMC1852384	1/2007	S48-PMC1852384	['all routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [Serum electrolytes, Glucose, hba1c, calcium, albumin, Lipid profile, Liver function tests, complete Blood count, Platelets, Serum Insulin, iron, ferritin, Vitamin B12, 25-Oh Vitamin D, and Thiamine (Vitamin B1)].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_17234', 'glucose', 140, 'glucose'), ('CHEBI_18059', 'lipid', 174, 'lipid'), ('UBERON_0002107', 'liver', 189, 'liver'), ('UBERON_0000178', 'blood', 220, 'blood'), ('CL_0000233', 'platelet', 233, 'platelets'), ('UBERON_0001977', 'blood serum', 244, 'serum'), ('PR_000045358', 'insulin family protein', 250, 'insulin'), ('CHEBI_33279', 'vitamin D5', 275, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 283, 'B12'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 288, '25-OH'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin D'), ('CHEBI_26948', 'vitamin B1', 309, 'thiamine'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 319, 'vitamin B1')]
PMC1868729	3/2007	S31-PMC1868729	['types of outcome measures\noffspring diastolic and systolic Blood pressure in mm hg; incidence of hypertension.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood')]
PMC1868729	3/2007	S33-PMC1868729	['medline and embase (1966 to 2005) were searched in december 2005 using the following search strategy\n#1 search calcium [title] 84110\n#2 search Pregnan* 568541\n#3 search "Blood pressure" 247471\n#4 search hyperten* 241702\n#5 search #1 and #2 and (#3 or #4) 253\n2.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 143, 'pregnan'), ('UBERON_0000178', 'blood', 170, 'blood')]
PMC1868729	3/2007	S98-PMC1868729	['the authors measured the offspring Blood pressure in hospital when the babies were 2–4 days old, and at home at 1, 6 and 12 months.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC1868729	3/2007	S102-PMC1868729	['it assessed maternal Calcium Intake during the first and second trimesters using a validated semi-quantitative ffq, and measured offspring Blood pressure at Birth and at 6 months.']	N/A	N/A	[('CHEBI_22313', 'alkaline earth metal atom', 21, 'calcium'), ('GO_0007631', 'feeding behavior', 29, 'intake'), ('UBERON_0000178', 'blood', 139, 'blood'), ('GO_0007567', 'parturition', 157, 'birth')]
PMC1868729	3/2007	S111-PMC1868729	['children were assessed at a mean age of 9 years and Blood pressure was measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood')]
PMC1868729	3/2007	S119-PMC1868729	['two of them adjusted for Blood pressure measurement conditions [12,23].']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood')]
PMC1913535	6/2007	S65-PMC1913535	['pre-eclampsia, high Blood Sugar), b) maternally perceived Gestational stress, c) markers of Prenatal-growth (e.g.']	N/A	N/A	[('CHEBI_73302', '(dT)5', 20, 'blood sugar'), ('UBERON_0000178', 'blood', 20, 'blood'), ('GO_0007565', 'female pregnancy', 58, 'gestational'), ('GO_0007565', 'female pregnancy', 92, 'prenatal')]
PMC1913535	6/2007	S78-PMC1913535	['Birth weight (r = .991), smoking during Pregnancy (kappa = .806), high Blood pressure during Pregnancy kappa = .716) [35].']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'birth'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0000178', 'blood', 71, 'blood'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy')]
PMC1913535	6/2007	S114-PMC1913535	['given the current numbers of children Born by ivf in the rare groups, this design will be most useful for examining trait measures or common conditions and risk factors such as emotional and behavioural symptoms, Cognitive ability, asthma, Blood pressure and bmi.']	N/A	N/A	[('GO_0007567', 'parturition', 38, 'born'), ('GO_0050890', 'cognition', 213, 'cognitive'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC1974834	3/2007	S6-PMC1974834	['all the above, except crp, were also measured in Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC1974834	3/2007	S10-PMC1974834	['conclusion\nan Antiatherogenic diet in Pregnancy did not significantly influence maternal or fetal Blood concentrations of a range of biomarkers for inflammation.']	N/A	N/A	[('CHEBI_50850', 'etabonate ester', 14, 'antiatherogenic'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC1974834	3/2007	S25-PMC1974834	['both the intervention and control groups followed the same schedule of Blood sampling, physician and dietician visits and assessments (figure 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 71, 'blood')]
PMC1974834	3/2007	S37-PMC1974834	['laboratory methods\nBlood samples for measuring the risk markers (hereinafter referred to as biomarkers) were obtained at each visit after an overnight fast of at least 10 hours.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'Blood')]
PMC1974834	3/2007	S41-PMC1974834	['all the above, except crp, were also measured in Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC1974834	3/2007	S43-PMC1974834	['Blood for the preparation of Platelet-poor citrated Plasma was collected, immediately placed on ice and centrifuged within 30 minutes (maternal samples) to 1 hour (Cord Blood samples) for determination of Pai-1, Pai-2, Tpaag and Vwf.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000233', 'platelet', 29, 'platelet'), ('UBERON_0001969', 'blood plasma', 52, 'plasma'), ('UBERON_0002240', 'spinal cord', 164, 'cord'), ('UBERON_0000178', 'blood', 169, 'blood'), ('PR_000014702', 'plasminogen activator inhibitor 1', 205, 'PAI-1'), ('PR_000014700', 'serpin B9', 212, 'PAI-2'), ('PR_000016588', 'nucleoprotein TPR', 219, 'tPAag'), ('PR_000017310', 'vomeronasal type-1 receptor 3', 229, 'vWF')]
PMC1974834	3/2007	S79-PMC1974834	['no differences in baseline characteristics or dietary variables between the groups were observed before randomisation.9\n\ncaption (table-wrap): table 1\n\ncharacteristics of participants at baselinecharacteristiccontrolintervention p -valueno.149141age (years)29.8 (3.4)29.6 (3.7)0.7nulliparous (%)65.170.90.3gestational age at entry (week)19 (1.1)19 (1.1)0.919 (5.4)*19 (4.9)*bmi (kg/m2)24.3 (2.7)24.3 (2.9)0.9bmi (%) >25 (kg/m2)32.936.20.6systolic Blood pressure (mmhg)105 (10)106 (9)0.9diastolic Blood pressure (mmhg)65 (8)64 (8)0.4\nvalues are mean (sd).']	N/A	N/A	[('UBERON_0000178', 'blood', 447, 'blood'), ('UBERON_0000178', 'blood', 496, 'blood')]
PMC2022638	10/2007	S38-PMC2022638	['many environmental Toxicants are conveyed transplacentally, and the Blood–Brain Barrier remains relatively permeable to many of these Compounds until well into the first year of Life (andersen et al.']	N/A	N/A	[('CHEBI_35704', 'N(2)-acetyl-L-lysine', 19, 'toxicants'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0000052', 'fornix of brain', 74, 'brain barrier'), ('CHEBI_36357', 'polyatomic entity', 134, 'compounds'), ('UBERON_0000104', 'life cycle', 178, 'life')]
PMC2022676	10/2007	S28-PMC2022676	['ketoacidosis results when Carbohydrate Intake is restricted and the body turns to other energy sources, such as fat; Acids known as Ketones build up in the Blood.']	N/A	N/A	[('CHEBI_16730', 'chloramphenicol 3-acetate', 26, 'carbohydrate'), ('GO_0007631', 'feeding behavior', 39, 'intake'), ('CHEBI_37527', 'acid', 117, 'acids'), ('CHEBI_17087', 'ketone', 132, 'ketones'), ('UBERON_0000178', 'blood', 156, 'blood')]
PMC2022678	10/2007	S0-PMC2022678	['determinants of Arsenic Metabolism: Blood Arsenic metabolites, Plasma Folate, Cobalamin, and Homocysteine concentrations in maternal–newborn pairs\n\nabstract\n\nbackground\nin bangladesh, tens of millions of People have been Consuming waterborne Arsenic for decades.']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 16, 'Arsenic'), ('GO_0018871', '1-aminocyclopropane-1-carboxylate metabolic process', 16, 'Arsenic Metabolism'), ('UBERON_0000178', 'blood', 36, 'Blood'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 42, 'Arsenic'), ('UBERON_0001969', 'blood plasma', 63, 'Plasma'), ('CHEBI_81245', 'Vulpecholate', 70, 'Folate'), ('CHEBI_15982', 'cob(I)alamin', 78, 'Cobalamin'), ('CHEBI_5759', 'Honokiol', 93, 'Homocysteine'), ('NCBITaxon_10088', 'Mus <genus>', 204, 'people'), ('GO_0007631', 'feeding behavior', 221, 'consuming'), ('CHEBI_27563', 'arsenic atom', 242, 'arsenic')]
PMC2022678	10/2007	S3-PMC2022678	['methods\nMaternal and Cord Blood pairs were collected and concentrations of total as were analyzed for 101 pairs, and as Metabolites for 30 pairs.']	N/A	N/A	[('UBERON_0000976', 'humerus', 8, 'Maternal'), ('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_25212', 'metabolite', 120, 'metabolites')]
PMC2022678	10/2007	S55-PMC2022678	['we also describe Blood as Metabolites in the 30 maternal–Cord pairs that had the highest total Blood as.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_25212', 'metabolite', 26, 'metabolites'), ('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC2022678	10/2007	S66-PMC2022678	['sample collection and storage\nnear the time of Delivery, women were asked to provide written informed consent, to answer a brief questionnaire, to provide a Blood and Urine sample before Delivery, and to allow a Blood sample to be obtained from the discarded Umbilical Cord after the Birth Of the Baby.']	N/A	N/A	[('GO_0007567', 'parturition', 47, 'delivery'), ('UBERON_0000178', 'blood', 157, 'blood'), ('UBERON_0001088', 'urine', 167, 'urine'), ('GO_0007567', 'parturition', 187, 'delivery'), ('UBERON_0000178', 'blood', 212, 'blood'), ('UBERON_0002331', 'umbilical cord', 259, 'umbilical cord'), ('GO_0007567', 'parturition', 284, 'birth of'), ('GO_0007567', 'parturition', 297, 'baby')]
PMC2022678	10/2007	S67-PMC2022678	['the maternal and Cord Blood samples were typically taken within 1–2 hr of each other.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 17, 'cord'), ('UBERON_0000178', 'blood', 22, 'blood')]
PMC2022678	10/2007	S68-PMC2022678	['the questionnaire was administered by a trained nurse, who also obtained the Blood and Urine samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0001088', 'urine', 87, 'urine')]
PMC2022678	10/2007	S70-PMC2022678	['in three cases, Cord Blood was not collected; we therefore report on a sample size of 101.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 16, 'cord'), ('UBERON_0000178', 'blood', 21, 'blood')]
PMC2022678	10/2007	S71-PMC2022678	['Blood samples were processed and frozen at −80°c immediately in the hospital laboratory.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2022678	10/2007	S88-PMC2022678	['Maternal and Cord Venous whole Blood samples were analyzed for total Blood as concentration using a perkin-elmer elan drc ii icp-ms equipped with an as 93+ autosampler as described elsewhere (hall et al.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0001638', 'vein', 18, 'venous'), ('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC2022678	10/2007	S90-PMC2022678	['briefly, the as concentration of the standard Solution used for instrument calibration was chosen to cover the expected range of As concentrations in the Blood samples: 5, 25, and 50 μg/l.']	N/A	N/A	[('CHEBI_75958', 'solution', 46, 'solution'), ('CHEBI_22868', 'bile salt', 129, 'As'), ('UBERON_0000178', 'blood', 154, 'blood')]
PMC2022678	10/2007	S95-PMC2022678	['as Metabolite measurements\nUrinary as and Blood as Metabolites were separated by high performance liquid chromatography (hplc), with a perkinelmer hplc series 200 (perkinelmer), and then quantified by icp-ms-drc, using methods adapted fromreuter and neubauer (2003).']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 3, 'metabolite'), ('UBERON_0001088', 'urine', 27, 'Urinary'), ('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_25212', 'metabolite', 51, 'metabolites')]
PMC2022678	10/2007	S96-PMC2022678	['whole Blood specimens were digested using methods fromcsanaky et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC2022678	10/2007	S102-PMC2022678	['calibration standards of a Mixture of as Metabolites were processed similar to Blood samples to achieve the same ph and composition.']	N/A	N/A	[('CHEBI_60004', 'mixture', 27, 'mixture'), ('CHEBI_25212', 'metabolite', 41, 'metabolites'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC2022678	10/2007	S103-PMC2022678	['concentrations of calibration standards were chosen to cover the expected range of Metabolite as concentrations in Blood samples.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 83, 'metabolite'), ('UBERON_0000178', 'blood', 115, 'blood')]
PMC2022678	10/2007	S104-PMC2022678	['excellent separation by hplc coupled with very low detection limits of icp-ms-drc allowed us to detect Mma, Dma, as+3, and as+5, without online digestion of Organic forms, with great precision in Blood samples containing total as concentrations ≥ 10 μg/l.']	N/A	N/A	[('CHEBI_34840', 'methyl methacrylate', 103, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 108, 'DMA'), ('CHEBI_77514', '6-phenylundecane', 157, 'organic'), ('UBERON_0000178', 'blood', 196, 'blood')]
PMC2022678	10/2007	S106-PMC2022678	['therefore, we report the sum value for the concentrations of asc + asb in Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 74, 'blood')]
PMC2022678	10/2007	S108-PMC2022678	['we purchased Blood samples with known concentrations of 23 different elements (including as) from the institut de sante publique du quebec (quebec, canada), for validation of icp-ms analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC2022678	10/2007	S109-PMC2022678	['we also created our own set of Blood specimens spiked with five Metabolites (asc, As+3, dma, Mma, As+5) in three different concentrations to cover the expected range of as in study participant samples; these were spiked at the beginning of the study, aliquoted, and frozen.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_25212', 'metabolite', 64, 'metabolites'), ('CHEBI_22868', 'bile salt', 82, 'As'), ('CHEBI_34840', 'methyl methacrylate', 93, 'MMA'), ('CHEBI_22868', 'bile salt', 98, 'As')]
PMC2022678	10/2007	S112-PMC2022678	['to calculate the relative proportions of Inas, Mma, and dma, the amounts of asb and asc were first subtracted from total Blood as values.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 41, 'InAs'), ('CHEBI_34840', 'methyl methacrylate', 47, 'MMA'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC2022678	10/2007	S114-PMC2022678	['Plasma Folate, b12, and Homocysteine\nwe analyzed Plasma concentrations of Folate and total cobalamin from maternal and Cord Blood samples by radioimmunoassay (quantaphase ii; bio-rad laboratories, richmond, ca, usa) as described previously (reuter and neubauer 2003).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_30863', '5-azaorotic acid', 7, 'folate'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 24, 'homocysteine'), ('UBERON_0001969', 'blood plasma', 49, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 74, 'folate'), ('UBERON_0002240', 'spinal cord', 119, 'cord'), ('UBERON_0000178', 'blood', 124, 'blood')]
PMC2022678	10/2007	S120-PMC2022678	['scatterplots were used to examine the relationships between maternal and Cord Blood measures.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC2022678	10/2007	S121-PMC2022678	['we tested bivariate correlations of variables of interest based on estimated spearman correlation coefficients, and used paired t -tests to detect mean difference between maternal and Cord measures or between maternal Blood and Urine measures.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 184, 'cord'), ('UBERON_0000178', 'blood', 218, 'blood'), ('UBERON_0001088', 'urine', 228, 'urine')]
PMC2022678	10/2007	S123-PMC2022678	['the outcomes variables, including maternal Urinary as Metabolites (%dma, %Mma, and %Inas), maternal Blood as Metabolites, and Cord Blood as Metabolites (%Dma, %Mma, %As+3, and % As+5) were regressed against the main predictors variables, Folate, b12, and Homocysteine, in separate models.']	N/A	N/A	[('UBERON_0001088', 'urine', 43, 'urinary'), ('CHEBI_25212', 'metabolite', 54, 'metabolites'), ('CHEBI_34840', 'methyl methacrylate', 74, 'MMA'), ('CHEBI_33284', 'nutrient', 84, 'InAs'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_25212', 'metabolite', 109, 'metabolites'), ('UBERON_0002240', 'spinal cord', 126, 'cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('CHEBI_25212', 'metabolite', 140, 'metabolites'), ('CHEBI_17874', 'dihydrozeatin', 154, 'DMA'), ('CHEBI_34840', 'methyl methacrylate', 160, 'MMA'), ('CHEBI_22868', 'bile salt', 166, 'As'), ('CHEBI_22868', 'bile salt', 178, 'As'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 255, 'homocysteine')]
PMC2022678	10/2007	S126-PMC2022678	['control variables for maternal Blood as Metabolites were age and parity; for Cord Blood as Metabolites, adjustments were made only for Birth weight.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_25212', 'metabolite', 40, 'metabolites'), ('UBERON_0002240', 'spinal cord', 77, 'cord'), ('UBERON_0000178', 'blood', 82, 'blood'), ('CHEBI_25212', 'metabolite', 91, 'metabolites'), ('GO_0007567', 'parturition', 135, 'birth')]
PMC2022678	10/2007	S129-PMC2022678	['there were no significant differences when these characteristics were compared between the subset for whom Blood as Metabolite data was obtained and the remaining 71 women (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_39382', 'flufenoxuron', 116, 'metabolite')]
PMC2022678	10/2007	S130-PMC2022678	['mean values of Water as, Urinary as, and total Blood as concentrations, as well as Plasma Folate, B12, and Homocysteine measurements are summarized intable 2.']	N/A	N/A	[('CHEBI_15377', 'water', 15, 'water'), ('UBERON_0001088', 'urine', 25, 'urinary'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001969', 'blood plasma', 83, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 90, 'folate'), ('CHEBI_27778', 'abequose', 98, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 98, 'B12'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 107, 'homocysteine')]
PMC2022678	10/2007	S134-PMC2022678	['the mean Cord total Blood as values of 15.7 μg/l in the total sample ( n = 101) and 23.13 mg/l in the subset ( n = 30) exceeded the mean maternal total Blood as of 11.9 μg/l ( n = 101) and 20.02 mg/l ( n = 30) by 32% ( p< 0.0001) and 16% ( p< 0.0001), respectively.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC2022678	10/2007	S137-PMC2022678	['the relative proportions of As+3, As+5, Mma, and dma were virtually identical in terms of mean values in maternal and Cord Blood (table 3).']	N/A	N/A	[('CHEBI_22868', 'bile salt', 28, 'As'), ('CHEBI_22868', 'bile salt', 34, 'As'), ('CHEBI_34840', 'methyl methacrylate', 40, 'MMA'), ('UBERON_0002240', 'spinal cord', 118, 'cord'), ('UBERON_0000178', 'blood', 123, 'blood')]
PMC2022678	10/2007	S139-PMC2022678	['compared with maternal Urine (table 3), maternal Blood contained substantially higher proportions of Inas (i.e., As+3+ As+5) and Mma but less Dma.']	N/A	N/A	[('UBERON_0001088', 'urine', 23, 'urine'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_33284', 'nutrient', 101, 'InAs'), ('CHEBI_22868', 'bile salt', 113, 'As'), ('CHEBI_22868', 'bile salt', 119, 'As'), ('CHEBI_34840', 'methyl methacrylate', 129, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 142, 'DMA')]
PMC2022678	10/2007	S140-PMC2022678	['the spearman correlation coefficient between the sum of Urinary As Metabolites and the sum of Blood as Metabolites is 0.88.']	N/A	N/A	[('UBERON_0001088', 'urine', 56, 'urinary'), ('CHEBI_22868', 'bile salt', 64, 'As'), ('CHEBI_25212', 'metabolite', 67, 'metabolites'), ('UBERON_0000178', 'blood', 94, 'blood'), ('CHEBI_25212', 'metabolite', 103, 'metabolites')]
PMC2022678	10/2007	S141-PMC2022678	['for maternal and Cord Blood as analyses, we compared the total As concentration with the sum of as Metabolite concentration values obtained by hplc-icp-ms. to do so, we adjusted for the hplc percent recovery.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 17, 'cord'), ('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_22868', 'bile salt', 63, 'As'), ('CHEBI_39382', 'flufenoxuron', 99, 'metabolite')]
PMC2022678	10/2007	S142-PMC2022678	['the same approach was used to compare total Urine As concentrations obtained by gfaa to those derived from the sum of Urinary As Metabolites via hplc-icp-ms. recoveries for the hplc-icp-ms methods were 57% for Cord Blood ( n = 30), 69% for maternal Blood ( n = 30), and 89% for maternal Urine ( n = 101).']	N/A	N/A	[('UBERON_0001088', 'urine', 44, 'urine'), ('CHEBI_22868', 'bile salt', 50, 'As'), ('UBERON_0001088', 'urine', 118, 'urinary'), ('CHEBI_22868', 'bile salt', 126, 'As'), ('CHEBI_25212', 'metabolite', 129, 'metabolites'), ('UBERON_0002240', 'spinal cord', 210, 'cord'), ('UBERON_0000178', 'blood', 215, 'blood'), ('UBERON_0000178', 'blood', 249, 'blood'), ('UBERON_0001088', 'urine', 287, 'urine')]
PMC2022678	10/2007	S143-PMC2022678	['comparison of the recovered-adjusted sum of as Metabolite concentrations with the measured total as concentrations, for Cord Blood, maternal Blood, and maternal Urine, shows good agreement (table 3) with concordance correlation coefficient of 0.87, 0.91, and 0.99, respectively.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 47, 'metabolite'), ('UBERON_0009472', 'axilla', 120, 'cord blood'), ('UBERON_0000178', 'blood', 141, 'blood'), ('UBERON_0001088', 'urine', 161, 'urine')]
PMC2022678	10/2007	S154-PMC2022678	['we used multiple linear regression analyses to examine the predictors of maternal total Blood as.']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood')]
PMC2022678	10/2007	S156-PMC2022678	['because total Blood As and Water As had skewed distribution, these variables were log-transformed.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_22868', 'bile salt', 20, 'As'), ('CHEBI_15377', 'water', 27, 'water'), ('CHEBI_22868', 'bile salt', 33, 'As')]
PMC2022678	10/2007	S159-PMC2022678	['parity was not associated with Cord total Blood as before or after controlling for maternal total Blood as.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC2022678	10/2007	S162-PMC2022678	['discussion\nthe appearance of as in Cord Blood is extremely troubling because Gestation is a period of high sensitivity to Carcinogens (anderson et al.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 35, 'cord'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0007565', 'female pregnancy', 77, 'gestation'), ('CHEBI_50903', 'carcinogenic agent', 122, 'carcinogens')]
PMC2098747	10/2007	S16-PMC2098747	['for each patient, Blood tests for both Genetic and acquired causes of thrombophilia were performed (see table1).']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('SO_0000704', 'gene', 39, 'genetic')]
PMC2100429	9/2007	S37-PMC2100429	['a fasting Blood sample was collected, followed by a 1.75\xa0g/kg body weight oral anhydrous Glucose load and a further Blood sample 120\xa0min later.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_17234', 'glucose', 89, 'glucose'), ('UBERON_0000178', 'blood', 116, 'blood')]
PMC2148036	9/2007	S34-PMC2148036	["hypertension was defined as sustained Blood pressures of at least 140/90 mm hg on or after 20 completed weeks' Gestation and on at least two occasions at least four hours apart."]	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007565', 'female pregnancy', 111, 'gestation')]
PMC2231404	10/2007	S6-PMC2231404	['results\nmedian Blood Folate concentrations of all participants were well above Plasma and Rbc Folate cut-off levels indicative of deficiency (6.7 and 317 nmol/l, respectively) and all, except for 2 subjects, were above the cut-off for ntd-risk reduction (>906 nmol/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 21, 'folate'), ('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CL_0000232', 'erythrocyte', 90, 'RBC'), ('CHEBI_30863', '5-azaorotic acid', 94, 'folate')]
PMC2231404	10/2007	S32-PMC2231404	['methods\n\nsubjects\nthe dietary Folate data and Blood Folate concentrations presented for the observational study presented herein were collected as part of a prospective, randomized control trial designed to assess the efficacy of supplemental [6S]-5-Methyltetrahydrofolate ([6S]-5-Methylthf) versus Folic Acid during Lactation (n = 69).']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 30, 'folate'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 52, 'folate'), ('CHEBI_37983', 'sulfur-35 atom', 244, '6S'), ('CHEBI_20612', '5-methyltetrahydrofolate', 248, '5-methyltetrahydrofolate'), ('CHEBI_61527', 'D-fructofuranose 6-phosphate(2-)', 275, '6S]-5-methylTHF'), ('CHEBI_30751', 'formic acid', 299, 'folic acid'), ('GO_0007595', 'lactation', 317, 'lactation')]
PMC2231404	10/2007	S40-PMC2231404	['participants were then given instructions on the completion of 3-d weighed Food records and Blood samples were collected.']	N/A	N/A	[('CHEBI_33290', 'food', 75, 'food'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC2231404	10/2007	S41-PMC2231404	['three-d weighed Food records and additional Blood samples were collected at 4- and 16-wk Postpartum (± 1 wk).']	N/A	N/A	[('CHEBI_33290', 'food', 16, 'food'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0007565', 'female pregnancy', 89, 'postpartum')]
PMC2231404	10/2007	S45-PMC2231404	['laboratory procedures\nBlood samples for the analysis of Plasma and Rbc folate were collected in edta-treated tubes at 36 wk Gestation and at 4- and 16-wk Postpartum.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'Blood'), ('UBERON_0001969', 'blood plasma', 56, 'plasma'), ('CL_0000232', 'erythrocyte', 67, 'RBC'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('GO_0007565', 'female pregnancy', 154, 'postpartum')]
PMC2231404	10/2007	S47-PMC2231404	['hematocrit was measured immediately using freshly collected Blood with the use of an electronic hematology analyzer (hmx, beckman coulter, miami, florida).']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood')]
PMC2231404	10/2007	S48-PMC2231404	['aliquots (100 μl) of whole Blood were diluted 10-fold with Ascorbic Acid and ddh2o (1% wt:vol) and incubated at 37°c to allow for the deconjugation of Folate.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_22652', 'ascorbic acid', 59, 'ascorbic acid'), ('CHEBI_30863', '5-azaorotic acid', 151, 'folate')]
PMC2231404	10/2007	S60-PMC2231404	['Blood Folate concentrations were normalized using logarithmic transformations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_30863', '5-azaorotic acid', 6, 'folate')]
PMC2231404	10/2007	S66-PMC2231404	['when dietary and Blood values were assigned to the same quartile, it was concluded that the Blood Folate value for that subject correctly classified their dietary Folate intake.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0000178', 'blood', 92, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 98, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 163, 'folate')]
PMC2231404	10/2007	S73-PMC2231404	['results\n\nsubject characteristics\nonly those subjects from the overall study who completed 3-d weighed Food records and had provided a concomitant Blood sample for Folate analysis were included in the present analyses (4-wk Postpartum, n = 53; 16 wks Postpartum, n = 55).']	N/A	N/A	[('CHEBI_33290', 'food', 102, 'food'), ('UBERON_0000178', 'blood', 146, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 163, 'folate'), ('GO_0007565', 'female pregnancy', 223, 'postpartum'), ('GO_0007565', 'female pregnancy', 250, 'postpartum')]
PMC2231404	10/2007	S79-PMC2231404	['biochemical indexes\nmedian Blood Folate concentrations during Lactation were well above Plasma and Rbc Folate cut-off levels indicative of deficiency (6.7 and 317 nmol/l, respectively) [34] (table1).']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 33, 'folate'), ('GO_0007595', 'lactation', 62, 'lactation'), ('UBERON_0001969', 'blood plasma', 88, 'plasma'), ('CL_0000232', 'erythrocyte', 99, 'RBC'), ('CHEBI_30863', '5-azaorotic acid', 103, 'folate')]
PMC2265032	3/2008	S2-PMC2265032	['Rats receiving daily doses of Arsenic equivalent to the levels in groundwater from heavily Arsenic-contaminated areas of the bengal basin retained significantly less of the element in Blood and Liver and Excreted significantly more in Urine when Fed 2 mg/ml Age.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27563', 'arsenic atom', 30, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 91, 'arsenic'), ('UBERON_0000178', 'blood', 184, 'blood'), ('UBERON_0002107', 'liver', 194, 'liver'), ('GO_0007588', 'excretion', 204, 'excreted'), ('UBERON_0001088', 'urine', 235, 'urine'), ('GO_0007631', 'feeding behavior', 246, 'fed'), ('CHEBI_80551', 'APC', 258, 'AGE')]
PMC2290997	4/2008	S88-PMC2290997	['after three months, those who used the full-spectrum tanning bed had an average 180% increase in their 25(Oh)D levels and an average 6 mm hg decrease in their Systolic and Diastolic Blood pressures, bringing them into the normal range.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 103, '25(OH)D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 159, 'systolic'), ('GO_0007586', 'digestion', 172, 'diastolic'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC2290997	4/2008	S89-PMC2290997	['in constrast, the group that used the uva-only tanning bed showed no change in either 25(Oh)D or Blood pressure.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('UBERON_0000178', 'blood', 97, 'blood')]
PMC2290997	4/2008	S174-PMC2290997	['uvr increases Blood levels of natural Opiates called Endorphins.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_33866', 'mannonates', 38, 'opiates'), ('PR_000007209', 'steroid hormone receptor ERR2', 53, 'endorphins')]
PMC2360554	10/2006	S10-PMC2360554	['maternal haemoglobin concentrations, Red Cell indices and the date the Blood was drawn were abstracted from the medical record.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 37, 'red cell'), ('UBERON_0000178', 'blood', 71, 'blood')]
PMC2409299	5/2008	S30-PMC2409299	['seven Blood films were positive for malaria parasites out of all the 8, 16 and 52 week visits when the infants were venesected and all samples examined for malaria parasites.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC2409299	5/2008	S31-PMC2409299	['there were an additional 28 positive Blood films from the remaining four-weekly visits (1309 visits in total), when Capillary Blood was examined only in febrile infants.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0001982', 'capillary', 116, 'capillary'), ('UBERON_0000178', 'blood', 126, 'blood')]
PMC2409299	5/2008	S33-PMC2409299	['the geometric mean Cord Blood Lymphocyte and Leucocyte counts were both higher in wet season births compared to dry season births (p = 0.007 and p = 0.0014 for Lymphocyte and Leucocyte counts respectively).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CL_0000542', 'lymphocyte', 30, 'lymphocyte'), ('CL_0000738', 'leukocyte', 45, 'leucocyte'), ('CL_0000542', 'lymphocyte', 160, 'lymphocyte'), ('CL_0000738', 'leukocyte', 175, 'leucocyte')]
PMC2409299	5/2008	S122-PMC2409299	['Cord Blood was collected at Birth (10 ml) and Venous samples obtained at 8, 16 and 52 week of age (3, 4 and 6 ml respectively).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0001638', 'vein', 46, 'venous')]
PMC2409299	5/2008	S123-PMC2409299	['Capillary Blood was examined by thick film for malaria parasites every four weeks, in any infant with intercurrent fever of 37.5°c or above, and on each Venous Blood sample.']	N/A	N/A	[('UBERON_0001982', 'capillary', 0, 'Capillary'), ('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001638', 'vein', 153, 'venous'), ('UBERON_0000178', 'blood', 160, 'blood')]
PMC2409299	5/2008	S126-PMC2409299	['laboratory methods\nT-Lymphocyte (cd3+, Cd4+, Cd8+, B-Cell (Cd19+), and Natural Killer Cell (Cd56+) subpopulations were enumerated in whole Blood samples at Birth (Cord Blood) and at 8, 16 and 52 weeks of age by flow cytometry (facscalibur, beckton dickinson uk ltd, oxford, uk) using appropriate isotypic controls (cyto-stat, beckman-coulter international s.a., nyon, switzerland).']	N/A	N/A	[('CL_0000084', 'T cell', 19, 'T-lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 39, 'CD4'), ('PR_000005170', 'CD37 molecule', 45, 'CD8'), ('CL_0000236', 'B cell', 51, 'B-cell'), ('PR_000001309', 'CD70 molecule', 59, 'CD19'), ('CL_0000623', 'natural killer cell', 71, 'natural killer cell'), ('PR_000001309', 'CD70 molecule', 92, 'CD56'), ('UBERON_0000178', 'blood', 139, 'blood'), ('GO_0007567', 'parturition', 156, 'birth'), ('UBERON_0002240', 'spinal cord', 163, 'cord'), ('UBERON_0000178', 'blood', 168, 'blood')]
PMC2409299	5/2008	S127-PMC2409299	["edta Anticoagulated whole Blood samples were labelled within 6 hours of collection, Red Cells were Lysed according to the manufacturer's instructions, and the labelled cells stabilised and fixed."]	N/A	N/A	[('GO_0006915', 'apoptotic process', 5, 'anticoagulated'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CL_0000232', 'erythrocyte', 84, 'red cells'), ('GO_0019835', 'cytolysis', 99, 'lysed')]
PMC2409299	5/2008	S131-PMC2409299	['absolute counts of each cell sub-population were calculated in relation to Whole Blood Lymphocyte counts, measured as full Blood count and White Cell differential on the same fresh Blood sample (celloscope 1260, analys instrument ab).']	N/A	N/A	[('UBERON_0000473', 'testis', 75, 'whole blood'), ('CL_0000542', 'lymphocyte', 87, 'lymphocyte'), ('UBERON_0000178', 'blood', 123, 'blood'), ('CL_0000448', 'white fat cell', 139, 'white cell'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC2430236	6/2008	S126-PMC2430236	['2006), and assessment of cotinine, a Metabolite of Nicotine, in Blood or Urine.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 37, 'metabolite'), ('CHEBI_25501', 'neoxanthin', 51, 'nicotine'), ('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0001088', 'urine', 73, 'urine')]
PMC2529404	9/2008	S78-PMC2529404	['Tail bleeds were used to sample Blood Glucose and measured using the accu-check active meter (roche).']	N/A	N/A	[('UBERON_0002415', 'tail', 0, 'Tail'), ('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_17234', 'glucose', 38, 'glucose')]
PMC2529404	9/2008	S79-PMC2529404	['after a baseline fasting Glucose level was obtained, Mice were challenged with 2 g/kg Dextrose prepared in 0.9% saline and Blood Glucose checked at 30, 65 and 90 minutes.']	N/A	N/A	[('CHEBI_17234', 'glucose', 25, 'glucose'), ('NCBITaxon_10088', 'Mus <genus>', 53, 'mice'), ('CHEBI_23623', 'deoxyglucose', 86, 'dextrose'), ('UBERON_0000178', 'blood', 123, 'blood'), ('CHEBI_17234', 'glucose', 129, 'glucose')]
PMC2575191	10/2008	S26-PMC2575191	['Blood was collected by Cardiac puncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 23, 'cardiac')]
PMC2575191	10/2008	S82-PMC2575191	["authors' contributions\ndcb designed the study, collected assay Blood samples, and drafted the manuscript."]	N/A	N/A	[('UBERON_0000178', 'blood', 63, 'blood')]
PMC2575191	10/2008	S83-PMC2575191	['csj collected assay Blood samples, and performed the statistical analysis and helped draft the manuscript.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood')]
PMC2575191	10/2008	S85-PMC2575191	['wdr helped with the study design, collected assay Blood samples, and was responsible for daily Animal husbandry.']	N/A	N/A	[('UBERON_0000178', 'blood', 50, 'blood'), ('NCBITaxon_33208', 'Metazoa', 95, 'animal')]
PMC2581757	11/2008	S5-PMC2581757	['introduction\nPreeclampsia is a disorder of Pregnancy characterized by Pregnancy-induced hypertension (≥140\xa0mmhg systolic and/or ≥90\xa0mmhg diastolic Blood pressure), new-onset proteinuria (≥300\xa0mg protein/day), and edema occurring in the second half of Pregnancy.']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 13, 'Preeclampsia'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0000178', 'blood', 147, 'blood'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC2581757	11/2008	S42-PMC2581757	['the patients in our study included Pregnant women with normal Blood pressure, Preeclamptic women admitted to our hospital who had been or not under regular care, and also those who were referred from private sectors or primary health centers.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('UBERON_0000178', 'blood', 62, 'blood'), ('GO_0007565', 'female pregnancy', 78, 'preeclamptic')]
PMC2581757	11/2008	S47-PMC2581757	['for this group, 21 women who had developed severe Preeclamptic conditions agreed to donate Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'preeclamptic'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC2581757	11/2008	S50-PMC2581757	['they were always instructed to fast between 9 p.m. till retiring in the night before the Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 89, 'blood')]
PMC2581757	11/2008	S53-PMC2581757	['for at least 2\xa0h before coming for Blood sampling; 8\xa0ml of Venous Blood was collected in edta-treated tubes from the Cubital Vein.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('UBERON_0001638', 'vein', 59, 'venous'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001663', 'cerebral vein', 117, 'cubital vein')]
PMC2581757	11/2008	S55-PMC2581757	['the criteria for dividing women into normotensive and preeclamptic groups have been set at a Blood pressure of 140/90\xa0mmhg or higher, proteinuria and edema.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'blood')]
PMC2581757	11/2008	S70-PMC2581757	['isolation of Erythrocyte and hemolysate preparation\nthe Blood samples were centrifuged at 1000\xa0g for 15\xa0min at 4°c and the isolated Red Cells were washed 4–5 times with 0.154\xa0m Nacl to remove Plasma and buffy Coat.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 13, 'erythrocyte'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CL_0000232', 'erythrocyte', 132, 'red cells'), ('CHEBI_26710', 'sodium chloride', 177, 'NaCl'), ('UBERON_0001969', 'blood plasma', 192, 'plasma'), ('UBERON_0010166', 'coat of hair', 209, 'coat')]
PMC2581757	11/2008	S100-PMC2581757	['results\nthe systolic and diastolic Blood pressures of patients with preeclampsia who were taking or not taking Vitamin supplements were higher (statistically extremely significant p<0.0001) than those of normotensive patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CHEBI_33229', 'vitamin (role)', 111, 'vitamin')]
PMC2582131	11/2008	S36-PMC2582131	['during this period, a total of 953 Pregnant women provided Blood samples and completed interviews.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('UBERON_0000178', 'blood', 59, 'blood')]
PMC2582131	11/2008	S48-PMC2582131	['participants provided a 20 ml non-fasting Blood sample around 16 weeks of Gestation and reported the hours since last Eating at the time of the Blood draw.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0051318', 'G1 phase', 118, 'eating'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC2582131	11/2008	S49-PMC2582131	['immediately after Blood samples were collected, they were fractionated by using standard procedures and stored at −80°c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC2582131	11/2008	S59-PMC2582131	['all reported confidence intervals were calculated at the 95% level and all reported p-values are two-tailed.10.1371/journal.pone.0003753.t001\n\ncaption (table-wrap): table 1\ncharacteristics of study participants according to Gestational diabetes (gdm) case-control status.characteristicsgdm casescontrolsp-value(n\u200a=\u200a57)(n\u200a=\u200a114)n (%)n (%)maternal age at interview (years)34.3±4.8133.1±3.90.09 <35 29 (50.9)72 (63.2)0.12 ≥35 28 (41.1)42 (36.8)maternal race/ethnicity white/non-hispanic 40 (70.2)96 (84.2)0.03 african american 2 (3.5)6 (5.3) others 15 (26.3)12 (10.5)nulliparous27 (47.4)62 (54.4)0.39consumed Prenatal vitamins49 (86.0)105 (92.1)0.21consumed≥2 servings of fish weekly27 (47.4)65 (57.0)0.23consumed≥1 glass of Milk daily22 (38.6)42 (36.8)0.82smoked during Pregnancy3 (5.3)7 (6.1)0.82family history of diabetes mellitus14 (24.6)15 (13.2)0.06physical inactivity during Pregnancy9 (15.8)9 (7.9)0.11pre-Pregnancy body mass index (kg/m2)26.7±7.2123.3±3.80.001pre-Pregnancy body mass index (kg/m2) <25 29 (50.9)84 (73.7)0.003 ≥25 28 (49.1)30 (26.3)Gestational age at Blood collection (weeks)16.3±2.1116.1±2.20.59gestational age at Glucose screening test (weeks)26.9±2.6126.4±2.50.25season of estimated time of conception* (march–may) spring 21 (36.8)42 (36.8)1.00 (june–august) summer 17 (29.8)34 (29.8) (september–november) autumn 13 (22.8)26 (22.8) (december–february) winter 6 (10.5)12 (10.5)Maternal Plasma 25-Hydroxyvitamin D concentrations (ng/ml) mean±sd 24.2±8.5130.1±9.7<0.001\nmean±sd (standard deviation).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 224, 'gestational'), ('GO_0007565', 'female pregnancy', 606, 'Prenatal'), ('UBERON_0001913', 'milk', 722, 'Milk'), ('GO_0007565', 'female pregnancy', 768, 'Pregnancy3'), ('GO_0007565', 'female pregnancy', 879, 'Pregnancy9'), ('GO_0007565', 'female pregnancy', 911, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 970, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 1054, 'Gestational'), ('UBERON_0000178', 'blood', 1073, 'Blood'), ('CHEBI_17234', 'glucose', 1137, 'Glucose'), ('UBERON_0000976', 'humerus', 1401, 'Maternal'), ('UBERON_0001969', 'blood plasma', 1410, 'Plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 1417, '25-Hydroxyvitamin D')]
PMC2639364	2/2009	S1-PMC2639364	['methods the offspring from a maternal Prenatal protein-energy supplementation trial were enrolled into a follow-up study of chronic disease risk factors including Blood pressure.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('UBERON_0000178', 'blood', 163, 'blood')]
PMC2639364	2/2009	S2-PMC2639364	['subjects were 11–17 years of age and Blood pressure was measured in triplicate using an automated monitor (omron 705it).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood')]
PMC2639364	2/2009	S4-PMC2639364	['results there was no difference in Blood pressure between those whose mothers had consumed protein-energy biscuits during Pregnancy and those whose mothers had consumed the same supplement post-partum.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC2639364	2/2009	S5-PMC2639364	['for systolic Blood pressure the intention-to-treat regression coefficient was 0.46 (95% ci: –1.12, 2.04).']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC2639364	2/2009	S6-PMC2639364	['mean systolic Blood pressure for control children was 110.2 (sd ± 9.3) mmhg and for intervention children was 110.8 (sd ± 8.8) mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC2639364	2/2009	S7-PMC2639364	['mean diastolic Blood pressure for control children was 64.7 (sd ± 7.7) mmhg and for intervention children was 64.6 (sd ± 7.6) mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC2639364	2/2009	S30-PMC2639364	["Blood pressure was measured in triplicate using the automated omron 705it device (omron, uk) and following the manufacturer's instructions."]	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2639364	2/2009	S32-PMC2639364	['if the Blood pressure readings on the second visit were within the normal range these new values were entered into the database and used in the analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood')]
PMC2639364	2/2009	S48-PMC2639364	['models were adjusted for covariates relating to Blood pressure but unrelated to supplementation: age, sex, rural or urban location and season of Birth (fitted as fourier terms20).']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007567', 'parturition', 145, 'birth')]
PMC2639364	2/2009	S52-PMC2639364	['we fitted the body composition variables (bmi, % body fat and % Trunk fat) as quartiles to look at any interaction with supplementation on Blood pressure; using a multi-level regression model fitted with the maximum likelihood method.']	N/A	N/A	[('UBERON_0002100', 'trunk', 64, 'trunk'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC2639364	2/2009	S57-PMC2639364	['linear regression models were fitted with factors relating to current Blood pressure: age, sex, % body fat and rural or urban location.']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'blood')]
PMC2639364	2/2009	S64-PMC2639364	['excluded Individuals (from the 1317 recruited) were 46 preterm subjects, three Individuals with implausible Blood pressure readings and one with ambiguity about their treatment allocation.']	N/A	N/A	[('NCBITaxon_1', 'root', 9, 'individuals'), ('NCBITaxon_1', 'root', 79, 'individuals'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC2639364	2/2009	S65-PMC2639364	['mean systolic Blood pressure for boys was 109.9 (sd ± 9.2) mmhg and for girls was 111.1 (sd ± 8.8) mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC2639364	2/2009	S66-PMC2639364	['mean diastolic Blood pressure for boys was 63.9 (sd ± 8.0) mmhg and for girls it was 65.5 (sd ± 7.2) mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC2639364	2/2009	S67-PMC2639364	['caption (table-wrap): table 2\n\ndescriptive data (means and sd in parentheses) for the offspring of the protein-energy supplementation trial, enrolled into the follow-upcontrolinterventionmales ( n = 338)females ( n = 321)males ( n = 321)females ( n = 287)Birth weight (g)2923 (425)2822 (402)3011 (439)2924 (374)Birth length (cm)49.7 (2.2)#3549.1 (2.1)#4149.8 (2.1)#2449.2 (2.1)#37age (y)14.1 (1.5)14.1 (1.5)14.1 (1.5)14.2 (1.5)systolic bp (mmhg)109.4 (9.5)111.0 (8.9)110.5 (8.9)111.1 (8.7)diastolic bp (mmhg)63.7 (8.1)65.8 (7.0)64.2 (7.8)65.2 (7.4)pulse pressure (mmhg)a45.7 (7.4)45.2 (6.5)46.3 (7.0)45.9 (6.5)mean Arterial pressure (mmhg)b78.9 (7.9)80.9 (7.1)79.6 (7.5)80.5 (7.2)height (cm)150.1 (11.0)152.8 (9.4)150.7 (10.5)151.6 (9.2)weight (kg)36.8 (9.0)41.2 (9.7)37.5 (8.0)41.3 (10.5)hazc−1.5 (1.1)−0.8 (1.1)−1.5 (1.1)−1.0 (1.0)bmi z -score−1.6 (1.1)−1.1 (1.2)−1.4 (1.0)−1.0 (1.2)body fat (%)12.6 (3.0)#119.3 (4.3)12.6 (2.8)#619.5 (4.7)#2trunk fat (%)d12.0 (3.0)#114.8 (4.6)#111.9 (2.7)#615.2 (5.0)#3\nacalculated as systolic—diastolic Blood pressure.']	N/A	N/A	[('GO_0007567', 'parturition', 255, 'Birth'), ('GO_0007567', 'parturition', 311, 'Birth'), ('UBERON_0001637', 'artery', 615, 'arterial'), ('UBERON_0000178', 'blood', 1040, 'blood')]
PMC2639364	2/2009	S72-PMC2639364	['intention-to-treat analysis\nthere was no effect of Prenatal compared to Postnatal maternal protein-energy supplementation on either offspring systolic Blood pressure, diastolic Blood pressure, pulse pressure or map in adolescence (table 3).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('GO_0007567', 'parturition', 72, 'postnatal'), ('UBERON_0000178', 'blood', 151, 'blood'), ('UBERON_0000178', 'blood', 177, 'blood')]
PMC2639364	2/2009	S73-PMC2639364	['caption (table-wrap): table 3\n\neffect of maternal supplementation on offspring Blood pressure; intention-to-treat analysisunadjusted regression coefficienta(95% ci) p -valueadjusted regression coefficientb(95% ci) p -valuesystolic (mmhg)0.46 (−1.12, 2.04)0.5700.47 (−1.14, 2.08)0.566diastolic (mmhg)0.09 (−1.31, 1.13)0.890−0.01 (−1.24, 1.23)0.994pulse pressure (mmhg)c0.69 (−0.03, 1.41)0.0600.64 (−0.06, 1.33)0.072map (mmhg)d0.10 (−1.20, 1.40)0.8810.16 (−1.16, 1.48)0.814\nacoefficient from generalised estimating equations (gee) with original village of residence (cluster) modelled as a random effect.']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood')]
PMC2639364	2/2009	S75-PMC2639364	['ccalculated as systolic—diastolic Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood')]
PMC2639364	2/2009	S77-PMC2639364	['there were no interactions between treatment group and age, sex, location (rural or urban) or season of Birth for any of the Blood pressure outcomes (data not shown).']	N/A	N/A	[('GO_0007567', 'parturition', 104, 'birth'), ('UBERON_0000178', 'blood', 125, 'blood')]
PMC2639364	2/2009	S84-PMC2639364	['regression coefficient (error bars = ±2 × se) for the effect of supplementation on systolic Blood pressure is displayed for each quartile of percentage body fat separately\n\nper-protocol analysis\nfor most of the Blood pressure outcomes there remained no association with the intervention when investigated with a per-protocol analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC2639364	2/2009	S90-PMC2639364	['individuals who had been Born in july had lower systolic Blood pressure than Individuals Born during the remainder of the year (figure 3) after adjustment for age, sex, location and current body fat percentage.']	N/A	N/A	[('GO_0007567', 'parturition', 25, 'born'), ('UBERON_0000178', 'blood', 57, 'blood'), ('NCBITaxon_1', 'root', 77, 'individuals'), ('GO_0007567', 'parturition', 89, 'born')]
PMC2639364	2/2009	S91-PMC2639364	['this pattern was not repeated for the other Blood pressure outcomes: season of Birth was unrelated to diastolic Blood pressure, pulse pressure and map (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0007567', 'parturition', 79, 'birth'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC2639364	2/2009	S93-PMC2639364	['middle line represents the variation in systolic Blood pressure with month of Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007567', 'parturition', 78, 'birth')]
PMC2639364	2/2009	S94-PMC2639364	['upper and lower lines represent 95% confidence interval\n\ndiscussion\namongst gambian adolescents aged 11–17 years there was no difference in Blood pressure between those whose mothers had received protein-energy dense biscuits during Pregnancy and those who received the same biscuits during Lactation.']	N/A	N/A	[('UBERON_0000178', 'blood', 140, 'blood'), ('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('GO_0007595', 'lactation', 291, 'lactation')]
PMC2639364	2/2009	S113-PMC2639364	['systolic Blood pressure was lowest for Individuals who were Born in july, and highest for Individuals Born in december and january.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('NCBITaxon_1', 'root', 39, 'individuals'), ('GO_0007567', 'parturition', 60, 'born'), ('NCBITaxon_1', 'root', 90, 'individuals'), ('GO_0007567', 'parturition', 102, 'born')]
PMC2642759	1/2009	S1-PMC2642759	['it results from small Blood clots inducing scarring within csf channels impeding csf circulation.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC2642759	1/2009	S12-PMC2642759	['drainage, irrigation and Fibrinolytic therapy as a way of removing Blood to inhibit progressive Deposition Of Matrix Proteins, permanent Hydrocephalus and Shunt dependency, are invasive and experimental.']	N/A	N/A	[('GO_0042730', 'fibrinolysis', 25, 'fibrinolytic'), ('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0009594', 'detection of nutrient', 96, 'deposition of matrix proteins'), ('GO_0031012', 'extracellular matrix', 110, 'matrix'), ('UBERON_4100114', 'anterior distal condyle of femur', 137, 'hydrocephalus'), ('UBERON_0003037', 'septum', 155, 'shunt')]
PMC2642759	1/2009	S75-PMC2642759	['fluctuations in Cerebral Blood pressure and flow can rupture the primitive germinal Matrix Vessels or lead to infarction of the Metabolically active germinal Matrix.']	N/A	N/A	[('UBERON_0001893', 'telencephalon', 16, 'cerebral'), ('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0031012', 'extracellular matrix', 84, 'matrix'), ('UBERON_0000055', 'vessel', 91, 'vessels'), ('GO_0008152', 'metabolic process', 128, 'metabolically'), ('GO_0031012', 'extracellular matrix', 158, 'matrix')]
PMC2642759	1/2009	S81-PMC2642759	['the germinal Matrix is Metabolically active with a rich supply of Blood via thin, fragile Capillary Networks, supplied by branches of the Anterior Cerebral Artery.']	N/A	N/A	[('GO_0031012', 'extracellular matrix', 13, 'matrix'), ('GO_0008152', 'metabolic process', 23, 'metabolically'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0003479', 'thoracic cavity vein', 90, 'capillary networks'), ('UBERON_0001624', 'anterior cerebral artery', 138, 'anterior cerebral artery')]
PMC2642759	1/2009	S83-PMC2642759	['Venous Blood flows through the terminal Vein, which drains via the Internal Cerebral Vein into the Vein Of Galen [23].']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001638', 'vein', 40, 'vein'), ('UBERON_0000976', 'humerus', 67, 'internal'), ('UBERON_0001663', 'cerebral vein', 76, 'cerebral vein'), ('UBERON_0006666', 'great cerebral vein', 99, 'vein of Galen')]
PMC2642759	1/2009	S87-PMC2642759	['the Autoregulation Of Blood Flow in response to changes in Blood pressure in the germinal matrix circulation is underdeveloped in premature infants, and the thin Microvasculature is susceptible to rupture.']	N/A	N/A	[('GO_0002028', 'regulation of sodium ion transport', 4, 'autoregulation of blood flow'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000178', 'blood', 59, 'blood'), ('UBERON_0002200', 'vasculature of head', 162, 'microvasculature')]
PMC2642759	1/2009	S118-PMC2642759	['a: sagittal scan presenting with bilateral grade iii Intraventricular haemorrhage, with Blood in the caudo-Thalamic groove (arrow).']	N/A	N/A	[('UBERON_0006250', 'infundibular recess of 3rd ventricle', 53, 'intraventricular'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0001391', 'popliteus muscle', 107, 'thalamic')]
PMC2642759	1/2009	S122-PMC2642759	['four grades identified for ivh are\ngrade i or mild haemorrhage is confined to the subependymal germinal matrix with no Blood clot in the Ventricular Lumen.']	N/A	N/A	[('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0011894', 'lumen of vagina', 137, 'ventricular lumen')]
PMC2642759	1/2009	S189-PMC2642759	['they randomly assigned 70 preterm infants who had Gestational ages of 24 to 34 weeks with progressively enlarging Cerebral Ventricles after ivh to two groups, (1) drainage, irrigation, and Fibrinolytic therapy to wash out Blood and cytokines and (2) tapping of Csf by reservoir as required, to control excessive expansion and signs of raised icp (standard treatment).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'gestational'), ('UBERON_0004086', 'brain ventricle', 114, 'cerebral ventricles'), ('GO_0042730', 'fibrinolysis', 189, 'fibrinolytic'), ('UBERON_0000178', 'blood', 222, 'blood'), ('UBERON_0001359', 'cerebrospinal fluid', 261, 'CSF')]
PMC2646054	3/2009	S65-PMC2646054	['after an overnight fast, ldlr−/−Adult offspring were deeply anesthetized with 2% Isoflurane and weighed, Blood was collected by retro-Orbital Sinus puncture, tissues were harvested after Cervical dislocation, and Gonadal Fat Pads were dissected and weighed.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 32, 'adult'), ('CHEBI_6015', 'isoflurane', 81, 'isoflurane'), ('UBERON_0000178', 'blood', 105, 'blood'), ('UBERON_0006318', 'orbitalis muscle', 134, 'orbital sinus'), ('UBERON_0005434', 'cervical region', 187, 'cervical'), ('UBERON_0003428', 'gonadal fat pad', 213, 'gonadal fat pads')]
PMC2646054	3/2009	S71-PMC2646054	['in the second study, Blood samples were taken from females 1–2 weeks Postpartum, while maintaining the same diet they were on during Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('GO_0007565', 'female pregnancy', 69, 'postpartum'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy')]
PMC2646054	3/2009	S76-PMC2646054	['the following morning, fasting Glucose was measured in Blood collected from Saphenous Vein puncture, after which 2 mg/g Glucose load was administered Intraperitoneally.']	N/A	N/A	[('CHEBI_17234', 'glucose', 31, 'glucose'), ('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0007318', 'saphenous vein', 76, 'saphenous vein'), ('CHEBI_17234', 'glucose', 120, 'glucose'), ('UBERON_0000007', 'pituitary gland', 150, 'intraperitoneally')]
PMC2646054	3/2009	S77-PMC2646054	['serial Blood Glucose measurements were performed at 0.5-h intervals over the next 2 h from Saphenous Venipunctures.']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_17234', 'glucose', 13, 'glucose'), ('UBERON_0004110', 'midnasal cavity', 91, 'saphenous venipunctures')]
PMC2646054	3/2009	S78-PMC2646054	['the one touch ultra glucometer (lifescan) was used to measure whole-Blood Glucose concentrations (30).']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_17234', 'glucose', 74, 'glucose')]
PMC2646054	3/2009	S84-PMC2646054	['Mice were fasted overnight, and retro-Orbital Blood was collected under Isoflurane anesthesia.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('UBERON_0001697', 'orbit of skull', 38, 'orbital'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_6015', 'isoflurane', 72, 'isoflurane')]
PMC2670501	4/2009	S78-PMC2670501	['assays\nhormonal analyses were performed at Birth on a mixed Venous and Arterial Cord Blood sample.']	N/A	N/A	[('GO_0007567', 'parturition', 43, 'birth'), ('UBERON_0001638', 'vein', 60, 'venous'), ('UBERON_0002061', 'truncus arteriosus', 71, 'arterial cord'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC2670501	4/2009	S130-PMC2670501	['at Birth, Cord Blood leptin was lower in the fgr group.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002240', 'spinal cord', 10, 'cord'), ('UBERON_0000178', 'blood', 15, 'blood')]
PMC2671035	5/2009	S48-PMC2671035	['Fed Glucose was measured between 9:00a.m.and 11:00a.m.in Tail Vein Blood samples (ascensia elite; bayer, pittsburgh, pa) before Pentobarbital anesthesia (150 mg/kg i.p.)']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Fed'), ('CHEBI_17234', 'glucose', 4, 'glucose'), ('UBERON_0003481', 'tail vein', 57, 'tail vein'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_7983', 'pentobarbital', 128, 'pentobarbital')]
PMC2671035	5/2009	S49-PMC2671035	['and Blood sampling via Cardiac puncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000948', 'heart', 23, 'cardiac')]
PMC2671035	5/2009	S87-PMC2671035	['caption (table-wrap): table 1\n\ngrowth and hormonal data, age 3 weeksc-cc-uu-cu-ubirth weight (g)1.59 ± 0.011.56 ± 0.031.23 ± 0.05*1.09 ± 0.02*†body weight (g)16.4 ± 1.17.7 ± 0.8*‡17.8 ± 0.78.4 ± 0.9*‡body length (cm)7.8 ± 0.16.0 ± 0.2*‡7.7 ± 0.16.2 ± 0.2*‡Gonadal fat weight (g)0.18 ± 0.020.018 ± 0.004*‡0.25 ± 0.03§0.041 ± 0.005*‡Gonadal fat/body weight (%)1.1 ± 0.10.22 ± 0.04*‡1.4 ± 0.1§0.40 ± 0.04*‡sum of Fat Pad weights/body weight (%)#2.8 ± 0.20.5 ± 0.1*‡3.7 ± 0.3§1.2 ± 0.1§Blood Glucose (mmol/l)8.9 ± 0.25.5 ± 0.5§8.2 ± 0.36.1 ± 1.1§Corticosterone (ng/ml)151 ± 18234 ± 14167 ± 21341 ± 63‖¶Insulin (pmol/l)445 ± 70115 ± 35§545 ± 100275 ± 40§t4 (μg/dl)8.7 ± 0.77.1 ± 0.98.8 ± 0.86.1 ± 0.2*†T4 resin binding (%)40.8 ± 1.240.0 ± 1.641.5 ± 1.536.2 ± 1.6*†leptin (ng/dl)6.1 ± 0.40.8 ± 0.2*‡5.9 ± 0.42.0 ± 0.5*‡adiponectin (ng/ml)7.8 ± 1.213.3 ± 4.1*¶5.2 ± 0.98.9 ± 1.1resistin (ng/ml)2.6 ± 0.31.3 ± 0.1*2.0 ± 0.2§1.9 ± 0.3§Il-6 (pg/ml)4.0 ± 0.35.2 ± 0.94.8 ± 1.14.7 ± 0.5Mcp-1 (pg/ml)47 ± 460 ± 836 ± 649 ± 8Pai-1 (ng/ml)4.5 ± 0.45.9 ± 0.2§3.6 ± 0.34.4 ± 0.6Tnf-Α (pg/ml)9.5 ± 0.58.4 ± 0.49.1 ± 0.410.9 ± 1.2\ndata are means ± se.']	N/A	N/A	[('UBERON_0000991', 'gonad', 256, 'Gonadal'), ('UBERON_0000991', 'gonad', 331, 'Gonadal'), ('UBERON_0003916', 'fat pad', 410, 'fat pad'), ('UBERON_0000178', 'blood', 482, 'Blood'), ('CHEBI_17234', 'glucose', 488, 'glucose'), ('CHEBI_16827', 'corticosterone', 542, 'Corticosterone'), ('PR_000045358', 'insulin family protein', 598, 'Insulin'), ('PR_000016190', 'trichohyalin-like protein 1', 697, 'T4'), ('PR_000001470', 'interleukin-28B', 926, 'IL-6'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 973, '5MCP-1'), ('PR_000001890', 'mucin-1', 1010, '8PAI-1'), ('PR_000009167', 'involucrin', 1060, '6TNF-α')]
PMC2672462	4/2009	S33-PMC2672462	['Blood Glucose levels are usually monitored in the fasting state and 1–2 hours after meals.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose')]
PMC2672462	4/2009	S140-PMC2672462	['they were randomized to receive treatment for gdm, including dietary advice, Blood Glucose monitoring, and Insulin as required, or standard Pregnancy care.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_17234', 'glucose', 83, 'glucose'), ('PR_000045358', 'insulin family protein', 107, 'insulin'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC2679409	5/2009	S447-PMC2679409	['Iron (or Iron-Folic Acid) supplementation\n\nbackground\nanaemia is defined as the reduction in the normal number of Red Blood Cells and quantity of haemoglobin in the Blood, defined by the who as haemoglobin <11 g/dl [89].']	N/A	N/A	[('CHEBI_24870', 'ion', 0, 'Iron'), ('CHEBI_24870', 'ion', 9, 'iron'), ('CHEBI_30751', 'formic acid', 14, 'folic acid'), ('CL_0000232', 'erythrocyte', 114, 'red blood cells'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0000178', 'blood', 165, 'blood')]
PMC2679409	5/2009	S647-PMC2679409	['list of abbreviations used\nanc: Antenatal care; ci: confidence interval; enmr: early neonatal mortality rate; fgm: Female Genital Mutilation; hiv: Human immunodeficiency virus; hr: hazard ratio: ipi: interpregnancy interval; iugr: Intrauterine growth restriction; lbw: low Birth weight; loe: level of evidence; nrt: Nicotine replacement therapy; nmr: neonatal mortality rate; ns: nonsignificant; ntd: Neural Tube defect; or: odds ratio; pe: pre-eclampsia; pih: Pregnancy-induced hypertension; pmr: Perinatal mortality rate; rct: randomised controlled trial; rd: risk difference; sb: Stillbirth; sbp: systolic Blood pressure; sbr: stillbirth rate; sga: small for Gestational age; stds: Sexually transmitted diseases; tba: traditional Birth attendant; who: world health organization.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'antenatal'), ('GO_0009560', 'embryo sac egg cell differentiation', 115, 'female genital mutilation'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'human'), ('UBERON_0022293', 'reproductive gland secretion', 231, 'intrauterine'), ('GO_0007567', 'parturition', 273, 'birth'), ('CHEBI_25501', 'neoxanthin', 316, 'nicotine'), ('UBERON_0001049', 'neural tube', 401, 'neural tube'), ('GO_0007565', 'female pregnancy', 461, 'pregnancy'), ('GO_0036268', 'swimming', 498, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 498, 'perinatal'), ('GO_0001966', 'thigmotaxis', 583, 'stillbirth'), ('UBERON_0000178', 'blood', 609, 'blood'), ('GO_0007565', 'female pregnancy', 662, 'gestational'), ('GO_0007565', 'female pregnancy', 685, 'Sexually'), ('GO_0007567', 'parturition', 733, 'birth')]
PMC2685772	4/2009	S37-PMC2685772	['on Gestation week 12, 25 and 33, their body weights were measured in light clothing without shoes on the scale (seca delta, aj medical, stockholm, sweden) and a Blood sample was drawn to estimate Plasma levels of Estradiol and Progesterone.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'gestation'), ('UBERON_0000178', 'blood', 161, 'blood'), ('UBERON_0001969', 'blood plasma', 196, 'plasma'), ('CHEBI_23965', 'estradiol', 213, 'estradiol'), ('CHEBI_17026', 'progesterone', 227, 'progesterone')]
PMC2687585	2/2006	S4-PMC2687585	['we recorded their Birth weight and measured their current anthropometric data, Blood pressure, Lipid profile, homa-ir, and Homa-Β, and compared these parameters among the groups.']	N/A	N/A	[('GO_0007567', 'parturition', 18, 'birth'), ('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_18059', 'lipid', 95, 'lipid'), ('PR_000008689', 'homeobox protein Hox-A13', 123, 'HOMA-β')]
PMC2687585	2/2006	S24-PMC2687585	['diastolic Blood pressure was determined as korotkoff phase v. the mean of the two measurements was used in further analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood')]
PMC2687585	2/2006	S25-PMC2687585	['Blood collection and serological testing\nparticipants fasted from 10 pm to 9 am, at which time Blood samples were collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC2687585	2/2006	S34-PMC2687585	['the physiological characteristics (systolic Blood pressure, diastolic Blood pressure, total Cholesterol, Triglyceride, hdl-Cholesterol, ldl-Cholesterol, fasting Plasma Glucose, insulin, c-peptide, homa-ir, and Homa-Β) were adjusted using a general linear model; the covariates used were age, sex, height, weight, waist circumference, body fat percentage, and tanner stage.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_16113', 'cholesterol', 92, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 105, 'triglyceride'), ('CHEBI_16113', 'cholesterol', 123, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 140, 'cholesterol'), ('UBERON_0001969', 'blood plasma', 161, 'plasma'), ('CHEBI_17234', 'glucose', 168, 'glucose'), ('PR_000008689', 'homeobox protein Hox-A13', 210, 'HOMA-β')]
PMC2687585	2/2006	S42-PMC2687585	['Blood pressure, fasting Plasma Glucose, Insulin, c-peptide, homa-ir, and Homa-Β were not significantly different between males and females.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 24, 'plasma'), ('CHEBI_17234', 'glucose', 31, 'glucose'), ('PR_000045358', 'insulin family protein', 40, 'insulin'), ('PR_000008689', 'homeobox protein Hox-A13', 73, 'HOMA-β')]
PMC2704503	6/2007	S21-PMC2704503	['Cerebrospinal Fluid (csf) studies, including cytology, gram stain, culture, cryptococcus Antigen, and stain for Acid-fast bacilli, were normal (protein = 32; Glucose = 69; Leukocytes = 2; 92% Lymphocytes; Red Blood Cells [Rbc] = 1).']	N/A	N/A	[('UBERON_0001359', 'cerebrospinal fluid', 0, 'Cerebrospinal fluid'), ('CHEBI_59132', 'antigen', 89, 'antigen'), ('CHEBI_37527', 'acid', 112, 'acid'), ('CHEBI_17234', 'glucose', 158, 'glucose'), ('CL_0000738', 'leukocyte', 172, 'leukocytes'), ('CL_0000542', 'lymphocyte', 192, 'lymphocytes'), ('CL_0000232', 'erythrocyte', 205, 'red blood cells'), ('UBERON_0000178', 'blood', 209, 'blood'), ('CL_0000232', 'erythrocyte', 222, 'RBC')]
PMC2704503	6/2007	S37-PMC2704503	['her systolic Blood pressure ranged from 104 to 137 mm of mercury (mmhg) and the diastolic from 55 to 60 mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC2707610	7/2009	S75-PMC2707610	['Blood samples were taken at 15, 30, 60, and 90 minutes to monitor Glucose.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 66, 'glucose')]
PMC2707610	7/2009	S79-PMC2707610	['after measurement of Naso-Anal (n-a) length, Blood was collected by Cardiac puncture and Blood Glucose was measured immediately.']	N/A	N/A	[('UBERON_0000004', 'nose', 21, 'naso'), ('UBERON_0001245', 'anus', 26, 'anal'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0000948', 'heart', 68, 'cardiac'), ('UBERON_0000178', 'blood', 89, 'blood'), ('CHEBI_17234', 'glucose', 95, 'glucose')]
PMC2707610	7/2009	S105-PMC2707610	['fat and Organ weights, Blood and Plasma hormone concentrations, mrna Expression in all Tissues were analyzed using factorial anova, if the data were normally distributed.']	N/A	N/A	[('UBERON_0000062', 'organ', 8, 'organ'), ('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('GO_0010467', 'gene expression', 69, 'expression'), ('UBERON_0000479', 'tissue', 87, 'tissues')]
PMC2707610	7/2009	S155-PMC2707610	['Glucose Homeostasis in offspring\nfasting Blood Glucose was at similar higher levels in all hfd-Fed groups (p<0.001, hfd effect).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('GO_0043062', 'extracellular structure organization', 0, 'Glucose homeostasis'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_17234', 'glucose', 47, 'glucose'), ('GO_0007631', 'feeding behavior', 95, 'fed')]
PMC2717130	7/2009	S3-PMC2717130	['Blood and Hair were collected at delivery and analyzed for Arsenic using inductively coupled Plasma mass spectrometry with dynamic reaction cell.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001037', 'strand of hair', 10, 'hair'), ('CHEBI_27563', 'arsenic atom', 59, 'arsenic'), ('UBERON_0001969', 'blood plasma', 93, 'plasma')]
PMC2717130	7/2009	S6-PMC2717130	['adjusting for age, native-american race, Prepregnancy body mass index, medicaid use, and marital status, women in the highest quartile of Blood Arsenic exposure had 2.8 higher odds of impaired gtt than women in the lowest quartile of exposure (95% confidence interval, 1.1–6.9) ( p -trend = 0.008).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'prepregnancy'), ('UBERON_0000178', 'blood', 138, 'blood'), ('CHEBI_27563', 'arsenic atom', 144, 'arsenic')]
PMC2717130	7/2009	S52-PMC2717130	['participants who were missing information on Blood Arsenic ( n = 23) or Blood Glucose ( n = 34) were excluded, leaving a total of 532 women included in this analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27563', 'arsenic atom', 51, 'arsenic'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_17234', 'glucose', 78, 'glucose')]
PMC2717130	7/2009	S55-PMC2717130	['laboratory measurements\nmaternal Blood and Hair samples were collected at Delivery (± 12 hr) and analyzed for total Arsenic concentration at the hsph trace metals laboratory (boston, ma).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0001037', 'strand of hair', 43, 'hair'), ('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27563', 'arsenic atom', 116, 'arsenic')]
PMC2717130	7/2009	S63-PMC2717130	['whole Blood was collected in Trace Element–free tubes [bd vacutainer royal blue top, Venous Blood collection tubes with k2edta #368381 (becton dickinson, franklin lakes, nj)].']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 29, 'trace element'), ('UBERON_0001638', 'vein', 85, 'venous'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC2717130	7/2009	S64-PMC2717130	['one milliliter of Blood was transferred into a 15-ml plastic tube, digested with 2 ml concentrated hno3acid (optima, seastar chemical co., pittsburgh, pa) for 24 hr, and then diluted to 10 ml with deionized Water after adding 1 ml 30% Hydrogen Peroxide (ultrex ultrapure Reagents, j.t.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_15377', 'water', 207, 'water'), ('CHEBI_16240', 'hydrogen peroxide', 235, 'hydrogen peroxide'), ('CHEBI_33893', 'reagent', 271, 'Reagents')]
PMC2717130	7/2009	S69-PMC2717130	['the limit of detection for Blood Arsenic was 0.2 μg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27563', 'arsenic atom', 33, 'arsenic')]
PMC2717130	7/2009	S70-PMC2717130	['quality control measures for both Blood and Hair included analysis of the following: an initial calibration verification standard [national institute of standard and technology (nist; gaithersburg, md) standard reference material #1643e (trace elements in Water)]; a Solution of 1 ng/ml standard Solution of Arsenic (nist traceable); continuous calibration standards; procedural blanks; and certified reference material gbw-07601 (Human Hair; institute of geophysical and geochemical exploration, langfang, china).']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001037', 'strand of hair', 44, 'hair'), ('CHEBI_15377', 'water', 256, 'water'), ('CHEBI_75958', 'solution', 267, 'solution'), ('CHEBI_75958', 'solution', 296, 'solution'), ('CHEBI_27563', 'arsenic atom', 308, 'arsenic'), ('NCBITaxon_9606', 'Homo sapiens', 431, 'human'), ('UBERON_0001037', 'strand of hair', 437, 'hair')]
PMC2717130	7/2009	S74-PMC2717130	['samples with Blood Arsenic concentration < 0.2 μg/l ( n = 4; 0.7%), Hair Arsenic concentration < 0.2 ng/g ( n = 4; 2%), or insufficient sample weight for analysis ( n = 18; 10%) were reported as less than the limit of detection and not included in the analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_27563', 'arsenic atom', 19, 'arsenic'), ('UBERON_0001037', 'strand of hair', 68, 'hair'), ('CHEBI_27563', 'arsenic atom', 73, 'arsenic')]
PMC2717130	7/2009	S75-PMC2717130	['maternal Blood (Plasma) Glucose was measured at a Prenatal visit between 24 and 28 weeks Gestation after a 1-hr, 50-g oral Glucose tolerance test (gtt) as part of routine Prenatal care (acog 2001), and results were obtained from the medical record.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_17234', 'glucose', 24, 'glucose'), ('GO_0007565', 'female pregnancy', 50, 'prenatal'), ('GO_0007565', 'female pregnancy', 89, 'gestation'), ('CHEBI_17234', 'glucose', 123, 'glucose'), ('GO_0007565', 'female pregnancy', 171, 'prenatal')]
PMC2717130	7/2009	S97-PMC2717130	['Hair Arsenic concentration, available on a subset of participants, ranged from 1.1 to 724.4 ng/g (ppb) ( n = 180; mean 27.4 ± 61.6) and was not significantly correlated with Blood Glucose level (spearman’s rho = 0.04; p = 0.6).']	N/A	N/A	[('UBERON_0001037', 'strand of hair', 0, 'Hair'), ('CHEBI_27563', 'arsenic atom', 5, 'arsenic'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_17234', 'glucose', 180, 'glucose')]
PMC2717130	7/2009	S98-PMC2717130	['among the subset of women with both exposure bio-markers available ( n = 179), Blood and Hair Arsenic levels were not significantly correlated with each other (spearman’s rho = −0.13; p = 0.08).']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0001037', 'strand of hair', 89, 'hair'), ('CHEBI_27563', 'arsenic atom', 94, 'arsenic')]
PMC2717130	7/2009	S101-PMC2717130	['using a more sensitive screening criterion (Blood Glucose > 130 mg/dl), > 20% had impaired gtt results.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_17234', 'glucose', 50, 'glucose')]
PMC2717130	7/2009	S103-PMC2717130	['in multivariate analyses ( n = 456), adjusting for age, native-american race/ethnicity, Prepregnancy bmi, medicaid use, and marital status, women in the highest quartile of Blood Arsenic exposure had 2.79 higher odds of impaired gtt (> 140 mg/dl) than women in the lowest quartile of exposure [95% confidence interval (ci), 1.13–6.87] (table 2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 88, 'prepregnancy'), ('UBERON_0000178', 'blood', 173, 'blood'), ('CHEBI_27563', 'arsenic atom', 179, 'arsenic')]
PMC2717130	7/2009	S105-PMC2717130	['using the more sensitive criterion (> 130 mg/dl), women in the highest quartile of Blood Arsenic exposure had 2.35 higher odds of impaired gtt (> 130 mg/dl) than women in the lowest quartile of exposure (95% ci, 1.18–4.69) ( p -trend = 0.006).']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_27563', 'arsenic atom', 89, 'arsenic')]
PMC2722408	7/2009	S20-PMC2722408	['exposing fetal Rats to high levels of Glucocorticoids reduces Birth weight and results in Adults with high Blood levels of Insulin and Glucose.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 15, 'rats'), ('CHEBI_36597', 'phthalazine', 38, 'glucocorticoids'), ('GO_0007567', 'parturition', 62, 'birth'), ('UBERON_0007023', 'adult organism', 90, 'adults'), ('UBERON_0000178', 'blood', 107, 'blood'), ('PR_000045358', 'insulin family protein', 123, 'insulin'), ('CHEBI_17234', 'glucose', 135, 'glucose')]
PMC2722408	7/2009	S26-PMC2722408	['the offspring are hypertensive, show vascular changes, and have high Blood Insulin levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('PR_000045358', 'insulin family protein', 75, 'insulin')]
PMC2722583	1/2009	S43-PMC2722583	['anthropometry and Blood samples were collected from participants during village visits\n\nsample size\nmean recruitment haemoglobin for the pmmst study was 11.7 g/dl, (sd 1.5 g/dl) for a population of 1156.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC2722583	1/2009	S55-PMC2722583	['Venous Blood was placed in edta, sedivette and Serum tubes (sarstedt monovette, uk).']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001977', 'blood serum', 47, 'serum')]
PMC2722583	1/2009	S59-PMC2722583	['laboratory analysis\nhaematological analysis included haemoglobin concentration, White Blood Cell count, mean cell volume (mcv), mean cell haemoglobin (mch), Reticulocyte count (cel-dyn 3700 analyser, abbott diagnostics, usa and medonic ca530, clinical diagnostic solutions, inc., usa), and Zinc Protoporphyrin concentration (znpp) (aviv zp hematofluorometer model 206, analis scientific instruments, belgium).']	N/A	N/A	[('CL_0000738', 'leukocyte', 80, 'white blood cell'), ('UBERON_0000178', 'blood', 86, 'blood'), ('CL_0000558', 'reticulocyte', 157, 'reticulocyte'), ('CHEBI_33340', 'zinc group element atom', 290, 'zinc'), ('CHEBI_15430', 'protoporphyrin', 295, 'protoporphyrin')]
PMC2722583	1/2009	S61-PMC2722583	['malaria Blood films were prepared and stained with giemsa stain and 100 microscopic fields examined to determine parasite count.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood')]
PMC2722583	1/2009	S63-PMC2722583	['both cell-dyn and medonic ca530 analysers were used for processing of Haematological samples due to a technical fault with the cell-dyn machine.']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'haematological')]
PMC2722583	1/2009	S78-PMC2722583	['there were no differences in Haematological parameters.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'haematological')]
PMC2724426	7/2009	S34-PMC2724426	['women were excluded if they had any of the following: significant complications of Pregnancy; acute or chronic illness or diseases; any hematological disorders; any conditions that would interfere with the absorption, Metabolism or Excretion Of Iron or Folic Acid; on Antibiotic therapy; known or suspected allergies to supplement ingredients; anemia (hb<110 g/l) or elevated hemoglobin (= 144 g/l) or a Blood transfusion 3 months prior to enrollment.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0008152', 'metabolic process', 218, 'metabolism'), ('GO_0006881', 'extracellular sequestering of iron ion', 232, 'excretion of iron'), ('CHEBI_30751', 'formic acid', 253, 'folic acid'), ('GO_0007631', 'feeding behavior', 253, 'folic acid'), ('CHEBI_33282', 'antibacterial agent', 268, 'antibiotic'), ('UBERON_0000178', 'blood', 404, 'blood')]
PMC2724426	7/2009	S57-PMC2724426	['during each assessment an indwelling intravenous catheter was inserted and six Venous Blood samples (5 ml each) were drawn at 0, 1, 2, 3, 4 and 8 hours after supplement ingestion.']	N/A	N/A	[('UBERON_0001638', 'vein', 79, 'venous'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC2724426	7/2009	S58-PMC2724426	['Blood samples were collected without and with the Anticoagulant edta for latter determination of iron and Folate biochemical indices, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_50249', 'anticoagulant', 50, 'anticoagulant'), ('CHEBI_30863', '5-azaorotic acid', 106, 'folate')]
PMC2724426	7/2009	S60-PMC2724426	['Serum and Plasma were separated from whole Blood by centrifugation (1500 rpm for 15 min at 4°c).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0001969', 'blood plasma', 10, 'plasma'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC2724426	7/2009	S68-PMC2724426	['supplements were taken with a standardized morning snack, consisting of oatmeal cookies, apple sauce and juice, after the first Blood draw.']	N/A	N/A	[('UBERON_0000178', 'blood', 128, 'blood')]
PMC2724426	7/2009	S77-PMC2724426	['hb concentration was determined directly from capillary Blood via Finger prick and measured using a portable hemocue b-hb photometer (hemocue, angelholm, sweden) by the trained study coordinator using standardized techniques.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0002389', 'manual digit', 66, 'finger')]
PMC2724426	7/2009	S78-PMC2724426	['initial Blood samples on the first assessment day were used to determine Serum ferritin concentration and Serum Transferrin Receptor (Stfr) for overall hematological status.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('PR_000001679', 'trace amine-associated receptor 5', 112, 'transferrin receptor'), ('PR_000015619', 'sorcin', 134, 'sTfR')]
PMC2724426	7/2009	S91-PMC2724426	['a whole Blood Folate standard prepared by the national institutes for biological standards and control (nibsc code 95/528, certified content of 29.51 nmol/l (13 ng/ml), nibsc hertfordshire en6 3qg united kingdom) was used to assess the accuracy and precision of the Folate bioassay (a Plasma folate certified standard does not exist).']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 14, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 266, 'folate'), ('UBERON_0001969', 'blood plasma', 285, 'plasma')]
PMC2724426	7/2009	S92-PMC2724426	['the overall inter-assay coefficient of variation for the whole Blood Folate standard was 9.1% with a mean value of 32.2 ± 2.9 nmol/l (14.2 ± 1.3 ng/ml).']	N/A	N/A	[('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate')]
PMC2726293	9/2009	S50-PMC2726293	['Femoral Artery catheterization surgery\nat approximately p70 a subset of the Rats was implanted with a catheter in the left Femoral Artery for Blood sampling as has been previously described (spencer et al., 2005a).']	N/A	N/A	[('UBERON_0001530', 'common carotid artery plus branches', 0, 'Femoral artery'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 76, 'rats'), ('UBERON_0002060', 'femoral artery', 123, 'femoral artery'), ('UBERON_0000178', 'blood', 142, 'blood')]
PMC2726293	9/2009	S55-PMC2726293	['stressor setup, application and Blood sampling\non the day of the stressor experiment, the Rats (15 males from 5 sl and 3 ll and 18 females from 6 sl and 2 ll) were brought into the testing room at 07:00\xa0h and allowed 2\xa0h to acclimatize to the room.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rats')]
PMC2726293	9/2009	S56-PMC2726293	['a baseline Blood sample was taken immediately prior to the 15\xa0min restraint stress (restraint of the Rat in a ventilated perspex tube, 7\xa0cm in diameter, 24\xa0cm in length, with an adjustable restraining length between 10 and 18\xa0cm).']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 101, 'rat')]
PMC2726293	9/2009	S57-PMC2726293	['at the end of the restraint period, catheters were attached to a syringe outside the cage to allow Blood sampling without further handling.']	N/A	N/A	[('UBERON_0000178', 'blood', 99, 'blood')]
PMC2726293	9/2009	S58-PMC2726293	['Blood samples (0.4\xa0ml, immediately replaced with an equal volume of heparinized saline) were collected immediately prior to and 30 and 60\xa0min after onset of the stressor.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2726293	9/2009	S59-PMC2726293	['Blood samples were kept on ice until the end of the experiment, when they were centrifuged and the Plasma aliquots stored at −20\xa0°c until assayed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 99, 'plasma')]
PMC2727050	8/2009	S4-PMC2727050	['Pubertal age was monitored and Blood samples collected in Adulthood for Endocrine analyses.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Pubertal'), ('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0000113', 'post-juvenile adult stage', 58, 'adulthood'), ('GO_0006397', 'mRNA processing', 72, 'endocrine')]
PMC2727050	8/2009	S139-PMC2727050	['Blood was collected into heparinised vacutainer tubes and stored on ice until centrifugation and removal of Plasma for analysis.10.1371/journal.pone.0006744.t002\n\ncaption (table-wrap): table 2\ndescription of Early Life nutrition and offspring groups.pre-Pregnancypregnancylactationoffspring Postnatal dietgroup (sample size)100% control dietcontrolcont (18)high fatcont+hf (16)100% control diet50% control diet100% control dietcontrolunp (14)high fatunp+hf (14)100% control diet50% control dietcontrolunl (12)high fatunl+hf (12)100% control diet50% control dietcontrolunpl (12)high fatunpl+hf (12)100% control diet100% high fat dietcontrolplhf (16)high fatplhf+hf (16)100% high fat dietcontrolmhf (16)high fatmhf+hf (16)\n\nestrous staging in Adult offspring\nin order to assess stage of Estrous Cycle in Adult offspring, Vaginal smears were collected at the time of post mortem after pentobarbitone injection prior to decapitation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 108, 'plasma'), ('UBERON_0001847', 'lobule of pinna', 208, 'early life'), ('GO_0060685', 'regulation of prostatic bud formation', 254, 'pregnancyPregnancyLactationOffspring'), ('GO_0007567', 'parturition', 291, 'Postnatal'), ('UBERON_0007023', 'adult organism', 741, 'Adult'), ('GO_0044849', 'estrous cycle', 785, 'estrous cycle'), ('UBERON_0007023', 'adult organism', 802, 'adult'), ('UBERON_0001987', 'placenta', 819, 'vaginal')]
PMC2756957	10/2009	S97-PMC2756957	['(0.5 g.kg−1) and Blood samples collected for measurement of Plasma Glucose and Insulin (by elisa, seemethods).']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001969', 'blood plasma', 60, 'plasma'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('PR_000045358', 'insulin family protein', 79, 'insulin')]
PMC2756957	10/2009	S138-PMC2756957	['assessment of Metabolic flexibility in the lean and obese state\n\nbaseline\nfasted Blood biochemistry when lean and obese are given intable s2.']	N/A	N/A	[('GO_0008152', 'metabolic process', 14, 'metabolic'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC2756957	10/2009	S213-PMC2756957	['the obese Individual, in response to elevated Blood Glucose, responded with markedly blunted excursions in Plasma Metabolites and biochemistry (table 3for Plasma biochemistry and supplementaryfigure s5for nefa).']	N/A	N/A	[('NCBITaxon_1', 'root', 10, 'individual'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_17234', 'glucose', 52, 'glucose'), ('UBERON_0001969', 'blood plasma', 107, 'plasma'), ('CHEBI_25212', 'metabolite', 114, 'metabolites'), ('UBERON_0001969', 'blood plasma', 155, 'plasma')]
PMC2756957	10/2009	S250-PMC2756957	['experimental protocols\n\nGlucose tolerance test\nafter 24 h fasting, Blood (5 ml) was withdrawn into a K+edta Blood tube at −10 and −5 min relative to injection of a bolus dose of Glucose Solution (i.v.']	N/A	N/A	[('CHEBI_17234', 'glucose', 24, 'Glucose'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_52071', 'dextran', 101, 'K'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_17234', 'glucose', 178, 'glucose'), ('CHEBI_75958', 'solution', 186, 'solution')]
PMC2756957	10/2009	S252-PMC2756957	['subsequent Blood samples (2 ml) were collected at 10, 20, 30, 60, 90 and 120 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood')]
PMC2756957	10/2009	S253-PMC2756957	['whole Blood was centrifuged (800 g for 10 mins at 4°c) and Plasma collected and frozen at −20°c for further analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma')]
PMC2756957	10/2009	S255-PMC2756957	['the dose of Insulin given is designed to reduce resting Plasma Glucose by ∼1–1.5 mm over a 15–16 min period and from this the percentage decline in Blood Glucose concentration per minute (%min−1) from 4 to 16 min relative to baseline (0 and 2 mins) is calculated[60].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 12, 'insulin'), ('UBERON_0001969', 'blood plasma', 56, 'plasma'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('UBERON_0000178', 'blood', 148, 'blood'), ('CHEBI_17234', 'glucose', 154, 'glucose')]
PMC2756957	10/2009	S257-PMC2756957	['Blood samples (2 ml) were collected into K+edta Blood tubes at 2, 4, 6, 8, 10, 12, 14 and 16 minutes later.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_52071', 'dextran', 41, 'K'), ('UBERON_0000178', 'blood', 48, 'blood')]
PMC2756957	10/2009	S258-PMC2756957	['whole Blood was centrifuged (800 g for 10 mins at 4°c) and Plasma collected and frozen at −20°c for further analysis of Plasma Metabolites.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('UBERON_0001969', 'blood plasma', 120, 'plasma'), ('CHEBI_25212', 'metabolite', 127, 'metabolites')]
PMC2756957	10/2009	S272-PMC2756957	['assays of Blood and Plasma\n\nBlood biochemistry\nduring each gtt, baseline (−10 min) and +120 min whole Blood samples were auto-analysed for concentrations of Glucose, K+,Na+, Ca2+, Cl−(mmol.l−1) ph, p Co2, p O2, and Hco3−(mmhg; abl805-flex, radiometer, crawley, uk), subsequently, all gtt Plasma samples were assayed for concentrations (mmol.l−1) of Glucose, Urea, Triacylglycerides (Tag), Glycerol (µmol.l−1) and non-esterified Fatty Acids (nefas) whilst baseline samples were also analysed for concentrations of amino acids (nmoles.ml−1), Cholesterol, hdl, ldl, Glycerol (all mmol.l−1and by randox rx imola, co antrim, uk), haemoglobin (g/dl; osm3, radiometer, crawley, uk) and haematocrit (%).']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001969', 'blood plasma', 20, 'plasma'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_17234', 'glucose', 157, 'glucose'), ('CHEBI_30050', 'gold(0)', 166, 'K+,'), ('CHEBI_26710', 'sodium chloride', 169, 'Na+,'), ('CHEBI_3312', 'calcium dichloride', 174, 'Ca2+,'), ('CHEBI_16236', 'ethanol', 180, 'Cl−('), ('CHEBI_16526', 'carbon dioxide', 200, 'CO2'), ('CHEBI_15379', 'dioxygen', 207, 'O2'), ('CHEBI_37566', 'S-beta-D-glucosyl-L-cysteine', 215, 'HCO3−('), ('UBERON_0001969', 'blood plasma', 288, 'plasma'), ('CHEBI_17234', 'glucose', 349, 'glucose'), ('CHEBI_16199', 'urea', 358, 'urea'), ('CHEBI_17855', 'triglyceride', 364, 'triacylglycerides'), ('CHEBI_17855', 'triglyceride', 383, 'TAG'), ('CHEBI_17754', 'glycerol', 389, 'glycerol'), ('CHEBI_35366', 'fatty acid', 428, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 540, 'cholesterol'), ('CHEBI_17754', 'glycerol', 563, 'glycerol')]
PMC2756957	10/2009	S313-PMC2756957	['caption (supplementary-material): table s2\n\nbaseline Blood biochemistry in lean and obese Adult Sheep.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0007023', 'adult organism', 90, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 96, 'sheep')]
PMC2756957	10/2009	S314-PMC2756957	['the change in resting Blood biochemistry from a lean to obese state as measdured on an abl-800flex (radiometer ltd, uk).']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC2798111	12/2010	S64-PMC2798111	['laboratory measurements\nfor this component of the study, circulating 25(Oh)D3Was measured in ng/ml in infant Blood samples by established methods [30] in the laboratory of dr. bruce hollis, musc.']	N/A	N/A	[('CHEBI_73386', 'Ala-Val-Asp-Ser', 69, '25(OH)D3was'), ('PR_000027795', 'trypsin', 69, '25(OH)D3was'), ('UBERON_0000178', 'blood', 109, 'blood')]
PMC2817394	1/2010	S18-PMC2817394	['optimizing Uteroplacental Blood flow with the use of inhalational Anesthetic Agents and Uterine tocolytics allows for the maintenance of fetal oxygenation.']	N/A	N/A	[('UBERON_0012469', 'external anal region', 11, 'uteroplacental'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_51231', 'DAPI', 66, 'anesthetic agents'), ('UBERON_0000995', 'uterus', 88, 'uterine')]
PMC2817394	1/2010	S48-PMC2817394	['a type and cross for four units of packed Red Blood Cells were obtained, and the Blood products were brought to the operating room.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 42, 'red blood cells'), ('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC2817394	1/2010	S93-PMC2817394	['the average Blood loss was 848\u2009ml [3].']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC2821904	2/2010	S34-PMC2821904	['in all cases offspring were studied Postnatally for alterations in Agtr1B Expression and Dna Methylation at 1 week of Life and at 4 weeks for Blood pressure.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'postnatally'), ('PR_000003570', 'ATP-binding cassette sub-family G member 1', 67, 'Agtr1b'), ('GO_0010467', 'gene expression', 74, 'expression'), ('GO_0006306', 'DNA methylation', 89, 'DNA methylation'), ('UBERON_0000104', 'life cycle', 118, 'life'), ('UBERON_0000178', 'blood', 142, 'blood')]
PMC2821904	2/2010	S37-PMC2821904	['offspring were weaned onto standard laboratory Chow and Blood pressure was measured at four weeks of age.']	N/A	N/A	[('CHEBI_33290', 'food', 47, 'chow'), ('UBERON_0000178', 'blood', 56, 'blood')]
PMC2821904	2/2010	S131-PMC2821904	['Blood pressure determination\nsystolic Blood pressure was determined using an iitc model 229 Blood pressure monitor as reported previously[16],[23],[25].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000178', 'blood', 92, 'Blood')]
PMC2821904	2/2010	S136-PMC2821904	['Blood pressure, which was determined in triplicate for each Animal, was derived using a preset algorithm via appropriate software.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 60, 'animal')]
PMC2825514	1/2010	S40-PMC2825514	['Blood (200 μl) was collected from the Aorta in heparinised vials.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000947', 'aorta', 38, 'aorta')]
PMC2825514	1/2010	S43-PMC2825514	['additionally and for the other Animals, Venous Blood was collected from the Saphenous Vein prior sacrifice for Metabolite analyses.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 31, 'animals'), ('UBERON_0001638', 'vein', 40, 'venous'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0007318', 'saphenous vein', 76, 'saphenous vein'), ('CHEBI_39382', 'flufenoxuron', 111, 'metabolite')]
PMC2825514	1/2010	S61-PMC2825514	['the assay was performed with Serum or Plasma obtained after collection of Blood samples on edta.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC2831512	3/2010	S34-PMC2831512	['however, Otoscopic examination of the left External Auditory Canal revealed minimal dark Blood and 1\u2009cm superficial thrombus blocked a clear view of the Eardrum.']	N/A	N/A	[('UBERON_0002280', 'otolith', 9, 'otoscopic'), ('UBERON_2001617', 'trunk sensory canal', 43, 'external auditory canal'), ('GO_0007605', 'sensory perception of sound', 52, 'auditory'), ('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0002364', 'tympanic membrane', 153, 'eardrum')]
PMC2831512	3/2010	S65-PMC2831512	['as this case illustrates, comanagement with an Otolaryngologist is helpful for any Pregnant or Post-Partum patient with Blood observed in the Ear Canal, or whenever subjective change in Hearing is noted.']	N/A	N/A	[('UBERON_0003684', 'abdominal cavity', 47, 'otolaryngologist'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('GO_0007567', 'parturition', 95, 'post'), ('GO_0007567', 'parturition', 100, 'partum'), ('UBERON_0000178', 'blood', 120, 'blood'), ('UBERON_0001352', 'external acoustic meatus', 142, 'ear canal'), ('GO_0007605', 'sensory perception of sound', 186, 'hearing')]
PMC2841444	2/2010	S140-PMC2841444	['undernourished Pregnant women consume less Vitamins and Minerals in their diets and have reduced Blood volume and decreased Uterine Blood flow [49].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_33277', 'gamma-tocotrienol', 43, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 56, 'minerals'), ('UBERON_0000178', 'blood', 97, 'blood'), ('UBERON_0000995', 'uterus', 124, 'uterine'), ('UBERON_0000178', 'blood', 132, 'blood')]
PMC2841444	2/2010	S415-PMC2841444	['benefits of delayed Cord clamping included higher circulating Blood volume during the first 24 hours of Life, less need for Blood transfusions and lower incidence of Intraventricular hemorrhage (rr= 0.53, 95% ci= 0.35 - 0.79).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('UBERON_0000178', 'blood', 124, 'blood'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 166, 'intraventricular')]
PMC2849017	9/2007	S5-PMC2849017	['prior to Folic Acid fortification of the Food supply in canada, the Folate intakes of women were low, and their Blood Folate concentrations while not sufficiently low to produce overt signs of Folate deficiency (eg.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 9, 'folic acid'), ('CHEBI_33290', 'food', 41, 'food'), ('CHEBI_30863', '5-azaorotic acid', 68, 'folate'), ('UBERON_0000178', 'blood', 112, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 118, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 193, 'folate')]
PMC2849017	9/2007	S128-PMC2849017	['among women who do not consume a Folic Acid supplement during either Pregnancy or Lactation, one can expect a further decline in Blood Folate concentrations immediately post-Partum (houghton et al., 2006;mackey & picciano, 1999;qvist et al., 1986).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 33, 'folic acid'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007595', 'lactation', 82, 'lactation'), ('UBERON_0000178', 'blood', 129, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 135, 'folate'), ('GO_0007567', 'parturition', 174, 'partum')]
PMC2849017	9/2007	S150-PMC2849017	['typically Individuals that are homozygous for the mthfr c677t variant, exhibit reduced Folate status as measured by Red Blood Cell Folate concentration (parle-mcdermott et al., 2006).']	N/A	N/A	[('NCBITaxon_1', 'root', 10, 'individuals'), ('CHEBI_30863', '5-azaorotic acid', 87, 'folate'), ('CL_0000232', 'erythrocyte', 116, 'red blood cell'), ('UBERON_0000178', 'blood', 120, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 131, 'folate')]
PMC2849017	9/2007	S171-PMC2849017	['in a retrospective review of Red Blood Cell concentrations (n=8,884) from a large laboratory database (mds laboratories), ray et al.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 29, 'red blood cell'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC2849017	9/2007	S238-PMC2849017	['in the first Trimester of Pregnancy, lee reported the Red Blood Cell Folate concentration of women not Consuming a Folic Acid-containing supplement to be 613+152 nmol/l.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 13, 'trimester'), ('GO_0007565', 'female pregnancy', 26, 'pregnancy'), ('CL_0000232', 'erythrocyte', 54, 'red blood cell'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate'), ('GO_0007631', 'feeding behavior', 103, 'consuming'), ('CHEBI_30751', 'formic acid', 115, 'folic acid')]
PMC2850511	4/2010	S48-PMC2850511	['conditions that can produce fetal or neonatal hypoxia include maternal-fetal genotype incompatibilities at Genes that produce Red Blood Cell Antigens, such as the rhd locus.']	N/A	N/A	[('SO_0000704', 'gene', 107, 'genes'), ('CL_0000232', 'erythrocyte', 126, 'red blood cell'), ('UBERON_0000178', 'blood', 130, 'blood'), ('CHEBI_59132', 'antigen', 141, 'antigens')]
PMC2850511	4/2010	S49-PMC2850511	['the rhd Gene produces a Red Blood Cell Antigen called the rhesus d factor.']	N/A	N/A	[('SO_0000704', 'gene', 8, 'gene'), ('CL_0000232', 'erythrocyte', 24, 'red blood cell'), ('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_59132', 'antigen', 39, 'antigen')]
PMC2850511	4/2010	S50-PMC2850511	['an Individual who is determined to be rhesus d positive has Red Blood Cells (Rbcs) with this Antigen, while someone classified as rhesus d negative lacks this Antigen [48].']	N/A	N/A	[('NCBITaxon_1', 'root', 3, 'individual'), ('CL_0000232', 'erythrocyte', 60, 'red blood cells'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CL_0000232', 'erythrocyte', 77, 'RBCs'), ('CHEBI_59132', 'antigen', 93, 'antigen'), ('CHEBI_59132', 'antigen', 159, 'antigen')]
PMC2850511	4/2010	S81-PMC2850511	['abo maternal-fetal genotype incompatibility occurs when a Pregnant woman has type o Blood and her Fetus has type a or b [48].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 58, 'pregnant'), ('UBERON_0000178', 'blood', 84, 'blood'), ('UBERON_0000312', 'inner cambium layer of periosteum', 98, 'fetus')]
PMC2880107	5/2010	S41-PMC2880107	['Blood was collected, centrifuged for 15 mins at 1500 × g at 4°c and stored at -20°c for further analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2888390	6/2010	S98-PMC2888390	['these include the sodium-dependent high affinity uptake transporter, which is predominantly Expressed by Adult Neurons, the Choline-like transporter, which is sodium-independent and low affinity and Expressed by cells throughout the body, and the Blood-Brain Barrier transporter.']	N/A	N/A	[('GO_0010467', 'gene expression', 92, 'expressed'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('CL_0000540', 'neuron', 111, 'neurons'), ('CHEBI_15354', 'choline', 124, 'choline'), ('GO_0010467', 'gene expression', 199, 'expressed'), ('UBERON_0000178', 'blood', 247, 'blood-'), ('UBERON_0000052', 'fornix of brain', 253, 'brain barrier')]
PMC2888576	6/2010	S103-PMC2888576	['at 10 days of age lun Mice were hypoglycemic with non-fasted Blood Glucose levels of approximately 60 mg%, compared to Mice on a control diet (100 mg%).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 22, 'mice'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'mice')]
PMC2889879	5/2010	S140-PMC2889879	['Vitamin D is to a large extent Metabolized in the body through sun exposure, and People with dark skin need more sun exposure to maintain adequate Blood levels.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0008152', 'metabolic process', 31, 'metabolized'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'people'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC2898025	5/2010	S50-PMC2898025	['once in the Circulatory System, Compounds enter the Brain of the infant relatively quickly as the Blood-Brain Barrier is not fully operational until at least 6 months of age [10].']	N/A	N/A	[('UBERON_0001009', 'circulatory system', 12, 'circulatory system'), ('CHEBI_36357', 'polyatomic entity', 32, 'compounds'), ('UBERON_0000955', 'brain', 52, 'brain'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0000052', 'fornix of brain', 104, 'brain barrier')]
PMC2898025	5/2010	S51-PMC2898025	['at Birth, children are less able to Detoxify chemicals and other inorganic substances commonly used on farms [33,34], and they tend to have higher concentrations in their Blood due to a decreased capacity to bind Plasma protein [35].']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('GO_0098754', 'detoxification', 36, 'detoxify'), ('UBERON_0000178', 'blood', 171, 'blood'), ('UBERON_0001969', 'blood plasma', 213, 'plasma')]
PMC2909243	6/2010	S83-PMC2909243	['Blood pressure was measured on the right Arm with a digital device (dash 3000, ge medical systems, usa) and a standard 12 lead electrocardiogram was taken and interpreted to identify any occult ischaemic Heart disease or Cardiac arrhythmia.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001460', 'arm', 41, 'arm'), ('UBERON_0000948', 'heart', 204, 'heart'), ('UBERON_0000948', 'heart', 221, 'cardiac')]
PMC2909243	6/2010	S94-PMC2909243	['Blood collection\nfasting Blood samples were taken from the Anterior Cubital Fossa for subsequent Glucose, Insulin, hba1c, hormonal, inflammatory and dna analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0003720', 'anterior cranial fossa', 59, 'anterior cubital fossa'), ('CHEBI_17234', 'glucose', 97, 'glucose'), ('PR_000045358', 'insulin family protein', 106, 'insulin')]
PMC2909243	6/2010	S127-PMC2909243	['all participants received detailed feedback on clinically relevant parameters (ecg, bone Mineral density and Blood pressure) that were also fed back to their general practitioners.']	N/A	N/A	[('CHEBI_46662', 'mineral', 89, 'mineral'), ('UBERON_0000178', 'blood', 109, 'blood')]
PMC2922376	8/2010	S100-PMC2922376	['mothers withdrew for personal reasons prior to Delivery, inadequate dna yield, infant Cord Blood sample was not obtained at Birth) leaving 49 maternal and infant samples that were not treated with sri Medications, and 33 samples that were treated with sri Medications.']	N/A	N/A	[('GO_0007567', 'parturition', 47, 'delivery'), ('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood'), ('GO_0007567', 'parturition', 124, 'birth'), ('CHEBI_25441', 'mycothiols', 201, 'medications'), ('CHEBI_25441', 'mycothiols', 256, 'medications')]
PMC2922376	8/2010	S103-PMC2922376	['Maternal Blood (mid 3rdtrimester) and Neonatal Cord (Venous) Blood samples were obtained for genotyping and Dna Methylation analysis.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001759', 'vagus nerve', 38, 'neonatal'), ('UBERON_0002240', 'spinal cord', 47, 'cord'), ('UBERON_0001638', 'vein', 53, 'venous'), ('UBERON_0000178', 'blood', 61, 'blood'), ('GO_0006306', 'DNA methylation', 108, 'DNA methylation')]
PMC2922376	8/2010	S108-PMC2922376	['genotyping\nGenomic dna was extracted from maternal and newborn Leukocytes using the flexigene dna Blood kit (qiagen, valencia, ca).']	N/A	N/A	[('SO_0001026', 'genome', 11, 'Genomic'), ('CL_0000738', 'leukocyte', 63, 'leukocytes'), ('UBERON_0000178', 'blood', 98, 'Blood')]
PMC2936567	9/2010	S6-PMC2936567	['Blood pressure (bp) and Heart rate (hr) were assessed in conscious unrestrained wild-type Mice by telemetry.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 24, 'heart'), ('NCBITaxon_10088', 'Mus <genus>', 90, 'mice')]
PMC2936567	9/2010	S62-PMC2936567	['Blood pressure catheters were surgically inserted in the Carotid Artery and miniaturized implants (ta11pa-c10, data science international inc) placed in a subcutaneous pouch under anesthesia (Ketamine/xylasine Mixture).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0005396', 'carotid artery segment', 57, 'carotid artery'), ('CHEBI_6121', 'ketamine', 192, 'ketamine'), ('CHEBI_60004', 'mixture', 210, 'mixture')]
PMC2936567	9/2010	S84-PMC2936567	['Blood sampling and analysis\nBlood was collected at sacrifice between 2 and 4 pm after 6 hours fasting by Cardiac puncture in edta tubes and Plasma was obtained by centrifugation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('UBERON_0000948', 'heart', 105, 'cardiac'), ('UBERON_0001969', 'blood plasma', 140, 'plasma')]
PMC2936567	9/2010	S85-PMC2936567	["for Glucose concentration analysis, proteins were precipitated by addition of 200 µl Hclo4(0.33n) to 20 µl Blood and concentration was determined by the Glucose oxidase method using trinder's Reagent (stanbio laboratory, texas, usa)."]	N/A	N/A	[('CHEBI_17234', 'glucose', 4, 'glucose'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 85, 'HClO4'), ('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_17234', 'glucose', 153, 'glucose'), ('CHEBI_33893', 'reagent', 192, 'reagent')]
PMC2936567	9/2010	S118-PMC2936567	['circadian variation of Blood pressure and Heart rate\nusing telemetry, systolic Blood pressure (sbp), diastolic Blood pressure (dbp) and Heart rate (hr) were continuously recorded during 24 h in 3- and 9-mo c57bl6/j male Mice.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0000948', 'heart', 42, 'heart'), ('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0000178', 'blood', 111, 'blood'), ('UBERON_0000948', 'heart', 136, 'heart'), ('NCBITaxon_10088', 'Mus <genus>', 220, 'mice')]
PMC2936567	9/2010	S129-PMC2936567	['shaded zone on the x-axis indicates night period (activity period for Mice).10.1371/journal.pone.0012656.t002\n\ncaption (table-wrap): table 2\nday and night average values of Blood pressure and Heart rate in 3- or 9-mo male Mice.chow dietob dietanova 3-months old (n\u200a=\u200a5) Clpclp interactionmaternal dietpost-weaning dietsbp (mmhg) day 111±5112±2113±2117±3nsnsns night 125±5127±2125±2132±3nsnsnsdbp (mmhg) day 90±487±494±298±3nsns 0.0251night 103±5100±4102±2112±3nsnsnsmean hr (bpm) day 490±12471±16499±11527±10nsns 0.017night 530±23514±17524±14548±15nsnsns chow dietob dietanova9-months old (n\u200a=\u200a5) Clpclp interactionmaternal dietpost-weaning dietsbp (mmhg) day 102±5120±2*142±7126±9 0.00760.0086<0.0001night 116±9125±2163±13128±4 0.0195 ns 0.0073 dbp (mmhg) day 85±699±499±6103±2nsnsns night 99±11103±2111±8105±5nsnsnsmean hr (bpm) day 472±28511±16513±28577±5*ns 0.00390.0026night 496±34519±13556±22563±5nsns 0.0028\ndata are presented as mean ± sem for n observations per group.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 70, 'mice'), ('UBERON_0000178', 'blood', 173, 'blood'), ('UBERON_0000948', 'heart', 192, 'heart'), ('NCBITaxon_10088', 'Mus <genus>', 222, 'mice'), ('PR_000005639', 'connector enhancer of kinase suppressor of ras 3', 270, 'CLPCLP'), ('PR_000005639', 'connector enhancer of kinase suppressor of ras 3', 597, 'CLPCLP')]
PMC2936567	9/2010	S137-PMC2936567	['the magnitude of delta Blood pressure reduction in Mice from lp was not significant (figure 3b).']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'mice')]
PMC2936567	9/2010	S187-PMC2936567	['in a Rat study, when the lp diet was given during Gestation and maintained throughout Life, catch-up growth did not occur and Blood pressure as well as Renal Glomerular structure remained unaltered[26].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 5, 'rat'), ('GO_0007565', 'female pregnancy', 50, 'gestation'), ('UBERON_0000104', 'life cycle', 86, 'life'), ('UBERON_0000178', 'blood', 126, 'blood'), ('UBERON_0000074', 'renal glomerulus', 152, 'renal glomerular')]
PMC2936567	9/2010	S198-PMC2936567	['thus, lp male offspring featured a loss of Circadian Rhythms of both Blood pressure and Heart rate.']	N/A	N/A	[('GO_0007623', 'circadian rhythm', 43, 'circadian rhythms'), ('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0000948', 'heart', 88, 'heart')]
PMC2936567	9/2010	S218-PMC2936567	['in rodents, fetal exposure to excess Glucocorticoids via maternal stress (calorie restriction) or Drug treatment (Dexamethasone) lowered Birth weight, increased Glucose and Insulin levels and also increased Blood pressure in the Adult progeny[42].']	N/A	N/A	[('CHEBI_36597', 'phthalazine', 37, 'glucocorticoids'), ('CHEBI_23888', 'drug', 98, 'drug'), ('CHEBI_41879', 'dexamethasone', 114, 'dexamethasone'), ('GO_0007567', 'parturition', 137, 'birth'), ('CHEBI_17234', 'glucose', 161, 'glucose'), ('PR_000045358', 'insulin family protein', 173, 'insulin'), ('UBERON_0000178', 'blood', 207, 'blood'), ('UBERON_0007023', 'adult organism', 229, 'adult')]
PMC2939583	8/2010	S90-PMC2939583	['pre-Natal history\ndata were collected from Pregnant women regarding all Prenatal visits that included weight, Blood pressure, Uterine height, Gestational age, duration of Pregnancy, ultrasounds, and events during Pregnancy based on medical records in basic Health Care units or in hospitals.']	N/A	N/A	[('GO_0007567', 'parturition', 4, 'natal'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('GO_0007565', 'female pregnancy', 72, 'prenatal'), ('UBERON_0000178', 'blood', 110, 'blood'), ('UBERON_0000995', 'uterus', 126, 'uterine'), ('GO_0007565', 'female pregnancy', 142, 'gestational'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('UBERON_0004151', 'cardiac chamber', 257, 'health care')]
PMC2939651	8/2010	S3-PMC2939651	['Blood parameters were measured under Fed and 14-h fasting conditions at different ages (2, 4 and 5 months).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007631', 'feeding behavior', 37, 'fed')]
PMC2939651	8/2010	S44-PMC2939651	['at 3 different ages (2, 4 and 5 months), Blood samples (n = 8 Animals/group) were collected (in heparinized containers) from the Saphenous Vein of control and cr Animals, under different Feeding conditions: ad libitum - Animals provided with free access to Chow diet - and fasting - Animals deprived of Food for 14 h. in both conditions, samples were obtained without anesthesia and during the first 2 h of the beginning of the light cycle.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('NCBITaxon_33208', 'Metazoa', 62, 'animals'), ('UBERON_0007318', 'saphenous vein', 129, 'saphenous vein'), ('NCBITaxon_33208', 'Metazoa', 162, 'animals'), ('GO_0007631', 'feeding behavior', 187, 'feeding'), ('NCBITaxon_33208', 'Metazoa', 220, 'animals'), ('CHEBI_33290', 'food', 257, 'chow'), ('NCBITaxon_33208', 'Metazoa', 283, 'animals'), ('CHEBI_33290', 'food', 303, 'food')]
PMC2939651	8/2010	S45-PMC2939651	['Plasma was obtained by centrifugation of Blood at 700 g for 10 min, and stored at -20°c until analysis.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 41, 'blood')]
PMC2939651	8/2010	S47-PMC2939651	['measurement of circulating parameters under Fed/fasting conditions, and calculation of the Homeostatic model assessment for Insulin resistance at different ages\nBlood Glucose concentration was measured by accu-chek glucometer (roche diagnostics, barcelona, spain).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 44, 'fed'), ('GO_0042592', 'homeostatic process', 91, 'homeostatic'), ('PR_000045358', 'insulin family protein', 124, 'insulin'), ('UBERON_0000178', 'blood', 161, 'Blood'), ('CHEBI_17234', 'glucose', 167, 'glucose')]
PMC2939651	8/2010	S99-PMC2939651	['caption (table-wrap): table 1\n\nBlood parametersglucose(mg/dl)Insulin(μg/l)leptin(μg/l)Triglycerides(mg/ml)Nefa(μg/l)controlcrcontrolcrcontrolcrcontrolcrcontrolcrmalesad libitum98 ± 495 ± 40.774 ± 0.1661.44 ± 0.27#3.52 ± 0.433.38 ± 0.440.669 ± 0.1931.48 ± 0.20#0.447 ± 0.0540.895 ± 0.054#2 month-old14-h fasting65 ± 2+66 ± 3+0.115 ± 0.029+0.103 ± 0.026+0.832 ± 0.053+0.471 ± 0.086+0.447 ± 0.0651.30 ± 0.24#0.622 ± 0.0771.21 ± 0.03+ #anovafrxffrr,f ad libitum73 ± 277 ± 21.44 ± 0.242.29 ± 0.607.34 ± 0.749.48 ± 0.711.25 ± 0.251.57 ± 0.130.765 ± 0.0791.12 ± 0.164 month-old14-h fasting64 ± 3+72 ± 30.468 ± 0.094+1.15 ± 0.29+ #4.23 ± 0.31+4.82 ± 0.33+0.636 ± 0.153+1.12 ± 0.10+ #0.842 ± 0.1441.35 ± 0.11#anovafffr,fr ad libitum77 ± 580 ± 21.47 ± 0.412.69 ± 0.68#8.17 ± 1.2515.3 ± 1.6#1.06 ± 0.161.94 ± 0.23#1.27 ± 0.071.17 ± 0.145 month-old14-h fasting63 ± 3+65 ± 3+0.583 ± 0.147+1.43 ± 0.35+ #4.44 ± 0.78+6.17 ± 0.84+1.02 ± 0.211.31 ± 0.21+1.20 ± 0.101.26 ± 0.07 anovafr,frxfr femalesad libitum92 ± 3100 ± 50.657 ± 0.1151.55 ±0.35#3.38 ± 0.442.87 ± 0.320.373 ± 0.0630.946 ± 0.142#0.529 ± 0.0570.921 ± 0.047#2 month-old14-h fasting71 ± 2+71 ± 3+0.134 ± 0.019+0.134 ±0.014+0.448 ± 0.055+0.511 ± 0.129+0.516 ± 0.1480.633 ± 0.2170.657 ± 0.0851.28 ± 0.11+ #anovafrxffrr,f ad libitum84 ± 682 ± 21.27 ± 0.161.86 ±0.355.59 ± 0.266.31 ± 0.370.747 ± 0.1761.66 ± 0.38#0.715 ± 0.0901.35 ± 0.15#4 month-old14-h fasting67 ± 3+67 ± 1+0.246 ± 0.045+0.465 ±0.120+2.03 ± 0.17+2.09 ± 0.10+0.496 ± 0.119+0.693 ± 0.102+0.826 ± 0.1051.26 ± 0.08#anovafffr,fr ad libitum80 ± 181 ± 31.47 ± 0.192.34 ± 0.33#7.21 ± 0.676.21 ± 0.4490.909 ± 0.2901.44 ± 0.300.957 ± 0.0681.10 ± 0.095 month-old14-h fasting69 ± 2+60 ± 3+ #0.251 ± 0.033+0.476 ± 0.103+2.98 ± 0.20+3.25 ± 0.162+1.14 ± 0.321.19 ± 0.291.17 ± 0.091.30 ± 0.12 anovafr, ff\ncirculating Glucose, Insulin, leptin, Triacylglicerides and non-esterified Fatty Acid (nefa) in male and female offspring of controls and caloric restricted dams during Gestation (cr) at the ages of 2, 4 and 5 months, under ad libitum Feeding conditions and after 14 h fasting conditions.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('PR_000045358', 'insulin family protein', 61, 'Insulin'), ('CHEBI_17855', 'triglyceride', 86, 'Triglycerides'), ('CHEBI_13389', 'NAD', 106, 'NEFA'), ('CHEBI_17234', 'glucose', 1810, 'glucose'), ('PR_000045358', 'insulin family protein', 1819, 'insulin'), ('CHEBI_17855', 'triglyceride', 1836, 'triacylglicerides'), ('CHEBI_35366', 'fatty acid', 1873, 'fatty acid'), ('GO_0007565', 'female pregnancy', 1967, 'gestation'), ('GO_0007631', 'feeding behavior', 2033, 'feeding')]
PMC2939651	8/2010	S117-PMC2939651	['Blood Lipid profile was significantly altered in cr Animals as of the early stages of Life (table1).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_18059', 'lipid', 6, 'lipid'), ('NCBITaxon_33208', 'Metazoa', 52, 'animals'), ('UBERON_0000104', 'life cycle', 86, 'life')]
PMC2945165	10/2010	S33-PMC2945165	['fasting Blood samples were obtained from all mothers and from the Umbilical Cord of all newborns at the time of Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0002331', 'umbilical cord', 66, 'umbilical cord'), ('GO_0007567', 'parturition', 112, 'delivery')]
PMC2945165	10/2010	S35-PMC2945165	['during two follow-up visits, at 6 and 12 months, a full clinical and anthropometric assessment was performed, which included questions about Feeding patterns or intercurrent illness, and a sample of Blood was obtained.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 141, 'feeding'), ('UBERON_0000178', 'blood', 199, 'blood')]
PMC2945165	10/2010	S36-PMC2945165	['Blood samples were centrifuged, and aliquots of Plasma or Serum were used for Glucose and Insulin measurements by the hospital clinical laboratory or frozen (at −80°c) until assessed by the laboratory of experimental diabetes and Aging, the mount sinai school of medicine (new york, ny).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 48, 'plasma'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_17234', 'glucose', 78, 'glucose'), ('PR_000045358', 'insulin family protein', 90, 'insulin'), ('GO_0007568', 'aging', 230, 'Aging')]
PMC2945165	10/2010	S74-PMC2945165	['Serum levels of Cml ( a ) and Methylglyoxal derivatives ( b ) were measured by elisas in maternal (m) and Umbilical Cord Blood from newborns at delivery (0) and children at age 6 and 12 months.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000005890', 'crooked neck-like protein 1', 16, 'CML'), ('CHEBI_17158', 'methylglyoxal', 30, 'methylglyoxal'), ('UBERON_0002331', 'umbilical cord', 106, 'umbilical cord'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC2958873	10/2010	S4-PMC2958873	['Blood samples were collected on Gestation weeks 8-9 (baseline) and 36-37 (end of intervention).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 32, 'gestation')]
PMC2958873	10/2010	S12-PMC2958873	['dietary Phytoestrogens are examples of such Compounds, as they are found in the Amniotic Fluid and the Umbilical Cord Blood [1].']	N/A	N/A	[('CHEBI_76989', 'phytoestrogen', 8, 'phytoestrogens'), ('CHEBI_36357', 'polyatomic entity', 44, 'compounds'), ('UBERON_0000173', 'amniotic fluid', 80, 'amniotic fluid'), ('UBERON_0002331', 'umbilical cord', 103, 'umbilical cord'), ('UBERON_0000178', 'blood', 118, 'blood')]
PMC2963768	10/2010	S28-PMC2963768	['in an order based on closeness in age to the index case, caregivers of the listed children were approached until a control participant was recruited, consent was obtained, and a Blood specimen was collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 178, 'blood')]
PMC2963768	10/2010	S40-PMC2963768	['a Venous Blood specimen was collected by standard methods, separated into Serum aliquots, and stored at -20 °c or less.']	N/A	N/A	[('UBERON_0001638', 'vein', 2, 'venous'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC2966409	10/2010	S1-PMC2966409	['using 120 paired maternal-Umbilical Cord Blood samples randomly selected from a prospective Birth cohort in bangladesh, we quantified Dna Methylation by pyrosequencing seven Cpg positions in the Promoter Region of P16 , four cpg positions in the Promoter Region of P53 , line-1 and alu .']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 26, 'umbilical cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0007567', 'parturition', 92, 'birth'), ('GO_0006306', 'DNA methylation', 134, 'DNA methylation'), ('SO_0001334', 'hydroxywybutosine', 174, 'CpG'), ('SO_0000167', 'promoter', 195, 'promoter region'), ('PR_000001245', 'rhodopsin', 214, 'p16'), ('SO_0000167', 'promoter', 246, 'promoter region'), ('PR_000003035', 'cellular tumor antigen p53', 265, 'p53')]
PMC2966409	10/2010	S31-PMC2966409	['results\naverage Blood Dna Methylation levels, expressed at %5mc (percentage of cytosines that are methylated over unmethylated cytosines at a given cpg position), are presented intable 1.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('GO_0006306', 'DNA methylation', 22, 'DNA methylation')]
PMC2966409	10/2010	S33-PMC2966409	['paired t-tests detected very slight differences in %5mc between maternal and Umbilical Cord Blood with Umbilical Cord Blood containing, on average, 0.5% (p\u200a=\u200a0.007) more methylated cytosines at line-1 compared to maternal Blood.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0002331', 'umbilical cord', 103, 'umbilical cord'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0000178', 'blood', 222, 'blood')]
PMC2966409	10/2010	S34-PMC2966409	['whereas, maternal Blood contained on average 0.25% (p\u200a=\u200a0.006) more methylated cytosines at alu compared to Umbilical Cord Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0002331', 'umbilical cord', 108, 'umbilical cord'), ('UBERON_0000178', 'blood', 123, 'blood')]
PMC2966409	10/2010	S36-PMC2966409	['on average, daughters had 0.4% less Dna Methylation at line-1 (m\u200a=\u200a−0.43, sd\u200a=\u200a1.48, p\u200a=\u200a0.04), and 0.3% more Dna Methylation at alu (m\u200a=\u200a0.32, sd\u200a=\u200a0.76, p\u200a=\u200a0.003) compared to their mothers.10.1371/journal.pone.0013730.t001\n\ncaption (table-wrap): table 1\ngeneral descriptive statistics for paired maternal-Cord Blood samples included in the analysis.Maternal Bloodcord Bloodt-test nmeansdmeansddif.p-valuealu103 25.20.7124.960.780.250.007 line-198 80.112.1080.581.92−0.460.006 P16 Pos1 100 2.611.652.411.430.200.31pos2 100 3.031.662.831.290.200.25pos3 100 1.350.661.380.76−0.030.75pos4 100 2.181.022.050.980.130.24pos5 100 2.160.702.070.910.090.46pos6 100 1.230.701.300.78−0.070.41pos7 100 2.902.172.381.130.520.02 p53 pos1 87 2.801.762.550.900.260.23Pos2 87 7.922.527.392.290.540.13pos3 87 2.770.972.410.710.360.008pos4 87 3.831.653.681.280.150.48\nDna Methylation was also measured at 7 and 4 cpg dinucleotides within the Promoter regions of P16 and P53 , respectively.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0006306', 'DNA methylation', 110, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 308, 'cord'), ('UBERON_0000178', 'blood', 313, 'blood'), ('UBERON_0000976', 'humerus', 352, 'Maternal'), ('UBERON_0003061', 'blood island', 361, 'BloodCord'), ('UBERON_0000178', 'blood', 371, 'BloodT'), ('PR_000012433', 'neuroendocrine convertase 1', 479, 'p16 pos1'), ('PR_000036876', 'serine/threonine-protein kinase STK11 isoform 2', 751, '23pos2'), ('GO_0006306', 'DNA methylation', 851, 'DNA methylation'), ('SO_0000167', 'promoter', 925, 'promoter'), ('PR_000001245', 'rhodopsin', 945, 'p16'), ('PR_000003035', 'cellular tumor antigen p53', 953, 'p53')]
PMC2966409	10/2010	S39-PMC2966409	['paired t-tests detected very slight differences in %5mc at position 7 in p16 with Umbilical Cord Blood containing, on average, 0.5% (p\u200a=\u200a0.02) more methylated cytosines at this cpg dinucleotide compared to maternal Blood.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 82, 'umbilical cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('UBERON_0000178', 'blood', 215, 'blood')]
PMC2966409	10/2010	S42-PMC2966409	['paired t-tests detected a very slight difference in %5mc at position 3 in P53 with Umbilical Cord Blood containing, on average, 0.2% (p\u200a=\u200a0.008) more methylated cytosines compared to maternal Blood.']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 74, 'p53'), ('UBERON_0002331', 'umbilical cord', 83, 'umbilical cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0000178', 'blood', 192, 'blood')]
PMC2966409	10/2010	S51-PMC2966409	['in the randomly re-assigned data, there was no correlation between maternal-Umbilical Cord samples at line-1 , alu , P16 or P53 (data not shown).10.1371/journal.pone.0013730.t002\n\ncaption (table-wrap): table 2\nspearman correlation coefficients between Umbilical Cord Blood and maternal Blood for each epigenetic marker.Umbilical Cord Blood line-1alup16p53 pos 1pos 2pos3pos4pos 5pos 6pos 7pos 1pos 2pos 3pos 4 maternal Bloodline-1 0.63†−0.25‡0.24‡0.49†0.44†0.42†0.110.39†0.44†0.20‡−0.030.140.33† Alu −0.26†0.31†−0.04−0.16−0.1−0.13−0.03−0.17−0.27†−0.080.10.01−0.28† P16 pos 10.28†−0.030.38†0.36†0.41†0.42†0.20‡0.41†0.41†0.11−0.11−0.050.13pos 20.44†−0.21‡0.44†0.49†0.45†0.51†0.160.42†0.47†0.17−0.16−0.090.27†pos 30.42†−0.110.35†0.39†0.35†0.41†0.26†0.41†0.42†0.14−0.18−0.090.2pos 40.31†0.030.46†0.42†0.47†0.54†0.160.41†0.43†0.17−0.0600.20‡pos 50.090.140.33†0.23‡0.32†0.30†0.170.28†0.19‡0.02−0.010.03−0pos 60.47†−0.130.37†0.46†0.42†0.46†0.22‡0.46†0.43†0.13−0.14−0.080.19pos 70.35†−00.37†0.43†0.42†0.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 76, 'umbilical cord'), ('PR_000001245', 'rhodopsin', 117, 'p16'), ('PR_000003035', 'cellular tumor antigen p53', 124, 'p53'), ('UBERON_0002331', 'umbilical cord', 252, 'umbilical cord'), ('UBERON_0000178', 'blood', 267, 'blood'), ('UBERON_0000178', 'blood', 286, 'blood'), ('UBERON_0002331', 'umbilical cord', 319, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 334, 'Blood'), ('UBERON_0003061', 'blood island', 419, 'BloodLine'), ('CHEBI_30872', 'oxaloamino group', 496, 'Alu'), ('PR_000001245', 'rhodopsin', 565, 'p16')]
PMC2966409	10/2010	S58-PMC2966409	['at 6 of the 7 cpg positions screened in P16 , the %5mc in maternal Blood significantly predicted the %5mc in the corresponding cpg positions in the Umbilical Cord Blood (figure 1c P16 position 1: β\u200a=\u200a0.19, p\u200a=\u200a0.003;figure 1d P16 position 2: β\u200a=\u200a0.27, p\u200a=\u200a0.0005;figure 1f P16 position 4: β\u200a=\u200a0.43, p<0.0001;figure 1h P16 position 6: β\u200a=\u200a0.33, p\u200a=\u200a0.003;figure 1i P16 position 7: β\u200a=\u200a0.17, p\u200a=\u200a0.001).']	N/A	N/A	[('PR_000001245', 'rhodopsin', 40, 'p16'), ('UBERON_0000178', 'blood', 67, 'blood'), ('UBERON_0007118', 'umbilicus', 148, 'umbilical'), ('UBERON_0009472', 'axilla', 158, 'cord blood'), ('PR_000001245', 'rhodopsin', 180, 'p16'), ('PR_000001245', 'rhodopsin', 226, 'p16'), ('PR_000001245', 'rhodopsin', 273, 'p16'), ('PR_000001245', 'rhodopsin', 318, 'p16'), ('PR_000001245', 'rhodopsin', 364, 'p16')]
PMC2966409	10/2010	S120-PMC2966409	['peripheral Blood collection and dna extraction\na peripheral whole Blood sample was collected from the participant when they enrolled in the study and Umbilical Cord Blood was collected at the time of Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'Blood'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0002331', 'umbilical cord', 150, 'umbilical cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('GO_0007567', 'parturition', 200, 'delivery')]
PMC2966409	10/2010	S121-PMC2966409	['dna was extracted from 4 mls of whole Blood using puregene dna isolation kits (qiagen/gentra systems, minneapolis, mn) following manufacturers instructions.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood')]
PMC2966409	10/2010	S138-PMC2966409	['in total, 120 paired maternal-Umbilical Cord Blood samples underwent Dna Methylation analysis.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 30, 'umbilical cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0006306', 'DNA methylation', 69, 'DNA methylation')]
PMC2966409	10/2010	S140-PMC2966409	['the success of pyrosequencing ranged from 100% for alu in maternal Blood to 79% for P53 in Umbilical Cord Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('PR_000003035', 'cellular tumor antigen p53', 84, 'p53'), ('UBERON_0002331', 'umbilical cord', 91, 'umbilical cord'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC2966409	10/2010	S142-PMC2966409	['statistical analysis\ndescriptive statistics were calculated for the maternal and Cord Blood samples.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 81, 'cord'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC2966409	10/2010	S143-PMC2966409	['differences between Umbilical Cord Blood and maternal Blood %5mc were evaluated using wilcoxon-rank sum tests.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 20, 'umbilical cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC2966409	10/2010	S145-PMC2966409	['multiple linear regression models were used to evaluate the relationship between %5mc in Umbilical Cord Blood (dependent variable) and maternal Blood (predictor) for each marker.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 89, 'umbilical cord'), ('UBERON_0000178', 'blood', 104, 'blood'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC2984417	10/2010	S44-PMC2984417	['for the diagnosis of Placental abruption, we required evidence of Blood clot (retroplacental clots) or bleeding behind the Placenta accompanied by at least 2 of the following signs and symptoms: 1) Vaginal bleeding in late Pregnancy that was not associated with Placenta previa or Cervical lesions; 2) Uterine tenderness and/or abdominal pain; and 3) fetal distress or death.']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001987', 'placenta', 123, 'placenta'), ('UBERON_0001987', 'placenta', 198, 'vaginal'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy'), ('UBERON_0001987', 'placenta', 262, 'placenta'), ('UBERON_0005434', 'cervical region', 281, 'cervical'), ('UBERON_0000995', 'uterus', 302, 'uterine')]
PMC2991548	10/2010	S36-PMC2991548	['caption (table-wrap): table\xa03\n\nassessments in mothers, fathers and their children in the Prenatal phaseearly Pregnancymid-Pregnancylate Pregnancybirthmother\xa0physical examination+++\xa0questionnaire+++\xa0interviews\xa0fetal ultrasound examination+++\xa0detailed fetal ultrasounds\xa0Blood sample++\xa0Urine sample+++father\xa0physical examination+\xa0questionnaire+\xa0interview\xa0Blood sample+child\xa0physical examination+\xa0Cord Blood+\n+\xa0=\xa0assessment in whole cohort\ns\xa0=\xa0assessment only in subgroup\nearly Pregnancy: Gestational age\xa0<\xa018\xa0weeks; mid-Pregnancy: Gestational age 18–25\xa0weeks; late Pregnancy: Gestational age\xa0>\xa025\xa0weeks\n\ncaption (table-wrap): table\xa04\n\nassessments in mothers, fathers and children during the preschool periodage (months)2346111214182430364548child\xa0questionnaire (parent)++++++++\xa0physical examination+++++++++\xa0ultrasoundsss\xa0Airway inflammationss\xa0behavioural observationsss\xa0bacterial carriagessss\xa0Blood samplessmother specific\xa0questionnaire+++s\xa0interaction with childssfather specific\xa0questionnaire+\xa0interaction with childs\n+\xa0=\xa0assessment in whole cohort\ns\xa0=\xa0assessment only in subgroup\ndutch is defined as two parents and four grandparents born in the netherlands.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 89, 'prenatal'), ('GO_0007565', 'female pregnancy', 109, 'pregnancyMid'), ('GO_0006412', 'translation', 122, 'pregnancyLate'), ('GO_0001782', 'B cell homeostasis', 136, 'pregnancyBirthMother'), ('UBERON_0000178', 'blood', 268, 'Blood'), ('UBERON_0001088', 'urine', 283, 'Urine'), ('UBERON_0000178', 'blood', 352, 'Blood'), ('UBERON_0000948', 'heart', 393, 'Cord'), ('UBERON_0000178', 'blood', 398, 'blood'), ('GO_0007565', 'female pregnancy', 474, 'pregnancy'), ('GO_0007565', 'female pregnancy', 485, 'gestational'), ('GO_0007565', 'female pregnancy', 517, 'pregnancy'), ('GO_0007565', 'female pregnancy', 528, 'gestational'), ('GO_0007565', 'female pregnancy', 562, 'pregnancy'), ('GO_0007565', 'female pregnancy', 573, 'gestational'), ('UBERON_0001005', 'respiratory airway', 819, 'Airway'), ('UBERON_0000178', 'blood', 891, 'Blood')]
PMC2991548	10/2010	S78-PMC2991548	['data collection in the Prenatal phase\n\nphysical examinations\nphysical examinations were planned at each visit in early Pregnancy, mid-Pregnancy and late Pregnancy and included height, weight and Blood pressure measurements of both parents.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('UBERON_0000178', 'blood', 195, 'blood')]
PMC2991548	10/2010	S110-PMC2991548	['biological samples\nBlood samples were collected in early and mid-Pregnancy and at Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'Blood'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007567', 'parturition', 82, 'birth')]
PMC2991548	10/2010	S112-PMC2991548	['the planned amounts of Venous Blood taken were 35 and 20\xa0ml in early Pregnancy and mid-Pregnancy, respectively, from the mother and 10\xa0ml from father.']	N/A	N/A	[('UBERON_0001638', 'vein', 23, 'venous'), ('UBERON_0000178', 'blood', 30, 'blood'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC2991548	10/2010	S113-PMC2991548	['at Delivery, 30\xa0ml Cord Blood was collected.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood')]
PMC2991548	10/2010	S114-PMC2991548	['Blood samples are currently available for 97, 83 and 67% of the participating mothers, partners and children, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2991548	10/2010	S123-PMC2991548	['dna and Genome wide association studies\ndna from both parents (whole Blood) and children (Cord Blood) has been extracted, normalised and plated and is currently used for several genotype studies.']	N/A	N/A	[('SO_0001026', 'genome', 8, 'genome'), ('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0002240', 'spinal cord', 90, 'cord'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC2991548	10/2010	S155-PMC2991548	['Blood pressure was measured at the age of 24\xa0months [239].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC2991548	10/2010	S157-PMC2991548	['biological materials have been collected, including bacterial colonization measured by Nasal- and Nasopharyngeal swabs at the ages of 1.5, 6, 14 and 24\xa0months, Cortisol day rhythm measured by repeated Salivary samples at the age of 14\xa0months and, if parents give consent, Blood samples at the ages of 6, 14 and 24\xa0months [242–251].']	N/A	N/A	[('UBERON_0000004', 'nose', 87, 'nasal'), ('UBERON_0011692', 'enameloid', 98, 'nasopharyngeal'), ('CHEBI_17650', 'cortisol', 160, 'cortisol'), ('UBERON_0001836', 'saliva', 201, 'salivary'), ('UBERON_0000178', 'blood', 272, 'blood')]
PMC2992766	12/2010	S61-PMC2992766	['Trunk Blood was collected in heparinized tubes and centrifuged, and the Plasma was stored at −80°c for hormone and substrate analyses.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 72, 'plasma')]
PMC2992766	12/2010	S62-PMC2992766	['fetal Blood from all of the fetuses in the same litter was pooled, and their Plasma was stored as indicated above.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 77, 'plasma')]
PMC2992766	12/2010	S67-PMC2992766	['at 0 min, Blood was obtained from the dorsal Tail Vein for measures of blood Glucose and plasma Insulin, and then an Intraperitoneal bolus of Glucose (2 mg Glucose per gram of body weight) was given and serial Blood Glucose measurements were done using the hemacue Glucose analyzer (angelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0003481', 'tail vein', 45, 'tail vein'), ('CHEBI_17234', 'glucose', 77, 'glucose'), ('PR_000045358', 'insulin family protein', 96, 'insulin'), ('UBERON_2001932', 'sensory canal tubular ossicle', 117, 'intraperitoneal'), ('CHEBI_17234', 'glucose', 142, 'glucose'), ('CHEBI_17234', 'glucose', 156, 'glucose'), ('UBERON_0000178', 'blood', 210, 'blood'), ('CHEBI_17234', 'glucose', 216, 'glucose'), ('CHEBI_17234', 'glucose', 265, 'glucose')]
PMC2992766	12/2010	S138-PMC2992766	['caption (table-wrap): table 3\n\nEndocrine-Metabolic parameters in offspring of normal and western diet-Fed Pregnant Rats at Birthcontrolcontrol+aoxwesternwestern+aoxfetal d (18) ( n = 5 litters)\u2003\u2003\u2003\u2003leptin (ng/ml)2.2 ± 0.21.9 ± 0.22.1 ± 0.12.3 ± 0.2\u2003\u2003\u2003\u2003ffa (μeq/ml)35.3 ± 2.827.9 ± 3.133.2 ± 4.630.2 ± 4.9\u2003\u2003\u2003\u2003Blood Glucose (mg/dl)54.4 ± 6.757.9 ± 5.961.6 ± 7.758.14 ± 6.3\u2003\u2003\u2003\u2003Insulin (ng/ml)1.49 ± 0.071.51 ± 0.081.58 ± 0.091.55 ± 0.08birth ( n = 5 litters)\u2003\u2003\u2003\u2003leptin (ng/ml)2.8 ± 0.32.9 ± 0.23.8 ± 0.1*3.0 ± 0.3\u2003\u2003\u2003\u2003ffa (μeq/ml)64.8 ± 6.957.9 ± 5.1105.7 ± 9.9*76.6 ± 7.5\u2003\u2003\u2003\u2003Blood Glucose (mg/dl)88.2 ± 8.877.4 ± 9.481.0 ± 8.386.6 ± 9.4\u2003\u2003\u2003\u2003Insulin (ng/ml)0.47 ± 0.060.49 ± 0.060.68 ± 0.07*0.47 ± 0.072 weeks ( n = 5 litters)\u2003\u2003\u2003\u2003leptin (ng/ml)4.2 ± 0.63.9 ± 0.77.8 ± 0.9*4.1 ± 0.8\u2003\u2003\u2003\u2003ffa (μeq/ml)38.5 ± 4.241 ± 4.352.5 ± 5.5*43 ± 5.6\u2003\u2003\u2003\u2003Blood Glucose (mg/dl)93.6 ± 10.497.2 ± 11.5104.4 ± 9.795.4 ± 9.5\u2003\u2003\u2003\u2003Insulin (ng/ml)0.81 ± 0.050.84 ± 0.041.9 ± 0.02*0.92 ± 0.012 months ( n = 8)\u2003\u2003\u2003\u2003leptin (ng/ml)14.7 ± 1.513.2 ± 2.525 ± 1.9*14.5 ± 1.9\u2003\u2003\u2003\u2003ffa (μeq/ml)15.7 ± 1.312.4 ± 1.413.4 ± 1.612.9 ± 1.5\u2003\u2003\u2003\u2003Blood Glucose (mg/dl)118.8 ± 10.8117 ± 11.9120.6 ± 14.0122.0 ± 14.4\u2003\u2003\u2003\u2003Insulin (ng/ml)1.4 ± 0.061.8 ± 0.042.9 ± 0.09*1.9 ± 0.05\ndata are means ± se.']	N/A	N/A	[('GO_0006897', 'endocytosis', 31, 'Endocrine ... metabolic'), ('GO_0007631', 'feeding behavior', 102, 'fed'), ('GO_0007565', 'female pregnancy', 106, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 115, 'rats'), ('GO_0044582', 'butyryl-CoA catabolic process to butanol', 123, 'birthControlControl'), ('UBERON_0000178', 'blood', 307, 'Blood'), ('CHEBI_17234', 'glucose', 313, 'glucose'), ('PR_000045358', 'insulin family protein', 373, 'Insulin'), ('UBERON_0000178', 'blood', 571, 'Blood'), ('CHEBI_17234', 'glucose', 577, 'glucose'), ('PR_000045358', 'insulin family protein', 636, 'Insulin'), ('UBERON_0000178', 'blood', 832, 'Blood'), ('CHEBI_17234', 'glucose', 838, 'glucose'), ('PR_000045358', 'insulin family protein', 900, 'Insulin'), ('UBERON_0000178', 'blood', 1093, 'Blood'), ('CHEBI_17234', 'glucose', 1099, 'glucose'), ('PR_000045358', 'insulin family protein', 1164, 'Insulin')]
PMC2994393	8/2010	S6-PMC2994393	['effective Renal Blood flows were lower in tdf, tdl, and tsf Rats (tdf 4.6±0.8 ml/min/g Kidney weight (kw), tdl 3.0±0.9 ml/min/g kw, and tsf 2.8±0.7 ml/min/g kw) than in tsl (7.7±0.9 ml/min/g kw) or control Rats (7.3±1.6 ml/min/g kw).']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('UBERON_0000178', 'blood', 16, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 60, 'rats'), ('UBERON_0002113', 'kidney', 87, 'kidney'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 206, 'rats')]
PMC2994393	8/2010	S95-PMC2994393	[': Intraperitoneal; sem: standard error of means; na: Sodium; Pah: P-Aminohippuric Acid; gfr: Glomerular filtration rate; erbf: effective Renal Blood flow; rvr: Renal Vascular resistance; map: mean Arterial pressure; Feh2O: fractional Water Excretion; fena: fractional Sodium Excretion\n\ncompeting interests\nthe authors declare that they have no competing interests.']	N/A	N/A	[('UBERON_2001932', 'sensory canal tubular ossicle', 2, 'intraperitoneal'), ('CHEBI_52632', 'potassium-39 atom', 53, 'sodium'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 61, 'PAH'), ('CHEBI_35697', 'trans-cinnamic acid', 66, 'p-aminohippuric acid'), ('UBERON_0000074', 'renal glomerulus', 93, 'glomerular'), ('UBERON_0002113', 'kidney', 137, 'renal'), ('UBERON_0000178', 'blood', 143, 'blood'), ('UBERON_0002113', 'kidney', 160, 'renal'), ('UBERON_0000116', 'lung saccule', 166, 'vascular'), ('UBERON_0001637', 'artery', 197, 'arterial'), ('CHEBI_65894', 'F390C', 216, 'FEH2O'), ('CHEBI_15377', 'water', 234, 'water'), ('GO_0007588', 'excretion', 240, 'excretion'), ('CHEBI_52632', 'potassium-39 atom', 268, 'sodium'), ('GO_0007588', 'excretion', 275, 'excretion')]
PMC3004407	12/2010	S3-PMC3004407	['a single Blood sample was taken to measure circulating 25(Oh)D as indicator of Vitamin D status [25(Oh)D < 20\u2009ng/ml (50\u2009nmol/l deficiency; <32\u2009ng/ml (80\u2009nmol/l) insufficiency].']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 99, '(OH ... D')]
PMC3004407	12/2010	S34-PMC3004407	['each woman had been prescribed a Prenatal Vitamin containing 400\u2009iu of Vitamin D at her first Prenatal visit; compliance with the Prenatal vitamin regimen at the time of the Blood sampling was also recorded.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 42, 'vitamin'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('GO_0007565', 'female pregnancy', 130, 'prenatal'), ('UBERON_0000178', 'blood', 174, 'blood')]
PMC3004407	12/2010	S35-PMC3004407	['a Blood sample was drawn with the Gestational age (weeks) recorded at the time of the Blood sampling.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('GO_0007565', 'female pregnancy', 34, 'gestational'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC3004407	12/2010	S36-PMC3004407	['Blood was processed and Serum separated for later analysis for total circulating 25-Hydroxy-Vitamin D [25(Oh)D], Serum calcium, phosphorus, and creatinine, and intact Parathyroid hormone (pth).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_70487', '(-)-sanguinolignan C', 81, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('UBERON_0001132', 'parathyroid gland', 167, 'parathyroid')]
PMC3004407	12/2010	S37-PMC3004407	['season was calculated from the date that the Blood sample was drawn according to the following categories: winter, december-march; spring, april-may; summer, june-september; fall, october-november.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC3016256	12/2010	S72-PMC3016256	['levels of scfa can be measured in Stool or Blood.']	N/A	N/A	[('UBERON_0001988', 'feces', 34, 'stool'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC3028350	2/2011	S53-PMC3028350	['Blood samples were collected and Serum was then separated by centrifugation and stored at −80°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 33, 'serum')]
PMC3028350	2/2011	S79-PMC3028350	['Glucose Plasma concentrations were determined using an accu-chek advantage Glucose meter (roche diagnostics) using Blood collected from the Tail in fasting conditions and after Glucose injection (at 15, 30, 60, 90, and 120 min).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('UBERON_0001969', 'blood plasma', 8, 'plasma'), ('CHEBI_17234', 'glucose', 75, 'glucose'), ('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0002415', 'tail', 140, 'tail'), ('CHEBI_17234', 'glucose', 177, 'glucose')]
PMC3029215	1/2011	S2-PMC3029215	['methods\nfrom self-identified, healthy, 20 to 29-year-old aa (n = 21) and ca (n = 17), we established cultures of Blood outgrowth Endothelial Cells (boec) and applied microarray profiling.']	N/A	N/A	[('UBERON_0000178', 'blood', 113, 'blood'), ('CL_0000115', 'endothelial cell', 129, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 129, 'endothelial')]
PMC3029215	1/2011	S80-PMC3029215	['of the 45 subjects providing Blood samples for this study, we subsequently excluded three aa and four ca because their boec cultures failed quality control testing (see below).']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood')]
PMC3029215	1/2011	S83-PMC3029215	['Endothelial culture (boec, Blood outgrowth Endothelial Cells)\nsubjects donated 50 to 100 ml of citrated Peripheral Blood that we immediately used to obtain Peripheral Blood Mononuclear Cells that were then placed in a special culture system (on Collagen I; with multiple Endothelial growth factors) [38].']	N/A	N/A	[('UBERON_0001986', 'endothelium', 0, 'Endothelial'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CL_0000115', 'endothelial cell', 43, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 43, 'endothelial'), ('UBERON_0012101', 'perinatal stage', 104, 'peripheral'), ('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0012101', 'perinatal stage', 156, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 173, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 173, 'mononuclear'), ('PR_000003266', 'collagen type II alpha chain', 245, 'collagen I'), ('UBERON_0001986', 'endothelium', 271, 'endothelial')]
PMC3029215	1/2011	S272-PMC3029215	['it resides at the physical and functional interface between Blood and Tissue and somehow integrates the input from a panoply of biological modifiers.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0000479', 'tissue', 70, 'tissue')]
PMC3029215	1/2011	S283-PMC3029215	['compared to the majority of Individuals having the ε3 Isoform (Gene frequency approximately 0.77), the fewer Individuals having the ε2 Isoform (Gene frequency approximately 0.08) have the highest levels of Blood Apoe and lower Cholesterol levels and protection from Cardiovascular disease and stroke.']	N/A	N/A	[('NCBITaxon_1', 'root', 28, 'individuals'), ('SO_0001060', 'sequence_variant', 54, 'isoform'), ('SO_0000704', 'gene', 63, 'gene'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('SO_0001060', 'sequence_variant', 135, 'isoform'), ('SO_0000704', 'gene', 144, 'gene'), ('UBERON_0000178', 'blood', 206, 'blood'), ('PR_000004155', 'apolipoprotein E', 212, 'APOE'), ('CHEBI_16113', 'cholesterol', 227, 'cholesterol'), ('UBERON_0004535', 'cardiovascular system', 266, 'cardiovascular')]
PMC3029215	1/2011	S351-PMC3029215	['abbreviations\naa: african americans; boec: Blood outgrowth Endothelial Cells; ca: caucasian americans; fdr: false discovery rate; gsea: Gene set enrichment analysis; psph: l-phosphoserine phosphatase; Psphl: the Psp-Homolog; rma: robust multiarray average; sam: significance analysis of microarray.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('CL_0000115', 'endothelial cell', 59, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 59, 'endothelial'), ('SO_0000704', 'gene', 136, 'gene'), ('PR_000013459', 'tyrosine-protein phosphatase non-receptor type 4', 201, 'PSPHL'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 212, 'PSP-'), ('SO_0000853', 'homologous_region', 216, 'homolog')]
PMC3029215	1/2011	S356-PMC3029215	['jn recruited subjects, obtained Blood samples, established boec cultures, and performed quality control measures.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC3031146	1/2011	S143-PMC3031146	['the Blood obtained to isolate Genomic dna was collected after Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('SO_0001026', 'genome', 30, 'genomic'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC3031146	1/2011	S173-PMC3031146	['from eligible arkansas nbdps participants, we assessed Dna Methylation in 180 cases and 187 controls for whom frozen Blood samples were available.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('UBERON_0000178', 'blood', 117, 'blood')]
PMC3031146	1/2011	S174-PMC3031146	['Blood samples were collected by research nurses during home visits in arkansas that occurred between 2001 and 2008.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3031146	1/2011	S180-PMC3031146	['sample preparation and processing\nfasting Blood samples were collected in edta-vacutainer tubes and immediately chilled on ice before they were centrifuged at 4000×g for 10 min at 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC3031146	1/2011	S181-PMC3031146	["dna was isolated from the stored frozen Blood samples according the manufacturer's protocol for the puregene dna isolation kit ( gentra systems , minneapolis, mn)."]	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood')]
PMC3032617	5/2010	S52-PMC3032617	['patients were reviewed every month until Delivery (average 6-8 months) and each of this visits included midwife routine Gestational assessment, weight, Blood pressure, Heart rate and any other obvious body abnormality or Gestant complaint.']	N/A	N/A	[('GO_0007567', 'parturition', 41, 'delivery'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('UBERON_0000178', 'blood', 152, 'blood'), ('UBERON_0000948', 'heart', 168, 'heart'), ('GO_0007565', 'female pregnancy', 221, 'gestant')]
PMC3032617	5/2010	S67-PMC3032617	['wilcoxon signed rank test was used to assess changes from baseline to Delivery in Blood systolic pressure (sbp).']	N/A	N/A	[('GO_0007567', 'parturition', 70, 'delivery'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC3032617	5/2010	S86-PMC3032617	['from baseline to Delivery there was a significant increase in systolic Blood pressure both in the Vitamin C and control groups, (table 4).']	N/A	N/A	[('GO_0007567', 'parturition', 17, 'delivery'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin C')]
PMC3034879	12/2010	S38-PMC3034879	['a second, fasting Blood sample from the mother was collected 2\xa0days Postpartum during the hospital stay between late october and mid-december 2007.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007565', 'female pregnancy', 68, 'postpartum')]
PMC3034879	12/2010	S39-PMC3034879	['at Birth, Cord Blood was obtained from the Umbilical Vein after Cord clamping in 81 subjects.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002240', 'spinal cord', 10, 'cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0002066', 'umbilical vein', 43, 'umbilical vein'), ('UBERON_0002240', 'spinal cord', 64, 'cord')]
PMC3034879	12/2010	S55-PMC3034879	['a Blood sample was obtained for laboratory analyses from all but one child.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood')]
PMC3038155	1/2011	S43-PMC3038155	['at Delivery, we collected data related to labor, Umbilical Cord Blood and Birth outcomes, including Birth weight.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0002331', 'umbilical cord', 49, 'umbilical cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('GO_0007567', 'parturition', 74, 'birth'), ('GO_0007567', 'parturition', 100, 'birth')]
PMC3052301	3/2011	S46-PMC3052301	['Blood samples were taken from the Tail-tip.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002415', 'tail', 34, 'tail')]
PMC3052301	3/2011	S47-PMC3052301	['Blood Glucose measurement was performed with a glucometer (bayer ascensia elite®).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose')]
PMC3052301	3/2011	S51-PMC3052301	['Heart rate (hr), Left Ventricular pressure (Lvp), contraction, systolic Blood pressure (sbp) and diastolic Blood pressure (dbp).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'heart'), ('UBERON_0002084', 'heart left ventricle', 17, 'left ventricular'), ('UBERON_0005414', 'zone of polarizing activity', 44, 'LVP'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0000178', 'blood', 107, 'blood')]
PMC3052301	3/2011	S98-PMC3052301	['fasting Blood Glucose levels under basal conditions were not significantly altered in either the c-hp or hp-c Mice.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_17234', 'glucose', 14, 'glucose'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'mice')]
PMC3066640	12/2011	S27-PMC3066640	['the Fetal Circulation contains higher levels of total calcium, ionized calcium, and mg compared to maternal Blood [16].']	N/A	N/A	[('UBERON_0000922', 'embryo', 4, 'fetal'), ('UBERON_0009075', 'membrana tympaniformis', 10, 'circulation'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC3075531	7/2010	S20-PMC3075531	['in attention to exclusion criteria (not to give Blood sample or usage of Vitamin D supplement during the study period) none of the case and control populations were not excluded from our research.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3075531	7/2010	S21-PMC3075531	['to be sure that sun exposure didn’t influence our analysis, we decided to take Blood sample in winter (from december to february).']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood')]
PMC3075531	7/2010	S22-PMC3075531	['two ml Blood sample was taken from all participants and then, 25-Hydroxy Vitamin D was measured using proper kit (immunodiagnostic systems – ids – made by uk).']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 62, '25-hydroxy vitamin D')]
PMC3076295	3/2011	S94-PMC3076295	['three informants felt that increased accountability, either to a group, to a physician doing weight checks and/or Blood tests, or by logging in personal data on-line, would have helped them.']	N/A	N/A	[('UBERON_0000178', 'blood', 114, 'blood')]
PMC3081498	7/2006	S73-PMC3081498	['the aim is to achieve Blood Glucose as near normal as possible without excessive risk of hypoglycaemia.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_17234', 'glucose', 28, 'glucose')]
PMC3083444	4/2011	S5-PMC3083444	['we excluded students born before 1925 or aged over 25 years at examination and those with missing values in confounders from the analyses, resulting in 12,546 and 12,516 students for analysis of systolic and diastolic Blood pressure, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 218, 'blood')]
PMC3083444	4/2011	S41-PMC3083444	['height, weight, and Blood pressure were also recorded.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood')]
PMC3083444	4/2011	S96-PMC3083444	['results\ntables 1and2show the adjusted mean Blood pressure stratified by the year of examination or the year of Birth for men and women, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0007567', 'parturition', 111, 'birth')]
PMC3083444	4/2011	S102-PMC3083444	['for the other models, the second component added little to the explained variance in Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood')]
PMC3083444	4/2011	S117-PMC3083444	['the outcome variable is systolic Blood pressure (sbp).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood')]
PMC3083444	4/2011	S122-PMC3083444	['the outcome variable is systolic Blood pressure (sbp).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood')]
PMC3083444	4/2011	S127-PMC3083444	['students who attended the university in the 1960s had lower Blood pressure than those attending university in the 1950s.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood')]
PMC3095501	6/2011	S88-PMC3095501	['caption (table-wrap): table 3\n\nmean differences (and 95% cis) in bmi, waist circumference (wc), and Blood pressure and the risk (odds ratios and 95% cis) of overweight and central adiposity in mothers 16 y after Pregnancy by institute of medicine (iom) categories of Gestational weight gain 1outcome and iom categoryno.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy'), ('GO_0007565', 'female pregnancy', 267, 'gestational')]
PMC3095501	6/2011	S90-PMC3095501	['sbp, systolic Blood pressure; dbp, diastolic Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC3095501	6/2011	S97-PMC3095501	['caption (table-wrap): table 4\n\nmean differences (and 95% cis) in bmi, waist circumference (wc), and Blood pressure and the risk (odds ratios and 95% cis) of obesity in mothers 16 y after Pregnancy by Prepregnancy weight and Gestational weight gain (gwg) with results stratified by Prepregnancy bmi 1gwg 19–28 wk (per 400-g/wk change) 2 gwg ≥29 wk(per 400-g/wk change) 2 no.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 187, 'pregnancy'), ('GO_0007565', 'female pregnancy', 200, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 224, 'gestational'), ('GO_0007565', 'female pregnancy', 281, 'prepregnancy')]
PMC3095501	6/2011	S99-PMC3095501	['sbp, systolic Blood pressure; dbp, diastolic Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC3095978	4/2011	S4-PMC3095978	['14,425 subjects aged 20–100 (mean 41.4 ± 15.1) were screened with a physical examination and Blood tests.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'blood')]
PMC3095978	4/2011	S26-PMC3095978	['the national Cholesterol education programme (ncep) expert panel on detection, evaluation, and treatment of high Blood Cholesterol in Adults (Adult treatment panel, or atp, iii) [3], the national Heart, Lung and Blood institute, and the american Heart association [4] have released a report on the criteria for diagnosing and managing ms.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 13, 'Cholesterol'), ('UBERON_0000178', 'blood', 113, 'blood'), ('CHEBI_16113', 'cholesterol', 119, 'cholesterol'), ('UBERON_0007023', 'adult organism', 134, 'adults'), ('UBERON_0007023', 'adult organism', 142, 'adult'), ('UBERON_0000948', 'heart', 196, 'Heart'), ('UBERON_0002048', 'lung', 203, 'Lung'), ('UBERON_0000178', 'blood', 212, 'Blood'), ('UBERON_0000948', 'heart', 246, 'Heart')]
PMC3095978	4/2011	S27-PMC3095978	['the panel describes ms as the presence of any three of the following: Abdominal obesity, dislipidemia (high levels of Triglycerides, low hdl), increased Blood pressure, and elevated fasting Glucose.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 70, 'abdominal'), ('CHEBI_17855', 'triglyceride', 118, 'triglycerides'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_17234', 'glucose', 190, 'glucose')]
PMC3095978	4/2011	S56-PMC3095978	['the data recorded included family and medical history for Kidney disease, high Blood pressure, diabetes, Cardiovascular disease and any current medication or treatment.']	N/A	N/A	[('UBERON_0002113', 'kidney', 58, 'kidney'), ('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0004535', 'cardiovascular system', 105, 'cardiovascular')]
PMC3095978	4/2011	S58-PMC3095978	['physiological measurements\nBlood pressure was measured by the auscultatory method with a random zero mercury sphygmomanometer and standard cuff (12 × 34\u2009cm).']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'Blood')]
PMC3095978	4/2011	S59-PMC3095978	['the Blood pressure measurement was taken in the seated position, quietly in a chair with feet on the floor and an Arm support at the Heart level.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001460', 'arm', 114, 'arm'), ('UBERON_0000948', 'heart', 133, 'heart')]
PMC3095978	4/2011	S189-PMC3095978	['the Abdominal Adipose Tissue results in release of Free Fatty Acids directly in the Portal Veins and altered Lipid levels in the Blood [30].']	N/A	N/A	[('UBERON_0001744', 'lymphoid tissue', 4, 'abdominal adipose tissue'), ('GO_0010147', 'fructan catabolic process', 51, 'free fatty acids'), ('CHEBI_35366', 'fatty acid', 56, 'fatty acids'), ('UBERON_0002007', 'medulla of lymph node', 84, 'portal veins'), ('CHEBI_18059', 'lipid', 109, 'lipid'), ('UBERON_0000178', 'blood', 129, 'blood')]
PMC3095978	4/2011	S211-PMC3095978	['there was also a high level of Blood Glucose.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_17234', 'glucose', 37, 'glucose')]
PMC3098253	5/2011	S2-PMC3098253	['fasting body weight, height and Blood pressure were measured following standard procedures.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC3098253	5/2011	S44-PMC3098253	['written consent was obtained from every subject before body composition measurement, physical examination, and Blood sample collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 111, 'blood')]
PMC3098253	5/2011	S56-PMC3098253	["ascertainment of obesity related risk factors\nall participants' Blood pressures were measured by two physicians using standardized mercury sphygmomanometers."]	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood')]
PMC3098253	5/2011	S57-PMC3098253	['two consecutive readings of Blood pressure were taken in the right Arm according to 1999 who/international society of hypertension guidelines on hypertension[29]with the participant in a seated position after 5 minutes of rest.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_0001460', 'arm', 67, 'arm')]
PMC3098253	5/2011	S59-PMC3098253	['a Venous Blood sample (10 ml) was taken after a 12-hr fast before bia measurement.']	N/A	N/A	[('UBERON_0001638', 'vein', 2, 'venous'), ('UBERON_0000178', 'blood', 9, 'blood')]
PMC3098253	5/2011	S79-PMC3098253	['bmi, body mass index; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; fg, fasting Glucose; tc, total Cholesterol; tg, Triglyceride; hdl, high-density lipoprotein.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('CHEBI_16113', 'cholesterol', 114, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 131, 'triglyceride')]
PMC3099599	5/2011	S81-PMC3099599	['these large Veins, the Bridging Veins (Bv), are substantial and move Blood from the Brain to the Dural Sinuses.']	N/A	N/A	[('UBERON_0000964', 'cornea', 12, 'veins'), ('GO_0030674', 'protein-macromolecule adaptor activity', 23, 'bridging'), ('UBERON_0000964', 'cornea', 32, 'veins'), ('UBERON_0013657', 'hump', 39, 'BV'), ('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0005486', 'venous dural sinus', 97, 'dural sinuses')]
PMC3099599	5/2011	S85-PMC3099599	['furthermore, larger Bleeds, when found, are relatively contained due to lower Capillary pressures, as compared to bvs with higher pressures that increase the mass of extravasated Blood.']	N/A	N/A	[('UBERON_0005394', 'cortical layer V', 20, 'bleeds'), ('UBERON_0001982', 'capillary', 78, 'capillary'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC3099599	5/2011	S126-PMC3099599	['increasing Intraocular pressure (iop) decreases flow through the Eye by increasing Intracapillary pressure, decreasing both Ingress and Egress Of Blood from the Eye, contributing to the Metabolic compromises, capillary wall damage and leakage of Blood, and rh.']	N/A	N/A	[('UBERON_2000442', 'supraneural bone', 11, 'intraocular'), ('UBERON_0000970', 'eye', 65, 'eye'), ('UBERON_2000674', 'interopercle', 83, 'intracapillary'), ('GO_0007631', 'feeding behavior', 124, 'ingress ...'), ('GO_0035873', 'lactate transmembrane transport', 136, 'egress of blood'), ('UBERON_0000178', 'blood', 146, 'blood'), ('UBERON_0000970', 'eye', 161, 'eye'), ('GO_0008152', 'metabolic process', 186, 'metabolic'), ('UBERON_0000178', 'blood', 246, 'blood')]
PMC3099599	5/2011	S133-PMC3099599	['similarly, when Capillary Blood flow to the Eye decreases, a relative or absolute hypoxemia occurs in the Retinal Capillary Cell Wall, damaging the capillary wall that then leaks, forming rh.51this is the same mechanism that creates idh and sdh during harmful Hypoxic-ischemic periods in the Brain.']	N/A	N/A	[('UBERON_0001982', 'capillary', 16, 'capillary'), ('UBERON_0000178', 'blood', 26, 'blood'), ('UBERON_0000970', 'eye', 44, 'eye'), ('CL_0000681', 'radial glial cell', 106, 'retinal capillary cell'), ('UBERON_0000966', 'retina', 106, 'retinal'), ('UBERON_0001982', 'capillary', 114, 'capillary'), ('UBERON_0000060', 'anatomical wall', 129, 'wall'), ('GO_0008219', 'cell death', 260, 'hypoxic'), ('UBERON_0000955', 'brain', 292, 'brain')]
PMC3099599	5/2011	S147-PMC3099599	['the sequence starts in the Macula area, dense with Capillaries, which leaks first and Blood can accumulate under the Internal Limiting Membrane (Ilm) the most anterior Layer Of the Retina (figure 6d).']	N/A	N/A	[('UBERON_0000054', 'macula', 27, 'macula'), ('UBERON_0001982', 'capillary', 51, 'capillaries'), ('UBERON_0000178', 'blood', 86, 'blood'), ('UBERON_0001794', 'inner limiting layer of retina', 117, 'internal limiting membrane'), ('UBERON_2001341', 'intervening zone', 145, 'ILM'), ('UBERON_0001781', 'layer of retina', 168, 'layer of ... retina')]
PMC3099599	5/2011	S150-PMC3099599	['in the most extreme hypoxic states or with dic, Blood overflows these Schisis Cavities and other areas of dense Rh, leading to frank Vitreous hemorrhage (figure 6b) along with more widespread rh to extending to the periphery of the Retina.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0004118', 'vasculature of iris', 70, 'schisis cavities'), ('UBERON_0004369', "Reichert's membrane", 112, 'RH'), ('UBERON_0001797', 'vitreous humor', 133, 'vitreous'), ('UBERON_0000966', 'retina', 232, 'retina')]
PMC3099599	5/2011	S151-PMC3099599	['when Blood diffuses into the Vitreous and is widely distributed, a cloudy appearance results that can obscure the Retinal landmarks (figure 6c).']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'Blood'), ('UBERON_0001797', 'vitreous humor', 29, 'vitreous'), ('UBERON_0000966', 'retina', 114, 'retinal')]
PMC3102012	10/2011	S14-PMC3102012	['it was uncomplicated, and she was asymptomatic till morning, when she woke up in a pool of Blood followed by a lower Abdominal menstrual-like pain.']	N/A	N/A	[('UBERON_0000178', 'blood', 91, 'blood'), ('UBERON_0000916', 'abdomen', 117, 'abdominal')]
PMC3102012	10/2011	S20-PMC3102012	['resuscitation with Intravenous Fluids was started immediately at the emergency department, and Blood was sent for cross matching and lab works.']	N/A	N/A	[('UBERON_0034986', 'sacral nerve plexus', 19, 'intravenous'), ('CHEBI_37958', 'dye', 31, 'fluids'), ('UBERON_0006314', 'bodily fluid', 31, 'fluids'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC3102012	10/2011	S21-PMC3102012	['packed Red Blood Cells (Rbcs) was started as soon as it was available.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 7, 'red blood cells'), ('UBERON_0000178', 'blood', 11, 'blood'), ('CL_0000232', 'erythrocyte', 24, 'RBCs')]
PMC3102012	10/2011	S24-PMC3102012	['p-time was 100 seconds, aptt−104 seconds, Fibrinogen <50, d−dimer−980\u2009ng/ml, and her b-Hcg in Blood was raised.']	N/A	N/A	[('GO_0033258', 'plastid DNA metabolic process', 42, 'Fibrinogen'), ('CHEBI_17883', 'hydrogen chloride', 87, 'HCG'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC3103150	3/2011	S36-PMC3103150	['laboratory measurements:\nBlood (4 ml) was drawn for estimation of Serum calcium, phosphate, alkaline phosphatase (alp), 25Ohd and parathormone (pth) for both infant and mother.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'Blood'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 120, '25OHD')]
PMC3107676	4/2011	S52-PMC3107676	['women were questioned about Drugs taken (start and stop dates, frequency of use) for specific illnesses and diseases (e.g., asthma, diabetes, high Blood pressure, infections, Respiratory illnesses, seizures) and about specific products (e.g., Ampicillin, Metoprolol, Propranolol, Phenytoin, pseudoephedrine).']	N/A	N/A	[('CHEBI_23888', 'drug', 28, 'drugs'), ('UBERON_0000178', 'blood', 147, 'blood'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_28971', 'ampicillin', 243, 'ampicillin'), ('CHEBI_6794', 'metaraminol', 255, 'metoprolol'), ('CHEBI_8499', 'propranolol', 267, 'propranolol'), ('CHEBI_8107', 'phenytoin', 280, 'phenytoin')]
PMC3107945	5/2011	S1-PMC3107945	['methods\nwe studied Blood pressure in 471 nine-year-old indian children whose Placental length, breadth and weight were measured in a prospective Birth cohort study.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001987', 'placenta', 77, 'placental'), ('GO_0007567', 'parturition', 145, 'birth')]
PMC3107945	5/2011	S2-PMC3107945	['results\nin the daughters of short mothers (<median height), systolic Blood pressure (sbp) rose as Placental breadth increased (β = 0.69 mmhg/cm, p = 0.05) and as the ratio of Placental surface area to Birthweight increased (p = 0.0003).']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('UBERON_0001987', 'placenta', 175, 'placental'), ('GO_0007596', 'blood coagulation', 201, 'birthweight')]
PMC3107945	5/2011	S34-PMC3107945	['the children’s Blood pressures were measured at the age of 9 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC3107945	5/2011	S49-PMC3107945	['the Placentae were initially checked for completeness, and the Cord clamp was released to allow the Blood to drain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placentae'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC3107945	5/2011	S60-PMC3107945	['systolic and diastolic Blood pressures were measured in the left Arm using an automated Blood pressure monitor (dinamap8100, criticon, fl, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0001460', 'arm', 65, 'arm'), ('UBERON_0000178', 'blood', 88, 'blood')]
PMC3107945	5/2011	S66-PMC3107945	['analysis sample\nBlood pressure was recorded for all 539 children who attended the 9.5-year follow-up.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'Blood')]
PMC3107945	5/2011	S84-PMC3107945	['among boys, neither systolic nor diastolic pressure was related to Birthweight, Head circumference, Birth length or the length of Gestation.table 2shows the trends in Blood pressure with Placental size.']	N/A	N/A	[('GO_0007596', 'blood coagulation', 67, 'birthweight'), ('UBERON_0000033', 'head', 80, 'head'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007565', 'female pregnancy', 130, 'gestation'), ('UBERON_0000178', 'blood', 167, 'blood'), ('UBERON_0001987', 'placenta', 187, 'placental')]
PMC3107945	5/2011	S90-PMC3107945	['caption (table-wrap): table 2\n\nBlood pressure at 9.5 years among boys and girls according to Placental sizeboysgirlssystolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)systolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)Placentanmean(sd)nmean(sd)nmean(sd)nmean(sd)breadth (cm)\u2003≤1668102.9(8.9)6858.7(6.5)83100.6(8.4)8359.2(6.3)\u20031753102.6(7.8)5358.9(7.7)5098.4(8.1)5056.1(7.2)\u20031846100.3(8.5)4658.6(6.4)4998.5(9.0)4958.3(6.7)\u2003>1861101.6(8.0)6158.0(7.0)61101.4(8.5)6157.5(6.2)p for trend (unadjusted)2280.092280.672430.502430.12p for trend*2280.012280.502430.832430.09length (cm)\u2003≤1856101.8(8.4)5658.3(7.1)6499.1(8.2)6458.5(5.8)\u200319.551103.2(8.1)5159.4(5.9)6899.8(8.6)6858.7(8.0)\u20032167101.5(8.1)6758.7(7.2)6499.7(9.1)6456.9(5.9)\u2003>2154101.6(8.9)5457.8(7.1)47101.4(8.3)4757.6(6.4)p for trend (unadjusted)2280.602280.752430.072430.29p for trend*2280.152280.532430.592430.19weight (g)\u2003≤35056102.5(8.9)5658.5(7.6)5899.4(8.1)5858.6(7.4)\u200340057101.1(7.6)5758.7(6.5)8099.6(8.5)8058.6(6.5)\u200345058103.6(8.5)5859.4(6.6)44100.1(9.3)4457.9(5.6)\u2003>45057100.6(8.2)5757.5(6.8)61100.6(8.6)6156.6(6.6)p for trend (unadjusted)2280.152280.242430.802430.02p for trend*2280.012280.122430.242430.01area (cm2)\u2003≤22550102.4(8.3)5059.2(7.5)5999.7(8.3)5958.9(5.8)\u200326054102.8(9.0)5458.3(6.1)6499.3(8.6)6458.9(7.7)\u200330074102.1(7.6)7458.8(7.1)6799.4(8.7)6756.5(6.3)\u2003>30050100.5(8.6)5057.7(6.8)53101.5(8.5)5357.6(6.2)p for trend (unadjusted)2280.222280.702430.182430.14p for trend*2280.032280.492430.862430.10area/Birth weight (cm2/kg)\u2003≤8062102.9(8.9)6259.6(7.5)4999.2(8.5)4958.4(5.6)\u20039051102.6(8.4)5157.9(7.3)50100.2(7.0)5058.3(6.5)\u200310052101.9(7.9)5258.2(6.9)6598.2(9.3)6557.4(7.6)\u2003>10063100.6(8.0)6358.3(5.8)79101.6(8.6)7957.9(6.4)p for trend (unadjusted)2280.102280.222430.012430.93p for trend*2280.182280.302430.0042430.89\nthe means are unadjusted.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('UBERON_0001987', 'placenta', 93, 'placental'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0000178', 'blood', 156, 'blood'), ('UBERON_0000178', 'blood', 186, 'blood'), ('UBERON_0000178', 'blood', 217, 'blood'), ('UBERON_0001844', 'cochlea', 238, 'PlacentanMean'), ('GO_0007567', 'parturition', 1490, 'birth')]
PMC3107945	5/2011	S96-PMC3107945	['systolic Blood pressure rose as the ratio of area to Birthweight increased.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007596', 'blood coagulation', 53, 'birthweight')]
PMC3107945	5/2011	S97-PMC3107945	['diastolic Blood pressure fell as Placental weight increased.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001987', 'placenta', 33, 'placental')]
PMC3107945	5/2011	S98-PMC3107945	['intable 3, the trends in Blood pressure with Placental size among girls are divided according to the mother’s median height.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0001987', 'placenta', 45, 'placental')]
PMC3107945	5/2011	S102-PMC3107945	['caption (table-wrap): table 3\n\nBlood pressure at 9.5 years among girls according to mother’s height and Placental sizeshort motherstall motherssystolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)systolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)placentanmean(sd)nmean(sd)nmean(sd)nmean(sd)breadth (cm)\u2003≤164998.8(7.9)4958.7(6.5)34103.2(8.7)3460.0(5.9)\u2003172598.1(8.4)2556.7(7.0)2598.7(7.9)2555.4(7.5)\u20031822100.6(8.6)2259.2(7.8)2796.8(9.0)2757.4(5.6)\u2003>1832101.7(9.2)3257.8(6.2)29101.1(7.8)2957.3(6.4)p for trend (unadjusted)1280.0491280.911150.251150.03p for trend*1280.111280.831150.091150.02length (cm)\u2003≤183999.0(7.6)3958.5(5.9)2599.3(9.1)2558.5(5.7)\u200319.53699.0(9.4)3658.6(8.8)32100.8(7.6)3258.9(7.1)\u20032127100.4(8.3)2756.0(5.2)3799.2(9.7)3757.5(6.3)\u2003>2126100.9(8.7)2659.3(5.8)21102.00(7.8)2155.4(6.5)p for trend (unadjusted)1280.171280.901150.241150.07p for trend*1280.371280.581150.831150.02weight (g)\u2003≤35034100.9(9.0)3459.1(8.4)2497.3(6.2)2457.9(5.8)\u20034005199.5(8.2)5159.1(6.1)2999.9(9.2)2957.6(7.0)\u20034501797.0(6.8)1754.8(4.9)27102.1(10.2)2759.8(5.2)\u2003>45026100.3(9.4)2657.3(6.0)35100.9(8.2)3556.1(7.1)p for trend (unadjusted)1280.541280.051150.341150.24p for trend*1280.231280.101150.921150.09area (cm2)\u2003≤2253698.6(7.5)3658.3(6.0)23101.6(9.3)2359.7(5.6)\u20032603598.7(9.3)3558.7(8.1)29100.1(7.8)2959.2(7.3)\u20033003399.9(8.0)3356.8(7.1)3498.8(9.4)3456.2(5.5)\u2003>30024102.4(9.1)2459.0(5.2)29100.8(8.2)2956.5(6.9)p for trend (unadjusted)1280.071280.991150.971150.03p for trend*1280.181280.701150.401150.01area/Birth weight (cm2/g)\u2003≤ 802397.2(6.8)2357.1(4.7)26100.9(9.6)2659.6(6.2)\u2003902699.3(7.0)2658.4(6.5)24101.0(7.0)2458.1(6.7)\u20031003998.9(9.4)3957.9(8.1)2697.1(9.1)2656.7(7.0)\u2003>10040102.0(9.0)4058.8(6.7)39101.2(8.4)3956.9(6.1)p for trend (unadjusted)1280.00031280.061150.831150.07p for trend*1280.00021280.04991150.681150.08\nthe means are unadjusted.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('UBERON_0001987', 'placenta', 104, 'placental'), ('UBERON_0000178', 'blood', 152, 'blood'), ('UBERON_0000178', 'blood', 183, 'blood'), ('UBERON_0000178', 'blood', 213, 'blood'), ('UBERON_0000178', 'blood', 244, 'blood'), ('GO_0007567', 'parturition', 1514, 'birth')]
PMC3107945	5/2011	S146-PMC3107945	['strengths and limitations of the study\nin the parthenon study, Placental and Newborn size and childhood Blood pressure were measured by trained research staff according to standard protocols.']	N/A	N/A	[('UBERON_0001987', 'placenta', 63, 'placental'), ('UBERON_0000025', 'tube', 77, 'newborn'), ('UBERON_0000178', 'blood', 104, 'blood')]
PMC3111740	5/2011	S6-PMC3111740	['the rate at which each Carbohydrate raises Blood Glucose levels after Ingestion, can be measured via the dietary Glycemic index (gi).']	N/A	N/A	[('CHEBI_16730', 'chloramphenicol 3-acetate', 23, 'carbohydrate'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_17234', 'glucose', 49, 'glucose'), ('GO_0007631', 'feeding behavior', 70, 'ingestion'), ('GO_0006096', 'glycolytic process', 113, 'glycemic')]
PMC3117679	5/2011	S42-PMC3117679	['at the end of each experiment, the fasted Mice were anesthetized by Intraperitoneal injection of avertin (2,2,2-Tribromoethanol) (t-4840-2, sigma-aldrich chemie gmbh, steinheim, germany) (125 mg/kg) to obtain Blood samples by Heart puncture.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mice'), ('UBERON_2001932', 'sensory canal tubular ossicle', 68, 'intraperitoneal'), ('CHEBI_42330', '2,2,2-trifluoroethanol', 106, '2,2,2-tribromoethanol'), ('UBERON_0000178', 'blood', 209, 'blood'), ('UBERON_0000948', 'heart', 226, 'heart')]
PMC3117679	5/2011	S43-PMC3117679	['the Plasma was stored at -20°c for later analysis of the leptin levels, and the White Blood Cells were used to determine the leptin Promoter methylation.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 4, 'plasma'), ('CL_0000738', 'leukocyte', 80, 'white blood cells'), ('UBERON_0000178', 'blood', 86, 'blood'), ('GO_0007128', 'meiotic prophase I', 132, 'promoter'), ('SO_0000167', 'promoter', 132, 'promoter')]
PMC3119798	10/2010	S46-PMC3119798	['Gene analysis\nGenomic dna was extracted from White Blood Cells using standard methods.']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Gene'), ('SO_0001026', 'genome', 14, 'Genomic'), ('CL_0000738', 'leukocyte', 45, 'white blood cells'), ('UBERON_0000178', 'blood', 51, 'blood')]
PMC3124144	5/2011	S55-PMC3124144	['Duodenale causes a greater Blood loss than n. americanus .']	N/A	N/A	[('UBERON_0001234', 'left adrenal gland', 0, 'duodenale'), ('UBERON_0000178', 'blood', 27, 'blood')]
PMC3127778	5/2011	S78-PMC3127778	['these included the presence of petechiae, and Blood in or around the Nasal area.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0000004', 'nose', 69, 'nasal')]
PMC3131279	7/2011	S173-PMC3131279	['Blood was collected into heparinised tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3134395	6/2011	S9-PMC3134395	['when Iodine Intake is sufficient, the proportion cleared from the Blood by the Thyroid ranges from 10% to 80% of absorbed Iodine [1].']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 5, 'iodine'), ('GO_0007631', 'feeding behavior', 12, 'intake'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('CHEBI_24859', 'iodine atom', 122, 'iodine')]
PMC3134395	6/2011	S10-PMC3134395	['the active Transport Of Iodine From the Blood Into the Thyroid is Regulated by Thyroid-Stimulating Hormone (Tsh) from the Pituitary Gland and by the concentration of Iodine in the Blood.']	N/A	N/A	[('GO_0001658', 'branching involved in ureteric bud morphogenesis', 11, 'transport of iodine from ... blood into ... thyroid'), ('CHEBI_24859', 'iodine atom', 24, 'iodine'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002046', 'thyroid gland', 55, 'thyroid'), ('GO_0065007', 'biological regulation', 66, 'regulated'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 79, 'thyroid-stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 79, 'thyroid'), ('PR_000016711', 'TSC22 domain family protein 1', 108, 'TSH'), ('UBERON_0000007', 'pituitary gland', 122, 'pituitary gland'), ('CHEBI_24859', 'iodine atom', 166, 'iodine'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC3134395	6/2011	S131-PMC3134395	['no difference was found in maternal or Cord Blood Thyroid Hormone levels.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_60311', 'thyroid hormone', 50, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 50, 'thyroid')]
PMC3134915	1/2011	S58-PMC3134915	['*1960 – 1979209146.7178.117885.2ii**.1980 – 198427631.13813.823585.1iii.1985 – 199355920.4447.951391.8total1960 - 19931,044191.8999.592688.7\n* based on the review of admission and medical files of female patients in 1980 admitted to the study hospital between 1960 and 1979.29,30\n**based on the continuous ascertainment of Pregnant women by a psychologist.31\n***based on the ascertainment of Pregnant women by a sensitive Pregnancy test in the Blood samples of all admitted women from 15 years to 50 years.32\nsocio-demographic status of self-poisoned Pregnant women\nthe age distribution of self-poisoned Pregnant women is shown intable 2.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 323, 'pregnant'), ('GO_0007565', 'female pregnancy', 392, 'pregnant'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000178', 'blood', 444, 'blood'), ('GO_0007565', 'female pregnancy', 551, 'pregnant'), ('GO_0007565', 'female pregnancy', 604, 'pregnant')]
PMC3156909	9/2011	S23-PMC3156909	['Blood collection and Cervical dislocation were carried out after anaesthesia with 1.45% Isoflurane.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0005434', 'cervical region', 21, 'cervical'), ('CHEBI_6015', 'isoflurane', 88, 'isoflurane')]
PMC3156909	9/2011	S45-PMC3156909	['Lipid utilization\nBlood was collected via retro-Orbital puncture and Plasma was recovered by centrifugation.']	N/A	N/A	[('CHEBI_18059', 'lipid', 0, 'Lipid'), ('UBERON_0000178', 'blood', 18, 'Blood'), ('UBERON_0001697', 'orbit of skull', 48, 'orbital'), ('UBERON_0001969', 'blood plasma', 69, 'plasma')]
PMC3156909	9/2011	S68-PMC3156909	['for the Postprandial Plasma Triglyceride test, apoeko Mice after 3 months treatment with lipistase or vehicle from the Antenatal study were fasted for 12 h. after fasting, they received 300 µl of Soy Oil containing or not lipistase (17 µl/l) by Oral gavages and Blood samples were collected before gavages (time 0) and every hour during 5 h.\n\nstatistics\nanalysis of variance for repeated measurements, paired or unpaired t -test, was used where appropriate.']	N/A	N/A	[('GO_0007567', 'parturition', 8, 'postprandial'), ('UBERON_0001969', 'blood plasma', 21, 'plasma'), ('CHEBI_17855', 'triglyceride', 28, 'triglyceride'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'mice'), ('GO_0007567', 'parturition', 119, 'antenatal'), ('CHEBI_62458', 'sophoradiol', 196, 'soy oil'), ('UBERON_0000165', 'mouth', 245, 'oral'), ('UBERON_0000178', 'blood', 262, 'blood')]
PMC3168906	11/2011	S43-PMC3168906	['Blood pressure and proteinuria were measured in Pregnant women at their visits in the Prenatal care clinics.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 48, 'pregnant'), ('GO_0007565', 'female pregnancy', 86, 'prenatal')]
PMC3171895	9/2011	S21-PMC3171895	['the release of Trophoblast plugs with flow of Blood into the Intervillous space leads to the generation of oxidative stress [20].']	N/A	N/A	[('UBERON_0000088', 'trophoblast', 15, 'trophoblast'), ('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0005911', 'cell-cell junction', 61, 'intervillous')]
PMC3184661	9/2006	S16-PMC3184661	['data sources\nwe searched pubmed and embase for relevant articles by using the key words “fish”, “fish oils”, “Omega 3 Fatty Acids”, “polyunsaturated Fatty Acids”, “Pufa”, “Eicosapentaenoic Acid”, “Epa”, “Docosahexaenoic Acid”, “Dha” and “Blood pressure” or “Arterial hypertension”, using a combined text word and mesh heading search strategy.']	N/A	N/A	[('CHEBI_82673', "2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine", 110, 'omega 3'), ('CHEBI_35366', 'fatty acid', 118, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 164, 'PUFA'), ('CHEBI_31001', 'octacosanoic acid', 172, 'Eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 197, 'EPA'), ('CHEBI_78869', 'octacosapentaenoic acid', 204, 'Docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 228, 'DHA'), ('UBERON_0000178', 'blood', 238, 'blood'), ('UBERON_0001637', 'artery', 258, 'arterial')]
PMC3184661	9/2006	S67-PMC3184661	['measurements have included systemic Arterial compliance index, flow-mediated dilation of the muscular Conduit Brachial Artery and Blood flow in the microcirculation of the Forearm and of Coronary Arteries.']	N/A	N/A	[('UBERON_0001637', 'artery', 36, 'arterial'), ('UBERON_0009979', 'condyle', 102, 'conduit'), ('UBERON_0001398', 'brachial artery', 110, 'brachial artery'), ('UBERON_0000178', 'blood', 130, 'blood'), ('UBERON_0002386', 'forelimb zeugopod', 172, 'forearm'), ('UBERON_0005985', 'coronary vessel', 187, 'coronary'), ('UBERON_0001637', 'artery', 196, 'arteries')]
PMC3192058	10/2011	S36-PMC3192058	['Blood samples were collected from Fossa Orbitalis to determine Blood Glucose by an automatic glucometer (roche, germany) at 0, 30, 60, 120 and 180 min after the Glucose load.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_3000802', 'fossa glenoidalis', 34, 'fossa orbitalis'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_17234', 'glucose', 69, 'glucose'), ('CHEBI_17234', 'glucose', 161, 'glucose')]
PMC3192058	10/2011	S39-PMC3192058	['two groups of male Rats at 3, 7, 10, 15 weeks of age were fasted overnight for 12 hours, and in the morning of the next day, Blood samples were taken for determination of Blood Glucose and Serum Insulin.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 19, 'rats'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0000178', 'blood', 171, 'blood'), ('CHEBI_17234', 'glucose', 177, 'glucose'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('PR_000045358', 'insulin family protein', 195, 'insulin')]
PMC3192058	10/2011	S41-PMC3192058	['Blood samples were collected from Fossa Orbitalis sequentially before and 15, 30, 60, 120 min after Glucose administration.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_3000802', 'fossa glenoidalis', 34, 'fossa orbitalis'), ('CHEBI_17234', 'glucose', 100, 'glucose')]
PMC3192058	10/2011	S42-PMC3192058	['Blood Glucose was measured using an automatic Glucometer (roche, germany).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_24321', 'glutamo group', 46, 'glucometer')]
PMC3192058	10/2011	S46-PMC3192058	['after laparotomy and Occlusion Of the Pancreatic Duct near the Duodenum, Rat Blood was drawn.']	N/A	N/A	[('GO_0048513', 'animal organ development', 21, 'occlusion of ... duct'), ('UBERON_0007329', 'pancreatic duct', 38, 'pancreatic duct'), ('UBERON_0002114', 'duodenum', 63, 'duodenum'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rat'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC3192058	10/2011	S69-PMC3192058	['Blood samples were collected via Tail Vein at 0, 20, 40, 60, and 90 min subsequently to measure Glucose concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0003481', 'tail vein', 33, 'tail vein'), ('CHEBI_17234', 'glucose', 96, 'glucose')]
PMC3192058	10/2011	S89-PMC3192058	['3).10.1371/journal.pone.0025167.g003\n\ncaption (fig): figure 3\nBlood Glucose levels during an Intraperitoneal Glucose tolerance test in newborn pups in iugr (△) and control (•) Rats.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'Blood'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('UBERON_2001932', 'sensory canal tubular ossicle', 93, 'intraperitoneal'), ('CHEBI_17234', 'glucose', 109, 'glucose'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 176, 'rats')]
PMC3192058	10/2011	S95-PMC3192058	['4a–d).10.1371/journal.pone.0025167.g004\n\ncaption (fig): figure 4\nBlood Glucose levels during an Intraperitoneal Glucose tolerance test at 3 weeks (a), 7 weeks (b), 10 weeks (c) and 15 weeks (d) of age in iugr (△) and control (•) Rats.']	N/A	N/A	[('UBERON_0000178', 'blood', 65, 'Blood'), ('CHEBI_17234', 'glucose', 71, 'glucose'), ('UBERON_2001932', 'sensory canal tubular ossicle', 96, 'intraperitoneal'), ('CHEBI_17234', 'glucose', 112, 'glucose'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 229, 'rats')]
PMC3192420	7/2011	S53-PMC3192420	['fractional growth rate (fgr) from Birth to 40 d of age and from 3 to 7 months of age was determined in each Animal using the following formula:\nfgr 1–40 d = (weight at 40 d − weight at Birth)/weight at Birth\nfgr 3–7 months = (weight at 7 months − weight at 3 months)/weight at 3 months\nBlood samples (5 ml) were collected in the morning before Feeding at 3, 7, and 16 months of age from each Animal, collected from the Jugular Vein into heparinized and K+edta-coated tubes.']	N/A	N/A	[('GO_0007567', 'parturition', 34, 'birth'), ('NCBITaxon_33208', 'Metazoa', 108, 'animal'), ('GO_0007567', 'parturition', 185, 'birth'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0000178', 'blood', 286, 'Blood'), ('GO_0007631', 'feeding behavior', 344, 'feeding'), ('NCBITaxon_33208', 'Metazoa', 392, 'animal'), ('UBERON_0004711', 'jugular vein', 419, 'jugular vein'), ('CHEBI_29103', 'potassium(1+)', 453, 'K+')]
PMC3192420	7/2011	S55-PMC3192420	['additional Blood sampling over a 24-h period, at 2, 4, 8, and 24 h after Feeding, was undertaken at 16 months of age.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('GO_0007631', 'feeding behavior', 73, 'feeding')]
PMC3198285	11/2011	S30-PMC3198285	['gdm diagnosis was based on the modified australasian diabetes in Pregnancy society (adips) criteria: fasting Blood Glucose level (bgl) ≥5.5 mmol/l, 1-h bgl ≥10.0 mmol/l, or 2-h bgl ≥8.0 mmol/l.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 65, 'Pregnancy'), ('UBERON_0000178', 'blood', 109, 'blood'), ('CHEBI_17234', 'glucose', 115, 'glucose')]
PMC3198285	11/2011	S54-PMC3198285	['data collection\nsubjects provided Blood samples at baseline and ∼36 weeks’ Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('GO_0007565', 'female pregnancy', 75, 'gestation')]
PMC3198285	11/2011	S80-PMC3198285	['at baseline, subjects in the lgi group had significantly higher 2-h postload Blood Glucose levels (lgi 8.6 ± 1.2 mmol/l vs. hf 8.0 ± 1.3 mmol/l; p = 0.024) but were otherwise similar to those in the hf group.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_17234', 'glucose', 83, 'glucose')]
PMC3208550	11/2011	S40-PMC3208550	['at 0830 h after overnight fasting (12 h) and Blood samples were obtained from the Right Ventricle.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002080', 'heart right ventricle', 82, 'right ventricle')]
PMC3208550	11/2011	S41-PMC3208550	['the Blood was centrifuged (2,000× g , 4°c, 15 min) and the separated Serum was stored at −70°c for subsequent determination of Serum Insulin, Corticosterone, and leptin.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('UBERON_0001977', 'blood serum', 127, 'serum'), ('PR_000045358', 'insulin family protein', 133, 'insulin'), ('CHEBI_16827', 'corticosterone', 142, 'corticosterone')]
PMC3208550	11/2011	S52-PMC3208550	['briefly, at w16 Rats were fasted overnight, a fasting Blood sample was taken from a Tail Vein, and then the Rats were injected with 2.0 g D-Glucose (50% stock Solution in saline)/kg body weight Intraperitoneally.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 16, 'rats'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0003481', 'tail vein', 84, 'tail vein'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rats'), ('CHEBI_17634', 'D-glucose', 138, 'D-glucose'), ('CHEBI_75958', 'solution', 159, 'solution'), ('UBERON_0000007', 'pituitary gland', 194, 'intraperitoneally')]
PMC3208550	11/2011	S53-PMC3208550	['thereafter, Blood samples were drawn at 30-, 60- and 120-min intervals after the Glucose injection, and Glucose levels were measured by a Glucose meter (accu-chek; roche, mannheim, germany).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_17234', 'glucose', 81, 'glucose'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('CHEBI_17234', 'glucose', 138, 'glucose')]
PMC3219760	10/2011	S81-PMC3219760	['the diagnosis of anemia is simple and objective: the who defines it as a decline in Blood hemoglobin to a level less than 13 g/dl in men and 12 g/dl in women.']	N/A	N/A	[('UBERON_0000178', 'blood', 84, 'blood')]
PMC3227644	11/2011	S55-PMC3227644	['different letters indicate significantly different (p<0.05) values between generations.10.1371/journal.pone.0028282.g003\n\ncaption (fig): figure 3\nmaternal Blood Metabolite concentrations and mrna Expression of Genes involved in Hepatic Gluconeogenesis and Ketogenesis.']	N/A	N/A	[('UBERON_0000178', 'blood', 155, 'blood'), ('CHEBI_39382', 'flufenoxuron', 161, 'metabolite'), ('GO_0010467', 'gene expression', 196, 'expression'), ('SO_0000704', 'gene', 210, 'genes'), ('UBERON_0002107', 'liver', 228, 'hepatic'), ('GO_0006094', 'gluconeogenesis', 236, 'gluconeogenesis'), ('GO_0001822', 'kidney development', 256, 'ketogenesis')]
PMC3227644	11/2011	S161-PMC3227644	['Blood was collected into heparinised tubes, Plasma was separated by centrifugation and stored at −80°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 44, 'plasma')]
PMC3227644	11/2011	S165-PMC3227644	['measurements of Metabolites in Blood\nβhb and Glucose concentrations in Plasma were measured as described using a konelab 20[36].']	N/A	N/A	[('CHEBI_25212', 'metabolite', 16, 'metabolites'), ('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('UBERON_0001969', 'blood plasma', 71, 'plasma')]
PMC3235789	12/2011	S43-PMC3235789	['Preeclampsia was defined as a Blood pressure on two separate readings taken at least 4 hours apart of 140/90 or more and ≥300\u2009mg of protein in a 24-hour Urine sample (proteinuria).']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0001088', 'urine', 153, 'urine')]
PMC3235789	12/2011	S60-PMC3235789	['biological specimens and Nutrient analyses\nBlood samples were obtained at the time of the Delivery admission for all consented subjects.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 25, 'Nutrient'), ('UBERON_0000178', 'blood', 43, 'Blood'), ('GO_0007567', 'parturition', 90, 'delivery')]
PMC3235789	12/2011	S61-PMC3235789	['nonfasting Venous Blood drawn routinely as part of the Delivery admission was obtained, and an extra aliquot of edta Plasma was centrifuged and stored at −80°c degrees.']	N/A	N/A	[('UBERON_0001638', 'vein', 11, 'venous'), ('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007567', 'parturition', 55, 'delivery'), ('UBERON_0001969', 'blood plasma', 117, 'plasma')]
PMC3235789	12/2011	S113-PMC3235789	['the prefortification mean Red Blood Cell Folate was lower for non-hispanic black compared with non-hispanic white women, and fortification produced a smaller shift in mean Red Blood Cell Folate levels for black compared with white women [47].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 26, 'red blood cell'), ('UBERON_0000178', 'blood', 30, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 41, 'folate'), ('CL_0000232', 'erythrocyte', 172, 'red blood cell'), ('UBERON_0000178', 'blood', 176, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 187, 'folate')]
PMC3237352	4/2011	S44-PMC3237352	['the case mother had concentrations of Serum cotinine, Blood lead, and Urinary phthalates ranging from the 25th to 84th percentiles within the cohort (table 1).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0001088', 'urine', 70, 'urinary')]
PMC3240629	12/2011	S5-PMC3240629	['egg-lpd, lpd and emb-lpd offspring displayed significantly elevated systolic Blood pressure at 52 weeks compared to respective controls (egg-npd, npd).']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood')]
PMC3240629	12/2011	S20-PMC3240629	['in the Sheep, reductions in Maternal Food Intake, or Feeding of diets deficient in b Vitamins and methionine during the Periconceptional period (between 60 days Preconception to 31 days Gestational age), elevates fetal Blood pressure, induces Cardiovascular and Renal abnormalities, impairs Glucose tolerance and Insulin resistance and increases adiposity in Adult offspring[18],[19],[20],[21].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'sheep'), ('GO_0007618', 'mating', 28, 'maternal'), ('CHEBI_33290', 'food', 37, 'food'), ('GO_0007631', 'feeding behavior', 37, 'food intake'), ('GO_0007631', 'feeding behavior', 53, 'feeding'), ('CHEBI_33277', 'gamma-tocotrienol', 85, 'vitamins'), ('GO_0007565', 'female pregnancy', 120, 'periconceptional'), ('GO_0007565', 'female pregnancy', 161, 'preconception'), ('GO_0007565', 'female pregnancy', 186, 'gestational'), ('UBERON_0000178', 'blood', 219, 'blood'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0002113', 'kidney', 262, 'renal'), ('CHEBI_17234', 'glucose', 291, 'glucose'), ('PR_000045358', 'insulin family protein', 313, 'insulin'), ('UBERON_0007023', 'adult organism', 359, 'adult')]
PMC3240629	12/2011	S46-PMC3240629	['systolic Blood pressure\nat 52 weeks of age, offspring sbp was measured by Tail-Cuff plethysmography as previously described[25],[26].']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0002415', 'tail', 74, 'tail'), ('UBERON_0003124', 'chorion', 79, 'cuff')]
PMC3240629	12/2011	S50-PMC3240629	['Blood samples were removed via Cardiac puncture and kept on ice to clot before centrifugation for 10 minutes at 10,000 g and 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 31, 'cardiac')]
PMC3240629	12/2011	S84-PMC3240629	['systolic Blood pressure (sbp)\negg-lpd males and females displayed elevated sbp at 52 weeks of age when compared to egg-npd offspring (fig.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC3240629	12/2011	S89-PMC3240629	['mean systolic Blood pressure at 52 weeks of age from (a) offspring Fed npd or lpd exclusively during Oocyte Maturation (Egg-npd and Egg-lpd respectively), or (b) Fed npd or lpd throughout Gestation, or lpd exclusively during Preimplantation development (emb-lpd).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007631', 'feeding behavior', 67, 'fed'), ('CL_0000023', 'oocyte', 101, 'oocyte'), ('GO_0007618', 'mating', 108, 'maturation'), ('CL_0002322', 'embryonic stem cell', 120, 'Egg'), ('CL_0002322', 'embryonic stem cell', 132, 'Egg'), ('GO_0007631', 'feeding behavior', 162, 'fed'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0006412', 'translation', 225, 'preimplantation')]
PMC3241136	9/2010	S26-PMC3241136	['furthermore, the concentration of Bisphenol A in Amniotic Fluid exceeds the concentration in maternal Blood implicating accumulation of Bisphenol A in fetal compartment (reviewed in maffini et al.,2006).']	N/A	N/A	[('CHEBI_33216', 'bisphenol A', 34, 'bisphenol A'), ('UBERON_0000173', 'amniotic fluid', 49, 'amniotic fluid'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_33216', 'bisphenol A', 136, 'bisphenol A')]
PMC3248362	11/2011	S22-PMC3248362	["recruitment of cohort and follow-up to time of Delivery\n\npatients and study setting\ntrained research assistants approached consecutive Pregnant women at the time they presented for routine ultrasound examination (most subjects), Prenatal Blood drawing, or first- or second-Trimester obstetric clinic visits at four large maternity hospitals affiliated with mcgill university or l'université de montréal in montréal, canada."]	N/A	N/A	[('GO_0007567', 'parturition', 47, 'delivery'), ('GO_0007565', 'female pregnancy', 135, 'pregnant'), ('GO_0007565', 'female pregnancy', 229, 'prenatal'), ('UBERON_0000178', 'blood', 238, 'blood'), ('GO_0009294', 'DNA mediated transformation', 273, 'trimester')]
PMC3248362	11/2011	S28-PMC3248362	['after the interview, non-fasting Blood samples were obtained by venipuncture and immediately placed on ice.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood')]
PMC3248362	11/2011	S40-PMC3248362	['bearly-onset preeclampsia defined as occurrence at < 34 weeks Gestation [18]\ncsevere preeclampsia defined as presence of any of the following: seizure, hellp, proteinuria ≥ 3 g/24 hours or diastolic Blood pressure > 110 mm hg [18]\nprimarily for recruiting convenience, controls (n = 443) were study women who Delivered at the same hospital closest in calendar time to a case, but did not have Preeclampsia.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'gestation'), ('UBERON_0000178', 'blood', 199, 'blood'), ('GO_0007567', 'parturition', 309, 'delivered'), ('GO_0007128', 'meiotic prophase I', 393, 'preeclampsia')]
PMC3248362	11/2011	S79-PMC3248362	['caption (table-wrap): table 2\n\ncomparison of preeclampsia cases, non-cases and controls: demographic, medical and obstetric characteristics ascertained at 24-26 week study visitcharacteristiccases(n = 113)non-cases*(n = 5107)controls(n = 443)age category\u2003< 20 years3%3%3%\u200320-34 years78%79%79%\u2003> 34 years19%18%18%hospital recruited\u2003hôpital st. luc15%22%24%\u2003hôpital maisonneuve rosemont39%36%37%\u2003royal victoria hospital22%18%17%\u2003jewish general hospital24%24%22%body mass index before Pregnancy, kg/m2\u2003< 18.52%8%9%\u200318.5 to < 2552%63%60%\u200325 to < 3027%18%18%\u2003≥ 3019%11%13%primigravida40%35%34%use of Prenatal Vitamins92%92%92%diabetes before Pregnancy or prior to 24 weeks Gestation6%2%1%high Blood pressure before Pregnancy8%4%3%previous Preeclampsia or eclampsia (among women with prior Pregnancy lasting > 20 wks)21%3%3%smoke currently10%16%16%\n* non-cases = study cohort (n = 5337) excluding cases (n = 113) and women who developed Gestational hypertension without Preeclampsia (n = 117).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 482, 'pregnancy'), ('GO_0007565', 'female pregnancy', 595, 'prenatal'), ('CHEBI_46448', 'ubiquinone-7', 604, 'vitamins92'), ('GO_0007565', 'female pregnancy', 637, 'pregnancy'), ('GO_0007565', 'female pregnancy', 668, 'gestation6'), ('UBERON_0000178', 'blood', 688, 'blood'), ('GO_0007565', 'female pregnancy', 710, 'pregnancy8'), ('GO_0007128', 'meiotic prophase I', 734, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 784, 'pregnancy'), ('GO_0007565', 'female pregnancy', 931, 'gestational'), ('GO_0007128', 'meiotic prophase I', 964, 'preeclampsia')]
PMC3249602	12/2011	S29-PMC3249602	['she was evaluated with complete Blood count (cbc), esr, Urea and creatinine, hiv serology, and later excision biopsy.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_16199', 'urea', 56, 'Urea')]
PMC3257747	3/2011	S56-PMC3257747	['Folate deficiency is defined as a Serum Folate concentration <7 nmol/l (~3 ng/ml) or a Red Blood Cell Folate concentration <315 nmol/l (~140 ng/ml) [15].']	N/A	N/A	[('CHEBI_81245', 'Vulpecholate', 0, 'Folate'), ('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 40, 'folate'), ('CL_0000232', 'erythrocyte', 87, 'red blood cell'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate')]
PMC3257747	3/2011	S117-PMC3257747	['if the body’s ability to reduce Folic Acid is exceeded, Unmetabolized Folic Acid will be found circulating in the Blood.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 32, 'folic acid'), ('GO_0031319', 'detection of cAMP', 56, 'unmetabolized'), ('CHEBI_30751', 'formic acid', 70, 'folic acid'), ('UBERON_0000178', 'blood', 114, 'blood')]
PMC3260090	12/2011	S146-PMC3260090	['Blood quantum specifications).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'blood')]
PMC3262346	12/2011	S15-PMC3262346	['at the time of consultation, Platelet count was 76,000/l (150–450/l) with a mean Platelet volume (mpv) of 12.3 fl (7.4–12.0 fl), hemoglobin was 10.1 mg/dl (12.0–16.0 mg/l), and White Blood Cell count was 4400/l (4.8–10.8/l) with a normal differential.']	N/A	N/A	[('CL_0000233', 'platelet', 29, 'platelet'), ('CL_0000233', 'platelet', 81, 'platelet'), ('CL_0000738', 'leukocyte', 177, 'white blood cell'), ('UBERON_0000178', 'blood', 183, 'blood')]
PMC3263630	1/2012	S102-PMC3263630	['in the mothers with preexisting t2dm in the manitoba oji-cree, 25% of their children eligible for Blood Glucose screening (>7 years old) had t2dm and 43% of those >10 years old had t2dm [3].']	N/A	N/A	[('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_17234', 'glucose', 104, 'glucose')]
PMC3263848	7/2011	S10-PMC3263848	['other variables with significantly increased compliance using the team-based method were compliance with checking a Blood Glucose value, diagnosing gerd, and prescribing Medication such as Analgesics and multivitamins.']	N/A	N/A	[('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_17234', 'glucose', 122, 'glucose'), ('CHEBI_60211', 'compound Z', 170, 'medication'), ('CHEBI_35480', 'analgesic', 189, 'analgesics')]
PMC3263848	7/2011	S56-PMC3263848	['for Blood Glucose value checked, 132 (42%) patients were tested with the team-based approach and 9 (5.9%) patients were tested with the traditional method, p = 0.000.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_17234', 'glucose', 10, 'glucose')]
PMC3264579	1/2012	S49-PMC3264579	['Blood collection and biochemical analysis\nafter a fast of 24 h Rats were rapidly euthanized between 09h00 am and 11h00 am by Co2Inhalation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 63, 'rats'), ('CHEBI_62809', 'trans-heme d hydroxychlorin gamma-spirolactone(1-)', 125, 'CO2inhalation')]
PMC3264579	1/2012	S50-PMC3264579	['Blood was collected in heparinised tubes (laboratoires léo sa, st quentin en yvelines, france) and centrifuged at 2500 g for 15 min at 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3268605	8/2011	S101-PMC3268605	['note that Adult Kidney weight and Tail-Cuff Blood pressure data, which were published previously (koeners et al.,2008b), are included in the table for the sake of convenience.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('UBERON_0002113', 'kidney', 16, 'kidney'), ('UBERON_0008894', 'pharyngeal gill precursor', 34, 'tail-cuff'), ('UBERON_0000178', 'blood', 44, 'blood')]
PMC3268605	8/2011	S105-PMC3268605	['Perinatal Molsidomine decreased systolic Blood pressure in Adult fhh offspring (koeners et al.,2008b).']	N/A	N/A	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('CHEBI_30629', 'diethylenetriamine', 10, 'molsidomine'), ('UBERON_0000178', 'blood', 41, 'blood'), ('UBERON_0007023', 'adult organism', 59, 'adult')]
PMC3268605	8/2011	S108-PMC3268605	['caption (table-wrap): table 1\n\nbiometrical data of control fhh and fhh during Molsidomine (2\u2009days and 2 weeks) or after Perinatal molsidomine (adult) .malesfemalescontrolsmolsidominecontrolsmolsidomine 2 days number of pups/number of litters12/712/712/619/10rkw/bw (mg/g)4.9\u2009±\u20090.14.8\u2009±\u20090.15.3\u2009±\u20090.14.9\u2009±\u20090.1#2 weeks number/litters15/817/1013/818/10rkw/bw (mg/g)5.2\u2009±\u20090.15.3\u2009±\u20090.15.3\u2009±\u20090.15.5\u2009±\u20090.1 adult number/litters23/1013/424/1016/5rkw/bw (mg/g)3.8\u2009±\u20090.13.4\u2009±\u20090.03#4.4\u2009±\u20090.14.3\u2009±\u20090.1systolic Blood pressure (mmhg)158\u2009±\u20093139\u2009±\u20094#145\u2009±\u20095118\u2009±\u20095#\n#p\u2009<\u20090.05 vs. controls of same gender.']	N/A	N/A	[('CHEBI_30629', 'diethylenetriamine', 78, 'molsidomine'), ('GO_0036268', 'swimming', 120, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 120, 'perinatal'), ('UBERON_0000178', 'blood', 496, 'blood')]
PMC3268605	8/2011	S200-PMC3268605	['subsequently siblings of these shr had a lower Blood pressure than control shr.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood')]
PMC3270452	1/2012	S98-PMC3270452	['after supplementation, Red Blood Cell (Rbc) Dha concentration and the percentage of total Fatty Acids (%tfa) in Pregnant women ( n = 54) were higher in the Fish Oil group than in the placebo group from 28\u2009wks to Delivery ( p< 0.05).']	N/A	N/A	[('CL_0000232', 'erythrocyte', 23, 'red blood cell'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CL_0000232', 'erythrocyte', 39, 'RBC'), ('CHEBI_17874', 'dihydrozeatin', 44, 'DHA'), ('CHEBI_35366', 'fatty acid', 90, 'fatty acids'), ('GO_0007565', 'female pregnancy', 112, 'pregnant'), ('CHEBI_34766', 'Furamizole', 156, 'fish oil'), ('GO_0007567', 'parturition', 212, 'delivery')]
PMC3271033	1/2012	S28-PMC3271033	['procedures\nCord Blood was obtained at Birth for analysis of 25(Oh)D and ionized calcium.']	N/A	N/A	[('UBERON_0000948', 'heart', 11, 'Cord'), ('UBERON_0000178', 'blood', 16, 'blood'), ('GO_0007567', 'parturition', 38, 'birth'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 66, 'D')]
PMC3271033	1/2012	S42-PMC3271033	['Cord Blood and infant Blood at three months of age were analyzed for 25(Oh)D concentration by diasorin radioimmunoassay (diasorin inc., stillwater mn) at yale university.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D')]
PMC3271033	1/2012	S45-PMC3271033	['Ionized calcium was measured from Cord Blood using standard clinical measurement techniques in the Blood gas laboratories of the respective hospitals.']	N/A	N/A	[('CHEBI_5893', 'indapamide', 0, 'Ionized'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC3271033	1/2012	S62-PMC3271033	['results\n\nCord Blood and initial Bone mineralization values\na total of 49 singleton infants were enrolled at one week of age for this research project.']	N/A	N/A	[('UBERON_0000948', 'heart', 9, 'Cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007567', 'parturition', 32, 'bone')]
PMC3273459	2/2012	S3-PMC3273459	['at −5, 24, 66, and 108 days post Coitum (dpc) fasted Blood was collected.']	N/A	N/A	[('GO_0007620', 'copulation', 33, 'coitum'), ('UBERON_0000178', 'blood', 53, 'blood')]
PMC3273459	2/2012	S50-PMC3273459	['in Exp2, again a group of nulliparous sows was inseminated and 9 sows per dietary group (lp, ap, hp) were investigated for a diurnal Blood Metabolite profile at 92 dpc.']	N/A	N/A	[('PR_000007209', 'steroid hormone receptor ERR2', 3, 'EXP2'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_39382', 'flufenoxuron', 139, 'metabolite')]
PMC3273459	2/2012	S56-PMC3273459	['Blood sampling\nafter overnight Food withdrawal in sows of Exp1, Blood samples were taken at −5, 24, 66, and 108 dpc by venipuncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_33290', 'food', 31, 'food'), ('PR_000007209', 'steroid hormone receptor ERR2', 58, 'EXP1'), ('UBERON_0000178', 'blood', 64, 'blood')]
PMC3273459	2/2012	S57-PMC3273459	['in Exp2, sows were surgically fitted with an indwelling Jugular Vein catheter on 84 dpc to allow diurnal Blood sampling on 92 dpc.']	N/A	N/A	[('PR_000007209', 'steroid hormone receptor ERR2', 3, 'EXP2'), ('UBERON_0004711', 'jugular vein', 56, 'jugular vein'), ('UBERON_0000178', 'blood', 105, 'blood')]
PMC3273459	2/2012	S65-PMC3273459	['at 92 dpc, diurnal Blood collection from the catheter started at 08:00 h and was continued at 2-hourly intervals until the next morning 08:00 h. on the sampling day, a meal with 50% of the daily allowance (2.7 kg/d) was Fed at 07:00 h, one hour before the first Blood sample, and the second meal was Consumed at 13:00 h.\nBlood was immediately put on ice and centrifuged at 1500× g at 4°c for 20 min and the supernatant was stored at −20°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('GO_0007631', 'feeding behavior', 220, 'fed'), ('UBERON_0000178', 'blood', 262, 'blood'), ('GO_0007631', 'feeding behavior', 300, 'consumed'), ('UBERON_0000178', 'blood', 321, 'Blood')]
PMC3273459	2/2012	S66-PMC3273459	['tubes containing f-edta (s-monovette, 1.2 g edta/l Blood, 1 g Fluoride/l Blood; sarstedt ag & co, nümbrecht, germany) were used for the analysis of Glucose, Triacylglycerol (tg), non-esterified Fatty Acids (nefa), total Cholesterol (c), low density Lipoprotein Cholesterol (ldlc), high density Lipoprotein Cholesterol (hdlc), and Insulin-Like Growth Factor-I (Igf-I) concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_17051', 'fluoride', 62, 'fluoride'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_17234', 'glucose', 148, 'glucose'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 157, 'triacylglycerol'), ('CHEBI_35366', 'fatty acid', 194, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 220, 'cholesterol'), ('CHEBI_24911', 'isopiperitenol', 249, 'lipoprotein cholesterol'), ('CHEBI_39015', 'apolipoprotein', 294, 'lipoprotein'), ('CHEBI_16113', 'cholesterol', 306, 'cholesterol'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 330, 'insulin-like growth factor-I'), ('PR_000008919', 'interferon alpha-6', 360, 'IGF-I')]
PMC3273459	2/2012	S67-PMC3273459	['Serum monovettes (monovette z, sarstedt ag & co, nümbrecht, germany) were used for the measurement of Urea and Serum protein levels, and tubes containing Li-Heparin (14–15 kiu/l Blood) were used to determine Insulin, glucagon, leptin, Cortisol and Progesterone (p4) concentrations.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_16199', 'urea', 102, 'urea'), ('UBERON_0001977', 'blood serum', 111, 'serum'), ('CHEBI_16382', 'iodide', 154, 'Li-'), ('CHEBI_28304', 'heparin', 157, 'heparin'), ('UBERON_0000178', 'blood', 178, 'blood'), ('PR_000045358', 'insulin family protein', 208, 'insulin'), ('CHEBI_17650', 'cortisol', 235, 'cortisol'), ('CHEBI_17026', 'progesterone', 248, 'progesterone')]
PMC3276895	11/2011	S36-PMC3276895	['samples of Venous Blood were drawn from each subject (patients and controls) after an overnight fast for measurement of Serum Fa and Serum Ige.']	N/A	N/A	[('UBERON_0001638', 'vein', 11, 'venous'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_30751', 'formic acid', 126, 'FA'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 139, 'IgE')]
PMC3276895	11/2011	S37-PMC3276895	['the Blood samples were left to clot for up to 60 minutes at room temperature (22°c) and then centrifuged at 3 000 rpm for 10 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3276988	9/2011	S5-PMC3276988	['all dna samples were purified from peripheral Blood by standard techniques.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood')]
PMC3276988	9/2011	S35-PMC3276988	['all dna samples were purified from peripheral Blood by standard techniques[14] after the subjects provided written informed consent and approval was obtained from the institutional “Human ethical committee” (hec).']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'Human')]
PMC3276988	9/2011	S36-PMC3276988	['sample collection\nperipheral Blood samples of volume 10 ml were collected by anti-Cubital Vein puncture from patients and controls in plastic falcon tubes containing edta.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0001663', 'cerebral vein', 82, 'cubital vein')]
PMC3277098	12/2011	S106-PMC3277098	['Pregnancy\nduring Pregnancy the foetus is exposed to Vitamin D through Cord Blood supply and the ability of 25(Oh)D and 24,25(Oh)d to cross the Placenta [23].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 70, 'cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('CHEBI_51686', 'haematoxylin', 124, '(OH'), ('UBERON_0001987', 'placenta', 143, 'placenta')]
PMC3290837	10/2011	S4-PMC3290837	['Blood pressure and Glomerular number were measured in Adult offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000074', 'renal glomerulus', 19, 'glomerular'), ('UBERON_0007023', 'adult organism', 54, 'adult')]
PMC3290837	10/2011	S5-PMC3290837	['results\ncontrol Rats cross fostered to another control mother had a lower Blood pressure than low protein Rats cross fostered to another low protein mother (133 ± 4 vs. 151 ± 4 mm hg, p < 0.05) and a greater number of Glomeruli (28,388 ± 989 vs. 25,045 ± 851, p < 0.05).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 16, 'rats'), ('UBERON_0000178', 'blood', 74, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 106, 'rats'), ('UBERON_0000074', 'renal glomerulus', 218, 'glomeruli')]
PMC3290837	10/2011	S39-PMC3290837	['measurement of Blood pressure\nBlood pressure was measured at 10 weeks of age by Tail cuff using a Blood pressure analyzer (model 179; iitc, woodland hills, calif., usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'Blood'), ('UBERON_0000178', 'blood', 30, 'Blood'), ('UBERON_0002415', 'tail', 80, 'tail'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC3290837	10/2011	S40-PMC3290837	['Rats were trained for 4 days by placing Rats in a lucite tube and inflating the Tail Blood Pressure cuff several times 1 day prior to the actual measurement of Blood pressure on the 5th day.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 40, 'rats'), ('UBERON_0002415', 'tail', 80, 'tail'), ('UBERON_0013756', 'venous blood', 85, 'blood pressure'), ('UBERON_0000178', 'blood', 160, 'blood')]
PMC3290837	10/2011	S41-PMC3290837	['Blood pressure was measured at least four times in each Rat, and the mean of the values was used as the Blood pressure for that Rat.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rat'), ('UBERON_0000178', 'blood', 104, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 128, 'rat')]
PMC3290837	10/2011	S42-PMC3290837	['the investigator who measured the Blood pressure was blinded to the origin of the Rats being studied.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 82, 'rats')]
PMC3290837	10/2011	S69-PMC3290837	['the Kidneys of the low protein group raised by a mother that Ate a low protein diet weighed 1.21 ± 0.05 g, which was not different from than that of the 6% group raised by a mother who ate a 20% protein diet during Pregnancy 1.27 ± 0.03 g, or the 20% group raised by a mother who ate a 6% diet during Pregnancy 1.20 ± 0.08 g.\nBlood pressure of control diet Rats raised by their mothers was 134 ± 5 mm hg, which was not different from the control Rats that were fostered to controls (133 ± 4 mm hg).']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidneys'), ('GO_0009636', 'response to toxic substance', 61, 'ate'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007565', 'female pregnancy', 301, 'pregnancy'), ('UBERON_0000178', 'blood', 326, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 357, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 446, 'rats')]
PMC3290837	10/2011	S70-PMC3290837	['the Blood pressure of the low protein group raised by their own mother was 150 ± 2 versus 151 ± 4 mm hg in the 6% group raised by a low protein diet mother.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3290837	10/2011	S73-PMC3290837	['ten-week-old low protein Rat offspring that were reared by mothers Fed a low protein diet had a significantly higher Blood pressure than those whose mothers were Fed a control diet and cross fostered to mothers that Ate a control diet.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rat'), ('GO_0007631', 'feeding behavior', 67, 'fed'), ('UBERON_0000178', 'blood', 117, 'blood'), ('GO_0007631', 'feeding behavior', 162, 'fed'), ('GO_0009636', 'response to toxic substance', 216, 'ate')]
PMC3290837	10/2011	S126-PMC3290837	['cross fostering control Rats to mothers that had dietary protein deprivation did not have a significant effect on Blood pressure, while cross fostering Rats from mothers that had dietary protein deprivation to controls resulted in normalization of Blood pressure.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 24, 'rats'), ('UBERON_0000178', 'blood', 114, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 152, 'rats'), ('UBERON_0000178', 'blood', 248, 'blood')]
PMC3295346	9/2011	S4-PMC3295346	['Prenatal lead exposure was assessed by measurement of maternal Tibia and Patella lead using in vivo k-shell x-ray fluorescence and Cord Blood lead using atomic absorption spectrometry.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('UBERON_0000979', 'tibia', 63, 'tibia'), ('UBERON_0002446', 'patella', 73, 'patella'), ('UBERON_0002240', 'spinal cord', 131, 'cord'), ('UBERON_0000178', 'blood', 136, 'blood')]
PMC3295346	9/2011	S55-PMC3295346	['anthropometric data from the mother and newborn, and Umbilical Cord and maternal Venous Blood samples were gathered within 12 hr of Delivery.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 53, 'umbilical cord'), ('UBERON_0001638', 'vein', 81, 'venous'), ('UBERON_0000178', 'blood', 88, 'blood'), ('GO_0007567', 'parturition', 132, 'delivery')]
PMC3295346	9/2011	S64-PMC3295346	['medical history, physical examination, bp measurements, and Venous Blood samples were collected from or performed on mothers and children.']	N/A	N/A	[('UBERON_0001638', 'vein', 60, 'venous'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC3295346	9/2011	S73-PMC3295346	['Umbilical Cord Blood lead was analyzed using an Atomic absorption spectrometry instrument (model 3000; perkinelmer, chelmsford, ma, usa), and child concurrent Blood lead was analyzed using inductively coupled Plasma mass spectrometry (elan 6100; perkinelmer, norwalk, ct, usa).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('CHEBI_33250', 'atom', 48, 'atomic'), ('UBERON_0000178', 'blood', 159, 'blood'), ('UBERON_0001969', 'blood plasma', 209, 'plasma')]
PMC3295346	9/2011	S75-PMC3295346	['Blood pressure end points.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3295346	9/2011	S82-PMC3295346	['Umbilical Cord Blood lead concentrations were transformed to their natural logarithmic values to normalize the right-skewed distribution.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood')]
PMC3295346	9/2011	S104-PMC3295346	['Umbilical Cord Blood lead had a mean of 5.51 ± 3.45 μg/dl.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood')]
PMC3295346	9/2011	S105-PMC3295346	['the mean for available concurrent Blood lead levels was 2.96 ± 1.72 μg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood')]
PMC3295346	9/2011	S111-PMC3295346	['boys had slightly higher Blood lead levels at the time of bp measurement than did girls ( p = 0.10) (table 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood')]
PMC3295346	9/2011	S115-PMC3295346	['caption (table-wrap): table 1\n\ncharacteristics of the study participants, overall and by child sex.variable a overall ( n = 457)girls ( n = 211)boys ( n = 246) p -value b maternal characteristics during index Pregnancymaternal age (years)25.6 ± 5.425.7 ± 5.525.6 ± 5.30.56maternal education (years)10.5 ± 3.010.3 ± 2.810.7 ± 3.20.39smoking during Pregnancy (% yes)3.54.32.80.16calories (kcal)1.44 ± 0.581.45 ± 0.611.44 ± 0.560.75calcium (mg)2,303 ± 7082,313 ± 7662,296 ± 6570.80iron (mg)20.7 ± 15.421.2 ± 15.220.2 ± 15.70.47tibia lead (μg/g)9.3 (3.3–16.1)9.99 (3.5–16.3)9.1 (3.1–16)0.33patella lead (μg/g)11.6 (4.5–19.9)10.8 (4.6–20.9)12.2 (4.5–18.5)0.92maternal characteristics during follow-upsbp (mmhg)109.9 ± 11.3109.2 ± 11109.3 ± 110.32dbp (mmhg)72 ± 8.471.5 ± 8.372.3 ± 8.30.74child characteristics at Birthgestational age (weeks)39 ± 1.338.9 ± 1.339.1 ± 1.30.69birth weight (g)3,130 ± 4323,066 ± 4403,190 ± 418< 0.01cord Blood lead (μg/dl) c 5.51 ± 3.455.67 ± 3.675.48 ± 3.270.63child characteristics at follow-upage (years)10.7 ± 2.410.6 ± 2.410.8 ± 2.40.79birth order2.04 ± 1.132.03 ± 1132.05 ± 1130.82height (cm)143 ± 14142 ± 12145 ± 15.4< 0.01bmi (kg/m2)20 ± 3.919.7 ± 3.720.2 ± 4.10.15Blood lead (μg/dl) d 2.96 ± 1.722.75 ± 1.663.55 ± 1.760.10sbp (mmhg)94.9 ± 10.594.6 ± 10.595 ± 10.50.66dbp (mmhg)61.4 ± 8.260.7 ± 8.461.5 ± 8.20.52 a values are median (iqr) for bone lead, percentage for smoking during Pregnancy, and mean ± sd for all other variables.']	N/A	N/A	[('GO_0012501', 'programmed cell death', 209, 'pregnancyMaternal'), ('GO_0007565', 'female pregnancy', 347, 'pregnancy'), ('GO_0007602', 'phototransduction', 808, 'birthGestational'), ('UBERON_0000178', 'blood', 928, 'blood'), ('CHEBI_49166', '6-((18)F)fluoro-L-dopa', 1195, '15Blood'), ('GO_0007565', 'female pregnancy', 1416, 'pregnancy')]
PMC3295346	9/2011	S117-PMC3295346	['c children with Umbilical Cord Blood lead level, n = 323: 143 girls and 180 boys.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 16, 'umbilical cord'), ('UBERON_0000178', 'blood', 31, 'blood')]
PMC3295346	9/2011	S118-PMC3295346	['d children with concurrent Blood lead level, n = 367: 176 girls and 191 boys.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood')]
PMC3295346	9/2011	S121-PMC3295346	['maternal age, dietary Intake of calories, calcium, and iron during Pregnancy, weight at Birth, Birth order, and child Blood lead were not significantly associated with bp.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 22, 'intake'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007567', 'parturition', 88, 'birth'), ('GO_0007567', 'parturition', 95, 'birth'), ('UBERON_0000178', 'blood', 118, 'blood')]
PMC3295346	9/2011	S122-PMC3295346	['caption (table-wrap): table 2\n\nparameter estimate (mean ± sd) from simple linear regression of child bp in relation to maternal lead biomarkers and other factors.Sbpdbpvariableoverall ( n = 457)boys ( n = 246)girls ( n = 211)overall ( n = 457)boys ( n = 246)girls ( n = 211)maternal characteristics during index Pregnancymaternal age (years)0.03 ± 0.090.03 ± 0.090.04 ± 0.09–0.10 ± 0.1–0.09 ± 0.1–0.11 ± 0.1maternal education (years)–0.12 ± 0.2–0.10 ± 0.2–0.16 ± 0.2–0.17 ± 0.1–0.14 ± 0.1–0.24 ± 0.1smoking during Pregnancy (% yes)–0.91 ± 3.0–0.86 ± 3.0–1.01 ± 3.0–2.0 ± 2.17–1.88 ± 2.2–2.27 ± 2.2calories (kcal)0.58 ± 0.720.57 ± 0.750.59 ± 0.750.55 ± 0.500.70 ± 0.530.43 ± 0.52calcium (mg)–0.67 ± 0.9–0.62 ± 0.9–0.75 ± 1.0–0.39 ± 0.7–0.17 ± 0.7–0.71 ± 0.73iron (mg)–0.16 ± 0.3–0.05 ± 0.4–0.28 ± 0.4–0.09 ± 0.20.04 ± 0.27–0.24 ± 0.25Tibia lead (μg/g)0.10 ± 0.0**0.07 ± 0.060.13 ± 0.05**0.05 ± 0.040.03 ± 0.050.07 ± 0.05patella lead (μg/g)0.08 ± 0.040.08 ± 0.050.07 ± 0.050.04 ± 0.040.04 ± 0.040.026 ± 0.04maternal characteristics during follow-upsbp (mmhg)0.32 ± 0.040.32 ± 0.040.32 ± 0.040.20 ± 0.030.20 ± 0.030.19 ± 0.03dbp (mmhg)0.38 ± 0.060.38 ± 0.060.38 ± 0.060.29 ± 0.050.29 ± 0.050.29 ± 0.05child characteristics at Birthgestational age (weeks)0.30 ± 0.380.30 ± 0.380.30 ± 0.380.41 ± 0.310.41 ± 0.310.39 ± 0.31birth weight (g)1.53 ± 1.281.53 ± 1.281.52 ± 1.351.3 ± 0.951.28 ± 0.951.09 ± 1.02birth order0.05 ± 0.45–0.13 ± 0.50.27 ± 0.50–0.31 ± 0.3–0.37 ± 0.4–0.25 ± 0.38cord Blood lead (μg/dl)0.32 ± 0.18033 ± 0.190.31 ± 0.220.26 ± 0.12**0.28 ± 0.14**0.24 ± 0.14child characteristics during follow-upchild age (years)1.49 ± 0.18*1.48 ± 0.19*1.52 ± 0.19*1.19 ± 0.15*1.2 ± 0.15*1.18 ± 0.16*child height (cm)0.25 ± 0.03*0.25 ± 0.03*0.25 ± 0.03*0.19 ± 0.02*0.19 ± 0.03*0.19 ± 0.03*child bmi (kg/m2)1.01 ± 0.13*1.0 ± 0.13*1.02 ± 0.12*0.61 ± 0.10*0.62 ± 0.10*0.60 ± 0.10*child Blood lead (μg/dl)0.20 ± 0.130.22 ± 0.140.15 ± 0.20–0.01 ± 0.20.03 ± 0.14–0.10 ± 0.22* p< 0.001, ** p< 0.05, derived from testing linear regression coefficients.']	N/A	N/A	[('PR_000002097', 'sodium channel protein type 11 subunit alpha', 162, 'SBPDBPVariableOverall'), ('GO_0012501', 'programmed cell death', 312, 'pregnancyMaternal'), ('GO_0007565', 'female pregnancy', 514, 'pregnancy'), ('UBERON_0010514', 'strand of duvet hair', 831, '25Tibia'), ('GO_0007602', 'phototransduction', 1223, 'birthGestational'), ('UBERON_0000178', 'blood', 1481, 'blood'), ('UBERON_0000178', 'blood', 1877, 'blood')]
PMC3295346	9/2011	S125-PMC3295346	['adjusted Tibia, Patella, and Cord Blood lead were not significantly associated with sbp (table 3).']	N/A	N/A	[('UBERON_0000979', 'tibia', 9, 'tibia'), ('UBERON_0002446', 'patella', 16, 'patella'), ('UBERON_0002240', 'spinal cord', 29, 'cord'), ('UBERON_0000178', 'blood', 34, 'blood')]
PMC3295346	9/2011	S131-PMC3295346	['Cord Blood lead was not associated with sbp or dbp.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC3295346	9/2011	S132-PMC3295346	['there were no significant interactions between sex and Cord Blood lead.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 55, 'cord'), ('UBERON_0000178', 'blood', 60, 'blood')]
PMC3295346	9/2011	S133-PMC3295346	['caption (table-wrap): table 3\n\nadjusted difference [β-coefficient (95% ci)] in child bp for an iqr increase in maternal bone ( n = 457) and Cord Blood lead ( n = 323), overall and by sex.measuretibia lead (iqr = 13 μg/g)Patella lead (iqr = 16 μg/g)Cord Blood lead (iqr = 4 μg/dl)overallsbp0.96 (–0.13, 2.05)0.44 (–0.72, 1.61)0.92 (–0.55, 2.39)dbp0.46 (–0.52, 1.33)0.23 (–0.74, 1.20)0.92 (–0.11, 1.95)Girlssbp2.11 (0.69, 3.52)**0.87 (–0.75, 2.49)0.75 (–1.13, 2.63)dbp1.60 (0.28, 2.91)*0.83 (–0.66, 2.31)0.96 (–0.22, 2.15)boyssbp–0.34 (–1.98, 1.30)0.01 (–1.64, 1.65)1.23 (–1.11, 3.56)dbp–0.83 (–2.05, 0.38)–0.38 (–1.56, 0.79)0.84 (–0.91, 2.59)all models were adjusted for maternal education; smoking during Pregnancy; dietary intakes of calories, calcium, and iron during Pregnancy; infant Birth order; Gestational age and weight at Birth; and child age, height, and bmi at the time of bp measurement.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 140, 'cord'), ('UBERON_0000178', 'blood', 145, 'blood'), ('UBERON_0002446', 'patella', 220, 'Patella'), ('UBERON_0000948', 'heart', 248, 'Cord'), ('UBERON_0000178', 'blood', 253, 'blood'), ('PR_000007881', 'homeobox protein GBX-1', 400, 'GirlsSBP2'), ('GO_0007565', 'female pregnancy', 705, 'pregnancy'), ('GO_0007565', 'female pregnancy', 770, 'pregnancy'), ('GO_0007567', 'parturition', 788, 'birth'), ('GO_0007565', 'female pregnancy', 801, 'gestational'), ('GO_0007567', 'parturition', 831, 'birth')]
PMC3295346	9/2011	S139-PMC3295346	['all models adjusted as in table 3 and with additional adjustment for child’s concurrent Blood lead level at the time of bp measurement.']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood')]
PMC3295346	9/2011	S145-PMC3295346	['caption (fig): figure 1\n\npartial residual plots of systolic Blood pressure (sbp) and Tibia lead levels, and smoothed terms (regression curve and 95% ci) derived from additive models for overall group ( a ), boys ( b ), and girls ( c ), adjusted for maternal education, smoking during Pregnancy; dietary intakes of calories, calcium, and iron during Pregnancy and infant Birth order; Gestational age and weight at Birth, and child age, height, and bmi at the time of bp measurement.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0000979', 'tibia', 85, 'tibia'), ('GO_0007565', 'female pregnancy', 284, 'pregnancy'), ('GO_0007565', 'female pregnancy', 349, 'pregnancy'), ('GO_0007567', 'parturition', 370, 'birth'), ('GO_0007565', 'female pregnancy', 383, 'gestational'), ('GO_0007567', 'parturition', 413, 'birth')]
PMC3295739	12/2011	S5-PMC3295739	['results\nportion of t 9 and t 11, but also of c 9, t 11 cla was higher in maternal than in fetal Blood Lipids.']	N/A	N/A	[('UBERON_0000178', 'blood', 96, 'blood'), ('CHEBI_18059', 'lipid', 102, 'lipids')]
PMC3295739	12/2011	S9-PMC3295739	['a high dairy fat Intake resulted in elevated portions of t 11 and its δ9-desaturation product c 9, t 11 cla in maternal Blood.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 17, 'intake'), ('UBERON_0000178', 'blood', 120, 'blood')]
PMC3295739	12/2011	S39-PMC3295739	['methods\n\nsubjects and study design\nBlood samples from 55 mothers together with Cord Blood from their neonates were collected at Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'Blood'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('GO_0007567', 'parturition', 128, 'birth')]
PMC3295739	12/2011	S46-PMC3295739	['sample collection and preparation for gas chromatography\nmaternal Blood was drawn at Birth from a Peripheral Vein.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('GO_0007567', 'parturition', 85, 'birth'), ('UBERON_0001546', 'posterior tibial vein', 98, 'peripheral vein')]
PMC3295739	12/2011	S47-PMC3295739	['fetal Blood was drawn by venipuncture from the Placental portion of the Umbilical Cord immediately after clamping.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0002331', 'umbilical cord', 72, 'umbilical cord')]
PMC3295739	12/2011	S48-PMC3295739	['Blood was collected in edta-tubes (s-monovette 9 ml ke3, sarstedt).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3295739	12/2011	S73-PMC3295739	['caption (table-wrap): table 2\n\nmaternal and infant characteristics (n = 55 mother-child pairs)infant sex: male, n (%)32 (58.2)Gestational age (wk)39.5 ± 1.071birth weight (g)3450 ± 4761birth length (cm)50.4 ± 2.501delivery method, n (%)\u2003spontaneous labour31 (56.4)\u2003elective caesarean20 (36.4)\u2003caesarean after failure to progress in labour4 (7.30)parity at entry, n (%)\u2003034 (61.8)\u2003111 (20.0)\u2003≥26 (10.1)maternal age (years)29.2 ± 5.281maternal bmi before Pregnancy (kg/m2)22.3 ± 2.61maternal bmi at Birth (kg/m2)27.8 ± 2.841maternal atopy, n (%)16 (29.1)tobacco exposition (maternal and/or paternal smoking) in Pregnancy, n (%)18 (32.7)\nall Blood donors.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 126, 'Gestational'), ('GO_0007565', 'female pregnancy', 453, 'pregnancy'), ('GO_0007567', 'parturition', 497, 'birth'), ('GO_0007565', 'female pregnancy', 609, 'pregnancy'), ('UBERON_0000178', 'blood', 639, 'blood')]
PMC3295739	12/2011	S85-PMC3295739	['Fatty Acid profile in maternal and fetal Blood Lipids (n = 55)\n\n- trans Fatty Acids\nthe mean total t Fa, as well as t 9 and T 11 in Plasma and Erythrocyte Lipids were significantly higher in maternal compared to fetal Lipids (table3).']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_18059', 'lipid', 47, 'lipids'), ('CHEBI_35366', 'fatty acid', 72, 'fatty acids'), ('CHEBI_30751', 'formic acid', 101, 'FA'), ('PR_000016555', 'thymocyte selection-associated high mobility group box protein TOX', 124, 't 11'), ('UBERON_0001969', 'blood plasma', 132, 'plasma'), ('CL_0000232', 'erythrocyte', 143, 'erythrocyte'), ('CHEBI_18059', 'lipid', 155, 'lipids'), ('CHEBI_18059', 'lipid', 218, 'lipids')]
PMC3295739	12/2011	S109-PMC3295739	['caption (table-wrap): table 4\n\ncorrelation (r) between t Fa and lc-pufas in maternal and fetal Plasma and Erythrocytes (n = 55)n-6n-3n-6 lc-pufan-3 lc-pufac20:4 n-6aac22:5 n-6dpac20:5 n-3epac22:5 n-3dpac22:6 n-3dha a) between different Fatty Acids within the same Blood fraction (e.g., Pmatto Pmat) c18:1 t 9pmat-0.33•-0.28•-0.11-0.18-0.28•-0.33•-0.26pfet-0.21-0.07-0.08-0.40••-0.36••-0.24-0.35••emat0.13-0.18-0.050.180.030.130.06efet-0.260.03-0.060.020.01-0.260.00c18:1 t 11pmat-0.080.050.25-0.190.06-0.120.11pfet-0.240.020.070.06-0.01-0.220.01emat-0.32•-0.29•0.07-0.06-0.13-0.36••-0.10efet-0.31•-0.010.040.140.10-0.30•0.11total t fapmat-0.250.040.16-0.24-0.07-0.22-0.01pfet-0.22-0.030.06-0.04-0.09-0.21-0.07emat-0.30•-0.31•-0.02-0.05-0.16-0.32•-0.13efet-0.30•0.01-0.070.00-0.02-0.29•-0.02 b) between different maternal and fetal Fatty Acids within the respective Blood fraction (e.g., Pmatto pfet) c18:1 t 9pmat→ pfet-0.14-0.140.00-0.05-0.15-0.17-0.13C18:1 t 11-0.190.050.100.210.08-0.200.10total t Fa-0.24-0.050.090.08-0.08-0.21-0.05c18:1 t 9emat→ efet0.15-0.11-0.19-0.12-0.040.08-0.06c18:1 t 11-0.09-0.160.46••0.41••0.26-0.120.29•total t Fa-0.01-0.170.29•0.240.20-0.030.21\npearson correlation coefficient (r); • p < 0.05; •• p < 0.01.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 57, 'FA'), ('UBERON_0001969', 'blood plasma', 95, 'plasma'), ('CL_0000232', 'erythrocyte', 106, 'erythrocytes'), ('CHEBI_35366', 'fatty acid', 236, 'fatty acids'), ('UBERON_0000178', 'blood', 264, 'blood'), ('PR_000013431', 'tuberoinfundibular peptide of 39 residues', 286, 'Pmatto'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 293, 'Pmat'), ('CHEBI_35366', 'fatty acid', 831, 'fatty acids'), ('UBERON_0000178', 'blood', 865, 'blood'), ('PR_000013431', 'tuberoinfundibular peptide of 39 residues', 887, 'Pmatto'), ('CHEBI_73165', 'elf18', 951, '13C18'), ('CHEBI_30751', 'formic acid', 1001, 'FA'), ('CHEBI_30751', 'formic acid', 1142, 'FA')]
PMC3295739	12/2011	S115-PMC3295739	['association between dairy Fat Intake and Fatty Acid profile of Blood Lipids (n = 41)\na high maternal Intake of dairy fat (> 40 g/d; n = 14) resulted in an elevated amount of Milk specific Fatty Acids such as c15:0, c17:0 and t 11 in both maternal Lipid fractions (pmatand emat) compared to mothers with lower dairy fat intake (n = 27; table5).']	N/A	N/A	[('CHEBI_33290', 'food', 26, 'fat'), ('GO_0007631', 'feeding behavior', 30, 'intake'), ('CHEBI_35366', 'fatty acid', 41, 'fatty acid'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_18059', 'lipid', 69, 'lipids'), ('GO_0007631', 'feeding behavior', 101, 'intake'), ('UBERON_0001913', 'milk', 174, 'milk'), ('CHEBI_35366', 'fatty acid', 188, 'fatty acids'), ('CHEBI_18059', 'lipid', 247, 'lipid')]
PMC3295739	12/2011	S123-PMC3295739	['a high dairy fat intake did not result in a negative correlation between t 11 and t 9 in all maternal and fetal Blood Lipids (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 112, 'blood'), ('CHEBI_18059', 'lipid', 118, 'lipids')]
PMC3295739	12/2011	S142-PMC3295739	['-individual trans Fatty Acids in Blood Lipids\nhardly any data are available in the literature concerning individual trans C18:1 such as t 11 and t 9 in maternal and/or fetal Blood Lipids.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 18, 'fatty acids'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_18059', 'lipid', 39, 'lipids'), ('CHEBI_75508', '5-bromo-4-chloro-3-indolyl phosphate', 122, 'C18'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_18059', 'lipid', 180, 'lipids')]
PMC3295739	12/2011	S151-PMC3295739	['-conjugated Linoleic Acids in the diet and Blood Lipids\ndairy fat contains cla (mainly c 9, t 11 cla), which is formed by δ9-desaturation of t 11 [23].']	N/A	N/A	[('CHEBI_25048', 'linolenic acid', 12, 'linoleic acids'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_18059', 'lipid', 49, 'lipids')]
PMC3295739	12/2011	S158-PMC3295739	['a high dairy fat intake in mothers (> 40 g/d) resulted in increased c 9, t 11 cla and total t Fa, especially t 11 in Blood Lipids.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 94, 'FA'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_18059', 'lipid', 123, 'lipids')]
PMC3295739	12/2011	S167-PMC3295739	['- trans Fatty Acids and Long Chain-Pufa in maternal and fetal Blood Lipids\nthe composition of maternal dietary fat and body fat depot [14,35] strongly accounts for the Fatty Acid composition in fetal Tissue.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 8, 'fatty acids'), ('CHEBI_66557', 'laurolistine', 24, 'long chain'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 35, 'PUFA'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_18059', 'lipid', 68, 'lipids'), ('CHEBI_35366', 'fatty acid', 168, 'fatty acid'), ('UBERON_0000479', 'tissue', 200, 'tissue')]
PMC3295739	12/2011	S172-PMC3295739	['Dha) in Blood Lipids.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_18059', 'lipid', 14, 'lipids')]
PMC3295739	12/2011	S189-PMC3295739	['in addition, the essential n-3 lc-pufa were elevated in fetal Blood Lipids.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_18059', 'lipid', 68, 'lipids')]
PMC3296991	2/2012	S2-PMC3296991	['Maternal and Cord Blood were collected from 80 mother-infant pairs and infant wbbmc was measured by dual energy x-ray absorptiometry 8–21 days post-Birth.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007567', 'parturition', 148, 'birth')]
PMC3296991	2/2012	S35-PMC3296991	['Maternal Venous Blood was collected upon admission to the alta bates medical center labor and Delivery unit and Cord Blood collected immediately post Delivery.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001638', 'vein', 9, 'venous'), ('UBERON_0000178', 'blood', 16, 'blood'), ('GO_0007586', 'digestion', 94, 'Delivery'), ('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood'), ('GO_0007567', 'parturition', 150, 'delivery')]
PMC3296991	2/2012	S36-PMC3296991	['Blood samples were kept at 4 °c until centrifuged and Serum stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 54, 'serum')]
PMC3296991	2/2012	S49-PMC3296991	['of 275 women initially enrolled, Cord Blood samples from 80 infants with successful dxa scans were selected for measurement of balp, allowing for detection of correlation ρ > 0.28 between study variables at α = 0.05 and power = 0.8.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood')]
PMC3296991	2/2012	S84-PMC3296991	['none of the measured indices differed significantly in the maternal or Cord Blood of women who did or did not take daily Prenatal Vitamins containing 400 iu Vitamin D. the Food and nutrition board recommendation for Vitamin D intake by Pregnant women was raised in 2010 from 200 to 600 iu/day [22].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 71, 'cord'), ('UBERON_0000178', 'blood', 76, 'blood'), ('GO_0007565', 'female pregnancy', 121, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 130, 'vitamins'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_33290', 'food', 172, 'Food'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnant')]
PMC3313761	3/2012	S10-PMC3313761	['Blood sugar checked at that time was normal.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3316748	10/2011	S7-PMC3316748	['neither Prenatal diets nor Postnatal Feeding affected Blood Insulin concentrations.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'prenatal'), ('GO_0007567', 'parturition', 27, 'postnatal'), ('GO_0007631', 'feeding behavior', 37, 'feeding'), ('UBERON_0000178', 'blood', 54, 'blood'), ('PR_000045358', 'insulin family protein', 60, 'insulin')]
PMC3316748	10/2011	S9-PMC3316748	['maternal protein restriction had no effect on biometry or Blood biochemical parameters.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood')]
PMC3316748	10/2011	S67-PMC3316748	['analysis of body composition and measurements of biochemical Blood parameters\nat the end of the experimental period, the Animals were anesthetized by Sodium Thiopental injection (40\xa0mg/kg body weight) after an overnight fast, and euthanized by Cardiac puncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('NCBITaxon_33208', 'Metazoa', 121, 'animals'), ('CHEBI_59795', 'thiohemiacetal', 150, 'sodium thiopental'), ('UBERON_0000948', 'heart', 244, 'cardiac')]
PMC3324379	3/2012	S38-PMC3324379	['the participants answered questionnaires including the dhq on the day of Blood sample collection or within 7 days after the Blood sample collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0000178', 'blood', 124, 'blood')]
PMC3324379	3/2012	S48-PMC3324379	['biological markers\nBlood samples were centrifuged for 10 minutes at 3000 rpm to separate Serum within 6 hours after Blood collection, and the Serum samples were stored at -80°c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'Blood'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('UBERON_0000178', 'blood', 116, 'blood'), ('UBERON_0001977', 'blood serum', 142, 'serum')]
PMC3347007	4/2012	S37-PMC3347007	['during the study, the women filled out a recruitment form, a Food frequency questionnaire (ffq), participated in four telephone interviews, and donated two Blood samples during Pregnancy and one Blood sample from the Umbilical Cord at Delivery (figure 1).']	N/A	N/A	[('CHEBI_33290', 'food', 61, 'food'), ('UBERON_0000178', 'blood', 156, 'blood'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('UBERON_0000178', 'blood', 195, 'blood'), ('UBERON_0002331', 'umbilical cord', 217, 'umbilical cord'), ('GO_0007567', 'parturition', 235, 'delivery')]
PMC3347007	4/2012	S42-PMC3347007	['caption (fig): figure 1\n\ntiming of activities in the danish national Birth cohort study.—Blood draw.']	N/A	N/A	[('GO_0007567', 'parturition', 69, 'Birth'), ('UBERON_0000178', 'blood', 89, 'blood')]
PMC3347028	3/2012	S206-PMC3347028	['no differences were noted between groups in baseline 25(Oh)D ( p = 0.24), but differences between groups were noted in Vitamin D status within one month of Delivery ( p< 0.0001) and in Cord Blood ( p = 0.0001), with improved status in the 4000-iu group overall.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'delivery'), ('UBERON_0002240', 'spinal cord', 185, 'cord'), ('UBERON_0000178', 'blood', 190, 'blood')]
PMC3348565	4/2012	S62-PMC3348565	['we collected Venous Blood samples from randomly selected blocks of children on the basis of the assumption that each block had an equal number of children from the Vitamin D3And placebo groups.']	N/A	N/A	[('UBERON_0001638', 'vein', 13, 'venous'), ('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_61991', 'maltotriose trisaccharide', 164, 'vitamin D3and'), ('PR_000027594', 'histone H3', 164, 'vitamin D3and')]
PMC3350953	4/2012	S29-PMC3350953	['patients were given dietary advice about the nutritional requirements of Pregnancy [1], and nurse educators showed them how to self-monitor Blood Glucose.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_17234', 'glucose', 146, 'glucose')]
PMC3355057	5/2012	S65-PMC3355057	['all bmi ranges399 cluster randomised.219 in non-intervention arm; 180 in intervention armattended a study-specific individual Antenatal Lifestyle counselling clinic including group exercisegestational diabetes; Gestational weight gain; Birthweightstatistically significant reduction in Birthweight and macrosomia but no statistically significant difference in Gestational diabetesnascimento et al ., 2011 [44]predominantly white/brazilpregnant women of all bmi categories82 randomised.42 in non-intervention arm; 40 in intervention armattended a group-based exercise under supervision and received a home exercise counsellinggestational weight gain; raised Blood pressure; Perinatal outcomeno statistically significant difference in Gestational weight gain in terms of Gestational weight gain, raised Blood pressure or Perinatal outcome\nbmi: body mass index; sd: standard deviation\n\ncaption (table-wrap): table 3\n\nsummary of the studies that met the criteria of the systematic review on lifestyle interventions in overweight and obese Pregnant women: non-randomised trialsauthor (year)ethnic group/countryparticipants/settingsample sizeinterventionoutcome measure(s)conclusiongray-donald et al.']	N/A	N/A	[('GO_0007567', 'parturition', 126, 'antenatal'), ('GO_0006266', 'DNA ligation', 136, 'lifestyle'), ('GO_0007565', 'female pregnancy', 211, 'gestational'), ('GO_0048148', 'behavioral response to cocaine', 236, 'birthweightStatistically'), ('GO_0007596', 'blood coagulation', 286, 'birthweight'), ('GO_0007565', 'female pregnancy', 360, 'gestational'), ('UBERON_0000178', 'blood', 657, 'blood'), ('GO_0036268', 'swimming', 673, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 673, 'perinatal'), ('GO_0007565', 'female pregnancy', 733, 'gestational'), ('GO_0007565', 'female pregnancy', 769, 'gestational'), ('UBERON_0000178', 'blood', 801, 'blood'), ('GO_0036268', 'swimming', 819, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 819, 'perinatal'), ('GO_0007565', 'female pregnancy', 1035, 'pregnant')]
PMC3356951	4/2012	S25-PMC3356951	['Vitamin D (D represents D2, or D3, or both) that is Ingested is incorporated into chylomicrons, which are absorbed into the Lymphatic System and enter the Venous Blood.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 11, 'D'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 24, 'D2'), ('PR_000001177', 'D(2) dopamine receptor', 31, 'D3'), ('GO_0007631', 'feeding behavior', 52, 'ingested'), ('UBERON_0006558', 'lymphatic part of lymphoid system', 124, 'lymphatic system'), ('UBERON_0001638', 'vein', 155, 'venous'), ('UBERON_0000178', 'blood', 162, 'blood')]
PMC3357266	6/2012	S68-PMC3357266	['Adult awake 10-month-old male Animals received 0.5 g/kg Glucose via the Tail Vein, and Blood was obtained at 0, 5, 15, 30, 60, and 120 min subsequently to measure plasma Glucose and Insulin concentrations.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_33208', 'Metazoa', 30, 'animals'), ('CHEBI_17234', 'glucose', 56, 'glucose'), ('UBERON_0003481', 'tail vein', 72, 'tail vein'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_17234', 'glucose', 170, 'glucose'), ('PR_000045358', 'insulin family protein', 182, 'insulin')]
PMC3357266	6/2012	S83-PMC3357266	['Blood sampling was performed every 10 min over a 45-min period after achieving clamp conditions.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3360698	5/2012	S3-PMC3360698	['design\nmaternal and Cord Blood dna were available from a convenience sample of 101 mother/newborn pairs.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood')]
PMC3360698	5/2012	S4-PMC3360698	['measures of As exposure included maternal Urinary As (uas), maternal Blood As (Mbas) and Cord Blood as (cbas).']	N/A	N/A	[('CHEBI_22868', 'bile salt', 12, 'As'), ('UBERON_0001088', 'urine', 42, 'urinary'), ('CHEBI_22868', 'bile salt', 50, 'As'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_22868', 'bile salt', 75, 'As'), ('UBERON_0002185', 'bronchus', 79, 'mbAs'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC3360698	5/2012	S38-PMC3360698	['sample collection and storage\nnear the time of Delivery, women were asked to provide written informed consent, to answer a brief questionnaire, to provide a Blood and Urine sample prior to Delivery, and to allow for a Blood sample to be obtained from the discarded Umbilical Cord after the Birth Of the Baby.']	N/A	N/A	[('GO_0007567', 'parturition', 47, 'delivery'), ('UBERON_0000178', 'blood', 157, 'blood'), ('UBERON_0001088', 'urine', 167, 'urine'), ('GO_0007567', 'parturition', 189, 'delivery'), ('UBERON_0000178', 'blood', 218, 'blood'), ('UBERON_0002331', 'umbilical cord', 265, 'umbilical cord'), ('GO_0007567', 'parturition', 290, 'birth of'), ('GO_0007567', 'parturition', 303, 'baby')]
PMC3360698	5/2012	S39-PMC3360698	['the questionnaire was administered by a trained nurse, who also obtained the Blood and Urine samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0001088', 'urine', 87, 'urine')]
PMC3360698	5/2012	S42-PMC3360698	['Whole Blood for Blood as measurements was aliquoted into acid-washed tubes.']	N/A	N/A	[('UBERON_0004043', 'semicircular canal ampulla', 0, 'Whole'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000178', 'blood', 16, 'blood')]
PMC3360698	5/2012	S52-PMC3360698	['total Urinary and Blood as measurements\nUrinary as (uas) concentrations were assayed by graphite furnace atomic absorption spectrophotometry (gfaa) using a perkin-elmer aanalyst 600 system (shelton, ct) as described[30].']	N/A	N/A	[('UBERON_0001088', 'urine', 6, 'Urinary'), ('UBERON_0000178', 'blood', 18, 'Blood'), ('UBERON_0001088', 'urine', 40, 'Urinary')]
PMC3360698	5/2012	S57-PMC3360698	['Maternal and Cord Blood samples were analyzed for total Blood as concentration using a perkin-elmer elan drc ii icp-ms equipped with an as 93+ autosampler as described[27].']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0000178', 'blood', 56, 'blood')]
PMC3360698	5/2012	S58-PMC3360698	['briefly, the as concentration of the standard Solution used for instrument calibration was chosen to cover the expected range of As concentrations in the Blood samples: 5, 25 and 50 µg/l.']	N/A	N/A	[('CHEBI_75958', 'solution', 46, 'solution'), ('CHEBI_22868', 'bile salt', 129, 'As'), ('UBERON_0000178', 'blood', 154, 'blood')]
PMC3360698	5/2012	S63-PMC3360698	["dna extraction\nGenomic dna was isolated at columbia university from 300 µl of frozen whole Blood samples using the flexigene dna kit (qiagen) following the manufacturer's protocol, except for an additional centrifugation step at 10,000× g for 5 min immediately after protease digestion to pellet any remaining proteins or Lipids."]	N/A	N/A	[('SO_0001026', 'genome', 15, 'Genomic'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_18059', 'lipid', 322, 'lipids')]
PMC3360698	5/2012	S73-PMC3360698	['each dna sample was processed in duplicate and each processing run included samples for background (reaction Mixture with all components except sssi enzyme), a hypomethylation control (hela cell dna) and a quality control sample (dna extracted from a whole-Blood sample).']	N/A	N/A	[('CHEBI_60004', 'mixture', 109, 'mixture'), ('UBERON_0000178', 'blood', 257, 'blood')]
PMC3360698	5/2012	S96-PMC3360698	['Plasma Folate, Cobalamin and Homocysteine\nPlasma Folate and total cobalamin from maternal and Cord Blood were analyzed by radioimmunoassay (quantaphase ii, bio-rad laboratories, richmond ca) as described previously[39].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_81245', 'Vulpecholate', 7, 'Folate'), ('CHEBI_15982', 'cob(I)alamin', 15, 'Cobalamin'), ('CHEBI_5759', 'Honokiol', 29, 'Homocysteine'), ('UBERON_0001969', 'blood plasma', 42, 'Plasma'), ('CHEBI_30863', '5-azaorotic acid', 49, 'folate'), ('UBERON_0002240', 'spinal cord', 94, 'cord'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC3366289	7/2011	S4-PMC3366289	['iron status and Micronutrients were measured in Serum, whole Blood, and in Breast Milk samples.']	N/A	N/A	[('CHEBI_33839', 'macromolecule', 16, 'micronutrients'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 75, 'breast milk')]
PMC3366289	7/2011	S44-PMC3366289	['non-fasting Blood samples including edta-whole Blood and whole Blood for Serum were collected between 10.00 am and 12.00 pm by venepuncture into Trace Element-free vacutainers that were wrapped in aluminum foil.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0000178', 'blood', 63, 'blood'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 145, 'trace element')]
PMC3366289	7/2011	S46-PMC3366289	['whole Blood, Serum and Breast Milk were portioned into eppendorf tubes and frozen at −20\xa0°c in maela camp before being transported to the smru office in mae sot to be stored at −80\xa0°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 13, 'serum'), ('UBERON_0001348', 'brown adipose tissue', 23, 'breast milk')]
PMC3366289	7/2011	S56-PMC3366289	['further significant differences in Blood parameters between the groups (premffw vs. mffw) were reassessed after exclusion of those women with elevated crp and/or agp.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC3366289	7/2011	S81-PMC3366289	['Thiamine\nThiamine and its phosphate esters in 0.5\xa0ml of whole Blood or Breast Milk were analyzed using precolumn derivatization, reversed-phase liquid chromatography and fluorescence detection [20].']	N/A	N/A	[('CHEBI_32215', 'thiamphenicol', 0, 'Thiamine'), ('CHEBI_32215', 'thiamphenicol', 9, 'Thiamine'), ('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000310', 'breast', 71, 'breast'), ('UBERON_0001913', 'milk', 78, 'milk')]
PMC3366289	7/2011	S82-PMC3366289	['the separation of Thiamine and its phosphate esters Thiamine monophosphate (tmp) and Thiamine Diphosphate (tdp) was achieved using a 5\xa0μm analytical column (grom-sil 120 ods-4 he, 125\xa0×\xa04\xa0mm, grom, germany) and a mobile phase consisting Methanol [17.5% (v:v) for whole Blood and 27.5% (v:v) for Milk] and phosphate buffer (ph 7) at a flow rate of 0.8\xa0ml/min.']	N/A	N/A	[('CHEBI_26948', 'vitamin B1', 18, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 52, 'thiamine'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 85, 'thiamine diphosphate'), ('CHEBI_17790', 'methanol', 237, 'methanol'), ('UBERON_0000178', 'blood', 269, 'blood'), ('UBERON_0001913', 'milk', 295, 'milk')]
PMC3366289	7/2011	S84-PMC3366289	['for internal quality control, pools of whole Blood and Milk were analyzed within each batch ( n \xa0=\xa012) of samples giving inter-batch cv’s for Whole Blood tdp of <7% and for Tmp and Thiamine in milk of <5%.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0001913', 'milk', 55, 'milk'), ('UBERON_0007688', 'anlage', 142, 'whole'), ('UBERON_0000178', 'blood', 148, 'blood'), ('PR_000016450', 'transmembrane protease serine 11D', 173, 'TMP'), ('CHEBI_26948', 'vitamin B1', 181, 'thiamine')]
PMC3366289	7/2011	S93-PMC3366289	['independent predictors of Blood and milk Micronutrients and respective deficiencies were identified using linear and logistic regression.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_33839', 'macromolecule', 41, 'micronutrients')]
PMC3366289	7/2011	S95-PMC3366289	['the following covariates were included in the initial models: maternal age, height and weight, parity, smoking status, constant Consumption (2–3 times/day) of fish paste, years of living in the camp and in thailand, mother’s religion (christian, buddhist or muslim), weeks of individual supplements provided at the time of Blood draw, Acute Phase proteins (agp >1\xa0g/l, crp >5\xa0mg/l), hemoglobin, anemia and Blood Micronutrients.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 128, 'consumption'), ('UBERON_0000178', 'blood', 323, 'blood'), ('GO_0006953', 'acute-phase response', 335, 'acute phase'), ('UBERON_0000178', 'blood', 406, 'blood'), ('CHEBI_33839', 'macromolecule', 412, 'micronutrients')]
PMC3366289	7/2011	S111-PMC3366289	['caption (table-wrap): table\xa04\n\nrisk factors for iron deficiency (stfr >8.5\xa0mg/l, ferritin <12\xa0μg/l), zinc deficiency (zinc <0.66\xa0mg/l), anemia (hemoglobin <120\xa0g/l) and low whole-Blood tdp (<50\xa0μg/l) in Postpartum, by outcomeblood parameterodds ratio95% ci p valuestfr >8.5\xa0mg/la\xa0tdp <50\xa0μg/l2.381.02, 5.560.044\xa0age (years)0.900.84, 0.960.002\xa0smoking (=1)3.351.39, 8.100.007\xa0hb <120\xa0g/l2.261.09, 4.710.029\xa0mffw (=1)0.460.22, 0.950.037ferritin <12\xa0μg/lb\xa0tdp <50\xa0μg/l5.031.87, 13.40.001\xa0Retinol <1.05\xa0μmol/l7.031.22, 40.50.029\xa0hb <120\xa0g/l2.721.10, 6.730.030zinc <0.66\xa0mg/lc\xa0mffw (=1)0.340.18, 0.650.001\xa0hb <120\xa0g/l3.171.56, 6.420.001hemoglobin <120\xa0g/ld\xa0Zinc <0.66\xa0mg/l3.581.73, 7.410.001\xa0Ferritin <12\xa0μg/l3.431.39, 8.420.007\xa0agp >1\xa0g/l3.031.25, 7.380.014tdp <50\xa0μg/le\xa0Ferritin <12\xa0μg/l4.491.77, 11.40.002\xa0in maela (years)1.161.02, 1.320.020\xa0christian (=1)0.390.16, 0.940.035\nrisk factors are listed in the order they were entered in the (forward) models\nastfr (soluble Transferrin Receptor) >8.5\xa0mg/l, n \xa0=\xa048/178 (27%)\nbserum ferritin <12 μgl, n \xa0=\xa027/148 (18%), women with agp >1\xa0g/l and/or crp >5\xa0mg/l were excluded\ncserum Zinc <0.66\xa0mg/l, n \xa0=\xa0108/178 (61%)\ndhemoglobin <120\xa0g/l (anemia), n \xa0=\xa064/178 (36%)\netdp <50\xa0μg/l, n \xa0=\xa033/178 (19%)\niron and Thiamine in Breast Milk were significantly higher in the mffw group (table\xa05).']	N/A	N/A	[('UBERON_0000178', 'blood', 179, 'blood'), ('GO_0007565', 'female pregnancy', 203, 'postpartum'), ('CHEBI_27810', 'resorcinol', 485, 'Retinol'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 652, 'Zinc'), ('CHEBI_80820', 'Eucarvone', 687, 'Ferritin'), ('CHEBI_80820', 'Eucarvone', 767, 'Ferritin'), ('PR_000001679', 'trace amine-associated receptor 5', 968, 'transferrin receptor'), ('CHEBI_33340', 'zinc group element atom', 1125, 'zinc'), ('CHEBI_26948', 'vitamin B1', 1252, 'thiamine'), ('UBERON_0000310', 'breast', 1264, 'breast'), ('UBERON_0001913', 'milk', 1271, 'milk')]
PMC3366289	7/2011	S117-PMC3366289	['whole-Blood tdp adjusted for hemoglobin explained 24 and 26% of the variance ( r2) in Thiamine and total Thiamine (Thiamine\xa0+\xa0tmp) in breast Milk.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_26948', 'vitamin B1', 86, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 105, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 115, 'thiamine'), ('UBERON_0001913', 'milk', 141, 'milk')]
PMC3366289	7/2011	S123-PMC3366289	['the strongest predictors of iron deficiency were having low whole-Blood tdp, low Serum Retinol, anemia and being a smoker.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_26536', 'retinoic acid', 87, 'retinol')]
PMC3376765	6/2012	S44-PMC3376765	['a capillary Blood sample was obtained from a Finger prick to measure hb concentrations using a b-Hemoglobin analyzer.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('UBERON_0002389', 'manual digit', 45, 'finger'), ('CHEBI_5679', 'herniarin', 97, 'Hemoglobin')]
PMC3376765	6/2012	S45-PMC3376765	['Venous Blood was collected for measuring Serum ferritin and crp using a nephelometric immunoassay reactive kit and for determining Serum zinc using a flame atomic absorption spectroscopy method [16].']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('UBERON_0001977', 'blood serum', 131, 'serum')]
PMC3376765	6/2012	S46-PMC3376765	['Venous Blood was collected after an overnight fast using trace Mineral free syringes; tubes were centrifuged within an hour at 3,000\u2009rpm for 10 minutes at 4°c.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_46662', 'mineral', 63, 'mineral')]
PMC3376765	6/2012	S51-PMC3376765	['a total of 369 women or 88% also provided an endline Blood sample (i.e., 52 women refused).']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood')]
PMC3378453	4/2012	S84-PMC3378453	['Pon1 is synthesized in the Liver and Secreted in Blood where it is incorporated into high density lipoproteins (hdl).']	N/A	N/A	[('PR_000013050', 'suppressor of SWI4 1', 0, 'PON1'), ('UBERON_0002107', 'liver', 27, 'liver'), ('GO_0046903', 'secretion', 37, 'secreted'), ('UBERON_0000178', 'blood', 49, 'blood')]
PMC3378453	4/2012	S109-PMC3378453	['in a group of newborns with the highest levels of the Organophosphate Chlorpyrifos measurable in their Umbilical Cord Blood, Birth weight averaged 150 grams less than the group with the lowest exposure [49].']	N/A	N/A	[('CHEBI_37512', 'organic thiophosphate', 54, 'organophosphate'), ('CHEBI_34631', 'chlorpyrifos', 70, 'chlorpyrifos'), ('UBERON_0002331', 'umbilical cord', 103, 'umbilical cord'), ('UBERON_0000178', 'blood', 118, 'blood'), ('GO_0007567', 'parturition', 125, 'birth')]
PMC3378453	4/2012	S187-PMC3378453	['abbreviations\nadhd: attention-deficit-hyperactivity-disorder; ag: silver; apa: american psychiatric association; asd: autism spectrum disorder; bi: bismuth; Ca: Calcium; cd: cadmium; cdc: center for disease control and prevention; Cu: copper; Dap: Dialkyl Phosphate; dsm: diagnostic and statistical manual of mental disorders; eu: european union; Gsh: Glutathione; hdl: high density lipoprotein; hfcs: high Fructose Corn Syrup; hg: mercury; mg: magnesium; mt: metallothionein; nbp: national biomonitoring program; nhanes: national health and nutrition examination survey; ohi: other health impaired; op: Organophosphate Pesticide; P: Phosphorus; Pb: lead; pdd: pervasive developmental delay; pdp: Pesticide data program; pon1: paraoxonase-1; Rbc: Red Blood Cell; sah: S-Adenosylhomocysteine; sam: S-Adenosylmethionine; thcy: total Plasma Homocysteine; usda: united states department of agriculture; wbc: White Blood Cell; zn: Zinc.']	N/A	N/A	[('CHEBI_32588', 'potassium chloride', 157, 'Ca'), ('CHEBI_31341', 'calcium dihydroxide', 161, 'Calcium'), ('CHEBI_17996', 'chloride', 231, 'Cu'), ('CHEBI_4450', 'desmopressin', 243, 'DAP'), ('CHEBI_16648', 'dialkyl phosphate', 248, 'Dialkyl phosphate'), ('CHEBI_16856', 'glutathione', 347, 'GSH'), ('CHEBI_16856', 'glutathione', 352, 'Glutathione'), ('CHEBI_28757', 'fructose', 407, 'fructose'), ('CHEBI_33306', 'carbon group element atom', 416, 'corn'), ('CHEBI_46950', 'sultam', 421, 'syrup'), ('CHEBI_37512', 'organic thiophosphate', 604, 'organophosphate'), ('CHEBI_39207', 'spinosyn', 620, 'pesticide'), ('CHEBI_53758', 'PAP', 631, 'P'), ('CHEBI_35885', 'secondary phosphine', 634, 'phosphorus'), ('CHEBI_37983', 'sulfur-35 atom', 646, 'Pb'), ('CHEBI_33292', 'fuel', 697, 'Pesticide'), ('CL_0000232', 'erythrocyte', 742, 'RBC'), ('CL_0000232', 'erythrocyte', 747, 'red blood cell'), ('UBERON_0000178', 'blood', 751, 'blood'), ('CHEBI_17575', 'S-(5-deoxy-D-ribos-5-yl)-L-homocysteine', 768, 'S-adenosylhomocysteine'), ('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 797, 'S-adenosylmethionine'), ('UBERON_0001969', 'blood plasma', 831, 'plasma'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 838, 'homocysteine'), ('CL_0000235', 'macrophage', 904, 'White blood cell'), ('UBERON_0000178', 'blood', 910, 'blood'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 926, 'Zinc')]
PMC3382418	6/2012	S81-PMC3382418	['Blood and Organs sampling\nat the end of the Suckling Period (pnd 21), randomly chosen pups from each group were killed by decapitation after light anesthesia 3\u2009h after the beginning of the light period.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000062', 'organ', 10, 'organs'), ('GO_0001967', 'suckling behavior', 44, 'suckling'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 44, 'suckling period')]
PMC3382418	6/2012	S84-PMC3382418	['Trunk Blood was sampled in chilled test-tubes containing aprotinin (5000\u2009iu/ml, iniprol, laboratoires choay, paris) and edta (1.2\u2009mg/ml, merck, darmstadt).']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood')]
PMC3382418	6/2012	S139-PMC3382418	['caption (table-wrap): table 5\n\nBlood Glucose and Plasma concentrations of Triglycerides, Cholesterol, immunoreactive Insulin, and Ghrelin (mean\u2009±\u2009sem) in offspring from dams Fed either a Gestational Control diet (ca group) ad libitum , or a restricted control (cr group), a high-fat (hf group), or a high-Carbohydrate (hc group) diet ad libitum for 6\u2009h during the light period, in addition to two normal meals given during the dark period .timegroup of ratscacrhfhc weaning Blood Glucose (mmol/l)7.8\u2009±\u20090.17.8\u2009±\u20090.37.6\u2009±\u20090.47.7\u2009±\u20090.5triglycerides (mmol/l)1.2\u2009±\u20090.11.3\u2009±\u20090.21.1\u2009±\u20090.11.5\u2009±\u20090.3Cholesterol (mmol/l)3.0\u2009±\u20090.33.1\u2009±\u20090.22.9\u2009±\u20090.13.1\u2009±\u20090.2insulin (ng/ml)3.1\u2009±\u20090.34.0\u2009±\u20090.43.2\u2009±\u20090.52.8\u2009±\u20090.6 postnatal week 20 Blood Glucose (mmol/l)8.3\u2009±\u20090.39.1\u2009±\u20090.38.9\u2009±\u20090.29.6\u2009±\u20090.3**Triglycerides (mmol/l)3.5\u2009±\u20090.23.5\u2009±\u20090.33.3\u2009±\u20090.23.3\u2009±\u20090.2cholesterol (mmol/l)2.8\u2009±\u20090.12.6\u2009±\u20090.12.6\u2009±\u20090.12.8\u2009±\u20090.1insulin (ng/ml)15.1\u2009±\u20091.415.5\u2009±\u20091.112.8\u2009±\u20090.819.8\u2009±\u20091.7* § ###Ghrelin (pg/ml)810\u2009±\u200958667\u2009±\u200950761\u2009±\u200951681\u2009±\u200949\n* p \u2009<\u20090.05 and ** p \u2009<\u20090.01 vs ca;§p \u2009<\u20090.05 vs Cr;###p \u2009<\u20090.001 vs hf .']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('CHEBI_17234', 'glucose', 37, 'glucose'), ('UBERON_0001969', 'blood plasma', 49, 'plasma'), ('CHEBI_17855', 'triglyceride', 74, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 89, 'cholesterol'), ('PR_000045358', 'insulin family protein', 117, 'insulin'), ('PR_000007988', 'gastric inhibitory polypeptide receptor', 130, 'ghrelin'), ('GO_0007631', 'feeding behavior', 174, 'fed'), ('GO_0007530', 'sex determination', 187, 'gestational control'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 305, 'carbohydrate'), ('UBERON_0000178', 'blood', 474, 'Blood'), ('CHEBI_17234', 'glucose', 480, 'glucose'), ('CHEBI_16933', 'ergosterol', 589, '3Cholesterol'), ('UBERON_0000178', 'blood', 716, 'Blood'), ('CHEBI_17234', 'glucose', 722, 'glucose'), ('CHEBI_17855', 'triglyceride', 776, 'Triglycerides'), ('PR_000008031', 'GLIPR1-like protein 1', 952, 'Ghrelin'), ('CHEBI_37987', 'Cy3 dye', 1049, 'Cr')]
PMC3385436	2/2012	S38-PMC3385436	['Cord Blood samples for Organochlorine analyses were collected at the infant’s Birth; the Serum fraction was removed after centrifugation and stored at –20°c.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_69390', 'oxystemokerrine', 23, 'organochlorine'), ('GO_0007567', 'parturition', 78, 'birth'), ('UBERON_0001977', 'blood serum', 89, 'serum')]
PMC3387174	6/2012	S4-PMC3387174	['Thiamine diphosphate (tdp) in whole Blood and Thiamine in Breast-Milk of 636 Lactating women were measured.']	N/A	N/A	[('CHEBI_32215', 'thiamphenicol', 0, 'Thiamine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('CHEBI_26948', 'vitamin B1', 46, 'thiamine'), ('UBERON_0000310', 'breast', 58, 'breast'), ('UBERON_0001913', 'milk', 65, 'milk'), ('GO_0007594', 'puparial adhesion', 77, 'lactating')]
PMC3387174	6/2012	S6-PMC3387174	['mean Whole Blood tdp (130 nmol/l) and total Thiamine in Breast-Milk (755 nmol/l) were within the upper range reported for well-nourished women.']	N/A	N/A	[('UBERON_0007688', 'anlage', 5, 'whole'), ('UBERON_0000178', 'blood', 11, 'blood'), ('CHEBI_26948', 'vitamin B1', 44, 'thiamine'), ('UBERON_0000310', 'breast', 56, 'breast'), ('UBERON_0001913', 'milk', 63, 'milk')]
PMC3387174	6/2012	S7-PMC3387174	['the prevalence of women with low whole Blood tdp (<65 nmol/l) was 5% and with deficient Breast-Milk total Thiamine (<300 nmol/l) was 4%.']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0000310', 'breast', 88, 'breast'), ('UBERON_0001913', 'milk', 95, 'milk'), ('CHEBI_26948', 'vitamin B1', 106, 'thiamine')]
PMC3387174	6/2012	S24-PMC3387174	['direct measurement of tdp in whole Blood or Erythrocytes by hplc with fluorometric detection of its thiochrome derivative was shown to be a more sensitive and specific index of Thiamine nutrition than using etka[7],[8].']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000232', 'erythrocyte', 44, 'erythrocytes'), ('CHEBI_26948', 'vitamin B1', 177, 'thiamine')]
PMC3387174	6/2012	S25-PMC3387174	['tdp, the principle biologically active form of Thiamine, represents >80% of all Thiamine in whole Blood[9],[10].']	N/A	N/A	[('CHEBI_26948', 'vitamin B1', 47, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 80, 'thiamine'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC3387174	6/2012	S34-PMC3387174	['Capillary Blood for hematocrit measurements were done on site in maela camp.']	N/A	N/A	[('UBERON_0001982', 'capillary', 0, 'Capillary'), ('UBERON_0000178', 'blood', 10, 'blood')]
PMC3387174	6/2012	S36-PMC3387174	['non-fasting edta-whole Blood (5 ml) was collected between 10∶00 am and 12∶00 midday by venepuncture into vacutainers.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood')]
PMC3387174	6/2012	S38-PMC3387174	['whole Blood and Breast-Milk were portioned into eppendorf tubes and frozen at −20°c before transportation to the smru office in mae sot where they were stored at −80°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000310', 'breast', 16, 'breast'), ('UBERON_0001913', 'milk', 23, 'milk')]
PMC3387174	6/2012	S40-PMC3387174	['Thiamine in whole Blood and Breast-Milk\nThiamine Diphosphate (tdp) in whole Blood (edta) and Thiamine and Thiamine monophosphate (tmp) in Breast-Milk samples were determined using precolumn derivatization, reversed-phase liquid chromatography and fluorescence detection as previously described[13]with modifications.']	N/A	N/A	[('CHEBI_32215', 'thiamphenicol', 0, 'Thiamine'), ('UBERON_0000178', 'blood', 18, 'Blood'), ('UBERON_0000310', 'breast', 28, 'Breast'), ('UBERON_0001913', 'milk', 35, 'milk'), ('CHEBI_9536', 'thiamylal', 40, 'Thiamine diphosphate'), ('UBERON_0000178', 'blood', 76, 'blood'), ('CHEBI_26948', 'vitamin B1', 93, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 106, 'thiamine'), ('UBERON_0000310', 'breast', 138, 'breast'), ('UBERON_0001913', 'milk', 145, 'milk')]
PMC3387174	6/2012	S41-PMC3387174	['in brief, 500 µl of edta whole Blood or 500 µl of Breast-Milk was deproteinized by the addition of 7% (w/w) cold Perchloric Acid.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0000310', 'breast', 50, 'breast'), ('UBERON_0001913', 'milk', 57, 'milk'), ('CHEBI_29221', 'perchloric acid', 113, 'perchloric acid')]
PMC3387174	6/2012	S44-PMC3387174	['the separation of Thiamine and its phosphate Esters was achieved using a 5 µ m analytical column (grom-sil 120 ods-4 he, 125×4 mm, grom, germany) and an isocratic mobile phase consisting of Methanol (17.5% vol/vol for whole Blood tdp and 27.5% vol/vol for Breast-Milk Thiamine) and phosphate buffer (0.15 m, ph 7) at a flow rate of 0.8 ml/min.']	N/A	N/A	[('CHEBI_26948', 'vitamin B1', 18, 'thiamine'), ('CHEBI_35701', 'ester', 45, 'esters'), ('CHEBI_17790', 'methanol', 190, 'methanol'), ('UBERON_0000178', 'blood', 224, 'blood'), ('UBERON_0000310', 'breast', 256, 'breast'), ('UBERON_0001913', 'milk', 263, 'milk'), ('CHEBI_26948', 'vitamin B1', 268, 'thiamine')]
PMC3387174	6/2012	S46-PMC3387174	['for internal quality control, pools of whole Blood and Milk were analysed within each batch (n\u200a=\u200a12) of samples giving inter-batch coefficients of variation for Whole Blood tdp of <7% and for Tmp and Thiamine in Breast-Milk of <4.5%.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0001913', 'milk', 55, 'milk'), ('UBERON_0007688', 'anlage', 161, 'whole'), ('UBERON_0000178', 'blood', 167, 'blood'), ('PR_000016450', 'transmembrane protease serine 11D', 192, 'TMP'), ('CHEBI_26948', 'vitamin B1', 200, 'thiamine'), ('UBERON_0000310', 'breast', 212, 'breast'), ('UBERON_0001913', 'milk', 219, 'milk')]
PMC3387174	6/2012	S63-PMC3387174	['multivariate linear and logistic regression models with a forward stepwise approach were applied to identify independent predictors and respective deficiencies of Whole Blood tdp and Breast-Milk Thiamine.']	N/A	N/A	[('UBERON_0007688', 'anlage', 163, 'whole'), ('UBERON_0000178', 'blood', 169, 'blood'), ('UBERON_0000310', 'breast', 183, 'breast'), ('UBERON_0001913', 'milk', 190, 'milk'), ('CHEBI_26948', 'vitamin B1', 195, 'thiamine')]
PMC3387174	6/2012	S64-PMC3387174	['the following covariates (at 12 weeks post Partum) were examined: maternal age, body mass index (bmi), parity, smoking status (yes/no), regular Chewing of Betel nut (areca) (y/n), daily Consumption of Fermented fish (y/n), years of the living in the maela camp, women’s religion (christian, buddhist or muslim), days of provided supplements at the time of Blood draw, hemoglobin levels, anemia defined as hemoglobin levels <120 g/l (y/n), Whole Blood tdp (in nmol/l or <65 nmol/l) and the Tmp to total Thiamine ratio (in % or ≥the median of 63%).']	N/A	N/A	[('GO_0007567', 'parturition', 43, 'partum'), ('GO_0071626', 'mastication', 144, 'chewing'), ('CHEBI_29238', 'tritium atom', 155, 'betel'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'betel'), ('GO_0007631', 'feeding behavior', 186, 'consumption'), ('CHEBI_36946', 'thiourea', 201, 'fermented'), ('UBERON_0000178', 'blood', 356, 'blood'), ('UBERON_0000473', 'testis', 439, 'whole blood'), ('PR_000016450', 'transmembrane protease serine 11D', 489, 'TMP'), ('CHEBI_26948', 'vitamin B1', 502, 'thiamine')]
PMC3387174	6/2012	S75-PMC3387174	['the analysis by mass spectrometry in the selected Ion monitoring mode confirmed Tmp ( m/z 343; m/z 381) and Thiamine ( m/z 265) as well as higher tmp than Thiamine concentrations in the Milk pools from maela and stuttgart.10.1371/journal.pone.0036280.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the study population, whole Blood tdp and Breast-Milk Thiamine at 12 weeks post Partum1–6.characteristics n \u200a=\u200a636age (y)126.8 (21.0, 31.8)parity ( n )3 (2, 4)bmi (kg/m2)21.7 (20.0, 23.5)in maela (y)8.8 (5.8, 10.9)Thiamine supplements (d)2286 (258, 303)smokers (%)27daily Betel nut (%)25fish paste, 2–3x/d (%)57buddhist (%)43christian (%)40muslim (%)17 whole Bloodn\u200a=\u200a636 tdp (nmol/l)3129.8±42.1<65 nmol/l (%)4.9hemoglobin (g/l)125.7±11.8<120 g/l (%)31Tdp/hb (ng/g)4477.2±154.2 Breast-Milkn\u200a=\u200a636 Tmp (nmol/l)445.7±147.7thiamine (nmol/l)5297.0 (278.9–315.8)total Thiamine (nmol/l)6755.4 (730.4–780.7)<300 nmol/l (%)4.1tmp per total Thiamine (%)63.5 (62.2–64.7)\nmedian (interquartile range), all such values.']	N/A	N/A	[('CHEBI_24870', 'ion', 50, 'ion'), ('PR_000016450', 'transmembrane protease serine 11D', 80, 'TMP'), ('CHEBI_26948', 'vitamin B1', 108, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 155, 'thiamine'), ('UBERON_0001913', 'milk', 186, 'milk'), ('UBERON_0000178', 'blood', 334, 'blood'), ('UBERON_0000310', 'breast', 348, 'breast'), ('UBERON_0001913', 'milk', 355, 'milk'), ('CHEBI_26948', 'vitamin B1', 360, 'thiamine'), ('GO_0007567', 'parturition', 386, 'partum1'), ('CHEBI_32215', 'thiamphenicol', 520, 'Thiamine'), ('CHEBI_29238', 'tritium atom', 578, 'betel'), ('NCBITaxon_10088', 'Mus <genus>', 578, 'betel'), ('UBERON_0000178', 'blood', 665, 'bloodN'), ('CHEBI_63057', 'EHNA', 756, '31TDP'), ('UBERON_0000310', 'breast', 784, 'Breast'), ('UBERON_0001913', 'milk', 791, 'milkN'), ('PR_000016450', 'transmembrane protease serine 11D', 803, 'TMP'), ('CHEBI_26948', 'vitamin B1', 869, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 938, 'thiamine')]
PMC3387174	6/2012	S81-PMC3387174	['five percent of all studied women had low Whole Blood tdp (<65 nmol/l) and four percent had deficient Breast-Milk Thiamine (total Thiamine <300 nmol/l) (table 1).']	N/A	N/A	[('UBERON_0007688', 'anlage', 42, 'whole'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0000310', 'breast', 102, 'breast'), ('UBERON_0001913', 'milk', 109, 'milk'), ('CHEBI_26948', 'vitamin B1', 114, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 130, 'thiamine')]
PMC3387174	6/2012	S83-PMC3387174	['neither the Chewing of Betel nut, daily consumption of Fermented fish nor the days of provided Thiamine supplements post-Partum at time of Blood draw were associated with concentrations of whole Blood tdp.']	N/A	N/A	[('GO_0071626', 'mastication', 12, 'chewing'), ('CHEBI_29238', 'tritium atom', 23, 'betel'), ('NCBITaxon_10088', 'Mus <genus>', 23, 'betel'), ('CHEBI_36946', 'thiourea', 55, 'fermented'), ('CHEBI_26948', 'vitamin B1', 95, 'thiamine'), ('GO_0007567', 'parturition', 121, 'partum'), ('UBERON_0000178', 'blood', 139, 'blood'), ('UBERON_0000178', 'blood', 195, 'blood')]
PMC3387174	6/2012	S87-PMC3387174	['independent predictors of total Breast-Milk Thiamine included whole Blood tdp and the ratio of tmp to total Thiamine (r2\u200a=\u200a0.37 and 0.12, respectively); [square root] total Thiamine in Breast increased (+0.06, 95% ci 0.05 to 0.07) per unit increase in whole Blood tdp and decreased (−0.13, 95% ci −0.15 to −0.11) per unit increase in tmp ratio.']	N/A	N/A	[('UBERON_0000310', 'breast', 32, 'breast'), ('UBERON_0001913', 'milk', 39, 'milk'), ('CHEBI_26948', 'vitamin B1', 44, 'thiamine'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_26948', 'vitamin B1', 108, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 173, 'thiamine'), ('UBERON_0000310', 'breast', 185, 'breast'), ('UBERON_0000178', 'blood', 258, 'blood')]
PMC3387174	6/2012	S93-PMC3387174	['wb tdp, Whole Blood Thiamine Diphosphate.']	N/A	N/A	[('UBERON_0007688', 'anlage', 8, 'whole'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 20, 'thiamine diphosphate')]
PMC3387174	6/2012	S96-PMC3387174	['total Thiamine, sum of Thiamine and Tmp.10.1371/journal.pone.0036280.t003\n\ncaption (table-wrap): table 3\nwhole Blood tdp and Thiamine, tmp and total Thiamine in Breast-Milk of women with a low (<63%) compared to those with a high (≥63%) tmp to total Thiamine ratio1–3.Tmp<63% (n\u200a=\u200a323)tmp≥63% (n\u200a=\u200a313) p value wb tdp 1 (nmol/l) 149.3±38.9109.7±35.3<0.001 Breast-Milktmp 2 (nmol/l) 443.7±153.8447.9±141.40.721 Thiamine (nmol/l) 502.4 (477–528)141.4 (132–151)<0.001 total Thiamine 3 (nmol/l) 946.0 (911–981)581.1 (557–605)<0.001\nwb tdp, Whole Blood Thiamine Diphosphate.']	N/A	N/A	[('CHEBI_26948', 'vitamin B1', 6, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 23, 'thiamine'), ('PR_000016450', 'transmembrane protease serine 11D', 36, 'TMP'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_26948', 'vitamin B1', 125, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 149, 'thiamine'), ('UBERON_0000310', 'breast', 161, 'breast'), ('UBERON_0001913', 'milk', 168, 'milk'), ('CHEBI_26948', 'vitamin B1', 250, 'thiamine'), ('PR_000016450', 'transmembrane protease serine 11D', 268, 'TMP'), ('UBERON_0000310', 'breast', 356, 'Breast'), ('UBERON_0013691', 'buttock', 363, 'milkTMP'), ('CHEBI_32215', 'thiamphenicol', 410, 'Thiamine'), ('CHEBI_26948', 'vitamin B1', 471, 'thiamine'), ('UBERON_0007688', 'anlage', 536, 'whole'), ('UBERON_0000178', 'blood', 542, 'blood'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 548, 'thiamine diphosphate')]
PMC3387174	6/2012	S98-PMC3387174	['total Thiamine, sum of Thiamine and Tmp.10.1371/journal.pone.0036280.t004\n\ncaption (table-wrap): table 4\nrisk factors for deficient Breast-Milk total Thiamine (<300 nmol/l; n\u200a=\u200a26/636) and low Whole Blood tdp (<65 nmol/l; n\u200a=\u200a31/636)1–3.odds ratio95% ci p value total Thiamine 1 <300 nmol/l wb Tdp2<65  nmol/l14.85.76, 38.2<0.001tmp3ratio ≥63%4.021.30, 12.40.016smoker (\u200a=\u200a1)2.601.09, 6.220.031 Whole Blood tdp<65 nmol/l tmp≥63%7.532.60, 21.8<0.001\ntotal Thiamine, sum of tmp and Thiamine.']	N/A	N/A	[('CHEBI_26948', 'vitamin B1', 6, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 23, 'thiamine'), ('PR_000016450', 'transmembrane protease serine 11D', 36, 'TMP'), ('UBERON_0000310', 'breast', 132, 'breast'), ('UBERON_0001913', 'milk', 139, 'milk'), ('CHEBI_26948', 'vitamin B1', 150, 'thiamine'), ('UBERON_0007688', 'anlage', 193, 'whole'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_26948', 'vitamin B1', 268, 'thiamine'), ('PR_000016211', 'tectonic-3', 294, 'TDP2'), ('UBERON_0004043', 'semicircular canal ampulla', 395, 'Whole'), ('UBERON_0000178', 'blood', 401, 'blood'), ('CHEBI_26948', 'vitamin B1', 455, 'thiamine'), ('CHEBI_26948', 'vitamin B1', 480, 'thiamine')]
PMC3387174	6/2012	S99-PMC3387174	['wb tdp, Whole Blood Thiamine Diphosphate.']	N/A	N/A	[('UBERON_0007688', 'anlage', 8, 'whole'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 20, 'thiamine diphosphate')]
PMC3387174	6/2012	S100-PMC3387174	['tmp, Thiamine Monophosphate.10.1371/journal.pone.0036280.g001\n\ncaption (fig): figure 1\nThiamine and Thiamine monophosphate (tmp) in Breast-Milk by quartiles of Whole Blood Thiamine Diphosphate (tdp).']	N/A	N/A	[('CHEBI_9532', 'thiamine(1+) diphosphate', 5, 'thiamine monophosphate'), ('CHEBI_32215', 'thiamphenicol', 87, 'Thiamine'), ('CHEBI_26948', 'vitamin B1', 100, 'thiamine'), ('UBERON_0000310', 'breast', 132, 'breast'), ('UBERON_0001913', 'milk', 139, 'milk'), ('UBERON_0007688', 'anlage', 160, 'whole'), ('UBERON_0000178', 'blood', 166, 'blood'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 172, 'thiamine diphosphate')]
PMC3400371	7/2012	S44-PMC3400371	['in the second Trimester, Blood volume increases by 45% with an increase in Plasma volume of 50%; Red Cell mass is raised by 35% which amounts to about 450\u2009mg of iron in a 55\u2009kg woman [4].']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 14, 'trimester'), ('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('CL_0000232', 'erythrocyte', 97, 'red cell')]
PMC3400371	7/2012	S56-PMC3400371	['Iron supplements can be given by mouth and parenteral route as intramuscular and intravenous injections; in addition, it can be administered as Blood transfusion and recombinant erythropoietin with iron.']	N/A	N/A	[('CHEBI_24870', 'ion', 0, 'Iron'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC3403156	7/2012	S84-PMC3403156	['children (8–13 years old) Born growth restricted exhibit increased levels of Lipid Peroxidation and have higher Blood pressures compared to age-matched children of normal Birth weight [65–67].']	N/A	N/A	[('GO_0007567', 'parturition', 26, 'born'), ('CHEBI_18059', 'lipid', 77, 'lipid'), ('GO_0032622', 'interleukin-19 production', 77, 'lipid peroxidation'), ('UBERON_0000178', 'blood', 112, 'blood'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC3403156	7/2012	S89-PMC3403156	['Pregnant Rats Fed a low-protein diet have offspring (10–12 weeks old) that exhibit elevated Arterial Blood pressures and increased vasoconstrictor responsiveness to angiotensin ii [74].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 9, 'rats'), ('GO_0007631', 'feeding behavior', 14, 'fed'), ('UBERON_0001637', 'artery', 92, 'arterial'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC3403156	7/2012	S117-PMC3403156	['a homozygous No Synthase 3 deficient Mouse was cross bred to generate paternally and maternally derived heterozygous offspring with high Blood pressures [93].']	N/A	N/A	[('CHEBI_16382', 'iodide', 13, 'NO'), ('PR_000011493', 'cleavage and polyadenylation specificity factor subunit 5', 13, 'NO synthase 3'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'mouse'), ('UBERON_0000178', 'blood', 137, 'blood')]
PMC3404653	3/2012	S3-PMC3404653	['Dna Methylation at Cpg Sites in P16 ( n = 7) and P53 ( n = 4), and in line-1 and alu repetitive elements (3 Cpg Sites in each), was quantified using pyrosequencing in 113 pairs of maternal and Umbilical Blood samples.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 19, 'CpG sites'), ('PR_000001245', 'rhodopsin', 32, 'p16'), ('PR_000003035', 'cellular tumor antigen p53', 49, 'p53'), ('SO_0000036', 'matrix_attachment_site', 108, 'CpG sites'), ('UBERON_0007118', 'umbilicus', 193, 'umbilical'), ('UBERON_0000178', 'blood', 203, 'blood')]
PMC3404653	3/2012	S78-PMC3404653	['whole Blood was collected in an edta-coated vacutainer (bd scientific, franklin lakes, nj, usa) from the mother at the time of enrollment and at 28 weeks Gestation via venipucture.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('GO_0007565', 'female pregnancy', 154, 'gestation')]
PMC3404653	3/2012	S79-PMC3404653	['Blood was collected from the Umbilical Cord shortly after Birth via a syringe or by Milking the Cord.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002331', 'umbilical cord', 29, 'umbilical cord'), ('GO_0007567', 'parturition', 58, 'birth'), ('GO_0007601', 'visual perception', 84, 'milking'), ('UBERON_0002240', 'spinal cord', 96, 'cord')]
PMC3404653	3/2012	S80-PMC3404653	['dna was extracted from 4 ml whole Blood using puregene dna isolation Solutions following manufacturer’s instructions (qiagen/gentra systems, minneapolis, mn, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_75958', 'solution', 69, 'solutions')]
PMC3404653	3/2012	S92-PMC3404653	['caption (table-wrap): table 1\n\ngeneral description of the population providing maternal and Umbilical Cord Blood (n = 113).variablenmean ± sdminimummaximumcesarean section (yes)6 (5.3%)Premature (< 37 weeks)13 (11.5%)infant sex (male)50 (44.3%)Prenatal Vitamins (no)2 (1.8%)maternal age (years)11323.5 ± 4.21838maternal bmi11321.0 ± 3.113.429.0birth weight (g)1132,786 ± 3351,7403,520gestational age at enrollment (weeks)11313.3 ± 4.84.725.9maternal drinking-Water as (μg/l)11314.8 ± 36.2< 1230total Urinary as (μg/l)11325.3 ± 260.30.05260.3total Urinary as (μg/g creatinine)1131.01 ± 2.60.00421.87urinary creatinine (mg/dl)11335.6 ± 31.73.4172.8cord Blood Leukocytes (%mc)line-110980.6 ± 1.976.285.3alu11325.0 ± 0.876.085.1p16 position 11122.4 ± 1.40.879.17p16 position 21122.8 ± 1.31.086.98p16 position 31121.4 ± 0.806.09p16 position 41122.1 ± 1.00.855.82p16 position 51122.1 ± 0.91.067.66p16 position 61121.3 ± 0.805.03p16 position 71122.4 ± 1.10.886.60p53 position 11032.5 ± 0.907.91p53 position 21037.5 ± 2.82.9524.13p53 position 31032.5 ± 1.3013.22p53 position 41033.7 ± 1.5012.58maternal Blood Leukocytes (%mc)line-110180.2 ± 2.176.085.1alu10325.2 ± 0.725.527.5p16 position 11012.6 ± 1.50.6010.87p16 position 21013.1 ± 1.71.0512.51p16 position 31011.4 ± 0.603.21p16 position 41012.2 ± 1.00.735.45p16 position 51012.2 ± 0.71.234.54p16 position 61011.2 ± 0.703.22p16 position 71012.9 ± 2.21.0616.73p53 position 1912.8 ± 1.71.4015.59p53 position 2918.3 ± 2.73.9118.84p53 position 3912.8 ± 1.01.577.03p53 position 4913.8 ± 1.508.6\n\ncaption (table-wrap): table 2\n\ndistribution of Water and Urinary Arsenic concentrations.percentileminimum10th25th50th75th90thmaximumdrinking Water as (μg/l)< 1< 1< 11.23.761230total Urinary as (μg/l)0.052.675.9512.3529.5460.30260.29total Urinary as (μg as/g creatinine)0.0040.180.30.480.801.4221.87\nnon-cpg cytosine residues were used to verify Bisulfite conversion.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 92, 'umbilical cord'), ('UBERON_0000178', 'blood', 107, 'blood'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 185, 'Premature'), ('GO_0007565', 'female pregnancy', 244, 'Prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 253, 'vitamins'), ('CHEBI_15377', 'water', 459, 'water'), ('UBERON_0001088', 'urine', 500, 'urinary'), ('UBERON_0001088', 'urine', 547, 'urinary'), ('CL_0000081', 'blood cell', 651, 'blood leukocytes'), ('UBERON_0000178', 'blood', 651, 'blood'), ('CL_0000081', 'blood cell', 1095, 'blood leukocytes'), ('UBERON_0000178', 'blood', 1095, 'blood'), ('CHEBI_15377', 'water', 1582, 'water'), ('UBERON_0001088', 'urine', 1592, 'urinary'), ('CHEBI_27563', 'arsenic atom', 1600, 'arsenic'), ('CHEBI_15377', 'water', 1676, 'Water'), ('UBERON_0001088', 'urine', 1717, 'urinary'), ('UBERON_0001088', 'urine', 1773, 'urinary'), ('CHEBI_29874', 'bromine dioxide', 1880, 'bisulfite')]
PMC3404653	3/2012	S94-PMC3404653	['the success of pyrosequencing in the maternal samples from Blood drawn at the time of enrollment was 76%, 76%, 75%, and 61% for alu, line-1, P16 , and P53 .']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 138, '1'), ('PR_000001245', 'rhodopsin', 141, 'p16'), ('PR_000003035', 'cellular tumor antigen p53', 151, 'p53')]
PMC3404653	3/2012	S95-PMC3404653	['to increase the number of maternal samples, Dna Methylation results for Blood collected at 28 weeks Gestational age was substituted for the failed samples.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 44, 'DNA methylation'), ('UBERON_0000178', 'blood', 72, 'blood'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
PMC3404653	3/2012	S96-PMC3404653	['subsequently, maternal samples include Blood drawn at the time of enrollment and at 28 weeks Gestational age.']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0007565', 'female pregnancy', 93, 'gestational')]
PMC3404653	3/2012	S113-PMC3404653	['additionally, Cord Blood models are adjusted for prematurity (< 37 or ≥ 37 weeks Gestation).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 14, 'cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('GO_0007565', 'female pregnancy', 81, 'gestation')]
PMC3404653	3/2012	S114-PMC3404653	['results\nin this analysis we used data from 114 paired maternal and Umbilical Cord Blood samples.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 67, 'umbilical cord'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC3404653	3/2012	S154-PMC3404653	['the association between as exposure and methylation in P16 and P53 in maternal Blood are presented intable 5.']	N/A	N/A	[('PR_000001245', 'rhodopsin', 55, 'p16'), ('PR_000003035', 'cellular tumor antigen p53', 63, 'p53'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC3406997	5/2012	S47-PMC3406997	['the body weights of the newborn Piglets were determined Postpartum and Blood samples were immediately taken from the Subclavian Vein of unsuckled piglets for further analysis.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 32, 'piglets'), ('GO_0007565', 'female pregnancy', 56, 'postpartum'), ('UBERON_0000178', 'blood', 71, 'blood'), ('UBERON_0001587', 'subclavian vein', 117, 'subclavian vein')]
PMC3406997	5/2012	S55-PMC3406997	['Blood collection and biochemical analyses in Piglets\nBlood samples were collected from unsuckled and 90-days old Piglets for Serum and Plasma evaluations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 45, 'piglets'), ('UBERON_0000178', 'blood', 53, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 113, 'piglets'), ('UBERON_0001977', 'blood serum', 125, 'serum'), ('UBERON_0001969', 'blood plasma', 135, 'plasma')]
PMC3406997	5/2012	S103-PMC3406997	['combined administration of Akg and Hmb in the ah group of sows induced significantly higher concentration of aspartate, threonine, serine, glutamine, proline, glycine, citruline, valine, cystine, methionine, isoleucine, leucine, tyrosine, phenylalanine, ornithine, lysine, histidine and arginine in Blood Plasma when compared to the control newborns (p\u2009<\u20090.05).']	N/A	N/A	[('PR_000003888', 'A-kinase anchor protein 14', 27, 'AKG'), ('PR_000008840', 'huntingtin', 35, 'HMB'), ('UBERON_0000178', 'blood', 299, 'blood'), ('UBERON_0001969', 'blood plasma', 305, 'plasma')]
PMC3407995	7/2012	S104-PMC3407995	['during Pregnancy the rate of Cell Division and Erythrocyte Formation increases dramatically as the Uterus enlarges, the Placenta develops, maternal Blood volume increases and the Embryo develops into a foetus [58].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('GO_0051301', 'cell division', 29, 'cell division'), ('CL_0000232', 'erythrocyte', 47, 'erythrocyte'), ('GO_0042418', 'epinephrine biosynthetic process', 47, 'erythrocyte formation'), ('UBERON_0000995', 'uterus', 99, 'uterus'), ('UBERON_0001987', 'placenta', 120, 'placenta'), ('UBERON_0000178', 'blood', 148, 'blood'), ('UBERON_0000922', 'embryo', 179, 'embryo')]
PMC3407995	7/2012	S180-PMC3407995	['a double-blind, randomised, placebo-controlled study including 83 women who received either 4 g of Fish Oil providing 2.24 g Dha and 1.12 g Epa or placebo per day from 20 weeks Gestation until Delivery reported the Fatty Acid composition of Cord Blood collected at the time of Delivery in both groups [90].']	N/A	N/A	[('CHEBI_34766', 'Furamizole', 99, 'fish oil'), ('CHEBI_17874', 'dihydrozeatin', 125, 'DHA'), ('CHEBI_34733', 'EPN', 140, 'EPA'), ('GO_0007565', 'female pregnancy', 177, 'gestation'), ('GO_0007567', 'parturition', 193, 'delivery'), ('CHEBI_35366', 'fatty acid', 215, 'fatty acid'), ('UBERON_0002240', 'spinal cord', 241, 'cord'), ('UBERON_0000178', 'blood', 246, 'blood'), ('GO_0007567', 'parturition', 277, 'delivery')]
PMC3407995	7/2012	S216-PMC3407995	['the odds of children with maximal Neurological optimality scores increases with every unit increment in Cord Blood dha at Delivery.']	N/A	N/A	[('UBERON_0001016', 'nervous system', 34, 'neurological'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('UBERON_0000178', 'blood', 109, 'blood'), ('GO_0007567', 'parturition', 122, 'delivery')]
PMC3407995	7/2012	S230-PMC3407995	['there was no difference between groups for maternal hemorrhage, Antenatal hospitalization, Nose bleeds, Vaginal Blood loss, constipation, nausea or vomiting at 28 or 36 weeks Gestation.']	N/A	N/A	[('GO_0007567', 'parturition', 64, 'antenatal'), ('UBERON_0000004', 'nose', 91, 'nose'), ('UBERON_0001987', 'placenta', 104, 'vaginal'), ('UBERON_0000178', 'blood', 112, 'blood'), ('GO_0007565', 'female pregnancy', 175, 'gestation')]
PMC3407995	7/2012	S279-PMC3407995	['a cross-sectional study including 50 women in labour with a singleton term Pregnancy in pakistan measured Vitamin D status in maternal Blood before Delivery and Cord Blood at Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0000178', 'blood', 135, 'blood'), ('GO_0007567', 'parturition', 148, 'delivery'), ('UBERON_0002240', 'spinal cord', 161, 'cord'), ('UBERON_0000178', 'blood', 166, 'blood'), ('GO_0007567', 'parturition', 175, 'delivery')]
PMC3407995	7/2012	S308-PMC3407995	['maternal Vitamin D was measured at the 24th and 34th weeks of Pregnancy and at Delivery and infant Vitamin D was measured in Umbilical Blood at Birth and on the sixth day following Birth.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('GO_0007567', 'parturition', 79, 'delivery'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0007118', 'umbilicus', 125, 'umbilical'), ('UBERON_0000178', 'blood', 135, 'blood'), ('GO_0007567', 'parturition', 144, 'birth'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC3409554	7/2012	S40-PMC3409554	['iron absorption is increased by Consumption of Food items with a high content of Iron with a high bioavailability, for example, beef, pork, poultry, fish, and Food items containing Blood products.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 32, 'consumption'), ('CHEBI_33290', 'food', 47, 'food'), ('CHEBI_24870', 'ion', 81, 'iron'), ('CHEBI_33290', 'food', 159, 'food'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC3409554	7/2012	S66-PMC3409554	['the growing Brain has a demand for a balanced supply of Iron across the Blood-Brain Barrier [20].']	N/A	N/A	[('UBERON_0000955', 'brain', 12, 'brain'), ('CHEBI_24870', 'ion', 56, 'iron'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0000052', 'fornix of brain', 78, 'brain barrier')]
PMC3409554	7/2012	S183-PMC3409554	['Pregnancy induces extraordinary high demands for iron in order to increase maternal Red Blood Cell mass and secure a normal Development Of the Fetus.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CL_0000232', 'erythrocyte', 84, 'red blood cell'), ('UBERON_0000178', 'blood', 88, 'blood'), ('GO_0051402', 'neuron apoptotic process', 124, 'development of ... fetus')]
PMC3409554	7/2012	S193-PMC3409554	['Postpartum women:\n\nhigher iron status at Delivery,\nlower prevalence of Postpartum iron deficiency, and ida due to peripartum Blood losses.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('GO_0007567', 'parturition', 41, 'delivery'), ('GO_0007565', 'female pregnancy', 71, 'postpartum'), ('UBERON_0000178', 'blood', 125, 'blood')]
PMC3414394	7/2012	S3-PMC3414394	['using Bisulfite pyrosequencing of Cord Blood dna from 508 infants, we measured methylation at differentially methylated regions (dmrs) Regulating Imprinted Genes Igf2/H19, Dlk1/Meg3, mest, peg3, peg10/sgce, Nnat and Plagl1 .']	N/A	N/A	[('CHEBI_29874', 'bromine dioxide', 6, 'bisulfite'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0065007', 'biological regulation', 135, 'regulating'), ('GO_0071514', 'genetic imprinting', 146, 'imprinted'), ('SO_0000704', 'gene', 156, 'genes'), ('PR_000008989', 'interleukin-1 family member 7', 162, 'IGF2'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 167, 'H19'), ('PR_000006522', 'protein delta homolog 2', 172, 'DLK1'), ('PR_000010330', 'talin rod domain-containing protein 1', 177, 'MEG3'), ('PR_000011208', 'nidogen-1', 207, 'NNAT'), ('PR_000012889', 'BPI fold-containing family A member 1', 216, 'PLAGL1')]
PMC3414394	7/2012	S133-PMC3414394	['Dna Methylation analysis\nmaternal Peripheral Blood samples were collected at enrollment and infant Cord Blood specimens were collected at Birth.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0012101', 'perinatal stage', 34, 'peripheral'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002240', 'spinal cord', 99, 'cord'), ('UBERON_0000178', 'blood', 104, 'blood'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3415261	7/2012	S99-PMC3415261	['during the first days of Rat Life, besides Nk Cells, there is a significant proportion of Tcr Γδ + iels (figure 2(a)) [30,54], while these cells appear later in Blood [55].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rat'), ('UBERON_0000104', 'life cycle', 29, 'life'), ('CL_0000623', 'natural killer cell', 43, 'NK cells'), ('GO_0005634', 'nucleus', 43, 'NK'), ('PR_000016190', 'trichohyalin-like protein 1', 90, 'TCR γδ'), ('UBERON_0000178', 'blood', 161, 'blood')]
PMC3415261	7/2012	S190-PMC3415261	['for this purpose, maternal Blood samples at different Gestational/Suckling ages could easily be obtained by experimental procedures performed in accordance with the institutional guidelines for the care and use of laboratory Animals established by the corresponding ethical committee [76].']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007565', 'female pregnancy', 54, 'gestational'), ('GO_0001967', 'suckling behavior', 66, 'suckling'), ('NCBITaxon_33208', 'Metazoa', 225, 'animals')]
PMC3420688	5/2012	S14-PMC3420688	['pnh is a clonal Hematopoietic disorder characterized by a somatic mutation in the Pig-A Gene that results in deficiency of complement protective Glycosylphosphatidylinositol proteins Cd55 and Cd59 on the Surface Of Blood Cells.']	N/A	N/A	[('GO_0030097', 'hemopoiesis', 16, 'hematopoietic'), ('PR_000012720', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform', 82, 'PIG-A'), ('SO_0000704', 'gene', 88, 'gene'), ('CHEBI_24410', 'glycosylphosphatidylinositol', 145, 'glycosylphosphatidylinositol'), ('PR_000001309', 'CD70 molecule', 183, 'CD55'), ('PR_000001309', 'CD70 molecule', 192, 'CD59'), ('GO_0009986', 'cell surface', 204, 'surface of ... cells'), ('CL_0000081', 'blood cell', 215, 'blood cells'), ('UBERON_0000178', 'blood', 215, 'blood')]
PMC3420688	5/2012	S30-PMC3420688	['she was taking Prenatal vitamins and denied chemical exposure, smoking or alcohol use, or a family history of Blood disorders.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'prenatal'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC3420688	5/2012	S34-PMC3420688	['complete Blood counts showed pancytopenia: wbc: 3.8 × 109/l; anc: 1.4 × 109/l; nadir anc: 0.1 × 109/l; hb: 3.4\u2009g/dl; Platelets: 3 × 109/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000233', 'platelet', 117, 'platelets')]
PMC3420688	5/2012	S90-PMC3420688	['pnh, an acquired Hematopoietic Stem Cell disorder of the Pig-A Gene, results in increased sensitivity of Blood Cells to Complement-mediated Destruction.']	N/A	N/A	[('CL_0000037', 'hematopoietic stem cell', 17, 'hematopoietic stem cell'), ('GO_0030097', 'hemopoiesis', 17, 'hematopoietic'), ('PR_000012720', 'phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform', 57, 'PIG-A'), ('SO_0000704', 'gene', 63, 'gene'), ('CL_0000081', 'blood cell', 105, 'blood cells'), ('UBERON_0000178', 'blood', 105, 'blood'), ('GO_0007620', 'copulation', 120, 'complement'), ('GO_0009556', 'microsporogenesis', 140, 'destruction')]
PMC3423345	8/2012	S4-PMC3423345	['maternal Blood was collected at 16 and 36 weeks of Gestation and infant Neurodevelopment was assessed at 18 months of age for 154 mother-infant pairs.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 51, 'gestation'), ('GO_0007399', 'nervous system development', 72, 'neurodevelopment')]
PMC3423345	8/2012	S47-PMC3423345	['laboratory methods\nBlood samples were collected from each woman at 16 and 36 weeks of Gestation; the women were requested to refrain from Eating after waking until Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'Blood'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('GO_0051318', 'G1 phase', 138, 'eating'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC3424155	8/2012	S3-PMC3424155	['results\nthe first two generations of the vitd- group had higher Blood pressure at 6 months of age than the offspring of the sc group as well as an increase in Renin and At1R Expression.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('PR_000014368', 'RuvB-like 1', 159, 'renin'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 169, 'AT1r'), ('GO_0010467', 'gene expression', 174, 'expression')]
PMC3424155	8/2012	S47-PMC3424155	['from three to six months, all Animals had systolic Blood pressure (bp) measured weekly with a non-invasive Tail-Cuff plethysmography (letica le 5100, panlab, barcelona, spain).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 30, 'animals'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0002415', 'tail', 107, 'tail'), ('UBERON_0003124', 'chorion', 112, 'cuff')]
PMC3424155	8/2012	S89-PMC3424155	['Blood pressure (figure 3)10.1371/journal.pone.0041740.g003\n\ncaption (fig): figure 3\nsystolic Blood pressure evolution in both the f1 and f2 generations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC3424155	8/2012	S91-PMC3424155	['Blood pressure increased continually from 3 to 6 months of age in both groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3426771	1/2012	S92-PMC3426771	['over time this leads to further Nephron loss, Glomerular injury[55]and rising local Blood pressure eventually manifests as systemic hypertension.']	N/A	N/A	[('UBERON_0001285', 'nephron', 32, 'nephron'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0000178', 'blood', 84, 'blood')]
PMC3426771	1/2012	S96-PMC3426771	['the Renin–angiotensin system is a multi-Organ System that Regulates Blood pressure and hypertension is one of the most common outcomes of nutritional programming.']	N/A	N/A	[('PR_000014368', 'RuvB-like 1', 4, 'renin'), ('UBERON_0000467', 'anatomical system', 40, 'organ system'), ('GO_0065007', 'biological regulation', 58, 'regulates'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC3426771	1/2012	S99-PMC3426771	['Ang Ii Regulates Blood Pressure by both stimulating Sodium transporters[56]and by increasing the Production and release Of Aldosterone[57].']	N/A	N/A	[('CHEBI_27436', 'methyltestosterone', 0, 'Ang II'), ('PR_000003539', 'ATP-binding cassette sub-family A member 12', 0, 'Ang II'), ('GO_0065007', 'biological regulation', 7, 'regulates'), ('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0060208', 'proestrus', 23, 'pressure'), ('CHEBI_52632', 'potassium-39 atom', 52, 'sodium'), ('GO_0006750', 'glutathione biosynthetic process', 97, 'production ... of aldosterone'), ('CHEBI_27584', 'aldosterone', 123, 'aldosterone')]
PMC3426771	1/2012	S100-PMC3426771	['offspring Born to mothers Fed a low protein diet during Pregnancy go onto develop high Blood pressure.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'born'), ('GO_0007631', 'feeding behavior', 26, 'fed'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('UBERON_0000178', 'blood', 87, 'blood')]
PMC3426771	1/2012	S124-PMC3426771	['moreover, in Rats with hypertension programmed by a maternal low protein diet, Adrenalectomy normalises Blood pressure, whilst adrenalectomy with Corticosterone replacement maintains higher pressure[73].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rats'), ('UBERON_0002085', 'interatrial septum', 79, 'adrenalectomy'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_16827', 'corticosterone', 146, 'corticosterone')]
PMC3427250	8/2012	S4-PMC3427250	['Blood samples were collected and a questionnaire was completed face-to-face.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3427250	8/2012	S44-PMC3427250	['data collection\nBlood samples were collected from the Antecubital Vein and a general questionnaire about socio-demographic and socio-economic characteristics, smoking and Alcohol Consumption during Pregnancy and during the 4 weeks prior to the interview, diseases and medication and use of Food Supplements was completed in a face-to-face interview conducted by the study nurse.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'Blood'), ('UBERON_0001545', 'anterior tibial vein', 54, 'antecubital vein'), ('CHEBI_30879', 'alcohol', 171, 'alcohol'), ('GO_0007631', 'feeding behavior', 179, 'consumption'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_35217', 'alkaline earth coordination entity', 290, 'food supplements')]
PMC3427250	8/2012	S48-PMC3427250	['analysis of samples\napproximately 5 ml whole Blood was collected by venipuncture in a non-heparinized tube.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC3432839	8/2012	S65-PMC3432839	['caption (table-wrap): table\xa02\n\nunadjusted differences in measures of estimated dietary Intake of ω-3 and mean Blood levels according to Growing pains at 8.5\u2005yearsno Growing painsgrowing painsp valuematernal Prenatal ffq (mean (sd))\u2003total ω-30.15 (0.15)0.16 (0.15)0.614\u2003dha0.07 (0.07)0.07 (0.07)0.593\u2003epa0.05 (0.05)0.05 (0.05)0.654breastfeeding duration\u2003none (20.7%)1172 (77.7%)336 (22.3%)0.193\u2003up to 3\u2005months (31.2%)1775 (78.2%)495 (21.8%)\u2003>3\u2005months (48.2%)2797 (79.7%)712 (20.3%)child ffq at 3\u2005years (mean (sd))\u2003total n30.06 (0.06)0.06 (0.05)0.443\u2003dha0.02 (0.03)0.03 (0.03)0.449\u2003epa0.02 (0.02)0.02 (0.02)0.439child ffq at 6\u2005years (mean (sd))\u2003total n30.08 (0.09)0.09 (0.09)0.173\u2003dha0.03 (0.04)0.03 (0.04)0.217\u2003epa0.02 (0.02)0.02 (0.02)0.233child Plasma levels at 7\u2005years (mean (sd))\u2003aa (20:4n6)6.45 (1.32)6.36 (1.32)0.087\u2003Dha (22:6n3)1.89 (0.52)1.90 (0.53)0.426\u2003Epa (20:5n3)0.64 (0.20)0.64 (0.20)0.797\u2003La (18:2n6)30.6 (3.16)30.7 (3.25)0.511\u2003ala (18:3n3)0.71 (0.28)0.72 (0.27)0.318maternal Prenatal Red Cell levels (mean (sd))\u2003aa (20:4n6)6.16 (2.98)\xa06.11 (2.97)0.727\u2003Dha (22:6n3)2.32 (1.36)2.25 (1.31)0.215\u2003Epa (20:5n3)0.27 (0.18)0.27 (0.17)0.331\u2003la (18:2n6)11.10 (2.70)10.98 (2.82)0.610\u2003ala (18:3n3)0.14 (0.07)0.14 (0.07)0.676\naa, arachidonic acid; ala, Α-Linolenic Acid; Dha, Decosahexaenoic Acid; Epa, Eicosapentaenoic Acid; ffq, calculated from seafood Intake using Food frequency questionnaire; La, Linoleic Acid.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 87, 'intake'), ('UBERON_0000178', 'blood', 110, 'blood'), ('GO_0040007', 'growth', 136, 'growing'), ('GO_0040007', 'growth', 165, 'growing'), ('GO_0007565', 'female pregnancy', 207, 'prenatal'), ('UBERON_0001969', 'blood plasma', 746, 'plasma'), ('CHEBI_17874', 'dihydrozeatin', 822, 'DHA'), ('CHEBI_34733', 'EPN', 862, 'EPA'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 902, 'LA'), ('GO_0007565', 'female pregnancy', 989, 'prenatal'), ('CL_0000232', 'erythrocyte', 998, 'red cell'), ('CHEBI_17874', 'dihydrozeatin', 1066, 'DHA'), ('CHEBI_34733', 'EPN', 1106, 'EPA'), ('CHEBI_86354', '2-hydroxyacrylic acid', 1254, 'α-linolenic acid'), ('CHEBI_17874', 'dihydrozeatin', 1272, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 1277, 'decosahexaenoic acid'), ('CHEBI_34733', 'EPN', 1299, 'EPA'), ('CHEBI_36003', 'decenoic acid', 1304, 'eicosapentaenoic acid'), ('GO_0007631', 'feeding behavior', 1356, 'intake'), ('CHEBI_33290', 'food', 1369, 'food'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 1399, 'LA'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 1403, 'linoleic acid')]
PMC3432839	8/2012	S83-PMC3432839	["in addition, the levels of 5 different ω-3 and ω-6 Fatty Acids measured in the mothers’ Blood in Pregnancy, and in the child'S Blood at age 7\u2005years, were not associated with Limb pain."]	N/A	N/A	[('CHEBI_35366', 'fatty acid', 51, 'fatty acids'), ('UBERON_0000178', 'blood', 88, 'blood'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('UBERON_0005432', 'aortic sac', 125, 's'), ('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0002101', 'limb', 174, 'limb')]
PMC3436647	4/2012	S135-PMC3436647	['at the time of Delivery, Placental Tissue, Cord Blood, Heel Stick Blood and Meconium are collected.']	N/A	N/A	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0001987', 'placenta', 25, 'placental'), ('UBERON_0000479', 'tissue', 35, 'tissue'), ('UBERON_0002240', 'spinal cord', 43, 'cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0015852', 'narwhal tusk', 55, 'heel stick'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0007109', 'meconium', 76, 'meconium')]
PMC3436647	4/2012	S187-PMC3436647	['caption (table-wrap): table 3\n\ndomains of risk factor data collected from interviews, diaries and other self-report formsrisk factor domainsinterviewsdiariesother self-report formsademographicsm, ffmedication exposurem, fm, sm, f, smedical conditionsmmm, f, Spesticidessm, sdietmsmhome environmental exposuresmm, sm, fhealth behaviors/lifestylesm, fmental condition/history/symptomsmmm, f, svaccine historym, spersonal product usemm, smanthropometricsmmmmedical proceduresmm, sm, foccupational historym, f\naincludes the following forms: home walkthrough survey, maternal interview update, charge family medical history form, dietary history questionnaires (Preconception, 1 to 20 weeks, 21 to 36 weeks and Postnatal), health behaviors questionnaires (Preconception, Pregnancy and paternal), paternal interview, 24-hour recalls (Food and environment), stress and depression surveys, Postnatal diaries, Blood draw information form, maternal medical history, post-partum environmental exposures and dust field log.']	N/A	N/A	[('CHEBI_82784', 'PVP38-Ag NP', 258, 'SPesticidesSM'), ('GO_0007565', 'female pregnancy', 657, 'preconception'), ('GO_0007567', 'parturition', 706, 'postnatal'), ('GO_0007565', 'female pregnancy', 751, 'preconception'), ('GO_0007565', 'female pregnancy', 766, 'pregnancy'), ('CHEBI_33290', 'food', 828, 'food'), ('GO_0007567', 'parturition', 882, 'Postnatal'), ('UBERON_0000178', 'blood', 901, 'Blood')]
PMC3436647	4/2012	S191-PMC3436647	['Venous Blood is collected from both, and fathers are also provided with a home Semen collection kit.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001968', 'semen', 79, 'semen')]
PMC3436647	4/2012	S192-PMC3436647	['biosampling in mothers begins at enrollment with the collection of Blood, first void Urine and Hair.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('UBERON_0001088', 'urine', 85, 'urine'), ('UBERON_0001037', 'strand of hair', 95, 'hair')]
PMC3436647	4/2012	S195-PMC3436647	['Umbilical Cord Blood and Placental samples are collected as close to Delivery as possible.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0001987', 'placenta', 25, 'placental'), ('GO_0007567', 'parturition', 69, 'delivery')]
PMC3436647	4/2012	S198-PMC3436647	['heel stick cards are left at the hospital, and newborn Blood is collected by hospital staff after neonatal screening whenever possible without an additional Heel stick.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0015875', 'heel', 157, 'heel')]
PMC3436647	4/2012	S203-PMC3436647	['at the six-month clinic visit, mothers again provide Blood, Urine and Hair samples, and a first Venous Blood sample, another diaper Urine sample and a Hair sample are taken from the infant sibling.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0001088', 'urine', 60, 'urine'), ('UBERON_0001037', 'strand of hair', 70, 'hair'), ('UBERON_0001638', 'vein', 96, 'venous'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0001088', 'urine', 132, 'urine'), ('UBERON_0001037', 'strand of hair', 151, 'hair')]
PMC3436647	4/2012	S204-PMC3436647	["biosampling concludes with infant siblings' providing Venous Blood and diaper/pull-up pad Urine samples during the 12- and 24-month follow-up clinic visits."]	N/A	N/A	[('UBERON_0001638', 'vein', 54, 'venous'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001088', 'urine', 90, 'urine')]
PMC3436647	4/2012	S207-PMC3436647	['caption (table-wrap): table 4\n\nearli biosampling time points by biosample and participant typeasamplemotherfatherprobandinfant siblingbloode, pre-2nd, pre-3rd, post-6 monthseepost-6 months, post-12 months, post-24 monthshaire, pre-2nd, pre-3rd, post-6 monthspost-6 months, post-12 months, post-24 monthsurinee, pre-2nd, pre-3rd, post-6 monthspost-1 week, post-3 months, post-6 months, post-12 months, post-24 monthssemeneplacenta, Cord Blooddheel stick Blood, Meconiumdbreast Milkpost-1 week, post-3 months\nad, Delivery; e, enrollment; earli, early autism risk longitudinal investigation; pre-2nd, second Prenatal visit; pre-3rd, third Prenatal visit; post-1 week, 1 week Postnatal; post-3 months, 3 months Postnatal; post-6 months, 6 months Postnatal; post-12 months, 12 months Postnatal; post-24 months, 24 months Postnatal.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 431, 'cord'), ('UBERON_0001981', 'blood vessel', 436, 'bloodDHeel'), ('UBERON_0000178', 'blood', 453, 'blood'), ('UBERON_0008785', 'upper limb segment', 460, 'meconiumDBreast milkPost'), ('GO_0007567', 'parturition', 511, 'delivery'), ('GO_0007565', 'female pregnancy', 605, 'prenatal'), ('GO_0007565', 'female pregnancy', 636, 'prenatal'), ('GO_0007567', 'parturition', 672, 'postnatal'), ('GO_0007567', 'parturition', 707, 'postnatal'), ('GO_0007567', 'parturition', 742, 'postnatal'), ('GO_0007567', 'parturition', 779, 'postnatal'), ('GO_0007567', 'parturition', 816, 'postnatal')]
PMC3436647	4/2012	S209-PMC3436647	['processing on-site is minimal for Venous Blood, limited to centrifuging as dictated by tube type, with samples shipped next-day delivery to the central laboratory and biorepository (clbr).']	N/A	N/A	[('UBERON_0001638', 'vein', 34, 'venous'), ('UBERON_0000178', 'blood', 41, 'blood')]
PMC3436647	4/2012	S215-PMC3436647	['Blood sample processing at the clbr generates a repository of multiple aliquots of stored Plasma, Serum, whole Blood, extracted dna and Peripheral Blood Mononuclear Cells (Pbmcs), including aliquots processed and saved to allow for establishment of cell lines.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CL_0000111', 'peripheral neuron', 136, 'peripheral'), ('UBERON_0012101', 'perinatal stage', 136, 'peripheral blood'), ('CL_0000208', 'pH receptor cell', 147, 'blood mononuclear cells'), ('GO_0031097', 'medial cortex', 153, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 172, 'PBMCs')]
PMC3436647	4/2012	S221-PMC3436647	['items of particular interest include specific clinical tests or results in mothers (for example, type of ultrasound, Blood pressure, Blood Glucose levels) and newborns (for example, oxygen saturation values, fetal Heart rate tracings, newborn screening results) and details regarding indications and dates for procedures and Medications.']	N/A	N/A	[('UBERON_0000178', 'blood', 117, 'blood'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_17234', 'glucose', 139, 'glucose'), ('UBERON_0000948', 'heart', 214, 'heart'), ('CHEBI_25441', 'mycothiols', 325, 'medications')]
PMC3436647	4/2012	S269-PMC3436647	['abbreviations\nadi-r: autism diagnostic interview-revised; ados: autism diagnostic observation schedule; aosi: autism observation scale for infants; asd: autism spectrum disorder; bsrc: baby siblings research consortium; cbcl: child behavior checklist; clbr: central laboratory and biorepository; cnv: copy number variation; cpt: cell preparation tube; csbs dp: communication and symbolic behavior scales developmental profile; dnam: Dna Methylation; earli: early autism risk longitudinal investigation; edta: Ethylenediaminetetraacetic Acid; gwas: Genomewide association study; ibis: infant Brain imaging study; marbles: markers of autism risk in babies-Learning early signs; pbmc: Peripheral Blood Mononuclear Cell; pdd nos: pervasive developmental disorder not otherwise specified; seed: study to explore early development; sst: Serum separator tube; srs: social responsiveness scale.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 433, 'DNA methylation'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 509, 'Ethylenediaminetetraacetic acid'), ('SO_0001026', 'genome', 548, 'Genomewide'), ('UBERON_0000955', 'brain', 591, 'Brain'), ('GO_0007612', 'learning', 654, 'Learning'), ('CL_0002500', 'P enteroendocrine cell', 682, 'Peripheral blood mononuclear cell'), ('UBERON_0000178', 'blood', 693, 'blood'), ('GO_0031097', 'medial cortex', 699, 'mononuclear'), ('UBERON_0001977', 'blood serum', 831, 'Serum')]
PMC3463445	9/2012	S15-PMC3463445	['the electrical stimulation of the Ventromedial Hypothalamic Nucleus induces the immediate activation of Hepatic Glycogenolysis [10], whereas the stimulation of the Lateral Hypothalamus leads to a prompt enhancement of Glycogen Synthesis that allows an increase in Blood Glucose levels [11].']	N/A	N/A	[('UBERON_0001925', 'ventral lateral nucleus of thalamus', 34, 'ventromedial hypothalamic nucleus'), ('UBERON_0002107', 'liver', 104, 'hepatic'), ('GO_0005981', 'regulation of glycogen catabolic process', 112, 'glycogenolysis'), ('UBERON_0002736', 'lateral nuclear group of thalamus', 164, 'lateral hypothalamus'), ('CHEBI_24384', 'glycogens', 218, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 218, 'glycogen synthesis'), ('UBERON_0000178', 'blood', 264, 'blood'), ('CHEBI_17234', 'glucose', 270, 'glucose')]
PMC3463445	9/2012	S58-PMC3463445	['these programmed Rats can no longer Secrete as much Insulin as the rising Blood Glucose levels demand [8].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 17, 'rats'), ('GO_0046903', 'secretion', 36, 'secrete'), ('PR_000045358', 'insulin family protein', 52, 'insulin'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_17234', 'glucose', 80, 'glucose')]
PMC3463445	9/2012	S90-PMC3463445	['during Blood Glucose level oscillations, the Β-Cells receive inputs from the Parasympathetic and Sympathetic systems to participate in Glycemic Regulation.']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_17234', 'glucose', 13, 'glucose'), ('CL_0002200', 'oxyphil cell of thyroid', 45, 'β-cells'), ('UBERON_0004148', 'cardiac vein', 77, 'parasympathetic'), ('UBERON_0000402', 'nasal vestibule', 97, 'sympathetic'), ('GO_0006094', 'gluconeogenesis', 135, 'glycemic regulation')]
PMC3463445	9/2012	S92-PMC3463445	['before and during Food Intake, Vagus Nerve activity is responsible for the rise in Insulin Blood levels.']	N/A	N/A	[('CHEBI_33290', 'food', 18, 'food'), ('GO_0007631', 'feeding behavior', 18, 'food intake'), ('UBERON_0001759', 'vagus nerve', 31, 'vagus nerve'), ('PR_000045358', 'insulin family protein', 83, 'insulin'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC3465343	10/2012	S202-PMC3465343	['after Parturition, the two groups of female Rats were Fed an ain-93g diet sufficient in Vitamin A (4 Retinol equivalents (re)/g diet) to Feed the rest of neonates for two weeks until being killed.10.1371/journal.pone.0046565.t004\n\ncaption (table-wrap): table 4\nformulation of modified ain-93g Growing Rodent diet without added Vitamin A.ingredientamountgm/kgcasein, Lactic, 30 mesh200l-cystine3corn starch397.486maltodextrin 10132sucrose100cellulose,bw20050cottonseed oil70t-Butylhydroquinone0.014mineral Mix s10022g35vitamin Mix s1300210choline bitartrate2.5\n\nSerum Vitamin A measurement\nthe Tail Blood of female Rats was collected for detecting Serum Retinol level before Mating and after Parturition.']	N/A	N/A	[('GO_0019230', 'proprioception', 6, 'parturition'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 44, 'rats'), ('GO_0007631', 'feeding behavior', 54, 'fed'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 101, 'retinol'), ('GO_0007631', 'feeding behavior', 137, 'feed'), ('GO_0040007', 'growth', 293, 'growing'), ('NCBITaxon_33208', 'Metazoa', 301, 'rodent'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin A'), ('CHEBI_35571', 'mancude organic heterocyclic parent', 366, 'lactic'), ('CHEBI_28224', 'Peptidyl-L-arginine', 475, 'butylhydroquinone0'), ('CHEBI_60004', 'mixture', 505, 'mix'), ('CHEBI_60004', 'mixture', 526, 'mix'), ('UBERON_0001977', 'blood serum', 561, 'Serum'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin A'), ('UBERON_0002415', 'tail', 593, 'tail'), ('UBERON_0000178', 'blood', 598, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 614, 'rats'), ('UBERON_0001977', 'blood serum', 647, 'serum'), ('CHEBI_26536', 'retinoic acid', 653, 'retinol'), ('GO_0007618', 'mating', 674, 'mating'), ('GO_0019230', 'proprioception', 691, 'parturition')]
PMC3465343	10/2012	S203-PMC3465343	['six neonatal Rats were anesthetized at the day of Birth and the whole Blood was obtained from the Right Ventricle Of the Heart, which was exposed after thoracotomy.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rats'), ('GO_0007567', 'parturition', 50, 'birth'), ('UBERON_0000178', 'blood', 70, 'blood'), ('UBERON_0002078', 'right cardiac atrium', 98, 'right ventricle of ... heart')]
PMC3465343	10/2012	S204-PMC3465343	['Blood samples were collected in edta-coated tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3469234	9/2012	S21-PMC3469234	['the patient was managed with vasopressors, Blood products, and Fluid replacement.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('UBERON_0006314', 'bodily fluid', 63, 'fluid')]
PMC3469234	9/2012	S35-PMC3469234	['antenatal supplementation with oral Iron can maximize iron stores and improving the oxygen-carrying capacity of Blood.']	N/A	N/A	[('CHEBI_24870', 'ion', 36, 'iron'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC3470091	9/2012	S37-PMC3470091	['also, Blood samples were used to prepare Serums, which were kept frozen at -80°c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 41, 'serums')]
PMC3470091	9/2012	S38-PMC3470091	['fasting Blood samples were also obtained on follow ups and were used to prepare Serums, which were kept similarly.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001977', 'blood serum', 80, 'serums')]
PMC3478561	11/2012	S42-PMC3478561	['on pnd21, one male and one female pup per litter was killed by decapitation, and Blood was collected, centrifuged at 4°c to collect Plasma, and stored at −80°c for hormone analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0001969', 'blood plasma', 132, 'plasma')]
PMC3478561	11/2012	S60-PMC3478561	['a baseline Blood sample (∼200 μl) was taken via a small Tail nick for determination of Plasma Insulin.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0002415', 'tail', 56, 'tail'), ('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('PR_000045358', 'insulin family protein', 94, 'insulin')]
PMC3478561	11/2012	S61-PMC3478561	['baseline fasted Blood Glucose was determined at the same time by a handheld freestyle Glucose meter (therasense, alameda, ca).']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_17234', 'glucose', 22, 'glucose'), ('CHEBI_17234', 'glucose', 86, 'glucose')]
PMC3478561	11/2012	S63-PMC3478561	['Blood samples were collected at 15, 30, 45, 60, and 120 min after Glucose gavage to determine plasma Insulin levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('PR_000045358', 'insulin family protein', 101, 'insulin')]
PMC3478561	11/2012	S64-PMC3478561	['Blood Glucose was determined at each interval using the Glucometer.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_24321', 'glutamo group', 56, 'glucometer')]
PMC3478561	11/2012	S72-PMC3478561	['Blood was collected into a heparinized microcentrifuge tube, centrifuged at 4°c to collect Plasma, and stored at −80°c until analysis for leptin concentration.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 91, 'plasma')]
PMC3478561	11/2012	S121-PMC3478561	['at weaning, hf-chow males had significantly lower baseline Blood Glucose and plasma Insulin compared with the chow-chow males ( p< 0.05;fig.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_17234', 'glucose', 65, 'glucose'), ('PR_000045358', 'insulin family protein', 84, 'insulin')]
PMC3478561	11/2012	S135-PMC3478561	['Blood Glucose ( a and b ) and Plasma Insulin ( c and d ) were determined for 2 h after oral administration of Glucose.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0001969', 'blood plasma', 30, 'plasma'), ('PR_000045358', 'insulin family protein', 37, 'insulin'), ('CHEBI_17234', 'glucose', 110, 'glucose')]
PMC3478561	11/2012	S201-PMC3478561	['Blood Glucose ( a and b ) and Plasma Insulin ( c and d ) were determined for 2 h after oral administration of Glucose.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0001969', 'blood plasma', 30, 'plasma'), ('PR_000045358', 'insulin family protein', 37, 'insulin'), ('CHEBI_17234', 'glucose', 110, 'glucose')]
PMC3481751	6/2010	S54-PMC3481751	['when group care started, at first participants engaged in self-Care activities of weight and Blood pressure assessment; they recorded their own results in their medical records.']	N/A	N/A	[('GO_0007567', 'parturition', 63, 'care'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC3483668	10/2012	S134-PMC3483668	['growth achievement, Red Blood Cell Fatty Acid levels, and morbidity did not differ between the groups [66].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 20, 'red blood cell'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_35366', 'fatty acid', 35, 'fatty acid')]
PMC3485340	10/2012	S29-PMC3485340	['upon arrival, maternal vitc levels in Plasma were obtained by Blood sampling (39.8±11.8 µm).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC3485340	10/2012	S60-PMC3485340	['at arrival and two times during Gestation, 300 µl Blood samples were taken from the v. Saphena at its superficial course on Tibia in eight random dams of each group for verification of vitc status (data not shown).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 32, 'gestation'), ('UBERON_0000178', 'blood', 50, 'blood'), ('UBERON_0001743', 'ligament of larynx', 87, 'saphena'), ('UBERON_0000979', 'tibia', 124, 'tibia')]
PMC3485340	10/2012	S63-PMC3485340	['upon the disappearance of voluntary Reflexes, Thoracotomy was performed and an Intracardial Blood sample was collected by 5 ml syringe and 18g Hypodermic needle previously flushed with 15% tripotassium-edta[21].']	N/A	N/A	[('GO_0060004', 'reflex', 36, 'reflexes'), ('UBERON_0002347', 'thoracic vertebra', 46, 'thoracotomy'), ('UBERON_3000720', 'stegochordal', 79, 'intracardial'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0000949', 'endocrine system', 143, 'hypodermic')]
PMC3485340	10/2012	S65-PMC3485340	['Blood samples were immediately centrifuged and stabilized after sampling.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3488908	4/2010	S82-PMC3488908	['we used the more definitive strategy for identifying Cd4+Cd25+Cd127Lo/−Regulatory Cells to examine presymptomatic differences in the activity and frequency of Tregs in Cord Blood.']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 53, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 57, 'CD25'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 62, 'CD127lo'), ('CL_0000232', 'erythrocyte', 71, 'regulatory cells'), ('GO_0065007', 'biological regulation', 71, 'regulatory'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 159, 'Tregs'), ('UBERON_0002240', 'spinal cord', 168, 'cord'), ('UBERON_0000178', 'blood', 173, 'blood')]
PMC3489539	8/2012	S33-PMC3489539	['caption (table-wrap): table 3\n\nparasitaemia and anaemia among Pregnant women attending Antenatal clinics and Delivery units\xa0 antenatal clinicsrajnandgoan n\u2009=\u20091498bastar n\u2009=\u20091198 peripheral parasitaemia†\u2003overall*1 (0.1)34 (2.8)\u2003by species*\xa0\xa0\u2003 P. falciparum 0 (0)29 (2.4)\u2003 p. vivax 1 (0.1)5 (0.4)\u2003mixed0 (0)1 (0.1)anaemia\u2003overall* (hgb\u2009<\u200911\u2009g/dl)957 (63.9)861 (71.9)\u2003moderate/severe* (hgb\u2009<\u20099\u2009g/dl)183 (12.2)249 (20.8)\xa0 Delivery units \xa0 rajnandgoan n\u2009=\u2009547bastar n\u2009=\u2009481 peripheral parasitaemia†\xa0\xa0\u2003overall*3 (0.6)16 (3.4)\u2003by species*\xa0\xa0\u2003 P. falciparum 1 (0.2)12 (2.7)\u2003 P. Vivax 2 (0.4)3 (0.6)\u2003mixed0 (0)1 (0.2)anaemia\xa0\xa0\u2003overall* (hgb\u2009<\u200911\u2009g/dl)459 (83.9)304 (63.9)\u2003moderate/severe* (hgb\u2009<\u20099\u2009g/dl)64 (11.7)91 (19.1)Placental parasitaemia†\xa0\xa0\u2003overall16 (3.2)17 (3.6)\u2003by species\xa0\xa0\u2003\u2009 P. falciparum 6 (1.2)12 (2.5)\u2003\u2009 p. Vivax 9 (1.8)3 (0.6)\u2003\u2009mixed1 (0.2)2 (0.4)Cord Blood parasitaemia†0 (0)2 (0.4)\nnumbers presented are n (%).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 109, 'delivery'), ('28', 'ABO (human)', 242, 'P'), ('GO_0007586', 'digestion', 418, 'Delivery'), ('28', 'ABO (human)', 535, 'P'), ('28', 'ABO (human)', 566, 'P'), ('NCBITaxon_10088', 'Mus <genus>', 569, 'vivax'), ('UBERON_0001987', 'placenta', 711, 'Placental'), ('28', 'ABO (human)', 776, 'P'), ('NCBITaxon_10088', 'Mus <genus>', 811, 'vivax'), ('UBERON_0000948', 'heart', 852, 'Cord'), ('UBERON_0000178', 'blood', 857, 'blood')]
PMC3489539	8/2012	S35-PMC3489539	['†parasitaemia was defined by presence of Parasites on Blood or Tissue impression smear and/or by positive rdt.']	N/A	N/A	[('CL_0000652', 'pinealocyte', 41, 'parasites'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0000479', 'tissue', 63, 'tissue')]
PMC3489539	8/2012	S36-PMC3489539	['rdts were not performed on Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 27, 'cord'), ('UBERON_0000178', 'blood', 32, 'blood')]
PMC3489539	8/2012	S38-PMC3489539	['caption (table-wrap): table 4\n\nunivariate and multivariate logistic regression analysis of factors associated with peripheral parasitaemia and/or Placental parasitaemia among Pregnant women attending Antenatal clinics and women at Delivery units\xa0 ancduunivariate analysismultivariate analysisunivariate analysismultivariate analysispotential factorsperipheral parasitaemia prevalenceodds ratio (95% ci)adjusted odds ratio (95% ci)peripheral parasitaemia prevalenceodds ratio (95% ci)adjusted odds ratio (95% ci) district (malaria transmission)stable (bastar district)34/1198 (2.8%)43.7 (6.0-319.9)43.4 (5.6-335.2)18/474 (3.8%)1.2 (0.6-2.4)-unstable (rajnandgoan district)1/1498 (0.1%)16/502 (3.2%)age (years)< 205/242 (2.1%)1.7 (0.7-4.4)-2/65 (3.1%)0.9 (0.2-3.8)-≥ 2030/2454 (1.2%)31/909 (3.4%)gravidityprimi-/secundigravid26/2056 (1.3%)0.9 (0.4-1.9)-28/768 (3.7%)1.5 (0.6-4.0)-multigravid9/640 (1.4%)5/206 (2.4%)moderate anemia (< 9\u2003g/dl)yes22/432 (5.1%)9.3 (4.6-18.6)3.7 (1.8 – 7.7)11/145 (7.6%)3.0 (1.4-6.3)2.5 (1.1-5.4)no13/2261 (0.6%)22/828 (2.7%)feverwithin past week23/239 (9.6%)21.7 (10.6-44.2)3.2 (1.2 – 8.6)8/50 (16.0%)6.8 (2.9-16.1)5.8 (2.4-13.9)no fever in past week12/2457 (0.5%)25/923 (2.7%)bednet use last nightyes4/742 (0.5%)0.9 (0.2-5.1)-5/203 (2.5%)0.7 (0.3-1.8)-no2/345 (0.6%)28/771 (3.6%)indoor residual sprayingyes (ever)8/697 (1.2%)0.8 (0.4-1.9)-4/261 (1.5%)0.4 (0.1-1.1)-no (never)27/1999 (1.4%)29/712 (4.1%)educationno formal schooling25/571 (4.4%)7.8 (3.7-16.3)4.6 (2.0 – 10.7)13/265 (4.9%)1.8 (0.9-3.6)-at least some schooling10/1711 (0.6%)20/709 (2.8%)castetribal caste15/602 (2.5%)2.6 (1.3-5.2)0.7 (0.3 -1.6)10/282 (3.6%)1.1 (0.5-2.3)-other caste20/2091 (1.0%)23/690 (3.3%)home ownershipyes35/2348 (1.5%)-\xa029/873 (3.3%)0.8 (0.3-2.4)-no0/348 (0%)4/101 (4.0%)wall materialmud35/1942 (1.8%)-\xa025/743 (3.4%)1.0 (0.4-2.2)-no mud0/754 (0%)8/231 (3.5%)primary cooking fuelbiomass35/2134 (1.6%)-\xa026/792 (3.3%)0.8 (0.4-2.0)-non-biomass0/563 (0%)\xa0\xa07/181 (3.9%)\xa0\xa0\n\ncaption (table-wrap): table 5\n\nprevalence of adverse singleton Birth outcomes stratified by site and presence versus absence of Placental parasitaemia\xa0 rajnandgaonbastarplacental parasitaemia¶Placental parasitaemia¶presentabsentpresentabsent \xa0 n/d†(%)n/d†(%)n/d†(%)n/d†(%) Stillbirth0/15 (0)12/487 (2.5)1/16 (6.3)10/448 (2.2)low birth weight3/15 (20.0)98/472 (20.8)9/15 (60.0)a128/437 (29.3)agestational hypertension*2/15 (13.3)113/475 (23.8)1/15 (6.7)44/438 (10.1)Birth weight (grams)2500270022802500median (range)2050-32501400-37501700-3000a1075-4085agestational age (weeks)38 (38-40)38 (32-42)36 (32-40)36 (30-44)\n¶parasitaemia defined by presence of parasites on Blood or Tissue impression smear and/or by positive rapid diagnostic test.']	N/A	N/A	[('UBERON_0001987', 'placenta', 146, 'placental'), ('GO_0007565', 'female pregnancy', 175, 'pregnant'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('GO_0007567', 'parturition', 231, 'delivery'), ('GO_0007567', 'parturition', 2044, 'birth'), ('UBERON_0001987', 'placenta', 2109, 'placental'), ('UBERON_0001987', 'placenta', 2173, 'Placental'), ('GO_0001964', 'startle response', 2254, 'Stillbirth0'), ('GO_0007567', 'parturition', 2446, 'Birth'), ('UBERON_0000178', 'blood', 2648, 'blood'), ('UBERON_0000479', 'tissue', 2657, 'tissue')]
PMC3489539	8/2012	S83-PMC3489539	['Blood was obtained by finger-stick for haemoglobin determination, malaria rapid diagnostic test (rdt), and preparation of thin and thick Blood smears.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 137, 'blood')]
PMC3489539	8/2012	S85-PMC3489539	['the study team also informed clinic staff when additional Parasitaemic Individuals were identified through Blood smears so that treatment could be provided as per indian national programme guidelines [13].']	N/A	N/A	[('GO_0001822', 'kidney development', 58, 'parasitaemic'), ('NCBITaxon_1', 'root', 71, 'individuals'), ('UBERON_0000178', 'blood', 107, 'blood')]
PMC3489539	8/2012	S90-PMC3489539	['a physical examination was performed and Blood pressure was measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC3489539	8/2012	S91-PMC3489539	['Blood was obtained by maternal Finger-stick soon after Delivery for haemoglobin determination, rdt, thin and thick malaria Blood film preparation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002389', 'manual digit', 31, 'finger'), ('GO_0007567', 'parturition', 55, 'delivery'), ('UBERON_0000178', 'blood', 123, 'blood')]
PMC3489539	8/2012	S92-PMC3489539	['Placental Blood was obtained by incision for preparation of thin and thick Blood smears, and rdt.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0000178', 'blood', 75, 'blood')]
PMC3489539	8/2012	S94-PMC3489539	['a drop of Cord Blood was taken to prepare Blood smears; rdts were not performed with Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 10, 'cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC3489539	8/2012	S97-PMC3489539	['women with positive rdt or Blood smear results were referred for treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood')]
PMC3489539	8/2012	S101-PMC3489539	['results of any Blood smears performed in the hospital were reviewed, but study personnel did not perform additional smears.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC3489539	8/2012	S102-PMC3489539	['laboratory procedures\nthick and thin smears prepared from Peripheral Blood of anc and du subjects, Placental Blood and Placental impression from du subjects, and Cord Blood were giemsa-stained (3% stain for 45-60\u2009minutes) and examined under 100× oil immersion [16].']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 58, 'peripheral blood'), ('UBERON_0013777', 'skin of palm of manus', 99, 'placental blood'), ('UBERON_0001987', 'placenta', 119, 'placental'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC3489539	8/2012	S103-PMC3489539	['asexual parasite forms were counted until a minimum of 200 White Blood Cells (Wbcs) had been examined.']	N/A	N/A	[('CL_0000738', 'leukocyte', 59, 'white blood cells'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CL_0000784', 'plasmacytoid dendritic cell', 78, 'WBCs')]
PMC3489539	8/2012	S111-PMC3489539	['study definitions\nperipheral parasitaemia: presence of asexual p. falciparum or p. vivax parasitic forms on Blood smears and/or positive rdt from peripheral Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0000178', 'blood', 157, 'blood')]
PMC3489539	8/2012	S112-PMC3489539	['Placental parasitaemia: presence of asexual p. falciparum or p. vivax parasitic forms on Placental Blood or impression smear of maternal side of Placenta or by rdt.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 89, 'placental'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0001987', 'placenta', 145, 'placenta')]
PMC3489539	8/2012	S161-PMC3489539	['Cord Blood smears were positive in only two cases in bastar, one with p. falciparum and the other with p. vivax .']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC3496584	7/2012	S22-PMC3496584	['defective Neuronal Development and susceptibility Genes make the infant vulnerable to environmental triggers that activate Mast Cells to release Mediators that disrupt the Gut-Blood–Brain barriers causing Brain inflammation.']	N/A	N/A	[('CL_0000540', 'neuron', 10, 'neuronal'), ('GO_0007399', 'nervous system development', 10, 'neuronal development'), ('SO_0000704', 'gene', 50, 'genes'), ('CL_0000097', 'mast cell', 123, 'mast cells'), ('CHEBI_35222', 'inhibitor', 145, 'mediators'), ('UBERON_0001555', 'digestive tract', 172, 'gut'), ('UBERON_0000178', 'blood', 176, 'blood'), ('UBERON_0000955', 'brain', 182, 'brain'), ('UBERON_0000955', 'brain', 205, 'brain')]
PMC3496584	7/2012	S173-PMC3496584	['abbreviations\nasd: autism spectrum disorders; pdd-nos: disorder-not otherwise specified; Crh: Corticotropin-Releasing Hormone; mchat: modified checklist for autism in toddlers; Lps: Lipopolysaccharide; Bbb: Blood–brain-barrier; Ros: Reactive Oxygen Species; npbi: non-protein bound iron; 3-nt: 3-Nitrotyrosine; 3Nt-3: Neurotrophin; dsm iv: diagnostic and statistical manual of mental disorders; mia: maternal Immune Activation; tlr: toll-like receptor; Tnf: Tumor Necrosis Factor; Poly(I:c): polyinosinic:Polycytidylic Acid; xmrv: xenotropic murine leukemia virus-related Virus; Csf: Cerebrospinal Fluid; Mcp-1: Macrophage Chemo-Attractant Protein-1; Tgf-Β1: Transforming Growth Factor-Beta1; nt: neurotensin; Vegf: Vascular Endothelial Growth Factor; Jak2/Stat3: Janus Tyrosine Kinase-2/Signal Transducer And Activator Of Transcription-3.']	N/A	N/A	[('PR_000005864', 'protein CREG2', 89, 'CRH'), ('CHEBI_3898', 'Cortol', 94, 'Corticotropin'), ('PR_000005959', 'cysteine and glycine-rich protein 2', 94, 'Corticotropin-releasing hormone'), ('CHEBI_16412', 'lipopolysaccharide', 177, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 182, 'Lipopolysaccharide'), ('UBERON_0006099', 'Brodmann (1909) area 1', 202, 'BBB'), ('UBERON_0000178', 'blood', 207, 'Blood–'), ('CHEBI_8756', 'RNA (poly(A))', 228, 'ROS'), ('CHEBI_26523', 'reactive oxygen species', 233, 'Reactive oxygen species'), ('CHEBI_86269', '3-nitrotyrosine', 294, '3-nitrotyrosine'), ('PR_000008757', 'heparan sulfate 2-O-sulfotransferase 1', 311, '3NT-3'), ('PR_000021998', 'neurotrophin', 318, 'Neurotrophin'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 409, 'immune activation'), ('UBERON_0002405', 'immune system', 409, 'immune'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 453, 'TNF'), ('PR_000016483', 'tumor necrosis factor receptor superfamily member 19', 458, 'Tumor necrosis factor'), ('CHEBI_37311', 'einsteinium molecular entity', 481, 'poly'), ('CHEBI_51686', 'haematoxylin', 486, 'I'), ('CHEBI_26206', 'polysialic acid', 505, 'polycytidylic acid'), ('NCBITaxon_1', 'root', 572, 'virus'), ('UBERON_0001359', 'cerebrospinal fluid', 579, 'CSF'), ('UBERON_0001359', 'cerebrospinal fluid', 584, 'Cerebrospinal fluid'), ('PR_000010439', 'myeloid leukemia factor 1', 605, 'MCP-1'), ('CL_0000235', 'macrophage', 612, 'Macrophage'), ('PR_000010133', 'mitogen-activated protein kinase kinase kinase 14', 612, 'Macrophage chemo-attractant protein-1'), ('PR_000000183', 'TGF-beta 2', 651, 'TGF-β1'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 659, 'Transforming growth factor-beta1'), ('PR_000017279', 'testis-specific basic protein Y 1', 710, 'VEGF'), ('PR_000017312', 'vomeronasal type-1 receptor 5', 716, 'Vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 725, 'endothelial'), ('PR_000009211', 'lysine-specific demethylase 3A', 752, 'JAK2'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 757, 'STAT3'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 764, 'Janus tyrosine kinase-2'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 788, 'signal transducer and activator of transcription-3')]
PMC3501517	11/2012	S41-PMC3501517	['complete Blood cell count and differential was measured from whole Blood (phoenix central laboratory, seattle, wa).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC3503401	11/2012	S4-PMC3503401	['Blood samples were taken from 367 women at their first Antenatal visit between 7 and 11 weeks Gestation for measurement of Thyroid Stimulating Hormone (Tsh) and free thyroxine (ft4) levels and spot Urine samples for Urinary Iodine Excretion were taken at the same time as Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 55, 'antenatal'), ('GO_0007565', 'female pregnancy', 94, 'gestation'), ('UBERON_0002046', 'thyroid gland', 123, 'thyroid'), ('CHEBI_66524', 'streptokordin', 131, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 152, 'TSH'), ('UBERON_0001088', 'urine', 198, 'urine'), ('UBERON_0001088', 'urine', 216, 'urinary'), ('CHEBI_24859', 'iodine atom', 224, 'iodine'), ('GO_0007588', 'excretion', 231, 'excretion'), ('UBERON_0000178', 'blood', 272, 'blood')]
PMC3503401	11/2012	S34-PMC3503401	['all women consented to have their Blood and Urine samples assessed for this study and freely provided the historical information.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001088', 'urine', 44, 'urine')]
PMC3504314	11/2012	S226-PMC3504314	['leptin in Milk comes from both the maternal Blood source (casabiell et al.,1997) and from its production in the Mammary Gland (smith-kirwin et al.,1998).']	N/A	N/A	[('UBERON_0001913', 'milk', 10, 'milk'), ('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0001911', 'mammary gland', 112, 'mammary gland')]
PMC3513049	2/2012	S5-PMC3513049	['household Pets were assessed during Pregnancy and Serum level of 25 (Oh)D (25-Hydroxyvitamin D) in Cord Blood was used as the measure of Vitamin D and a marker of maternal level.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 10, 'pets'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 65, '25 (OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 75, '25-hydroxyvitamin D'), ('UBERON_0002240', 'spinal cord', 99, 'cord'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3513828	11/2012	S27-PMC3513828	['admission laboratory tests revealed acute hepatitis and were as follows (table 1): total Bilirubin 16.4\u2009mg/dl, aspartate aminotransferase (ast) 1001\u2009iu/l, alanine aminotransferase (alt) 1269\u2009iu/l, alkaline phosphatase 105\u2009iu/l, gamma glutamyl transferase (ggt) 66\u2009iu/l, Serum albumin 2.2\u2009gm/dl, Serum creatinin 0.6\u2009mg/dl, White Blood Cell count (wbc) 12.6\u2009k/ μ l, Platelets 161\u2009k/ μ l, and hemoglobin 12.6\u2009gm/dl.']	N/A	N/A	[('CHEBI_16990', 'bilirubin IXalpha', 89, 'bilirubin'), ('UBERON_0001977', 'blood serum', 270, 'serum'), ('UBERON_0001977', 'blood serum', 295, 'serum'), ('CL_0000738', 'leukocyte', 322, 'white blood cell'), ('UBERON_0000178', 'blood', 328, 'blood'), ('CL_0000233', 'platelet', 364, 'platelets')]
PMC3513828	11/2012	S54-PMC3513828	['she received one unit of packed Red Blood Cells, nine units of fresh frozen Plasma and ten units of Platelets during surgery.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 32, 'red blood cells'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CL_0000233', 'platelet', 100, 'platelets')]
PMC3515553	12/2012	S35-PMC3515553	['assessment of Cord Blood Vitamin B-12 concentration\na 10% sample of the alspac cohort, known as the children in focus (cif) group, attended clinics at the university of bristol at various time intervals between 4 and 61 months of age.']	N/A	N/A	[('UBERON_0000948', 'heart', 14, 'Cord'), ('UBERON_0000178', 'blood', 19, 'Blood'), ('PR_000017269', 'ventral anterior homeobox 2', 25, 'Vitamin B-12')]
PMC3515553	12/2012	S38-PMC3515553	['from these groups, five hundred children (250 girls, 250 boys) were selected to contribute a Cord Blood sample.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC3515553	12/2012	S66-PMC3515553	['linear regression was also used in the analysis of the association of maternal dietary Intake, Cord Blood Vitamin B-12 and genotypes with offspring iq.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 87, 'intake'), ('UBERON_0002240', 'spinal cord', 95, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 106, 'vitamin B-12')]
PMC3515553	12/2012	S85-PMC3515553	['the representativeness of the alspac subsets used in the analyses of iq and Cord Blood Vitamin B12 is examined intables s1ands2.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 76, 'cord'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_33279', 'vitamin D5', 87, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 87, 'vitamin B12')]
PMC3515553	12/2012	S173-PMC3515553	['supporting information\n\ncaption (supplementary-material): table s1\n\nrepresentativeness of the sub-sample of children with Cord Blood Vitamin B-12 levels, and the sample used for iq analysis, with respect to the full alspac sample.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 133, 'vitamin B-12')]
PMC3521768	12/2012	S72-PMC3521768	['Blood sample collection and laboratory analysis\nBlood samples were collected, stored, transported and processed following standard procedures.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 48, 'Blood')]
PMC3521768	12/2012	S73-PMC3521768	['six ml of Blood was collected from Antecubital Vein using plain and closed sarstedt® Blood collection system and stainless steel needles.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001545', 'anterior tibial vein', 35, 'antecubital vein'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC3521768	12/2012	S74-PMC3521768	['the Blood was allowed to clot for 20 minutes and centrifuged at 3000 rotations per minute for 10 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3521768	12/2012	S145-PMC3521768	['linear modeling of predictors of Birthweight\nin the bivariate linear regression model altitude of the kebeles, number of anc visits, Diastolic Blood pressure during Pregnancy were not associated to Birthweight (p>0.05) .']	N/A	N/A	[('GO_0007596', 'blood coagulation', 33, 'birthweight'), ('GO_0007586', 'digestion', 133, 'diastolic'), ('UBERON_0000178', 'blood', 143, 'blood'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007596', 'blood coagulation', 198, 'birthweight')]
PMC3527219	11/2012	S3-PMC3527219	['Cortisol, total protein and Immunoglobulin (Igg, Igm, Iga) concentrations were measured in the Blood of sows over the course of Pregnancy.']	N/A	N/A	[('CHEBI_17650', 'cortisol', 0, 'Cortisol'), ('GO_0019814', 'immunoglobulin complex', 28, 'immunoglobulin'), ('GO_0071735', 'IgG immunoglobulin complex', 44, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 49, 'IgM'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 54, 'IgA'), ('UBERON_0000178', 'blood', 95, 'blood'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy')]
PMC3527219	11/2012	S4-PMC3527219	['Cortisol, total protein, Immunoglobulins, Lymphocyte Proliferation, Immune Cell counts, and cytokines were assessed in the Blood of offspring at baseline and under challenging conditions (weaning; Lipopolysaccharide (Lps) administration).']	N/A	N/A	[('CHEBI_17650', 'cortisol', 0, 'Cortisol'), ('GO_0019814', 'immunoglobulin complex', 25, 'immunoglobulins'), ('CL_0000542', 'lymphocyte', 42, 'lymphocyte'), ('GO_0046651', 'lymphocyte proliferation', 42, 'lymphocyte proliferation'), ('CL_0000738', 'leukocyte', 68, 'immune cell'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0000178', 'blood', 123, 'blood'), ('CHEBI_16412', 'lipopolysaccharide', 197, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 217, 'LPS')]
PMC3527219	11/2012	S22-PMC3527219	['for example, a low protein diet in Rodent Pregnancy has induced high Blood pressure and Renal dysfunction in the offspring [25], and Prenatal high dietary protein exposure resulted in increased adiposity in young Rats [26].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 35, 'rodent'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0002113', 'kidney', 88, 'renal'), ('GO_0007565', 'female pregnancy', 133, 'prenatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 213, 'rats')]
PMC3527219	11/2012	S37-PMC3527219	['after overnight Food withdrawal, Blood samples of sows were taken on gd −5, 24, 66 and 108 by Jugular Vein puncture.']	N/A	N/A	[('CHEBI_33290', 'food', 16, 'food'), ('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0004711', 'jugular vein', 94, 'jugular vein')]
PMC3527219	11/2012	S38-PMC3527219	['edta Blood samples were centrifuged at 2000\u2009×\u2009 g for 15 min at 4°c to separate Plasma, which was analysed for Cortisol.']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_17650', 'cortisol', 110, 'cortisol')]
PMC3527219	11/2012	S39-PMC3527219	['whole Blood samples were allowed to clot for 4 h at room temperature and centrifuged at 1000\u2009×\u2009 g for 15 min at 4°c to obtain Serum for analyses of total protein and Immunoglobulins Igg, Iga and Igm.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('GO_0019814', 'immunoglobulin complex', 166, 'immunoglobulins'), ('GO_0071735', 'IgG immunoglobulin complex', 182, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 187, 'IgA'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 195, 'IgM')]
PMC3527219	11/2012	S46-PMC3527219	['the timeline for Blood sampling and distribution of Animals in the different diet groups are summarised in figure\u20091.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('NCBITaxon_33208', 'Metazoa', 52, 'animals')]
PMC3527219	11/2012	S47-PMC3527219	['caption (fig): figure 1\n\ntimeline: summary of Blood sampling and distribution of Animals in different diet groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('NCBITaxon_33208', 'Metazoa', 81, 'animals')]
PMC3527219	11/2012	S57-PMC3527219	['Blood samples from the offspring were taken while Animals were in a supine position by Anterior Vena Cava puncture on d1, d27, d29 and d47 as well as by Jugular Vein puncture on d80 and d180 (the whole procedure lasted approximately 1 min).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 50, 'animals'), ('UBERON_0001076', 'neural spine', 87, 'anterior vena cava'), ('UBERON_0004711', 'jugular vein', 153, 'jugular vein')]
PMC3527219	11/2012	S58-PMC3527219	['Blood samples without anti-Coagulant were treated as described above to obtain Serum for analyses of total protein and Immunoglobulins Igg, Igm and Iga (d1, d27, d80 and d180).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0050817', 'coagulation', 27, 'coagulant'), ('UBERON_0001977', 'blood serum', 79, 'serum'), ('GO_0019814', 'immunoglobulin complex', 119, 'immunoglobulins'), ('GO_0071735', 'IgG immunoglobulin complex', 135, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 140, 'IgM'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 148, 'IgA')]
PMC3527219	11/2012	S59-PMC3527219	['additionally, heparinised Blood samples were stored on ice until processing for the Proliferation assay (d1 and d27).']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('GO_0008283', 'cell proliferation', 84, 'proliferation')]
PMC3527219	11/2012	S60-PMC3527219	['one day before (d27) and one day after weaning (d29), edta-Plasma samples were used for Cortisol analyses, and heparinised Blood samples were collected and stored on ice until processing for the Proliferation assay and flow cytometric analysis (ap, n\u2009=\u200920; lp, n\u2009=\u200917; hp, n\u2009=\u200920).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_17650', 'cortisol', 88, 'cortisol'), ('UBERON_0000178', 'blood', 123, 'blood'), ('GO_0008283', 'cell proliferation', 195, 'proliferation')]
PMC3527219	11/2012	S63-PMC3527219	['Blood samples were taken immediately before Lps injection (0h, baseline for all measures), 1 h later for analysis of Tnf-Α, and 3 and 6 h later to measure Cortisol and cytokines (Tnf-Α, Il-6 and Il-10).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_16412', 'lipopolysaccharide', 44, 'LPS'), ('PR_000000134', 'tumor necrosis factor alpha', 117, 'TNF-α'), ('CHEBI_17650', 'cortisol', 155, 'cortisol'), ('PR_000000134', 'tumor necrosis factor alpha', 179, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 186, 'IL-6'), ('PR_000001470', 'interleukin-28B', 195, 'IL-10')]
PMC3527219	11/2012	S64-PMC3527219	['Blood samples were treated as described previously.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3527219	11/2012	S77-PMC3527219	['briefly, Peripheral Blood Mononuclear Cells (Pbmc) were isolated from heparinised Blood by density gradient centrifugation, and the cell concentration was adjusted to 5\u2009×\u2009106cells/ml in complete rpmi-1640 medium (sigma-aldrich, deisenhofen, germany).']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 9, 'peripheral blood mononuclear cells'), ('UBERON_0012101', 'perinatal stage', 9, 'peripheral blood'), ('GO_0031097', 'medial cortex', 26, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 45, 'PBMC'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC3527219	11/2012	S94-PMC3527219	['the model for Blood parameters of sows comprised the fixed effects diet (ap, lp, hp), replicate (1 to 6), repeated factor time (gd\u2009−\u20095, gd24, gd66, gd108) and all two-way interactions.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC3527219	11/2012	S99-PMC3527219	['the model for basal Blood parameters in offspring comprised the fixed effects diet, age (d1, d27, d80, d180), sex, replicate, all two-way interactions between the fixed effects and the random sow effect.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood')]
PMC3527219	11/2012	S135-PMC3527219	['Blood samples were taken on d1 (ap, n\u2009=\u200943; lp, n\u2009=\u200951; hp, n\u2009=\u200948), d27 (ap, n\u2009=\u200942; lp, n\u2009=\u200946; hp, n\u2009=\u200941), d80 (ap, n\u2009=\u200924; lp, n\u2009=\u200925; hp, n\u2009=\u200920) and d180 (ap, n\u2009=\u200923; lp, n\u2009=\u200924; hp, n\u2009=\u200921).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3527219	11/2012	S149-PMC3527219	['Blood samples were taken before (d27) and after weaning (d29).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3527219	11/2012	S157-PMC3527219	['Blood samples were taken before (d27) and after weaning (d29).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3527219	11/2012	S165-PMC3527219	['Blood samples were taken before (d27) and after weaning (d29).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3527219	11/2012	S177-PMC3527219	['Blood samples were taken before (0 h) and after Lps challenge (1 h, 3 h, 6 h).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_16412', 'lipopolysaccharide', 48, 'LPS')]
PMC3527219	11/2012	S237-PMC3527219	['abbreviations\nap: adequate protein; cona: concanavalin a; gd: Gestation day; hp: high protein; lp: low protein; Lps: Lipopolysaccharide; pbmc: Peripheral Blood Mononuclear Cells.']	N/A	N/A	[('GO_0006266', 'DNA ligation', 62, 'Gestation'), ('CHEBI_16412', 'lipopolysaccharide', 112, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 117, 'Lipopolysaccharide'), ('CL_0000111', 'peripheral neuron', 143, 'Peripheral blood mononuclear cells'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0031097', 'medial cortex', 160, 'mononuclear')]
PMC3532199	11/2012	S240-PMC3532199	['reducing the frequency of Blood collection and of in-Person attendance by mailing Pills and conducting follow up by phone also make subjects more willing to maintain active participation after enrollment.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 53, 'person'), ('CHEBI_35710', 'pinane', 82, 'pills')]
PMC3532199	11/2012	S333-PMC3532199	['the clinical coordinator will complete the enrollment form, and will obtain a Blood sample (about 8 ml) from the subject for baseline measures of Rbc, hemoglobin, b12, and Serum/Rbc folate.']	N/A	N/A	[('UBERON_0000178', 'blood', 78, 'blood'), ('CL_0000232', 'erythrocyte', 146, 'RBC'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CL_0000232', 'erythrocyte', 178, 'RBC')]
PMC3532199	11/2012	S334-PMC3532199	['Blood samples will be analyzed at a maximum of 2 weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3532199	11/2012	S400-PMC3532199	['Blood collection\nFolate (Serum and Rbc) levels will be assessed, at baseline (prior to supplementation), every 12 months after enrollment, and at Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_81245', 'Vulpecholate', 17, 'Folate'), ('UBERON_0001977', 'blood serum', 25, 'Serum'), ('CL_0000232', 'erythrocyte', 35, 'RBC'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3532199	11/2012	S460-PMC3532199	['complete Blood tests will be performed on collected samples at enrollment to help detect anemia.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC3532199	11/2012	S472-PMC3532199	['measurement methods\n\ndescription of data forms\ntable2describes the data forms that will be used for this study:\n\ncaption (table-wrap): table 2\n\ndata formsform #form titledescriptioncompleted by fa00sampling and initial recruitment log formdocuments the outcomes of searching the clinical records for potentially eligible subjects and of initial contacts with potentially eligible subjects including their interest in participation in the study.clinical coordinatorfa01contact formdocuments contact information for each potentially eligible subject and updated contact information for participating subjects.information extracted initially from clinical records and reviewed/updated with potentially eligible subjects and participating subjects by the clinical coordinator.fa02screening formdocuments eligibility for participation for each study subject selected.clinical coordinatorfa03enrollment formdocuments marital status, information about children, and smoking, alcohol use, Menstruation, contraception and Gynecological care of the study subject.clinical coordinatorfa04enrollment confirmation formrecords Blood test results, and study Medication delivery to the subject, and plans for follow-up visit.']	N/A	N/A	[('GO_0042703', 'menstruation', 981, 'menstruation'), ('UBERON_0001155', 'colon', 1013, 'gynecological'), ('UBERON_0000178', 'blood', 1113, 'blood'), ('CHEBI_60211', 'compound Z', 1143, 'medication')]
PMC3532199	11/2012	S494-PMC3532199	['collection of biological samples/shipping\neach Blood sample will consist of 4–12 millimeters of Peripheral Venous Blood collected from the subject.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0012101', 'perinatal stage', 96, 'peripheral venous blood')]
PMC3532199	11/2012	S495-PMC3532199	['Blood will be collected by the clinical coordinator or other qualified staff in vacuum tubes either containing anti-coagulant (1.5 ml) or not.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3532199	11/2012	S496-PMC3532199	['all Blood collection tubes will be identified by date, name, and subject id number.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3532199	11/2012	S497-PMC3532199	['Blood samples will be delivered to the laboratory to be analyzed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3532199	11/2012	S498-PMC3532199	['Blood samples obtained during follow-up outside of the clinic (such as at subject home) will be stored in portable freezers before being delivered to the laboratory.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3532199	11/2012	S512-PMC3532199	['training will include (1) conducting recruitment, interviews, completion of data collection forms; (2) delivery of intervention; (3) Blood collection; (4) ethical conduct of research.']	N/A	N/A	[('UBERON_0000178', 'blood', 133, 'blood')]
PMC3532199	11/2012	S519-PMC3532199	['co- principal investigator: will oversee clinical case definition, provide access to subjects through the clinic, develop protocol and moo, direct the study personnel, be responsible for translations and oversee the laboratory analysis of Blood samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 239, 'blood')]
PMC3532199	11/2012	S523-PMC3532199	['clinical coordinators/study nurses (local units—brazil): will be responsible for ensuring the proper conduct of the study, maintaining master files of the protocol and the moo, acting as the liaison between study subjects and the clinic, conducting follow-up of subjects including dispensing the study Pills and collection of Blood samples, monitoring Pregnancies that occur in the subject group, maintaining an inventory of dispensed and stored Drugs, distributing and receiving back Folic Acid pill boxes, keeping the warehouse supplied with all biological material needed, coordinating Blood analysis with the clinic laboratory, checking laboratory data (principally to monitor B12 deficiency), printing questionnaires to be administered to study subjects, keying in questionnaire data to the computer, performing the re-keying of a pre-determined percentage of data forms, entering free-text data in the main computer in english, editing all data entry done, and communicating with rti for correction and transmission of entered data.']	N/A	N/A	[('CHEBI_35710', 'pinane', 302, 'pills'), ('UBERON_0000178', 'blood', 326, 'blood'), ('GO_0007565', 'female pregnancy', 352, 'pregnancies'), ('CHEBI_23888', 'drug', 446, 'drugs'), ('CHEBI_30751', 'formic acid', 485, 'folic acid'), ('UBERON_0000178', 'blood', 589, 'blood'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 681, 'B12')]
PMC3532199	11/2012	S533-PMC3532199	['training materials\ntraining materials will include the protocol, the manual of operations (moo), hand-outs, overheads, slides, role-playing, case-discussions, data forms, and phlebotomy equipment (if study staff will be involved in Blood collection).']	N/A	N/A	[('UBERON_0000178', 'blood', 232, 'blood')]
PMC3532199	11/2012	S542-PMC3532199	['facilities\n\ncomputer hardware and software\nthe study clinics will be equipped with desktop personal computers which will be used for entry of questionnaire data, keeping the study pills inventory, counts of unused Pills, Blood analysis results, and other study files.']	N/A	N/A	[('CHEBI_35710', 'pinane', 214, 'pills'), ('UBERON_0000178', 'blood', 221, 'blood')]
PMC3532199	11/2012	S545-PMC3532199	['laboratory equipment\nthe laboratory at each hospital with which the clinic is affiliated will be used for analysis of subject Blood samples if possible.']	N/A	N/A	[('UBERON_0000178', 'blood', 126, 'blood')]
PMC3533960	10/2012	S66-PMC3533960	['exclusion criteria included: 1) currently Pregnant, 2) regularly Consumed ifa or mm supplements in the past 2 months, 3) severe anemia (hemoglobin [hb]< 7 g/l; based on testing at enrollment), 4) history of high risk Pregnancy and 5) reported chronic hematological diseases, hereditary defects of Red Blood Cells or hemoglobin.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007631', 'feeding behavior', 65, 'consumed'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('CL_0000232', 'erythrocyte', 297, 'red blood cells'), ('UBERON_0000178', 'blood', 301, 'blood')]
PMC3533960	10/2012	S86-PMC3533960	['during Prenatal visits, doctors record obstetric history, morbidity, workload, depression, vital signs, anthropometric measurements, hemoglobin values, urinalysis results, Blood Glucose and collect Venous Blood (for the first and second Pregnancy semesters).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'prenatal'), ('UBERON_0000178', 'blood', 172, 'blood'), ('CHEBI_17234', 'glucose', 178, 'glucose'), ('UBERON_0001638', 'vein', 198, 'venous'), ('UBERON_0000178', 'blood', 205, 'blood'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy')]
PMC3533960	10/2012	S98-PMC3533960	['upon leaving the study, these women will undergo a health assessment and a hemoglobin test on capillary Blood using hemocue®.']	N/A	N/A	[('UBERON_0000178', 'blood', 104, 'blood')]
PMC3533960	10/2012	S100-PMC3533960	['caption (table-wrap): table 2\n\ndata collection and measurementsmeasurementspre-pregnancypregnancybirthpost-Partum \xa0\xa0 6-12 weeks23-28 weeks30-36 weeks \xa0\xa0 maternal \xa0\xa0\xa0\xa0\xa0\xa0demographics, ses status√\xa0\xa0\xa0\xa0\xa0obgyn history√\xa0\xa0\xa0\xa0\xa0Food frequency questionnaire√\xa0\xa0\xa0\xa0\xa0helminthic infections√\xa0\xa0\xa0\xa0\xa0mental health√√√√\xa0√morbidity\xa0√√√\xa0√periodontitis screening\xa0√√√\xa0\xa0workload\xa0√√√\xa0\xa0Blood pressure√√√√\xa0\xa0anthropometry√√√√\xa0√hematological measures\xa0\xa0\xa0\xa0\xa0\xa0Hemoglobin√√√√\xa0√Serum ferritin√√√\xa0\xa0√Transferrin Receptor√√√\xa0\xa0√infection indicators (crp, agp)√√√\xa0\xa0√other biological indicators\xa0\xa0\xa0\xa0\xa0\xa0Vitamin A√√√\xa0\xa0√Blood Glucose\xa0√√\xa0\xa0\xa0Urine protein\xa0√√√\xa0\xa0 Fetal Development (ultrasound) \xa0√√√\xa0\xa0 Birth information \xa0\xa0\xa0\xa0√\xa0 child measurement \xa0\xa0\xa0\xa0\xa0\xa0Gestational age\xa0\xa0\xa0\xa0√\xa0anthropometry\xa0\xa0\xa0\xa0√√hematological measures\xa0\xa0\xa0\xa0\xa0\xa0hemoglobin\xa0\xa0\xa0\xa0\xa0√Serum ferritin\xa0\xa0\xa0\xa0√\xa0Transferrin Receptor\xa0\xa0\xa0\xa0√\xa0infant Feeding practices\xa0\xa0\xa0\xa0\xa0√ supplement information \xa0\xa0\xa0\xa0\xa0\xa0supplement consumption√√√√\xa0\xa0side effects√√√√\xa0\xa0\n\nmeasurement of key outcomes\nBirth size : infant anthropometry is measured as early as possible within seven days after Birth and at one and three months Postpartum using standard procedures [34,35].']	N/A	N/A	[('GO_0007567', 'parturition', 107, 'partum'), ('UBERON_0001013', 'adipose tissue', 107, 'partum'), ('CHEBI_33290', 'food', 217, 'Food'), ('GO_0007596', 'blood coagulation', 355, 'Blood'), ('UBERON_0000178', 'blood', 355, 'Blood'), ('CHEBI_5679', 'herniarin', 422, 'Hemoglobin'), ('UBERON_0001977', 'blood serum', 438, 'Serum'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 458, 'Transferrin receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 554, 'Vitamin A'), ('CHEBI_33290', 'food', 569, 'Blood'), ('UBERON_0000178', 'blood', 569, 'Blood'), ('CHEBI_17234', 'glucose', 575, 'Glucose'), ('UBERON_0001088', 'urine', 588, 'Urine'), ('GO_0060132', 'prolactin secreting cell development', 608, 'Fetal development'), ('GO_0007567', 'parturition', 646, 'Birth'), ('GO_0007565', 'female pregnancy', 695, 'Gestational'), ('UBERON_0001977', 'blood serum', 779, 'Serum'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 799, 'Transferrin receptor'), ('GO_0007631', 'feeding behavior', 832, 'feeding'), ('GO_0007567', 'parturition', 961, 'Birth'), ('GO_0007567', 'parturition', 1052, 'birth'), ('GO_0007565', 'female pregnancy', 1086, 'postpartum')]
PMC3533960	10/2012	S108-PMC3533960	['Venous Blood samples (5 ml) are collected from women by trained nurses at baseline, during the first and the second Prenatal visits and at three months post-partum.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('GO_0007565', 'female pregnancy', 116, 'prenatal')]
PMC3533960	10/2012	S110-PMC3533960	['infants’ anemia and iron status : infant iron status is measured in Cord Blood samples (5 ml) obtained at Delivery.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 68, 'cord'), ('UBERON_0000178', 'blood', 73, 'blood'), ('GO_0007567', 'parturition', 106, 'delivery')]
PMC3533960	10/2012	S112-PMC3533960	['hb concentration is measured at three months of age from a capillary Blood sample using hemocue® [39].']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood')]
PMC3533960	10/2012	S135-PMC3533960	['other information collected in the three Prenatal visits includes symptoms of Preeclampsia (Blood pressure, edema, albumin in Urine) and fasting Blood Glucose in the first and second Trimester.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'prenatal'), ('GO_0007128', 'meiotic prophase I', 78, 'preeclampsia'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0001088', 'urine', 126, 'urine'), ('UBERON_0000178', 'blood', 145, 'blood'), ('CHEBI_17234', 'glucose', 151, 'glucose'), ('GO_0009294', 'DNA mediated transformation', 183, 'trimester')]
PMC3534321	12/2012	S73-PMC3534321	['another trial studied 74 primigravida women at 28-29 weeks of Gestation with normal Blood pressure and a positive roll-over test, as well as map at least 80\u2009mmhg.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'gestation'), ('UBERON_0000178', 'blood', 84, 'blood')]
PMC3534321	12/2012	S77-PMC3534321	['[28] reported that women with normal Blood pressure in their first Pregnancy who were in paid employment had higher Blood pressure and higher risk of developing Preeclampsia than those who were not in paid employment.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('UBERON_0000178', 'blood', 116, 'blood'), ('GO_0007128', 'meiotic prophase I', 161, 'preeclampsia')]
PMC3534399	10/2012	S91-PMC3534399	['at each visit, the following assessments are made: standard Antenatal check: including Blood pressure; haemoglobin; Urine sample.']	N/A	N/A	[('GO_0007567', 'parturition', 60, 'antenatal'), ('UBERON_0000178', 'blood', 87, 'blood'), ('UBERON_0001088', 'urine', 116, 'urine')]
PMC3534399	10/2012	S99-PMC3534399	['following Delivery a sample of Cord Blood (15 ml) is collected and the Placenta transported on ice to the mrc keneba laboratory for processing.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'delivery'), ('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001987', 'placenta', 71, 'placenta')]
PMC3534399	10/2012	S100-PMC3534399	['on arrival, Cord Blood samples are processed and Placental material is collected for the assessment of Placental Micronutrient Transport proteins.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001987', 'placenta', 49, 'placental'), ('UBERON_0001987', 'placenta', 103, 'placental'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 113, 'micronutrient'), ('GO_0006828', 'manganese ion transport', 113, 'micronutrient transport')]
PMC3534399	10/2012	S125-PMC3534399	['at 12, 24 and 52 weeks of age, a Venous Blood sample is collected from infants for the assessment of Antibody response to vaccination, Micronutrient status, with residual aliquots biobanked for further biomarker measurements.']	N/A	N/A	[('UBERON_0001638', 'vein', 33, 'venous'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 135, 'micronutrient')]
PMC3534399	10/2012	S126-PMC3534399	['Cord Blood and samples from 12 and 24 week bleeds will be used to assess anti-diphtheria, tetanus Toxoid, haemophilus b influenzae, opv and hepatitis b Antibody titres will be measured.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_29238', 'tritium atom', 98, 'toxoid'), ('GO_0042571', 'immunoglobulin complex, circulating', 152, 'antibody')]
PMC3538633	1/2013	S0-PMC3538633	['pre-weaning growth Hormone treatment reverses hypertension and Endothelial dysfunction in Adult male offspring of mothers undernourished during Pregnancy\n\nabstract\nmaternal undernutrition results in elevated Blood pressure (bp) and Endothelial dysfunction in Adult offspring.']	N/A	N/A	[('CHEBI_5762', 'hordatine A', 19, 'Hormone'), ('UBERON_0001986', 'endothelium', 63, 'Endothelial'), ('UBERON_0007023', 'adult organism', 90, 'Adult'), ('GO_0007565', 'female pregnancy', 144, 'Pregnancy'), ('UBERON_0000178', 'blood', 208, 'blood'), ('UBERON_0001986', 'endothelium', 232, 'endothelial'), ('UBERON_0007023', 'adult organism', 259, 'adult')]
PMC3538633	1/2013	S7-PMC3538633	['systolic Blood pressure (sbp) was measured at day 150 by Tail cuff plethysmography.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0002415', 'tail', 57, 'tail')]
PMC3538633	1/2013	S59-PMC3538633	['at Postnatal day 140, systolic Blood pressure was measured via Tail Cuff plethysmography as described previously[33](model 179, iitc Life science inc, usa) and Heart/Respiration rates assessed via pulse oximetry as detailed below.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'postnatal'), ('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0002486', 'glottis', 63, 'tail cuff'), ('UBERON_0000104', 'life cycle', 133, 'Life'), ('UBERON_0000948', 'heart', 160, 'heart'), ('GO_0045333', 'cellular respiration', 166, 'respiration')]
PMC3538633	1/2013	S61-PMC3538633	['systolic Blood pressure (sbp), oxygen saturation, Heart and Respiration rates\nsystolic Blood pressure (sbp) at day 150 was recorded by Tail cuff plethysmography according to the manufacturer’s instructions (model 179 with an automatic cuff inflation pump (nw20), iitc, Life science, woodland hills, ca) as previously described[38],[39].']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'Blood'), ('UBERON_0000948', 'heart', 50, 'Heart'), ('GO_0045333', 'cellular respiration', 60, 'Respiration'), ('UBERON_0000178', 'blood', 87, 'blood'), ('UBERON_0002415', 'tail', 135, 'tail'), ('UBERON_0000104', 'life cycle', 269, 'Life')]
PMC3538633	1/2013	S67-PMC3538633	['Blood oxygen (O2)saturation, Heart rate and Breath rate were monitored using a small Animal pulse oximeter collar placed around the Neck (mouseqx +plus; starr life sciences, usa.).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_15379', 'dioxygen', 14, 'O2'), ('UBERON_0000948', 'heart', 29, 'heart'), ('UBERON_0000310', 'breast', 44, 'breath'), ('NCBITaxon_33208', 'Metazoa', 85, 'animal'), ('UBERON_0000974', 'neck', 132, 'neck')]
PMC3538633	1/2013	S112-PMC3538633	['systolic Blood pressure (sbp) recordings\nsbp at day 140 was significantly increased in un-s male offspring when compared to con-s and con-gh offspring and normalised in un-gh Animals (figure 2).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 175, 'animals')]
PMC3538633	1/2013	S114-PMC3538633	['Prenatal diet or gh treatment did not have any effect on percentage oxygen (O2) saturation (un-s 95.83±0.31, con-s 95.63±0.35, con-gh 95.8±0.27, un-Gh 95.9±0.24, Heart rate (un-s 315±6, con-s 324±10, con-gh 319±9, un-gh 311±17 or breathing rate (un-s 100±1.83, con-s 98±1.9, con-gh 98.9±2.1, un-gh 101±1.5).10.1371/journal.pone.0053505.g002\n\ncaption (fig): figure 2\nsystolic Blood pressure (sbp) at Postnatal day 140 in male offspring as quantified via Tail-cuff plethysmography.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_15379', 'dioxygen', 76, 'O2'), ('UBERON_0003124', 'chorion', 148, 'GH'), ('UBERON_0000948', 'heart', 162, 'heart'), ('UBERON_0000178', 'blood', 375, 'blood'), ('GO_0007567', 'parturition', 399, 'postnatal'), ('UBERON_0002415', 'tail', 453, 'tail')]
PMC3543392	12/2012	S217-PMC3543392	['abbreviations\nala: Linolenic Acid; ara: Arachidonic Acid; bp: Blood pressure; cad: Coronary Artery disease; cefa: Cholesterol Ester Fatty Acid; cvd: Cardiovascular diseases; Dha: Docosahexaenoic Acid; disc: dietary interventio dietary intervention study in children; dbp: diastolic bp; espghan: european society of pediatric Gastroenterology hepatology and nutrition; Epa: Eicosapentaenoic Acid; foad: fetal origins of Adult disease; Hdl-C: High-density Lipoprotein Cholesterol; Hmg-Coa: Hydroxymethylglutaril Coenzyme A; Igf-1: Insulin Growth Factor 1; ir: Insulin resistance; La: Linoleic Acid; lbw: low Birthweight; lcpufa: Long Chain polyunsaturated Fatty Acids; ldl-c: low-density lipoprotein Cholesterol; mufa: monounsaturated Fatty Acid; ms: Metabolic syndrome; pufa: polyunsaturated Fatty Acids; sbp: systolic bp; strip: special turku Coronary risk factor intervention project; tc: total Cholesterol; t2dm: type 2 diabetes mellitus; tg: Triglycerides; who: world health organization.']	N/A	N/A	[('CHEBI_16494', 'lipoic acid', 19, 'Linolenic acid'), ('CHEBI_15843', 'arachidonic acid', 40, 'Arachidonic acid'), ('UBERON_0000178', 'blood', 62, 'Blood'), ('UBERON_0001621', 'coronary artery', 83, 'Coronary artery'), ('CHEBI_82381', '5-Aminoacenaphthene', 114, 'Cholesterol ester fatty acid'), ('UBERON_0004535', 'cardiovascular system', 149, 'Cardiovascular'), ('CHEBI_17874', 'dihydrozeatin', 174, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 179, 'Docosahexaenoic acid'), ('UBERON_0010898', 'gastralium', 325, 'gastroenterology'), ('CHEBI_34733', 'EPN', 368, 'EPA'), ('CHEBI_31001', 'octacosanoic acid', 373, 'Eicosapentaenoic acid'), ('UBERON_0007023', 'adult organism', 419, 'adult'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 434, 'HDL-C'), ('PR_000008466', 'hepatitis B virus X-interacting protein', 441, 'High'), ('PR_000009893', 'acyl-CoA:lysophosphatidylglycerol acyltransferase 1', 454, 'lipoprotein'), ('CHEBI_16113', 'cholesterol', 466, 'cholesterol'), ('CHEBI_17883', 'hydrogen chloride', 479, 'HMG'), ('CHEBI_15346', 'coenzyme A', 483, 'CoA'), ('CHEBI_15729', 'L-ornithine', 488, 'Hydroxymethylglutaril coenzyme A'), ('PR_000008929', 'interferon-related developmental regulator 1', 522, 'IGF-1'), ('PR_000008929', 'interferon-related developmental regulator 1', 529, 'Insulin growth factor 1'), ('PR_000045358', 'insulin family protein', 558, 'Insulin'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 578, 'LA'), ('CHEBI_16494', 'lipoic acid', 582, 'Linoleic acid'), ('GO_0007596', 'blood coagulation', 606, 'birthweight'), ('CHEBI_6541', 'losartan', 627, 'Long chain'), ('CHEBI_35366', 'fatty acid', 654, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 698, 'cholesterol'), ('CHEBI_35366', 'fatty acid', 733, 'fatty acid'), ('GO_0008152', 'metabolic process', 749, 'Metabolic'), ('CHEBI_35366', 'fatty acid', 791, 'fatty acids'), ('UBERON_0005985', 'coronary vessel', 843, 'coronary'), ('CHEBI_16113', 'cholesterol', 896, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 945, 'Triglycerides')]
PMC3551641	11/2012	S122-PMC3551641	['collection and storage of biological material\na 5-ml sample of maternal Blood was taken intravenously by a qualified professional.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood')]
PMC3551641	11/2012	S123-PMC3551641	['Blood from the Umbilical Cord was collected by Hand-Milking before Expulsion Of the Placenta.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002331', 'umbilical cord', 15, 'umbilical cord'), ('UBERON_0002398', 'manus', 47, 'hand'), ('GO_0007601', 'visual perception', 52, 'milking'), ('GO_0010467', 'gene expression', 67, 'expulsion of ... placenta'), ('UBERON_0001987', 'placenta', 84, 'placenta')]
PMC3552819	12/2012	S41-PMC3552819	['visits involved a checklist of symptoms related to hypo- and hypercalcemia (decreased appetite, weight loss, vomiting, fever or chills, constipation, Abdominal pain, excessive thirst, frequent Urination, muscle weakness, Back, Arm, or Leg pain, confusion, or depression), Blood pressure measurement, and confirmation of fetal viability.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 150, 'abdominal'), ('GO_0060073', 'micturition', 193, 'urination'), ('UBERON_0001137', 'dorsum', 221, 'back'), ('UBERON_0001460', 'arm', 227, 'arm'), ('UBERON_0000978', 'leg', 235, 'leg'), ('UBERON_0000178', 'blood', 272, 'blood')]
PMC3552819	12/2012	S46-PMC3552819	['specimen collection and biochemical analyses\nparticipants provided up to six scheduled Blood specimens and at least seven Urine samples during the 10-week follow-up period beginning on the day of supplement administration (figure\u20092).']	N/A	N/A	[('UBERON_0000178', 'blood', 87, 'blood'), ('UBERON_0001088', 'urine', 122, 'urine')]
PMC3552819	12/2012	S49-PMC3552819	['in the single-dose only groups, Blood collection thereafter was scheduled predominantly in the first month because this was when the peak [25(Oh)D] [11] and the highest risk of hypercalcemia were anticipated.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_71657', 'versiconol acetate', 139, '25(OH)D')]
PMC3552819	12/2012	S51-PMC3552819	['in Pregnant participants, Venous Cord Blood samples were collected immediately following Delivery of the Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('UBERON_0001638', 'vein', 26, 'venous'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007567', 'parturition', 89, 'delivery'), ('UBERON_0001987', 'placenta', 105, 'placenta')]
PMC3552819	12/2012	S52-PMC3552819	['caption (fig): figure 2\n\nBlood and Urine specimen collection schedules.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'Blood'), ('UBERON_0001088', 'urine', 35, 'urine')]
PMC3552819	12/2012	S55-PMC3552819	['Serum samples (separated from maternal Venous and Umbilical Vein Blood) and random spot Urine specimens were maintained at +4°c prior to same-day transfer to the laboratory.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0001638', 'vein', 39, 'venous'), ('UBERON_0002066', 'umbilical vein', 50, 'umbilical vein'), ('UBERON_0000178', 'blood', 65, 'blood'), ('UBERON_0001088', 'urine', 88, 'urine')]
PMC3552819	12/2012	S88-PMC3552819	['Cord Blood specimens were available for 12 of 13 Pregnant participants in the single-dose only group.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007565', 'female pregnancy', 49, 'pregnant')]
PMC3552819	12/2012	S120-PMC3552819	['event 2.380.7471 post-event 2.460.1680 range 2.38 to 2.480.05 to 0.7471 to 116 Cord Blood 2.69–722 Pregnancy : referral to hospital due to severe headache and vomiting.32 weeks Gestation; day 17 of follow-up.']	N/A	N/A	[('UBERON_0000948', 'heart', 79, 'Cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('GO_0007565', 'female pregnancy', 99, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC3552819	12/2012	S123-PMC3552819	['event 2.260.7485 post-event 2.291.0475 range 2.24 to 2.370.22 to 1.0446 to 85 Cord Blood 2.51–493 Pregnancy : physician suspected irregular fetal Heart rate; asymptomatic.34 weeks Gestation; day 28 of follow-up.']	N/A	N/A	[('UBERON_0000948', 'heart', 78, 'Cord'), ('UBERON_0000178', 'blood', 83, 'blood'), ('GO_0007565', 'female pregnancy', 98, 'Pregnancy'), ('UBERON_0000948', 'heart', 146, 'heart'), ('GO_0007565', 'female pregnancy', 180, 'gestation')]
PMC3552819	12/2012	S132-PMC3552819	['b.all values refer to Serum concentrations in maternal Venous Blood except for the row labeled “Cord Blood”.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('UBERON_0013756', 'venous blood', 55, 'venous blood'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC3552819	12/2012	S174-PMC3552819	['Cord Blood biochemistry\namong participants who had received a single dose at baseline and for whom Cord Blood specimens were collected (n=12), the geometric mean Cord Serum [25(Oh)D] was 50 nmol/l (95% ci, 40 to 62; range, 29 to 80).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0002240', 'spinal cord', 99, 'cord'), ('UBERON_0000178', 'blood', 104, 'blood'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D')]
PMC3553086	1/2013	S4-PMC3553086	['Dna Methylation was analysed using epityper in Blood samples from two well-characterized cohorts; the bioair study of severe asthma in Adults and the swedish Birth cohort bamse.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('GO_0007567', 'parturition', 158, 'birth')]
PMC3553086	1/2013	S47-PMC3553086	['peripheral Blood donations were obtained from six healthy Adult male donors.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0007023', 'adult organism', 58, 'adult')]
PMC3553086	1/2013	S49-PMC3553086	['dark grey bars represent Lymphoid Cells, light grey bars Myeloid Cells and black bar whole Blood.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 25, 'lymphoid cells'), ('CL_0000763', 'myeloid cell', 57, 'myeloid cells'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC3553086	1/2013	S95-PMC3553086	['Cpg Site 5 was not associated with any asthma outcome in children.10.1371/journal.pone.0053877.t003\n\ncaption (table-wrap): table 3\ncharacteristics of the bamse study population (n\u200a=\u200a546).controlsasthma everp-valuen273273age (years)8.3±0.58.4±0.5nsgender (% boys)48.461.5<0.05rs2168891 cc/ct/tt (%)89.0/11.0/0188.4/11.6/02nsrs2168890 cc/ct/tt (%)77.3/21.9/0.8376.9/22.4/0.84nsrs2530547 cc/ct/tt (%)46.9/40.8/12.2538.6/47.9/13.52nsrs887020 aa/ag/gg (%)16.8/48.4/34.8621.4/50.8/27.87nsallergic asthma0136nanon-allergic asthma0137nacurrent asthma0123naparental smoking in infancy (%)17.726.1<0.05current parental smoking (%)17.022.6nscurrent dietary Folate intake ( µg/day)217.0±36.9214.2±31.4nscurrent bmi (kg/m2)17.1±1.817.3±2.0nssampling season of Blood samplesnsjanuary-march8786april-june7887july-september4038october-december6862\nbmi – body mass index, ns – non significant, na – not analyzed.']	N/A	N/A	[('SO_0000409', 'binding_site', 0, 'CpG site'), ('CHEBI_30863', '5-azaorotic acid', 646, 'folate'), ('UBERON_0000178', 'blood', 747, 'blood')]
PMC3553086	1/2013	S101-PMC3553086	['p-value for linear regression model adjusted for gender, age at Blood sampling and plate used for Sodium-Bisulfite treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_86477', 'sodium sulfite', 98, 'sodium-bisulfite')]
PMC3553086	1/2013	S113-PMC3553086	['p: p-value for linear regression model adjusted for gender, age at Blood sampling and plate used for Sodium-Bisulfite treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_86477', 'sodium sulfite', 101, 'sodium-bisulfite')]
PMC3553086	1/2013	S166-PMC3553086	['Blood samples from 56 mild asthmatics, 67 severe asthmatics and 48 copd patients were collected at baseline and dna was extracted for investigation of Dna Methylation status and Genetic variation in Npsr1 (table 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0006306', 'DNA methylation', 151, 'DNA methylation'), ('SO_0000704', 'gene', 178, 'genetic'), ('PR_000001622', 'neuropeptide Y receptor type 1', 199, 'NPSR1')]
PMC3553086	1/2013	S182-PMC3553086	['sampling season is the time of the year when Blood samples were collected at 8 years of age, and were investigated in three-month seasons using january to march as reference category.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC3553086	1/2013	S190-PMC3553086	['isolated cell types from Blood\nperipheral Blood, 450 ml, was collected from six healthy Adult male Blood donors, age 38±13.6 years as described elsewhere[25].']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0007023', 'adult organism', 88, 'adult'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC3553086	1/2013	S191-PMC3553086	['briefly, whole Blood, Peripheral Blood Mononuclear Cells (pbmc), Cd4+T Cells, Cd8+T-Cells, Cd56+Nk Cells, Cd19+B Cells, cd14+Monocytes, Granulocytes, Neutrophils and Eosinophils were isolated.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000111', 'peripheral neuron', 22, 'peripheral blood'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CL_0000226', 'single nucleate cell', 39, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 39, 'mononuclear'), ('PR_000001204', 'C-C chemokine receptor type 8', 65, 'CD4'), ('CL_0000084', 'T cell', 69, 'T cells'), ('PR_000005170', 'CD37 molecule', 78, 'CD8'), ('CL_0000084', 'T cell', 82, 'T-cells'), ('PR_000001309', 'CD70 molecule', 91, 'CD56'), ('CL_0000623', 'natural killer cell', 96, 'NK cells'), ('GO_0005634', 'nucleus', 96, 'NK'), ('PR_000001309', 'CD70 molecule', 106, 'CD19'), ('CL_0000236', 'B cell', 111, 'B cells'), ('CL_0000576', 'monocyte', 125, 'monocytes'), ('CL_0000094', 'granulocyte', 136, 'granulocytes'), ('CL_0000775', 'neutrophil', 150, 'neutrophils'), ('CL_0000771', 'eosinophil', 166, 'eosinophils')]
PMC3553086	1/2013	S212-PMC3553086	['one µg of dna obtained from Peripheral Blood Cells was modified by Sodium Bisulfite using the ez dna methylation™ kit (zymo research, ca, usa).']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 28, 'peripheral blood cells'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_86477', 'sodium sulfite', 67, 'sodium bisulfite')]
PMC3553086	1/2013	S225-PMC3553086	['linear regression analyses performed for the bamse data were adjusted for the potential confounders gender, age at Blood sampling and plate used for Sodium-Bisulfite treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 115, 'blood'), ('CHEBI_86477', 'sodium sulfite', 149, 'sodium-bisulfite')]
PMC3553086	1/2013	S245-PMC3553086	['caption (supplementary-material): figure s5\n\nDna Methylation levels (%) in the Npsr1 Promoter region in Blood Cells from six healthy Adult male Blood donors (age 38±13.6 years).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 45, 'DNA methylation'), ('PR_000001622', 'neuropeptide Y receptor type 1', 79, 'NPSR1'), ('SO_0000167', 'promoter', 85, 'promoter'), ('CL_0000081', 'blood cell', 104, 'blood cells'), ('UBERON_0000178', 'blood', 104, 'blood'), ('UBERON_0007023', 'adult organism', 133, 'adult'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC3556301	1/2013	S1-PMC3556301	['methods\nPlasma Glucose, Lipids, homa –ir (Homeostasis model assessment of Insulin resistance) and aasi, as obtained from 24-hour ambulatory Blood pressure monitoring in Third Trimester Pregnancy and at three months Postpartum, were measured in three groups of women: controls (n = 32), women with gdm on diet (n = 42) and women with gdm requiring insulin treatment (n = 10).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 8, 'Plasma'), ('CHEBI_17234', 'glucose', 15, 'glucose'), ('CHEBI_18059', 'lipid', 24, 'lipids'), ('GO_0042592', 'homeostatic process', 42, 'homeostasis'), ('PR_000045358', 'insulin family protein', 74, 'insulin'), ('UBERON_0000178', 'blood', 140, 'blood'), ('GO_0042793', 'plastid transcription', 169, 'third trimester'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'postpartum')]
PMC3556301	1/2013	S26-PMC3556301	['Blood pressure displays a Circadian pattern with a Blood pressure reduction (dipping) during the night-time, and this also occurs during normal Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0051216', 'cartilage development', 26, 'circadian'), ('UBERON_0000178', 'blood', 51, 'blood'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy')]
PMC3556301	1/2013	S43-PMC3556301	['women with gdm received structured dietary and exercise advice and were taught home Blood Glucose monitoring by a diabetes specialist nurse.']	N/A	N/A	[('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_17234', 'glucose', 90, 'glucose')]
PMC3556301	1/2013	S47-PMC3556301	['Ambulatory Blood pressure recordings\ntwenty-four-hour Ambulatory Blood pressure measurements were conducted using an Ambulatory Blood pressure system (spacelabs 90207; spacelabs medical, inc., redmond, washington, usa.)']	N/A	N/A	[('GO_0007602', 'phototransduction', 0, 'Ambulatory'), ('UBERON_0000178', 'blood', 11, 'blood'), ('GO_0040011', 'locomotion', 54, 'ambulatory'), ('UBERON_0000178', 'blood', 65, 'blood'), ('GO_0040011', 'locomotion', 117, 'ambulatory'), ('UBERON_0000178', 'blood', 128, 'blood')]
PMC3556301	1/2013	S49-PMC3556301	['we programmed the recorders to take Blood pressure readings at 15- minute intervals during the daytime and every 30-minutes during the night-time.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood')]
PMC3556301	1/2013	S52-PMC3556301	['aasi was calculated as 1 minus the regression slope diastolic Blood pressure values plotted against systolic pressures obtained from individual twenty-four-hour monitoring [15].']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood')]
PMC3556301	1/2013	S54-PMC3556301	['the nocturnal Blood pressure fall was defined as the difference between individual daytime and night-time values of systolic and diastolic pressures, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC3556301	1/2013	S56-PMC3556301	['assays\novernight fasting Blood samples were acquired for laboratory measurements.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood')]
PMC3556301	1/2013	S97-PMC3556301	['after adjustment for bmi, the differences did not remain statistically significant in Postpartum systolic Blood pressures.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 86, 'postpartum'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC3556301	1/2013	S109-PMC3556301	['bp , Blood pressure, aasi , Ambulatory Arterial stiffness index, bpm , beats per minute.']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0040011', 'locomotion', 28, 'ambulatory'), ('UBERON_0001637', 'artery', 39, 'arterial')]
PMC3556301	1/2013	S122-PMC3556301	['caption (table-wrap): table 3\n\nsignificant correlations between selected variables and aasi during Pregnancy and after Delivery\xa0 aasi during Pregnancy (n=84)aasi after Delivery (n=58) systolic bp whole 24 h during Pregnancyr = 0.247*r = 0.212systolic bp night-time during Pregnancyr = 0.286**r = 0.244diastolic bp night-time during Pregnancyr = 0.215*r = 0.204systolic bp whole 24h 3 months after deliveryr = 0.225r = 0.341*diastolic bp whole 24h 3 months after deliveryr = 0.032r = 0.280*systolic bp night-time 3 months after deliveryr = 0.227r = 0.410**diastolic bp night-time 3 months after deliveryr = 0.045r = 0.395**bmi before Pregnancyr = 0.248*r = 0.078woman’s ager = 0.245*r = 0.246nocturnal Diastolic dipping during Pregnancyr = -0.386**r = -0.317*nocturnal systolic dipping 3 months after Deliveryr = -0.077r = -0.344*\naasi , Ambulatory Arterial stiffness index, bp , Blood pressure, bmi , body mass index.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('GO_0007567', 'parturition', 119, 'delivery'), ('GO_0007565', 'female pregnancy', 141, 'pregnancy'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007565', 'female pregnancy', 214, 'pregnancyr'), ('GO_0007565', 'female pregnancy', 272, 'pregnancyr'), ('GO_0007565', 'female pregnancy', 332, 'pregnancyr'), ('GO_0007565', 'female pregnancy', 633, 'pregnancyr'), ('GO_0007586', 'digestion', 701, 'diastolic'), ('GO_0007565', 'female pregnancy', 726, 'pregnancyr'), ('GO_0007567', 'parturition', 800, 'deliveryr'), ('GO_0040011', 'locomotion', 837, 'ambulatory'), ('UBERON_0001637', 'artery', 848, 'arterial'), ('UBERON_0000178', 'blood', 879, 'blood')]
PMC3556301	1/2013	S170-PMC3556301	['abbreviations\naasi: ambulatory Arterial stiffness index; gdm: Gestational diabetes mellitus; fmd: flow mediated dilation; bp: Blood pressure; homa-ir: Homeostasis model assessment of Insulin resistance; ldl: low density lipoprotein; hdl: high density lipoprotein; bmi: body mass index; ogtt: oral Glucose tolerance test.']	N/A	N/A	[('UBERON_0001637', 'artery', 31, 'arterial'), ('GO_0007565', 'female pregnancy', 62, 'Gestational'), ('UBERON_0000178', 'blood', 126, 'Blood'), ('GO_0042592', 'homeostatic process', 151, 'Homeostasis'), ('PR_000045358', 'insulin family protein', 183, 'insulin'), ('CHEBI_17234', 'glucose', 297, 'glucose')]
PMC3556415	1/2013	S20-PMC3556415	['initial physical examination on admission revealed a fatigued woman with a weight of 62\u2009kg, height of 178\u2009cm, Blood pressure of 110/75\u2009mmhg, pulse 80 beats per minute, and temperature of 36.5°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 110, 'blood')]
PMC3556415	1/2013	S23-PMC3556415	['all laboratory investigations, including full Blood count, Liver function tests, and Thyroid function tests were within normal range.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0002046', 'thyroid gland', 85, 'thyroid')]
PMC3559868	1/2013	S40-PMC3559868	['hypertensive disorders were classified according to the national high Blood pressure education program[18].']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'Blood')]
PMC3561108	9/2012	S256-PMC3561108	['this manifested in the discomfort they endured by Eating less than they desired, Eating foods they did not enjoy, doing Blood Glucose levels and administering Insulin, and trying to meet with exercise requirements.']	N/A	N/A	[('GO_0051318', 'G1 phase', 50, 'eating'), ('GO_0051318', 'G1 phase', 81, 'eating'), ('UBERON_0000178', 'blood', 120, 'blood'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('CHEBI_66075', 'inflexin', 159, 'insulin'), ('PR_000045358', 'insulin family protein', 159, 'insulin')]
PMC3568875	1/2013	S3-PMC3568875	['an extensive evaluation including Red Blood Cell Antigen identification and cross-reaction failed to reveal the cause for her hemolysis.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 34, 'red blood cell'), ('UBERON_0000178', 'blood', 38, 'blood'), ('CHEBI_59132', 'antigen', 49, 'antigen')]
PMC3568875	1/2013	S20-PMC3568875	['a Hemolytic Transfusion reaction is defined as the rapid Destruction Of Red Blood Cells following a transfusion, and it occurs, in the united states, in 1 out of every 40,000 transfused units with incidence higher for those with repeat transfusions [6,8].']	N/A	N/A	[('GO_0060047', 'heart contraction', 2, 'hemolytic transfusion'), ('GO_0048468', 'cell development', 57, 'destruction of ... blood cells'), ('CL_0000232', 'erythrocyte', 72, 'red blood cells'), ('UBERON_0000178', 'blood', 76, 'blood')]
PMC3568875	1/2013	S22-PMC3568875	['conventional therapy produced worsening disease, and the patient was ultimately treated by withholding Blood products.']	N/A	N/A	[('CHEBI_30152', 'carbonylidene group', 103, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC3568875	1/2013	S38-PMC3568875	['she was Transfused with 2 units of type-specific cytomegalovirus (Cmv) negative packed Red Blood Cells (Prbcs) as an outpatient with no signs of an adverse reaction.']	N/A	N/A	[('GO_0009293', 'transduction', 8, 'transfused'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'CMV'), ('CL_0000232', 'erythrocyte', 87, 'red blood cells'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CL_0000696', 'PP cell', 104, 'PRBCs')]
PMC3568875	1/2013	S47-PMC3568875	['transfusion Medicine was consulted, and 2 units of type-specific Blood screened for multiple Antibodies were Transfused (table 1).']	N/A	N/A	[('CHEBI_6807', 'methadone', 12, 'medicine'), ('UBERON_0000178', 'blood', 65, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibodies'), ('GO_0009293', 'transduction', 109, 'transfused')]
PMC3568875	1/2013	S51-PMC3568875	['the patient was screened for various known Immunogenic Red Blood Cell Antigens.']	N/A	N/A	[('CHEBI_60816', 'immunogen', 43, 'immunogenic'), ('CL_0000232', 'erythrocyte', 55, 'red blood cell'), ('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_59132', 'antigen', 70, 'antigens')]
PMC3571634	12/2012	S3-PMC3571634	['pbgls were assessed using a portable Blood analyser.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood')]
PMC3571634	12/2012	S4-PMC3571634	['subjects were asked to indicate their satiety rating at each Blood sample collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood')]
PMC3571634	12/2012	S30-PMC3571634	['anthropometry and self Blood Glucose monitoring (sbgm)\nsubjects were weighed at the first study session in light clothing and with shoes off, and their height was obtained from their electronic medical record.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'Blood'), ('CHEBI_17234', 'glucose', 29, 'Glucose')]
PMC3571634	12/2012	S39-PMC3571634	['quantification of fasting and Postprandial Blood Glucose levels\nFinger prick Blood samples were collected before the start of the meal, and at 15, 30, 45, 60, 75, 90 and 120 min after the start of the meal.']	N/A	N/A	[('GO_0008283', 'cell proliferation', 30, 'Postprandial'), ('UBERON_0000178', 'blood', 43, 'Blood'), ('CHEBI_17234', 'glucose', 49, 'Glucose'), ('UBERON_0002046', 'thyroid gland', 64, 'Finger'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC3571634	12/2012	S40-PMC3571634	['the Blood samples were analysed immediately after collection using a portable Blood analyser (hemocue Glucose analyzer 201, hemocue australia pty ltd., wamberal, australia).']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000178', 'blood', 78, 'blood'), ('CHEBI_17234', 'glucose', 102, 'Glucose')]
PMC3571634	12/2012	S46-PMC3571634	['mean ± sem bgl for all subjects (figure 1), as well as that of the individual subjects (figure 2) were plotted against time to obtain Postprandial Blood Glucose curves, and the incremental area under the Glucose curve (iaucglucose) was calculated by the trapezoidal rule.']	N/A	N/A	[('GO_0007567', 'parturition', 134, 'postprandial'), ('UBERON_0000178', 'blood', 147, 'blood'), ('CHEBI_17234', 'glucose', 153, 'glucose'), ('CHEBI_17234', 'glucose', 204, 'glucose')]
PMC3571634	12/2012	S49-PMC3571634	['the time point with the highest mean Blood Glucose level was deemed as the time of peak pbgl for the overall analysis (figure 1), and the peak pbgl time for individual subjects were also identified (figure 2).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('CHEBI_17234', 'glucose', 43, 'glucose')]
PMC3571634	12/2012	S50-PMC3571634	['caption (fig): figure 1\n\nmean ± sem Postprandial Blood Glucose level of the 10 subjects.']	N/A	N/A	[('GO_0007567', 'parturition', 36, 'postprandial'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_17234', 'glucose', 55, 'glucose')]
PMC3571634	12/2012	S53-PMC3571634	['peak Blood Glucose levels were circled.']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_17234', 'glucose', 11, 'glucose')]
PMC3571634	12/2012	S94-PMC3571634	['in addition, the non-continuous nature of Blood sample collection did not allow accurate determination of the actual peak time.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC3574039	1/2013	S40-PMC3574039	['at 90 d of age, the Animals were euthanized with Co2After fasting 12 h. Blood samples were collected, and Serum was obtained by centrifugation to determine the Lipid profile (Triglycerides, total Cholesterol, ldl Cholesterol and hdl), blood Glucose and Insulin.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 20, 'animals'), ('CHEBI_87163', 'dihydroisopentenyldehydrorhodopin', 49, 'CO2after'), ('UBERON_0000178', 'blood', 72, 'Blood'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_18059', 'lipid', 160, 'lipid'), ('CHEBI_17855', 'triglyceride', 175, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 196, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 213, 'cholesterol'), ('CHEBI_17234', 'glucose', 241, 'glucose'), ('PR_000045358', 'insulin family protein', 253, 'insulin')]
PMC3574039	1/2013	S68-PMC3574039	['Blood samples were obtained from the cut Tip Of the Tail 0, 30, 60 and 120 min later to determine Serum Glucose and Insulin concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0010162', 'post-anal tail tip', 41, 'tip of ... tail'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('PR_000045358', 'insulin family protein', 116, 'insulin')]
PMC3574039	1/2013	S72-PMC3574039	['Blood samples were obtained from the cut Tip Of the Tail 0, 5, 10 and 15 min later to measure Glucose levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0010162', 'post-anal tail tip', 41, 'tip of ... tail'), ('CHEBI_17234', 'glucose', 94, 'glucose')]
PMC3575022	2/2013	S36-PMC3575022	['at weaning, one male and one female from each litter were fasted and humanely killed and Blood samples were collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 89, 'blood')]
PMC3575022	2/2013	S40-PMC3575022	['dams were fasted and humanely killed at weaning, and Blood samples collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood')]
PMC3575022	2/2013	S58-PMC3575022	['the Glucose concentration of samples of Blood from the Tail Vein was measured at 0, 15, 30, 60, 90, and 120 min in conscious, semi restrained Animals (glucomen sensor, a. menarini diagnostics, it).']	N/A	N/A	[('CHEBI_17234', 'glucose', 4, 'glucose'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0003481', 'tail vein', 55, 'tail vein'), ('NCBITaxon_33208', 'Metazoa', 142, 'animals')]
PMC3575022	2/2013	S113-PMC3575022	['Blood Glucose concentrations after administration of a bolus dose of Glucose (1 g/kg, i.p.)']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_17234', 'glucose', 69, 'glucose')]
PMC3577465	2/2013	S59-PMC3577465	['Lungs were dissected once the effluent from the Left Atrium incision was clear of Blood.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lungs'), ('UBERON_0002079', 'left cardiac atrium', 48, 'left atrium'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC3578836	2/2013	S73-PMC3578836	['Serum metabolite analysis\nBlood was collected via orbital bleed at the time Mice were sacrificed.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0000178', 'blood', 26, 'Blood'), ('NCBITaxon_10088', 'Mus <genus>', 76, 'mice')]
PMC3578836	2/2013	S74-PMC3578836	['Blood was allowed to Coagulate for at least 30 minutes on ice, after which Serum was isolated via centrifugation at 5000 rpm (2700 × g) for 15 minutes at 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0050890', 'cognition', 21, 'coagulate'), ('UBERON_0001977', 'blood serum', 75, 'serum')]
PMC3578836	2/2013	S245-PMC3578836	['Il-6 can alter the pattern of Protein Biosynthesis in the Liver, augmenting the synthesis of C-Reactive Protein, a marker of inflammation measurable in peripheral Blood[45].']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'IL-6'), ('GO_0006412', 'translation', 30, 'protein biosynthesis'), ('UBERON_0002107', 'liver', 58, 'liver'), ('PR_000005890', 'crooked neck-like protein 1', 93, 'C-reactive protein'), ('UBERON_0000178', 'blood', 163, 'blood')]
PMC3581200	3/2013	S30-PMC3581200	['approximately 16 days before the experiment, sampling catheters were inserted in the Femoral Artery and the Hepatic Portal, left Common Hepatic and Common Iliac Veins; infusion catheters were placed in Jejunal and Splenic Veins for Delivery Of Glucose and Hormones into the Portal Circulation; and ultrasonic Blood flow cuffs (transonic systems, ithaca, ny) were positioned around the Hepatic Artery, Portal Vein, and External Iliac Vein as previously described (10,11).']	N/A	N/A	[('UBERON_0002060', 'femoral artery', 85, 'femoral artery'), ('UBERON_0001594', 'azygos vein', 108, 'hepatic portal'), ('UBERON_0013201', 'olfactory pathway', 129, 'common hepatic ...'), ('UBERON_0001139', 'common iliac vein', 148, 'common iliac veins'), ('UBERON_0001947', 'red nucleus', 202, 'jejunal ...'), ('UBERON_0001213', 'intestinal villus', 214, 'splenic veins'), ('GO_0009887', 'animal organ morphogenesis', 232, 'delivery of glucose ... hormones'), ('CHEBI_17234', 'glucose', 244, 'glucose'), ('UBERON_0002630', 'body of caudate nucleus', 274, 'portal circulation'), ('UBERON_0000178', 'blood', 309, 'blood'), ('UBERON_0001193', 'hepatic artery', 385, 'hepatic artery'), ('UBERON_0002017', 'portal vein', 401, 'portal vein'), ('UBERON_0001316', 'external iliac vein', 418, 'external iliac vein')]
PMC3581200	3/2013	S43-PMC3581200	['analysis of Blood Lactate, Glycerol, and alanine levels; plasma Glucose, Insulin, glucagon, Cortisol, and nonesterified fatty acid (nefa) levels; specific radioactivity of [3H]Glucose; and Hepatic Glycogen were carried out as described previously (7,10,15,16).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_24996', 'lactate', 18, 'lactate'), ('CHEBI_17754', 'glycerol', 27, 'glycerol'), ('CHEBI_17234', 'glucose', 64, 'glucose'), ('PR_000045358', 'insulin family protein', 73, 'insulin'), ('CHEBI_17650', 'cortisol', 92, 'cortisol'), ('CHEBI_29238', 'tritium atom', 173, '3H'), ('CHEBI_17234', 'glucose', 176, 'glucose'), ('UBERON_0002107', 'liver', 189, 'hepatic'), ('CHEBI_24384', 'glycogens', 197, 'glycogen')]
PMC3581200	3/2013	S55-PMC3581200	['mixing of the Glucose infusate in the Hepatic circulation was evaluated by recovery of P -Aminohippuric Acid in the Portal and Hepatic Vein Blood, using predefined exclusion criteria (15).']	N/A	N/A	[('CHEBI_17234', 'glucose', 14, 'glucose'), ('UBERON_0002107', 'liver', 38, 'hepatic'), ('CHEBI_35697', 'trans-cinnamic acid', 87, 'p -aminohippuric acid'), ('UBERON_0010166', 'coat of hair', 116, 'portal ...'), ('UBERON_0001143', 'hepatic vein', 127, 'hepatic vein'), ('UBERON_0000178', 'blood', 140, 'blood')]
PMC3581200	3/2013	S63-PMC3581200	['hindlimb balance was the difference between substrate concentrations in the Artery and the Common Iliac Vein multiplied by External Iliac Artery Blood flow (11).']	N/A	N/A	[('UBERON_0001637', 'artery', 76, 'artery'), ('UBERON_0001139', 'common iliac vein', 91, 'common iliac vein'), ('UBERON_0001308', 'external iliac artery', 123, 'external iliac artery'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC3581200	3/2013	S76-PMC3581200	['caption (table-wrap): table 1\n\nPlasma Insulin, glucagon, and Cortisol concentrations\n\nHepatic Blood flow.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 31, 'Plasma'), ('PR_000045358', 'insulin family protein', 38, 'insulin'), ('CHEBI_17650', 'cortisol', 61, 'cortisol'), ('UBERON_0002107', 'liver', 86, 'Hepatic'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC3581200	3/2013	S77-PMC3581200	['in all groups, Portal Blood flow declined ∼20% in response to somatostatin infusion, and an increase in Arterial Blood flow partially compensated for the fall in Portal Flow (table 2).']	N/A	N/A	[('UBERON_0001851', 'cortex', 15, 'portal'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0001637', 'artery', 104, 'arterial'), ('UBERON_0000178', 'blood', 113, 'blood'), ('UBERON_0000445', 'habenular trigone', 162, 'portal flow')]
PMC3581200	3/2013	S79-PMC3581200	['caption (table-wrap): table 2\n\nHepatic Blood flow\n\nGlucose Metabolism.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'Hepatic'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_17234', 'glucose', 51, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 51, 'Glucose metabolism')]
PMC3581200	3/2013	S80-PMC3581200	['the Blood Glucose concentrations were significantly higher in n than in p under basal conditions, whereas the Glucose concentrations in p-hff did not differ from those in p (fig.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_17234', 'glucose', 10, 'glucose'), ('CHEBI_17234', 'glucose', 110, 'glucose')]
PMC3581200	3/2013	S111-PMC3581200	['Arterial Blood Lactate concentrations rose in all groups at the onset of the experimental period (fig.']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_24996', 'lactate', 15, 'lactate')]
PMC3582478	2/2013	S26-PMC3582478	['sixty percent of central kyn is peripherally derived, being readily transported over the Blood–Brain Barrier, where it is converted to Kyna by Astrocytes and to wider kyn pathway products, including the excitotoxic Quinolinic Acid (Quin), by Microglia.']	N/A	N/A	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0000052', 'fornix of brain', 95, 'brain barrier'), ('PR_000009311', 'kinesin-like protein KIF3A', 135, 'KYNA'), ('CL_0000127', 'astrocyte', 143, 'astrocytes'), ('CHEBI_16675', 'quinolinic acid', 215, 'quinolinic acid'), ('CHEBI_82525', 'Pronetalol hydrochloride', 232, 'QUIN'), ('CL_0000129', 'microglial cell', 242, 'microglia')]
PMC3585827	1/2013	S3-PMC3585827	['methods\ndetailed information on health behaviors including diet and physical activity, and Blood samples for Metabolic parameters and dna are collected from Pregnant women of south asian ancestry who are free of significant chronic disease.']	N/A	N/A	[('UBERON_0000178', 'blood', 91, 'blood'), ('GO_0008152', 'metabolic process', 109, 'metabolic'), ('GO_0007565', 'female pregnancy', 157, 'pregnant')]
PMC3585827	1/2013	S5-PMC3585827	['at Delivery, Cord Blood and newborn anthropometric indices (i.e.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC3585827	1/2013	S21-PMC3585827	['further, south asians have more Adipose Tissue and develop abnormal Glucose, Lipids, and Blood pressure at a significantly lower body mass index (bmi) compared to white caucasians [13].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 32, 'adipose tissue'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('CHEBI_18059', 'lipid', 77, 'lipids'), ('UBERON_0000178', 'blood', 89, 'blood')]
PMC3585827	1/2013	S26-PMC3585827	['increased Glucose, abnormal Lipids and elevated Blood pressure) [15].']	N/A	N/A	[('CHEBI_17234', 'glucose', 10, 'glucose'), ('CHEBI_18059', 'lipid', 28, 'lipids'), ('UBERON_0000178', 'blood', 48, 'blood')]
PMC3585827	1/2013	S81-PMC3585827	['anthropometric measurements (height, weight, Skinfold thickness), Blood pressure, Urine sample, and a fasting Blood sample for Glucose, Insulin, Micronutrients (i.e.']	N/A	N/A	[('UBERON_0009007', 'superficial inguinal lymph node', 45, 'skinfold'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001088', 'urine', 82, 'urine'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_17234', 'glucose', 127, 'glucose'), ('PR_000045358', 'insulin family protein', 136, 'insulin'), ('CHEBI_33839', 'macromolecule', 145, 'micronutrients')]
PMC3585827	1/2013	S103-PMC3585827	['inter-country measurements\nall questionnaires, physical measurement protocols, adiposity assessments, and Blood collection protocols for key measures will be standardized between the three centres.']	N/A	N/A	[('UBERON_0000178', 'blood', 106, 'blood')]
PMC3585827	1/2013	S124-PMC3585827	['Blood samples are stored for future measurement of maternal Insulin sensitivity by analysis of stored samples for fasting Insulin at the time of the ogtt [30].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('PR_000045358', 'insulin family protein', 60, 'insulin'), ('PR_000045358', 'insulin family protein', 122, 'insulin')]
PMC3585827	1/2013	S213-PMC3585827	['Cord Blood will be collected from the Umbilical Vein after the Cord has been cut and before Placenta Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0002066', 'umbilical vein', 38, 'umbilical vein'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0001987', 'placenta', 92, 'placenta'), ('GO_0007567', 'parturition', 101, 'delivery')]
PMC3585827	1/2013	S214-PMC3585827	['a total of 18.5 ml of Blood is collected to obtain, Plasma, Serum, buffy coat (for dna) and paxgene (for rna) samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0001969', 'blood plasma', 52, 'plasma'), ('UBERON_0001977', 'blood serum', 60, 'serum')]
PMC3585827	1/2013	S224-PMC3585827	['caption (table-wrap): table 2\n\ntiming and type of measurement in start canada and indiameasuresantenatal visit (m)Birth (m, b)first year (m, b)12 month (m, b)24 month (m, b)36 month (m, f, b) \xa0 t1t2t3 \xa0 3 mth6 mth9 mth \xa0\xa0\xa0 demographics \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ageic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0expected Delivery dateic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medical and obstetric history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0gravidaic\xa0c (m)\xa0\xa0\xa0\xa0\xa0\xa0current Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0current increased Blood pressureic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0increased Cholesterolic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0other major medical conditions checklistic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0family historyic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medications usedic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Pregnancy history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Live Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Still Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Abortions (therapeutic and spontaneous)ic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0pre-eclampsiaii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Multivitamin useii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 social determinants \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0self-reported ethnicity - for self, parents and grandparentsi\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0mother tongueic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0religious denominationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0years in canada\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place immigrated fromic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place of birthic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0annual household incomeic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0occupationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0marital statusic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0educationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0social supportic\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0social status-mccarthur\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c\xa0\xa0acculturation\xa0\xa0\xa0\xa0\xa0\xa0\xa0c (m)\xa0\xa0Alcohol and tobacco use\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal depression\xa0i/c\xa0\xa0\xa0(m)\xa0i/c (m)\xa0\xa0intimate partner violence\xa0\xa0\xa0\xa0\xa0\xa0\xa0c(m)\xa0\xa0home environment and parenting\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0infant temperament\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/ci/ci/csleep patterns\xa0\xa0\xa0\xa0cc\xa0i/c\xa0\xa0 diet \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ffq\xa0i (mf)/c (m)\xa0i (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m)24 hour recalli (m)ii(m)\xa0ii (m)ii/c (m)\xa0i/c (mother for baby)infant Feeding questions\xa0\xa0\xa0ii/ci/c\xa0i/c\xa0i/cphysical activityii/ci\xa0\xa0\xa0\xa0i/c (m)c (m)i/c (m) anthropometric measures \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Blood pressureii/cii/c (b)\xa0\xa0\xa0i/ci/ci/cheight/Lengthii/cii/c (b)i/c (b)\xa0ii/c\xa0i/cweightii/cii/c (b)i/c (b)i/c (b)1ii/ci/ci/Cwaist and Hip circumferenceii/ci\xa0\xa0\xa0\xa0i/ci/ci/cskin foldsii/cii/c (b)i\xa0ii/c (b)i/c (b)i/c (b, m)Head circumference\xa0\xa0\xa0i/c (b)i/ci/cii/c (b)\xa0i/c (b)Chest, mid upper Arm circumference\xa0\xa0\xa0i/c (b)iiii/c (b)\xa0i/c (b)fetal ultrasound\xa0i/c (m)i/c (m)i (b)\xa0\xa0\xa0i (b)i (b)i (b)dlw\xa0\xa0\xa0\xa0\xa0\xa0\xa0ii\xa0bia\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (b)Blood specimens\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0hemoglobini (m)c (m)\xa0i/c (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m, f)fasting Glucose\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)75 g ogtt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Insulin\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)Lipids\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c\xa0i/calt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Micronutrients (b12 Folate)\xa0i/ci\xa0\xa0\xa0\xa0\xa0\xa0\xa0dna/long term storage (Urine sample)\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Birth visit\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0type of Delivery\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Pregnancy weight gain\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0duration of labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0low Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature Delivery\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Blood loss\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Epidural\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0apgar scores (1 min & 5 min)\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Vitamin K given\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0adverse outcomes\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Placenta\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Cord Blood\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0\nlegend: i india, c canada, b baby, m mother.']	N/A	N/A	[('GO_0007567', 'parturition', 114, 'Birth'), ('GO_0007586', 'digestion', 268, 'Delivery'), ('GO_0007565', 'female pregnancy', 359, 'gestational'), ('UBERON_0000178', 'blood', 407, 'blood'), ('CHEBI_62415', 'propanoyl-AMP', 441, 'cholesterolIC'), ('GO_0007565', 'female pregnancy', 567, 'Pregnancy'), ('GO_0019668', 'anaerobic catabolism of pairs of amino acids', 594, 'Live BirthsIC'), ('GO_0034209', 'sterol acetylation', 615, 'Still BirthsIC'), ('GO_0006915', 'apoptotic process', 637, 'Abortions'), ('GO_0007565', 'female pregnancy', 691, 'Gestational'), ('CHEBI_7025', 'mupirocin', 746, 'Multivitamin'), ('CHEBI_30879', 'alcohol', 1198, 'Alcohol'), ('GO_0007631', 'feeding behavior', 1538, 'Feeding'), ('UBERON_0000178', 'blood', 1653, 'Blood'), ('PR_000009651', 'laminin subunit alpha-2', 1698, 'LengthII'), ('UBERON_0007356', 'crop', 1774, 'CWaist'), ('UBERON_0006337', 'distal early tubule', 1785, 'Hip'), ('UBERON_0000033', 'head', 1869, 'Head'), ('UBERON_0012131', 'centrale', 1919, 'Chest'), ('UBERON_0001460', 'arm', 1936, 'arm'), ('UBERON_0000178', 'blood', 2067, 'Blood'), ('CHEBI_17234', 'glucose', 2149, 'Glucose'), ('PR_000045358', 'insulin family protein', 2221, 'Insulin'), ('CHEBI_18059', 'lipid', 2268, 'Lipids'), ('CHEBI_34850', 'milrinone lactate', 2319, 'Micronutrients'), ('CHEBI_81245', 'Vulpecholate', 2339, 'Folate'), ('UBERON_0001088', 'urine', 2381, 'urine'), ('GO_0007567', 'parturition', 2410, 'Birth'), ('GO_0007586', 'digestion', 2445, 'Delivery'), ('GO_0007565', 'female pregnancy', 2469, 'Pregnancy'), ('GO_0007567', 'parturition', 2544, 'Birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2572, 'Premature'), ('GO_0007586', 'digestion', 2582, 'Delivery'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2606, 'Premature'), ('UBERON_0000178', 'blood', 2638, 'Blood'), ('UBERON_2000660', 'epural', 2664, 'Epidural'), ('GO_0007567', 'parturition', 2688, 'Birth'), ('CHEBI_28384', 'vitamin K', 2760, 'Vitamin K'), ('UBERON_0001987', 'placenta', 2819, 'Placenta'), ('UBERON_0000948', 'heart', 2839, 'Cord'), ('UBERON_0000178', 'blood', 2844, 'Blood')]
PMC3586494	2/2013	S9-PMC3586494	['a consensus group for the international diabetes federation defines Metabolic syndrome as central obesity, plus any two of the following: raised Triglycerides, reduced high-density lipoprotein (hdl) Cholesterol, raised fasting Plasma Glucose, and raised Blood pressure [2].']	N/A	N/A	[('GO_0008152', 'metabolic process', 68, 'metabolic'), ('CHEBI_17855', 'triglyceride', 145, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 199, 'cholesterol'), ('UBERON_0001969', 'blood plasma', 227, 'plasma'), ('CHEBI_17234', 'glucose', 234, 'glucose'), ('UBERON_0000178', 'blood', 254, 'blood')]
PMC3586494	2/2013	S117-PMC3586494	['a Human study determined Vitamin A, c, and e levels in the Umbilical Cord Blood of term and preterm infants and the Blood of their mothers taken at the time of Delivery [52].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 2, 'human'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('UBERON_0002331', 'umbilical cord', 59, 'umbilical cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('UBERON_0000178', 'blood', 116, 'blood'), ('GO_0007567', 'parturition', 160, 'delivery')]
PMC3586494	2/2013	S133-PMC3586494	['offspring from dams that had received Dexamethasone during 22–29 days Gestation, but not days 59–66 of Gestation, had elevated Blood pressures.']	N/A	N/A	[('CHEBI_41879', 'dexamethasone', 38, 'dexamethasone'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('GO_0007565', 'female pregnancy', 103, 'gestation'), ('UBERON_0000178', 'blood', 127, 'blood')]
PMC3586494	2/2013	S219-PMC3586494	['in Rats, a high Fructose diet for 2 weeks resulted in increases in systolic Blood pressure as well as Plasma Insulin and Triglyceride concentrations as compared to Rats Fed a normal Chow [91].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_28757', 'fructose', 16, 'fructose'), ('UBERON_0000178', 'blood', 76, 'blood'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('PR_000045358', 'insulin family protein', 109, 'insulin'), ('CHEBI_17855', 'triglyceride', 121, 'triglyceride'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 164, 'rats'), ('GO_0007631', 'feeding behavior', 169, 'fed'), ('CHEBI_33290', 'food', 182, 'chow')]
PMC3586494	2/2013	S232-PMC3586494	['offspring risk of the Metabolic syndrome increased significantly with increasing maternal fasting Blood Glucose as well as 2-hour Blood Glucose following an oral Glucose load.']	N/A	N/A	[('GO_0008152', 'metabolic process', 22, 'metabolic'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('UBERON_0000178', 'blood', 130, 'blood'), ('CHEBI_17234', 'glucose', 136, 'glucose'), ('CHEBI_17234', 'glucose', 162, 'glucose')]
PMC3586494	2/2013	S260-PMC3586494	['indeed, in this study offspring exposed to the Micronutrient restricted diet had significantly reduced body weight and Crown-to-Rump length at Birth as well as increased systolic Blood pressure and Insulin levels post-weaning as compared to those exposed to a control diet.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 47, 'micronutrient'), ('UBERON_0000993', 'oviduct', 119, 'crown'), ('UBERON_0013691', 'buttock', 128, 'rump'), ('GO_0007567', 'parturition', 143, 'birth'), ('UBERON_0000178', 'blood', 179, 'blood'), ('PR_000045358', 'insulin family protein', 198, 'insulin')]
PMC3596600	7/2010	S5-PMC3596600	['case report\nthe patient, a 36-year-old, gravidity-two parity-one (g2p1) female presented to the hospital at 37 w of Gestation for induction of labor secondary to Intrauterine growth retardation and increased Blood pressure.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 116, 'gestation'), ('UBERON_0022293', 'reproductive gland secretion', 162, 'intrauterine'), ('UBERON_0000178', 'blood', 208, 'blood')]
PMC3596600	7/2010	S35-PMC3596600	['laboratory results revealed a normal White Blood Cell count of 9.8×103/mm3.']	N/A	N/A	[('CL_0000738', 'leukocyte', 37, 'white blood cell'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC3596600	7/2010	S36-PMC3596600	['Blood cultures were taken at this time.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3596600	7/2010	S46-PMC3596600	['both Blood cultures and aspirate samples grew Penicillin sensitive staphylococcus aureus (s. aureus) .']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_17334', 'penicillin', 46, 'penicillin')]
PMC3599191	1/2013	S132-PMC3599191	['Peripheral Blood Mononuclear Cells from healthy young women whose mothers experienced major negative Life events during their Pregnancy (Prenatal stress, ps group), and from a female comparison group, were stimulated with Phytohemagglutinin (pha), and subsequent Cytokine Production was measured.']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 0, 'Peripheral blood mononuclear cells'), ('UBERON_0000178', 'blood', 11, 'blood'), ('GO_0031097', 'medial cortex', 17, 'mononuclear'), ('UBERON_0000104', 'life cycle', 101, 'life'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007565', 'female pregnancy', 137, 'Prenatal'), ('CHEBI_52428', 'phenethicillin(1-)', 222, 'phytohemagglutinin'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 263, 'cytokine production')]
PMC3600625	2/2013	S23-PMC3600625	['Blood pressure was assessed on all recruited Individuals.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_1', 'root', 45, 'individuals')]
PMC3600625	2/2013	S33-PMC3600625	['Blood pressure was measured in triplicate using an automated oscillometric device (omron 705it, morton medical ltd) under standard conditions: the first measurement was taken after the subject had been seated at rest for 5 min, with 1 min between each subsequent measurement.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3600625	2/2013	S34-PMC3600625	['the mean of the three readings was used as an estimate of average Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood')]
PMC3600625	2/2013	S41-PMC3600625	['maternal Blood pressure was measured by a single mercury sphygmomanometer reading at four time points in Pregnancy; 8–10, 14–15, 19–20 and 30–31 weeks of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('GO_0007565', 'female pregnancy', 154, 'gestation')]
PMC3600625	2/2013	S63-PMC3600625	['u-as 18 months refers to child Urinary Arsenic measurements at 18 months of age\n\ncaption (table-wrap): table 1\n\ncharacteristics of study cohortlost to follow-uparecruited into 4.5 y follow-upblood pressure samplegfr samplekidney volume samplenmean (sd)bnmean (sd)bnmean (sd)bnmean (sd)bmaternal characteristics\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)76826.1 (5.8)249926.6 (6.0)133426.7 (6.0)114526.6 (6.0)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003wealth indexc7250.63 (−1.76, 2.00)23860.38 (−1.65, 1.80)13320.10 (−1.93, 1.74)10380.68 (−1.26, 1.91)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003early Pregnancy (week 8) bmi (kg/m2)76720.2 (2.7)249020.1 (2.7)132819.9 (2.6)114220.3 (2.8)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Maternal Urinary Arsenic (µg/l) week 8 gest−−169280.5 (38, 208)117885 (38, 216)67570 (37, 182)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003week 30 gest−−178082.5 (42, 228)128382 (41, 228)66183 (44, 243)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003maternal Urinary cadmium(µg/l) week 8 gest−−12800.63 (0.38, 1.0)11590.63 (0.38, 1.01)2800.63 (0.41, 1.06)children characteristics,\u2003infancy\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Gestational age (weeks)76839.1 (1.9)249939.2 (1.6)133439.2 (1.7)114539.2 (1.6)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth weight (kg)7682.67 (0.45)24982.70 (0.40)13332.69 (0.40)11452.73 (0.40)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth length (cm)76748.0 (4.9)249747.86 (2.39)133248.0 (2.54)114547.74 (2.14)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Breastfeeding pattern at 4 monthsd67354.7% exclusive, 33.1% predominant248459.7% exclusive, 28.3% predominant132860.8% exclusive, 27.7% predominant113658.3% exclusive, 30.2% predominant\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Urinary Arsenic at 18 months (µg/l)−−181633.9 (18.2, 77.4)127533.6 (18.1, 76.5)70133.4 (17.9, 73.6)\u20034.5 y follow-up\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)−−24994.6 (0.14)13344.5 (0.14)11454.6 (0.10)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003male (%)−−249951.6%133452.7%114550.9%\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003height (cm)−−249999.8 (4.3)133399.6 (4.7)114599.8 (4.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003weight (kg)−−249913.76 (1.66)133413.67 (1.62)114513.81 (1.63)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003impedance indexe−−22660.13 (0.01)12100.13 (0.01)10260.13 (0.01)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003systolic Blood pressure (mmhg)−−249991.4 (7.6)132191.3 (7.9)113691.7 (7.5)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003diastolic Blood pressure (mmhg)−−249954.4 (6.5)132154.2 (6.8)113654.8 (6.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Glomerular filtration ratef(ml/min/1.73 m2)−−1321158.3 (35.2)1334158.2 (35.2)150164.0 (35.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Kidney volume (cm3/m2)g−−1136103.7 (15.5)150104.7 (15.1)1145103.8 (15.5)\nabbreviations: gfr, Glomerular filtration rate; bmi, body mass index.']	N/A	N/A	[('UBERON_0001088', 'urine', 31, 'urinary'), ('CHEBI_27563', 'arsenic atom', 39, 'arsenic'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy'), ('UBERON_0000976', 'humerus', 595, 'Maternal'), ('UBERON_0001088', 'urine', 604, 'urinary'), ('CHEBI_27563', 'arsenic atom', 612, 'arsenic'), ('UBERON_0001088', 'urine', 777, 'urinary'), ('GO_0007565', 'female pregnancy', 914, 'Gestational'), ('GO_0007567', 'parturition', 1000, 'Birth'), ('GO_0007567', 'parturition', 1084, 'Birth'), ('UBERON_0000165', 'mouth', 1169, 'Breastfeeding'), ('UBERON_0001088', 'urine', 1362, 'Urinary'), ('CHEBI_27563', 'arsenic atom', 1370, 'arsenic'), ('UBERON_0000178', 'blood', 1801, 'blood'), ('UBERON_0000178', 'blood', 1884, 'blood'), ('UBERON_0000074', 'renal glomerulus', 1957, 'Glomerular'), ('UBERON_0002113', 'kidney', 2057, 'Kidney'), ('UBERON_0000074', 'renal glomerulus', 2150, 'glomerular')]
PMC3600625	2/2013	S78-PMC3600625	['average systolic Blood pressure was 91.1 ± 7.5 mmhg for girls and 91.4 ± 7.7 mmhg for boys, whereas diastolic Blood pressure was 55.0 ± 6.4 mmhg for girls and 53.8 ± 6.5 mmhg for boys.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC3600625	2/2013	S87-PMC3600625	['u-cd in Pregnancy was not associated with systolic or diastolic Blood pressure in early Pregnancy (data not shown).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'pregnancy'), ('UBERON_0000178', 'blood', 64, 'blood'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC3600625	2/2013	S95-PMC3600625	['similarly there was no interaction between child sex, parental wealth index, maternal early Pregnancy (week 8) bmi or maternal Blood pressure and the effect of u-as and u-cd on Blood pressure or Kidney function at 4.5 years (data not shown).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0000178', 'blood', 177, 'blood'), ('UBERON_0002113', 'kidney', 195, 'kidney')]
PMC3608974	2/2013	S163-PMC3608974	['[85] evaluated Blood Serum from 120 children age 8–15\xa0years with ais, biotesting was performed on male wistar Rats with Thoracic Spinal Cord transection.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0001977', 'blood serum', 21, 'serum'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 110, 'rats'), ('UBERON_0000915', 'thoracic segment of trunk', 120, 'thoracic'), ('UBERON_0002240', 'spinal cord', 129, 'spinal cord')]
PMC3610650	3/2013	S88-PMC3610650	['the copper deficient Mice at p45 were anemic with decreased hemoglobin (hb), hematocrit (hct) and Red Blood Cell count (Rbc) (figure 1b), along with elevated Serum Erythropoietin levels, weight loss and cardiomegaly (data not shown).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 21, 'mice'), ('CL_0000232', 'erythrocyte', 98, 'red blood cell'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CL_0000232', 'erythrocyte', 120, 'RBC'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_24009', 'eumelanin', 164, 'erythropoietin')]
PMC3614477	3/2013	S95-PMC3614477	['of these, 15 (34%) were over 27 weeks Gestation; seven declined for other reasons including being too busy (n=1), being uncomfortable with the Blood samples (n=2), or no reason indicated (n=4); five took the information but did not want a follow-up call or email; one was already involved with apron; 13 (30%) provided their contact information (email and/or phone number) for follow up and three (7%) booked appointments directly for the research project.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'gestation'), ('UBERON_0000178', 'blood', 143, 'blood')]
PMC3614838	9/2011	S30-PMC3614838	['maternal Blood sampling and the determination of body weights, Food Intake and Organ weights\nthe mothers (n=4 per group) were weighed prior to Mating; on days 7, 14 and 20 of Gestation; and on the day of Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_33290', 'food', 63, 'food'), ('GO_0007631', 'feeding behavior', 63, 'food intake'), ('UBERON_0000062', 'organ', 79, 'organ'), ('GO_0007618', 'mating', 143, 'mating'), ('GO_0007565', 'female pregnancy', 175, 'gestation'), ('GO_0007567', 'parturition', 204, 'delivery')]
PMC3614838	9/2011	S32-PMC3614838	['after 3 h of fasting, Blood was collected prior to Mating and on days 7, 14 and 20 of Gestation to measure Blood Glucose concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0007618', 'mating', 51, 'mating'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_17234', 'glucose', 113, 'glucose')]
PMC3614838	9/2011	S33-PMC3614838	['on the day of Delivery, Blood Glucose, Serum Insulin and Serum glucagon concentrations were determined.']	N/A	N/A	[('GO_0007567', 'parturition', 14, 'delivery'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_17234', 'glucose', 30, 'glucose'), ('UBERON_0001977', 'blood serum', 39, 'serum'), ('PR_000045358', 'insulin family protein', 45, 'insulin'), ('UBERON_0001977', 'blood serum', 57, 'serum')]
PMC3614838	9/2011	S38-PMC3614838	['neonatal gender distribution, Blood sampling, Liver, Pancreas and Heart collection\nwithin 24 h of Birth, the gender was identified in the neonatal offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0002107', 'liver', 46, 'liver'), ('UBERON_0001264', 'pancreas', 53, 'pancreas'), ('UBERON_0000948', 'heart', 66, 'heart'), ('GO_0007567', 'parturition', 98, 'birth')]
PMC3614838	9/2011	S40-PMC3614838	['Blood was collected from individual neonates for the determination of Glucose concentrations (n=38-56 per group).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 70, 'glucose')]
PMC3614838	9/2011	S41-PMC3614838	['for the determination of Serum Insulin, Serum Glucagon concentrations, Serum Triglyceride and Serum ffa concentrations, the Blood from neonates per litter was pooled (n=4 per group) in order to constitute sufficient volumes for analyses.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('PR_000045358', 'insulin family protein', 31, 'insulin'), ('UBERON_0001977', 'blood serum', 40, 'serum'), ('CHEBI_17754', 'glycerol', 46, 'glucagon'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('CHEBI_17855', 'triglyceride', 77, 'triglyceride'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('UBERON_0000178', 'blood', 124, 'blood')]
PMC3614838	9/2011	S45-PMC3614838	['determination of Blood Glucose, Serum Insulin, Glucagon, Triglyceride and ffa concentrations\nin mothers and neonates, Blood Glucose concentrations were determined with a glucometer (precision qd, medisense inc, oxfordshire, uk) employing the oxidase method.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_17234', 'glucose', 23, 'glucose'), ('UBERON_0001977', 'blood serum', 32, 'serum'), ('PR_000045358', 'insulin family protein', 38, 'insulin'), ('CHEBI_17754', 'glycerol', 47, 'glucagon'), ('CHEBI_17855', 'triglyceride', 57, 'triglyceride'), ('UBERON_0000178', 'blood', 118, 'blood'), ('CHEBI_17234', 'glucose', 124, 'glucose')]
PMC3614838	9/2011	S96-PMC3614838	['maternal Blood Glucose, Serum Insulin and Serum glucagon concentrations\nthere were no differences in maternal Blood Glucose concentrations before Gestation, during Gestation or on the day of delivery (fig.1a).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_17234', 'glucose', 15, 'glucose'), ('UBERON_0001977', 'blood serum', 24, 'serum'), ('PR_000045358', 'insulin family protein', 30, 'insulin'), ('UBERON_0001977', 'blood serum', 42, 'serum'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_17234', 'glucose', 116, 'glucose'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('GO_0007565', 'female pregnancy', 164, 'gestation')]
PMC3614838	9/2011	S98-PMC3614838	['caption (fig): figure 1\n\nmaternal Blood Glucose, Serum Insulin and Serum glucagon concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_17234', 'glucose', 40, 'glucose'), ('UBERON_0001977', 'blood serum', 49, 'serum'), ('PR_000045358', 'insulin family protein', 55, 'insulin'), ('UBERON_0001977', 'blood serum', 67, 'serum')]
PMC3614838	9/2011	S99-PMC3614838	['(a), maternal Blood Glucose concentrations during Pregnancy; (b), maternal Serum Insulin concentrations on the day of Delivery; (c), maternal Serum glucagon concentrations on the day of Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_17234', 'glucose', 20, 'glucose'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('PR_000045358', 'insulin family protein', 81, 'insulin'), ('GO_0007567', 'parturition', 118, 'delivery'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('GO_0007567', 'parturition', 186, 'delivery')]
PMC3614838	9/2011	S115-PMC3614838	['neonatal Blood Glucose, Serum Insulin, Glucagon, Triglyceride and ffa concentrations\nthe 20f neonates displayed elevated Blood Glucose concentrations compared to control neonates (fig.2a).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_17234', 'glucose', 15, 'glucose'), ('UBERON_0001977', 'blood serum', 24, 'serum'), ('PR_000045358', 'insulin family protein', 30, 'insulin'), ('CHEBI_17754', 'glycerol', 39, 'glucagon'), ('CHEBI_17855', 'triglyceride', 49, 'triglyceride'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CHEBI_17234', 'glucose', 127, 'glucose')]
PMC3614838	9/2011	S117-PMC3614838	['caption (fig): figure 2\n\nneonatal Blood Glucose, Serum Insulin and Serum glucagon concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_17234', 'glucose', 40, 'glucose'), ('UBERON_0001977', 'blood serum', 49, 'serum'), ('PR_000045358', 'insulin family protein', 55, 'insulin'), ('UBERON_0001977', 'blood serum', 67, 'serum')]
PMC3614838	9/2011	S118-PMC3614838	['(a), neonatal Blood Glucose concentrations; (b), neonatal Serum Insulin concentrations; (c), neonatal Serum Glucagon concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_17234', 'glucose', 20, 'glucose'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('PR_000045358', 'insulin family protein', 64, 'insulin'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_17754', 'glycerol', 108, 'glucagon')]
PMC3615950	3/2013	S6-PMC3615950	['in pediatric age diagnosis of hypertension or high normal Blood pressure is made with repeated office Blood Pressure measurements that show values exceeding the reference values.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0013756', 'venous blood', 102, 'blood pressure')]
PMC3615950	3/2013	S10-PMC3615950	['the probability of facing a secondary form of hypertension is inversely proportional to the child’s age and directly proportional to Blood pressure levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 133, 'blood')]
PMC3615950	3/2013	S26-PMC3615950	['definition\nhypertension in children is defined using a statistical criterion, the limit being the 95thpercentile of the distribution of the systo-diastolic Blood pressure values, according to gender, age and height.']	N/A	N/A	[('UBERON_0000178', 'blood', 156, 'blood')]
PMC3615950	3/2013	S27-PMC3615950	['in order to conform to the Adult terminology pre-hypertension or high-normal pressure hypertension is defined as Blood pressure values consistently above or equal to the 90thpercentile, but lower than the 95th[4] (table\xa01).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 27, 'adult'), ('UBERON_0000178', 'blood', 113, 'blood')]
PMC3615950	3/2013	S28-PMC3615950	['caption (table-wrap): table 1\n\ndefinition and classification of hypertension in children and adolescentscategorysystolic or diastolic Blood pressure percentile normal< 90thpre-hypertension≥ 90thand < 95th≥ 120/80 mmhg independently of the 90thpercentile value in adolescentsstage 1 hypertension≥ 95thand < 99th+ 5 mmhgstage 2 hypertension≥ 99th+ 5 mmhg\n4° report on the diagnosis, evaluation and treatment of high Blood pressure in children and adolescents.']	N/A	N/A	[('UBERON_0000178', 'blood', 134, 'blood'), ('UBERON_0000178', 'blood', 414, 'Blood')]
PMC3615950	3/2013	S35-PMC3615950	['Blood pressure values increase progressively until the age of 17–18 years when Adult values are reached.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0007023', 'adult organism', 79, 'adult')]
PMC3615950	3/2013	S43-PMC3615950	['methodology for Blood pressure recording in children and reference values\nfor correct Blood pressure recording it is necessary to conform the measuring procedure to the method used for the construction of the reference tables.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC3615950	3/2013	S61-PMC3615950	['children above 3 years of age should have their Blood pressure measured every year on the occasion of the periodic visits.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood')]
PMC3615950	3/2013	S68-PMC3615950	['caption (table-wrap): table 2\n\nBlood pressure percentiles for boys by age and height\xa0 systolic (mmhg) percentile of heightdiastolic (mmhg) percentile of heightage (years)bp percentile5th10th25th50th75th90th95th5th10th25th50th75th90th95th 190th9495979910010210349505152535354\xa095th989910110310410610654545556575858\xa099th10510610811011211311461626364656666290th979910010210410510654555657585859\xa095th10110210410610810911059596061626363\xa099th10911011111311511711766676869707171390th10010110310510710810959596061626363\xa095th10410510710911011211363636465666767\xa099th11111211411611811912071717273747575490th10210310510710911011162636465666667\xa095th10610710911111211411566676869707171\xa099th11311411611812012112274757677787879590th10410510610811011111265666768696970\xa095th10810911011211411511669707172737474\xa099th11511611812012112312377787980818182690th10510610811011111311368686970717272\xa095th10911011211411511711772727374757676\xa099th11611711912112312412580808182838484790th10610710911111311411570707172737474\xa095th11011111311511711811974747576777878\xa099th11711812012212412512682828384858686890th10710911011211411511671727273747576\xa095th11111211411611811912075767778797980\xa099th11912012212312512712783848586878788990th10911011211411511711872737475767677\xa095th11311411611811912112176777879808181\xa099th120121123125127128129848586878888891090th11111211411511711911973737475767778\xa095th11511611711912112212377787980818182\xa099th122123125127128130130858686888889901190th11311411511711912012174747576777878\xa095th11711811912112312412578787980818282\xa099th124125127129130132132868687888990901290th11511611812012112312374757576777879\xa095th11912012212312512712778798081828283\xa099th126127129131133134135868788899090911390th11711812012212412512675757677787979\xa095th12112212412612812913079798081828383\xa099th128130131133135136137878788899091911490th12012112312512612812875767778797980\xa095th12412512712813013213280808182838484\xa099th131132134136138139140878889909192921590th12212412512712913013176777879808081\xa095th12612712913113313413581818283848585\xa099th134135136138140142142888990919293931690th12512612813013113313478787980818282\xa095th12913013213413513713782838384858687\xa099th136137139141143144145909091929394941790th12712813013213413513680808182838484\xa095th1213213413613813914084858687878889\xa099th13914014114314514614792939394959697\n4° report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood')]
PMC3615950	3/2013	S70-PMC3615950	['caption (table-wrap): table 3\n\nBlood pressure percentiles for girls by age and height\xa0 systolic (mmhg0 percentile of heightdiastolic (mmhg) percentile of heightage (years)bp percentile5th10th25th50th75th90th95th5th10th25th50th75th90th95th 190th97979810010110210352535354555556\xa095th10010110210410510610756575758595960\xa099th10810810911111211311464646565666767290th989910010110310410557585859606161\xa095th10210310410510710810964626263646565\xa099th10911011111211411511669697070717272390th10010010210310410610661626263646465\xa095th10410410510710810911065666667686869\xa099th11111111311411511611773737474757676490th10110210310410610710864646566676768\xa095th10510610710811011111268686970717172\xa099th11211311411511711811976767677787979590th10310310510610710910966676768696970\xa095th10710710811011111211370717172737374\xa099th11411411611711812012078787979808181690th10410510610810911011168686970707172\xa095th10810911011111311411572727374747576\xa099th11511611711912012112280808081828383790th10610710810911111211369707071727273\xa095th11011111211311511611673747475767677\xa099th11711811912012212312481818282838484890th10810911011111311411471717172737474\xa095th11211211411511611811875757576777878\xa099th11912012112212312512582828383848586990th11011011211311411611672727273747575\xa095th11411411511711811912076767677787979\xa099th121121123124125127127838384848586871090th11211211411511611811873737374757676\xa095th11611611711912012112277777778798080\xa099th123123125126127129129848485868687881190th11411411611711811912074747475767777\xa095th11811811912112212312478787879808181\xa099th125125126128129130131858586878788891290th116116117119120121122757587576777878\xa095th11912012112312412512679797980818282\xa099th127127128130131132133868687888889901390th11711811912112212312476767677787979\xa095th12112212312412612712880808081828383\xa099th128129130132133134135878788898990911490th11912012112212412512577777778798080\xa095th12312312512612712912981818182838484\xa099th130131132133135136136888889909091921590th12012112212312512612778787879808181\xa095th12412512612712913013182828283848585\xa099th131132133134136137138898990919192931690th12112212312412612712878787980818182\xa095th12512612712813013113282828384858586\xa099th132133134135137138139909090919293931790th12212212312512612712878797980818182\xa095th12512612712913013113282838384858586\xa099th13313313413613713813990909191929393\n4° report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood')]
PMC3615950	3/2013	S72-PMC3615950	['twenty-hour hour Blood pressure monitoring (ambulatory Blood pressure monitoring) is validated and used in Adults for the diagnosis of hypertension.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0000178', 'blood', 55, 'Blood'), ('UBERON_0007023', 'adult organism', 107, 'adults')]
PMC3615950	3/2013	S73-PMC3615950	['it allows to identify “White Coat hypertension” (elevated office Blood pressure values and normal ambulatory Blood pressure monitoring values) and “masked hypertension” (normal office Blood pressure values and elevated ambulatory Blood pressure monitoring values).']	N/A	N/A	[('UBERON_0001347', 'white adipose tissue', 23, 'white'), ('UBERON_0010166', 'coat of hair', 29, 'coat'), ('UBERON_0000178', 'blood', 65, 'blood'), ('UBERON_0000178', 'blood', 109, 'Blood'), ('UBERON_0000178', 'blood', 184, 'blood'), ('UBERON_0000178', 'blood', 230, 'Blood')]
PMC3615950	3/2013	S78-PMC3615950	['caption (table-wrap): table 4\n\nreference values of 24-h Ambulatory Blood pressure by age and genderage (years)boysgirls \xa0 daynightdaynight \xa0 75th90th95th75th90th95th75th90th95th75th90th95th 5116/76120/79123/8199/59103/62106/65114/77118/80121/82100/81105/66108/696116/76121/79124/81100/59105/63108/66155/77120/80122/82101/61106/65110/687117/76122/80125/82101/60106/64110/67116/77121/80123/82102/60107/65111/678117/76122/80125/82102/60108/64111/67117/76122/80124/82103/60108/64112/679118/76123/80126/82103/60109/64112/67118/76122/80125/82103/59109/64112/610119/76124/80127/82104/60110/64113/67119/76123/79126/81104/59110/64113/6711121/76126/80129/82105/60111/64115/67120/76120/79127/81105/59110/63114/6612123/76128/80132/82107/60113/64116/67121/76125/80128/82105/59110/63114/6613126/76131/801365/82109/60115/64119/67122/77126/80129/82106/59111/63114/6614129/77134/80138/82112/61118/64121/67123/77127/80130/82106/59111/63114/6515132/77137/81141/83114/61120/64123/66124/77128/80130/82107/59111/63114/6516135/78140/81144/84117/61123/64126/66124/77129/77131/82107/59111/63114/65\nwühl e et al., german working group on pediatric hypertension.']	N/A	N/A	[('GO_0040011', 'locomotion', 56, 'ambulatory'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC3615950	3/2013	S79-PMC3615950	['“distribution of 24-h Ambulatory Blood pressure in children: normalized reference values and role of body dimensions”.']	N/A	N/A	[('GO_0040011', 'locomotion', 22, 'ambulatory'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC3615950	3/2013	S81-PMC3615950	['caption (table-wrap): table 5\n\nreference values of 24-h Ambulatory Blood pressure by height and genderheight (cm)boysgirlsdaynightdaynight \xa0 75th90th95th75th90th95th75th90th95th75th90th95th 120116/77111/80125/8299/58103/61106/63114/77118/80120/8299/60103/63106/65125117/76122/80125/82100/58105/61108/63115/77119/80121/82100/60104/63107/66130117/76122/80126/82101/59106/62110/64116/76120/80122/82101/59106/63108/66135117/76123/80126/82102/59108/63111/65116/76120/80123/82102/59107/63109/66140118/76123/80126/82104/60109/63113/65117/76121/80124/82103/59108/63110/66145119/76124/79127/81105/60111/64144/6611876123/80125/82103/59109/63112/66150120/76125/79128/81106/60112/64116/66119/76124/80127/82104/59110/63113/66155122/76127/79130/81107/60113/64117/66121/76125/80128/82106/59111/63114/66160124/76129/79133/81108/60144/64188/66122/76126/80129/82106/59111/63114/66165126/76132/80135/82110/60116/64119/66123/77127/80130/82107/59112/63114/66170128/77134/80138/82112/61117/64121/66124/77128/80131/82108/61112/67115/71175130/77136/81140/83113/61119/64112/66125/78129/81131/82109/59113/63115/66180132/77138/81142/83115/61120/64124/66n/an/an/an/an/an/a185134/78140/81144/84116/61122/64125/66n/an/an/an/an/an/a\nwühl e et al., german working group on pediatric hypertension.']	N/A	N/A	[('GO_0040011', 'locomotion', 56, 'ambulatory'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC3615950	3/2013	S82-PMC3615950	['“distribution of 24-h Ambulatory Blood pressure in children: normalized reference values and role of body dimensions”.']	N/A	N/A	[('GO_0040011', 'locomotion', 22, 'ambulatory'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC3615950	3/2013	S88-PMC3615950	['caption (table-wrap): table 6\n\nreference values of home Blood pressure by height and genderheight (cm)boysgirls \xa0 n50th95thn50th95th 120-12923105/64119/7636101/64119/74130-13951108/64101/7751103/64120/76140-14939110/65125/7761105/65122/77150-15941112/65126/7871108/66123/77160-16945115/65123/78148110/66124/78170-17991117/66132/7846112/66125/79180-18957121/67134/797114/67128/80\nstergiou gs et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood')]
PMC3615950	3/2013	S89-PMC3615950	['“home Blood pressure normalcy in children and adolescents: the arsakeion school study”.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC3615950	3/2013	S139-PMC3615950	['•use standardized methods and suitable instruments for a correct measurement of Blood pressure in the child and interpret the values according to the most extensive and updated tables.']	N/A	N/A	[('UBERON_0000178', 'blood', 80, 'blood')]
PMC3615950	3/2013	S140-PMC3615950	['•monitor Blood pressure during annual control visits from the age of three.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC3615950	3/2013	S149-PMC3615950	['for children with high normal Blood pressure values it is sufficient to implement dietary and behavioral therapy and perform period Blood Pressure controls.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0013756', 'venous blood', 132, 'blood pressure')]
PMC3615950	3/2013	S151-PMC3615950	['in the first case it is suitable to send the patient to a specialist center because of the high probability of secondary hypertension, whereas in the second case the presence of Peripheral Pulses and negative results of simple diagnostic tests (Blood sodium, potassium, creatinine, Thyroid hormones, Urine test) would direct towards the diagnosis of essential hypertension.']	N/A	N/A	[('UBERON_0000121', 'perineurium', 178, 'peripheral pulses'), ('UBERON_0000178', 'blood', 245, 'blood'), ('UBERON_0002046', 'thyroid gland', 282, 'thyroid'), ('UBERON_0001088', 'urine', 300, 'urine')]
PMC3615950	3/2013	S152-PMC3615950	['in the latter condition, the family pediatrician can start dietary-behavioral therapy and send the child to a specialist center if no satisfactory improvement in Blood pressure values is achieved.']	N/A	N/A	[('UBERON_0000178', 'blood', 162, 'blood')]
PMC3615950	3/2013	S180-PMC3615950	['•sedentary behavior\nadequate physical activity lasting 40 minutes for 3–5 times a week causes a reduction in Blood pressure values [51,53].']	N/A	N/A	[('UBERON_0000178', 'blood', 109, 'blood')]
PMC3615950	3/2013	S183-PMC3615950	['some Drugs increase Blood pressure (Steroids, Erythropoietin, theophylline, beta-Stimulants, Cyclosporine, tacrolimus, Tricyclic Antidepressants, Antipsychotics, nasal decongestionants, Oral Contraceptives).']	N/A	N/A	[('CHEBI_23888', 'drug', 5, 'drugs'), ('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_35341', 'steroid', 36, 'steroids'), ('CHEBI_24009', 'eumelanin', 46, 'erythropoietin'), ('CHEBI_90005', '4-Hydroxyisovaleric acid', 80, '-stimulants'), ('CHEBI_65719', 'cytosporic acid', 93, 'cyclosporine'), ('CHEBI_35849', '2-thienyl group', 119, 'tricyclic'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 129, 'antidepressants'), ('CHEBI_35323', 'N-substituted amine', 146, 'antipsychotics'), ('CHEBI_48107', 'nitric acid', 186, 'oral contraceptives')]
PMC3615950	3/2013	S185-PMC3615950	['some Psychoactive Drugs and particularly Cocaine and Amphetamines raise Blood pressure as well.']	N/A	N/A	[('CHEBI_37396', 'proteoglycan', 5, 'psychoactive drugs'), ('CHEBI_33011', 'manganide', 41, 'cocaine'), ('CHEBI_2674', 'amodiaquine', 53, 'amphetamines'), ('UBERON_0000178', 'blood', 72, 'blood')]
PMC3615950	3/2013	S186-PMC3615950	['•cigarette smoke\ninfants whose mothers smoked during Pregnancy have higher Blood pressure than babies Born from non-smoking mothers [57] and they show an increased hypertensive response to stress compared to peers up to the age of one year [58].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007567', 'parturition', 102, 'born')]
PMC3615950	3/2013	S195-PMC3615950	['in those years menghetti published mean systolic Blood pressure values in 6.000 italian full-term newborns between 43.1 mmhg on the first day and 62.0 mmhg after 6 days of Life using ultrasound techniques [63].']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood'), ('UBERON_0000104', 'life cycle', 172, 'life')]
PMC3615950	3/2013	S208-PMC3615950	['first-line laboratory test are: Urine test, Serum ionogram, Blood count, Blood Urea nitrogen and creatinine.']	N/A	N/A	[('UBERON_0001088', 'urine', 32, 'urine'), ('UBERON_0001977', 'blood serum', 44, 'serum'), ('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_16199', 'urea', 79, 'urea')]
PMC3615950	3/2013	S273-PMC3615950	['both Renin-angiotensin-Aldosterone system blockers and beta-Blockers reduce Blood pressure by inactivation of the Renin-angiotensin-aldosterone system and by reducing peripheral vascular resistance (r Drugs).']	N/A	N/A	[('PR_000014368', 'RuvB-like 1', 5, 'renin'), ('CHEBI_27584', 'aldosterone', 23, 'aldosterone'), ('CHEBI_35225', 'buffer', 60, 'blockers'), ('UBERON_0000178', 'blood', 76, 'blood'), ('PR_000014368', 'RuvB-like 1', 114, 'renin'), ('CHEBI_23888', 'drug', 201, 'drugs')]
PMC3615950	3/2013	S275-PMC3615950	['in subjects with preserved Renal function the Blood pressure lowering efficacy is practically identical for renin-angiotensin-Aldosterone system Blockers, beta-Blockers, Calcium Antagonists and Diuretics.']	N/A	N/A	[('UBERON_0002113', 'kidney', 27, 'renal'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_27584', 'aldosterone', 126, 'aldosterone'), ('CHEBI_35225', 'buffer', 145, 'blockers'), ('CHEBI_35225', 'buffer', 160, 'blockers'), ('CHEBI_38808', 'calcium channel modulator', 170, 'calcium antagonists'), ('CHEBI_35498', 'diuretic', 194, 'diuretics')]
PMC3615950	3/2013	S301-PMC3615950	['Blood pressure measurement of children and adolescents is definitely the most simple and economic of these procedures.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3616124	4/2013	S62-PMC3616124	['hypertension was diagnosed using Blood pressure measurements obtained during or after 20 weeks Gestation, excluding intraoperative and intrapartum systolic Blood pressures.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('GO_0007565', 'female pregnancy', 95, 'gestation'), ('UBERON_0000178', 'blood', 156, 'blood')]
PMC3616124	4/2013	S63-PMC3616124	['severe pah was defined as a systolic Blood pressure of 160 mm hg or more, or a diastolic Blood pressure of 110 mm hg or more on two occasions 2 to 240 hours apart, or a single severely elevated Blood pressure measurement that led to treatment with Antihypertensive Medication.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0000178', 'blood', 194, 'blood'), ('CHEBI_46673', 'D-arabinosone', 248, 'antihypertensive'), ('CHEBI_60211', 'compound Z', 265, 'medication')]
PMC3616124	4/2013	S65-PMC3616124	['mild preeclampsia was defined as mild pah with proteinuria documented within the 3 days preceding or following the elevated Blood pressure measurement.']	N/A	N/A	[('UBERON_0000178', 'blood', 124, 'blood')]
PMC3616124	4/2013	S71-PMC3616124	['if additional subjects were required, investigators could obtain samples from the 7,720 women not in the prediction cohort, in whom very little Blood was collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 144, 'blood')]
PMC3616124	4/2013	S85-PMC3616124	['Plasma Ascorbate\nBlood was collected in vials containing Metaphosphoric Acid, and frozen at −80 c[31].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_2874', 'Asimicin', 7, 'Ascorbate'), ('UBERON_0000178', 'blood', 17, 'Blood'), ('CHEBI_25218', 'methacrylate', 57, 'metaphosphoric acid')]
PMC3616124	4/2013	S116-PMC3616124	['hp phenotype groups did not differ with respect to pre-Pregnancy bmi, Blood pressure at randomization, smoking, history of a previous Pregnancy, or family history of preeclampsia (table 1).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('UBERON_0000178', 'blood', 70, 'blood'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC3616124	4/2013	S118-PMC3616124	['analyses were also adjusted for diastolic Blood pressure at randomization, which differed between phenotype groups in the prediction cohort (table s10) but not in the pooled cohort.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC3616124	4/2013	S130-PMC3616124	['adjusted for group (treatment vs. placebo), race/ethnicity, age, education, vitamin use and diastolic Blood pressure at randomization.']	N/A	N/A	[('UBERON_0000178', 'blood', 102, 'blood')]
PMC3616124	4/2013	S131-PMC3616124	['treatment response\nvitamin c and e supplementation did not prevent the primary outcome or any form of Preeclampsia among white/other, black or hispanic women of any hp phenotype after adjusting for vitamin use, age, education, and diastolic Blood pressure at randomization (data not shown).']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia'), ('UBERON_0000178', 'blood', 241, 'blood')]
PMC3616124	4/2013	S134-PMC3616124	['this adverse effect was not seen in hp 1-1 or 2-1 hispanics (p>0.05), or in white/other or black women of any phenotype.10.1371/journal.pone.0060479.t003\n\ncaption (table-wrap): table 3\nodds ratios for effect of treatment in hispanic women in the weighted pooled cohort.outcomephenotypeor (95% ci)*p*Preeclampsiahp 1-10.71 (0.39, 1.29)0.27hp 2-10.95 (0.61, 1.50)0.83hp 2-23.30 (1.61, 6.82)<0.01late onset preeclampsiahp 1-10.70 (0.36, 1.35)0.29hp 2-11.02 (0.63, 1.66)0.92hp 2-23.01 (1.38, 6.57)<0.01\nadjusted for vitamin use, age, education and diastolic Blood pressure at randomization.']	N/A	N/A	[('GO_0006412', 'translation', 299, 'PreeclampsiaHp'), ('UBERON_0000178', 'blood', 554, 'blood')]
PMC3616124	4/2013	S138-PMC3616124	['hispanic 2-2 women who were not taking Prenatal Vitamins at randomization had a smaller increase in Preeclampsia risk with supplementation than hispanic 2-2 women who were taking Prenatal Vitamins at randomization (2.01; 0.80–5.01, p\u200a=\u200a0.14 vs. 7.83; 2.01–30.53, p<0.01,table 4).10.1371/journal.pone.0060479.t004\n\ncaption (table-wrap): table 4\nodds ratios for treatment effect in hispanic Hp 2-2 women according to Prenatal/Multivitamin use at randomization.outcomevitamin use at randomizationor (95% ci)*p*preeclampsiayes7.83 (2.01, 30.53)<0.01no2.01 (0.80, 5.01)0.14late onset preeclampsiayes8.23 (1.64, 41.28)0.01no1.91 (0.73, 5.00)0.18\nadjusted for age, education and diastolic Blood pressure at randomization.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 48, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 100, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 179, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 188, 'vitamins'), ('PR_000008443', 'huntingtin-associated protein 1', 389, 'Hp 2'), ('PR_000010222', 'muscleblind-like protein 2', 394, '2'), ('GO_0007565', 'female pregnancy', 415, 'prenatal'), ('CHEBI_7025', 'mupirocin', 424, 'multivitamin'), ('UBERON_0000178', 'blood', 682, 'blood')]
PMC3616124	4/2013	S213-PMC3616124	['*adjusted for treatment group (Vitamins vs. placebo), age, race/ethnicity, education, Vitamin use prior to randomization, and diastolic Blood pressure at randomization.†the primary outcome was severe pah, or mild or severe pah with elevated Liver enzymes, elevated Serum creatinine, thrombocytopenia, eclamptic seizure, fetal growth restriction, medically indicated Preterm Birth or Perinatal death.']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 31, 'vitamins'), ('CHEBI_33229', 'vitamin (role)', 86, 'vitamin'), ('UBERON_0000178', 'blood', 136, 'blood'), ('UBERON_0002107', 'liver', 241, 'liver'), ('UBERON_0001977', 'blood serum', 265, 'serum'), ('GO_0007565', 'female pregnancy', 366, 'preterm'), ('GO_0007567', 'parturition', 374, 'birth'), ('GO_0036268', 'swimming', 383, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 383, 'perinatal')]
PMC3616124	4/2013	S229-PMC3616124	['*adjusted for group (treatment vs. placebo), race/ethnicity, age, education, Vitamin use and diastolic Blood pressure at randomization†significantly different from 1, p<0.05.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 77, 'vitamin'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC3616124	4/2013	S232-PMC3616124	['*adjusted for Vitamin use, age, education and diastolic Blood pressure at randomization\n(doc)\n\ncaption (media)\n\nclick here for additional data file.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 14, 'vitamin'), ('UBERON_0000178', 'blood', 56, 'blood')]
PMC3616124	4/2013	S234-PMC3616124	['*adjusted for Vitamin use, age, education and diastolic Blood pressure at randomization\n(doc)\n\ncaption (media)\n\nclick here for additional data file.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 14, 'vitamin'), ('UBERON_0000178', 'blood', 56, 'blood')]
PMC3622346	3/2013	S3-PMC3622346	['on physical examination, her Blood pressure was severely elevated.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood')]
PMC3622346	3/2013	S30-PMC3622346	['the Vital Signs were Blood pressure 170/110\u2009mmhg, temperature 98.4°f, Heart rate 75/min, Respiratory rate 32/min, and oxygen saturation 96% on room air.']	N/A	N/A	[('UBERON_0010210', 'blood clot', 4, 'vital signs'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0000948', 'heart', 70, 'heart'), ('UBERON_0001004', 'respiratory system', 89, 'respiratory')]
PMC3622346	3/2013	S34-PMC3622346	['complete Blood count (cbc) and comprehensive Metabolic profile were drawn, which did not show any abnormality.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0008152', 'metabolic process', 45, 'metabolic')]
PMC3622346	3/2013	S48-PMC3622346	['her Blood pressure persistently elevated above 160/90\u2009mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3622346	3/2013	S50-PMC3622346	['in the icu, her Blood pressure was managed with intravenous Hydralazine injection.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_5775', 'hydralazine', 60, 'hydralazine')]
PMC3622346	3/2013	S64-PMC3622346	['her Blood pressure normalized without other oral hypertensive agents.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3622346	3/2013	S67-PMC3622346	['her Blood pressure remained normal without Blood pressure medication and no proteinuria.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC3622346	3/2013	S117-PMC3622346	['Nifedipine improves Renal Blood flow which resulted in diuresis.']	N/A	N/A	[('CHEBI_7575', 'nimodipine', 0, 'Nifedipine'), ('UBERON_0002113', 'kidney', 20, 'renal'), ('UBERON_0000178', 'blood', 26, 'blood')]
PMC3622346	3/2013	S122-PMC3622346	['intravenous Labetalol was also used to lower her Blood pressure.']	N/A	N/A	[('CHEBI_31764', 'Laudanosoline', 12, 'labetalol'), ('UBERON_0000178', 'blood', 49, 'blood')]
PMC3635203	2/2013	S36-PMC3635203	['Blood samples were obtained from both parents during Pregnancy and from mothers and children (Umbilical Cord) at Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('UBERON_0002331', 'umbilical cord', 94, 'umbilical cord'), ('GO_0007567', 'parturition', 113, 'birth')]
PMC3640235	10/2012	S44-PMC3640235	['there are two clinical conditions in which Blood Hcg titers are especially helpful: trophoblastic disease and ectopic Pregnancies.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 49, 'hCG'), ('GO_0007565', 'female pregnancy', 118, 'pregnancies')]
PMC3641012	4/2013	S45-PMC3641012	['data collection and laboratory analyses\nthe baseline visit consisted of a detailed questionnaire, anthropometry, Blood pressure measurement, specimen collection, and supplement administration.']	N/A	N/A	[('UBERON_0000178', 'blood', 113, 'blood')]
PMC3641012	4/2013	S48-PMC3641012	['Venous Blood specimens were collected at baseline and once between Gestational weeks 30 and 37 (the specific week was randomly varied among participants); these specimens were drawn immediately preceding the weekly Vitamin D dose administration; a third specimen was collected around the time of Delivery, irrespective of when the last Vitamin D dose was received.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('GO_0007565', 'female pregnancy', 67, 'gestational'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'delivery'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC3641012	4/2013	S49-PMC3641012	['study personnel were on-call to attend Deliveries at the maternity center, where they completed a Delivery record and collected maternal and Cord Blood specimens.']	N/A	N/A	[('GO_0007567', 'parturition', 39, 'deliveries'), ('GO_0007567', 'parturition', 98, 'delivery'), ('UBERON_0002240', 'spinal cord', 141, 'cord'), ('UBERON_0000178', 'blood', 146, 'blood')]
PMC3641012	4/2013	S53-PMC3641012	['Maternal Venous Blood was collected into Serum separator tubes by standard methods, and Cord Blood specimens were collected from the Umbilical Vein immediately after Delivery of the Placenta.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001638', 'vein', 9, 'venous'), ('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('UBERON_0002066', 'umbilical vein', 133, 'umbilical vein'), ('GO_0007567', 'parturition', 166, 'delivery'), ('UBERON_0001987', 'placenta', 182, 'placenta')]
PMC3641012	4/2013	S74-PMC3641012	['albumin-adjusted Serum calcium concentration (adj-ca) above 2.60\xa0mmol/l prompted repeat Blood sampling within 24\xa0hours of the first sample report to the physician.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 17, 'serum'), ('UBERON_0000178', 'blood', 88, 'blood')]
PMC3641012	4/2013	S109-PMC3641012	['Cord Blood specimens were collected from 67 and 65 mother-infant pairs in the Placebo and Vitamin D groups, respectively.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_26130', 'biological pigment', 78, 'placebo'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3641012	4/2013	S117-PMC3641012	['caption (table-wrap): table 2\n\nSerum 25(Oh)D categories at baseline and delivery, by supplementation group\xa0 placebo1vitamin D1P2Maternal baseline(n\u2009=\u200980)(n\u2009=\u200980) \xa0\u2003\u2003\xa0<30\xa0nmol/l21 (26.3)18 (22.5)0.88\u2003\u2003\xa030 – 49\xa0nmol/l32 (40.0)32 (40.0)\xa0\u2003\u2003\xa050 – 79\xa0nmol/l21 (26.3)25 (31.3)\xa0\u2003\u2003\xa0>\u2009=\u200980\xa0nmol/l6 (7.5)5 (6.3)\xa0 Maternal Delivery(n\u2009=\u200963)(n\u2009=\u200967) \xa0\u2003\u2003\xa0<30\xa0nmol/l23 (35.9)0 (0)<0.001\u2003\u2003\xa030 – 49\xa0nmol/l27 (42.2)0 (0)\xa0\u2003\u2003\xa050 – 79\xa0nmol/l10 (15.9)2 (3.0)\xa0\u2003\u2003\xa0>\u2009=\u200980\xa0nmol/l3 (4.8)65 (97.0)\xa0 Cord Blood(n\u2009=\u200967)(n\u2009=\u200965) \xa0\u2003\u2003\xa0<30\xa0nmol/l21 (31.3)1 (1.5)<0.001\u2003\u2003\xa030 – 49\xa0nmol/l33 (49.3)2 (3.1)\xa0\u2003\u2003\xa050 – 79\xa0nmol/l9 (13.4)7 (10.8)\xa0\u2003\u2003\xa0>\u2009=\u200980\xa0nmol/l4 (6.0)55 (84.6)\xa0\n1n (%).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 31, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('PR_000006495', 'protein dispatched homolog 1', 124, 'D1p2Maternal'), ('GO_0007618', 'mating', 302, 'Maternal'), ('GO_0007586', 'digestion', 311, 'Delivery'), ('UBERON_0000948', 'heart', 470, 'Cord'), ('UBERON_0000178', 'blood', 475, 'blood')]
PMC3641012	4/2013	S134-PMC3641012	['caption (table-wrap): table 4\n\nbiochemical measures for maternal baseline, maternal Delivery, and Cord Blood specimens, by supplementation groupbiomarker (units)placebovitamin dgroup difference1group-by-time effect2(n\u2009=\u200980)(n\u2009=\u200980)mean95% cimean95% ci25(Oh)D (nmol/l) \xa0\xa0\xa0\xa0\xa0\xa0\u2003\u2003\xa0baseline344.0\u2009±\u200920.945.4\u2009±\u200918.41.4[−4.8, 7.5]––\u2003\u2003\xa0Delivery (n\u2009=\u2009130)438.4\u2009±\u200918.1134.4\u2009±\u200930.796.0***[87.6, 104.8]94.6***[85.0, 104.1]\u2003\u2003\xa0Cord (n\u2009=\u2009132)539.0\u2009±\u200918.7102.8\u2009±\u200928.663.9***[55.8, 72.0]–– Calcium (mmol/l) \xa0\xa0\xa0\xa0\xa0\xa0\u2003\u2003\xa0baseline2.27\u2009±\u20090.092.25\u2009±\u20090.09−0.02[−0.04, 0.01]––\u2003\u2003\xa0Delivery (n\u2009=\u2009130)2.31\u2009±\u20090.112.32\u2009±\u20090.100.02[−0.02, 0.05]0.03[−0.01, 0.07]albumin-adjusted calcium (mmol/l) \xa0\xa0\xa0\xa0\xa0\xa0\u2003\u2003\xa0baseline2.36\u2009±\u20090.072.35\u2009±\u20090.07−0.01[−0.03, 0.01]––\u2003\u2003\xa0Delivery (n\u2009=\u2009130)2.40\u2009±\u20090.082.43\u2009±\u20090.090.03*[0.00, 0.06]0.04*[0.01, 0.07]pth (pmol/l)6\xa0\xa0\xa0\xa0\xa0\xa0\u2003\u2003\xa0baseline2.7 (0.3, 9.3)2.9 (0.5, 9.4)0.02[−0.7, -0.2]––\u2003\u2003\xa0Delivery (n\u2009=\u2009129)73.9 (0.3, 20.5)2.3 (0.3, 9.8)−0.51***[−0.8, -0.3]−0.53***[−0.8, -0.3]Urinary calcium-Creatinine ratio (mmol/mmol)8\xa0\xa0\xa0\xa0\xa0\xa0\u2003\u2003\xa0baseline0.24 (0.0, 0.68)0.22 (0.0, 0.88)−0.01[−0.07, 0.05]––\u2003\u2003\xa02\xa0weeks (n\u2009=\u2009151)90.26 (0.0, 1.11)0.26 (0.0, 1.25)0.03[−0.04, 0.10]––\u2003\u2003\xa0Delivery (n\u2009=\u2009125)100.13 (0.0, 1.26)0.20 (0.0, 2.26)0.04[−0.05, 0.14]0.07[−0.03, 0.16]\n1mean difference [95% ci] between the Placebo and Vitamin D group at a given time, by ordinary least square estimation.']	N/A	N/A	[('GO_0007567', 'parturition', 84, 'delivery'), ('UBERON_0002240', 'spinal cord', 98, 'cord'), ('UBERON_0000178', 'blood', 103, 'blood'), ('CHEBI_33010', 'chromide(1-)', 253, '(OH)D'), ('GO_0007586', 'digestion', 327, 'Delivery'), ('UBERON_0000948', 'heart', 412, 'Cord'), ('CHEBI_31341', 'calcium dihydroxide', 472, 'Calcium'), ('GO_0007586', 'digestion', 551, 'Delivery'), ('GO_0007586', 'digestion', 721, 'Delivery'), ('GO_0007586', 'digestion', 874, 'Delivery'), ('UBERON_0001088', 'urine', 962, 'Urinary'), ('CHEBI_16737', 'creatinine', 978, 'creatinine'), ('GO_0007586', 'digestion', 1151, 'Delivery'), ('CHEBI_26130', 'biological pigment', 1276, 'placebo'), ('CHEBI_27300', 'vitamin D', 1288, 'vitamin D')]
PMC3641012	4/2013	S169-PMC3641012	['there were no cases of hypercalcemia in either group, defined a priori as adj-ca >2.60\xa0nmol/l on two separate consecutive Blood specimens.']	N/A	N/A	[('UBERON_0000178', 'blood', 122, 'blood')]
PMC3641012	4/2013	S213-PMC3641012	['discussion\namong Pregnant women with relatively low average baseline Vitamin D status in dhaka, 3rd-Trimester Vitamin D3 supplementation (35,000\xa0iu/week) significantly raised maternal and neonatal (Cord Blood) Serum 25(Oh)D concentrations above the iom cut-off for sufficiency (50\xa0nmol/l) in virtually all participants without inducing hypercalcemia or other apparent short-term clinical adverse effects.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 100, 'trimester'), ('CHEBI_33279', 'vitamin D5', 110, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 110, 'vitamin D3'), ('UBERON_0002240', 'spinal cord', 198, 'cord'), ('UBERON_0000178', 'blood', 203, 'blood'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 216, '25(OH ... D')]
PMC3650171	2/2013	S58-PMC3650171	['[134]no association with Adult Blood pressureroseboom et al.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 25, 'adult'), ('UBERON_0000178', 'blood', 31, 'blood')]
PMC3650171	2/2013	S59-PMC3650171	['[135]\xa0age 59\xa0yearsmoderate increase in systolic but not diastolic Blood pressurestein et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood')]
PMC3650171	2/2013	S60-PMC3650171	['[136]greater Blood pressure increase during stresspainter et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC3650171	2/2013	S84-PMC3650171	['offspring of Rat dams given Dexamethasone during Pregnancy have reduced Birth weight and increased Blood pressure and Glucose intolerance in Adulthood [46,47].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rat'), ('CHEBI_41879', 'dexamethasone', 28, 'dexamethasone'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('GO_0007567', 'parturition', 72, 'birth'), ('UBERON_0000178', 'blood', 99, 'blood'), ('CHEBI_17234', 'glucose', 118, 'glucose'), ('UBERON_0000113', 'post-juvenile adult stage', 141, 'adulthood')]
PMC3650171	2/2013	S127-PMC3650171	['Adults who were exposed to famine in utero showed altered Dna Methylation in the Promoters of several Imprinted and non-Imprinted Genes in White Blood Cells.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adults'), ('GO_0006306', 'DNA methylation', 58, 'DNA methylation'), ('SO_0000167', 'promoter', 81, 'promoters'), ('GO_0071514', 'genetic imprinting', 102, 'imprinted'), ('GO_0071514', 'genetic imprinting', 120, 'imprinted'), ('SO_0000704', 'gene', 130, 'genes'), ('CL_0000738', 'leukocyte', 139, 'white blood cells'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC3651971	5/2013	S32-PMC3651971	['the women in the substudy area gave Blood and Urine samples during Pregnancy and at 3\u2005months Postpartum; they were also weighed and measured during the first Trimester of Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001088', 'urine', 46, 'urine'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007565', 'female pregnancy', 93, 'postpartum'), ('GO_0009294', 'DNA mediated transformation', 158, 'trimester'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3651971	5/2013	S66-PMC3651971	["a staff member drew a capillary Blood sample from the middle Finger of each child's non-dominant Hand using a bd genie lancet (bd franklin lakes, new jersey, usa), and collected the Blood in a microcuvette for haemoglobin testing in a b-hemoglobin analyzer (hemocue, lake forest, california, usa)."]	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0002389', 'manual digit', 61, 'finger'), ('UBERON_0002398', 'manus', 97, 'hand'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC3652177	4/2013	S38-PMC3652177	['in the Human Embryo, a Beating, Tubular Heart with Extra- and Intraembryonic Circulations bringing Blood to the Heart is present at 21 days.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 7, 'human'), ('UBERON_0000922', 'embryo', 13, 'embryo'), ('GO_0007567', 'parturition', 23, 'beating'), ('UBERON_0000084', 'ureteric bud', 32, 'tubular heart'), ('UBERON_0010166', 'coat of hair', 51, 'extra- ...'), ('UBERON_0002705', 'midline nuclear group', 62, 'intraembryonic circulations'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0000948', 'heart', 112, 'heart')]
PMC3652177	4/2013	S54-PMC3652177	['we analyzed different parameters of the Cardiac Cycle and Umbilical Blood flow using ultrasound (vevo 770, visualsonics, inc., toronto, ca, instrumentation) with a 40\u2009mhz transducer or a clinical instrument (philips sonos 5500, andover, ma) with a 12\u2009mhz transducer.']	N/A	N/A	[('GO_0006906', 'vesicle fusion', 40, 'cardiac cycle'), ('UBERON_0000948', 'heart', 40, 'cardiac'), ('UBERON_0007118', 'umbilicus', 58, 'umbilical'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC3652177	4/2013	S56-PMC3652177	['Maternal Uterine Artery Blood flow velocity waveforms were obtained, and the pulsatility index was calculated.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002493', 'uterine artery', 9, 'uterine artery'), ('UBERON_0000178', 'blood', 24, 'blood')]
PMC3652177	4/2013	S57-PMC3652177	['Blood flow in the Heart and Blood Vessels was detected in each Embryo using two-dimensional real-time echocardiography.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 18, 'heart'), ('UBERON_0001981', 'blood vessel', 28, 'blood vessels'), ('UBERON_0000922', 'embryo', 63, 'embryo')]
PMC3652177	4/2013	S58-PMC3652177	['color doppler was used to identify the Embryonic Heart and directed pulse doppler to obtain Blood flow velocity waveforms (figure 1).']	N/A	N/A	[('UBERON_0000922', 'embryo', 39, 'embryonic'), ('UBERON_0000948', 'heart', 49, 'heart'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC3652177	4/2013	S68-PMC3652177	['multiple mechanotransducing structures and Molecules coordinate detection of Blood flow forces with Morphogenesis [39–42].']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 43, 'molecules'), ('UBERON_0000178', 'blood', 77, 'blood'), ('GO_0009653', 'anatomical structure morphogenesis', 100, 'morphogenesis')]
PMC3652177	4/2013	S97-PMC3652177	["central to the Placenta's function is its Vascular Labyrinth, a parallel series of finely branched Blood Vessels and Trophoblasts that Regulate Nutrient, Gas, and waste exchange while keeping the maternal-fetal Blood supplies separate."]	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placenta'), ('UBERON_0001862', 'vestibular labyrinth', 42, 'vascular labyrinth'), ('UBERON_0001981', 'blood vessel', 99, 'blood vessels'), ('CL_0000351', 'trophoblast cell', 117, 'trophoblasts'), ('UBERON_0000088', 'trophoblast', 117, 'trophoblasts'), ('GO_0065007', 'biological regulation', 135, 'regulate'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CHEBI_24338', 'glutathionyl selenide anion', 154, 'gas'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC3653849	5/2013	S134-PMC3653849	['Blood was collected immediately, and the Liver (without the Gall Bladder) samples were snap-frozen in liquid nitrogen immediately and stored at −80°c for further analysis.10.1371/journal.pone.0063855.t003\n\ncaption (table-wrap): table 3\ncomposition and Nutrient content of experimental diets.splpingredient ( g/kg )corn580528soybean meal1200bran150110bone meal105corn sugar100270cahpo407fiber11010attapulgite030premix24040calculated compositiondigestible energy ( mj/kg )13.113.1crude protein (%)12.16.1crude fiber (%)2.72.3n-free extracts640.7713.0cp135.967.7protein∶Carbohydrate31∶10.51∶4.7Calcium (%)1.21.2phosphorous (%)0.40.4\nthe fiber concentrate arbocel®was purchased from jrs (germany)\nthe premix contains (per kilogram): Vitamin a: 72 mg; Cholecalciferol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0002110', 'gall bladder', 60, 'gall bladder'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_52472', 'alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc', 567, 'carbohydrate31'), ('CHEBI_24870', 'ion', 581, '∶'), ('CHEBI_33325', 'radium atom', 590, '7Calcium'), ('CHEBI_33229', 'vitamin (role)', 729, 'vitamin'), ('CHEBI_52550', 'theopalauamide', 747, 'cholecalciferol')]
PMC3660281	5/2013	S161-PMC3660281	['when there is a Docosahexaenoic Acid deficiency in the Perinatal Period, an increased Blood pressure is observed later.']	N/A	N/A	[('CHEBI_36003', 'decenoic acid', 16, 'docosahexaenoic acid'), ('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal period'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC3664621	5/2013	S92-PMC3664621	['maternal bp (Blood pressure) was measured by the same phn using an automated bp monitor (omron m6) under standard conditions with two repeated measurements.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC3664621	5/2013	S123-PMC3664621	['caption (table-wrap): table 2\n\nsecondary maternal and neonatal outcomes in the trial groups (mean or frequency and 95% ci)\xa0 interventioncontrolp valuemissing (n in groups) n9689\xa0\xa0 maternal \xa0\xa0\xa0\xa0first trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)119.1 (116.9 to 121.2)116.5 (114.3 to 118.7)0.10a4, 5\u2003\u2009diastolic Blood pressure (mmhg)73.9 (72.4 to 75.4)72.1 (70.0 to 74.1)0.14a4, 5second trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)116.8 (114.7 to 119.0)117.7 (115.4 to 119.9)0.59a2, 6\u2003\u2009diastolic Blood pressure (mmhg)71.7 (70.1 to 73.3)70.5 (68.5 to 72.5)0.33a2, 6\u2003\u2009physical exercise (h/week)*4.2 (3.6 to 4.7)4.5 (3.6 to 5.4)0.62b2, 5ogtt (Gestational weeks 26–28)\xa0\xa0\xa0\xa0\u2003\u2009fasting-0 h (mmol/l)4.8 (4.7 to 4.8)4.9 (4.8 to 5.0)0.12b-\u2003\u20091 h (mmol/l)8.7 (8.4 to 9.0)9.0 (8.7 to 9.4)0.21a-\u2003\u20092 h (mmol/l)6.8 (6.6 to 7.1)6.9 (6.6 to 7.1)0.77a-\u2003\u2009pathological ogtt result (cp)14.6% (8.9% to 23.0%)29.2% (20.8% to 39.4%)0.016c\xa0third Trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)122.4 (120.1 to 124.6)122.5 (120.0 to 125.0)0.79b3, 4\u2003\u2009diastolic Blood pressure (mmhg)77.8 (76.1 to 79.5)75.2 (73.2 to 77.3)0.052a3, 4\u2003\u2009physical exercise (h/week)*3.4 (3.0 to 3.8)3.2 (2.5 to 3.9)0.11b4, 4\u2003\u2009Gestational weight gain until 37 gw (kg)11.4 (10.4 to 12.5)12.7 (11.5 to 14.0)0.11a2, 0\u2003\u2009min – max−4.9 to 27.2−1.0 to 34.7\xa0\xa0 Neonatal \xa0\xa0\xa0\xa0non-complicated Vaginal delivery77.1% (67.7% to 84.4%)75.3% (65.4% to 83.1%)0.77c-Gestational age at birth39.8 (39.4 to 40.1)39.4 (39.2 to 39.7)0.084b-sex of the newborn (boy)51.0% (41.2% to 60.8%)50.6% (40.4% to 60.7%)0.95c-Birth weight (grams)3509 (3404 to 3615)3507 (3417 to 3596)0.97a-ponderal index (weight, kg/length, m3)27.4 (26.9 to 27.9)27.5 (27.0 to 27.9)0.89a-large for Gestational age7.3% (3.6% to 14.3%)5.6% (2.4% to 12.5%)0.64c-small for Gestational age13.5% (8.1% to 21.8%)6.7% (3.1% to 13.9%)0.13c-exclusive breastfeeding (months)3.0 (2.5 to 3.4)2.8 (2.3 to 3.2)0.52b8, 0\naindependent samples t -test,bmann-whitney u -test,cchi-square test,dfisher’s exact test; ogtt, oral Glucose tolerance test (75 g Glucose load, 2-hour); cp\u2009=\u2009capillary Plasma Glucose; ci, confidence interval; *level of at least slightly out of Breath; gw, Gestational weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 223, 'blood'), ('UBERON_0000178', 'blood', 309, 'blood'), ('UBERON_0000178', 'blood', 408, 'blood'), ('UBERON_0000178', 'blood', 494, 'blood'), ('GO_0007565', 'female pregnancy', 638, 'Gestational'), ('GO_0009294', 'DNA mediated transformation', 917, 'trimester'), ('UBERON_0000178', 'blood', 941, 'blood'), ('UBERON_0000178', 'blood', 1027, 'blood'), ('GO_0007565', 'female pregnancy', 1168, 'Gestational'), ('GO_0007569', 'cell aging', 1293, 'Neonatal'), ('GO_0007601', 'visual perception', 1322, 'vaginal'), ('UBERON_0001987', 'placenta', 1322, 'vaginal'), ('GO_0007565', 'female pregnancy', 1388, 'Gestational'), ('GO_0007567', 'parturition', 1531, 'Birth'), ('GO_0007565', 'female pregnancy', 1687, 'gestational'), ('GO_0007565', 'female pregnancy', 1758, 'gestational'), ('CHEBI_17234', 'glucose', 1995, 'glucose'), ('CHEBI_17234', 'glucose', 2024, 'glucose'), ('UBERON_0001969', 'blood plasma', 2062, 'plasma'), ('CHEBI_17234', 'glucose', 2069, 'glucose'), ('UBERON_0000310', 'breast', 2138, 'breath'), ('GO_0007565', 'female pregnancy', 2150, 'gestational')]
PMC3664621	5/2013	S227-PMC3664621	['abbreviations\ngwg: Gestational weight gain; sds: standard deviation score; gdm: Gestational diabetes mellitus; bmi: body mass index; ogtt: oral Glucose tolerance test; phn: public health nurse; bp: Blood pressure; ci: confidence interval.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('GO_0007565', 'female pregnancy', 80, 'Gestational'), ('CHEBI_17234', 'glucose', 144, 'glucose'), ('UBERON_0000178', 'blood', 198, 'Blood')]
PMC3668200	5/2013	S35-PMC3668200	['when large amounts of Vitamin D (1,000 iu/day) are supplemented during the last trimester to achieve 25(Oh)D concentrations of 50 nmol/l in Pregnant woman, the Vitamin D concentration in the Cord Blood is consequently increased.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 191, 'cord'), ('UBERON_0000178', 'blood', 196, 'blood')]
PMC3669365	5/2013	S69-PMC3669365	['measurement of Plasma levels of Triglycerides, Free Fatty Acids (ffas), Ketone bodies, and Glucose\nat the time of decapitation, Trunk Blood was collected for measurement of Triglycerides, ffas, and Ketone body levels.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 15, 'Plasma'), ('CHEBI_17855', 'triglyceride', 32, 'Triglycerides'), ('CHEBI_26590', 'sabinol', 47, 'Free Fatty Acids'), ('CHEBI_17087', 'ketone', 72, 'Ketone'), ('CHEBI_17234', 'glucose', 91, 'Glucose'), ('UBERON_0002100', 'trunk', 128, 'trunk'), ('UBERON_0000178', 'blood', 134, 'blood'), ('CHEBI_17855', 'triglyceride', 173, 'triglycerides'), ('CHEBI_17087', 'ketone', 198, 'ketone')]
PMC3669365	5/2013	S72-PMC3669365	['Glucose was detected from Tail Blood by a Glucose biosensor (lifescan, inc., milpitas, ca, usa).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('UBERON_0002415', 'tail', 26, 'tail'), ('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_17234', 'glucose', 42, 'glucose')]
PMC3669365	5/2013	S94-PMC3669365	['the results of behavioral tests, real-time rt-pcr, Blood Glucose, and measurements of Plasma substances were analyzed by mann-whitney u test.']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_17234', 'glucose', 57, 'glucose'), ('UBERON_0001969', 'blood plasma', 86, 'plasma')]
PMC3669365	5/2013	S97-PMC3669365	['dr female Mice displayed a marked decrease in Blood Glucose (figure s1b).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 10, 'mice'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_17234', 'glucose', 52, 'glucose')]
PMC3669365	5/2013	S145-PMC3669365	['at Gestation day 17, the fetuses of dr Mice showed a marked decrease in Blood Glucose (figure 5a).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'gestation'), ('NCBITaxon_10088', 'Mus <genus>', 39, 'mice'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_17234', 'glucose', 78, 'glucose')]
PMC3669365	5/2013	S226-PMC3669365	['maternal Blood Glucose concentration (b) on Gestation day 17.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_17234', 'glucose', 15, 'glucose'), ('GO_0007565', 'female pregnancy', 44, 'gestation')]
PMC3672018	5/2013	S6-PMC3672018	['additionally, a validated method will be used to determine neonatal Vitamin D status using stored dried Blood spots (dbs) from Individuals who developed the aforementioned disease entities as Adults and their time and gender-matched controls.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000178', 'blood', 104, 'blood'), ('NCBITaxon_1', 'root', 127, 'individuals'), ('UBERON_0007023', 'adult organism', 192, 'adults')]
PMC3672018	5/2013	S53-PMC3672018	['additionally, a validated method will be used to determine neonatal Vitamin D status using stored dried Blood spots (dbs) from Individuals who develop the aforementioned disease entities as Adults and their time and gender-matched controls.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000178', 'blood', 104, 'blood'), ('NCBITaxon_1', 'root', 127, 'individuals'), ('UBERON_0007023', 'adult organism', 190, 'adults')]
PMC3674738	5/2013	S76-PMC3674738	['treatment focuses on removing leucine from Blood with dialysis or by reversing Catabolism through Feeding.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0009056', 'catabolic process', 79, 'catabolism'), ('GO_0007631', 'feeding behavior', 98, 'feeding')]
PMC3674738	5/2013	S128-PMC3674738	['primary Cerebral Folate deficiency (cfd) is characterized by normal Blood but low Csf levels of 5-Methylhydrofolate (5-mthf), the physiologically active form of Folate.']	N/A	N/A	[('UBERON_0001893', 'telencephalon', 8, 'cerebral'), ('CHEBI_30863', '5-azaorotic acid', 17, 'folate'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0001359', 'cerebrospinal fluid', 82, 'CSF'), ('CHEBI_81290', '5-Phenyl-1,3-pentadiyne', 96, '5-methylhydrofolate'), ('CHEBI_30863', '5-azaorotic acid', 161, 'folate')]
PMC3678445	5/2013	S147-PMC3678445	['Folate inadequacy results in increased Homocysteine in Blood and Tissues, which stimulates Osteoclast activity [42].']	N/A	N/A	[('CHEBI_81245', 'Vulpecholate', 0, 'Folate'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 39, 'homocysteine'), ('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0000479', 'tissue', 65, 'tissues'), ('CL_0000092', 'osteoclast', 91, 'osteoclast')]
PMC3679768	5/2013	S10-PMC3679768	['mechanisms leading to Aortic dissection involve a weakening of the layers Of the Aorta allowing Blood to enter the Media and separate the Intimal and Adventitial Layers creating a false lumen.']	N/A	N/A	[('UBERON_0000947', 'aorta', 22, 'aortic'), ('UBERON_0002828', 'ventral cochlear nucleus', 74, 'of'), ('UBERON_0000947', 'aorta', 81, 'aorta'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 115, 'media'), ('GO_0005622', 'intracellular anatomical structure', 138, 'intimal'), ('UBERON_0004103', 'alveolar ridge', 138, 'intimal'), ('UBERON_0002724', 'limen of insula', 150, 'adventitial layers')]
PMC3679768	5/2013	S12-PMC3679768	['these changes include increased total circulatory volume, increased systemic Blood pressure, and structural changes in the Aortic Wall secondary to the hormonal effects of Estrogen and Progesterone [4].']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0004663', 'aorta wall', 123, 'aortic wall'), ('CHEBI_50114', 'estrogen', 172, 'estrogen'), ('CHEBI_17026', 'progesterone', 185, 'progesterone')]
PMC3683620	5/2013	S129-PMC3683620	['gc are the principal mediators of the stress response, encouraging, for example, Memory formation, Blood flow to Skeletal muscle, and suppression of further hpa axis activity [reviewed in sapolsky et al.']	N/A	N/A	[('GO_0007613', 'memory', 81, 'memory'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0004288', 'skeleton', 113, 'skeletal')]
PMC3683620	5/2013	S140-PMC3683620	['Corticotropin-Releasing Hormone (Crh) is released into the Median Eminence, followed by Adrenocorticotropic Hormone (Acth) release from the Anterior Pituitary into the Blood stream.']	N/A	N/A	[('PR_000005959', 'cysteine and glycine-rich protein 2', 0, 'Corticotropin-releasing hormone'), ('PR_000005864', 'protein CREG2', 33, 'CRH'), ('UBERON_0002197', 'median eminence of neurohypophysis', 59, 'median eminence'), ('PR_000003775', '1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase', 88, 'adrenocorticotropic hormone'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 117, 'ACTH'), ('UBERON_0002196', 'adenohypophysis', 140, 'anterior pituitary'), ('UBERON_0000178', 'blood', 168, 'blood')]
PMC3685533	6/2013	S5-PMC3685533	['Vitamin D was measured in the Cord Blood at Birth and in neonatal Serum during Metabolic screening.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 30, 'cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0007567', 'parturition', 44, 'birth'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('GO_0008152', 'metabolic process', 79, 'metabolic')]
PMC3685533	6/2013	S6-PMC3685533	['results\n25Ohd levels were (mean\u2009±\u2009sd) 21.4\u2009±\u200911 ng/ml in Cord Blood and 14.9\u2009±\u20097 ng/ml in Serum after Birth.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 8, '25OHD'), ('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0001977', 'blood serum', 90, 'serum'), ('GO_0007567', 'parturition', 102, 'birth')]
PMC3685533	6/2013	S8-PMC3685533	['in Cord Blood, 25Ohd levels were higher in italian newborns than in north african (p\u2009<\u20090.004) and african (p\u2009<\u20090.01).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 3, 'cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 15, '25OHD')]
PMC3685533	6/2013	S70-PMC3685533	['results\nthe mean Vitamin D levels in all subjects were 21.4\u2009±\u200911 ng/ml on Cord Blood and 14.9\u2009±\u20097 ng/ml in neonatal Serum.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 74, 'cord'), ('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0001977', 'blood serum', 116, 'serum')]
PMC3685533	6/2013	S73-PMC3685533	['caption (fig): figure 1\n\nVitamin D levels (21Ohd) in Cord Blood and Serum levels by skin colour and ethnic origin.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('CHEBI_72583', 'WR-1065', 43, '21OHD'), ('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0001977', 'blood serum', 68, 'serum')]
PMC3685533	6/2013	S74-PMC3685533	['in Cord Blood, 25Ohd values were <20 ng/ml in 30 cases (55.5%): 18 (33.3%) had mild Vitamin D deficiency (between 10 and 20 ng/ml) and 12 (22.2%) had severe deficiency (<10 ng/ml).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 3, 'cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 15, '25OHD'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3685533	6/2013	S79-PMC3685533	['25Ohd levels analysed by skin colour\nVitamin D levels on Cord Blood were higher in neonates with fair skin (fs) than with dark skin (p\u2009<\u20090.0001), both with light olive/light brown (lob) (p\u2009<\u20090.01) or medium brown/black skin (mbb) (p\u2009<\u20090.01).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_28384', 'vitamin K', 37, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC3685533	6/2013	S82-PMC3685533	['caption (table-wrap): table 1\n\nVitamin D levels on Cord Blood (25Ohd cb) and neonatal Serum (25ohd n) by skin colour\xa0 fsdark skin \xa0\xa0 lobmbb \xa0 321020ga 38.8\u2009±\u20091.139.5\u2009±\u20091.139.5\u2009±\u20091.2 bw 3175\u2009±\u20094553420\u2009±\u20095393303\u2009±\u2009318 25Ohd cb 26.8\u2009±\u200913a,b10.6\u2009±\u20096.9a14.7\u2009±\u20096.2b25ohd n 17.1\u2009±\u20098a8.3\u2009±\u20094a,c15.3\u2009±\u20098c\nabbreviations: ga Gestational age, bw Birth weight, fs very fair/fair skin, lob light olive/light brown, mbb medium brown/black skin.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 51, 'cord'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 63, '25OHD'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 216, '25OHD'), ('GO_0007565', 'female pregnancy', 314, 'gestational'), ('GO_0007567', 'parturition', 334, 'Birth')]
PMC3685533	6/2013	S86-PMC3685533	['in Cord Blood, 25Ohd levels were higher in fs than lob (p\u2009<\u20090,004) and mbb (p\u2009<\u20090.04) regardless of maternal supplementation.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 3, 'cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 15, '25OHD')]
PMC3685533	6/2013	S93-PMC3685533	['nan had 25Ohd levels lower than an (p\u2009<\u20090.02) without significant differences in Cord Blood levels.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 8, '25OHD'), ('UBERON_0002240', 'spinal cord', 81, 'cord'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC3685533	6/2013	S95-PMC3685533	['caption (table-wrap): table 3\n\nVitamin D levels on Cord Blood (25Ohd cb) and neonatal Serum (25ohd n) by mothers’ country of origin\xa0 italynorth africaafricaasialatin america \xa0 32101055ga 38.8\u2009±\u20091.139.5\u2009±\u20091.139.7\u2009±\u20090.938.8\u2009±\u20091.640\u2009±\u20091.1 bw 3175\u2009±\u20094553420\u2009±\u20095393425\u2009±\u20093003039\u2009±\u20092443291\u2009±\u2009279 25ohd cb 26.8\u2009±\u200913a,b10.6\u2009±\u20096.9a14.3\u2009±\u20097b16.5\u2009±\u20094.919.5\u2009±\u200910 25Ohd n 17.1\u2009±\u20098c8.3\u2009±\u20094c,d14\u2009±\u20095.7d12.2\u2009±\u2009719.3\u2009±\u200910\nabbreviations: ga Gestational age, bw Birth weight; a: p\u2009<\u20090.004 italy vs north africa; b: p\u2009<\u20090.01 italy vs africa; c: p\u2009<\u20090.03 italy vs north africa; d: p\u2009<\u20090.02 africa vs north africa.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 51, 'cord'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 63, '25OHD'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 351, '25OHD'), ('GO_0007565', 'female pregnancy', 423, 'gestational'), ('GO_0007567', 'parturition', 443, 'Birth')]
PMC3685533	6/2013	S97-PMC3685533	['Gestational age not correlated with Cord Blood Vitamin D or neonatal Serum levels.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001977', 'blood serum', 69, 'serum')]
PMC3685567	5/2013	S45-PMC3685567	['body weight, blood Glucose and β −Ketones ( β − hydroxybutyrate ) were measured weekly, using an abbott “precision xtra” Glucometer which required a relatively minute Blood volume of 0.6-1.5 μ l/test [15] drawn from the Tail Vein.']	N/A	N/A	[('CHEBI_17234', 'glucose', 19, 'glucose'), ('CHEBI_17087', 'ketone', 34, 'ketones'), ('CHEBI_24321', 'glutamo group', 121, 'glucometer'), ('UBERON_0000178', 'blood', 167, 'blood'), ('UBERON_0003481', 'tail vein', 220, 'tail vein')]
PMC3685567	5/2013	S46-PMC3685567	['Cholesterol and Triglycerides were tested at the end of the Feeding period, and required a combined whole-Blood volume of 190 μ l, collected from the Saphenous Vein.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 0, 'Cholesterol'), ('CHEBI_17855', 'triglyceride', 16, 'triglycerides'), ('GO_0007631', 'feeding behavior', 60, 'feeding'), ('UBERON_0000178', 'blood', 106, 'blood'), ('UBERON_0007801', 'pygostyle', 150, 'saphenous'), ('UBERON_0001638', 'vein', 160, 'vein')]
PMC3685567	5/2013	S68-PMC3685567	['results\n\nMetabolic status of pre-Mated female Mice\naverage body weight and Blood Glucose of kd female Mice did not statistically differ from those of sd female Mice (p > 0.1) prior to Mating.']	N/A	N/A	[('GO_0008152', 'metabolic process', 9, 'Metabolic'), ('GO_0007618', 'mating', 33, 'mated'), ('NCBITaxon_10088', 'Mus <genus>', 46, 'mice'), ('UBERON_0000178', 'blood', 75, 'blood'), ('CHEBI_17234', 'glucose', 81, 'glucose'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 160, 'mice'), ('GO_0007618', 'mating', 184, 'mating')]
PMC3685567	5/2013	S70-PMC3685567	['caption (table-wrap): table 1\n\nbody weight and Blood Metabolites of female sd and kd Mice\xa0\xa0 weightglucoseketonecholesteroltriglyceridenum.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_25212', 'metabolite', 53, 'metabolites'), ('NCBITaxon_10088', 'Mus <genus>', 85, 'mice')]
PMC3686716	6/2013	S14-PMC3686716	['for instance, in comparison to their non-low-Birth-weight term-Born peers, vlbw subjects have higher Blood pressure[7]–[10]as well as impaired Glucose Regulation[11],[12].']	N/A	N/A	[('GO_0007567', 'parturition', 45, 'birth'), ('GO_0007567', 'parturition', 63, 'born'), ('UBERON_0000178', 'blood', 101, 'blood'), ('CHEBI_17234', 'glucose', 143, 'glucose'), ('GO_0006094', 'gluconeogenesis', 143, 'glucose regulation')]
PMC3686716	6/2013	S35-PMC3686716	['furthermore, Blood samples were drawn for epigenetic analyses ( Igf2 methylation fraction measurement).']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('PR_000008989', 'interleukin-1 family member 7', 64, 'IGF2')]
PMC3686716	6/2013	S36-PMC3686716	['these samples were taken in a fasting state and Blood was stored as edta Blood in a freezer (–20°c).']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC3686716	6/2013	S48-PMC3686716	['Genomic dna was extracted from whole peripheral edta Blood by using qiaamp dna Blood maxi kit (qiagen®); 500 ng of dna was then Bisulfite-treated using the Ez Dna Methylation kit (zymo research corporation, irvine, ca, usa) according to manufacturer’s instructions.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000178', 'blood', 79, 'Blood'), ('CHEBI_29874', 'bromine dioxide', 128, 'bisulfite'), ('PR_000007209', 'steroid hormone receptor ERR2', 156, 'EZ'), ('GO_0006306', 'DNA methylation', 159, 'DNA Methylation')]
PMC3690969	7/2013	S228-PMC3690969	['dna samples from the charge study participants and the university of minnesota were from whole Blood, whereas the ceph and agre samples were from Transformed Lymphoblastoid Cells.']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood'), ('GO_0009294', 'DNA mediated transformation', 146, 'transformed'), ('CL_0000784', 'plasmacytoid dendritic cell', 158, 'lymphoblastoid cells')]
PMC3691177	6/2013	S47-PMC3691177	['25(Oh)D was measured in mothers prior to randomisation, and in offspring at Birth (Cord Blood) using a radio-immunoassay (diasorin, stilwater, mn) in a clinical biochemistry laboratory that participates in the international Vitamin D external quality assessment program (deqas).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 0, '25(OH)D'), ('GO_0007567', 'parturition', 76, 'birth'), ('UBERON_0002240', 'spinal cord', 83, 'cord'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CHEBI_28384', 'vitamin K', 224, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 224, 'Vitamin D')]
PMC3691177	6/2013	S81-PMC3691177	['model adjusted for mother’s ethnic group, presence of household smokers, maternal smoking in Pregnancy, exclusive breast-feeding to four months, any parental allergic history, any child vitamin supplementation, number of children in the household, age mother left full-time education and baseline concentration of 25(Oh)D in maternal Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 314, '25(OH)D'), ('UBERON_0000178', 'blood', 334, 'blood')]
PMC3691177	6/2013	S85-PMC3691177	['model adjusted for mother’s ethnic group, presence of household smokers, maternal smoking in Pregnancy, exclusive breast-feeding to four months, any parental allergic history, any child vitamin supplementation, number of children in the household, age mother left full-time education and baseline concentration of 25(Oh)D in maternal Blood.10.1371/journal.pone.0066627.t004\n\ncaption (table-wrap): table 4\nclinical outcomes at age three years.controlbolus Vitamin drror p aor† p (%)(%)(95% ci)(95% ci)(95% ci)wheeze ever14/50 (28)15/52 (29)1.03 (0.56, 1.91)1.04 (0.44, 2.47)0.931.17 (0.44, 3.10)0.75recurrent wheezing7/50 (14)9/52 (17)1.24 (0.50 (3.07)1.29 (0.44, 3.77)0.651.91 (0.53, 6.75)0.31wheezing in the last year8/50 (16)9/52 (17)1.08 (0.45, 2.58)1.10 (0.39, 3.12)0.861.29 (0.40, 4.15)0.66wheeze with positive api7/50 (14)9/51 (18)1.26 (0.51, 3.12)1.32 (0.45, 3.86)0.622.01 (0.58, 6.99)0.27any Bronchodilator use4/49 (8)14/48 (29)3.57 (1.27, 10.09)4.63 (1.40, 15.34)0.008*5.43 (1.39, 21.20)0.02*eczema ever15/49 (31)15/48 (31)1.02 (0.56, 1.85)1.03 (0.44, 2.44)0.950.86 (0.32, 2.28)0.76eczema in the last year7/49 (14)9/48 (19)1.31 (0.53, 3.24)1.39 (0.47, 4.08)0.551.97 (0.47, 8.27)0.36atopy7/27 (26)7/32 (22)0.84 (0.34, 2.11)0.80 (0.24, 2.66)0.720.31 (0.05, 1.83)0.20allergic rhinitis7/49 (14)4/46 (9)0.61 (0.19, 1.94)0.57 (0.16, 2.10)0.400.91 (0.20, 4.11)0.90food allergy diagnosed3/49 (6)4/47 (9)1.36 (0.32, 5.78)1.43 (0.30, 6.75)0.651.31 (0.24, 7.18)0.76>4 urti/year7/50 (14)9/48 (19)1.34 (0.54, 3.31)1.42 (0.48, 4.17)0.531.72 (0.49, 6.04)0.39lrti ever11/50 (22)17/47 (36)1.64 (0.86, 3.14)2.01 (0.82, 4.92)0.122.87 (1.03, 8.03)0.05*primary health care recordrecurrent wheeze3/31 (10)6/34 (18)1.82 (0.50, 6.68)2.00 (0.46, 8.80)0.351.85 (0.36, 9.66)0.47eczema6/31 (19)5/34 (15)0.76 (0.26, 2.24)0.72 (0.20, 2.64)0.620.63 (0.11, 3.59)0.60food allergy2/31 (7)0/34 (0)0.0 (-, -) ----\nbolus Vitamin D versus control.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 314, '25(OH)D'), ('UBERON_0000178', 'blood', 334, 'blood'), ('CHEBI_33229', 'vitamin (role)', 455, 'Vitamin'), ('CHEBI_60874', 'phenylacetylglycine(1-)', 900, 'bronchodilator'), ('CHEBI_27300', 'vitamin D', 1893, 'vitamin D')]
PMC3691177	6/2013	S87-PMC3691177	['model adjusted for mother’s ethnic group, presence of household smokers, maternal smoking in Pregnancy, exclusive breast-feeding to four months, any parental allergic history, any child vitamin supplementation, number of children in the household, age mother left full-time education and baseline concentration of 25(Oh)D in maternal Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 314, '25(OH)D'), ('UBERON_0000178', 'blood', 334, 'blood')]
PMC3691177	6/2013	S92-PMC3691177	['for 122 children assessed at 3 years, Cord Blood 25(Oh)D levels were available.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 49, '25 ... OH ... D')]
PMC3691177	6/2013	S94-PMC3691177	['there was also no correlation between ln Cord Blood 25(Oh)D level and ln total Ige at age three years for 68 children (beta coefficient\u200a=\u200a−0.05, p\u200a=\u200a0.72).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 41, 'cord'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 79, 'IgE')]
PMC3691177	6/2013	S130-PMC3691177	['when we analysed our own data on Cord Blood 25(Oh)D concentration and wheezing, atopy, total Ige level and frequency of Respiratory infection in the first three years, no significant relationship was found.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 93, 'IgE'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory')]
PMC3693967	6/2013	S36-PMC3693967	['sample collection and processing\na collection of up to 10\xa0ml of whole Blood in a k2edta vacutainer was obtained for dna sampling and pharmacogenetic testing upon enrollment in the study.']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'blood')]
PMC3693967	6/2013	S38-PMC3693967	['if a whole Blood sample could not be obtained from the enrolled patient for any reason a Saliva sample was taken for dna sampling and pharmacogenetic testing using an oragene® Saliva kit collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0004339', 'vault of skull', 89, 'saliva'), ('UBERON_0004339', 'vault of skull', 176, 'saliva')]
PMC3693967	6/2013	S39-PMC3693967	['dna was extracted from whole Blood samples using the qiaamp® dna mini kits (qiagen inc., valencia, ca).']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood')]
PMC3698442	7/2013	S47-PMC3698442	['Blood was collected by Cardiac puncture into tubes containing lithium Heparin and Plasma separated from cells by centrifugation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 23, 'cardiac'), ('CHEBI_28304', 'heparin', 70, 'heparin'), ('UBERON_0001969', 'blood plasma', 82, 'plasma')]
PMC3699531	7/2013	S121-PMC3699531	['Macrophages originate from Pluripotent Stem Cells in the Bone Marrow, differentiate into Monocytes in the Blood and infiltrate body Tissues as Macrophages.']	N/A	N/A	[('CL_0000235', 'macrophage', 0, 'Macrophages'), ('CL_0002311', 'mammotroph', 27, 'pluripotent'), ('CL_0000034', 'stem cell', 39, 'stem cells'), ('UBERON_0002371', 'bone marrow', 57, 'bone marrow'), ('CL_0000576', 'monocyte', 89, 'monocytes'), ('UBERON_0000178', 'blood', 106, 'blood'), ('UBERON_0000479', 'tissue', 132, 'tissues'), ('CL_0000235', 'macrophage', 143, 'macrophages')]
PMC3700139	2/2011	S91-PMC3700139	['maternal obesity and diabetes result in maternal hyperglycemia [54], and as Glucose can readily pass through the Blood-Placenta barrier, it is transferred to the fetus.']	N/A	N/A	[('CHEBI_17234', 'glucose', 76, 'glucose'), ('UBERON_0000178', 'blood', 113, 'blood'), ('UBERON_0001987', 'placenta', 119, 'placenta')]
PMC3702144	5/2012	S72-PMC3702144	['in our study 15 (3.3%) of mothers who used herbal Medicines reported some side effects that included mild or moderate form of nausea, gastric pain, low Blood pressure and urticarial that relieved without any intervention.']	N/A	N/A	[('CHEBI_25179', 'melanins', 50, 'medicines'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC3702144	5/2012	S86-PMC3702144	['“hijamat” - a traditional practice of extracting tainted Blood from multiple superficial cuts- and also, tm/cam methods such as chiropractics, biofeedback, homeopathy, yoga etc were not been used by our participants.']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood')]
PMC3702339	6/2013	S62-PMC3702339	['Blood sample collection, Serum extraction, and laboratory analysis\nVenous Blood was collected using stainless steel needles and plain tubes (sarstedt monovette®, germany).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 25, 'serum'), ('UBERON_0001638', 'vein', 67, 'Venous'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC3702339	6/2013	S63-PMC3702339	['the Blood was clotted for 20 minutes and consecutively centrifuged at 3000×g for 10 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC3702339	6/2013	S107-PMC3702339	['prevalence of Vitamin A deficiency among Pregnant women in rural sidama, southern ethiopia, february 2011\nabout 59 (8.4%) of the Blood samples were positive for crp (crp ≥5 mg/dl).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('UBERON_0000178', 'blood', 129, 'blood')]
PMC3702421	6/2013	S16-PMC3702421	['abnormal Glucose, Insulin, Blood pressure, and Lipids) in aboriginal People, we propose to recruit and follow prospectively aboriginal Pregnant mothers and their offspring from the six Nations reserve near brantford, ontario and surrounding areas.']	N/A	N/A	[('CHEBI_17234', 'glucose', 9, 'glucose'), ('PR_000045358', 'insulin family protein', 18, 'insulin'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_18059', 'lipid', 47, 'lipids'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'people'), ('GO_0007565', 'female pregnancy', 135, 'pregnant'), ('UBERON_0000979', 'tibia', 185, 'Nations')]
PMC3702421	6/2013	S84-PMC3702421	['systolic and diastolic Blood pressure is measured using an automated bp monitor (omron intelli sense, model hem-757).']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood')]
PMC3702421	6/2013	S86-PMC3702421	['caption (table-wrap): table 2\n\nproposed measures and timing of measures in abcmeasuresantenatal visit1birth visit6\xa0months post Delivery (telephone)1\xa0year visit2\xa0year visit3\xa0year visitdemographics - x\xa0\xa0\xa0\xa0\xa0agex\xa0\xa0x1x1x1hcnx\xa0\xa0x1,3x1,3x1,3address/postal codex\xa0\xa0x1x1x1family doctor - infox\xa0\xa0x1x1x1midwife/obgyn infox\xa0\xa0\xa0\xa0\xa0expected Delivery datex\xa0\xa0\xa0\xa0\xa0 medical history x\xa0\xa0\xa0\xa0\xa0diabetesx\xa0\xa0\xa0\xa0x1increased Blood pressurex\xa0\xa0\xa0\xa0x1increased Cholesterolx\xa0\xa0\xa0\xa0X1Other major medical historyx\xa0\xa0\xa0\xa0x1family historyx\xa0\xa0\xa0\xa0\xa0medications usedx\xa0\xa0\xa0\xa0x1past Pregnancy info x\xa0\xa0\xa0\xa0\xa0gtpalx\xa0\xa0\xa0\xa0\xa0still Birthsx\xa0\xa0\xa0\xa0\xa0past gest.']	N/A	N/A	[('GO_0007567', 'parturition', 127, 'delivery'), ('GO_0007586', 'digestion', 324, 'Delivery'), ('UBERON_0000178', 'blood', 391, 'blood'), ('CHEBI_16113', 'cholesterol', 422, 'cholesterolX'), ('CHEBI_25822', 'p-cumate', 438, 'X1Other'), ('GO_0007565', 'female pregnancy', 522, 'Pregnancy'), ('GO_0050909', 'sensory perception of taste', 560, 'BirthsX')]
PMC3702421	6/2013	S87-PMC3702421	['dmx\xa0\xa0\xa0\xa0\xa0pre-eclampsiax\xa0\xa0\xa0\xa0\xa0low Birth weightx\xa0\xa0\xa0\xa0\xa0premature birthx\xa0\xa0\xa0\xa0\xa0 social determinants x\xa0\xa0\xa0\xa0\xa0years living on the reservex\xa0\xa0\xa0\xa0\xa0place of Birthx\xa0\xa0\xa0\xa0\xa0religious practicesx\xa0\xa0\xa0\xa0\xa0annual household incomex\xa0\xa0x1x1x1occupationx\xa0\xa0x1x1x1marital statusx\xa0\xa0x1x1x1educationx\xa0\xa0\xa0\xa0xsocial supportx\xa0\xa0x1x1x1domestic violencex\xa0\xa0x1x1x1depressionx\xa0x1x1x1x1health behaviours \xa0\xa0\xa0\xa0\xa0\xa0cigarette exposurex\xa0\xa0xxxdiet/infant feedingx\xa0x3x3x3x3activity/sedentary behavioursx\xa0x3x3x3x3physical exam x\xa0\xa0xxxblood pressurexx2\xa0x3x3x1,3height/lengthxx2x3x3x3x1,3weightxx2x3x1,3x1,3x1,3waist and hip circumferencexx2\xa0x3x3x1,3skin foldsxx2\xa0x3x3x1,3head circumference (baby only)\xa0x2xxxxfetal ultrasoundx\xa0\xa0\xa0\xa0\xa0 Blood analysis x\xa0\xa0\xa0\xa0\xa0Hemoglobinx\xa0\xa0\xa0\xa0\xa0Glucose\xa0x2\xa0x3x3x375\xa0g ogtt (0, 60, 120\xa0min)x\xa0\xa0\xa0\xa0\xa0Insulinxx2\xa0x3x3x3adiponectinxx\xa0xxxleptinxx2\xa0xxxlipid profilexx2\xa0x3x3x3cbc\xa0x2\xa0x3x3x3aliquots for future analysisxx2\xa0x3x3x3dna long-term storagexx2\xa0\xa0\xa0\xa0 Birth visit \xa0\xa0\xa0\xa0\xa0\xa0type of delivery\xa0x\xa0\xa0\xa0\xa0duration of labour\xa0x\xa0\xa0\xa0\xa0Premature labour\xa0x\xa0\xa0\xa0\xa0Blood loss\xa0x\xa0\xa0\xa0\xa0Birth weight\xa0x\xa0\xa0\xa0\xa0apgar scores (1 and 5\xa0min)\xa0x\xa0\xa0\xa0\xa0adverse outcomes\xa0x\xa0\xa0\xa0\xa0Placenta & Cord blood\xa0x\xa0\xa0\xa0\xa0Stool\xa0\xa0\xa0X3\xa0\xa0Breastmilk\xa0X4\xa0\xa0\xa0\xa0\n1: all measurements taken in the mother,2: measurements taken in newborn at Birth,3measurements taken in infant,4: collected from mother at 6\xa0weeks.']	N/A	N/A	[('GO_0007567', 'parturition', 31, 'Birth'), ('GO_0042633', 'hair cycle', 139, 'BirthX'), ('UBERON_0000178', 'blood', 665, 'Blood'), ('CHEBI_5646', 'Hellicoside', 686, 'HemoglobinX'), ('CHEBI_17234', 'glucose', 702, 'Glucose'), ('PR_000008919', 'interferon alpha-6', 751, 'InsulinXX2'), ('GO_0007567', 'parturition', 901, 'Birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 965, 'Premature'), ('UBERON_0000178', 'blood', 987, 'Blood'), ('GO_0007567', 'parturition', 1003, 'Birth'), ('UBERON_0001987', 'placenta', 1075, 'Placenta'), ('UBERON_0000948', 'heart', 1086, 'Cord'), ('UBERON_0001988', 'feces', 1102, 'Stool'), ('UBERON_0012353', 'fin skeleton', 1110, 'X3'), ('UBERON_0013538', 'Brodmann (1909) area 7', 1114, 'Breastmilk'), ('UBERON_2002112', 'preural 3 vertebra', 1125, 'X4'), ('GO_0007567', 'parturition', 1208, 'birth')]
PMC3702421	6/2013	S101-PMC3702421	['three Blood samples are collected: fasting, 60, and 120\xa0minutes [29].']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC3702421	6/2013	S107-PMC3702421	['a Cord Blood sample for biochemistry (i.e.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 2, 'cord'), ('UBERON_0000178', 'blood', 7, 'blood')]
PMC3702421	6/2013	S109-PMC3702421	['newborn’s physical characteristics including Birth weight, skin fold thickness, length, Abdominal, Head, and Arm circumference and Blood pressure are measured within 72\xa0hours after Birth.']	N/A	N/A	[('GO_0007567', 'parturition', 45, 'birth'), ('UBERON_0000916', 'abdomen', 88, 'abdominal'), ('UBERON_0000033', 'head', 99, 'head'), ('UBERON_0001460', 'arm', 109, 'arm'), ('UBERON_0000178', 'blood', 131, 'blood'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC3702421	6/2013	S116-PMC3702421	['an annual Blood sample will be collected from the infant to measure the complete Blood count to screen for iron deficiency anemia, and for analysis of Glucose, Insulin, and Lipids.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_17234', 'glucose', 151, 'glucose'), ('PR_000045358', 'insulin family protein', 160, 'insulin'), ('CHEBI_18059', 'lipid', 173, 'lipids')]
PMC3705320	3/2013	S46-PMC3705320	['weekly assessments included a checklist of symptoms and Blood pressure measurement.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood')]
PMC3705320	3/2013	S47-PMC3705320	['in nh and ph, participants provided up to six scheduled Blood specimens and at least seven Urine samples during a 10-week follow-up period beginning on the day of Supplement administration (day 0), according to one of two randomly assigned sampling schedules, a or b (figure 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0001088', 'urine', 91, 'urine'), ('CHEBI_16158', 'steroid sulfate', 163, 'supplement')]
PMC3705320	3/2013	S49-PMC3705320	['Urine was collected at visits without scheduled Blood collection up to day 70 (figure 1).']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 48, 'blood')]
PMC3705320	3/2013	S50-PMC3705320	['participants in pl were asked to provide three Blood specimens and four Urine specimens (schedule c infigure 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001088', 'urine', 72, 'urine')]
PMC3705320	3/2013	S52-PMC3705320	['caption (fig): figure 1\n\nBlood and Urine specimen collection schedules.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'Blood'), ('UBERON_0001088', 'urine', 35, 'urine')]
PMC3705320	3/2013	S85-PMC3705320	['the proportion of participants and Cord Blood specimens with [25(Oh)D] ≥ 50 nmol/l or ≥80 nmol/l were compared across groups using log-binomial regression.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 35, 'cord'), ('UBERON_0000178', 'blood', 40, 'blood'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25(OH)D')]
PMC3708703	6/2013	S24-PMC3708703	['each woman was interviewed and had Blood taken for hemoglobin and iron indices (ferritin) before receiving daily Iron–Folic Acid supplementation (426 women), twice weekly Iron–Folic Acid supplementation (425 women), or twice weekly Iron–Folic Acid supplementation plus Micronutrients (407 women).']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CHEBI_24870', 'ion', 113, 'iron'), ('CHEBI_30751', 'formic acid', 118, 'folic acid'), ('CHEBI_24870', 'ion', 171, 'iron'), ('CHEBI_30751', 'formic acid', 176, 'folic acid'), ('CHEBI_24870', 'ion', 232, 'iron'), ('CHEBI_30751', 'formic acid', 237, 'folic acid'), ('CHEBI_33839', 'macromolecule', 269, 'micronutrients')]
PMC3708703	6/2013	S78-PMC3708703	['Maternal Venous Blood was collected for hemoglobin and iron indices (ferritin and Transferrin Receptor) at enrolment, 32 wk Gestation, and 6 mo Postpartum.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001638', 'vein', 9, 'venous'), ('UBERON_0000178', 'blood', 16, 'blood'), ('PR_000001679', 'trace amine-associated receptor 5', 82, 'transferrin receptor'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('GO_0007565', 'female pregnancy', 144, 'postpartum')]
PMC3708703	6/2013	S111-PMC3708703	['five millilitres of maternal Venous Blood was collected for iron indices (Ferritin and Transferrin Receptor) and Serum Folate, Vitamin B12, and Vitamin D levels; maternal Urine was collected for Urinary Iodine concentration at 32 wk Gestation; and 1 ml of infant Venous Blood was collected for Serum ferritin.']	N/A	N/A	[('UBERON_0001638', 'vein', 29, 'venous'), ('UBERON_0000178', 'blood', 36, 'blood'), ('PR_000007309', 'fatty acid-binding protein, liver', 74, 'ferritin'), ('PR_000001679', 'trace amine-associated receptor 5', 87, 'transferrin receptor'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_33279', 'vitamin D5', 127, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 127, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('UBERON_0001088', 'urine', 171, 'urine'), ('UBERON_0001088', 'urine', 195, 'urinary'), ('CHEBI_24859', 'iodine atom', 203, 'iodine'), ('GO_0007565', 'female pregnancy', 233, 'gestation'), ('UBERON_0001638', 'vein', 263, 'venous'), ('UBERON_0000178', 'blood', 270, 'blood'), ('UBERON_0001977', 'blood serum', 294, 'serum')]
PMC3710934	7/2013	S275-PMC3710934	['hypertension\ntwo of the studies concerned maternal Intake of Iron during Pregnancy and Blood pressure of the offspring aged 3 and 7 years (47,48).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 51, 'intake'), ('CHEBI_24870', 'ion', 61, 'iron'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0000178', 'blood', 87, 'blood')]
PMC3710934	7/2013	S280-PMC3710934	['those women who had received Iron supplement at any Trimester in Pregnancy had a significantly lower systolic Blood pressure, −0.63 mm hg (95% ci: −1.09–(−0.17)) (48).']	N/A	N/A	[('CHEBI_24870', 'ion', 29, 'iron'), ('GO_0009294', 'DNA mediated transformation', 52, 'trimester'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC3710934	7/2013	S284-PMC3710934	['two other studies on Blood pressure and Iron intake in Adults were explored, one prospective observational study and one cross sectional study (49,50).']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('CHEBI_24870', 'ion', 40, 'iron'), ('UBERON_0007023', 'adult organism', 55, 'adults')]
PMC3710934	7/2013	S383-PMC3710934	['controls were recruited among healthy friends and non-Blood-related family members of patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood')]
PMC3717170	5/2013	S8-PMC3717170	['when there is a need to increase Blood calcium levels (e.g., during growth or Pregnancy), 1,25(Oh)2D3Acts in the Intestine to increase calcium absorption.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_37958', 'dye', 90, '1,'), ('CHEBI_73774', 'enterobacterial common antigen', 92, '25(OH)2D3acts'), ('UBERON_0000160', 'intestine', 113, 'intestine')]
PMC3717170	5/2013	S55-PMC3717170	['infusion of Angiotensin Ii led to increased Blood pressure, increased Myocyte hypertrophy, increased Expression of the hypertrophy-sensitive fetal Gene program (i.e., Atrial Natriuretic Peptide, B-Type Natriuretic Peptide, and Alpha Skeletal Actin Gene Expression), and increased Cardiac Interstitial fibrosis with augmented Procollagen 1 and 3 Expression.']	N/A	N/A	[('CHEBI_48432', 'angiotensin II', 12, 'angiotensin II'), ('UBERON_0000178', 'blood', 44, 'blood'), ('CL_0000187', 'muscle cell', 70, 'myocyte'), ('GO_0010467', 'gene expression', 101, 'expression'), ('SO_0000704', 'gene', 147, 'gene'), ('UBERON_0002081', 'cardiac atrium', 167, 'atrial'), ('CHEBI_83229', 'amino acid opine', 174, 'natriuretic peptide'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 174, 'natriuretic peptide'), ('PR_000004759', 'Bloom syndrome protein', 195, 'B-type natriuretic peptide'), ('CHEBI_35482', 'opioid analgesic', 202, 'natriuretic'), ('PR_000003609', 'Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3', 227, 'alpha skeletal actin'), ('UBERON_0004288', 'skeleton', 233, 'skeletal'), ('GO_0010467', 'gene expression', 248, 'gene expression'), ('SO_0000704', 'gene', 248, 'gene'), ('UBERON_0000948', 'heart', 280, 'cardiac'), ('UBERON_0005169', 'interstitial tissue', 288, 'interstitial'), ('PR_000013194', 'peroxiredoxin-4', 325, 'procollagen 1'), ('GO_0010467', 'gene expression', 345, 'expression')]
PMC3717170	5/2013	S138-PMC3717170	['in dose-response analyses, the risk of type 2 diabetes was reduced by 4% for each 4 ng/ml increment in Blood 25(Oh)d3concentration.']	N/A	N/A	[('UBERON_0000178', 'blood', 103, 'blood'), ('CHEBI_30778', 'gallic acid', 109, '25(OH)')]
PMC3718280	6/2013	S4-PMC3718280	['markers of iron status, inflammation and hepcidin were measured in maternal and Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC3718280	6/2013	S5-PMC3718280	['student’s t test was used to compare obese and lean groups, and pearson correlation coefficients were determined between maternal and Cord Blood values.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 134, 'cord'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC3718280	6/2013	S6-PMC3718280	['results\nmaternal C-Reactive Protein (Crp) (p<0.01) and Hepcidin (p<0.01) were higher, and cord Blood iron (p<0.01) was lower in the obese group.']	N/A	N/A	[('PR_000005890', 'crooked neck-like protein 1', 17, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 37, 'CRP'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 55, 'hepcidin'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC3718280	6/2013	S30-PMC3718280	['Cord Blood was harvested from the neonates of 10 obese women and 11 control women.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC3718280	6/2013	S31-PMC3718280	['measurements in maternal and Cord Blood\nmaternal Blood was collected at 24-28 weeks of Gestation, after an 8-14 hour fast, one hour after Ingestion of a 50g Glucose drink.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 29, 'cord'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('GO_0007631', 'feeding behavior', 138, 'ingestion'), ('CHEBI_17234', 'glucose', 157, 'glucose')]
PMC3718280	6/2013	S32-PMC3718280	['Blood was collected at this time to minimize venipuncture in subjects.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3718280	6/2013	S33-PMC3718280	['Cord Blood was collected after Delivery via syringe aspiration from the Umbilical Vein.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 31, 'delivery'), ('UBERON_0002066', 'umbilical vein', 72, 'umbilical vein')]
PMC3718280	6/2013	S34-PMC3718280	['Cord Blood could not be collected from all subjects.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC3718280	6/2013	S60-PMC3718280	['adjusting for mode of Delivery did not affect hepcidin or inflammation differences in Cord Blood.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'delivery'), ('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC3718280	6/2013	S61-PMC3718280	['Serum iron and tsat were found to be significantly lower in Cord Blood from ob compared to lc [iron: ob, 97.3 ± 29.9 μg/dl vs. lc, 147.7 ± 21.7 μg/dl, p<0.01; and tsat: ob, 39.6% vs. lc, 63.5%, p=0.01] (figure 1i-j).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0002240', 'spinal cord', 60, 'cord'), ('UBERON_0000178', 'blood', 65, 'blood')]
PMC3720837	7/2013	S47-PMC3720837	['concurrently, Blood samples were drawn by puncture of the Orbital Sinus[45], into 5 ml sterile heparinized vacuum tubes (vacutainer™ systems europe).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0006318', 'orbitalis muscle', 58, 'orbital sinus')]
PMC3720837	7/2013	S48-PMC3720837	['immediately after recovery, the Blood was centrifuged at 1500 g for 15 min and the Plasma was separated and stored into polypropylene vials at −20°c until assay for determination of leptin and parameters of Carbohydrate, Protein and Lipids Metabolism.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0001969', 'blood plasma', 83, 'plasma'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 207, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 221, 'protein ...'), ('CHEBI_18059', 'lipid', 233, 'lipids'), ('GO_0006629', 'lipid metabolic process', 233, 'lipids metabolism')]
PMC3720837	7/2013	S57-PMC3720837	['immediately, for each Conceptus, Blood samples were drawn from Heart and/or Umbilical Cord with heparinised syringes, samples of Allantoic and Amniotic Fluids were obtained by aspiration through the Chorioallantoic and Amniochorion Membranes, respectively, and one sample of around 1 cm2of Placental Tissue (including Trophoblast and Uterine Endometrium) was collected for histological evaluation.']	N/A	N/A	[('UBERON_0004716', 'conceptus', 22, 'conceptus'), ('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0000948', 'heart', 63, 'heart'), ('UBERON_0002331', 'umbilical cord', 76, 'umbilical cord'), ('UBERON_0001428', 'intermedium', 129, 'allantoic'), ('UBERON_0000053', 'macula lutea', 143, 'amniotic fluids'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 199, 'chorioallantoic'), ('UBERON_0001493', 'axillary nerve', 219, 'amniochorion membranes'), ('UBERON_0001987', 'placenta', 290, 'placental'), ('UBERON_0000479', 'tissue', 300, 'tissue'), ('UBERON_0000088', 'trophoblast', 318, 'trophoblast'), ('UBERON_0001295', 'endometrium', 334, 'uterine endometrium')]
PMC3728489	7/2013	S35-PMC3728489	['the primary role of dnk cells is to promote Uterine vascular changes in the Decidua in order to maximize maternal Blood flow through the Placenta.']	N/A	N/A	[('UBERON_0000995', 'uterus', 44, 'uterine'), ('UBERON_0002450', 'decidua', 76, 'decidua'), ('UBERON_0000178', 'blood', 114, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placenta')]
PMC3728489	7/2013	S143-PMC3728489	['maternal malnutrition\nduring Pregnancy, maternal malnutrition hampers Placentation, with resulting changes in Placental size, morphology and Blood flow (belkacemi et al.,2010) that thereby reduce the supply of Nutrients to the fetus.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0001890', 'placenta development', 70, 'placentation'), ('UBERON_0001987', 'placenta', 110, 'placental'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_33284', 'nutrient', 210, 'nutrients')]
PMC3734354	7/2013	S127-PMC3734354	['fmri uses the different magnetic properties of oxygenated and deoxygenated Blood to image areas of Brain activity.']	N/A	N/A	[('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0000955', 'brain', 99, 'brain')]
PMC3736889	11/2010	S28-PMC3736889	['Plasma Lipid profile\nfasting Blood was collected using Cardiac puncture into tubes containing 4.5 mm edta, ph 7.5.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_18059', 'lipid', 7, 'lipid'), ('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0000948', 'heart', 55, 'cardiac')]
PMC3736889	11/2010	S29-PMC3736889	['Plasma was collected after centrifugation of whole Blood at 3000 g for 15 min.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 51, 'blood')]
PMC3736889	11/2010	S34-PMC3736889	['Blood Glucose concentrations were measured using a commercially available Glucometer (lifescan inc, ca, usa) in the fasted Animals from the Tail Blood at the time of sacrificing the Animals.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_24321', 'glutamo group', 74, 'glucometer'), ('NCBITaxon_33208', 'Metazoa', 123, 'animals'), ('UBERON_0002415', 'tail', 140, 'tail'), ('UBERON_0000178', 'blood', 145, 'blood'), ('NCBITaxon_33208', 'Metazoa', 182, 'animals')]
PMC3739737	8/2013	S187-PMC3739737	['at the end of experimentation, a terminal Blood sample was taken from each Rat by Cardiac puncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 75, 'rat'), ('UBERON_0000948', 'heart', 82, 'cardiac')]
PMC3742769	8/2013	S44-PMC3742769	['Blood was percutaneously aspirated from the Left Cardiac Ventricle after 0, 2, 4, and 6 h of anesthesia (n\u200a=\u200a3 per time point).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002084', 'heart left ventricle', 44, 'left cardiac ventricle')]
PMC3742769	8/2013	S45-PMC3742769	['from these samples, we measured partial pressures of Carbon Dioxide and oxygen, ph, and Blood Lactate and Glucose levels with a radiometer abl 800 Blood gas analyzer (radiometer, copenhagen, denmark).']	N/A	N/A	[('CHEBI_16526', 'carbon dioxide', 53, 'carbon dioxide'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CHEBI_24996', 'lactate', 94, 'lactate'), ('CHEBI_17234', 'glucose', 106, 'glucose'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC3742769	8/2013	S117-PMC3742769	['a: ph; b: paco2; c: pao2; d: Blood Lactate concentration; e: Blood Glucose concentration.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'Blood'), ('CHEBI_24996', 'lactate', 35, 'lactate'), ('UBERON_0000178', 'blood', 61, 'Blood'), ('CHEBI_17234', 'glucose', 67, 'glucose')]
PMC3742769	8/2013	S119-PMC3742769	['sevo treatment could decrease ph (a) due to hypercarbia (b) and increase the Blood Glucose concentration; n\u200a=\u200a3 at each time.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_17234', 'glucose', 83, 'glucose')]
PMC3742894	7/2013	S3-PMC3742894	['mothers who came for anc during the study period and who met the inclusion criteria were interviewed and a capillary Blood sample was taken.']	N/A	N/A	[('UBERON_0000178', 'blood', 117, 'blood')]
PMC3742894	7/2013	S49-PMC3742894	['Blood sample was collected via finger-prick with disposable lancet and hemoglobin level was determined by laboratory technicians using portable digital hemoglobin meter (hemocue ab angelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3743371	7/2013	S33-PMC3743371	['after two weeks women who achieved fbs and bs 2 hr pp Blood Glucose Control continued their diet, otherwise commenced Insulin treatment\n\ncaption (table-wrap): table 1\n\ncomposition of low glycemic load diet with 1800 kcal administrated to diabetics patients*\n\nstatistical analysis\ndata are reported as mean ± sd.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('CHEBI_17234', 'glucose', 60, 'glucose'), ('GO_0065007', 'biological regulation', 68, 'control'), ('PR_000045358', 'insulin family protein', 118, 'insulin')]
PMC3743371	7/2013	S34-PMC3743371	['Blood Glucose data were analyzed by independent sample t -test and chi-square test to compare Blood Glucose concentration before and after intervention and between two groups of “fiber” and “without fiber”.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0000178', 'blood', 94, 'blood'), ('CHEBI_17234', 'glucose', 100, 'glucose')]
PMC3743371	7/2013	S35-PMC3743371	['Blood Glucose monitoring\nafter two weeks dietary intervention Plasma Blood Glucose monitored using fasting Blood Glucose and 2 hours Postprandial Plasma Blood Glucose.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0001969', 'blood plasma', 62, 'plasma'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_17234', 'glucose', 75, 'glucose'), ('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_17234', 'glucose', 113, 'glucose'), ('GO_0007567', 'parturition', 133, 'postprandial'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000178', 'blood', 153, 'blood'), ('CHEBI_17234', 'glucose', 159, 'glucose')]
PMC3743371	7/2013	S40-PMC3743371	['based on diagnosis of gdm all participated subjects were diabetes without significant differences in fasting Blood Glucose of two groups at the beginning of the study (100.4 ± 16.3 and 108.0 ± 20.3 in “fiber” and “without fiber” groups respectively, p = 0.2).']	N/A	N/A	[('UBERON_0000178', 'blood', 109, 'blood'), ('CHEBI_17234', 'glucose', 115, 'glucose')]
PMC3743371	7/2013	S41-PMC3743371	['in “fiber” group fasting Blood Glucose concentration before intervention and after intervention were 100.4 ± 16.3 and 86.3 ± 11.3 respectively which resulted in 14% (14 mlg/dl) reduction ( p = 0.001).']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_17234', 'glucose', 31, 'glucose')]
PMC3743371	7/2013	S43-PMC3743371	['similarly 2 hr pp Blood concentration in “fiber” and “without fiber” group reduced by 29.6% and 21.3% respectively compare to 2 hr gtt.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC3743371	7/2013	S45-PMC3743371	['caption (table-wrap): table 2\n\ncomparison of Blood Glucose concentration between “fiber” and “without fiber” groups\nthe Postprandial Blood Glucose in two groups of “fiber” and “without fiber” after intervention were 115.1 ± 18.1 and 136.9 ± 18.7 respectively, which the difference was significant ( p = 0.003) [table 2].']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_17234', 'glucose', 51, 'glucose'), ('GO_0007567', 'parturition', 120, 'postprandial'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_17234', 'glucose', 139, 'glucose')]
PMC3743371	7/2013	S46-PMC3743371	["regarding to Blood Glucose Control based our study's criteria, 11 (61.1%) patients in “fiber” group and 3 (23.1%) patients in “without fiber” groups achieved Blood Glucose Control (chi-square, p = 0.04) [table 3]."]	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_17234', 'glucose', 19, 'glucose'), ('GO_0046323', 'glucose import', 19, 'glucose control'), ('UBERON_0000178', 'blood', 158, 'blood'), ('CHEBI_17234', 'glucose', 164, 'glucose'), ('GO_0065007', 'biological regulation', 172, 'control')]
PMC3743371	7/2013	S56-PMC3743371	['similarly 2 hrs pp Blood concentration reduced by 29.6% and 21.3% in “fiber” and “without fiber” group respectively compare to 2 hrs gtt.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood')]
PMC3743371	7/2013	S63-PMC3743371	['the mechanism behind the fact that the lgl diet plus fiber Intake was more effective in Blood Glucose of gdm subjects is that fiber slows Carbohydrate absorption and reducing gi of meal.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 59, 'intake'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CHEBI_17234', 'glucose', 94, 'glucose'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 138, 'carbohydrate')]
PMC3743734	9/2013	S24-PMC3743734	['subjects and methods\n\nparticipants and study design\nthe 79 women from the villages of keneba and manduar, west kiang, the gambia, who had taken part in a trial of Pregnancy Calcium supplementation and Blood pressure (international trial registry: isrctn96502494) and who had dxa scans at l52 as part of a substudy (1) were eligible for the study.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 163, 'pregnancy'), ('CHEBI_22313', 'alkaline earth metal atom', 173, 'calcium'), ('UBERON_0000178', 'blood', 201, 'blood')]
PMC3749995	8/2013	S45-PMC3749995	['proportions of dams were euthanized (rising concentration of Co2With Cervical dislocation) at different stages of Gestation (4 days [cd, n\u200a=\u200a10; sd, n\u200a=\u200a10] and 20 days [cd, n\u200a=\u200a10; sd, n\u200a=\u200a6]; term, 21±1 days) for Blood collection (into li-Heparin tubes) and Plasma.']	N/A	N/A	[('CHEBI_86320', '1alpha,25-dihydroxyvitamin D2', 61, 'CO2with'), ('UBERON_0005434', 'cervical region', 69, 'cervical'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('UBERON_0000178', 'blood', 215, 'blood'), ('CHEBI_28304', 'heparin', 241, 'heparin'), ('UBERON_0001969', 'blood plasma', 260, 'plasma')]
PMC3749995	8/2013	S51-PMC3749995	['baseline Renal function was established in two cohorts of offspring at 8 and 12 weeks of age (control diet, male [n\u200a=\u200a6] female [n\u200a=\u200a5]; 4% Nacl, male [n\u200a=\u200a5] female [n\u200a=\u200a5]) by 24 h Urine collection in a Metabolic crate (after 24 h acclimatisation to the environment) with a paired Blood sample collected at 24 h.\nSalt-stimulated Renal function at 12 weeks of age.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'renal'), ('CHEBI_26710', 'sodium chloride', 140, 'NaCl'), ('UBERON_0001088', 'urine', 183, 'urine'), ('GO_0008152', 'metabolic process', 205, 'metabolic'), ('UBERON_0000178', 'blood', 283, 'blood'), ('CHEBI_17418', 'valeric acid', 315, 'Salt'), ('UBERON_0002113', 'kidney', 331, 'renal')]
PMC3749995	8/2013	S54-PMC3749995	['Blood pressure assessment by telemetry.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3749995	8/2013	S61-PMC3749995	['after 5–7 days, Blood pressure was measured continuously for a 48 h period at a sampling rate of 2×15 sec periods per min (dataquest a.r.t gold v4.02; dsi, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood')]
PMC3749995	8/2013	S110-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3749995	8/2013	S153-PMC3749995	['after 5 days Feeding of a low (0.26%; standard Chow) or high-Salt (4%; td.08162) diet.10.1371/journal.pone.0072682.g002\n\ncaption (fig): figure 2\nSalt-exposed offspring have increased Blood pressure throughout the Circadian Cycle.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 13, 'feeding'), ('CHEBI_33290', 'food', 47, 'chow'), ('CHEBI_24866', 'salt', 61, 'salt'), ('CHEBI_17418', 'valeric acid', 145, 'Salt'), ('UBERON_0000178', 'blood', 183, 'blood'), ('GO_0006099', 'tricarboxylic acid cycle', 213, 'circadian cycle')]
PMC3749995	8/2013	S154-PMC3749995	['for Blood pressure, assessed by telemetry, data are from control diet; n\u200a=\u200a6 dams, n\u200a=\u200a6/6 [male/female] offspring or high-Salt (4% Salt) diet; n\u200a=\u200a6 dams, n\u200a=\u200a5/5 [male/female] offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_24866', 'salt', 123, 'salt'), ('CHEBI_24866', 'salt', 132, 'salt')]
PMC3749995	8/2013	S174-PMC3749995	['ns, not significant.10.1371/journal.pone.0072682.t003\n\ncaption (table-wrap): table 3\noffspring Renal function is unaffected by maternal Salt-exposure.Renal functional parameters at baseline in Adult offspring at 8 weeks of age ± maternal Salt p valuesex−ve+ves.e.d.saltsexsalt*sex Urine output (ml/min/kg bw)male 20.030.15.30.07<.001ns female 33.943.3 osmolal clearance (ml/min/kg bw)male 0.050.070.1ns0.002ns female 0.110.08 free Water clearance (ml/min/kg bw)male 20.027.93.3ns<.001ns female 34.735.2\na 24 h Urine collection with paired Blood sample enabled analysis of Renal function in offspring.']	N/A	N/A	[('UBERON_0002113', 'kidney', 95, 'renal'), ('CHEBI_24866', 'salt', 136, 'salt'), ('UBERON_0002113', 'kidney', 150, 'Renal'), ('UBERON_0007023', 'adult organism', 193, 'adult'), ('CHEBI_24866', 'salt', 238, 'salt'), ('UBERON_0001088', 'urine', 281, 'Urine'), ('CHEBI_15377', 'water', 431, 'water'), ('UBERON_0001088', 'urine', 510, 'urine'), ('UBERON_0000178', 'blood', 539, 'blood'), ('UBERON_0002113', 'kidney', 572, 'renal')]
PMC3749995	8/2013	S180-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function in offspring.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3749995	8/2013	S186-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function in Salt-loaded offspring.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('CHEBI_24866', 'salt', 87, 'salt')]
PMC3749995	8/2013	S278-PMC3749995	['perspective\nfrom a nutritional perspective, one price of progress is an inevitable and inescapable dietary Intake of excess Salt, which increases the Blood pressure of an Individual Consuming excess Salt but also the next generation exposed in utero .']	N/A	N/A	[('GO_0007631', 'feeding behavior', 107, 'intake'), ('CHEBI_24866', 'salt', 124, 'salt'), ('UBERON_0000178', 'blood', 150, 'blood'), ('NCBITaxon_1', 'root', 171, 'individual'), ('GO_0007631', 'feeding behavior', 182, 'consuming'), ('CHEBI_24866', 'salt', 199, 'salt')]
PMC3751294	8/2013	S255-PMC3751294	['Insulin can cross the Blood–Brain barrier (bbb) [142].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000955', 'brain', 28, 'brain')]
PMC3756974	8/2013	S15-PMC3756974	['Catechin eliminates Free Radicals and decreases Cholesterol level preventing cancer development, high Blood pressure, Arterial sclerosis, Thrombosis, Heart attacks and Brain strokes and Aging arrestment [5].']	N/A	N/A	[('CHEBI_3461', 'Casuarictin', 0, 'Catechin'), ('CHEBI_26519', 'radical', 20, 'free radicals'), ('CHEBI_16113', 'cholesterol', 48, 'cholesterol'), ('UBERON_0000178', 'blood', 102, 'blood'), ('UBERON_0001637', 'artery', 118, 'arterial'), ('GO_0007596', 'blood coagulation', 138, 'thrombosis'), ('UBERON_0000948', 'heart', 150, 'heart'), ('UBERON_0000955', 'brain', 168, 'brain'), ('GO_0007568', 'aging', 186, 'aging')]
PMC3756974	8/2013	S61-PMC3756974	['then, Pentobarbital anesthesia was induced and Blood samples were collected, then the Livers, Kidneys, and Heart were removed immediately and weighed.']	N/A	N/A	[('CHEBI_7983', 'pentobarbital', 6, 'pentobarbital'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0002107', 'liver', 86, 'livers'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('UBERON_0000948', 'heart', 107, 'heart')]
PMC3756974	8/2013	S63-PMC3756974	['Blood chemistry\nPlasma samples were separated by centrifugation at 800 × g for 10 min at 4°c and total Cholesterol (T-Cho), Blood Urea nitrogen (bun), creatinine (cre), Na+and K+levels were determined using an autoanalyzer for Blood chemistry (fuji, dry-chem3500v; fuji film, tokyo, japan).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 16, 'Plasma'), ('CHEBI_16113', 'cholesterol', 103, 'cholesterol'), ('CHEBI_53424', 'polysorbate 20', 116, 'T'), ('CHEBI_23243', 'cineole', 118, 'cho'), ('UBERON_0000178', 'blood', 124, 'blood'), ('CHEBI_16199', 'urea', 130, 'urea'), ('CHEBI_29101', 'sodium(1+)', 169, 'Na+'), ('CHEBI_29103', 'potassium(1+)', 176, 'K+'), ('UBERON_0000178', 'blood', 227, 'blood')]
PMC3756974	8/2013	S102-PMC3756974	['t-cho, total Cholesterol; bun, Blood Urea Nitrogen; cre, creatinine; cc, control on control; lp, control on protein restricted; lpcl, 0.12% gte diet on protein restricted; lpch, 0.24% gte diet on protein restricted.bp< 0.05 compared with lp.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 13, 'cholesterol'), ('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_33268', 'monoatomic nitrogen', 37, 'urea nitrogen')]
PMC3760821	9/2013	S5-PMC3760821	['Cord Blood 25Ohd was measured at Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 11, '25OHD'), ('GO_0007567', 'parturition', 33, 'delivery')]
PMC3760821	9/2013	S8-PMC3760821	['Vitamin D levels in all Cord Blood were <50 nmol/l.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 24, 'cord'), ('UBERON_0000178', 'blood', 29, 'blood')]
PMC3760821	9/2013	S10-PMC3760821	['25Ohd levels within Cord Blood were significantly lower for women with diabetes classified as obese vs. normal weight at booking [normal weight bmi <25 kg/m2vs.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood')]
PMC3760821	9/2013	S56-PMC3760821	['in all subjects, Blood samples were obtained at booking and at 20, 28, 32, 36, and 38 weeks of Gestation and within 48 hours post-Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0007565', 'female pregnancy', 95, 'gestation'), ('GO_0007567', 'parturition', 130, 'delivery')]
PMC3760821	9/2013	S67-PMC3760821	['Cord Blood collection\nCord Blood was collected from 56 of the babies Born to women with t1dm vs. 25 from control women.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'Blood'), ('UBERON_0000948', 'heart', 22, 'Cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007567', 'parturition', 69, 'born')]
PMC3760821	9/2013	S68-PMC3760821	['twenty millilitres of Venous Cord Blood was taken from the Cord immediately after clamping and cutting of the Umbilical Cord.']	N/A	N/A	[('UBERON_0005487', 'vitelline vein', 22, 'venous cord'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0002331', 'umbilical cord', 110, 'umbilical cord')]
PMC3760821	9/2013	S95-PMC3760821	['multivariate models for Cord Blood 25Ohd and hba1cwere estimated based on both maternal and neonatal measures using multiple linear regression.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 24, 'cord'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 35, '25OHD')]
PMC3760821	9/2013	S120-PMC3760821	['levels of 25Ohd in women with t1dm at the final stage of Pregnancy, post-Delivery and within Cord Blood\nwithin season, 25Ohd levels from the t1dm group were compared between samples taken at the final stage of Pregnancy, post-Delivery and from Cord Blood ( figure 1a ).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 10, '25OHD'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0007567', 'parturition', 73, 'delivery'), ('UBERON_0009472', 'axilla', 93, 'cord blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 119, '25OHD'), ('GO_0007565', 'female pregnancy', 210, 'pregnancy'), ('GO_0007567', 'parturition', 226, 'delivery'), ('UBERON_0002240', 'spinal cord', 244, 'cord'), ('UBERON_0000178', 'blood', 249, 'blood')]
PMC3760821	9/2013	S123-PMC3760821	['in all seasons, 25Ohd levels at the final stage of Pregnancy were significantly greater than those of Cord Blood.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 16, '25OHD'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 102, 'cord'), ('UBERON_0000178', 'blood', 107, 'blood')]
PMC3760821	9/2013	S129-PMC3760821	['(b) comparison of mean 25Ohd levels (nmol/l) between normal weight (bmi at booking <25 kg/m2; n\u200a=\u200a22–24) and obese (bmi at booking >30 kg/m2; n\u200a=\u200a16–17) t1dm women in the final Pregnancy sample (wk 31–38) and neonatal Cord Blood.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 23, '25OHD'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 218, 'cord'), ('UBERON_0000178', 'blood', 223, 'blood')]
PMC3760821	9/2013	S148-PMC3760821	['maternal age at Delivery, Subscapular Skinfold, Triceps Skinfold, sds bmi and sds height did not impact significantly on Cord Blood Vitamin D levels.']	N/A	N/A	[('GO_0007567', 'parturition', 16, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 26, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 48, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 121, 'cord'), ('UBERON_0000178', 'blood', 126, 'blood'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3760821	9/2013	S169-PMC3760821	['further, 25Ohd levels within Cord Blood were significantly lower in neonates from women classified as obese at booking compared with those classified as normal weight.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 9, '25OHD'), ('UBERON_0002240', 'spinal cord', 29, 'cord'), ('UBERON_0000178', 'blood', 34, 'blood')]
PMC3766643	8/2013	S23-PMC3766643	['their data included measures of maternal exposures in Blood samples collected near Delivery (days 1–3 after daughter’s Birth during 1960–63) in relation to her daughter’s ttp decades later.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007567', 'parturition', 83, 'delivery'), ('GO_0007567', 'parturition', 119, 'birth')]
PMC3773018	4/2013	S3-PMC3773018	['we defined fs as specific Ige ≥0.35kua/l to any of eight common Food Allergens; and persistently low Vitamin D status as Cord Blood 25(Oh)D <11ng/ml and Postnatal 25(Oh)D <30ng/ml.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 26, 'IgE'), ('CHEBI_33290', 'food', 64, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 69, 'allergens'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 121, 'cord'), ('UBERON_0000178', 'blood', 126, 'blood'), ('CHEBI_33010', 'chromide(1-)', 134, '(OH)D'), ('GO_0007567', 'parturition', 153, 'postnatal'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 169, 'D')]
PMC3773018	4/2013	S42-PMC3773018	['when looking at the studied children overall (figure 1), Cord Blood total 25(Oh)D concentration (ng/ml) was quite low (n=460, purple curve: 14.16 ± 7.90 ng/ml, (mean ± s.d)).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D')]
PMC3773018	4/2013	S52-PMC3773018	['individually, neither Cord Blood nor Postnatal low Vitamin D status was significantly associated with any fs (table 3).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007567', 'parturition', 37, 'postnatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3773449	8/2013	S62-PMC3773449	['faster weight gain during the first 6 months of Life, promoted by a high protein diet, favours the accumulation of the Metabolic Visceral Adipose Tissue, reduces Insulin sensitivity, and increases Blood pressure later in Life [56–58].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 48, 'life'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('UBERON_0010155', 'parietomastoid suture', 129, 'visceral adipose tissue'), ('PR_000045358', 'insulin family protein', 162, 'insulin'), ('UBERON_0000178', 'blood', 197, 'blood'), ('UBERON_0000104', 'life cycle', 221, 'life')]
PMC3773449	8/2013	S72-PMC3773449	['Blood pressure, fasting Insulin, and leptin levels are elevated in young Adults iugr Rat offspring nourished during the peripubertal period by a Hypercaloric diet (applied after the weaning) [72].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('PR_000045358', 'insulin family protein', 24, 'insulin'), ('UBERON_0007023', 'adult organism', 73, 'adults'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 85, 'rat'), ('CHEBI_5740', 'Hiyodorilactone A', 145, 'hypercaloric')]
PMC3773449	8/2013	S214-PMC3773449	['high Salt intakes are known to increase Blood pressure levels and the risk of ckd, especially in overweight patients [80,152,153].']	N/A	N/A	[('CHEBI_24866', 'salt', 5, 'salt'), ('UBERON_0000178', 'blood', 40, 'blood')]
PMC3781185	7/2013	S39-PMC3781185	['Blood Glutathione Redox status and global methylation (pp.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_16856', 'glutathione', 6, 'Glutathione'), ('CHEBI_50845', 'doxycycline', 18, 'Redox')]
PMC3783381	9/2013	S188-PMC3783381	['this team is well equipped with ultrasonographic facilities along with a small laboratory for basic Blood and Urine tests and a well-established labor room.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('UBERON_0001088', 'urine', 110, 'urine')]
PMC3794936	10/2013	S41-PMC3794936	['Serum was obtained by centrifugation of Blood samples at 10,000 rpm/5 min.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0000178', 'blood', 40, 'blood')]
PMC3794936	10/2013	S184-PMC3794936	['body weight (b) Blood Glucose (c) Serum Triglyceride (d) Liver Triglyceride of Gcn2;db dko ( Gcn2 −/−; db/db ) and db/db ( Gcn2+/+;db/db ) Mice (mean ± sem, n\u200a=\u200a4, *p<0.05, Gcn2;db dko versus db/d b Mice).']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'Blood'), ('CHEBI_17234', 'glucose', 22, 'glucose'), ('UBERON_0001977', 'blood serum', 34, 'Serum'), ('CHEBI_17855', 'triglyceride', 40, 'triglyceride'), ('UBERON_0002107', 'liver', 57, 'Liver'), ('CHEBI_17855', 'triglyceride', 63, 'triglyceride'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 79, 'Gcn2'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 93, 'Gcn2'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 123, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 173, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 199, 'mice')]
PMC3798907	8/2013	S24-PMC3798907	['for comparison, we included control cultures supplemented with a second antioxidant, Vitamin C, for which there is no evidence of any associations between maternal intake, maternal Blood levels, cbmc responses and childhood wheeze/asthma [9,10,11].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 85, 'vitamin C'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC3798907	8/2013	S29-PMC3798907	['after Delivery, Cord Blood samples were collected to harvest Serum, (in tubes with no Anticoagulant) and cbmc, (in Sodium Heparin tubes).']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0002240', 'spinal cord', 16, 'cord'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001977', 'blood serum', 61, 'serum'), ('CHEBI_50249', 'anticoagulant', 86, 'anticoagulant'), ('CHEBI_28790', 'serotonin', 115, 'sodium heparin')]
PMC3798907	8/2013	S30-PMC3798907	['Blood was also obtained from Adults, including 18 atopic patients attending the Chest clinic at aberdeen royal infirmary and 21 healthy volunteers recruited from university staff.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0007023', 'adult organism', 29, 'adults'), ('UBERON_0012131', 'centrale', 80, 'Chest')]
PMC3798907	8/2013	S48-PMC3798907	['statistical analyses\nbased on our previous work [12], a study supplementing at least 40 Cord Blood samples had 80% power to detect a 20% difference in Cbmc Proliferation, 30% difference in Ifn-Γ secretion and a 15% difference in Il-4 secretion, at the 5% level of significance.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CL_0002062', 'type I pneumocyte', 151, 'CBMC'), ('GO_0070343', 'white fat cell proliferation', 151, 'CBMC proliferation'), ('PR_000008920', 'interferon alpha-7', 189, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 229, 'IL-4')]
PMC3798907	8/2013	S101-PMC3798907	['we were unable to demonstrate any associations between cbmc responses and maternal Blood Α-Tocopherol at 10 weeks Gestation and Delivery, nor with Cord Blood Α-Tocopherol.']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_27725', 'butin', 89, 'α-tocopherol'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('GO_0007567', 'parturition', 128, 'delivery'), ('UBERON_0002240', 'spinal cord', 147, 'cord'), ('UBERON_0000178', 'blood', 152, 'blood'), ('CHEBI_27725', 'butin', 158, 'α-tocopherol')]
PMC3813450	10/2013	S17-PMC3813450	['first, their body size allows application of the same imaging techniques routinely used in Humans and serial sampling of large amounts of Blood and Tissues.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 91, 'humans'), ('UBERON_0000178', 'blood', 138, 'blood'), ('UBERON_0000479', 'tissue', 148, 'tissues')]
PMC3813450	10/2013	S61-PMC3813450	['Blood samples were drawn by Jugular venipuncture with 5 ml sterile Heparin Blood vacuum tubes (vacutainertmsystems europe).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0004741', 'cleithrum', 28, 'jugular'), ('CHEBI_28304', 'heparin', 67, 'heparin'), ('UBERON_0000178', 'blood', 75, 'blood')]
PMC3813450	10/2013	S62-PMC3813450	['immediately after recovery, the Blood was centrifuged at 1500g for 15 min and the Plasma was separated and stored into polypropylene vials at -20°c until assayed.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0001969', 'blood plasma', 82, 'plasma')]
PMC3813450	10/2013	S65-PMC3813450	['evaluation of Blood indexes of Carbohydrates and Lipids Metabolism during juvenile development\nPlasma indexes of Carbohydrates and Lipids Metabolism were assessed, in Blood samples obtained as previously described, monthly after starting ad libitum access to the fat diet (120 days).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_16646', 'carbohydrate', 31, 'carbohydrates'), ('CHEBI_18059', 'lipid', 49, 'lipids'), ('GO_0006629', 'lipid metabolic process', 49, 'lipids metabolism'), ('UBERON_0001969', 'blood plasma', 95, 'Plasma'), ('CHEBI_16646', 'carbohydrate', 113, 'carbohydrates'), ('CHEBI_18059', 'lipid', 131, 'lipids'), ('GO_0006629', 'lipid metabolic process', 131, 'lipids metabolism'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC3814422	10/2013	S40-PMC3814422	['assessment of maternal and offspring 25(Oh) D concentrations\nmaternal non-fasting Blood samples taken as part of routine Antenatal care were collected and stored initially at −20°c and then at −80°c, with no further freeze–thaw cycles to the time of 25(Oh)D assessment.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 37, '25(OH) D'), ('UBERON_0000178', 'blood', 82, 'blood'), ('GO_0007567', 'parturition', 121, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 250, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 250, '25(OH)D')]
PMC3814422	10/2013	S51-PMC3814422	["as Bloods were sampled at random Gestational lengths during Pregnancy, to make the measures more comparable across mothers, we adjusted each woman's measure of 25(Oh)D to the date corresponding to their respective 3rd trimester midpoint (34 weeks) using a sine–cosine regression model."]	N/A	N/A	[('UBERON_0000178', 'blood', 3, 'bloods'), ('GO_0007565', 'female pregnancy', 33, 'gestational'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 163, 'OH)D')]
PMC3817352	10/2013	S34-PMC3817352	['Pregnant women health records start within the first 12 weeks of Pregnancy, and include general information (age, occupation, education, date of first visit, numbers of Pregnancy/infants, last Menstrual period, expected Delivery date, smoking habits, etc), history of diseases, family history of diseases, clinical measurements (height, weight, Blood pressure, Gynaecological examinations, ultrasonography, Gestational diabetes (gdm) screening test and other lab tests), complications during Pregnancy, Pregnancy outcomes (Delivery modes, labor complications, etc), and Postnatal period examinations (<42 days after Delivery).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy'), ('GO_0007613', 'memory', 193, 'menstrual'), ('UBERON_0001347', 'white adipose tissue', 193, 'menstrual'), ('GO_0007567', 'parturition', 220, 'delivery'), ('UBERON_0000178', 'blood', 345, 'blood'), ('UBERON_0001700', 'geniculate ganglion', 361, 'gynaecological'), ('GO_0007565', 'female pregnancy', 407, 'gestational'), ('GO_0007565', 'female pregnancy', 492, 'pregnancy'), ('GO_0007565', 'female pregnancy', 503, 'pregnancy'), ('GO_0007567', 'parturition', 523, 'delivery'), ('GO_0007567', 'parturition', 570, 'postnatal'), ('GO_0007567', 'parturition', 616, 'delivery')]
PMC3817352	10/2013	S36-PMC3817352	['the information of Feeding modalities (exclusive Breast feeding, mixed Breast and Formula Feeding, weaned from Breast feeding, and exclusive Formula Feeding) during the first 12 months, and the measurements of recumbent length/height, weight, Blood hemoglobin, and Blood pressure (from 3 years old) are collected and available in each health examination.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 19, 'feeding'), ('UBERON_0000310', 'breast', 49, 'breast'), ('GO_0007567', 'parturition', 71, 'breast'), ('UBERON_0000310', 'breast', 71, 'breast'), ('GO_0090440', 'abscisic acid transmembrane transporter activity', 82, 'formula feeding'), ('UBERON_0000310', 'breast', 111, 'breast'), ('GO_0090440', 'abscisic acid transmembrane transporter activity', 141, 'formula feeding'), ('UBERON_0000178', 'blood', 243, 'blood'), ('UBERON_0000178', 'blood', 265, 'blood')]
PMC3817352	10/2013	S45-PMC3817352	['Blood pressure was measured using a standardized mercury sphygmomanometer (xj11d, shanghai medical instruments co., china).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3818269	11/2013	S53-PMC3818269	['after 21 days of Lactation, the male offspring were weighed and Blood Glucose taken, after which they were forced to fast overnight (20:00–09:00).']	N/A	N/A	[('GO_0007595', 'lactation', 17, 'lactation'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_17234', 'glucose', 70, 'glucose')]
PMC3818269	11/2013	S55-PMC3818269	['Blood samples were drawn from the Tip Of the Tail at 0, 30, 60, 90 and 120\xa0min after administration of the Glucose load.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0010162', 'post-anal tail tip', 34, 'tip of ... tail'), ('CHEBI_17234', 'glucose', 107, 'glucose')]
PMC3818269	11/2013	S56-PMC3818269	['Blood Glucose concentrations were measured with a Glucometer (accu-check active; roche diagnostics, mannheim, germany).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_24321', 'glutamo group', 50, 'glucometer')]
PMC3818269	11/2013	S57-PMC3818269	['Blood chemistry analysis\nafter exsanguination of the Animals at 3 weeks, the Blood was centrifuged to obtain the Plasma sample.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_33208', 'Metazoa', 53, 'animals'), ('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0001969', 'blood plasma', 113, 'plasma')]
PMC3818269	11/2013	S161-PMC3818269	['lower Carbohydrate Intake results in lower Postprandial increase in Blood Glucose level, resulting in lower Postprandial Insulin secretion and suppression of Igf-1 Signaling Pathway.']	N/A	N/A	[('CHEBI_16730', 'chloramphenicol 3-acetate', 6, 'carbohydrate'), ('GO_0007631', 'feeding behavior', 19, 'intake'), ('GO_0007567', 'parturition', 43, 'postprandial'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_17234', 'glucose', 74, 'glucose'), ('GO_0007567', 'parturition', 108, 'postprandial'), ('PR_000045358', 'insulin family protein', 121, 'insulin'), ('GO_0038100', 'nodal binding', 158, 'IGF-1 signaling pathway'), ('PR_000008929', 'interferon-related developmental regulator 1', 158, 'IGF-1')]
PMC3820434	12/2012	S25-PMC3820434	['Blood concentrations of inflammatory markers are lowered following weight loss [14].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC3820434	12/2012	S40-PMC3820434	['elvs from obese Mice were absorbed by Peripheral Blood Monocytes, which then differentiated into Activated Macrophages with increased secretion of Tnf- Α and Il-6.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 16, 'mice'), ('UBERON_0012101', 'perinatal stage', 38, 'peripheral'), ('CL_0000081', 'blood cell', 49, 'blood'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CL_0000576', 'monocyte', 55, 'monocytes'), ('CL_0002627', 'mature astrocyte', 97, 'activated macrophages'), ('PR_000016492', 'TNFAIP3-interacting protein 1', 147, 'Tnf- α'), ('PR_000008988', 'interleukin-1 family member 5', 158, 'Il-6')]
PMC3820434	12/2012	S64-PMC3820434	['inflamed cls+ obese subjects displayed higher Plasma Insulin, homeostasis model assessment (homa), Triglycerides, Glucose, Blood pressure, High sensitive C-Reactive Protein (Hs-Crp) and lower hdl-Cholesterol, and Brachial Artery flow-mediated dilation compared with lean subjects.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 46, 'plasma'), ('PR_000045358', 'insulin family protein', 53, 'insulin'), ('CHEBI_17855', 'triglyceride', 99, 'triglycerides'), ('CHEBI_17234', 'glucose', 114, 'glucose'), ('UBERON_0000178', 'blood', 123, 'blood'), ('PR_000008550', '3-hydroxyisobutyryl-CoA hydrolase, mitochondrial', 139, 'high'), ('PR_000005890', 'crooked neck-like protein 1', 154, 'C-reactive protein'), ('PR_000006060', 'CWF19-like protein 1', 174, 'hs-CRP'), ('CHEBI_16113', 'cholesterol', 196, 'cholesterol'), ('UBERON_0001398', 'brachial artery', 213, 'brachial artery')]
PMC3820434	12/2012	S70-PMC3820434	['the Macrophage-Derived Apoptosis Inhibitor Of Macrophage (Aim) protein is increased in Blood and is incorporated into Adipocytes, thereby inducing Lipolysis in at.']	N/A	N/A	[('CL_0000235', 'macrophage', 4, 'macrophage'), ('PR_000010134', 'mitogen-activated protein kinase kinase kinase 15', 4, 'macrophage-derived apoptosis inhibitor of macrophage'), ('GO_0006915', 'apoptotic process', 23, 'apoptosis'), ('CHEBI_35222', 'inhibitor', 33, 'inhibitor'), ('CL_0000235', 'macrophage', 46, 'macrophage'), ('PR_000003890', 'A-kinase anchor protein 3', 58, 'AIM'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CL_0000136', 'fat cell', 118, 'adipocytes'), ('GO_0016042', 'lipid catabolic process', 147, 'lipolysis')]
PMC3820434	12/2012	S84-PMC3820434	['it defined mets components as (1) waist circumference ≥102\u2009cm in men and ≥88\u2009cm in women; (2) fasting Triglycerides ≥150\u2009mg/dl (1.70\u2009mmol/l); (3) hdl-Cholesterol <40\u2009mg/dl (1.03\u2009mmol/l) in men and <50\u2009mg/dl (1.29\u2009mmol/l) in women; (4) Blood pressure ≥130/85\u2009mmhg; (5) fasting-Glucose ≥100\u2009mg/dl (5.55\u2009mmol/l).']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 102, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 150, 'cholesterol'), ('UBERON_0000178', 'blood', 235, 'blood'), ('CHEBI_17234', 'glucose', 276, 'glucose')]
PMC3820434	12/2012	S146-PMC3820434	['with decreasing crf, increases occurred in obesity, Triglycerides, Triglyceride/hdl lipoprotein ratios, Blood pressure, mets and diabetes, and smoking [64].']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 52, 'triglycerides'), ('CHEBI_17855', 'triglyceride', 67, 'triglyceride'), ('UBERON_0000178', 'blood', 104, 'blood')]
PMC3820434	12/2012	S186-PMC3820434	['furthermore, smoking was found to increase the number and level of oxidation products of Phospholipids (oxpapc) in Peripheral Blood Mononuclear Cells causing Ros Generation via nox activation due to Reduced Glutathione.']	N/A	N/A	[('CHEBI_16247', 'phospholipid', 89, 'phospholipids'), ('CL_0000111', 'peripheral neuron', 115, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 115, 'peripheral'), ('UBERON_0000178', 'blood', 126, 'blood'), ('CL_0000226', 'single nucleate cell', 132, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 132, 'mononuclear'), ('CHEBI_8756', 'RNA (poly(A))', 158, 'ROS'), ('GO_0031099', 'regeneration', 158, 'ROS generation'), ('CHEBI_16856', 'glutathione', 199, 'reduced glutathione')]
PMC3826669	10/2013	S5-PMC3826669	['Blood samples were collected from each Individual and dna was extracted.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_1', 'root', 39, 'individual')]
PMC3826669	10/2013	S119-PMC3826669	['two milliliters of Venous Blood samples were collected in edta (Ethylenediaminetetraacetic Acid - an Anticoagulant for Blood samples-) tubes from these 314 subjects.']	N/A	N/A	[('UBERON_0001638', 'vein', 19, 'venous'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 64, 'Ethylenediaminetetraacetic acid'), ('CHEBI_50249', 'anticoagulant', 101, 'anticoagulant'), ('UBERON_0000178', 'blood', 119, 'blood')]
PMC3826669	10/2013	S143-PMC3826669	['he examined the patients, collected Bloods and stored them.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'bloods')]
PMC3826669	10/2013	S144-PMC3826669	['sn took the Bloods and participated in the Genetical laboratory part.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'bloods'), ('SO_0000704', 'gene', 43, 'genetical')]
PMC3829207	11/2013	S134-PMC3829207	['for example, many with an have compromised Cardiovascular status and shifts in Fluid balance, with some being dehydrated and some overhydrated; reduced Blood levels of albumin and anemia.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 43, 'cardiovascular'), ('UBERON_0006314', 'bodily fluid', 79, 'fluid'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC3855580	10/2013	S38-PMC3855580	['at 13.5\xa0years of age, Glucose, Insulin and Lipid concentrations were measured using fasting Blood samples.']	N/A	N/A	[('CHEBI_17234', 'glucose', 22, 'glucose'), ('PR_000045358', 'insulin family protein', 31, 'insulin'), ('CHEBI_18059', 'lipid', 43, 'lipid'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC3855580	10/2013	S97-PMC3855580	['maternal Folate, Vitamin B12 and Homocysteine concentrations were not associated with offspring Blood pressure or fasting Lipid concentrations (data not shown).']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 9, 'folate'), ('CHEBI_33279', 'vitamin D5', 17, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 17, 'vitamin B12'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 33, 'homocysteine'), ('UBERON_0000178', 'blood', 96, 'blood'), ('CHEBI_18059', 'lipid', 122, 'lipid')]
PMC3860105	7/2013	S41-PMC3860105	['the questionnaire included socio demographic characteristics of age and occupation, nutrition education topics of fruits and vegetables, whole grains, and low fat milks, Blood groups, results of Urinary and Blood tests, vital sign measurements and history of diseases including diabetes, tuberculosis and Cardiovascular.']	N/A	N/A	[('UBERON_0000178', 'blood', 170, 'blood'), ('UBERON_0001088', 'urine', 195, 'urinary'), ('UBERON_0000178', 'blood', 207, 'blood'), ('UBERON_0004535', 'cardiovascular system', 305, 'cardiovascular')]
PMC3860105	7/2013	S65-PMC3860105	['only one woman had an abnormal Blood pressure, one had diabetes, one had nephropathy, and six women had a history of Cardiovascular disease.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0004535', 'cardiovascular system', 117, 'cardiovascular')]
PMC3862451	1/2014	S35-PMC3862451	['no differences were shown in the physiology between the treatment and control populations in terms of body size, composition, Blood pressure, and Metabolic markers (11).']	N/A	N/A	[('UBERON_0000178', 'blood', 126, 'blood'), ('GO_0008152', 'metabolic process', 146, 'metabolic')]
PMC3868354	4/2013	S39-PMC3868354	['first morning fasting Urine samples and non-fasted morning Blood spots were collected approximately weekly at participants’ homes and transported to mrc keneba laboratory for processing.']	N/A	N/A	[('UBERON_0001088', 'urine', 22, 'urine'), ('UBERON_0000178', 'blood', 59, 'blood')]
PMC3869952	12/2013	S49-PMC3869952	['after written informed consent, the field workers collect Blood by Finger prick and prepare dried Blood spots for ano-nymized hiv testing (8).']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0002389', 'manual digit', 67, 'finger'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC3873449	12/2013	S59-PMC3873449	['Serum 25-Hydroxyvitamin D measurement\nBlood samples were collected from all women at 15-20 weeks of Gestation.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('UBERON_0000178', 'blood', 38, 'Blood'), ('GO_0007565', 'female pregnancy', 100, 'gestation')]
PMC3873449	12/2013	S60-PMC3873449	['the Blood samples were centrifuged and Serum samples were stored at -80°cuntil use.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001977', 'blood serum', 39, 'serum')]
PMC3876120	12/2013	S85-PMC3876120	['at the end of the experimental process (21 days) the offspring were euthanized by decapitation ( n between 6 to 8 males and females randomly selected 6–7 litters per maternal dietary group), Blood collected and Plasma stored at −20 °c, and Liver was dissected, weighted and stored at −80 °c for later analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 191, 'blood'), ('UBERON_0001969', 'blood plasma', 211, 'plasma'), ('UBERON_0002107', 'liver', 240, 'liver')]
PMC3877972	12/2013	S67-PMC3877972	['Blood Glucose threshold values for fasting ogtt and at 1\xa0h, 2\xa0h, were 5.1, 10.0, 8.5\xa0mmol/l (92, 180, 153\xa0mg/dl), respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose')]
PMC3882256	1/2014	S6-PMC3882256	['no associations were observed apart from maternal Iron Intake from supplements with offspring systolic Blood pressure (−0.8 mmhg, 99% ci −1.7 to 0, p\u200a=\u200a0.01 in the sample with all relevant data observed, and −0.7 mmhg, 99% ci −1.3 to 0, p\u200a=\u200a0.008 in the sample with missing data imputed).']	N/A	N/A	[('CHEBI_24870', 'ion', 50, 'iron'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC3882256	1/2014	S90-PMC3882256	['95% confidence intervals.10.1371/journal.pone.0084684.t002\n\ncaption (table-wrap): table 2\nsample characteristics by dietary iron intake as assessed by Food frequency questionnaire at 32 weeks Gestation (n\u200a=\u200a2958 for all, except where Cord ferritin data is used: n\u200a=\u200a795).dietary iron intake≥14.8 mg/day#(n\u200a=\u200a319)<14.8 mg/day (n\u200a=\u200a2,639)p value* dietary iron intake ## (mg/day) (m, sd ** ) 16.9 (1.9 )10.1 (2.5)– dietary Vitamin C intake ## (mg/day) (m, sd) 119.3 (35.6)81.8 (32.1)<0.001 age of mother (yrs) (m, sd) 30.0 (4.2)29.5 (4.2)0.02 pre-Pregnancy bmi (kg/m2) (m, sd) 21.7 (2.5)22.9 (3.6)<0.001 total energy Intake (kj) (m, sd) 10,100 (1,921)7,167 (1,645)<0.001 smoking in Pregnancy (%, 95% ci *** ) 10.7 (7.5, 14.6)15.0 (14.6, 14.4)0.001 caucasian (%, 95% ci) 98.1 (96.0, 99.3)99.0 (98.4, 99.3)0.2 university degree (%, 95% ci) 27.0 (22.2, 32.2)17.6 (16.2, 19.1)<0.001 vegetarian (%, 95% ci) 11.9 (8.3, 16.6)5.5 (4.6, 6.4)<0.001 primigravida (%, 95% ci) 48.0 (42.4, 53.6)51.0 (47.0, 50.9)0.8 early Pregnancy maternal anemia (<11 g/dl) (%, 95% ci) 6.6 (4.1, 9.9)4.1 (3.4, 4.9)0.04 report taking Iron supplements before 32 wks Gestation (%, 95% ci) 48.3 (42.7, 53.9)44.5 (42.6, 46.4)0.2 Cord Ferritin (µg/l) (m,sd) 151.9 (104.8) (n\u200a=\u200a−83)165.4 (123.6) (n\u200a=\u200a712)0.3 child systolic Blood pressure (mmhg) (m, sd) 103.9 (8.7)103.6 (8.8)0.5 child diastolic Blood pressure (mmhg) (m, sd) 60.3 (7.3)59.5 (7.8)0.08 child pulse wave velocity (m/s) (m, sd) 7.7 (1.3)7.5 (1.2)0.1 child flow mediated dilatation (%) (m, sd) 8.3 (3.5)8.0 (3.4)0.1 child body mass index (kg/m2) (m, sd) 17.9 (2.7)18.1 (3.0)0.2 child gender (male) (%, 95% ci) 55.2 (49.5, 60.7)50.3 (48.3, 52.2)0.1 Birthweight (g) (m, sd) 3,439 (486)3,450 (500)0.7 Gestational age (wks) (m, sd) 39.5 (1.6)39.6 (1.6)0.3\n#reference Nutrient intake (rni) for iron for women aged 19–50 years in the uk.']	N/A	N/A	[('CHEBI_33290', 'food', 151, 'food'), ('GO_0007565', 'female pregnancy', 192, 'gestation'), ('UBERON_0002240', 'spinal cord', 234, 'cord'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin C'), ('PR_000004900', 'complement C3', 428, 'C'), ('GO_0007565', 'female pregnancy', 544, 'pregnancy'), ('GO_0007631', 'feeding behavior', 614, 'intake'), ('GO_0007565', 'female pregnancy', 679, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1005, 'pregnancy'), ('CHEBI_24870', 'ion', 1101, 'iron'), ('GO_0007565', 'female pregnancy', 1132, 'gestation'), ('UBERON_0000948', 'heart', 1192, 'Cord'), ('CHEBI_5018', 'ferreirin', 1197, 'ferritin'), ('UBERON_0000178', 'blood', 1285, 'blood'), ('UBERON_0000178', 'blood', 1357, 'blood'), ('GO_0007608', 'sensory perception of smell', 1671, 'Birthweight'), ('GO_0007565', 'female pregnancy', 1721, 'Gestational'), ('CHEBI_33284', 'nutrient', 1786, 'nutrient')]
PMC3897149	10/2013	S8-PMC3897149	['in Dpd deficiency (omim 274270), thymine and uracil accumulate in Blood and Cerebrospinal Fluid resulting in their excess Excretion in Urine.']	N/A	N/A	[('PR_000006642', 'histone-lysine N-methyltransferase, H3 lysine-79 specific', 3, 'DPD'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001359', 'cerebrospinal fluid', 76, 'cerebrospinal fluid'), ('GO_0007588', 'excretion', 122, 'excretion'), ('UBERON_0001088', 'urine', 135, 'urine')]
PMC3897149	10/2013	S26-PMC3897149	['caption (table-wrap): table 1\n\nsummary of other investigations done for this patient\nhis Red Blood Cell (Rbc) galatose-1-phosphate was elevated, while his Rbc galt activity was 25% of the concurrent control [table 1].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 89, 'red blood cell'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CL_0000232', 'erythrocyte', 105, 'RBC'), ('CL_0000232', 'erythrocyte', 155, 'RBC')]
PMC3907150	1/2014	S70-PMC3907150	['female carriers of agammaglobulinemia, an x-linked Immune deficiency, exhibit non-random xci in B Cell Lymphocytes [48], and female carriers of wiskott-aldrich syndrome exhibit non-random inactivation in all Blood Cell lineages [49].']	N/A	N/A	[('UBERON_0002405', 'immune system', 51, 'immune'), ('CL_0000236', 'B cell', 96, 'B cell lymphocytes'), ('CL_0000081', 'blood cell', 208, 'blood cell'), ('UBERON_0000178', 'blood', 208, 'blood')]
PMC3907150	1/2014	S225-PMC3907150	['a periconceptual modest reduction of b Vitamins resulted in Adult phenotypes that included elevated Blood pressure, Insulin resistance, and obesity.']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 39, 'vitamins'), ('UBERON_0007023', 'adult organism', 60, 'adult'), ('UBERON_0000178', 'blood', 100, 'blood'), ('PR_000045358', 'insulin family protein', 116, 'insulin')]
PMC3914197	7/2012	S13-PMC3914197	['on admission, her Blood pressure was 108/60\u2009mmhg, pulse 95 beats/minute, temperature 97°f, Respiratory rate of 17 breaths/min, and saturating 98% on ambient air.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001004', 'respiratory system', 91, 'respiratory')]
PMC3914197	7/2012	S19-PMC3914197	['Urinalysis was significant for a specific gravity of 1.008, Red Blood Cells 8–10/high-power field, and 30\u2009mg/dl of protein.']	N/A	N/A	[('UBERON_0001286', "Bowman's space", 0, 'Urinalysis'), ('CL_0000232', 'erythrocyte', 60, 'red blood cells'), ('UBERON_0000178', 'blood', 64, 'blood')]
PMC3914197	7/2012	S20-PMC3914197	['complete Blood count showed hemoglobin of 13.7\u2009g/dl, hematocrit 42.6%, White Blood Cell count 15,200/mm3, and Platelet count of 76,000/mm3.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000738', 'leukocyte', 71, 'white blood cell'), ('UBERON_0000178', 'blood', 77, 'blood'), ('CL_0000233', 'platelet', 110, 'platelet')]
PMC3915248	2/2014	S33-PMC3915248	['of these, 267 provided Blood and Urine samples so the researchers could look for markers of biological damage.23the average age of study participants was 51.5 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0001088', 'urine', 33, 'urine')]
PMC3925765	9/2013	S57-PMC3925765	['maternal obesity phenotype, Blood parameters and breeding\nin calculating numbers of f0 to breed we used past fertility rates of 75% (controls) and 40% or less (obese mothers) (c=12, cex=10, mo=32 and moex=22).to study the f0 phenotype pre-breeding, at day 120, six Rats per group and end of Lactation, 8 Rats per groups, were fasted for 4 hours and euthanized by decapitation (Rodent guillotine.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 265, 'rats'), ('GO_0007595', 'lactation', 291, 'lactation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 304, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 377, 'Rodent')]
PMC3925765	9/2013	S65-PMC3925765	['at pnd 2 pups die if removed for fasting Blood thus pups were taken directly from mothers, Blood was pooled from offspring killed by decapitation to equalize litters to 10.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC3925765	9/2013	S68-PMC3925765	['at offspring pnd 36, one male and one female offspring per litter (n= 8) were randomly chosen, fasted 4 h and euthanized by decapitation, Trunk Blood obtained and Fat Depots excised and weighed.']	N/A	N/A	[('UBERON_0002100', 'trunk', 138, 'trunk'), ('UBERON_0000178', 'blood', 144, 'blood'), ('UBERON_0012349', 'digital pad', 163, 'fat depots')]
PMC3925765	9/2013	S69-PMC3925765	['Blood measurements\nGlucose, Triglycerides, Cholesterol enzymatically by synchron cx auto analyser (beckman coulter, co.), Insulin, leptin, Corticosterone, Testosterone and Estradiol were determined by ria(19–21).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 19, 'Glucose'), ('CHEBI_17855', 'triglyceride', 28, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 43, 'cholesterol'), ('PR_000045358', 'insulin family protein', 122, 'insulin'), ('CHEBI_16827', 'corticosterone', 139, 'corticosterone'), ('CHEBI_17347', 'testosterone', 155, 'testosterone'), ('CHEBI_23965', 'estradiol', 172, 'estradiol')]
PMC3925765	9/2013	S186-PMC3925765	['Uterine Blood flow.']	N/A	N/A	[('UBERON_0000995', 'uterus', 0, 'uterine'), ('UBERON_0000178', 'blood', 8, 'blood')]
PMC3926113	1/2014	S36-PMC3926113	['they were weighed once every week and Blood was sampled (~300\xa0µl) once in every two weeks from v. Saphena at its superficial course on Tibia to verify vitc status (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0001743', 'ligament of larynx', 98, 'saphena'), ('UBERON_0000979', 'tibia', 135, 'tibia')]
PMC3926113	1/2014	S44-PMC3926113	['immediately following Delivery of each pup, the body weight was recorded, an Intracardial Blood sample was taken and the pup was euthanized by decapitation, the procedure lasting no more than 2 minutes.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'delivery'), ('UBERON_3000720', 'stegochordal', 77, 'intracardial'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC3926113	1/2014	S47-PMC3926113	['Blood samples were centrifuged, stabilized and frozen after the Intracardial Blood sampling of the final pup from each dam.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_3000720', 'stegochordal', 64, 'intracardial'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC3926113	1/2014	S48-PMC3926113	['once all the pups were removed from the Uterus, Thoracotomy of the dam was performed and an Intracardial Blood sample was taken before sacrificing by decapitation and exsanguination.']	N/A	N/A	[('UBERON_0000995', 'uterus', 40, 'uterus'), ('UBERON_0002347', 'thoracic vertebra', 48, 'thoracotomy'), ('UBERON_3000720', 'stegochordal', 92, 'intracardial'), ('UBERON_0000178', 'blood', 105, 'blood')]
PMC3933171	3/2014	S21-PMC3933171	['Vitamin D status during hospitalisation\nBlood specimens were obtained within 48\u2005h of Birth, at 4\u2005weeks of age and at 36\u2005weeks pma or at discharge.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000178', 'blood', 40, 'Blood'), ('GO_0007567', 'parturition', 85, 'birth')]
PMC3933171	3/2014	S22-PMC3933171	['Serum 25(Oh)D concentrations were measured from the dried Blood spots using liquid chromatography/tandem mass spectrometry (zrt laboratories in beaverton, oregon).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 6, '25(OH ... D'), ('UBERON_0000178', 'blood', 58, 'blood')]
PMC3937317	2/2014	S45-PMC3937317	['at the first anc visit, Blood, Stool and Urine samples were collected, in addition to maternal anthropometrics, and basic demographic information.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0001988', 'feces', 31, 'stool'), ('UBERON_0001088', 'urine', 41, 'urine')]
PMC3937317	2/2014	S51-PMC3937317	['measures\nBlood was drawn at anc visits to make both thick and thin Blood smears at Antenatal care and at Delivery for maternal Peripheral, Cord and Placental samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'Blood'), ('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0007567', 'parturition', 83, 'antenatal'), ('GO_0007567', 'parturition', 105, 'delivery'), ('UBERON_0003060', 'pronephric duct', 127, 'peripheral ...'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0001987', 'placenta', 148, 'placental')]
PMC3937317	2/2014	S52-PMC3937317	['the remaining Blood was processed and stored at the laboratory, under temperature controlled conditions, for subsequent pcr analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC3937317	2/2014	S67-PMC3937317	['Cord Blood hemoglobin levels were also determined and Cord (fetal) hemoglobin defined by hemoglobin <12.5 g/dl, as previously defined[7].']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0002240', 'spinal cord', 54, 'cord')]
PMC3937317	2/2014	S79-PMC3937317	['results\nof the 813 women screened at anc, 706 (88%) consented women had Blood and Urine samples available for anemia, malaria, and schistosomiasis evaluation, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0001088', 'urine', 82, 'urine')]
PMC3938466	2/2014	S33-PMC3938466	['trained obstetricians (research fellows) reviewed labor and Delivery medical records as well as Prenatal medical records using a standardized abstraction form to collect information about medical and reproductive histories, Blood pressure values, any Pregnancy complications experienced by the participant, and the condition of the newborn after Delivery.17,20\nwe defined ptb in accordance with the guidelines set by the american college of obstetricians and gynecologists.21the date of the last Menstrual Period was used to define Gestational age and confirmed by an ultrasound examination before 20 weeks of Gestation.']	N/A	N/A	[('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('UBERON_0000178', 'blood', 224, 'blood'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy'), ('GO_0007567', 'parturition', 346, 'delivery'), ('GO_0007613', 'memory', 496, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 496, 'menstrual period'), ('GO_0007565', 'female pregnancy', 532, 'gestational'), ('GO_0007565', 'female pregnancy', 610, 'gestation')]
PMC3946277	3/2014	S86-PMC3946277	['Glucose (0.5 g.kg body weight−1) was administered as an intravenous bolus over 3 minutes and Arterial Blood samples (3 ml into chilled edta tubes) were collected immediately before (0 min) and at 10, 20, 30, 60, and 120 min after the start of the Glucose administration (time 0).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('UBERON_0001637', 'artery', 93, 'arterial'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_17234', 'glucose', 247, 'glucose')]
PMC3946277	3/2014	S87-PMC3946277	['all Blood samples were centrifuged immediately (10 min at 4°c) and Plasma was stored at –20°c for later laboratory analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001969', 'blood plasma', 67, 'plasma')]
PMC3946277	3/2014	S244-PMC3946277	['there is unequal provision of Umbilical Venous Blood between the Liver Lobes in fetal Life, with predominantly more going to the left Lobe, such that each Lobe may be differentially sensitive to changes in maternal Nutrient provision.']	N/A	N/A	[('UBERON_0007118', 'umbilicus', 30, 'umbilical'), ('UBERON_0001638', 'vein', 40, 'venous'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001113', 'lobe of liver', 65, 'liver lobes'), ('UBERON_0000104', 'life cycle', 86, 'life'), ('UBERON_0009912', 'anatomical lobe', 134, 'lobe'), ('UBERON_0009912', 'anatomical lobe', 155, 'lobe'), ('CHEBI_33284', 'nutrient', 215, 'nutrient')]
PMC3970319	5/2013	S4-PMC3970319	['a total of 77% of eligible Individuals were recruited and Blood pressure, Kidney size by ultrasound, and Glomerular filtration rate (gfr; calculated from Plasma cystatin c) were assessed.']	N/A	N/A	[('NCBITaxon_1', 'root', 27, 'individuals'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0002113', 'kidney', 74, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 105, 'glomerular'), ('UBERON_0001969', 'blood plasma', 154, 'plasma')]
PMC3970319	5/2013	S21-PMC3970319	['the provision of protein-energy supplements during Pregnancy in the gambia was found to be unrelated to any of the cvd risk factors studied, including body composition, Blood pressure, and Lipid profile in adolescents (9).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('UBERON_0000178', 'blood', 169, 'blood'), ('CHEBI_18059', 'lipid', 189, 'lipid')]
PMC3970319	5/2013	S44-PMC3970319	['bp: number of Individuals recruited for whom Blood pressure was measured, mm hg.']	N/A	N/A	[('NCBITaxon_1', 'root', 14, 'individuals'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC3970319	5/2013	S54-PMC3970319	['Blood pressure was assessed on all Individuals recruited into the 4.5-y follow-up.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_1', 'root', 35, 'individuals')]
PMC3970319	5/2013	S56-PMC3970319	['Blood pressure was measured on all Individuals in triplicate using an automated oscillometric device (omron 705it, morton medical).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_1', 'root', 35, 'individuals')]
PMC3970319	5/2013	S83-PMC3970319	['linear regression models were fitted adjusted for covariates relating to Blood pressure and Kidney function as appropriate.']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0002113', 'kidney', 92, 'kidney')]
PMC3970319	5/2013	S98-PMC3970319	['the mean systolic Blood pressure was 91.1 ± 7.5 mm hg for girls and 91.4 ± 7.7 mm hg for boys.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC3970319	5/2013	S99-PMC3970319	['mean diastolic Blood pressure was 55.0 ± 6.4 mm hg for girls and 53.8 ± 6.5 mm hg for boys.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC3970319	5/2013	S102-PMC3970319	['neither Kidney volume nor gfr was associated with Blood pressure (data not shown).']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'kidney'), ('UBERON_0000178', 'blood', 50, 'blood')]
PMC3970319	5/2013	S112-PMC3970319	['there was no association of this intervention with systolic Blood pressure or with either Kidney volume or gfr.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0002113', 'kidney', 90, 'kidney')]
PMC3970319	5/2013	S117-PMC3970319	['in the unadjusted intention-to-treat analysis, there was no association between the Micronutrient intervention and offspring Blood pressure or Kidney function ( table 5 ).']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0002113', 'kidney', 143, 'kidney')]
PMC3970319	5/2013	S119-PMC3970319	['there was no effect of the high- compared with low-iron intervention on offspring Blood pressure ( table 6 ).']	N/A	N/A	[('UBERON_0000178', 'blood', 82, 'blood')]
PMC3970319	5/2013	S121-PMC3970319	['caption (table-wrap): table 4\n\neffect of maternal Food intervention on offspring Blood pressure and Kidney function at 4.5 y in bangladesh1n model 12p value r2(%) n model 23p value r2(%) n model 34p value r2(%)systolic pressure (mm hg)23120.46 (−0.16, 1.08)0.15 (0.05)21960.42 (−0.21, 1.05)0.19 (0.03)19690.57 (−0.08, 1.21)0.09 (0.09)diastolic pressure (mm hg)23120.58 (0.06, 1.11)0.03 (0.16)21960.59 (0.05, 1.13)0.03 (0.16)19690.72 (0.16, 1.28)0.01 (0.26)Kidney volume (cm3/m2)1068−0.09 (−1.98, 1.79)0.92 (−0.09)9680.01 (−1.90, 1.91)0.99 (−0.09)8610.45 (−1.55, 2.45)0.66 (−0.08)Gfr5[ml/(min\u2009·\u20091.73 m2)]1224−1.86 (−5.79, 2.08)0.36 (−0.01)1222−1.92 (−5.77, 1.94)0.33 (−0.00)1093−1.23 (−5.27, 2.80)0.55 (−0.05)\nvalues are regression coefficients (β) showing the difference in mean Blood pressure (95% ci) for Individuals Born to women invited to receive Food Supplements early in Pregnancy (coded 0) compared with the usual time (coded 1), derived from linear regression analysis.']	N/A	N/A	[('CHEBI_33290', 'food', 50, 'food'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0002113', 'kidney', 100, 'kidney'), ('UBERON_0002113', 'kidney', 456, 'Kidney'), ('PR_000007949', 'GDNF family receptor alpha-2', 579, 'GFR5'), ('UBERON_0000178', 'blood', 779, 'blood'), ('NCBITaxon_1', 'root', 807, 'individuals'), ('GO_0007567', 'parturition', 819, 'born'), ('CHEBI_33290', 'food', 852, 'food'), ('CHEBI_33341', 'titanium atom', 857, 'supplements'), ('GO_0007565', 'female pregnancy', 878, 'pregnancy')]
PMC3970319	5/2013	S125-PMC3970319	['model 2, additionally adjusted for age, sex, wealth index, tertiles of maternal wk 8 of Gestation Blood pressure (Blood pressure models only), and season of Birth fitted as fourier terms (36).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0000178', 'blood', 114, 'blood'), ('GO_0007567', 'parturition', 157, 'birth')]
PMC3970319	5/2013	S128-PMC3970319	['caption (table-wrap): table 5\n\neffect of maternal multiple Micronutrient supplementation on offspring Blood pressure and Kidney function at 4.5 y in bangladesh1n model 12p value r2(%) n model 23p value r2(%) n model 34p value r2(%)systolic pressure (mm hg)23120.05 (−0.71, 0.81)0.90 (−0.04)21960.05 (−0.73, 0.82)0.90 (−0.04)19690.22 (−0.58, 1.02)0.58 (−0.03)diastolic pressure (mm hg)23120.55 (−0.10, 1.20)0.09 (0.08)21960.60 (−0.07, 1.26)0.08 (0.09)19690.87 (0.18, 1.56)0.01 (0.25)Kidney volume (cm3/m2)1069−0.98 (−3.30, 1.34)0.41 (−0.03)968−1.75 (−4.09, 0.60)0.14 (0.11)861−1.45 (−3.89, 1.00)0.25 (0.04)Gfr5[ml/(min\u2009·\u20091.73 m2)]12241.30 (−3.55, 6.14)0.60 (−0.06)12222.08 (−2.66, 6.83)0.39 (−0.02)10933.43 (−1.56, 8.42)0.18 (0.07)\nvalues are regression coefficients (β) showing the difference in mean Blood pressure (95% ci) for Individuals Born to women in the mms compared with the fe30f intervention group, derived from linear regression analysis.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 59, 'micronutrient'), ('UBERON_0000178', 'blood', 102, 'blood'), ('UBERON_0002113', 'kidney', 121, 'kidney'), ('UBERON_0002113', 'kidney', 482, 'Kidney'), ('PR_000007949', 'GDNF family receptor alpha-2', 605, 'GFR5'), ('UBERON_0000178', 'blood', 801, 'blood'), ('NCBITaxon_1', 'root', 829, 'individuals'), ('GO_0007567', 'parturition', 841, 'born')]
PMC3970319	5/2013	S132-PMC3970319	['model 2, additionally adjusted for age, sex, wealth index, tertiles of maternal Blood pressure (Blood pressure models only), and season of Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0000178', 'blood', 96, 'blood'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC3970319	5/2013	S139-PMC3970319	['there was no association between the number of Food packets consumed and offspring Blood pressure, Kidney volume, or gfr ( supplemental table 2 ).']	N/A	N/A	[('CHEBI_33290', 'food', 47, 'food'), ('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0002113', 'kidney', 99, 'kidney')]
PMC3970319	5/2013	S140-PMC3970319	['similarly, there was no association between tablet Consumption as measured by bottle opening and offspring Blood pressure, Kidney volume, or gfr ( supplemental table 3 ).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 51, 'consumption'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC3970319	5/2013	S144-PMC3970319	['no other effects of the Food or Micronutrient interventions on offspring Blood pressure, Kidney volume, or gfr were observed and there was no interaction between the interventions on the outcomes studied.']	N/A	N/A	[('CHEBI_33290', 'food', 24, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 32, 'micronutrient'), ('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0002113', 'kidney', 89, 'kidney')]
PMC3970319	5/2013	S152-PMC3970319	['two other trials, both from nepal, of multiple-Micronutrient supplementation in Pregnancy have published data on offspring Blood pressure.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 47, 'micronutrient'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0000178', 'blood', 123, 'blood')]
PMC3970319	5/2013	S172-PMC3970319	['model 2, additionally adjusted for age, sex, wealth index, tertiles of maternal Blood pressure (Blood pressure models only), and season of Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0000178', 'blood', 96, 'blood'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC3973641	4/2014	S108-PMC3973641	['in this context, there is an increase of Cellular Proliferation and One-Carbon Metabolism resulting from Placental Development, fetal growth, Uterine enlargement and expansion of Blood volume[27].']	N/A	N/A	[('GO_0008283', 'cell proliferation', 41, 'cellular proliferation'), ('GO_0006730', 'one-carbon metabolic process', 68, 'one-carbon metabolism'), ('GO_0001890', 'placenta development', 105, 'placental development'), ('UBERON_0001987', 'placenta', 105, 'placental'), ('UBERON_0000995', 'uterus', 142, 'uterine'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC3973641	4/2014	S182-PMC3973641	['Blood was collected in tubes (becton dickinson, new england, uk) containing Ethylenediaminetetraacetic Acid (edta) and stored on ice, and up to 90 minutes, centrifuged at 3000 rpm for 10 minutes at 4 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 76, 'ethylenediaminetetraacetic acid')]
PMC3973835	3/2014	S83-PMC3973835	['a Venous edta Blood sample for measurement of glycosylated haemoglobin (hba1c) is collected.']	N/A	N/A	[('UBERON_0001638', 'vein', 2, 'venous'), ('UBERON_0000178', 'blood', 14, 'blood')]
PMC3973835	3/2014	S98-PMC3973835	['at every Antenatal visit, weight, Blood pressure, Urine analysis data as well as Pregnancy complications are routinely documented in the maternity card.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'antenatal'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001088', 'urine', 50, 'urine'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC3973835	3/2014	S121-PMC3973835	['to obtain additional information on the presence and severity of diagnosed gdm, edta Blood is collected for the measurement of the glycosylated haemoglobin concentration between the 30thand 34thweek of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood'), ('GO_0007565', 'female pregnancy', 202, 'gestation')]
PMC3991049	11/2013	S34-PMC3991049	['Blood samples were obtained for Serum levels of calcium, phosphorus, alkaline phosphatase, total protein and albumin, 25-Hydroxyvitamin D level and Parathyroid hormone (pth).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 32, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 118, '25-hydroxyvitamin D'), ('UBERON_0001132', 'parathyroid gland', 148, 'parathyroid')]
PMC3991049	11/2013	S35-PMC3991049	['the same Blood tests done at entry in the first trimester were repeated in 2ndtrimester and 3rdtrimester.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC3991049	11/2013	S54-PMC3991049	['the range of Vitamin D level in 61 Umbilical Cord Blood samples of the newborns was 3 and 59\xa0ng/ml with a mean level of 22.36\xa0ng/ml (table 1).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 35, 'umbilical cord'), ('UBERON_0000178', 'blood', 50, 'blood')]
PMC3994635	8/2010	S3-PMC3994635	['we collected Blood and Urine from the subjects at 20 wk Gestation and at 13 wk Postpartum.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0001088', 'urine', 23, 'urine'), ('GO_0007565', 'female pregnancy', 56, 'gestation'), ('GO_0007565', 'female pregnancy', 79, 'postpartum')]
PMC3994635	8/2010	S18-PMC3994635	['subjects and methods\n\nparticipants and study design\na subset of 125 participants in a trial of Pregnancy Calcium supplementation and Blood pressure in rural gambian women (international trial registry: isrctn96502494) was invited to participate in an investigation of bone outcomes for the mother and infant in the first year Postpartum.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_22313', 'alkaline earth metal atom', 105, 'calcium'), ('UBERON_0000178', 'blood', 133, 'blood'), ('GO_0007565', 'female pregnancy', 326, 'postpartum')]
PMC3994635	8/2010	S29-PMC3994635	['Blood and Urine samples were collected at 13 wk Postpartum.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 10, 'urine'), ('GO_0007565', 'female pregnancy', 48, 'postpartum')]
PMC3994635	8/2010	S30-PMC3994635	['Blood and Urine were collected at 20 wk of Pregnancy before the start of supplementation, and samples were available for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 10, 'urine'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy')]
PMC3994635	8/2010	S46-PMC3994635	['successful Blood and Urine collections were obtained from the majority of subjects ( n = 123; except n = 115 for Urine at 13 wk).']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0001088', 'urine', 21, 'urine'), ('UBERON_0001088', 'urine', 113, 'urine')]
PMC3994635	8/2010	S47-PMC3994635	['overnight-fasting Blood samples were collected into precooled tubes containing lithium Heparin for most analytes or potassium edta for Parathyroid hormone (pth).']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_28304', 'heparin', 87, 'heparin'), ('UBERON_0001132', 'parathyroid gland', 135, 'parathyroid')]
PMC3994935	5/2014	S32-PMC3994935	['after informed consent, women reported to the ctrc clinic, where they had a fasting (≥10 h) Venous Blood sample collected (day 1) and were then placed on a washout/control diet for 2 days (described below).']	N/A	N/A	[('UBERON_0001638', 'vein', 92, 'venous'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC3994935	5/2014	S34-PMC3994935	['after 3 days of the first diet, on day 6, the women reported to the ctrc fasted; a baseline Blood sample was collected, and the cgms monitor was removed.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood')]
PMC3994935	5/2014	S35-PMC3994935	['a prepared breakfast meal, as outlined below, was administered consistent with the first diet assignment, and hourly Blood samples were collected for 5 h to study the Postprandial breakfast response.']	N/A	N/A	[('UBERON_0000178', 'blood', 117, 'blood'), ('GO_0007567', 'parturition', 167, 'postprandial')]
PMC3994935	5/2014	S57-PMC3994935	['Blood measures\nPlasma Glucose was measured using hexokinase (beckman coulter, brea, ca).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 15, 'Plasma'), ('CHEBI_17234', 'glucose', 22, 'glucose')]
PMC3994935	5/2014	S81-PMC3994935	['Blood was sampled hourly for 5 h to measure Postprandial tg, ffa, Glucose, c-peptide, and Insulin.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 44, 'postprandial'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('PR_000045358', 'insulin family protein', 90, 'insulin')]
PMC3999948	4/2014	S120-PMC3999948	['the primary outcome in the study was a reduction in excessive weight gain during Pregnancy, and the secondary outcomes were maternal weight gain, Blood pressure, quality of Life, and fetal outcomes (newborn weight, apgar scores, prematurity rate, and adequacy).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0000178', 'blood', 146, 'blood'), ('UBERON_0000104', 'life cycle', 173, 'life')]
PMC4002571	12/2013	S3-PMC4002571	['Blood samples were collected before and after chronic stress, and Serum acth, Corticosterone, Glucose, Insulin, total Cholesterol, Triglyceride and Free Fatty Acids levels were measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_16827', 'corticosterone', 78, 'corticosterone'), ('CHEBI_17234', 'glucose', 94, 'glucose'), ('PR_000045358', 'insulin family protein', 103, 'insulin'), ('CHEBI_16113', 'cholesterol', 118, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 131, 'triglyceride'), ('CHEBI_37958', 'dye', 148, 'free'), ('CHEBI_35366', 'fatty acid', 153, 'fatty acids')]
PMC4002571	12/2013	S28-PMC4002571	['after Birth and the initiation of a normal diet, the iugr offspring induced by pne showed low basal activity but an enhanced sensitivity of the hpa axis to chronic stress, as well as gc-dependent phenotypic alterations of the Blood Glucose and Lipid Metabolism14.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'birth'), ('UBERON_0000178', 'blood', 226, 'blood'), ('CHEBI_17234', 'glucose', 232, 'glucose'), ('GO_0007369', 'gastrulation', 232, 'glucose ...'), ('CHEBI_18059', 'lipid', 244, 'lipid'), ('GO_0090452', 'lithium ion transmembrane transport', 244, 'lipid metabolism14')]
PMC4002571	12/2013	S61-PMC4002571	['at pw16, the Animals were fasted for 12 h, and Blood was taken via the Vena Caudalis within 3 min to measure levels of acth, cort, Glucose, Insulin, tch, tg and ffa.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 13, 'animals'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0005486', 'venous dural sinus', 71, 'vena caudalis'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('PR_000045358', 'insulin family protein', 140, 'insulin')]
PMC4002571	12/2013	S67-PMC4002571	['Blood samples were collected via the Vena Caudalis within 5 min before and after chronic stress, and the Serum was prepared by centrifugation at 17 205× g for 15 min at 4 °c and then stored at −80 °c until it was used to measure the levels of acth, cort, Glucose, insulin, tch, tg, and ffa.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0005486', 'venous dural sinus', 37, 'vena caudalis'), ('UBERON_0001977', 'blood serum', 105, 'serum'), ('CHEBI_17234', 'glucose', 255, 'glucose')]
PMC4002571	12/2013	S69-PMC4002571	["analysis for Blood samples\nSerum Acth and Cort were detected using radioimmunoassay and an elisa kit, respectively, following the manufacturer's protocol."]	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0001977', 'blood serum', 27, 'Serum'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 33, 'ACTH'), ('PR_000005866', 'cAMP-responsive element modulator', 42, 'CORT')]
PMC4014765	3/2014	S2-PMC4014765	['methods: we measured the concentrations of 8 Phthalate Metabolites, Bisphenol A, 25 Polychlorinated Biphenyls (Pcbs), 6 Organochlorine Pesticides, 8 Brominated flame Retardants, and 4 Perfluoroalkyl substances in Blood or Urine samples from 175 Pregnant women in the home (health outcomes and measures of the environment) study (cincinnati, oh).']	N/A	N/A	[('CHEBI_29262', 'diphosphonate(2-)', 45, 'phthalate'), ('CHEBI_25212', 'metabolite', 55, 'metabolites'), ('CHEBI_33216', 'bisphenol A', 68, 'bisphenol A'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 84, 'polychlorinated biphenyls'), ('CHEBI_26199', 'polyprenol', 111, 'PCBs'), ('CHEBI_39429', 'hexafluoroacetone', 120, 'organochlorine pesticides'), ('CHEBI_22923', 'bromate salt', 149, 'brominated'), ('CHEBI_33865', 'rhamnonates', 166, 'retardants'), ('CHEBI_81797', 'cyflufenamid', 184, 'perfluoroalkyl'), ('UBERON_0000178', 'blood', 213, 'blood'), ('UBERON_0001088', 'urine', 222, 'urine'), ('GO_0007565', 'female pregnancy', 245, 'pregnant')]
PMC4017421	7/2011	S25-PMC4017421	['in addition, the maternal Blood volume increases by up to 40% of the value for non Pregnant state resulting in decreased Nutrient concentrations with advancing Gestation (9).']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_33284', 'nutrient', 121, 'nutrient'), ('GO_0007565', 'female pregnancy', 160, 'gestation')]
PMC4021291	4/2014	S76-PMC4021291	['hemoglobin was estimated by mixing fresh whole Blood with k3-edta prior to analysis by an automated hematology analyzer (sysmex xs-800i, sysmex india,).']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood')]
PMC4021291	4/2014	S78-PMC4021291	['Erythrocyte ferritin was measured in fresh Blood and analyzed using an enzyme immunoassay imx-ferritin kit and an imx analyzer.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 0, 'Erythrocyte'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC4026129	1/2014	S63-PMC4026129	['iasvis reduced to iasiiimainly in the Blood or Liver by one of several Mammalian enzymes that utilize Glutathione (Gssh) or Dithiothreitol (Dtt) as reductants.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0002107', 'liver', 47, 'liver'), ('NCBITaxon_40674', 'Mammalia', 71, 'mammalian'), ('CHEBI_16856', 'glutathione', 102, 'glutathione'), ('CHEBI_86624', 'G b1-G', 115, 'GSSH'), ('CHEBI_18320', '1,4-dithiothreitol', 124, 'dithiothreitol'), ('CHEBI_18320', '1,4-dithiothreitol', 140, 'DTT')]
PMC4026129	1/2014	S76-PMC4026129	['no associations with Line-1 methylation.hossain et al., 2012 [50•]newborns from thailand (n\u2009=\u200971); in vitro exposure to Arsenite (Lymphoblasts)Arsenic in Cord Blood\u2009=\u20090.51-10.37\xa0μg/g; Toenail\u2009=\u2009nd-8.23; Hair\u2009=\u2009nd-0.38\xa0μg/g; in vitro short term: 0, 10, 20, 50\xa0μm Naaso2For 0, 2, 4, 8\xa0h; in vitro long term: 0, 0.5, 1\xa0μm Naaso2For 0, 2, 4, 6, 8\xa0weekscord Blood Lymphocytes; Lymphoblast Cell line rpmi1788global Dna Methylation was calculated by determination of total 5-Methyldeoxycytidine content via hplc-ms/ms and the Dna Methylation status of Line-1 using combined Bisulfite restriction analysis (cobra).']	N/A	N/A	[('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 21, 'LINE-1'), ('CHEBI_29866', 'arsenite(3-)', 120, 'arsenite'), ('CL_0000542', 'lymphocyte', 130, 'lymphoblasts'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 143, 'Arsenic'), ('UBERON_0002240', 'spinal cord', 154, 'cord'), ('UBERON_0000178', 'blood', 159, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 184, 'toenail'), ('UBERON_0001037', 'strand of hair', 203, 'hair'), ('CHEBI_7492', 'nedocromil', 262, 'NaAsO2for'), ('CHEBI_7492', 'nedocromil', 319, 'NaAsO2for'), ('CL_0000081', 'blood cell', 353, 'blood lymphocytes'), ('UBERON_0000178', 'blood', 353, 'blood'), ('CL_0000453', 'Langerhans cell', 372, 'Lymphoblast cell'), ('GO_0006306', 'DNA methylation', 409, 'DNA methylation'), ('CHEBI_20598', '5-methoxycarbonylmethyluridine', 466, '5-methyldeoxycytidine'), ('GO_0006306', 'DNA methylation', 519, 'DNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 545, 'LINE-1'), ('CHEBI_29874', 'bromine dioxide', 567, 'bisulfite')]
PMC4029895	5/2014	S60-PMC4029895	['non-plausible values were identified and dropped from the analysis, for example, height <100\xa0cm and weight <18\xa0kg, systolic Blood pressure <50\xa0mmhg and diastolic Blood pressure <40\xa0mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 124, 'blood'), ('UBERON_0000178', 'blood', 162, 'blood')]
PMC4029895	5/2014	S94-PMC4029895	['caption (table-wrap): table 1\n\nlist of quality of care indicators\xa0 part a. accepted indicators \xa0\xa0 initiation and number of Antenatal visits \xa0 1 percentage of Pregnant women who began anc during the first Trimester of Gestation\xa0 2 percentage of women with low risk Pregnancy†who at the end of the Pregnancy had at least four anc visits\xa0\xa0 health education \xa0 3 percentage of Pregnant women who had documented educational activities provided by the maternity nurse or social worker\xa0 4 percentage of overweight/obese (pre-Pregnancy bmi ≥ 25 kg/m2) Pregnant women who had documented nutritional counselling provided by the nutrition service\xa0\xa0 screening \xa0 5 percentage of Pregnant women who were referred to or had documented Rh and Blood group test\xa0 6 percentage of Pregnant women who were referred to haemoglobin test during the first two anc visits\xa0 7 percentage of Pregnant women who were referred to fasting Plasma Glucose test during the first two anc visits and between weeks 24 and 28 of Gestation\xa0 8 percentage of Pregnant women who were referred to obstetric ultrasound between weeks 18 and 22 of Gestation\xa0 9 percentage of Pregnant women who were referred to vdrl test (syphilis screening) during the first two anc visits\xa0\xa0 nutritional supplementation \xa0 10 percentage of Pregnant women who had prescription of Folic Acid during the first Trimester of Gestation\xa0\xa0 treatment and referrals to the obstetrician-gynecologist \xa0 11 percentage of Pregnant women diagnosed with bacterial vaginosis or trichomoniasis, who had Vaginal Metronidazol prescription in adequate doses and duration\xa0 12 percentage of Pregnant women with systolic Blood pressure ≥ 140 mmhg, or diastolic Blood pressure ≥ 90 mmhg who was referred to the second or third level of care\xa0 13 percentage of Pregnant women with pre-existing degenerative chronic disease (diabetes, hypertension, lupus, Heart disease) who were referred to the second or third level of care\xa0 14 percentage of Pregnant women between 20–32 weeks with Symphysis-Fundal height 4 cm less than indicated by their Gestational age, who were referred to ultrasound or another level of care\xa0\xa0 part b. discarded indicatorsreasons of elimination 1.']	N/A	N/A	[('GO_0007567', 'parturition', 123, 'antenatal'), ('GO_0007565', 'female pregnancy', 158, 'pregnant'), ('GO_0009294', 'DNA mediated transformation', 204, 'trimester'), ('GO_0007565', 'female pregnancy', 217, 'gestation'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('GO_0007565', 'female pregnancy', 296, 'pregnancy'), ('GO_0007565', 'female pregnancy', 372, 'pregnant'), ('GO_0007565', 'female pregnancy', 517, 'pregnancy'), ('GO_0007565', 'female pregnancy', 543, 'pregnant'), ('GO_0007565', 'female pregnancy', 665, 'pregnant'), ('PR_000013773', 'retinoblastoma-associated protein', 719, 'Rh'), ('UBERON_0000178', 'blood', 726, 'blood'), ('GO_0007565', 'female pregnancy', 760, 'pregnant'), ('GO_0007565', 'female pregnancy', 862, 'pregnant'), ('UBERON_0001969', 'blood plasma', 906, 'plasma'), ('CHEBI_17234', 'glucose', 913, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'gestation'), ('GO_0007565', 'female pregnancy', 1016, 'pregnant'), ('GO_0007565', 'female pregnancy', 1100, 'gestation'), ('GO_0007565', 'female pregnancy', 1127, 'pregnant'), ('GO_0007565', 'female pregnancy', 1275, 'pregnant'), ('CHEBI_30751', 'formic acid', 1314, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 1342, 'trimester'), ('GO_0007565', 'female pregnancy', 1355, 'gestation'), ('GO_0007565', 'female pregnancy', 1443, 'pregnant'), ('UBERON_0001987', 'placenta', 1520, 'vaginal'), ('CHEBI_81835', 'Glyphosate-monoammonium', 1528, 'metronidazol'), ('GO_0007565', 'female pregnancy', 1603, 'pregnant'), ('UBERON_0000178', 'blood', 1632, 'blood'), ('UBERON_0000178', 'blood', 1672, 'blood'), ('GO_0007565', 'female pregnancy', 1769, 'pregnant'), ('UBERON_0000948', 'heart', 1863, 'heart'), ('GO_0007565', 'female pregnancy', 1951, 'pregnant'), ('UBERON_0002216', 'symphysis', 1991, 'symphysis'), ('UBERON_0003631', 'pedal digit 1', 2001, 'fundal'), ('GO_0007565', 'female pregnancy', 2049, 'gestational')]
PMC4029895	5/2014	S96-PMC4029895	['percentage of Pregnant women who had their Blood pressure measured at each anc visit.3.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC4029895	5/2014	S140-PMC4029895	['caption (table-wrap): table 4\n\nquality of careindicators%initiation and number of Antenatal visits \xa0pregnant women who began anc during the first Trimester of Gestation n\u2009=\u20095342 40.6women with low risk Pregnancy† who at the end of the Pregnancy had at least 4 anc visits n\u2009=\u20094300 63.5 education for health \xa0pregnant women with documented educational activities provided by the maternity nurse or social worker n\u2009=\u20095342 20.7overweight/obese (pre-Pregnancy bmi\u2009≥\u200925\xa0kg/m2) Pregnant women who had documented nutritional counseling provided by the nutrition service n\u2009=\u20091754 26.0 screeningn\u2009=\u20095342 Pregnant women referred to or had documented rh and Blood group test23.9pregnant women referred to hemoglobin test during the first 2 anc visits41.9pregnant women referred to fasting Plasma Glucose test during the first 2 anc visits and between weeks 24 and 28 of Gestation41.1pregnant women referred to obstetric ultrasound between weeks 18 and 22 of Gestation4.4pregnant women referred to vdrl test (syphilis screening) during the first 2 anc visits40.1 supplementationn\u2009=\u20092169 pregnant women prescribed Folic Acid during the first Trimester of Gestation64.6 treatment and references to the obstetrician-gynecologists consultation at the second level of care \xa0pregnant women diagnosed with bacterial vaginosis or trichomoniasis who had Vaginal Metronidazol prescription n\u2009=\u200995 45.3pregnant women with systolic Blood pressure ≥140\xa0mmhg, or diastolic\u2009≥\u200990\xa0mmhg referred to the second or third level of care n\u2009=\u2009291 69.1pregnant women with pre-existing degenerative chronic disease (diabetes, hypertension, lupus, Heart disease) referred to the second or third level of care n\u2009=\u200954 92.6pregnant women between 20–32 weeks with Symphysis-Fundal height 4\xa0cm less than indicated by their Gestational age, referred to ultrasound or another level of care n\u2009=\u20091445 60.3 percentage of recommended care††,mean (standard deviation) 32.7 (22.2)\nn: indicates the number of women eligible for the evaluated indicator; †low risk Pregnancy: <4 points at the obstetric risk scored system of ehr;††proportion of Antenatal Care procedures that a woman received relative the total number of indicators for which she was eligible.']	N/A	N/A	[('GO_0007567', 'parturition', 82, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 146, 'trimester'), ('GO_0007565', 'female pregnancy', 159, 'gestation'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007565', 'female pregnancy', 445, 'pregnancy'), ('GO_0007565', 'female pregnancy', 471, 'pregnant'), ('GO_0007565', 'female pregnancy', 594, 'Pregnant'), ('UBERON_0000178', 'blood', 646, 'blood'), ('UBERON_0001969', 'blood plasma', 777, 'plasma'), ('CHEBI_17234', 'glucose', 784, 'glucose'), ('GO_0007565', 'female pregnancy', 858, 'gestation41'), ('GO_0007565', 'female pregnancy', 946, 'gestation4'), ('CHEBI_30751', 'formic acid', 1100, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 1128, 'trimester'), ('GO_0007565', 'female pregnancy', 1141, 'gestation64'), ('UBERON_0001987', 'placenta', 1332, 'vaginal'), ('CHEBI_81835', 'Glyphosate-monoammonium', 1340, 'metronidazol'), ('UBERON_0000178', 'blood', 1406, 'blood'), ('UBERON_0000948', 'heart', 1607, 'heart'), ('UBERON_0002216', 'symphysis', 1719, 'symphysis'), ('UBERON_0003631', 'pedal digit 1', 1729, 'fundal'), ('GO_0007565', 'female pregnancy', 1777, 'gestational'), ('GO_0007565', 'female pregnancy', 2008, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 2088, 'antenatal care')]
PMC4029895	5/2014	S150-PMC4029895	['in vietnam the investigators defined a typical minimum anc content: seven items on bio-medical assessments (body weight, Blood pressure, Fundal height, fetal Heart rate, Vaginal examination, Urine testing, and ultrasound), four items on care provision (tetanus Toxoid immunization, provision of tablets or advice on iron/folate Supplement, malaria prevention, and preparation for safe delivery), and two items on health promotion/education (resting and nutrition) [19].']	N/A	N/A	[('UBERON_0000178', 'blood', 121, 'blood'), ('UBERON_0003631', 'pedal digit 1', 137, 'fundal'), ('UBERON_0000948', 'heart', 158, 'heart'), ('UBERON_0001987', 'placenta', 170, 'vaginal'), ('UBERON_0001088', 'urine', 191, 'urine'), ('CHEBI_29238', 'tritium atom', 261, 'toxoid'), ('CHEBI_16158', 'steroid sulfate', 328, 'supplement')]
PMC4034700	5/2014	S103-PMC4034700	['long-term infusion of Et-1 into Sheep also induced preeclampsia-like symptoms, i.e., hypertension, proteinuria, and decreased Uteroplacental Blood flow (greenberg et al., 1997).']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 22, 'ET-1'), ('NCBITaxon_10088', 'Mus <genus>', 32, 'sheep'), ('UBERON_0012469', 'external anal region', 126, 'uteroplacental'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4034700	5/2014	S125-PMC4034700	['in early Gestation of normal Pregnancy, the Spiral Arteries undergo substantial remodeling by invasive Extravillous Trophoblasts, which penetrate into the Myometrium and convert muscular Spiral Arteries into flaccid Tubes with no muscularis or elastic lamina, capable of supplying the hugely expanded Blood flow of the Third Trimester Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'gestation'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('UBERON_0002537', 'hermaphrodite gonad', 44, 'spiral arteries'), ('UBERON_0001387', 'fibularis longus', 103, 'extravillous'), ('CL_0000351', 'trophoblast cell', 116, 'trophoblasts'), ('UBERON_0001296', 'myometrium', 155, 'myometrium'), ('UBERON_0002537', 'hermaphrodite gonad', 187, 'spiral arteries'), ('UBERON_0000025', 'tube', 216, 'tubes'), ('UBERON_0000178', 'blood', 301, 'blood'), ('UBERON_0003829', 'urethra muscle tissue', 319, 'third trimester'), ('UBERON_0001987', 'placenta', 335, 'placenta')]
PMC4034700	5/2014	S241-PMC4034700	['H2S therapy restores Blood flow to Ischemic Tissues in a no-dependent manner, by stimulating nos Expression and Hif-1Α and Vegf Expression and activity (bir et al., 2012).']	N/A	N/A	[('CHEBI_15377', 'water', 0, 'H2S'), ('PR_000008594', 'histone H2B type 1-O', 0, 'H2S'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001834', 'upper lip', 35, 'ischemic'), ('UBERON_0000479', 'tissue', 44, 'tissues'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 112, 'HIF-1α'), ('PR_000017279', 'testis-specific basic protein Y 1', 123, 'VEGF'), ('GO_0010467', 'gene expression', 128, 'expression')]
PMC4034700	5/2014	S250-PMC4034700	['they reported a significant reduction in Blood pressure, and proteinuria, as well as concomitant reduction in Sflt-1 levels and increase in free maternal vegf concentrations in the treated group of Animals (holwerda et al., 2014).wang et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 110, 'sFlt-1'), ('NCBITaxon_33208', 'Metazoa', 198, 'animals')]
PMC4037119	5/2014	S32-PMC4037119	['moreover, in Human subjects, cr results in a multitude of health benefits [38], including reductions in Abdominal Fat mass, increased Insulin sensitivity, and reduced levels of proinflammatory cytokines, Reactive Oxygen Species, and atherosclerotic Lipids in the Blood [39,40].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('UBERON_0007808', 'adipose tissue of abdominal region', 104, 'abdominal fat'), ('PR_000045358', 'insulin family protein', 134, 'insulin'), ('CHEBI_26523', 'reactive oxygen species', 204, 'reactive oxygen species'), ('CHEBI_18059', 'lipid', 249, 'lipids'), ('UBERON_0000178', 'blood', 263, 'blood')]
PMC4037119	5/2014	S109-PMC4037119	['the encore (exercise and nutrition interventions for Cardiovascular health) study involved 124 participants (mean age: 52 ± 9 years) with elevated Blood pressure, sedentary lifestyles, and a body mass index (bmi) greater than 25 [85].']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 53, 'Cardiovascular'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC4037119	5/2014	S432-PMC4037119	['further to this, intervention with a Flavonol-rich drink derived largely from cocoa increased Blood flow, as measured by the Blood oxygen level-dependent (bold) signal on fmri, in certain Regions Of the Brain as well as modifying the bold response during a task switching test [249].']	N/A	N/A	[('CHEBI_5078', 'flavonol', 37, 'flavonol'), ('UBERON_0000178', 'blood', 94, 'blood'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0002616', 'regional part of brain', 188, 'regions of ... brain')]
PMC4037583	5/2014	S84-PMC4037583	["gr polymorphisms\nfor the Bcl I, n363s, tth111 i, and Er22/23ek gr polymorphisms dna was extracted using the phusion Blood direct pcr kit (new england biolabs, uk), according to the manufacturer's instructions."]	N/A	N/A	[('PR_000002304', 'apoptosis regulator BAX isoform 6', 25, 'Bcl I'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 53, 'ER22'), ('UBERON_0000178', 'blood', 116, 'Blood')]
PMC4051754	6/2014	S243-PMC4051754	['Blood profiling\na large Metabolic profiling including 18 parameters was performed in Plasma collected every 7 days from −28 to +28 day relative to Parturition.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0008152', 'metabolic process', 24, 'metabolic'), ('UBERON_0001969', 'blood plasma', 85, 'plasma'), ('GO_0019230', 'proprioception', 147, 'parturition')]
PMC4054662	7/2014	S4-PMC4054662	['whole-Blood Se concentration was measured at baseline and 35 weeks, and Plasma Selenoprotein P (Sepp1) concentration at 35 weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 12, 'Se'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('PR_000014629', 'semaphorin-6A', 79, 'selenoprotein P'), ('PR_000014660', 'septin-8', 96, 'SEPP1')]
PMC4054662	7/2014	S8-PMC4054662	['at 35 weeks, significantly higher concentrations of whole-Blood Se and Plasma Sepp1 were observed in the Se-treated group than in the placebo group.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 64, 'Se'), ('UBERON_0001969', 'blood plasma', 71, 'plasma'), ('PR_000014660', 'septin-8', 78, 'SEPP1'), ('CHEBI_37972', 'phosphorus-32 atom', 105, 'Se')]
PMC4054662	7/2014	S52-PMC4054662	['a Blood sample (10\xa0ml) was taken from all recruits at trial entry.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood')]
PMC4054662	7/2014	S53-PMC4054662	['whole Blood was used to measure se concentration, while the remainder was separated into Plasma and Serum and banked.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 89, 'plasma'), ('UBERON_0001977', 'blood serum', 100, 'serum')]
PMC4054662	7/2014	S54-PMC4054662	['if separate, explicit, consent had been given, an additional 5\xa0ml of Blood were taken as part of the same procedure for potential Genetic analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('SO_0000704', 'gene', 130, 'genetic')]
PMC4054662	7/2014	S56-PMC4054662	['the following information was recorded by the trial midwife: Blood pressure; date of the last Menstrual Period/Gestational age; weight; height; haematocrit; ethnicity; family history of pre-eclampsia; chronic illness, e.g.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('GO_0007613', 'memory', 94, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 94, 'menstrual period'), ('GO_0007565', 'female pregnancy', 111, 'gestational')]
PMC4054662	7/2014	S61-PMC4054662	['Blood and Urine samples were taken again, separated as appropriate into Serum and Plasma, and banked for the measurement of different components related to the risk of pre-eclampsia.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 10, 'urine'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('UBERON_0001969', 'blood plasma', 82, 'plasma')]
PMC4054662	7/2014	S66-PMC4054662	['Se status was measured by whole-Blood Se concentration and Plasma concentration of Selenoprotein P (Sepp1), the carrier of Se in the Plasma.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 0, 'Se'), ('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 38, 'Se'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('PR_000014629', 'semaphorin-6A', 83, 'selenoprotein P'), ('PR_000014660', 'septin-8', 100, 'SEPP1'), ('CHEBI_37972', 'phosphorus-32 atom', 123, 'Se'), ('UBERON_0001969', 'blood plasma', 133, 'plasma')]
PMC4054662	7/2014	S67-PMC4054662	['whole-Blood concentration of Se, a longer-term measure of Se status than Plasma Se, was determined at baseline and 35 weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 29, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 58, 'Se'), ('UBERON_0001969', 'blood plasma', 73, 'plasma'), ('CHEBI_37972', 'phosphorus-32 atom', 80, 'Se')]
PMC4054662	7/2014	S69-PMC4054662	['measurement of outcomes\n\nwhole-Blood Selenium\nthe analysis was carried out at the sas trace element unit, southampton general hospital by dynamic reaction cell-inductively coupled plasma ms on an elan 6100 drc plus (sciex perkin-elmer).']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_27568', 'selenium atom', 37, 'selenium')]
PMC4054662	7/2014	S71-PMC4054662	['samples were run against a Bovine Blood calibration curve spiked with Se (Se standard Solution 1000\xa0ppm; fisher chemical).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 27, 'bovine'), ('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 70, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 74, 'Se'), ('CHEBI_75958', 'solution', 86, 'solution')]
PMC4054662	7/2014	S74-PMC4054662	['a certified reference material (trace elements whole Blood: seronorm; sero) assured accuracy: observed values 1·44 (sd0·25)\xa0μmol/l ( n 42) for lot number 1103129 (target value 1·42\xa0μmol/l) and 3·02 (sd0·19)\xa0μmol/l ( n 32) for lot number 1003193 (target value 3·29\xa0μmol/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'Blood')]
PMC4054662	7/2014	S122-PMC4054662	['(56)and taking the density of whole Blood to be 1·06\xa0kg/l, we calculated the equivalent whole-Blood se cut-off point to be 106·5\xa0μg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC4054662	7/2014	S123-PMC4054662	['as Pregnancy causes an expansion of Blood volume from the non-Pregnant state, the equivalent whole-Blood se cut-off value would be 95·1\xa0μg/l, assuming that the increase was the same as that observed in Plasma volume at 12 weeks of Gestation, i.e.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('UBERON_0000178', 'blood', 36, 'blood'), ('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0001969', 'blood plasma', 202, 'plasma'), ('GO_0007565', 'female pregnancy', 231, 'gestation')]
PMC4054662	7/2014	S125-PMC4054662	['this value represents a cut-off between the bottom third and the bottom quarter of baseline whole-Blood se.']	N/A	N/A	[('UBERON_0000178', 'blood', 98, 'blood')]
PMC4054662	7/2014	S131-PMC4054662	['these covariates were log baseline Blood se (adjusted or unadjusted for baseline haematocrit) and log baseline haematocrit.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4054662	7/2014	S134-PMC4054662	['subgroups with low Se status (quartiles and tertiles) were defined as Blood Se concentration at baseline divided by haematocrit concentration at baseline.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 19, 'Se'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 76, 'Se')]
PMC4054662	7/2014	S140-PMC4054662	['hypertension is defined as diastolic Blood pressure ≥\xa090\xa0mmhg on two occasions (\xa0≥\xa04\xa0h apart).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood')]
PMC4054662	7/2014	S154-PMC4054662	['caption (table-wrap): table 1\n\nbaseline characteristics of the 229 participants, overall and by treatment group (mean values and standard deviations; numbers and percentages; medians and ranges)overall ( n 229)Se-treated group ( n 115)placebo group ( n 114)meansdmeansdmeansd p *age (years)30·734·1830·354·5531·113·750·166gestational age at recruitment (weeks)12·300·8812·260·8512·340·910·500age of mother at the time of leaving education (years)20·792·9720·592·8721·003·070·296ethnicity (caucasian)0·124 n 213104109%93·090·495·6bmi (kg/m2)24·593·9924·774·1124·413·880·499underweight, bmi\xa0<\xa018·5\xa0kg/m20·361† n 202%0·901·8normal body weight, bmi 18·5–24·9\xa0kg/m2n 1366571%59·456·562·3overweight, bmi 25–29·9\xa0kg/m2n 703832%30·633·028·1obese, bmi\xa0≥\xa030\xa0kg/m2n 21129%9·210·47·9non-smoker0·098 n 1568373%68·172·264·0stopped smoking before Conception n 59236%25·820·031·6stopped smoking when Pregnant n 1495%6·17·84·4consumes alcohol0·669 n 1346668%58·857·460·2se status: whole-Blood Se concentration (μmol/l)0·352median1·311·311·32range0·84–3·330·84–3·330·84–2·19pentraxin 31·090·421·090·401·100·440·858\np value for a comparison between the Se-treated and placebo groups.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 210, 'Se'), ('GO_0007620', 'copulation', 832, 'conception'), ('GO_0007565', 'female pregnancy', 884, 'pregnant'), ('UBERON_0000178', 'blood', 970, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 976, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 1134, 'Se')]
PMC4054662	7/2014	S158-PMC4054662	['the overall median whole-Blood Se concentration at baseline was 1·31 (range 0·84–3·33)\xa0μmol/l (table 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 31, 'Se')]
PMC4054662	7/2014	S159-PMC4054662	['by 35 weeks, whole-Blood Se concentration had increased significantly in the Se-treated group (seetable 2), whereas there was a significant reduction (12\xa0%) in the placebo group.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 25, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 77, 'Se')]
PMC4054662	7/2014	S161-PMC4054662	['caption (table-wrap): table 2\n\neffect of Selenium supplementation on the parameters of Selenium status (median values and ranges)placeboseparameter of se statusmedianrangemedianrange p *whole-Blood Se concentration (μmol/l)baseline ( n 230)1·320·84–2·191·310·95–3·330·352435 weeks ( n 215)1·160·69–2·151·871·05–3·73<\xa00·0001 p (baseline v. 35 weeks)<\xa00·0001<\xa00·0001plasma Sepp1 concentration (μg/ml)35 weeks ( n 215)3·000·90–5·805·302·40–7·40<\xa00·0001\nSepp1, Selenoprotein P.\np value for a comparison between the placebo and Se-treated groups at 35 weeks.']	N/A	N/A	[('CHEBI_27568', 'selenium atom', 41, 'selenium'), ('CHEBI_27568', 'selenium atom', 87, 'selenium'), ('UBERON_0000178', 'blood', 192, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 198, 'Se'), ('PR_000014660', 'septin-8', 371, 'SEPP1'), ('PR_000014660', 'septin-8', 450, 'SEPP1'), ('PR_000014629', 'semaphorin-6A', 457, 'selenoprotein P'), ('CHEBI_37972', 'phosphorus-32 atom', 523, 'Se')]
PMC4054662	7/2014	S164-PMC4054662	['Whole-Blood Selenium concentration at 35 weeks., placebo;, Selenium.']	N/A	N/A	[('UBERON_0007688', 'anlage', 0, 'whole'), ('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_27568', 'selenium atom', 12, 'selenium'), ('CHEBI_27568', 'selenium atom', 59, 'selenium')]
PMC4054662	7/2014	S177-PMC4054662	['in all participants, adjustment for Blood se and haematocrit covariates at baseline and for haematocrit at 35 weeks made no substantial difference to the results.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood')]
PMC4054662	7/2014	S183-PMC4054662	['in all participants, adjustment for Blood se and haematocrit covariates at baseline and for haematocrit at 35 weeks made no substantial difference to the results.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood')]
PMC4054662	7/2014	S189-PMC4054662	['caption (table-wrap): table 5\n\nresults for soluble Vascular Endothelial Growth Factor Receptor-1 by quartile of whole-Blood Selenium concentration at baseline (mean values and 95\xa0% confidence intervals)data subset by quartile of Se at baseline* n Se treatment, geometric mean (ng/ml)placebo geometric mean (ng/ml)Se:placebo ratio p (Se treatment v. placebo)mean95\xa0% ci1st (bottom) quartile505·227·490·700·49, 0·980·0392nd quartile517·537·461·010·70, 1·450·9623rd quartile517·356·451·140·80, 1·620·4574th quartile517·327·520·970·69, 1·380·880\ndivision into quartiles by baseline se status corrected for haematocrit.']	N/A	N/A	[('PR_000001968', 'tyrosine-protein phosphatase non-receptor type substrate 1', 51, 'vascular endothelial growth factor receptor-1'), ('UBERON_0001986', 'endothelium', 60, 'endothelial'), ('UBERON_0000178', 'blood', 118, 'blood'), ('CHEBI_27568', 'selenium atom', 124, 'selenium'), ('CHEBI_37972', 'phosphorus-32 atom', 229, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 247, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 313, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 333, 'Se')]
PMC4054662	7/2014	S223-PMC4054662	['above a Whole-Blood se concentration of 1·3\xa0μmol/l, Plasma gpx activity is maximised(74).']	N/A	N/A	[('UBERON_0007688', 'anlage', 8, 'whole'), ('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0001969', 'blood plasma', 52, 'plasma')]
PMC4061886	7/2013	S64-PMC4061886	['Intoxication levels\npeak Blood Alcohol concentrations (bacs) were measured from Blood taken two hours after the dark cycle commenced on gd 10 or gd 20 for 1st or 2nd trimester equivalent exposure, respectively.']	N/A	N/A	[('GO_0044419', 'biological process involved in interspecies interaction between organisms', 0, 'Intoxication'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_30879', 'alcohol', 31, 'alcohol'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC4061886	7/2013	S65-PMC4061886	['Blood taken 2 h following the last Feeding of the Ethanol diet on pnd 10 was used to measure peak bac levels for 3rd trimester equivalent exposure.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007631', 'feeding behavior', 35, 'feeding'), ('CHEBI_16236', 'ethanol', 50, 'ethanol')]
PMC4061886	7/2013	S177-PMC4061886	['Blood samples to assess Bac were taken on gd 10 for the 1st trimester equivalent exposure condition, gd20 for the 2nd trimester equivalent exposure condition, and pnd 10 for the 3rd trimester equivalent exposure condition.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('SO_0000153', 'BAC', 24, 'BAC')]
PMC4061886	7/2013	S183-PMC4061886	['abbreviations: Blood Alcohol concentration (Bac); Dentate Gyrus (Dg); Gestational day (gd); long-term potentiation (ltp); Postnatal day (pnd); theta burst stimulation (tbs).']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'Blood'), ('CHEBI_30879', 'alcohol', 21, 'alcohol'), ('UBERON_0001348', 'brown adipose tissue', 44, 'BAC'), ('UBERON_0001885', 'dentate gyrus of hippocampal formation', 50, 'Dentate gyrus'), ('UBERON_0001885', 'dentate gyrus of hippocampal formation', 65, 'DG'), ('GO_0007565', 'female pregnancy', 70, 'Gestational'), ('GO_0007567', 'parturition', 122, 'Postnatal')]
PMC4061886	7/2013	S224-PMC4061886	['Blood Alcohol concentration assay\nfor all Ethanol-Fed dams a single Tail Blood sample was obtained on gd10 for 1st trimester equivalent exposure or gd20 for 2nd trimester equivalent exposure, approximately two hours after the beginning of the dark phase.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_30879', 'alcohol', 6, 'Alcohol'), ('CHEBI_16236', 'ethanol', 42, 'ethanol'), ('GO_0007631', 'feeding behavior', 50, 'fed'), ('UBERON_0002415', 'tail', 68, 'tail'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC4061886	7/2013	S225-PMC4061886	['for Animals that were exposed to Ethanol in the 3rd trimester, a Tail Blood sample was obtained from the pups on pnd10, approximately two hours after the last Feeding of Ethanol-containing diet of the day.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animals'), ('CHEBI_16236', 'ethanol', 33, 'ethanol'), ('UBERON_0002415', 'tail', 65, 'tail'), ('UBERON_0000178', 'blood', 70, 'blood'), ('GO_0007631', 'feeding behavior', 159, 'feeding'), ('CHEBI_16236', 'ethanol', 170, 'ethanol')]
PMC4061886	7/2013	S226-PMC4061886	['Blood was collected in a microcentrifuge tube and allowed to clot overnight at 4 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4065350	12/2013	S31-PMC4065350	['at the Aortic-Pulmonary plan, around 80–85% of the poorly saturated Blood (50% oxygen) ejected by the Right Ventricle (Rv) into the main Pulmonary Artery passes through the Ductus Arteriosus to the Descending Aorta (around 75 ml/min), and as a result will mix with the Blood coming from the Left Ventricle (Lv).']	N/A	N/A	[('UBERON_0000947', 'aorta', 7, 'aortic'), ('UBERON_0002048', 'lung', 14, 'pulmonary'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0002080', 'heart right ventricle', 102, 'right ventricle'), ('UBERON_0005404', 'frontonasal suture', 119, 'RV'), ('UBERON_0002012', 'pulmonary artery', 137, 'pulmonary artery'), ('UBERON_0002254', 'thyroglossal duct', 173, 'ductus arteriosus'), ('UBERON_0001514', 'descending aorta', 198, 'descending aorta'), ('UBERON_0000178', 'blood', 269, 'blood'), ('UBERON_0002084', 'heart left ventricle', 291, 'left ventricle'), ('UBERON_0004621', 'lumbar vertebra 5', 307, 'LV')]
PMC4065350	12/2013	S34-PMC4065350	['the remaining Blood will nourish the Organs and the inferior body half (yajima et al.,2013).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0000062', 'organ', 37, 'organs')]
PMC4065350	12/2013	S45-PMC4065350	['hemodynamic alterations during the immediate neonatal period occur at the moment of cessation of placentary Blood Circulation, Lung insufflation, Pulmonary Vasodilation, and Foramen Ovale closure.']	N/A	N/A	[('GO_0008015', 'blood circulation', 108, 'blood circulation'), ('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0002048', 'lung', 127, 'lung'), ('UBERON_0002048', 'lung', 146, 'pulmonary'), ('GO_0042311', 'vasodilation', 156, 'vasodilation'), ('UBERON_0006699', 'foramen cecum of tongue', 174, 'foramen ovale')]
PMC4065350	12/2013	S47-PMC4065350	['some minutes after Birth, 90% of the Blood ejected by the Rv is directed to the Pulmonary Arteries.']	N/A	N/A	[('GO_0007567', 'parturition', 19, 'birth'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0005404', 'frontonasal suture', 58, 'RV'), ('UBERON_0002012', 'pulmonary artery', 80, 'pulmonary arteries')]
PMC4065350	12/2013	S48-PMC4065350	['with the decrease in Pulmonary vascular resistance there is an increase in Pulmonary Blood flow, which culminates with ductal occlusion (obladen,2011; hong et al.,2013).']	N/A	N/A	[('UBERON_0002048', 'lung', 21, 'pulmonary'), ('UBERON_0002048', 'lung', 75, 'pulmonary'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC4065350	12/2013	S49-PMC4065350	['the functional Closure of Ductus Arteriosus is initiated by a mechanism induced by the higher Blood oxygen concentration (coceani,2013).']	N/A	N/A	[('GO_0065007', 'biological regulation', 15, 'closure'), ('UBERON_0002254', 'thyroglossal duct', 26, 'ductus arteriosus'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC4065350	12/2013	S108-PMC4065350	['the higher resistance in the ductus generates Blood flow turbulence, with an increase in systolic and diastolic velocities (dvs) and a decrease in Ductal pulsatility index (pi).']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0001505', 'coracobrachialis muscle', 147, 'ductal')]
PMC4072587	6/2014	S63-PMC4072587	['Vitamin D analyses\nfive mls of Venous Blood was collected from each Pregnant woman at 32 weeks Gestation, and one ml of Venous Blood was collected from each infant at 6 months of age.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001638', 'vein', 31, 'venous'), ('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 95, 'gestation'), ('UBERON_0001638', 'vein', 120, 'venous'), ('UBERON_0000178', 'blood', 127, 'blood')]
PMC4072587	6/2014	S64-PMC4072587	['Serum samples were frozen at −20°c and transported to the alfred hospital, melbourne, and analysis for Vitamin D was performed on those with a sufficient volume of Blood.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC4073172	6/2014	S54-PMC4073172	['for the non-Pregnant women, interviews were made at home; however, the Pregnant women were invited to the nearby health posts so that Blood samples can easily be collected.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('GO_0007565', 'female pregnancy', 71, 'pregnant'), ('UBERON_0000178', 'blood', 134, 'blood')]
PMC4073172	6/2014	S58-PMC4073172	['among Pregnant women, hemoglobin concentration was determined using a drop of capillary Blood via hemocue Hb 301 following standard procedures.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'pregnant'), ('UBERON_0000178', 'blood', 88, 'blood'), ('PR_000008840', 'huntingtin', 106, 'Hb 301')]
PMC4077117	6/2014	S55-PMC4077117	['in the gambia, no differences were found in Blood pressure, Plasma Glucose and Lipids, or other Cardiovascular risk factors between People Born in the ‘Hungry’ or ‘harvest’ seasons [20].']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0001969', 'blood plasma', 60, 'plasma'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('CHEBI_18059', 'lipid', 79, 'lipids'), ('UBERON_0004535', 'cardiovascular system', 96, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'people'), ('GO_0007567', 'parturition', 139, 'born'), ('GO_0007605', 'sensory perception of sound', 152, 'hungry')]
PMC4090565	6/2014	S61-PMC4090565	['Abdominal aimt was defined as the distance between the leading edge of the Blood-Intima interface and the leading edge of the Media-Adventitia interface on the far Wall Of the Vessel, as previously described [8,19].']	N/A	N/A	[('UBERON_0000916', 'abdomen', 0, 'Abdominal'), ('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0009472', 'axilla', 81, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 126, 'media'), ('UBERON_0015792', 'prostate gland dorsal lobe', 132, 'adventitia'), ('UBERON_0001168', 'wall of small intestine', 164, 'wall of ... vessel')]
PMC4090565	6/2014	S71-PMC4090565	['collection of Blood sample\nMaternal Blood was collected during the first stage of labor or before receiving anesthesia in case of elective cesarean section.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'Blood'), ('UBERON_0000976', 'humerus', 27, 'Maternal'), ('UBERON_0000178', 'blood', 36, 'blood')]
PMC4090565	6/2014	S74-PMC4090565	['Blood was put in sterile, Pyrogen-free tubes and it was centrifuged (3000\u2009g/min for 10\u2009min at 5°c) after clotting; the supernatant Serum was kept frozen at −80°c until assay.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_26407', 'pyrans', 26, 'pyrogen'), ('UBERON_0001977', 'blood serum', 131, 'serum')]
PMC4099383	7/2014	S122-PMC4099383	['Cord Blood samples are collected from subjects at the time of Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 62, 'delivery')]
PMC4099383	7/2014	S125-PMC4099383	['caption (table-wrap): table 1\n\ndata collection schedule of the cohort for childhood origin of asthma and allergic diseases (cocoa) study\xa0\xa0\xa0\xa0\xa0 scheduled visits of the mother-child pair when the child is the indicated age \xa0 enrollment (26thga)36thgabirth1 mo6 mo1\xa0yr2\xa0yrs3\xa0yrs4\xa0yrs5\xa0yrs6\xa0yrs7\xa0yrs8\xa0yrs9\xa0yrs10\xa0yrs informed consent √ \xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0general questionnaire\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal eligibility √√ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0familial demographics √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0familial socioeconomic status √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0familial history of allergic and Respiratory diseases √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0maternal health questionnaires\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal general health √√√ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal Life Style √√√ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal diet/nutrition √√√ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal psychosocial stress\xa0 √ \xa0\xa0 √√√√√ \xa0 √ \xa0\xa0\xa0\xa0child’s health questionnaire\xa0\xa0\xa0\xa0 √√√√√√√√√√√ child’s general health\xa0\xa0\xa0\xa0 √√√√√√√√√√√ child’s diet/nutrition\xa0\xa0\xa0\xa0 √√ \xa0 √ \xa0\xa0 √ \xa0 √√√ child’s medication\xa0\xa0\xa0\xa0 √√√√√√√√√√√ child’s allergic and Respiratory illness\xa0\xa0\xa0\xa0 √√√√√√√√√√√ child’s Psychological development\xa0\xa0\xa0\xa0 √√√√√ \xa0 √ \xa0 √√√ physician’s examination of child\xa0\xa0 √ \xa0 √√√√√√√√√√√ clinical measurement\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0scorad index\xa0\xa0\xa0\xa0 √√√√√√√√√√√ allergy skin test\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0mother\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0father\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0child\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0 √ \xa0\xa0 √ \xa0spirometryof child\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0ios of child\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0feno of child\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0Methacholine challenge test\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0 √ \xa0respiratory Virus (Nasopharyngeal aspiration)\xa0\xa0at every episode of Respiratory Viral illness\xa0\xa0\xa0\xa0\xa0\xa0\xa0Blood sampling\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal Blood\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0paternal Blood\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Cord Blood\xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0child’s Blood\xa0\xa0 √ \xa0\xa0 √ \xa0 √ \xa0\xa0 √ \xa0\xa0 √ *\xa0Urine sampling of child\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0 √ \xa0\xa0 √ \xa0Feces sampling of child\xa0\xa0\xa0 √√ \xa0\xa0 √ \xa0\xa0 √ \xa0\xa0\xa0\xa0skin microbiome of child\xa0\xa0\xa0\xa0 √ \xa0\xa0 √ \xa0\xa0 √ \xa0\xa0\xa0\xa0x-ray (bone-age) of child\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 √ \xa0\xa0\xa0questionnaire about the indoor environment\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0indoor environment assessment\xa0 √ \xa0\xa0 √√√√√√√√√√√ dust sample collection\xa0 √ \xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0indoor Air-Pollutant measurements\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0microbial sample collection\xa0 √ \xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0outdoor Air-Pollutant assessment\xa0 √ \xa0\xa0 √ \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\n*lh, fsh measurement at 9\xa0years of age.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 540, 'respiratory'), ('UBERON_0000104', 'life cycle', 673, 'life'), ('GO_0051320', 'S phase', 678, 'style'), ('UBERON_0001004', 'respiratory system', 974, 'respiratory'), ('GO_0030163', 'protein catabolic process', 1018, 'psychological'), ('CHEBI_6818', 'Methantheline bromide', 1377, 'Methacholine'), ('NCBITaxon_1', 'root', 1435, 'virus'), ('UBERON_0011692', 'enameloid', 1442, 'nasopharyngeal'), ('UBERON_0001004', 'respiratory system', 1490, 'respiratory'), ('NCBITaxon_1', 'root', 1502, 'viral'), ('UBERON_0000178', 'blood', 1522, 'Blood'), ('UBERON_0000178', 'blood', 1560, 'blood'), ('UBERON_0000178', 'blood', 1591, 'blood'), ('UBERON_0000948', 'heart', 1613, 'Cord'), ('UBERON_0000178', 'blood', 1618, 'blood'), ('UBERON_0000178', 'blood', 1648, 'blood'), ('UBERON_0001088', 'urine', 1679, 'Urine'), ('GO_0007601', 'visual perception', 1723, 'Feces'), ('UBERON_0001988', 'feces', 1723, 'Feces'), ('CHEBI_35086', 'm-Benzenesulfonium diazonium chloride', 2007, 'air'), ('CHEBI_75260', 'penicillinate salt', 2011, 'pollutant'), ('CHEBI_35086', 'm-Benzenesulfonium diazonium chloride', 2104, 'air'), ('CHEBI_75260', 'penicillinate salt', 2108, 'pollutant')]
PMC4099383	7/2014	S146-PMC4099383	['Blood samples for measuring Gene Expression and cytokine levels and to obtain dna\nthe collaborating obstetricians are directly involved in the Delivery and collect the Cord Blood at Birth according to a standard protocol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0010467', 'gene expression', 28, 'gene expression'), ('SO_0000704', 'gene', 28, 'gene'), ('GO_0007567', 'parturition', 143, 'delivery'), ('UBERON_0002240', 'spinal cord', 168, 'cord'), ('UBERON_0000178', 'blood', 173, 'blood'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC4099383	7/2014	S147-PMC4099383	['paternal Blood is obtained at Birth while maternal Blood is obtained when the child is 6\xa0months of age.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 30, 'birth'), ('UBERON_0000178', 'blood', 51, 'blood')]
PMC4099383	7/2014	S148-PMC4099383	['Blood is also obtained from the child at the first, third, sixth, and ninth birthdays.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4099383	7/2014	S149-PMC4099383	['the Cord Blood is collected into a Blood bag containing cpda1 Anticoagulant, after which the cocoa coordinator transports the bag to the laboratory in the main center.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000178', 'blood', 35, 'blood'), ('CHEBI_50249', 'anticoagulant', 62, 'anticoagulant')]
PMC4099383	7/2014	S151-PMC4099383	['the Mononuclear Cells in the Cord Blood are isolated by using the density gradient separation method and then cultured according to the method described by our previous study [37].']	N/A	N/A	[('CL_0000226', 'single nucleate cell', 4, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 4, 'mononuclear'), ('UBERON_0002240', 'spinal cord', 29, 'cord'), ('UBERON_0000178', 'blood', 34, 'blood')]
PMC4099383	7/2014	S153-PMC4099383	['Plasma is generated from parental and child Blood samples and analyzed at a central laboratory for the presence of Antibodies to allergens.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 115, 'antibodies')]
PMC4099383	7/2014	S161-PMC4099383	['a certified nurses uses an automatic bp recorder to measure the child’s Blood pressure (bp) a maximum of three times on the right Arm while the child is seated and after the child has rested for 5\xa0min.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0001460', 'arm', 130, 'arm')]
PMC4100392	6/2014	S168-PMC4100392	['intravenous administration of the soluble Extracellular Domain of klotho, which is also found in the Blood, binds to its putative receptor and inhibits the Insulin pathway [120].']	N/A	N/A	[('GO_0005576', 'extracellular region', 42, 'extracellular'), ('SO_0000417', 'polypeptide_domain', 56, 'domain'), ('UBERON_0000178', 'blood', 101, 'blood'), ('PR_000045358', 'insulin family protein', 156, 'insulin')]
PMC4106226	7/2014	S97-PMC4106226	['in particular, the mean systolic Blood pressure and diastolic Blood pressure were 106.66\u2009±\u200911.80\xa0mmhg and 70.25\u2009±\u20097.34\xa0mmhg, respectively, in males, and 109.83\u2009±\u200911.66\xa0mmhg and 72.23\u2009±\u20098.26\xa0mmhg, respectively, in females (p\u2009<\u20090.01).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC4106226	7/2014	S99-PMC4106226	['Blood pressure increased with age with a prevalence of obesity of 1.9%.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4110237	7/2014	S176-PMC4110237	['selection of herds\nfour well-managed conventional herds were selected based on these criteria: 1) persistent problems with diarrhoea during the first week of Life with a poor response to Antibiotic treatment, 2) vaccination of sows against escherichia coli and clostridium perfringens type c, 3) failure of preventive management interventions, 4) Prrs negative farrowing unit as demonstrated in Blood samples tested by elisa/ipt or pcr and 5) negative results of routine diagnostic examination for enteritis in five Piglets.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 158, 'life'), ('CHEBI_33282', 'antibacterial agent', 187, 'antibiotic'), ('PR_000013319', 'neurotrypsin', 347, 'PRRS'), ('UBERON_0000178', 'blood', 395, 'blood'), ('NCBITaxon_33208', 'Metazoa', 516, 'piglets')]
PMC4113768	7/2014	S46-PMC4113768	['concentrations of 25(Oh)D, total anti-oxidative capacity (tac) and activities of Glutathione peroxidase (gpx), catalase and Superoxide dismutase (sod) were assessed in fasting Blood samples.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 18, '25(OH)D'), ('CHEBI_16856', 'glutathione', 81, 'glutathione'), ('CHEBI_18421', 'superoxide', 124, 'superoxide'), ('UBERON_0000178', 'blood', 176, 'blood')]
PMC4113768	7/2014	S68-PMC4113768	['eligibility for this study was restricted to mccs participants with dried Blood spots from baseline Blood samples and without a pre-baseline cancer diagnosis.']	N/A	N/A	[('UBERON_0000178', 'blood', 74, 'blood'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC4113768	7/2014	S71-PMC4113768	['concentrations of 25Ohd in dried Blood spots were measured using liquid chromatography-tandem mass spectrometry (lc-ms/ms).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 18, '25OHD'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC4113768	7/2014	S75-PMC4113768	['results: there was good agreement between measurements of 25Ohd from dried Blood spots and Plasma ( r -squared = 0.73).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 58, '25OHD'), ('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0001969', 'blood plasma', 91, 'plasma')]
PMC4113768	7/2014	S127-PMC4113768	['fasting Blood samples were obtained for assessment of Serum 25(Oh)D.\nresults: partial correlations assessed the relationship between 25(Oh)D and bone geometry, adjusting for body mass index (bmi).']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D')]
PMC4113768	7/2014	S154-PMC4113768	['participants completed a sleep questionnaire (the pittsburgh sleep quality index; psqi n = 27 c; n = 13 a), and gave fasted Blood samples for hplc measurement of 25-Hydroxy Vitamin D (25(Oh)D) ( n = 27 c; n = 14 a).']	N/A	N/A	[('UBERON_0000178', 'blood', 124, 'blood'), ('CHEBI_43141', '3-hydroxypropoxy group', 162, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D')]
PMC4113768	7/2014	S193-PMC4113768	['25Ohd and 3-Epi-25Ohd were measured in Cord Blood obtained at Delivery.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_62409', 'trans,trans-deca-2,4-dienoyl-CoA', 10, '3-epi'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 16, '25OHD'), ('UBERON_0002240', 'spinal cord', 39, 'cord'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0007567', 'parturition', 62, 'delivery')]
PMC4113768	7/2014	S217-PMC4113768	['at each visit, Blood was taken for Serum 25(Oh)D and Vitamin D binding protein quantification, full Blood count, whole-Blood immunophenotyping by flow cytometry and in vitro Infection with hiv-1, followed by functional flow cytometry.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0001977', 'blood serum', 35, 'serum'), ('CHEBI_71657', 'versiconol acetate', 41, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 41, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000178', 'blood', 100, 'blood'), ('UBERON_0000178', 'blood', 119, 'blood'), ('GO_0007586', 'digestion', 174, 'infection')]
PMC4113768	7/2014	S222-PMC4113768	['Vitamin D supplementation increased total White Blood Cell count, Lymphocyte count, Neutrophil count, Rbc and rdw.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000738', 'leukocyte', 42, 'white blood cell'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CL_0000542', 'lymphocyte', 66, 'lymphocyte'), ('CL_0000775', 'neutrophil', 84, 'neutrophil'), ('CL_0000232', 'erythrocyte', 102, 'RBC')]
PMC4113768	7/2014	S232-PMC4113768	['relative risks (rrs) of lrti in relation to 25(Oh)D Cord Blood levels were estimated by log-binomial regression after adjustment for potential confounders (gender, siblings under 5 years of age, premature Delivery and breastfeeding duration).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 50, 'D'), ('UBERON_0002240', 'spinal cord', 52, 'cord'), ('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0007567', 'parturition', 205, 'delivery')]
PMC4113768	7/2014	S257-PMC4113768	['Blood samples were analysed at baseline and one month.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4113768	7/2014	S259-PMC4113768	['in addition the whole Blood transcriptome was analysed along with the primary Vitamin D Receptor, vdr.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_28384', 'vitamin K', 78, 'Vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 78, 'Vitamin D receptor')]
PMC4113768	7/2014	S275-PMC4113768	['Blood samples were collected from all patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4113768	7/2014	S292-PMC4113768	['Blood sample was collected at admission.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4113768	7/2014	S293-PMC4113768	['during autumn 2012, Blood samples were collected from healthy Adults working in our lab.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0007023', 'adult organism', 62, 'adults')]
PMC4113768	7/2014	S307-PMC4113768	['Blood sample from Ba was collected 6(1–16) h after injury.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0005405', 'pararenal fat', 18, 'BA')]
PMC4113768	7/2014	S492-PMC4113768	['potential associations were evaluated by linear and logistic regression models adjusted for confounding by age, sex, smoking, bmi, physical activity, dietary habits, and month of Blood sampling.']	N/A	N/A	[('UBERON_0000178', 'blood', 179, 'blood')]
PMC4113768	7/2014	S564-PMC4113768	['Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration was measured at enrolment, 36 weeks Gestation, on Cord Blood samples, and at 2, 4 and 6 months of age.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('UBERON_0002240', 'spinal cord', 101, 'cord'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC4113768	7/2014	S685-PMC4113768	['feasibility and acceptability of assessing Vitamin D status in primary schoolchildren using a finger-prick dried Capillary Blood spot method\n\ngriffiths, c.j.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('UBERON_0001982', 'capillary', 113, 'Capillary'), ('UBERON_0000178', 'blood', 123, 'Blood')]
PMC4113768	7/2014	S724-PMC4113768	['Vitamin D is activated in two Hydroxylation steps, firstly into the main Metabolite in Blood circulation, 25-Oh-Vitamin D3, by Cyp2R1 and Cyp27A1.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0044444', 'cytoplasmic part', 30, 'hydroxylation'), ('CHEBI_39382', 'flufenoxuron', 73, 'metabolite'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_75393', 'Y-27632', 106, '25-OH-'), ('CHEBI_33279', 'vitamin D5', 112, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 112, 'vitamin D3'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 127, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 138, 'CYP27A1')]
PMC4113768	7/2014	S973-PMC4113768	['concentrations of 25-Hydroxy Vitamin D in Umbilical Cord Blood and achievement of gross motor outcomes in infants\n\nmccarthy, e.k.']	N/A	N/A	[('CHEBI_43141', '3-hydroxypropoxy group', 18, '25-Hydroxy'), ('CHEBI_28384', 'vitamin K', 29, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 29, 'Vitamin D'), ('UBERON_0002331', 'umbilical cord', 42, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 57, 'Blood')]
PMC4113768	7/2014	S997-PMC4113768	['Blood from mothers at 15 weeks Gestation and Umbilical Cords at Delivery were processed to Serum within 3 h and stored at −80 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 31, 'gestation'), ('UBERON_0002283', 'nail matrix', 45, 'umbilical cords'), ('GO_0007567', 'parturition', 64, 'delivery'), ('UBERON_0001977', 'blood serum', 91, 'serum')]
PMC4113768	7/2014	S1074-PMC4113768	['participants completed a detailed questionnaire and fasting Blood samples were collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood')]
PMC4113768	7/2014	S1224-PMC4113768	['Blood samples were collected by venepuncture from 100% of pairs: 15 ml from mothers (overnight fasted) and 3 ml from infants.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4113768	7/2014	S1290-PMC4113768	['they were invited to the study clinic for qus of the distal Radius and Midshaft Tibia, Blood sampling for measurement of 25-Hydroxy Vitamin D3(25Ohd) by radioimmunoassay, as well as medical examination, anthropometry, and Motor Development testing.']	N/A	N/A	[('UBERON_0001423', 'radius bone', 60, 'radius'), ('UBERON_0004341', 'primitive streak', 71, 'midshaft'), ('UBERON_0000979', 'tibia', 80, 'tibia'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_63991', '15-epi-lipoxin B4', 121, '25-hydroxy vitamin D3'), ('PR_000017299', 'VIP peptides', 132, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 143, '25OHD'), ('GO_0009653', 'anatomical structure morphogenesis', 222, 'motor development')]
PMC4113768	7/2014	S1517-PMC4113768	['background: low Blood concentrations of Serum 25-Hydroxy Vitamin D (s-25(Oh)D) are common during winter months.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0001977', 'blood serum', 40, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 46, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D')]
PMC4113768	7/2014	S1696-PMC4113768	['method: for the above said purpose Blood samples from the local population has been collected, before sample collection a detailed interview was done to ask about their life style particularly about sun exposure.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4113768	7/2014	S1756-PMC4113768	['a 15 ml Blood sample was collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood')]
PMC4113768	7/2014	S1815-PMC4113768	['methods applied in the study included: medical history and physical examination, and also laboratory tests: Blood haemoglobin, albumin, protein and creatinine Serum levels, calcium, magnesium, Inorganic Phosphorous Serum levels and alkaline phosphatase activity.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('CHEBI_33466', 'monoatomic phosphorus', 193, 'inorganic phosphorous'), ('UBERON_0001977', 'blood serum', 215, 'serum')]
PMC4113768	7/2014	S1855-PMC4113768	['methods: Human Umbilical Vein Endothelial Cells (Huvecs) were cultured in ebm-2 media with 2% foetal Bovine Serum containing increasing concentrations (0, 10−13, 10−11, 10−9or 10−7m) of 25(Oh)2D3For 24 h, and dna contents or key marker Genes of Blood Pressure Regulation were measured.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 9, 'Human'), ('CL_0010002', 'epithelial cell of umbilical artery', 15, 'umbilical vein endothelial cells'), ('UBERON_0002066', 'umbilical vein', 15, 'umbilical vein'), ('UBERON_0001986', 'endothelium', 30, 'endothelial'), ('CL_0002674', 'H minus', 49, 'HUVECs'), ('NCBITaxon_33208', 'Metazoa', 101, 'bovine'), ('UBERON_0001977', 'blood serum', 108, 'serum'), ('CHEBI_86922', 'Pinoresinol biphenyl', 186, '25(OH)2D3for'), ('SO_0000704', 'gene', 236, 'genes'), ('GO_0008217', 'regulation of blood pressure', 245, 'blood pressure regulation'), ('UBERON_0000178', 'blood', 245, 'blood')]
PMC4113768	7/2014	S1873-PMC4113768	['at baseline, week 6 and week 12 study visits, anthropometric measurements and a fasting Blood sample were taken and compliance assessed.']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood')]
PMC4113768	7/2014	S1914-PMC4113768	['all patients hospitalized between 1 april 2010 and 31 march 2013 underwent Blood sample to test Vitamin D (25Oh-D) level.']	N/A	N/A	[('UBERON_0000178', 'blood', 75, 'blood'), ('CHEBI_28384', 'vitamin K', 96, 'Vitamin D'), ('CHEBI_67980', 'Stipuleanoside R2', 107, '25OH-D')]
PMC4113768	7/2014	S1918-PMC4113768	['results: 520 patients underwent Blood test, there were respectively 272 males (52.3%) and 248 females (47.7%).']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC4113768	7/2014	S2003-PMC4113768	['Serum 25(Oh) Vitamin D concentrations were measured on fasting Blood samples by either hplc or a chemiluminescence immunoassay.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_30778', 'gallic acid', 6, '25(OH)'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0000178', 'blood', 63, 'blood')]
PMC4113768	7/2014	S2028-PMC4113768	['anthropometrics, Blood pressure and a fasted Blood samples (for 25Ohd and Lipid analysis) were collected from each participant at week 0 (baseline) and week 12.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('CHEBI_18059', 'lipid', 74, 'lipid')]
PMC4113768	7/2014	S2029-PMC4113768	['results: at baseline, the Prm women had a significantly lower body mass index (bmi) and Blood pressure (bp) than the pom women (22.9 ± 3.1 vs 24.7 ± 3.8 kg/m2, 116 ± 12/76 ± 9 mmhg vs. 128 ± 17/83 ± 10 mmhg respectively; p< 0.001), and significantly lower Cholesterol, high-density lipoprotein (hdl) and low density lipoprotein (ldl) levels (5.1 ± 0.9 vs. 6.0 ± 1.0 mmol/l, 1.81 ± 0.34 vs. 1.91 ± 0.46 mmol/l, 2.89 ± 0.77 vs. 3.62 ± 0.89 mmol/l respectively; p< 0.001).']	N/A	N/A	[('PR_000001570', 'P2Y purinoceptor 13', 26, 'PrM'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CHEBI_16113', 'cholesterol', 256, 'cholesterol')]
PMC4113768	7/2014	S2057-PMC4113768	['Vitamin D Endocrine system was evaluated in all children: 25-Oh-D (25-Oh-d125i ria kit, diasorin), 1,25-Dihydroxy-Vitamin D (1,25-Oh2-D) (1,25-Oh-d125i ria kit, diasorin), parathormone (pth) (n-tact pth sp irma kit, diasorin®), calcium and Phosphorus levels were measured following Blood withdrawal.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002049', 'vasculature', 10, 'endocrine'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 58, '25-OH-D'), ('CHEBI_75393', 'Y-27632', 67, '25-OH-'), ('CHEBI_67814', 'Neurosporaside peracetate', 104, 'dihydroxy-'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_78731', '9(R)-HPETE', 126, ',25-OH2-D'), ('CHEBI_17996', 'chloride', 139, ','), ('CHEBI_75393', 'Y-27632', 140, '25-OH-'), ('CHEBI_35885', 'secondary phosphine', 240, 'phosphorus'), ('UBERON_0000178', 'blood', 282, 'blood')]
PMC4113768	7/2014	S2119-PMC4113768	['the survey instruments comprised questionnaires (including a semi-quantitative Food frequency questionnaire; ffq), interviews, physical examinations, and measurements in Blood samples.']	N/A	N/A	[('CHEBI_33290', 'food', 79, 'food'), ('UBERON_0000178', 'blood', 170, 'blood')]
PMC4113768	7/2014	S2166-PMC4113768	['results: 28 eligible trials were identified, of which 23 trials with mean Blood pressure data could be included in meta-analysis (2313 participants).']	N/A	N/A	[('UBERON_0000178', 'blood', 74, 'blood')]
PMC4113768	7/2014	S2169-PMC4113768	['the overall treatment effect for systolic Blood pressure was 0.2 mmhg (95% ci −1.3 to 1.6; i2= 37%) and for diastolic Blood pressure was 0.1 mmhg (95% ci −0.6 to 0.8; i2= 18%).']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0000178', 'blood', 118, 'blood')]
PMC4113768	7/2014	S2170-PMC4113768	['no relationship was evident between size of Blood pressure reduction and either baseline systolic Blood pressure or 25-Hydroxy Vitamin D level on meta-regression.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 116, '25-hydroxy vitamin D')]
PMC4113768	7/2014	S2175-PMC4113768	['Vitamin D therapy to reduce Blood pressure and Left Ventricular hypertrophy in resistant hypertension a randomised controlled trial\n\nwitham, m.d.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('UBERON_0002084', 'heart left ventricle', 47, 'Left Ventricular')]
PMC4113768	7/2014	S2184-PMC4113768	['patients with supine office Blood pressure >140/90 mmhg on 3 or more Antihypertensive Agents and baseline 25-Hydroxy Vitamin D levels <75 nmol/l received 100,000 units oral Vitamin D3Or matching placebo every 2 months.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_35440', '(1R,2S)-3-phenylcyclohexa-3,5-diene-1,2-diol', 69, 'antihypertensive agents'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 106, '25-hydroxy vitamin D'), ('CHEBI_76020', 'poly[d(TTC)]', 173, 'vitamin D3or'), ('PR_000025569', 'amyloid-beta precursor protein sequence variant T714I (human)', 173, 'vitamin D3or')]
PMC4113768	7/2014	S2185-PMC4113768	['office and 24 h Ambulatory Blood pressure, Glucose and Cholesterol were measured at baseline, 2, 4 and 6 months; Left Ventricular mass index was measured by Cardiac magnetic resonance imaging on a subgroup at baseline and 6 months.']	N/A	N/A	[('GO_0040011', 'locomotion', 16, 'ambulatory'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_17234', 'glucose', 43, 'glucose'), ('CHEBI_16113', 'cholesterol', 55, 'cholesterol'), ('UBERON_0002084', 'heart left ventricle', 113, 'left ventricular'), ('UBERON_0000948', 'heart', 157, 'cardiac')]
PMC4113768	7/2014	S2186-PMC4113768	['the primary outcome was between-group difference in mean 24 h Ambulatory Blood pressure at 6 months.']	N/A	N/A	[('GO_0040011', 'locomotion', 62, 'ambulatory'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC4113768	7/2014	S2188-PMC4113768	['mean age was 63 (sd 11) years, mean baseline office Blood pressure was 154/84(13/10) mmhg and mean baseline 25-Hydroxy Vitamin D level was 42(16) nmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 111, 'hydroxy vitamin D')]
PMC4113768	7/2014	S2192-PMC4113768	['conclusion: six months of intermittent, high-dose oral Vitamin D3Did not reduce Blood pressure or Left Ventricular mass in patients with resistant hypertension.']	N/A	N/A	[('CHEBI_75970', "2'-phospho-cyclic ADP-ribose(3-)", 55, 'vitamin D3did'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 55, 'vitamin D3did'), ('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0002084', 'heart left ventricle', 98, 'left ventricular')]
PMC4113768	7/2014	S2201-PMC4113768	['endothelial function was measured using flow-mediated dilatation of the Brachial Artery, along with pulse wave velocity, Blood pressure, Cholesterol, Insulin resistance measured using homa-ir, Interleukin 6, Tumour Necrosis Factor Alpha, markers of oxidative stress, and the piper fatigue scale.']	N/A	N/A	[('UBERON_0001398', 'brachial artery', 72, 'brachial artery'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CHEBI_16113', 'cholesterol', 137, 'cholesterol'), ('PR_000045358', 'insulin family protein', 150, 'insulin'), ('PR_000008988', 'interleukin-1 family member 5', 193, 'interleukin 6'), ('PR_000016185', 'transcription factor 7-like 1', 208, 'tumour necrosis factor alpha')]
PMC4113768	7/2014	S2204-PMC4113768	['mean age was 49 (sd 13) years, mean baseline pulse wave velocity was 7.8 m/s (sd 2.3), mean baseline office Blood pressure was 128/78 (18/12) mmhg and mean baseline 25-Hydroxy Vitamin D level was 46(18) nmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 165, '25-hydroxy vitamin D')]
PMC4113768	7/2014	S2206-PMC4113768	['no improvement was seen in Blood pressure, Endothelial function, Cholesterol, Insulin resistance, oxidative stress or inflammatory markers.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0001986', 'endothelium', 43, 'endothelial'), ('CHEBI_16113', 'cholesterol', 65, 'cholesterol'), ('PR_000045358', 'insulin family protein', 78, 'insulin')]
PMC4113768	7/2014	S2290-PMC4113768	['a total of 256 subjects filled a general questionnaire, height and weight were measured and Blood extracted ascertaining total 25-Hydroxy Vitamin D, calcium, Phosphorous and alkaline phophatase from a Vitamin D external quality assessment (deqas)-certified laboratory.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('CHEBI_43141', '3-hydroxypropoxy group', 127, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_30207', 'phosphorus(.)', 158, 'phosphorous'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4113768	7/2014	S2305-PMC4113768	['anthropometrics were obtained and fasting Blood samples were taken for ascertaining Lipid and Thyroid profile, as well as measuring pth, 25(Oh) Vitamin D and calcium.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_18059', 'lipid', 84, 'lipid'), ('UBERON_0002046', 'thyroid gland', 94, 'thyroid'), ('CHEBI_30778', 'gallic acid', 137, '25(OH)'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4113768	7/2014	S2336-PMC4113768	['anthropometrics and fasting Blood were collected (0, 6, 12, 18 months) to monitor Serum 25-Hydroxy Vitamin D using specific elisa, and to determine Metabolic profiles by standard methods.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 88, '25-hydroxy vitamin D'), ('GO_0008152', 'metabolic process', 148, 'metabolic')]
PMC4113768	7/2014	S2361-PMC4113768	['anthropometrics were performed and fasting Blood samples were taken at baseline and every 3 months for 1 year.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood')]
PMC4113768	7/2014	S2362-PMC4113768	['fasting Blood Glucose, corrected calcium and Lipid profiles were measured routinely.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_17234', 'glucose', 14, 'glucose'), ('CHEBI_18059', 'lipid', 45, 'lipid')]
PMC4113768	7/2014	S2474-PMC4113768	['25-Hydroxy Vitamin D (25Ohd) concentration of their Blood was measured.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 0, '25-hydroxy vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 22, '25OHD'), ('UBERON_0000178', 'blood', 52, 'blood')]
PMC4113768	7/2014	S2503-PMC4113768	['dietary Calcium Intake was estimated from a 4-day Food diary; Serum 25(Oh)D, Pth and Oestradiol were measured from Venous Blood samples at 0, 6 and 12 months.']	N/A	N/A	[('CHEBI_22313', 'alkaline earth metal atom', 8, 'calcium'), ('GO_0007631', 'feeding behavior', 16, 'intake'), ('CHEBI_33290', 'food', 50, 'food'), ('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 71, 'OH ... D'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 77, 'PTH'), ('CHEBI_25657', 'octyl group', 85, 'oestradiol'), ('UBERON_0001638', 'vein', 115, 'venous'), ('UBERON_0000178', 'blood', 122, 'blood')]
PMC4113768	7/2014	S2505-PMC4113768	['all Blood samples were stored and assayed at the end of the study.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4113768	7/2014	S2569-PMC4113768	['results: this analysis included 385 of the 430 participants randomised to one of the two Vitamin D doses who provided post-supplementation Blood samples and had adequate snp data.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC4113768	7/2014	S2619-PMC4113768	['secondary outcome measures included Blood pressure, body mass index, waist circumference, Fructosamine, Lipid and Apolipoprotein levels, Liver function tests, c-reactive protein level and safety of supplementation.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('CHEBI_24111', 'fructoside', 90, 'fructosamine'), ('CHEBI_18059', 'lipid', 104, 'lipid'), ('CHEBI_39015', 'apolipoprotein', 114, 'apolipoprotein'), ('UBERON_0002107', 'liver', 137, 'liver')]
PMC4113768	7/2014	S2655-PMC4113768	['long-term monthly Vitamin D3Supplementation and Blood pressure in healthy Adults: a randomized controlled trial\n\nscragg, r.; slow, s.; stewart, a.w.']	N/A	N/A	[('CHEBI_61993', 'maltotriose', 18, 'Vitamin D3Supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 18, 'Vitamin D3Supplementation'), ('UBERON_0000178', 'blood', 48, 'Blood'), ('UBERON_0007023', 'adult organism', 74, 'Adults')]
PMC4113768	7/2014	S2702-PMC4113768	['incidences of high to toxic 25-Hydroxy Vitamin D levels amongst users of a direct-to-the-public Blood spot Vitamin D testing service\n\nshea, r.l.']	N/A	N/A	[('CHEBI_43141', '3-hydroxypropoxy group', 28, '25-Hydroxy'), ('CHEBI_28384', 'vitamin K', 39, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 39, 'Vitamin D'), ('UBERON_0000178', 'blood', 96, 'Blood'), ('CHEBI_28384', 'vitamin K', 107, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 107, 'Vitamin D')]
PMC4113768	7/2014	S3029-PMC4113768	['methods: Umbilical Cord Blood was processed to Serum within 3hrs of collection at Delivery and stored at −80 °c.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 9, 'Umbilical cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0001977', 'blood serum', 47, 'serum'), ('GO_0007567', 'parturition', 82, 'delivery')]
PMC4113768	7/2014	S3071-PMC4113768	['there were no differences between the groups in Blood pressure or Lipid concentration.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_18059', 'lipid', 66, 'lipid')]
PMC4113768	7/2014	S3138-PMC4113768	['exclusion criteria were: Nonhuman studies (cell, Animal); review articles; studies lacking Blood level data pre- and post-treatment; no control group; bolus treatments (weekly, monthly, yearly); Vitamin D < 5 mcg (200 iu) or >20 mcg (800 iu); baseline 25(Oh)d > 75 nmol/l; patient studies (e.g., diabetes, cancer, cvd); studies < 2 months; age < 19 years.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 25, 'nonhuman'), ('NCBITaxon_33208', 'Metazoa', 49, 'animal'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 252, '25(OH')]
PMC4113768	7/2014	S3184-PMC4113768	['socioeconomic, demographic, and sun exposure data were obtained; anthropometry measured; and capillary Blood (Finger prick) to determine Serum 25(Oh)D levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0002389', 'manual digit', 110, 'finger'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 143, '25(OH)D')]
PMC4113768	7/2014	S3197-PMC4113768	['season of Blood sampling, health, lifestyle, socio-economic and anthropometric data were collected and included as potential predictors of Vitamin D status in regression models.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4113768	7/2014	S3225-PMC4113768	['25(Oh)D3Was collected from each child by capillary Venous sampling, and stored as dried Blood spots before shipment to zrt laboratories (beaverton, or, usa).']	N/A	N/A	[('CHEBI_73386', 'Ala-Val-Asp-Ser', 0, '25(OH)D3was'), ('PR_000027795', 'trypsin', 0, '25(OH)D3was'), ('UBERON_0001638', 'vein', 51, 'venous'), ('UBERON_0000178', 'blood', 88, 'blood')]
PMC4113771	7/2014	S24-PMC4113771	['gi is used to classify different Carbohydrate Foods according to Glycaemic response gi is defined as “the incremental area under the Blood Glucose response curve of a test Food containing 50 g available Carbohydrate expressed as a percentage of the response to the same amount of available Carbohydrate from a reference Food”, the reference Food usually being Glucose or white bread [10].']	N/A	N/A	[('CHEBI_16730', 'chloramphenicol 3-acetate', 33, 'carbohydrate'), ('CHEBI_33290', 'food', 46, 'foods'), ('GO_0006096', 'glycolytic process', 65, 'glycaemic'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_17234', 'glucose', 139, 'glucose'), ('CHEBI_33290', 'food', 172, 'food'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 203, 'carbohydrate'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 290, 'carbohydrate'), ('CHEBI_33290', 'food', 320, 'food'), ('CHEBI_33290', 'food', 341, 'food'), ('CHEBI_17234', 'glucose', 360, 'glucose')]
PMC4120194	7/2014	S230-PMC4120194	['predictors of decreased response to cbt were severity of panic disorder, strength of Blood/injury fears, earlier age of initial onset of panic symptoms, comorbid social anxieties, and degree of agoraphobic avoidance [174,175].']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood')]
PMC4120194	7/2014	S323-PMC4120194	['the most prevalent phobia types include Animal (e.g., Insects, snakes), natural environment (e.g., heights, storms, Water), situational (e.g., flying, enclosed spaces), and Blood-injection-injury (b-i-i) (e.g., Blood, dentists, hospitals) [305,306].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 40, 'animal'), ('NCBITaxon_1', 'root', 54, 'insects'), ('CHEBI_15377', 'water', 116, 'water'), ('UBERON_0000178', 'blood', 173, 'blood'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC4120194	7/2014	S339-PMC4120194	['caption (table-wrap): table 16\n\ndsm-5 diagnosis of specific phobia• marked fear or anxiety about a specific object or situation (e.g., flying, seeing Blood)• the phobic object or situation almost always provokes immediate fear or anxiety and is actively avoided or endured with marked fear or anxiety• the fear or anxiety is out of proportion to the actual danger posed by the specific object or situation• the fear, anxiety, or avoidance is persistent, typically ≥6 months• there is marked distress or functional impairment\nadapted from dsm-5 [26].']	N/A	N/A	[('UBERON_0000178', 'blood', 150, 'blood')]
PMC4120194	7/2014	S1238-PMC4120194	['richter - peggy.richter@sunnybrook.ca; melisa robichaud - robichau@mail.ubc.ca; john r. walker - jwalker@cc.umanitoba.ca\n\nadditional contributors to the comorbidity section\ngordon asmundson10, larry j. klassen11, raymond w. lam12, roger s. mcintyre13, isaac szpindel14\n10department of psychology, university of regina, regina, s4s 0a2, canada;11department of psychiatry, faculty of medicine, university of manitoba, winnipeg, r3t 2n2, canada;12department of psychiatry, university of british columbia, vancouver, v6t 2a1, canada;13departments of psychiatry and pharmacology, university of toronto, toronto, m5s 1a1, canada;14attention and Learning related disorders, start clinic, toronto, m4w 2n4, canada\nemail: gordon asmundson - gordon.asmundson@uregina.ca; larry j. klassen - larryjklassen@hotmail.com; raymond w. lam - r.lam@ubc.ca; roger s. mcintyre - roger.mcintyre@uhn.ca; isaac szpindel - iszpindel@startclinic.ca\n\nlist of abbreviations used\naacap: american academy of child and adolescent psychiatry; abm: attention bias modification; acog: american congress of obstetricians and gynecologists; adhd: attention-deficit/hyperactivity disorder; apa: american psychiatric association; asd: acute stress disorder; b-i-i: Blood-injection-injury; bpd: borderline personality disorder; cbt: cognitive behavioral therapy; cbwt: Cognitive behavioral writing therapy; cchs: canadian community health survey; chd: Coronary Heart disease; cpt: Cognitive processing therapy; cr: controlled release; dbt: dialectical behavioral therapy; ddi: Drug-Drug interactions; dirt: danger ideation reduction therapy; dsm-5: diagnostic and statistical manual of mental disorders, 5thedition; emdr: Eye movement desensitization and reprocessing; erp: exposure with response prevention; fda: Food and drug administration; gad: generalized anxiety disorder; hars: hamilton anxiety rating scale; hdl: high-density lipoprotein; icbt: internet-based cbt; ipt: interpersonal therapy; iv: intravenous; ldl: low-density lipoprotein; maoi: Monoamine oxidase Inhibitor; mbct: mindfulness-based Cognitive therapy; mbt: mindfulness-based therapy; mdd: major depressive disorder; mini-spin: mini-social phobia inventory; mri: magnetic resonance imaging; n/a: not available; nassa: noradrenergic and specific serotonergic antidepressant; ncs-a: national comorbidity survey – adolescent supplement; ncs-r: national comorbidity survey – Replication; nmda: n -methyl-d-aspartate; nnt: number needed to treat; nppo-reac: neuro psycho physical optimization-radio electric asymmetric conveyor; Nsaid: Nonsteroidal Anti-Inflammatory Drug; ocd: obsessive-compulsive disorder; odt: orally disintegrating tablet; pnas: poor neonatal adaptation syndrome; ptsd: posttraumatic stress disorder; qol: quality of life; rct: randomized controlled trial; reac: radioelectric asymmetric conveyor; rima: reversible Inhibitors of Monoamine Oxidase A; rr: relative risk; rtms: repetitive transcranial magnetic stimulation; sad: social anxiety disorder; set: social effectiveness therapy; shat: spiritual-hypnosis assisted therapy; snri: Serotonin–Norepinephrine Reuptake Inhibitor; sr: sustained release; ssri: selective Serotonin reuptake Inhibitor; sud: substance use disorder; tc: Total Cholesterol; Tca: Tricyclic Antidepressant; tf-cbt: trauma-focused-cbt; tg: Triglycerides; vldl: very-low-density lipoprotein; vre: virtual reality exposure; xl: extended release; xr: extended release; y-bocs: yale-brown obsessive compulsive scale.']	N/A	N/A	[('GO_0007612', 'learning', 639, 'Learning'), ('UBERON_0000178', 'blood', 1227, 'blood'), ('GO_0050890', 'cognition', 1330, 'cognitive'), ('UBERON_0004151', 'cardiac chamber', 1413, 'coronary heart'), ('GO_0050890', 'cognition', 1442, 'cognitive'), ('CHEBI_23888', 'drug', 1538, 'drug'), ('CHEBI_23888', 'drug', 1543, 'drug'), ('UBERON_0000970', 'eye', 1683, 'eye'), ('CHEBI_33290', 'food', 1775, 'Food'), ('CHEBI_17134', 'octopamine', 2015, 'monoamine'), ('CHEBI_35222', 'inhibitor', 2033, 'inhibitor'), ('GO_0050890', 'cognition', 2068, 'cognitive'), ('GO_0006260', 'DNA replication', 2405, 'Replication'), ('CHEBI_18009', 'NADP(+)', 2558, 'NSAID'), ('CHEBI_35474', 'anxiolytic drug', 2565, 'nonsteroidal anti-inflammatory drug'), ('CHEBI_35222', 'inhibitor', 2865, 'inhibitors'), ('CHEBI_17134', 'octopamine', 2879, 'monoamine'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 2879, 'monoamine oxidase A'), ('CHEBI_28790', 'serotonin', 3085, 'serotonin'), ('CHEBI_73966', 'nitric oxide synthase activator', 3095, 'norepinephrine reuptake inhibitor'), ('CHEBI_28790', 'serotonin', 3169, 'serotonin'), ('CHEBI_35222', 'inhibitor', 3188, 'inhibitor'), ('CHEBI_66254', 'topopyrone C', 3232, 'total cholesterol'), ('CHEBI_17855', 'triglyceride', 3251, 'TCA'), ('CHEBI_50940', 'tetracyclic antidepressant', 3256, 'tricyclic antidepressant'), ('CHEBI_17855', 'triglyceride', 3314, 'triglycerides')]
PMC4122175	8/2014	S166-PMC4122175	['Animals were fasted overnight and Blood was collected in the morning before, and 30, 60, and 120 min after an Intraperitoneal injection of 2 g/kg body weight dextrose as described previously (harper et al.,2014).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Animals'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_2001932', 'sensory canal tubular ossicle', 110, 'intraperitoneal')]
PMC4124499	8/2014	S70-PMC4124499	['Postprandial Blood Glucose levels were recorded with results ≥7.8\xa0mmol/l categorised as Glucose intolerance [42,43].']	N/A	N/A	[('GO_0008283', 'cell proliferation', 0, 'Postprandial'), ('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_17234', 'glucose', 19, 'glucose'), ('CHEBI_17234', 'glucose', 88, 'glucose')]
PMC4132016	8/2014	S61-PMC4132016	['Tissue collection\nat 7 months of age, overnight starved male offspring were killed by Pentobarbital overdose, Blood was collected by decapitation and various Tissues were isolated, frozen in liquid Nitrogen and stored at −80°c until use.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('CHEBI_7983', 'pentobarbital', 86, 'pentobarbital'), ('UBERON_0000178', 'blood', 110, 'blood'), ('UBERON_0000479', 'tissue', 158, 'tissues'), ('CHEBI_33300', 'pnictogen', 198, 'Nitrogen')]
PMC4141279	8/2014	S61-PMC4141279	['Blood was collected from the Tail Vein at 0 (baseline), 30, 60, 120 and 180 min (ranieri et al.,2010) following ip injection and glycemia (blood Glucose concentration) was measured using a commercial glucometer (statstrip xpress-i, nova biomedical, a. menarini diagnostic) (titta et al.,2010).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0003481', 'tail vein', 29, 'tail vein'), ('CHEBI_17234', 'glucose', 145, 'glucose')]
PMC4141279	8/2014	S66-PMC4141279	['Blood samples were collected at 08:30 a.m., 12 h after removal of the Food, from the Tail Vein in potassium edta coated tubes (1.6 mg edta/ml Blood; sarstedt, germany).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_33290', 'food', 70, 'food'), ('UBERON_0003481', 'tail vein', 85, 'tail vein'), ('UBERON_0000178', 'blood', 142, 'blood')]
PMC4141279	8/2014	S76-PMC4141279	['all subjects underwent an acute restraint stress (30 min) and Blood samples were collected by a Tail nick at different time points, i.e.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0002415', 'tail', 96, 'tail')]
PMC4143239	8/2014	S88-PMC4143239	['similar or higher numbers of White Blood Cells migrated onto slides in malnourished children, predominantly Granulocytes and a lower proportion of Monocytes and Macrophages[28]–[31].']	N/A	N/A	[('CL_0000738', 'leukocyte', 29, 'white blood cells'), ('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000094', 'granulocyte', 108, 'granulocytes'), ('CL_0000576', 'monocyte', 147, 'monocytes'), ('CL_0000235', 'macrophage', 161, 'macrophages')]
PMC4143239	8/2014	S125-PMC4143239	['Innate Immune System\nthe Innate Immune System delivers an unspecific response relying on Leukocytes (like Granulocytes, Monocytes and Macrophages), as well as soluble factors in Blood (like Acute Phase proteins and the complement system)[24].']	N/A	N/A	[('GO_0009689', 'induction of phytoalexin biosynthetic process', 0, 'Innate immune'), ('UBERON_0002405', 'immune system', 7, 'immune system'), ('GO_0007449', 'proximal/distal pattern formation, imaginal disc', 25, 'innate immune system'), ('UBERON_0002405', 'immune system', 32, 'immune system'), ('CL_0000738', 'leukocyte', 89, 'leukocytes'), ('CL_0000094', 'granulocyte', 106, 'granulocytes'), ('CL_0000576', 'monocyte', 120, 'monocytes'), ('CL_0000235', 'macrophage', 134, 'macrophages'), ('UBERON_0000178', 'blood', 178, 'blood'), ('GO_0006953', 'acute-phase response', 190, 'acute phase')]
PMC4143239	8/2014	S127-PMC4143239	['White Blood Cells of the innate Immune System\nthirty-eight articles described number and function of Leukocytes of the innate Immune System ( table s5 ).']	N/A	N/A	[('CL_0002204', 'brush cell', 0, 'White blood cells'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0002405', 'immune system', 32, 'immune system'), ('CL_0000738', 'leukocyte', 101, 'leukocytes'), ('UBERON_0002405', 'immune system', 126, 'immune system')]
PMC4143239	8/2014	S198-PMC4143239	['Lymphocytes in Blood\nfifty-eight articles reported either total numbers of Lymphocytes or Lymphocyte subsets in Blood ( table s11 ).']	N/A	N/A	[('CL_0000849', 'crypt olfactory receptor neuron', 0, 'Lymphocytes'), ('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000542', 'lymphocyte', 75, 'lymphocytes'), ('CL_0000542', 'lymphocyte', 90, 'lymphocyte'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4143239	8/2014	S202-PMC4143239	['T-Lymphocytes in Blood\nnumbers of T-Lymphocytes were described in 29 articles ( table s11 ).']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T-lymphocytes'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CL_0000084', 'T cell', 34, 'T-lymphocytes')]
PMC4143835	8/2014	S96-PMC4143835	['there were no significant differences between nursery and fernery workers in report of maternal diagnosis of high Blood pressure ( p = 0.38), diabetes or high Blood Sugar ( p = 0.28) or premature labor (p = 0.76) experienced during their most recent Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 114, 'blood'), ('UBERON_0000178', 'blood', 159, 'blood'), ('CHEBI_24870', 'ion', 165, 'sugar'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC4154213	5/2014	S74-PMC4154213	['the search format was as follows: {(chemical name) or [chemical abstracts service number (cas)]} and (biomarker or biological marker or biological monitoring or Urine or Blood).']	N/A	N/A	[('UBERON_0001088', 'urine', 161, 'urine'), ('UBERON_0000178', 'blood', 170, 'blood')]
PMC4154213	5/2014	S82-PMC4154213	['the summaries followed a standard format that included the most sensitive method or methods found a ) for each biological medium (primarily Blood and Urine); b ) for the parent Compound, Metabolites, and adducts; and c ) for general population and occupational settings.']	N/A	N/A	[('UBERON_0000178', 'blood', 140, 'blood'), ('UBERON_0001088', 'urine', 150, 'urine'), ('CHEBI_36357', 'polyatomic entity', 177, 'compound'), ('CHEBI_25212', 'metabolite', 187, 'metabolites')]
PMC4154213	5/2014	S92-PMC4154213	['for these, we reviewed full papers and identified analytical methods for Blood and Urine, detection limits, and detection frequencies in nhanes analyses of the general population.']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0001088', 'urine', 83, 'urine')]
PMC4154213	5/2014	S128-PMC4154213	['2012acrylamidehb adducts of Acrylamide and Glycidamidema Metabolites> 50 (Blood)alwis et al.']	N/A	N/A	[('CHEBI_28619', 'acrylamide', 28, 'acrylamide'), ('CHEBI_87221', 'flavianic acid', 43, 'glycidamideMA'), ('CHEBI_25212', 'metabolite', 57, 'metabolites'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC4154213	5/2014	S131-PMC4154213	['1999atrazinenoneatrazine Mercapturate< 5cdc 2009benzenebenzenema Metabolites> 50 (Blood)alwis et al.']	N/A	N/A	[('CHEBI_31823', 'mercury dichloride', 25, 'mercapturate'), ('CHEBI_25212', 'metabolite', 65, 'metabolites'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC4154213	5/2014	S138-PMC4154213	['2008pfoaserum: pfoanone> 50cdc 2012styrenestyrenema Metabolite, Mandelic Acid> 25 (Blood)alwis et al.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 52, 'metabolite'), ('CHEBI_30794', 'malonic acid', 64, 'mandelic acid'), ('UBERON_0000178', 'blood', 83, 'blood')]
PMC4154213	5/2014	S159-PMC4154213	['common approaches include measuring dna and hemoglobin adducts in Blood (il’yasova et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood')]
PMC4154213	5/2014	S179-PMC4154213	['methods for biomonitoring them typically involve measuring the parent Compound in Blood or Urine, or dna or hemoglobin adducts of the parent Compound (see supplemental material, table s1).']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 70, 'compound'), ('UBERON_0000178', 'blood', 82, 'blood'), ('UBERON_0001088', 'urine', 91, 'urine'), ('CHEBI_36357', 'polyatomic entity', 141, 'compound')]
PMC4154213	5/2014	S183-PMC4154213	['exposures to Trinitrotoluene and Dinitrotoluene, used in explosives and munitions, also produce elevated levels of tda in Urine and Blood (echa 2013).']	N/A	N/A	[('CHEBI_27135', 'trinitrotoluene', 13, 'trinitrotoluene'), ('CHEBI_23824', 'diol', 33, 'dinitrotoluene'), ('UBERON_0001088', 'urine', 122, 'urine'), ('UBERON_0000178', 'blood', 132, 'blood')]
PMC4154213	5/2014	S200-PMC4154213	['others have measured Benzene in Urine and Breath, Benzene Metabolites in Urine, and adducts to proteins and dna in Blood and dried Blood spots (see supplemental material, table s1).']	N/A	N/A	[('CHEBI_36737', 'bilene', 21, 'benzene'), ('UBERON_0001088', 'urine', 32, 'urine'), ('UBERON_0000310', 'breast', 42, 'breath'), ('CHEBI_36737', 'bilene', 50, 'benzene'), ('CHEBI_25212', 'metabolite', 58, 'metabolites'), ('UBERON_0001088', 'urine', 73, 'urine'), ('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0000178', 'blood', 131, 'blood')]
PMC4154213	5/2014	S249-PMC4154213	['common exposure biomarkers are protein or dna adducts in Blood or Tissues, the parent Compound in Blood or Hair, and the parent Compound or Metabolites in Urine (see supplemental material, table s1).']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_36357', 'polyatomic entity', 86, 'compound'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0001037', 'strand of hair', 107, 'hair'), ('CHEBI_36357', 'polyatomic entity', 128, 'compound'), ('CHEBI_25212', 'metabolite', 140, 'metabolites'), ('UBERON_0001088', 'urine', 155, 'urine')]
PMC4154213	5/2014	S258-PMC4154213	['gc-ms and lc-ms/ms methods in Blood and Urine are more precise, sensitive, and specific (blair 2010;rosner et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0001088', 'urine', 40, 'urine')]
PMC4154213	5/2014	S279-PMC4154213	['2007) and hemoglobin adducts in Blood (zwirner-baier and neumann 1999).']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC4154213	5/2014	S287-PMC4154213	['exposure biomarkers include measurement of the parent Compound in Blood, Urine, Breast Milk, and other Tissues using immunoassay methods with fluorescence detection as well as lc-Ms/ms approaches (hooper et al.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 54, 'compound'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001088', 'urine', 73, 'urine'), ('UBERON_0001348', 'brown adipose tissue', 80, 'breast milk'), ('UBERON_0000479', 'tissue', 103, 'tissues'), ('CHEBI_18303', 'phosphatidyl-L-serine', 179, 'MS')]
PMC4154213	5/2014	S302-PMC4154213	['they are widely detected in Blood samples in the united states (lau et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood')]
PMC4154213	5/2014	S310-PMC4154213	['pfcs are persistent and are readily measured in Blood in the general u.s. population as well as in groups exposed occupationally or through industrial contamination.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood')]
PMC4154213	5/2014	S323-PMC4154213	['nhanes and others have measured Styrene and its Metabolites and adducts in Blood samples from the general population (blount et al.']	N/A	N/A	[('CHEBI_27452', 'styrene', 32, 'styrene'), ('CHEBI_25212', 'metabolite', 48, 'metabolites'), ('UBERON_0000178', 'blood', 75, 'blood')]
PMC4154213	5/2014	S383-PMC4154213	['2007persistent organochlorinesdde [(Ddt Metabolite) in older Adult Blood)nullnullbrody et al.']	N/A	N/A	[('CHEBI_16130', 'DDT', 36, 'DDT'), ('CHEBI_39382', 'flufenoxuron', 40, 'metabolite'), ('UBERON_0007023', 'adult organism', 61, 'adult'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC4154213	5/2014	S384-PMC4154213	['2007a; snedeker 2001ntp 1978ddt (in Blood at young age)limited positivebno studybrody et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood')]
PMC4154213	5/2014	S386-PMC4154213	['2007—pcbs (in older Adult Blood)nullnullbrody et al.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 20, 'adult'), ('UBERON_0000178', 'blood', 26, 'blood')]
PMC4154213	5/2014	S556-PMC4154213	['biological exposure measures are powerful when they can assess the biologically active component (parent or Metabolite) in Blood or at the target Tissue and during the appropriate exposure window.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 108, 'metabolite'), ('UBERON_0000178', 'blood', 123, 'blood'), ('UBERON_0000479', 'tissue', 146, 'tissue')]
PMC4155824	8/2014	S304-PMC4155824	['list of abbreviations used\nafm: atomic force microscopy; cfu: colony forming units; cpg: cytosine-guanine dinucleotide; Dc: Dendritic Cell; Egf-R: Epidermal Growth Factor Receptor; eps: exopolysaccharide; Git: Gastrointestinal Tract; Iec: Intestinal Epithelial Cell; is: insertion sequence; lta: lipoteichoic Acid; lgg: lactobacillus rhamnosus gg; mamp: Microbe-associated molecular pattern; Pbmc: Peripheral Blood Mononuclear Cells; pg: peptidoglycan; prr: pattern recognition receptor; qs: Quorum Sensing; vre: Vancomycin-resistant enterococci.']	N/A	N/A	[('CL_0000784', 'plasmacytoid dendritic cell', 120, 'DC'), ('CL_0000635', "Deiter's cell", 124, 'Dendritic cell'), ('PR_000006901', 'early endosome antigen 1', 140, 'EGF'), ('PR_000013773', 'retinoblastoma-associated protein', 144, 'R'), ('PR_000006910', 'elongation factor 2 kinase', 147, 'Epidermal growth factor receptor'), ('UBERON_0007376', 'outer epithelium', 147, 'Epidermal'), ('UBERON_0001091', 'calcareous tooth', 205, 'GIT'), ('UBERON_0001555', 'digestive tract', 210, 'Gastrointestinal tract'), ('CL_0002284', 'type X enteroendocrine cell', 234, 'IEC'), ('CL_0002563', 'intestinal epithelial cell', 239, 'Intestinal epithelial cell'), ('UBERON_0001277', 'intestinal epithelium', 239, 'Intestinal epithelial'), ('CHEBI_37527', 'acid', 309, 'acid'), ('NCBITaxon_10088', 'Mus <genus>', 354, 'Microbe'), ('CL_0002246', 'peripheral blood stem cell', 392, 'PBMC'), ('CL_0002510', 'CD103-negative, langerin-positive lymph node dendritic cell', 398, 'Peripheral Blood Mononuclear Cells'), ('UBERON_0000178', 'blood', 409, 'Blood'), ('GO_0030061', 'mitochondrial crista', 415, 'Mononuclear'), ('GO_0007099', 'centriole replication', 492, 'Quorum sensing'), ('CHEBI_28001', 'vancomycin', 513, 'vancomycin')]
PMC4160672	7/2014	S59-PMC4160672	['the measurements for the control subjects were done on the 7thday of the last Menstrual Period after a negative Blood Pregnancy test.']	N/A	N/A	[('GO_0007613', 'memory', 78, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 78, 'menstrual period'), ('UBERON_0000178', 'blood', 112, 'blood'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC4160672	7/2014	S62-PMC4160672	['these include hemoglobin, Blood group and genotype, Urinalysis, fasting Blood sugar and 2 h Postprandial.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('UBERON_0001286', "Bowman's space", 52, 'urinalysis'), ('UBERON_0000178', 'blood', 72, 'blood'), ('GO_0007567', 'parturition', 92, 'postprandial')]
PMC4160835	9/2014	S51-PMC4160835	['the diagnostic criteria for pre-eclampsia in norway, according to the guidelines issued by the society for gynecology, are Blood pressure >140/90 after 20\u2005weeks of Gestation, combined with proteinuria >+1 dipstick on at least 2 occasions.']	N/A	N/A	[('UBERON_0000178', 'blood', 123, 'blood'), ('GO_0007565', 'female pregnancy', 164, 'gestation')]
PMC4160835	9/2014	S53-PMC4160835	['Blood pressure measurement and urinalysis for protein are carried out at each Antenatal visit.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 78, 'antenatal')]
PMC4161853	8/2014	S26-PMC4161853	['Arterial Blood enters the Spleen through the Splenic Artery (Sa) that branches in multiple Arterioles.']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0002106', 'spleen', 26, 'spleen'), ('UBERON_0009659', 'spermatic artery', 45, 'splenic artery'), ('UBERON_0001854', 'saccule of membranous labyrinth', 61, 'SA'), ('UBERON_0001980', 'arteriole', 91, 'arterioles')]
PMC4161853	8/2014	S30-PMC4161853	['most of the Arterial Blood that enters the Spleen is drained into the Marginal Zone (Mz) through small open ended capillaries named Penicilli.']	N/A	N/A	[('UBERON_0001637', 'artery', 12, 'arterial'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002106', 'spleen', 43, 'spleen'), ('UBERON_3010452', 'non-involuting marginal zone', 70, 'marginal zone'), ('UBERON_2005031', 'dorsal longitudinal vein', 85, 'MZ'), ('CHEBI_17334', 'penicillin', 132, 'penicilli')]
PMC4161853	8/2014	S31-PMC4161853	['ninety per cent of the Blood that enter the Mz is drained directly into (1) open ended Venous Sinuses (Vs) or (2) Penicilli-vs connections, constituting the fast pathway.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_2005031', 'dorsal longitudinal vein', 44, 'MZ'), ('UBERON_0002463', 'muscle of posterior compartment of hindlimb stylopod', 87, 'venous sinuses'), ('UBERON_0005432', 'aortic sac', 103, 'VS'), ('CHEBI_17334', 'penicillin', 114, 'penicilli')]
PMC4161853	8/2014	S32-PMC4161853	['ten per cent of the Blood is drain into the open circulation of the Perifollicular Zone (Pfz) and Red Pulp (Rp) constituting the slow pathway.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0003069', 'otic placode', 68, 'perifollicular zone'), ('UBERON_0009133', 'pleuroperitoneal membrane', 89, 'PFz'), ('UBERON_0001250', 'red pulp of spleen', 98, 'red pulp'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 108, 'RP')]
PMC4161853	8/2014	S37-PMC4161853	['most of the Blood flow is deposited in the Mz through Capillaries branched from Splenic Central Arterioles (figure\xa01).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('UBERON_2005031', 'dorsal longitudinal vein', 43, 'MZ'), ('UBERON_0001982', 'capillary', 54, 'capillaries'), ('UBERON_0010290', 'scleral ossicle', 80, 'splenic central arterioles')]
PMC4161853	8/2014	S38-PMC4161853	['the small Capillaries in the Mz called Penicilli distribute part of the Blood flow to the follicles, the Pfz and the Rp [6].']	N/A	N/A	[('UBERON_0001982', 'capillary', 10, 'capillaries'), ('UBERON_2005031', 'dorsal longitudinal vein', 29, 'MZ'), ('CHEBI_17334', 'penicillin', 39, 'penicilli'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0009133', 'pleuroperitoneal membrane', 105, 'PFz'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 117, 'RP')]
PMC4161853	8/2014	S41-PMC4161853	['distribution of the Blood Cells is not random.']	N/A	N/A	[('CL_0000081', 'blood cell', 20, 'blood cells'), ('UBERON_0000178', 'blood', 20, 'blood')]
PMC4161853	8/2014	S42-PMC4161853	['ninety per cent of the Blood flow coming out from the Mz is drained directly into open ended Venous Sinuses (Vs) or Penicillin-vs connections, and from there to the Splenic Venous Circulation constituting the fast pathway.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_2005031', 'dorsal longitudinal vein', 54, 'MZ'), ('UBERON_0002463', 'muscle of posterior compartment of hindlimb stylopod', 93, 'venous sinuses'), ('UBERON_0005432', 'aortic sac', 109, 'VS'), ('CHEBI_17334', 'penicillin', 116, 'penicillin'), ('UBERON_0002206', 'mammillary body', 165, 'splenic venous circulation')]
PMC4161853	8/2014	S43-PMC4161853	['ten percent of the Blood is drained into an open Circulation System in the Pfz and the Rp (slow pathway) [6,18].']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0025593', 'serotonergic system', 49, 'circulation system'), ('UBERON_0009133', 'pleuroperitoneal membrane', 75, 'PFz'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 87, 'RP')]
PMC4161853	8/2014	S46-PMC4161853	['Blood-borne pathogens and debris can also be captured in the rp.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4161853	8/2014	S106-PMC4161853	['most of the Arterial Blood that enters the Spleen runs through the Mz inhabited by a special set of cells, such as Macrophages Expressing unique combinations of pattern recognition receptors, as well as Mz B Cells that can be readily activated [19].']	N/A	N/A	[('UBERON_0001637', 'artery', 12, 'arterial'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002106', 'spleen', 43, 'spleen'), ('UBERON_2005031', 'dorsal longitudinal vein', 67, 'MZ'), ('CL_0000235', 'macrophage', 115, 'macrophages'), ('GO_0010467', 'gene expression', 127, 'expressing'), ('CL_0000485', 'mucosal type mast cell', 203, 'MZ'), ('CL_0000236', 'B cell', 206, 'B cells')]
PMC4161853	8/2014	S183-PMC4161853	['Ca: Central Arteriole; Vs: Venous Sinuses; Rbc: Red Blood Cell; irbc: infected Rbc; Mø: Macrophages; Pc: Plasma Cells; Dc: Dendritic Cells; Mz B Cells: Marginal Zone B Cells.']	N/A	N/A	[('UBERON_2005019', 'efferent lamellar arteriole', 0, 'CA'), ('UBERON_2000474', 'intercalar', 4, 'central arteriole'), ('UBERON_0005432', 'aortic sac', 23, 'VS'), ('UBERON_0002463', 'muscle of posterior compartment of hindlimb stylopod', 27, 'venous sinuses'), ('CL_0000232', 'erythrocyte', 43, 'RBC'), ('CL_0000232', 'erythrocyte', 48, 'red blood cell'), ('UBERON_0000178', 'blood', 52, 'blood'), ('CL_0000232', 'erythrocyte', 79, 'RBC'), ('CL_0000485', 'mucosal type mast cell', 84, 'MØ'), ('CL_0000235', 'macrophage', 88, 'macrophages'), ('CL_0000696', 'PP cell', 101, 'PC'), ('CL_0000786', 'plasma cell', 105, 'plasma cells'), ('CL_0000784', 'plasmacytoid dendritic cell', 119, 'DC'), ('CL_0000451', 'dendritic cell', 123, 'dendritic cells'), ('UBERON_2005031', 'dorsal longitudinal vein', 140, 'MZ'), ('CL_0000236', 'B cell', 143, 'B cells'), ('CL_0000845', 'marginal zone B cell of spleen', 152, 'marginal zone'), ('CL_0000236', 'B cell', 166, 'B cells')]
PMC4161853	8/2014	S198-PMC4161853	['Rbc: Red Blood Cell; Bm: Bone Marrow; mz B Cells: Marginal Zone B Cells; Mø: Macrophages; ibi: invasive bacterial infection; crp: complement Regulatory proteins.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 0, 'RBC'), ('CL_0000232', 'erythrocyte', 5, 'red blood cell'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0005401', 'cerebral hemisphere gray matter', 21, 'BM'), ('UBERON_0002371', 'bone marrow', 25, 'bone marrow'), ('CL_0002492', 'strial marginal cell', 30, 'marrow'), ('CL_0000236', 'B cell', 41, 'B cells'), ('CL_0000845', 'marginal zone B cell of spleen', 50, 'marginal zone'), ('CL_0000236', 'B cell', 64, 'B cells'), ('CL_0000485', 'mucosal type mast cell', 73, 'MØ'), ('CL_0000235', 'macrophage', 77, 'macrophages'), ('GO_0065007', 'biological regulation', 141, 'regulatory')]
PMC4161944	9/2014	S20-PMC4161944	['Hematopoietic Stem Cells (Hscs) are the canonical precursors of all Immune Cell lineages and are defined by their capability to replace all Blood lineages in lacking recipients (1).']	N/A	N/A	[('CL_0000037', 'hematopoietic stem cell', 0, 'Hematopoietic stem cells'), ('GO_0030097', 'hemopoiesis', 0, 'Hematopoietic'), ('CL_0000545', 'T-helper 1 cell', 26, 'HSCs'), ('CL_0000738', 'leukocyte', 68, 'immune cell'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0000178', 'blood', 140, 'blood')]
PMC4161944	9/2014	S216-PMC4161944	['Restimulation Of Peripheral Mononuclear Blood Cells from mexican neonates vaccinated with different Bcg stains displayed significantly different levels of Interferon-Gamma, Il-12B, Il27, il-1, Il-6, and Il-24 mrna (165).']	N/A	N/A	[('GO_0051716', 'cellular response to stimulus', 0, 'Restimulation of ... cells'), ('CL_0000111', 'peripheral neuron', 17, 'peripheral'), ('CL_0000226', 'single nucleate cell', 28, 'mononuclear blood cells'), ('GO_0031097', 'medial cortex', 28, 'mononuclear'), ('UBERON_0000178', 'blood', 40, 'blood'), ('CHEBI_33250', 'atom', 100, 'BCG'), ('PR_000008919', 'interferon alpha-6', 155, 'interferon-gamma'), ('PR_000001371', 'interleukin-13 receptor subunit alpha-1', 173, 'IL-12B'), ('PR_000001470', 'interleukin-28B', 181, 'IL27'), ('PR_000000037', 'BMP receptor type-2', 189, '-1'), ('PR_000001470', 'interleukin-28B', 193, 'IL-6'), ('PR_000001470', 'interleukin-28B', 203, 'IL-24')]
PMC4166817	10/2014	S52-PMC4166817	['[15] each Blood sample in 1 mg/ml Ethylenediaminetetraacetate was centrifuged at 12,000 rpm for 15 min at 4°c to separate the Plasma.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_63877', 'diethanolammonium nitrate', 34, 'ethylenediaminetetraacetate'), ('UBERON_0001969', 'blood plasma', 126, 'plasma')]
PMC4166817	10/2014	S115-PMC4166817	['[22] expansion of deep Arteries delivers warm Blood to cooled Extremities.']	N/A	N/A	[('UBERON_0001637', 'artery', 23, 'arteries'), ('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0007614', 'extensor digiti minimi muscle', 62, 'extremities')]
PMC4169453	9/2014	S59-PMC4169453	['laboratory measurements\nBlood samples were collected from the mother-infant pairs at every visit.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'Blood')]
PMC4169453	9/2014	S60-PMC4169453	['the baseline neonatal biochemical status was analyzed using Umbilical Cord Blood collected at Delivery.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 60, 'umbilical cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007567', 'parturition', 94, 'delivery')]
PMC4169453	9/2014	S106-PMC4169453	['because the primary endpoint was maternal Serum 25(Oh)D during supplementation, primary analysis was restricted to women who provided a Blood sample at baseline and v3 or v6.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 48, '25(OH ... D'), ('UBERON_0000178', 'blood', 136, 'blood')]
PMC4169551	9/2014	S70-PMC4169551	['Blood was collected from the Jugular Vein on 20 sows at both the 87thand the 108thday of Gestation and on 212 piglets at the 7thday and on 186 piglets at the 21stday of Lactation (figure 1) .']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0004711', 'jugular vein', 29, 'jugular vein'), ('GO_0007565', 'female pregnancy', 89, 'gestation'), ('GO_0007595', 'lactation', 169, 'lactation')]
PMC4169551	9/2014	S71-PMC4169551	['after the Blood had clotted, Serum was separated by centrifugation and stored at −20°c for later analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001977', 'blood serum', 29, 'serum')]
PMC4172780	9/2014	S73-PMC4172780	['Tissue processing\nAnimals were deeply anesthetized with Pentobarbital prior to Cardiac perfusion with pbs to expunge Blood from the Cerebrovasculature.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('NCBITaxon_33208', 'Metazoa', 18, 'Animals'), ('CHEBI_7983', 'pentobarbital', 56, 'pentobarbital'), ('UBERON_0000948', 'heart', 79, 'cardiac'), ('UBERON_0000178', 'blood', 117, 'blood'), ('UBERON_0006694', 'cerebellum vasculature', 132, 'cerebrovasculature')]
PMC4173670	9/2014	S65-PMC4173670	['this method of Ethanol administration leads to Blood Ethanol concentrations of 287\u2009±\u20093.5\u2009mg/dl within 15\u2009min of the second injection.']	N/A	N/A	[('CHEBI_16236', 'ethanol', 15, 'ethanol'), ('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_16236', 'ethanol', 53, 'ethanol')]
PMC4176103	10/2013	S39-PMC4176103	['at this first Antenatal visit, women’s medical history was taken along with routine Blood tests and an ultrasound scan to confirm the Pregnancy.']	N/A	N/A	[('GO_0007567', 'parturition', 14, 'antenatal'), ('UBERON_0000178', 'blood', 84, 'blood'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC4183922	6/2014	S29-PMC4183922	['weight, Food Intake, and ambient Glucose measurements\nweight and Blood Glucose measurements were collected from dams every two days between 10:00 and 11:00 am.']	N/A	N/A	[('CHEBI_33290', 'food', 8, 'food'), ('GO_0007631', 'feeding behavior', 8, 'food intake'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_17234', 'glucose', 71, 'glucose')]
PMC4183922	6/2014	S30-PMC4183922	['circulating Blood Glucose measurements were collected from a Tail tip using a one touch ultra handheld Glucose meter (lifescan, inc).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_17234', 'glucose', 18, 'glucose'), ('UBERON_0002415', 'tail', 61, 'tail'), ('CHEBI_17234', 'glucose', 103, 'glucose')]
PMC4183922	6/2014	S35-PMC4183922	['Blood Glucose measurements were collected by Tail tip at the start and end of the fast.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0002415', 'tail', 45, 'tail')]
PMC4183922	6/2014	S37-PMC4183922	['Blood Glucose levels were measured before and 15, 30, 45, 60, 90, and 120 minutes after Glucose injection.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_17234', 'glucose', 88, 'glucose')]
PMC4183922	6/2014	S38-PMC4183922	['for measurement of Insulin Release in response to Glucose, Animals were killed at 0, 30, or 60 minutes after Glucose injection and Truncal Blood collected for further analysis.']	N/A	N/A	[('GO_0006880', 'intracellular sequestering of iron ion', 19, 'insulin release'), ('PR_000045358', 'insulin family protein', 19, 'insulin'), ('CHEBI_17234', 'glucose', 50, 'glucose'), ('NCBITaxon_33208', 'Metazoa', 59, 'animals'), ('CHEBI_17234', 'glucose', 109, 'glucose'), ('UBERON_0002061', 'truncus arteriosus', 131, 'truncal'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC4183922	6/2014	S40-PMC4183922	['Blood Glucose levels were measured before and 15, 30, 45, 60, 75, and 90 minutes after Insulin injection.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('PR_000045358', 'insulin family protein', 87, 'insulin')]
PMC4183922	6/2014	S42-PMC4183922	['Serum Insulin levels\nTruncal Blood was collected from terminally anesthetized Mice.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000045358', 'insulin family protein', 6, 'insulin'), ('UBERON_0002061', 'truncus arteriosus', 21, 'Truncal'), ('UBERON_0000178', 'blood', 29, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'mice')]
PMC4183922	6/2014	S43-PMC4183922	['Blood samples were centrifuged for 15 minutes at 3000 g and Plasma collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 60, 'plasma')]
PMC4183922	6/2014	S47-PMC4183922	['after 1 hour, Blood Glucose levels were ascertained to be below 2.5 mm and Animals culled by overdose of Anesthetic (euthatal).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_17234', 'glucose', 20, 'glucose'), ('NCBITaxon_33208', 'Metazoa', 75, 'animals'), ('CHEBI_38867', 'anaesthetic', 105, 'anesthetic')]
PMC4183922	6/2014	S77-PMC4183922	['female offspring of hfd-Fed dams is more vulnerable to Metabolic disturbance than males\nat p4 no difference in body weight or Blood Glucose was noted between unsexed offc and offhfd (figure 3a).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 24, 'fed'), ('GO_0008152', 'metabolic process', 55, 'metabolic'), ('UBERON_0000178', 'blood', 126, 'blood'), ('CHEBI_17234', 'glucose', 132, 'glucose')]
PMC4183922	6/2014	S78-PMC4183922	['at p21 both female and male offhfd pups had significantly increased weight and Blood Glucose (figure 3b).']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_17234', 'glucose', 85, 'glucose')]
PMC4183922	6/2014	S80-PMC4183922	['male offhfd body weight normalized within a week of weaning; Blood Glucose levels also returned to normal within 3 days (figure 3d).']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_17234', 'glucose', 67, 'glucose')]
PMC4183922	6/2014	S84-PMC4183922	['a, body weight and Blood Glucose of (unsexed) p4 offspring from Chow-Fed (offc) or hfd-Fed (offhfd) dams (n = 15).']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_17234', 'glucose', 25, 'glucose'), ('CHEBI_33290', 'food', 64, 'chow'), ('GO_0007631', 'feeding behavior', 69, 'fed'), ('GO_0007631', 'feeding behavior', 87, 'fed')]
PMC4183922	6/2014	S85-PMC4183922	['b, female and male offc and offhfd body weight and Blood Glucose at p21/weaning (n = 33–42; **, p< .01; ***, p< .001; 1-way anova).']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_17234', 'glucose', 57, 'glucose')]
PMC4183922	6/2014	S86-PMC4183922	['c, female body weight and Blood Glucose curves after weaning until 8 weeks of age.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_17234', 'glucose', 32, 'glucose')]
PMC4183922	6/2014	S95-PMC4183922	['c, 8-week-old female and male offc and offhfd were fasted at 9:00 am for 6 hours and Blood Glucose measured at 1 and 6 hours (n = 13–15; *, p< .05; 2-way repeated measures anova).']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood'), ('CHEBI_17234', 'glucose', 91, 'glucose')]
PMC4183922	6/2014	S109-PMC4183922	['to further analyze this sexual dimorphism in Glucose-responsive Pvh Gene Expression, Pvh Gene Expression was plotted against Blood Glucose levels for all Adult male and female offc Mice (figure 6).']	N/A	N/A	[('CHEBI_17234', 'glucose', 45, 'glucose'), ('PR_000013502', 'parvalbumin alpha', 64, 'PVH'), ('GO_0010467', 'gene expression', 68, 'gene expression'), ('SO_0000704', 'gene', 68, 'gene'), ('PR_000013502', 'parvalbumin alpha', 85, 'PVH'), ('GO_0010467', 'gene expression', 89, 'gene expression'), ('SO_0000704', 'gene', 89, 'gene'), ('UBERON_0000178', 'blood', 125, 'blood'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('UBERON_0007023', 'adult organism', 154, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 181, 'mice')]
PMC4183922	6/2014	S124-PMC4183922	['Blood Glucose drop is expressed as %prefast (n = 10–14; **, p< .01; *, p< .05; 2-way repeated measures anova).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose')]
PMC4188019	1/2010	S3-PMC4188019	['method : from august 1 2009 until november 30 2009 we systematically determined 25-Hydroxy Vitamin D (25-Oh Vitamin D) in each Blood sample taken from Pregnant women visiting the Antenatal clinic.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 80, '25-hydroxy vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 102, '25-OH'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000178', 'blood', 127, 'blood'), ('GO_0007565', 'female pregnancy', 151, 'pregnant'), ('GO_0007567', 'parturition', 179, 'antenatal')]
PMC4188019	1/2010	S27-PMC4188019	['in each Blood sample that was taken from Pregnant women consulting the Antenatal clinic, we determined 25-Oh Vitamin D. the nurse taking the Blood samples put every patient in a category according to their sun exposure.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('GO_0007567', 'parturition', 71, 'antenatal'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 103, '25-OH'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4192458	9/2014	S85-PMC4192458	['controls were women who Delivered immediately after the case in the same hospital and had not more than one elevated Blood pressure reading after 20 weeks of Pregnancype cases: 26.0 ± 4.8; gh cases: 26.2 ± 4.3; controls: 26.1 ± 4.220-item ffq (dairy Foods only)after Delivery (retrospective, first 20 weeks’ Gestation)diet onlypecand gh\u2003paknahad et al., 2008 [28]iran9246 cases, 46 controlspregnant women attending al-zahra and shaheed beheshti hospitals in isfahan.']	N/A	N/A	[('GO_0007567', 'parturition', 24, 'delivered'), ('UBERON_0000178', 'blood', 117, 'blood'), ('GO_0007605', 'sensory perception of sound', 158, 'pregnancyPE'), ('CHEBI_33290', 'food', 250, 'foods'), ('GO_0007567', 'parturition', 267, 'delivery'), ('GO_0007565', 'female pregnancy', 308, 'gestation')]
PMC4192458	9/2014	S92-PMC4192458	['controls were Pregnant women with normal Blood pressure referred to this hospital for Prenatal care, matched for Gestational agecases: 28.73 ± 6.04; controls: 25.36 ± 4.84148-item ffqbat diagnosis (retrospectively, past 3 months)diet with supplementsgh\u2003reyes et al., 2012 [56]colombia402201 cases, 201 controlspregnant women recruited from six colombian cities between 2006 and 2009.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('GO_0007565', 'female pregnancy', 113, 'gestational')]
PMC4193194	10/2014	S32-PMC4193194	['this causes a reduced remodeling of the maternal Spiral Arteries eventually leading to a decrease in Blood flow to the Placenta.']	N/A	N/A	[('UBERON_0002537', 'hermaphrodite gonad', 49, 'spiral arteries'), ('UBERON_0000178', 'blood', 101, 'blood'), ('UBERON_0001987', 'placenta', 119, 'placenta')]
PMC4193194	10/2014	S34-PMC4193194	['in order to compensate the Blood flow deficiency, the mother develops hypertension to increase the Blood flow, usually at the end of the second or third Trimester of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0000178', 'blood', 99, 'blood'), ('GO_0009294', 'DNA mediated transformation', 153, 'trimester'), ('GO_0007565', 'female pregnancy', 166, 'gestation')]
PMC4193194	10/2014	S40-PMC4193194	['these cells, that are Placental native (redman and sargent,2005), are the reunion of two subtypes: syncytiotrophoblasts, that are responsible for the formation of a primary external layer in direct contact with maternal Blood, and Cytotrophoblasts, that conform the inner layer, and differentiate and invade the maternal Endometrial Stroma (hunkapiller and fisher,2008).']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placental'), ('UBERON_0000178', 'blood', 220, 'blood'), ('CL_0000722', 'cystoblast', 231, 'cytotrophoblasts'), ('UBERON_0002337', 'endometrial stroma', 321, 'endometrial stroma')]
PMC4193194	10/2014	S46-PMC4193194	['due of defective Trophoblast invasion, intermittency of Arterial Blood flow occurs, resulting in periods of ischemia/reperfusion, creating a hypoxic environment which favors oxidative stress, consequent oxidative damage and inflammation (myatt and webster,2009) (figure1).']	N/A	N/A	[('UBERON_0000088', 'trophoblast', 17, 'trophoblast'), ('UBERON_0001637', 'artery', 56, 'arterial'), ('UBERON_0000178', 'blood', 65, 'blood')]
PMC4193194	10/2014	S81-PMC4193194	['immediately after Placental Reperfusion injury, reestablished Blood flow releases cytokines and other inflammatory factors like Tumor Necrosis Factor-Alpha (Tnf-Α), interleukin (il)-6, and Il-10, C-Reactive Protein (Crp), and damaging levels of Ros like Superoxide, in response to these events.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0000003', 'reproduction', 28, 'reperfusion'), ('UBERON_0000178', 'blood', 62, 'blood'), ('PR_000016185', 'transcription factor 7-like 1', 128, 'tumor necrosis factor-alpha'), ('PR_000000134', 'tumor necrosis factor alpha', 157, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 189, 'IL-10'), ('PR_000005890', 'crooked neck-like protein 1', 196, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 216, 'CRP'), ('CHEBI_8756', 'RNA (poly(A))', 245, 'ROS'), ('CHEBI_18421', 'superoxide', 254, 'superoxide')]
PMC4210519	10/2014	S54-PMC4210519	['Trunk Blood was collected into heparinised and Serum tubes, centrifuged at 2,000 × g for 10 min; and Plasma and Serum aliquots were removed and stored at -80°c until analysis.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 47, 'serum'), ('UBERON_0001969', 'blood plasma', 101, 'plasma'), ('UBERON_0001977', 'blood serum', 112, 'serum')]
PMC4210519	10/2014	S73-PMC4210519	['Blood sample analyses\nPlasma Glucose concentration was measured by the spectrometric Glucose oxidase/peroxidase-anti-peroxidase method (mtidiagnostics, idstein, germany; sensitivity 0.11 mmol/l)), and Plasma Triglyceride concentration by the spectrometric gpo method (wak-chemie, steinbach, germany, sensitivity 0.05 mmol/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 22, 'Plasma'), ('CHEBI_17234', 'glucose', 29, 'glucose'), ('CHEBI_17234', 'glucose', 85, 'glucose'), ('UBERON_0001969', 'blood plasma', 201, 'plasma'), ('CHEBI_17855', 'triglyceride', 208, 'triglyceride')]
PMC4210519	10/2014	S103-PMC4210519	['caption (table-wrap): table 1\n\nAnimal data and Blood variables of offspring ofad libitum-Fed (ad) and undernourished (un) mothersvariableunitadunp value3n/groupbody weight1g647\u2009±\u200914590\u2009±\u200913<0.0132body length1cm28.5\u2009±\u20090.227.4\u2009±\u20090.1<0.00132food Intake2G/d/rat29.9\u2009±\u20090.628.3\u2009±\u20090.5<0.0532food Intake/g bwtg/g0.047\u2009±\u20090.0010.049\u2009±\u20090.001n.s.32glucosemmol/l8.71\u2009±\u20090.468.92\u2009±\u20090.42n.s.32triglyceridesmmol/l1.66\u2009±\u20090.112.04\u2009±\u20090.12<0.0532rpatg5.69\u2009±\u20090.375.65\u2009±\u20090.42n.s32rpat % bwt%0.87\u2009±\u20090.040.93\u2009±\u20090.05n.s32\nvalues are given as mean\u2009±\u2009sem.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 31, 'Animal'), ('UBERON_0000178', 'blood', 47, 'blood'), ('GO_0007631', 'feeding behavior', 89, 'fed'), ('GO_0007631', 'feeding behavior', 243, 'intake2g'), ('GO_0007631', 'feeding behavior', 289, 'intake')]
PMC4213680	12/2014	S50-PMC4213680	['Blood was collected immediately and Serum was separated by centrifugation at 3,000× g for 10 min at 4°c and stored at −20°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 36, 'serum')]
PMC4216170	7/2014	S117-PMC4216170	['Whole-Blood Folate levels were measured in samples collected at 16 weeks Gestation using previously described methods (fazili and pfeiffer 2004).']	N/A	N/A	[('UBERON_0004043', 'semicircular canal ampulla', 0, 'Whole'), ('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 12, 'folate'), ('GO_0007565', 'female pregnancy', 73, 'gestation')]
PMC4216170	7/2014	S118-PMC4216170	['we classified women into terciles based on the distribution of whole Blood Folate concentrations (34–387, 392–597, and 599–1,660 nmol/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 75, 'folate')]
PMC4216170	7/2014	S165-PMC4216170	['the associations between Prenatal Urinary bpa concentrations and child bmi did not differ according to terciles of maternal whole-Blood Folate levels (emm p = 0.74).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('UBERON_0001088', 'urine', 34, 'urinary'), ('UBERON_0000178', 'blood', 130, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 136, 'folate')]
PMC4216381	10/2014	S37-PMC4216381	['Urine specimens, for a future speciated Arsenic analysis, and Blood specimens for future Genetic and nutritional analyses were collected at the time of the interview, and archived at -20\xa0c.\n\nWater analysis\ntrained study staff collected drinking Water samples on-site into 50\xa0ml screw-top Polyethylene containers previously decontaminated with Nitric Acid (Hno3) and rinsed.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('CHEBI_27563', 'arsenic atom', 40, 'arsenic'), ('UBERON_0000178', 'blood', 62, 'blood'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_15377', 'water', 191, 'Water'), ('CHEBI_15377', 'water', 245, 'water'), ('CHEBI_53551', 'poly(methylene)', 288, 'polyethylene'), ('CHEBI_48107', 'nitric acid', 343, 'nitric acid'), ('CHEBI_36275', 'HETE', 356, 'HNO3')]
PMC4221707	11/2014	S30-PMC4221707	['participants, who were consecutively recruited between september 2006 and march 2009, were part of a longitudinal study (pregnut) where dietary intake, height, and weight were measured and Blood sampled during Pregnancy and Postpartum.']	N/A	N/A	[('UBERON_0000178', 'blood', 189, 'blood'), ('GO_0007565', 'female pregnancy', 210, 'pregnancy'), ('GO_0007565', 'female pregnancy', 224, 'postpartum')]
PMC4222017	8/2014	S40-PMC4222017	['finally, two milliliters Blood sample was drawn from each Pregnant woman to evaluate hb concentration.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC4224012	11/2014	S1-PMC4224012	['children Born to mothers in the study group were a mean 204 g heavier at 2·5 years of age and their systolic Blood pressure was a mean 2·5 mm hg lower than children Born to mothers in the control group.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'born'), ('UBERON_0000178', 'blood', 109, 'blood'), ('GO_0007567', 'parturition', 165, 'born')]
PMC4224012	11/2014	S3-PMC4224012	['methods\nfor this follow-up study, we identified children from the original trial and measured anthropometry, body composition with bioelectrical impedance (with population-specific isotope calibration), Blood pressure, and Renal dimensions by ultrasound.']	N/A	N/A	[('UBERON_0000178', 'blood', 203, 'blood'), ('UBERON_0002113', 'kidney', 223, 'renal')]
PMC4224012	11/2014	S5-PMC4224012	['main outcomes of the follow-up at 8 years were z scores for weight-for-age, height-for-age, and body-mass index (bmi)-for-age according to who child growth standards for children aged 5–19 years, and Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 200, 'blood')]
PMC4224012	11/2014	S9-PMC4224012	['we recorded no difference in Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood')]
PMC4224012	11/2014	S53-PMC4224012	['we used an omron m6 electronic Blood pressure monitor (omron healthcare, japan) with a paediatric cuff, or Adult cuff if needed.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0007023', 'adult organism', 107, 'adult')]
PMC4224012	11/2014	S110-PMC4224012	['we recorded no difference in systolic and diastolic Blood pressure between the groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood')]
PMC4224012	11/2014	S121-PMC4224012	['discussion\nat follow-up at 8·5 years, we recorded no differences in anthropometric outcomes (with or without adjustment for Birth size), conditional relative growth, or Blood pressure between groups whose mothers were allocated Antenatally to either multiple Micronutrient or Iron and Folic Acid supplements.']	N/A	N/A	[('GO_0007567', 'parturition', 124, 'birth'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0007288', 'sperm axoneme assembly', 228, 'antenatally'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 259, 'micronutrient'), ('CHEBI_24870', 'ion', 276, 'iron'), ('CHEBI_30751', 'formic acid', 285, 'folic acid')]
PMC4231349	10/2013	S5-PMC4231349	['maternal Metabolic status was also tracked during Lactation, by following their body weight, Blood Glucose, Ketone, Cholesterol, and Triglyceride concentrations.']	N/A	N/A	[('GO_0008152', 'metabolic process', 9, 'metabolic'), ('GO_0007595', 'lactation', 50, 'lactation'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_17234', 'glucose', 99, 'glucose'), ('CHEBI_17087', 'ketone', 108, 'ketone'), ('CHEBI_16113', 'cholesterol', 116, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 133, 'triglyceride')]
PMC4231349	10/2013	S8-PMC4231349	['this resulted in stabilization of Blood Ketones of the kd dams, and aversion of the fatal ketoacidosis.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_17087', 'ketone', 40, 'ketones')]
PMC4231349	10/2013	S59-PMC4231349	['during Lactation, and between p2.5 and p20.5, maternal body weight, Blood Glucose and β −Ketones ( β − hydroxybutyrate ) were measured every other day.']	N/A	N/A	[('GO_0007595', 'lactation', 7, 'lactation'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_17234', 'glucose', 74, 'glucose'), ('CHEBI_17087', 'ketone', 89, 'ketones')]
PMC4231349	10/2013	S60-PMC4231349	['Glucose and Ketone concentrations were measured with an abbott “precision xtra” Glucometer which required 0.6-1.5 μ l of whole-Blood per test [20], drawn from the Tail Vein.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('CHEBI_17087', 'ketone', 12, 'ketone'), ('CHEBI_24321', 'glutamo group', 80, 'glucometer'), ('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0003481', 'tail vein', 163, 'tail vein')]
PMC4231349	10/2013	S129-PMC4231349	['their Blood Ketone concentration, which was elevated at p2.5, dropped to a concentration of 1-3 mmol/l by p4.5.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_17087', 'ketone', 12, 'ketone')]
PMC4231349	10/2013	S131-PMC4231349	['further, their Blood Glucose concentration stabilized by p6.5-8.5, and did not continue to increase past the normal range exhibited by the sd control dams.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CHEBI_17234', 'glucose', 21, 'glucose')]
PMC4231349	10/2013	S133-PMC4231349	['caption (fig): figure 4\n\nBlood Glucose and Ketone concentration over time in kd and sd dams following separation from their litters at p2.5, and until p20.5.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'Blood'), ('CHEBI_17234', 'glucose', 31, 'glucose'), ('CHEBI_17087', 'ketone', 43, 'ketone')]
PMC4231606	10/2013	S6-PMC4231606	['children underwent a Blood draw for Vitamin D (25(Oh)D), calcium, Parathyroid hormone, and albumin levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 66, 'parathyroid')]
PMC4231606	10/2013	S47-PMC4231606	['venipunctures for children with s-ecc were drawn by the attending anesthetist during surgery while Blood samples from controls were obtained by a research nurse at the manitoba institute of child health following the application of a topical Anaesthetic (emla) to the Anticubital Fossa.']	N/A	N/A	[('UBERON_0000178', 'blood', 99, 'blood'), ('CHEBI_38867', 'anaesthetic', 242, 'anaesthetic'), ('UBERON_0006661', 'epicranial aponeurosis', 268, 'anticubital fossa')]
PMC4233040	11/2014	S187-PMC4233040	['maternal Polycyclic Aromatic Hydrocarbons (Pah) exposure induced Promoter methylation of an asthma related Gene, Ifn-Γ, in Cord White Blood Cells from children in a study cohort [33].']	N/A	N/A	[('CHEBI_33666', 'polycyclic hydrocarbon', 9, 'polycyclic aromatic hydrocarbons'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 43, 'PAH'), ('SO_0000167', 'promoter', 65, 'promoter'), ('SO_0000704', 'gene', 107, 'gene'), ('PR_000008920', 'interferon alpha-7', 113, 'IFN-γ'), ('UBERON_0002240', 'spinal cord', 123, 'cord'), ('CL_0000738', 'leukocyte', 128, 'white blood cells'), ('UBERON_0000178', 'blood', 134, 'blood')]
PMC4243771	8/2014	S33-PMC4243771	['caption (table-wrap): table 1\n\nbody weight and Blood biochemistry of the sows as measured at 0, 40 and 108\xa0days of Gestationdays of gestation040108p sow weight (kg)c215.5\u2009±\u200913.4236.6\u2009±\u200911.8287.7\u2009±\u200910.5hf209.8\u2009±\u20099.2254.6\u2009±\u20098.6281.8\u2009±\u20098.7hdl (mmol/l)c0.55\u2009±\u20090.050.55\u2009±\u20090.05*0.42\u2009±\u20090.03#*\u2009<\u20090.05; #\u2009<\u20090.01hf0.66\u2009±\u20090.050.77\u2009±\u20090.04*0.56\u2009±\u20090.04#ldl (mmol/l)c0.68\u2009±\u20090.060.87\u2009±\u20090.050.74\u2009±\u20090.03hf0.75\u2009±\u20090.060.98\u2009±\u20090.080.84\u2009 ± \u20090.08glucose (mmol/l)c3.88\u2009±\u20090.573.93\u2009±\u20090.123.93\u2009±\u20090.10hf3.58\u2009±\u20090.514.11\u2009±\u20090.083.70\u2009±\u20090.17\nvalues are means\u2009±\u2009sem.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('GO_0007565', 'female pregnancy', 115, 'gestationDays')]
PMC4243771	8/2014	S108-PMC4243771	['on 0, 40 and 108\xa0days of Gestation fasting Blood samples were taken from each Animal.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'gestation'), ('UBERON_0000178', 'blood', 43, 'blood'), ('NCBITaxon_33208', 'Metazoa', 78, 'animal')]
PMC4243771	8/2014	S114-PMC4243771	['at 7\xa0days after Parturition, the median Birth weight offspring (c: 6 females, 1 male; hf: 4 females, 3 males) in each litter were weighed, a Blood sample collected, the piglet sedated with 10% Ketamine and then euthanized with (50\xa0mg/kg) t-61 (intervet, boxmeer, holland) followed by exsanguination.']	N/A	N/A	[('GO_0019230', 'proprioception', 16, 'parturition'), ('GO_0007567', 'parturition', 40, 'birth'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_6121', 'ketamine', 193, 'ketamine')]
PMC4246417	11/2014	S31-PMC4246417	['Genome-scale analysis\nwe employed rrbs on dna from whole Blood to obtain single-nucleotide high-resolution Dna Methylation data on a Genomic scale13.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genome'), ('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0006306', 'DNA methylation', 107, 'DNA methylation'), ('SO_0001026', 'genome', 133, 'genomic')]
PMC4246417	11/2014	S224-PMC4246417	['a telephone interview was performed with all participants and included questions on socio-demographic characteristics and medications for diabetes, Cholesterol and Blood pressure.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 148, 'cholesterol'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC4246417	11/2014	S230-PMC4246417	['Serum total Cholesterol, high-density lipoprotein Cholesterol and Triglycerides were collected from the baseline fasting Blood draw and immediately measured by standard methods and ldl Cholesterol was calculated for Individuals with a Triglyceride concentration lower than 400\u2009mg\u2009dl−1using the friedewald formula.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_16113', 'cholesterol', 12, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 50, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 66, 'triglycerides'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CHEBI_16113', 'cholesterol', 185, 'cholesterol'), ('NCBITaxon_1', 'root', 216, 'individuals'), ('CHEBI_17855', 'triglyceride', 235, 'triglyceride')]
PMC4246417	11/2014	S231-PMC4246417	['sequencing and Dna Methylation calling\nGenomic dna was extracted from whole Blood using the salting-out method.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 15, 'DNA methylation'), ('SO_0001026', 'genome', 39, 'Genomic'), ('UBERON_0000178', 'blood', 76, 'blood')]
PMC4249952	12/2014	S2-PMC4249952	['a tungsten atomizer absorption spectrophotometer was employed to determine Blood lead levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 75, 'blood')]
PMC4249952	12/2014	S3-PMC4249952	['results\nthe arithmetic mean, geometric mean and median of Blood lead levels of 0- to 6-year-old children from shanghai were 22.49 µg/l, 19.65 µg/l and 19.5 µg/l, including 0.26% (6/2291) with concentrations ≥100 µg/l and 2.7% (61/2291) with concentrations ≥50 µg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood')]
PMC4249952	12/2014	S5-PMC4249952	['the Blood lead levels increased with age.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4249952	12/2014	S8-PMC4249952	['conclusions\nthe Blood lead levels of children in shanghai were lower than the earlier data of shanghai and those of published studies in china, but higher than the Blood lead levels of developed countries.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC4249952	12/2014	S9-PMC4249952	['the Blood lead levels of urban districts are higher than the central districts with the industrial transformation.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4249952	12/2014	S15-PMC4249952	['lead is absorbed and spread through the Blood, resulting in long-term accumulation in the Liver, Kidney, Spleen, Lung, and Brain.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002106', 'spleen', 105, 'spleen'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000955', 'brain', 123, 'brain')]
PMC4249952	12/2014	S22-PMC4249952	['the average Blood lead levels of chinese urban children from 0 to 6 years of age decreased from 70–100 µg/l to 25–60 µg/l over the period from the end of the 1990s until 2009[5],[6].']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC4249952	12/2014	S23-PMC4249952	['the prevalence of children with higher Blood lead levels (≥100 µg/l) decreased from 30–50% to 1.5–15%[7],[8].']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood')]
PMC4249952	12/2014	S24-PMC4249952	['according to the earlier surveys of our team in shanghai, the Blood lead level decreased from 83 µg/l to 38.08 µg/l from 1997 to 2008.our early survey included five districts, they were jingan, jiading, chongming, yangpu and xuhui.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood')]
PMC4249952	12/2014	S25-PMC4249952	['the Blood lead levels declined 7 µg/l, 3 µg/l, 2 µg/l, 2 µg/l and 4 µg/l from 1997 to 1999, respectively[9],[10].']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4249952	12/2014	S35-PMC4249952	['1991 america center for disease control criteria for Blood poisoning (bll ≥100 µg/l) and low lead exposure (bll ≥50–100 µg/l) were used.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood')]
PMC4249952	12/2014	S39-PMC4249952	['nurses and medical staff were required to cut their Nails short and wash their Hands with a 2% edta (Na2) tampon before Blood sampling.']	N/A	N/A	[('UBERON_0001705', 'nail', 52, 'nails'), ('UBERON_0002398', 'manus', 79, 'hands'), ('CHEBI_33310', 'neon atom', 101, 'Na2)'), ('UBERON_0000178', 'blood', 120, 'blood')]
PMC4249952	12/2014	S41-PMC4249952	["children's Hands were cleaned with soap and Water, dried, and 3 ml Venous Blood was then collected."]	N/A	N/A	[('UBERON_0002398', 'manus', 11, 'hands'), ('CHEBI_15377', 'water', 44, 'water'), ('UBERON_0001638', 'vein', 67, 'venous'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC4249952	12/2014	S43-PMC4249952	['a tungsten atomizer absorption spectrophotometer (pinaacle900z, usa) was used to determine Blood lead levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 91, 'blood')]
PMC4249952	12/2014	S47-PMC4249952	['experienced staff nurses performed Blood sampling.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4249952	12/2014	S50-PMC4249952	['Blood lead levels greater than 100 µg/l were retested and the average reported.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4249952	12/2014	S58-PMC4249952	['the arithmetic mean, geometric mean and median of Blood lead levels of 0- to 6-year-old children from shanghai were 22.49 µg/l, 19.65 µg/l and 19.5 µg/l, including 0.26% (6/2291) with concentrations ≥100 µg/l and 2.7% (61/2291) with concentrations ≥50 µg/l.10.1371/journal.pone.0113297.t001\n\ncaption (table-wrap): table 1\ngeneral characteristics.characteristicsboy/girl1186/1105age (months)0–119.6% (221)12–3531% (710)36–7259.4%(1360)jingan district17.2% (393)jiading district17.2% (394)chongming district18.8% (431)yangpu district12.6% (289)xuhui district16.9% (387)pudong district17.3% (397)\nlead levels by gender were shown intable 2.']	N/A	N/A	[('UBERON_0000178', 'blood', 50, 'blood')]
PMC4249952	12/2014	S62-PMC4249952	['the Blood lead levels were significantly increased with the age, and the 3 to 6 year-old was the highest in all ages.10.1371/journal.pone.0113297.t003\n\ncaption (table-wrap): table 3\ndifference in lead level by ages (µg/l).agesnumberarithmetic meangeometric meanmedianrange0–11 m22119.3216.38173–5912–35 m71021.1718.38a193–12236–72 m136023.8420.95ab214–246χ235.06p0.000\nthe age of 1 to 3-year-old is higher than 0 to 1-year-old, p<0.001;\nthe age of 3 to 6-year-old is higher than 1 to 3-year-old, p<0.001.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4249952	12/2014	S63-PMC4249952	['the geometric mean of Blood lead levels of jingan, jiading, chongming, yangpu and xuhui districts were significantly lower than the data in 1997 of shanghai.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC4249952	12/2014	S76-PMC4249952	['we found the arithmetic mean, geometric mean and median of Blood lead levels of 0 to 1-year-old,1 to 3-year-old and 3 to 6-year-old children from shanghai were 22.49 µg/l, 19.65 µg/l and 19.5 µg/l, including 0.2% (4/2291) with concentrations ≥100 µg/l and 2.4% (46/2291) with concentrations ≥50 µg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood')]
PMC4249952	12/2014	S90-PMC4249952	['yangpu district was an old industrial area in 1997, there were factories such as lead smelters and other lead related industries, so the highest Blood lead levels of children was found in yangpu district, chongming is a relatively suburban district, and there was no industrial development, so it was at a low Blood lead at that period of time.']	N/A	N/A	[('UBERON_0000178', 'blood', 145, 'blood'), ('UBERON_0000178', 'blood', 310, 'blood')]
PMC4249952	12/2014	S114-PMC4249952	['every year, tens of thousands of children are screened in china, and a considerable number of children with elevated Blood lead levels and lead poisoning are identified.']	N/A	N/A	[('UBERON_0000178', 'blood', 117, 'blood')]
PMC4251419	12/2014	S144-PMC4251419	['free versus total Serum 25(Oh)D\nVitamin D Metabolites in Blood are largely tightly bound to Vdbp, with a small proportion of the total concentration loosely bound to albumin or unbound (free) [82].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 32, 'Vitamin D'), ('CHEBI_25212', 'metabolite', 42, 'metabolites'), ('UBERON_0000178', 'blood', 57, 'blood'), ('PR_000017279', 'testis-specific basic protein Y 1', 92, 'VDBP')]
PMC4256222	12/2014	S3-PMC4256222	['a Blood sample was drawn and Serum was stored, which later was analyzed for the concentration of 25-Hydroxyvitamin D (25(Oh)D) by the liquid chromatography coupled with a tandem mass spectrometric method (lc-ms/ms).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 97, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC4256222	12/2014	S15-PMC4256222	['during Pregnancy Vitamin D is transported from the mother to the fetus through the Placenta in the form of 25-Hydroxyvitamin D (25(Oh)D), and at Birth the concentration in Umbilical Cord Blood is around 80% of maternal Blood concentration[2].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001987', 'placenta', 83, 'placenta'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 107, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('GO_0007567', 'parturition', 145, 'birth'), ('UBERON_0002331', 'umbilical cord', 172, 'umbilical cord'), ('UBERON_0000178', 'blood', 187, 'blood'), ('UBERON_0000178', 'blood', 219, 'blood')]
PMC4256222	12/2014	S30-PMC4256222	['a Blood sample was drawn and the women provided consent for themselves and their unborn child for participation and later data linkage to danish health registers.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood')]
PMC4256222	12/2014	S32-PMC4256222	['exposure assessment\nthe Blood sample taken in week 30 of Gestation was immediately separated into Serum, Plasma and Erythrocytes and frozen at −20°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('GO_0007565', 'female pregnancy', 57, 'gestation'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('CL_0000232', 'erythrocyte', 116, 'erythrocytes')]
PMC4256222	12/2014	S47-PMC4256222	['we defined season of Blood draw on the basis of ultraviolet b (uvb) index values from the danish metrological institute: mar/apr/maj, jun/jul/aug, sep/oct/nov and dec/jan/feb.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood')]
PMC4256222	12/2014	S86-PMC4256222	['if the Blood sample was drawn in dec/jan/feb, the offspring had a significantly higher hr for fractures (hr\u200a=\u200a1.39, 95%ci: 1.01–1.92) compared with jun/jul/aug (reference).']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood')]
PMC4260194	12/2014	S168-PMC4260194	['yeah, especially for the Blood” [27:2].']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood')]
PMC4260194	12/2014	S237-PMC4260194	['and we drink like hot tea with cinnamon, cinnamon with ginger for cleaning the Blood after Delivering the baby” [7:1].']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0006900', 'vesicle budding from membrane', 91, 'delivering')]
PMC4263713	12/2014	S51-PMC4263713	["Blood was immediately harvested from the Rats'S Femoral Arteries, and Feces were collected from the Ileum."]	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 41, 'rats'), ('UBERON_0001348', 'brown adipose tissue', 41, 'rats'), ('UBERON_0005432', 'aortic sac', 46, 's'), ('UBERON_0001530', 'common carotid artery plus branches', 48, 'femoral arteries'), ('UBERON_0001988', 'feces', 70, 'feces'), ('UBERON_0002116', 'ileum', 100, 'ileum')]
PMC4268639	11/2014	S20-PMC4268639	['each also received standard Perinatal evaluations including body mass index (bmi), weight gain, Blood pressure, and 1-hour non-fasting 50-gm glucose tolerance testing.']	N/A	N/A	[('GO_0036268', 'swimming', 28, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 28, 'perinatal'), ('UBERON_0000178', 'blood', 96, 'blood')]
PMC4271720	12/2014	S239-PMC4271720	['(2014)used chip to profile H3K9 Acetylation, H3K4 Trimethylation, and H3K9 Dimethylation in Blood Monocytes and Lymphocytes from diabetes patients.']	N/A	N/A	[('GO_0043973', 'histone H3-K4 acetylation', 27, 'H3K9 acetylation'), ('GO_0034729', 'histone H3-K79 methylation', 45, 'H3K4 trimethylation'), ('GO_0034971', 'histone H3-R17 methylation', 70, 'H3K9 dimethylation'), ('CL_0000081', 'blood cell', 92, 'blood monocytes'), ('UBERON_0000178', 'blood', 92, 'blood'), ('CL_0000542', 'lymphocyte', 112, 'lymphocytes')]
PMC4275593	9/2014	S62-PMC4275593	['by around 1960, researchers had developed several techniques for diagnosing Folate deficiency, including biochemical tests and Animal and microbiological assays of Blood Serum, each of varying degrees of sensitivity and specificity.']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 76, 'folate'), ('NCBITaxon_33208', 'Metazoa', 127, 'animal'), ('UBERON_0000178', 'blood', 164, 'blood'), ('UBERON_0001977', 'blood serum', 170, 'serum')]
PMC4275593	9/2014	S66-PMC4275593	['like other methods of Blood analysis in this period, diagnostic tests for Folate deficiency migrated beyond the expert province of haematology into other clinical disciplines (wailoo, 1999, pp.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 74, 'folate')]
PMC4275595	9/2014	S145-PMC4275595	['and then you’d be examined afterwards and that was it.’ theresa, whose first baby was Born in 1948 explained: ‘well, you just informed the district nurse and she came once a\xa0month and took your Blood pressure and found out if the baby was in the right position and that was it.’ phyllis, who was living in shipton-under-wychwood and had her first baby in 1946 said: ‘well in those days when you were Pregnant the doctor only saw you at four\xa0months and eight\xa0months, that’s all the medical, you know, that’s the only time that he wanted to see you’.']	N/A	N/A	[('GO_0007567', 'parturition', 86, 'born'), ('UBERON_0000178', 'blood', 194, 'blood'), ('GO_0007565', 'female pregnancy', 400, 'pregnant')]
PMC4277409	12/2014	S44-PMC4277409	['Tissues were thoroughly washed in ice-cold pbs to remove any Blood.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('UBERON_0000178', 'blood', 61, 'blood')]
PMC4280220	12/2014	S1-PMC4280220	['Maternal Blood and Placental samples collected from participants in the peruvian abruptio Placentae epidemiology study were genotyped using illumina’s cardio-metabochip platform.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001987', 'placenta', 19, 'placental'), ('UBERON_0001987', 'placenta', 90, 'Placentae')]
PMC4280220	12/2014	S25-PMC4280220	['pa was diagnosed based on evidence of retroplacental bleeding (fresh Blood) entrapped between the Decidua and the Placenta or Blood clots behind the Placenta and any two of the following: (i) Vaginal bleeding in late Pregnancy not due to Placenta previa or Cervical lesions; (ii) Uterine tenderness and/or Abdominal pain; and, (iii) non-reassuring fetal status or death.']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0002450', 'decidua', 98, 'decidua'), ('UBERON_0001987', 'placenta', 114, 'placenta'), ('UBERON_0000178', 'blood', 126, 'blood'), ('UBERON_0001987', 'placenta', 149, 'placenta'), ('UBERON_0001987', 'placenta', 192, 'vaginal'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('UBERON_0001987', 'placenta', 238, 'placenta'), ('UBERON_0005434', 'cervical region', 257, 'cervical'), ('UBERON_0000995', 'uterus', 280, 'uterine'), ('UBERON_0000916', 'abdomen', 306, 'abdominal')]
PMC4280220	12/2014	S28-PMC4280220	['a subset of these cases and controls that also provided Blood samples (222 pa cases and 198 controls) were also included in the maternal-Placental Genetic interaction investigations.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placental'), ('SO_0000704', 'gene', 147, 'genetic')]
PMC4280220	12/2014	S49-PMC4280220	['similar quality control procedures were performed on the maternal Blood genotype data, resulting in 222 pa case and 198 controls among maternal-Placental pairs.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001987', 'placenta', 144, 'placental')]
PMC4284764	12/2014	S29-PMC4284764	['note that weights and bp data from three-month-old offspring, which in part was published previously [4], is included in this study for the sake of comparison.ijms-15-23255-t001_table 1\n\ncaption (table-wrap): table 1\n\nweights and functional parameters in Rats at three months of age.groupscontroll-Namel-Name + citmortality0%0%0%body weight (bw) (g)524 ± 30478 ± 15469 ± 9left kidney weight (g)2.08 ± 0.161.87 ± 0.101.95 ± 0.04left Kidney weight/100 g bw0.39 ± 0.010.39 ± 0.010.42 ± 0.01heart weight (g)1.56 ± 0.101.61 ± 0.041.62 ± 0.04heart weight/100 g bw0.30 ± 0.010.34 ± 0.020.35 ± 0.01systolic Blood pressure (mmhg)149 ± 2165 ± 1a152 ± 2bdiastolic Blood pressure (mmhg)102 ± 4107 ± 487 ± 2a,bmean Arterial pressure (mmhg)117 ± 2126 ± 3a109 ± 1b\nn = 6/group,ap< 0.05 vs. control;bp<0.05 vs. L-Name.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 255, 'rats'), ('CHEBI_32875', 'methyl group', 298, 'NAMEl'), ('CHEBI_13389', 'NAD', 304, 'NAME'), ('UBERON_0002113', 'kidney', 432, 'kidney'), ('UBERON_0000178', 'blood', 599, 'blood'), ('UBERON_0000178', 'blood', 653, 'blood'), ('UBERON_0001637', 'artery', 702, 'arterial'), ('CHEBI_75819', '8-oxo-ETE', 795, 'l-NAME')]
PMC4284764	12/2014	S113-PMC4284764	['Blood pressure (bp) was measured in conscious Rats by an indirect Tail-cuff method (bp-2000, visitech systems, inc., apex, nc, usa) [10].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 46, 'rats'), ('UBERON_0002415', 'tail', 66, 'tail')]
PMC4284764	12/2014	S115-PMC4284764	['heparinized Blood samples were collected at sacrifice.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC4284764	12/2014	S144-PMC4284764	['Blood pressure (bp) was analyzed by 2-way repeated-measures anova and tukey’s post hoc test.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4287506	10/2014	S58-PMC4287506	['for women with induced Abortions or Miscarriages, those who reported Vaginal bleeding (other than Blood spotting) heavier than a normal period in the three days after a Pregnancy outcome were classified with hemorrhage (table\xa01).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 23, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 36, 'miscarriages'), ('UBERON_0001987', 'placenta', 69, 'vaginal'), ('UBERON_0000178', 'blood', 98, 'blood'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC4292443	1/2015	S50-PMC4292443	['we then quickly took each Rat from its cage and nicked the end off the Tail with a sharp razor blade to extract ~20 μl of baseline Blood sample into a heparinized capillary tube for measurement of Plasma Triglycerides.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 26, 'rat'), ('UBERON_0002415', 'tail', 71, 'tail'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0001969', 'blood plasma', 197, 'plasma'), ('CHEBI_17855', 'triglyceride', 204, 'triglycerides')]
PMC4292443	1/2015	S52-PMC4292443	['Blood samples were kept on ice until the end of the experiment, when they were centrifuged and the Plasma aliquots stored at −20°c until assayed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 99, 'plasma')]
PMC4292443	1/2015	S53-PMC4292443	['we also measured basal Glucose levels at this time using an accu-chek performa Blood Glucose meter (roche diagnostics; castle hill, nsw, au).']	N/A	N/A	[('CHEBI_17234', 'glucose', 23, 'glucose'), ('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_17234', 'glucose', 85, 'glucose')]
PMC4292819	1/2015	S52-PMC4292819	['briefly, the study visits took place at the sahlgrenska university hospital and included collection of Blood samples and body composition measurements.']	N/A	N/A	[('UBERON_0000178', 'blood', 103, 'blood')]
PMC4292819	1/2015	S94-PMC4292819	['laboratory analyses\nVenous Blood samples were obtained after an overnight fast.']	N/A	N/A	[('UBERON_0001638', 'vein', 20, 'Venous'), ('UBERON_0000178', 'blood', 27, 'blood')]
PMC4292819	1/2015	S99-PMC4292819	['analyses of Long Chain polyunsaturated Fatty Acids in Serum Phospholipids\nmaternal fasting Blood samples were obtained by venipuncture during each Trimester.']	N/A	N/A	[('CHEBI_66557', 'laurolistine', 12, 'long chain'), ('CHEBI_35366', 'fatty acid', 39, 'fatty acids'), ('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_16247', 'phospholipid', 60, 'phospholipids'), ('UBERON_0000178', 'blood', 91, 'blood'), ('GO_0009294', 'DNA mediated transformation', 147, 'trimester')]
PMC4292819	1/2015	S198-PMC4292819	['Fat Metabolism is altered during Pregnancy; initially fat is stored in the fat depots, but later in Pregnancy Breakdown Of Fat Tissue [30], leads to higher levels of free Fatty Acids in the Blood [31].']	N/A	N/A	[('GO_0046444', 'FMN metabolic process', 0, 'Fat metabolism'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0019485', 'beta-alanine catabolic process to L-alanine', 110, 'breakdown of fat tissue'), ('UBERON_0000479', 'tissue', 127, 'tissue'), ('CHEBI_35366', 'fatty acid', 171, 'fatty acids'), ('UBERON_0000178', 'blood', 190, 'blood')]
PMC4298806	11/2013	S42-PMC4298806	['nutritional status was measured by height-for-age and body mass index z-scores (haz and bmiz, respectively) based on the international reference standard,26and anemia status (Blood hemoglobin level <11.5 g/dl measured by Fingerstick with b-Hemoglobin analyzer, hemocue, lake forest, ca, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 175, 'blood'), ('UBERON_0015147', 'pinna hair', 221, 'fingerstick'), ('CHEBI_5679', 'herniarin', 240, 'Hemoglobin')]
PMC4302388	1/2015	S4-PMC4302388	['whole-Blood Se concentration was measured at 12 and 35 weeks, Toenail Se concentration at 16 weeks, Plasma Selenoprotein P (Sepp1) concentration at 35 weeks and Plasma Glutathione peroxidase (Gpx3) activity at 12, 20 and 35 weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 12, 'Se'), ('UBERON_0009567', 'nail of pedal digit', 62, 'toenail'), ('CHEBI_37972', 'phosphorus-32 atom', 70, 'Se'), ('UBERON_0001969', 'blood plasma', 100, 'plasma'), ('PR_000014629', 'semaphorin-6A', 107, 'selenoprotein P'), ('PR_000014660', 'septin-8', 124, 'SEPP1'), ('UBERON_0001969', 'blood plasma', 161, 'plasma'), ('CHEBI_16856', 'glutathione', 168, 'glutathione'), ('PR_000008210', 'glutathione peroxidase 1', 192, 'GPx3')]
PMC4302388	1/2015	S9-PMC4302388	['after adjustment, whole-Blood Se concentration was higher in women Consuming brazil nuts ( p =\xa00·040) and in those Consuming more than two seafood portions per week ( p =\xa00·054).']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 30, 'Se'), ('GO_0007631', 'feeding behavior', 67, 'consuming'), ('GO_0007631', 'feeding behavior', 115, 'consuming')]
PMC4302388	1/2015	S27-PMC4302388	['to establish the Se status, we used a range of measures at various Gestational ages: (1) whole-Blood Se concentration at baseline (12 weeks) and after 23 weeks of treatment with Se or placebo (35 weeks); (2) Toenail Se concentration in clippings collected at 16 weeks (a measure of pre-Pregnancy se status); (3) Plasma Glutathione peroxidase (Gpx3) activity at 12, 20 and 35 weeks; (4) Plasma selenoprotein p (Sepp1) concentration at 35 weeks.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 17, 'Se'), ('GO_0007565', 'female pregnancy', 67, 'gestational'), ('UBERON_0000178', 'blood', 95, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 101, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 178, 'Se'), ('UBERON_0009567', 'nail of pedal digit', 208, 'toenail'), ('CHEBI_37972', 'phosphorus-32 atom', 216, 'Se'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy'), ('UBERON_0001969', 'blood plasma', 312, 'plasma'), ('CHEBI_16856', 'glutathione', 319, 'glutathione'), ('PR_000008210', 'glutathione peroxidase 1', 343, 'GPx3'), ('UBERON_0001969', 'blood plasma', 386, 'plasma'), ('PR_000014660', 'septin-8', 410, 'SEPP1')]
PMC4302388	1/2015	S32-PMC4302388	['Blood, Plasma and Toenail samples originated from the sprint (selenium in pregnancy intervention) study (trial registration no.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 7, 'plasma'), ('UBERON_0009567', 'nail of pedal digit', 18, 'toenail')]
PMC4302388	1/2015	S34-PMC4302388	['Blood samples, from which Plasma was prepared, were collected at baseline (12 weeks), 20 and 35 weeks, while Toenail clippings were collected at 16 weeks, as described previously(9).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 26, 'plasma'), ('UBERON_0009567', 'nail of pedal digit', 109, 'toenail')]
PMC4302388	1/2015	S38-PMC4302388	['hypertension was defined as diastolic Blood pressure (dbp) ≥\xa090\xa0mmhg on two occasions (4\xa0h apart).']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood')]
PMC4302388	1/2015	S45-PMC4302388	['Selenium status measurements\nwhole-Blood samples were stored at −\xa020°c until thawed for analysis, and were analysed in duplicate.']	N/A	N/A	[('CHEBI_27568', 'selenium atom', 0, 'Selenium'), ('UBERON_0000178', 'blood', 35, 'blood')]
PMC4302388	1/2015	S47-PMC4302388	['the cv for the Blood se assay was 0·25\xa0% at 1·4\xa0μmol/l and 0·17\xa0% at 3·0\xa0μmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC4302388	1/2015	S67-PMC4302388	['statistical analyses\nwhole-Blood Se, Toenail Se and Sepp1 concentrations and Gpx3 activity were not normally distributed, hence data are presented as medians and range values.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 33, 'Se'), ('UBERON_0009567', 'nail of pedal digit', 37, 'toenail'), ('CHEBI_37972', 'phosphorus-32 atom', 45, 'Se'), ('PR_000014660', 'septin-8', 52, 'SEPP1'), ('PR_000008210', 'glutathione peroxidase 1', 77, 'GPx3')]
PMC4302388	1/2015	S69-PMC4302388	['the wilcoxon matched-pair test was used to compare the changes in Gpx3 activity from 12 to 20 weeks, 12 to 35 weeks and 20 to 35 weeks, and the change in whole-Blood Se concentration from 12 to 35 weeks in the Se-treated and placebo groups.']	N/A	N/A	[('PR_000008210', 'glutathione peroxidase 1', 66, 'GPx3'), ('UBERON_0000178', 'blood', 160, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 166, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 210, 'Se')]
PMC4302388	1/2015	S71-PMC4302388	['the mann–whitney test was used to compare the differences in whole-Blood Se and Toenail Se concentrations between the groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 73, 'Se'), ('UBERON_0009567', 'nail of pedal digit', 80, 'toenail'), ('CHEBI_37972', 'phosphorus-32 atom', 88, 'Se')]
PMC4302388	1/2015	S82-PMC4302388	['caption (table-wrap): table 1\n\nselenium status in uk Pregnant women at 12 (baseline), 20 and 35 weeks of Gestation (median values and ranges)measurementsall participantsplacebo groupse groupparameterswomen ( n )week of gestationmedianrangemedianrangemedianrange p †(placebo group v. Se group)whole-Blood Se concentration (μmol/l)‡229121·310·84–3·331·320·84–2·191·310·95–3·330·565toenail Se concentration (μg/g)§218160·610·46–1·110·600·46–1·100·620·46–1·110·387gpx3 activity (units/l)2271272·442·5–141·972·052·6–138·872·742·5–141·90·601gpx3 activity (units/l)22120na75·446·6–113·878·2*43·9–169·70·225Gpx3 activity (units/l)21535na73·447·3–126·875·4**42·4–139·30·125whole-Blood se concentration (μmol/l)‡21535na1·16***0·69–2·151·87***1·05–3·73<\xa00·0001plasma Sepp1 concentration (mg/l)‡21535na3·000·90–5·805·302·40–7·40<\xa00·0001\nGpx3, Plasma Glutathione peroxidase; na, not applicable; Sepp1, Selenoprotein P.\n* p value for difference in gpx activity in se group by wilcoxon matched pairs test (12 v. 20 weeks) =\xa00.025; ** p value for difference in gpx activity in se group by wilcoxon matched pairs test (12 v. 35 weeks) =\xa00.014; *** p value for difference in whole-Blood Se in placebo and Se groups by wilcoxon matched pairs test (12 v. 35 weeks) <\xa00.0001.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'pregnant'), ('GO_0007565', 'female pregnancy', 105, 'gestation'), ('CHEBI_37972', 'phosphorus-32 atom', 283, 'Se'), ('UBERON_0000178', 'blood', 298, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 304, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 387, 'Se'), ('PR_000005450', 'chromatin accessibility complex protein 1', 596, '225GPx3'), ('UBERON_0000178', 'blood', 670, 'blood'), ('PR_000014660', 'septin-8', 756, 'SEPP1'), ('PR_000008210', 'glutathione peroxidase 1', 825, 'GPx3'), ('UBERON_0001969', 'blood plasma', 831, 'plasma'), ('CHEBI_16856', 'glutathione', 838, 'glutathione'), ('PR_000014660', 'septin-8', 882, 'SEPP1'), ('PR_000014629', 'semaphorin-6A', 889, 'selenoprotein P'), ('UBERON_0000178', 'blood', 1163, 'blood'), ('CHEBI_37972', 'phosphorus-32 atom', 1169, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 1187, 'Se')]
PMC4302388	1/2015	S99-PMC4302388	['women who were classified as middle class and above had a significantly higher se status as measured in both whole Blood and Toenails than those classified as lower middle class and below.']	N/A	N/A	[('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 125, 'toenails')]
PMC4302388	1/2015	S101-PMC4302388	["caption (table-wrap): table 2\n\npredictors of Selenium status (number of women; median values and interquartile ranges)12-week whole-Blood se (μmol/l)toenail se (μg/g)women ( n )medianinterquartile range p adjusted p *women ( n )medianinterquartile range p adjusted p *demographic factorssocial classmiddle and above1011·331·22–1·480·027na†980·630·59–0·690·004na†lower middle and below1281·301·14–1·451200·600·55–0·65smoking statusnever smoked1561·321·19–1·470·529na†1480·610·57–0·670·261na†ex-smoker731·301·18–1·46700·610·54–0·66ethnicitycaucasian2131·311·18–1·470·438na†2020·610·56–0·670·869na†other161·341·25–1·48160·620·55–0·63bmi<\xa025\xa0kg/m21381·351·19–1·480·183na†1310·610·56–0·670·841na†≥\xa025\xa0kg/m2911·291·16–1·44870·610·56–0·68dietary factorsseafood<\xa02 portions/week981·271·14–1·410·0100·054950·590·54–0·650·0120·078≥\xa02 portions/week1211·361·21–1·481180·630·57–0·69meat<\xa07 portions/week1081·331·19–1·470·5400·2991070·610·56–0·660·7290·610≥\xa07 portions/week1111·301·16–1·461060·610·56–0·68brazil nutsnon-consumer1931·301·16–1·460·0050·0401870·600·56–0·660·0340·147consumer261·401·31–1·61260·660·60–0·72offal (Liver)non-consumer1821·311·18–1·470·5830·7651760·610·56–0·660·7020·804consumer371·351·22–1·45370·620·56–0·72dairy products≤\xa01 portion/d1101·301·16–1·450·4230·6721070·610·56–0·670·9160·112>1 portion/d1091·321·19–1·481060·610·57–0·67cows' Milk<\xa0280\xa0ml/d1461·321·18–1·460·9200·9831440·600·56–0·660·0160·083≥\xa0280\xa0ml/d731·321·21–1·46690·630·57–0·70\nna, not applicable."]	N/A	N/A	[('CHEBI_27568', 'selenium atom', 45, 'selenium'), ('UBERON_0000178', 'blood', 132, 'blood'), ('UBERON_0002107', 'liver', 1111, 'liver'), ('UBERON_0001913', 'milk', 1348, 'milk')]
PMC4302388	1/2015	S105-PMC4302388	['women who reported Consuming at least two portions of seafood (white fish, oily fish or other seafood) per week had a significantly higher concentration of Se in both whole Blood and Toenails ( p =\xa00·001 for each); the significance disappeared after adjustment, but remained close to significance for whole-Blood se concentration ( p =\xa00·054).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 19, 'consuming'), ('CHEBI_37972', 'phosphorus-32 atom', 156, 'Se'), ('UBERON_0000178', 'blood', 173, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 183, 'toenails'), ('UBERON_0000178', 'blood', 307, 'blood')]
PMC4302388	1/2015	S106-PMC4302388	['Intake of dairy products, meat and poultry, or Liver did not significantly affect se status (whole Blood and Toenails).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Intake'), ('UBERON_0002107', 'liver', 47, 'liver'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 109, 'toenails')]
PMC4302388	1/2015	S119-PMC4302388	['caption (table-wrap): table 3\n\nunadjusted and adjusted risk factors for the development of pre-eclampsia (pe)/Pregnancy-induced hypertension (pih) determined by logistic regression (odds ratios and 95\xa0% confidence intervals).unadjusted model*adjusted model 1†adjusted model 2‡risk factorswomen ( n )or95\xa0% ci p women ( n )adjusted or95\xa0% ci p women ( n )adjusted or95\xa0% ci p baseline diastolic bp2271·141·07, 1·21<\xa00·00052171·101·03, 1·180·0052101·121·04, 1·200·002bmi (kg/m2)2271·201·09, 1·32<\xa00·00052171·131·00, 1·270·0492101·080·96, 1·220·214toenail se, 16 weeks (μg/g)∥2170·340·164, 0·720·0052170·380·17, 0·870·0212100·320·13, 0·780·013treatment (se v. placebo)2270·390·15, 1·060·0662170·350·11, 1·080·0672100·300·09, 1·000·049age (years)2270·990·88, 1·100·818na§na§history of pe in mother2270·670·08, 5·380·710na§na§history of pe in sister2271·760·20, 15·420·608na§na§whole-Blood se, 12 weeks (μmol/l)2270·810·13, 5·000·816na§na§whole-Blood se, 35 weeks (μmol/l)2150·390·13, 1·220·106na§na§Sepp1, 35 weeks (mg/l)2150·720·51, 1·010·060na§na§\nbp, Blood pressure; na, not applicable; Sepp1, Selenoprotein P.\nrisk factors for the development of pe/pih assessed individually by logistic regression.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('UBERON_0000178', 'blood', 879, 'blood'), ('UBERON_0000178', 'blood', 940, 'blood'), ('PR_000014660', 'septin-8', 995, 'SEPP1'), ('UBERON_0000178', 'blood', 1050, 'blood'), ('PR_000014660', 'septin-8', 1086, 'SEPP1'), ('PR_000014629', 'semaphorin-6A', 1093, 'selenoprotein P')]
PMC4302388	1/2015	S139-PMC4302388	['women who were older, of higher social class (based on occupation) and left education at a later age had significantly higher se status (whole Blood and Toenails).']	N/A	N/A	[('UBERON_0000178', 'blood', 143, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 153, 'toenails')]
PMC4302429	1/2015	S3-PMC4302429	['bacterial titers in Blood, Spleen, and Brain homogenates were determined.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0002106', 'spleen', 27, 'spleen'), ('UBERON_0000955', 'brain', 39, 'brain')]
PMC4302429	1/2015	S6-PMC4302429	['Vitamin D deficiency did not inhibit Leukocyte recruitment into the Subarachnoid space and did not lead to an increased density of bacteria in Blood, Spleen, or Brain homogenates.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000738', 'leukocyte', 37, 'leukocyte'), ('UBERON_0003997', 'hyoid bone greater horn', 68, 'subarachnoid'), ('UBERON_0000178', 'blood', 143, 'blood'), ('UBERON_0002106', 'spleen', 150, 'spleen'), ('UBERON_0000955', 'brain', 161, 'brain')]
PMC4302429	1/2015	S35-PMC4302429	['methods\n\nVitamin D3 concentration in the Blood\nto produce different Vitamin D3 concentrations in the circulation, Mice were Fed with a diet containing either low (l-vitd; Vitamin D3 concentration below the detection level; normal Calcium and Phosphate concentrations), standard (s-vitd; Vitamin D3 concentration 1,500\xa0iu/kg Food; normal Calcium and Phosphate concentrations), or high (h-vitd; Vitamin D3 concentration 75,000\xa0iu/kg Food; normal Calcium and phosphate concentrations) Vitamin D3 concentrations (all from ssniff spezialdiäten gmbh, soest, germany).']	N/A	N/A	[('CHEBI_33237', 'vitamin D4', 9, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D3'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_33279', 'vitamin D5', 68, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 68, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 114, 'mice'), ('GO_0007631', 'feeding behavior', 124, 'fed'), ('CHEBI_33279', 'vitamin D5', 171, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 171, 'vitamin D3'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 242, 'phosphate'), ('CHEBI_33279', 'vitamin D5', 287, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 287, 'vitamin D3'), ('CHEBI_33290', 'food', 324, 'food'), ('CHEBI_22313', 'alkaline earth metal atom', 337, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 349, 'phosphate'), ('CHEBI_33279', 'vitamin D5', 393, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 393, 'vitamin D3'), ('CHEBI_33290', 'food', 431, 'food'), ('CHEBI_22313', 'alkaline earth metal atom', 444, 'calcium'), ('CHEBI_33279', 'vitamin D5', 482, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 482, 'vitamin D3')]
PMC4302429	1/2015	S45-PMC4302429	['bacteria were Grown overnight on Blood agar plates, harvested in 0.9% saline and stored at −80\xa0°c.']	N/A	N/A	[('GO_0040007', 'growth', 14, 'grown'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC4302429	1/2015	S55-PMC4302429	['Blood was drawn by Cardiac puncture and 10\xa0μl was used for the determination of bacterial concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 19, 'cardiac')]
PMC4302429	1/2015	S56-PMC4302429	['the remaining Blood was stored at 4°c for 30\xa0min and then centrifuged at 3,000\u2009 g for 10\xa0min at 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC4302429	1/2015	S61-PMC4302429	['bacterial titers in homogenates and Blood were determined by plating serial 10-fold dilutions in 0.9% saline on Sheep Blood agar plates (detection limit: 100\xa0cfu/ml, respectively).']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'sheep'), ('UBERON_0000178', 'blood', 118, 'blood')]
PMC4302429	1/2015	S111-PMC4302429	['bacterial titers in the Blood of Mice of all three groups were also not significantly different.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'mice')]
PMC4302429	1/2015	S112-PMC4302429	['control Mice injected with sterile saline all had sterile Cerebellar and Spleen homogenates and Blood cultures.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 8, 'mice'), ('UBERON_0002037', 'cerebellum', 58, 'cerebellar'), ('UBERON_0002106', 'spleen', 73, 'spleen'), ('UBERON_0000178', 'blood', 96, 'blood')]
PMC4302607	1/2015	S79-PMC4302607	['is your baby moving?,” check your Blood pressure, measure your tummy, and out you go.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood')]
PMC4303849	1/2015	S43-PMC4303849	['Calcitriol production is then boosted, thereby increasing Blood calcium levels by promoting absorption of dietary Calcium from the Gastrointestinal Tract, increasing Renal Tubular calcium reabsorption and stimulating the Release Of Calcium From Bone.']	N/A	N/A	[('CHEBI_17823', 'calcitriol', 0, 'Calcitriol'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_22313', 'alkaline earth metal atom', 114, 'calcium'), ('UBERON_0001555', 'digestive tract', 131, 'gastrointestinal tract'), ('UBERON_0004200', 'kidney pyramid', 166, 'renal tubular'), ('GO_0051594', 'detection of glucose', 221, 'release of calcium from bone')]
PMC4303849	1/2015	S191-PMC4303849	['intable 4, studies that evaluated Serum 25Ohd levels and the risk for gdm are shown.nutrients-07-00443-t004_table 4\n\ncaption (table-wrap): table 4\n\nobservational studies on 25Ohd Serum levels and risk for Gdm development.referencesample size (gdm cases vs. controls)weeks of Gestation for Blood sampling25ohd cut offrisk for Gdm development (or (95% ci))[169]20 gdm and 40 controlsat delivery<50 nmol/l30.78 (4.65–203.90)[177]68 gdm and 1,246 controls26–28<25 nmol/l3.6 (1.7–7.8)[171]116 gdm and 219 controls15–18<73.5 nmol/l2.21 (1.19–4.13)[178]200 gdm and 200 controls26–28<25 nmol/l1.80 (1.209–2.678)[172]54 gdm and 111 controls24–28<37.5 nmol/l2.66 (1.26–5.6)<50 nmol/l2.02 (0.88–4.6)[173]57 gdm and 114 controls16<50 nmol/l3.74 (1.47–9.50)[170]81 gdm and 226 controlsbetween 2nd and 3rd trimester<50 nmol/l1.92 (0.89–4.17)\ngdm = Gestational diabetes mellitus; or = odds ratio; ci = confidence interval.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 40, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 173, '25OHD'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('GO_0070477', 'endospore core', 205, 'GDM'), ('GO_0006266', 'DNA ligation', 275, 'Gestation'), ('UBERON_0000178', 'blood', 289, 'Blood'), ('GO_0070477', 'endospore core', 325, 'GDM'), ('GO_0007565', 'female pregnancy', 834, 'Gestational')]
PMC4309881	2/2015	S47-PMC4309881	['prior to Mating, body weight, Blood Glucose and β −Ketones ( β − hydroxybutyrate ) were measured in randomly chosen Animals from both groups.']	N/A	N/A	[('GO_0007618', 'mating', 9, 'mating'), ('UBERON_0000178', 'blood', 30, 'blood'), ('CHEBI_17234', 'glucose', 36, 'glucose'), ('CHEBI_17087', 'ketone', 51, 'ketones'), ('NCBITaxon_33208', 'Metazoa', 116, 'animals')]
PMC4309881	2/2015	S48-PMC4309881	['Blood concentrations were measured using an abbott “precision xtra” Glucometer, which required a relatively minute Blood volume of 0.6–1.5\xa0 μ l/test (abbott2006) drawn from the Tail Vein.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_24321', 'glutamo group', 68, 'glucometer'), ('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0003481', 'tail vein', 177, 'tail vein')]
PMC4309881	2/2015	S56-PMC4309881	['of the Mice that did not undergo the neurobehavioral tests, a subset was randomly selected to undergo weight, Blood Glucose, and Blood Ketone measurements at 8-weeks of age.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'mice'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_17234', 'glucose', 116, 'glucose'), ('UBERON_0000178', 'blood', 129, 'blood'), ('CHEBI_17087', 'ketone', 135, 'ketone')]
PMC4309881	2/2015	S136-PMC4309881	['caption (table-wrap): table 1\n\nbody weight, Blood Glucose, Blood Ketones, and Brain volume for Adult male and female Mice (mean ± stdv)sd femalessd maleskd femaleskd malesbody weight (g)29.2 ± 2.937.3 ± 3.427.9 ± 3.236.5 ± 4.4blood Glucose (mmol/l)5.9 ± 1.37.4 ± 1.04.8 ± 1.15.1 ± 1.0blood Ketones (mmol/l)0.3 ± 0.10.4 ± 0.10.4 ± 0.20.4 ± 0.1brain volume (mm)527.6 ± 60.5511.5 ± 54.5\nsd, standard diet; kd, Ketogenic diet.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_17234', 'glucose', 50, 'glucose'), ('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_17087', 'ketone', 65, 'ketones'), ('UBERON_0000955', 'brain', 78, 'brain'), ('UBERON_0007023', 'adult organism', 95, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mice'), ('CHEBI_17234', 'glucose', 232, 'glucose'), ('CHEBI_17087', 'ketone', 290, 'ketones'), ('CHEBI_75715', "dUMP 3'-end residue", 407, 'ketogenic'), ('GO_0000241', 'diakinesis', 407, 'ketogenic')]
PMC4309881	2/2015	S185-PMC4309881	['since Ketones cross the Blood-Brain barrier though Proton-linked Monocarboxylic Acid transporters (mct), they can then also enter Neurons (again through mct or diffusion), be incorporated into their Atp Synthesis pathway, and reduce oxidative stress in Neuronal Cells (nehlig2004; morris2005; maalouf et\xa0al.2009).']	N/A	N/A	[('CHEBI_17087', 'ketone', 6, 'ketones'), ('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0000955', 'brain', 30, 'brain'), ('CHEBI_24636', 'proton', 51, 'proton'), ('CHEBI_35737', 'monothiocarboxylic acid', 65, 'monocarboxylic acid'), ('CL_0000540', 'neuron', 130, 'neurons'), ('GO_0006754', 'ATP biosynthetic process', 199, 'ATP synthesis'), ('CL_0000540', 'neuron', 253, 'neuronal cells')]
PMC4309881	2/2015	S205-PMC4309881	['Adult male kd Mice were also found to have reduced Blood Glucose concentration compared with sd males.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_10088', 'Mus <genus>', 14, 'mice'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_17234', 'glucose', 57, 'glucose')]
PMC4311629	1/2015	S56-PMC4311629	['this Tissue also responds to Insulin with a 5-fold increase in Glucose Uptake, without any change in Blood flow (orava et al.,2011), while under cold exposure, Glucose Uptake increases by 12-folds, dissipating energy as a function of increased Blood flow (orava et al.,2011).']	N/A	N/A	[('UBERON_0000479', 'tissue', 5, 'tissue'), ('PR_000045358', 'insulin family protein', 29, 'insulin'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('GO_0046323', 'glucose import', 63, 'glucose uptake'), ('UBERON_0000178', 'blood', 101, 'blood'), ('CHEBI_17234', 'glucose', 160, 'glucose'), ('GO_0046323', 'glucose import', 160, 'glucose uptake'), ('UBERON_0000178', 'blood', 244, 'blood')]
PMC4314531	11/2014	S65-PMC4314531	['retroorbital Blood draws were performed at 4 and 14 weeks post-transplant and peripheral Blood was stained with Antibodies against Cd45.1 and Cd45.2 for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibodies'), ('PR_000001304', 'CD300 molecule-like protein', 131, 'CD45.1'), ('PR_000001304', 'CD300 molecule-like protein', 142, 'CD45.2')]
PMC4314531	11/2014	S70-PMC4314531	['Blood draws and analysis were performed as before.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4314531	11/2014	S94-PMC4314531	['in sum, chronic hfd-Fed, obese dams were less fertile and their offspring exhibited multiple indications of adverse Metabolic programming, including growth retardation at day 14.5\xa0dpc, a decrease in Hspc content in fetal Livers, and a concomitant increase in differentiated Blood Cells.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 20, 'fed'), ('GO_0008152', 'metabolic process', 116, 'metabolic'), ('CL_0000037', 'hematopoietic stem cell', 199, 'HSPC'), ('UBERON_0002107', 'liver', 221, 'livers'), ('CL_0000081', 'blood cell', 274, 'blood cells'), ('UBERON_0000178', 'blood', 274, 'blood')]
PMC4314535	10/2014	S43-PMC4314535	['Blood Glucose levels were measured on p180 after overnight fasting using a glucometer (onetouch ultra, johnson & johnson).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose')]
PMC4314535	10/2014	S46-PMC4314535	['Ghrelin assays\npups were decapitated on p8, p12, p14, p16, p22 and p60 and Trunk Blood was collected in a chilled tube containing pefabloc (aebsf, roche diagnostics).']	N/A	N/A	[('PR_000008031', 'GLIPR1-like protein 1', 0, 'Ghrelin'), ('UBERON_0002100', 'trunk', 75, 'trunk'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC4314535	10/2014	S50-PMC4314535	['for this, p16 Mice were injected with various doses of Ghrelin (5, 10, and 50\xa0ug/kg) or saline, and 15\xa0min after injection the Trunk Blood was collected as described above.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 14, 'mice'), ('CHEBI_69086', 'glycyrin', 55, 'ghrelin'), ('PR_000007988', 'gastric inhibitory polypeptide receptor', 55, 'ghrelin'), ('UBERON_0002100', 'trunk', 127, 'trunk'), ('UBERON_0000178', 'blood', 133, 'blood')]
PMC4316389	1/2015	S116-PMC4316389	['Blood transfusion (for antepartum hemorrhage, Postpartum hemorrhage, complications of abortion, ectopic Pregnancy, Uterine rupture)\nfacilities that offer the seven basic signal functions are considered bemoc facilities.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 46, 'postpartum'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('UBERON_0000995', 'uterus', 115, 'uterine')]
PMC4316389	1/2015	S190-PMC4316389	['in the study area, there was no centralized Blood bank; only the tertiary medical college hospital maintained a facility Blood bank.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC4316389	1/2015	S191-PMC4316389	['in the other 13 facilities, clinicians required families to procure Blood before surgeries could be performed.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood')]
PMC4316389	1/2015	S192-PMC4316389	['for Blood acquisition, patients could either exchange Blood through voluntary associations or purchase Blood from unregulated private diagnostic centers.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC4316389	1/2015	S193-PMC4316389	['of the annual volume of Blood that was procured in gaibandha in 2010 (1,700 bags), voluntary exchange programs provided 66% of this total, while private Blood banks provided 34% [24].']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0000178', 'blood', 153, 'blood')]
PMC4316389	1/2015	S194-PMC4316389	['the largest voluntary exchange association in bangladesh is called sandhani ; through this group families can exchange donated Blood for the Blood type needed for surgery.']	N/A	N/A	[('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4316389	1/2015	S195-PMC4316389	['sandhani attendants perform the required screening tests (except for malaria screening) and Blood typing at their offices for a cost of 250 taka (us$3.05).']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood')]
PMC4316389	1/2015	S196-PMC4316389	['for patients at the district hospital, Blood bags were provided for free and malaria screening was performed.']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood')]
PMC4316389	1/2015	S197-PMC4316389	['patients at other facilities had to purchase Blood bags at a cost ranging from 120 to 170 taka (us$1.46-$2.07) per bag.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC4316389	1/2015	S201-PMC4316389	['laboratory capacity\nfor cemoc services, laboratory capacity was defined based on the provision of cross-matching tests, which determine the compatibility between donor and recipient Blood prior to Blood transfusion.']	N/A	N/A	[('UBERON_0000178', 'blood', 182, 'blood'), ('UBERON_0000178', 'blood', 197, 'blood')]
PMC4316389	1/2015	S225-PMC4316389	['half of the surveyed health facility administrators (n = 7) cited the need for a 24-hour centralized Blood bank at the district level from which residents can acquire Blood without donation or purchase to decrease the complicated process of safe Blood acquisition.']	N/A	N/A	[('UBERON_0000178', 'blood', 101, 'blood'), ('UBERON_0000178', 'blood', 167, 'blood'), ('UBERON_0000178', 'blood', 246, 'blood')]
PMC4329745	10/2014	S24-PMC4329745	['a 2 milliliters (ml) sample of Blood was taken from all participants and Serum 25-Hydroxy Vitamin D (25-Ohd) levels were determined by the electrochemiluminiscence method (roche, cobas e411, ger many) by one specialist.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 79, '25-hydroxy vitamin D'), ('CHEBI_72765', 'verruculogen', 101, '25-OHD')]
PMC4334594	2/2015	S21-PMC4334594	['Urine analysis demonstrated 3+ Blood and the microscopic examination was negative for Red Blood Cells.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 31, 'blood'), ('CL_0000232', 'erythrocyte', 86, 'red blood cells'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC4334594	2/2015	S24-PMC4334594	['donath landsteiner Antibody testing was performed using a Blood sample that was immediately immersed into an insulated container filled with Water at 37°c, and directly delivered to the testing laboratory.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibody'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_15377', 'water', 141, 'water')]
PMC4334594	2/2015	S51-PMC4334594	['this prevents Adsorption Of anti-p Antibodies Onto autologous Red Blood Cells at low temperatures.']	N/A	N/A	[('GO_0030154', 'cell differentiation', 14, 'adsorption of ... onto ... cells'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('CL_0000232', 'erythrocyte', 62, 'red blood cells'), ('UBERON_0000178', 'blood', 66, 'blood')]
PMC4341080	3/2015	S59-PMC4341080	['a random cohort of 362 lambs from live twin litters (bcs2.0 [control n = 62, adlib n = 56], bcs2.5 [control n = 62, adlib n = 60] or bcs3.0 [control n = 60, adlib n = 62]) were Blood sampled at 24 to 36 hours of age by Jugular venipuncture (becton dickinson vacutainer systems, franklin lakes, nj, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 177, 'blood'), ('UBERON_0004741', 'cleithrum', 219, 'jugular')]
PMC4341080	3/2015	S60-PMC4341080	['post collection, Blood samples were placed on ice before centrifugation at 1,000 g for 15 min.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood')]
PMC4341080	3/2015	S63-PMC4341080	['a sub-sample of the Lambs that had had a Blood sample collected (bcs2.0 [control n = 20, adlib n = 20], bcs2.5 [control n = 20, adlib n = 20] or bcs3.0 [control n = 20, adlib n = 20]) was also subjected to indirect open-circuit calorimetry (mccutcheon et al., 1983;kerslake et al., 2009).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 20, 'lambs'), ('UBERON_0000178', 'blood', 41, 'blood')]
PMC4351952	3/2015	S53-PMC4351952	['100 μl of whole Blood was collected from the Tail Vein and immediately mixed with 0.2 ml of 6.6% Perchloric Acid, frozen and stored at -2°c until assayed.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0003481', 'tail vein', 45, 'tail vein'), ('CHEBI_29221', 'perchloric acid', 97, 'perchloric acid')]
PMC4351952	3/2015	S54-PMC4351952	['Serum Ethanol standards were created by mixing whole Blood from untreated Rats with known amounts of Ethanol ranging from 0 to 240 mg Ethanol/dl and then mixing 100 μl aliquots of each standard with Perchloric Acid and storing the standards frozen with the samples.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_16236', 'ethanol', 6, 'ethanol'), ('UBERON_0000178', 'blood', 53, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 74, 'rats'), ('CHEBI_16236', 'ethanol', 101, 'ethanol'), ('CHEBI_16236', 'ethanol', 134, 'ethanol'), ('CHEBI_29221', 'perchloric acid', 199, 'perchloric acid')]
PMC4352208	2/2015	S41-PMC4352208	['participants were considered eligible if they met the following criteria: age 18 to 45 years old, in labor with a live singleton fetus, Gestational age ≥ 37 weeks, and not a Cord Blood donor.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 136, 'gestational'), ('UBERON_0002240', 'spinal cord', 174, 'cord'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC4352208	2/2015	S50-PMC4352208	['sample collection\nafter Delivery, a single tube of approximately 14 ml of whole Blood was collected from the Umbilical Cord in a standard edta tube.']	N/A	N/A	[('GO_0007567', 'parturition', 24, 'delivery'), ('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0002331', 'umbilical cord', 109, 'umbilical cord')]
PMC4352208	2/2015	S54-PMC4352208	['Mercury and Selenium sample analysis\nUmbilical Cord Blood and Placental Tissue samples collected were shipped to the energy & environmental research center at the university of north dakota.']	N/A	N/A	[('CHEBI_39378', 'homopteran inhibitor of chitin biosynthesis', 0, 'Mercury'), ('CHEBI_27568', 'selenium atom', 12, 'selenium'), ('UBERON_0002331', 'umbilical cord', 37, 'Umbilical cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('UBERON_0000479', 'tissue', 72, 'tissue')]
PMC4352208	2/2015	S55-PMC4352208	['individual samples of Blood and Placental Tissue (~0.25 g) were weighed into single-use, Trace Element-free 50-ml digestion tubes (environmental express, mt.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0001987', 'placenta', 32, 'placental'), ('UBERON_0000479', 'tissue', 42, 'tissue'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 89, 'trace element')]
PMC4352208	2/2015	S68-PMC4352208	['analytical blanks and whole Blood controls (utak laboratories, valencia ca) for Mercury and Selenium were digested and run alongside samples in all batches.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_16170', 'mercury(0)', 80, 'mercury'), ('CHEBI_27568', 'selenium atom', 92, 'selenium')]
PMC4352208	2/2015	S104-PMC4352208	['Mercury and Selenium analysis in Umbilical Cord Blood and Placentas\nfigure 1illustrates Hg and Se concentrations in Umbilical Cord Blood and Placentas, respectively.']	N/A	N/A	[('CHEBI_39378', 'homopteran inhibitor of chitin biosynthesis', 0, 'Mercury'), ('CHEBI_27568', 'selenium atom', 12, 'Selenium'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0001987', 'placenta', 58, 'placentas'), ('CHEBI_15377', 'water', 88, 'Hg'), ('CHEBI_37972', 'phosphorus-32 atom', 95, 'Se'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0001987', 'placenta', 141, 'placentas')]
PMC4352208	2/2015	S105-PMC4352208	['there were significant increases in Umbilical Cord Blood hg contents in the groups reporting maternal fish Consumption, compared to the maternal group reporting no Fish Consumption (none versus <12 oz/wk: p-value 0.004, 2.4 fold change; none versus ≥12 oz/wk: p-value 0.001, 2.7 fold change), but no difference between hg contents of samples from groups with Maternal Consumption rates of <12 oz/wk versus ≥12 oz/wk.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 36, 'umbilical cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('GO_0007631', 'feeding behavior', 107, 'consumption'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 164, 'fish'), ('GO_0007631', 'feeding behavior', 169, 'consumption'), ('GO_0007618', 'mating', 359, 'maternal'), ('GO_0007631', 'feeding behavior', 368, 'consumption')]
PMC4352208	2/2015	S112-PMC4352208	['Placenta and Cord Blood hg values were plotted for the samples in the same order in the lower panel.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC4354412	3/2015	S115-PMC4354412	['blocking the staining of mcd14 on Blood Monocytes using Milk supernatant\nthe same monoclonal Antibody used to stain the milk cells (Mil-2) was also used for the Monocyte staining.']	N/A	N/A	[('CL_0000081', 'blood cell', 34, 'blood monocytes'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001913', 'milk', 56, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody'), ('PR_000010450', 'protein AF-10', 132, 'MIL-2'), ('CL_0000576', 'monocyte', 161, 'monocyte')]
PMC4358904	3/2015	S47-PMC4358904	['pih was identified when Blood pressure after the twentieth week of Pregnancy was ≥140 × 90\xa0mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy')]
PMC4372177	2/2015	S47-PMC4372177	['caption (table-wrap): table 1\n\ntops family study of epigenetics (tfse) cohort characteristicschildren and adolescentsadults(mean\u2009±\u2009sd)(mean\u2009±\u2009sd) overweight and obese32%73%Waist over mets threshold15%52%homa over mets threshold17%32%Hypertriglyceride9%20%Hdl-C over mets threshold51%66%mets prevalencena24%phenotypegirls ( n \u2009=\u200921)boys ( n \u2009=\u200932)female ( n \u2009=\u200985)male ( n \u2009=\u200954)\u2003\u2009weight, kg56.35\u2009±\u200922.9758.53\u2009±\u200925.1582.98\u2009±\u200919.6394.60\u2009±\u200923.36\u2003\u2009height, cm157.81\u2009±\u200913.09159.69\u2009±\u200920.93164.62\u2009±\u20096.87177.31\u2009±\u20096.38\u2003\u2009bmi, kg/m222.10\u2009±\u20097.5021.80\u2009±\u20095.7030.75\u2009±\u20097.6630.04\u2009±\u20096.76\u2003\u2009bmi%55.61\u2009±\u200934.2066.91\u2009±\u200926.16nana\u2003\u2009waist circumference (wc), cm68.15\u2009±\u200914.0575.16\u2009±\u200918.1593.87\u2009±\u200917.89101.58\u2009±\u200916.92\u2003\u2009Subcutaneous fat (subqf), g361.49\u2009±\u2009263.70123.31\u2009±\u200995.00319.34\u2009±\u2009191.59255.94\u2009±\u2009131.42\u2003\u2009Visceral fat (Vf), g78.57\u2009±\u200924.0243.66\u2009±\u200925.27170.84\u2009±\u2009149.50265.24\u2009±\u200994.95\u2003\u2009vf/subqf0.32\u2009±\u20090.200.45\u2009±\u20090.200.56\u2009±\u20090.321.13\u2009±\u20090.40\u2003\u2009total Abdominal Fat (Taf), g440.05\u2009±\u2009287.49166.97\u2009±\u2009114.39490.18\u2009±\u2009300.40521.18\u2009±\u2009204.41\u2003\u2009fasting Glucose (fg), mmol/l82.28\u2009±\u20098.4486.47\u2009±\u20098.5484.26\u2009±\u200913.0786.58\u2009±\u200915.37\u2003\u2009fasting Insulin (fi), pmol/l14.81\u2009±\u20095.5013.73\u2009±\u20095.6916.12\u2009±\u200915.6721.07\u2009±\u200922.91\u2003\u2009Insulin/Glucose (igr)0.18\u2009±\u20090.060.16\u2009±\u20090.070.44\u2009±\u20091.660.52\u2009±\u20091.42\u2003\u2009homeostasis model assessment Insulin resistance (homa-ir)3.03\u2009±\u20091.222.94\u2009±\u20091.323.53\u2009±\u20093.794.69\u2009±\u20095.15\u2003\u2009Triglycerides (Tg), mmol/l78.52\u2009±\u200928.1178.00\u2009±\u200945.44100.07\u2009±\u200952.44117.69\u2009±\u200962.38\u2003\u2009total Cholesterol (tc), mmol/l152.76\u2009±\u200922.71142.66\u2009±\u200925.78193.06\u2009±\u200941.21194.61\u2009±\u200938.77\u2003\u2009ldl-Cholesterol (ldl-c), mmol/l89.29\u2009±\u200924.6285.75\u2009±\u200923.15125.91\u2009±\u200938.39133.82\u2009±\u200936.28\u2003\u2009hdl-Cholesterol (hdl-c), mmol/l46.95\u2009±\u20099.9341.31\u2009±\u20099.5046.29\u2009±\u200913.4637.68\u2009±\u20099.93\u2003\u2009systolic Blood pressure (sbp), mmhg105.50\u2009±\u20095.00107.55\u2009±\u200910.42127.34\u2009±\u200918.56129.61\u2009±\u200913.97\u2003\u2009diastolic Blood pressure (dbp), mmhg66.94\u2009±\u20098.3069.45\u2009±\u20099.5976.79\u2009±\u200910.8981.94\u2009±\u200911.39\u2003\u2009adiponectin, ng/ml14.42\u2009±\u20095.9610.45\u2009±\u20095.019.67\u2009±\u20095.527.95\u2009±\u20096.29\u2003\u2009leptin, ng/ml13.46\u2009±\u200911.266.66\u2009±\u20097.1723.72\u2009±\u200914.159.85\u2009±\u20097.22\n\ncaption (table-wrap): table 2\n\npair-wise relationships within tfse pedigreesnumber of relative pairsfamilial relationshipproportion of Alleles shared ibd 196parent-offspring1/2212siblings1/291grandparent-grandchild1/4439avuncular1/41half siblings1/413great grandparent-grandchild1/8275grand avuncular1/82half avuncular1/8454first cousins1/8598first cousins, 1\xa0rem1/161half first cousins1/16236second cousins1/32\nibd identical by descent.']	N/A	N/A	[('UBERON_0000088', 'trophoblast', 172, 'Waist'), ('CHEBI_5801', 'hydroxychloroquine', 233, 'Hypertriglyceride9'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 255, 'HDL-C'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 689, 'Subcutaneous'), ('UBERON_0002405', 'immune system', 777, 'Visceral'), ('UBERON_0002824', 'vestibular ganglion', 791, 'VF'), ('UBERON_0007808', 'adipose tissue of abdominal region', 914, 'abdominal fat'), ('UBERON_0003671', 'anterior cruciate ligament of knee joint', 929, 'TAF'), ('CHEBI_17234', 'glucose', 1006, 'glucose'), ('PR_000045358', 'insulin family protein', 1086, 'insulin'), ('PR_000045358', 'insulin family protein', 1158, 'Insulin'), ('CHEBI_17234', 'glucose', 1166, 'glucose'), ('PR_000045358', 'insulin family protein', 1254, 'insulin'), ('CHEBI_17855', 'triglyceride', 1328, 'Triglycerides'), ('CHEBI_17855', 'triglyceride', 1343, 'TG'), ('CHEBI_16113', 'cholesterol', 1416, 'Cholesterol'), ('CHEBI_16113', 'cholesterol', 1502, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 1589, 'cholesterol'), ('UBERON_0000178', 'blood', 1676, 'blood'), ('UBERON_0000178', 'blood', 1769, 'blood'), ('SO_0001023', 'allele', 2111, 'alleles')]
PMC4372177	2/2015	S51-PMC4372177	['our models also accounted for the fixed effects of sex and Blood Cell subtype proportions.']	N/A	N/A	[('CL_0000081', 'blood cell', 59, 'blood cell'), ('UBERON_0000178', 'blood', 59, 'blood')]
PMC4372177	2/2015	S234-PMC4372177	['clinical phenotypes for all subjects included weight, height, bmi, waist circumference (wc), hip circumference (hc), waist to hip ratio (whr), fasting Glucose (fg), fasting Insulin (fi), Insulin to Glucose ratio (igr), Homeostasis model assessment (homa), plasma Triglycerides (tg), total Cholesterol (tc), low density Lipoprotein Cholesterol (Ldl-C), high density lipoprotein Cholesterol (Hdl-C), systolic and Diastolic Blood pressure (sbp and dbp), and pulse.']	N/A	N/A	[('CHEBI_17234', 'glucose', 151, 'glucose'), ('PR_000045358', 'insulin family protein', 173, 'insulin'), ('PR_000045358', 'insulin family protein', 187, 'insulin'), ('CHEBI_17234', 'glucose', 198, 'glucose'), ('GO_0042592', 'homeostatic process', 219, 'homeostasis'), ('CHEBI_17855', 'triglyceride', 263, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 289, 'cholesterol'), ('CHEBI_24911', 'isopiperitenol', 319, 'lipoprotein cholesterol'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 344, 'LDL-c'), ('CHEBI_16113', 'cholesterol', 377, 'cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 390, 'HDL-c'), ('GO_0007586', 'digestion', 411, 'diastolic'), ('UBERON_0000178', 'blood', 421, 'blood')]
PMC4372177	2/2015	S263-PMC4372177	['Peripheral Blood Cell subtype estimation\nto estimate cell-type proportions, we used the r minfi package and estimatecellcounts function [123,124].']	N/A	N/A	[('CL_0002576', 'perineural cell', 0, 'Peripheral blood cell'), ('UBERON_0000178', 'blood', 11, 'blood')]
PMC4377862	2/2015	S83-PMC4377862	['biomarkers\nBlood collection and analyses were outsourced to the hunter area pathology service, a national association of testing authorities (nata)-accredited laboratory.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'Blood')]
PMC4377862	2/2015	S85-PMC4377862	['fasting Blood samples were analysed for fasting Glucose (mmol/l), fasting Insulin (miu/l), glycosylated haemoglobin (hba1c, %), Lipids (Total Cholesterol, ldl, hdl, and Triglycerides, in mmol/l), and C-Reactive Protein (mg/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_17234', 'glucose', 48, 'glucose'), ('PR_000045358', 'insulin family protein', 74, 'insulin'), ('CHEBI_18059', 'lipid', 128, 'lipids'), ('CHEBI_66254', 'topopyrone C', 136, 'total cholesterol'), ('CHEBI_17855', 'triglyceride', 169, 'triglycerides'), ('CHEBI_18245', 'carboxylato group', 200, 'C'), ('PR_000005890', 'crooked neck-like protein 1', 200, 'C-reactive protein')]
PMC4377888	3/2015	S228-PMC4377888	['over time this excessive pressure results in Glomerular sclerosis [20], further reductions filtration surface area a further increase in systemic Blood pressure.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 45, 'glomerular'), ('UBERON_0000178', 'blood', 146, 'blood')]
PMC4377888	3/2015	S263-PMC4377888	['investigating the spontaneously hypertensive Rat (shr), black and colleagues [147] report no change in Nephron number but a 29 mmhg increase in Blood pressure (measured via Tail cuff plethysmography).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 45, 'Rat'), ('UBERON_0001285', 'nephron', 103, 'nephron'), ('UBERON_0000178', 'blood', 144, 'blood'), ('UBERON_0002415', 'tail', 173, 'tail')]
PMC4377888	3/2015	S285-PMC4377888	['offspring exposed to a high protein diet (20% w/w) in utero and cross-fostered to a mother Fed a low-protein (6% protein) diet showed increased Blood pressure and Expression of the co-transporters after Birth relative to control Animals (20% protein throughout Life) [109].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 91, 'fed'), ('UBERON_0000178', 'blood', 144, 'blood'), ('GO_0010467', 'gene expression', 163, 'expression'), ('GO_0007567', 'parturition', 203, 'birth'), ('NCBITaxon_33208', 'Metazoa', 229, 'animals'), ('UBERON_0000104', 'life cycle', 261, 'life')]
PMC4377888	3/2015	S297-PMC4377888	['[107] using an Uteroplacental insufficiency model in Rats to induce fetal growth restriction report that offspring that were growth restricted in utero and Postnatally had higher Blood pressure as well as a Nephron deficit, compared to controls.']	N/A	N/A	[('UBERON_0012469', 'external anal region', 15, 'uteroplacental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rats'), ('GO_0007565', 'female pregnancy', 156, 'postnatally'), ('UBERON_0000178', 'blood', 179, 'blood'), ('UBERON_0001285', 'nephron', 207, 'nephron')]
PMC4377888	3/2015	S298-PMC4377888	['meanwhile, offspring that were restricted in utero and were then cross-fostered to control dams did not have a reduced Nephron endowment or increased Blood pressure [107].']	N/A	N/A	[('UBERON_0001285', 'nephron', 119, 'nephron'), ('UBERON_0000178', 'blood', 150, 'blood')]
PMC4377896	3/2015	S46-PMC4377896	['Breastfeeding, child Fish Consumption, maternal Dental & lifestyle questionnaires.Neurodevelopmental testing of child completed by mother using alspac adaption of the macarthur communicative development inventory (mcdi) at 15 months and denver developmental screening test (ddst) at 18 months of age.fish and Seafood Intake measured via a validated ffq (calibrated for lc n -3pufas in Blood) at 28 weeks Gestation.infant Cognition measured usingvisual Recognition Memory (vrm) paradigm at 6 months of age.seafood Consumption assessed at 32 weeks Gestation via ffq.postal questionnaires on diet, education, social, behavioural and developmental outcomes at child age: 6, 18, 30, 42, and 81 months.wechsler intelligence scale for children iii used to assess intelligence quotient (iq) at 8 years and strengths and difficulties questionnaire (sdq) conducted.']	N/A	N/A	[('UBERON_0000165', 'mouth', 0, 'Breastfeeding'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 21, 'fish'), ('GO_0007631', 'feeding behavior', 26, 'consumption'), ('UBERON_0001091', 'calcareous tooth', 48, 'dental'), ('GO_0007285', 'primary spermatocyte growth', 82, 'Neurodevelopmental'), ('CHEBI_34973', 'Selfotel', 309, 'seafood'), ('GO_0007631', 'feeding behavior', 317, 'intake'), ('UBERON_0000178', 'blood', 385, 'blood'), ('GO_0007565', 'female pregnancy', 404, 'gestation'), ('GO_0050890', 'cognition', 421, 'cognition'), ('GO_0009451', 'RNA modification', 452, 'Recognition'), ('GO_0007613', 'memory', 464, 'Memory'), ('GO_0007631', 'feeding behavior', 513, 'consumption'), ('GO_0007565', 'female pregnancy', 546, 'gestation')]
PMC4379001	3/2015	S128-PMC4379001	['dna extraction\nGenomic dna was extracted from three control and three ntd samples, respectively, according to manufacturer’s instructions of dneasy Blood & Tissue kit (qiagen, germany).']	N/A	N/A	[('SO_0001026', 'genome', 15, 'Genomic'), ('UBERON_0000178', 'blood', 148, 'Blood'), ('UBERON_0000479', 'tissue', 156, 'Tissue')]
PMC4380381	3/2015	S24-PMC4380381	['she was afebrile with a Blood pressure of 111/64mmhg and Heart rate of 62 beats per minute.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0000948', 'heart', 57, 'heart')]
PMC4380381	3/2015	S29-PMC4380381	['laboratory studies revealed a Leukocytosis of 13.6 × 109white Blood Cells/l and normal electrolytes.']	N/A	N/A	[('GO_0007596', 'blood coagulation', 30, 'leukocytosis'), ('CL_0000081', 'blood cell', 62, 'blood cells'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC4380518	9/2014	S19-PMC4380518	['laboratory analysis\nmaternal Blood was obtained at the initial visit (median Gestational age 9.6 weeks, iqr 8.4–11.4) and again in the late second/early third trimester (mean 26.0 weeks’ Gestation, iqr 25.0–26.9).']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood'), ('GO_0007565', 'female pregnancy', 77, 'gestational'), ('GO_0007565', 'female pregnancy', 187, 'gestation')]
PMC4380518	9/2014	S20-PMC4380518	['approximately 10 ml of Blood was drawn in Ethylene Diamine Tetraacetic Acid Plasma tubes at each study visit; the samples were kept at 4°c until processing for storage within 4 hours of venipuncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 42, 'ethylene diamine tetraacetic acid'), ('UBERON_0001969', 'blood plasma', 76, 'plasma')]
PMC4383120	1/2015	S10-PMC4383120	['Umbilical Blood gas pco2was slightly higher, and po2was marginally lower in group bf.']	N/A	N/A	[('UBERON_0007118', 'umbilicus', 0, 'Umbilical'), ('UBERON_0000178', 'blood', 10, 'blood')]
PMC4383120	1/2015	S31-PMC4383120	["following application of routine monitors (noninvasive Blood pressure [bp] measurement, electrocardiography, and pulse oximetry) and insertion of a peripheral 18-gauge Intravenous (iv) Cannula, a rapid infusion of lactated ringer's Solution 15 ml/kg was administered."]	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0034986', 'sacral nerve plexus', 168, 'intravenous'), ('UBERON_0004741', 'cleithrum', 185, 'cannula'), ('CHEBI_75958', 'solution', 232, 'solution')]
PMC4383120	1/2015	S44-PMC4383120	['neonatal outcome was assessed by the apgar score and Umbilical Cord Blood gas analysis.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 53, 'umbilical cord'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC4383226	2/2015	S18-PMC4383226	['the surveys contained information about the vaccines and supplements the children received, and whether their Blood showed signs of infection with malaria-causing plasmodium parasites.']	N/A	N/A	[('UBERON_0000178', 'blood', 110, 'blood')]
PMC4383226	2/2015	S45-PMC4383226	["results\n\nchildren's characteristics\nof 20,984 children who presented health cards during survey interviews, 18,413 were eligible for Blood screening from which 12,058 provided capillary Blood for malaria testing (figure 1)."]	N/A	N/A	[('UBERON_0000178', 'blood', 133, 'blood'), ('UBERON_0000178', 'blood', 186, 'blood')]
PMC4383226	2/2015	S46-PMC4383226	['from these, 8672 (72%) were tested using both thick Blood films and rapid P. Falciparum Histidine Rich Protein-2 ( pƒ Hrp-2) tests, 3356 (28%) were tested only with Blood films, and 30 (0.2%) were tested with only rapid P ƒhrp-2 tests.']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood'), ('PR_000012567', 'peroxisome assembly factor 2', 74, 'P'), ('PR_000029959', 'smad9 isoform 3 (human)', 77, 'falciparum'), ('PR_000008809', 'heat shock 70 kDa protein 4L', 88, 'histidine rich protein-2'), ('PR_000008820', 'heat shock protein beta-8', 118, 'HRP-2'), ('UBERON_0000178', 'blood', 165, 'blood'), ('PR_000012567', 'peroxisome assembly factor 2', 220, 'P'), ('PR_000000164', 'BMP2', 226, '-2')]
PMC4383226	2/2015	S47-PMC4383226	['among those tested, we identified 3544 (30%) with positive Blood films for plasmodium spp.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood')]
PMC4383226	2/2015	S69-PMC4383226	['of children with positive Blood test (%)unadjusted rradjusted rr (95% ci)‡,§no vaccinevaccineunweightedweighted (ipw)(a) plasmodium species (parasitemia)*\u2003bacille calmette guerin (bcg)8013/8140 (98)41 (32)2227 (28)0.811.25 (0.81–1.91)1.24 (0.76–2.05)\u2003diphtheria–tetanus–pertussis (dtp)8044/8235 (98)83 (44)2202 (27)0.490.88 (0.64–1.20)0.06 (0.01–0.47)\u2003measles6450/8069 (80)473 (29)1784 (28)0.931.11 (0.96–1.29)1.01 (0.20–5.19)\u2003poliomyelitis8231/8272 (99)14 (34)2278 (28)0.740.80 (0.37–1.73)0.74 (0.27–2.01)\u2003vitamin a supplement2182/3523 (62)596 (44)438 (20)0.310.46 (0.39–0.54)0.43 (0.36–0.52)(b) plasmodium falciparum (antigenemia)\u2003bacille calmette guerin (bcg)6006/6047 (99)9 (22)2102 (35)1.914.06 (2.00–8.28)3.52 (1.66–7.48)\u2003diphtheria–tetanus–pertussis (dtp)5933/6054 (98)59 (49)2049 (35)0.551.34 (0.88–2.02)0.06 (0.01–0.38)\u2003measles4776/5937 (80)410 (35)1679 (35)0.991.15 (0.97–1.38)0.68 (0.15–3.12)\u2003poliomyelitis6.072/6084 (99)5 (42)2111 (35)0.751.39 (0.55–3.49)0.93 (0.37–2.35)\u2003vitamin a supplement629/1749 (36)621 (56)75 (12)0.100.23 (0.17–0.29)0.22 (0.16–0.29)\nHrp-2: Histidine Rich Protein-2; rr: relative risk; ci: confidence interval; ipw: inverse probability weighted model.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('PR_000008820', 'heat shock protein beta-8', 1069, 'HRP-2'), ('PR_000008809', 'heat shock 70 kDa protein 4L', 1076, 'histidine rich protein-2')]
PMC4383226	2/2015	S87-PMC4383226	["of children with positive Blood film (%)unadjusted rradjusted model3no Vitamin avitamin arr (95% ci)p value (interaction term)adjusted rr‡(95%ci)p value (interaction term)(a) individual levelchildren's characteristics\u2003age at malaria screening6–35 months484 (43)344 (20)0.330.46 (0.38–0.55)<0.01#0.26 (0.20–0.34)<0.01#36–59 months112 (54)94 (21)0.230.34 (0.25–0.47)0.09 (0.05–0.14)\u2003gendergirl274 (44)226 (21)0.340.54 (0.44–0.67)0.290.23 (0.16–0.32)0.99boy322 (45)212 (19)0.290.40 (0.32–0.49)0.23 (0.17–0.30)\u2003Pregnancy order of childprimigravidae522 (47)366 (21)0.300.45 (0.38–0.53)0.270.20 (0.15–0.27)0.04multigravidae74 (31)72 (15)0.410.51 (0.39–0.66)0.33 (0.22–0.48)\u2003Birth weight2500 mg or greater332 (42)204 (15)0.240.39 (0.32–0.48)0.010.27 (0.20–0.36)0.02less than 2500 mg264 (48)234 (28)0.430.53 (0.43–0.66)0.13 (0.09–0.18)\u2003treatment for Intestinal worms during past 6 monthsnot received554 (46)212 (25)0.390.50 (0.40–0.61)0.080.38 (0.28–0.52)0.07received37 (30)221 (17)0.460.66 (0.52–0.86)0.15 (0.11–0.21)malaria-based interventions\u2003malaria treatment during previous weeknot received550 (44)404 (19)0.310.44 (0.37–0.52)0.240.20 (0.16–0.27)0.02received46 (49)34 (33)0.510.88 (0.62–1.26)1.01 (0.60–1.68)\u2003mother took Antimalarial during child's Gestational periodno102 (28)226 (22)0.690.78 (0.59–1.03)<0.0010.38 (0.19–0.74)0.05yes491 (50)210 (19)0.230.36 (0.30–0.45)0.20 (0.16–0.27)\u2003family owns bed netdoes not own bed net141 (47)123 (22)0.320.43 (0.34–0.56)0.420.20 (0.15–0.26)0.70owns bed net455 (44)315 (41)0.310.48 (0.40–0.58)0.24 (0.18–0.32)(b) community level (primary sampling unit)\u2003type of settingrural518 (50)370 (25)0.350.46 (0.39–0.56)0.950.22 (0.17–0.30)0.91urban78 (26)68 (9.4)0.290.34 (0.22–0.51)0.22 (0.12–0.40)Genetic mechanisms of malaria protection\u2003mean predicted hbs Allele frequency§less than 2.5%14 (20)104 (14)0.780.78 (0.32–1.91)<0.01#-0.26#2.5–4.9%181 (41)269 (25)1.490.95 (0.64–1.42)0.96 (0.24–3.91)5% or greater401 (48)65 (18)0.210.31 (0.17–0.56)0.17 (0.08–0.39)\u2003median predicted g6pdd Allele frequency§less than 7.5%336 (47)47 (11)0.045.42 (2.01–14.6)<0.001#1.43 (0.28–7.21)0.02#7.5–14.9%194 (43)128 (18)0.800.89 (0.52–1.50)0.41 (0.12–1.34)15% or greater66 (40)263 (25)0.650.74 (0.46–1.19)-climate of communities surveyed\u2003season of malaria transmissiondry season198 (42)220 (19)0.320.40 (0.31–0.52)0.450.06 (0.03–0.13)<0.001wet season398 (46)218 (22)0.320.53 (0.42–0.66)0.39 (0.28–0.53)\u2003length of rainy seasonless than 120 days168 (49)151 (21)0.270.43 (0.31–0.61)<0.001#0.28 (0.15–0.50)0.03#120–179 days334 (56)105 (26)0.270.45 (0.33–0.62)0.22 (0.15–0.31)180 days or more94 (23)182 (17)0.700.77 (0.56–1.05)0.21 (0.10–0.43)\u2003length of time enhanced vegetation index above annual meanless than 120 days105 (42)220 (21)0.380.50 (0.37–0.69)0.18#0.37 (0.09–1.60)0.84#120–179 days486 (52)206 (27)0.340.52 (0.42–0.66)0.33 (0.24–0.45)180 days or more5 (3.3)12 (3.2)0.970.43 (0.12–1.62)0.66 (0.16–2.85)\u2003range of enhanced vegetation index per yearless than 0.2046 (25)41 (7.9)0.260.38 (0.22–0.63)0.18#0.24 (0.13–0.47)0.13#0.20–0.29247 (44)105 (17)0.250.48 (0.36–0.64)0.36 (0.25–0.53)0.30 or greater303 (51)292 (28)0.380.48 (0.39–0.61)0.19 (0.13–0.29)\u2003annual mean for enhanced vegetation indexless than 0.20150 (37)21 (7.2)0.130.17 (0.11–0.28)<0.01#0.16 (0.10–0.25)0.01#0.20–0.29309 (59)89 (24)0.220.51 (0.37–0.70)0.34 (0.23–0.51)0.30 or greater137 (33)328 (22)0.560.61 (0.46–0.81)0.56 (0.20–1.53)\nHrp-2: Histidine Rich Protein 2; rr: relative risk; ci: confidence interval; na: not applicable: ref: reference category; hbs: hemoglobin s; G6Pd: Glucose 6-Phosphate dehydrogenase deficiency."]	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_33229', 'vitamin (role)', 71, 'vitamin'), ('GO_0007565', 'female pregnancy', 507, 'Pregnancy'), ('GO_0007567', 'parturition', 668, 'Birth'), ('UBERON_0000160', 'intestine', 842, 'intestinal'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 1219, 'antimalarial'), ('GO_0007565', 'female pregnancy', 1247, 'gestational'), ('SO_0000704', 'gene', 1728, 'Genetic'), ('SO_0001023', 'allele', 1788, 'allele'), ('SO_0001023', 'allele', 2014, 'allele'), ('PR_000008820', 'heat shock protein beta-8', 3415, 'HRP-2'), ('PR_000008820', 'heat shock protein beta-8', 3422, 'histidine rich protein 2'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 3556, 'G6PD'), ('CHEBI_14314', 'D-glucose 6-phosphate', 3562, 'glucose 6-phosphate')]
PMC4383226	2/2015	S123-PMC4383226	['Blood films and antigenemia readings are used to identify two different outcomes (i.e.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4383226	2/2015	S124-PMC4383226	['Blood films test for plasmodium spp.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'blood')]
PMC4383226	2/2015	S158-PMC4383226	['eligible subjects for our analysis included children 6–59 months of age who, during survey interviews, provided Blood samples for malaria screening and had their history of vaccination and Vitamin A supplementation documented based on health records.']	N/A	N/A	[('UBERON_0000178', 'blood', 112, 'blood'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin A')]
PMC4383226	2/2015	S188-PMC4383226	['was determined by reading giemsa-stained thick Blood films.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood')]
PMC4383226	2/2015	S191-PMC4383226	['Capillary Blood was collected during household interviews and tested onsite for malaria antigenemia.']	N/A	N/A	[('UBERON_0001982', 'capillary', 0, 'Capillary'), ('UBERON_0000178', 'blood', 10, 'blood')]
PMC4383226	2/2015	S193-PMC4383226	['thick Blood smears were prepared by trained technicians for all children, and sent for gold standard testing of malaria to the centre national de recherche et de formation sur le paludisme (burkina faso), centro de investigações em saúde de manhiça (mozambique), trac/plus malaria unit in kigali (rwanda) and department of parasitology at the université cheikh anta diop (senegal).']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC4383226	2/2015	S196-PMC4383226	['determination of current hiv status among mothers\ncapillary Blood was collected during household interviews from all women aged 15–29 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood')]
PMC4383226	2/2015	S218-PMC4383226	['ethical considerations\nprior to enrolling in the survey, the parent/Adult responsible for the child had to provide written informed consent to participate, along with additional informed consent for Blood sample collection and testing.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 68, 'adult'), ('UBERON_0000178', 'blood', 199, 'blood')]
PMC4383226	2/2015	S223-PMC4383226	['protocols for Blood specimen collection, hiv and malaria testing were also approved by icf macro international institutional review board (irb) [all countries] in compliance with u.s. dhhs regulation 45 cfr 46 for ‘protection of Human subjects’ research, national ethics committees [burkina faso, rwanda and senegal] and u.s. centers for disease control [rwanda only].']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 229, 'Human')]
PMC4383437	3/2015	S52-PMC4383437	['medical and obstetric history variables relevant to the tested outcomes were combined into an obstetric/fetal risk factor variable, which included history of Kidney disease; hypertension; anemia; Heart disease; seizures; diabetes; hiv; Rh negative status; asthma; Sexually Transmitted infections; abnormal Blood Clotting; Thyroid disorders; Vaginal, Cervical, or Urinary Tract infections; Endocrine disorders; abnormal Pregnancy weight gain (<4\u2009kg or >18\u2009kg); Preeclampsia; or abnormal bleeding during Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 158, 'kidney'), ('UBERON_0000948', 'heart', 196, 'heart'), ('PR_000013773', 'retinoblastoma-associated protein', 236, 'Rh'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 264, 'sexually transmitted'), ('GO_0007596', 'blood coagulation', 306, 'blood clotting'), ('UBERON_0000178', 'blood', 306, 'blood'), ('UBERON_0002046', 'thyroid gland', 322, 'thyroid'), ('UBERON_0001987', 'placenta', 341, 'vaginal'), ('UBERON_0005434', 'cervical region', 350, 'cervical'), ('UBERON_0001553', 'medial tarsal artery', 363, 'urinary tract'), ('GO_0006397', 'mRNA processing', 389, 'endocrine'), ('UBERON_0002049', 'vasculature', 389, 'endocrine'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 460, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy')]
PMC4383546	4/2015	S45-PMC4383546	['administration of Glucose (1.5mg/g bodyweight) after overnight fasting, and then the Blood Glucose levels were measured 0, 15, 30, 45, 60, 90, 120, and 150 min following Glucose challenge.']	N/A	N/A	[('CHEBI_17234', 'glucose', 18, 'glucose'), ('UBERON_0000178', 'blood', 85, 'blood'), ('CHEBI_17234', 'glucose', 91, 'glucose'), ('CHEBI_17234', 'glucose', 170, 'glucose')]
PMC4383575	1/2015	S3-PMC4383575	['Cord Blood bulky dna adduct levels were measured by the32p-postlabeling technique ( n = 511).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC4383575	1/2015	S22-PMC4383575	['2009), and Cord Blood (godschalk et al.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 11, 'cord'), ('UBERON_0000178', 'blood', 16, 'blood')]
PMC4383575	1/2015	S55-PMC4383575	['Cord Blood dna adduct measurements were available from 630 newborns Born to women with singleton Deliveries.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 68, 'born'), ('GO_0007567', 'parturition', 97, 'deliveries')]
PMC4383575	1/2015	S96-PMC4383575	['Blood collection and bulky dna adduct analysis (32P-postlabeling) .']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_37972', 'phosphorus-32 atom', 48, '32P')]
PMC4383575	1/2015	S97-PMC4383575	['Cord Blood was collected immediately after Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 43, 'delivery')]
PMC4383575	1/2015	S121-PMC4383575	['all Cord Blood samples ( n = 511) had detectable levels of bulky dna adducts, ranging from 0.6 to 87.5 adducts/108nt.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood')]
PMC4388824	4/2015	S49-PMC4388824	['Adipose Tissue was processed within 15 min of collection, thoroughly washed in ice-cold pbs to remove any Blood.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC4390148	4/2015	S63-PMC4390148	['Blood was collected via Cardiac puncture for Glucose (accu-check Glucose monitor, roche diagnostics australia), Plasma Triglycerides and hormone analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 24, 'cardiac'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('CHEBI_17234', 'glucose', 65, 'glucose'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_17855', 'triglyceride', 119, 'triglycerides')]
PMC4390148	4/2015	S79-PMC4390148	['final body weight, Blood Glucose, Plasma Insulin, Triglycerides and Organ weights were analyzed by two-way anova (maternal diet x maternal activity), followed by post hoc lsd.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_17234', 'glucose', 25, 'glucose'), ('UBERON_0001969', 'blood plasma', 34, 'plasma'), ('PR_000045358', 'insulin family protein', 41, 'insulin'), ('CHEBI_17855', 'triglyceride', 50, 'triglycerides'), ('UBERON_0000062', 'organ', 68, 'organ')]
PMC4390148	4/2015	S118-PMC4390148	['**p < .01 maternal hfd effect;††p < .01 maternal exercise effect.10.1371/journal.pone.0120980.t002\n\ncaption (table-wrap): table 2\noffspring body weight, Visceral fat, total fat, muscle mass, Blood Glucose, Plasma Insulin and Triglyceride concentrations at pnd19.malefemalecs (17)ce (14)fs (16)fe (12)cs (18)ce (13)fs (21)fe (12)body weight (g)33.4 ± 1.030.0 ± 0.649.7 ± 2.7**49.8 ± 2.6**31.5 ± 0.928.9 ± 0.547.3 ± 1.4*46.8 ± 1.4*Visceral fat (mg)125.4 ± 5.3107.5 ± 3.9†229.0 ± 17.3**250.0 ± 13.1**106.7 ± 6.390.3 ± 7.1234.6 ± 10.8*213.5 ± 13.7*total Wat (mg)283.6 ± 24.8223.1 ± 19.5675.6 ± 66.9**713.9 ± 41.6**143.5 ± 8.8122.3 ± 7.8385.8 ± 2.4**387.0 ± 22.9**total muscle (mg)161.9 ± 7.6137.3 ± 4.4221.8 ± 19.6**236.3 ± 23.9**149.0 ± 7.0141.8 ± 10.4197.7 ± 14.4**209.7 ± 15.9**Blood Glucose (mmol.l-1)7.6 ± 0.37.8 ± 0.28.7 ± 0.3**7.9 ± 0.4†7.6 ± 0.17.6 ± 0.18.5 ± 0.2**8.2 ± 0.2**Plasma Insulin (ng.ml-1)1.8 ± 0.21.3 ± 0.1†1.7 ± 0.21.0 ± 0.1†0.6 ± 0.10.7 ± 0.12.1 ± 0.2**2.1 ± 0.2**Plasma tg (mmol.l-1)26.6 ± 2.720.8 ± 2.6†27.1 ± 3.432.7 ± 4.7*16.1 ± 1.215.0 ± 2.922.6 ± 2.321.9 ± 1.9\nbody weight, Visceral fat, total Wat, muscle mass, Blood Glucose, Plasma Insulin and Triglyceride concentrations in male and female offspring at pnd19.']	N/A	N/A	[('UBERON_0002075', 'viscus', 153, 'visceral'), ('UBERON_0000178', 'blood', 191, 'blood'), ('CHEBI_17234', 'glucose', 197, 'glucose'), ('UBERON_0001969', 'blood plasma', 206, 'plasma'), ('PR_000045358', 'insulin family protein', 213, 'insulin'), ('CHEBI_17855', 'triglyceride', 225, 'triglyceride'), ('UBERON_0002405', 'immune system', 429, 'Visceral'), ('UBERON_0006337', 'distal early tubule', 550, 'WAT'), ('UBERON_0000178', 'blood', 777, 'Blood'), ('CHEBI_17234', 'glucose', 783, 'glucose'), ('UBERON_0001969', 'blood plasma', 880, 'Plasma'), ('PR_000045358', 'insulin family protein', 887, 'insulin'), ('UBERON_0001969', 'blood plasma', 982, 'Plasma'), ('UBERON_0002075', 'viscus', 1098, 'visceral'), ('UBERON_0006337', 'distal early tubule', 1118, 'WAT'), ('UBERON_0000178', 'blood', 1136, 'blood'), ('CHEBI_17234', 'glucose', 1142, 'glucose'), ('UBERON_0001969', 'blood plasma', 1151, 'plasma'), ('PR_000045358', 'insulin family protein', 1158, 'insulin'), ('CHEBI_17855', 'triglyceride', 1170, 'triglyceride')]
PMC4390148	4/2015	S216-PMC4390148	['modest voluntary exercise by obese dams prior to and during Pregnancy had benefits in normalizing their Blood Glucose concentrations during the Lactation window.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_17234', 'glucose', 110, 'glucose'), ('GO_0007595', 'lactation', 144, 'lactation')]
PMC4392553	3/2015	S593-PMC4392553	['low Mn bioavailability from the Blood supply to the Brain leads to impaired function of glutamine synthase and a build-up of glutamate and Ammonia in the Brain, both of which are neurotoxic.']	N/A	N/A	[('CHEBI_25614', 'nylons', 4, 'Mn'), ('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0000955', 'brain', 52, 'brain'), ('CHEBI_16134', 'ammonia', 139, 'ammonia'), ('UBERON_0000955', 'brain', 154, 'brain')]
PMC4393585	4/2015	S34-PMC4393585	['routine Blood examinations were performed in all of them.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood')]
PMC4393585	4/2015	S36-PMC4393585	['malaria diagnosis\nthe microscopic diagnosis was performed by thick Blood smear in all women.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood')]
PMC4393585	4/2015	S39-PMC4393585	['the thick Blood smear was performed at the moment of recruitment and monthly when the patient returned to Antenatal evaluation.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('GO_0007567', 'parturition', 106, 'antenatal')]
PMC4393585	4/2015	S126-PMC4393585	['all initiated treatment on the same day of diagnosis of vivax malaria by the thick Blood film.']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood')]
PMC4396835	1/2015	S3-PMC4396835	['25(Oh)D levels were analysed in the stored dried Blood spots taken in the Neonatal Period for Metabolic screening.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('UBERON_0000178', 'blood', 49, 'blood'), ('UBERON_0007221', 'neonate stage', 74, 'neonatal period'), ('GO_0008152', 'metabolic process', 94, 'metabolic')]
PMC4396835	1/2015	S37-PMC4396835	['we examined 25(Oh)D levels in dried Blood spot samples taken during the Neonatal Period from children Born in sweden, who later were diagnosed with asd.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 12, '25(OH)D'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0007221', 'neonate stage', 72, 'neonatal period'), ('GO_0007567', 'parturition', 102, 'born')]
PMC4396835	1/2015	S59-PMC4396835	['asd, autism spectrum disorder; dbs, dried Blood spots.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC4396835	1/2015	S72-PMC4396835	['methods\n\nstored dried Blood spots\nin sweden, all newborns are tested for certain neuro-Metabolic disorders.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0008152', 'metabolic process', 87, 'metabolic')]
PMC4396835	1/2015	S76-PMC4396835	['all dried Blood samples were analysed at the queensland Brain institute, university of queensland, brisbane, australia for 25(Oh)D.\n\nVitamin D analyses\n25(Oh)D can exist in two forms: 25-Hydroxyvitamin D3(25(Oh)D3) and 25-Hydroxyvitamin D2(25(Oh)d2); the latter can only be obtained from dietary sources and supplements.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0000955', 'brain', 56, 'Brain'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 133, 'Vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('CHEBI_63991', '15-epi-lipoxin B4', 184, '25-hydroxyvitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 205, '25(OH)D3'), ('CHEBI_86319', '25-hydroxyvitamin D2', 219, '25-hydroxyvitamin D2'), ('CHEBI_63056', 'zinc cation', 240, '25(OH')]
PMC4396888	3/2015	S100-PMC4396888	['caption (table-wrap): table 5\n\nservices and counselling received during ancoverall (n\u2009=\u2009279)cpw (n\u2009=\u2009144)rdw (n\u2009=\u2009135)medical care past history was asked227 (81.4)117 (81.3)110 (81.5)physical examination245 (87.8)124 (86.1)121 (89.6)body weight measured235 (84.2)120 (83.3)115 (85.2)Blood pressure measured247 (88.5)126 (87.5)121 (89.6)Blood test done229 (82)110 (76.4)119 (88.2)Urine test done226 (81)107 (74.3)119 (88.2)ifa prescription given230 (82.4)113 (78.5)117 (86.7)Calcium prescription given232 (83.2)113 (78.5)119 (88.2) counselling on anc regular follow-up198 (71)94 (65.3)104 (77.1)hospital Birthing170 (60.9)82 (56.9)88 (65.2)importance of tt217 (77.8)104 (72.2)113 (83.7)regular ifa218 (78.1)107 (74.3)111 (82.2)diet164 (58.8)70 (48.6)94 (69.6)Breast Feeding initiation110 (39.4)41 (28.5)69 (51.1)exclusive Breast Feeding118 (42.3)45 (31.3)73 (54.1)Family Planning104 (37.3)43 (29.9)61 (45.2) counselling on dealing with symptoms vomiting86 (30.82)38 (26.4)48 (35.6)constipation49 (17.6)23 (15.9)26 (19.3)Gastric fullness53 (19)26 (18.1)27 (20)pain55 (19.8)26 (18.2)29 (21.5)swelling56 (20.1)26 (18.2)30 (22.2)headache67 (24.1)29 (20.1)38 (28.2)bleeding72 (25.8)33 (22.9)39 (28.9)fatigue83 (29.8)37 (25.7)46 (34.1)\n(cpw: currently Pregnant women, rdw: recently Delivered women, anc- Antenatal care, tt: tetanus Toxoid, ifa: Iron and Folic Acid).']	N/A	N/A	[('UBERON_0000178', 'blood', 283, 'Blood'), ('UBERON_0000178', 'blood', 336, 'Blood'), ('UBERON_0001088', 'urine', 379, 'Urine'), ('CHEBI_31341', 'calcium dihydroxide', 474, 'Calcium'), ('GO_0048513', 'animal organ development', 603, 'birthing170'), ('UBERON_0000310', 'breast', 758, 'Breast'), ('GO_0007631', 'feeding behavior', 765, 'feeding'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 821, 'breast feeding118'), ('UBERON_0000310', 'breast', 821, 'breast'), ('GO_0034374', 'low-density lipoprotein particle remodeling', 863, 'Family planning104'), ('UBERON_0001844', 'cochlea', 1019, 'Gastric'), ('GO_0007565', 'female pregnancy', 1245, 'Pregnant'), ('GO_0006281', 'DNA repair', 1275, 'Delivered'), ('GO_0007565', 'female pregnancy', 1297, 'Antenatal'), ('CHEBI_26933', 'tetraric acid', 1325, 'Toxoid'), ('CHEBI_24870', 'ion', 1338, 'Iron'), ('CHEBI_30751', 'formic acid', 1347, 'Folic Acid')]
PMC4404267	4/2015	S46-PMC4404267	['maternal Blood and Urine sampling was aligned with routine clinical assessment visits within the Antenatal clinic.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001088', 'urine', 19, 'urine'), ('GO_0007567', 'parturition', 97, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 97, 'antenatal')]
PMC4404267	4/2015	S47-PMC4404267	['each spot Urine sample (no Preservative added) was collected at approximately the same time as a Blood sample into a lithium Heparin Plasma separator tube (pst).']	N/A	N/A	[('UBERON_0001088', 'urine', 10, 'urine'), ('CHEBI_33952', 'sorbose derivative', 27, 'preservative'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_28304', 'heparin', 125, 'heparin'), ('UBERON_0001969', 'blood plasma', 133, 'plasma')]
PMC4404267	4/2015	S48-PMC4404267	['Venous Cord Blood sampling (in k2edta) was aligned with routine collection from healthy term (37-41 weeks) Deliveries (altruistic Cord Blood donors) at the queensland Cord Blood bank at the mater.']	N/A	N/A	[('UBERON_0005296', 'ovary sex cord', 0, 'Venous cord'), ('UBERON_0000178', 'blood', 12, 'blood'), ('GO_0007567', 'parturition', 107, 'deliveries'), ('UBERON_0002240', 'spinal cord', 130, 'cord'), ('UBERON_0000178', 'blood', 135, 'blood'), ('UBERON_0000948', 'heart', 167, 'Cord'), ('UBERON_0000178', 'blood', 172, 'Blood')]
PMC4404558	4/2015	S47-PMC4404558	['Maternal Blood (enrolment, Delivery, iptp visits, passive case detection visits), and Placental biopsies were used to characterise malarial infection.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 27, 'delivery'), ('UBERON_0001987', 'placenta', 86, 'placental')]
PMC4404558	4/2015	S48-PMC4404558	['thick smears were used to count the number of asexual parasites per 200 Leukocytes (wbc) (or per 500 if <10 parasites/200 wbcs), assuming 8000 wbcs/μl of Blood.']	N/A	N/A	[('CL_0000738', 'leukocyte', 72, 'leukocytes'), ('UBERON_0000178', 'blood', 154, 'blood')]
PMC4404558	4/2015	S50-PMC4404558	['in addition, quantitative real-time polymerase chain reaction (qpcr) was performed on maternal Blood [20].']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood')]
PMC4404558	4/2015	S59-PMC4404558	['women with active Placental malaria were coded as a having had a ‘recent infection’ for the bw measurement, while women with past Placental malaria were coded as having had an infection prior to or at enrolment provided they were Peripheral Blood negative throughout.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('UBERON_0001987', 'placenta', 130, 'placental'), ('UBERON_0012101', 'perinatal stage', 230, 'peripheral'), ('UBERON_0000178', 'blood', 241, 'blood')]
PMC4405493	4/2015	S37-PMC4405493	['vitals including body mass index (bmi) and Blood pressure were measured at initial and all subsequent obstetric appointments in accordance with standard-of-care procedures.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood')]
PMC4405493	4/2015	S45-PMC4405493	['Plasma preparation and Vitamin D elisa\nmaternal Blood was collected by venipuncture in vacutainer edta-containing tubes at 5 to 12 weeks Gestational age and the date of the Blood draw was recorded.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007565', 'female pregnancy', 137, 'gestational'), ('UBERON_0000178', 'blood', 173, 'blood')]
PMC4405493	4/2015	S96-PMC4405493	['thirty-eight percent of the Blood draws occurred in the winter, 19% in the spring, 22% in the summer, and 21% in the fall.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood')]
PMC4405511	3/2015	S17-PMC4405511	['babies Born through cesarean are 5 times more in the risk of initial Pulmonary Blood pressure compared with the babies Born through Vaginal Delivery (2).']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'born'), ('UBERON_0002048', 'lung', 69, 'pulmonary'), ('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0007567', 'parturition', 119, 'born'), ('GO_0007601', 'visual perception', 132, 'vaginal'), ('UBERON_0001987', 'placenta', 132, 'vaginal'), ('GO_0007567', 'parturition', 140, 'delivery')]
PMC4407308	4/2015	S57-PMC4407308	['additionally, Gestation occurring in the warmer months where ewes shuttle Blood flow to the periphery of the body to dissipate heat rather than to the core could ultimately decrease Placental Blood Flow and Placental growth [27].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestation'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 182, 'placental'), ('UBERON_0001987', 'placenta', 182, 'placental'), ('GO_0007567', 'parturition', 192, 'blood flow'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0001987', 'placenta', 207, 'placental')]
PMC4407308	4/2015	S90-PMC4407308	['in addition, factors that alter fetal weight such as genotype, maternal Nutrient Intake, environmental heat stress, high altitude, and fecundity, result in parallel alterations in Placental weight and Uterine Blood flow [53].']	N/A	N/A	[('CHEBI_33284', 'nutrient', 72, 'nutrient'), ('GO_0007631', 'feeding behavior', 81, 'intake'), ('UBERON_0001987', 'placenta', 180, 'placental'), ('UBERON_0000995', 'uterus', 201, 'uterine'), ('UBERON_0000178', 'blood', 209, 'blood')]
PMC4407308	4/2015	S91-PMC4407308	['in the Sheep, Uterine and Placental Blood flows progress in a non-linear pattern with an early rise in Blood flow between days 40–70 as the Placental Cotyledon develops and a second increase in flow between days 120–140 [54].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'sheep'), ('UBERON_0000995', 'uterus', 14, 'uterine'), ('UBERON_0001987', 'placenta', 26, 'placental'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0010008', 'placental cotyledon', 140, 'placental cotyledon')]
PMC4407308	4/2015	S155-PMC4407308	['in the case of Lactating dairy Cows, Blood Glucose levels are lower in comparison to their non-Lactating contemporaries [112].']	N/A	N/A	[('GO_0007594', 'puparial adhesion', 15, 'lactating'), ('NCBITaxon_33208', 'Metazoa', 31, 'cows'), ('UBERON_0000178', 'blood', 37, 'blood'), ('CHEBI_17234', 'glucose', 43, 'glucose'), ('GO_0007594', 'puparial adhesion', 95, 'lactating')]
PMC4407379	4/2015	S10-PMC4407379	['Blood and Milk samples were obtained at weaning, and Blood was analyzed for Plasma Urea nitrogen (pun), Milk was analyzed for total protein and fat content.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001913', 'milk', 10, 'milk'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_16199', 'urea', 83, 'urea'), ('UBERON_0001913', 'milk', 104, 'milk')]
PMC4407379	4/2015	S119-PMC4407379	['Milk and Blood collection\nat weaning, eight sows were randomly selected from each dietary treatment for Blood collection.']	N/A	N/A	[('UBERON_0001913', 'milk', 0, 'Milk'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000178', 'blood', 104, 'blood')]
PMC4407379	4/2015	S121-PMC4407379	['immediately following piglet removal at weaning, selected sows were snared and 10\xa0ml of Blood was collected via Jugular venipuncture in non-heparinized collection tubes (bd vaccutainer, franklin lakes, n.j., u.s.a.).']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0004741', 'cleithrum', 112, 'jugular')]
PMC4407379	4/2015	S124-PMC4407379	['Blood was centrifuged and the Plasma portion collected and frozen at −20°c until analysis for Plasma Urea nitrogen (pun).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 30, 'plasma'), ('UBERON_0001969', 'blood plasma', 94, 'plasma'), ('CHEBI_16199', 'urea', 101, 'urea')]
PMC4408096	4/2015	S60-PMC4408096	['the final study visit was conducted at the local ward clinic, where participants’ height, weight, and muac were measured and peripheral venous Blood was collected by trained laboratory technicians using edta vacutainer tubes and transported to mchukwi mission hospital in mchukwi, pwani region, for determination of complete Blood cell counts using a sysmex kx-21n automated hematology analyzer.']	N/A	N/A	[('UBERON_0000178', 'blood', 143, 'blood'), ('UBERON_0000178', 'blood', 325, 'blood')]
PMC4408096	4/2015	S61-PMC4408096	['peripheral Venous Blood was also used to prepare a thin Blood smear to type anemia and a thick Blood smear that was read by two independent laboratory technicians to assess malaria parasitemia.']	N/A	N/A	[('UBERON_0001638', 'vein', 11, 'venous'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC4408096	4/2015	S65-PMC4408096	['outcome measures\nhemoglobin concentration (hb), mean corpuscular volume (mcv), Red Cell distribution width (rdw, measured as the coefficient of variation or cv of the mcv x 100 [22]), and mean corpuscular hemoglobin (mch) were measured by complete Blood cell count.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 79, 'red cell'), ('UBERON_0000178', 'blood', 248, 'blood')]
PMC4410178	4/2015	S40-PMC4410178	['two days before sacrifice, systolic Blood pressure and Heart rate were measured by noninvasive Tail-Cuff plethysmography (hugo-sachs elektronik, freiburg, germany) and one day before sacrifice oral Glucose tolerance test was performed.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000948', 'heart', 55, 'heart'), ('UBERON_0002415', 'tail', 95, 'tail'), ('UBERON_0003124', 'chorion', 100, 'cuff'), ('CHEBI_17234', 'glucose', 198, 'glucose')]
PMC4410178	4/2015	S42-PMC4410178	['Blood Glucose levels were measured using standard Glucose meter in Blood from the Tail, before Glucose administration and 15, 30, 60, 90 and 120 minutes thereafter.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_17234', 'glucose', 50, 'glucose'), ('UBERON_0000178', 'blood', 67, 'blood'), ('UBERON_0002415', 'tail', 82, 'tail'), ('CHEBI_17234', 'glucose', 95, 'glucose')]
PMC4410178	4/2015	S44-PMC4410178	['Urine from Bladder and Blood samples from the Abdominal Aorta (Serum and k3edta Plasma) were collected under i.p.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0018707', 'bladder organ', 11, 'bladder'), ('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0001516', 'abdominal aorta', 46, 'abdominal aorta'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('UBERON_0001969', 'blood plasma', 80, 'plasma')]
PMC4410178	4/2015	S71-PMC4410178	['kruskal-wallismrp-/\u2028cola-vs mrp+/\u2028cola-mrp-/\u2028cola- vs mrp-/\u2028cola+mrp-/\u2028cola- vs mrp+/\u2028cola+mrp+/\u2028cola- vs mrp-/\u2028cola+mrp+/\u2028cola-vs mrp+/\u2028cola+mrp-/\u2028cola+\u2028vs mrp+/\u2028cola+Fluid Consumption (/d/Rat) 19.8 \u2028 ±3.617.3 \u2028 ±1.472.0 \u2028 ±5.063.2 \u2028 ±14.4<0.001>0.9990.002<0.001<0.001<0.001>0.999 initial weight\u2028(g) 156 \u2028 ±40119 \u2028 ±30159 \u2028 ±42120 \u2028 ±320.0430.414>0.9990.3030.240>0.9990.169 Blood pressure (mmhg) 141 \u2028 ±19123 \u2028 ±10125 \u2028 ±12127 \u2028 ±200.057 Heart rate447\u2028±49429\u2028±67501\u2028±28485\u2028±53 0.004 0.8480.1010.293 0.0070.028 0.876insulin (miu/l) 2.99 \u2028 ±2.392.22 \u2028 ±1.6513.29 \u2028 ±7.268.80 \u2028 ±4.75<0.001>0.9990.0010.030<0.0010.003>0.999 homa-ir 0.600 \u2028 ±0.4530.588 \u2028 ±0.4843.355 \u2028 ±1.7362.536 \u2028 ±1.270<0.001>0.999<0.0010.009<0.0010.003>0.999 Cholesterol (mmol/l)1.62\u2028±0.271.61\u2028±0.311.85\u2028±0.331.77\u2028±0.340.245 Tag (mmol/l)0.60 \u2028 ±0.210.59 \u2028 ±0.181.44 \u2028 ±0.641.20 \u2028 ±0.67<0.001>0.9990.0080.0120.0060.008>0.999 ast activity (ukat/l)1.66\u2028±0.331.90\u2028±0.441.82\u2028±0.331.56\u2028±0.260.076ages fluorescence (au/g alb) 278 \u2028 ±47281 \u2028 ±99246 \u2028 ±64322 \u2028 ±1270.156 Frustosamine (mmol/l) 1.49 \u2028 ±0.381.64 \u2028 ±0.242.39 \u2028 ±0.772.51 \u2028 ±0.68<0.001>0.9990.0090.0030.0600.017>0.999 tbars (umol/) 5.90 \u2028 ±0.835.10 \u2028 ±0.726.74 \u2028 ±0.756.91 \u2028 ±1.15<0.0010.1420.1440.034<0.001<0.0010.964 frap (umol/)165.3\u2028±28.2179.1\u2028±32.5225.0\u2028±47.5216.9\u2028±59.40.0050.869 0.0170.035 0.0570.1140.969urine alb/crea (mg/mmol) 41.8 \u2028 ±24.833.2 \u2028 ±20.857.6 \u2028 ±30.459.0 \u2028 ±48.90.157\nmrp – Maillard Reaction products; homa-ir – model assessment of Insulin resistance; Tag – Triacylglycerols; ast – aspartate transaminase; ages – advanced Glycation end Products; tbars – Thiobarbituric Acid Reactive Substances; frap – Ferric Reducing antioxidant power; alb/crea – albumine to creatinine ratio.']	N/A	N/A	[('CHEBI_30808', 'iron trichloride', 168, 'Fluid'), ('GO_0007631', 'feeding behavior', 174, 'consumption'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 190, 'rat'), ('UBERON_0000178', 'blood', 375, 'Blood'), ('UBERON_0000948', 'heart', 439, 'Heart'), ('CHEBI_16113', 'cholesterol', 726, 'Cholesterol'), ('CHEBI_17855', 'triglyceride', 792, 'TAG'), ('CHEBI_5178', 'Fruticosonine', 1029, 'Frustosamine'), ('CHEBI_6673', 'malvalic acid', 1417, 'Maillard'), ('GO_0008152', 'metabolic process', 1417, 'Maillard reaction'), ('PR_000045358', 'insulin family protein', 1475, 'insulin'), ('CHEBI_17855', 'triglyceride', 1495, 'TAG'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 1501, 'triacylglycerols'), ('GO_0007565', 'female pregnancy', 1565, 'glycation'), ('CHEBI_38873', 'prothiofos', 1579, 'products'), ('CHEBI_51172', 'decasilsesquioxane cage', 1597, 'thiobarbituric acid reactive substances'), ('CHEBI_73396', 'oxolane ring', 1645, 'ferric reducing')]
PMC4410178	4/2015	S78-PMC4410178	['Blood pressure and Heart rate\nBlood pressure did not differ significantly between the groups and Heart rate was slightly higher in Coca-Cola drinking groups (table 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 19, 'heart'), ('UBERON_0000178', 'blood', 30, 'Blood'), ('UBERON_0000948', 'heart', 97, 'heart'), ('CHEBI_15579', '(25S)-5beta-spirostan-3beta-yl beta-D-glucoside', 131, 'Coca-Cola')]
PMC4411147	4/2015	S6-PMC4411147	['Fetal development an median Uterine Artery Blood flow were assessed monthly from 36dpc until term using b-mode and doppler ultrasonography.']	N/A	N/A	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('UBERON_0002493', 'uterine artery', 28, 'uterine artery'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC4411147	4/2015	S66-PMC4411147	['briefly, in longitudinal color doppler section of the Artery, Blood-flow waveforms were measured at an interrogation angle between doppler ultrasound beam and flow direction from 45° to 60°, with the volume sample mark located in the middle of the Vessel.']	N/A	N/A	[('UBERON_0001637', 'artery', 54, 'artery'), ('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000055', 'vessel', 248, 'vessel')]
PMC4411147	4/2015	S69-PMC4411147	['total Blood flow volume (bfv) to the Pregnant Uterus was estimated following the equations presented by herzog et al .[4].']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('UBERON_0000995', 'uterus', 46, 'uterus')]
PMC4411147	4/2015	S73-PMC4411147	['the Pregnant Uterus from each heifer was collected and the Fetus excised, Blood sampled, measured (crl and bpd, as previously described; [7]) and weighed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'pregnant'), ('UBERON_0000995', 'uterus', 13, 'uterus'), ('UBERON_0000312', 'inner cambium layer of periosteum', 59, 'fetus'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC4411147	4/2015	S78-PMC4411147	['this was carried out using the Tail-Cuff system previously described and validated for calves [13] at 6, 8 and 10 months of age (200, 250 and 350d, respectively), using a non-invasive Blood pressure monitor (cardell veterinary monitor 9401bp, sharn veterinary).']	N/A	N/A	[('UBERON_0002415', 'tail', 31, 'tail'), ('UBERON_0003124', 'chorion', 36, 'cuff'), ('UBERON_0000178', 'blood', 184, 'blood')]
PMC4411147	4/2015	S95-PMC4411147	['moreover Heifers in the low periconception diet carrying male fetuses had an increased pi (p = 0.05) and a reduced bfv at 150dpc (p = 0.02), compared to those that received the high periconception diet.10.1371/journal.pone.0125694.g001\n\ncaption (fig): fig 1\nBlood flow volume according to sex and peri and preconception diet.']	N/A	N/A	[('NCBITaxon_7955', 'Danio rerio', 9, 'heifers'), ('UBERON_0000178', 'blood', 258, 'Blood')]
PMC4411147	4/2015	S96-PMC4411147	['mean (±sem) estimated Blood flow volume (cm3) in Heifers carrying male (m) or female (f) fetuses by treatment diet in a) experiment 1 (low 7%cp, m n = 20 and f n = 8; and high 14%cp,m n = 25 and f n = 11, from 60d prior to Conception to 23dpc) and in b) experiment 2 (low 10%cp, m n = 13 and f n = 3; and high 18%cp, m n = 7 and f n = 11 from -60d to Conception); ** denotes p≤0.01.10.1371/journal.pone.0125694.g002\n\ncaption (fig): fig 2\nmedian Uterine Artery diameter according to peri and preconception diet.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('NCBITaxon_7955', 'Danio rerio', 49, 'heifers'), ('GO_0007620', 'copulation', 223, 'conception'), ('GO_0007620', 'copulation', 351, 'conception'), ('UBERON_0000995', 'uterus', 445, 'Uterine'), ('UBERON_0001637', 'artery', 453, 'Artery')]
PMC4411147	4/2015	S110-PMC4411147	['in combination periconception low protein diet increased Blood flow to fetus over Gestation by reducing pi (resistance) and increasing tamv (velocity;fig 6).10.1371/journal.pone.0125694.g006\n\ncaption (fig): fig 6\nmean Blood flow volume change according to sex and periconception diet.']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0007565', 'female pregnancy', 82, 'gestation'), ('UBERON_0000178', 'blood', 218, 'Blood')]
PMC4411147	4/2015	S111-PMC4411147	['mean Blood flow volume change (bfv ∆) over time (as a ratio of the initial measure at 120dpc) of Heifers according to fetal sex and periconception diet (male: peri high *, n = 25, and peri low □, n = 20; female: peri high ●, n = 11, and peri low ■, n = 8).']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'Blood'), ('NCBITaxon_7955', 'Danio rerio', 97, 'heifers')]
PMC4411147	4/2015	S134-PMC4411147	['Blood pressure in progeny\nlow protein during the periconception period (7% cp) decreased systolic Blood pressure (p<0.05) in female progeny at six months of age with no effect at eight or ten months (fig 11).10.1371/journal.pone.0125694.g011\n\ncaption (fig): fig 11\nArterial Blood pressure according to periconception diet.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0001637', 'artery', 265, 'Arterial'), ('UBERON_0000178', 'blood', 274, 'Blood')]
PMC4411147	4/2015	S135-PMC4411147	['Arterial Blood pressure (mean ±sem) in male (left) and female (right) calves of Heifers Fed low (7% cp □; n = 28) or high (14% cp ●; n = 36) periconception diet from 60 days prior Conception to 23days post Conception in experiment 1.']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('UBERON_0000178', 'blood', 9, 'blood'), ('NCBITaxon_7955', 'Danio rerio', 80, 'heifers'), ('GO_0007631', 'feeding behavior', 88, 'fed'), ('GO_0007620', 'copulation', 180, 'conception'), ('GO_0007620', 'copulation', 206, 'conception')]
PMC4411147	4/2015	S157-PMC4411147	['in expt 1 (7% vs 14%cp) the male Feto-Placental Unit received greater Blood flow than the female at 120dpc, this being achieved by decreased resistance (pi), increased velocity (tamv) and increased diameter of the Mua.']	N/A	N/A	[('UBERON_0000981', 'femur', 33, 'feto'), ('UBERON_0013765', 'digestive system element', 38, 'placental unit'), ('UBERON_0000178', 'blood', 70, 'blood'), ('UBERON_2005032', 'optic vein', 214, 'MUA')]
PMC4411147	4/2015	S158-PMC4411147	['throughout Gestation the low protein in both the periconception and preconception diet enhanced Blood flow to the fetus by reducing resistance and increasing volume flow in the mua.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'gestation'), ('UBERON_0000178', 'blood', 96, 'blood')]
PMC4411147	4/2015	S190-PMC4411147	['conclusions\nprotein restriction during the peri-Conception period and first trimester altered Uterine Blood flow in primiparous Heifers.']	N/A	N/A	[('GO_0007620', 'copulation', 48, 'conception'), ('UBERON_0000995', 'uterus', 94, 'uterine'), ('UBERON_0000178', 'blood', 102, 'blood'), ('NCBITaxon_7955', 'Danio rerio', 128, 'heifers')]
PMC4416008	4/2015	S60-PMC4416008	['in both the Os and the Crt, maternal hb was evaluated at baseline from a Finger prick Blood sample, using a hemoglobinometer (hemocue ab, angelholm sweden) and a sample of Venous Blood was taken and centrifuged.']	N/A	N/A	[('UBERON_0008832', 'outer spiral sulcus', 12, 'OS'), ('UBERON_0000948', 'heart', 23, 'CRT'), ('UBERON_0002389', 'manual digit', 73, 'finger'), ('UBERON_0000178', 'blood', 86, 'blood'), ('UBERON_0001638', 'vein', 172, 'venous'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC4416008	4/2015	S64-PMC4416008	['infant hb was evaluated using a hemoglobinometer (hemocue ab, angelholm sweden) in the field from Heel prick sample of Blood.']	N/A	N/A	[('UBERON_0015875', 'heel', 98, 'heel'), ('UBERON_0000178', 'blood', 119, 'blood')]
PMC4419394	4/2015	S4-PMC4419394	['Igf1 methylation was measured in dna isolated from the Mononuclear fraction of Umbilical Cord Blood collected after Delivery.']	N/A	N/A	[('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 0, 'IGF1'), ('GO_0031097', 'medial cortex', 55, 'mononuclear'), ('UBERON_0002331', 'umbilical cord', 79, 'umbilical cord'), ('UBERON_0000178', 'blood', 94, 'blood'), ('GO_0007567', 'parturition', 116, 'delivery')]
PMC4419394	4/2015	S108-PMC4419394	['Umbilical Cord Blood samples were collected after Delivery into standard edta collection tubes.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('GO_0007567', 'parturition', 50, 'delivery')]
PMC4419394	4/2015	S112-PMC4419394	['dna was isolated from the Mononuclear fraction of Umbilical Cord Blood using the qiagen ez1 dna Tissue kit (qiagen, valencia, ca, usa) according to the method of lum et al.']	N/A	N/A	[('GO_0031097', 'medial cortex', 26, 'mononuclear'), ('UBERON_0002331', 'umbilical cord', 50, 'umbilical cord'), ('UBERON_0000178', 'blood', 65, 'blood'), ('UBERON_0000479', 'tissue', 96, 'tissue')]
PMC4425955	4/2015	S20-PMC4425955	['in Humans, Blood pressure is higher in men than in women (baylis et\xa0al.1988; august and oparil1999) and the incidence of hypertension is greater in men until women reach their seventh decade (wyndham et\xa0al.1987; joles et\xa0al.2010b), with men exhibiting a more rapid decline in Renal function than women (everitt et\xa0al.1983).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0002113', 'kidney', 276, 'renal')]
PMC4425955	4/2015	S46-PMC4425955	['systolic, diastolic Blood pressures, and Heart rate were collected over 24\xa0h periods, continuously for five consecutive days.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0000948', 'heart', 41, 'heart')]
PMC4425955	4/2015	S50-PMC4425955	['Blood was collected by Cardiac puncture into lithium-Heparin microtubes (sarstedt, leicester, uk), centrifuged at 830 g for 10\xa0min, and stored at −20°c prior to analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 23, 'cardiac'), ('CHEBI_28304', 'heparin', 53, 'heparin')]
PMC4425955	4/2015	S135-PMC4425955	['caption (fig): figure 4\n\nmean Arterial Blood pressure (map) and Heart rate (hr) in control (con) and low-protein (mlp) intact (Sham) and ovariectomized (ovx) offspring at 12\xa0months of age.']	N/A	N/A	[('UBERON_0001637', 'artery', 30, 'arterial'), ('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0000948', 'heart', 64, 'heart'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 127, 'SHAM')]
PMC4425955	4/2015	S208-PMC4425955	['mean Arterial Blood pressure was significantly lower in the intact control females in compare to mlp groups and ovariectomized females (fig.4).']	N/A	N/A	[('UBERON_0001637', 'artery', 5, 'arterial'), ('UBERON_0000178', 'blood', 14, 'blood')]
PMC4425955	4/2015	S211-PMC4425955	['Angiotensin Ii acting via Agtr2 can lower Blood pressure by acting directly on Vascular dilation or via activation of Protein Dephosphorylation, the No-Cgmp system and phospholipase a, which in turn mediates release of arachidonic Acid (gerritsen et\xa0al.2010).']	N/A	N/A	[('CHEBI_2718', 'angiotensin I', 0, 'Angiotensin II'), ('PR_000001180', 'opsin-5', 26, 'AGTR2'), ('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0000116', 'lung saccule', 79, 'vascular'), ('GO_0046777', 'protein autophosphorylation', 118, 'protein dephosphorylation'), ('CHEBI_16382', 'iodide', 149, 'NO'), ('CHEBI_17361', "cytidine 5'-monophosphate", 152, 'cGMP'), ('GO_0019401', 'alditol biosynthetic process', 231, 'acid')]
PMC4427001	4/2015	S57-PMC4427001	['Blood samples and 25-Hydroxyvitamin D measurement\nsamples of peripheral edta-Blood were taken from each participant between 24th and 30th weeks of Pregnancy during their scheduled visit in Prenatal centre by gynaecologist in non-gdm subjects or by diabetologist during their first visit of diabetes centre and repeatedly 6 weeks–12 months Postpartum ibid.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_27844', "2',3'-cyclic AMP", 18, '25-Hydroxyvitamin D'), ('UBERON_0000178', 'blood', 77, 'blood'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('GO_0007565', 'female pregnancy', 339, 'postpartum')]
PMC4427001	4/2015	S84-PMC4427001	["after Delivery, 30 of 47 (63.8%) women with gdm and 10 of 29 (34.5%) controls remained deficient ( p = 0.012, fischer's exact test), although majority of Blood samples Postpartum were taken in summer."]	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0007565', 'female pregnancy', 168, 'postpartum')]
PMC4430416	5/2015	S5-PMC4430416	['outcomes measures were body mass index, Abdominal circumference, sum of Skinfold thickness, and Blood pressure measurements at 4 years of age.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 40, 'abdominal'), ('UBERON_0009007', 'superficial inguinal lymph node', 72, 'skinfold'), ('UBERON_0000178', 'blood', 96, 'blood')]
PMC4430416	5/2015	S6-PMC4430416	['a subsample of 525 children provided non-fasting Blood samples for Lipid measurements.']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_18059', 'lipid', 67, 'lipid')]
PMC4430416	5/2015	S31-PMC4430416	['of 1363 singleton live births in the rhea study, 879 children participated at the 4 years follow up, during which anthropometry and non-fasting Blood samples were obtained from 785 children.']	N/A	N/A	[('UBERON_0000178', 'blood', 144, 'blood')]
PMC4430416	5/2015	S35-PMC4430416	['of them a subset of 348 women provided fasting Blood samples for Glucose and Lipid measurements, due to the timing of enrollment in the study.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_17234', 'glucose', 65, 'glucose'), ('CHEBI_18059', 'lipid', 77, 'lipid')]
PMC4430416	5/2015	S36-PMC4430416	['a subsample of 525 children provided non-fasting Blood samples at the 4 year follow up (mean: 4.2 years, sd: 0.2).']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood')]
PMC4430416	5/2015	S45-PMC4430416	['maternal hyperglycemia in early Pregnancy was defined as a maternal fasting Blood Glucose level ≥92 mg/dl [27].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('UBERON_0000178', 'blood', 76, 'blood'), ('CHEBI_17234', 'glucose', 82, 'glucose')]
PMC4430416	5/2015	S46-PMC4430416	['maternal Blood pressure in early Pregnancy\nsystolic (sbp) and diastolic (dbp) Blood pressure were measured at the ultrasound examination.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC4430416	5/2015	S47-PMC4430416	['measurements were taken by using an electronic Blood pressure monitor after 10 minutes of rest in a sitting position.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood')]
PMC4430416	5/2015	S59-PMC4430416	['child Blood pressure at 4 years of age\nat 4 years of age, trained research assistants measured systolic (sbp) and diastolic Blood pressure (dbp) after 5 minutes rest in the seated position, at the child right Arm with a cuff of appropriate size for Arm circumference using a dinamap pro care 400, which utilizes an oscillometric method.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000178', 'blood', 124, 'blood'), ('UBERON_0001460', 'arm', 209, 'arm'), ('UBERON_0001460', 'arm', 249, 'arm')]
PMC4430416	5/2015	S81-PMC4430416	['there were no significant differences in socio- demographic characteristics between women who provided fasting Blood samples and those who did not (s2 table).10.1371/journal.pone.0126327.t001\n\ncaption (table-wrap): table 1\nmother- child characteristics by pre-Pregnancy overweight/obesity status, rhea Pregnancy cohort, crete, greece.pre-Pregnancy obesity statusno excess weightoverweight/obese p - valuea(n = 409)(n = 209) maternal characteristics \xa0\xa0\xa0\xa0maternal age at Delivery (yr), mean (sd) 29.87 (0.2)29.98 (0.3)0.891\xa0\xa0\xa0\xa0education, n (%)<0.001\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 low 49 (12.0)54 (25.8)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 medium 208 (50.9)102 (48.8)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 high 152 (37.2)53 (25.4)greek origin, n (%) 384 (93.9)199 (95.2)0.499primiparous, n (%) 194 (47.4)70 (33.5)0.001smoking during Pregnancy, n (%) 126 (30.8)70 (33.5)0.497gestational diabetes, n (%) 32 (8.4)18 (9.2)0.758gestational hypertension, n (%) 15 (4.0)14 (7.1)0.106gestational weight gain (kg), n (%)<0.001\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 inadequate 114 (27.9)15 (7.2)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 adequate 155 (37.9)81 (38.8)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 excessive 140 (34.2)113 (54.1)\xa0\xa0\xa0\xa0caesarian section, n (%) 195 (48.0)115 (55.0)0.100 Metabolic profile in early Pregnancy (n = 348) Glucose (mg/dl), mean (sd) 74.93 (0.7)76.10 (1.2)0.341insulin (mg/dl), mean (sd) 9.33 (0.9)12.75 (1.5)<0.001tc (mg/dl), mean (sd) 195.49 (2.3)203.87 (3.7)0.025ldl-C (mg/dl), mean (sd) 113.87 (1.8)123.14 (3.0)0.008hdl-C (mg/dl), mean (sd) 60.18 (0.9)55.42 (1.3)0.007tg (mg/dl), mean (sd) 108.04 (2.8)126.23 (4.8)<0.001sbp (mmhg), mean (sd) 105.06 (0.5)109.92 (0.8)<0.001dbp (mmhg), mean (sd) 69.27 (0.5)71.31 (0.7)0.013 child characteristics in infancy \xa0\xa0\xa0\xa0sex, girl, n (%) 201 (49.1)93 (44.5)0.274\xa0\xa0\xa0\xa0Birth weight (kg), mean (sd) 3.20 (0.02)3.21 (0.03)0.887\xa0\xa0\xa0\xa0Gestational age (weeks), mean (sd) 38.32 (0.07)38.08 (0.11)0.123\xa0\xa0\xa0\xa0duration of breastfeeding (months), mean (sd) 4.69 (0.2)3.44 (0.3)<0.001\xa0\xa0\xa0\xa0day care attendance in the first 2 years of Life, n (%) 79 (19.5)36 (17.3)0.518 child characteristics at 4 years of age bmi (kg/m2), mean (sd) 16.11 (0.08)16.93 (0.15)<0.001overweight/obese, n (%) 74 (18.1)60 (28.7)0.002waist circumference (cm), mean (sd) 52.90 (0.2)54.66 (0.4)<0.001waist circumference ≥90th pct, n (%) 35 (8.7)37 (17.9)<0.001sum of Skinfolds (mm), mean (sd) 37.78 (0.7)43.29 (1.1)<0.001tc (mg/dl), mean (sd) 156.39 (1.5)158.97 (2.0)0.247Ldl-C (mg/dl), mean (sd) 69.98 (27.4)69.58 (26.7)0.856hdl-C (mg/dl), mean (sd) 47.17 (0.6)47.78 (0.8)0.518tg (mg/dl), mean (sd) 69.69 (1.5)70.40 (2.1)0.690time spent watching tv (hours/day), n (%) 0.019\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 almost never 124 (30.5)52 (25.0)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 1–2 hours/day 251 (61.8)126 (60.6)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 more than 3 hours/day 31 (7.6)30 (14.4)energy Intake (kcals/day), mean (sd) 1583.5 (23.0)1594.3 (32.1)0.752\nbmi, body mass index; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density\nLipoprotein Cholesterol; tg, Triglyceride; crp, C-Reactive Protein; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; pct, percentile\nap -values obtained by mann-whitney u test for two independent samples, and χ2test or fisher exact test with monte-carlo correction.']	N/A	N/A	[('UBERON_0000178', 'blood', 111, 'blood'), ('GO_0007565', 'female pregnancy', 260, 'pregnancy'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('GO_0007565', 'female pregnancy', 338, 'pregnancy'), ('GO_0007567', 'parturition', 469, 'delivery'), ('GO_0007565', 'female pregnancy', 750, 'pregnancy'), ('GO_0008152', 'metabolic process', 1103, 'Metabolic'), ('GO_0007565', 'female pregnancy', 1130, 'pregnancy'), ('CHEBI_17234', 'glucose', 1150, 'Glucose'), ('PR_000000037', 'BMP receptor type-2', 1312, '-C'), ('PR_000000037', 'BMP receptor type-2', 1366, '-C'), ('GO_0007567', 'parturition', 1651, 'Birth'), ('GO_0007565', 'female pregnancy', 1711, 'Gestational'), ('UBERON_0000104', 'life cycle', 1899, 'life'), ('UBERON_0009007', 'superficial inguinal lymph node', 2206, 'skinfolds'), ('PR_000010755', 'metaxin-1', 2308, '247LDL-C'), ('PR_000000037', 'BMP receptor type-2', 2368, '-C'), ('GO_0007631', 'feeding behavior', 2652, 'intake'), ('CHEBI_16113', 'cholesterol', 2746, 'Cholesterol'), ('PR_000009780', 'legumain', 2759, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 2778, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 2790, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 2803, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 2823, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 2835, 'Cholesterol'), ('CHEBI_17855', 'triglyceride', 2852, 'Triglyceride'), ('PR_000005890', 'crooked neck-like protein 1', 2871, 'C-reactive protein'), ('UBERON_0000178', 'blood', 2905, 'Blood'), ('UBERON_0000178', 'blood', 2936, 'Blood')]
PMC4430416	5/2015	S92-PMC4430416	['we found no association between pre-Pregnancy bmi and offspring non-fasting Lipid levels or Blood pressure percentiles at 4 years of age (table 2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('CHEBI_18059', 'lipid', 76, 'lipid'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC4430416	5/2015	S104-PMC4430416	['7.41)hdl-c(mg/dl)5250.59 (-1.38, 2.56)0.43 (-1.63, 2.49)0.59 (-1.54, 2.73) Blood pressure levelsβ-coef.']	N/A	N/A	[('UBERON_0000178', 'blood', 75, 'Blood')]
PMC4430416	5/2015	S107-PMC4430416	['(95%ci) sbp percentiles4880.26 (-0.17, 0.69)0.30 (-0.13, 0.75)0.21 (-0.24, 0.67)dbp percentiles488-0.07 (-0.49, 0.34)-0.11 (-0.53, 0.31)-0.10 (-0.54, 0.33)\nbmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; pct, percentile\nmodel 1: adjusted for child sex.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 213, 'Cholesterol'), ('PR_000009780', 'legumain', 226, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 245, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 257, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 270, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 290, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 302, 'Cholesterol'), ('UBERON_0000178', 'blood', 329, 'Blood'), ('UBERON_0000178', 'blood', 360, 'Blood')]
PMC4430416	5/2015	S108-PMC4430416	['(except models using offspring systolic and diastolic Blood pressure percentiles as an outcome)\nmodel 2: model 1 further adjusted for maternal age, education level, parity, smoking during Pregnancy\nmodel 3: model 2 additionally adjusted for Gestational weight gain, Birth weight, breastfeeding duration, and tv watching at 4\nyears of age (hours/day).']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'gestational'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC4430416	5/2015	S114-PMC4430416	['no association was found between maternal fasting Cholesterol levels and offspring Blood pressure percentiles at 4 years of age (table 3).']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 50, 'cholesterol'), ('UBERON_0000178', 'blood', 83, 'blood')]
PMC4430416	5/2015	S130-PMC4430416	['(95%ci) tc(mg/dl)294 4.14 (1.00, 7.28)3.43 (0.04, 6.83) 3.25 (-0.53, 7.04) 2.09 (0.56, 3.61)1.93 (0.28, 3.58) 1.90 (-0.04, 3.85)Hdl-C(mg/dl)294-0.18 (-1.47, 1.11)-0.59 (-2.06, 0.87)-1.04 (-2.74, 0.65)-0.35 (-0.95, 0.24)-0.56 (-1.24, 0.10)-0.71 (-1.49, 0.06) Blood pressure levelsβ-coef.']	N/A	N/A	[('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 128, 'HDL-C'), ('UBERON_0000178', 'blood', 258, 'Blood')]
PMC4430416	5/2015	S136-PMC4430416	['(95%ci) sbp percentiles284-0.05 (-0.35, 0.24)-0.07 (-0.40, 0.25)-0.06 (-0.42, 0.29)-0.04 (-0.19, 0.09)-0.05 (-0.22, 0.10)-0.06 (-0.24, 0.10)dbp percentiles284-0.19 (-0.50, 0.12)-0.19 (-0.52, 0.12)-0.15 (-0.51, 0.21)-0.08 (-0.23, 0.06)-0.09 (-0.24, 0.06)-0.09 (-0.27, 0.07)\nbmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; pct, percentile\nmodel 1: adjusted for child sex.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 330, 'Cholesterol'), ('PR_000009780', 'legumain', 343, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 362, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 374, 'Cholesterol'), ('PR_000001993', 'C-C motif chemokine 21', 374, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 387, 'HDL-C'), ('CHEBI_6453', 'Lichesterol', 407, 'Lipoprotein Cholesterol'), ('PR_000001993', 'C-C motif chemokine 21', 419, 'Cholesterol'), ('UBERON_0000178', 'blood', 446, 'Blood'), ('UBERON_0000178', 'blood', 477, 'Blood')]
PMC4430416	5/2015	S137-PMC4430416	['(except models using offspring systolic and diastolic Blood pressure percentiles as an outcome)\nmodel 2: model 1 further adjusted for maternal age, education level, parity, smoking during Pregnancy and pre-Pregnancy bmi\nmodel 3: model 2 additionally adjusted for Gestational weight gain, Birth weight, breastfeeding duration, and tv watching at 4 years of age (hours/day).']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy'), ('GO_0007565', 'female pregnancy', 263, 'gestational'), ('GO_0007567', 'parturition', 288, 'birth')]
PMC4430416	5/2015	S152-PMC4430416	['(95%ci) tc(mg/dl)458-0.33 (-2.50, 1.83)-0.81 (-3.05, 1.42)-0.97 (-3.22, 1.27)-0.85 (-3.50, 1.79)-1.03 (-3.70, 1.63)-1.12 (-3.86, 1.60)Hdl-C(mg/dl)4580.64 (-0.26, 1.54)0.80 (-0.16, 1.77)0.80 (-0.20, 1.80)-0.21 (-1.23, 0.80)0.04 (-1.00, 1.10)-0.02 (-1.11, 1.05) Blood pressure levelsβ-coeff.']	N/A	N/A	[('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 134, 'HDL-C'), ('UBERON_0000178', 'blood', 260, 'Blood')]
PMC4430416	5/2015	S158-PMC4430416	['(95%ci) sbp percentiles4220.05 (-0.12, 0.22)0.04 (-0.15, 0.23)0.08 (-0.10, 0.27)0.10 (-0.10, 0.31)0.08 (-0.13, 0.30)0.07 (-0.14, 0.29)dbp percentiles4220.00 (-0.18, 0.19)0.04 (-0.14, 0.24)0.02 (-0.16, 0.22)0.08 (-0.12, 0.29)0.06 (-0.14, 0.27)0.07 (-0.15, 0.29)\nbmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; pct, percentile\nmodel 1: adjusted for child sex.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 318, 'Cholesterol'), ('PR_000009780', 'legumain', 331, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 350, 'Lipoprotein'), ('PR_000009890', 'lysophosphatidylcholine acyltransferase 1', 350, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 362, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 375, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 395, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 407, 'Cholesterol'), ('UBERON_0000178', 'blood', 434, 'Blood'), ('UBERON_0000178', 'blood', 465, 'Blood')]
PMC4430416	5/2015	S159-PMC4430416	['(except models using offspring systolic and diastolic Blood pressure percentiles as an outcome)\nmodel 2: model 1 further adjusted for maternal age, education level, parity, smoking during Pregnancy and pre-Pregnancy bmi\nmodel 3: model 2 additionally adjusted for Gestational weight gain, Birth weight, breastfeeding duration, and tv watching at 4 years of age (hours/day).']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy'), ('GO_0007565', 'female pregnancy', 263, 'gestational'), ('GO_0007567', 'parturition', 288, 'birth')]
PMC4430416	5/2015	S220-PMC4430416	['caption (supplementary-material): s2 table\nmaternal and child characteristics of women who provided fasting Blood samples in early Pregnancy and those who did not, rhea pregnancy cohort crete, greece.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC4430416	5/2015	S224-PMC4430416	['bmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 57, 'Cholesterol'), ('PR_000009780', 'legumain', 70, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 89, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 101, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 114, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 134, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 146, 'Cholesterol'), ('UBERON_0000178', 'blood', 173, 'Blood'), ('UBERON_0000178', 'blood', 204, 'Blood')]
PMC4430416	5/2015	S225-PMC4430416	['all models were adjusted for child sex (except models using offspring systolic and diastolic Blood pressure percentiles as an outcome) maternal age, education level, parity, smoking during Pregnancy, Gestational weight gain, Birth weight, breastfeeding duration, tv watching at 4 years of age (hours/day) and paternal bmi.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('GO_0007565', 'female pregnancy', 200, 'gestational'), ('GO_0007567', 'parturition', 225, 'birth')]
PMC4430416	5/2015	S230-PMC4430416	['bmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure; model 1: adjusted for child sex.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 57, 'Cholesterol'), ('PR_000009780', 'legumain', 70, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 89, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 101, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 114, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 134, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 146, 'Cholesterol'), ('UBERON_0000178', 'blood', 173, 'Blood'), ('UBERON_0000178', 'blood', 204, 'Blood')]
PMC4430416	5/2015	S231-PMC4430416	['(except models using offspring systolic and diastolic Blood pressure percentiles as an outcome).']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood')]
PMC4430416	5/2015	S237-PMC4430416	['(except models using offspring systolic and diastolic Blood pressure percentiles as an outcome) model 2: model 1 further adjusted for maternal age, education level, parity, smoking during Pregnancy and pre-Pregnancy bmi.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy')]
PMC4430416	5/2015	S242-PMC4430416	['bmi, body mass index; wc, waist circumference; tc, total Cholesterol; Ldl-C, low density Lipoprotein Cholesterol; Hdl-C, high density Lipoprotein Cholesterol; sbp, systolic Blood pressure; dbp, diastolic Blood pressure;.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 57, 'Cholesterol'), ('PR_000009780', 'legumain', 70, 'LDL-C'), ('CHEBI_39015', 'apolipoprotein', 89, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 101, 'Cholesterol'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 114, 'HDL-C'), ('CHEBI_39015', 'apolipoprotein', 134, 'Lipoprotein'), ('CHEBI_16113', 'cholesterol', 146, 'Cholesterol'), ('UBERON_0000178', 'blood', 173, 'Blood'), ('UBERON_0000178', 'blood', 204, 'Blood')]
PMC4430416	5/2015	S243-PMC4430416	['model 1: adjusted for child sex (except models using offspring systolic and diastolic Blood pressure percentiles as an outcome).']	N/A	N/A	[('UBERON_0000178', 'blood', 86, 'blood')]
PMC4438573	5/2015	S38-PMC4438573	['Plasma sample collection and malaria detection\nBlood Plasma samples were collected from participants at study entry and at 36 gw.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 47, 'Blood'), ('UBERON_0001969', 'blood plasma', 53, 'plasma')]
PMC4438573	5/2015	S40-PMC4438573	['Parasitized Red Blood Cells (prbcs) were counted microscopically against 200 Leucocytes under 100 x magnification.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Parasitized'), ('CL_0000232', 'erythrocyte', 12, 'red blood cells'), ('UBERON_0000178', 'blood', 16, 'blood'), ('CL_0000738', 'leukocyte', 77, 'leucocytes')]
PMC4438573	5/2015	S42-PMC4438573	['briefly, Genomic dna was extracted from dried Blood spots using chelex®100 (bio-rad, ca, usa) and a quantitative real-time pcr assay was performed to amplify the p. falciparum Lactate dehydrogenase ( pfldh ) Gene.']	N/A	N/A	[('SO_0001026', 'genome', 9, 'genomic'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_24996', 'lactate', 176, 'lactate'), ('SO_0000704', 'gene', 208, 'gene')]
PMC4446740	4/2015	S94-PMC4446740	['no significant differences were found between child gender and bp measurements.nutrients-07-03078-t002_table 2\n\ncaption (table-wrap): table 2\n\ncharacteristics of children in the women and their children’s health study.child characteristicsmalesfemales p1birth gender [ n (%)]67 (51.9)62 (48.1)0.66gestational age (week)39.5 ± 1.3239.3 ± 2.10.45birthweight (g)3618.7 ± 552.73318.2 ± 591.20.003length (cm)51.9 ± 2.850.3 ± 4.00.01 3 monthsn 6460weight (kg)6.5 ± 0.85.7 ± 0.7<0.001length (cm)63.0 ± 2.560.6 ± 2.8<0.001bmi16.1 ± 1.515.2 ± 1.5<0.001bmi z -score−0.5 (−1.2, 0.2)−0.7 (−1.7, −0.1)0.26 n 2021systolic Blood pressure (mmhg)96.0 (82.5, 104.5)396.0 (86.0, 103.0)0.77diastolic Blood pressure (mmhg)60.0 (34.0, 66.5)55.0 (47.0, 59.0)0.68 6 monthsn 6153weight8.2 ± 1.17.3 ± 1.0<0.001length69.3 ± 2.966.4 ± 3.0<0.001bmi17.0 ± 1.416.5 ± 1.50.03bmi z -score−0.2 (−0.9, 0.4)−0.3 (−0.9, 0.3)0.72 n 3636systolic Blood pressure (mmhg)101.0 (96.0, 108.0)103.0 (95.5, 109.0)0.78diastolic Blood pressure (mmhg)57.0 (51.0, 65.5)52.5 (45.5, 62.0)0.30 9 monthsn 5456weight9.5 ± 1.48.5 ± 1.0<0.001length73.9 ± 2.971.3 ± 2.9<0.001bmi17.1 ± 1.716.6 ± 1.20.03bmi z -score−0.1 (−0.9, 0.8)−0.04 (−0.7, 0.5)0.76 n 4048systolic Blood pressure (mmhg)103.0 (98.0, 109.0)101.5 (93.5, 110.0)0.78diastolic Blood pressure (mmhg)55.5 (49.5, 62.0)56.5 (46.0, 61.5)0.54 12 monthsn 5755weight10.5 ± 1.39.3 ± 1.0<0.001length78.0 ± 3.375.1 ± 2.9<0.001bmi17.1 ± 1.416.4 ± 0.90.001bmi z -score0.1 (−0.5, 0.8)0.1 (−0.5, 0.5)0.24 n 3738systolic Blood pressure (mmhg)98.0 (94.0, 106.0)98.5 (94.0, 108.0)0.81diastolic Blood pressure (mmhg)58.0 (50.0, 66.0)56.0 (46.0, 62.0)0.59 24 monthsn 4744weight13.5 ± 1.612.6 ± 1.80.009length89.1 ± 4.986.7 ± 4.20.02bmi17.0 ± 1.316.7 ± 1.30.37bmi z -score1.0 (−0.1, 1.4)0.7 (0.06, 1.2)0.97 n 3532systolic Blood pressure (mmhg)100.0 (96.0, 105.5)98.0 (92.0, 104.0)0.13diastolic Blood pressure (mmhg)61.0 (56.0, 65.0)61.0 (58.0, 64.5)0.63 36 monthsn 4238weight15.4 ± 1.814.4 ± 2.80.06length97.4 ± 5.795.0 ± 7.30.11bmi16.1 ± 1.415.8 ± 1.50.34bmi z -score0.4 (−0.5, 1.3)0.2 (−0.3, 0.7)0.60 n 3633systolic Blood pressure (mmhg)103.0 (98.5, 111.0)104.0 (97.0, 113.0)0.87diastolic Blood pressure (mmhg)63.0 (59.5, 66.0)62.0 (58.0, 67.0)0.90 48 monthsn 4045weight17.7 ± 2.117.4 ± 3.00.61length105.3 ± 7.4103.6 ± 5.80.24bmi15.1 ± 1.316.1 ± 2.50.61bmi z -score0.4 (−0.2, 1.3)0.3 (−1.2, 0.8)0.69 n 2628systolic Blood pressure (mmhg)101.0 (95.0, 114.0)106.0 (94.0, 115.0)0.72diastolic Blood pressure (mmhg)65.0 (59.0, 66.0)65.0 (58.5, 67.5)0.89systolic Blood pressure up to 4 years (mmhg)101.5 (97.0, 106.3)101.6 (94.7, 106.3)0.78diastolic Blood pressure up to 4 years (mmhg)60.3 (55.3, 63.5)57.0 (50.3, 61.0)0.01\n1p values were derived by 2-sample t tests or the kruskal-wallis test;2mean ± sd (all such values);3median; 25th and 75th percentiles in parentheses (all such values).']	N/A	N/A	[('UBERON_0000178', 'blood', 608, 'blood'), ('UBERON_0000178', 'blood', 680, 'blood'), ('UBERON_0000178', 'blood', 907, 'blood'), ('UBERON_0000178', 'blood', 980, 'blood'), ('UBERON_0000178', 'blood', 1208, 'blood'), ('UBERON_0000178', 'blood', 1281, 'blood'), ('UBERON_0000178', 'blood', 1509, 'blood'), ('UBERON_0000178', 'blood', 1580, 'blood'), ('UBERON_0000178', 'blood', 1805, 'blood'), ('UBERON_0000178', 'blood', 1877, 'blood'), ('UBERON_0000178', 'blood', 2101, 'blood'), ('UBERON_0000178', 'blood', 2174, 'blood'), ('UBERON_0000178', 'blood', 2400, 'blood'), ('UBERON_0000178', 'blood', 2473, 'blood'), ('UBERON_0000178', 'blood', 2541, 'blood'), ('UBERON_0000178', 'blood', 2628, 'blood')]
PMC4446740	4/2015	S103-PMC4446740	['n -6: n -3, omega-6-to-omega-3.1all values are medians; 25th and 75th percentiles in parentheses.nutrients-07-03078-t004_table 4\n\ncaption (table-wrap): table 4\n\nmixed-model regression analysis of the associations between diet during Pregnancy and child systolic Blood pressure up to age 4 years.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 233, 'pregnancy'), ('UBERON_0000178', 'blood', 262, 'blood')]
PMC4446740	4/2015	S104-PMC4446740	['results presented for all dietary data ( n = 129)1.systolic Blood pressure (mmhg)crude modeladjusted model (a)adjusted model (b)maternal dietβ coefficient95% ci P2Β coefficient95% ci P2Β coefficient95% ci P2Protein (% e)−0.36−0.88, 0.160.17−0.39−0.90, 0.120.13−0.48−0.99, 0.030.07polyunsaturated fat (% e)0.69−0.02, 1.410.060.68−0.04, 1.400.060.730.003, 1.450.05omega-6 Fatty Acids (% e) 0.840.05, 1.640.040.860.06, 1.660.040.890.09, 1.690.03 fibre (g)0.09−0.06, 0.240.240.260.001, 0.530.050.270.002, 0.540.05p:c ratio−10.93−24.53, 2.670.12−12.23−25.70, 1.240.07 −14.14−27.68, −0.600.04energy adjusted values protein (g)−0.07−0.16, 0.020.13−0.08−0.16, 0.010.09−0.09−0.17, 0.0030.06polyunsaturated fat (g) 0.430.06, 0.800.020.420.05, 0.800.030.440.06, 0.810.02 Omega-6 Fatty Acids (g) 0.500.10, 0.900.020.500.09, 0.900.020.510.10, 0.920.01 fibre (g)0.20−0.07, 0.460.140.270.01, 0.530.050.270.01, 0.540.05\np:c, protein to Carbohydrate.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'Blood'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 161, 'P2β'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 183, 'P2β'), ('PR_000013043', 'POU domain, class 4, transcription factor 3', 205, 'P2Protein'), ('CHEBI_86010', 'EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitor', 367, '-6'), ('CHEBI_35366', 'fatty acid', 370, 'fatty acids'), ('CHEBI_80362', 'Sarafotoxin S6b', 760, 'Omega-6'), ('CHEBI_35366', 'fatty acid', 768, 'fatty acids'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 920, 'carbohydrate')]
PMC4446740	4/2015	S112-PMC4446740	['plotted onto arrays of maternal dietary Macronutrient composition points are fitted surfaces for the response variable (child mean systolic Blood pressure).']	N/A	N/A	[('CHEBI_33937', 'macronutrient', 40, 'macronutrient'), ('UBERON_0000178', 'blood', 140, 'blood')]
PMC4446740	4/2015	S113-PMC4446740	['the isolines for the child mean systolic Blood pressure rise in elevation from dark blue to dark red.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC4446764	5/2015	S33-PMC4446764	['maternal Cardiovascular capacity also changes dramatically during Pregnancy, with decreases in Systemic Arterial Blood pressure and vascular resistance and increases in Cardiac output, Heart rate, Heart stroke volume, and Blood volume [14].']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 9, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('UBERON_0004341', 'primitive streak', 95, 'systemic'), ('UBERON_0001793', 'nerve fiber layer of retina', 104, 'arterial blood'), ('UBERON_0000948', 'heart', 169, 'cardiac'), ('UBERON_0000948', 'heart', 185, 'heart'), ('UBERON_0000948', 'heart', 197, 'heart'), ('UBERON_0000178', 'blood', 222, 'blood')]
PMC4446764	5/2015	S93-PMC4446764	['additionally, Blood flow to the Small Intestine increases with Estradiol-17Β infusion [14].']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0002108', 'small intestine', 32, 'small intestine'), ('CHEBI_23965', 'estradiol', 63, 'estradiol'), ('CHEBI_76287', 'pentachloroethane', 73, '17β')]
PMC4446764	5/2015	S121-PMC4446764	['microscopically, livestock species have Epitheliochorial placentation, with six cellular layers separating maternal and fetal Blood.']	N/A	N/A	[('UBERON_0003230', 'epithelium of carpal region', 40, 'epitheliochorial'), ('UBERON_0000178', 'blood', 126, 'blood')]
PMC4446764	5/2015	S133-PMC4446764	[', a Blood flow related measure; [21]) that exist from mid- to late-Gestation [75].']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('GO_0007565', 'female pregnancy', 67, 'gestation')]
PMC4446764	5/2015	S138-PMC4446764	['when Placental growth is restricted in ewes, Umbilical and Uterine Blood flows are reduced, limiting fetal growth [79].']	N/A	N/A	[('UBERON_0001987', 'placenta', 5, 'placental'), ('UBERON_0007118', 'umbilicus', 45, 'umbilical'), ('UBERON_0000995', 'uterus', 59, 'uterine'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC4446764	5/2015	S142-PMC4446764	[', on day 50), Umbilical Blood flow of singleton fetuses was reduced compared to adequately Fed control Ewes [80].']	N/A	N/A	[('UBERON_0007118', 'umbilicus', 14, 'umbilical'), ('UBERON_0000178', 'blood', 24, 'blood'), ('GO_0007631', 'feeding behavior', 91, 'fed'), ('UBERON_0000970', 'eye', 103, 'ewes')]
PMC4446764	5/2015	S156-PMC4446764	['by using color doppler ultrasonography to assess Uterine Blood flow and vascular resistance throughout Gestation in Pregnant beef Cows, we were able to examine the same Animal continuously throughout Gestation with no surgical preparation and with minimal interference to dam.']	N/A	N/A	[('UBERON_0000995', 'uterus', 49, 'uterine'), ('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0007565', 'female pregnancy', 103, 'gestation'), ('GO_0007565', 'female pregnancy', 116, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 130, 'cows'), ('NCBITaxon_33208', 'Metazoa', 169, 'animal'), ('GO_0007565', 'female pregnancy', 200, 'gestation')]
PMC4446764	5/2015	S158-PMC4446764	['[88] measured Uterine Blood flow in Cows during the Estrous Cycle.']	N/A	N/A	[('UBERON_0000995', 'uterus', 14, 'uterine'), ('UBERON_0000178', 'blood', 22, 'blood'), ('NCBITaxon_33208', 'Metazoa', 36, 'cows'), ('GO_0044849', 'estrous cycle', 52, 'estrous cycle')]
PMC4446764	5/2015	S162-PMC4446764	[', day 30–270) resistance index decreased and Uterine Blood flow increased exponentially with increased Blood flow in ipsilateral vs. contralateral Horns [89,93].']	N/A	N/A	[('UBERON_0000995', 'uterus', 45, 'uterine'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0006967', 'horn', 147, 'horns')]
PMC4446764	5/2015	S192-PMC4446764	['on day 130 of Gestation, ewes were anesthetized and concurrent Blood samples were collected from a catheterized maternal Saphenous Artery and the gravid Uterine Vein.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestation'), ('UBERON_0000178', 'blood', 63, 'blood'), ('UBERON_0005628', 'ileal artery', 121, 'saphenous artery'), ('UBERON_0001214', 'pancreatic tributary of splenic vein', 153, 'uterine vein')]
PMC4446764	5/2015	S193-PMC4446764	['immediately following this collection, the Gravid Uterine Horn was dissected and concurrent Blood samples were collected from the Umbilical Vein and Umbilical Artery.']	N/A	N/A	[('UBERON_0005395', 'cortical layer VI', 43, 'gravid'), ('UBERON_0009885', 'interlobar artery', 50, 'uterine horn'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0002066', 'umbilical vein', 130, 'umbilical vein'), ('UBERON_0001310', 'umbilical artery', 149, 'umbilical artery')]
PMC4446764	5/2015	S194-PMC4446764	['this concurrent Blood sampling procedure was used to calculate gravid Uterine flux of Nutrients, which is equal to Uterine Blood flow multiplied by the maternal Arterial-Venous concentration difference (maternal Saphenous Artery–gravid Uterine Vein) of any given substance.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0000995', 'uterus', 70, 'uterine'), ('CHEBI_33284', 'nutrient', 86, 'nutrients'), ('UBERON_0000995', 'uterus', 115, 'uterine'), ('UBERON_0000178', 'blood', 123, 'blood'), ('UBERON_0001637', 'artery', 161, 'arterial'), ('UBERON_0001638', 'vein', 170, 'venous'), ('UBERON_0005628', 'ileal artery', 212, 'saphenous artery'), ('UBERON_0001214', 'pancreatic tributary of splenic vein', 236, 'uterine vein')]
PMC4446764	5/2015	S195-PMC4446764	['fetal flux of Nutrients was calculated by taking Umbilical Blood flow multiplied by the fetal Venous-Arterial concentration difference (Umbilical Vein-Umbilical Artery) of any given substance [111].']	N/A	N/A	[('CHEBI_33284', 'nutrient', 14, 'nutrients'), ('UBERON_0007118', 'umbilicus', 49, 'umbilical'), ('UBERON_0000178', 'blood', 59, 'blood'), ('UBERON_0001638', 'vein', 94, 'venous'), ('UBERON_0001637', 'artery', 101, 'arterial'), ('UBERON_0002066', 'umbilical vein', 136, 'umbilical vein'), ('UBERON_0001310', 'umbilical artery', 151, 'umbilical artery')]
PMC4446764	5/2015	S196-PMC4446764	['in this experimental model, we observed a decrease in both Umbilical Artery and Uterine Artery Blood flow (table 5).']	N/A	N/A	[('UBERON_0001310', 'umbilical artery', 59, 'umbilical artery'), ('UBERON_0002493', 'uterine artery', 80, 'uterine artery'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC4448820	5/2015	S348-PMC4448820	['Hypomethylation Of Hepatic Dna occurs in response to Vitamin A treatment in Rats (204), and hypermethylation of long Interspersed Element (line) 1 is found in peripheral Blood White Cells of Vitamin A–deficient children (205).']	N/A	N/A	[('GO_0033526', 'tetrapyrrole biosynthetic process from glutamate', 0, 'Hypomethylation of ... DNA'), ('UBERON_0002107', 'liver', 19, 'hepatic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 76, 'rats'), ('SO_0002006', 'zinc_repressed_element', 117, 'interspersed element'), ('CL_0000081', 'blood cell', 170, 'blood white cells'), ('UBERON_0000178', 'blood', 170, 'blood'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 199, 'A')]
PMC4448820	5/2015	S933-PMC4448820	['loss of Enterocytes results in declining Circulations of citrulline in the Blood and is shown in cytotoxic treatment–induced mucositis (40).']	N/A	N/A	[('CL_0000584', 'enterocyte', 8, 'enterocytes'), ('UBERON_0002595', 'orbital sulcus', 41, 'circulations'), ('UBERON_0000178', 'blood', 75, 'blood')]
PMC4448820	5/2015	S1302-PMC4448820	['caption (table-wrap): table 11\n\nsummary of commonly used biomarkers of inflammation1biomarker of inflammationnormal rangesettings where usedclinical vs. population useuse in resource-limited settingscommentswbc4–11,000/μlacute inflammation (usually infection)clinicalyvaries by agecrp0.001–10 mg/lacute, subclinical, chronicclinical, populationyagp0.6–1.0 g/lsubclinicalpopulationyesr0–30 mm/hacute, subclinical, chronicclinicalyincreases with age and higher in femalesalbumin30–50 g/lacute inflammation (usually infection)clinicalndecreased during Pregnancypct≤0.5 μg/lacute inflammation (usually infection)clinicalnil-6—chronicpopulationnuse in Agingtnf-Αr1—chronicpopulationnuse in Aging\nagp, Α1-Acid Glycoprotein; crp, C-Reactive Protein; esr, Erythrocyte sedimentation rate; n, no; pct, procalcitonin; Tnf-Αr1, Tnf-Α Receptor 1; wbc, White Blood Cell; y, yes.']	N/A	N/A	[('GO_0007605', 'sensory perception of sound', 549, 'pregnancyPCT'), ('GO_0006914', 'autophagy', 647, 'agingTNF'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 655, '-αR1'), ('GO_0007568', 'aging', 685, 'aging'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 696, 'α1-acid glycoprotein'), ('CHEBI_37527', 'acid', 699, 'acid'), ('CHEBI_17089', 'glycoprotein', 704, 'glycoprotein'), ('PR_000005890', 'crooked neck-like protein 1', 723, 'C-reactive protein'), ('CL_0000232', 'erythrocyte', 748, 'erythrocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 807, 'TNF-αR1'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 816, 'TNF-α receptor 1'), ('CL_0000738', 'leukocyte', 839, 'white blood cell'), ('UBERON_0000178', 'blood', 845, 'blood')]
PMC4452737	6/2015	S3-PMC4452737	['methods\nin this observational study, fasting Glucose, Sorbitol and Fructose concentrations were measured using gas-chromatography-liquid mass spectroscopy in Cerebrospinal Fluid (Csf), maternal Plasma, and Venous Cord Blood collected from 25 Pregnant women (6 lean, 10 overweight/obese, and 9 t2dm/Gestational dm) undergoing Spinal anesthesia and elective cesarean section.']	N/A	N/A	[('CHEBI_17234', 'glucose', 45, 'glucose'), ('CHEBI_30911', 'glucitol', 54, 'sorbitol'), ('CHEBI_28757', 'fructose', 67, 'fructose'), ('UBERON_0001359', 'cerebrospinal fluid', 158, 'cerebrospinal fluid'), ('UBERON_0001359', 'cerebrospinal fluid', 179, 'CSF'), ('UBERON_0001969', 'blood plasma', 194, 'plasma'), ('UBERON_0005487', 'vitelline vein', 206, 'venous cord'), ('UBERON_0000178', 'blood', 218, 'blood'), ('GO_0007565', 'female pregnancy', 242, 'pregnant'), ('GO_0007565', 'female pregnancy', 298, 'gestational'), ('UBERON_0001130', 'vertebral column', 325, 'spinal')]
PMC4452737	6/2015	S7-PMC4452737	['Cord Blood Sorbitol was also ~7-fold higher than maternal Plasma Sorbitol levels (p = 0.001).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_30911', 'glucitol', 11, 'sorbitol'), ('UBERON_0001969', 'blood plasma', 58, 'plasma'), ('CHEBI_30911', 'glucitol', 65, 'sorbitol')]
PMC4452737	6/2015	S8-PMC4452737	['there were no differences in Plasma, Csf, and Cord Blood Glucose, Fructose, or Sorbitol levels between groups.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 29, 'plasma'), ('UBERON_0001359', 'cerebrospinal fluid', 37, 'CSF'), ('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_17234', 'glucose', 57, 'glucose'), ('CHEBI_28757', 'fructose', 66, 'fructose'), ('CHEBI_30911', 'glucitol', 79, 'sorbitol')]
PMC4452737	6/2015	S34-PMC4452737	['maternal Blood was collected at the time of iv insertion.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC4452737	6/2015	S36-PMC4452737	['Csf cell counts were obtained to ensure absence of contamination from Blood.']	N/A	N/A	[('CL_0000051', 'common lymphoid progenitor', 0, 'CSF'), ('UBERON_0000178', 'blood', 70, 'blood')]
PMC4452737	6/2015	S38-PMC4452737	['following infant Delivery a sterile segment of Umbilical Cord was doubly clamped and Cord Venous Blood was drawn prior to Delivery of the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 17, 'delivery'), ('UBERON_0002331', 'umbilical cord', 47, 'umbilical cord'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0001638', 'vein', 90, 'venous'), ('UBERON_0000178', 'blood', 97, 'blood'), ('GO_0007567', 'parturition', 122, 'delivery'), ('UBERON_0001987', 'placenta', 138, 'placenta')]
PMC4459664	4/2015	S79-PMC4459664	['two main levels of care were defined: basic emergency obstetric care (bemoc) and comprehensive emergency obstetric care (cemoc), with bemoc facilities providing basic obstetric services and cemoc facilities providing basic obstetric services as well as c-sections and Blood transfusions.']	N/A	N/A	[('UBERON_0000178', 'blood', 268, 'blood')]
PMC4459664	4/2015	S193-PMC4459664	['the availability of comprehensive emergency obstetric care services at health facilities, including c-section and Blood transfusion, improved care seeking from formal providers.']	N/A	N/A	[('UBERON_0000178', 'blood', 114, 'blood')]
PMC4462496	8/2013	S3-PMC4462496	['the children underwent physical examination; weight, height, waist circumference, Blood pressure (bp) were measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 82, 'blood')]
PMC4462496	8/2013	S44-PMC4462496	['the children were measured: weight, height, waist circumference (wc) and Blood pressure (bp).']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood')]
PMC4463828	5/2015	S35-PMC4463828	['Trunk Blood was collected in heparinized tubes and stored on ice until centrifugation and removal of Plasma for analysis.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 101, 'plasma')]
PMC4466139	6/2015	S4-PMC4466139	["maternal Blood samples after Delivery and newborns' Blood Spots were analyzed for 25Ohd levels in 533 pairs."]	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 29, 'delivery'), ('UBERON_0001969', 'blood plasma', 52, 'blood spots'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 82, '25OHD')]
PMC4466139	6/2015	S42-PMC4466139	['Blood samples were collected post-Partum during routine analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 34, 'partum')]
PMC4477503	6/2015	S116-PMC4477503	['three informants described with the term tetrah a form of suppurative mastitis with presence of Blood in milk.']	N/A	N/A	[('UBERON_0000178', 'blood', 96, 'blood')]
PMC4477503	6/2015	S246-PMC4477503	['Camels are by far the main source of veterinary Remedies: Milk and Milk cream are used to treat skin diseases such as mange; Camel Blood is put in Eye Drops to treat inflammations; cooked Camel skin to treat gingivitis; the Placenta is drenched to calves with diarrhoea.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Camels'), ('CHEBI_26536', 'retinoic acid', 48, 'remedies'), ('UBERON_0001913', 'milk', 58, 'milk'), ('UBERON_0001913', 'milk', 67, 'milk'), ('NCBITaxon_33208', 'Metazoa', 125, 'camel'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0000970', 'eye', 147, 'eye'), ('CHEBI_38682', 'bromoform', 151, 'drops'), ('NCBITaxon_33208', 'Metazoa', 188, 'camel'), ('UBERON_0001987', 'placenta', 224, 'placenta')]
PMC4477503	6/2015	S251-PMC4477503	[')drytopicaludder infectionsmastitiscamphortopicalmangedonkey Bones ( equus asinus l.)burnt, grinded and dissolved in wateroral buguashish donkey Faeces ( equus asinus l.)grinded and dissolved in Wateroraldiarrhoeaexhaust engine oilcoat is cuttopicalmangetick infestationsfermented Milk (Camel/goat)topicalskin conditionsfood crustcollected from the bottom of the pot after cooking and then grindedtopicalwoundshematite/red ochre [iron(Iii) Oxide Fe2O3]grinded and dissolved in Water or oiltopicalhematomasheadstrokebroken ribsabscesseshyena Feces and/or Blood ( hyaena hyaena l.)Oral aulisis Insecticide spraytopicalticksfleasmilk cream (Camel/goat milk)coat is cuttopicalmangedermatomycosiseye dropskin necrosis ( shdan )Eye inflammation Larvar rock saltgrinded and heated in fattopicalcamelpoxgrinded and dissolved in Waterwoundsdietary supplementsoapdissolved in Water and oil, the floating fat is then collectedtopicalmangefleasspiny-tailed lizard ( uromastix acanthinura bell.']	N/A	N/A	[('UBERON_0001474', 'bone element', 61, 'bones'), ('UBERON_0001988', 'feces', 145, 'faeces'), ('CHEBI_51023', '1,5-dihydro-4H-imidazol-4-one', 195, 'waterOralDiarrhoeaExhaust'), ('UBERON_0001913', 'milk', 281, 'milk'), ('NCBITaxon_33208', 'Metazoa', 287, 'camel'), ('CHEBI_44423', 'hydroxyurea', 435, 'III) oxide'), ('CHEBI_30808', 'iron trichloride', 446, 'Fe2O3'), ('CHEBI_15377', 'water', 477, 'water'), ('NCBITaxon_10088', 'Mus <genus>', 541, 'feces'), ('UBERON_0001988', 'feces', 541, 'feces'), ('UBERON_0000178', 'blood', 554, 'blood'), ('UBERON_0000978', 'leg', 579, 'Oral'), ('CHEBI_29608', 'isoformononetin', 592, 'Insecticide'), ('NCBITaxon_33208', 'Metazoa', 638, 'camel'), ('UBERON_0000970', 'eye', 722, 'Eye'), ('NCBITaxon_10088', 'Mus <genus>', 739, 'Larvar'), ('UBERON_0002548', 'larva', 739, 'Larvar'), ('CHEBI_33303', 'chalcogen', 820, 'waterWoundsDietary'), ('CHEBI_15377', 'water', 866, 'water')]
PMC4488056	7/2015	S19-PMC4488056	['these premature deaths and diseases are largely preventable by the implementation of effective interventions that address reductions in risk factors (tobacco, excessive alcohol use, poor diet, physical inactivity, high Blood pressure) and enable Health Systems to effectively respond [1].']	N/A	N/A	[('UBERON_0000178', 'blood', 219, 'blood'), ('UBERON_0002423', 'hepatobiliary system', 246, 'health systems')]
PMC4490503	6/2015	S185-PMC4490503	['they reported no significant heterogeneity between studies in regards to timing of Blood collection, assay method, or diagnostic criteria for gdm [94].']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood')]
PMC4490503	6/2015	S226-PMC4490503	['Retinol-Binding Protein-4 (Rbp-4)\nRetinol-Binding Protein-4 (Rbp-4) is a Blood carrier protein for Retinol synthesized in Hepatocytes and Adipocytes [97].']	N/A	N/A	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('PR_000013890', 'arginine-glutamic acid dipeptide repeats protein', 0, 'Retinol-Binding Protein-4'), ('PR_000013829', 'calcipressin-1', 27, 'RBP-4'), ('CHEBI_27810', 'resorcinol', 34, 'Retinol'), ('PR_000013799', 'RNA-binding protein 41', 34, 'Retinol-binding protein-4'), ('PR_000013829', 'calcipressin-1', 61, 'RBP-4'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_26536', 'retinoic acid', 99, 'retinol'), ('CL_0000182', 'hepatocyte', 122, 'hepatocytes'), ('CL_0000136', 'fat cell', 138, 'adipocytes')]
PMC4490503	6/2015	S326-PMC4490503	['[137] performed a prospective study of 150 women looking at maternal Lipids including Serum tg, Cholesterol, free Fatty Acids (ffa), Glycerol, Insulin and Glucose in maternal Serum and Cord Blood during the third trimester.']	N/A	N/A	[('CHEBI_18059', 'lipid', 69, 'lipids'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_16113', 'cholesterol', 96, 'cholesterol'), ('CHEBI_35366', 'fatty acid', 114, 'fatty acids'), ('CHEBI_17754', 'glycerol', 133, 'glycerol'), ('PR_000045358', 'insulin family protein', 143, 'insulin'), ('CHEBI_17234', 'glucose', 155, 'glucose'), ('UBERON_0001977', 'blood serum', 175, 'serum'), ('UBERON_0002240', 'spinal cord', 185, 'cord'), ('UBERON_0000178', 'blood', 190, 'blood')]
PMC4492644	6/2015	S1-PMC4492644	['Metabolic syndrome is characterized by the presence of a variety of Metabolic disturbances including obesity, hyperlipidemia, hypertension, and elevated fasting Blood Sugar.']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolic'), ('GO_0008152', 'metabolic process', 68, 'metabolic'), ('UBERON_0000178', 'blood', 161, 'blood'), ('CHEBI_24870', 'ion', 167, 'sugar')]
PMC4492644	6/2015	S31-PMC4492644	['high Blood pressure and other Metabolic perturbations were observed in all offspring Born to Nutrient restricted mothers compared to offspring of mothers who were not Nutrient restricted.']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0008152', 'metabolic process', 30, 'metabolic'), ('GO_0007567', 'parturition', 85, 'born'), ('CHEBI_33284', 'nutrient', 93, 'nutrient'), ('CHEBI_33284', 'nutrient', 167, 'nutrient')]
PMC4492644	6/2015	S53-PMC4492644	['elevated maternal Blood Glucose triggers the Production Of Reactive Oxygen Species.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_17234', 'glucose', 24, 'glucose'), ('GO_1903409', 'reactive oxygen species biosynthetic process', 45, 'production of reactive oxygen species'), ('CHEBI_26523', 'reactive oxygen species', 59, 'reactive oxygen species')]
PMC4494359	11/2013	S176-PMC4494359	['veterinary practitioners have used Blood transfusions and surgical ligation with variable success.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4499946	7/2015	S67-PMC4499946	['the informed consent process is undertaken in conjunction with the iterative eligibility assessment: preliminary screening (based on age, location of residence, plans to remain in referral area), detailed medical screening by a study physician, poc testing (Blood pressure, Urine dip, hb), and obstetric ultrasound.']	N/A	N/A	[('UBERON_0000178', 'blood', 258, 'blood'), ('UBERON_0001088', 'urine', 274, 'urine')]
PMC4499946	7/2015	S71-PMC4499946	['two additional consent procedures are undertaken at a later time for supplemental study procedures: (1) husbands of enrolled participants are approached to obtain consent for paternal anthropometry and Blood specimen collection, and (2) enrolled participants are approached at or beyond 30 weeks of Gestation to request the participation of their infant in an ari substudy during the 0- to 6-month Postnatal period (detailed methods of the ari substudy will be presented elsewhere).']	N/A	N/A	[('UBERON_0000178', 'blood', 202, 'blood'), ('GO_0007565', 'female pregnancy', 299, 'gestation'), ('GO_0007567', 'parturition', 398, 'postnatal')]
PMC4499946	7/2015	S147-PMC4499946	['poc tests include Blood pressure measurement, Urine dipstick testing, and Hb concentration estimation.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001088', 'urine', 46, 'urine'), ('PR_000008609', 'hexokinase-2', 74, 'Hb')]
PMC4499946	7/2015	S148-PMC4499946	['maternal systolic and diastolic Blood pressure is measured using an automated digital Blood pressure monitor (watchbp home; microlife usa, clearwater, fl, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC4499946	7/2015	S152-PMC4499946	['maternal hb will be measured at enrollment (as part of the eligibility screening process) in a finger-stick Blood sample using a handheld hemoglobinometer (hb 201; hemocue, ängelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood')]
PMC4499946	7/2015	S173-PMC4499946	['specimen collection\n\nBlood specimen collection\ntrained phlebotomists collect maternal Blood, paternal Blood, Cord Venous and Arterial Blood, and infant Blood specimens according to standard sampling procedures (table\xa03).']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'Blood'), ('UBERON_0000178', 'blood', 86, 'blood'), ('UBERON_0000178', 'blood', 102, 'blood'), ('UBERON_0002240', 'spinal cord', 109, 'cord'), ('UBERON_0001638', 'vein', 114, 'venous'), ('UBERON_0001637', 'artery', 125, 'arterial'), ('UBERON_0000178', 'blood', 134, 'blood'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC4499946	7/2015	S174-PMC4499946	['following filling, bd vacutainer Serum (red top) and Ethylenediaminetetraacetic Acid (edta) (lavender or blue top) Blood collection tubes (bd diagnostics, franklin lakes, nj, usa) are inverted according to the manufacturer’s instructions and centrifuged immediately (edta) or after 30 minutes (Serum) at low speed for 15 minutes, and the supernatant (Plasma or Serum) is transferred via micropipettes in 0.25-ml aliquots into prelabeled microfuge tubes (fisherbrand free-standing microcentrifuge tubes with screw caps; thermo fisher scientific, waltham, ma, usa).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 53, 'ethylenediaminetetraacetic acid'), ('UBERON_0000178', 'blood', 115, 'blood'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('UBERON_0001969', 'blood plasma', 351, 'plasma'), ('UBERON_0001977', 'blood serum', 361, 'serum')]
PMC4499946	7/2015	S175-PMC4499946	['whole Blood aliquots (1.5 or 0.5 ml, depending on size of Blood draw and laboratory requirements) are drawn from edta tubes immediately after mixing (before centrifugation) for paternal Blood, maternal Blood at Delivery, and Cord Venous Blood specimens.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0000178', 'blood', 186, 'blood'), ('UBERON_0000178', 'blood', 202, 'blood'), ('GO_0007567', 'parturition', 211, 'delivery'), ('UBERON_0002240', 'spinal cord', 225, 'cord'), ('UBERON_0001638', 'vein', 230, 'venous'), ('UBERON_0000178', 'blood', 237, 'blood')]
PMC4499946	7/2015	S176-PMC4499946	['within 30 minutes of Blood collection, Serum and Plasma aliquots are placed in a portable ultracold freezer (shuttle ult-25n; stirling ultracold, athens, oh, usa) and maintained at less than −70 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001977', 'blood serum', 39, 'serum'), ('UBERON_0001969', 'blood plasma', 49, 'plasma')]
PMC4499946	7/2015	S178-PMC4499946	['one Serum aliquot from each maternal and infant 3- and 6-month Blood specimen is reserved at 2–8 °c for same- or next-day Serum calcium measurement.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('UBERON_0000178', 'blood', 63, 'blood'), ('UBERON_0001977', 'blood serum', 122, 'serum')]
PMC4499946	7/2015	S180-PMC4499946	['as soon as possible within 30 minutes of Delivery Of the Placenta, a site on the Umbilical Cord attached to the Placenta is cleansed using dry cotton gauze to wipe away any maternal Blood.']	N/A	N/A	[('GO_0008218', 'bioluminescence', 41, 'delivery of'), ('GO_0007565', 'female pregnancy', 57, 'placenta'), ('UBERON_0001987', 'placenta', 57, 'placenta'), ('UBERON_0002331', 'umbilical cord', 81, 'umbilical cord'), ('UBERON_0001987', 'placenta', 112, 'placenta'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC4499946	7/2015	S181-PMC4499946	['the Umbilical Vein is cannulated, and Blood is collected into collection tubes in the following order: (1) Serum (red top) tube, (2) edta (lavender top) tube, and (3) trace element (blue top) tube with edta.']	N/A	N/A	[('UBERON_0002066', 'umbilical vein', 4, 'umbilical vein'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0001977', 'blood serum', 107, 'serum')]
PMC4499946	7/2015	S182-PMC4499946	['any remaining extractable Blood is collected in edta (lavender top) tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood')]
PMC4499946	7/2015	S183-PMC4499946	['attempts are made to collect a total of 20–40 ml of Cord Blood.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 52, 'cord'), ('UBERON_0000178', 'blood', 57, 'blood')]
PMC4499946	7/2015	S185-PMC4499946	['Placental weight and specimen collection\nafter collection of Cord Blood, the Umbilical Cord and Membranes are removed from the Placenta; the Blood is drained; and the Placenta is weighed to the nearest 0.5 g (ibalance i2500; my weigh canada, vancouver, bc, canada).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0002240', 'spinal cord', 61, 'cord'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord'), ('UBERON_0000922', 'embryo', 96, 'membranes'), ('UBERON_0001987', 'placenta', 127, 'placenta'), ('UBERON_0000178', 'blood', 141, 'blood'), ('UBERON_0001987', 'placenta', 167, 'placenta')]
PMC4499946	7/2015	S204-PMC4499946	['for epigenetic studies, dna and mrna will be extracted from Blood and Placental specimens using techniques previously described [53].']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0001987', 'placenta', 70, 'placental')]
PMC4499946	7/2015	S206-PMC4499946	['where possible, paternal whole Blood specimens will be collected to enable the identification of Allele-specific patterns.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('SO_0001023', 'allele', 97, 'allele')]
PMC4499946	7/2015	S280-PMC4499946	['when caregivers permit scheduled infant Blood sampling, Serum calcium will be routinely measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC4509429	7/2015	S40-PMC4509429	['there were no significant differences in the primary endpoint, which included fasting, pre- and postprandial, and mean Blood Glucose levels as well as a1c.']	N/A	N/A	[('UBERON_0000178', 'blood', 119, 'blood'), ('CHEBI_17234', 'glucose', 125, 'glucose')]
PMC4509429	7/2015	S139-PMC4509429	['patients met target Blood Glucose goals for gdm, and there were no cases of eclampsia.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_17234', 'glucose', 26, 'glucose')]
PMC4509429	7/2015	S191-PMC4509429	['Postpartum management\nfor women with Gestational diabetes, Blood Glucose levels can be variable for both mother and infant in the immediate Postpartum period.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('GO_0007565', 'female pregnancy', 37, 'gestational'), ('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_17234', 'glucose', 65, 'glucose'), ('GO_0007565', 'female pregnancy', 140, 'postpartum')]
PMC4509429	7/2015	S225-PMC4509429	['but it is all she can do to test her Blood Sugars several times each day.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('CHEBI_26822', 'sulfide', 43, 'sugars')]
PMC4512131	8/2015	S83-PMC4512131	['wbc, White Blood Cell.']	N/A	N/A	[('CL_0000738', 'leukocyte', 5, 'white blood cell'), ('UBERON_0000178', 'blood', 11, 'blood')]
PMC4514967	12/2014	S28-PMC4514967	["by age 2, Blood Flow and Metabolism in the Brain reach Adult levels, while at the end of the first decade of Life Glucose Metabolism and Blood flow are almost twice Adult levels (at a time that the child's Brain-to-body-weight ratio remains several fold higher than in Adults)."]	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('GO_0007601', 'visual perception', 16, 'flow'), ('GO_0008152', 'metabolic process', 25, 'metabolism'), ('UBERON_0000955', 'brain', 43, 'brain'), ('UBERON_0007023', 'adult organism', 55, 'adult'), ('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_17234', 'glucose', 114, 'glucose'), ('GO_0006006', 'glucose metabolic process', 114, 'glucose metabolism'), ('UBERON_0000178', 'blood', 137, 'blood'), ('UBERON_0007023', 'adult organism', 165, 'adult'), ('UBERON_0000955', 'brain', 206, 'brain'), ('UBERON_0007023', 'adult organism', 269, 'adults')]
PMC4514967	12/2014	S29-PMC4514967	['Blood Flow and Metabolism finally achieve Adult levels during the third decade.']	N/A	N/A	[('GO_0001967', 'suckling behavior', 0, 'Blood flow'), ('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0008152', 'metabolic process', 15, 'metabolism'), ('UBERON_0007023', 'adult organism', 42, 'adult')]
PMC4516109	5/2015	S35-PMC4516109	['its concentration in the Umbilical Cord is about 4-7% of the concentration detected in the maternal Blood.1certolizumab Pegol is a humanized anti-Tnf Antibody fab fragment with high affinity to Tnf,conjugated with 2 Polyethylene Glycol Molecules.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 25, 'umbilical cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_63618', 'pravastatin', 120, 'pegol'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 146, 'TNF'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibody'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 194, 'TNF'), ('CHEBI_46793', 'poly(ethylene glycol)', 216, 'polyethylene glycol'), ('CHEBI_36357', 'polyatomic entity', 236, 'molecules')]
PMC4516109	5/2015	S61-PMC4516109	["Drug concentration was determined in maternal Blood, Cord Blood, Breast Milk and the Infant's Blood."]	N/A	N/A	[('CHEBI_23888', 'drug', 0, 'Drug'), ('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 65, 'breast milk'), ('UBERON_0000003', 'naris', 85, 'infant'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC4528901	9/2014	S19-PMC4528901	['Blood pressure, temperature, and Heart rate were 105/55 mm hg, 100.7°f, and 124 beats/min, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 33, 'heart')]
PMC4528901	9/2014	S24-PMC4528901	['laboratory data revealed a White Blood Cell count of 2040/cm3(absolute Neutrophil count 1410/cm3), hemoglobin 8.1 g/dl, hematocrit 24.9%, and Platelet count 145 000/cm3.']	N/A	N/A	[('CL_0000738', 'leukocyte', 27, 'white blood cell'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CL_0000775', 'neutrophil', 71, 'neutrophil'), ('CL_0000233', 'platelet', 142, 'platelet')]
PMC4528901	9/2014	S27-PMC4528901	['the Blood Urea Nitrogen was <3 mg/dl and creatinine 0.5 g/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_33268', 'monoatomic nitrogen', 10, 'urea nitrogen')]
PMC4528901	9/2014	S35-PMC4528901	['further laboratory evaluation revealed no Acetaminophen in the Blood.']	N/A	N/A	[('CHEBI_15343', 'acetaldehyde', 42, 'acetaminophen'), ('UBERON_0000178', 'blood', 63, 'blood')]
PMC4528901	9/2014	S87-PMC4528901	['abbreviations: inr, international normalized ratio; Aflp, acute fatty Liver of Pregnancy; hellp, Hemolysis, elevated Liver enzymes, and low Platelets; iv, Intravenous; bp, Blood pressure; Nac, N -Acetylcysteine.']	N/A	N/A	[('SO_0001830', 'AFLP_fragment', 52, 'AFLP'), ('UBERON_0002107', 'liver', 70, 'liver'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0030097', 'hemopoiesis', 97, 'hemolysis'), ('UBERON_0002107', 'liver', 117, 'liver'), ('CL_0000233', 'platelet', 140, 'platelets'), ('UBERON_0034986', 'sacral nerve plexus', 155, 'intravenous'), ('UBERON_0000178', 'blood', 172, 'blood'), ('CHEBI_7421', 'NAC', 188, 'NAC'), ('CHEBI_70981', '6-formylpterin', 193, 'N -acetylcysteine')]
PMC4532364	8/2015	S125-PMC4532364	['further, the trial was conducted in a population with very low dietary intakes of N-3 Fatty Acids including preformed Dha (55 mg/d)[32] and the offspring exposed in utero to Dha had higher Cord Blood levels compared to the placebo group [31].']	N/A	N/A	[('CHEBI_35418', 'N-acetylneuraminate', 82, 'n-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 118, 'DHA'), ('CHEBI_17874', 'dihydrozeatin', 174, 'DHA'), ('UBERON_0002240', 'spinal cord', 189, 'cord'), ('UBERON_0000178', 'blood', 194, 'blood')]
PMC4534102	8/2015	S32-PMC4534102	['the following search string was employed—“dermatoglyphics” [mesh] or “Palmar Prints” [all fields] and (“hypertension” [mesh] or “Blood pressure” [all fields]).']	N/A	N/A	[('UBERON_0008878', 'palmar part of manus', 70, 'Palmar prints'), ('UBERON_0000178', 'blood', 129, 'Blood')]
PMC4534102	8/2015	S34-PMC4534102	['mesh terms “hypertension” included entry terms: Blood pressure, high/Blood pressures, high/high Blood pressure/high Blood pressures, under its mesh tree.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'Blood'), ('UBERON_0000178', 'blood', 69, 'Blood'), ('UBERON_0000178', 'blood', 96, 'Blood'), ('UBERON_0000178', 'blood', 116, 'Blood')]
PMC4534102	8/2015	S71-PMC4534102	['significantly larger atd angle on Left Hand of femalescontrolnrnr20nrhealthy People.no family history of high Blood pressurebulagouda et al.']	N/A	N/A	[('UBERON_0004548', 'left eye', 34, 'left hand'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'people'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC4534102	8/2015	S86-PMC4534102	['[26]west bengal indiacasesnrmore than 20\xa0years of age131nrdiagnosed as hypertensive and family history of hypertensionqualitative traitsin hypertensives (both sexes): double loop and arch more and Whorl, Ulnar Loop and Radial Loop are less.quantitative traitscontrolnrmore than 20\xa0years of age145nrnormal Blood pressure (not diagnosed as hypertensives) and absence of family history of hypertensionin hypertensives (both sexes): average ridge counts per Finger were high.']	N/A	N/A	[('UBERON_0001091', 'calcareous tooth', 197, 'whorl'), ('UBERON_0001705', 'nail', 204, 'ulnar loop'), ('UBERON_2000171', 'interhyal bone', 219, 'radial loop'), ('UBERON_0000178', 'blood', 305, 'blood'), ('UBERON_0002389', 'manual digit', 454, 'finger')]
PMC4534102	8/2015	S95-PMC4534102	['the last of the 3 readings of systolic and diastolic Blood pressure was used in the analysisno significant differencescomparison groupnrage matched128sex matched to casesage, sex, and school matched comparison groupgodfrey et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood')]
PMC4534102	8/2015	S100-PMC4534102	['mean sbp rose by 0.49\xa0mmhg for each degree decrease in Palmar angle on the right Hand [32]\nm male, f female, nr not reported, arc absolute ridge count, trc total ridge count, bp Blood pressure, sbp systolic Blood pressure, dbp diastolic Blood pressure, arc absolute ridge counts\n\ncharacteristics of the studied populations\nout of 17 studies, eight were conducted in india [16–19,21–23,26], two in the uk [30,31], two in the usa [28,29], two in nigeria [20,27], one in czech republic [24], one in turkey [25], and one in iran [15].']	N/A	N/A	[('UBERON_0006849', 'scapula', 55, 'palmar'), ('UBERON_0002398', 'manus', 81, 'hand'), ('UBERON_0000178', 'blood', 178, 'blood'), ('UBERON_0000178', 'blood', 207, 'blood'), ('UBERON_0000178', 'blood', 237, 'blood')]
PMC4539876	7/2015	S112-PMC4539876	['iqs were lower for those exposed to Valproate compared to Carbamazepine, ltg, and Phenytoin, after controlling for maternal iqs and Blood levels of Anticonvulsant Medications.']	N/A	N/A	[('CHEBI_30846', '3-furoic acid', 36, 'valproate'), ('CHEBI_3387', 'carbamazepine', 58, 'carbamazepine'), ('CHEBI_8107', 'phenytoin', 82, 'phenytoin'), ('UBERON_0000178', 'blood', 132, 'blood'), ('CHEBI_35624', 'azaspiro compound', 148, 'anticonvulsant'), ('CHEBI_25441', 'mycothiols', 163, 'medications')]
PMC4539881	7/2015	S24-PMC4539881	['Glomerular filtration rate and Renal Blood flow are increased.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 0, 'Glomerular'), ('UBERON_0002113', 'kidney', 31, 'renal'), ('UBERON_0000178', 'blood', 37, 'blood')]
PMC4539881	7/2015	S26-PMC4539881	['vulnerability factors for the fetus include small total Plasma volume, decreased albumin with increased levels of free Drugs, decreased Hepatic enzyme formation, decreased gfr, and immature Blood-Brain Barrier.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 56, 'plasma'), ('CHEBI_23888', 'drug', 119, 'drugs'), ('UBERON_0002107', 'liver', 136, 'hepatic'), ('UBERON_0000178', 'blood', 190, 'blood-'), ('UBERON_0000052', 'fornix of brain', 196, 'brain barrier')]
PMC4539881	7/2015	S294-PMC4539881	['Plasma, Cord Blood, and Urine samples were measured in 26 Deliveries and Breast Milk samples in one patient.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0002240', 'spinal cord', 8, 'cord'), ('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0001088', 'urine', 24, 'urine'), ('GO_0007567', 'parturition', 58, 'deliveries'), ('UBERON_0000310', 'breast', 73, 'breast'), ('UBERON_0001913', 'milk', 80, 'milk')]
PMC4545890	8/2015	S21-PMC4545890	['height, weight, and fasting Bloods were taken at 28 weeks of Pregnancy (+/-5 days).']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'bloods'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC4547703	8/2015	S3-PMC4547703	['maternal Blood Lipids were detected close to Delivery Of Fetus in sptd group and in ftd group with Gestational age-matched.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_18059', 'lipid', 15, 'lipids'), ('GO_0009605', 'response to external stimulus', 45, 'delivery of fetus'), ('GO_0007565', 'female pregnancy', 99, 'gestational')]
PMC4547703	8/2015	S4-PMC4547703	['Cord Blood Lipids were detected after Delivery in two groups.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_18059', 'lipid', 11, 'lipids'), ('GO_0007567', 'parturition', 38, 'delivery')]
PMC4547703	8/2015	S5-PMC4547703	['three genotypes both in maternal and Cord Blood were determined by real time pcr.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 37, 'cord'), ('UBERON_0000178', 'blood', 42, 'blood')]
PMC4547703	8/2015	S39-PMC4547703	['detection of Blood Lipids\nin sptd subjects, 3.5 ml of Venous Blood were collected close to Delivery Of Fetus, while in the ftd subjects, the same volume of Venous Blood were collected between 28+0and 36+6gestational week matched with sptd subjects.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_18059', 'lipid', 19, 'lipids'), ('UBERON_0001638', 'vein', 54, 'venous'), ('UBERON_0000178', 'blood', 61, 'blood'), ('GO_0009605', 'response to external stimulus', 91, 'delivery of fetus'), ('UBERON_0001638', 'vein', 156, 'venous'), ('UBERON_0000178', 'blood', 163, 'blood')]
PMC4547703	8/2015	S40-PMC4547703	['three and one-half milliliter of Umbilical Arterial Blood in two groups were collected after Delivery.']	N/A	N/A	[('UBERON_0007118', 'umbilicus', 33, 'umbilical'), ('UBERON_0001637', 'artery', 43, 'arterial'), ('UBERON_0000178', 'blood', 52, 'blood'), ('GO_0007567', 'parturition', 93, 'delivery')]
PMC4547703	8/2015	S41-PMC4547703	['Blood samples were sent to the clinical laboratory center in beijing friendship hospital.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4547703	8/2015	S43-PMC4547703	['detection of Gene polymorphisms in the maternal Blood and Umbilical Cord Blood\nthe Blood Cells from maternal Venous Blood and Umbilical Arterial Blood were separated by centrifugation at 3,000 rpm for 20 min.']	N/A	N/A	[('SO_0000704', 'gene', 13, 'gene'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0002331', 'umbilical cord', 58, 'umbilical cord'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CL_0000081', 'blood cell', 83, 'blood cells'), ('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0001638', 'vein', 109, 'venous'), ('UBERON_0000178', 'blood', 116, 'blood'), ('UBERON_0007118', 'umbilicus', 126, 'umbilical'), ('UBERON_0001637', 'artery', 136, 'arterial'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC4547703	8/2015	S55-PMC4547703	['the comparison of Blood Lipids with different genotypes was carried out with analysis of variance (anova).']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_18059', 'lipid', 24, 'lipids')]
PMC4547703	8/2015	S66-PMC4547703	['the level of tg in the Cord Blood was not significantly different between the two groups (fig 1).10.1371/journal.pone.0135785.g001\n\ncaption (fig): fig 1\nthe level of maternal Blood and Umbilical Blood Lipids in preterm and full-term groups.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_0000178', 'blood', 175, 'blood'), ('UBERON_0007118', 'umbilicus', 185, 'umbilical'), ('UBERON_0000178', 'blood', 195, 'blood'), ('CHEBI_18059', 'lipid', 201, 'lipids')]
PMC4547703	8/2015	S67-PMC4547703	['the genotypes of Abca1 , Apoe , and Hmgcr Genes and Allele frequency distribution in maternal and Cord Blood\nhmgcr Gene rs12916 locus has three genotypes: cc, ct, and tt.']	N/A	N/A	[('PR_000003555', 'ATP-binding cassette sub-family C member 10', 17, 'ABCA1'), ('PR_000004155', 'apolipoprotein E', 25, 'APOE'), ('PR_000008629', 'high mobility group protein HMGI-C', 36, 'HMGCR'), ('SO_0000704', 'gene', 42, 'genes'), ('SO_0001023', 'allele', 52, 'allele'), ('UBERON_0002240', 'spinal cord', 98, 'cord'), ('UBERON_0000178', 'blood', 103, 'blood'), ('SO_0000704', 'gene', 115, 'gene')]
PMC4547703	8/2015	S69-PMC4547703	['moreover, there were no significant differences in the three Genes genotypes and Allele frequency distribution in the Cord Blood Cells between the sptd and ftd groups ( p>0.05) (table 3).10.1371/journal.pone.0135785.t003\n\ncaption (table-Wrap): table 3\nAbca1 , apoe and hmgcr Genes polymorphism and variant in maternal Blood and Umbilical Cord Blood in full-term and ptbs groups.']	N/A	N/A	[('SO_0000704', 'gene', 61, 'genes'), ('SO_0001023', 'allele', 81, 'allele'), ('CL_0000162', 'parietal cell', 118, 'cord blood cells'), ('UBERON_0002240', 'spinal cord', 118, 'cord'), ('UBERON_0000178', 'blood', 123, 'blood'), ('PR_000017453', 'protein Wnt-9b', 237, 'WRAP'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 252, 'ABCA1'), ('SO_0000704', 'gene', 275, 'genes'), ('UBERON_0000178', 'blood', 318, 'blood'), ('UBERON_0002331', 'umbilical cord', 328, 'umbilical cord'), ('UBERON_0000178', 'blood', 343, 'blood')]
PMC4547703	8/2015	S76-PMC4547703	['the Lipid levels in the subjects were not associated with different genotypes of the Hmgcr Gene rs12916 loci in the Cord Blood.']	N/A	N/A	[('CHEBI_18059', 'lipid', 4, 'lipid'), ('PR_000008629', 'high mobility group protein HMGI-C', 85, 'HMGCR'), ('SO_0000704', 'gene', 91, 'gene'), ('UBERON_0002240', 'spinal cord', 116, 'cord'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC4547703	8/2015	S77-PMC4547703	['moreover, the Lipid levels were not associated with different genotypes of Abca1 Gene rs2422493 and Apoe Genes rs7412 determined from the maternal and Cord Blood of all subjects (tables4and5).10.1371/journal.pone.0135785.t004\n\ncaption (table-wrap): table 4\nthe level of maternal Blood Lipids in different Snps of Abca1 rs2422493, Apoe rs7412 and hmgcr rs12916(x¯\u2009±\u2009s, mmol/l).Lipids Abca1 rs2422493 genotypes Apoe rs7412 genotypes hmgcr rs12916 genotypespreterm groupcc (n = 34)ct (n = 71)tt (n = 55)cc (n = 129)ct (n = 27)tt (n = 1)cc (n = 37)ct (n = 66)tt (n = 57)tcho6.20±1.505.97±1.136.40±1.426.15±1.306.22±1.405.296.12±1.326.01±1.256.37±1.41Tg3.06±1.242.93±1.113.29±1.253.02±1.123.29±1.384.42.95±0.93*2.80±0.91*3.44±1.46*Hdl1.69±0.341.78±0.371.82±0.461.74±0.411.89±0.371.271.83±0.411.74±0.421.77±0.38Ldl3.47±0.843.38±0.703.64±0.893.49±0.803.50±0.762.973.37±0.75*3.41±0.79*3.71±0.79*full-term goupcc(n = 36)ct(n = 61)tt(n = 50)cc(n = 124)ct(n = 22)tt(n = 1)cc(n = 23)ct(n = 72)tt(n = 52)tcho6.42±1.036.28±1.256.58±1.146.41±1.136.39±1.405.696.05±0.996.41±1.186.56±1.21Tg3.31±1.523.26±1.103.51±1.183.31±1.183.57±1.293.83.05±0.973.48±1.353.31±1.18hdl1.90±0.391.86±0.341.92±0.401.85±0.372.04±0.361.861.85±0.381.87±0.371.93±0.38Ldl3.65±0.683.59±0.803.78±0.743.66±0.733.69±0.873.083.45±0.663.66±0.773.78±0.76\n* p<0.0510.1371/journal.pone.0135785.t005\n\ncaption (table-wrap): table 5\nthe level of Umbilical Cord Blood Lipids in different Snps of Abca1 rs2422493, Apoe rs7412 and Hmgcr rs12916(x¯\u2009±\u2009s, mmol/l).']	N/A	N/A	[('CHEBI_18059', 'lipid', 14, 'lipid'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 75, 'ABCA1'), ('SO_0000704', 'gene', 81, 'gene'), ('PR_000004155', 'apolipoprotein E', 100, 'APOE'), ('SO_0000704', 'gene', 105, 'genes'), ('UBERON_0002240', 'spinal cord', 151, 'cord'), ('UBERON_0000178', 'blood', 156, 'blood'), ('UBERON_0000178', 'blood', 279, 'blood'), ('CHEBI_18059', 'lipid', 285, 'lipids'), ('SO_0000694', 'SNP', 305, 'SNPs'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 313, 'ABCA1'), ('PR_000004155', 'apolipoprotein E', 330, 'APOE'), ('CHEBI_18059', 'lipid', 376, 'Lipids'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 383, 'ABCA1'), ('PR_000004155', 'apolipoprotein E', 409, 'APOE'), ('PR_000017550', '14-3-3 protein gamma', 644, '41TG3'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 726, 'HDL1'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 803, '38LDL3'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 1069, '21TG3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 1225, '38LDL3'), ('UBERON_0002331', 'umbilical cord', 1393, 'umbilical cord'), ('UBERON_0000178', 'blood', 1408, 'blood'), ('CHEBI_18059', 'lipid', 1414, 'lipids'), ('SO_0000694', 'SNP', 1434, 'SNPs'), ('PR_000003555', 'ATP-binding cassette sub-family C member 10', 1442, 'ABCA1'), ('PR_000004155', 'apolipoprotein E', 1459, 'APOE'), ('PR_000008629', 'high mobility group protein HMGI-C', 1475, 'HMGCR')]
PMC4547703	8/2015	S79-PMC4547703	['women had lower concentrations of tcho, tg, hdl and ldl in maternal Blood in sptd group than in ftd group with Gestational age-matched, while had higher concentrations of tcho, hdl and ldl in Cord Blood in sptd group than in ftd group.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007565', 'female pregnancy', 111, 'gestational'), ('UBERON_0002240', 'spinal cord', 192, 'cord'), ('UBERON_0000178', 'blood', 197, 'blood')]
PMC4553961	3/2015	S3-PMC4553961	['maternal peripheral systolic Blood pressure (sbp) and diastolic Blood pressure (dbp) were taken from the Brachial Arm, and central sbp and pulse pressures (pps) were derived from Radial Artery pressure waveforms between the 26th and the 28th week of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0001868', 'skin of chest', 105, 'brachial arm'), ('UBERON_0001404', 'radial artery', 179, 'radial artery'), ('GO_0007565', 'female pregnancy', 250, 'gestation')]
PMC4553961	3/2015	S21-PMC4553961	['women with incomplete information on Plasma pc pufas (n\u200a=\u200a166) or Blood pressures (n\u200a=\u200a245) were excluded, leaving a final sample of 751 (64.6% of the cohort) women for analysis.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 37, 'plasma'), ('UBERON_0000178', 'blood', 66, 'blood')]
PMC4553961	3/2015	S23-PMC4553961	['Blood pressure measurements\nmaternal Blood pressures and Heart rates were taken by trained research coordinators based on a standardized protocol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0000948', 'heart', 57, 'heart')]
PMC4553961	3/2015	S24-PMC4553961	['peripheral systolic Blood pressure (sbp) and diastolic Blood pressure (dbp) were measured thrice from the Brachial Arm at 30 to 60-second intervals with an oscillometric device mc3100 (healthstats international pte ltd, singapore).']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0001868', 'skin of chest', 106, 'brachial arm')]
PMC4553961	3/2015	S32-PMC4553961	['Plasma Phosphatidylcholine Fatty Acid composition\nfasting Blood samples were taken between the 26th and the 28th week of Gestation.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_15759', '2,3-epoxyphylloquinone', 7, 'Phosphatidylcholine'), ('CHEBI_35366', 'fatty acid', 27, 'Fatty Acid'), ('UBERON_0000178', 'blood', 58, 'blood'), ('GO_0007565', 'female pregnancy', 121, 'gestation')]
PMC4553961	3/2015	S49-PMC4553961	['we also repeated our analysis for the continuous measures of Blood pressure outcomes in a subgroup of 383 women who did not use Fish Oil supplements.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_34766', 'Furamizole', 128, 'fish oil')]
PMC4553961	3/2015	S65-PMC4553961	['caption (table-wrap): table 3\n\nmultivariate-adjusted association between maternal Plasma pc n-3 Pufas and Blood pressures at the 26th to the 28th week of Gestation\n\ncaption (fig): figure 1\n\nmultivariate-adjusted association between maternal Plasma pc N-3 Pufas (tertiles) and Blood pressures at the 26th to the 28th week of Gestation.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 82, 'Plasma'), ('CHEBI_86926', 'S a S b S', 96, 'PUFAs'), ('UBERON_0000178', 'blood', 106, 'Blood'), ('GO_0006266', 'DNA ligation', 154, 'Gestation'), ('UBERON_0001969', 'blood plasma', 241, 'plasma'), ('31', 'ACACA (human)', 251, 'n'), ('CHEBI_86926', 'S a S b S', 255, 'PUFAs'), ('UBERON_0000178', 'blood', 276, 'blood'), ('GO_0007565', 'female pregnancy', 324, 'gestation')]
PMC4553961	3/2015	S66-PMC4553961	['dbp = diastolic Blood pressure, pc = Phosphatidylcholine, pp = pulse pressure, Pufa = polyunsaturated Fatty Acid, sbp = systolic Blood pressure.∗p for trend\u200a≤\u200a0.05;∗∗p for trend <\u200a0.001.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_36710', 'interferon inducer', 37, 'phosphatidylcholine'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 79, 'PUFA'), ('CHEBI_35366', 'fatty acid', 102, 'fatty acid'), ('UBERON_0000178', 'blood', 129, 'blood')]
PMC4553961	3/2015	S69-PMC4553961	['caption (table-wrap): table 4\n\nmultivariate-adjusted association between maternal Plasma pc n-6 Pufas and Blood pressures at the 26th to the 28th week of Gestation\n\ncaption (fig): figure 2\n\nmultivariate-adjusted association between maternal Plasma pc N-6 Pufas (tertiles) and Blood pressures at the 26th to the 28th week of Gestation.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 82, 'Plasma'), ('CHEBI_86926', 'S a S b S', 96, 'PUFAs'), ('UBERON_0000178', 'blood', 106, 'Blood'), ('GO_0006266', 'DNA ligation', 154, 'Gestation'), ('UBERON_0001969', 'blood plasma', 241, 'plasma'), ('31', 'ACACA (human)', 251, 'n'), ('CHEBI_86926', 'S a S b S', 255, 'PUFAs'), ('UBERON_0000178', 'blood', 276, 'blood'), ('GO_0007565', 'female pregnancy', 324, 'gestation')]
PMC4553961	3/2015	S70-PMC4553961	['dbp = diastolic Blood pressure, pc = Phosphatidylcholine, pp = pulse pressure, Pufa = polyunsaturated Fatty Acid, sbp = systolic Blood pressure.∗p for trend\u200a≤\u200a0.05.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_36710', 'interferon inducer', 37, 'phosphatidylcholine'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 79, 'PUFA'), ('CHEBI_35366', 'fatty acid', 102, 'fatty acid'), ('UBERON_0000178', 'blood', 129, 'blood')]
PMC4553961	3/2015	S91-PMC4553961	['second, the Blood pressure measurements were performed by trained research personnel, following a standard protocol.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC4553961	3/2015	S95-PMC4553961	['we were also unable to examine maternal Blood pressure changes during Pregnancy as they were measured only between the 26th and the 28th week of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 145, 'gestation')]
PMC4569192	9/2015	S4-PMC4569192	['at Delivery Cord Blood c-peptide and leptin were measured.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood')]
PMC4569192	9/2015	S11-PMC4569192	['additionally female fetuses had higher concentrations of both Cord Blood leptin and c-peptide at Birth when compared to male offspring (b = 0.38, p<0.001 and b = 0.31, p = 0.03 respectively).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4569192	9/2015	S47-PMC4569192	['Cord Blood concentrations of fetal leptin and c-peptide were also measured.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC4569192	9/2015	S51-PMC4569192	['fetal Insulin resistance was assessed by Cord Blood C-Peptide estimation.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 6, 'insulin'), ('UBERON_0002240', 'spinal cord', 41, 'cord'), ('UBERON_0000178', 'blood', 46, 'blood'), ('PR_000005890', 'crooked neck-like protein 1', 52, 'C-peptide')]
PMC4569192	9/2015	S52-PMC4569192	['Cord Blood Haemolysis occurred in approximately 17% of samples prohibiting analysis of leptin and c-peptide in these cases.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0030097', 'hemopoiesis', 11, 'haemolysis')]
PMC4569192	9/2015	S71-PMC4569192	['in Cord Blood at Delivery c-peptide results were obtained in 82.5% of the cohort (n = 480, 254 male and 226 female) and leptin in 80.9% (n = 471, 248 male and 223 female).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 3, 'cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('GO_0007567', 'parturition', 17, 'delivery')]
PMC4569192	9/2015	S77-PMC4569192	['additionally female fetuses had higher concentrations of both Cord Blood leptin and Cord Blood c-peptide when compared to male offspring (b = 0.38, p<0.001 and b = 0.31, p = 0.03 respectively).table 3.10.1371/journal.pone.0137215.t001\n\ncaption (table-wrap): table 1\nbaseline characteristics.baseline characteristicoverallfemale fetusmale fetusp-valuebmi (kg/m2)26.78 (4.9)26.35 (4.6)27.17 (5.1)0.05early Pregnancy Glucose (mmol\\l)4.41 (0.3)4.37 (0.3)4.44 (0.3)0.06smoking (n)3114170.7gestation at Delivery (days)281.53 (9.7)281.62 (8.6)281.43 (10.6)0.7\ndata presented as mean and standard deviations or n. bmi is body mass index as calculated at first Antenatal consultation.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('UBERON_0002240', 'spinal cord', 84, 'cord'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0007565', 'female pregnancy', 404, 'pregnancy'), ('CHEBI_17234', 'glucose', 414, 'glucose'), ('GO_0007567', 'parturition', 497, 'delivery'), ('GO_0007567', 'parturition', 652, 'antenatal')]
PMC4569192	9/2015	S80-PMC4569192	['* a p-value of less than 0.05 considered statistically significant.10.1371/journal.pone.0137215.t003\n\ncaption (table-Wrap): table 3\na comparison of maternal and fetal Insulin resistance and leptin between female and male offspring.femalemalecrude p-valuebetaadjusted p-value95% ci for betamean ± sdmedianmean ± sdmedianearly Pregnancy homa1.66±1.141.142.34±3.01.690.002-0.190.011*-0.34,-0.05early Pregnancy leptin (pg/ml)15250.81±625.6212240.8117280.84±19702.7813868.310.7100.070.274-0.06,+0.19homa at 28 weeks2.32±2.991.773.04±4.972.050.067-0.090.217-0.24,+0.06leptin at 28 weeks (pg/ml)19713.37±15056.7716401.4620327.68±15046.7616682.040.8160.020.741-0.11,+0.16cord Blood c-peptide (pg/ml)562.82±698.01259.76454.65±639.71164.680.0610.310.027*+0.04,+0.59cord Blood leptin (pg/ml)29768.54±23140.7524017.3324094.15±20468.0418669.770.0010.38<0.001*+0.23,+0.53\ndata presented as mean and standard deviations and median.']	N/A	N/A	[('PR_000017453', 'protein Wnt-9b', 117, 'WRAP'), ('PR_000045358', 'insulin family protein', 167, 'insulin'), ('GO_0007565', 'female pregnancy', 325, 'pregnancy'), ('GO_0007565', 'female pregnancy', 397, 'pregnancy'), ('UBERON_0000178', 'blood', 668, 'blood'), ('UBERON_0000178', 'blood', 760, 'blood')]
PMC4571073	9/2015	S60-PMC4571073	['for the research diagnosis of Placental abruption, we required evidence of Blood clot behind the Placenta accompanied by at least two of the following signs and symptoms: (1) Vaginal bleeding in late Pregnancy that was not associated with Placenta previa or Cervical lesions; (2) Uterine tenderness and/or Abdominal pain; and (3) fetal distress or death.']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placental'), ('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0001987', 'placenta', 97, 'placenta'), ('UBERON_0001987', 'placenta', 175, 'vaginal'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('UBERON_0001987', 'placenta', 239, 'placenta'), ('UBERON_0005434', 'cervical region', 258, 'cervical'), ('UBERON_0000995', 'uterus', 280, 'uterine'), ('UBERON_0000916', 'abdomen', 306, 'abdominal')]
PMC4581239	8/2015	S71-PMC4581239	['[50] reported that Animals Fed a diet high in manganese (classified as a toxic heavy metal in high doses) do not exhibit high levels of Blood Manganese when the diet also contains adequate amounts of calcium.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 19, 'animals'), ('GO_0007631', 'feeding behavior', 27, 'fed'), ('UBERON_0000178', 'blood', 136, 'blood'), ('CHEBI_33351', 'seaborgium atom', 142, 'manganese')]
PMC4586450	10/2015	S154-PMC4586450	['systolic and diastolic Blood pressures were measured at several ages using a dinamap 9301 vital signs monitor (morton medical, london, uk).']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood')]
PMC4586451	10/2015	S52-PMC4586451	['(2012)30fads Genescord Blood Fatty Acidsinfant at Birthsteer et al.']	N/A	N/A	[('SO_0005852', 'gene_subarray', 13, 'genesCord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_31595', 'iron tricyanide', 29, 'fatty acidsInfant'), ('GO_0042048', 'olfactory behavior', 50, 'birthSteer')]
PMC4586451	10/2015	S126-PMC4586451	['child’s anthropometric measurements, bone mass, and Blood pressure\nheight and weight were measured at the research clinics between the ages of 7 years and 15 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood')]
PMC4586451	10/2015	S129-PMC4586451	['systolic and diastolic Blood pressures were measured using a dinamap 9301 vital signs monitor (morton medical, london, uk).']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood')]
PMC4586451	10/2015	S195-PMC4586451	['diastolic Blood pressure not associated with any of the dietary variablesblood pressure (systolic) at 15 y, n = 472321carbohydrate quartilesadjustments as above plus paternal diet\nβ = 0.67 (95% ci, −0.31 to 1.65)\nβ = 0.02 (95% ci, −0.76 to 1.59)\nβ = 0.73 (95% ci, −0.90 to 2.34) p = 0.5\nβ = 0.52 (95% ci, −0.51 to 1.57)\nβ = 0.66 (95% ci, −0.58 to 1.90)\nβ = 1.03 (95% ci, −0.69 to 2.75) p = 0.3statistical methods and dietary factors as above.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood')]
PMC4586532	8/2015	S36-PMC4586532	['after removal from the Uterus, fetuses were weighed and decapitated and the Trunk Blood was used for Fa analysis.']	N/A	N/A	[('UBERON_0000995', 'uterus', 23, 'uterus'), ('UBERON_0002100', 'trunk', 76, 'trunk'), ('UBERON_0000178', 'blood', 82, 'blood'), ('CHEBI_30751', 'formic acid', 101, 'FA')]
PMC4586532	8/2015	S38-PMC4586532	['Blood was collected on ice-chilled tubes containing 1 g/l of Na2-edta and pooled per litter from each mother.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_26710', 'sodium chloride', 61, 'Na2')]
PMC4586532	8/2015	S39-PMC4586532	['the pooled fetal Blood was centrifuged and Plasma aliquots were stored at −20 °c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001969', 'blood plasma', 43, 'plasma')]
PMC4586532	8/2015	S40-PMC4586532	['Blood Glucose (Glucometer, precision qid, medisense, oxfordshire, uk) and Serum Insulin (Rat Insulin radio-immunoassay (ria) kit, linco research, st. charles, mo, usa) concentrations were measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_24321', 'glutamo group', 15, 'glucometer'), ('UBERON_0001977', 'blood serum', 74, 'serum'), ('PR_000045358', 'insulin family protein', 80, 'insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 89, 'rat'), ('PR_000045358', 'insulin family protein', 93, 'insulin')]
PMC4588865	8/2015	S40-PMC4588865	['Blood samples were collected from all consenting alspac mothers and their offspring at several clinics at different time points.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4588865	8/2015	S105-PMC4588865	['after empirical optimization of our regression models (seesupplementary dataavailable at ije online: ewas regression model optimization) in which we confirmed that the assumption of a linear relationship between bmi/gwg and Cord Blood Dna Methylation is valid [for 94.2–100% of probes tested, the model fit was not improved (likelihood ratio test p -value\u2009>\u20090.05) by the inclusion of a quadratic term for pre-Pregnancy bmi/gwg], we carried out ewas of offspring methylation regressed on pre-Pregnancy bmi or gwg.figure s2(available assupplementary dataat ije online) shows Genomic inflation values (lambdas) and quantile-quantile (q-q) plots for each ewas conducted using model 2.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 224, 'cord'), ('UBERON_0000178', 'blood', 229, 'blood'), ('GO_0006306', 'DNA methylation', 235, 'DNA methylation'), ('GO_0007565', 'female pregnancy', 409, 'pregnancy'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('SO_0001026', 'genome', 573, 'genomic')]
PMC4588865	8/2015	S114-PMC4588865	['manhattan plots showing the results of epigenome-wide association studies (ewas) of Cord Blood Dna Methylation in offspring of underweight ( n \u2009=\u200924), overweight (n\u2009=\u200994) and obese ( n \u2009=\u200932) mothers compared with offspring of normal weight mothers ( n \u2009=\u2009577).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 84, 'cord'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0006306', 'DNA methylation', 95, 'DNA methylation')]
PMC4588865	8/2015	S125-PMC4588865	['associations between maternal or paternal obesity and offspring Cord Blood Dna Methylation [mean difference in methylation (%) compared with offspring of normal weight mothers/fathers].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('GO_0006306', 'DNA methylation', 75, 'DNA methylation')]
PMC4588865	8/2015	S141-PMC4588865	['full results of this longitudinal analysis are presented in file s2 (available assupplementary dataat ije online).table 3andfigure 4a show results of longitudinal analysis of the top five sites found differentially methylated in Cord Blood, between offspring of normal weight and obese mothers.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 229, 'cord'), ('UBERON_0000178', 'blood', 234, 'blood')]
PMC4588865	8/2015	S154-PMC4588865	['longitudinal analysis of top five sites found differentially methylated in Cord Blood, between offspring of normal weight and obese mothersgene region (cpg)estimated Cord Blood methylation in offspring of normal weight mothers (%)estimated Cord Blood methylation in offspring of obese mothers (%)age 0–7 years: average yearly change for offspring of normal weight mothers (%)age 0–7 years: average yearly change for offspring of obese mothers (%)age 0–7 years: p -value for difference in methylation changeage 7–17 years: average yearly change for offspring of normal weight mothers (%)age 7–17 years: average yearly change for offspring of obese mothers (%)age 7–17 years: p -value for difference in methylation changeunnamed (cg00526953)70.3366.17−2.00−1.270.13−0.49−0.390.76 Suclg2 (cg02321096)61.6054.520.961.840.007−0.09−0.130.88 fam129b (cg03270036)96.9288.02−0.660.774.13e-09−0.14−0.320.28 Kif15;kiaa1143 (cg17546649)9.9214.970.46−0.200.00030.010.000.90 Stab2 (cg23131355)92.7388.210.100.681.29e-05−0.07−0.070.96\ntable 4andfigure 4b show results of longitudinal analysis of the top five sites found differentially methylated in Cord Blood, between offspring of normal weight and underweight mothers.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('UBERON_0002240', 'spinal cord', 240, 'cord'), ('UBERON_0000178', 'blood', 245, 'blood'), ('PR_000015829', 'small ubiquitin-related modifier 1', 778, 'SUCLG2'), ('PR_000009295', 'kinesin-like protein KIF1A', 897, 'KIF15'), ('PR_000015727', 'double-stranded RNA-binding protein Staufen homolog 2', 961, 'STAB2'), ('UBERON_0009472', 'axilla', 1135, 'cord blood')]
PMC4588865	8/2015	S156-PMC4588865	['for example, at cg07232095 (on the Gene body of Tmem201), Cord Blood methylation was almost 12% higher in the offspring of normal weight mothers.']	N/A	N/A	[('SO_0000704', 'gene', 35, 'gene'), ('PR_000029805', 'transmembrane protein 214', 48, 'TMEM201'), ('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood')]
PMC4588866	8/2015	S5-PMC4588866	['Dna Methylation was assessed using the illumina 450k array in Whole Blood among 422 Individuals with Prenatal famine exposure and 463 time- or sibling-controls without Prenatal famine exposure.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0007688', 'anlage', 62, 'whole'), ('UBERON_0000178', 'blood', 68, 'blood'), ('NCBITaxon_1', 'root', 84, 'individuals'), ('GO_0007565', 'female pregnancy', 101, 'prenatal'), ('GO_0007565', 'female pregnancy', 168, 'prenatal')]
PMC4588866	8/2015	S40-PMC4588866	['briefly, 500\u2009ng of Genomic dna from whole Blood isolated using the salting-out technique was Bisulfite-treated using the ez-96 Dna Methylation kit (zymo research, orange county, usa).']	N/A	N/A	[('SO_0001026', 'genome', 19, 'genomic'), ('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_29874', 'bromine dioxide', 93, 'bisulfite'), ('GO_0006306', 'DNA methylation', 127, 'DNA methylation')]
PMC4588866	8/2015	S122-PMC4588866	['there was no interaction of famine exposure and sex, and the cell composition of Blood did not affect the observed patterns of famine exposure and methylation (supplementary table 4, available as supplementary data at ije online), except for cg11496778 ( Osbpl5 / Mrgprg ) for which the methylation change after famine exposure became more pronounced after Cellular adjustment (from −1.5% to −2.3%).']	N/A	N/A	[('UBERON_0000178', 'blood', 81, 'blood'), ('PR_000012044', 'oxysterol-binding protein 2', 255, 'OSBPL5'), ('PR_000001662', 'proteinase-activated receptor 2', 264, 'MRGPRG'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 357, 'cellular')]
PMC4591141	10/2015	S24-PMC4591141	['in the 2003 study from bermuda, our research established a mean Cord Blood mercury concentration of 8.3 μg/l (range 1–32.1 μg/l) [5].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC4591141	10/2015	S49-PMC4591141	['in 2010, our research team returned to bermuda and conducted a study on Prenatal exposure to environmental Contaminants including an analysis of mercury concentrations in Pregnant women’s Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 72, 'prenatal'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 107, 'contaminants'), ('GO_0007565', 'female pregnancy', 171, 'pregnant'), ('UBERON_0000178', 'blood', 188, 'blood')]
PMC4591141	10/2015	S81-PMC4591141	['it is also a good time for survey administration, because women are required to spend an hour in the clinic/hospital waiting room between Blood draws, allowing sufficient time to complete the survey.']	N/A	N/A	[('UBERON_0000178', 'blood', 138, 'blood')]
PMC4591978	10/2015	S42-PMC4591978	['approximately half of this substudy area (31 sectors) was selected for an additional intensive home-based Cord Blood collection protocol.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood')]
PMC4591978	10/2015	S43-PMC4591978	['a primary outcome of this study was concentrations of maternal and fetal growth factors, assessed at 10 and 32 weeks Gestation (maternal) and at Birth (fetal, from Cord Blood).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007567', 'parturition', 145, 'birth'), ('UBERON_0002240', 'spinal cord', 164, 'cord'), ('UBERON_0000178', 'blood', 169, 'blood')]
PMC4591978	10/2015	S44-PMC4591978	['from february 2009 to april 2010, newly Pregnant women in the selected substudy area were asked for consent (by the same process described for the parent trial) for Cord Blood collection after enrolling in the parent study at a median of 9.6 (iqr 7.7, 11.7) weeks Gestation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('UBERON_0002240', 'spinal cord', 165, 'cord'), ('UBERON_0000178', 'blood', 170, 'blood'), ('GO_0007565', 'female pregnancy', 264, 'gestation')]
PMC4591978	10/2015	S46-PMC4591978	['those >28 weeks Gestation at the time of enrollment were excluded from the Cord Blood substudy.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'gestation'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC4591978	10/2015	S47-PMC4591978	['sample size (n = 310 Cord Blood samples) was set to detect differences in Micronutrient status.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 74, 'micronutrient')]
PMC4591978	10/2015	S52-PMC4591978	['before supplementation (~10 wks) and at 32 weeks Gestation, the technicians collected 7 ml of maternal Venous Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 49, 'gestation'), ('UBERON_0001638', 'vein', 103, 'venous'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC4591978	10/2015	S54-PMC4591978	['Blood collection tubes were immediately stored in padded, insulated cold boxes with ice packs until technicians returned to the central lab for processing.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4591978	10/2015	S58-PMC4591978	['immediately following Birth and separation of the Infant and Placenta, Cord Venous Blood (7 ml) was collected by the trained nurse midwives from the Placental side with a syringe; transferred to a 7 ml Blood collection tube; put in a padded, insulated cold box with ice packs; and transported to the field-based laboratory for processing.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'birth'), ('UBERON_0000003', 'naris', 50, 'infant'), ('UBERON_0001987', 'placenta', 61, 'placenta'), ('UBERON_0002240', 'spinal cord', 71, 'cord'), ('UBERON_0001638', 'vein', 76, 'venous'), ('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0001987', 'placenta', 149, 'placental'), ('UBERON_0000178', 'blood', 202, 'blood')]
PMC4591978	10/2015	S59-PMC4591978	['Cord Blood processing typically occurred 1–2 hours after collection.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC4591978	10/2015	S60-PMC4591978	['Maternal and Cord Blood tubes were centrifuged and separated Plasma was measured into multiple aliquots and immediately stored in liquid nitrogen until received at our us laboratory.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001969', 'blood plasma', 61, 'plasma')]
PMC4591978	10/2015	S100-PMC4591978	['in all, 500 Pregnant women were enrolled in the substudy, from whom 396 paired maternal Blood samples and 325 Cord Blood samples were included in the analysis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0002240', 'spinal cord', 110, 'cord'), ('UBERON_0000178', 'blood', 115, 'blood')]
PMC4591978	10/2015	S109-PMC4591978	['some mothers were not met at 32 weeks, but were met at Birth for Cord Blood collection.10.1371/journal.pone.0137269.t001\n\ncaption (table-wrap): table 1\ncharacteristics of mothers and their offspring by supplementation allocation in rural bangladesh, 2008–2009.overalliron and Folic Acidmultiple Micronutrients p valuemean ± sd\xa0or n (%) maternal (baseline) (n = 396)(n = 191)(n = 205)\xa0\xa0\xa0\xa0\xa0age, y23.4 ± 5.223.6 ± 5.423.1 ± 5.00.34\xa0\xa0\xa0\xa0height, cm148.9 ± 5.4149.3 ± 5.5148.6 ± 5.20.21\xa0\xa0\xa0\xa0bmi, kg/m219.5 ± 2.419.6 ± 2.619.4 ± 2.20.42\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0<18.5152 (38.4)64 (33.5)88 (42.9)0.07\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa018.5–24.9236 (59.6)121 (63.4)115 (56.1)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0≥25.08 (2.0)6 (3.1)2 (1.0)\xa0\xa0\xa0\xa0muac, cm23.7 ± 2.423.8 ± 2.423.6 ± 2.50.65\xa0\xa0\xa0\xa0Hemoglobin, g/l119 ± 10119 ± 11120 ± 100.37\xa0\xa0\xa0\xa0parity0.63\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa00148 (37.4)71 (37.2)77 (37.6)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa01140 (35.4)64 (33.5)76 (37.1)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0≥2108 (27.3)56 (29.3)52 (25.4)\xa0\xa0\xa0\xa0completed years of school5.6 ± 3.85.7 ± 4.05.5± 3.70.54\xa0\xa0\xa0\xa0has monetary earnings1154 (38.9)69 (36.1)85 (41.5)0.28 infant (Birth) (n = 325)(n = 152)(n = 173)\xa0\xa0\xa0\xa0Birth weight (g)2683 (229)2723 (332)2648 (316)0.10\xa0\xa0\xa0\xa0Placental weight (g)2351.0 (4.1)343.1 (5.4)358.0 (6.0)0.11\xa0\xa0\xa0\xa0Gestational age (week)39.1 (0.1)39.3 (0.1)39.1 (0.1)0.37\xa0\xa0\xa0\xa0small for Gestational age3205 (63.1)113 (65.3)92 (60.5)0.37\xa0\xa0\xa0\xa0low Birth weight (<2.5 kg)106 (33.6)46 (30.3)60 (34.7)0.40\xa0\xa0\xa0\xa0preterm (<37 weeks)25 (7.7)13 (7.5)12 (7.9)0.90\n1represents economic activities that provide income since few women in this setting have formal paid jobs.']	N/A	N/A	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_46927', 'dioxanecarboxylic acid', 276, 'folic acidMultiple'), ('CHEBI_33839', 'macromolecule', 295, 'micronutrients'), ('CHEBI_5679', 'herniarin', 703, 'Hemoglobin'), ('GO_0007567', 'parturition', 998, 'birth'), ('GO_0007567', 'parturition', 1036, 'Birth'), ('UBERON_0001987', 'placenta', 1090, 'Placental'), ('GO_0007565', 'female pregnancy', 1152, 'Gestational'), ('GO_0007565', 'female pregnancy', 1222, 'gestational'), ('GO_0007567', 'parturition', 1279, 'birth')]
PMC4598849	10/2015	S1-PMC4598849	['as part of the china-anhui Birth cohort (c-abc) study, we measured Cord Blood levels of 25(Oh)D in 1491 neonates in hefei, china.']	N/A	N/A	[('GO_0007567', 'parturition', 27, 'Birth'), ('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 88, '25(OH)D')]
PMC4598849	10/2015	S4-PMC4598849	['compared with neonates in the lowest decile of Cord Blood 25(Oh)D levels, neonates in four deciles (the fourth, fifth, sixth and seventh deciles) had significantly increased Birth weight and decreased risk of sga.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 47, 'cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007567', 'parturition', 174, 'birth')]
PMC4598849	10/2015	S25-PMC4598849	['the mean Cord Blood 25(Oh)D level was 39.43\u2009nmol/l (sd\u2009=\u200920.35), ranged from 6.06 to 119.64.table 1shows the characteristics of 1 491 Pregnant women across increasing deciles of Cord Blood 25-Hydoxyvitamin D levles.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 20, '25(OH)D'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('UBERON_0002240', 'spinal cord', 178, 'cord'), ('UBERON_0000178', 'blood', 183, 'blood'), ('CHEBI_67462', '3-epi-caryoptin', 189, '25-hydoxyvitamin D')]
PMC4598849	10/2015	S26-PMC4598849	['with increasing deciles of Cord Blood 25(Oh)D, the percentage of Birth during summer to autumn and male infant increased ( p \u2009<\u20090.05 for the trend).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 27, 'cord'), ('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 38, '25(OH)D'), ('GO_0007567', 'parturition', 65, 'birth')]
PMC4598849	10/2015	S85-PMC4598849	['at Birth, midwives or study nurses collected the newborn’s anthropometric details and Cord Blood, when available.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood')]
PMC4598849	10/2015	S87-PMC4598849	['finally, we obtained full data including Cord Blood from 1491 mother-infant pairs.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 41, 'cord'), ('UBERON_0000178', 'blood', 46, 'blood')]
PMC4598849	10/2015	S90-PMC4598849	['Cord Blood 25-Hydoxyvitamin D\nCord Blood sample was collected immediately after Delivery and Anticoagulated by use of Sodium Heparin.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_67462', '3-epi-caryoptin', 11, '25-hydoxyvitamin D'), ('UBERON_0000948', 'heart', 30, 'Cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0007567', 'parturition', 80, 'delivery'), ('GO_0006915', 'apoptotic process', 93, 'anticoagulated'), ('CHEBI_28790', 'serotonin', 118, 'sodium heparin')]
PMC4598849	10/2015	S103-PMC4598849	['statistical analysis\nCord Blood 25(Oh)D concentrations were divided into deciles.']	N/A	N/A	[('UBERON_0000948', 'heart', 21, 'Cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D')]
PMC4598849	10/2015	S114-PMC4598849	['Cord Blood 25-Hydroxyvitamin D and Fetal growth in the china-anhui Birth cohort study.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'Blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 11, '25-hydroxyvitamin D'), ('GO_0008618', '7-methylguanosine metabolic process', 35, 'Fetal'), ('GO_0007567', 'parturition', 67, 'Birth')]
PMC4613350	9/2015	S87-PMC4613350	['exclusion: spontaneous Miscarriage prior to 20 weeks, loss to follow-up or fetal anomalies diagnosed in the second Trimester;28exclusion: high risk Pregnancies;29definition controls: randomly selected women without reported Pregnancy-associated hypertension;30definition controls: had Blood collected and stored on the same day, which did not develop any Pregnancy complications and resulted in the Live Birth of phenotypically normal neonates;31unknown in- and exclusion criteria;32inclusion: singleton Pregnancies;33,34gestational age matched controls;35exclusion: multiparity, chronic hypertension, diabetes, multiple Gestation, Connective Tissue disorder, any long-term use of Medicine other than Prenatal Vitamins, and Miscarriage before viability;36exclusion: diabetes, Connective Tissue disease, Renal disorders, essential hypertension;37exclusion: previous systemic disorders or Drug use, chronic hypertension, diabetes, Renal disorders, recent or present fever or infectious disease, malignancies, Autoimmune diseases and multiple Pregnancies;38exclusion: early-onset pe, multiple Gestations, Pregnancies with fetal chromosomal or major structural anomaly, Miscarriages;39unknown inclusion/exclusion criteria;40exclusion: cases showing Intrahepatic Cholestasis of Pregnancy, abortion, peripartum cardiomyopathy, and other complications.']	N/A	N/A	[('GO_0046660', 'female sex differentiation', 23, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 115, 'trimester'), ('GO_0007565', 'female pregnancy', 148, 'pregnancies'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('UBERON_0000178', 'blood', 285, 'blood'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0006266', 'DNA ligation', 399, 'live'), ('GO_0007567', 'parturition', 404, 'birth'), ('GO_0007565', 'female pregnancy', 504, 'pregnancies'), ('GO_0007565', 'female pregnancy', 621, 'gestation'), ('UBERON_0002384', 'connective tissue', 632, 'connective tissue'), ('CHEBI_6807', 'methadone', 681, 'medicine'), ('GO_0007565', 'female pregnancy', 701, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 710, 'vitamins'), ('GO_0046660', 'female sex differentiation', 724, 'miscarriage'), ('UBERON_0002384', 'connective tissue', 776, 'connective tissue'), ('UBERON_0002113', 'kidney', 803, 'renal'), ('CHEBI_23888', 'drug', 887, 'drug'), ('UBERON_0002113', 'kidney', 929, 'renal'), ('UBERON_0001442', 'skeleton of manus', 1007, 'autoimmune'), ('GO_0007565', 'female pregnancy', 1040, 'pregnancies'), ('GO_0007565', 'female pregnancy', 1090, 'gestations'), ('GO_0007565', 'female pregnancy', 1102, 'pregnancies'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 1166, 'miscarriages'), ('UBERON_0001226', 'major calyx', 1245, 'intrahepatic'), ('GO_0000075', 'cell cycle checkpoint signaling', 1258, 'cholestasis'), ('GO_0007565', 'female pregnancy', 1273, 'pregnancy')]
PMC4613350	9/2015	S95-PMC4613350	['legend: ( 1 ) Activin-A; ( 2 ) Adam-12; ( 3 ) Α Fetoprotein; ( 4 ) α-1-macroglobulin; ( 5 ) anti-Cd63 (Gp53, Lysosomal secretion); ( 6 ) Chemerin; ( 7 ) C-Reactive Protein; ( 8 ) cystatin C; ( 9 ) Endoglin; ( 10 ) E-Selectin; ( 11 ) fetal dna; ( 12 ) fetal hemoglobin (ratio); ( 13 ) Fibronectin; ( 14 ) free Β-Hcg; ( 15 ) free leptin index; ( 16 ) Grp78 (Glucose Regulated Protein) ratio c-term/full length; ( 17 ) Htr-A1 (High-Temperature Requirement A1); ( 18 ) Inhibin-A; ( 19 ) Ngal (Neutrophil Gelatinase-Associated Lipocalin); ( 20 ) Papp-A; ( 21 ) Pbmc (Peripheral Blood Mononuclear Cell) Mirna; ( 22 ) Plgf; ( 23 ) Pp-13; ( 24 ) P-Selectin; ( 25 ) soluble endoglin; ( 26 ) Sflt/Plgf ratio; ( 27 ) Sflt-1; ( 28 ) Svegfr-1 (Vascular Endothelial Growth Factor); ( 29 ) Tnf-R1 (Tumor Necrosis Factor Receptor).']	N/A	N/A	[('PR_000000210', 'activin receptor type-2B isoform ActR-IIBtrunc', 14, 'activin-A'), ('PR_000003719', 'disintegrin and metalloproteinase domain-containing protein 23', 31, 'ADAM-12'), ('PR_000003593', 'ankyrin repeat and BTB/POZ domain-containing protein 2', 46, 'α fetoprotein'), ('PR_000001309', 'CD70 molecule', 97, 'CD63'), ('PR_000001509', 'probable G-protein coupled receptor 146', 103, 'GP53'), ('GO_0005764', 'lysosome', 109, 'lysosomal'), ('CHEBI_23103', 'chitodextrin', 137, 'chemerin'), ('PR_000005399', 'glutathione-specific gamma-glutamylcyclotransferase 2', 137, 'chemerin'), ('PR_000005890', 'crooked neck-like protein 1', 153, 'C-reactive protein'), ('PR_000004900', 'complement C3', 188, 'C'), ('PR_000007090', 'glycerophosphocholine cholinephosphodiesterase ENPP6', 197, 'endoglin'), ('PR_000001447', 'cadherin-1', 214, 'E-selectin'), ('PR_000007500', 'fibroblast growth factor 9', 284, 'fibronectin'), ('PR_000000035', 'BMP receptor type-1A', 309, 'β-hCG'), ('PR_000008210', 'glutathione peroxidase 1', 349, 'GRP78'), ('CHEBI_17234', 'glucose', 356, 'glucose'), ('PR_000007989', 'ARF GTPase-activating protein GIT1', 356, 'glucose regulated protein'), ('GO_0065007', 'biological regulation', 364, 'regulated'), ('PR_000008820', 'heat shock protein beta-8', 416, 'Htr-A1'), ('PR_000008441', 'hydroxyacid oxidase 1', 424, 'High-Temperature Requirement A1'), ('PR_000009070', 'integrator complex subunit 3', 465, 'inhibin-A'), ('PR_000010960', 'N-acetyl-D-glucosamine kinase', 483, 'NGAL'), ('CL_0000775', 'neutrophil', 489, 'neutrophil'), ('PR_000011041', 'nuclear receptor coactivator 2', 489, 'neutrophil gelatinase-associated lipocalin'), ('PR_000012271', 'pappalysin-2', 541, 'PAPP-A'), ('CL_0002246', 'peripheral blood stem cell', 556, 'PBMC'), ('CL_0000111', 'peripheral neuron', 562, 'peripheral blood mononuclear cell'), ('UBERON_0000178', 'blood', 573, 'blood'), ('GO_0031097', 'medial cortex', 579, 'mononuclear'), ('SO_0000276', 'miRNA', 597, 'miRNA'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 611, 'PlGF'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 624, 'PP-13'), ('PR_000001245', 'rhodopsin', 638, 'P-selectin'), ('PR_000014791', 'protein O-mannose kinase', 682, 'sFLT'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 687, 'PlGF'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 706, 'sFlt-1'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 721, 'sVEGFR-1'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 731, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 740, 'endothelial'), ('PR_000001958', 'tumor necrosis factor receptor superfamily member 1A', 775, 'TNF-R1'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 783, 'tumor necrosis factor receptor')]
PMC4613350	9/2015	S110-PMC4613350	['legend: ( 1 ) Papp-A, afp, ue3, hcg (total or free β), Inhibin-A; ( 2 ) mean pi + Activin-A; ( 3 ) Plgf/seng-ratio; ( 4 ) Papp-A and free leptin index; ( 5 ) Pp-13, ua-pi, Aix-75 (measure of Arterial stiffness); ( 6 ) Cystatin-C, Crp, Uterine Artery resistance index; ( 7 ) Hbf ratio and a1m; ( 8 ) Activin-A, Inhibin-A, Plgf and ua-pi; ( 9 ) african american race, systolic Blood pressure, bmi, education level, Adam12, Papp-A, Plgf; ( 10 ) bmi, education mother and htra1; ( 11 ) maternal characteristics, Plgf; ( 12 ) maternal characteristics, Adam12; ( 13 ) maternal characteristics, Plgf; ( 14 ) Sflt-1, Plgf, Papp-A, Inhibin A, bmi, map; ( 15 ) Plgf, map, bmi, high fruit intake, Uterine Artery doppler resistive index (ua-ri) * validation cohort; ( 16 ) Plgf, map, bmi, high fruit intake, ua-ri * training cohort.']	N/A	N/A	[('PR_000012271', 'pappalysin-2', 14, 'PAPP-A'), ('PR_000009070', 'integrator complex subunit 3', 55, 'inhibin-A'), ('PR_000000210', 'activin receptor type-2B isoform ActR-IIBtrunc', 82, 'activin-A'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 99, 'PlGF'), ('PR_000012271', 'pappalysin-2', 122, 'PAPP-A'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 158, 'PP-13'), ('PR_000003910', 'aflatoxin B1 aldehyde reductase member 4', 172, 'AIx-75'), ('UBERON_0001637', 'artery', 191, 'arterial'), ('PR_000005969', 'cystatin-F', 218, 'cystatin-C'), ('PR_000005890', 'crooked neck-like protein 1', 230, 'CRP'), ('UBERON_0002493', 'uterine artery', 235, 'uterine artery'), ('PR_000008608', 'hexokinase-1', 274, 'HbF'), ('PR_000000210', 'activin receptor type-2B isoform ActR-IIBtrunc', 299, 'activin-A'), ('PR_000009070', 'integrator complex subunit 3', 310, 'inhibin-A'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 321, 'PlGF'), ('UBERON_0000178', 'blood', 375, 'blood'), ('PR_000003710', 'disintegrin and metalloproteinase domain-containing protein 11', 413, 'ADAM12'), ('PR_000012271', 'pappalysin-2', 421, 'PAPP-A'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 429, 'PlGF'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 508, 'PlGF'), ('PR_000003710', 'disintegrin and metalloproteinase domain-containing protein 11', 547, 'ADAM12'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 588, 'PlGF'), ('PR_000014791', 'protein O-mannose kinase', 601, 'sFLT-1'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 609, 'PlGF'), ('PR_000012271', 'pappalysin-2', 615, 'PAPP-A'), ('PR_000045358', 'insulin family protein', 623, 'inhibin A'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 651, 'PlGF'), ('UBERON_0002493', 'uterine artery', 686, 'uterine artery'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 761, 'PlGF')]
PMC4618150	10/2015	S71-PMC4618150	['other factors include weight, smoking status, Blood donation intensity and previous Pregnancies [27].']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0007565', 'female pregnancy', 84, 'pregnancies')]
PMC4619070	10/2015	S46-PMC4619070	['the following Maternal Pregnancy outcomes were recorded: Gestational hypertension (Blood pressure\u2009≥\u2009140/90\xa0mmhg), Preeclampsia [hypertension with proteinuria or in combination with reduced fetal growth or the ‘Hemolysis elevated Liver enzymes and low Platelets’ (helpp)-syndrome], Preterm Delivery (<37\xa0weeks of Gestation) and cesarean section (planned\u2009+\u2009emergency sections combined).']	N/A	N/A	[('GO_0007618', 'mating', 14, 'maternal'), ('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('UBERON_0000178', 'blood', 83, 'blood'), ('GO_0007128', 'meiotic prophase I', 114, 'preeclampsia'), ('GO_0030097', 'hemopoiesis', 210, 'Hemolysis'), ('UBERON_0002107', 'liver', 229, 'Liver'), ('CL_0000233', 'platelet', 251, 'Platelets'), ('GO_0007565', 'female pregnancy', 281, 'preterm'), ('GO_0007567', 'parturition', 289, 'delivery'), ('GO_0007565', 'female pregnancy', 312, 'gestation')]
PMC4624803	10/2015	S1-PMC4624803	['material\nUmbilical Cord Blood samples collected at Birth from 202 children later diagnosed with attention deficit/hyperactivity disorder were analysed for Vitamin D content and compared with 202 matched controls.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 9, 'Umbilical cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('GO_0007567', 'parturition', 51, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4624803	10/2015	S30-PMC4624803	['after exclusion of the children who were either not Born in malmö, not linked to the swedish medical Birth registry (smbr) or for whom no Umbilical Blood Serum was stored, 202 children remained.']	N/A	N/A	[('GO_0007567', 'parturition', 52, 'born'), ('GO_0007567', 'parturition', 101, 'Birth'), ('UBERON_0007118', 'umbilicus', 138, 'umbilical'), ('UBERON_0000178', 'blood', 148, 'blood'), ('UBERON_0001977', 'blood serum', 154, 'serum')]
PMC4624803	10/2015	S33-PMC4624803	['almost all child Deliveries in malmö take place at the skåne university hospital maternity unit, where maternal and Umbilical Cord Blood samples have been collected and stored in the mmub.']	N/A	N/A	[('GO_0007567', 'parturition', 17, 'deliveries'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood')]
PMC4624803	10/2015	S34-PMC4624803	['Maternal Blood was collected by venepuncture, a few hours prior to Delivery, and Cord Blood was collected by drainage into sterile sample tubes immediately after Birth.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 67, 'delivery'), ('UBERON_0002240', 'spinal cord', 81, 'cord'), ('UBERON_0000178', 'blood', 86, 'blood'), ('GO_0007567', 'parturition', 162, 'birth')]
PMC4624803	10/2015	S39-PMC4624803	['the first newborn in the pool of controls with an available Umbilical Blood sample in the mmub was chosen.']	N/A	N/A	[('UBERON_0007118', 'umbilicus', 60, 'umbilical'), ('UBERON_0000178', 'blood', 70, 'blood')]
PMC4625530	10/2015	S53-PMC4625530	['hiv-exposed infants were prescribed daily Nevirapine for six weeks, followed by hiv testing at 3-months of age using dried Blood spot hiv dna-pcr that was analyzed at bugando medical centre in mwanza city, the closest regional hospital laboratory.']	N/A	N/A	[('CHEBI_63613', 'nevirapine', 42, 'nevirapine'), ('UBERON_0000178', 'blood', 123, 'blood')]
PMC4630792	11/2015	S139-PMC4630792	['anti- müllerian Hormone measurements\nSerum was derived from whole Tail-Blood samples collected prior to sacrifice.']	N/A	N/A	[('CHEBI_5762', 'hordatine A', 16, 'Hormone'), ('UBERON_0001977', 'blood serum', 37, 'Serum'), ('UBERON_0002415', 'tail', 66, 'tail'), ('UBERON_0000178', 'blood', 71, 'blood')]
PMC4630792	11/2015	S151-PMC4630792	['Telomere length analysis\nhigh-molecular weight dna was extracted using the dneasy Blood and Tissue kit (qiagen, hilden, germany) according to the manufacturer’s instructions.']	N/A	N/A	[('GO_0070063', 'RNA polymerase binding', 0, 'Telomere'), ('SO_0000623', 'snRNA_encoding', 0, 'Telomere'), ('UBERON_0000178', 'blood', 82, 'Blood'), ('UBERON_0000479', 'tissue', 92, 'Tissue')]
PMC4630792	11/2015	S162-PMC4630792	['Mitochondrial Dna copy number quantification\ntotal dna (Mitochondrial and Nuclear) was extracted using the dneasy Blood and Tissue kit (qiagen, hilden, germany) according to the manufacturer’s instructions.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('GO_0005739', 'mitochondrion', 56, 'mitochondrial'), ('GO_0005634', 'nucleus', 74, 'nuclear'), ('UBERON_0000178', 'blood', 114, 'Blood'), ('UBERON_0000479', 'tissue', 124, 'Tissue')]
PMC4632423	10/2015	S35-PMC4632423	['a Venous Blood sample was taken and Serum and Plasma frozen at −80 °c, and after a light refreshment, participants completed questionnaires regarding Food Intake and physical activity during early and late Pregnancy.']	N/A	N/A	[('UBERON_0001638', 'vein', 2, 'venous'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001977', 'blood serum', 36, 'serum'), ('UBERON_0001969', 'blood plasma', 46, 'plasma'), ('CHEBI_33290', 'food', 150, 'food'), ('GO_0007631', 'feeding behavior', 150, 'food intake'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy')]
PMC4641416	11/2015	S4-PMC4641416	['neonatal anthropometric and skinfold measurements were compared with fetal leptin and c-peptide results from Cord Blood in 185 cases.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 109, 'cord'), ('UBERON_0000178', 'blood', 114, 'blood')]
PMC4641416	11/2015	S53-PMC4641416	['methods\nthis is a follow on study of 185 infants Born to women from the rolo randomised controlled trial on whom Cord Blood c-peptide and leptin data were available as well as anthropometry at Birth.']	N/A	N/A	[('GO_0007567', 'parturition', 49, 'born'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0000178', 'blood', 118, 'blood'), ('GO_0007567', 'parturition', 193, 'birth')]
PMC4641416	11/2015	S56-PMC4641416	['Bloods including c-peptide and leptin were taken in early and late Pregnancy and Fetal sample from Cord Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Bloods'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('UBERON_0000922', 'embryo', 81, 'fetal'), ('UBERON_0002240', 'spinal cord', 99, 'cord'), ('UBERON_0000178', 'blood', 104, 'blood')]
PMC4641416	11/2015	S65-PMC4641416	['Cord Bloods were collected at Delivery and neonatal anthropometric measurements were taken during the first 72\xa0h of Life including; Birthweight, length, Occipital Frontal Head circumference (Ofc), Chest, Abdominal, Thigh and mid upper Arm circumferences.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'bloods'), ('GO_0007567', 'parturition', 30, 'delivery'), ('UBERON_0000104', 'life cycle', 116, 'life'), ('GO_0007596', 'blood coagulation', 132, 'birthweight'), ('UBERON_2001420', 'anal fin pterygiophore', 153, 'occipital frontal head'), ('UBERON_0004145', 'outflow tract', 191, 'OFC'), ('UBERON_0001443', 'chest', 197, 'chest'), ('UBERON_0000916', 'abdomen', 204, 'abdominal'), ('UBERON_0000376', 'hindlimb stylopod', 215, 'thigh'), ('UBERON_0001460', 'arm', 235, 'arm')]
PMC4641416	11/2015	S75-PMC4641416	['fetal Insulin resistance was assessed via Cord Blood C-Peptide estimation.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 6, 'insulin'), ('UBERON_0002240', 'spinal cord', 42, 'cord'), ('UBERON_0000178', 'blood', 47, 'blood'), ('PR_000005890', 'crooked neck-like protein 1', 53, 'C-peptide')]
PMC4641416	11/2015	S79-PMC4641416	['descriptive statistics were employed to describe baseline maternal and neonatal characteristics, Cord Blood c-peptide and leptin concentrations and neonatal anthropometry.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood')]
PMC4641416	11/2015	S81-PMC4641416	['correlations between Cord Blood C-Peptide and leptin and each of the neonatal anthropometric measures were analysed.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('PR_000005890', 'crooked neck-like protein 1', 32, 'C-peptide')]
PMC4641416	11/2015	S100-PMC4641416	['caption (table-wrap): table 2\n\nmultiple linear regression of the association between neonatal anthropometry and Cord Blood c-peptide and leptinbs.e.b.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood')]
PMC4661500	11/2014	S48-PMC4661500	['in situations of increasing physical and/or psychological stressors patients show lower magnesium levels in Blood[18].']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood')]
PMC4661500	11/2014	S90-PMC4661500	['in this group of subjects selenium was measured in whole Blood samples; magnesium was measured both in whole Blood as well as in Serum samples and compared to selenium levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0001977', 'blood serum', 129, 'serum')]
PMC4661500	11/2014	S458-PMC4661500	['patients with Thyroid diseases can have anti-myoglobin Antibodies in Blood[128],[130].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 14, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC4661500	11/2014	S618-PMC4661500	['the Chickens presented high levels of Selenium in Blood while Liver selenoproteins were low.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'chickens'), ('CHEBI_27568', 'selenium atom', 38, 'selenium'), ('UBERON_0000178', 'blood', 50, 'blood'), ('UBERON_0002107', 'liver', 62, 'liver')]
PMC4663588	11/2015	S9-PMC4663588	['introduction\nMetabolic syndrome is a cluster of Metabolic disorders and it is defined as a combination of central obesity and Insulin resistance plus any two of the following four factors: raised Triglycerides, reduced hdl, raised Blood pressure and raised fasting Plasma Glucose [1].']	N/A	N/A	[('GO_0008152', 'metabolic process', 13, 'Metabolic'), ('GO_0008152', 'metabolic process', 48, 'metabolic'), ('PR_000045358', 'insulin family protein', 126, 'insulin'), ('CHEBI_17855', 'triglyceride', 196, 'triglycerides'), ('UBERON_0000178', 'blood', 231, 'blood'), ('UBERON_0001969', 'blood plasma', 265, 'plasma'), ('CHEBI_17234', 'glucose', 272, 'glucose')]
PMC4663588	11/2015	S228-PMC4663588	['when the southampton diet was given to the dams, higher systolic Blood pressure was found in the offspring at 4 week of age [96,97].']	N/A	N/A	[('UBERON_0000178', 'blood', 65, 'blood')]
PMC4663588	11/2015	S235-PMC4663588	['low protein diet during Lactation significantly increased Blood pressures, as it did in the cafeteria-Fed Rats.']	N/A	N/A	[('GO_0007595', 'lactation', 24, 'lactation'), ('UBERON_0000178', 'blood', 58, 'blood'), ('GO_0007631', 'feeding behavior', 102, 'fed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 106, 'rats')]
PMC4663588	11/2015	S242-PMC4663588	['at 9 months of age, low protein offspring lost the difference in Blood pressure between day and night which normally occurs.']	N/A	N/A	[('UBERON_0000178', 'blood', 65, 'blood')]
PMC4663588	11/2015	S251-PMC4663588	['young Adult Humans had an increased systolic Blood pressure at ages 27–30 year when Born to women Consuming a high-meat low Carbohydrate diet during Pregnancy (0.45 kg meat/day) [104].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 6, 'adult'), ('NCBITaxon_9606', 'Homo sapiens', 12, 'humans'), ('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0007567', 'parturition', 84, 'born'), ('GO_0007631', 'feeding behavior', 98, 'consuming'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 124, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC4663588	11/2015	S252-PMC4663588	['in wistar Rats, when were Fed either a normal (20% of total calories) or high protein (40% of total calories) diet throughout Pregnancy and Lactation, Blood pressure was higher at week 4 of age and persisted throughout the study in male offspring Born to high protein Fed dams [20].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 10, 'rats'), ('GO_0007631', 'feeding behavior', 26, 'fed'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007595', 'lactation', 140, 'lactation'), ('UBERON_0000178', 'blood', 151, 'blood'), ('GO_0007567', 'parturition', 247, 'born'), ('GO_0007631', 'feeding behavior', 268, 'fed')]
PMC4663588	11/2015	S310-PMC4663588	['adding glycine which reduces Plasma Homocysteine to the “southampton” diet normalizes Blood pressure.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 29, 'plasma'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 36, 'homocysteine'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC4663588	11/2015	S332-PMC4663588	['for example, baps with angiotensin converting enzyme (ace) inhibitory activity lower Blood pressure in experimental Animals.']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood'), ('NCBITaxon_33208', 'Metazoa', 116, 'animals')]
PMC4663588	11/2015	S429-PMC4663588	['however, low-protein diet Fed throughout Gesattion and Postnatal Life resulted in a decrease in Islet Blood Vessel density and also in Pancreatic Insulin content and Pancreatic and Islet Blood flow [202].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 26, 'fed'), ('GO_0007565', 'female pregnancy', 41, 'gesattion'), ('GO_0007567', 'parturition', 55, 'postnatal'), ('UBERON_0000104', 'life cycle', 65, 'life'), ('CL_0000214', 'synovial cell', 96, 'islet'), ('UBERON_0002533', 'post-anal tail bud', 96, 'islet'), ('UBERON_0001981', 'blood vessel', 102, 'blood vessel'), ('UBERON_0001264', 'pancreas', 135, 'pancreatic'), ('PR_000045358', 'insulin family protein', 146, 'insulin'), ('UBERON_0001264', 'pancreas', 166, 'pancreatic'), ('CL_0000214', 'synovial cell', 181, 'islet'), ('UBERON_0002533', 'post-anal tail bud', 181, 'islet'), ('UBERON_0000178', 'blood', 187, 'blood')]
PMC4666222	11/2015	S30-PMC4666222	['estimated Blood loss was 300\xa0cc.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood')]
PMC4666222	11/2015	S42-PMC4666222	['hemoglobin and hematocrit were 9.5\xa0g/dl and 28.5\xa0% respectively, White Blood Cell count was 8.9\xa0×\xa0103/μl and Thyroid Stimulating Hormone was 1.28\xa0uiu/ml.']	N/A	N/A	[('CL_0000738', 'leukocyte', 65, 'white blood cell'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_75182', 'tolylfluanid', 109, 'thyroid stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 109, 'thyroid')]
PMC4666222	11/2015	S57-PMC4666222	['patient remained afebrile with complete Blood count showing a White Blood Cell count of 2.5\xa0×\xa0103/μl, a creatinine of 1.0\xa0mg/dl, and a Blood Urea nitrogen of 19\xa0mg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('CL_0000738', 'leukocyte', 62, 'white blood cell'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0000178', 'blood', 135, 'blood'), ('CHEBI_16199', 'urea', 141, 'urea')]
PMC4666222	11/2015	S58-PMC4666222	['three days early these values were White Blood Cell count of 9.6\xa0×\xa0103/μl, creatinine of 0.8\xa0mg/dl, and Blood Urea nitrogen of 6\xa0mg/dl.']	N/A	N/A	[('CL_0000738', 'leukocyte', 35, 'white blood cell'), ('UBERON_0000178', 'blood', 41, 'blood'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_16199', 'urea', 110, 'urea')]
PMC4666222	11/2015	S61-PMC4666222	['shortly after arrival to our institution’s labor and Delivery unit, a rapid response was called secondary to a pulse of 140/min, Respiratory rate of 30/min, and Blood pressure of 121/66\xa0mmhg.']	N/A	N/A	[('GO_0007567', 'parturition', 53, 'delivery'), ('UBERON_0001004', 'respiratory system', 129, 'respiratory'), ('UBERON_0000178', 'blood', 161, 'blood')]
PMC4666222	11/2015	S71-PMC4666222	['results of Blood cultures and Uterine cultures later confirmed gas infection.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0000995', 'uterus', 30, 'uterine')]
PMC4666222	11/2015	S80-PMC4666222	['intraoperatively, the patient required 7u packed Red Blood Cells, 5u fresh frozen Plasma, 3u Platelets, 10u cryoprecipitate.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 49, 'red blood cells'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0001969', 'blood plasma', 82, 'plasma'), ('CL_0000233', 'platelet', 93, 'platelets')]
PMC4666222	11/2015	S84-PMC4666222	['she required an additional 4u packed Red Blood Cells, 4u fresh frozen Plasma, 2u Platelets, and 2u cryoprecipitate.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 37, 'red blood cells'), ('UBERON_0000178', 'blood', 41, 'blood'), ('UBERON_0001969', 'blood plasma', 70, 'plasma'), ('CL_0000233', 'platelet', 81, 'platelets')]
PMC4668747	12/2015	S7-PMC4668747	['ob nest patients will be assigned to a dedicated nursing team, scheduled for 8 pre-planned office visits with a physician or midwife and 6 telephone or online nurse visits (compared to 12 pre-planned physician or midwife office visits in the usual care group), and provided fetal Heart rate and Blood pressure home monitoring equipment and information on joining an online care community.']	N/A	N/A	[('UBERON_0000948', 'heart', 280, 'heart'), ('UBERON_0000178', 'blood', 295, 'blood')]
PMC4668747	12/2015	S109-PMC4668747	['caption (table-wrap): table 3\n\ncomparison of visit schedule by week of Gestation, usual care and ob nest groupsweekusual care groupob nest groupcare provided (both groups)1-7drop-in Pregnancy educationdrop-in Pregnancy educationinteractive self-education8new ob office visit with registered nurse/cnmnew ob office visit with registered nurse/cnmindividualized Pregnancy education, bedside ultrasound, history, lab ordering, discuss Genetic options12new ob office visit with physician/cnmnew ob office visit with physicianphysical exam including pap if needed and review plan of care16connected care visit with registered nurseaeducation and review of care18ultrasound, registered nurse visitultrasound, registered nurse visitultrasound; mid-Pregnancy education24routine ob office visit with physician/cnmconnected care visit with registered nursearoutineb28routine ob office visit with physician/cnmroutine ob office visit with physician/cnmroutineb(lab ordering)33routine ob office visit with physician/cnmconnected care visit with registered nursearoutineb36routine ob office visit with physician/cnmroutine ob office visit with physician/cnmroutineb(lab ordering)38routine ob office visit with physician/cnmconnected care visit with registered nursearoutineb39routine ob office visit with physician/cnmroutine ob office visit with physician/cnmroutineb40routine ob office visit with physician/cnmconnected care visit with registered nursearoutineb41routine ob office visit with physician/cnm; registered nurse visit; ultrasoundroutine ob office visit with physician/cnm; nurse visit; ultrasoundover 40\xa0weeks bi-weekly monitoring1\xa0week Postpartumconnected care visit with registered nurseaeducation and review of care8\xa0weeks Postpartumroutine ob visit with physician/cnmroutine ob office visit with physician/cnmtotal visits to clinic128\nabbr: cnm\u2009=\u2009certified nurse midwife\naconnected care visits with nurses are scheduled contacts by phone or online patient portal\nbroutine\u2009=\u2009check maternal Blood pressure, maternal weight, and Fetal Heart rate, and provide education\ncompared to usual care, ob nest patients will have 4 fewer office visits.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 71, 'gestation'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0007565', 'female pregnancy', 360, 'pregnancy'), ('SO_0000704', 'gene', 432, 'genetic'), ('GO_0007565', 'female pregnancy', 741, 'pregnancy'), ('GO_0007605', 'sensory perception of sound', 1638, 'PostpartumConnected'), ('GO_0019230', 'proprioception', 1727, 'PostpartumRoutine'), ('UBERON_0000178', 'blood', 1994, 'blood'), ('UBERON_0000922', 'embryo', 2031, 'fetal'), ('UBERON_0000948', 'heart', 2037, 'heart')]
PMC4668747	12/2015	S116-PMC4668747	['patients will be asked to keep a weekly journal of weight, fetal Heart rate, and Blood pressure readings and report those to nurses at the connected care visits.']	N/A	N/A	[('UBERON_0000948', 'heart', 65, 'heart'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC4670104	12/2015	S36-PMC4670104	['during home visits, children of consenting parents were asked to fast overnight, and phlebotomists collected Venous Blood samples the next morning from 94% (n = 3,305) of eligible children.']	N/A	N/A	[('UBERON_0001638', 'vein', 109, 'venous'), ('UBERON_0000178', 'blood', 116, 'blood')]
PMC4670104	12/2015	S42-PMC4670104	['from the 1,000 specimens, specimens were ordered by date of field Blood collection within each original maternal supplement allocation stratum of 200 specimens, and following a chance start every other specimen was selected for inclusion into the proteomics archive, yielding a total of 500 samples (n = 100 per maternal group) [17].']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood')]
PMC4670104	12/2015	S76-PMC4670104	['in addition, we identified differentially abundant proteins between children who reported at least one day of symptomatic morbidity (fever, diarrhea, productive cough, or rapid breathing) and children without any symptoms in the week prior to Blood sampling.']	N/A	N/A	[('UBERON_0000178', 'blood', 243, 'blood')]
PMC4673623	11/2015	S42-PMC4673623	['maternal morphometrics were performed at the time of group assembly and again after 3, 9, and 18\xa0months; dual beam x-ray absorptiometry (dexa) was performed at the time of group assembly and again after 6, 12, and 18\xa0months; and measures of Serum ldl-Cholesterol and Triglycerides in Venous Blood samples were performed at the time of group assembly and again after 3\xa0months.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_16113', 'cholesterol', 251, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 267, 'triglycerides'), ('UBERON_0001638', 'vein', 284, 'venous'), ('UBERON_0000178', 'blood', 291, 'blood')]
PMC4673623	11/2015	S50-PMC4673623	['Blood samples for Metabolite measurements were taken from the maternal Uterine Vein and Fetal Umbilical Vein at c-section, and processed to provide Serum and Plasma which were stored at −80°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_39382', 'flufenoxuron', 18, 'metabolite'), ('UBERON_0001214', 'pancreatic tributary of splenic vein', 71, 'uterine vein'), ('UBERON_0000922', 'embryo', 88, 'fetal'), ('UBERON_0002066', 'umbilical vein', 94, 'umbilical vein'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('UBERON_0001969', 'blood plasma', 158, 'plasma')]
PMC4673623	11/2015	S84-PMC4673623	['Homocysteine was 36% higher in maternal Blood and 28% higher in Fetal Blood in the hf-hed group (vs. control) ( p \xa0<\xa00.05).']	N/A	N/A	[('CHEBI_5759', 'Honokiol', 0, 'Homocysteine'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0000922', 'embryo', 64, 'fetal'), ('UBERON_0000178', 'blood', 70, 'blood')]
PMC4673623	11/2015	S87-PMC4673623	['betaine, which is derived from Choline and serves as an alternate to Folate as a source of Methyl Groups for conversion of Homocysteine to methionine, was lower in both the maternal (−39%; p \xa0<\xa00.02) and fetal (−36%, p \xa0<\xa00.02) Blood in the hf-hed group (vs. control).']	N/A	N/A	[('CHEBI_15354', 'choline', 31, 'choline'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate'), ('CHEBI_33961', 'mu4-sulfido-quadro-tetracopper(5+)', 91, 'methyl groups'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 123, 'homocysteine'), ('UBERON_0000178', 'blood', 228, 'blood')]
PMC4673623	11/2015	S88-PMC4673623	['Dimethylglycine, the Metabolite produced when betaine is used as a Methyl Donor and source of one-carbon units for Folate-mediated One-Carbon Metabolism, tended to be lower (−45%) in maternal Blood ( p \xa0<\xa00.1) of the hf-hed group (vs. control); Fetal Blood also exhibited lower Dimethylglycine but statistical significance was not achieved (fig.3).']	N/A	N/A	[('CHEBI_28212', 'deethylatrazine', 0, 'Dimethylglycine'), ('CHEBI_39382', 'flufenoxuron', 21, 'metabolite'), ('CHEBI_81933', 'methasulfocarb', 67, 'methyl donor'), ('CHEBI_30863', '5-azaorotic acid', 115, 'folate'), ('GO_0006730', 'one-carbon metabolic process', 131, 'one-carbon metabolism'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0000922', 'embryo', 245, 'fetal'), ('UBERON_0000178', 'blood', 251, 'blood'), ('CHEBI_28212', 'deethylatrazine', 278, 'dimethylglycine')]
PMC4673623	11/2015	S91-PMC4673623	['(b)\xa0amino acids in ctr (open, n \xa0=\xa021–22) and hf-hed (filled, n \xa0=\xa05) mat and fet Blood at 0.9\xa0g. data are mean\xa0±\xa0sem; * p \xa0<\xa00.05 versus ctr;†0.05\xa0<\xa0 p \xa0<\xa00.10 versus ctr.']	N/A	N/A	[('UBERON_0000178', 'blood', 82, 'blood')]
PMC4673623	11/2015	S100-PMC4673623	['caption (fig): figure 4\n\nLipid parameters in Baboon Pregnancy at 0.9\xa0g in control (open, n \xa0=\xa08–11) and hf-hed (filled, n \xa0=\xa05) maternal (Mat) and fetal (fet) Blood.']	N/A	N/A	[('CHEBI_18059', 'lipid', 25, 'Lipid'), ('NCBITaxon_33208', 'Metazoa', 45, 'baboon'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('UBERON_0001448', 'metatarsal bone', 138, 'MAT'), ('UBERON_0000178', 'blood', 159, 'blood')]
PMC4673623	11/2015	S111-PMC4673623	['maternal obesity alters circulating concentrations of Methyl-Nutrients\nmaternal and Fetal Blood concentrations of Vitamin B-12 were depleted in the hf-hed group as compared with the control group.']	N/A	N/A	[('CHEBI_33837', 'conjugated protein', 54, 'methyl-nutrients'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0000178', 'blood', 90, 'blood'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12')]
PMC4675066	12/2015	S53-PMC4675066	['a Blood sample was also collected at baseline by venepuncture to assess Thyroid Hormone concentrations, including Thyroid-Stimulating Hormone (Tsh), thyroglobulin (tg), free Triiodothyronine (ft3) and free Thyroxine (ft4).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('CHEBI_60311', 'thyroid hormone', 72, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 72, 'thyroid'), ('CHEBI_9437', 'temoporfin', 114, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 114, 'thyroid'), ('CHEBI_66524', 'streptokordin', 122, 'stimulating hormone'), ('CHEBI_17855', 'triglyceride', 143, 'TSH'), ('CHEBI_26982', 'threo-3-methylmalic acid', 174, 'triiodothyronine'), ('CHEBI_17842', 'trypanothione', 206, 'thyroxine')]
PMC4675066	12/2015	S54-PMC4675066	['Thyroid function of newborns was also assessed from Cord Blood (tsh, ft3, ft4 and tg) and from newborn screening (tsh only).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 0, 'Thyroid'), ('UBERON_0002240', 'spinal cord', 52, 'cord'), ('UBERON_0000178', 'blood', 57, 'blood')]
PMC4675066	12/2015	S99-PMC4675066	['ga Gestational age\n\ncaption (table-wrap): table 3\n\nbiomarkers of Iodine statusiodineplaceboeffect (95\xa0% ci) p valuecord Blood n \u2009=\u200919 n \u2009=\u200922free Triiodothyronine, pmol/la2.3 (0.4)2.3 (0.6)0.0 (−0.4, 0.3)0.81free Thyroxine, pmol/la14.4 (2.1)13.8 (2.3)0.6 (−0.9, 2.2)0.40thyroid-stimulating hormone, miu/lb8.2 (5.9–13.5)6.6 (4.5–9.6)n/a0.25thyroglobulin, μg/lb73.0 (48.0–100.0)64.0 (44.0–121.0)n/a0.66(n\u2009=\u200928)(n\u2009=\u200929)newborn tsh, miu/la2.1 (1.0)2.2 (1.2)−0.1 (−0.7, 0.5)0.79newborn tsh\u2009>\u20095c0 (0.0)0 (0.0)n/an/a(n\u2009=\u200920)(n\u2009=\u200925)Breast milk Iodine at 6\xa0weeks’ post-Partum, μg/lb106.0 (84.0–146.0)124.0 (76.0–155.0)n/a0.74\nci confidence interval, n/a not applicable, Tsh Thyroid-Stimulating Hormone\nadata are presented as mean (standard deviation), and the treatment effect is the difference in means\nbdata are presented as median (interquartile range)\ncdata are presented as number (percentage)\n\nPregnancy and other clinical outcomes\nthe mean Birth weight, length, Head circumference and Gestational Age at Birth did not differ between the groups (table\xa04).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'gestational'), ('CHEBI_24859', 'iodine atom', 65, 'iodine'), ('UBERON_0000178', 'blood', 120, 'blood'), ('CHEBI_26982', 'threo-3-methylmalic acid', 146, 'triiodothyronine'), ('CHEBI_17842', 'trypanothione', 213, 'thyroxine'), ('UBERON_0000310', 'breast', 525, 'Breast'), ('CHEBI_24859', 'iodine atom', 537, 'iodine'), ('GO_0007567', 'parturition', 561, 'partum'), ('PR_000016711', 'TSC22 domain family protein 1', 662, 'TSH'), ('CHEBI_9437', 'temoporfin', 666, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 666, 'thyroid'), ('PR_000004775', 'BMP-binding endothelial regulator protein', 673, '-stimulating hormone'), ('CHEBI_66524', 'streptokordin', 674, 'stimulating hormone'), ('GO_0007565', 'female pregnancy', 892, 'Pregnancy'), ('GO_0007567', 'parturition', 939, 'birth'), ('UBERON_0000033', 'head', 961, 'head'), ('GO_0007565', 'female pregnancy', 984, 'gestational age'), ('GO_0007567', 'parturition', 1003, 'birth')]
PMC4682386	12/2015	S36-PMC4682386	['[18]\nto maximise the available information, mother-infant pairs were only eligible to be included in the current study if the child attended the 2 year clinical examination and the following biological samples collected 3 months Postpartum were available: Breast Milk from the mother, a Blood sample from the infant and Stool samples from both.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 229, 'postpartum'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk'), ('UBERON_0000178', 'blood', 287, 'blood'), ('UBERON_0001988', 'feces', 320, 'stool')]
PMC4682386	12/2015	S38-PMC4682386	['amissing 1 or more of the following biological samples collected at 3 months post-Partum: Breast Milk and Stool samples from mother, Blood and Stool samples from the infant.']	N/A	N/A	[('GO_0007567', 'parturition', 82, 'partum'), ('UBERON_0001348', 'brown adipose tissue', 90, 'breast milk'), ('UBERON_0001988', 'feces', 106, 'stool'), ('UBERON_0000178', 'blood', 133, 'blood'), ('UBERON_0001988', 'feces', 143, 'stool')]
PMC4682815	12/2015	S61-PMC4682815	['Placental weight was measured after removing Blood clots, cutting the Umbilical Cord flush with its insertion into the Placenta, trimming away surrounding membranes and removing the Amnion from the Basal Plate.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002331', 'umbilical cord', 70, 'umbilical cord'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000305', 'amnion', 182, 'amnion'), ('UBERON_0004064', 'neural tube basal plate', 198, 'basal plate')]
PMC4682819	12/2015	S37-PMC4682819	['Milk and Blood sample collection\nMilk and Blood samples of each dam were collected on days 5, 10 and 15 of Lactation, and under ad libitum Feeding conditions.']	N/A	N/A	[('UBERON_0001913', 'milk', 0, 'Milk'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001913', 'milk', 33, 'Milk'), ('UBERON_0000178', 'blood', 42, 'blood'), ('GO_0007595', 'lactation', 107, 'lactation'), ('GO_0007631', 'feeding behavior', 139, 'feeding')]
PMC4682819	12/2015	S40-PMC4682819	['for Plasma isolation, Blood samples (over 400–600 μl approximately) were collected from the Saphenous Vein in heparinized containers and then centrifuged at 1000 g for 10 min to obtain the Plasma, which was subsequently stored at −20°c until its use.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 4, 'plasma'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0007318', 'saphenous vein', 92, 'saphenous vein'), ('UBERON_0001969', 'blood plasma', 189, 'plasma')]
PMC4683742	12/2015	S68-PMC4683742	['baby-friendly hospitals, peer facilitators) including mainstreaming breastfeeding into the scale-up of mnhprenatal care• maternity waiting homes, some combined with mch services and income generation activities• yoga for high risk Pregnancies• education for first time Childbearing women• group Prenatal caremedical products and health technologiesmaternal• non-pneumatic anti-shock garment to stabilize and resuscitate hypovolemic shock• automated Blood pressure devices for low resource settings• single use obstetric emergency kits• misoprostol for community-based use, storage and application system for Oxytocin Delivery and balloon condom catheter to treat intractable Uterine bleeding• foilized Polyethylene pouch to store neviparine• low-cost, low-tech devices: portable ob ultrasound and doppler, simplified partograph, vacuum delivery/emoc devices, Birth simulator, cell-phone-based malaria diagnostics, hemoglobinmeter, emoc transporter (eranger)• clean delivery kitsneonatal• low-cost devices: ventilator support, temperature measurement, pulse oximeter and phototherapy• devices to prevent pmtct (e.g.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 231, 'pregnancies'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 269, 'childbearing'), ('GO_0007565', 'female pregnancy', 295, 'prenatal'), ('UBERON_0000178', 'blood', 449, 'blood'), ('CHEBI_7872', 'oxytocin', 608, 'oxytocin'), ('GO_0007567', 'parturition', 617, 'delivery'), ('UBERON_0000995', 'uterus', 675, 'uterine'), ('CHEBI_53551', 'poly(methylene)', 702, 'polyethylene'), ('GO_0007567', 'parturition', 859, 'birth')]
PMC4683742	12/2015	S98-PMC4683742	['the array of Maternal health technologies include non-pneumatic anti-shock garments to stabilize and resuscitate hypovolemic shock in Pregnant women, automated Blood pressure devices tailored for low resource settings, single use obstetric emergency kits, and low-cost, low-tech devices such as portable obstetrical ultrasound equipment [38,66].']	N/A	N/A	[('GO_0007618', 'mating', 13, 'maternal'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('UBERON_0000178', 'blood', 160, 'blood')]
PMC4685088	12/2015	S51-PMC4685088	['clinical chorioamnionitis is evidenced by fever >37.5°c, Uterine tenderness, foul smelling vaginal discharge, Abdominal pain, maternal tachycardia with a Heart rate >100\u2009bpm, fetal \xadtachycardia hr >160\u2009bpm, and White Blood Cell (wbc) count\u2009>15,000/mm3(38,39).']	N/A	N/A	[('UBERON_0000995', 'uterus', 57, 'uterine'), ('UBERON_0000916', 'abdomen', 110, 'abdominal'), ('UBERON_0000948', 'heart', 154, 'heart'), ('CL_0000738', 'leukocyte', 211, 'white blood cell'), ('UBERON_0000178', 'blood', 217, 'blood')]
PMC4689556	12/2015	S87-PMC4689556	['levels of 25(Oh)D at baseline in the mother, in Cord Blood and at age three years in the child were all normally distributed after natural log transformation.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 10, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 10, '25(OH ... D'), ('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood')]
PMC4689556	12/2015	S107-PMC4689556	['the characteristics of children with complete records in each randomization group are shown intable 4.10.1371/journal.pone.0145303.t003\n\ncaption (table-wrap): table 3\ncharacteristics of children with complete e-hr data, incomplete e-hr data and for whom no e-hr data were received.complete(n = 99)incomplete(n = 12)not received(n = 69)male sex, n (%)52/99 (53)7/12 (58)34/69 (49)Gestational age, weeks39.6 (1.57)40.5 (1.27)39.6 (1.27)Delivery by caesarean section, n (%)30/99 (30)4/12 (33)23/69 (33)Cord Blood 25(Oh) Vitamin D available, n (%)79/99 (80)7/12 (58)55/69 (80)mean Cord Blood 25(Oh) vit d (nmol/l)26.9 (13.6)30.6 (19.1)24.3 (11.0)maternal ethnicity, n (%)\u2003asian25/99 (25)3/12 (25)17/69 (25)\u2003middle eastern25/99 (25)5/12 (42)15/69 (22)\u2003black21/99 (21)2/12 (17)21/69 (30)\u2003caucasian28/99 (28)2/12 (17)16/69 (23)maternal age at booking, years32 (6.45)30 (5.47)30 (6.02)maternal smoking in Pregnancy, n (%)13/99 (13)0/12 (0)6/69 (9)multiparous, n (%)65/99 (66)5/12 (42)31/69 (45)maternal bmi at booking27 (6.07)26 (5.51)25 (4.99)maternal 25(Oh) vit D at Delivery available n(%)86/99 (87)10/12 (83)62/69 (90)maternal 25(Oh) vit d at Delivery42.65 (22.2)44.0 (22.3)37.9 (18.0)\ncontinuous data are presented as mean (standard deviation).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 379, 'Gestational'), ('GO_0007586', 'digestion', 434, 'Delivery'), ('UBERON_0000948', 'heart', 499, 'Cord'), ('UBERON_0000178', 'blood', 504, 'blood'), ('CHEBI_30778', 'gallic acid', 510, '25(OH)'), ('CHEBI_28384', 'vitamin K', 517, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 577, 'cord'), ('UBERON_0000178', 'blood', 582, 'blood'), ('CHEBI_63056', 'zinc cation', 588, '25(OH'), ('GO_0007565', 'female pregnancy', 897, 'pregnancy'), ('CHEBI_63056', 'zinc cation', 1045, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1056, 'D'), ('GO_0007567', 'parturition', 1061, 'delivery'), ('CHEBI_63056', 'zinc cation', 1123, '25(OH'), ('GO_0007567', 'parturition', 1139, 'delivery42')]
PMC4689556	12/2015	S108-PMC4689556	['bmi = body mass index.10.1371/journal.pone.0145303.t004\n\ncaption (table-wrap): table 4\ncharacteristics of children with complete e-hr data.control (n = 31)daily (n = 36)bolus (n = 32)male sex, n (%)15/31 (48)22/36 (61)17/32 (53)Gestational age, months39.92 (1.28)39.40 (1.53)39.72 (1.66)Delivery by caesarean section, n (%)10/31 (32)10/36 (28)10/32 (31)Cord Blood 25(Oh) Vitamin D available, n (%)24/31 (77)29/36 (81)26/32 (81)mean Cord Blood 25(Oh) vit d (nmol/l)18.8 (9.4)34.1 (16.3)26.4(8.31)maternal ethnicity, n (%)\u2003asian6/31 (19)10/36 (28)9/32 (28)\u2003middle eastern11/31 (35)8/36 (22)6/32 (19)\u2003black5/31 (16)8/36 (22)8/32 (25)\u2003caucasian9/31 (29)10/36 (28)9/32 (28)maternal age at booking, years30 (7)32 (6)32 (6)maternal highest education, years20 (3)20 (4)20 (3)family history of atopy, n (%)13/29 (45)23/35 (63)15/31 (48)maternal smoking in Pregnancy, n (%)5/31 (16)5/36 (14)3/31 (10)number children in household2 (1)2 (1)3 (1)multiparous, n (%)19/31 (61)25/36 (69)21/32 (66)maternal bmi > 30 at booking, n (%)9/31 (29)4/36 (11)4/32 (12.5)maternal 25(Oh) vit D at Delivery available n(%)26/31(83)33/36 (92)27/32 (84)maternal 25(Oh) vit D at Delivery33.0 (17.6)55.3(27.0)36.5(9.5)\ncontinuous and ordinal data are presented as mean (standard deviation).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 228, 'Gestational'), ('GO_0007586', 'digestion', 287, 'Delivery'), ('UBERON_0000948', 'heart', 353, 'Cord'), ('UBERON_0000178', 'blood', 358, 'blood'), ('CHEBI_30778', 'gallic acid', 364, '25(OH)'), ('CHEBI_28384', 'vitamin K', 371, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 432, 'cord'), ('UBERON_0000178', 'blood', 437, 'blood'), ('CHEBI_63056', 'zinc cation', 443, '25(OH'), ('GO_0007565', 'female pregnancy', 847, 'pregnancy'), ('CHEBI_63056', 'zinc cation', 1054, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1065, 'D'), ('GO_0007567', 'parturition', 1070, 'delivery'), ('CHEBI_63056', 'zinc cation', 1131, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1142, 'D'), ('GO_0007567', 'parturition', 1147, 'delivery33')]
PMC4690051	12/2015	S31-PMC4690051	['of the 1455 live births, 1020 mother-child dyads completed the 2-year clinic exam and had mothers who provided Blood for 25(Oh)D levels during the second Trimester.figure 1outlines the participants available for this study.']	N/A	N/A	[('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 121, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 154, 'trimester')]
PMC4690060	12/2015	S39-PMC4690060	['Blood samples were taken by Cardiac puncture, and major Organs were weighed and snap-frozen in liquid N2.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 28, 'cardiac'), ('UBERON_0000062', 'organ', 56, 'organs'), ('CHEBI_17997', 'dinitrogen', 102, 'N2')]
PMC4690060	12/2015	S47-PMC4690060	['Plasma amino acid concentration\nall Blood samples were collected into heparinized capillary tubes and stored on ice until centrifuged in a hematocrit centrifuge.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 36, 'blood')]
PMC4691762	12/2015	S55-PMC4691762	['infants will be invited in for a clinical assessment, Blood sample and allergy testing at age 12\u2005months at the completion of the intervention.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood')]
PMC4691762	12/2015	S56-PMC4691762	['an optional rch clinic visit at age 6\u2005months will be offered to participants and will include an eczema examination and Blood draw.']	N/A	N/A	[('UBERON_0000178', 'blood', 120, 'blood')]
PMC4692114	1/2016	S2-PMC4692114	['edta-treated Cord Blood samples were analyzed by flow cytometry and the software kaluza1.2 using Cd45 and Cd34-specific fluorescent Antibodies to identify the hspc population (Cd34+cells within the cd45dimblast gate).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('PR_000001309', 'CD70 molecule', 97, 'CD45'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 106, 'CD34'), ('GO_0042571', 'immunoglobulin complex, circulating', 132, 'antibodies'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 176, 'CD34')]
PMC4692114	1/2016	S3-PMC4692114	['the proportion of Cd34+Cd45Dimhspcs among the Nucleated Cells was significantly ( p \u2009<\u20090.05, statistical power\u2009=\u200960.8%) higher in the cord Blood samples of neonates Born to mothers with gdm (median 0.38%) compared to neonates Born to nondiabetic mothers (median 0.32%) and according to treatment types ( p \u2009<\u20090.05) median: control 0.32%, gdm-diet only 0.37%, gdm-on Insulin 0.45%; control versus gdm on Insulin ( p \u2009<\u20090.05).']	N/A	N/A	[('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 18, 'CD34'), ('PR_000002114', 'voltage-dependent L-type calcium channel subunit alpha-1D', 23, 'CD45dimHSPCs'), ('CL_0002242', 'nucleate cell', 46, 'nucleated cells'), ('UBERON_0000178', 'blood', 139, 'blood'), ('GO_0007567', 'parturition', 165, 'born'), ('GO_0007567', 'parturition', 226, 'born'), ('PR_000045358', 'insulin family protein', 366, 'insulin'), ('PR_000045358', 'insulin family protein', 403, 'insulin')]
PMC4692114	1/2016	S13-PMC4692114	['patients and Cord Blood collection\naltogether, 45 Pregnant women with gdm as well as 42 control Pregnant women were enrolled immediately after their routine ogtt between the 24th and 28th Gestational week on a voluntary basis after signing the informed consent.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('GO_0007565', 'female pregnancy', 188, 'gestational')]
PMC4692114	1/2016	S17-PMC4692114	['Cord Blood samples were collected from the Umbilical Vein using the Cord clamping technique as soon as it was possible after Birth.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0002066', 'umbilical vein', 43, 'umbilical vein'), ('UBERON_0002240', 'spinal cord', 68, 'cord'), ('GO_0007567', 'parturition', 125, 'birth')]
PMC4692114	1/2016	S20-PMC4692114	['flow cytometric analysis\nedta-treated Cord Blood samples were analyzed by flow cytometry (beckman coulter navios flow cytometer, kaluza 1.2 software).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC4692114	1/2016	S24-PMC4692114	['residual Red Blood Cells (Rbc) were filtered out from the Leukocytes according to their absent Cd45 Expression.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 9, 'red blood cells'), ('UBERON_0000178', 'blood', 13, 'blood'), ('CL_0000232', 'erythrocyte', 26, 'RBC'), ('CL_0000738', 'leukocyte', 58, 'leukocytes'), ('PR_000001309', 'CD70 molecule', 95, 'CD45'), ('GO_0010467', 'gene expression', 100, 'expression')]
PMC4692114	1/2016	S32-PMC4692114	['Red Blood Cells were separated from Nucleated Cells according to their absent Cd45 Expression in the undead (nonpermeable for 7-aad) cell population.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 0, 'Red blood cells'), ('UBERON_0000178', 'blood', 4, 'blood'), ('CL_0002242', 'nucleate cell', 36, 'nucleated cells'), ('PR_000001309', 'CD70 molecule', 78, 'CD45'), ('GO_0010467', 'gene expression', 83, 'expression')]
PMC4692114	1/2016	S49-PMC4692114	['we found a significant difference (kruskal–wallis test p \u2009<\u20090.05) in the proportion of Hspcs among the Nucleated Cord Blood Cell population among different study groups according to the maternal gdm diagnosis and treatment types (control: median 0.32% [sd20.03], gdm requiring only diet 0.37% [sd20.07], and gdm on Insulin therapy 0.45% [sd20.05]) (fig.']	N/A	N/A	[('CL_0000743', 'hypertrophic chondrocyte', 87, 'HSPCs'), ('CL_0002242', 'nucleate cell', 103, 'nucleated'), ('GO_0005634', 'nucleus', 103, 'nucleated'), ('CL_0000421', 'coelomocyte', 113, 'cord blood cell'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0000178', 'blood', 118, 'blood'), ('PR_000045358', 'insulin family protein', 315, 'insulin')]
PMC4692114	1/2016	S54-PMC4692114	['box plot of the proportion of Hematopoietic Stem and Progenitor Cells among Nucleated Cord Blood Cells in different study groups according to maternal Gestational diabetes mellitus (gdm) diagnosis and Insulin therapy.']	N/A	N/A	[('CL_0008001', 'hematopoietic precursor cell', 30, 'hematopoietic stem ... progenitor cells'), ('GO_0030097', 'hemopoiesis', 30, 'hematopoietic'), ('CL_0002242', 'nucleate cell', 76, 'nucleated'), ('GO_0005634', 'nucleus', 76, 'nucleated'), ('CL_0000162', 'parietal cell', 86, 'cord blood cells'), ('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood'), ('GO_0007565', 'female pregnancy', 151, 'gestational'), ('CHEBI_66075', 'inflexin', 201, 'insulin'), ('PR_000045358', 'insulin family protein', 201, 'insulin')]
PMC4699824	12/2015	S14-PMC4699824	['Nifedipine, a Calcium Channel Blocker did not affect Blood pressure in programmed Rats [16].']	N/A	N/A	[('CHEBI_7575', 'nimodipine', 0, 'Nifedipine'), ('CHEBI_38215', 'calcium channel blocker', 14, 'calcium channel blocker'), ('UBERON_0000178', 'blood', 53, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 82, 'rats')]
PMC4699824	12/2015	S35-PMC4699824	['measurement of Blood pressure\nBlood pressure was measured in the 6 groups at 6 months of age.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'Blood'), ('UBERON_0000178', 'blood', 30, 'Blood')]
PMC4699824	12/2015	S36-PMC4699824	['the investigator that measured the Blood pressure was blinded as to which group the Rat belonged.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 84, 'rat')]
PMC4699824	12/2015	S37-PMC4699824	['Rats were trained for 4 days for measurement of systolic Blood pressure.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('UBERON_0000178', 'blood', 57, 'blood')]
PMC4699824	12/2015	S39-PMC4699824	['the Blood pressure was measured using Tail cuff with a coda Blood non-invasive pressure analyzer (kent scientific corporation, torrington, ct), which uses a volume pressure recording.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0002415', 'tail', 38, 'tail'), ('UBERON_0000178', 'blood', 60, 'Blood')]
PMC4699824	12/2015	S41-PMC4699824	['the average of six Blood pressure readings was used as the Blood pressure for that Rat.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0000178', 'blood', 59, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 83, 'rat')]
PMC4699824	12/2015	S46-PMC4699824	['Blood collections\nafter measurement of Blood pressure and the Urine collection, Blood was obtained by retro-Orbital puncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0001088', 'urine', 62, 'urine'), ('UBERON_0000178', 'blood', 80, 'blood'), ('UBERON_0001697', 'orbit of skull', 108, 'orbital')]
PMC4699824	12/2015	S47-PMC4699824	['Rats were anesthetized with Isoflurane and Blood was collected with a heparinized capillary and placed in a chilled tube containing 20 μmol/l enalaprilat, 5 mmol/l edta, 10 μmol/l Pepstatin A and 1 mmol/l 1,10-phenanthrolene (all chemicals were from sigma chemical co., st. louis, mo) to prevent Peptide Degradation [30–32].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_6015', 'isoflurane', 28, 'isoflurane'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_7989', 'pepstatin A', 180, 'pepstatin A'), ('GO_0043171', 'peptide catabolic process', 296, 'peptide degradation')]
PMC4699824	12/2015	S48-PMC4699824	['the Blood was centrifuged at 1,200 g for 10 min at 4°c and then stored at -80°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4699824	12/2015	S49-PMC4699824	['Urine and Blood assays\nUrine protein was measured using the bradford assay (bio-rad laboratories, hercules, ca).']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 10, 'Blood'), ('UBERON_0001088', 'urine', 23, 'Urine')]
PMC4699824	12/2015	S52-PMC4699824	['for measurement of Blood and Urine Angiotensin Ii, we used a protocol similar to that previously described by our laboratory [30,33,34].']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001088', 'urine', 29, 'urine'), ('PR_000002200', 'cytoplasmic tyrosine-protein kinase BMX', 35, 'angiotensin II')]
PMC4699824	12/2015	S64-PMC4699824	['results\nin the first series of experiments we measured Blood pressure in the 6 groups in a blinded fashion as shown infig 1.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood')]
PMC4699824	12/2015	S66-PMC4699824	['the 6% group that received continuous Enalapril (6%Ce) had a reduction in Blood pressure to a value not different than the 20% group and the 20%ce group.']	N/A	N/A	[('CHEBI_4784', 'enalapril', 38, 'enalapril'), ('CHEBI_17996', 'chloride', 51, 'CE'), ('UBERON_0000178', 'blood', 74, 'blood')]
PMC4699824	12/2015	S68-PMC4699824	['the 20% continuous Enalapril group had a lower Blood pressure than the 20% group and the 6% and 20% transient enalapril groups.10.1371/journal.pone.0146183.g001\n\ncaption (fig): fig 1\neffect of continuous and transient Enalapril on Blood pressure in control and programmed Rats.']	N/A	N/A	[('CHEBI_4784', 'enalapril', 19, 'enalapril'), ('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_4784', 'enalapril', 218, 'enalapril'), ('UBERON_0000178', 'blood', 231, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 272, 'rats')]
PMC4699824	12/2015	S74-PMC4699824	['Blood pressure was measured by Tail cuff after 4 days of training.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002415', 'tail', 31, 'tail')]
PMC4699824	12/2015	S75-PMC4699824	['the Blood pressures were measured in a blinded fashion.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4699824	12/2015	S77-PMC4699824	['the continuous enalapril groups had a lower Blood pressure than the corresponding transient enalapril group.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood')]
PMC4699824	12/2015	S117-PMC4699824	['we find that both continuous and transient therapy with Enalapril normalized the Blood pressure in Adult offspring due to maternal dietary protein deprivation.']	N/A	N/A	[('CHEBI_4784', 'enalapril', 56, 'enalapril'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0007023', 'adult organism', 99, 'adult')]
PMC4700169	12/2015	S44-PMC4700169	['on physical exam, the patient was tachycardic with stable Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood')]
PMC4701853	1/2016	S4-PMC4701853	['at Delivery, Placenta and Cord Blood were sampled and newborn anthropometry measured.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0001987', 'placenta', 13, 'placenta'), ('UBERON_0002240', 'spinal cord', 26, 'cord'), ('UBERON_0000178', 'blood', 31, 'blood')]
PMC4701853	1/2016	S53-PMC4701853	['collection and analysis of Blood samples\nmaternal Venous Blood was collected at 24 and 34 weeks of Gestation and during labor.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0001638', 'vein', 50, 'venous'), ('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0007565', 'female pregnancy', 99, 'gestation')]
PMC4701853	1/2016	S54-PMC4701853	['Umbilical Venous Blood samples were collected within 30 minutes after Placental Delivery from a double-clamped section of Umbilical Cord.']	N/A	N/A	[('UBERON_0008883', 'osteoid', 0, 'Umbilical venous'), ('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0007565', 'female pregnancy', 70, 'placental'), ('UBERON_0001987', 'placenta', 70, 'placental'), ('GO_0007567', 'parturition', 80, 'delivery'), ('UBERON_0002331', 'umbilical cord', 122, 'umbilical cord')]
PMC4701853	1/2016	S56-PMC4701853	['Blood samples for Serum preparation were left at 4 c for 15 minutes to allow Blood clotting, centrifuged at 3500 rpm for 10 minutes, and the Serum fraction transferred into sterile tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 18, 'serum'), ('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0001977', 'blood serum', 141, 'serum')]
PMC4701853	1/2016	S114-PMC4701853	['Maternal, Placental, and Cord Blood Metabolic characteristics: n, ow, o, gdmn, and gdmo Pregnant womenmaternal Blood at termn (n = 59)ow (n = 29)o (n = 22)Gdmn (n = 14)Gdmo (n = 11)Glucose (mmol/liter)4.3 ± 1.34.6 ± 1.35.3 ± 2.3a6.0 ± 2.2c6.1 ± 1.9ctriglyceride (mmol/liter)11.7 ± 3.913.2 ± 4.212.8 ± 4.311.6 ± 3.912.3 ± 3.3leptin (μg/liter)16.0 ± 13.624.2 ± 23.533.9 ± 21.9b21.1 ± 16.436.6 ± 19.9bmonocyte count (×109/liter)0.5 ± 0.20.6 ± 0.20.6 ± 0.20.6 ± 0.30.40 ± 0.2cord Blooddn (n = 33)ow (n = 18)o (n = 16)Gdn (n = 10)Gdo (n = 7)Glucose (mmol/liter)3.8 ± 1.23.6 ± 1.23.3 ± 1.33.9 ± 0.74.3 ± 1.0triglyceride (mmol/liter)2.7 ± 1.12.5 ± 0.82.5 ± 1.42.5 ± 1.32.5 ± 1.2leptin (μg/liter)19.7 ± 17.932.7 ± 19.662.3 ± 69.0a42.6 ± 31.5a36.6 ± 19.9monocyte count (×109/liter)1.0 ± 0.41.1 ± 0.41.4 ± 0.6a1.2 ± 0.81.1 ± 0.4placental Tissuen (n = 59)ow (n = 29)o (n = 22)Gdn (n = 14)Gdo (n = 11)total Placental tg (mg/g) per Placental weight (g)19.9 ± 10.022.0 ± 10.923.9 ± 12.819.7 ± 10.628.3 ± 16.5arelative Placental Tbars1.0 ± 0.30.9 ± 0.30.8 ± 0.21.0 ± 0.31.0 ± 0.3\nabbreviations: gdmn, Gestational diabetic normal weight; gdmo, Gestational diabetic mellitus obese; n, normal weight; o, obese; ow, overweight; tbars, Thiobarbituric Acid reactive substance; tg, Triglyceride.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001987', 'placenta', 10, 'Placental'), ('UBERON_0000948', 'heart', 25, 'Cord'), ('UBERON_0000178', 'blood', 30, 'Blood'), ('GO_0008152', 'metabolic process', 36, 'Metabolic'), ('GO_0007565', 'female pregnancy', 88, 'Pregnant'), ('UBERON_0000178', 'blood', 111, 'Blood'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'GDMN'), ('CHEBI_74612', "Ins-1-P-Cer B/B' 34:0(1-)", 168, 'GDMO'), ('CHEBI_17234', 'glucose', 181, 'Glucose'), ('UBERON_0000178', 'blood', 476, 'BlooddN'), ('CHEBI_16038', 'phosphatidylethanolamine', 513, 'GDN'), ('CHEBI_37038', "purine ribonucleoside 5'-diphosphate", 525, 'GDO'), ('CHEBI_17234', 'glucose', 536, 'Glucose'), ('UBERON_0000479', 'tissue', 828, 'TissueN'), ('CHEBI_16038', 'phosphatidylethanolamine', 865, 'GDN'), ('CHEBI_37038', "purine ribonucleoside 5'-diphosphate", 877, 'GDO'), ('UBERON_0001987', 'placenta', 895, 'placental'), ('UBERON_0001987', 'placenta', 919, 'placental'), ('UBERON_0001987', 'placenta', 1004, 'placental'), ('PR_000016139', 'TATA box-binding protein-like 2', 1014, 'TBARS1'), ('GO_0007565', 'female pregnancy', 1086, 'gestational'), ('GO_0007565', 'female pregnancy', 1128, 'gestational'), ('CHEBI_9592', 'tiglic acid', 1216, 'thiobarbituric acid'), ('CHEBI_17855', 'triglyceride', 1260, 'triglyceride')]
PMC4701853	1/2016	S152-PMC4701853	['Plasma leptin concentrations were raised in Cord Blood of infants Born to obese and obese gdm mothers.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007567', 'parturition', 66, 'born')]
PMC4714725	1/2016	S260-PMC4714725	['ascvd risk factors include ldl Cholesterol ≥100 mg/dl (2.6 mmol/l), high Blood pressure, smoking, overweight and obesity, and family history of premature ascvd.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 31, 'cholesterol'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC4719746	1/2016	S32-PMC4719746	['data from questionnaires, measurements and Blood samples were collected at 15 and 28\xa0weeks of Gestation, through interviews by specially trained and certified midwives according to the study protocol, assisted by professional interpreters when needed.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0007565', 'female pregnancy', 94, 'gestation')]
PMC4719746	1/2016	S77-PMC4719746	['numbers are frequencies (%) and means (sd)totalwestern europeasouth asiamiddle eastsub-saharan africaeast asiaothern\u2009=\u2009748n\u2009=\u2009304n\u2009=\u2009189n\u2009=\u2009113n\u2009=\u200951n\u2009=\u200940n\u2009=\u200951100\xa0%41\xa0%25\xa0%15\xa0%6.8\xa0%5.3\xa0%6.8\xa0%pre-Pregnancy maternal status\u2003years of maternal age; mean (sd)29.9 (4.9)30.9 (4.5)28.7 (4.5)29.6 (5.5)28.1 (5.2)31.1 (4.5)29.3 (5.1)\u2003parity; n (%)\u2003\u2003para 0340 (46)156 (51)78 (41)39 (35)22 (43)17 (42)28 (55)\u2003\u2003para 1259 (34)113 (37)63 (33)39 (35)11 (22)16 (40)17 (33)\u2003\u2003para ≥2149 (20)35 (12)48 (25)35 (30)18 (35)7 (18)6 (12)ᅟeducation level; n (%)bᅟᅟ<10\xa0years119 (16)10 (3.3)33 (18)41 (36)22 (43)8 (20)5 (9.8)ᅟᅟ10-12 years296 (40)93 (30)95 (50)51 (45)22 (43)16 (40)19 (37)ᅟᅟ>12\xa0years327 (44)199 (66)60 (32)19 (17)7 (14)16 (40)26 (51)ᅟpre-Pregnancy bmib(kg/m2); mean (sd)24.6 (4.8)24.6 (4.8)23.7 (4.1)25.8 (5.0)26.1 (6.1)22.2 (3.4)24.9 (5.4)status at inclusionᅟgestational week; mean (sd)15.4 (3.6)14.5 (2.4)15.9 (4.1)15.6 (3.3)17.9 (5.4)16.4 (4.3)15.5 (3.4)ᅟseason of Blood sample; n (%)ᅟᅟwinter395 (53)158 (52)92 (49)70 (62)32 (63)22 (55)21 (41)ᅟvitamin d supplements; n (%)bᅟᅟno or <10\xa0μg daily past two weeks307 (41)104 (34)93 (49)55 (49)25 (49)12 (30)18 (35)status at Gestational week 28ᅟgestational week; mean (sd)28.8 (1.4)28.7 (1.3)28.7 (1.4)29.0 (1.6)29.0 (1.5)28.7 (1.2)29.0 (1.7)ᅟweight gain (week 28 minus 15); mean (sd)6.6 (3.2)6.7 (2.7)6.5 (3.3)6.7 (3.6)4.6 (3.0)6.2 (2.5)8.0 (3.9)ᅟseason of Blood sample; n (%)ᅟᅟwinter410 (55)178 (59)97 (51)65 (57)28 (55)17 (57)25 (49)ᅟvitamin d supplements; n (%)bᅟᅟno or <10\xa0μg daily past two weeks243 (33)115 (38)41 (22)37 (33)20 (40)14 (35)16 (31)\nnotes:\ncountries with ≥10 Individuals are listed: 304 women from western europe, primarily from norway ( n \u2009=\u2009278), 189 women from south asia, primarily from pakistan n \u2009=\u2009120), sri lanka ( n \u2009=\u200956) and india ( n \u2009=\u200912), 113 women from the middel east, primarily from iraq (n\u2009=\u200934), morocco ( n \u2009=\u200927), turkey (n\u2009=\u200925), afghanistan ( n \u2009=\u200912), 51 women from sub-saharan africa, primarily from somalia ( n \u2009=\u200932), 40 women from east asia, primarily vietnam ( n \u2009=\u200917), philippines ( n \u2009=\u200912).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 197, 'pregnancy'), ('GO_0007565', 'female pregnancy', 728, 'pregnancy'), ('UBERON_0000178', 'blood', 958, 'blood'), ('GO_0007565', 'female pregnancy', 1162, 'gestational'), ('UBERON_0000178', 'blood', 1395, 'blood'), ('NCBITaxon_1', 'root', 1616, 'individuals')]
PMC4719746	1/2016	S125-PMC4719746	['the Blood samples were analyzed at the same laboratory with standardized methods.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4721332	11/2014	S118-PMC4721332	['in addition to alterations in Blood flow, stress-induced activation of the Sympathetic Nervous System leads to the release of Epinephrine and norepinephrine.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0000013', 'sympathetic nervous system', 75, 'sympathetic nervous system'), ('CHEBI_48509', 'triflic anhydride', 126, 'epinephrine')]
PMC4722751	1/2016	S5-PMC4722751	['among 484 mother-infant pairs, Dna Methylation at Regulatory sequences of Genomically Imprinted Genes was measured in Umbilical Cord Blood dna using Bisulfite pyrosequencing.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 31, 'DNA methylation'), ('GO_0065007', 'biological regulation', 50, 'regulatory'), ('SO_0001026', 'genome', 74, 'genomically'), ('GO_0071514', 'genetic imprinting', 86, 'imprinted'), ('SO_0000704', 'gene', 96, 'genes'), ('UBERON_0002331', 'umbilical cord', 118, 'umbilical cord'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_29874', 'bromine dioxide', 149, 'bisulfite')]
PMC4722751	1/2016	S34-PMC4722751	['Blood draw occurred during the first Trimester for most participants (64\xa0%).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0009294', 'DNA mediated transformation', 37, 'trimester')]
PMC4722751	1/2016	S37-PMC4722751	['caption (table-wrap): table 1\n\nstudy participant characteristics by maternal b Vitamin concentrations: newborn epigenetic study ( n \u2009=\u2009496)variableb12(ng/l)plp (nm/l)pa (nm/l)hcy (umol/l) n \u2009=\u2009489 n \u2009=\u2009496 n \u2009=\u2009496 n \u2009=\u2009480 n (%)median (range)age at Delivery (year)\u200320–29278 (56%)428.44 (56.13–2628.11)6.66 (0.00–54.90)2.85 (0.00–179.19)0.69 (0.30–1.34)\u200318–<\u20092022 (4%)419.05 (216.96–834.27)7.30 (1.25–32.19)3.43 (0.00–24.92)0.75 (0.44–0.98)\u200330–35147 (30%)495.38 (151.24–3664.91)8.46 (0.00–173.86)3.70 (0.00–218.44)0.70 (0.33–1.54)\u200336+50 (10%)411.46 (148.62–2779.17)9.02 (0.41–76.90)2.85 (0.00–122.61)0.71 (0.35–1.07)race/ethnicity\u2003black186 (42%)431.76 (109.44–1249.75)5.62 (0.00–34.58)2.41 (0.00–130.60)0.70 (0.30–1.54)\u2003white133 (30%)493.67 (56.13–3664.91)8.87 (0.00–173.86)4.85 (0.00–218.44)0.73 (0.44–1.19)\u2003hispanic121 (28%)432.25 (93.47–2779.17)8.07 (1.60–30.24)2.94 (0.00–30.01)0.69 (0.33–1.22)Preterm Birth\u2003term468 (94%)444.02 (56.13–3664.91)7.35 (0.00–173.86)3.21 (0.00–218.44)0.70 (0.30–1.54)\u2003Preterm29 (6%)485.71 (162.05–891.89)7.91 (0.00–34.58)3.24 (0.00–30.01)0.66 (0.33–1.08)marital status\u2003married186 (38%)485.98 (148.62–3664.91)8.89 (0.00–173.86)4.25 (0.00–218.44)0.71 (0.30–1.22)\u2003never married141 (29%)443.03 (56.13–2628.11)5.86 (0.95–34.58)2.57 (0.00–130.60)0.70 (0.35–1.34)\u2003living with partner136 (28%)406.87 (133.52–1570.18)7.73 (0.00–31.59)2.94 (0.00–35.09)0.69 (0.44–1.54)\u2003other28 (5%)398.20 (128.05–2779.17)7.55 (0.00–35.12)2.55 (0.00–11.38)0.71 (0.33–1.10)parity (at enrollment)\u2003multiparous320 (65%)443.89 (56.13–3664.91)6.74 (0.00–173.86)2.77 (0.00–218.44)0.69 (0.33–1.54)\u2003nulliparous176 (35%)454.01 (109.44–1600.50)9.02 (0.00–63.59)4.34 (0.00–186.65)0.71 (0.30–1.21)household income\u2003<$25,000215 (55%)414.91 (128.05–2779.17)6.66 (0.00–56.00)2.71 (0.00–30.01)0.68 (0.35–1.34)\u2003$25,000–$49,99954 (14%)426.39 (162.05–855.61)6.25 (0.00–173.86)3.20 (0.00–218.44)0.72 (0.30–1.54)\u2003$50,000–$100,00073 (18%)500.13 (143.07–3664.91)9.92 (0.00–76.90)4.67 (0.00–179.19)0.73 (0.43–1.19)\u2003>$100,00050 (13%)507.86 (148.62–1600.50)11.32 (1.34–63.59)5.52 (0.79–186.65)0.68 (0.44–1.10)education\u2003college graduate145 (29%)508.50 (148.62–3664.91)9.15 (0.00–173.86)4.60 (0.00–218.44)0.70 (0.30–1.21)\u2003high school/ged108 (22%)381.84 (56.13–1038.75)6.02 (0.00–54.90)2.63 (0.00–179.19)0.70 (0.40–1.14)\u2003less than high school166 (34%)437.94 (93.47–2779.17)6.78 (0.00–35.12)2.74 (0.00–30.01)0.68 (0.33–1.34)\u2003some college75 (15%)415.24 (195.26–1600.50)7.08 (0.00–56.00)3.18 (0.00–119.67)0.72 (0.48–1.54)body mass index (kg/m2)\u200318.5–24.99195 (41%)482.78 (93.47–2779.17)8.35 (0.00–173.86)3.95 (0.00–218.44)0.70 (0.40–1.22)\u200325–29.99149 (31%)436.88 (140.80–3664.91)6.92 (0.41–52.23)2.75 (0.00–130.60)0.69 (0.30–1.34)\u2003>29.99135 (28%)392.29 (56.13–1570.18)5.85 (0.00–39.70)2.78 (0.00–36.57)0.71 (0.40–1.54)smoking status\u2003no smoking358 (74%)450.11 (93.47–2779.17)7.91 (0.00–173.86)3.31 (0.00–218.44)0.70 (0.30–1.34)\u2003smoking prior to Pregnancy49 (10%)433.03 (195.26–3664.91)7.71 (0.00–70.22)3.42 (0.00–129.48)0.65 (0.44–1.04)\u2003smoking during Pregnancy79 (16%)447.62 (56.13–1570.18)5.27 (0.35–39.70)2.74 (0.30–130.60)0.71 (0.40–1.54)Folic Acid supplementation\u2003yes433 (89%)441.19 (56.13–2779.17)7.04 (0.00–76.90)3.08 (0.00–186.65)0.70 (0.30–1.54)\u2003no52 (11%)461.59 (143.07–3664.91)9.87 (2.34–173.86)3.49 (0.00–218.44)0.69 (0.45–1.19)Gestational diabetes\u2003no461 (94%)447.62 (56.13–3664.91)7.35 (0.00–173.86)3.10 (0.00–218.44)0.69 (0.30–1.54)\u2003yes30 (6%)415.23 (195.26–841.23)9.07 (1.43–33.29)3.41 (0.93–36.57)0.72 (0.53–1.07)Gestational age at Blood draw\u20031st trimester316 (64%)455.71 (56.13–3664.91)8.85 (0.00–173.86)3.51 (0.00–218.44)0.71 (0.30–1.54)\u20032nd trimester166 (33%)415.23 (109.44–2779.17)5.77 (0.00–32.19)2.70 (0.00–36.57)0.66 (0.40–1.34)\u20033rd trimester15 (3%)301.80 (216.96–759.84)3.06 (0.35–11.64)2.16 (0.00–30.01)0.62 (0.44–1.03)infant sex\u2003male248 (50%)444.75 (109.44–3664.91)7.33 (0.00–76.90)3.25 (0.00–179.19)0.70 (0.33–1.19)\u2003female249 (50%)447.77 (56.13–2779.17)7.54 (0.00–173.86)3.18 (0.00–218.44)0.69 (0.30–1.54)\nb12vitamin B12, plp Pyridoxal Phosphate, pa 4-Pyridoxic Acid, Hcy Homocysteine\n\nassociations between maternal Micronutrient concentrations (e.g., b12, plp, pa, and Hcy) and Birth weight\nthe mean Birth weight in our study sample was 3294\xa0g (standard deviation\u2009=\u2009541\xa0g).']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 79, 'vitamin'), ('GO_0007567', 'parturition', 250, 'delivery'), ('GO_0007128', 'meiotic prophase I', 898, 'Preterm'), ('GO_0007567', 'parturition', 906, 'birth'), ('GO_0007128', 'meiotic prophase I', 1000, 'Preterm29'), ('GO_0007608', 'sensory perception of smell', 2914, 'pregnancy49'), ('GO_0007565', 'female pregnancy', 3021, 'pregnancy79'), ('CHEBI_30751', 'formic acid', 3111, 'Folic acid'), ('GO_0007565', 'female pregnancy', 3309, 'Gestational'), ('GO_0007565', 'female pregnancy', 3498, 'Gestational'), ('UBERON_0000178', 'blood', 3517, 'blood'), ('CHEBI_27778', 'abequose', 4013, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 4013, 'B12'), ('CHEBI_26435', 'pyrimidine deoxyribonucleoside triphosphate', 4022, 'pyridoxal phosphate'), ('CHEBI_30913', 'L-pipecolic acid', 4046, '4-pyridoxic acid'), ('CHEBI_37958', 'dye', 4064, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 4064, 'Hcy'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 4068, 'homocysteine'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 4112, 'micronutrient'), ('CHEBI_37958', 'dye', 4166, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 4166, 'Hcy'), ('GO_0007567', 'parturition', 4175, 'birth'), ('GO_0007567', 'parturition', 4197, 'birth')]
PMC4722751	1/2016	S39-PMC4722751	['all models adjusted for race/ethnicity, Gestational age at Blood draw and Delivery, marital status, parity, income, pre-Pregnancy bmi, and maternal smoking.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 40, 'gestational'), ('UBERON_0000178', 'blood', 59, 'blood'), ('GO_0007567', 'parturition', 74, 'delivery'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy')]
PMC4722751	1/2016	S47-PMC4722751	['table\xa03shows the linear associations between maternal Micronutrient concentrations and age 3-year wg adjusted for Gestational age at Blood draw, maternal race/ethnicity, maternal pre-Pregnancy bmi, household income, breastfeeding, and age 3-year caloric intake.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 54, 'micronutrient'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('UBERON_0000178', 'blood', 133, 'blood'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy')]
PMC4722751	1/2016	S76-PMC4722751	['Blood concentrations of Hcy during Pregnancy are variable: a slight decrease during early Gestation; a nadir between 20 and 32\xa0weeks; and subsequent rise after Delivery [26].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_37958', 'dye', 24, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 24, 'Hcy'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007565', 'female pregnancy', 90, 'gestation'), ('GO_0007567', 'parturition', 160, 'delivery')]
PMC4722751	1/2016	S115-PMC4722751	['of the remaining women, we measured b vitamin/hcy concentrations from the maternal Venous Blood of the first 528, 63\xa0% of which was drawn during the first Trimester.']	N/A	N/A	[('UBERON_0001638', 'vein', 83, 'venous'), ('UBERON_0000178', 'blood', 90, 'blood'), ('GO_0009294', 'DNA mediated transformation', 155, 'trimester')]
PMC4722751	1/2016	S116-PMC4722751	['these analyses are restricted to the 496 singleton infant-mother pairs in whose Blood draw and Birth weight data were available.']	N/A	N/A	[('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007567', 'parturition', 95, 'birth')]
PMC4722751	1/2016	S117-PMC4722751	['data collection\ndata collection occurred at multiple time points throughout the study period as follows: (1) upon enrollment, participants provided peripheral Blood samples (Gestational age at enrollment: range\u2009=\u20094.0–32.5\xa0weeks, mean\u2009=\u200912\xa0weeks) and completed a self-administered questionnaire which queried women on their sociodemographic, Reproductive, and lifestyle characteristics in the 6\xa0months prior; (2) upon Delivery, Birth outcomes were abstracted from medical records and infant cord Blood specimens were obtained to assess offspring methylation; and (3) at age 3\xa0years, data on child anthropometry and dietary characteristics were obtained for 273 of the 496 offspring for whom maternal b Vitamins were measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 159, 'blood'), ('GO_0007565', 'female pregnancy', 174, 'gestational'), ('GO_0000003', 'reproduction', 341, 'reproductive'), ('GO_0007567', 'parturition', 417, 'delivery'), ('GO_0007567', 'parturition', 427, 'birth'), ('UBERON_0000178', 'blood', 495, 'blood'), ('CHEBI_33277', 'gamma-tocotrienol', 701, 'vitamins')]
PMC4722751	1/2016	S154-PMC4722751	['for all models, we considered adjustment for the following covariates: maternal age, race/ethnicity, Gestational age at Delivery, marital status, parity upon enrollment, household, maternal education, maternal bmi at lmp, maternal smoking, maternal Fa supplementation, Gestational diabetes, Gestational age at Blood draw, and infant sex.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007567', 'parturition', 120, 'delivery'), ('CHEBI_30751', 'formic acid', 249, 'FA'), ('GO_0007565', 'female pregnancy', 269, 'gestational'), ('GO_0007565', 'female pregnancy', 291, 'gestational'), ('UBERON_0000178', 'blood', 310, 'blood')]
PMC4728620	1/2016	S90-PMC4728620	['as was the case with Cognitive outcomes, boys and girls in the Fish oil group were found to have comparable diastolic and mean Arterial Blood pressures, whereas girls had higher Blood pressures than boys in the control group [64].']	N/A	N/A	[('GO_0050890', 'cognition', 21, 'cognitive'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 63, 'fish'), ('UBERON_0001637', 'artery', 127, 'arterial'), ('UBERON_0000178', 'blood', 136, 'blood'), ('UBERON_0000178', 'blood', 178, 'blood')]
PMC4728639	1/2016	S48-PMC4728639	['sample collection\nat days zero (e0, just prior to Mating), seven (e7, early Pregnancy), 14 (e14, mid Pregnancy) and 20 (e20, near-term), Blood was collected from the Tail after 3 h of fasting.']	N/A	N/A	[('GO_0007618', 'mating', 50, 'mating'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy'), ('UBERON_0000178', 'blood', 137, 'blood'), ('UBERON_0002415', 'tail', 166, 'tail')]
PMC4728639	1/2016	S50-PMC4728639	['after the mothers were anesthetized, the tip of the Tail was heated with a ultraviolet (uv) lamp to facilitate Blood flow then snipped with a surgical blade.']	N/A	N/A	[('UBERON_0002415', 'tail', 52, 'tail'), ('UBERON_0000178', 'blood', 111, 'blood')]
PMC4728639	1/2016	S51-PMC4728639	['Blood was collected in ice-cooled tubes containing 1 mg/ml of Na2-edta.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_26710', 'sodium chloride', 62, 'Na2')]
PMC4728639	1/2016	S53-PMC4728639	['after the last Blood collection (e20), mothers were maintained under anesthesia and whole Liver, lumbar adipose tissue, and Placenta were collected and stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC4728639	1/2016	S55-PMC4728639	['determination of Blood Glucose and Serum Insulin concentrations and Lipid profiles\nBlood Glucose (Glucometer, precision qid, medisense, cambridge, uk) and Serum Insulin (Rat Insulin ria kit, linco research, st. charles, mo, usa) concentrations were measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'Blood'), ('CHEBI_17234', 'glucose', 23, 'Glucose'), ('UBERON_0001977', 'blood serum', 35, 'Serum'), ('PR_000045358', 'insulin family protein', 41, 'Insulin'), ('CHEBI_18059', 'lipid', 68, 'Lipid'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('CHEBI_17234', 'glucose', 89, 'glucose'), ('CHEBI_24321', 'glutamo group', 98, 'glucometer'), ('UBERON_0001977', 'blood serum', 155, 'serum'), ('PR_000045358', 'insulin family protein', 161, 'insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 170, 'rat'), ('PR_000045358', 'insulin family protein', 174, 'insulin')]
PMC4728659	1/2016	S60-PMC4728659	['Blood was sampled from the Tip Of the Tail in conscious Rats followed by an oral Glucose gavage (2 g/kg).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0010162', 'post-anal tail tip', 27, 'tip of ... tail'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rats'), ('CHEBI_17234', 'glucose', 81, 'glucose')]
PMC4728659	1/2016	S61-PMC4728659	['at 15, 30, 60 and 90 min post-Glucose gavage, additional Blood was sampled from the Tail and immediately analyzed using a Blood Glucose meter (accu-chek Blood Glucose meter, laval, qc, canada).']	N/A	N/A	[('CHEBI_17234', 'glucose', 30, 'glucose'), ('UBERON_0000178', 'blood', 57, 'blood'), ('UBERON_0002415', 'tail', 84, 'tail'), ('UBERON_0000178', 'blood', 122, 'blood'), ('CHEBI_17234', 'glucose', 128, 'glucose'), ('UBERON_0000178', 'blood', 153, 'Blood'), ('CHEBI_17234', 'glucose', 159, 'Glucose')]
PMC4728659	1/2016	S64-PMC4728659	['a second ogtt for satiety hormone analysis was performed at the time of terminal Tissue collection and Blood sampled at 0, 15, 30, 60 and 90 min into tubes containing diprotinin-a, sigma protease inhibitor and roche pefabloc at concentrations previously described [12].']	N/A	N/A	[('UBERON_0000479', 'tissue', 81, 'tissue'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC4728659	1/2016	S66-PMC4728659	['the ogtt was a terminal procedure and after the 90 min Blood collection Rats were killed via over-anesthetization and Aortic cut.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 72, 'rats'), ('UBERON_0000947', 'aorta', 118, 'aortic')]
PMC4728659	1/2016	S117-PMC4728659	['Plasma satiety hormones and Blood Glucose\nin males, fasting Insulin was lower in hf1 and hp1 compared to c1 (table 3).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('CHEBI_17234', 'glucose', 34, 'Glucose'), ('PR_000045358', 'insulin family protein', 60, 'insulin')]
PMC4728659	1/2016	S132-PMC4728659	['caption (fig): figure 6\n\nBlood Glucose concentrations during an Oral Glucose tolerance test in male ( a ) and female ( b ) offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'Blood'), ('CHEBI_17234', 'glucose', 31, 'glucose'), ('UBERON_0000165', 'mouth', 64, 'oral'), ('CHEBI_17234', 'glucose', 69, 'glucose')]
PMC4729160	1/2016	S45-PMC4729160	['Blood sample collection,Serum extraction,and laboratory analysis\nfasting Blood samples were obtained by venipuncture from the Antecubital Vein in the morning of the next day after questioning, centrifuged within 0.5–1 h after collecting.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 24, 'serum'), ('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0001545', 'anterior tibial vein', 126, 'antecubital vein')]
PMC4730616	1/2016	S74-PMC4730616	['all participants in this trial are asked for informed consent of storage of maternal Blood (taken with routine laboratory analysis during hospital admission for hg), Cord Blood and Placental biopsies (taken at Birth) in an obstetrical biobank (the preeclampsia and non-Preeclampsia database, academic medical centre amsterdam, the netherlands).']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('UBERON_0001987', 'placenta', 181, 'placental'), ('GO_0007567', 'parturition', 210, 'birth'), ('GO_0007128', 'meiotic prophase I', 269, 'preeclampsia')]
PMC4730616	1/2016	S76-PMC4730616	['furthermore, Cord Blood will be used for the assessment of Plasma Lipids (Cholesterol, hdl, ldl, Triglycerides, Apolipoprotein a and B), Glucose, leptin and Thyroid function (tsh, ft4).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_18059', 'lipid', 66, 'lipids'), ('CHEBI_16113', 'cholesterol', 74, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 97, 'triglycerides'), ('CHEBI_39015', 'apolipoprotein', 112, 'Apolipoprotein'), ('PR_000000037', 'BMP receptor type-2', 133, 'B'), ('CHEBI_17234', 'glucose', 137, 'glucose'), ('UBERON_0002046', 'thyroid gland', 157, 'thyroid')]
PMC4732175	3/2016	S38-PMC4732175	['Blood was collected by Cardiac puncture following euthanasia for measurement of fasting Plasma Glucose (accu-check; roche, mannheim, germany) and total Plasma Lipids by gas chromatography [31].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 23, 'cardiac'), ('UBERON_0001969', 'blood plasma', 88, 'plasma'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_18059', 'lipid', 159, 'lipids')]
PMC4733817	3/2016	S41-PMC4733817	['after their first clinical visit which occurred at the time of enrollment, trained health care providers visited participants in their homes once per month to distribute Prenatal Vitamins, record symptoms, weigh participants, and measure their Blood pressure.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 170, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 179, 'vitamins'), ('UBERON_0000178', 'blood', 244, 'blood')]
PMC4734033	1/2016	S55-PMC4734033	['sample collection and analysis\nafter weaning (day 21), maternal Blood was drawn from the right Orbital Vein via a syringe for measuring the Serum zinc level.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0001661', 'deep temporal vein', 95, 'orbital vein'), ('UBERON_0001977', 'blood serum', 140, 'serum')]
PMC4734033	1/2016	S56-PMC4734033	['at the end of the mwm test, offspring Rats were anesthetized via short inhalation of Ether; Blood was then drawn from the right Orbital Vein via a syringe for measuring the Serum zinc level.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 38, 'rats'), ('CHEBI_25698', 'ether', 85, 'ether'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0001661', 'deep temporal vein', 128, 'orbital vein'), ('UBERON_0001977', 'blood serum', 173, 'serum')]
PMC4734033	1/2016	S57-PMC4734033	['the Blood samples were centrifuged (3,000 rpm for 5 min) (labofuge 400r, heraeus instrument, hanau, germany) and Serum samples were kept at 85°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001977', 'blood serum', 113, 'serum')]
PMC4736099	1/2016	S80-PMC4736099	['2, eleven collected no baseline Blood sample for haemoglobin [21–23,25,28,30,32,34–37], and one indicated clinical screening for anaemia, with baseline Sera storage, and exclusion only if hospital treatment was required [21].']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0001977', 'blood serum', 152, 'sera')]
PMC4736099	1/2016	S230-PMC4736099	['mean 149.8\xa0days pre- and 49.3\xa0days post-Conceptionmonthly capsule countsno85.7\xa0% – 93\xa0% complianceburkina faso [21]yesweeklymaximum 18\xa0monthsdirectly observed Intakeyestrial in progressireland [22]yesdailyat least 2\xa0months pre-Conceptiontablet counts and Blood testshyesnot reportedalgeria [38]nosingle dosageeither 1–3 months pre-Conception, or 1–3 months Gestationdirectly observednot applicable100 %imulti-country 1 [23]yesdailycontinuous until 12thweek Gestationthree monthly capsule countsyes7\xa0% discontinued;g3–8\xa0% took 50–79\xa0%; 0.8\xa0% took <50\xa0%multi-country 2 [29]nodailynot reportedself-reported sachet useyestrial in progressvietnam 2 [26]yesdailymaximum 18\xa0monthstwo weekly capsule countsyestrial in progressnepal [28]yesweekly≤3.5\xa0yearsdirectly observedno?>75\xa0% Pregnant\u2009≥\u200950\xa0%62\xa0% non-Pregnant\u2009≥\u200950\xa0%\nafrom time contraception stopped\nbzero adherence\ncincomplete adherence\ndpercentage total eligible doses consumed\nestarted Supplement before last Menstrual Period before Conception and stopped at end of first trimester\nfstarted Supplement during first trimester but after last Menstrual Period\ngstarted and stopped Supplement before last Menstrual Period before Conception\nhcount frequency not reported\niassuming no refusals\nthe adherence level is one criterion used to distinguish per protocol from intention-to-treat populations.']	N/A	N/A	[('GO_0097501', 'stress response to metal ion', 40, 'conceptionMonthly'), ('GO_0033257', 'Bcl3/NF-kappaB2 complex', 159, 'intakeYesTrial'), ('GO_0060002', 'plus-end directed microfilament motor activity', 227, 'conceptionTablet'), ('UBERON_0000178', 'blood', 255, 'blood'), ('GO_0007620', 'copulation', 331, 'conception'), ('GO_0007530', 'sex determination', 357, 'gestationDirectly'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 457, 'gestationThree'), ('GO_0007565', 'female pregnancy', 773, 'pregnant'), ('GO_0007565', 'female pregnancy', 797, 'pregnant'), ('CHEBI_16158', 'steroid sulfate', 935, 'supplement'), ('GO_0007613', 'memory', 958, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 958, 'menstrual period'), ('GO_0007620', 'copulation', 982, 'conception'), ('CHEBI_16158', 'steroid sulfate', 1040, 'supplement'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 1089, 'menstrual period'), ('CHEBI_16158', 'steroid sulfate', 1127, 'supplement'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 1150, 'menstrual period'), ('GO_0007620', 'copulation', 1174, 'conception')]
PMC4739392	2/2016	S6-PMC4739392	['at study start and end, Lung function parameters, specific Ige, in vitro Allergen-induced Cytokine Production in Peripheral Blood Mononuclear Cells (Pbmc), Plasma ecp, Urinary 8-Oxodg as marker of oxidation, Fatty Acid profiles of Erythrocytes, and routine Haematological parameters were determined.']	N/A	N/A	[('UBERON_0002048', 'lung', 24, 'lung'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 59, 'IgE'), ('CHEBI_50904', 'allergen', 73, 'allergen'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 90, 'cytokine production'), ('CL_0000111', 'peripheral neuron', 113, 'peripheral blood mononuclear cells'), ('UBERON_0012101', 'perinatal stage', 113, 'peripheral blood'), ('GO_0031097', 'medial cortex', 130, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 149, 'PBMC'), ('UBERON_0001969', 'blood plasma', 156, 'plasma'), ('UBERON_0001088', 'urine', 168, 'urinary'), ('CHEBI_82778', 'citrate-coated silver nanoparticle', 176, '8-oxodG'), ('CHEBI_35366', 'fatty acid', 208, 'fatty acid'), ('CL_0000232', 'erythrocyte', 231, 'erythrocytes'), ('UBERON_0000178', 'blood', 257, 'haematological')]
PMC4739392	2/2016	S7-PMC4739392	['prior to Blood samplings, 3-days dietary records were requested.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC4739392	2/2016	S50-PMC4739392	['combined gc-fid and silver-ion hplc analysisafatty Acid (common name)claplacebo oilc14:0 (Myristic Acid)00.1c16:0 (Palmitic Acid)0.18.2c18:0 (Stearic Acid)0.53.4c18:1 c 9 (Oleic Acid)1.819.9c18:1 c 11 (Vaccenic Acid)0.30c18:2 N -6 (Linoleic Acid)3.164.5c18:3 n -3 (Alpha-Linolenic Acid)0.21.0c20:0 (Arachidic Acid)0.10.5c20:1 (eicosenoic acid)0.50.3c20:5 N -3 (Eicosapentaenoic Acid)00other6.82.3∑ cla86.60 c 9, t 11b66.1 c 9, c 1119.2 t 9, t 11c0.9 t 10, c 120.1\nafor detailed information, please refer to [11]\nbcorrected for co-eluting t 8, c 10\nccorrected for co-eluting t 8, t 10\nat the beginning and at the end of the study, dietary records on the three preceding days were requested, Lung function parameters were assessed by Whole Body plethysmography and spirometry, and Venous Blood and 24\xa0h-Urine samples were collected for further analyses.']	N/A	N/A	[('CHEBI_37527', 'acid', 51, 'acid'), ('CHEBI_25459', 'myrtenic acid', 90, 'myristic acid'), ('CHEBI_15756', 'hexadecanoic acid', 115, 'palmitic acid'), ('CHEBI_28842', 'octadecanoic acid', 142, 'stearic acid'), ('CHEBI_30814', 'digallic acid', 172, 'oleic acid'), ('CHEBI_17418', 'valeric acid', 202, 'vaccenic acid'), ('CHEBI_70674', 'erythro-carolignan E', 226, 'n -'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 232, 'linoleic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 262, '3 ('), ('CHEBI_27432', 'alpha-linolenic acid', 265, 'alpha-linolenic acid'), ('CHEBI_28822', 'icosanoic acid', 299, 'arachidic acid'), ('CHEBI_76331', 'N-acetoxy-2-acetamidofluorene', 355, 'n -3 (eicosapentaenoic acid'), ('UBERON_0002048', 'lung', 690, 'lung'), ('UBERON_0000468', 'multicellular organism', 732, 'whole body'), ('UBERON_0001638', 'vein', 779, 'venous'), ('UBERON_0000178', 'blood', 786, 'blood'), ('UBERON_0001088', 'urine', 801, 'urine')]
PMC4739392	2/2016	S55-PMC4739392	['Blood sampling, preparation, and measurements\nprior to and after the 12-week intervention period, peripheral Blood was taken for immunological outcome measures (in vitro cytokine Production Of Leukocytes, specific Ige, Plasma ecp) and Metabolic outcome measures (routine Haematological parameters, analysis of Fatty Acid profiles of Rbc).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 109, 'blood'), ('GO_0002901', 'mature B cell apoptotic process', 179, 'production of leukocytes'), ('CL_0000738', 'leukocyte', 193, 'leukocytes'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 214, 'IgE'), ('UBERON_0001969', 'blood plasma', 219, 'plasma'), ('GO_0008152', 'metabolic process', 235, 'metabolic'), ('UBERON_0000178', 'blood', 271, 'haematological'), ('CHEBI_35366', 'fatty acid', 310, 'fatty acid'), ('CL_0000232', 'erythrocyte', 333, 'RBC')]
PMC4739392	2/2016	S56-PMC4739392	['in vitro Cytokine Production\nPeripheral Blood Mononuclear Cells (Pbmc) were purified from 9\xa0ml Heparin Blood by density gradient centrifugation.']	N/A	N/A	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 9, 'cytokine production'), ('CL_0000111', 'peripheral neuron', 29, 'Peripheral blood mononuclear cells'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0031097', 'medial cortex', 46, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 65, 'PBMC'), ('CHEBI_28304', 'heparin', 95, 'heparin'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC4739392	2/2016	S76-PMC4739392	['routine Haematological parameters\nSerum Cholesterol, Triacylglycerol (Tag), creatinine, alanine aminotransferase (alat), and aspartate aminotransferase (asat) were determined in the routine laboratory of the department of clinical medicine and laboratory diagnostics, friedrich schiller university of jena (head: dr. dr. michael kiehntopf), according to standard methods of the international federation of clinical chemistry and laboratory medicine.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'haematological'), ('UBERON_0001977', 'blood serum', 34, 'Serum'), ('CHEBI_16113', 'cholesterol', 40, 'cholesterol'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 53, 'triacylglycerol'), ('CHEBI_17855', 'triglyceride', 70, 'TAG')]
PMC4739392	2/2016	S104-PMC4739392	['all measured routine Haematological parameters were within their normal physiological range.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'haematological')]
PMC4739392	2/2016	S107-PMC4739392	['caption (table-wrap): table 3\n\nroutine Haematological parametersparameterplacebocla p valuestartendstartendgragr\u2009×\u2009tibcholesterol (mmol/l)4.48\u2009±\u20090.664.39\u2009±\u20090.784.32\u2009±\u20090.764.29\u2009±\u20090.77 0.6410.779 Tag (mmol/l)1.28\u2009±\u20090.691.29\u2009±\u20090.960.90\u2009±\u20090.600.92\u2009±\u20090.55 0.0430.494 creatinine (mmol/l)66.3\u2009±\u200911.664.4\u2009±\u20099.362.3\u2009±\u20095.563.9\u2009±\u20097.9 0.4840.103 asat (μmol/l\u2009×\u2009s)0.49\u2009±\u20090.110.44\u2009±\u20090.090.49\u2009±\u20090.070.48\u2009±\u20090.08 0.5620.186 alat (μmol/l\u2009×\u2009s)0.56\u2009±\u20090.130.55\u2009±\u20090.220.53\u2009±\u20090.100.49\u2009±\u20090.09 0.8850.291\ndata are expressed as means\u2009±\u2009sd;astudy group (placebo/cla),bstudy group (placebo/cla)\u2009×\u2009study time point (start/end); alat – alanine aminotransferase, asat – aspartate aminotransferase, tag – Triacylglycerol\n\ncaption (table-wrap): table 4\n\nuptake of Macronutrients, Ruminant fat, and diet-derived cla.']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'haematological'), ('CHEBI_17855', 'triglyceride', 194, 'TAG'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 673, 'triacylglycerol'), ('CHEBI_33839', 'macromolecule', 731, 'macronutrients'), ('NCBITaxon_33208', 'Metazoa', 747, 'ruminant')]
PMC4739392	2/2016	S121-PMC4739392	['no differences between the study groups and study time points were observed with regard to the Intake of total energy and of the Macronutrients Carbohydrates and protein during the preceding 3 days prior to the Blood sampling.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 95, 'intake'), ('CHEBI_33839', 'macromolecule', 129, 'macronutrients'), ('CHEBI_16646', 'carbohydrate', 144, 'carbohydrates'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC4740094	2/2016	S58-PMC4740094	['Blood samples were taken from the Tail Vein at 0, 30, 60, 90, and 120 min using a Glucometer.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0003481', 'tail vein', 34, 'tail vein'), ('CHEBI_24321', 'glutamo group', 82, 'glucometer')]
PMC4740094	2/2016	S89-PMC4740094	['Oral Glucose tolerance test\nafter administration of Glucose load in the mothers, Blood Glucose levels of all the groups, except n, peaked at 30 min (fig.']	N/A	N/A	[('UBERON_0000978', 'leg', 0, 'Oral'), ('CHEBI_17234', 'glucose', 5, 'glucose'), ('CHEBI_17234', 'glucose', 52, 'glucose'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_17234', 'glucose', 87, 'glucose')]
PMC4740094	2/2016	S92-PMC4740094	['at 120 min, the hfd group had the highest Blood Glucose concentration of 9.60±0.57 mmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_17234', 'glucose', 48, 'glucose')]
PMC4740094	2/2016	S94-PMC4740094	['in offspring, Blood Glucose levels of all the groups except hfd, peaked at 30 min.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_17234', 'glucose', 20, 'glucose')]
PMC4746875	10/2015	S25-PMC4746875	['we searched the databases using the following strategy: for scopus [title-abs-key (maternal or mother) and title-abs-key (calcium) and title-abs-key (Blood pressure)], and for pubmed [“others” (mesh)) or maternal) and “Blood pressure”(mesh) and “dietary supplements”(mesh)) or calcium].']	N/A	N/A	[('UBERON_0000178', 'blood', 150, 'blood'), ('UBERON_0000178', 'blood', 219, 'blood')]
PMC4752899	11/2015	S42-PMC4752899	['in addition, a Blood sample was obtained prior to administration of the study Agent to measure Serum chemistries and a complete Blood count (cbc).']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CHEBI_22339', 'alkyne', 78, 'agent'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('UBERON_0000178', 'blood', 128, 'blood')]
PMC4752899	11/2015	S57-PMC4752899	['prior to discharge, a repeat Blood sample was drawn for Serum chemistries and cbc.']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC4752899	11/2015	S58-PMC4752899	['in addition, after approximately n=100 subjects were recruited, the protocol was amended to include two additional Blood samples collected at varying times post-dosing for population pharmacokinetics, the results of which will be reported elsewhere.']	N/A	N/A	[('UBERON_0000178', 'blood', 115, 'blood')]
PMC4752899	11/2015	S71-PMC4752899	['the study pediatrician performed a history and physical examination and a Heel stick Blood sample was obtained for newborn screening, cbc, and the aforementioned iron and inflammatory analytes.']	N/A	N/A	[('UBERON_0015875', 'heel', 74, 'heel'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC4752899	11/2015	S78-PMC4752899	['sga was defined as Gestational age adjusted birthweight that was <10th percentile based on the multi-racial williams curves.29other secondary efficacy outcomes included change in maternal nutritional status, maternal anemia (hemoglobin < 11.0 g/dl), hemoglobin, and iron status at 32 weeks Gestation, newborn hemoglobin and iron status measured on a Heel Stick Blood sample at 2–6 days of Life, Prematurity defined as Gestation < 37 weeks, and parasitologic “cure” as defined by a >90% reduction in s. japonicum Egg count from screening to 22 weeks Gestation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'gestational'), ('GO_0007565', 'female pregnancy', 290, 'gestation'), ('UBERON_0015852', 'narwhal tusk', 350, 'heel stick'), ('UBERON_0000178', 'blood', 361, 'blood'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('GO_0007565', 'female pregnancy', 395, 'prematurity'), ('GO_0007565', 'female pregnancy', 418, 'gestation'), ('CL_0000025', 'egg cell', 512, 'egg'), ('GO_0007565', 'female pregnancy', 549, 'gestation')]
PMC4752899	11/2015	S120-PMC4752899	['there was a significant difference in the change in White Blood Cell and Lymphocyte counts with women in the placebo group experiencing a greater increase from pre- to post-treatment.']	N/A	N/A	[('CL_0000738', 'leukocyte', 52, 'white blood cell'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CL_0000542', 'lymphocyte', 73, 'lymphocyte')]
PMC4754476	2/2016	S31-PMC4754476	['her Blood pressure was in the range of 120–130/75–85\u2009mmhg and she was clinically euvolemic.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4754476	2/2016	S34-PMC4754476	['her initial dialysis prescription included 30\u2009l dialysate and a flow fraction (dialysis flow rate, qd/Blood flow rate, qb) of 40%.']	N/A	N/A	[('UBERON_0000178', 'blood', 102, 'blood')]
PMC4758803	2/2015	S20-PMC4758803	['the following keywords were searched: “epigenetics,” “Dna Methylation,” “Pregnancy,” “nutrition,” “offspring,” and “Cord Blood.” relevant free-access abstracts were identified and reviewed to determine appropriate studies.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 54, 'DNA methylation'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 116, 'cord'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC4763449	2/2016	S32-PMC4763449	['Blood flow was kept at 300\xa0ml/min during dialysis, and dialysate flow was 500\xa0ml/min.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4763449	2/2016	S37-PMC4763449	['Blood work was monitored initially once weekly and then at least once every 2\xa0weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4763449	2/2016	S47-PMC4763449	['1\n\nestimated fetal weight by Antenatal ultrasound demonstrated normal growth curve\nBlood pressure started to increase at 28\xa0weeks Gestation.']	N/A	N/A	[('GO_0007567', 'parturition', 29, 'antenatal'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('GO_0007565', 'female pregnancy', 130, 'gestation')]
PMC4763449	2/2016	S48-PMC4763449	['she was started on Labetalol 100\xa0mg orally twice per day for systolic Blood pressure in the range of 150\xa0mmhg and Diastolic Blood pressure in the range of 100\xa0mmhg, with good control until 33\xa0weeks of Gestation when Blood pressure rose again, and the Labetalol dose was progressively increased to 200\xa0mg every 6\xa0h. on clinical exam, she did not have evidence of volume overload.']	N/A	N/A	[('CHEBI_31764', 'Laudanosoline', 19, 'labetalol'), ('UBERON_0000178', 'blood', 70, 'blood'), ('GO_0007586', 'digestion', 114, 'diastolic'), ('UBERON_0000178', 'blood', 124, 'blood'), ('GO_0007565', 'female pregnancy', 201, 'gestation'), ('UBERON_0000178', 'blood', 216, 'blood'), ('CHEBI_31764', 'Laudanosoline', 251, 'labetalol')]
PMC4763449	2/2016	S49-PMC4763449	['because of uncontrolled Blood pressure (Blood pressure 160/110 to 170/102) she underwent c-section at 35\xa0weeks of Gestation, and gave Birth to a healthy girl weighing 2012\xa0g. she was not treated with Magnesium Sulphate.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('GO_0007567', 'parturition', 134, 'birth'), ('CHEBI_31795', 'magnesium sulfate heptahydrate', 200, 'magnesium sulphate')]
PMC4763449	2/2016	S54-PMC4763449	['Blood was drawn immediately prior to the Hemodialysis treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0030097', 'hemopoiesis', 41, 'hemodialysis')]
PMC4764298	2/2016	S30-PMC4764298	['the patients had Blood drawn for Genetic and biochemical analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('SO_0000704', 'gene', 33, 'genetic')]
PMC4764298	2/2016	S36-PMC4764298	['laboratory investigation was performed in a sub-set of study participants (902 participants in years 2006–2008) to determine the concentrations of Red Blood Cell (Rbc) Folate.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 147, 'red blood cell'), ('UBERON_0000178', 'blood', 151, 'blood'), ('CL_0000232', 'erythrocyte', 163, 'RBC'), ('CHEBI_30863', '5-azaorotic acid', 168, 'folate')]
PMC4764298	2/2016	S37-PMC4764298	['Blood was drawn from the Antecubital Vein or from the Hand of the participating women, and tested using the methods described by branum et al [19].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002386', 'forelimb zeugopod', 25, 'antecubital'), ('UBERON_0001638', 'vein', 37, 'vein'), ('UBERON_0002398', 'manus', 54, 'hand')]
PMC4764298	2/2016	S39-PMC4764298	['pe was defined as a Blood pressure greater than 140/90 mmhg on two occasions six hours apart and proteinuria greater than 2+ on dipstick or greater than 300 mg in 24 hour Urine collection, supplemented by clinical symptoms and lab test results such as hellp (hemolysis, elevated Liver enzymes, and low Platelet count), thrombocytopenia, Renal insufficiency, impaired Liver function, Pulmonary edema, Cerebral or Visual symptoms, and elevated Uric Acid levels, in the absence of proteinuria.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0001088', 'urine', 171, 'urine'), ('UBERON_0002107', 'liver', 279, 'liver'), ('CL_0000233', 'platelet', 302, 'platelet'), ('UBERON_0002113', 'kidney', 337, 'renal'), ('UBERON_0002107', 'liver', 367, 'liver'), ('UBERON_0002048', 'lung', 383, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 400, 'cerebral'), ('GO_0007601', 'visual perception', 412, 'visual'), ('CHEBI_27226', 'uric acid', 442, 'uric acid')]
PMC4764298	2/2016	S50-PMC4764298	['low Rbc Folate was defined as <10thpercentile of each Gestational week at which the Blood was taken.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 4, 'RBC'), ('CHEBI_30863', '5-azaorotic acid', 8, 'folate'), ('GO_0007565', 'female pregnancy', 54, 'gestational'), ('UBERON_0000178', 'blood', 84, 'blood')]
PMC4772030	1/2016	S14-PMC4772030	['Blood Mns and hemoglobin concentration in Pregnant women can be Modulated by Food rations, the provision of mn supplements, the availability of seasonal mn-rich Food, and also with normal physiological adaptations that occur during Gestation such as Plasma volume expansion [6,7,8,9,10,11,12,13].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001456', 'face', 6, 'MNs'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0065007', 'biological regulation', 64, 'modulated'), ('CHEBI_33290', 'food', 77, 'food'), ('CHEBI_33290', 'food', 161, 'food'), ('GO_0007565', 'female pregnancy', 232, 'gestation'), ('UBERON_0001969', 'blood plasma', 250, 'plasma')]
PMC4772030	1/2016	S22-PMC4772030	['all women gave written consent for a Blood sample, which was collected only once in the Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC4772030	1/2016	S45-PMC4772030	['laboratory investigations\ncapillary Blood for hematocrit measurement was collected on-site in the maela camp and used to derive hemoglobin levels [16].']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood')]
PMC4772030	1/2016	S47-PMC4772030	['non-fasting edta-whole Blood (5 ml) and whole Blood for Serum was collected between 10:00 a.m. and 12:00 midday by venipuncture into vacutainers.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood'), ('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC4772030	1/2016	S48-PMC4772030	['whole Blood and Serum were portioned into eppendorf tubes and frozen at −20 °c before transportation to the smru office in mae sot, where they were stored at −80 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 16, 'serum')]
PMC4772030	1/2016	S49-PMC4772030	['samples were then sent (on dry ice) to the university of hohenheim in stuttgart, germany for the analysis of iron status, infection markers, fat-soluble Vitamins and Trace Elements of Serum and Thiamine Diphosphate in whole Blood [5].']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 153, 'vitamins'), ('CHEBI_33301', 'bismuth atom', 166, 'trace elements'), ('UBERON_0001977', 'blood serum', 184, 'serum'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 194, 'thiamine diphosphate'), ('UBERON_0000178', 'blood', 224, 'blood')]
PMC4772030	1/2016	S54-PMC4772030	['Retinol, Α-/Γ-Tocopherol, and α-/Β-Carotene in Serum and Thiamine Diphosphate (tdp) in whole Blood were determined by hplc.']	N/A	N/A	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_37038', "purine ribonucleoside 5'-diphosphate", 9, 'α-/'), ('CHEBI_27725', 'butin', 12, 'γ-tocopherol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 33, 'β-carotene'), ('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_9532', 'thiamine(1+) diphosphate', 57, 'thiamine diphosphate'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC4772030	1/2016	S58-PMC4772030	['whole Blood samples were transferred to the institute of nutrition, jena, to analyze 5-Methyltetrahydrofolate (5-Mthf) by hplc as previously described [24] with modifications: samples were incubated with Dithiothreitol (20 g/l) in addition to Ascorbic Acid Solution (20 g/l), and an eurospher ii analytical column (100-5 Phenyl 250 × 4.6 mm, knauer gmbh, germany) in combination with a mobile phase consisting 17.5% Methanol ( v / v ) in Formic Acid buffer (70 mmol/l, ph 3.75) was used for the separation of 5-mthf.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_20612', '5-methyltetrahydrofolate', 85, '5-methyltetrahydrofolate'), ('CHEBI_60944', 'alpha-D-Galp-(1->3)-alpha-D-GalpNAc', 111, '5-MTHF'), ('CHEBI_18320', '1,4-dithiothreitol', 204, 'dithiothreitol'), ('CHEBI_22652', 'ascorbic acid', 243, 'ascorbic acid'), ('CHEBI_75958', 'solution', 257, 'solution'), ('CHEBI_30396', 'phenyl group', 321, 'Phenyl'), ('CHEBI_17790', 'methanol', 416, 'methanol'), ('CHEBI_30751', 'formic acid', 438, 'formic acid'), ('CHEBI_16382', 'iodide', 509, '5-')]
PMC4772030	1/2016	S61-PMC4772030	['statistical analysis\nmaternal characteristics and data on Blood Mns were described using means ± sd, frequencies (%) and medians with interquartile range.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0001456', 'face', 64, 'MNs')]
PMC4772030	1/2016	S62-PMC4772030	['Blood Mns and Mn deficiencies were compared between surveys (2006 vs. 2004) and for corresponding trimesters using the student′s t -test, the mann-whitney u test, or chi-squared analysis, as appropriate.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000831', 'mast cell progenitor', 6, 'MNs'), ('UBERON_0001456', 'face', 6, 'MNs'), ('UBERON_2001069', 'ventral fin fold', 14, 'MN')]
PMC4772030	1/2016	S64-PMC4772030	['factors associated with Blood Mns in Pregnancy were identified using backward stepwise linear regression ( p ≤ 0.05 to remain in model) using each Blood Mn as the dependent variable (distributions transformed to normal, where necessary).']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0001456', 'face', 30, 'MNs'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('UBERON_0000178', 'blood', 147, 'blood MN')]
PMC4772030	1/2016	S65-PMC4772030	['random effects were fitted for trimester of Blood draw and study year.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood')]
PMC4772030	1/2016	S73-PMC4772030	['years of residence in maela and weeks of provided Mn Supplements at Blood draw were higher in 2006 than in the 2004 survey.']	N/A	N/A	[('CHEBI_34840', 'methyl methacrylate', 50, 'MN'), ('CHEBI_33341', 'titanium atom', 53, 'supplements'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC4774132	3/2016	S123-PMC4774132	['during the first four days post-Partum, women are given meat and soup, tea with milk and Sugar, fat and porridge, and every morning and evening are given fresh Animal Blood to drink.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'partum'), ('CHEBI_24870', 'ion', 89, 'sugar'), ('NCBITaxon_33208', 'Metazoa', 160, 'animal'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC4774132	3/2016	S137-PMC4774132	['such women are given Cow’s Blood and often referred for facility-based Deliveries.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 21, 'cow'), ('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007567', 'parturition', 71, 'deliveries')]
PMC4774132	3/2016	S157-PMC4774132	['diseases are many, and if you touch the Blood you can be infected.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood')]
PMC4774132	3/2016	S161-PMC4774132	['[fgd with tbas, laikipia]\n\npractices of sbas in dispensaries\n\nAntenatal Care by sbas\nsbas provide a range of services for Pregnant women including: assessment of maternal weight, Blood pressure, Fundal height, foetal Heart rate, and foetal positioning.']	N/A	N/A	[('GO_0036503', 'ERAD pathway', 62, 'Antenatal care'), ('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('UBERON_0000178', 'blood', 179, 'blood'), ('UBERON_0003631', 'pedal digit 1', 195, 'fundal'), ('UBERON_0000948', 'heart', 217, 'heart')]
PMC4774132	3/2016	S163-PMC4774132	['some health facilities also provide a full Antenatal work-up, which includes ultrasound, Urinalysis, haemoglobin, Blood grouping and hiv testing.']	N/A	N/A	[('GO_0007567', 'parturition', 43, 'antenatal'), ('UBERON_0001286', "Bowman's space", 89, 'urinalysis'), ('UBERON_0000178', 'blood', 114, 'blood')]
PMC4778858	3/2016	S5-PMC4778858	['Maternal and Cord Blood Sera were analyzed for total 25-Ohd by hplc tandem mass spectrometry.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001977', 'blood serum', 24, 'sera'), ('CHEBI_72765', 'verruculogen', 53, '25-OHD')]
PMC4778858	3/2016	S7-PMC4778858	['results\nMaternal and Cord Blood (n = 360) mean levels (sd) of 25-Ohd were 37.2 (11.2) and 23.4 (9.2) ng/ml, respectively, and these levels were significantly different among the 3 field centers (anova p< 0.001).']	N/A	N/A	[('UBERON_0000976', 'humerus', 8, 'Maternal'), ('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_72765', 'verruculogen', 62, '25-OHD')]
PMC4778858	3/2016	S10-PMC4778858	['Cord Blood 25-Ohd was lower by 0.26 ng/ml for maternal bmi higher by 1 kg/m2(p<0.004).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_72765', 'verruculogen', 11, '25-OHD')]
PMC4778858	3/2016	S12-PMC4778858	['neither Birth weight nor neonatal adiposity was significantly associated with Cord Blood 25-Ohd levels.']	N/A	N/A	[('GO_0007567', 'parturition', 8, 'birth'), ('UBERON_0002240', 'spinal cord', 78, 'cord'), ('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_72765', 'verruculogen', 89, '25-OHD')]
PMC4778858	3/2016	S29-PMC4778858	['Cord Blood was collected at Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 28, 'delivery')]
PMC4778858	3/2016	S32-PMC4778858	['mother/neonate pairs (n = 360) were randomly sampled with evenly distributed seasons of Birth for 25-Ohd measurements on the relevant Blood sample.']	N/A	N/A	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_72765', 'verruculogen', 98, '25-OHD'), ('UBERON_0000178', 'blood', 134, 'blood')]
PMC4778858	3/2016	S35-PMC4778858	['Maternal and Cord Blood Sera were analyzed for total 25-Ohd by hplc tandem mass spectrometry as described [18].']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001977', 'blood serum', 24, 'sera'), ('CHEBI_72765', 'verruculogen', 53, '25-OHD')]
PMC4778858	3/2016	S41-PMC4778858	['Maternal and Cord Blood Sera were assayed for 25-Ohd in one batch to eliminate interassay variation.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001977', 'blood serum', 24, 'sera'), ('CHEBI_72765', 'verruculogen', 46, '25-OHD')]
PMC4778858	3/2016	S70-PMC4778858	['based on fasting, 1-hr and 2-hr Plasma Glucose levels from the 75-g ogtt, 16.4% of the women in this cohort would be classified as having Gestational diabetes mellitus according to the international association of diabetes and Pregnancy study groups (iadpsg) consensus panel [23].10.1371/journal.pone.0150221.t001\n\ncaption (table-wrap): table 1\nmaternal and neonatal characteristics.mean (sd) or n (%) maternal characteristics n = 360age (years)32.5 (4.6)Gestational age at ogtt and bmi measurement (wks)27.8 (1.4)bmi (kg/m2)28.5 (5.3)normal weight (<28.5)216 (60.0%)overweight (28.5–33)75 (20.8%)obese (>33)69 (19.2%)Serum 25-Ohd (ng/ml)37.2 (11.2)fasting Plasma Glucose (mg/dl)82.6 (6.6)Insulin sensitivity3.7 (1.4)Gestational diabetes mellitus^59 (16.4%)field centerchicago, il112 (31.1%)cleveland, oh118 (32.8%)toronto, on130 (36.1%) neonatal characteristics n = 360gestational age (wks)40.1 (0.7)Birth weight (g)3582.3 (429.2)adiposity (% fat)12.3 (3.3)Cord Blood 25-Ohd (ng/ml)23.4 (9.2)Birth seasonwinter181 (50.3%)summer179 (49.7%)\n^international association of diabetes and Pregnancy study groups consensus panel [23]\nMaternal and Cord Blood mean levels of 25-Ohd are displayed infig 1according to field center with the corresponding latitude.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 32, 'plasma'), ('CHEBI_17234', 'glucose', 39, 'glucose'), ('GO_0007565', 'female pregnancy', 138, 'gestational'), ('GO_0007565', 'female pregnancy', 227, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 455, 'Gestational'), ('UBERON_0001977', 'blood serum', 618, 'Serum'), ('CHEBI_72765', 'verruculogen', 624, '25-OHD'), ('PR_000004775', 'BMP-binding endothelial regulator protein', 626, '-OHD'), ('UBERON_0001969', 'blood plasma', 657, 'Plasma'), ('CHEBI_17234', 'glucose', 664, 'Glucose'), ('PR_000045358', 'insulin family protein', 689, 'Insulin'), ('GO_0007565', 'female pregnancy', 717, 'Gestational'), ('GO_0007567', 'parturition', 901, 'Birth'), ('UBERON_0000948', 'heart', 958, 'Cord'), ('UBERON_0000178', 'blood', 963, 'blood'), ('CHEBI_72765', 'verruculogen', 969, '25-OHD'), ('GO_0007567', 'parturition', 993, 'Birth'), ('GO_0007565', 'female pregnancy', 1083, 'Pregnancy'), ('UBERON_0000976', 'humerus', 1127, 'Maternal'), ('UBERON_0002240', 'spinal cord', 1140, 'cord'), ('UBERON_0000178', 'blood', 1145, 'blood'), ('CHEBI_72765', 'verruculogen', 1166, '25-OHD')]
PMC4778858	3/2016	S74-PMC4778858	['bars display mean levels +/- sd, solid gray for maternal Serum and hatched light grey for Cord Blood.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 57, 'serum'), ('UBERON_0002240', 'spinal cord', 90, 'cord'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC4778858	3/2016	S75-PMC4778858	['cleveland, oh: n = 118; maternal 25-ohd = 36.1 ± 10.6, Cord Blood = 25.0 ± 10.0 ng/ml; chicago, il: n = 112; maternal 25-Ohd = 41.7 ± 10.7, Cord Blood = 24.7 ± 9.0 ng/ml; toronto, on: n = 130; maternal 25-Ohd = 34.1 ± 11.0, Cord Blood = 20.6 ± 8.0 ng/ml.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 55, 'cord'), ('UBERON_0000178', 'blood', 60, 'blood'), ('CHEBI_72765', 'verruculogen', 118, '25-OHD'), ('UBERON_0002240', 'spinal cord', 140, 'cord'), ('UBERON_0000178', 'blood', 145, 'blood'), ('CHEBI_72765', 'verruculogen', 202, '25-OHD'), ('UBERON_0002240', 'spinal cord', 224, 'cord'), ('UBERON_0000178', 'blood', 229, 'blood')]
PMC4778858	3/2016	S76-PMC4778858	['field center levels of 25-Hydroxyvitamin D were significantly different for both maternal and Cord Blood, (anova p< 0.001).']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 23, '25-hydroxyvitamin D'), ('UBERON_0002240', 'spinal cord', 94, 'cord'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC4778858	3/2016	S82-PMC4778858	['additional adjustment for season at the time of ogtt and maternal Blood collection in the model for maternal 25-Ohd level did not appreciably change the results (data not shown).10.1371/journal.pone.0150221.t002\n\ncaption (table-wrap): table 2\nlinear regression analysis of the relationship between maternal Serum 25-Ohd at ogtt and maternal factors.univariate modeladjusted model^beta estimate (95% ci)p valuebeta estimate (95% ci)p valuebmi (kg/m2) at ogtt (27.8 wks)-0.48 (-0.71, -0.25)<0.001-0.40 (-0.62, -0.17)<0.001fasting Plasma Glucose (mg/dl)-0.02 (-0.22, 0.17)0.830.05 (-0.14, 0.25)0.59insulin sensitivity1.29 (0.40, 2.19)0.0050.40 (-0.60, 1.39)0.43gdm (yes v. no)0.18 (-3.20, 3.56)0.920.74 (-2.57, 4.04)0.66\n^all models were adjusted for maternal age and field center; fasting Plasma Glucose, Insulin sensitivity and gdm models were additionally adjusted for maternal bmi.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_72765', 'verruculogen', 109, '25-OHD'), ('UBERON_0001977', 'blood serum', 307, 'serum'), ('CHEBI_72765', 'verruculogen', 313, '25-OHD'), ('UBERON_0001969', 'blood plasma', 528, 'plasma'), ('CHEBI_17234', 'glucose', 535, 'glucose'), ('UBERON_0001969', 'blood plasma', 787, 'plasma'), ('CHEBI_17234', 'glucose', 794, 'glucose'), ('PR_000045358', 'insulin family protein', 803, 'insulin')]
PMC4778858	3/2016	S84-PMC4778858	['in univariate analysis, Cord Blood 25-Ohd is lower by 0.26 ng/ml for maternal bmi higher by 1 kg/m2(p<0.004).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 24, 'cord'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_72765', 'verruculogen', 35, '25-OHD')]
PMC4778858	3/2016	S86-PMC4778858	['neither Birth weight nor neonatal adiposity was significantly associated with Cord Blood 25-Ohd levels in unadjusted or adjusted models.']	N/A	N/A	[('GO_0007567', 'parturition', 8, 'birth'), ('UBERON_0002240', 'spinal cord', 78, 'cord'), ('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_72765', 'verruculogen', 89, '25-OHD')]
PMC4778858	3/2016	S87-PMC4778858	['Cord Blood levels of 25-Ohd were not different in the offspring of mothers with gdm compared to women without gdm in regression analyses (data not shown).10.1371/journal.pone.0150221.g002\n\ncaption (fig): fig 2\nmaternal bmi versus Cord Blood 25-Ohd levels.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_72765', 'verruculogen', 21, '25-OHD'), ('UBERON_0000948', 'heart', 230, 'Cord'), ('UBERON_0000178', 'blood', 235, 'Blood'), ('CHEBI_72765', 'verruculogen', 241, '25-OHD')]
PMC4778858	3/2016	S88-PMC4778858	['scatterplot of Cord Blood 25-Hydroxyvitamin D versus maternal bmi measured at ogtt, n = 360.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 15, 'cord'), ('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 26, '25-hydroxyvitamin D')]
PMC4778858	3/2016	S99-PMC4778858	['if we allow that 100 iu daily raises 25-Ohd by 1 ng/ml, this would translate to the need for an additional 600 iu of supplementation for mothers expecting in winter months to raise their neonate’s Cord Blood to summer levels [25].']	N/A	N/A	[('CHEBI_72765', 'verruculogen', 37, '25-OHD'), ('UBERON_0002240', 'spinal cord', 197, 'cord'), ('UBERON_0000178', 'blood', 202, 'blood')]
PMC4785305	3/2016	S49-PMC4785305	['exploratory outcomes include a composite outcome (incidence of gdm and c-section), maternal weight, Blood pressure, ill days, fetal and neonatal anthropometric measures, including neonatal length and weight, rate of small for Gestational age, apgar score, Placental weight and 1α-hydroxylase activity, in addition to other Placental and Genetic studies, that characterise Mineral and fuel Metabolism.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 226, 'gestational'), ('UBERON_0001987', 'placenta', 256, 'placental'), ('UBERON_0001987', 'placenta', 323, 'placental'), ('SO_0000704', 'gene', 337, 'genetic'), ('CHEBI_46662', 'mineral', 372, 'mineral'), ('GO_0008152', 'metabolic process', 389, 'metabolism')]
PMC4785305	3/2016	S78-PMC4785305	['during this visit, eligibility criteria will be verified and Blood tests for 25(Oh)D level, calcium, phosphate, magnesium, creatinine and Thyroid stimulating hormone (Tsh) will be withdrawn.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 83, 'D'), ('UBERON_0002046', 'thyroid gland', 138, 'thyroid'), ('CHEBI_17855', 'triglyceride', 167, 'TSH')]
PMC4785305	3/2016	S82-PMC4785305	['aub-mc clinical chemistry laboratory partakes in the quality assurance, evaluation and accreditation by the college of american pathologists43and is a participant in the Vitamin D external quality assurance surveillance (deqas) programme.44\n\ncaption (table-wrap): table\xa01\n\ntrial events and outcomes measurestrial event and outcomes measures11–13\u2005weeks (screening visit)15–18\u2005weeks (visit 1)20\u2005weeks24–28\u2005weeks28–32\u2005weeks (visit 2)37–42\u2005weeks delivery (visit 3)1\u2005month post Partum (visit 4)maternal height✓maternal weight, Blood pressure✓✓✓maternal health and diet assessment✓✓✓maternal 25(Oh)D, crea, ca×××maternal Cell count, ph, mg, alb, Tsh, 1,25(Oh)2D×pth××maternal Glucose (1\u2005h)✓maternal 24\u2005h (or spot) Urine collection for calcium and creatinine××maternal Vitamin D Binding Protein××maternal Genetic pathways of Vitamin D Metabolism×fetal us:\nCrown -Rump✓fetal us:\nFemur length\nabdominal circumference\nHead circumference\nbiparietal diameter✓newborn weight, length, Knee to Heel length apgar score✓Placental weight×Placental studies×newborn 25(Oh)D, ca, pth (Cord Blood)×newborn Genetic pathways of Vitamin D Metabolism×infant bone/fat mass×infant weight and length✓infant health and diet assessment✓\n✓test performed for clinical purpose.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 170, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 170, 'Vitamin D'), ('GO_0007567', 'parturition', 473, 'partum'), ('UBERON_0000178', 'blood', 522, 'blood'), ('CHEBI_71657', 'versiconol acetate', 586, '25(OH)D'), ('CL_0000573', 'retinal cone cell', 615, 'cell'), ('CHEBI_17855', 'triglyceride', 640, 'TSH'), ('CHEBI_17996', 'chloride', 646, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 647, '25(OH)2D'), ('CHEBI_17234', 'glucose', 670, 'glucose'), ('UBERON_0001088', 'urine', 708, 'urine'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 762, 'vitamin D binding protein'), ('SO_0000704', 'gene', 798, 'genetic'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 818, 'vitamin D metabolism'), ('UBERON_0002943', 'lingual gyrus', 849, 'crown -rump✓'), ('UBERON_0000981', 'femur', 871, 'Femur'), ('UBERON_0000033', 'head', 908, 'Head'), ('UBERON_0001465', 'knee', 971, 'knee'), ('UBERON_0015875', 'heel', 979, 'heel'), ('UBERON_0001987', 'placenta', 1003, 'Placental'), ('UBERON_0001987', 'placenta', 1020, 'Placental'), ('CHEBI_71657', 'versiconol acetate', 1046, '25(OH)D'), ('UBERON_0009472', 'axilla', 1064, 'cord blood'), ('SO_0000704', 'gene', 1084, 'genetic'), ('CHEBI_27300', 'vitamin D', 1104, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 1104, 'vitamin D metabolism')]
PMC4785305	3/2016	S100-PMC4785305	['second visit\nthis visit will take place at 28–32\u2005weeks ga, during which maternal weight and Blood pressure will be recorded, maternal health and diet assessed, in addition to assessment of adverse events, if any.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood')]
PMC4785305	3/2016	S102-PMC4785305	['Blood and Urine tests will be carried out (seetable 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 10, 'urine')]
PMC4785305	3/2016	S109-PMC4785305	['in addition, Blood tests at Delivery include Genetic studies such as Vitamin D Genes polymorphism and rna Expression of Vitamin D polymorphisms.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('GO_0007567', 'parturition', 28, 'delivery'), ('SO_0000704', 'gene', 45, 'genetic'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('SO_0000704', 'gene', 79, 'genes'), ('GO_0010467', 'gene expression', 106, 'expression'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4789467	3/2016	S85-PMC4789467	['Placental Fetal Capillary length and surface area is reduced, and the integrity and normal developmental architectural rearrangements of the Fetal Vasculature and maternal Blood spaces decreased, following exposure to low-iron or low-protein diets, or global Nutrient restriction (lewis et al.,2001a; rutland et al.,2007; schulz et al.,2012).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000922', 'embryo', 10, 'fetal'), ('UBERON_0001982', 'capillary', 16, 'capillary'), ('UBERON_0000922', 'embryo', 141, 'fetal'), ('UBERON_0002049', 'vasculature', 147, 'vasculature'), ('UBERON_0000178', 'blood', 172, 'blood'), ('CHEBI_33284', 'nutrient', 259, 'nutrient')]
PMC4789467	3/2016	S89-PMC4789467	['moreover, the Interhemal barrier is thinner, and the exchange surface area and proportions of maternal and/or fetal Blood compartments within the Placenta are increased in Mice and guinea pigs exposed to 12–13% hypoxia (gilbert et al.,1979; bacon et al.,1984; higgins et al.,2015; matheson et al.,2015).']	N/A	N/A	[('UBERON_0011631', 'tabular bone', 14, 'interhemal'), ('UBERON_0000178', 'blood', 116, 'blood'), ('UBERON_0001987', 'placenta', 146, 'placenta'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
PMC4789467	3/2016	S94-PMC4789467	['in many of the environmentally-manipulated Pregnancies, there are also changes in Uterine vascular responsiveness and/or Trophoblast remodeling of the maternal Spiral Arteries which have implications for Blood flow and the Delivery of substrates to the Placenta (ahokas et al.,1981,1983; itoh et al.,2002; taylor et al.,2003; alam et al.,2007; rosario et al.,2008; chakraborty et al.,2011; hayes et al.,2012,2014; rueda-clausen et al.,2014; lineker et al.,2015; skeffington et al.,2015).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 43, 'pregnancies'), ('UBERON_0000995', 'uterus', 82, 'uterine'), ('UBERON_0000088', 'trophoblast', 121, 'trophoblast'), ('UBERON_0002537', 'hermaphrodite gonad', 160, 'spiral arteries'), ('UBERON_0000178', 'blood', 204, 'blood'), ('GO_0007567', 'parturition', 223, 'delivery'), ('GO_0007565', 'female pregnancy', 253, 'placenta'), ('UBERON_0001987', 'placenta', 253, 'placenta')]
PMC4789467	3/2016	S182-PMC4789467	['Blood pressure assessments have predominately been performed in male offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4794442	3/2016	S39-PMC4794442	['her White Blood Cell count was 23.1 k/µl (range, 3.8–10.5 k/µl) and her Finger-stick Glucose was 113 mg/dl.']	N/A	N/A	[('CL_0000738', 'leukocyte', 4, 'white blood cell'), ('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0002389', 'manual digit', 72, 'finger'), ('CHEBI_17234', 'glucose', 85, 'glucose')]
PMC4796349	3/2015	S40-PMC4796349	['in this study, data were collected using form 1 for entry criteria and Blood sugar check-list, and form 2 containing demographic and obstetrics details, and a researcher-made lifestyle questionnaire including: diet, physical activity, self-Care in Pregnancy, perceived stress, and perceived social support.']	N/A	N/A	[('UBERON_0000178', 'blood', 71, 'blood'), ('GO_0051514', 'negative regulation of monopolar cell growth', 239, '-care'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC4796349	3/2015	S79-PMC4796349	['eligible women that met study inclusion criteria according to their Blood sugar level entered the study.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood')]
PMC4796349	3/2015	S80-PMC4796349	['women were divided into two groups of Gestational diabetic group and healthy group according to their Blood sugar level and diagnosis of Gestational diabetes in weeks 24-28.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('UBERON_0000178', 'blood', 102, 'blood'), ('GO_0007565', 'female pregnancy', 137, 'gestational')]
PMC4796349	3/2015	S108-PMC4796349	['participation in physical activities reduces Blood Sugar concentration, increases sensitivity to Insulin, improves Cardiovascular System, and reduces body fat.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_24870', 'ion', 51, 'sugar'), ('PR_000045358', 'insulin family protein', 97, 'insulin'), ('UBERON_0004535', 'cardiovascular system', 115, 'cardiovascular system')]
PMC4800153	3/2016	S109-PMC4800153	['women attending routine anc in sudan are prescribed ‘Fefol’, an iron and Folic Acid containing vitamin, as a prophylaxis for iron and Folic Acid deficiency anaemia during Pregnancy irrespective of their Blood haemoglobin level.']	N/A	N/A	[('CHEBI_5051', 'Fexofenadine hydrochloride', 53, 'Fefol'), ('CHEBI_30751', 'formic acid', 73, 'folic acid'), ('CHEBI_30751', 'formic acid', 134, 'folic acid'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('UBERON_0000178', 'blood', 203, 'blood')]
PMC4807004	3/2016	S95-PMC4807004	['these included modified Glucose tolerance test (mgtt), Urine full examination/microscopic examination (feme), Blood Sugar profile (bsp), haemoglobin a1c or glycated haemoglobin test for diabetes (hba1c), full Blood picture (fbp), iron studies and haemoglobin electrophoresis.']	N/A	N/A	[('CHEBI_17234', 'glucose', 24, 'Glucose'), ('UBERON_0001088', 'urine', 55, 'urine'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_24870', 'ion', 116, 'sugar'), ('UBERON_0000178', 'blood', 209, 'blood')]
PMC4807004	3/2016	S160-PMC4807004	['the 69% of low-risk women tested were all negative.10.1371/journal.pone.0152167.t005\n\ncaption (table-wrap): table 5\nadditional laboratory tests performed among low- and high-risk women in public-sector health clinics of selangor state (n = 522).all women (n = 522)low-risk (n = 375)high-risk (n = 147)additional tests, n (%)testedtestedtestedmgtt376 (72.0)258 (68.8)118 (80.3)Urine feme66 (29.9)105 (28.0)51 (34.7)bsp86 (16.5)3 (0.8)83 (56.5)hba1c51 (9.8)0 (0.0)51 (34.7)Fbp33 (6.3)10 (2.7)23 (15.6)iron studies28 (5.4)8 (2.1)20 (13.6)hb analysis (electrophoresis)19 (3.6)7 (1.9)12 (8.2)\nmodified Glucose tolerance test (mgtt), Urine full examination/microscopic examination (feme), Blood Sugar profile (bsp), haemoglobin a1c or glycated haemoglobin test (hba1c), full Blood picture (fbp), haemoglobin electrophoresis (hb analysis).']	N/A	N/A	[('UBERON_0001088', 'urine', 376, 'urine'), ('PR_000007395', 'F-box only protein 22', 471, 'FBP33'), ('CHEBI_17234', 'glucose', 597, 'glucose'), ('UBERON_0001088', 'urine', 628, 'urine'), ('UBERON_0000178', 'blood', 683, 'blood'), ('CHEBI_24870', 'ion', 689, 'sugar'), ('UBERON_0000178', 'blood', 769, 'blood')]
PMC4807004	3/2016	S163-PMC4807004	['majority of the investigations for anaemia–full Blood picture, iron studies, and haemoglobin electrophoresis–were performed on the high-risk group (table 5).']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood')]
PMC4807004	3/2016	S246-PMC4807004	['full Blood picture, iron studies, and haemoglobin electrophoresis were additional investigations for anaemic women whose haemoglobin level was less than 8g% [10].']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood')]
PMC4811107	3/2016	S1-PMC4811107	['25-Hydroxyvitamin D [25(Oh)D] was measured in Prenatal maternal and child Cord Blood samples of participants ( n = 241 pairs) in a Birth cohort.']	N/A	N/A	[('CHEBI_27844', "2',3'-cyclic AMP", 0, '25-Hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 46, 'prenatal'), ('UBERON_0002240', 'spinal cord', 74, 'cord'), ('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0007567', 'parturition', 131, 'birth')]
PMC4811107	3/2016	S3-PMC4811107	['Cord Blood as a percentage of Prenatal 25(Oh)D level was calculated and characteristics compared between those who did and did not have ≥25% and ≥50% of the maternal level and those who did and did not have a detectable 25(Oh)D level.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 45, 'D'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
PMC4811107	3/2016	S6-PMC4811107	["most children had a 25(Oh)D Cord Blood level less than half of their mother's; 15.4% had a level that was <25% of their mother's."]	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('UBERON_0002240', 'spinal cord', 28, 'cord'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC4811107	3/2016	S26-PMC4811107	['briefly, women were enrolled in their 3rd Trimester at which time they provided a Blood sample and completed an interview about their health.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 42, 'trimester'), ('UBERON_0000178', 'blood', 82, 'blood')]
PMC4811107	3/2016	S27-PMC4811107	["the child's Cord Blood was collected at Delivery."]	N/A	N/A	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0007567', 'parturition', 40, 'delivery')]
PMC4811107	3/2016	S34-PMC4811107	['25(Oh)D was measured in the stored samples from Pregnancy (3rd trimester) and Delivery (Cord Blood).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 0, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0007567', 'parturition', 78, 'delivery'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC4811107	3/2016	S47-PMC4811107	["maternal atopic status\nallergen-specific Ige (sige) levels in mothers' Prenatal Blood samples were assessed for a set of Allergens ( dermatophagoides farinae , Dog, Cat, timothy grass, ragweed, alternaria alternata , egg, and german cockroach)."]	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 41, 'IgE'), ('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_33663', 'cyclic hydrocarbon', 121, 'allergens'), ('NCBITaxon_33208', 'Metazoa', 160, 'dog'), ('NCBITaxon_33208', 'Metazoa', 165, 'cat')]
PMC4811107	3/2016	S62-PMC4811107	['descriptive information about the overall Prenatal and Cord Blood levels of 25(Oh)D is provided intable 1.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('UBERON_0002240', 'spinal cord', 55, 'cord'), ('UBERON_0000178', 'blood', 60, 'blood'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 82, 'D')]
PMC4811107	3/2016	S63-PMC4811107	['the mean Cord Blood 25(Oh)D level (10.9\u2009ng/ml) is nearly half of the mean maternal Prenatal level (23.6\u2009ng/ml).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 20, '25(OH)D'), ('GO_0007565', 'female pregnancy', 83, 'prenatal')]
PMC4811107	3/2016	S68-PMC4811107	['spearman correlations between the Prenatal-Cord Blood levels are presented intable 3.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'prenatal'), ('UBERON_0002240', 'spinal cord', 43, 'cord'), ('UBERON_0000178', 'blood', 48, 'blood')]
PMC4811107	3/2016	S75-PMC4811107	["most of the children had a 25(Oh)D Cord Blood level that was 50% or less of their mother's Prenatal level ( n = 149, 61.8%) and 37 children (15.4%) had a level that was less than 25% of their mother's level."]	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 27, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 35, 'cord'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0007565', 'female pregnancy', 91, 'prenatal')]
PMC4811441	3/2016	S5-PMC4811441	['Blood was collected at the first (t1) and third (t3) Trimester (mean Gestational weeks 10.8 and 33.4).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0009294', 'DNA mediated transformation', 53, 'trimester'), ('GO_0007565', 'female pregnancy', 69, 'gestational')]
PMC4811441	3/2016	S6-PMC4811441	['Blood pressure at Gestational weeks 10, 25, 32 and 37 as well as symptoms of Preeclampsia and Pregnancy-induced hypertension were retrieved from medical records.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 18, 'gestational'), ('GO_0007128', 'meiotic prophase I', 77, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC4811441	3/2016	S25-PMC4811441	['Blood pressure (bp) during normal Pregnancy initially decrease until mid-Pregnancy when it begins to increase [7].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy')]
PMC4811441	3/2016	S50-PMC4811441	['Blood samples were collected from each participant at two time points; before Gestational week 16 (preferably at week 8–12, first trimester, t1) and after Gestational week 31 (preferably at week 32–35, third trimester, t3), with Gestational age determined by routine ultrasound.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 78, 'gestational'), ('GO_0007565', 'female pregnancy', 155, 'gestational'), ('GO_0007565', 'female pregnancy', 229, 'gestational')]
PMC4811441	3/2016	S53-PMC4811441	['at the Antenatal care, Venous Blood samples were drawn in gel Serum separating tubes, centrifuged for 10 minutes within two hours of sampling and sent with regular laboratory transport to study personnel at gothenburg university.']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'antenatal'), ('UBERON_0001638', 'vein', 23, 'venous'), ('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0001977', 'blood serum', 62, 'serum')]
PMC4811441	3/2016	S54-PMC4811441	['Blood samples were kept from sunlight and refrigerated until and after transport.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4811441	3/2016	S65-PMC4811441	['systolic (sbp) and diastolic (dbp) Blood pressure were measured as a part of standard practice of care, at baseline (t1) and within two weeks of Gestational week 25, 32 and 37.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0007565', 'female pregnancy', 145, 'gestational')]
PMC4811441	3/2016	S103-PMC4811441	['Blood samples at t1 and t3 were obtained at mean (sd) Gestational week 10.8 (2.0) and 33.4 (1.8), respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 54, 'gestational')]
PMC4811441	3/2016	S106-PMC4811441	['at t1, 19% were unemployed and 60% of the women had studied at the university level (table 1).10.1371/journal.pone.0152198.t001\n\ncaption (table-wrap): table 1\ncharacteristics of participants.meanstandard deviationn age t1 (years)31.34.92000height (cm)166.86.31985bmi t1 (kg/m2)24.54.2197225(Oh)D t1 (nmol/l)64.524.5199425(Oh)d t3 (nmol/l)74.734.41834delta 25(Oh)Da(nmol/l)10.230.41827gestational age t1 (weeks)10.82.01994gestational age t3 (weeks)33.41.91829bp week 10 (mmhg) (sbp/dbp)111.5/66.311.2/8.11861bp week 25 (mmhg) (sbp/dbp)111.9/65.011.3/7.71915bp week 32 (mmhg) (sbp/dbp)113.1/66.811.9/8.51923bp week 37 (mmhg) (sbp/dbp)116.1/70.611.8/8.91880 n (%) unemployed/student367 (18.6)university-level education1190 (59.8)tobacco use at t189 (4.5)born in north europe1504 (75.0)nulliparity836 (41.8)excessive gwgb653 (36)preexisting medical conditionc58 (2.9)Preeclampsia80 (4.0)Pregnancy-induced hypertension160 (8.0)\nt1 = first trimester, bmi = body mass index, 25(Oh)D = 25-Hydroxyvitamin D, t3 = third trimester, bp = Blood pressure, gwg = Gestational weight gain\na.calculated as Serum 25(Oh)D at t3 minus 25(Oh)D at t1.']	N/A	N/A	[('CHEBI_33010', 'chromide(1-)', 290, '(OH)D'), ('CHEBI_17792', 'organohalogen compound', 322, 'OH'), ('CHEBI_63056', 'zinc cation', 356, '25(OH'), ('CHEBI_34695', 'Dicyclopentadiene', 362, 'Da'), ('GO_0006412', 'translation', 863, 'Preeclampsia80'), ('GO_0007565', 'female pregnancy', 883, 'Pregnancy'), ('CHEBI_71657', 'versiconol acetate', 968, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 978, '25-hydroxyvitamin D'), ('UBERON_0000178', 'blood', 1026, 'blood'), ('GO_0007565', 'female pregnancy', 1048, 'gestational'), ('UBERON_0001977', 'blood serum', 1088, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1094, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1114, '25(OH)D')]
PMC4811441	3/2016	S122-PMC4811441	['t1 25(Oh)D was not associated with pe in either bivariable or multivariable analysis.10.1371/journal.pone.0152198.t002\n\ncaption (table-wrap): table 2\nbivariable and multivariable logistic regression analysis of the determinants of preeclampsia.bivariable analysismultivariable modelabor95% c.i.pbor95% c.i.plowerupperlowerupper delta 25(Oh)D ≥30 (nmol/l)-1.3340.2640.1130.6130.002-1.5100.2210.0840.5810.002multifetal Gestation1.4974.4671.50213.2810.0072.42811.3322.34354.8210.003obesity t11.5144.5442.7587.486<0.0011.2213.3911.7266.663<0.001nulliparity1.3083.6982.2596.053<0.0011.4324.1882.2797.697<0.001dbp t10.0861.0901.0581.122<0.0010.0891.0941.0551.134<0.001preexisting medical condition t10.9592.6091.0086.7480.0481.2343.4351.03111.4470.045excessive gwg0.8872.4291.5393.834<0.0010.5171.6770.9512.9580.074assisted reproduction0.4441.5590.9872.4630.0570.2401.2710.6422.5150.491age ≥40 years t1-0.5460.5790.1402.4010.5790.1191.1260.2405.2750.880 bivariable analysisalternative multivariable modelsbor95% c.i.pbor95% c.i.pupperlowerupperlower 25(Oh)D t1 (nmol/l)0.0041.0040.9951.0140.3540.0041.0040.9911.0160.57125(Oh)D T3 (nmol/l)-0.0050.9950.9881.0020.173-0.0100.9900.9811.0000.043delta 25(Oh)D (nmol/l)-0.0090.9910.9820.9990.028-0.0130.9870.9770.9980.021\n25(Oh)D = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure, t3 = third Trimester\ndichotomous: multifetal Gestation, age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition, assisted reproduction and delta 25(Oh)D ≥30 (4th quartile vs. quartiles 1–3).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 3, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 5, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 334, '25(OH)D'), ('GO_0007565', 'female pregnancy', 417, 'gestation1'), ('CHEBI_71657', 'versiconol acetate', 1044, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 1115, '(OH)D'), ('CHEBI_37972', 'phosphorus-32 atom', 1121, 'T3'), ('CHEBI_71657', 'versiconol acetate', 1190, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1259, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 1269, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1318, 'gestational'), ('UBERON_0000178', 'blood', 1359, 'blood'), ('GO_0009294', 'DNA mediated transformation', 1386, 'trimester'), ('GO_0007565', 'female pregnancy', 1420, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 1546, '25(OH)D')]
PMC4811441	3/2016	S173-PMC4811441	['supporting information\n\ncaption (supplementary-material): s1 fig\nunadjusted systolic (sbp) and diastolic Blood pressure (dbp) trajectory in Pregnancy, grouped by Serum 25-hydroxyvitamin d (25(Oh)D) at baseline (t1).']	N/A	N/A	[('UBERON_0000178', 'blood', 105, 'blood'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D')]
PMC4811441	3/2016	S179-PMC4811441	['caption (supplementary-material): s2 table\nbivariable and multivariable linear regression analysis of the determinants of baseline Blood pressure.']	N/A	N/A	[('UBERON_0000178', 'blood', 131, 'blood')]
PMC4820961	3/2016	S30-PMC4820961	['before analyses, Dna Methylation levels were normalized and the normalized methylation m values were adjusted for sex, age, measured White Blood Cell percentages, the first ten principal components (pcs) from the genotype data, methylation array row and sample plate (see methods section).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 17, 'DNA methylation'), ('CL_0000738', 'leukocyte', 133, 'white blood cell'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC4820961	3/2016	S92-PMC4820961	['to further characterize sites with high versus low heritability, we analysed longitudinal Peripheral Blood Dna Methylation data from 31 Individuals (mean age 34 years;table 1) collected with an interval of on average 5 years, and Dna Methylation data from Blood and Buccal samples that were available for 22 Individuals (age 18 years;table 1).']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 90, 'peripheral'), ('UBERON_0000178', 'blood', 101, 'blood'), ('GO_0006306', 'DNA methylation', 107, 'DNA methylation'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('GO_0006306', 'DNA methylation', 230, 'DNA methylation'), ('UBERON_0000178', 'blood', 256, 'blood'), ('UBERON_0001567', 'cheek', 266, 'buccal'), ('NCBITaxon_1', 'root', 308, 'individuals')]
PMC4820961	3/2016	S156-PMC4820961	['the heritability of Dna Methylation at this site in Blood decreases from 0.54 at age 25 to 0.39 at age 50.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 20, 'DNA methylation'), ('UBERON_0000178', 'blood', 52, 'blood')]
PMC4820961	3/2016	S200-PMC4820961	['Venous Blood samples were drawn in the morning after an overnight fast, and multiple edta and other tubes were collected for isolation of dna and assessment of Haematological profiles.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0000178', 'blood', 160, 'haematological')]
PMC4820961	3/2016	S201-PMC4820961	['Blood, Urine and Buccal sample collection procedures were described in detail previously56.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0001567', 'cheek', 17, 'buccal')]
PMC4820961	3/2016	S203-PMC4820961	['in total, 3,264 Blood samples from 3,221 ntr participants were assessed for Genome-wide methylation, of which 3,089 samples from 3,057 subjects passed quality control.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('SO_0001026', 'genome', 76, 'genome')]
PMC4820961	3/2016	S204-PMC4820961	['only samples with good-quality Dna Methylation data and with White Blood Cell counts were retained for analysis, leaving 3,006 samples from 2,975 subjects.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 31, 'DNA methylation'), ('CL_0000738', 'leukocyte', 61, 'white blood cell'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC4820961	3/2016	S208-PMC4820961	['for a small subset of 11 mz pairs (male pairs=3, female pairs=8, age: 18 years), Genome-wide methylation data were available for two types of samples: Blood (as described above) and Buccal.']	N/A	N/A	[('SO_0001026', 'genome', 81, 'genome'), ('UBERON_0000178', 'blood', 151, 'blood'), ('UBERON_0001567', 'cheek', 182, 'buccal')]
PMC4820961	3/2016	S211-PMC4820961	['Buccal and Blood samples were collected around the same date.']	N/A	N/A	[('UBERON_0001567', 'cheek', 0, 'Buccal'), ('UBERON_0000178', 'blood', 11, 'blood')]
PMC4820961	3/2016	S214-PMC4820961	['cell counts\nthe following subtypes of White Blood Cells were counted in Blood samples: Neutrophils, Lymphocytes, Monocytes, Eosinophils and Basophils56.']	N/A	N/A	[('CL_0000738', 'leukocyte', 38, 'white blood cells'), ('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CL_0000775', 'neutrophil', 87, 'neutrophils'), ('CL_0000542', 'lymphocyte', 100, 'lymphocytes'), ('CL_0000576', 'monocyte', 113, 'monocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('CL_0000767', 'basophil', 140, 'basophils56')]
PMC4820961	3/2016	S223-PMC4820961	['genotype data used during qc of the Dna Methylation data\nof the 3,221 subjects for whom Peripheral Blood methylation samples were assessed with the illumina 450k array, 2,665 subjects had been previously genotyped or had a mz co-twin who had been genotyped one or multiple times on any of the following genotype arrays: affymetrix6, affymetrix-perlegen and illumina660.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('UBERON_0012101', 'perinatal stage', 88, 'peripheral'), ('UBERON_0000178', 'blood', 99, 'blood')]
PMC4820961	3/2016	S229-PMC4820961	['of the 2,975 subjects with good-quality Dna Methylation data and data on White Blood Cell counts, affy6 genotype data were available for 2,289 subjects and sequence data for 341 Individuals (numbers include both mz twins).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 40, 'DNA methylation'), ('CL_0000738', 'leukocyte', 73, 'white blood cell'), ('UBERON_0000178', 'blood', 79, 'blood'), ('NCBITaxon_1', 'root', 178, 'individuals')]
PMC4820961	3/2016	S235-PMC4820961	['Genomic dna (500\u2009ng) from whole Blood was bisulfite treated using the zymoresearch ez Dna Methylation kit (zymo research corp, irvine, ca, usa), following the standard protocol for illumina 450k micro-arrays, by the department of molecular epidemiology from the leiden university medical center (lumc), the netherlands.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0000178', 'blood', 32, 'blood'), ('GO_0006306', 'DNA methylation', 86, 'DNA Methylation')]
PMC4820961	3/2016	S238-PMC4820961	['the following text describes the quality control and processing of the Dna Methylation data from Blood samples.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 71, 'DNA methylation'), ('UBERON_0000178', 'blood', 97, 'blood')]
PMC4820961	3/2016	S286-PMC4820961	['before analysis, the normalized methylation m values were corrected for sex, age, array row, 96-well plate (dummy coded), White Blood Cell percentages (Neutrophils, Monocytes and Eosinophils; assessed at sample collection), and the first ten pcs derived from the genotype data, with the lm function in r. all analyses that included Genome-wide Snp data were performed on the residuals derived after correcting for these covariates.']	N/A	N/A	[('CL_0000738', 'leukocyte', 122, 'white blood cell'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000775', 'neutrophil', 152, 'neutrophils'), ('CL_0000576', 'monocyte', 165, 'monocytes'), ('CL_0000771', 'eosinophil', 179, 'eosinophils'), ('SO_0001026', 'genome', 332, 'genome'), ('SO_0000694', 'SNP', 344, 'SNP')]
PMC4820961	3/2016	S287-PMC4820961	['all other analyses (that is, twin correlations and twin models, longitudinal analyses and Blood–Buccal comparison) were performed on the residuals derived after correcting for the afore mentioned covariates minus the genotype pcs.']	N/A	N/A	[('UBERON_0000178', 'blood', 90, 'blood'), ('UBERON_0001567', 'cheek', 96, 'buccal')]
PMC4820961	3/2016	S313-PMC4820961	['longitudinal correlation and Blood–Buccal correlation\ndata from Individuals with Blood samples obtained at two repeated measures were analysed to calculate the correlation between Dna Methylation level at time point 1 and Dna Methylation level at time point 2 for each Cpg Site (mean interval=5 years).']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0001567', 'cheek', 35, 'buccal'), ('NCBITaxon_1', 'root', 64, 'individuals'), ('UBERON_0000178', 'blood', 81, 'blood'), ('GO_0006306', 'DNA methylation', 180, 'DNA methylation'), ('GO_0006306', 'DNA methylation', 222, 'DNA methylation'), ('SO_0000409', 'binding_site', 269, 'CpG site')]
PMC4820961	3/2016	S315-PMC4820961	['data from Individuals with illumina 450k methylation data from Blood samples and Buccal samples were analysed to calculate the correlation between Dna Methylation level in Blood and Buccal for each cpg.']	N/A	N/A	[('NCBITaxon_1', 'root', 10, 'individuals'), ('UBERON_0000178', 'blood', 63, 'blood'), ('UBERON_0001567', 'cheek', 81, 'buccal'), ('GO_0006306', 'DNA methylation', 147, 'DNA methylation'), ('UBERON_0000178', 'blood', 172, 'blood'), ('UBERON_0001567', 'cheek', 182, 'buccal')]
PMC4821682	9/2015	S3-PMC4821682	['Cord Blood ferritin was collected in a subsample ( n =16).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC4821682	9/2015	S20-PMC4821682	['children Born with low Cord Blood ferritin, the major storage form of iron, have greater academic problems in school and impaired Immediate Recall Memory, Delayed Recall Memory, and working Memory for their age (for a summary of findings see (7)).']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'born'), ('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('GO_0007566', 'embryo implantation', 130, 'immediate recall'), ('GO_0007613', 'memory', 147, 'memory'), ('GO_0008406', 'gonad development', 155, 'delayed recall'), ('GO_0007613', 'memory', 170, 'memory'), ('GO_0007613', 'memory', 190, 'memory')]
PMC4821682	9/2015	S32-PMC4821682	['between 34–36 Gestational weeks, maternal reports of iron Intake were obtained via self–report; for a subsample, Cord Blood ferritin was collected at birth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('GO_0007631', 'feeding behavior', 58, 'intake'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0000178', 'blood', 118, 'blood')]
PMC4821682	9/2015	S109-PMC4821682	['study visits\nparticipants were seen during three study visits during Pregnancy, Cord Blood collection occurred at Birth, and the infant mri sessions were conducted within, on average, 2.8 weeks (or 19.63 days) of Birth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood'), ('GO_0007567', 'parturition', 114, 'birth'), ('GO_0007567', 'parturition', 213, 'birth')]
PMC4821682	9/2015	S119-PMC4821682	['ferritin assay\nUmbilical Cord Blood was obtained for evaluation of Serum ferritin concentrations, determined in duplicate by chemoluminescent immunoassay (beckman coulter; brea, california, usa).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 15, 'Umbilical cord'), ('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0001977', 'blood serum', 67, 'serum')]
PMC4825100	2/2016	S49-PMC4825100	['a group of ten, young-Adult research staff volunteers, both men and non-Pregnant women, were recruited with informed consent to participate in a week-long study of Urinary and Blood Inositol concentrations, before, during and after oral Inositol supplementation (1·3 g/d).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 22, 'adult'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('UBERON_0001088', 'urine', 164, 'urinary'), ('UBERON_0000178', 'blood', 176, 'blood'), ('CHEBI_24848', 'inositol', 182, 'inositol'), ('CHEBI_24848', 'inositol', 237, 'inositol')]
PMC4825100	2/2016	S154-PMC4825100	['inositol assay using Urine and Blood samples\ninositol concentrations for the randomised women subjects, before Pregnancy, were determined by ms(18), using Urine samples collected at home and posted to the study centre.']	N/A	N/A	[('UBERON_0001088', 'urine', 21, 'urine'), ('UBERON_0000178', 'blood', 31, 'blood'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001088', 'urine', 155, 'urine')]
PMC4825100	2/2016	S175-PMC4825100	['this study allowed us to measure Blood concentrations compared with Urinary inositol Excretion in the same Individuals over the same time period.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0001088', 'urine', 68, 'urinary'), ('GO_0007588', 'excretion', 85, 'excretion'), ('NCBITaxon_1', 'root', 107, 'individuals')]
PMC4825100	2/2016	S185-PMC4825100	['3\n\nInositol concentration in Urine and Blood of research staff volunteers.']	N/A	N/A	[('CHEBI_28593', 'quinidine', 3, 'Inositol'), ('UBERON_0001088', 'urine', 29, 'urine'), ('UBERON_0000178', 'blood', 39, 'blood')]
PMC4825100	2/2016	S186-PMC4825100	['inositol was quantified by ms(18)in Urine (, inositol concentration µm/mmcreatinine) and Venous Blood Plasma (, inositol concentration in Blood (µm)) samples obtained from a group of ten volunteer subjects (subj 1–10) who took daily Inositol supplements (1·3 g) on days 1–7 of the experiment ().']	N/A	N/A	[('UBERON_0001088', 'urine', 36, 'urine'), ('UBERON_0001638', 'vein', 89, 'venous'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('UBERON_0000178', 'blood', 138, 'blood'), ('CHEBI_24848', 'inositol', 233, 'inositol')]
PMC4825100	2/2016	S188-PMC4825100	['Blood samples were obtained at these same times on days 0, 5 and 8.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4825101	10/2015	S64-PMC4825101	['or percentagea19972011bage (years)36.0 (7.76)50.0 (7.77)weight (kg)55.9 (9.18)61.5 (13.2)height (cm)161.2 (6.94)163.7 (6.84)bmi (kg/m2)21.5 (3.08)22.9 (4.50)***overweight/obese (%)6.86/1.1418.9/6.29***fat mass (kg)na18.1 (9.10)Trunk fat mass (kg)na8.97 (4.87)systolic Blood pressure (mmhg)106.5 (10.5)116.7 (17.5)***diastolic Blood pressure (mmhg)69.7 (7.68)71.3 (10.2)***hypertensive (%)13.1%31.6%***Glucose t0c(mmol/l)5.31 (5.23, 5.38)5.30 (5.19, 5.43)Glucose t30 (mmol/l)7.41 (7.22, 7.61)7.36 (7.07, 7.67)Glucose t120 (mmol/l)5.05 (5.28, 6.15)5.46 (5.20, 5.74)**Insulin t0 (pg/ml)d4.05 (4.03, 5.75)5.98 (5.46, 6.55)***Insulin T30(pg/ml)39.7 (36.6, 43.1)48.2 (43.2, 53.8)***Insulin t120 (pg/ml)13.2 (11.6, 15.0)20.2 (18.0, 22.7)***impaired Glucose tolerance (%)0.577.43***type 2 diabetes mellitus (%)02.86*\ndata presented for the 175 Individuals seen in 1997, who were traced in 2011.']	N/A	N/A	[('UBERON_0002100', 'trunk', 227, 'Trunk'), ('UBERON_0000178', 'blood', 268, 'blood'), ('UBERON_0000178', 'blood', 326, 'blood'), ('CHEBI_17234', 'glucose', 401, 'Glucose'), ('CHEBI_17234', 'glucose', 454, 'Glucose'), ('CHEBI_17234', 'glucose', 508, 'Glucose'), ('PR_000045358', 'insulin family protein', 565, 'Insulin'), ('PR_000002270', 'Bcl-2-like protein 11 isoform 16', 621, 'Insulin T30'), ('PR_000045358', 'insulin family protein', 676, 'Insulin'), ('CHEBI_17234', 'glucose', 742, 'glucose'), ('NCBITaxon_1', 'root', 836, 'individuals')]
PMC4825102	2/2016	S118-PMC4825102	['similarly, administration of 0·1 ml of bayberry fruit extracts (containing 150 μg of c3g)/10 g of body weight twice per day for 30 d significantly reduced Blood Glucose and improved Glucose tolerance in streptozotocin-induced diabetic Mice(97).']	N/A	N/A	[('UBERON_0000178', 'blood', 155, 'blood'), ('CHEBI_17234', 'glucose', 161, 'glucose'), ('CHEBI_17234', 'glucose', 182, 'glucose'), ('NCBITaxon_10088', 'Mus <genus>', 235, 'mice')]
PMC4829879	2/2016	S96-PMC4829879	['), the Chest was opened and Blood collected by Cardiac puncture.']	N/A	N/A	[('UBERON_0001443', 'chest', 7, 'chest'), ('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_0000948', 'heart', 47, 'cardiac')]
PMC4829879	2/2016	S97-PMC4829879	['an aliquot of whole Blood was analyzed for Glucose and Lipid profile (total Cholesterol, high-density lipoprotein Cholesterol, and Triglycerides) with cholestech ldx (alere, san diego, ca).']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_17234', 'glucose', 43, 'glucose'), ('CHEBI_18059', 'lipid', 55, 'lipid'), ('CHEBI_16113', 'cholesterol', 76, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 114, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 131, 'triglycerides')]
PMC4829879	2/2016	S98-PMC4829879	['the remaining Blood was centrifuged to separate the cellular fraction and frozen at −80 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood')]
PMC4829879	2/2016	S126-PMC4829879	['statement of financial support\nthis study was funded in part by a grant from the us national institutes of health, national Heart, Lung, and Blood institute (bethesda, md) grant ro1 hl-61007 to g.p.']	N/A	N/A	[('UBERON_0000948', 'heart', 124, 'Heart'), ('UBERON_0002048', 'lung', 131, 'Lung'), ('UBERON_0000178', 'blood', 141, 'Blood')]
PMC4829940	5/2016	S0-PMC4829940	['25-Hydroxyvitamin D in Pregnancy and Genome wide Cord Blood Dna Methylation in two Pregnancy cohorts (moba and alspac)\n\nabstract:author-highlightshighlights\n\nPregnancy Vitamin D and Cord Blood Dna Methylation compared in 1416 infants.']	N/A	N/A	[('CHEBI_27844', "2',3'-cyclic AMP", 0, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('SO_0001026', 'genome', 37, 'genome'), ('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0006306', 'DNA methylation', 60, 'DNA methylation'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 158, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 182, 'cord'), ('UBERON_0000178', 'blood', 187, 'blood'), ('GO_0006306', 'DNA methylation', 193, 'DNA methylation')]
PMC4829940	5/2016	S5-PMC4829940	['across 473,731cpg Dna Methylation Sites in Cord Blood dna, none were strongly associated with maternal 25-Hydroxyvitamin D after adjusting for multiple tests (false discovery rate (fdr)\xa0>\xa00.5; 473,731 tests).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 18, 'DNA methylation'), ('SO_0000351', 'synthetic_sequence', 18, 'DNA'), ('SO_0000134', 'genomically_imprinted', 22, 'methylation sites'), ('UBERON_0002240', 'spinal cord', 43, 'cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 103, '25-hydroxyvitamin D')]
PMC4829940	5/2016	S36-PMC4829940	['Blood samples were drawn from the mother and Blood from the Umbilical Cord Vein was collected with a syringe.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002087', 'atrioventricular canal', 60, 'umbilical cord vein')]
PMC4829940	5/2016	S42-PMC4829940	['from these two groups, there were 819 children with maternal 25-Hydroxyvitamin D levels and Cord Blood Dna Methylation profiles[25].']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('GO_0006306', 'DNA methylation', 103, 'DNA methylation')]
PMC4829940	5/2016	S50-PMC4829940	['Cord Blood Dna Methylation was assayed using the illumina infinium humanmethylation450 beadchip (www.illumina.com), which was designed to conduct epigenome-wide association studies (ewas) and includes 485,512 Methylation Sites per sample at Single-Nucleotide resolution.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0006306', 'DNA methylation', 11, 'DNA methylation'), ('SO_0000134', 'genomically_imprinted', 209, 'methylation sites'), ('SO_0000984', 'single', 241, 'single'), ('SO_0000028', 'base_pair', 248, 'nucleotide')]
PMC4829940	5/2016	S66-PMC4829940	['in the primary analysis, the models were adjusted for maternal pre-Pregnancy body mass index (bmi, continuous), offspring sex, maternal education (4 categories), maternal smoking (yes/no), maternal Folate Plasma values (continuous), parity (3 categories), maternal age (continuous), Birth season (four categories) and estimated cell type proportions (continuous matrix consisting of 6 (default) Blood Cell-types: Cd4+T Cells, Cd8+T Cells, Nk-Cells, B-Cells, Monocytes and Granulocytes).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 198, 'folate'), ('UBERON_0001969', 'blood plasma', 205, 'plasma'), ('GO_0007567', 'parturition', 283, 'birth'), ('CL_0000081', 'blood cell', 395, 'blood cell'), ('UBERON_0000178', 'blood', 395, 'blood'), ('CL_0000476', 'thyrotroph', 413, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 413, 'CD4'), ('CL_0000084', 'T cell', 417, 'T cells'), ('CL_0002038', 'T follicular helper cell', 426, 'CD8'), ('PR_000005170', 'CD37 molecule', 426, 'CD8'), ('CL_0000084', 'T cell', 430, 'T cells'), ('CL_0000623', 'natural killer cell', 439, 'NK-cells'), ('GO_0071561', 'nucleus-vacuole junction', 439, 'NK-'), ('CL_0000236', 'B cell', 449, 'B-cells'), ('CL_0000576', 'monocyte', 458, 'monocytes'), ('CL_0000094', 'granulocyte', 472, 'granulocytes')]
PMC4829940	5/2016	S85-PMC4829940	['Cord Blood Dna Methylation was assayed using the illumina humanmethylation450 platform and data pre-processed using procedures identical to those used for the moba dataset.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0006306', 'DNA methylation', 11, 'DNA methylation')]
PMC4829940	5/2016	S103-PMC4829940	['results\nthere was no association between mid-Pregnancy 25(Oh)D and Cord Blood Dna Methylation at any single site on the illumina humanmethylation450 beadchip among the 819 mother and child-pairs in moba and the 597 mother and child-pairs in alspac (at fdr\xa0<\xa00.05; 473,731 tests).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 45, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 55, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('GO_0006306', 'DNA methylation', 78, 'DNA methylation')]
PMC4835505	4/2016	S408-PMC4835505	['the arrows indicate the direction of Zn Transport From Maternal Blood to Milk.']	N/A	N/A	[('GO_0006009', 'glucose 1-phosphate phosphorylation', 37, 'Zn transport from maternal blood'), ('UBERON_0000178', 'blood', 64, 'blood'), ('GO_0007614', 'short-term memory', 73, 'milk'), ('UBERON_0001913', 'milk', 73, 'milk')]
PMC4840325	12/2015	S2-PMC4840325	['methods\nwhole Blood samples and information on diet and socio‐demographic factors were collected from Pregnant women ( n \xa0=\xa04484) enrolled in the avon longitudinal study of parents and children (alspac).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007565', 'female pregnancy', 102, 'pregnant')]
PMC4840325	12/2015	S3-PMC4840325	['the whole Blood samples were assayed for total mercury levels using inductively coupled Plasma dynamic reaction cell mass spectrometry (icp‐drc‐ms), and the women were retrospectively asked about features of their Dental care during the Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001969', 'blood plasma', 88, 'plasma'), ('UBERON_0001091', 'calcareous tooth', 214, 'dental'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy')]
PMC4840325	12/2015	S39-PMC4840325	['collection of Blood samples for trace metal estimations\nwhole Blood samples were collected in acid washed Heparin vacutainers (becton and dickinson) by midwives as early as possible in Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_28304', 'heparin', 106, 'heparin'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4840325	12/2015	S45-PMC4840325	['these samples were at room temperature for up to 3\xa0h during transfer, and were stored at 4°c as whole Blood in the original tubes for 18–19\xa0years before being sent for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 102, 'blood')]
PMC4840325	12/2015	S46-PMC4840325	['Gestations when Blood samples were taken were available for 4472 mothers (99.7%); 93% of Gestations were <18\xa0weeks with interquartile range 9–13\xa0weeks.']	N/A	N/A	[('GO_0006009', 'glucose 1-phosphate phosphorylation', 0, 'Gestations'), ('UBERON_0000178', 'blood', 16, 'blood'), ('GO_0007565', 'female pregnancy', 89, 'gestations')]
PMC4840325	12/2015	S47-PMC4840325	['analysis of samples\nthe centers for disease control and prevention (cdc) developed methods to prepare the samples for analysis of whole Blood mercury as well as of lead, Selenium, and cadmium (cdc method 3009.1) as described in our previous publication1.']	N/A	N/A	[('UBERON_0000178', 'blood', 136, 'blood'), ('CHEBI_27568', 'selenium atom', 170, 'selenium')]
PMC4840325	12/2015	S48-PMC4840325	['in brief, clotted whole Blood was digested to remove all clots, before being analyzed using inductively coupled Plasma dynamic reaction cell mass spectrometry (icp‐drc‐ms).']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0001969', 'blood plasma', 112, 'plasma')]
PMC4840325	12/2015	S76-PMC4840325	['caption (table-wrap): table 2\n\nrelationship between the unadjusted mean total Blood mercury level in Pregnancy and features of Dental care as ascertained at 33\xa0monthsfeatures of Dental care n mean (sd) total Blood hg μg/l p no.']	N/A	N/A	[('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy'), ('UBERON_0001091', 'calcareous tooth', 127, 'dental'), ('UBERON_0001091', 'calcareous tooth', 178, 'dental'), ('UBERON_0000178', 'blood', 208, 'blood')]
PMC4840325	12/2015	S97-PMC4840325	["caption (table-wrap): table 4\n\ncomparisons of variances attributable to dietary, socio‐demographic, and Dental factors to the mother's total Blood mercurygroup of factors r2(%)a."]	N/A	N/A	[('UBERON_0001091', 'calcareous tooth', 104, 'dental'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4840325	12/2015	S137-PMC4840325	['once absorbed the Mercury is widely distributed to fat‐rich Tissues and is readily transferred across the Placenta and Blood–Brain barriers.']	N/A	N/A	[('CHEBI_16170', 'mercury(0)', 18, 'mercury'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('UBERON_0001987', 'placenta', 106, 'placenta'), ('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0000955', 'brain', 125, 'brain')]
PMC4843009	4/2016	S153-PMC4843009	['Blood chemistry\nBlood specimens were obtained the day after the completion of the behavioral studies between 4–6 p.m. by puncturing the retro-Orbital Plexus.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 16, 'Blood'), ('UBERON_0002010', 'celiac nerve plexus', 142, 'orbital plexus')]
PMC4848989	4/2016	S132-PMC4848989	['Glucose tolerance test (ipgtt) and Insulin tolerance test (itt)\nafter an 8-h fast at pd 110, Blood samples were collected at five time points: before injection and at 15, 30, 60, and 120 min after the i.p.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('PR_000045358', 'insulin family protein', 35, 'Insulin'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC4856298	5/2016	S88-PMC4856298	['2014 study design: rct / research methods: interview and Blood sample analysis / location: iran / health care setting: 20 public health clinics in urban setting / target population: Pregnant women / size: intervention: 58, control: 58 educational : on Iron supplements (better absorption, side effects, function).']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood'), ('GO_0007565', 'female pregnancy', 182, 'Pregnant'), ('CHEBI_24870', 'ion', 252, 'iron')]
PMC4857329	12/2015	S21-PMC4857329	['on examination, vitals were as follows: temperature, 36.8°c; pulse, 93\u2009bpm; Respiratory rate, 18/min; Blood pressure, 119/81\u2009mmhg; O2Sat, 95% on room air.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 76, 'respiratory'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_86933', 'S b S r S', 131, 'O2sat')]
PMC4857329	12/2015	S40-PMC4857329	['Sputum, Blood and Pleural Fluid cultures were all negative.']	N/A	N/A	[('UBERON_0007311', 'sputum', 0, 'Sputum'), ('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001087', 'pleural fluid', 18, 'pleural fluid')]
PMC4857329	12/2015	S41-PMC4857329	['in the mean time, patient developed acute Blood loss anemia due to non-resolving hemorrhagic Pleural Effusions for which multiple Blood transfusions were given.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0002735', 'transverse pontine fibers', 93, 'pleural effusions'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC4859539	5/2016	S2-PMC4859539	['Blood samples were obtained during yearly visits from 133 children, ages 2–7, whose mothers had participated in a Pregnancy Vitamin D supplementation rct.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4859539	5/2016	S27-PMC4859539	['there were 194 children who participated in the follow-up study (55% of the original cohort), but Blood samples were obtained from 133 of those children.']	N/A	N/A	[('UBERON_0000178', 'blood', 98, 'blood')]
PMC4859539	5/2016	S28-PMC4859539	['study protocol\n\nhealth history information\nduring the yearly visits, 5-ml of whole Blood were obtained by Venous puncture, and the child’s health status, Medication usage, and hospitalization history were assessed by both standardized questionnaires completed by a parent of each child and the child’s medical records.']	N/A	N/A	[('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0001638', 'vein', 106, 'venous'), ('CHEBI_60211', 'compound Z', 154, 'medication')]
PMC4859539	5/2016	S37-PMC4859539	['Blood measures\ntotal circulating Serum 25(Oh)D concentration was measured in duplicate within the month the Blood sample was obtained using radioimmunoassay (ria; diasorin, stillwater, mn).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 33, 'serum'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 39, '25(OH)D'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC4859539	5/2016	S52-PMC4859539	['results\n\ncohort\nwhile 194 children had participated in the follow-up study (55% of the original cohort participating in the Vitamin D Pregnancy study), 133 (38%) had a Blood sample obtained at the time of the study visit and thus, were able to have Cathelicidin measured.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('UBERON_0000178', 'blood', 168, 'blood'), ('CHEBI_3364', 'Canthiumine', 249, 'cathelicidin')]
PMC4859539	5/2016	S121-PMC4859539	['of the original cohort of mothers participating in this Vitamin D supplementation trial, 55% of the children were available for follow-up, and of those, 68% of those who came for follow-up (38% of the original cohort) were able to have a Blood sample obtained at the time of the visit.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000178', 'blood', 238, 'blood')]
PMC4865384	5/2016	S20-PMC4865384	['(4), in 1992, compared pre- and Postprandial Blood Glucose levels to fetal macrosomia in patients with Pregestational diabetes.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'postprandial'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_17234', 'glucose', 51, 'glucose'), ('GO_0007565', 'female pregnancy', 103, 'pregestational')]
PMC4865384	5/2016	S62-PMC4865384	['they used a higher percentage of more Nutrient-dense Carbohydrate using the choice (choosing healthy options in Carbohydrate energy) diet (60% Carbohydrate, 45% fat, and 15% protein) with continuous Glucose monitoring to determine mean Blood Glucose.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 38, 'nutrient'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 53, 'carbohydrate'), ('CHEBI_16646', 'carbohydrate', 112, 'Carbohydrate'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 143, 'carbohydrate'), ('CHEBI_17234', 'glucose', 199, 'glucose'), ('UBERON_0000178', 'blood', 236, 'blood'), ('CHEBI_17234', 'glucose', 242, 'glucose')]
PMC4865386	5/2016	S5-PMC4865386	['participants tested their Blood Glucose four times daily.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_17234', 'glucose', 32, 'glucose')]
PMC4865386	5/2016	S36-PMC4865386	['one-hour ( p<0.01) and 2-hour ( p<0.001) Postprandial Blood Glucose levels were lower on the lc/hf diet than on the hc/lf (choice) diet.']	N/A	N/A	[('GO_0007567', 'parturition', 41, 'postprandial'), ('UBERON_0000178', 'blood', 54, 'blood'), ('CHEBI_17234', 'glucose', 60, 'glucose')]
PMC4865386	5/2016	S60-PMC4865386	['participants in both groups were instructed in self-Monitoring of Blood Glucose (smbg) with portable reflectance Memory meters (onetouch ultra, lifescan, milipitas, calif., or ascencia countour, bayer healthcare, whippany, n.j.).']	N/A	N/A	[('GO_0065007', 'biological regulation', 52, 'monitoring'), ('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_17234', 'glucose', 72, 'glucose'), ('GO_0007613', 'memory', 113, 'memory')]
PMC4865386	5/2016	S75-PMC4865386	['participants who did not complete Food logs were questioned orally about diet adherence during review of their Blood Glucose records with their care provider.']	N/A	N/A	[('CHEBI_33290', 'food', 34, 'food'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_17234', 'glucose', 117, 'glucose')]
PMC4865386	5/2016	S93-PMC4865386	['means and percentages of maternal characteristics by study groupmaternal characteristicslower-Carbohydrate diet group ( n = 37)usual Pregnancy diet group ( n = 31) p mean ± sd2hppbg (mg/dl)111.56 ± 14.45113.91 ± 16.180.61fasting Blood Glucose (mg/dl)90.52 ± 8.5391.97 ± 12.080.65bmi (kg/m2)33.84 ± 8.8431.80 ± 8.680.34total Pregnancy weight gain (lb)27.24 ± 16.0225.68 ±17.080.71age at Delivery (years)30.09 ± 6.1529.63 ± 5.190.74weight change from study entry to Birth (Lb)4.75 ± 6.204.41 ± 6.240.85weeks of Gestation at study entry29.17 ± 2.7830.50 ± 2.850.032weeks of Gestation at Delivery37.78 ± 1.6637.76 ± 1.740.96 percentage (%) need for Insulin therapy8.86.30.69oral Medication use:32.434.40.98before enrollment2.93.1after enrollmentincidence of induction of labor35.334.40.94incidence of primary cesarean section29.440.60.34composite maternal complications0.81\u2003none52.050.0\u2003≥147.150.0\ntables 1and2illustrate that there were no differences in individual or composite maternal comorbidities or neonatal complications between the intervention and control groups.']	N/A	N/A	[('CHEBI_16646', 'carbohydrate', 94, 'Carbohydrate'), ('GO_0007565', 'female pregnancy', 133, 'Pregnancy'), ('UBERON_0000178', 'blood', 229, 'blood'), ('CHEBI_17234', 'glucose', 235, 'glucose'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('GO_0007567', 'parturition', 386, 'delivery'), ('GO_0007567', 'parturition', 464, 'birth'), ('UBERON_0000118', 'lung bud', 471, 'lb'), ('GO_0007565', 'female pregnancy', 509, 'gestation'), ('GO_0007565', 'female pregnancy', 571, 'gestation'), ('GO_0008206', 'bile acid metabolic process', 584, 'delivery37'), ('PR_000045358', 'insulin family protein', 645, 'insulin'), ('CHEBI_60211', 'compound Z', 675, 'medication')]
PMC4865387	5/2016	S95-PMC4865387	['thirty-two healthy, obese subjects were admitted to the clinical translational research center (ctrc) after a 12-hour fast for a 24-hour feeding study during which Blood was drawn hourly and meals were administered at regimented times (indicated by arrows; baseline diet composition 55% Carbohydrate/30% fat).']	N/A	N/A	[('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 287, 'carbohydrate')]
PMC4865387	5/2016	S105-PMC4865387	['Blood was drawn hourly for 5 hours.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4865392	5/2016	S31-PMC4865392	['self-monitoring of Blood Glucose records were downloaded at each session and discussed.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_17234', 'glucose', 25, 'glucose')]
PMC4865392	5/2016	S39-PMC4865392	['ada, american diabetes association; hands, health access nurturing development services; pp, Postpartum; smbg, self-monitoring of Blood Glucose; u/s, ultrasonography.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 93, 'postpartum'), ('UBERON_0000178', 'blood', 130, 'blood'), ('CHEBI_17234', 'glucose', 136, 'glucose')]
PMC4872432	2/2016	S3-PMC4872432	["Blood samples were collected at 9–14 weeks' Gestation (75% of samples) or after 15 weeks (25%)."]	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 44, 'gestation')]
PMC4872432	2/2016	S36-PMC4872432	['Fatty Acid analysis\n\nBlood samples\nnon-fasting Blood samples were collected and after the biochemical measurements were made, the residual Serum samples were kept at −80\u2009°c until analysis.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('UBERON_0000178', 'blood', 21, 'Blood'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 139, 'serum')]
PMC4889866	5/2016	S8-PMC4889866	['there was no relationship between maternal and Cord Blood Vitamin D status with infectious diseases during infancy.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 47, 'cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4889866	5/2016	S38-PMC4889866	['briefly, maternal Blood was obtained during third Gestation and Umbilical Cord Blood collected at the time of Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007565', 'female pregnancy', 50, 'gestation'), ('UBERON_0002331', 'umbilical cord', 64, 'umbilical cord'), ('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0007567', 'parturition', 110, 'delivery')]
PMC4889866	5/2016	S49-PMC4889866	['Serum 25(Oh)D measurement\nSerum samples obtained from the Pregnant mother and Cord Blood were stored frozen in aliquotsat −80°c until analysis.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 9, 'OH ... D'), ('UBERON_0001977', 'blood serum', 26, 'Serum'), ('GO_0007565', 'female pregnancy', 58, 'pregnant'), ('UBERON_0002240', 'spinal cord', 78, 'cord'), ('UBERON_0000178', 'blood', 83, 'blood')]
PMC4889866	5/2016	S71-PMC4889866	['maternal and Cord Vitamin D levels\nthe median maternal Blood 25(Oh)D concentration was 15.18\u2009ng/ml (interquartile range (iq): 10.85–19.10\u2009ng/ml), and the median Cord Blood 25(Oh)D was 14.80\u2009ng/ml (iq: 10.02−18.86\u2009ng/ml).']	N/A	N/A	[('UBERON_0000948', 'heart', 13, 'Cord'), ('CHEBI_28384', 'vitamin K', 18, 'Vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('UBERON_0000178', 'blood', 55, 'blood'), ('CHEBI_71657', 'versiconol acetate', 61, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 61, '25(OH ... D'), ('UBERON_0009472', 'axilla', 161, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 172, '25(OH)D')]
PMC4889866	5/2016	S78-PMC4889866	['in Cord Blood Mononuclear Cells.']	N/A	N/A	[('CL_0000752', 'cone retinal bipolar cell', 3, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 3, 'cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('GO_0031097', 'medial cortex', 14, 'mononuclear')]
PMC4889866	5/2016	S86-PMC4889866	['Cord Blood Vitamin D level was also not correlated with any of the infectious disorders by 12 months of age.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4889866	5/2016	S135-PMC4889866	['regression analysis was used to determine the relation between maternal Blood 25(Oh)D concentration and tlr-induced cytokine response as continuous variables.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_71657', 'versiconol acetate', 78, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 78, '25 ... OH ... D')]
PMC4889866	5/2016	S138-PMC4889866	['Cord Blood Monocytes were collected and stimulated with Tlr9 ligand to test for the Expression of Tnf-Α, Il-6, and Il-10.']	N/A	N/A	[('CL_0000140', 'odontocyte', 0, 'Cord blood monocytes'), ('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('PR_000001155', 'Toll-like receptor 4', 56, 'TLR9'), ('GO_0010467', 'gene expression', 84, 'expression'), ('PR_000000134', 'tumor necrosis factor alpha', 98, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 105, 'IL-6'), ('PR_000001470', 'interleukin-28B', 115, 'IL-10')]
PMC4892656	6/2016	S49-PMC4892656	['catheterization and Blood sampling\npermanent indwelling catheter tubes were placed in both Jugular Veins at least one day prior to the first tolerance test to facilitate repeated collection of Blood samples as described by khanal et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0034981', 'superior bulb of internal jugular vein', 91, 'jugular veins'), ('UBERON_0000178', 'blood', 193, 'blood')]
PMC4892656	6/2016	S51-PMC4892656	['Blood samples were collected at different time points depending upon the tolerance test (see below) and all Blood samples were collected in edta tubes and processed as previously described [5].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC4892656	6/2016	S53-PMC4892656	['[4], except that the fasting period had a duration of 68 hours and Blood samples were collected at 13:00 (0 sample), 24, 48 and 68 hour after the onset of fasting (ftt).']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood')]
PMC4892656	6/2016	S57-PMC4892656	['laboratory analyses\nGlucose, non-esterified Fatty Acids (nefa), Triglycerides (tg), Blood Urea nitrogen (bun), creatinine, lactate, Β-Hydroxy-butyrate (bohb), γ-glutamyl transferase (ggt) and Cholesterol levels were determined in Plasma samples as previously described [4,5].']	N/A	N/A	[('CHEBI_17234', 'glucose', 20, 'Glucose'), ('CHEBI_35366', 'fatty acid', 44, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 64, 'triglycerides'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_16199', 'urea', 90, 'urea'), ('CHEBI_43141', '3-hydroxypropoxy group', 132, 'β-hydroxy'), ('CHEBI_16113', 'cholesterol', 192, 'cholesterol'), ('UBERON_0001969', 'blood plasma', 230, 'plasma')]
PMC4892656	6/2016	S104-PMC4892656	['(a) bun (Blood Urea nitrogen) (b) Cholesterol (c) tg (Triglycerides) and (d) ggt (γ-glutamyl transferase).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_16199', 'urea', 15, 'urea'), ('CHEBI_16113', 'cholesterol', 34, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 54, 'triglycerides')]
PMC4892656	6/2016	S234-PMC4892656	['(a) bun (Blood Urea nitrogen) (b) bun (c) Cholesterol (d) Cholesterol.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_16199', 'urea', 15, 'urea'), ('CHEBI_16113', 'cholesterol', 42, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 58, 'cholesterol')]
PMC4892913	10/2015	S53-PMC4892913	['informed consent was obtained for collection of leftover Urine and Cord Blood specimens for the pbb study and for future testing of stored specimens for environmental contaminants.']	N/A	N/A	[('UBERON_0001088', 'urine', 57, 'urine'), ('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood')]
PMC4896250	4/2016	S123-PMC4896250	['body temperature 98.5 f, Blood oxygen saturation 95 % in room air; no crackle, stridor, nor wheeze was audible.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood')]
PMC4896250	4/2016	S194-PMC4896250	['we took Blood samples to examine Food-specific Immunoglobulin e (Ige) levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_33290', 'food', 33, 'food'), ('GO_0019814', 'immunoglobulin complex', 47, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 65, 'IgE')]
PMC4896250	4/2016	S253-PMC4896250	['Blood samples were taken from the patients to measure Food Allergen-specific Ige.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_33290', 'food', 54, 'food'), ('CHEBI_50904', 'allergen', 59, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE')]
PMC4896250	4/2016	S732-PMC4896250	['sfse-g treatment significantly restored the altered total and differential cell count in Balf and Blood.']	N/A	N/A	[('UBERON_0001348', 'brown adipose tissue', 89, 'BALF'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC4896250	4/2016	S733-PMC4896250	['the blm induced peripheral Blood oxygen content reduction was significantly reversed by sfse-g treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood')]
PMC4896250	4/2016	S807-PMC4896250	['Blood chemistries, Liver and Kidney function tests, inflammatory markers (esr and crp) and Immunoglobulin levels were within the normal ranges in all patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0002113', 'kidney', 29, 'kidney'), ('GO_0019814', 'immunoglobulin complex', 91, 'immunoglobulin')]
PMC4896250	4/2016	S832-PMC4896250	['the symptoms are more in autoreactive urticaria (au) where auto-Antibodies in Blood flares-up the condition.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 64, 'antibodies'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC4896250	4/2016	S938-PMC4896250	['Blood, Spleen and Small Intestine were collected for Antibody, cytokine, Gene Expression and histological analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002106', 'spleen', 7, 'spleen'), ('UBERON_0002108', 'small intestine', 18, 'small intestine'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibody'), ('GO_0010467', 'gene expression', 73, 'gene expression'), ('SO_0000704', 'gene', 73, 'gene')]
PMC4896250	4/2016	S1050-PMC4896250	['levels of 25-Ohd were measured in Umbilical Cord Blood samples (n=724) and Serum samples drawn at the age of 2 years (n=369); the data were categorized in tertiles and quartiles.']	N/A	N/A	[('CHEBI_72765', 'verruculogen', 10, '25-OHD'), ('UBERON_0002331', 'umbilical cord', 34, 'umbilical cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('UBERON_0001977', 'blood serum', 75, 'serum')]
PMC4896250	4/2016	S1304-PMC4896250	['methods : Peripheral Blood Mononuclear Cells (Pbmcs) were treated with Flab and then inkt cells-derived and Intracellular cytokines were determined by elisa and flow cytometry, respectively, following the stimulation with A-galactosylceramide (a-Galcer).']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 10, 'Peripheral blood mononuclear cells'), ('UBERON_0000178', 'blood', 21, 'blood'), ('GO_0031097', 'medial cortex', 27, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 46, 'PBMCs'), ('PR_000007593', 'glutamate carboxypeptidase 2', 71, 'FlaB'), ('GO_0005622', 'intracellular anatomical structure', 108, 'intracellular'), ('20', 'ABCA2 (human)', 222, 'a'), ('CHEBI_34768', 'furfural', 246, 'GalCer')]
PMC4896250	4/2016	S1420-PMC4896250	['references\n(1) s.c. pitchford, Blood, 105 (2005), pp.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood')]
PMC4896250	4/2016	S1732-PMC4896250	['Cotinine (Cot) and Dolichol (Dol) were measured in Blood and Urine during Pregnancy.']	N/A	N/A	[('CHEBI_27965', 'conessine', 0, 'Cotinine'), ('CHEBI_18133', 'hexose', 10, 'Cot'), ('CHEBI_16091', 'dolichol', 19, 'dolichol'), ('CHEBI_4682', 'dolasetron', 29, 'Dol'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0001088', 'urine', 61, 'urine'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC4896250	4/2016	S1737-PMC4896250	['mothers of these children (92%) have had cot in Blood and elevated Urinal Dol Excretion in Pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0001088', 'urine', 67, 'urinal'), ('CHEBI_4682', 'dolasetron', 74, 'Dol'), ('GO_0007588', 'excretion', 78, 'excretion'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC4896250	4/2016	S1772-PMC4896250	['asthma control questionnaire (acq), Blood Eosinophils were assessed at the same time.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('CL_0000771', 'eosinophil', 42, 'eosinophils')]
PMC4896250	4/2016	S1783-PMC4896250	['methods: Eosinophils isolated from Peripheral Blood of normal Individuals were incubated in the presence or absence of monosodium Urate (msu) crystals and Atpγs, a non-hydrolysable atp analogue.']	N/A	N/A	[('CL_0000771', 'eosinophil', 9, 'Eosinophils'), ('UBERON_0012101', 'perinatal stage', 35, 'peripheral'), ('UBERON_0000178', 'blood', 46, 'blood'), ('NCBITaxon_1', 'root', 62, 'individuals'), ('CHEBI_46819', 'urate salt', 130, 'urate'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 155, 'ATPγS')]
PMC4896250	4/2016	S1899-PMC4896250	['Eosinophils from Peripheral Blood were extracted then stimulated with both Fungi.']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0012101', 'perinatal stage', 17, 'peripheral'), ('UBERON_0000178', 'blood', 28, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'fungi')]
PMC4896250	4/2016	S1940-PMC4896250	['counting of White Blood Cells, severity of disease was accessed in the first visit.']	N/A	N/A	[('CL_0000738', 'leukocyte', 12, 'white blood cells'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC4896250	4/2016	S2018-PMC4896250	['Blood was drawn from Orbital Vein and Serum ovalbumin and ovomucoid specific Igg1S were measured at day 36.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001661', 'deep temporal vein', 21, 'orbital vein'), ('UBERON_0001977', 'blood serum', 38, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 77, 'IgG1s')]
PMC4896250	4/2016	S2204-PMC4896250	['laboratory findings showed hemoglobin level 16.6 mg/dl, Platelet count 265,000/mm3, wbc counts 6300/mm3 with differential 16.7% of Eosinophils on corrected Blood chemistry.']	N/A	N/A	[('CL_0000233', 'platelet', 56, 'platelet'), ('CL_0000771', 'eosinophil', 131, 'eosinophils'), ('UBERON_0000178', 'blood', 156, 'blood')]
PMC4896250	4/2016	S2210-PMC4896250	['patient’s symptoms were relieved after surgery and followed Blood chemistry showed improvement of peripheral Eosinophilia 16.7% to 3.5%.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('CL_0000771', 'eosinophil', 109, 'eosinophilia')]
PMC4896250	4/2016	S2221-PMC4896250	['results: the Cord Blood Ige level did not have any predictive value for allergy development during the first 12 years of Life.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 24, 'IgE'), ('UBERON_0000104', 'life cycle', 121, 'life')]
PMC4896250	4/2016	S2232-PMC4896250	['complete Blood count was performed, which revealed Eosinophilia in peripheral Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000771', 'eosinophil', 51, 'eosinophilia'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC4896250	4/2016	S2246-PMC4896250	['in order to identify the infectious triggers, Blood samples were used to evaluate the level of Antibodies for toxocara cannis , toxoplasma gondii , herpes simplex virus, Epstein–Barr Virus, cytomegalovirus and measles virus.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 95, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'Epstein'), ('NCBITaxon_10088', 'Mus <genus>', 178, 'Barr virus')]
PMC4896250	4/2016	S2334-PMC4896250	['materials and methods: to the obtain nk cell, Blood Mononuclear Cells after isolation, the 1×106of viable cells were cultured in medium rpmi 1640 and affects by g2 vaccine in the times of 12, 24 and 48 hours at of 37°.']	N/A	N/A	[('CL_0000208', 'pH receptor cell', 46, 'Blood mononuclear cells'), ('UBERON_0000178', 'blood', 46, 'Blood'), ('GO_0031097', 'medial cortex', 52, 'mononuclear')]
PMC4896250	4/2016	S2364-PMC4896250	['Blood tests on admission showed hemoglobin 16.1 g/dl, total Leukocyte count 5265 /ul (Neutrophils 78.7%, Lymphocytes 11.2%, Eosinophils 4.9%), ast 47 iu/l, alt 49 iu/l, Serum Bilirubin 0.55 mg/dl, serum creatinine 0.91 mg/dl and Blood Glucose 95 mg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000738', 'leukocyte', 60, 'leukocyte'), ('CL_0000775', 'neutrophil', 86, 'neutrophils'), ('CL_0000542', 'lymphocyte', 105, 'lymphocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_16990', 'bilirubin IXalpha', 175, 'bilirubin'), ('UBERON_0000178', 'blood', 229, 'blood'), ('CHEBI_17234', 'glucose', 235, 'glucose')]
PMC4896250	4/2016	S2365-PMC4896250	['Urinalysis showed no Red Blood Cells or White Blood Cells.']	N/A	N/A	[('UBERON_0001286', "Bowman's space", 0, 'Urinalysis'), ('CL_0000232', 'erythrocyte', 21, 'red blood cells'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CL_0000738', 'leukocyte', 40, 'white blood cells'), ('UBERON_0000178', 'blood', 46, 'blood')]
PMC4896250	4/2016	S2413-PMC4896250	['cross-sectional data (Serum total Ige, Blood Eosinophil, fev1, bronchodilator response, pc20, asthma severity), and longitudinal data (number of exacerbations, mean ics dose, fev1 variability) were compared by the presence of Fungal sensitization, defined as positive (a/h > 1 or mean Wheal diameter greater than 3mm) skin prick test to Fungal Allergen ( aspergillus, alternaria, cladosporium, Epicoccum, fusarium, penicilliium, trichopyton ).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 34, 'IgE'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CL_0000771', 'eosinophil', 45, 'eosinophil'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'fungal'), ('UBERON_0001688', 'incus bone', 285, 'wheal'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'fungal'), ('CHEBI_50904', 'allergen', 344, 'allergen'), ('NCBITaxon_10088', 'Mus <genus>', 394, 'Epicoccum')]
PMC4896250	4/2016	S2459-PMC4896250	['methods: a Lymphocyte Transformation test (ltt) and Ifnγ-elispot assay using atds were performed using Peripheral Blood Mononuclear Cells from the patient.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 11, 'lymphocyte'), ('GO_0001572', 'lactosylceramide biosynthetic process', 11, 'lymphocyte transformation'), ('PR_000008920', 'interferon alpha-7', 52, 'IFNγ'), ('CL_0000111', 'peripheral neuron', 103, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 103, 'peripheral'), ('UBERON_0000178', 'blood', 114, 'blood'), ('CL_0000226', 'single nucleate cell', 120, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 120, 'mononuclear')]
PMC4896250	4/2016	S2462-PMC4896250	['Isoniazid/Rifampicin- specific T-Cell clones were generated from Blood of the patients, but not Pyrazinamide or Ethambutol.']	N/A	N/A	[('CHEBI_6011', 'isoficine', 0, 'Isoniazid'), ('CHEBI_17015', 'riboflavin', 10, 'rifampicin'), ('CL_0000084', 'T cell', 31, 'T-cell'), ('GO_0005854', 'nascent polypeptide-associated complex', 32, '-'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_45285', 'pyrazinecarboxamide', 96, 'pyrazinamide'), ('CHEBI_4877', 'ethambutol', 112, 'ethambutol')]
PMC4896250	4/2016	S2567-PMC4896250	['a180 the prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic korean Adults\n\njin-young lee1, kyoung won ha2, yun-jin jeung3, sehyo yune4, byung-jae lee4, dong-chull choi5, mi-jung oh6, young hee lim7\n\n1health promotion center, samsung medical center, south korea;2seoul samsung medical clinic;3clean medicine allergy clinic;4samsung medical center;5samsung medical center, sungkyunkwan university school of medicine;6bundang jesaeng hospital;7ansan sarang general hospital\n\ncorrespondence: jin-young lee – health promotion center, samsung medical center, south korea\npurpose: toxocariasis is the most common cause of peripheral Blood Eosinophilia in korea and produces Eosinophilic infiltration into various Organs, including the Lung.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 99, 'adults'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CL_0000771', 'eosinophil', 664, 'eosinophilia'), ('CL_0000771', 'eosinophil', 699, 'eosinophilic'), ('UBERON_0000062', 'organ', 738, 'organs'), ('UBERON_0002048', 'lung', 760, 'lung')]
PMC4896250	4/2016	S2717-PMC4896250	['characteristics of asthma sub-phenotypes were analyzed by disease severity, Pulmonary function, Blood Eosinophil counts, total Ige levels in Serum, and specific Ige Antibody to environmental Allergens.']	N/A	N/A	[('UBERON_0002048', 'lung', 76, 'pulmonary'), ('UBERON_0000178', 'blood', 96, 'blood'), ('CL_0000771', 'eosinophil', 102, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 127, 'IgE'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 161, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody'), ('CHEBI_33663', 'cyclic hydrocarbon', 191, 'allergens')]
PMC4896250	4/2016	S2719-PMC4896250	['there were no significant differences in the distribution of severity, fev1 percent predicted, Blood Eosinophil counts and total Ige levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood'), ('CL_0000771', 'eosinophil', 101, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE')]
PMC4896250	4/2016	S2759-PMC4896250	['dna was isolated from whole Blood and genotyped for the Single Nucleotide Polymorphisms (Snps) in Cd28, Ctla4, Cd40 and Cd40Lg .']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('SO_0000694', 'SNP', 56, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 89, 'SNPs'), ('PR_000001309', 'CD70 molecule', 98, 'CD28'), ('PR_000006021', 'chymotrypsin-like protease CTRL-1', 104, 'CTLA4'), ('PR_000001309', 'CD70 molecule', 111, 'CD40'), ('PR_000001309', 'CD70 molecule', 120, 'CD40LG')]
PMC4896250	4/2016	S2824-PMC4896250	['gross findings, functional study for skin barrier, Blood sampling, Bronchoalveolar lavage and biopsies of skin and Lung were done at 24 h after last treatment.']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0002183', 'lobar bronchus', 67, 'bronchoalveolar'), ('UBERON_0002048', 'lung', 115, 'lung')]
PMC4896250	4/2016	S2870-PMC4896250	['Expressions of Il-4, Il-13, and Inf-Γ of neonatal Cord Blood were examined by using quantitative real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expressions'), ('PR_000001470', 'interleukin-28B', 15, 'IL-4'), ('PR_000001470', 'interleukin-28B', 21, 'IL-13'), ('PR_000008917', 'interferon alpha-4', 32, 'INF-γ'), ('UBERON_0002240', 'spinal cord', 50, 'cord'), ('UBERON_0000178', 'blood', 55, 'blood')]
PMC4896250	4/2016	S2877-PMC4896250	['Il-4 and Ifn-Γ in Cord Blood of neonate with allergic mother had higher Expression than those of non-allergic mother.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 9, 'IFN-γ'), ('UBERON_0002240', 'spinal cord', 18, 'cord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('GO_0010467', 'gene expression', 72, 'expression')]
PMC4896250	4/2016	S2878-PMC4896250	['(p<0.05) the amounts of nutrition weren’t related to Neonatal Cord Blood Il-4 and Ifn- Γ.']	N/A	N/A	[('UBERON_0001759', 'vagus nerve', 53, 'neonatal'), ('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('PR_000001470', 'interleukin-28B', 73, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 82, 'IFN- γ')]
PMC4896250	4/2016	S3129-PMC4896250	['in patients with mild attack of asthma concentration vip in Blood was 88.81 ± 31.14 nmol/l, with moderate - 100.27 ± 16.27 nmol/l, severe - 107.34 ± 22.70 nmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood')]
PMC4896250	4/2016	S3150-PMC4896250	['Peripheral Blood Mononuclear Cells (Pbmc) were isolated from all the subjects and in vitro stimulated with hdm extracted (0μg/ml, 2.5 μg/ml, 5 μg/ml) for 48 hours, and then the relative percentage of Treg were measured by flow cytometry.']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 0, 'Peripheral blood mononuclear cells'), ('UBERON_0000178', 'blood', 11, 'blood'), ('GO_0031097', 'medial cortex', 17, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 36, 'PBMC'), ('CL_0000901', 'Tr1 cell', 200, 'Treg')]
PMC4896250	4/2016	S3242-PMC4896250	['general physical examination included clinical Blood and Urine analyses and screening for parasitic and Viral infections.']	N/A	N/A	[('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001088', 'urine', 57, 'urine'), ('NCBITaxon_1', 'root', 104, 'viral')]
PMC4896250	4/2016	S3243-PMC4896250	['Iaa consisted of: immunogram determination of levels of pro- and antiinflammatory cytokines (by fluorescence immunoassay); skin testing, challenge or elimination testing (if indicated), total and specific Ige Blood testing.']	N/A	N/A	[('CHEBI_32035', 'potassium hydroxide', 0, 'IAA'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE'), ('UBERON_0000178', 'blood', 209, 'blood')]
PMC4896250	4/2016	S3886-PMC4896250	['eno was measured with a niox mino analyzer and specific Ige (sige) to inhalant and Food Allergens measured in Blood by fluorescence enzyme immunoassay (phadia 100).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 56, 'IgE'), ('CHEBI_33290', 'food', 83, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 88, 'allergens'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC4896250	4/2016	S4234-PMC4896250	['the clinical features of the group 1 were younger, high Airway hyperreactivity and increased numbers of wbc in Blood.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 56, 'airway'), ('UBERON_0000178', 'blood', 111, 'blood')]
PMC4896250	4/2016	S4356-PMC4896250	['in vitro test, total Ige and Blood Eosinophil count was analysed.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 21, 'IgE'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CL_0000771', 'eosinophil', 35, 'eosinophil')]
PMC4896250	4/2016	S4358-PMC4896250	['the visual analogue scale of Nasal symptoms were no difference between two groups as in vitro test, total Ige and Blood Eosinophil count.']	N/A	N/A	[('UBERON_0000004', 'nose', 29, 'nasal'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 106, 'IgE'), ('UBERON_0000178', 'blood', 114, 'blood'), ('CL_0000771', 'eosinophil', 120, 'eosinophil')]
PMC4896250	4/2016	S4380-PMC4896250	['Blood samples were collected from mongolian Individuals (n=216) with allergic rhinitis: 86 males and 130 females in 4 different age groups (20-30, 31-40, 41-50 and 51-60).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_1', 'root', 44, 'individuals')]
PMC4896250	4/2016	S4423-PMC4896250	['we were collected 112 Serum of mongolian healthy Adult Blood donors: 58 males and 54 females in 4 different age groups (20-30, 31-40, 41-50 and 51-60).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('UBERON_0000178', 'blood', 55, 'blood')]
PMC4896250	4/2016	S4469-PMC4896250	['the material of history, Blood test, Lung function test, the concentrations of fraction of exhaled Nitric Oxide (Feno), vitro allergern test of asthmatic children were reserved.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002048', 'lung', 37, 'lung'), ('CHEBI_16480', 'nitric oxide', 99, 'nitric oxide'), ('CHEBI_32035', 'potassium hydroxide', 113, 'FeNO')]
PMC4896250	4/2016	S4664-PMC4896250	['ninety ad children, aged between 6 and 12 years, completed scoring of severity of ad (scorad), Blood tests for Serum total Ige, Blood Eosinophil counts, Serum Eosinophil Cationic protein (ecp) and Lipid profiles.']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood'), ('UBERON_0001977', 'blood serum', 111, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 123, 'IgE'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000771', 'eosinophil', 134, 'eosinophil'), ('UBERON_0001977', 'blood serum', 153, 'serum'), ('CL_0000771', 'eosinophil', 159, 'eosinophil'), ('CHEBI_36916', 'cation', 170, 'cationic'), ('CHEBI_18059', 'lipid', 197, 'lipid')]
PMC4896250	4/2016	S4867-PMC4896250	['the levels of Il-4,Il-13, Ifn-Γ in Peripheral Blood were detected by enzyme-linked immunosorbent assay after Proliferate in response to Α-Galcer.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 14, 'IL-4'), ('PR_000001470', 'interleukin-28B', 19, 'IL-13'), ('PR_000008920', 'interferon alpha-7', 26, 'IFN-γ'), ('UBERON_0012101', 'perinatal stage', 35, 'peripheral'), ('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0008283', 'cell proliferation', 109, 'proliferate'), ('CHEBI_33822', 'organic hydroxy compound', 136, 'α-Galcer')]
PMC4896250	4/2016	S4898-PMC4896250	['the issac questionnaire, Serum total Ige level, Blood Eosinophil percentage, skin prick test, Pulmonary function test and Methacholine challenge test were done at age 7 for baseline and age 11 years after follow up.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 37, 'IgE'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CL_0000771', 'eosinophil', 54, 'eosinophil'), ('UBERON_0002048', 'lung', 94, 'pulmonary'), ('CHEBI_6805', 'methacycline', 122, 'methacholine')]
PMC4896250	4/2016	S5011-PMC4896250	['skin prick test to 18 Allergens and Blood test were completed for 188 children with ad.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 22, 'allergens'), ('UBERON_0000178', 'blood', 36, 'blood')]
PMC4896250	4/2016	S5017-PMC4896250	['geometric means (range of 1 sd) of Blood Eosinophil percentage (5.78% [3.35-10.00]) and Serum Eosinophil Cationic protein concentration (48.98 μg/l [43.84-2,189.52]) in severe ad group were significantly higher than those of mild-to-moderate ad group (3.64% [1.67-7.96], 33.28 μg/l [12.02-92.20]).']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000771', 'eosinophil', 41, 'eosinophil'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('CL_0000771', 'eosinophil', 94, 'eosinophil'), ('CHEBI_36916', 'cation', 105, 'cationic')]
PMC4896250	4/2016	S5114-PMC4896250	['48 hours after the last challenge in all groups Blood was collected for differential cell count, Brochoalveolar Lavage Fluid (Balf) was sampled for the determination of inflammatory cells and Lungs were removed for histological analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0004212', 'glomerular capillary', 97, 'brochoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 126, 'BALF'), ('UBERON_0002048', 'lung', 192, 'lungs')]
PMC4896250	4/2016	S5128-PMC4896250	['the Blood test, inflammatory reactant test and serologic test were performed.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4896250	4/2016	S5183-PMC4896250	['the test of Blood of inspected was mixed up with a staphylococcus Antigen in the standard capillary of panchenkov and incubation 18-24 hours at a room temperature.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_59132', 'antigen', 66, 'antigen')]
PMC4896250	4/2016	S5192-PMC4896250	['methods: Peripheral Blood Neutrophils isolated from asthmatic as well as healthy controls were stimulated, or not, with Il-21, Il-23, and il-6 cytokines and levels of Gene as well as protein Expression of Il-17 cytokines were determined using rt-pcr and flow cytometry, respectively.']	N/A	N/A	[('CL_0000111', 'peripheral neuron', 9, 'Peripheral blood'), ('UBERON_0000178', 'blood', 20, 'blood'), ('CL_0000775', 'neutrophil', 26, 'neutrophils'), ('PR_000001470', 'interleukin-28B', 120, 'IL-21'), ('PR_000001470', 'interleukin-28B', 127, 'IL-23'), ('SO_0000704', 'gene', 167, 'gene'), ('GO_0010467', 'gene expression', 191, 'expression'), ('PR_000001470', 'interleukin-28B', 205, 'IL-17')]
PMC4896250	4/2016	S5194-PMC4896250	['results: Il-21, Il-23, and Il-6 induced the production of Il-17 cytokines within peripheral Blood Neutrophils.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 9, 'IL-21'), ('PR_000001470', 'interleukin-28B', 16, 'IL-23'), ('PR_000001470', 'interleukin-28B', 27, 'IL-6'), ('PR_000001470', 'interleukin-28B', 58, 'IL-17'), ('UBERON_0000178', 'blood', 92, 'blood'), ('CL_0000775', 'neutrophil', 98, 'neutrophils')]
PMC4896250	4/2016	S5536-PMC4896250	['patients Blood Eosinophils Leukocyte count, levels of total sesrum Imunoglobulin e, Serum Eosinophil Cationic protein and exhaled Nitric Oxide levels were determined.daily the patients received 1500 iu of Vitamin D3 orally.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000771', 'eosinophil', 15, 'eosinophils leukocyte'), ('GO_0019814', 'immunoglobulin complex', 67, 'imunoglobulin'), ('UBERON_0001977', 'blood serum', 84, 'serum'), ('CL_0000771', 'eosinophil', 90, 'eosinophil'), ('CHEBI_36916', 'cation', 101, 'cationic'), ('CHEBI_16480', 'nitric oxide', 130, 'nitric oxide'), ('CHEBI_33237', 'vitamin D4', 205, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 205, 'Vitamin D3')]
PMC4896250	4/2016	S5652-PMC4896250	['in addition, atopic patient’s Blood samples were collected and examined for Mirna Expression.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('GO_0007618', 'mating', 76, 'miRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('GO_0010467', 'gene expression', 82, 'expression')]
PMC4896250	4/2016	S5819-PMC4896250	['Blood Neutrophil was 85.3 % of total Leukocytes.']	N/A	N/A	[('CL_0000081', 'blood cell', 0, 'Blood neutrophil'), ('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000738', 'leukocyte', 37, 'leukocytes')]
PMC4896250	4/2016	S6248-PMC4896250	['Genome-wide Snp genotyping of the patients was performed using Genomic dna from peripheral Blood Lymphocytes.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genome'), ('SO_0000694', 'SNP', 12, 'SNP'), ('SO_0001026', 'genome', 63, 'genomic'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CL_0000542', 'lymphocyte', 97, 'lymphocytes')]
PMC4896250	4/2016	S6314-PMC4896250	['no Virus-specific Antibodies, bacteria, and Fungi were detected in Csf, Blood, and Urine.']	N/A	N/A	[('NCBITaxon_1', 'root', 3, 'virus'), ('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'fungi'), ('UBERON_0001359', 'cerebrospinal fluid', 67, 'CSF'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0001088', 'urine', 83, 'urine')]
PMC4896250	4/2016	S6340-PMC4896250	['methods: a clinical study was conducted at kk women’s and children’s hospital, where 55 Cord Blood samples from caesarean section-Delivered infants were collected to evaluate the response to Allergens in the Cord Blood Cells.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0007567', 'parturition', 130, 'delivered'), ('CHEBI_33663', 'cyclic hydrocarbon', 191, 'allergens'), ('CL_0000162', 'parietal cell', 208, 'cord blood cells'), ('UBERON_0002240', 'spinal cord', 208, 'cord'), ('UBERON_0000178', 'blood', 213, 'blood')]
PMC4896250	4/2016	S6341-PMC4896250	['freshly isolated Cord-Blood Mononuclear Cells (Cbmcs) were cultured in a 96-well plate at 100,000 cells per well (in triplicate per condition) and stimulated with the extracts from either one of major house dust mite species: blomia tropicalis (blot) and dermatophagoides Pteronyssinus (Derp).']	N/A	N/A	[('CL_0002092', 'bone marrow cell', 17, 'cord-blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 17, 'cord'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0031097', 'medial cortex', 28, 'mononuclear'), ('CL_0000979', 'IgG memory B cell', 47, 'CBMCs'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 272, 'pteronyssinus'), ('PR_000006265', 'dapper homolog 3', 287, 'DerP')]
PMC4896250	4/2016	S6398-PMC4896250	['a450 epidemiological characterization of Blood Eosinophils in the elderly population\n\nha kyeong won1, hye-ryun kang1, byung-keun kim2, sung do moon1, ju-young kim1, so-hee lee1, woo-jung song3, heung woo park3, min-koo kang1, sun-sin kim1, sang-heon cho4, kyung-up min4, yoon-seok chang3, kyoung hee sohn3, kyung-mook kim5, ki-woong kim2, hak chul jang2\n\n1seoul national university hospital, south korea;2seoul national university bundang hospital;3seoul national university college of medicine;4seoul national university medical research center;5pogunhan mom hospital\n\ncorrespondence: ha kyeong won – seoul national university hospital, south korea\nbackground: peripheral Blood Eosinophilia is a common clinical manifestation which draws medical attention.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'Blood'), ('CL_0000771', 'eosinophil', 47, 'Eosinophils'), ('UBERON_0000178', 'blood', 673, 'blood'), ('CL_0000771', 'eosinophil', 679, 'eosinophilia')]
PMC4896250	4/2016	S6402-PMC4896250	['the primary outcome was peripheral Blood Eosinophil counts and the upper limit of the 95% confidence interval for absolute count of Blood Eosinophil counts was calculated for normal ranges.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000771', 'eosinophil', 41, 'eosinophil'), ('UBERON_0000178', 'blood', 132, 'blood'), ('CL_0000771', 'eosinophil', 138, 'eosinophil')]
PMC4896250	4/2016	S6406-PMC4896250	['results: cutoff value for Blood Eosinophilia was less than 406.6x103/ml (n=1,000).']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CL_0000771', 'eosinophil', 32, 'eosinophilia')]
PMC4896250	4/2016	S6412-PMC4896250	['conclusion: the normal range of Peripheral Blood Eosinophils in the korean elderly was ≤ 406.6 x103/ml (upper 95th percentile), which was almost identical to the reference range in the literature.']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 32, 'peripheral'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CL_0000771', 'eosinophil', 49, 'eosinophils')]
PMC4896250	4/2016	S6494-PMC4896250	['eosinophilia in peripheral Blood and Hepatic involvement was more frequently noted in period ii, while enlarged Lymph Nodes in period i significantly.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0002107', 'liver', 37, 'hepatic'), ('UBERON_0000029', 'lymph node', 112, 'lymph nodes')]
PMC4896250	4/2016	S6693-PMC4896250	['to specigy the Antigen, elisa and western blot and Blood testing were also performed.']	N/A	N/A	[('CHEBI_59132', 'antigen', 15, 'antigen'), ('UBERON_0000178', 'blood', 51, 'blood')]
PMC4896250	4/2016	S6781-PMC4896250	['method\nwe sampled 64 patients (32 men and 32 women) who visited our department and took Blood test from january 2014 to december 2014.']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood')]
PMC4896250	4/2016	S6901-PMC4896250	['children with having fa had a higher Blood total Ige levels(238.7±414.6 iu/ml vs. 50.7±96.0 iu/ml, p =0.001) and Eosinophil(%)(7.0% ± 5.0% vs. 4.7% ±3.4%, p =0.001), and more frequent parental allergic history(70% vs. 59%, p =0.025).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 49, 'IgE'), ('CL_0000771', 'eosinophil', 113, 'eosinophil')]
PMC4896250	4/2016	S6945-PMC4896250	['the diagnostic utility was assessed using receiver operating curve (roc) analyses for Blood Eosinophils in predicting Sputum eosinophilia.']	N/A	N/A	[('UBERON_0000178', 'blood', 86, 'blood'), ('CL_0000771', 'eosinophil', 92, 'eosinophils'), ('UBERON_0007311', 'sputum', 118, 'sputum')]
PMC4896250	4/2016	S6988-PMC4896250	['levels of Blood Nitric Oxide (Nox), High Mobility Group Box-1 (Hmgb-1), thioredoxin, and Eosinophil-derived neurotoxin and Urine 8-Hydroxydeoxyguanosine (8-Ohdg), Nox, Biopyrrin, and 8-Isoprostanes were measured on admission day(acute phase), on hospital days 3–5(recovery phase), and 1–2 weeks after discharge(late phase).']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_16480', 'nitric oxide', 16, 'nitric oxide'), ('CHEBI_26710', 'sodium chloride', 30, 'NOx'), ('PR_000008629', 'high mobility group protein HMGI-C', 36, 'high mobility group box-1'), ('PR_000008650', 'jupiter microtubule associated homolog 1', 63, 'HMGB-1'), ('CL_0000771', 'eosinophil', 89, 'eosinophil'), ('UBERON_0001088', 'urine', 123, 'urine'), ('CHEBI_24909', 'hydrocarbyladenosine', 131, 'hydroxydeoxyguanosine'), ('CHEBI_78732', '9-HPETE', 154, '8-OHdG'), ('CHEBI_26710', 'sodium chloride', 163, 'NOx'), ('CHEBI_3093', 'bifenthrin', 168, 'biopyrrin'), ('CHEBI_38773', 'quinolinemonocarboxylate', 183, '8-isoprostanes')]
PMC4896250	4/2016	S7052-PMC4896250	['the Cord Blood obtained from 655 at Birth.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 36, 'birth')]
PMC4896250	4/2016	S7053-PMC4896250	['the 25(Oh)D and dna from their Cord Blood are measured and specific Ige Antibodies against Egg and Milk were performed at 1, 3yr of age.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 36, 'blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 68, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 72, 'antibodies'), ('CL_0000025', 'egg cell', 91, 'egg'), ('UBERON_0001913', 'milk', 99, 'milk')]
PMC4896250	4/2016	S7321-PMC4896250	['Blood samples were collected and Genomic dna was extracted.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('SO_0001026', 'genome', 33, 'genomic')]
PMC4896250	4/2016	S7430-PMC4896250	['Blood examination were performed and hemolytic anemia, positive anti Nuclear Antibody (ana) and anti dsdna, as well as proteinuria were observed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0005634', 'nucleus', 69, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody')]
PMC4896250	4/2016	S7541-PMC4896250	['Blood Eosinophil count and Serum levels of total Ige, specific Ige to Tsst-1 and Eosinophil Cationic protein (ecp) using immunocap were analyzed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 27, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 49, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 63, 'IgE'), ('PR_000016759', 'testis-specific Y-encoded protein 2', 70, 'TSST-1'), ('CL_0000771', 'eosinophil', 81, 'eosinophil'), ('CHEBI_36916', 'cation', 92, 'cationic')]
PMC4896250	4/2016	S7543-PMC4896250	['the level of Blood Eosinophil count, total Ige and ecp were not significantly different, but Serum specific Ige to Tsst-1 was different between crs with np and without np (p=0.26).']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CL_0000771', 'eosinophil', 19, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 43, 'IgE'), ('UBERON_0001977', 'blood serum', 93, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 108, 'IgE'), ('PR_000016759', 'testis-specific Y-encoded protein 2', 115, 'TSST-1')]
PMC4896250	4/2016	S7569-PMC4896250	['laboratory test results showed an elevated Blood Eosinophil count (1800 /mm3) and an elevated Serum specific Ige level to strawberry (measured by immunocap® [thermofisher scientific, uppsala, sweden] system, 3.98 ku/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('CL_0000771', 'eosinophil', 49, 'eosinophil'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 109, 'IgE')]
PMC4896250	4/2016	S7572-PMC4896250	['after using systemic Corticosteroid and Antihistamines, Blood Eosinophil count decreased to normal range and the patient’s symptoms were resolved.']	N/A	N/A	[('CHEBI_36916', 'cation', 21, 'corticosteroid'), ('CHEBI_22581', 'antiauxins', 40, 'antihistamines'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CL_0000771', 'eosinophil', 62, 'eosinophil')]
PMC4896250	4/2016	S7574-PMC4896250	['Blood Eosinophil count was 900 /mm3and Serum specific Ige levels to pineapple, celery, and sesame were 0.68 ku/l, 0.93 ku/l, and 0.77 ku/l, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 39, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 54, 'IgE')]
PMC4896250	4/2016	S7576-PMC4896250	['Blood Eosinophil count was 1,600 /mm3and Serum specific Ige level to almond was 4.63 ku/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 56, 'IgE')]
PMC4896250	4/2016	S7641-PMC4896250	['the numbers of positive Allergen skin responses and some Blood tests for Eosinophil count, total Ige, esr were collected as well.']	N/A	N/A	[('CHEBI_50904', 'allergen', 24, 'allergen'), ('UBERON_0000178', 'blood', 57, 'blood'), ('CL_0000771', 'eosinophil', 73, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 97, 'IgE')]
PMC4896250	4/2016	S7650-PMC4896250	['methods: Genomic dna was extracted from whole Blood of 56 patients with acute Rejection, and 56 patients with a stable graft function (sgf).']	N/A	N/A	[('SO_0001026', 'genome', 9, 'Genomic'), ('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0060033', 'anatomical structure regression', 78, 'rejection')]
PMC4896250	4/2016	S7747-PMC4896250	['the study covered the following allegro-diagnostic stages:\ni stage - for precise verification of the Allergen, patient’s Blood Serum was examined on a particular specific-Ige Antibodies by modern automated system - "immuno cap 100" (phadia, switzerland).']	N/A	N/A	[('CHEBI_50904', 'allergen', 101, 'allergen'), ('UBERON_0000178', 'blood', 121, 'blood'), ('UBERON_0001977', 'blood serum', 127, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibodies')]
PMC4896250	4/2016	S7910-PMC4896250	['digital Blood flow (Tissue Blood flow, Blood volume, and flow velocity) was measured with laser Tissue Blood flow meter before and after the standing position.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0000479', 'tissue', 20, 'tissue'), ('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0000479', 'tissue', 96, 'tissue'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC4896250	4/2016	S8010-PMC4896250	['Bronchoalveolar Lavage Fluid(Balf) was collected and total White Blood Cell count was determined on Blood Cell counting plate, and classification of proportion was determined under the optical microscope with diff-quick staining.']	N/A	N/A	[('UBERON_0013159', 'epithalamus mantle layer', 0, 'Bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 29, 'BALF'), ('CL_0000738', 'leukocyte', 59, 'white blood cell'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CL_0000081', 'blood cell', 100, 'blood cell'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC4896250	4/2016	S8129-PMC4896250	['Th17, Th2 Cells in peripheral Blood and ki-67, Stat5, Bcl-2 Expressed in Th17 Cells were detected by flow cytometry.']	N/A	N/A	[('CL_0000899', 'T-helper 17 cell', 0, 'Th17 ...'), ('CL_0000546', 'T-helper 2 cell', 6, 'Th2 cells'), ('UBERON_0000178', 'blood', 30, 'blood'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 47, 'STAT5'), ('PR_000004698', 'Bcl-2-like protein 2', 54, 'BCL-2'), ('GO_0010467', 'gene expression', 60, 'expressed'), ('CL_0000899', 'T-helper 17 cell', 73, 'Th17 cells')]
PMC4896250	4/2016	S8130-PMC4896250	['Expression of Rorγt-mrna in Peripheral Blood Mononuclear Cell (Pbmc)was detected by real-time quantitative polymerase chain reaction .concentrations of Il-17, Il-8 and Il-5 in induced Sputum supernatant, as well as concentrations of Il-17 in Plasma and in the culture supernatant from pma-stimulated pbmc were measured by enzyme linked immunosorbent assay.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000014163', 'nuclear receptor ROR-alpha', 14, 'RORγt'), ('CL_0000111', 'peripheral neuron', 28, 'peripheral blood'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CL_0000842', 'mononuclear cell', 45, 'mononuclear cell'), ('GO_0031097', 'medial cortex', 45, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 63, 'PBMC'), ('PR_000001470', 'interleukin-28B', 152, 'IL-17'), ('PR_000001470', 'interleukin-28B', 159, 'IL-8'), ('PR_000001470', 'interleukin-28B', 168, 'IL-5'), ('UBERON_0007311', 'sputum', 184, 'sputum'), ('PR_000001470', 'interleukin-28B', 233, 'IL-17'), ('UBERON_0001969', 'blood plasma', 242, 'plasma')]
PMC4896250	4/2016	S8131-PMC4896250	['results: the percentage of th17, ki-67+th17, Stat5+th17, Bcl-2+Th17 cells in Peripheral Blood and Expression level of Rorγt-mrna in pbmc were significantly higher in na group than in ea group, Pga group and hc group (both p<0.01).']	N/A	N/A	[('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 45, 'STAT5'), ('PR_000004698', 'Bcl-2-like protein 2', 57, 'BCL-2'), ('CL_0000545', 'T-helper 1 cell', 63, 'Th17'), ('UBERON_0012101', 'perinatal stage', 77, 'peripheral'), ('UBERON_0000178', 'blood', 88, 'blood'), ('GO_0010467', 'gene expression', 98, 'expression'), ('PR_000014163', 'nuclear receptor ROR-alpha', 118, 'RORγt'), ('CHEBI_53756', 'HIV-1 reverse transcriptase inhibitor', 193, 'PGA')]
PMC4896250	4/2016	S8133-PMC4896250	['the percentage of Th2 Cells in peripheral Blood and level of Il-5 in Sputum supernatant were significantly higher in ea group than in na group, pga group and hc group (both p<0.01).']	N/A	N/A	[('CL_0000546', 'T-helper 2 cell', 18, 'Th2 cells'), ('UBERON_0000178', 'blood', 42, 'blood'), ('PR_000001470', 'interleukin-28B', 61, 'IL-5'), ('UBERON_0007311', 'sputum', 69, 'sputum')]
PMC4896250	4/2016	S8177-PMC4896250	['Bronchoalveolar Lavage Fluid (Balf) was collected and White Blood Cell counts was operated.']	N/A	N/A	[('UBERON_0013159', 'epithalamus mantle layer', 0, 'Bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 30, 'BALF'), ('CL_0000738', 'leukocyte', 54, 'white blood cell'), ('UBERON_0000178', 'blood', 60, 'blood')]
PMC4896250	4/2016	S8331-PMC4896250	['material for study – Blood Serum, taken fasting from Ulnar Vein and Nasal lavage.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001977', 'blood serum', 27, 'serum'), ('UBERON_0001411', 'basilic vein', 53, 'ulnar vein'), ('UBERON_0000004', 'nose', 68, 'nasal')]
PMC4896250	4/2016	S8345-PMC4896250	['the samples used in this study were from the Birth cohort samples consisting of Cord Blood, 1-year and 2-year samples.']	N/A	N/A	[('GO_0007567', 'parturition', 45, 'birth'), ('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC4896250	4/2016	S8609-PMC4896250	['Genomic dna was extracted from whole Peripheral Blood with edta using qiagen kits, as instructed by supplier.']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0012101', 'perinatal stage', 37, 'peripheral'), ('UBERON_0000178', 'blood', 48, 'blood')]
PMC4896250	4/2016	S8635-PMC4896250	['immediately after administration of copaxonershe experienced, Life threatening anaphylaxis with urticaria, angioedema, Abdominal cramps, dyspnea, drop in Blood pressure and loss of consciousness.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 62, 'life'), ('UBERON_0000916', 'abdomen', 119, 'abdominal'), ('UBERON_0000178', 'blood', 154, 'blood')]
PMC4896250	4/2016	S8738-PMC4896250	['clinical examination of Ent, routine Blood counts, absolute eosionophil count, total Serum Ige estimation.']	N/A	N/A	[('UBERON_0016527', 'white matter of cerebral lobe', 24, 'ENT'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 91, 'IgE')]
PMC4896250	4/2016	S8759-PMC4896250	['clinical examination of Ent, routine Blood counts, absolute eosionophil count, Serum Ige estimation.']	N/A	N/A	[('UBERON_0016527', 'white matter of cerebral lobe', 24, 'ENT'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0001977', 'blood serum', 79, 'Serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 85, 'IgE')]
PMC4896250	4/2016	S8943-PMC4896250	['a mild Eosinophilia (7.2%) was detected in Peripheral Blood.']	N/A	N/A	[('CL_0000771', 'eosinophil', 7, 'eosinophilia'), ('UBERON_0012101', 'perinatal stage', 43, 'peripheral'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC4896250	4/2016	S9047-PMC4896250	['after five milliliters of the whole Blood was collected in a vacuum tube, Serum was separated by centrifugation at 3,000 rpm for 5 min, aliquoted into several round-bottom tubes and frozen at -80°c until use.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4896250	4/2016	S9092-PMC4896250	['the magnitude of driving impairment for Antihistamine Drugs was compared to sdlp increments seen at Blood Alcohol concentration (Bac) 0.05% (δsdlp= +2.4 cm) and Bac 0.08% (δsdlp= +4.3 cm), i.e.']	N/A	N/A	[('CHEBI_35684', 'antiplatyhelmintic drug', 40, 'antihistamine drugs'), ('UBERON_0000178', 'blood', 100, 'Blood'), ('CHEBI_30879', 'alcohol', 106, 'Alcohol'), ('UBERON_0001348', 'brown adipose tissue', 129, 'BAC'), ('UBERON_0001348', 'brown adipose tissue', 161, 'BAC')]
PMC4896250	4/2016	S9109-PMC4896250	['upon arrival of emergency unit team, he had low Blood preassure of 70/50 mmhg, and low oxygen saturation in 82% with altered mental status.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood')]
PMC4896250	4/2016	S9126-PMC4896250	['twenty-four hours after last challenge, we collected Blood, Balf, Lungs.']	N/A	N/A	[('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 60, 'BALF'), ('UBERON_0002048', 'lung', 66, 'lungs')]
PMC4896250	4/2016	S9368-PMC4896250	['Eosinophilia from Blood smear examination was found in 6 cases of da (46,2%).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilia'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC4896250	4/2016	S9456-PMC4896250	['Methacholine and Adenosine bronchial provocation test, Sputum induction, Blood sampling were performed before and after treatment with Corticosteroid for 4weeks.']	N/A	N/A	[('CHEBI_6818', 'Methantheline bromide', 0, 'Methacholine'), ('CHEBI_2468', 'secondary alpha-hydroxy ketone', 17, 'adenosine'), ('UBERON_0007311', 'sputum', 55, 'sputum'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_36916', 'cation', 135, 'corticosteroid')]
PMC4897157	5/2016	S101-PMC4897157	['Vitamin D passes to the fetus through the Placenta; 25-Hydroxy-Vitamin D concentrations in Umbilical Cord Blood at the time of Delivery range from 68% to 108% of maternal levels15).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0001987', 'placenta', 42, 'placenta'), ('CHEBI_70487', '(-)-sanguinolignan C', 52, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 91, 'umbilical cord'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0007567', 'parturition', 127, 'delivery')]
PMC4903143	5/2016	S54-PMC4903143	['the Blood-Brain Barrier is immature and more permeable to adverse Chemical Agents.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000052', 'fornix of brain', 10, 'brain barrier'), ('CHEBI_23084', 'cetraxates', 66, 'chemical agents')]
PMC4903143	5/2016	S189-PMC4903143	['in 2004, a sample of american neonates had their Cord Blood tested for a limited variety of different chemicals.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC4905827	1/2016	S8-PMC4905827	['in a Perinatal neb state, the Liver Triglyceride (tg) and Blood free Fatty Acid (nefa) levels increase [19,26] to compensate for the insufficient energy by degrading the fat accumulated in Adipose Tissues and mobilizing it to the Liver.']	N/A	N/A	[('GO_0036268', 'swimming', 5, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 5, 'perinatal'), ('UBERON_0002107', 'liver', 30, 'liver'), ('CHEBI_17855', 'triglyceride', 36, 'triglyceride'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_35366', 'fatty acid', 69, 'fatty acid'), ('UBERON_0001013', 'adipose tissue', 189, 'adipose tissues'), ('UBERON_0002107', 'liver', 230, 'liver')]
PMC4905827	1/2016	S38-PMC4905827	['Blood samples were collected from the Jugular Veins of 60 Cows (mild: 12, moderate: 20 and severe: 28) at the first examination and were evaluated for the Blood Urea nitrogen (bun), aspartate transaminase (ast), alanine aminotransferase (alt), alkaline phosphatase (alp), γ-glutamyl transpeptidase (γ-gtp), total Bilirubin (t-bil), Glucose (glu), Triglyceride (tg), non-esterified Fatty Acids (nefa), total Cholesterol (t-Cho) and total protein (tp) levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0034981', 'superior bulb of internal jugular vein', 38, 'jugular veins'), ('NCBITaxon_33208', 'Metazoa', 58, 'cows'), ('UBERON_0000178', 'blood', 155, 'blood'), ('CHEBI_16199', 'urea', 161, 'urea'), ('CHEBI_16990', 'bilirubin IXalpha', 313, 'bilirubin'), ('UBERON_0004058', 'biliary ductule', 313, 'bilirubin'), ('CHEBI_17234', 'glucose', 332, 'glucose'), ('CHEBI_17855', 'triglyceride', 347, 'triglyceride'), ('CHEBI_35366', 'fatty acid', 381, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 407, 'cholesterol'), ('CHEBI_33290', 'food', 422, 'Cho')]
PMC4905827	1/2016	S39-PMC4905827	['the samples were submitted to the health sciences research institute, inc. (yokohama, japan) for the analysis of the Blood chemistry.']	N/A	N/A	[('UBERON_0000178', 'blood', 117, 'blood')]
PMC4905827	1/2016	S40-PMC4905827	['the age, number of parities, body weight, interval between Deliveries, Postpartum day at the onset of Ketosis, frequency of treatment, duration for cure and the results of the Blood chemistry tests were compared among the three fl groups using a one-way analysis of variance and the tukey-kramer method.']	N/A	N/A	[('GO_0007567', 'parturition', 59, 'deliveries'), ('GO_0007565', 'female pregnancy', 71, 'postpartum'), ('GO_0001818', 'negative regulation of cytokine production', 102, 'ketosis'), ('UBERON_0000178', 'blood', 176, 'blood')]
PMC4905827	1/2016	S47-PMC4905827	['the Blood chemistry findings of samples collected from 89 Cows at the first examination for the diagnosis of fl are shown intable 2\n\ncaption (table-wrap): table 2.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('NCBITaxon_33208', 'Metazoa', 58, 'cows')]
PMC4905827	1/2016	S48-PMC4905827	['Blood chemistry in three severity groups of fatty Liversmild (n=12)moderate (n=20)severe (n=28)bun (mg/d l )13.5 ± 2.113.2 ± 1.113.1 ± 0.6ast (iu/ l )114.3 ± 12.3171.4 ± 21.2135.5 ± 21.4Alt (iu/ l )15.5 ± 2.320.2 ± 3.416.2 ± 1.6alp (u/ l )4.6 ± 0.65.1 ± 0.65.3 ± 0.6γ-gtp (u/ l )28.8 ± 3.622.1 ± 2.350.0 ± 13.5t-Bili (mg/d l )0.8 ± 0.20.8 ± 0.10.8 ± 0.1glu (mg/d l )72.7 ± 8.5a)50.2 ± 3.5b)49.2 ± 3.1b)Tg (mg/d l )18.1 ± 3.218.8 ± 1.328.0 ± 6.6nefa ( µ eq/ l )1,005.5 ± 141.9a)1,047.5 ± 88.9a)1,428.5 ± 108.7b)t-Cho (mg/d l )127.8 ± 23.789.1 ± 8.199.7 ± 10.9tp (g/m l )8.3 ± 0.47.7 ± 0.27.7 ± 0.2\nfatty Liver has been categorized into three classes: a mild fatty Liver (mild) with a fat deposition rate of 10–30%; moderate fatty Liver (moderate) with a fat deposition rate of 30–60%; and severe fatty Liver (severe) with a fat deposition rate of 60% or more.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001173', 'biliary tree', 50, 'liversMild'), ('UBERON_0001464', 'hip', 185, '4ALT'), ('CHEBI_17097', 'biphenyl', 312, 'Bili'), ('CHEBI_17855', 'triglyceride', 402, 'TG'), ('CHEBI_33290', 'food', 512, 'Cho'), ('UBERON_0002107', 'liver', 603, 'liver'), ('UBERON_0002107', 'liver', 663, 'liver'), ('UBERON_0002107', 'liver', 729, 'liver'), ('UBERON_0002107', 'liver', 801, 'liver')]
PMC4910255	6/2016	S6-PMC4910255	['secondary outcomes included other anthropometry, body composition, Blood pressure, and Cognitive and Lung function.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0050890', 'cognition', 87, 'cognitive'), ('UBERON_0002048', 'lung', 101, 'lung')]
PMC4910255	6/2016	S12-PMC4910255	['no differences were seen in body composition, Blood pressure, or Respiratory outcomes.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0001004', 'respiratory system', 65, 'respiratory')]
PMC4910255	6/2016	S47-PMC4910255	['secondary outcomes included categorical proportions of stunting (< –2 z scores height-for-age), underweight (< –2 z scores weight-for-age), wasting (< –2 z scores weight-for-height) and low body mass index (bmi) (< –2 z scores bmi-for-age), descriptions of body composition (lean and fat mass, skinfold thickness), Blood pressure, Cognitive tests, and Lung function.']	N/A	N/A	[('UBERON_0000178', 'blood', 315, 'blood'), ('GO_0050890', 'cognition', 331, 'cognitive'), ('UBERON_0002048', 'lung', 352, 'lung')]
PMC4910255	6/2016	S65-PMC4910255	['outcome measures were risk differences per 1000 Livebirths (mortality), differences in anthropometry z scores (height-for-age (haz) and weight-for-age (waz)) and absolute values (Head circumference and Blood pressure).']	N/A	N/A	[('GO_0008610', 'lipid biosynthetic process', 48, 'livebirths'), ('UBERON_0000033', 'head', 179, 'head'), ('UBERON_0000178', 'blood', 202, 'blood')]
PMC4910255	6/2016	S108-PMC4910255	['meta-analyses were conducted for mortality, weight, height, Head circumference and Blood pressure outcomes.']	N/A	N/A	[('UBERON_0000033', 'head', 60, 'head'), ('UBERON_0000178', 'blood', 83, 'blood')]
PMC4910255	6/2016	S189-PMC4910255	['Cognitive function\nthe bangladesh minimat, china, and indonesia trials all assessed subgroups of children: in bangladesh, children Born in a 19-month period, at 7\xa0months of age [48]; in china, in the middle year of the trial up to 1\xa0year of age [49] and at 8.8\xa0years [50]; and in indonesia, in women assigned to Blood tests and whose children were Born in a 6-month time period, at 3.5\xa0years of age [37].']	N/A	N/A	[('GO_0050890', 'cognition', 0, 'Cognitive'), ('GO_0007567', 'parturition', 131, 'born'), ('UBERON_0000178', 'blood', 312, 'blood'), ('GO_0007567', 'parturition', 348, 'born')]
PMC4912994	6/2016	S52-PMC4912994	['at this time, transfusion of Platelets continued and transfusion of two units of packed Red Blood Cells and two units of fresh frozen Plasma was initiated.']	N/A	N/A	[('CL_0000233', 'platelet', 29, 'platelets'), ('CL_0000232', 'erythrocyte', 88, 'red blood cells'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0001969', 'blood plasma', 134, 'plasma')]
PMC4918713	6/2015	S26-PMC4918713	['the shortage of iron limits Red Blood Cell Production and results in increased Erythrocyte Protoporphyrin concentration and increased Serum Transferrin Receptor (Stfr) levels.210this in turn leads to the development of ida.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 28, 'red blood cell'), ('GO_0000740', 'nuclear membrane fusion', 28, 'red blood cell production'), ('UBERON_0000178', 'blood', 32, 'blood'), ('CL_0000232', 'erythrocyte', 79, 'erythrocyte'), ('CHEBI_15430', 'protoporphyrin', 91, 'protoporphyrin'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('PR_000001679', 'trace amine-associated receptor 5', 140, 'transferrin receptor'), ('PR_000015619', 'sorcin', 162, 'sTfR')]
PMC4919374	6/2016	S11-PMC4919374	['chronic hypertension treatment goals are systolic Blood pressure 110–129\xa0mmhg and diastolic Blood pressure 65–79\xa0mmhg.']	N/A	N/A	[('UBERON_0000178', 'blood', 50, 'blood'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC4919374	6/2016	S126-PMC4919374	['htn\nfor patients who have chronic hypertension on Antihypertensives, target Blood pressure is systolic Blood pressure 110–129\xa0mmhg and diastolic Blood pressure 65–79\xa0mmhg [18,54•,60].']	N/A	N/A	[('CHEBI_51071', '2-styrylquinoline', 50, 'antihypertensives'), ('UBERON_0000178', 'blood', 76, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC4921626	6/2016	S40-PMC4921626	['Blood sampling and laboratory analyses\na nonfasting venipuncture Blood sample was drawn into a vacutainer tube containing edta (bd 367863, becton dickinson and co.) and into an iron free plastic tube.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 65, 'blood')]
PMC4921626	6/2016	S41-PMC4921626	['Blood samples were kept at room temperature, kept in an insulated container with ice packs, or refrigerated at 4°c for a maximum of 20\u2009min prior to processing.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4921626	6/2016	S42-PMC4921626	['for the determination of the complete Blood count, whole Blood aliquots of 0.5\u2009ml (sarstedt 2\u2009ml tubes) were prepared, refrigerated, and sent to inuulitsivik or tulattavik hospitals located in nunavik.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000178', 'blood', 57, 'blood')]
PMC4921626	6/2016	S60-PMC4921626	['the cutoff values for Red Blood Cell indices indicating, respectively, microcytosis and hypochromia were as follows: mcv < 72\u2009fl [20] and mchc (<320\u2009g/l) [21].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 22, 'red blood cell'), ('UBERON_0000178', 'blood', 26, 'blood')]
PMC4929134	8/2016	S59-PMC4929134	['preparation of Plasma samples and proteomics analysis\nduring the follow-up study in 2006-8, phlebotomists collected early morning fasting samples of Venous Blood (10\xa0ml in Sodium Heparin-containing tubes without Preservatives or Antioxidants).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 15, 'plasma'), ('UBERON_0001638', 'vein', 149, 'venous'), ('UBERON_0000178', 'blood', 156, 'blood'), ('CHEBI_28790', 'serotonin', 172, 'sodium heparin'), ('CHEBI_46791', 'methoxymethanol', 212, 'preservatives'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 229, 'antioxidants')]
PMC4929134	8/2016	S97-PMC4929134	['results\n\ncharacteristics of study population\ncharacteristics of 249 children at their ages of Blood collection (7.5±0.4\xa0yr) and Cognitive assessment a year later (8.4±0.7\xa0yr) are summarized intable 1, by which time about 67% and 80% of children had been to school.']	N/A	N/A	[('UBERON_0000178', 'blood', 94, 'blood'), ('GO_0050890', 'cognition', 128, 'cognitive')]
PMC4930210	7/2016	S1-PMC4930210	['methods\ndata and banked Blood samples collected in second Trimester from a subset of 537 women in the apron (alberta Pregnant outcomes and nutrition) study cohort were examined.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('GO_0009294', 'DNA mediated transformation', 58, 'trimester'), ('GO_0007565', 'female pregnancy', 117, 'Pregnant')]
PMC4930210	7/2016	S31-PMC4930210	['we used the apron cohort data and analyzed the banked Blood samples collected from the first 537 women recruited to apron in their second Trimester of Pregnancy (whose dietary data had been cleaned and linked to the biomedical data).']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0009294', 'DNA mediated transformation', 138, 'trimester'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC4930210	7/2016	S61-PMC4930210	['measurement of Vitamin D status\nmaternal Blood was collected at each clinic visit by a certified phlebotomist.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 41, 'blood')]
PMC4930210	7/2016	S62-PMC4930210	['the majority of apron participants were recruited in their second trimester; therefore, we used the Blood samples taken from their second trimester for this study (consequently, the dietary data from the second trimester were used for analysis).']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood')]
PMC4930210	7/2016	S64-PMC4930210	['information on processing Blood samples and integrity of Plasma samples has been previously reported [13].']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('UBERON_0001969', 'blood plasma', 57, 'plasma')]
PMC4930210	7/2016	S81-PMC4930210	['results\nBlood samples from 537 women from their second Trimester of Pregnancy who had complete dietary and clinical data were analyzed (sample characteristics intable 1).']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'Blood'), ('GO_0009294', 'DNA mediated transformation', 55, 'trimester'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC4933715	7/2016	S294-PMC4933715	['cmv\nthe diagnosis of maternal cmv is based on medical history, serological studies for Cmv or late diagnosis by preserved Blood, mostly from guthrie cards or dried Umbilical Cord.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 87, 'CMV'), ('UBERON_0000178', 'blood', 122, 'blood'), ('UBERON_0007118', 'umbilicus', 164, 'umbilical'), ('UBERON_0002240', 'spinal cord', 174, 'cord')]
PMC4934634	11/2015	S117-PMC4934634	['after nine weeks of supplementation of Vitamin D or placebo, the Vitamin D supplemented group had reductions in Serum Insulin, fasting Plasma Glucose levels, high sensitivity c-Reactive Protein (Hs-Crp), and Blood pressure compared to the placebo group.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001977', 'blood serum', 112, 'serum'), ('PR_000045358', 'insulin family protein', 118, 'insulin'), ('UBERON_0001969', 'blood plasma', 135, 'plasma'), ('CHEBI_17234', 'glucose', 142, 'glucose'), ('PR_000004806', 'bromodomain-containing protein 2', 176, '-reactive protein'), ('PR_000006060', 'CWF19-like protein 1', 195, 'hs-CRP'), ('UBERON_0000178', 'blood', 208, 'blood')]
PMC4939564	8/2015	S60-PMC4939564	['obese women with fasting Blood Sugars greater than 88.7 mg/dl and Postprandial Blood sugars greater than 123.8 mg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_26822', 'sulfide', 31, 'sugars'), ('GO_0007567', 'parturition', 66, 'postprandial'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC4939564	8/2015	S61-PMC4939564	['increased Blood pressure problems were significantly increased in obese women when Gestational weight gain was >0.6 lb.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('GO_0007565', 'female pregnancy', 83, 'gestational')]
PMC4939564	8/2015	S100-PMC4939564	['offspring whose mothers Consumed little protein relative to Carbohydrate during the third Trimester of Pregnancy had higher Blood pressures at Adult age [57].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 24, 'consumed'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 60, 'carbohydrate'), ('GO_0009294', 'DNA mediated transformation', 90, 'trimester'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('UBERON_0000178', 'blood', 124, 'blood'), ('UBERON_0007023', 'adult organism', 143, 'adult')]
PMC4940755	7/2015	S96-PMC4940755	['not validated in female cohort ( n \u2009=\u200994) but 30 cpgs validated in t2dm case-control cohortyes, validated in 1 of 2 cohorts[9]\u2003t2dm Malt1 methylation whole Blood ( n \u2009=\u200927 twins + n \u2009=\u2009263 Individuals) and other less significant dmrs (fdr\u2009<\u20090.1) overlapping t2dm gwas lociyes, other cohort[48]\u2003T2Dmmethylation in 1649 Cpg Sites, some overlapping t2dm, and obesity gwas loci such as Tcf7L2 , fto , and Kcnq1 in Pancreatic Islets ( n \u2009=\u200949)yes, technical[62]\u2003t2dmno differentially Methylated sites (after fdr correction) in t2dm discordant monozygotic twins ( n \u2009=\u200914 pairs).']	N/A	N/A	[('PR_000010050', 'transcription factor MafG', 132, 'MALT1'), ('UBERON_0000178', 'blood', 156, 'blood'), ('NCBITaxon_1', 'root', 189, 'individuals'), ('GO_0034207', 'steroid acetylation', 294, 'T2DMMethylation'), ('SO_0000036', 'matrix_attachment_site', 318, 'CpG sites'), ('PR_000016139', 'TATA box-binding protein-like 2', 382, 'TCF7L2'), ('PR_000000728', 'voltage-gated potassium channel subunit KCNQ1', 401, 'KCNQ1'), ('CL_0002079', 'pancreatic ductal cell', 410, 'pancreatic islets'), ('UBERON_0000006', 'islet of Langerhans', 410, 'pancreatic islets'), ('SO_0000161', 'methylated_adenine', 479, 'methylated')]
PMC4940755	7/2015	S98-PMC4940755	['1410 of these cpgs were also differentially methylated ( p \u2009<\u20090.05) in the t2dm discordant twinsyes, other cohort[63]longitudinal studies\u2003adiposity measured annually age 9–14 yearsincrease Pgc1A Promoter Methylation in Whole Blood children measured annually from 5–7\xa0years ( n \u2009=\u200940)no, but measures at multiple time points[54]maternal exposure or phenotype and epigenetic marks in offspring\u2003Prenatal famine181 dmrs in Adult Whole Blood ( n \u2009=\u200948), including in cdh23 , Smad7 , Insr , Cpt1A , Klf13 , Rftn1 (validated in n \u2009=\u2009120)yes, technical and 2nd cohort[68]\u2003variation Methyl donor intakechanges in mean methylation across Bola3 , loc654433 , Exd3 , Zfyve28 , Rbm46 , and Znf678 in Blood Leukocytes ( n \u2009=\u2009126) and Hair Follicles ( n \u2009=\u200982) of 2- to 8-month infantsno validation performed[69]\u2003periconceptional bmidecreased mean methylation across Bola3 , loc654433 , Exd3 , Zfyve28 , rbm46 , and Znf678 in Blood Leukocytes ( n \u2009=\u2009126) and Hair Follicles ( n \u2009=\u200982) of 2- to 8-month infantsno validation performed[69]\u2003Gestational weight gain early Pregnancyincreased methylation 4 cpgs in Mmp7 , Kcnk4 , Trpm5 , and Nfkb1 in newborn Cord Blood ( n \u2009=\u200988), no association in 2nd cohort ( n \u2009=\u2009170)not validated (technical and 2nd cohort)[71]\u2003Preconceptional bmidifferential methylation in Zcchc10 in newborn Cord Blood ( n \u2009=\u2009308), other less significant sites were found in Wnt16 , Acpl2 , C18Orf8 , Angptl2 , Sapcd2 , and Adcy3 no[73]\u2003Gestational diabetes42 cpgs in newborn cord Blood ( n \u2009=\u2009136).']	N/A	N/A	[('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 189, 'PGC1A'), ('GO_0007538', 'primary sex determination', 195, 'promoter methylation'), ('SO_0000167', 'promoter', 195, 'promoter'), ('UBERON_0007688', 'anlage', 219, 'whole'), ('UBERON_0000178', 'blood', 225, 'blood'), ('GO_0007565', 'female pregnancy', 392, 'Prenatal'), ('UBERON_0007023', 'adult organism', 419, 'adult'), ('UBERON_0007688', 'anlage', 425, 'whole'), ('UBERON_0000178', 'blood', 431, 'blood'), ('PR_000000364', 'smad2', 470, 'SMAD7'), ('PR_000008989', 'interleukin-1 family member 7', 478, 'INSR'), ('PR_000005800', 'carboxypeptidase A6', 485, 'CPT1A'), ('PR_000009364', 'krueppel-like factor 4', 493, 'KLF13'), ('PR_000014040', 'E3 ubiquitin-protein transferase RMND5B', 501, 'RFTN1'), ('CHEBI_32875', 'methyl group', 574, 'methyl'), ('PR_000004793', 'valacyclovir hydrolase', 628, 'BOLA3'), ('PR_000007209', 'steroid hormone receptor ERR2', 648, 'EXD3'), ('PR_000029880', 'zinc finger CCCH domain-containing protein 7A', 655, 'ZFYVE28'), ('PR_000013799', 'RNA-binding protein 41', 665, 'RBM46'), ('PR_000018050', 'zinc finger protein 644', 677, 'ZNF678'), ('CL_0000081', 'blood cell', 687, 'blood'), ('UBERON_0000178', 'blood', 687, 'blood'), ('CL_0000738', 'leukocyte', 693, 'leukocytes'), ('UBERON_0002073', 'hair follicle', 720, 'hair follicles'), ('PR_000004793', 'valacyclovir hydrolase', 852, 'BOLA3'), ('PR_000007209', 'steroid hormone receptor ERR2', 872, 'EXD3'), ('PR_000029880', 'zinc finger CCCH domain-containing protein 7A', 879, 'ZFYVE28'), ('PR_000018050', 'zinc finger protein 644', 901, 'ZNF678'), ('CL_0000081', 'blood cell', 911, 'blood'), ('UBERON_0000178', 'blood', 911, 'blood'), ('CL_0000738', 'leukocyte', 917, 'leukocytes'), ('UBERON_0002073', 'hair follicle', 944, 'hair follicles'), ('GO_0007565', 'female pregnancy', 1022, 'Gestational'), ('GO_0001781', 'neutrophil apoptotic process', 1052, 'pregnancyIncreased'), ('PR_000010482', 'matrix metalloproteinase-23', 1093, 'MMP7'), ('PR_000000792', 'voltage-gated potassium channel KCNH3', 1100, 'KCNK4'), ('PR_000016670', 'Cdc42-interacting protein 4', 1108, 'TRPM5'), ('PR_000011117', 'enhancer of filamentation 1', 1120, 'NFKB1'), ('UBERON_0002240', 'spinal cord', 1137, 'cord'), ('UBERON_0000178', 'blood', 1142, 'blood'), ('GO_0019230', 'proprioception', 1245, 'Preconceptional'), ('PR_000029880', 'zinc finger CCCH domain-containing protein 7A', 1292, 'ZCCHC10'), ('UBERON_0002240', 'spinal cord', 1311, 'cord'), ('UBERON_0000178', 'blood', 1316, 'blood'), ('PR_000017453', 'protein Wnt-9b', 1378, 'WNT16'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 1386, 'ACPL2'), ('PR_000030490', 'mucin-22', 1394, 'C18orf8'), ('PR_000004051', 'ankyrin repeat and SAM domain-containing protein 1A', 1404, 'ANGPTL2'), ('PR_000014450', 'histone deacetylase complex subunit SAP30L', 1414, 'SAPCD2'), ('PR_000003755', 'adenylate cyclase type 4', 1427, 'ADCY3'), ('GO_0007565', 'female pregnancy', 1440, 'Gestational'), ('UBERON_0000178', 'blood', 1484, 'blood')]
PMC4944244	7/2016	S5-PMC4944244	['a total of 396 respondents (99\xa0% response rate) aged 18–40 years completed self–administered and guided questionnaire (characteristics and risk factors), validated semi-quantitative Food frequency questionnaire for Vitamin D in malaysia (ffq Vitamin D/my), anthropometric measures (weight and height), Blood test for Serum 25(Oh)D, skin measurement using mexameter (mx 18) and fitzpatrick skin type chart measurement (fstcm).']	N/A	N/A	[('CHEBI_33290', 'food', 182, 'food'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0000178', 'blood', 302, 'blood'), ('UBERON_0001977', 'blood serum', 317, 'serum'), ('CHEBI_33010', 'chromide(1-)', 325, '(OH)D')]
PMC4944244	7/2016	S39-PMC4944244	['mothers with multiple Pregnancies or who refused Blood testing were also excluded from the study.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 22, 'pregnancies'), ('UBERON_0000178', 'blood', 49, 'blood')]
PMC4944244	7/2016	S69-PMC4944244	['results\na total of 396 respondents (99\xa0% response rate) aged 18–40 years completed the questionnaire, skin test measurement using fstcm and mx 18, anthropometric measurement, and Blood test for Vitamin D. the mean\u2009±\u2009sd age of the respondents was 28.06\u2009±\u20094.09\xa0years.']	N/A	N/A	[('UBERON_0000178', 'blood', 179, 'blood'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4946587	7/2016	S38-PMC4946587	['Igfbp-3 is reduced in the Cord Blood of infants with iugr.']	N/A	N/A	[('PR_000008940', 'intraflagellar transport protein 88', 0, 'IGFBP-3'), ('UBERON_0002240', 'spinal cord', 26, 'cord'), ('UBERON_0000178', 'blood', 31, 'blood')]
PMC4949006	7/2016	S125-PMC4949006	['concentrations of whole-Blood Iodine were 10 times above mean control levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_24859', 'iodine atom', 30, 'iodine')]
PMC4949006	7/2016	S184-PMC4949006	['Foods with a high-gi value cause a big rise in Blood Glucose, and Foods with a low-gi value cause a smaller rise.']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Foods'), ('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('CHEBI_33290', 'food', 66, 'foods')]
PMC4954778	7/2016	S42-PMC4954778	['a Blood sample was withdrawn from the Tail Vein and baseline Glucose was immediately assayed using a commercial Glucometer (medisense precision xtra, abbott laboratories, abbott park, il, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('UBERON_0003481', 'tail vein', 38, 'tail vein'), ('CHEBI_17234', 'glucose', 61, 'glucose'), ('CHEBI_24321', 'glutamo group', 112, 'glucometer')]
PMC4954778	7/2016	S43-PMC4954778	['upon the Glucose gavage, Blood Glucose concentrations were determined 15 and 60 min later and the incremental area under the curve (iauc) was calculated.']	N/A	N/A	[('CHEBI_17234', 'glucose', 9, 'glucose'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_17234', 'glucose', 31, 'glucose')]
PMC4954778	7/2016	S51-PMC4954778	['Trunk Blood was collected and centrifuged, and Plasma samples were added with 0.5% Ascorbic Acid to prevent Folate oxidation.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('CHEBI_22652', 'ascorbic acid', 83, 'ascorbic acid'), ('CHEBI_30863', '5-azaorotic acid', 108, 'folate')]
PMC4954778	7/2016	S59-PMC4954778	['Folate concentration analysis\nPlasma and Brain Folate concentrations were determined by the microbiological microtiter plate assay using lactobacillus casei .16,17\n\nHypothalamic global Dna Methylation analysis\ndna was isolated using the protocol outlined by the dneasy Blood and Tissue kit (qiagen tech., mississauga, on, canada).']	N/A	N/A	[('CHEBI_81245', 'Vulpecholate', 0, 'Folate'), ('UBERON_0001969', 'blood plasma', 30, 'Plasma'), ('UBERON_0000955', 'brain', 41, 'brain'), ('CHEBI_30863', '5-azaorotic acid', 47, 'folate'), ('UBERON_0001898', 'hypothalamus', 165, 'Hypothalamic'), ('GO_0006306', 'DNA methylation', 185, 'DNA Methylation'), ('UBERON_0000178', 'blood', 269, 'Blood'), ('UBERON_0000479', 'tissue', 279, 'Tissue')]
PMC4956033	7/2016	S163-PMC4956033	['in addition, the definition of pre-eclampsia employed at the time of study inception required two elevated Blood pressures separated by four hours and most refused to wait.']	N/A	N/A	[('UBERON_0000178', 'blood', 107, 'blood')]
PMC4964025	7/2016	S127-PMC4964025	['“if you have Blood left inside, you feel weak, … then you find khmer medicine to drink to make all the Blood come out..”; cambodian women’s perspectives [40].']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood')]
PMC4964025	7/2016	S130-PMC4964025	['caption (table-wrap): table 3\n\nexamples of ethno Medicine / healing Foods used by women during the Perinatal Periodauthorregionfood substanceseffectadams [43]tibetbutter Ingested by newbornin order for child to have a clear Mind and well-developed senses chang warm Barley Beer ingested by mothersayiasi [34]uganda waragi local Alcoholgenerally therapeutic, keeps Infant’s skin clearfarnes [38]ghanalocal herbs Ingested by mothersprevents sunsumyare (spiritual sickness), promotes maternal, fetal health, prevents complicationshadwiger [50]philippinesginger, carriedprotect unborn baby from aswang (evil spirits)lundberg [49]vietnampig’s trotter with Papaya or red Bean and potato, meat and eggsenrich Blood, help recovery, encourage Expulsion of the Lochia, stimulate Lactationmaimbola [41]zambiatraditional medicine applied to Vaginaprepare and widen the Birth Canal in Pregnant womenngomane [83]s africa mbita , ritlangi , mpundulo strengthen and preserve Pregnancyinduction, management of labour and management of pain mbheswan a, roots of xirhakarhan i, boiled dinda radoff [103]guatemalateas and baths from grasses and trees, Cypress, Pine, Oak, Pear, eucalyptusstimulate labour, reduce Postpartum bleedingraven [48]chinaginger and wineenrich Blood, help recovery, encourage expulsion of the Lochia, stimulate Lactationmeat and Eggssein [39]myanmarturmeric, Ingested or applied on skinprevent muscle pain and to prevent newborn from Abdominal painthapa [52]nepalmustard oil, turmeric, Eggs Ingestedregain energy post-partum, make Womb strong, relieve paintheroux [58]ghanabitter leaf, dandelion, prekos , Maringa , nim tree, and kontosi treat minor illness and maintain/improve Pregnancy fou-fou poundingprepare for labourwulandari [44]balitamarind, turmeric, cinnamon, clove, coconutimprove maternal and infant healthherbal medicines\nin many traditional societies, ethno-Medicine was an accepted part of the Perinatal experience and Herbs were prescribed by a range of religious and healthcare professionals, including herbalists, akomfo (witch doctor), christian pastors and Birth attendants.']	N/A	N/A	[('CHEBI_6807', 'methadone', 49, 'medicine'), ('CHEBI_33290', 'food', 68, 'foods'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0006787', 'middle white layer of superior colliculus', 99, 'perinatal periodAuthorRegionFood'), ('GO_0007631', 'feeding behavior', 170, 'ingested'), ('UBERON_0000003', 'naris', 224, 'mind'), ('CHEBI_33250', 'atom', 266, 'barley'), ('CHEBI_33250', 'atom', 273, 'beer'), ('CHEBI_53513', 'triblock copolymer', 328, 'alcoholGenerally'), ('UBERON_0000003', 'naris', 364, 'infant’'), ('GO_0007631', 'feeding behavior', 411, 'ingested'), ('NCBITaxon_10088', 'Mus <genus>', 651, 'papaya'), ('NCBITaxon_33208', 'Metazoa', 665, 'bean'), ('UBERON_0000178', 'blood', 702, 'blood'), ('GO_0010467', 'gene expression', 734, 'expulsion'), ('UBERON_0001155', 'colon', 751, 'lochia'), ('GO_0060132', 'prolactin secreting cell development', 769, 'lactationMaimbola'), ('UBERON_0013247', 'male paramesonephric duct', 829, 'vaginaPrepare'), ('GO_0007567', 'parturition', 857, 'birth'), ('UBERON_0001756', 'middle ear', 857, 'birth canal'), ('GO_0007565', 'female pregnancy', 872, 'pregnant'), ('GO_0016567', 'protein ubiquitination', 959, 'pregnancyInduction'), ('NCBITaxon_33208', 'Metazoa', 1132, 'cypress'), ('NCBITaxon_10088', 'Mus <genus>', 1141, 'pine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 1147, 'oak'), ('NCBITaxon_10088', 'Mus <genus>', 1152, 'pear'), ('GO_0007565', 'female pregnancy', 1193, 'postpartum'), ('UBERON_0000178', 'blood', 1249, 'blood'), ('UBERON_0001155', 'colon', 1298, 'lochia'), ('GO_0015902', 'carbonyl cyanide m-chlorophenylhydrazone transport', 1316, 'lactationMeat'), ('CL_0000025', 'egg cell', 1334, 'eggsSein'), ('GO_0007631', 'feeding behavior', 1364, 'ingested'), ('UBERON_0000916', 'abdomen', 1439, 'abdominal'), ('CL_0000025', 'egg cell', 1491, 'eggs'), ('GO_0097356', 'perinucleolar compartment', 1496, 'ingestedRegain'), ('UBERON_0002396', 'vomer', 1536, 'womb'), ('NCBITaxon_40674', 'Mammalia', 1611, 'maringa'), ('GO_0007565', 'female pregnancy', 1684, 'pregnancy'), ('CHEBI_6807', 'methadone', 1878, 'medicine'), ('GO_0036268', 'swimming', 1915, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1915, 'perinatal'), ('CHEBI_24593', 'hexyl group', 1940, 'herbs'), ('GO_0007567', 'parturition', 2083, 'birth')]
PMC4964025	7/2016	S141-PMC4964025	['in many parts of asia, post- Partum cultural practices necessarily involve restoring heat to the woman’s body; recognising that having lost energy and Blood during Delivery, both yin and yang are weakened.']	N/A	N/A	[('GO_0007567', 'parturition', 29, 'partum'), ('UBERON_0000178', 'blood', 151, 'blood'), ('GO_0007567', 'parturition', 164, 'delivery')]
PMC4971719	8/2016	S74-PMC4971719	['biomarkers\nmaternal Venous Blood was drawn at enrollment at 12–20 weeks ( n \u2009=\u2009117) and at 34–36 weeks Gestation ( n \u2009=\u2009112).']	N/A	N/A	[('UBERON_0001638', 'vein', 20, 'venous'), ('UBERON_0000178', 'blood', 27, 'blood'), ('GO_0007565', 'female pregnancy', 103, 'gestation')]
PMC4971719	8/2016	S75-PMC4971719	['the Blood was drawn after a 4\xa0h fast.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC4971719	8/2016	S76-PMC4971719	['all Blood samples were processed within 12\xa0h and aliquots of Serum or Plasma were frozen at −70° celsius under argon until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001977', 'blood serum', 61, 'serum'), ('UBERON_0001969', 'blood plasma', 70, 'plasma')]
PMC4971719	8/2016	S77-PMC4971719	['Blood sample analyses from the parent study included the Omega-3 Fatty Acids Eicosapentaenoic Acid (Epa) and Docosahexaenoic Acid (Dha) from Serum.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 57, 'omega-3 fatty acids'), ('CHEBI_36003', 'decenoic acid', 77, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 100, 'EPA'), ('CHEBI_36003', 'decenoic acid', 109, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 131, 'DHA'), ('UBERON_0001977', 'blood serum', 141, 'serum')]
PMC4971719	8/2016	S107-PMC4971719	['the flow of study participants and Blood samples is shown in fig.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4973215	8/2016	S1-PMC4973215	['study design:\nCord Blood Vitamin D levels were measured in 438 infants (276 black and 162 white).']	N/A	N/A	[('UBERON_0000948', 'heart', 14, 'Cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC4973215	8/2016	S20-PMC4973215	['previously collected Cord Blood samples from all singleton Births from november 2010 to april 2011 (one winter season) served as the study population.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('GO_0007567', 'parturition', 59, 'births')]
PMC4973215	8/2016	S25-PMC4973215	['Cord Blood 25(Oh)D levels were analyzed using the liaison 25 Oh Vitamin D assay (diasorin inc., stillwater, mn, usa).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_71657', 'versiconol acetate', 11, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 11, '25 ... OH ... D'), ('CHEBI_63058', '(2R,3S)-EHNA', 58, '25 OH'), ('CHEBI_28384', 'vitamin K', 64, 'Vitamin D')]
PMC4973215	8/2016	S37-PMC4973215	['the mean Cord Blood 25(Oh)D level for our study population ( n =438) was 46.9\u2009nmol\u2009l−1, with a range of 5.0 to 135.8\u2009nmol\u2009l−1.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 20, '25(OH)D')]
PMC4973215	8/2016	S42-PMC4973215	['compared with whites, blacks had a lower mean Cord Blood 25(Oh)D level and higher incidence of sga ( p ⩽0.01).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 57, '25(OH ... D')]
PMC4974775	8/2016	S48-PMC4974775	['session and content is based on healthy diet, exercise, healthy lifestyle, and Blood Glucose level monitoring.']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_17234', 'glucose', 85, 'glucose')]
PMC4974775	8/2016	S53-PMC4974775	['(eg, “in uncontrolled diabetes the Blood sugar is: (a) normal; (b).']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood')]
PMC4974775	8/2016	S73-PMC4974775	['the four modules covered: (1) Healthy Food choices, (2) healthy habits/healthy lifestyle, (3) emotions, family and Food, and (4) testing Blood Glucose level.']	N/A	N/A	[('GO_0010453', 'regulation of cell fate commitment', 30, 'healthy'), ('CHEBI_33290', 'food', 38, 'food'), ('CHEBI_33290', 'food', 115, 'food'), ('UBERON_0000178', 'blood', 137, 'blood'), ('CHEBI_17234', 'glucose', 143, 'glucose')]
PMC4974775	8/2016	S126-PMC4974775	['a normal 2\xa0h post-prandial (after meals) Blood Glucose level was also reported correctly in both groups (91.1\xa0% and 90\xa0%).']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_17234', 'glucose', 47, 'glucose')]
PMC4974775	8/2016	S127-PMC4974775	['the majority of women in both groups knew what they needed to do if their Blood Glucose level was high on one occasion (80.4\xa0% and 80\xa0%) and if it was high in two occasions in one week (60.7\xa0% and 60\xa0%).']	N/A	N/A	[('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_17234', 'glucose', 80, 'glucose')]
PMC4974775	8/2016	S134-PMC4974775	['caption (table-wrap): table 4\n\nmanagement of Gestational diabetes mellitusgroups p valueaintervention n (%)control n (%)you should check your Blood Glucose levelsᅟ- correct54 (96.4)58 (96.7)0.944ᅟ- incorrect2 (3.6)2 (3.3)Controlling your Blood Glucose levels:ᅟ- correct49 (87.5)52(86.7)0.894ᅟ- incorrect7 (12.5)8(13.3)if there is a social occasion, such as a party, you should:ᅟ- correct40 (71.4)51 (85)0.076ᅟ- incorrect16 (28.6)9 (15)when your Blood Glucose levels are high:ᅟ- correct47 (83.9)51 (85)0.873ᅟ- incorrect9 (16.1)9 (15)to Control Blood Glucose effectively you shouldᅟ- correct35 (62.5)44 (73.3)0.211ᅟ- incorrect21 (37.5)16 (26.7)gdm can be Controlled by:ᅟ- correct48 (85.7)58 (96.7)0.036bᅟ- incorrect8 (14.3)2 (3.3)when you are hungry in between meals:ᅟ- correct32 (57.1)48 (80)0.008bᅟ- incorrect24 (42.9)12 (20)\nachi-square test and chi-square exact test\nbp \u2009≤\u20090.05 was considered statistically significant\nin addition, the majority (76.8\xa0%) of women in the intervention group understood that they should get a follow up Glucose test at 6\xa0weeks set up compared to control group (81.7\xa0%).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 45, 'gestational'), ('UBERON_0000178', 'blood', 142, 'blood'), ('CHEBI_17234', 'glucose', 148, 'glucose'), ('GO_0065007', 'biological regulation', 221, 'Controlling'), ('UBERON_0000178', 'blood', 238, 'blood'), ('CHEBI_17234', 'glucose', 244, 'glucose'), ('UBERON_0000178', 'blood', 445, 'blood'), ('CHEBI_17234', 'glucose', 451, 'glucose'), ('GO_0065007', 'biological regulation', 535, 'control'), ('UBERON_0000178', 'blood', 543, 'blood'), ('CHEBI_17234', 'glucose', 549, 'glucose'), ('GO_0065007', 'biological regulation', 653, 'controlled'), ('CHEBI_17234', 'glucose', 1035, 'glucose')]
PMC4974775	8/2016	S141-PMC4974775	['more women with tertiary education reported correct answers for “time to test blood Glucose level” (62.1\xa0% vs 16.4\xa0%, p \u2009=\u20090.007) and “pricking Fingers for Blood Glucose test” (42.2\xa0% vs 22.4\xa0%, p \u2009=\u20090.009), compared to women with lower education level.']	N/A	N/A	[('CHEBI_17234', 'glucose', 84, 'glucose'), ('UBERON_0002389', 'manual digit', 144, 'fingers'), ('UBERON_0000178', 'blood', 156, 'blood'), ('CHEBI_17234', 'glucose', 162, 'glucose')]
PMC4974775	8/2016	S178-PMC4974775	['a statistically significant difference was reported on questions regarding pricking Fingers for testing Blood Glucose ( p \u2009<\u20090.05).']	N/A	N/A	[('UBERON_0002389', 'manual digit', 84, 'fingers'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_17234', 'glucose', 110, 'glucose')]
PMC4975560	7/2016	S38-PMC4975560	['data and Blood samples collection\ndata on socioeconomic, demographic, lifestyle and anthropometric variables were obtained at entry to Prenatal care (13.5 ± 0.7 weeks of Gestation), and updated at Gestational weeks 20 and 28.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 135, 'prenatal'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007565', 'female pregnancy', 197, 'gestational')]
PMC4975560	7/2016	S40-PMC4975560	['Blood samples were collected at entry (16.1 ± 0.7 Gestational weeks, mean ± se) and during the 3rdtrimester (29.5 ± 0.5).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 50, 'gestational')]
PMC4975560	7/2016	S42-PMC4975560	['briefly, whole Venous Blood was collected into edta - containing vacutainer tubes (becton, dickinson and company, franklin lakes, nj) and centrifuged to allow for collection of Plasma and the buffy Coat.']	N/A	N/A	[('UBERON_0001638', 'vein', 15, 'venous'), ('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0001969', 'blood plasma', 177, 'plasma'), ('UBERON_0010166', 'coat of hair', 198, 'coat')]
PMC4975560	7/2016	S43-PMC4975560	['the buffy coat enriched in White Blood Cells was used for dna extraction.']	N/A	N/A	[('CL_0000738', 'leukocyte', 27, 'white blood cells'), ('UBERON_0000178', 'blood', 33, 'blood')]
PMC4975560	7/2016	S44-PMC4975560	['all buffy Coats were prepared under optimal conditions within 2 hr after Blood collection and immediately aliquoted and stored at −80°c and not thawed until analyzed.']	N/A	N/A	[('UBERON_0010166', 'coat of hair', 10, 'coats'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC4975560	7/2016	S56-PMC4975560	['analytic procedures for Dna Methylation and Bisulfite sequencing\nGenomic dna (gdna) was extracted from Buffy Coat Of Blood using Blood & cell culture dna kit according to manufacturer’s instruction (qiagen, frederick, maryland), quantified by nanodrop 2000 spectrophotometer (thermo scientific, wilmington, de) and examined on 0.7% Agarose gel electrophoresis for dna integrity.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 24, 'DNA methylation'), ('CHEBI_29874', 'bromine dioxide', 44, 'bisulfite'), ('SO_0001026', 'genome', 65, 'Genomic'), ('UBERON_0013649', 'fused tarsal bones 1 and 2', 103, 'buffy coat of'), ('UBERON_0000178', 'blood', 117, 'blood'), ('UBERON_0000178', 'blood', 129, 'Blood'), ('CHEBI_2511', 'agarose', 332, 'agarose')]
PMC4975765	1/2016	S41-PMC4975765	['collection and analysis of Blood samples\nmaternal Peripheral Blood samples (5\xa0ml) were taken at the time of recruitment (30–34\xa0weeks of Gestation).']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'Blood'), ('UBERON_0012101', 'perinatal stage', 50, 'peripheral'), ('UBERON_0000178', 'blood', 61, 'blood'), ('GO_0007565', 'female pregnancy', 136, 'gestation')]
PMC4975765	1/2016	S42-PMC4975765	['in order to obtain Serum, the Blood was centrifuge at 2500× g at 4\xa0°c for 10\xa0min and was stored in small portions at −25\xa0°c for subsequent biochemical analysis.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('UBERON_0000178', 'blood', 30, 'blood')]
PMC4975765	1/2016	S47-PMC4975765	['concentration of hemoglobin (hgb) in Blood was determined using commercially available kits on pentra 60 hematology analyzer (horriba abx, france).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood')]
PMC4976416	7/2016	S52-PMC4976416	['these patients were evaluated clinically by parameters such as the melasma area index, Pigmentary intensity index, and by routine Blood and Urine tests.']	N/A	N/A	[('CHEBI_26130', 'biological pigment', 87, 'pigmentary'), ('UBERON_0000178', 'blood', 130, 'blood'), ('UBERON_0001088', 'urine', 140, 'urine')]
PMC4977046	3/2016	S105-PMC4977046	['trained study staff also conducted a medical record review to collect results of Gestational Blood Glucose testing.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_17234', 'glucose', 99, 'glucose')]
PMC4977046	3/2016	S106-PMC4977046	['as part of routine Prenatal care, women typically completed a nonfasting Glucose challenge test (gct) between 24 and 28 weeks Gestation, where Blood was sampled 1 hr after Ingestion of 50 g of Glucose.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_17234', 'glucose', 73, 'glucose'), ('GO_0007565', 'female pregnancy', 126, 'gestation'), ('UBERON_0000178', 'blood', 143, 'blood'), ('GO_0007631', 'feeding behavior', 172, 'ingestion'), ('CHEBI_17234', 'glucose', 193, 'glucose')]
PMC4977046	3/2016	S107-PMC4977046	['for those with a 1-hr gct result of 140–199 mg/dl an additional, fasting Oral Glucose tolerance test (ogtt) was performed, where Blood was sampled hourly for 3 hr after Ingesting 100 g of Glucose.']	N/A	N/A	[('UBERON_0000165', 'mouth', 73, 'oral'), ('CHEBI_17234', 'glucose', 78, 'glucose'), ('UBERON_0000178', 'blood', 129, 'blood'), ('GO_0007567', 'parturition', 169, 'ingesting'), ('CHEBI_17234', 'glucose', 188, 'glucose')]
PMC4977046	3/2016	S110-PMC4977046	['specifically, Gestational diabetes mellitus (gdm) was defined as a 1-hr gct result ≥ 200 mg/dl or failing the 1-hr gct (140–199 mg/dl) with two or more high values on the ogtt based on the american diabetes association criteria for a normal ogtt (committee on practice bulletins—obstetrics 2013) of Blood Glucose ≤ 95 mg/dl at baseline, ≤ 180 mg/dl at 1 hr, ≤ 155 mg/dl at 2 hr, and ≤ 140 mg/dl at 3 hr.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('UBERON_0000178', 'blood', 299, 'blood'), ('CHEBI_17234', 'glucose', 305, 'glucose')]
PMC4977046	3/2016	S132-PMC4977046	['avariableall ( n = 706)normal weight ( n = 406)overweight/obese ( n = 300) p -valuebprepregnancy bmi (kg/m2) (mean ± sd)25.3 ± 4.922.1 ± 1.629.8 ± 4.4< 0.001maternal age (years) (mean ± sd)31.1 ± 4.731.4 ± 4.730.6 ± 4.70.03education level [ n (%)]cless than 11th grade8 (1.1)3 (0.7)5 (1.7)0.01high school graduate or equivalent68 (9.7)34 (8.4)34 (11.4)junior college graduate, or some college or technical school153 (21.8)77 (19.1)76 (25.4)college graduate275 (39.1)157 (38.9)118 (39.5)postgraduate schooling199 (28.3)133 (32.9)66 (22.1)previous Pregnancies [ n (%)]d0281 (39.9)172 (42.6)109 (36.3)0.041271 (38.5)151 (37.4)120 (40.0)296 (13.6)58 (14.4)38 (12.7)≥ 356 (8.0)23 (5.7)33 (11.0)smoking status [ n (%)]never624 (88.4)357 (87.9)267 (89.0)0.58evere45 (6.4)29 (7.1)16 (5.3)current37 (5.2)20 (4.9)17 (5.7)maternal Gestational weight gain (lbs) (mean ± sd)f32.0 ± 12.133.8 ± 9.629.5 ± 14.5< 0.001maternal Gestational hyperglycemia [ n (%)]gnormal566 (83.0)332 (84.7)234 (80.7)0.37igt70 (10.3)37 (9.4)33 (11.4)gdm46 (6.7)23 (5.9)23 (7.9)1-hr Blood Glucose challenge test resultsg(mg/dl) (mean ± sd)113 ± 28112 ± 27114 ± 290.29home Water Arsenic concentration (μg/l) [median (iqr)]0.5 (0.1–2.7)0.5 (0.1–2.6)0.5 (0.1–2.8)0.94any Seafood in 2 days before Urine collection [ n (%)]112 (15.9)69 (17.0)43 (14.3)0.39any rice in 2 days before Urine collection [ n (%)]163 (23.1)102 (25.1)61 (20.3)0.16urinary Arsenic concentration (μg/l) [median (iqr)]Inorganic Arsenic (Ias)0.3 (0.1–0.5)0.2 (0.1–0.5)0.3 (0.1–0.5)0.49monomethylarsonic Acid (Mma)0.3 (0.1–0.5)0.3 (0.1–0.5)0.3 (0.1–0.6)0.41Dimethylarsinic Acid (Dma)2.8 (1.4–4.9)2.5 (1.3–4.8)2.9 (1.4–5.1)0.27total Arsenic (Ias + Mma + Dma)3.4 (1.7–6.0)3.3 (1.6–5.7)3.6 (1.8–6.1)0.34primary methylation index (Mma/ias)1.0 (0.5–1.8)1.0 (0.5–1.8)1.0 (0.5–1.8)0.84secondary methylation index (dma/Mma)10.4 (7.6–18.3)10.3 (7.6–17.7)10.6 (7.5–18.6)0.68infant Delivery mode [ n (%)]vaginal472 (66.9)291 (71.7)181 (60.3)< 0.01cesarean section234 (33.1)115 (28.3)119 (39.7)infant Birth outcomesgestational age (weeks) (mean ± sd)39.5 ± 1.639.6 ± 1.539.3 ± 1.70.02head circumference (cm) (mean ± sd)34.7 ± 1.734.5 ± 1.834.9 ± 1.7< 0.01birth length (cm) (mean ± sd)50.9 ± 2.750.9 ± 2.650.9 ± 2.80.92birth weight (g) (mean ± sd)3,462 ± 516.83,435 ± 488.63,499 ± 551.50.11ponderal index (kg/m3) (mean ± sd)26.3 ± 3.426.1 ± 3.326.6 ± 3.60.07birth weight status [ n (%)]hsmall for Gestational age37 (5.2)24 (5.9)13 (4.3)0.02average for Gestational age600 (85.0)353 (87.0)247 (82.3)large for Gestational age69 (9.8)29 (7.1)40 (13.3)anormal weight defined as Prepregnancy bmi 18.5–24.9 kg/m2and overweight/obese defined as Prepregnancy bmi ≥ 25 kg/m2; 25 underweight mothers (bmi < 18.5 kg/m2) excluded from analysis.bcalculated from an unpaired, 2-tailed t -test with an equal variance assumption to analyze the difference in means, a chi-square test to analyze the difference in proportions, or a wilcoxon–mann–whitney test to analyze the difference in medians by maternal weight status.ceducation data missing for 3 participants.dparity data missing for 2 participants.eparticipants who reported ever smoking but did not report smoking during Pregnancy or had missing data for smoking during Pregnancy were classified as ever smokers.fdata for Gestational weight gain available for a subset of 639 women.gmaternal hyperglycemia measured as part of usual Prenatal care.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 546, 'pregnancies'), ('GO_0007565', 'female pregnancy', 820, 'gestational'), ('GO_0007565', 'female pregnancy', 910, 'gestational'), ('UBERON_0000178', 'blood', 1046, 'blood'), ('CHEBI_17234', 'glucose', 1052, 'glucose'), ('CHEBI_15377', 'water', 1135, 'water'), ('CHEBI_27563', 'arsenic atom', 1141, 'arsenic'), ('CHEBI_34973', 'Selfotel', 1231, 'seafood'), ('UBERON_0001088', 'urine', 1256, 'urine'), ('UBERON_0001088', 'urine', 1339, 'urine'), ('CHEBI_27563', 'arsenic atom', 1405, 'arsenic'), ('CHEBI_5939', 'Interferon gamma-1b', 1448, 'Inorganic'), ('CHEBI_27563', 'arsenic atom', 1458, 'arsenic'), ('CHEBI_24870', 'ion', 1467, 'iAs'), ('CHEBI_37527', 'acid', 1532, 'acid'), ('CHEBI_34840', 'methyl methacrylate', 1538, 'MMA'), ('CHEBI_17549', '5-aminolevulinic acid', 1583, '41Dimethylarsinic acid'), ('CHEBI_17874', 'dihydrozeatin', 1607, 'DMA'), ('CHEBI_85195', '9,10-epoxyoctadecanoate', 1660, 'Arsenic'), ('CHEBI_24870', 'ion', 1669, 'iAs'), ('CHEBI_34840', 'methyl methacrylate', 1675, 'MMA'), ('CHEBI_17874', 'dihydrozeatin', 1681, 'DMA'), ('CHEBI_34840', 'methyl methacrylate', 1755, 'MMA'), ('CHEBI_34840', 'methyl methacrylate', 1839, 'MMA'), ('GO_0007567', 'parturition', 1899, 'delivery'), ('GO_0007567', 'parturition', 2017, 'birth'), ('GO_0007565', 'female pregnancy', 2412, 'gestational'), ('GO_0007565', 'female pregnancy', 2467, 'gestational'), ('GO_0007565', 'female pregnancy', 2522, 'gestational'), ('GO_0007565', 'female pregnancy', 2588, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 2652, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 3175, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3224, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3276, 'gestational'), ('GO_0007565', 'female pregnancy', 3386, 'prenatal')]
PMC4977046	3/2016	S133-PMC4977046	['results for 1-hr Blood Glucose screening and igt status available for a subset of 680 women; data on gdm status available for a subset of 682 women.hage- and sex-adjusted Birth weight percentiles were used to classify infants’ size-for-Gestational age, which included small (≤ 10th percentile) (sga), average (11–89th percentile) (aga), and large-for-Gestational age (≥ 90th percentile) (lga) (fenton et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_17234', 'glucose', 23, 'glucose'), ('GO_0007567', 'parturition', 171, 'birth'), ('GO_0007565', 'female pregnancy', 236, 'gestational'), ('GO_0007565', 'female pregnancy', 351, 'gestational')]
PMC4977046	3/2016	S149-PMC4977046	['in addition, 25 women were missing data on gdm status, and 27 women were missing data on igt and their 1-hr Blood Glucose screening.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_17234', 'glucose', 114, 'glucose')]
PMC4977046	3/2016	S224-PMC4977046	['2007), maternal Blood (claus henn et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood')]
PMC4977047	2/2016	S2-PMC4977047	['methods:\nwe collected maternal and Umbilical Cord Blood samples at Delivery from 622 mother–infant pairs residing near a mining-related superfund site in northeast oklahoma.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 35, 'umbilical cord'), ('UBERON_0000178', 'blood', 50, 'blood'), ('GO_0007567', 'parturition', 67, 'delivery')]
PMC4977047	2/2016	S3-PMC4977047	['Whole Blood Arsenic, lead, and manganese were measured using inductively coupled Plasma mass spectrometry.']	N/A	N/A	[('UBERON_0004043', 'semicircular canal ampulla', 0, 'Whole'), ('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_27563', 'arsenic atom', 12, 'arsenic'), ('UBERON_0001969', 'blood plasma', 81, 'plasma')]
PMC4977047	2/2016	S5-PMC4977047	['results:\nmedian (25th–75th percentile) maternal and Umbilical Cord Blood metal concentrations, respectively, were as follows: Arsenic, 1.4 (1.0–2.3) and 2.4 (1.8–3.3) μg/l; lead, 0.6 (0.4–0.9) and 0.4 (0.3–0.6) μg/dl; Manganese, 22.7 (18.8–29.3) and 41.7 (32.2–50.4) μg/l.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 52, 'umbilical cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_27563', 'arsenic atom', 126, 'arsenic'), ('CHEBI_33351', 'seaborgium atom', 218, 'manganese')]
PMC4977047	2/2016	S73-PMC4977047	['exposure assessment\nMaternal Blood and Umbilical Cord Blood samples were collected at Delivery (± 12 hr) and analyzed for total Arsenic concentration at the trace metals laboratory at hsph (boston, ma).']	N/A	N/A	[('UBERON_0000976', 'humerus', 20, 'Maternal'), ('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0002331', 'umbilical cord', 39, 'umbilical cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('GO_0007567', 'parturition', 86, 'delivery'), ('CHEBI_27563', 'arsenic atom', 128, 'arsenic')]
PMC4977047	2/2016	S74-PMC4977047	['Blood lead and manganese concentrations were also measured and considered as covariates in all analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4977047	2/2016	S75-PMC4977047	['Venous whole Blood was collected in trace element–free tubes (bd vacutainer royal blue top, with k2edta #368381; becton dickinson, franklin lakes, nj) and shipped frozen to the laboratory.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 13, 'blood')]
PMC4977047	2/2016	S76-PMC4977047	['Blood (1 ml) was digested with concentrated hno3acid, followed by addition of Hydrogen Peroxide and dilution with deionized Water.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_16240', 'hydrogen peroxide', 78, 'hydrogen peroxide'), ('CHEBI_15377', 'water', 124, 'water')]
PMC4977047	2/2016	S81-PMC4977047	['the limit of detection (lod) was 0.02 μg/dl for Blood Arsenic, lead, and manganese.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27563', 'arsenic atom', 54, 'arsenic')]
PMC4977047	2/2016	S100-PMC4977047	['all final multivariable models were adjusted for Blood lead and manganese, infant sex, maternal age at child’s Birth, race/ethnicity, parity, smoking during Pregnancy, education, Prenatal vitamin use, and hemoglobin.']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007567', 'parturition', 111, 'birth'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy'), ('GO_0007565', 'female pregnancy', 179, 'prenatal')]
PMC4977047	2/2016	S129-PMC4977047	['of 622 mother–infant pairs, data were not available for 4 (0.6%) maternal and 13 (2%) Cord Blood Arsenic measurements, 3 (0.5%) Cord Blood lead and Manganese measurements, and 24 (3.9%) Head circumference measurements at Birth.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 86, 'cord'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_27563', 'arsenic atom', 97, 'arsenic'), ('UBERON_0002240', 'spinal cord', 128, 'cord'), ('UBERON_0000178', 'blood', 133, 'blood'), ('CHEBI_33351', 'seaborgium atom', 148, 'manganese'), ('UBERON_0000033', 'head', 186, 'head'), ('GO_0007567', 'parturition', 221, 'birth')]
PMC4977047	2/2016	S133-PMC4977047	['median (25th–75th percentile) maternal and Umbilical Cord Blood metal concentrations, respectively, were, for Arsenic, 1.4 (0.97–2.3) and 2.4 (1.8–3.3) μg/l; lead, 0.60 (0.41–0.88) and 0.43 (0.28–0.62) μg/dl; Manganese, 22.7 (18.8–29.3) and 41.7 (32.2–50.4) μg/l.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 43, 'umbilical cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27563', 'arsenic atom', 110, 'arsenic'), ('CHEBI_33351', 'seaborgium atom', 209, 'manganese')]
PMC4977047	2/2016	S138-PMC4977047	['Cord Blood Manganese was significantly higher among boys than girls [geometric mean (geometric standard deviation)]: boys, 41.1 (1.5); girls, 37.4 (1.5) μg/l, p = 0.004).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_33351', 'seaborgium atom', 11, 'manganese')]
PMC4977047	2/2016	S140-PMC4977047	['caption (table-wrap): table 2\n\nmaternal and infant biomarkers.biomarkermaternal Bloodumbilical Cord Bloodcorran median (25th–75th percentile)range n median (25th–75th percentile)rangeas (μg/l)6181.4 (0.97–2.3)0.23–24.16092.4 (1.8–3.3)< lodb–13.20.35*pb (μg/dl)6220.60 (0.41–0.88)0.03–3.16190.43 (0.28–0.62)< lodb–3.90.75*mn (μg/l)62222.7 (18.8–29.3)8.0–117.461941.7 (32.2–50.4)5.4–139.10.39*aspearman’s correlation (corr) between maternal and infant Blood.blimit of detection is 0.02 μg/dl.']	N/A	N/A	[('UBERON_0012437', 'epithelial-mesenchymal boundary', 80, 'bloodUmbilical'), ('UBERON_0002240', 'spinal cord', 95, 'cord'), ('UBERON_0001981', 'blood vessel', 100, 'bloodCorran'), ('UBERON_0000178', 'blood', 450, 'blood')]
PMC4977047	2/2016	S148-PMC4977047	['adjusted effect estimates and 95% cis for all Birth outcomes across quartiles of maternal Blood Arsenic are presented infigure 1.']	N/A	N/A	[('GO_0007567', 'parturition', 46, 'birth'), ('UBERON_0000178', 'blood', 90, 'blood'), ('CHEBI_27563', 'arsenic atom', 96, 'arsenic')]
PMC4977047	2/2016	S151-PMC4977047	['caption (fig): figure 1\n\neffect estimates and 95% confidence intervals for quartiles of maternal Blood Arsenic with Birth weight (bw), Gestational age (ga), weight for Gestational age (bw for ga), and Head circumference (hc).']	N/A	N/A	[('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_27563', 'arsenic atom', 103, 'arsenic'), ('GO_0007567', 'parturition', 116, 'birth'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('GO_0007565', 'female pregnancy', 168, 'gestational'), ('UBERON_0000033', 'head', 201, 'head')]
PMC4977047	2/2016	S152-PMC4977047	['generalized additive models include maternal Blood lead and manganese (smoothed), maternal age at Delivery (smoothed), infant sex, race/ethnicity, parity, smoking during Pregnancy, maternal education, Prenatal vitamin use, and maternal hemoglobin at Delivery ( n\xa0 =\xa0596 for bw, ga, bw for ga; n\xa0 =\xa0574 for hc).']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0007567', 'parturition', 98, 'delivery'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy'), ('GO_0007565', 'female pregnancy', 201, 'prenatal'), ('GO_0007567', 'parturition', 250, 'delivery')]
PMC4977047	2/2016	S158-PMC4977047	['caption (fig): figure 2\n\neffect estimates and 95% confidence intervals for quartiles of Cord Blood Arsenic with Birth weight (bw), Gestational age (ga), weight for Gestational age (bw for ga), and Head circumference (hc).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_27563', 'arsenic atom', 99, 'arsenic'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007565', 'female pregnancy', 131, 'gestational'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('UBERON_0000033', 'head', 197, 'head')]
PMC4977047	2/2016	S159-PMC4977047	['generalized additive models include Cord Blood lead and manganese (smoothed), maternal age at Delivery (smoothed), infant sex, race/ethnicity, parity, smoking during Pregnancy, maternal education, Prenatal vitamin use, and maternal hemoglobin at Delivery ( n\xa0 =\xa0588 for bw, ga, bw for ga; n\xa0 =\xa0565 for hc).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0007567', 'parturition', 94, 'delivery'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('GO_0007565', 'female pregnancy', 197, 'prenatal'), ('GO_0007567', 'parturition', 246, 'delivery')]
PMC4977047	2/2016	S162-PMC4977047	['no significant interactions were observed between maternal or Cord Blood Arsenic with lead or manganese (see table s2).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_27563', 'arsenic atom', 73, 'arsenic')]
PMC4977047	2/2016	S163-PMC4977047	['when we included a cross-product term between Arsenic and sex, the interaction terms were not significant for maternal or Cord Blood Arsenic with any Birth outcomes (e.g., Birth weight: maternal as × sex, p = 0.6; data not shown).']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 46, 'arsenic'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('CHEBI_27563', 'arsenic atom', 133, 'arsenic'), ('GO_0007567', 'parturition', 150, 'birth'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC4977047	2/2016	S180-PMC4977047	['discussion\nin this u.s. population, Arsenic concentrations in maternal and Cord Blood were lower relative to studies conducted in asia and south america (ahmed et al.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 36, 'arsenic'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC4977047	2/2016	S187-PMC4977047	['2014), third-trimester maternal Blood = 0.44 μg/l (sanders et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC4977047	2/2016	S188-PMC4977047	['2012) vs. tar creek Cord Blood = 2.3 μg/l and maternal Blood = 1.5 μg/l.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0000178', 'blood', 55, 'blood')]
PMC4979151	8/2016	S2-PMC4979151	['in a subset of participants ( n \u2009=\u200980), Cord Blood Mononuclear Cells (cbmc) were cultured, non-adherent Lymphocytes were isolated to assess T Cell Cytokine Responses to Phytohemagglutinin (pha) and anti-cd3/anti-Cd28 (Icd3/Icd28), measured by multiplex assay.']	N/A	N/A	[('CL_0000752', 'cone retinal bipolar cell', 40, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('GO_0031097', 'medial cortex', 51, 'mononuclear'), ('CL_0000542', 'lymphocyte', 104, 'lymphocytes'), ('CL_0000084', 'T cell', 140, 'T cell'), ('GO_0001801', 'positive regulation of type IIb hypersensitivity', 147, 'cytokine responses'), ('CHEBI_52428', 'phenethicillin(1-)', 169, 'phytohemagglutinin'), ('PR_000001309', 'CD70 molecule', 212, 'CD28'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 218, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 223, 'iCD28')]
PMC4979151	8/2016	S36-PMC4979151	['Cord Blood collection, Plasma and non-adherent Lymphocyte isolation\nVenous Cord Blood was collected immediately after Delivery and transferred to the icddr,b laboratory in dhaka for same-day processing (within 2–18 h).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001969', 'blood plasma', 23, 'plasma'), ('CL_0000542', 'lymphocyte', 47, 'lymphocyte'), ('UBERON_0005296', 'ovary sex cord', 68, 'Venous cord'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007567', 'parturition', 118, 'delivery')]
PMC4979151	8/2016	S37-PMC4979151	['Cord Blood Plasma and Cbmcs were separated from whole Blood by ficoll-paque (amershan-pharamcia biotech, sweden) density gradient centrifugation.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001969', 'blood plasma', 11, 'plasma'), ('CL_0000979', 'IgG memory B cell', 22, 'CBMCs'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC4979151	8/2016	S88-PMC4979151	['caption (table-wrap): table 2\n\nconcentration of 25(oh)d3in baseline and Cord Blood samples25(Oh)d3nmol/Lplacebo ( n \u2009=\u200940)vitd ( n \u2009=\u200940) p -valueabaseline45.6\u2009±\u200921.442.6\u2009±\u200917.20.495cord Blood36.8\u2009±\u200916.2101.2\u2009±\u200929.9<0.000stratification of 25(Oh)D3Baseline\u2003\u2009<\u20093011 (27.5\xa0%)12 (30.0\xa0%)\u200330–4914 (35.0\xa0%)18 (45.0\xa0%)\u200350–7510 (25.0\xa0%)7 (17.5\xa0%)\u2003\u2009≥\u2009765 (12.5\xa0%)3 (7.5\xa0%)Cord Blood\u2003\u2009<\u20093017 (42.5\xa0%)1 (2.5\xa0%)\u200330–4917 (42.5\xa0%)1 (2.5\xa0%)\u200350–753 (7.5\xa0%)3 (7.5\xa0%)\u2003\u2009≥\u2009763 (7.5\xa0%)35 (87.5\xa0%)\ndata expressed as means\u2009±\u2009standard deviations and or numbers with percentages in parentheses\naindependent sample t test was used to assess the comparison of Serum 25(Oh)D3Concentrations between the two groups\n\ncytokine concentrations in stimulated Cord Blood Lymphocytes\nin the stimulation experiments, concentrations of all cytokines except for Il-4 were above the lod.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 72, 'cord'), ('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_51686', 'haematoxylin', 92, '(OH'), ('CHEBI_82475', '4-Hydroxyazobenzene', 103, 'LPlacebo'), ('UBERON_0001977', 'blood serum', 187, 'blood36'), ('CHEBI_78028', 'mitoguazone hydrochloride', 239, '25(OH)D3Baseline'), ('UBERON_0000948', 'heart', 363, 'Cord'), ('UBERON_0000178', 'blood', 368, 'blood'), ('UBERON_0001977', 'blood serum', 633, 'serum'), ('CHEBI_73735', 'gadoterate', 639, '25(OH)D3concentrations'), ('PR_000029413', 'putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32', 645, 'D3concentrations'), ('CL_0000107', 'autonomic neuron', 724, 'cord blood'), ('UBERON_0009472', 'axilla', 724, 'cord blood'), ('CL_0000542', 'lymphocyte', 735, 'lymphocytes'), ('PR_000001470', 'interleukin-28B', 822, 'IL-4')]
PMC4979151	8/2016	S165-PMC4979151	['abbreviations\n25(Oh)D3, 25-Hydroxy-Vitamin D3; cba, cytometric bead array; Cbmc, Cord Blood Mononuclear Cells; ccrs, c-C chemokine Receptors; hdac, Histone deacetylases; Icd3/Icd28, anti-cd3/anti-Cd28; Pha, Phytohemagglutinin; Tcr, T Cell Receptor Complex; Th, T Helper Cell type; tlrs, toll-like receptors; Tollip, Toll Interacting Protein; Treg, T Regulatory Cells; vitd3, Vitamin D3\n\npubmed central:']	N/A	N/A	[('CHEBI_62946', 'ammonium sulfate', 14, '25(OH)D3'), ('CHEBI_70487', '(-)-sanguinolignan C', 24, '25-hydroxy-'), ('CHEBI_33279', 'vitamin D5', 35, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 35, 'vitamin D3'), ('CL_0002062', 'type I pneumocyte', 75, 'CBMC'), ('CL_0000752', 'cone retinal bipolar cell', 81, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 81, 'cord'), ('UBERON_0000178', 'blood', 86, 'blood'), ('GO_0031097', 'medial cortex', 92, 'mononuclear'), ('PR_000004900', 'complement C3', 119, 'C'), ('PR_000014368', 'RuvB-like 1', 131, 'receptors'), ('CHEBI_15358', 'histone', 148, 'histone'), ('PR_000043452', 'core histone', 148, 'histone'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 170, 'iCD3'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 175, 'iCD28'), ('PR_000001309', 'CD70 molecule', 196, 'CD28'), ('CHEBI_34926', 'Pitrazepin', 202, 'PHA'), ('CHEBI_52428', 'phenethicillin(1-)', 207, 'phytohemagglutinin'), ('CL_0000084', 'T cell', 227, 'TCR'), ('CL_0000084', 'T cell', 232, 'T cell'), ('GO_0043235', 'receptor complex', 239, 'receptor complex'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 257, 'Th'), ('CL_0000912', 'helper T cell', 261, 'T helper cell'), ('PR_000016529', 'target of Myb protein 1', 308, 'TOLLIP'), ('PR_000016848', 'DNA-directed RNA polymerase I subunit RPA43', 316, 'toll interacting protein'), ('CL_0000901', 'Tr1 cell', 342, 'Treg'), ('CL_0000902', 'induced T-regulatory cell', 348, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 350, 'regulatory'), ('CHEBI_33279', 'vitamin D5', 375, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 375, 'vitamin D3')]
PMC4979959	8/2016	S76-PMC4979959	['assessment of co-variates\n\nBlood pressure measurement\nLeft Upper Arm Blood pressure was measured using the automatic omron sphygmomanometer (omron hem 705 lp, omron healthcare inc., us) with an upright seating posture after at least 5 minutes of rest [50,51].']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'Blood'), ('UBERON_0002079', 'left cardiac atrium', 54, 'Left upper arm'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC4979959	8/2016	S79-PMC4979959	['mean Arterial Blood pressure (mabp) was calculated as one third of the sbp plus two thirds of the dbp.']	N/A	N/A	[('UBERON_0001637', 'artery', 5, 'arterial'), ('UBERON_0000178', 'blood', 14, 'blood')]
PMC4988629	8/2016	S232-PMC4988629	['patients who presented with high Blood pressure in the first visited experienced mean reductions of 10.7mmhg and 6.2mmhg in systolic and diastolic Blood pressure respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC4988629	8/2016	S251-PMC4988629	['on average, systolic Blood pressures between control and treatment group were significantly different (143mmhg vs 126mmhg, p = 0.018).']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood')]
PMC4990280	8/2016	S3-PMC4990280	['Blood was collected from children to determine the concentration of hemoglobin (hb) and several Micronutrients.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_33839', 'macromolecule', 96, 'micronutrients')]
PMC4990280	8/2016	S41-PMC4990280	['a total of 551 children were enrolled in the current study, among them 7 children refused to give Blood and 4 Blood samples were clotted.']	N/A	N/A	[('UBERON_0000178', 'blood', 98, 'blood'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC4990280	8/2016	S42-PMC4990280	['finally, 540 Blood samples were available for analysis (fig 1).10.1371/journal.pone.0161294.g001\n\ncaption (fig): fig 1\nflow chart describing the enrolment of the children in the current study.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC4990280	8/2016	S53-PMC4990280	['assessment of Plasma biomarkers\nfive ml of fasting Venous Blood was collected in Lithium Heparin treated tubes (sarstedt monevette®, sweden) by trained Paramedics in the subcenters in matlab.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 14, 'plasma'), ('UBERON_0001638', 'vein', 51, 'venous'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_52634', 'sodium-23 atom', 81, 'Lithium'), ('CHEBI_28304', 'heparin', 89, 'heparin'), ('UBERON_0001694', 'petrous part of temporal bone', 152, 'paramedics')]
PMC4990280	8/2016	S54-PMC4990280	['a drop of Blood was used to measure hb by hemocuehb 201+ (hemocue ab, ängelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood')]
PMC4990280	8/2016	S55-PMC4990280	['the Blood samples were transported to the matlab laboratory for separation of Plasma which was thereafter stored in -80°c freezer until transported to the laboratory in icddr,b, dhaka.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001969', 'blood plasma', 78, 'plasma')]
PMC4990280	8/2016	S64-PMC4990280	['the complete Blood count (cbc) including mean corpuscular volume (mcv), mean corpuscular hb (mch), mean corpuscular hb concentration (mchc) and other Blood indices were determined using hematology analyzer (sysmex xt-1800i, kobe, japan).']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0000178', 'blood', 150, 'blood')]
PMC4992225	8/2016	S68-PMC4992225	['exclusion criteria were: the participants with the epds baseline scores of >13, not providing Blood sample at the onset of the study, and less than 8\xa0weeks Consumption of Vitamin D3Supplementations (for example due to preterm labor or stopping consumption), irregular consumption (for example every two/three days instead of daily consumption).']	N/A	N/A	[('UBERON_0000178', 'blood', 94, 'blood'), ('GO_0007631', 'feeding behavior', 156, 'consumption'), ('CHEBI_26915', 'tetrahydronicotinamide adenine dinucleotide phosphate', 171, 'vitamin D3supplementations'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 171, 'vitamin D3supplementations')]
PMC4992225	8/2016	S84-PMC4992225	['after separating the Serum from Blood sample, the Serum was kept under −20\xa0°c temperature until the laboratory test was done.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 21, 'serum'), ('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0001977', 'blood serum', 50, 'serum')]
PMC4992225	8/2016	S93-PMC4992225	['finally, the candidates were referred to the lab in order to provide Blood samples for determining Serum 25-Hydroxyvitamin D concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 105, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S98-PMC4992225	['maternal Blood samples were obtained at 26–28 weeks of Gestation (at baseline) and once more, at Childbirth (during first 24\xa0h after Birth in Postpartum ward).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 55, 'gestation'), ('GO_0007623', 'circadian rhythm', 97, 'childbirth'), ('GO_0007567', 'parturition', 133, 'birth'), ('GO_0007565', 'female pregnancy', 142, 'postpartum')]
PMC4992225	8/2016	S127-PMC4992225	['the remaining 169 participants were assigned to the control or Vitamin D groups with a block randomization design, and they were referred to the laboratory to provide Blood sample.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC4992225	8/2016	S129-PMC4992225	['at child Birth, Blood sample was collected for 130 mothers.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'birth'), ('UBERON_0000178', 'blood', 16, 'blood')]
PMC4992225	8/2016	S257-PMC4992225	['besides, Activated Lymphocytes can cross the Blood–Brain barrier and Secrete cytokines in the Brain [72].']	N/A	N/A	[('CL_0002129', 'regular atrial cardiac myocyte', 9, 'activated lymphocytes'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0000955', 'brain', 51, 'brain'), ('GO_0046903', 'secretion', 69, 'secrete'), ('UBERON_0000955', 'brain', 94, 'brain')]
PMC4995763	8/2016	S149-PMC4995763	['among women who attended anc and received calcium (n\u2009=\u20091173), 1150 (98.0\xa0%) reported that they had their Blood pressure measured at least once during anc, and 1006 (85.7\xa0%) had it taken at every anc visit.']	N/A	N/A	[('UBERON_0000178', 'blood', 105, 'blood')]
PMC4995781	8/2016	S32-PMC4995781	['cannulas were inserted in the Right and Left Jugular Veins to infuse Glucose and withdraw Blood during the Intravenous Glucose tolerance test [16].']	N/A	N/A	[('UBERON_0002078', 'right cardiac atrium', 30, 'right ...'), ('UBERON_0006195', 'renal sinus of left kidney', 40, 'left jugular veins'), ('CHEBI_17234', 'glucose', 69, 'glucose'), ('UBERON_0000178', 'blood', 90, 'blood'), ('UBERON_0034986', 'sacral nerve plexus', 107, 'intravenous'), ('CHEBI_17234', 'glucose', 119, 'glucose')]
PMC4995781	8/2016	S41-PMC4995781	['immediately after taking a baseline Blood sample (400\xa0μl), Rats received an Intravenous bolus of 1\xa0ml/kg body weight Glucose (50\xa0%\xa0w/v) over a 10-s interval.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 59, 'rats'), ('UBERON_0034986', 'sacral nerve plexus', 76, 'intravenous'), ('CHEBI_17234', 'glucose', 117, 'glucose')]
PMC4995781	8/2016	S42-PMC4995781	['Blood samples (200\xa0μl) were taken at 2, 5, 10, 15 and 30\xa0min and centrifuged at 12,000 × g for 1\xa0min.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC4995781	8/2016	S44-PMC4995781	['the remaining Blood Cells from the baseline and 10-min samples were pooled and re-suspended in 9\xa0g/l saline, 1 × 105u/l Heparin to a total volume of\u2009~\u2009600\xa0μl.']	N/A	N/A	[('CL_0000081', 'blood cell', 14, 'blood cells'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_28304', 'heparin', 120, 'heparin')]
PMC4995781	8/2016	S45-PMC4995781	['re-suspended Blood Cells were infused into the Animal between the 15- and 30-min Blood draws to maintain Body Fluids and hematocrit levels.']	N/A	N/A	[('CL_0000081', 'blood cell', 13, 'blood cells'), ('UBERON_0000178', 'blood', 13, 'blood'), ('NCBITaxon_33208', 'Metazoa', 47, 'animal'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0006314', 'bodily fluid', 105, 'body fluids')]
PMC4997421	8/2016	S29-PMC4997421	['Blood samples in nhanes were obtained by venipuncture and Serum Retinol was measured with the use of an isocratic, reversed-phase hplc [15].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_26536', 'retinoic acid', 64, 'retinol')]
PMC4998730	4/2016	S20-PMC4998730	['Blood was added dropwise on special filter paper, and filter papers with dried Blood spots were consistently measured.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC4998730	4/2016	S35-PMC4998730	['the peripheral venous Blood concentrations of alanine, Proline, and Tetradecanedioyl Carnitine were higher in preterm newborns than full-term newborns, and the concentration of Cerotoyl Carnitine was significantly lower in preterm newborns than in full-term infants.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('CHEBI_18133', 'hexose', 55, 'proline'), ('CHEBI_71047', '3-hydroxybenzenesulfonic acid', 68, 'tetradecanedioyl carnitine'), ('CHEBI_71328', 'callysponginol sulfonic acid A', 177, 'cerotoyl carnitine')]
PMC4998730	4/2016	S36-PMC4998730	['preterm and full-term aga newborns significantly differed in their Peripheral Blood concentrations of alanine, glutamine, Homocysteine, Pipecolic Acid, proline, Heptanoyl Carnitine, and sebacoyl carnitine ( p \u200a<\u200a0.05).']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 67, 'peripheral'), ('UBERON_0000178', 'blood', 78, 'blood'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 122, 'homocysteine'), ('CHEBI_30531', 'pimelic acid', 136, 'pipecolic acid'), ('CHEBI_71578', 'cyclic di-AMP', 161, 'heptanoyl carnitine')]
PMC4998730	4/2016	S39-PMC4998730	['of these, the Peripheral Venous Blood concentrations of Homocysteine, Heptanoyl Carnitine decanoyl Carnitine, Methylmalonyl Carnitine, Glutaryl Carnitine, sebacoyl carnitine, Hydroxyacetyl Carnitine, and Hydroxyhexadecenyl Carnitine were significantly higher in preterm newborns with iugr than in full-term newborns with iugr.']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 14, 'peripheral'), ('UBERON_0001638', 'vein', 25, 'venous'), ('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 56, 'homocysteine'), ('CHEBI_71578', 'cyclic di-AMP', 70, 'heptanoyl carnitine'), ('CHEBI_17126', 'carnitine', 99, 'carnitine'), ('CHEBI_71053', 'beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc', 110, 'methylmalonyl carnitine'), ('CHEBI_24271', 'glucosamines', 135, 'glutaryl carnitine'), ('CHEBI_71313', '4-carboxy-2-thioxobutanoyl-CoA', 175, 'hydroxyacetyl carnitine'), ('CHEBI_52675', '2-naphthoyl group', 204, 'hydroxyhexadecenyl'), ('CHEBI_17126', 'carnitine', 223, 'carnitine')]
PMC4999029	5/2016	S58-PMC4999029	['a small (25\xa0μl) Blood sample is taken by Brachial venipuncture from all captured Individuals and stored in 0.8\xa0ml of absolute Ethanol.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0001460', 'arm', 41, 'brachial'), ('NCBITaxon_1', 'root', 81, 'individuals'), ('CHEBI_16236', 'ethanol', 126, 'ethanol')]
PMC4999029	5/2016	S65-PMC4999029	['molecular methods\ndna for sexing and microsatellite analysis was extracted from Blood samples using Ammonium Acetate, following richardson et\xa0al .']	N/A	N/A	[('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_62946', 'ammonium sulfate', 100, 'ammonium acetate')]
PMC4999029	5/2016	S87-PMC4999029	["briefly, dna was extracted using a dneasy Blood and Tissue kit (qiagen) according to the manufacturer's instructions with modification of overnight Lysis at 37\xa0°c and a final dna elution volume of 80\xa0μl."]	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0000479', 'tissue', 52, 'tissue'), ('GO_0019835', 'cytolysis', 148, 'lysis')]
PMC4999029	5/2016	S92-PMC4999029	['we then calibrated quantification cycle (cq) values per amplicon across different plates by pooling six Blood samples as a ‘golden sample’ interplate calibrator (interplate repeatability for telomere amplicon\xa0=\xa00.94).']	N/A	N/A	[('UBERON_0000178', 'blood', 104, 'blood')]
PMC5013256	9/2016	S0-PMC5013256	['pathway markers for pro-resolving lipid mediators in Maternal and Umbilical Cord Blood: a secondary analysis of the mothers, Omega-3, and mental health study\n\nabstract\nthe Omega-3 Fatty Acids Docosahexaenoic Acid (Dha) and Eicosapentaenoic Acid (Epa) are precursors to Immune regulatory and specialized pro-resolving Mediators (spm) of inflammation termed resolvins, Maresins, and protectins.']	N/A	N/A	[('UBERON_0000976', 'humerus', 53, 'Maternal'), ('UBERON_0002331', 'umbilical cord', 66, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 81, 'Blood'), ('PR_000011599', 'protein BCAP', 125, 'Omega-3'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 172, 'omega-3 fatty acids'), ('CHEBI_36003', 'decenoic acid', 192, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 214, 'DHA'), ('CHEBI_36003', 'decenoic acid', 223, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 246, 'EPA'), ('UBERON_0002405', 'immune system', 269, 'immune'), ('CHEBI_35222', 'inhibitor', 317, 'mediators'), ('PR_000000021', 'noggin', 367, 'maresins')]
PMC5013256	9/2016	S6-PMC5013256	['levels of both 14-Hdha, a Maresin pathway marker, and 17-Hdha were significantly greater in Umbilical Cord Blood than in maternal Blood ( p< 0.001, both).']	N/A	N/A	[('CHEBI_78741', 'oxidopamine', 15, '14-HDHA'), ('PR_000010229', 'membrane-bound transcription factor site-1 protease', 26, 'maresin'), ('CHEBI_17883', 'hydrogen chloride', 57, 'HDHA'), ('UBERON_0002331', 'umbilical cord', 92, 'umbilical cord'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC5013256	9/2016	S40-PMC5013256	['maternal Blood was drawn at enrollment (visit 1) and again at 34–36 weeks Gestation (visit 3).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 74, 'gestation')]
PMC5013256	9/2016	S41-PMC5013256	['Umbilical Cord Blood was obtained after the Delivery of the infants Born to mothers enrolled in the study (visit 4).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('GO_0007567', 'parturition', 44, 'delivery'), ('GO_0007567', 'parturition', 68, 'born')]
PMC5013256	9/2016	S42-PMC5013256	['Serum aliquots prepared from each Blood collection and were stored at -70°c (mozurkewich et al., 2013).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0000178', 'blood', 34, 'blood')]
PMC5013256	9/2016	S43-PMC5013256	['all samples were processed and stored within 12 h. results of the Blood sample analyses for Fatty Acids have been previously described (mozurkewich et al., 2013).']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_35366', 'fatty acid', 92, 'fatty acids')]
PMC5013256	9/2016	S64-PMC5013256	['we analyzed log-transformed Resolvin pathway marker concentrations across visits 1, 3, and 4 (with visit 4 representing neonatal Cord Blood), with repeated measures (rm) anova with “visit” as the repeated factor and the three “groups” (Epa, Dha, and placebo) as the grouping factor.']	N/A	N/A	[('PR_000014373', 'retinoic acid receptor RXR-beta', 28, 'resolvin'), ('UBERON_0002240', 'spinal cord', 129, 'cord'), ('UBERON_0000178', 'blood', 134, 'blood'), ('CHEBI_34733', 'EPN', 236, 'EPA'), ('CHEBI_17874', 'dihydrozeatin', 241, 'DHA')]
PMC5013256	9/2016	S84-PMC5013256	['log transformed 4-Hdha levels did not significantly differ across the study visits and were not significantly different in the maternal Blood versus Umbilical Cord Blood ( figure2 ).']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 18, 'HDHA'), ('UBERON_0000178', 'blood', 136, 'blood'), ('UBERON_0002331', 'umbilical cord', 149, 'umbilical cord'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5013256	9/2016	S86-PMC5013256	['caption (fig): figure 2\n\nMaternal and Cord Blood log 4-Hdha concentration .']	N/A	N/A	[('UBERON_0000976', 'humerus', 25, 'Maternal'), ('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_17883', 'hydrogen chloride', 55, 'HDHA'), ('PR_000008533', 'homogentisate 1,2-dioxygenase', 55, 'HDHA')]
PMC5013256	9/2016	S89-PMC5013256	['14-Hdha levels were significantly increased in Umbilical Cord Blood compared to maternal Blood at both maternal Blood draw time points ( p< 0.001).']	N/A	N/A	[('CHEBI_78741', 'oxidopamine', 0, '14-HDHA'), ('UBERON_0002331', 'umbilical cord', 47, 'umbilical cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC5013256	9/2016	S90-PMC5013256	['there was no significant treatment effect of Epa- and Dha-rich Fish oil supplementation compared to placebo on 14-Hdha levels, in either maternal Blood or Umbilical Cord Blood ( figure4 ).']	N/A	N/A	[('CHEBI_34733', 'EPN', 45, 'EPA'), ('CHEBI_17874', 'dihydrozeatin', 54, 'DHA'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 63, 'fish'), ('CHEBI_78741', 'oxidopamine', 111, '14-HDHA'), ('UBERON_0000178', 'blood', 146, 'blood'), ('UBERON_0002331', 'umbilical cord', 155, 'umbilical cord'), ('UBERON_0000178', 'blood', 170, 'blood')]
PMC5013256	9/2016	S92-PMC5013256	['caption (fig): figure 4\n\nMaternal and Cord Blood log 14-Hdha concentrations .']	N/A	N/A	[('UBERON_0000976', 'humerus', 25, 'Maternal'), ('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_18320', '1,4-dithiothreitol', 53, '14-'), ('CHEBI_17883', 'hydrogen chloride', 56, 'HDHA'), ('PR_000008533', 'homogentisate 1,2-dioxygenase', 56, 'HDHA')]
PMC5013256	9/2016	S94-PMC5013256	['for the total cohort, 17-hdha levels significantly increased in maternal Blood between enrollment and 34–36 weeks ( p = 0.049).']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood')]
PMC5013256	9/2016	S95-PMC5013256	['concentrations of 17-hdha in Umbilical Cord Blood were significantly greater than in maternal Blood both at study entry and at 34–36 weeks Gestation ( p< 0.001; figure6 ).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 29, 'umbilical cord'), ('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 94, 'blood'), ('GO_0007565', 'female pregnancy', 139, 'gestation')]
PMC5013256	9/2016	S97-PMC5013256	['caption (fig): figure 6\n\nMaternal and Cord Blood log 17-Hdha concentrations .']	N/A	N/A	[('UBERON_0000976', 'humerus', 25, 'Maternal'), ('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CHEBI_18320', '1,4-dithiothreitol', 53, '17-'), ('CHEBI_17883', 'hydrogen chloride', 56, 'HDHA'), ('PR_000008533', 'homogentisate 1,2-dioxygenase', 56, 'HDHA')]
PMC5013256	9/2016	S132-PMC5013256	['mg carried out the Blood sample analyses described in this analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood')]
PMC5013256	9/2016	S133-PMC5013256	['kg designed this secondary analysis, carried out Blood sample analyses, and wrote the paper.']	N/A	N/A	[('UBERON_0000178', 'blood', 49, 'blood')]
PMC5013576	9/2016	S55-PMC5013576	['her physical exam on presentation was significant for a Blood pressure of 146/95\xa0mmhg, and 3+ pitting edema up to her Knees.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0001465', 'knee', 118, 'knees')]
PMC5013576	9/2016	S59-PMC5013576	['notable laboratory and imaging results included Serum creatinine concentration (scr) of 557 umol/l (6.3\xa0mg/dl), Blood Urea Nitrogen of 15.3\xa0mmol/l (43\xa0mg/dl), Serum albumin 15\xa0g/l (1.5\xa0g/dl), Total Cholesterol 10.55\xa0mmol/l (408\xa0mg/dl), Triglycerides 7.01\xa0mmol/l (621\xa0mg/dl), ldl 7.86\xa0mmol/l (304\xa0mg/dl), inr 0.96, ptt 33\xa0s, and pt 10.7\xa0s. a spot Urine protein:creatinine ratio was 20.8\xa0g/g.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 48, 'serum'), ('UBERON_0000178', 'blood', 112, 'blood'), ('CHEBI_33268', 'monoatomic nitrogen', 118, 'urea nitrogen'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('CHEBI_66254', 'topopyrone C', 192, 'total cholesterol'), ('CHEBI_17855', 'triglyceride', 236, 'triglycerides'), ('UBERON_0001088', 'urine', 346, 'urine')]
PMC5013576	9/2016	S60-PMC5013576	['Urine microscopy revealed 2–5 White Blood Cells per high power field and maltese crosses were diffusely present upon polarization.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('CL_0000738', 'leukocyte', 30, 'white blood cells'), ('UBERON_0000178', 'blood', 36, 'blood')]
PMC5013576	9/2016	S114-PMC5013576	['to investigate this, Venous Blood was collected in the setting of an irb-approved research protocol and Genomic dna was extracted and sent for whole Exome sequencing by illumina hiseq 2000 technology.']	N/A	N/A	[('UBERON_0001638', 'vein', 21, 'venous'), ('UBERON_0000178', 'blood', 28, 'blood'), ('SO_0001026', 'genome', 104, 'genomic'), ('SO_0001303', 'two_methylthio_N6_cis_hydroxyisopentenyl_adenosine', 149, 'exome')]
PMC5019390	9/2016	S37-PMC5019390	['for Hypothalamic Gene Expression and Blood parameters, a second cohort (cohort 2) was euthanized at pnd0, pnd7, pnd10, pnd14, pnd17, pnd21, and pnd28 (fig 1a).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamic'), ('GO_0010467', 'gene expression', 17, 'gene expression'), ('SO_0000704', 'gene', 17, 'gene'), ('UBERON_0000178', 'blood', 37, 'blood')]
PMC5019390	9/2016	S43-PMC5019390	['Trunk Blood was sampled and Tissues were rapidly removed, freeze-clamped and stored at –80°c.10.1371/journal.pone.0162517.g001\n\ncaption (fig): fig 1\neffect of a Perinatal hf diet on body weight and body composition in wistar and lou/c male Rats.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000479', 'tissue', 28, 'tissues'), ('GO_0036268', 'swimming', 161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 161, 'perinatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 240, 'rats')]
PMC5019390	9/2016	S60-PMC5019390	['Blood samples were collected by Tail nicking for further analyses of Plasma Glucose and Insulin concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002415', 'tail', 32, 'tail'), ('UBERON_0001969', 'blood plasma', 69, 'plasma'), ('CHEBI_17234', 'glucose', 76, 'glucose'), ('PR_000045358', 'insulin family protein', 88, 'insulin')]
PMC5021204	4/2016	S5-PMC5021204	['for face validity, these variables were forced into the model: treatment group (“less tight” or “tight” control), Antihypertensive type at randomization, and Blood pressure within 1 week before randomization.']	N/A	N/A	[('CHEBI_46673', 'D-arabinosone', 114, 'antihypertensive'), ('UBERON_0000178', 'blood', 158, 'blood')]
PMC5021204	4/2016	S61-PMC5021204	['caption (table-wrap): table 1\n\nbaseline maternal characteristics considered as candidate predictors for the occurrence of adverse Perinatal outcomes [ n (%) unless otherwise specified]variableprimary outcomea p bbirthweight <10th percentile p bno ( n = 676)yes ( n = 305)no ( n = 801)yes ( n = 175)treatment group“less tight”338 (68.6)155 (31.4)0.81411 (83.9)79 (16.1)0.14“tight”338 (69.3)150 (30.7)390 (80.2)96 (19.8)age (years)mean (sd)33.7 (5.8)34.0 (5.8)0.5433.7 (5.8)34.4 (5.9)0.06<35388 (69.8)168 (30.2)0.50467 (84.3)87 (15.7)0.04≥35288 (67.8)137 (32.2)334 (79.1)88 (20.9)ethnicitycaucasian/asian/other505 (68.4)233 (31.6)0.57602 (82.0)132 (18.0)0.94black/hispanic171 (70.4)72 (29.6)199 (82.2)43 (17.8)bmi (kg/m2)mean (sd)31.0 (7.3)31.2 (8.3)0.8131.5 (7.6)29.2 (7.5)<0.001<25148 (64.6)81 (35.4)0.11168 (73.7)60 (26.3)<0.001≥25522 (70.3)221 (29.7)625 (84.6)114 (15.4)unknown6 (0.9)3 (1.0)8 (1.0)1 (0.6)conceived through art21 (50.0)21 (50.0)0.00734 (81.0)8 (19.0)0.86unknown12 (1.8)5 (1.6)15 (1.9)2 (1.1)Gestational age at randomization (week)mean (sd)24.3 (6.4)24.5 (6.1)0.8524.3 (6.3)24.7 (6.6)0.42<20209 (70.1)89 (29.9)0.58241 (82.0)53 (18.0)0.96≥20467 (68.4)216 (31.6)560 (82.1)122 (17.9)nulliparous207 (62.9)122 (37.1)0.004258 (78.9)69 (21.1)0.07type of non‐proteinuric hypertensiongestational hypertension162 (65.1)87 (34.9)0.13196 (78.7)53 (21.3)0.11preexisting hypertension514 (70.2)218 (29.8)605 (83.2)122 (16.8)prior sbp ≥160 or dbp ≥110 mmhg in this Pregnancy83 (58.9)58 (41.1)0.005114 (81.4)26 (18.6)0.83antihypertensive use at randomization368 (65.5)194 (34.5)0.007460 (82.4)98 (17.6)0.73antihypertensive type at randomizationlabetalol ± other (not Methyldopa)144 (60.8)93 (39.2)0.001183 (78.2)51 (21.8)0.06methyldopa ± other (not Labetalol)174 (72.2)67 (27.8)210 (87.5)30 (12.5)other50 (59.5)34 (40.5)67 (79.8)17 (20.2)sbp within 1 week before randomization (mmhg)mean (sd)139.6 (10.0)141.1 (9.0)0.04140.3 (9.6)139.4 (10.0)0.31<140272 (72.3)104 (27.7)0.18299 (80.2)74 (19.8)0.10140–149266 (67.2)130 (32.8)336 (85.3)58 (14.7)≥150138 (66.0)71 (34.0)166 (79.4)43 (20.6)dbp within 1 week before randomization (mmhg)mean (sd)92.2 (4.7)92.9 (5.4)0.0492.3 (4.9)93.0 (5.3)0.12<90135 (71.8)53 (28.2)0.02154 (83.2)31 (16.8)0.2790–94340 (70.1)145 (29.9)406 (83.9)78 (16.1)95–99131 (71.2)53 (28.8)144 (78.7)39 (21.3)≥10070 (56.5)54 (43.5)97 (78.2)27 (21.8)in hospital at enrolment21 (34.4)40 (65.6)<0.00142 (70.0)18 (30.0)0.01gdm prior to randomization44 (69.8)19 (30.2)0.8753 (84.1)10 (15.9)0.66smoking during this Pregnancy38 (60.3)25 (39.7)0.1345 (71.4)18 (28.6)0.02aspirin at enrollment178 (69.3)79 (30.7)0.89221 (86.3)35 (13.7)0.04folic Acid or pnv Vitamin at enrolment450 (70.5)188 (29.5)0.13526 (83.0)108 (17.0)0.31unknown1 (0.1)01 (0.1)0pmr recruiting countryclow560 (68.2)261 (31.8)0.28671 (82.1)146 (17.9)0.91high116 (72.5)44 (27.5)130 (81.8)29 (18.2)\nart, artificial Reproductive technology; bmi, body mass index; dbp, diastolic Blood pressure; del, Delivery; gdm, Gestational diabetes mellitus; htn, hypertension; pet, preeclampsia; pmr, Perinatal mortality ratio; pnv, Prenatal vitamin; sbp, systolic Blood pressure).']	N/A	N/A	[('GO_0036268', 'swimming', 130, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 130, 'perinatal'), ('GO_0007565', 'female pregnancy', 1009, 'Gestational'), ('GO_0007565', 'female pregnancy', 1466, 'pregnancy83'), ('CHEBI_81933', 'methasulfocarb', 1667, 'methyldopa'), ('CHEBI_31764', 'Laudanosoline', 1749, 'labetalol'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy38'), ('CHEBI_37527', 'acid', 2649, 'acid'), ('CHEBI_33229', 'vitamin (role)', 2661, 'vitamin'), ('GO_0000003', 'reproduction', 2885, 'reproductive'), ('UBERON_0000178', 'blood', 2947, 'blood'), ('GO_0007567', 'parturition', 2968, 'delivery'), ('GO_0007565', 'female pregnancy', 2983, 'gestational'), ('GO_0036268', 'swimming', 3057, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 3057, 'perinatal'), ('GO_0007565', 'female pregnancy', 3089, 'prenatal'), ('UBERON_0000178', 'blood', 3121, 'blood')]
PMC5024431	9/2016	S137-PMC5024431	['other reasons included improving: fitness ( n\u2009= \u20098), body composition ( n\u2009= \u20097), diabetes/Blood Sugar Control ( n\u2009= \u20092), Blood Cholesterol ( n\u2009= \u20091), and health/energy levels ( n\u2009= \u20091).']	N/A	N/A	[('UBERON_0000178', 'blood', 90, 'blood'), ('CHEBI_24870', 'ion', 96, 'sugar'), ('GO_0065007', 'biological regulation', 102, 'control'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CHEBI_16113', 'cholesterol', 127, 'cholesterol')]
PMC5024513	9/2016	S87-PMC5024513	['all but two of the studies reporting biological markers collected Venous Blood samples which were analysed in laboratories using standard testing procedures.']	N/A	N/A	[('UBERON_0001638', 'vein', 66, 'venous'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5025575	9/2016	S5-PMC5025575	['a subsample ( n \u2009=\u200933) also gave a fasting Blood sample and completed a validated semi-quantitative ffq administered by a trained registered dietitian during a visit at the research center.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood')]
PMC5025575	9/2016	S67-PMC5025575	['upon entry into the study, Pregnant women were also asked whether they would be interested in an optional part of the study which required a visit at the research center to give a Blood sample and fill out the ffq.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC5025575	9/2016	S68-PMC5025575	['during that visit, which usually occurred within two weeks after filling the fvq and the Food record, a fasting Blood sample was drawn and dietary Intake was assessed using a ffq administered by a trained registered dietitian [23].']	N/A	N/A	[('CHEBI_33290', 'food', 89, 'food'), ('UBERON_0000178', 'blood', 112, 'blood'), ('GO_0007631', 'feeding behavior', 147, 'intake')]
PMC5025575	9/2016	S69-PMC5025575	['before the visit, Pregnant women were instructed to fast for at least 12\xa0h before their scheduled Blood sample (only Water was allowed), to avoid drinking alcohol the previous 48\xa0h and also to avoid doing intense physical activity the night before their appointment.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_15377', 'water', 117, 'water')]
PMC5025575	9/2016	S70-PMC5025575	['a Blood sample of 12\xa0ml was collected by a venipuncture on their non-dominant arm from a trained nurse.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood')]
PMC5025575	9/2016	S71-PMC5025575	['immediately after being collected, Blood samples were stored in a refrigerator kept at a temperature of -80\xa0°c until the assessment of Plasma Carotenoids concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('UBERON_0001969', 'blood plasma', 135, 'plasma'), ('CHEBI_50815', 'norgestimate', 142, 'carotenoids')]
PMC5025575	9/2016	S125-PMC5025575	['in addition, 33 respondents (participation rate: 67.4\xa0%) participated in the optional part of the study that is, the visit at the research center where a fasting Blood sample was drawn and the ffq was administered by a trained registered dietitian.']	N/A	N/A	[('UBERON_0000178', 'blood', 162, 'blood')]
PMC5025983	8/2015	S132-PMC5025983	['in that group, the average daily energy Intake per body weight was increased and, when the offspring reached 100\xa0days old, their systolic Blood pressure and Blood Insulin levels were elevated [58].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 40, 'intake'), ('UBERON_0000178', 'blood', 138, 'blood'), ('UBERON_0000178', 'blood', 157, 'blood'), ('PR_000045358', 'insulin family protein', 163, 'insulin')]
PMC5025983	8/2015	S134-PMC5025983	['on the 21st day of Gestation, compared to the standard diet group, the high fat diet group was 20\xa0% heavier, Consumed more energy, and had twice Insulin, 34\xa0% more Glucose, and 68\xa0% more Triglycerides in their Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'gestation'), ('GO_0007631', 'feeding behavior', 109, 'consumed'), ('PR_000045358', 'insulin family protein', 145, 'insulin'), ('CHEBI_17234', 'glucose', 164, 'glucose'), ('CHEBI_17855', 'triglyceride', 187, 'triglycerides'), ('UBERON_0000178', 'blood', 210, 'blood')]
PMC5025983	8/2015	S170-PMC5025983	['when these hormones penetrate the Blood–Brain barrier, neural signals in the acute nucleus part of the Hypothalamus also take part in Regulating energy balance.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0000955', 'brain', 40, 'brain'), ('UBERON_0001898', 'hypothalamus', 103, 'hypothalamus'), ('GO_0065007', 'biological regulation', 134, 'regulating')]
PMC5030620	9/2016	S192-PMC5030620	['*studies directly sampling the target Tissue or validating the same change in the Blood and target Tissue of an appropriate in vivo model.']	N/A	N/A	[('UBERON_0000479', 'tissue', 38, 'tissue'), ('UBERON_0000178', 'blood', 82, 'blood'), ('UBERON_0000479', 'tissue', 99, 'tissue')]
PMC5031324	9/2016	S64-PMC5031324	['[it] had the bullet points broken out so you can get the gist of it pretty quickly.”\n\nusefulness of web-based components\nparticipants verbalized that the link to healthy recipes and the “tracking your progress” page to record daily weights, exercise and Blood Glucose levels were the most useful website component.']	N/A	N/A	[('UBERON_0000178', 'blood', 254, 'blood'), ('CHEBI_17234', 'glucose', 260, 'glucose')]
PMC5031324	9/2016	S141-PMC5031324	['maternal Blood was collected in edta tubes, immediately inverted several times to prevent Coagulation and transported to the institution’s core lab.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0050817', 'coagulation', 90, 'coagulation')]
PMC5031324	9/2016	S143-PMC5031324	['in the Postpartum phase, fasting maternal Blood was collected in Serum separator tubes and transported on dry ice to the laboratory for analysis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'postpartum'), ('UBERON_0000178', 'blood', 42, 'blood'), ('UBERON_0001977', 'blood serum', 65, 'serum')]
PMC5031987	9/2016	S52-PMC5031987	['pooled sample was rinsed twice in 1.0\u2009ml pbs, 5\u2009min prior to dna extraction to remove traces of maternal Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 105, 'blood')]
PMC5035678	4/2016	S44-PMC5035678	['a Blood sample was collected at the time of recruitment from all study subjects.']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood')]
PMC5035678	4/2016	S60-PMC5035678	['after Glucose measurement, the Sera and whole Blood were kept at -80°c and 4°c, respectively, for testing of Lipids, Insulin, and hba1c.']	N/A	N/A	[('CHEBI_17234', 'glucose', 6, 'glucose'), ('UBERON_0001977', 'blood serum', 31, 'sera'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_18059', 'lipid', 109, 'lipids'), ('PR_000045358', 'insulin family protein', 117, 'insulin')]
PMC5035678	4/2016	S63-PMC5035678	['Blood Glucose measurement was carried out by the enzymatic (god - Glucose oxidase) method (pars azmun co., tehran, iran), and Hba1C measurement was performed with the enzymatic method (sekisui medical co., osaka, japan).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('PR_000002010', 'MHC class I histocompatibility antigen B alpha chain', 126, 'HbA1C')]
PMC5039809	10/2016	S40-PMC5039809	['biochemical analyses\na maternal Blood sample was obtained during the late-Pregnancy assessment.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC5045149	9/2016	S188-PMC5045149	['trial weeks consisted of first a dietary intervention whereby the results of the Blood Glucose testing were evaluated along with his self-reported dietary record to create a new diet plan, and second an exercise to practice mindful self-exploration of emotional experiences in response to his diet.']	N/A	N/A	[('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_17234', 'glucose', 87, 'glucose')]
PMC5045149	9/2016	S189-PMC5045149	['the new diet was written to mimic as much as possible kevin’s standard diet, but with the addition of Probiotic Food choices, and omission of foods that caused long duration Blood Sugar spikes.']	N/A	N/A	[('CHEBI_73033', 'pterocarpan', 102, 'probiotic'), ('CHEBI_33290', 'food', 112, 'food'), ('CHEBI_73302', '(dT)5', 174, 'blood sugar'), ('UBERON_0000178', 'blood', 174, 'blood')]
PMC5045784	10/2016	S3-PMC5045784	["study design:\nwe collected Umbilical Cord Blood samples from 44 preterm infants (Gestational age <29 weeks) Delivered at brigham and women's hospital in boston."]	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 27, 'umbilical cord'), ('UBERON_0000178', 'blood', 42, 'blood'), ('GO_0007565', 'female pregnancy', 81, 'gestational'), ('GO_0007567', 'parturition', 108, 'delivered')]
PMC5045784	10/2016	S4-PMC5045784	["in addition, with parental consent we collected Venous samples at 36 weeks' corrected age from 20 preterm infants Born before 29 weeks' Gestation (including 6 infants with previously collected Cord Blood)."]	N/A	N/A	[('UBERON_0001638', 'vein', 48, 'venous'), ('GO_0007567', 'parturition', 114, 'born'), ('GO_0007565', 'female pregnancy', 136, 'gestation'), ('UBERON_0002240', 'spinal cord', 193, 'cord'), ('UBERON_0000178', 'blood', 198, 'blood')]
PMC5045784	10/2016	S10-PMC5045784	["neither Cord Blood nor 36 weeks' corrected 25(Oh)D levels were associated with odds of death or bpd (adjusted odds ratio (or) 1.00, 95% confidence interval (ci): 0.73 to 1.37; and or 0.93, 95% ci: 0.61 to 1.43, respectively)."]	N/A	N/A	[('UBERON_0002240', 'spinal cord', 8, 'cord'), ('UBERON_0000178', 'blood', 13, 'blood'), ('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 43, '25(OH ... D')]
PMC5045784	10/2016	S21-PMC5045784	["we collected Umbilical Cord Blood at the time of Delivery from 44 extremely preterm infants (<29 weeks of Gestation) Born at brigham and women's hospital, a high-risk tertiary care center in boston, massachusetts, between 2010 and 2013."]	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 13, 'umbilical cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('GO_0007567', 'parturition', 49, 'delivery'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('GO_0007567', 'parturition', 117, 'born')]
PMC5045784	10/2016	S24-PMC5045784	["in addition, with written parental consent, we obtained Venous Blood samples at ~36 weeks' corrected Gestational age at the time of a medically indicated Blood draw from 20 infants also Born before 29 completed weeks of Gestation."]	N/A	N/A	[('UBERON_0001638', 'vein', 56, 'venous'), ('UBERON_0000178', 'blood', 63, 'blood'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('UBERON_0000178', 'blood', 154, 'blood'), ('GO_0007567', 'parturition', 186, 'born'), ('GO_0007565', 'female pregnancy', 220, 'gestation')]
PMC5045784	10/2016	S25-PMC5045784	['there were 6 subjects for which we had both Cord Blood and Venous Blood at 36 weeks.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('UBERON_0001638', 'vein', 59, 'venous'), ('UBERON_0000178', 'blood', 66, 'blood')]
PMC5045784	10/2016	S26-PMC5045784	['we refrigerated and centrifuged the Blood samples and stored Plasma aliquots at −80\u2009°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001969', 'blood plasma', 61, 'plasma')]
PMC5045784	10/2016	S35-PMC5045784	["we collected Cord Blood samples from 44 preterm infants, and Venous Blood at 36 weeks' corrected age from a separate group of 20 preterm infants."]	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('UBERON_0001638', 'vein', 61, 'venous'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC5045784	10/2016	S36-PMC5045784	['there were a total of 6 subjects for whom we collected both, Cord Blood and Venous Blood and measured 25(Oh)D levels.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 61, 'cord'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001638', 'vein', 76, 'venous'), ('UBERON_0000178', 'blood', 83, 'blood'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 102, '25(OH)D')]
PMC5045784	10/2016	S37-PMC5045784	["statistical analyses\nwe used generalized estimated equations for the comparison of the 25(Oh)D levels between the Cord Blood samples and the Venous samples at 36 weeks' corrected age to appropriately control for infants who had Blood at both time points."]	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 87, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 87, '25(OH ... D'), ('UBERON_0002240', 'spinal cord', 114, 'cord'), ('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0001638', 'vein', 141, 'venous'), ('UBERON_0000178', 'blood', 228, 'blood')]
PMC5045784	10/2016	S43-PMC5045784	["we had 44 subjects Born before 29 completed weeks of Gestation who had Cord Blood levels of 25(Oh)D measured, and 20 who had their 25(Oh)D levels measured at 36 weeks' corrected age."]	N/A	N/A	[('GO_0007567', 'parturition', 19, 'born'), ('GO_0007565', 'female pregnancy', 53, 'gestation'), ('UBERON_0002240', 'spinal cord', 71, 'cord'), ('UBERON_0000178', 'blood', 76, 'blood'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 92, '25(OH ... D'), ('CHEBI_33010', 'chromide(1-)', 133, '(OH)D')]
PMC5045784	10/2016	S45-PMC5045784	["levels of 25(Oh)D were significantly higher at 36 weeks' corrected age compared with Cord Blood levels (median (interquartile range): 61.6 (53.2 to 78.8) vs 31.4 (22.0 to 38.3) ng\u2009ml−1)."]	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 10, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 10, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC5045784	10/2016	S48-PMC5045784	['as shown intable 2, median 25(Oh)D levels at Birth were 30.4\u2009ng\u2009ml−1in preterm infants who subsequently died or developed bpd and 33.8\u2009ng\u2009ml−1in infants who survived without bpd, and there were no statistically significant differences in 25(Oh)D Cord Blood levels between these two groups ( p =0.6).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 27, '25(OH)D'), ('GO_0007567', 'parturition', 45, 'birth'), ('CHEBI_71657', 'versiconol acetate', 238, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 238, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 246, 'cord'), ('UBERON_0000178', 'blood', 251, 'blood')]
PMC5045784	10/2016	S49-PMC5045784	['Cord Blood levels of 25(Oh)D <20 or <30\u2009ng\u2009ml−1were not associated with the outcome of death or bpd (table 3).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 21, '25(OH ... D')]
PMC5045784	10/2016	S54-PMC5045784	["other morbidities of prematurity, including culture-proven sepsis, necrotizing enterocolitis, retinopathy of prematurity, Intraventricular hemorrhage and Periventricular leukomalacia were not associated with Cord Blood or 36 weeks' corrected age 25(Oh)D levels in our study cohort (table 1)."]	N/A	N/A	[('UBERON_0006250', 'infundibular recess of 3rd ventricle', 122, 'intraventricular'), ('UBERON_0002281', 'vestibular membrane of cochlear duct', 154, 'periventricular'), ('UBERON_0002240', 'spinal cord', 208, 'cord'), ('UBERON_0000178', 'blood', 213, 'blood'), ('CHEBI_71657', 'versiconol acetate', 246, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 246, '25(OH)D')]
PMC5051327	9/2016	S23-PMC5051327	['the diagnosis of suspected fetal distress was carried out with the discretion of the obstetrician in charge, mainly based on fetal Heart rate monitoring and/or fetal Blood sampling.']	N/A	N/A	[('UBERON_0000948', 'heart', 131, 'heart'), ('UBERON_0000178', 'blood', 166, 'blood')]
PMC5051406	9/2016	S66-PMC5051406	['Blood pressure measurements\nBlood pressure of subjects will be measured to the nearest 0.5\u2005mm\u2005hg using a digital Arm sphygmomanometer after a 10\u2005min rest while in a supine position.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('UBERON_0001460', 'arm', 113, 'arm')]
PMC5051406	9/2016	S73-PMC5051406	['weight, muac, and systolic and diastolic Blood pressure will be measured at recruitment and at each visit, while height will only be measured once at recruitment.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC5054961	9/2015	S73-PMC5054961	['caption (table-wrap): table 2\n\ncharacteristics of women with ( n \xa0=\xa0635) and without Food cravings ( n \xa0=\xa01004)cravingsno cravings p *valueage at interview (years) (sd)29.7 (5.5)29.7 (5.5)nsgestational age at interview28.9 (1.2)28.9 (1.2)nsyears in education (years)14.7 (2.9)15.1 (2.8)0.037smoking at interview†165 (26%)218 (22%)0.05employed at interview‡453 (72%)785 (78%)0.001previous children§347 (55%)477 (48%)0.002bmi (kg/m²) <16\xa0weeks gest (mean 12.1\xa0weeks\xa0±\xa02.3)25.8 (4.9)25.5 (4.9)nsweight (kg) <16\xa0weeks gest (mean 12.1\xa0weeks\xa0±\xa02.3)68.5 (14)67.5 (13)nsweight (kg) 29\xa0weeks75.8 (14)74.9 (13)nsheight (m) 29\xa0weeks163 (6.3)163 (6.3)nsbmi (kg/m²) 29\xa0weeks28.5 (4.9)28.3 (4.8)nsweight gain <16\xa0weeks – 3rd Trimester (mean 32.8\xa0weeks\xa0±\xa04.5)9.6 (5.4)8.9 (5.5)nsrate of weight gain (kg\xa0week−1)0.5 (0.2)0.4 (0.2)nsfasting Blood Glucose 29\xa0weeks (ogtt) mmol\xa0l−15.2 (1)5.2 (1)nshba1c 29\xa0weeks4.8 (0.4)4.8 (0.3)nsneonatal Birthweight3.5 (0.6)3.5 (0.5)nsbirthweight sds−0.1 (0.9)−0.1 (0.9)nsbirth length sds0.2 (1.1)0.1 (1.2)nshead circumference sds0.3 (1)0.2 (1)nsfemale child √310 (49%)474 (48%)ns\ndata are the mean (sd) or n (%) of subjects *t‐test for independent samples or chi‐squared tests †with cravings, n = 633, and without cravings, n = 998.']	N/A	N/A	[('CHEBI_33290', 'food', 85, 'food'), ('GO_0009294', 'DNA mediated transformation', 711, 'trimester'), ('UBERON_0000178', 'blood', 823, 'blood'), ('CHEBI_17234', 'glucose', 829, 'glucose'), ('GO_0007596', 'blood coagulation', 920, 'birthweight3')]
PMC5058640	11/2016	S14-PMC5058640	['the chips trial randomized women with nonsevere Pregnancy hypertension to a diastolic Blood pressure (dbp) target of 100 mm\u2009hg (“less tight” control) versus 85 mm\u2009hg (“tight” control) for a planned between-group difference in dbp of 5 mm\u2009hg.2the bp achieved was higher in less tight (versus tight) control by a mean of 5.8 mm\u2009hg systolic (95% confidence interval, 4.5–7.0; 138.8±0.5 mm\u2009hg versus 133.1±0.5 mm\u2009hg; p<0.001) and 4.6 mm\u2009hg diastolic (95% confidence interval, 3.7–5.4; 89.9±0.3 mm\u2009hg versus 85.3±0.3 mm\u2009hg; p<0.001).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC5062906	10/2016	S332-PMC5062906	['Tissues and Blood were harvested from all Animals post euthanasia.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('UBERON_0000178', 'blood', 12, 'blood'), ('NCBITaxon_33208', 'Metazoa', 42, 'animals')]
PMC5062906	10/2016	S333-PMC5062906	['quantification of Plasma 25(Oh)D\nBlood was collected by Cardiac puncture immediately after euthanizing the Animals.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 18, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 28, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('UBERON_0000178', 'blood', 33, 'Blood'), ('UBERON_0000948', 'heart', 56, 'cardiac'), ('NCBITaxon_33208', 'Metazoa', 107, 'animals')]
PMC5062906	10/2016	S334-PMC5062906	['Plasma was prepared from Heparin-treated Blood and snap-frozen in liquid nitrogen.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_28304', 'heparin', 25, 'heparin'), ('UBERON_0000178', 'blood', 41, 'blood')]
PMC5070159	10/2016	S55-PMC5070159	['caption (table-wrap): table 2\n\nAbdominal ectopic case reportsauthor (year)age/parityinfertility etiologyother pertinent historypriorectopicstimulation protocolegg #et no./timingfresh/frozen etmax Hcg level (miu/ml)location (e/h)stage at diagnosisrupture?interventionoutcomeoehniger (1988) [23]35 yog0p0endometriosislaparotomy x 2, left Salpingectomy, frozen Pelvis; right Hydrosalpinx with partial obstructionnofsh/pergonal (hmg/hcg), hcg trigger4442–44 hfreshnasigmoid Mesentery (e)~41\xa0days ptnoexploratory laparotomyremoval of Pregnancy Tissue by laparotomybassil (1991) [24]33 yonamale factornanaclomid/hmg, hcg trigger64nafreshnaposterior Uterus, Broad Ligament (h)19\xa0weeks Gestationnolaparotomy, right Adnexectomydelivery of viable twins at 34\xa0weeksferland (1991) [25]32 yog4p0030des exposure, secondary infertilityright Salpingectomy, left Hydrosalpinxtubal ectopiclong protocol w/Gnrh Agonist73Day 2 etfresh19,450retroperitoneal (e)37\xa0days ptyeslaparotomy, left Salpingectomyragni (1991) [26]32 yog1p0010pelvic adhesive diseaseright Adnexectomy, hysteropexytubal ectopiclong protocol w/Gnrh Agonist43Day 2 etfreshnaright Adnexa (h)12\xa0weeks Gestationnoselective reduction of Abdominal Pregnancy, laparotomylaparotomy for resorbing Abdominal Pregnancy, sab of iup at 16\xa0weeksbalmaceda (1993) [27]33 yog3p1021tubalright Salpingectomy, left Salpingostomytubal ectopic x 2short protocol, w/Gnrh agonist154day 4 etfresh4651abdominal - Broad Ligament (E)30\xa0days ptnolaparoscopy, salpingectomylaparoscopic removal of Abdominal ectopic, left Salpingectomyfisch (1995) [28]32 yog2p0020tubalbilateral Salpingectomytubal ectopic x 2long protocol w/Gnrh Agonist53Nafreshnaileum, Left Uterine Cornua (h)10\xa0weeks Gestationyesgastrostoscopy, sigmoidoscopy, tc scan, angiography, d&c, tagged Rbc scan, laparotomylaparotomy for Abdominal ectopic, d&c for incomplete ab of iupdelrosario (1996) [29]33 yog1p1001tubalbreast cancernonana4nafrozen563bladder (e)75\xa0days ptyesmethotrexate, laparoscopylaparoscopic removal of Pregnancy Tissuefisch (1996) [11]38 yog2p0020tuballaparoscopic Salpingectomy x 2, 8th Ivf cycletubal ectopic x 2long protocol w/Gnrh agonist144day 3 etfresh1730broad Ligament (e)21\xa0days ptyesexploratory laparotomyremoval of Pregnancy Tissue by laparotomymoonen-delarue (1996) [30]23 yog2p0020pelvic adhesive diseaseright Salpingectomytubal and Abdominal ectopicnanananafreshnaabdominal - Uterine Fundus (e)28\xa0weeksplacental abruptionlaparotomyfetal demise of Abdominal ectopic @ 28\xa0weekspisarska (1998) [31]35 yog2p0020unexplainednanolong protocol w/Gnrh agonist96nafresh6004bladder Serosa (h)6\xa0weeks Gestationnodiagnostic laparoscopylaparoscopic removal of ectopic Pregnancy (Bladder), term Delivery of iupdeshpande (1999) [32]33 yog1p0010endometriosisendometriosis, left Salpingectomy, patent right Tubenolong protocol w/Gnrh agonist82day 3 etfresh55,560twin Pregnancy in Broad Ligament (h)7\xa0weeks ptnolaparotomyremoval of twin ectopic Pregnancy by laparotomy at 7\xa0weeksscheiber (1999) [33]37 yog3p0030tubal factor endometriosisdorsalpingostomy, donor Oocytestubal ectopicnana2day 3 etfrozennaabdominal (h)8.5\xa0weeks ptnokcl selective reduction of Abdominal Pregnancyselective reduction of Abdominal Pregnancy, full term viable iupdmowski (2002) [34]34 yog0p0tubalbilateral Salpingectomynolong protocol w/Gnrh agonist153day 3 etfresh38,635retroperitoneal Pancreatic (e)41\xa0days ptyeslaparotomyretroperitoneal Subpancreatic ectopic removed by laparotomyjain (2002) [35]29 yog0p0unexplainednanonana2nananapouch of douglas (h)9\xa0weeks ptnalaparotomy at 4w weeks (no iup seen), selective reduction of ectopic at 13\xa0weeksselective reduction of Abdominal ectopic, removal by laparotomy, sab of iupcormio (2003) [36]30 yog2p0020tubalbilateral Salpingectomytubal ectopic x 2menotropins, Hcg trigger74day 3 etfresh256,400omentum, Uterine Fundus (h)13\xa0weeks Gestationnolaparotomylaparotomy for Abdominal ectopic; live iup Delivered at 36\xa0weeksreid (2003) [37]28 yog5p1041tubalbilateral Salpingectomytubal ectopic x3nana3nana5500retroperitoneal, Iliac bifurcation (e)63\xa0days ptnalaparotomyremoval of ectopic via laparotomykitade (2005) [38]37 yog0p0unexplainednanolong protocol w/Gnrh Agonist123Day 3 etfresh45,896splenic and Tubal (h)34\xa0days pt (Tubal), 46\xa0day pt (Splenic)tubal - no, Splenic - yes1) laparoscopic Salpingectomy 2) exploratory laparotomyremoval of Tubal ectopic by laparoscopy, removal of Splenic ectopic by laparotomy (12\xa0days later)ali (2006) [39]35natubalpelvic adhesionsnona111nafresh1524tube with omental/Peritoneal trophoblastic Tissue (h)3\xa0weeks pt - Tubal ectopic; 5\xa0weeks pt – Omental Tissuenolaparoscopic Salpingectomy; laparocopic removal of Omental/Peritoneal Trophoblastic Tissueremoval of Tubal and Peritoneal/Omental Pregnancy Tissue by 2 laparoscopiesapantaku (2006) [40]33g3p1021tubalbilateral Salpingectomytubal ectopic x 2nana2nafreshnaright Adnexa (e)6\xa0weeks ptnolaparoscopylaparoscopic removal of Pregnancy Tissueknopman (2007) [41]37 yog4p0040unexplainednanognrh antagonist92day 5 etfresh1023posterior Cul-De-Sac (h)7\xa0weeks, nonviable iup; 9\xa0weeks ectopicyeslaparoscopyd&c for non-viable iup; laparoscopy for Abdominal ectopicshih (2007) [42]33 yog0p0male factorpatent tubesnolong protocol w/Gnrh Agonist4Nanafresh901Cul-de-Sac(e)28\xa0days ptnolaparoscopy converted to laparotomyremoval of Pregnancy Tissue by laparotomyshojai (2007) [43]35 yog0p0structural, des exposurenanonana3nananaabdominal - Uterine Fundus (h)21\xa0weeks Gestationnolaparotomydelivery of viable twins at 32\xa0weeksiwama (2008) [44]31 yog1p0010tubalright Salpingectomy for Tubal ectopic after ivf, left Salpingectomy for Hydrosalpinxtubal ectopicnana3day 3 etfresh45, 369inferior Vena Cava/Retroperitoneal (e)32\xa0days pt: pul; 53\xa0days pt: Retroperitoneal ectopicyesd&c, mtx, diagnostic laparoscopy, repeat mtx, exploratory laparotomyruptured Retroperitoneal ectopic, removed by laparotomyhyvarinen (2009) [45]nananananananananananaabdominal (e)30\xa0weeks Gestationnolaparotomydelivery of viable fetus at 30\xa0weekszacche (2011) [46]36g1p1tubalbilateral Salpingectomy, pidnonana2nafreshnaabdominal (h)32\xa0weeks at cesarean deliverynolaparotomy, hysterectomyviable twin Pregnancies at 32\xa0weeks; hysterectomyangelova (2015) [47]33namale factorobturated left tubenashort protocol, w/Gnrh antagonistna2day 3 etfreshnaabdominal - Vesicouterine junction (e)23\xa0days ptnolaparoscopylaparoscopic removal of Pregnancy Tissuedalmia (2015) [48]37g1p0010endometriosistubal factorbilateral Salpingectomy for hydrosalpinxnananananana21,730left Adnexa (e)2\xa0weeks ptnomini-laparotomyremoval of ectopic via laparotomykoyama (2015) [49]32g5p1male factornanonana1nafrozen14,800retroperitoneal (e)10\xa0weeks Gestationnalaparoscopylaparoscopic removal of Pregnancy Tissue\nabbreviations : ab Abortion, d&c dilation and curettage, des Diethylstilbestrol, e ectopic, fsh follicle Stimulating Hormone, gnrh gonadotropin-Releasing Hormone, h heterotopic, hcg Human Chorionic Gonadotropin, hmg Human menopausal gonadotropin, hsg Hysterosalpingogram, iup Intrauterine Pregnancy, ivf in vitro Fertilization, Kcl Potassium Chloride, mtx Methotrexate, na not available, pid Pelvic inflammatory disease, pt post transfer, Rbc Red Blood Cell, tc technetium, sab spontaneous Abortion\n\nresults\na total of 28 cases of Abdominal ectopic Pregnancy after Ivf were identified.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 31, 'Abdominal'), ('CHEBI_17883', 'hydrogen chloride', 196, 'HCG'), ('UBERON_0001220', 'quadratus lumborum', 336, 'salpingectomy'), ('UBERON_0002355', 'pelvic region of trunk', 358, 'pelvis'), ('UBERON_0011601', 'gingiva of upper jaw', 372, 'hydrosalpinx'), ('UBERON_0002095', 'mesentery', 470, 'mesentery'), ('GO_0007565', 'female pregnancy', 529, 'pregnancy'), ('UBERON_0000479', 'tissue', 539, 'tissue'), ('UBERON_0000995', 'uterus', 643, 'uterus'), ('UBERON_0006472', 'Brodmann (1909) area 6', 651, 'broad ligament'), ('GO_0007538', 'primary sex determination', 678, 'gestationNoLaparotomy'), ('UBERON_0007646', 'endomeninx', 707, 'adnexectomyDelivery'), ('UBERON_0001220', 'quadratus lumborum', 826, 'salpingectomy'), ('UBERON_0010896', 'piston cartilage', 846, 'hydrosalpinxTubal'), ('PR_000008293', 'glutathione synthetase', 887, 'GnRH'), ('CHEBI_35845', 'gout suppressant', 892, 'agonist73Day'), ('UBERON_0010233', 'stroma of thyroid gland', 969, 'salpingectomyRagni'), ('UBERON_0002223', 'endolymphatic sac', 1040, 'adnexectomy'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 1093, 'GnRH agonist43Day'), ('PR_000008293', 'glutathione synthetase', 1093, 'GnRH'), ('UBERON_0004742', 'dentary', 1128, 'adnexa'), ('GO_0051294', 'establishment of spindle orientation', 1147, 'gestationNoSelective'), ('UBERON_0000916', 'abdomen', 1181, 'abdominal'), ('GO_0007565', 'female pregnancy', 1191, 'pregnancy'), ('UBERON_0000916', 'abdomen', 1237, 'abdominal'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('UBERON_0001220', 'quadratus lumborum', 1324, 'salpingectomy'), ('UBERON_0010749', 'middle pharyngeal constrictor', 1344, 'salpingostomyTubal'), ('PR_000008293', 'glutathione synthetase', 1392, 'GnRH'), ('UBERON_0006472', 'Brodmann (1909) area 6', 1436, 'broad ligament'), ('UBERON_0000922', 'embryo', 1452, 'E'), ('UBERON_0000916', 'abdomen', 1516, 'abdominal'), ('UBERON_2001425', 'basal plate cartilage', 1540, 'salpingectomyFisch'), ('UBERON_0010749', 'middle pharyngeal constrictor', 1597, 'salpingectomyTubal'), ('PR_000008293', 'glutathione synthetase', 1643, 'GnRH'), ('CHEBI_64432', '2-diazoniobenzoate', 1648, 'agonist53NAFreshNAIleum'), ('UBERON_0005457', 'left thymus lobe', 1673, 'left uterine cornua'), ('GO_0009873', 'ethylene-activated signaling pathway', 1705, 'gestationYesGastrostoscopy'), ('CL_0000232', 'erythrocyte', 1782, 'RBC'), ('UBERON_0000916', 'abdomen', 1817, 'abdominal'), ('GO_0007565', 'female pregnancy', 2007, 'pregnancy'), ('UBERON_0001277', 'intestinal epithelium', 2017, 'tissueFisch'), ('UBERON_0002207', 'xiphoid process', 2070, 'Salpingectomy'), ('UBERON_0001137', 'dorsum', 2093, 'IVF'), ('PR_000008293', 'glutathione synthetase', 2135, 'GnRH'), ('UBERON_0000211', 'ligament', 2173, 'Ligament'), ('GO_0007565', 'female pregnancy', 2231, 'pregnancy'), ('UBERON_0000479', 'tissue', 2241, 'tissue'), ('UBERON_0010749', 'middle pharyngeal constrictor', 2328, 'salpingectomyTubal'), ('UBERON_0000916', 'abdomen', 2351, 'abdominal'), ('UBERON_0000995', 'uterus', 2395, 'uterine'), ('UBERON_0003951', 'ocular fundus', 2403, 'fundus'), ('UBERON_0000916', 'abdomen', 2466, 'abdominal'), ('PR_000008293', 'glutathione synthetase', 2557, 'GnRH'), ('UBERON_0000043', 'tendon', 2590, 'serosa'), ('GO_0002007', 'detection of hypoxic conditions in blood by chemoreceptor signaling', 2608, 'gestationNoDiagnostic'), ('GO_0007565', 'female pregnancy', 2673, 'pregnancy'), ('UBERON_0018707', 'bladder organ', 2684, 'bladder'), ('GO_0007567', 'parturition', 2699, 'delivery'), ('UBERON_0001220', 'quadratus lumborum', 2780, 'salpingectomy'), ('UBERON_0016925', 'juxtaductal region of aortic arch', 2808, 'tubeNoLong'), ('CHEBI_63559', 'HBOA', 2830, 'GNRH'), ('GO_0007565', 'female pregnancy', 2868, 'pregnancy'), ('UBERON_0002185', 'bronchus', 2881, 'broad'), ('UBERON_0000211', 'ligament', 2887, 'ligament'), ('GO_0007565', 'female pregnancy', 2945, 'pregnancy'), ('CL_0000024', 'oogonial cell', 3061, 'oocytesTubal'), ('UBERON_0000916', 'abdomen', 3156, 'abdominal'), ('GO_0000050', 'urea cycle', 3166, 'pregnancySelective'), ('UBERON_0000916', 'abdomen', 3198, 'abdominal'), ('GO_0007565', 'female pregnancy', 3208, 'pregnancy'), ('UBERON_3000432', 'pila metoptica', 3282, 'SalpingectomyNoLong'), ('PR_000008293', 'glutathione synthetase', 3313, 'GnRH'), ('UBERON_0001264', 'pancreas', 3363, 'pancreatic'), ('UBERON_0001161', 'body of stomach', 3416, 'subpancreatic'), ('UBERON_0000916', 'abdomen', 3645, 'abdominal'), ('UBERON_0010749', 'middle pharyngeal constrictor', 3742, 'salpingectomyTubal'), ('PR_000006060', 'CWF19-like protein 1', 3785, 'hCG'), ('UBERON_0000995', 'uterus', 3827, 'uterine'), ('UBERON_0003951', 'ocular fundus', 3835, 'fundus'), ('GO_0007539', 'primary sex determination, soma', 3854, 'gestationNoLaparotomyLaparotomy'), ('UBERON_0000916', 'abdomen', 3890, 'abdominal'), ('GO_0007567', 'parturition', 3918, 'delivered'), ('UBERON_0010749', 'middle pharyngeal constrictor', 3982, 'salpingectomyTubal'), ('UBERON_0001273', 'ilium', 4041, 'iliac'), ('CHEBI_5533', 'granaticin', 4175, 'GnRH agonist123Day'), ('PR_000008293', 'glutathione synthetase', 4175, 'GnRH'), ('UBERON_0000025', 'tube', 4221, 'Tubal'), ('UBERON_0000025', 'tube', 4242, 'tubal'), ('UBERON_0002106', 'spleen', 4261, 'splenic'), ('UBERON_0002106', 'spleen', 4281, 'Splenic'), ('UBERON_0001220', 'quadratus lumborum', 4310, 'salpingectomy'), ('UBERON_0000025', 'tube', 4360, 'tubal'), ('UBERON_0002106', 'spleen', 4401, 'splenic'), ('UBERON_0001179', 'peritoneal cavity', 4522, 'peritoneal'), ('UBERON_0000479', 'tissue', 4547, 'tissue'), ('UBERON_0000025', 'tube', 4570, 'tubal'), ('UBERON_0001091', 'calcareous tooth', 4598, 'omental'), ('UBERON_0004273', 'cartilaginous joint suture', 4606, 'tissueNoLaparoscopic'), ('UBERON_0001220', 'quadratus lumborum', 4627, 'salpingectomy'), ('UBERON_0001091', 'calcareous tooth', 4665, 'omental'), ('UBERON_0001179', 'peritoneal cavity', 4673, 'peritoneal'), ('UBERON_0000088', 'trophoblast', 4684, 'trophoblastic'), ('UBERON_0004910', 'epithelium of male gonad', 4698, 'tissueRemoval'), ('UBERON_0000025', 'tube', 4715, 'tubal'), ('UBERON_0001179', 'peritoneal cavity', 4725, 'peritoneal'), ('UBERON_0001091', 'calcareous tooth', 4736, 'omental'), ('GO_0007565', 'female pregnancy', 4744, 'pregnancy'), ('UBERON_0000479', 'tissue', 4754, 'tissue'), ('UBERON_0010749', 'middle pharyngeal constrictor', 4823, 'salpingectomyTubal'), ('UBERON_0004742', 'dentary', 4873, 'adnexa'), ('GO_0007565', 'female pregnancy', 4930, 'pregnancy'), ('UBERON_0003335', 'serosa of colon', 4940, 'tissueKnopman'), ('UBERON_0003978', 'valve', 5036, 'cul'), ('UBERON_0003062', 'primitive knot', 5040, 'de'), ('UBERON_0009856', 'sac', 5043, 'sac'), ('UBERON_0000916', 'abdomen', 5143, 'abdominal'), ('CHEBI_67721', 'Officinoic acid B', 5226, 'GnRH agonist4NANAFresh901Cul'), ('PR_000008293', 'glutathione synthetase', 5226, 'GnRH'), ('UBERON_0009856', 'sac', 5258, 'sac'), ('GO_0007565', 'female pregnancy', 5322, 'pregnancy'), ('UBERON_0000479', 'tissue', 5332, 'tissue'), ('UBERON_0005203', 'trachea gland', 5430, 'uterine fundus'), ('GO_0007281', 'germ cell development', 5457, 'gestationNoLaparotomyDelivery'), ('UBERON_0002207', 'xiphoid process', 5554, 'Salpingectomy'), ('UBERON_0000025', 'tube', 5572, 'tubal'), ('UBERON_0001220', 'quadratus lumborum', 5602, 'salpingectomy'), ('UBERON_0010896', 'piston cartilage', 5620, 'hydrosalpinxTubal'), ('UBERON_0001681', 'nasal bone', 5679, 'Vena Cava'), ('UBERON_0003693', 'retroperitoneal space', 5689, 'Retroperitoneal'), ('UBERON_0003693', 'retroperitoneal space', 5737, 'retroperitoneal'), ('UBERON_0003693', 'retroperitoneal space', 5840, 'retroperitoneal'), ('GO_0007281', 'germ cell development', 5951, 'gestationNoLaparotomyDelivery'), ('UBERON_0002207', 'xiphoid process', 6047, 'Salpingectomy'), ('GO_0007565', 'female pregnancy', 6161, 'pregnancies'), ('PR_000008293', 'glutathione synthetase', 6272, 'GnRH'), ('UBERON_0003957', "Bruch's membrane", 6317, 'vesicouterine'), ('GO_0007565', 'female pregnancy', 6390, 'pregnancy'), ('UBERON_0000479', 'tissue', 6400, 'tissueDalmia'), ('UBERON_0001220', 'quadratus lumborum', 6468, 'salpingectomy'), ('UBERON_0004742', 'dentary', 6521, 'adnexa'), ('GO_0006309', 'apoptotic DNA fragmentation', 6677, 'gestationNALaparoscopyLaparoscopic'), ('GO_0007565', 'female pregnancy', 6723, 'pregnancy'), ('UBERON_0000479', 'tissue', 6733, 'tissue'), ('GO_0007602', 'phototransduction', 6759, 'Abortion'), ('CHEBI_34713', 'dimepiperate', 6801, 'Diethylstilbestrol'), ('PR_000015909', 'synaptotagmin-7', 6845, 'stimulating hormone'), ('PR_000004759', 'Bloom syndrome protein', 6883, '-releasing hormone'), ('NCBITaxon_10088', 'Mus <genus>', 6922, 'Human'), ('UBERON_0003124', 'chorion', 6928, 'chorionic'), ('PR_000001220', 'encephalopsin', 6938, 'gonadotropin'), ('NCBITaxon_10088', 'Mus <genus>', 6956, 'Human'), ('UBERON_0014762', 'fused metapodial bones 2-4', 6991, 'Hysterosalpingogram'), ('UBERON_0035108', 'temporalis fascia', 7016, 'Intrauterine'), ('GO_0007565', 'female pregnancy', 7029, 'pregnancy'), ('GO_0009566', 'fertilization', 7053, 'fertilization'), ('CHEBI_32588', 'potassium chloride', 7068, 'KCl'), ('CHEBI_8349', 'pradimicin A', 7072, 'Potassium chloride'), ('CHEBI_44185', 'methotrexate', 7096, 'Methotrexate'), ('UBERON_0002107', 'liver', 7132, 'Pelvic'), ('CL_0000232', 'erythrocyte', 7179, 'RBC'), ('CL_0000232', 'erythrocyte', 7183, 'Red blood cell'), ('UBERON_0000178', 'blood', 7187, 'blood'), ('GO_0007569', 'cell aging', 7230, 'abortion'), ('UBERON_0000916', 'abdomen', 7271, 'abdominal'), ('GO_0007565', 'female pregnancy', 7289, 'pregnancy'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 7305, 'IVF')]
PMC5073052	3/2016	S152-PMC5073052	['whole Blood was collected using heparinized micro-hematocrit capillary tubes via Eye bleed 2 h after Fitc-Dextran administration.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0000970', 'eye', 81, 'eye'), ('CHEBI_37926', 'fluorescein isothiocyanate', 101, 'FITC'), ('CHEBI_52071', 'dextran', 106, 'dextran')]
PMC5073590	10/2016	S5-PMC5073590	['participants\nmaternal whole Blood collected in the first half of Pregnancy was assayed for Mercury and Selenium.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_16170', 'mercury(0)', 91, 'mercury'), ('CHEBI_27568', 'selenium atom', 103, 'selenium')]
PMC5073590	10/2016	S38-PMC5073590	['samples were transported at room temperature for up to 3\u2005hours, and stored at 4°c as whole Blood in the original collection tubes for 18–19.5\u2005years before analysis.15\nanalyses of the Blood samples for whole Blood Mercury and Selenium were carried out by the laboratory of dr robert jones at the centers for disease control and prevention (cdc) (cdc method 3009.1; unpublished information).']	N/A	N/A	[('UBERON_0000178', 'blood', 91, 'blood'), ('UBERON_0000178', 'blood', 183, 'blood'), ('UBERON_0000178', 'blood', 207, 'blood'), ('CHEBI_16170', 'mercury(0)', 213, 'mercury'), ('CHEBI_27568', 'selenium atom', 225, 'selenium')]
PMC5073590	10/2016	S39-PMC5073590	['clotted whole Blood was digested to remove all Clots, before being analysed using inductively coupled Plasma dynamic reaction cell mass spectrometry (icp-drc-ms).16–19\nthe entire amount of clotted whole Blood was transferred to a digestion tube using concentrated Nitric Acid with the volume estimated from the weight.20the Blood sample was heated in a microwave oven at a controlled temperature and time during which the Organic matrix of the Blood was digested removing the clots.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0002536', 'arthropod sensillum', 47, 'clots'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('UBERON_0000178', 'blood', 203, 'blood'), ('CHEBI_48107', 'nitric acid', 264, 'nitric acid'), ('UBERON_0000178', 'blood', 324, 'blood'), ('CHEBI_77514', '6-phenylundecane', 422, 'organic'), ('UBERON_0000178', 'blood', 444, 'blood')]
PMC5073590	10/2016	S41-PMC5073590	['the standard additions method of calibration was used to optimise the analytical sensitivity of the method for the whole Blood samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 121, 'blood')]
PMC5073590	10/2016	S46-PMC5073590	['the Blood Selenium levels ranged from 17.0 to 324.1\u2005µg/l, with 5th, 10th, 50th, 90th and 95th centiles of 81.4, 86.7, 108.0, 139.0 and 152.5\u2005µg/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_27568', 'selenium atom', 10, 'selenium')]
PMC5073590	10/2016	S48-PMC5073590	['the maternal Blood mercury levels ranged from 0.17 to 12.76\u2005µg/l, with 5th, 10th, 50th, 90th and 95th centiles of 0.81, 0.99, 1.86, 3.33 and 4.02\u2005µg/l, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC5073590	10/2016	S75-PMC5073590	['caption (table-wrap): table\xa01\n\nmean Blood pressure and pulse levels (95% cis) for the offspring for whom there was a Prenatal Blood mercury measureage at measurement (years)nsystolic bp*diastolic bp*pulse rate†72207–998.43 (98.05 to 98.82)56.09 (55.82 to 56.37)83.19 (82.74 to 83.63)92125102.08 (101.69 to 102.46)57.10 (56.84 to 57.37)78.98 (78.54 to 79.42)111950104.98 (104.54 to 105.42)58.50 (58.21 to 58.79)75.54 (75.04 to 76.04)131540107.56 (107.05 to 108.07)58.11 (57.79 to 58.43)70.53 (69.97 to 71.08)151494–5122.97 (122.32 to 123.62)66.47 (65.99 to 66.95)74.23 (73.47 to 74.99)171268118.05 (117.44 to 118.66)63.85 (63.49 to 64.21)64.99 (64.46 to 65.53)\n*mm\u2005hg.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('GO_0007565', 'female pregnancy', 117, 'prenatal'), ('UBERON_0000178', 'blood', 126, 'blood')]
PMC5073590	10/2016	S76-PMC5073590	['†bpm.10.1136/bmjopen-2016-012425.supp1\n\n\nrelationships between Prenatal Fish Eating and mercury levels\nthe way in which the total Blood mercury varies with the amount of fish eaten is shown intable 2.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 63, 'prenatal'), ('GO_0007601', 'visual perception', 72, 'fish eating'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC5073590	10/2016	S81-PMC5073590	['caption (table-wrap): table\xa02\n\nmean (sd) and median levels of Prenatal total Blood mercury according to fish intakefrequencyoily fishwhite fishnmean (sd)mediannmean (sd)mediannever/rarely14791.75 (0.94)1.556441.63 (1.02)1.39once in 2\u2005weeks11392.28 (1.08)2.0813962.09 (0.99)1.921–3 times/week8032.52 (1.16)2.2713742.35 (1.14)2.104+ times/week422.38 (1.02)2.36492.34 (1.15)2.08r28.13%5.15%\n\nrelationships between Prenatal Fish Eating and offspring outcomes\nthe unadjusted mean bps and Heart rates of the offspring are compared between the children of women who ate Fish in Pregnancy and those who did not intable 3.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('UBERON_0000178', 'blood', 77, 'blood'), ('GO_0007565', 'female pregnancy', 411, 'prenatal'), ('GO_0007601', 'visual perception', 420, 'fish eating'), ('UBERON_0000948', 'heart', 483, 'heart'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 563, 'fish'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy')]
PMC5073590	10/2016	S84-PMC5073590	['caption (table-wrap): table\xa03\n\nunadjusted mean (95% confidence limits) of offspring resting Blood pressures and Heart rates in childhood and Adolescence according to whether the mother ate fish during Pregnancyage of offspringsystolic bp*Diastolic bp*Heart rate†mother ate fishmother ate fishmother ate fishoffspring (years)yesnoyesnoyesno798.4 (98.0 to 98.8)98.7 (97.6 to 99.9)56.0 (55.7 to 56.3)56.4 (55.6 to 57.2)83.0 (82.5 to 83.5)84.3‡ (83.0 to 85.7)9101.9 (101.4 to 102.3)103.0‡ (102.0 to 104.1)57.0 (56.7 to 57.3)57.8 (57.0 to 58.5)78.8 (78.3 to 79.3)80.5‡ (79.1 to 81.8)11105.1 (104.7 to 105.6)103.7‡ (102.4 to 105.1)58.5 (58.2 to 58.8)58.2 (57.4 to 59.1)75.3 (74.7 to 75.8)77.0‡ (75.7 to 78.4)13107.3 (106.8 to 107.9)108.7 (107.1 to 110.3)58.0 (57.6 to 58.3)58.6 (57.6 to 59.6)70.4 (69.8 to 71.0)71.6 (69.9 to 73.4)15123.1 (122.4 to 123.8)122.2 (120.4 to 123.9)66.7 (66.1 to 67.2)65.7 (64.3 to 67.1)74.0 (73.2 to 74.9)75.7 (73.5 to 77.8)17118.0 (117.3 to 118.6)119.3 (117.4 to 121.2)63.8 (63.4 to 64.1)64.5 (63.2 to 65.8)65.0 (64.4 to 65.6)64.8 (63.3 to 66.2)\nnumbers in each cell can be obtained from onlinesupplementary table s2.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0000948', 'heart', 112, 'heart'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence'), ('GO_0007608', 'sensory perception of smell', 201, 'pregnancyAge'), ('GO_0006281', 'DNA repair', 238, 'Diastolic'), ('UBERON_0000948', 'heart', 251, 'Heart')]
PMC5073590	10/2016	S94-PMC5073590	['caption (table-wrap): table\xa04\n\nrelationship between Prenatal mercury exposure and offspring systolic Blood pressure (mm\u2005\u2005hg)all childrenmother ate fishmother ate no fishage at Measurementnβ (95% ci)nβ (95% ci)nβ (95% ci)7\u2005years\u2003unadjusted2209−0.13 (−0.48 to +0.22)1825−0.04 (−0.41 to +0.34)270−0.07 (−1.60 to +1.45)(p=0.465)(p=0.854)(p=0.926)\u2003model a1874+0.13 (−0.26 to +0.53)1634+0.16 (−0.26 to +0.57)235+0.16 (−1.53 to +1.85)(p=0.506)(p=0.462)(p=0.852)\u2003model b1874+0.10 (−0.31 to +0.51)1634+0.15 (−0.29 to +0.58)235+0.12 (−1.58 to +1.81)(p=0.625)(p=0.511)(p=0.894)9\u2005years\u2003unadjusted2125−0.02 (−0.37 to +0.33)1753+0.23 (−0.16 to +0.62)258−0.60 (−2.05 to +0.86)(p=0.898)(p=0.243)(p=0.420)\u2003model a1800+0.18 (−0.22 to +0.58)1581+0.26 (−0.17 to +0.68)213−0.17 (−1.76 to +1.43)(p=0.377)(p=0.240)(p=0.837)\u2003model b1800+0.07 (−0.34 to +0.49)1581+0.19 (−0.26 to +0.63)213−0.27 (−1.85 to +1.32)0.734(p=0.412)(p=0.741)11\u2005years\u2003unadjusted1950+0.11 (−0.30 to +0.51)1621−0.07 (−0.51 to +0.37)223 +2.14 (+0.39 to +3.89) (p=0.606)(p=0.756) (p=0.017) \u2003model a1658+0.29 (−0.17 to +0.75)1470+0.02 (−0.47 to +0.50)182 +2.71 (+0.77 to +4.66) (p=0.220)(p=0.944) (p=0.006) \u2003model b1658+0.21 (−0.26 to +0.69)1470−0.05 (−0.56 to +0.45)182 +2.64 (+0.70 to +4.58) (p=0.377)(p=0.842) (p=0.008) 13\u2005years\u2003unadjusted1540−0.09 (−0.55 to +0.36)1288+0.01 (−0.49 to +0.51)177+0.42 (−1.77 to +2.60)(p=0.685)(p=0.976)(p=0.706)\u2003model a1326−0.03 (−0.55 to +0.49)1171+0.00 (−0.54 to +0.54)151+0.07 (−2.44 to +2.57)(p=0.916)(p=0.994)(p=0.958)\u2003model b1326−0.03 (−0.56 to +0.51)1171+0.02 (−0.54 to +0.58)151−0.00 (−2.54 to +2.53)(p=0.925)(p=0.944)(p=0.997)15\u2005years\u2003unadjusted1495+0.17 (−0.41 to +0.74)1242+0.45 (−0.21 to +1.10)177−1.79 (−3.99 to +0.41)(p=0.573)(p=0.181)(p=0.110)\u2003model a1283+0.28 (−0.37 to +0.92)1128+0.41 (−0.28 to +1.10)150− 2.20 ( − 4.61 to +0.20) (p=0.402)(p=0.248) (p=0.072) \u2003model b1283+0.19 (−0.48 to +0.85)1128+0.32 (−0.40 to +1.03)150− 2.21 ( − 4.64 to +0.21) (p=0.586)(p=0.384) (p=0.073) 17\u2005years\u2003unadjusted1268−0.04 (−0.58 to +0.50)1054+0.03 (−0.57 to +0.63)153 +2.45 (+0.02 to +4.88) (p=0.891)(p=0.922) (p=0.049) \u2003model a1102+0.12 (−0.44 to +0.69)964+0.16 (−0.43 to +0.75)134+1.74 (−0.82 to +4.30)(p=0.675)(p=0.596)(p=0.181)\u2003model b1102+0.15 (−0.44 to +0.73)964+0.19 (−0.42 to +0.80)134+1.73 (−0.86 to +4.31)(p=0.626)(p=0.542)(p=0.189)\nresults are shown in bold typeface where p<0.10.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('UBERON_0000178', 'blood', 101, 'blood'), ('PR_000010104', 'mannosyl-oligosaccharide 1,2-alpha-mannosidase IC', 176, 'measurementNβ')]
PMC5073590	10/2016	S95-PMC5073590	['β gives change in bp for each sd of maternal Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC5073590	10/2016	S103-PMC5073590	['caption (table-wrap): table\xa05\n\nsummary of adjusted associations (regression coefficients) between Prenatal Blood mercury and offspring diastolic Blood pressures (for full details, seeonline supplementary table s2)age of offspring (years)all casesmothers ate fishmothers ate no fish7+0.24 (−0.04 to +0.52)*+0.26 (−0.04 to +0.55)*+0.77 (−0.44 to +1.99)9+0.27 (−0.00 to +0.55)*+0.35 (+0.05 to +0.64)**−0.23 (−1.34 to +0.89)11+0.09 (−0.21 to +0.39)+0.02 (−0.29 to +0.34)+0.60 (−0.63 to +1.82)13+0.27 (−0.05 to +0.59)*+0.28 (−0.06 to +0.61)+0.51 (−0.93 to +1.96)15†−0.10 (−0.59 to +0.38)+0.01 (−0.51 to +0.52)−1.98 (−3.94 to −0.01)*17−0.01 (−0.38 to +0.36)+0.06 (−0.32 to +0.43)+0.18 (−1.78 to +2.14)\nregression coefficients give the increase (+) or decrease (−) in diastolic bp for each sd of mercury after controlling for model a.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC5073590	10/2016	S109-PMC5073590	['caption (table-wrap): table\xa06\n\nsummary of adjusted associations (regression coefficients) between Prenatal Blood Mercury and offspring Heart rate (for full details, see online supplementary table s3)age of offspring (years)all casesmothers ate fishmothers ate no fish7−0.17 (−0.62 to +0.29)−0.04 (−0.52 to +0.44)−0.68 (−2.74 to +1.37)9+0.12 (−0.33 to +0.57)+0.26 (−0.21 to +0.73)+0.25 (−1.80 to +2.29)11−0.44 (−0.95 to +0.07)*−0.27 (−0.81 to +0.28)−0.32 (−2.35 to +1.70)13+0.04 (−0.52 to +0.59)+0.15 (−0.44 to +0.73)−0.19 (−2.84 to +2.46)15−0.15 (−0.90 to +0.70)−0.04 (−0.86 to +0.78)−0.56 (−3.46 to +2.48)17−0.08 (−0.62 to +0.46)−0.10 (−0.68 to +0.49)+0.72 (−1.34 to +2.79)\nregression coefficients give the increase (+) or decrease (−) in Heart rate for each sd of mercury.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_16170', 'mercury(0)', 113, 'mercury'), ('UBERON_0000948', 'heart', 135, 'heart'), ('UBERON_0000948', 'heart', 740, 'heart')]
PMC5084009	10/2016	S33-PMC5084009	['briefly, women attending their first Antenatal visit with a viable singleton Pregnancy confirmed by ultrasonography that provided a fasting Blood sample at or before the 12th Gestational week (gw) were eligible to participate in the study.']	N/A	N/A	[('GO_0007567', 'parturition', 37, 'antenatal'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('UBERON_0000178', 'blood', 140, 'blood'), ('GO_0007565', 'female pregnancy', 175, 'gestational')]
PMC5084009	10/2016	S46-PMC5084009	['Blood sample collection and biochemical and Genetic determinations\nfasting Blood samples were collected at ≤12, 15, 24–27 and 34 gw and nonfasting samples on admission to hospital with confirmed labour and from the Umbilical Cord.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('SO_0000704', 'gene', 44, 'Genetic'), ('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0002331', 'umbilical cord', 215, 'umbilical cord')]
PMC5084009	10/2016	S47-PMC5084009	['Maternal Blood was drawn from the Antecubital Vein, and Cord Blood from the Vein, into vacutainers containing edta-k2.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001545', 'anterior tibial vein', 34, 'antecubital vein'), ('UBERON_0002240', 'spinal cord', 56, 'cord'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001638', 'vein', 76, 'vein')]
PMC5084009	10/2016	S49-PMC5084009	['Leukocytes were isolated from the Blood Cells remaining after Plasma separation and dna extracted from these using the puregene dna extraction kit (gentra systems, minneapolis, mn, usa).']	N/A	N/A	[('CL_0000346', 'hair follicle dermal papilla cell', 0, 'Leukocytes'), ('CL_0000081', 'blood cell', 34, 'blood cells'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001969', 'blood plasma', 62, 'plasma')]
PMC5084009	10/2016	S65-PMC5084009	['Plasma Folate, Choline, betaine, dimethylglycine and dimethylglycine/betaine ratio and thcy were compared between the different bhmt c.716g>a genotypes at each Gestational period and in the Cord by ancova adjusting for Gestational age (weeks) at the time of the Blood sample, and Plasma Folate status (in all models except for Plasma Folate models).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_30863', '5-azaorotic acid', 7, 'folate'), ('CHEBI_15354', 'choline', 15, 'choline'), ('GO_0007565', 'female pregnancy', 160, 'gestational'), ('UBERON_0002240', 'spinal cord', 190, 'cord'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('UBERON_0000178', 'blood', 262, 'blood'), ('UBERON_0001969', 'blood plasma', 280, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 287, 'folate'), ('UBERON_0001969', 'blood plasma', 327, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 334, 'folate')]
PMC5084009	10/2016	S147-PMC5084009	['samples were processed according to specific protocols to prevent artefacts in Plasma analyte concentrations caused by temperature and time before Separation Of Blood Cells [53].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('GO_0048469', 'cell maturation', 147, 'separation of ... cells'), ('CL_0000081', 'blood cell', 161, 'blood cells'), ('UBERON_0000178', 'blood', 161, 'blood')]
PMC5084041	10/2016	S2-PMC5084041	['Blood was drawn in the first (t1) and third trimester (t3).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5084041	10/2016	S47-PMC5084041	['data collection\ntwo Blood samples were collected from each participant: the first before Gestational week 17 (first trimester; t1) and a second one after Gestational week 31 (third trimester; t3).']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('GO_0007565', 'female pregnancy', 89, 'gestational'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
PMC5084041	10/2016	S53-PMC5084041	['laboratory analysis\nVenous Blood samples were centrifuged for 10 min within two hours of sampling and sent to the central laboratory at sahlgrenska university hospital.']	N/A	N/A	[('UBERON_0001638', 'vein', 20, 'Venous'), ('UBERON_0000178', 'blood', 27, 'blood')]
PMC5084041	10/2016	S54-PMC5084041	['the Blood samples were kept from sunlight in cardboard boxes, and kept refrigerated until and after transport.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC5084041	10/2016	S77-PMC5084041	['categorical variables were season (december–february, march–may, june–august, september–november), Vitamin D supplement use (any dose and frequency: no/yes), origin (defined as country of Birth, categorized as north europe, america, continental europe, africa and asia), recent travel to a southern latitude (<35° n within six months of Blood sampling: no/yes), sun-seeking behaviour (preference for sun, both sun and shade or shade in sunny weather), clothing style when sunny (often, seldom or never exposes more skin than Face and Hands to the sun in warm weather), parity (0, 1, 2, ≥3 children), education level (primary, secondary, university), employment (unemployed, fulltime, part time, parental leave) and tobacco use (any: no/yes).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007567', 'parturition', 188, 'birth'), ('UBERON_0000178', 'blood', 337, 'blood'), ('UBERON_0001456', 'face', 525, 'face'), ('UBERON_0002398', 'manus', 534, 'hands')]
PMC5084041	10/2016	S87-PMC5084041	['at t3, 1836 Blood samples were analysed for 25(Oh)D and values were available at both time-points for 1829 women.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 44, '25(OH ... D')]
PMC5085625	9/2016	S46-PMC5085625	['25(Oh)D concentration did not differ significantly ( p = 0.08) between groups considering seasons of taking Blood (spring/summer vs. autumn/winter, 21.1 vs. 19.5 ng/ml, p = ns).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 0, '25(OH)D'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC5085625	9/2016	S47-PMC5085625	['Serum levels of 25(Oh) (ng/ml) did not correlate significantly with Pregnancy duration, neonatal Birth weight and ph of the Umbilical Cord Blood (data not shown).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_30778', 'gallic acid', 16, '25(OH)'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 97, 'birth'), ('UBERON_0002331', 'umbilical cord', 124, 'umbilical cord'), ('UBERON_0000178', 'blood', 139, 'blood')]
PMC5085625	9/2016	S136-PMC5085625	['type a1 (corresponding to gdm g1) was defined as abnormal Oral Glucose tolerance test (ogtt), but normal Blood Glucose levels during fasting and one/two hours after a meal; diet modification was sufficient to control Glucose levels.']	N/A	N/A	[('UBERON_0000165', 'mouth', 58, 'oral'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('UBERON_0000178', 'blood', 105, 'blood'), ('CHEBI_17234', 'glucose', 111, 'glucose'), ('CHEBI_17234', 'glucose', 217, 'glucose')]
PMC5085625	9/2016	S139-PMC5085625	['Gestational hypertension was defined as a systolic Blood pressure >140 mmhg or diastolic Blood pressure >90 mmhg on two or more measurements at least six hours apart, occurring after 20 weeks of Gestation, without concomitant proteinuria.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0007565', 'female pregnancy', 195, 'gestation')]
PMC5085625	9/2016	S146-PMC5085625	['women presenting abnormal Blood pressure were additionally examined for the severity of hypertension and presence of preeclampsia.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood')]
PMC5085625	9/2016	S147-PMC5085625	['patient age, parity, body mass index (bmi), Gestational age at Delivery, route of Delivery, Birth weight and ph of the Umbilical Cord Blood were analyzed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('GO_0007567', 'parturition', 63, 'delivery'), ('GO_0007567', 'parturition', 82, 'delivery'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0002331', 'umbilical cord', 119, 'umbilical cord'), ('UBERON_0000178', 'blood', 134, 'blood')]
PMC5085625	9/2016	S148-PMC5085625	['the control group included 36 women with uncomplicated Pregnancies, normal Arterial Blood pressure and Glucose concentrations.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('UBERON_0001637', 'artery', 75, 'arterial'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_17234', 'glucose', 103, 'glucose')]
PMC5085625	9/2016	S151-PMC5085625	['methods\nBlood samples of 10-ml were obtained from the Cubital Vein and immediately separated by centrifugation.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'Blood'), ('UBERON_0001663', 'cerebral vein', 54, 'cubital vein')]
PMC5085625	9/2016	S161-PMC5085625	['relationships between Serum concentrations of 25(Oh)D (ng/ml),patient age, ph of the Umbilical Cord Blood and Birth weight were assessed on the basis of spearman’s rank correlation coefficient values.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 48, '(OH ... D'), ('UBERON_0002331', 'umbilical cord', 85, 'umbilical cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007567', 'parturition', 110, 'birth')]
PMC5090877	11/2016	S224-PMC5090877	['the ones that come here are educated on the types of Food to eat and we also give the iron tablets which is part of the routine Drugs we give each one of them [idi: health worker; udi peri-urban]\nbut those who don’t have money settle for the local means of building the Blood.']	N/A	N/A	[('CHEBI_33290', 'food', 53, 'food'), ('CHEBI_23888', 'drug', 128, 'drugs'), ('UBERON_0000178', 'blood', 270, 'blood')]
PMC5090877	11/2016	S226-PMC5090877	['yes, when they make the juice out of vegetables, they either add Malt to it and this helps to build the Blood [fgd: grandmother; udi]\nthe nurses always tell them to eat vegetable and take the Drug they gave at the clinic.']	N/A	N/A	[('CHEBI_33280', 'molecular messenger', 65, 'malt'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_23888', 'drug', 192, 'drug')]
PMC5090877	11/2016	S227-PMC5090877	['but there are lots of things that can be done to quickly replace Blood for a Pregnant woman.']	N/A	N/A	[('UBERON_0000178', 'blood', 65, 'blood'), ('GO_0007565', 'female pregnancy', 77, 'pregnant')]
PMC5090877	11/2016	S229-PMC5090877	['there are also People who mix the Blood of tortoise and Milk or you can also add malt drink to it.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 15, 'people'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001913', 'milk', 56, 'milk')]
PMC5090877	11/2016	S230-PMC5090877	['these things help a Pregnant woman to give her Blood until she has the baby [fgd: grandmothers; ezeagu rural].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('UBERON_0000178', 'blood', 47, 'blood')]
PMC5090877	11/2016	S241-PMC5090877	['once you wash them, blend them into juice and drink, it will build the Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 71, 'blood')]
PMC5090877	11/2016	S244-PMC5090877	['they also give them tablets that can give Blood [fgd: grandmothers, nsukka urban]\nthere are certain things that need to be done.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC5091916	11/2016	S112-PMC5091916	['Trunk Blood samples were briefly collected into tubes containing edta (6%) and centrifuged (1500 g for 10 minutes at 4°c).']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood')]
PMC5093227	10/2016	S1-PMC5093227	['to prevent these obstetric and Perinatal complications, women with diabetes have to Control levels of Blood Sugar, both prior to and during Pregnancy.']	N/A	N/A	[('GO_0036268', 'swimming', 31, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 31, 'perinatal'), ('GO_0065007', 'biological regulation', 84, 'control'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_24870', 'ion', 108, 'sugar'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC5093227	10/2016	S9-PMC5093227	['she experienced weight loss and Ketones were detected; furthermore, she was taking in less than the recommended amount of Foods for the Regulation of Blood Sugar levels.']	N/A	N/A	[('CHEBI_17087', 'ketone', 32, 'ketones'), ('CHEBI_33290', 'food', 122, 'foods'), ('GO_0065007', 'biological regulation', 136, 'regulation'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_24870', 'ion', 156, 'sugar')]
PMC5093227	10/2016	S43-PMC5093227	['through these efforts and Drug therapy, her Blood Glucose level has been kept near normal.']	N/A	N/A	[('CHEBI_23888', 'drug', 26, 'drug'), ('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_17234', 'glucose', 50, 'glucose')]
PMC5093227	10/2016	S47-PMC5093227	['we provided a daily menu comprising three meals and three snacks to Control Blood Sugar without producing Ketones.']	N/A	N/A	[('GO_0065007', 'biological regulation', 68, 'control'), ('CHEBI_73302', '(dT)5', 76, 'blood sugar'), ('UBERON_0000178', 'blood', 76, 'blood'), ('CHEBI_17087', 'ketone', 106, 'ketones')]
PMC5093227	10/2016	S53-PMC5093227	['she had reduced her Carbohydrate Intake to Regulate her Blood sugar and performed 1 hour of exercise after every meal.']	N/A	N/A	[('CHEBI_16730', 'chloramphenicol 3-acetate', 20, 'carbohydrate'), ('GO_0007631', 'feeding behavior', 33, 'intake'), ('GO_0065007', 'biological regulation', 43, 'regulate'), ('UBERON_0000178', 'blood', 56, 'blood')]
PMC5093227	10/2016	S85-PMC5093227	['after the Birth, the patient’s Medication was changed into oral Hypoglycemic Agents and her Blood sugar level was maintained within the normal range.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_60211', 'compound Z', 31, 'medication'), ('CHEBI_33568', 'adrenaline', 64, 'hypoglycemic agents'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC5093227	10/2016	S89-PMC5093227	['caption (table-wrap): table 1\nsummary of visitsvisit#1#2#3#4#5#6#7period, wkpreconceptionga 6ga 8ga 10ga 12ga 32after deliveryenergy Intake, kcal1,7741,4741,4309301,7022,0201,500weight, kg60.059.058.056.558.466.967.3weight change during Pregnancy, kg--−1−2.5−0.77.98.3urine Ketones--negative–1+1+–2+negative–tracenegative-a1c, %8.35.45.5--5.2-smbg--fbs < 95 mg/dlfbs < 95 mg/dlfbs < 95 mg/dlfbs 95–105 mg/dlnormal Rangepp1 140–200 mg/Dlpp1 < 140 mg/Dlpp1 < 140 mg/Dlpp1 < 140 mg/dlnutrition interventioneducation for diabetes and Preconception careeducation for diabetes in Pregnancydiet plan on Insulin therapyeducation for weight gain without producing ketonesincreased energy requirement of +340 kcal/day (second trimester)increased energy requirement of +450 kcal/day (third trimester)rearrangement energy requirement +320 kcal/day (Breast feeding), education for Postpartum care\nga, Gestational age; smbg, self-monitoring of Blood Glucose; fbs, fasting Blood Sugar; pp1, Postprandial 1 hour.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 133, 'intake'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_17087', 'ketone', 274, 'ketones'), ('PR_000013044', 'POU domain, class 5, transcription factor 1', 414, 'rangePP1'), ('PR_000006474', 'ATP-dependent RNA helicase A', 434, 'dLPP1'), ('PR_000006474', 'ATP-dependent RNA helicase A', 449, 'dLPP1'), ('PR_000006474', 'ATP-dependent RNA helicase A', 464, 'dLPP1'), ('GO_0007565', 'female pregnancy', 530, 'preconception'), ('GO_0007565', 'female pregnancy', 574, 'pregnancyDiet'), ('PR_000045358', 'insulin family protein', 596, 'insulin'), ('UBERON_0000310', 'breast', 837, 'breast'), ('GO_0007565', 'female pregnancy', 868, 'postpartum'), ('GO_0007565', 'female pregnancy', 888, 'gestational'), ('UBERON_0000178', 'blood', 930, 'blood'), ('CHEBI_17234', 'glucose', 936, 'glucose'), ('UBERON_0000178', 'blood', 958, 'blood'), ('CHEBI_24870', 'ion', 964, 'sugar'), ('GO_0007567', 'parturition', 976, 'postprandial')]
PMC5093279	10/2016	S66-PMC5093279	['moreover, mothers of children with asd present higher Blood levels of Interferon Gamma (Ifn Γ ), Il-4, and Il-5 amid Pregnancy [55].']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('PR_000002050', 'interferon regulatory factor 8', 70, 'interferon gamma'), ('PR_000008920', 'interferon alpha-7', 88, 'IFN γ'), ('PR_000001470', 'interleukin-28B', 97, 'IL-4'), ('PR_000001470', 'interleukin-28B', 107, 'IL-5'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC5093678	10/2016	S37-PMC5093678	['participants can still join the study if they decline the Cord Blood collection.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood')]
PMC5093678	10/2016	S38-PMC5093678	["examples of both consent forms are submitted as supporting information (see onlinesupplementary appendix 1).10.1136/bmjopen-2016-013495.supp1\n\nfollowing consent, baseline information will be obtained from the participants, Blood pressure will be measured, and an additional Lipid profile test will be carried out to assess the participant's suitability for randomisation."]	N/A	N/A	[('UBERON_0000178', 'blood', 223, 'blood'), ('CHEBI_18059', 'lipid', 274, 'lipid')]
PMC5093678	10/2016	S68-PMC5093678	['Blood will be collected from the Umbilical Cord and the Placenta using a syringe and a needle and saved in a 10\u2005ml Ethylenediaminetetraacetic Acid (edta) dry tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0001987', 'placenta', 56, 'placenta'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 115, 'ethylenediaminetetraacetic acid')]
PMC5094567	6/2016	S4-PMC5094567	['on e15.5, Cardiac and Umbilical Blood flow were examined by ultrasound.']	N/A	N/A	[('UBERON_0000948', 'heart', 10, 'cardiac'), ('UBERON_0007118', 'umbilicus', 22, 'umbilical'), ('UBERON_0000178', 'blood', 32, 'blood')]
PMC5096291	11/2016	S4-PMC5096291	['Blood Spots were collected from the children at Birth ( n \u2009=\u2009991) and Blood Leukocytes at 5\xa0years ( n \u2009=\u2009667).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Blood spots'), ('GO_0007567', 'parturition', 48, 'birth'), ('CL_0000081', 'blood cell', 70, 'blood leukocytes'), ('UBERON_0000178', 'blood', 70, 'blood')]
PMC5096291	11/2016	S36-PMC5096291	['(%)92 (48.4)93 (52.0)260 (50.3)242 (51.1)Dha in Cord Blood, mean (sd), % of total Fatty Acids7.9 (1.8)*6.4 (1.5)7.8 (1.8)*6.3 (1.5)\nabbreviations : Dha Docosahexaoneic Acid, iqr interquartile range\n*difference between the Dha and control group p \u2009<\u20090.001\n\nglobal Dna Methylation\nno significant differences in Line1 hypomethylation levels were found between the control and Dha-supplemented groups either at Birth or at 5\xa0years of age (table\xa02).']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 41, 'DHA'), ('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_83219', 'lactate ester', 82, 'fatty acids7'), ('CHEBI_17874', 'dihydrozeatin', 148, 'DHA'), ('CHEBI_73136', 'EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor', 152, 'docosahexaoneic acid'), ('CHEBI_17874', 'dihydrozeatin', 222, 'DHA'), ('GO_0006306', 'DNA methylation', 263, 'DNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 309, 'LINE1'), ('CHEBI_17874', 'dihydrozeatin', 373, 'DHA'), ('GO_0007567', 'parturition', 407, 'birth')]
PMC5096291	11/2016	S37-PMC5096291	['furthermore, no association was found between Dha concentration in Cord Blood and Line1 Dna Methylation in the whole study group, or when separated by treatment group or gender (data not shown).']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 46, 'DHA'), ('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 82, 'LINE1'), ('GO_0006306', 'DNA methylation', 88, 'DNA methylation')]
PMC5096291	11/2016	S157-PMC5096291	['at the 5-year appointments, between 25 march 2009 and 4 october 2013, a Blood sample was collected from those children whose primary carer consented to this procedure.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood')]
PMC5096291	11/2016	S158-PMC5096291	['the Blood samples were collected into edta Blood tubes and placed on ice; most samples were processed within 4\xa0h and all samples within 24\xa0h of collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood')]
PMC5096291	11/2016	S163-PMC5096291	['Blood spot punches were taken from guthrie cards of 991 domino children whose mothers had given consent.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5096291	11/2016	S177-PMC5096291	['samples were run in triplicate and the Line1 hypomethylation levels in the dna samples were normalized relative to an external reference dna sample from Human Blood (roche applied sciences, dee why, nsw, australia).']	N/A	N/A	[('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 39, 'LINE1'), ('NCBITaxon_9606', 'Homo sapiens', 153, 'human'), ('UBERON_0000178', 'blood', 159, 'blood')]
PMC5096291	11/2016	S205-PMC5096291	['the analyses were also performed with and without an adjustment for cell Mixture using reference data on cell-specific Dna Methylation signatures for Cord Blood [46].']	N/A	N/A	[('CHEBI_60004', 'mixture', 73, 'mixture'), ('GO_0006306', 'DNA methylation', 119, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('UBERON_0000178', 'blood', 155, 'blood')]
PMC5100620	10/2016	S32-PMC5100620	['only children who had anthropometric measurements at Birth were eligible for this follow-up ( n \u2009=\u20091667), whereof 1354 children participated in Blood sampling at 4.5 years.']	N/A	N/A	[('GO_0007567', 'parturition', 53, 'birth'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC5100620	10/2016	S51-PMC5100620	['paramedics collected overnight fasting Blood samples of 5\u2009ml Venous Blood using Li-Heparin-treated trace-element-free tubes (sarstedt monevette®, uppsala, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0001638', 'vein', 61, 'venous'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_43451', 'hydrogen iodide', 80, 'Li'), ('CHEBI_28304', 'heparin', 83, 'heparin')]
PMC5100620	10/2016	S55-PMC5100620	['Glucose was analysed in whole Blood at the field site health clinics by Hemocue®(hemocue, ängelholm, sweden).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('UBERON_0000178', 'blood', 30, 'blood'), ('CHEBI_46756', 'HEPES', 72, 'HemoCue')]
PMC5100627	10/2016	S3-PMC5100627	['Metabolic associations with birthweight were assessed by linear regression models adjusted for sex, Gestational age and age at Blood sampling.']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolic'), ('GO_0007565', 'female pregnancy', 100, 'gestational'), ('UBERON_0000178', 'blood', 127, 'blood')]
PMC5100627	10/2016	S29-PMC5100627	['methods\n\nstudy populations\nthe study comprised six finnish cohorts and one cohort from the uk (table 1): the children of the avon longitudinal study of parents and children (alspac; n = 2874; Metabolic profiles measured from Blood samples drawn at age 17);29the northern finland Birth cohort (nfbc) 1986 ( n = 5579; age 16);30nfbc 1966 ( n = 5412; age 31);31the Cardiovascular risk in young finns study (yfs; n = 2273; age 24–48);32the finntwin studies ft12 ( n = 767; age 21–25); ft16 ( n = 495, age 23–30);33and the helsinki Birth cohort study (hbcs; n = 890; age 62–75).8details of the cohorts related to the present study are described in thesupplementary methods(available assupplementary dataat ije online).']	N/A	N/A	[('GO_0008152', 'metabolic process', 192, 'metabolic'), ('UBERON_0000178', 'blood', 225, 'blood'), ('GO_0007567', 'parturition', 279, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 362, 'Cardiovascular'), ('GO_0007567', 'parturition', 527, 'Birth')]
PMC5100627	10/2016	S33-PMC5100627	['bmi was measured in Adolescence or Adulthood at the same time as the Blood sampling for Metabolic profiling in all cohorts (henceforth denoted Adult bmi).']	N/A	N/A	[('GO_0048848', 'neurohypophysis morphogenesis', 20, 'adolescence'), ('UBERON_0000113', 'post-juvenile adult stage', 35, 'adulthood'), ('UBERON_0000178', 'blood', 69, 'blood'), ('GO_0008152', 'metabolic process', 88, 'metabolic'), ('UBERON_0007023', 'adult organism', 143, 'adult')]
PMC5100627	10/2016	S37-PMC5100627	['characteristics of the seven cohortscharacteristicsnfbc 1986alspac childrenfinn-twinfinn-twinnfbc 1966young finns studyhelsinki Birth cohort studyft12ft16number of Individuals5579287476749554122273890Men [%]50.448.441.251.149.944.743.9age at Blood sampling [years]16.1 (0.4)17.8 (0.4)22.4 (0.6)26.2 (1.3)31.2 (0.4)39.2 (6.1)66.3 (2.9)Birthweight [g]3562 (541)3426 (546)2703 (507)2673 (495)3498 (523)3508 (543)3432 (470)Gestational age [week]39.4 (1.8)39.4 (1.6)36.9 (2.2)36.9 (2.5)40.0 (1.9)38.6 (1.2)40.0 (1.5)Adult body mass index [kg/m2]21.2 (3.4)23.0 (3.9)23.3 (3.9)23.8 (4.0)25.6 (4.1)26.3 (4.9)27.0 (4.1)systolic Blood pressure [mm hg]116 (13)115 (10)––125 (13)119 (14)143 (19)total-c [mmol/l]4.3 (0.8)3.8 (0.7)4.7 (0.9)5.0 (0.9)5.0 (1.0)5.1 (0.9)6.1 (1.0)hdl-c [mmol/l]1.4 (0.3)1.4 (0.2)1.8 (0.4)1.8 (0.4)1.5 (0.4)1.3 (0.3)1.7 (0.4)Triglycerides [mmol/l]0.70.80.91.21.01.11.2[0.6-1.0][0.7-1.0][0.7-1.2][0.9-1.62][0.7-1.4][0.8-1.5][0.9-1.7]Glucose [mmol/l]5.25.04.64.75.05.35.5[4.9-5.4][4.7-5.3][4.3-4.8][4.3-5.2][4.7-5.3][4.9-5.6][5.1-5.8]Insulin [iu/l]9.66.8––7.57.37.4[7.4-12.3][4.9-9.3][6.2-9.4][4.4-11.2][5.2-11.2]\nvalues are mean (sd) and median [interquartile range] for normally distributed and positively skewed variables, respectively.']	N/A	N/A	[('GO_0007567', 'parturition', 128, 'Birth'), ('NCBITaxon_10088', 'Mus <genus>', 164, 'individuals5579287476749554122273890Men'), ('UBERON_0000178', 'blood', 242, 'blood'), ('GO_0007608', 'sensory perception of smell', 334, 'Birthweight'), ('GO_0007565', 'female pregnancy', 419, 'Gestational'), ('UBERON_0007023', 'adult organism', 511, 'Adult'), ('UBERON_0000178', 'blood', 619, 'blood'), ('CHEBI_17855', 'triglyceride', 839, 'Triglycerides'), ('CHEBI_17234', 'glucose', 946, 'Glucose'), ('PR_000045358', 'insulin family protein', 1046, 'Insulin')]
PMC5100627	10/2016	S38-PMC5100627	['Lipid and Metabolite quantification\nfasting Blood samples were collected as part of the clinical examinations in Adolescence and in Adulthood and stored as Serum or edta Plasma at -80\u2009°c for subsequent biomarker profiling, as detailed insupplementary methods.']	N/A	N/A	[('CHEBI_18059', 'lipid', 0, 'Lipid'), ('CHEBI_39382', 'flufenoxuron', 10, 'metabolite'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0048848', 'neurohypophysis morphogenesis', 113, 'adolescence'), ('UBERON_0000113', 'post-juvenile adult stage', 132, 'adulthood'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('UBERON_0001969', 'blood plasma', 170, 'plasma')]
PMC5100627	10/2016	S45-PMC5100627	['associations were adjusted for sex, age at Blood sampling and Gestational age.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0007565', 'female pregnancy', 62, 'gestational')]
PMC5108118	7/2016	S74-PMC5108118	['their Blood samples were submitted to tandem mass spectroscopy for inborn errors of Metabolism, Urine for abnormal Metabolites and Organic Acids.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('GO_0008152', 'metabolic process', 84, 'metabolism'), ('UBERON_0001088', 'urine', 96, 'urine'), ('CHEBI_25212', 'metabolite', 115, 'metabolites'), ('CHEBI_64709', 'organic acid', 131, 'organic acids')]
PMC5118763	12/2016	S37-PMC5118763	['participating women were scheduled to visit health centers at weeks 14 and 30 of Pregnancy, at which time Venous Blood samples were collected.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0001638', 'vein', 106, 'venous'), ('UBERON_0000178', 'blood', 113, 'blood')]
PMC5118763	12/2016	S72-PMC5118763	['results\nof the 871 randomly selected enrolled Pregnant women, 641 singleton women contributed Blood samples at week 14 and at follow-up at week 30 ( figure 1 ).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 46, 'pregnant'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC5118763	12/2016	S74-PMC5118763	['women who did not provide a Blood sample at week 14 ( n = 38) or week 30 ( n = 69) were excluded from the analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood')]
PMC5118969	11/2016	S31-PMC5118969	['on physical examination, she was afebrile, the Heart rate was 79 beats per minute, the Respiratory rate was 16 breaths per minute, her Blood pressure was 122/55\u2009mmhg and oxygen saturation was 98% on room air.']	N/A	N/A	[('UBERON_0000948', 'heart', 47, 'heart'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory'), ('UBERON_0000178', 'blood', 135, 'blood')]
PMC5119728	11/2016	S56-PMC5119728	['tamura, 2005 [44]cohort study, 355 children followed to age of 5.3 years.supplementation of multivitamin/Mineral tablet that contained 400 ug Folic Acid from 19 weeks of Gestation until Delivery and maternal Blood Folate concentrations.no association.']	N/A	N/A	[('CHEBI_46662', 'mineral', 105, 'mineral'), ('CHEBI_30751', 'formic acid', 142, 'folic acid'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007567', 'parturition', 186, 'delivery'), ('UBERON_0000178', 'blood', 208, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 214, 'folate')]
PMC5119728	11/2016	S57-PMC5119728	['folate status in late Gestation assessed by Plasma and Erythrocyte Folate had no impact on Neurodevelopment of their children at age of 5.strengths: measured both supplementation and maternal Blood Folate concentration.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 22, 'gestation'), ('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('CL_0000232', 'erythrocyte', 55, 'erythrocyte'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('GO_0007399', 'nervous system development', 91, 'neurodevelopment'), ('UBERON_0000178', 'blood', 192, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 198, 'folate')]
PMC5119728	11/2016	S97-PMC5119728	['schlotz, 2010 [48]cohort study, 100 children followed to age of 8.75 years.maternal Red Blood Cell (Rbc) Folate was measured at 14 weeks of Gestation and Folate intake from diet and Supplement was assessed in early and late Pregnancy.beneficial.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 84, 'red blood cell'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CL_0000232', 'erythrocyte', 100, 'RBC'), ('CHEBI_30863', '5-azaorotic acid', 105, 'folate'), ('GO_0007565', 'female pregnancy', 140, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 154, 'folate'), ('CHEBI_16158', 'steroid sulfate', 182, 'supplement'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy')]
PMC5119728	11/2016	S111-PMC5119728	['maternal Micronutrient assays were performed using Plasma samples stored for 8y; 2. lack of data on maternal Folate supplement at the time of Blood sample collection; 3.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('UBERON_0001969', 'blood plasma', 51, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 109, 'folate'), ('UBERON_0000178', 'blood', 142, 'blood')]
PMC5119728	11/2016	S113-PMC5119728	['campoy, 2011 [50]cohort study, 154 children followed at age of 6.5 years.Folate concentrations were determined in maternal Blood 20 and 30 of Gestation and at Delivery, and in Cord Blood.no association.']	N/A	N/A	[('CHEBI_81245', 'Vulpecholate', 73, 'Folate'), ('UBERON_0000178', 'blood', 123, 'blood'), ('GO_0007565', 'female pregnancy', 142, 'gestation'), ('GO_0007567', 'parturition', 159, 'delivery'), ('UBERON_0002240', 'spinal cord', 176, 'cord'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC5121137	11/2016	S26-PMC5121137	['laboratory tests on admission reported hemoglobin of 16.2, a White Blood Cell count of 12,500 with a differential count of 62.9% Lymphocytes, and 17.8% Neutrophils.']	N/A	N/A	[('CL_0000738', 'leukocyte', 61, 'white blood cell'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CL_0000542', 'lymphocyte', 129, 'lymphocytes'), ('CL_0000775', 'neutrophil', 152, 'neutrophils')]
PMC5123236	11/2016	S61-PMC5123236	['the levene test assessed the difference in variance of maternal Red Blood Cell (Rbc) Dha at baseline and at Delivery (following Prenatal supplementation).']	N/A	N/A	[('CL_0000232', 'erythrocyte', 64, 'red blood cell'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CL_0000232', 'erythrocyte', 80, 'RBC'), ('CHEBI_17874', 'dihydrozeatin', 85, 'DHA'), ('GO_0007567', 'parturition', 108, 'delivery'), ('GO_0007565', 'female pregnancy', 128, 'prenatal')]
PMC5123236	11/2016	S106-PMC5123236	['3\n\nRed Blood Cell (Rbc) change and ses score.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 3, 'Red blood cell'), ('UBERON_0000178', 'blood', 7, 'blood'), ('CL_0000232', 'erythrocyte', 19, 'RBC')]
PMC5126873	11/2016	S77-PMC5126873	['the specific outcomes examined included gdm defined by iadpsg criteria, lga infant ( ≥ 90thpopulation birthweight centile calculated with who centiles), small for Gestational age (sga) infant (≤10thpopulation Birthweight centile), macrosomia (Birthweight ≥4\xa0kg) and pre-eclampsia (defined as systolic Blood pressure ≥140\xa0mm hg, diastolic Blood pressure ≥90\xa0mm hg, or both, on at least two occasions 4\xa0h apart, with proteinuria ≥300\xa0mg/24\xa0h or spot Urine protein:creatinine ratio ≥30\xa0mg/mmol creatinine, or Urine dipstick protein ≥2+).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 163, 'gestational'), ('GO_0007596', 'blood coagulation', 209, 'birthweight'), ('GO_0007596', 'blood coagulation', 243, 'birthweight'), ('UBERON_0000178', 'blood', 301, 'blood'), ('UBERON_0000178', 'blood', 338, 'blood'), ('UBERON_0001088', 'urine', 448, 'urine'), ('UBERON_0001088', 'urine', 506, 'urine')]
PMC5133057	10/2016	S27-PMC5133057	['Blood samples (5 ml) were obtained by peripheral venipuncture and allowed to clot by leaving them undisturbed at room temperature (15–30 min).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5133057	10/2016	S48-PMC5133057	['the Gestational age classification, at the time of Blood collection was given as follows: ≤14 weeks (first Trimester) or >14 to ≤20 weeks (second Trimester) [30].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'gestational'), ('UBERON_0000178', 'blood', 51, 'blood'), ('GO_0009294', 'DNA mediated transformation', 107, 'trimester'), ('GO_0009294', 'DNA mediated transformation', 146, 'trimester')]
PMC5133057	10/2016	S73-PMC5133057	['also, there was a difference in Retinol levels, comparing both moments of Blood collection ( p = 0.002) with the highest mean Retinol levels in the group that was in the first Trimester of Pregnancy (1.01 mmol/l; ci 95% 0.91–1.12 μmol/l).']	N/A	N/A	[('CHEBI_26536', 'retinoic acid', 32, 'retinol'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_26536', 'retinoic acid', 126, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 176, 'trimester'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC5133057	10/2016	S77-PMC5133057	['the following variables with p -values less than 0.20 in correlation analyses were selected to participate in the mlr model: sewage connected to the public network or existence of septic tank, basic sanitation, trimester at the time of Blood collection, pre-Gestational nutritional status and nutritional status at the time of Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 236, 'blood'), ('GO_0007565', 'female pregnancy', 258, 'gestational'), ('UBERON_0000178', 'blood', 327, 'blood')]
PMC5133238	12/2016	S5-PMC5133238	['Glenn Circulation involves a connection between the Superior Vena Cava and the Pulmonary Artery that results in passive Blood flow to the Lungs; thus, the Single Ventricle must supply Cardiac output to both the Systemic and Pulmonary Circulations.']	N/A	N/A	[('UBERON_0009670', 'rectal lumen', 0, 'Glenn circulation'), ('UBERON_0001585', 'anterior vena cava', 52, 'superior vena cava'), ('UBERON_0002012', 'pulmonary artery', 79, 'pulmonary artery'), ('UBERON_0000178', 'blood', 120, 'blood'), ('UBERON_0002048', 'lung', 138, 'lungs'), ('UBERON_0002289', 'midbrain cerebral aqueduct', 155, 'single ventricle'), ('UBERON_0000948', 'heart', 184, 'cardiac'), ('UBERON_0004292', 'cardiac skeleton', 211, 'systemic ...'), ('UBERON_0008874', 'pulmonary acinus', 224, 'pulmonary circulations')]
PMC5133238	12/2016	S6-PMC5133238	['the Glenn connection decreases the workload on the Single Ventricle by diverting Blood flow from the upper half of the body directly to the Lungs.']	N/A	N/A	[('UBERON_0002106', 'spleen', 4, 'Glenn'), ('UBERON_0002289', 'midbrain cerebral aqueduct', 51, 'single ventricle'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0002048', 'lung', 140, 'lungs')]
PMC5133238	12/2016	S7-PMC5133238	['the Inferior Vena Cava remains connected to the Right Atrium, creating a right-to-left shunt to allow mixing of oxygenated and deoxygenated Blood.']	N/A	N/A	[('UBERON_0001072', 'posterior vena cava', 4, 'inferior vena cava'), ('UBERON_0002078', 'right cardiac atrium', 48, 'right atrium'), ('UBERON_0000178', 'blood', 140, 'blood')]
PMC5133238	12/2016	S13-PMC5133238	['at 27 years of age, she had undergone glenn surgery to allow Blood to be routed directly from the Superior Vena Cava to the Lungs through phasic flow in the Pulmonary Artery (bidirectional Glenn shunt).']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001585', 'anterior vena cava', 98, 'superior vena cava'), ('UBERON_0002048', 'lung', 124, 'lungs'), ('UBERON_0002012', 'pulmonary artery', 157, 'pulmonary artery'), ('UBERON_0002106', 'spleen', 189, 'Glenn')]
PMC5133238	12/2016	S17-PMC5133238	['her Vital Signs were as follows: Blood pressure, 135/80 mmhg; Heart rate, 65 beats/min; Respiratory rate, 15 breaths/min; and oxygen saturation (sao2), 80% to 85% with a 5% increase after administration of 100% oxygen via Face mask at 4 l/min.']	N/A	N/A	[('UBERON_0002361', 'pia mater', 4, 'vital'), ('UBERON_0000025', 'tube', 10, 'signs'), ('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0000948', 'heart', 62, 'heart'), ('UBERON_0001004', 'respiratory system', 88, 'respiratory'), ('UBERON_0001456', 'face', 222, 'face')]
PMC5133238	12/2016	S24-PMC5133238	['upon completion of monitoring (invasive Blood pressure, ecg, and spo2) in the operating room, 1,000 ml of crystalloid was administered over 10 min, and combined Spinal-Epidural anesthesia using the needle-through-needle technique was performed with the patient in a sitting position.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0001130', 'vertebral column', 161, 'spinal'), ('UBERON_2000660', 'epural', 168, 'epidural')]
PMC5137891	12/2016	S4-PMC5137891	['hematological indicators were assessed at baseline (pre-Pregnancy), during Pregnancy, 3 months post-Partum, and in Cord Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007567', 'parturition', 100, 'partum'), ('UBERON_0002240', 'spinal cord', 115, 'cord'), ('UBERON_0000178', 'blood', 120, 'blood')]
PMC5137891	12/2016	S63-PMC5137891	['outcomes\nhemoglobin concentrations were measured from Capillary Blood samples (by Finger prick) at baseline (Preconception), each trimester during Pregnancy, and 3 months Postpartum for both women and their children using a portable field b-Hemoglobin analyzer [32].']	N/A	N/A	[('UBERON_0001982', 'capillary', 54, 'capillary'), ('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0002389', 'manual digit', 82, 'finger'), ('GO_0007565', 'female pregnancy', 109, 'preconception'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 171, 'postpartum'), ('CHEBI_5679', 'herniarin', 241, 'Hemoglobin')]
PMC5137891	12/2016	S68-PMC5137891	['Venous Blood samples (5 ml) were collected using Heparin-treated vacutainers after an overnight fasting.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_28304', 'heparin', 49, 'heparin')]
PMC5137891	12/2016	S69-PMC5137891	['child iron status was assessed at Delivery using Cord Blood samples (5 ml).']	N/A	N/A	[('GO_0007567', 'parturition', 34, 'delivery'), ('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC5137891	12/2016	S70-PMC5137891	['all Blood samples were obtained by trained staff at the commune health center or district hospital, stored in an icebox and transported within 4 h to tump’s hematology department where they were centrifuged at 1500g.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC5137891	12/2016	S90-PMC5137891	['intent to treat analyses was done for 1,581 women with Venous Blood samples at the first Prenatal visit, 1,249 women with Cord Blood samples and 1,291 women with Venous Blood samples at 3 month Postpartum (fig 1).10.1371/journal.pone.0167416.g001\n\ncaption (fig): fig 1\nflow diagram of participant progress throughout the study.']	N/A	N/A	[('UBERON_0001638', 'vein', 55, 'venous'), ('UBERON_0000178', 'blood', 62, 'blood'), ('GO_0007565', 'female pregnancy', 89, 'prenatal'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0001638', 'vein', 162, 'venous'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'postpartum')]
PMC5137891	12/2016	S94-PMC5137891	['there were no differences in baseline characteristics by treatment group at any time point (enrollment, Pregnancy cohort, women with known Birth outcomes, women with measurements at 3 mo Postpartum and women with Cord Blood measurements (data not shown).10.1371/journal.pone.0167416.t002\n\ncaption (table-wrap): table 2\nmaternal characteristics at baseline by intervention group1.variablemmifafa(n = 508)(n = 518)(n = 555) age at randomization, y 26.20 ± 4.7026.02 ± 4.2025.76 ± 4.24 age at first Marriage, y 21.74 ± 3.2721.83 ± 3.3021.85 ± 3.30 ethnic minority, % 52.6648.6447.20 education level, % primary school10.6312.9813.56secondary school26.9725.5823.69high school53.3553.6855.70college or higher9.067.757.05 work as farmers, % 81.5078.6877.76 having at least one child, % 79.9281.5978.48 anthropometric measurements height, cm152.8 ± 5.00152.6 ± 5.05152.9 ± 5.20weight, kg46.17 ± 5.7345.46 ± 5.1845.82 ± 5.44bmi, kg/m219.77 ± 2.0619.52 ± 1.9119.60 ± 2.10bmi<18.5, %29.2230.7431.88 Macronutrient intake/day total energy, kcal2241 ± 7862245 ± 7512202 ± 716carbohydrate (g)362.54 ± 107.85359.38 ± 113.11357.75 ± 110.14fat (g)50.30 ± 31.4351.67 ± 25.8949.13 ± 25.76protein (g)84.44 ± 36.1985.39 ± 33.8182.03 ± 31.41 Micronutrient intake/ day Iron, mg17.36 ± 8.2617.74 ± 7.6417.26 ± 8.13Zinc, mg10.61 ± 3.6210.62 ± 3.4410.40 ± 3.58vitamin C, mg236 ± 164246 ± 145250 ± 201folate, mg343 ± 211356 ± 192349 ± 196vitamin B12, μg2.15 ±2.332.01 ± 1.781.97 ± 1.85vitamin A, μg925.59 ± 730.47955.27 ± 647.19968.57 ± 813.34 % < ear [39] Iron, %25.7923.1724.68zinc, %14.9616.4116.76vitamin C, %5.123.676.31folate, %55.5150.9751.17vitamin B12, %62.4062.9364.32vitamin A, %29.3326.6424.32 hematological indicators hemoglobin, g/dl12.91 ± 1.3812.91 ± 1.3813.04 ± 1.26anemia, %21.4320.0017.18plasma tfr, mg/l4.90 ± 1.824.74 ± 1.484.67 ± 1.56plasma tfr >8.3, %3.973.121.81plasma Ferritin2, μg/l66.31 (61.92, 71.01)64.07 (60.09, 68.32)66.89 (61.98, 70.04)low iron store (ferritin <30 μg/l), %13.4114.0411.21iron deficiency (ferritin <12 μg/l), %3.552.922.71iron deficiency anemia, %1.591.951.08plasma rbp, μmol/l1.61 ± 0.421.62 ± 0.441.62 ± 0.40acute inflammation (crp >5 mg/l), %3.162.532.89chronic inflammation (agp >1 g/l), %4.935.654.16\n1sample of women with Venous Blood samples at the 1stprenatal visit.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('GO_0007567', 'parturition', 139, 'birth'), ('GO_0007565', 'female pregnancy', 187, 'postpartum'), ('UBERON_0002240', 'spinal cord', 213, 'cord'), ('UBERON_0000178', 'blood', 218, 'blood'), ('GO_0007618', 'mating', 496, 'marriage'), ('CHEBI_6699', 'Matricin', 988, 'Macronutrient'), ('CHEBI_6956', 'Mitragynine', 1219, 'Micronutrient'), ('CHEBI_24870', 'ion', 1245, 'Iron'), ('CHEBI_35830', 'diarsenic', 1287, '13Zinc'), ('CHEBI_18245', 'carboxylato group', 1341, 'C'), ('PR_000004900', 'complement C3', 1341, 'C'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 1418, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1465, 'A'), ('CHEBI_24870', 'ion', 1529, 'Iron'), ('CHEBI_18245', 'carboxylato group', 1581, 'C'), ('PR_000004900', 'complement C3', 1581, 'C'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 1629, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1658, 'A'), ('PR_000007447', 'follicular dendritic cell secreted peptide', 1865, 'Ferritin2'), ('UBERON_0001638', 'vein', 2248, 'venous'), ('UBERON_0000178', 'blood', 2255, 'blood')]
PMC5137891	12/2016	S106-PMC5137891	['no significant differences were observed for hemoglobin or anemia.10.1371/journal.pone.0167416.t003\n\ncaption (table-wrap): table 3\nhematological indicators from Preconception to Postpartum by intervention group (intention to treat analyses)1.variablemmifafa(n = 508)(n = 518)(n = 555) hemoglobin (g/dl) Prenatal at 1sttrimester (<14 wks)12.14 ± 1.4011.93 ± 1.2511.96 ± 1.35prenatal at 2ndtrimester (14–27.9 wks)11.22 ± 1.3111.20 ± 1.2511.29 ± 1.18prenatal at 3rdtrimester (≥28 wks)11.46 ± 1.3111.48 ± 1.3011.53 ± 1.31postpartum (3 mo)- mothers12.33 ± 1.2712.34 ± 1.2412.35 ± 1.28postpartum (3 mo)- children10.65 ± 1.3610.64 ± 1.2510.58 ± 1.33 anemia (%)2prenatal at 1sttrimester (<14 wks)17.9521.7417.87prenatal at 2ndtrimester (14–27.9 wks)37.6440.7539.67prenatal at 3rdtrimester (≥28 wks)33.7933.2031.62postpartum (3 mo)- mothers38.5539.3336.57postpartum (3 mo)- children42.1241.3543.28 Plasma Ferritin3(μg/l) Prenatal93.62a(89.27, 98.18)91.85a(87.59, 96.33)85.30b(81.54, 89.23)Postpartum (3 mo)114.11 (108.76, 119.73)112.70 (107.35, 118.32)109.68 (104.53, 115.09)Cord Blood178.88 (172.87, 185.10)184.19 (178.05, 190.54)175.12 (169.45, 180.98) Plasma Transferrin receptor (μg/l) Prenatal3.64 ± 1.24a3.44 ± 1.24b3.44 ± 1.22bpostpartum (3 mo)5.03 ± 1.34a4.85 ± 1.34b4.83 ± 1.34bcord Blood7.67 ± 2.907.30 ± 2.907.50 ± 2.88\n1values are mean ± sd for hemoglobin, and Transferrin Receptor, percentages for anemia and geometric mean and 95% ci for ferritin.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 161, 'preconception'), ('GO_0007565', 'female pregnancy', 178, 'postpartum'), ('GO_0007565', 'female pregnancy', 303, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 889, 'Plasma'), ('PR_000007447', 'follicular dendritic cell secreted peptide', 896, 'Ferritin3'), ('GO_0007565', 'female pregnancy', 912, 'Prenatal93'), ('GO_0007567', 'parturition', 980, 'Postpartum'), ('UBERON_0000948', 'heart', 1066, 'Cord'), ('UBERON_0001977', 'blood serum', 1071, 'blood178'), ('UBERON_0001969', 'blood plasma', 1146, 'Plasma'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 1153, 'transferrin'), ('GO_0019230', 'proprioception', 1181, 'Prenatal3'), ('UBERON_0000178', 'blood', 1283, 'blood7'), ('PR_000001679', 'trace amine-associated receptor 5', 1364, 'transferrin receptor')]
PMC5137891	12/2016	S109-PMC5137891	['Fa- Folic Acid, ifa- Iron and Folic Acid, mm- multiple Micronutrient\namong women who consumed Preconception Supplements for at least 26 weeks (per protocol analysis, n = 824), Plasma ferritin was not different between treatment groups during Pregnancy, but it was significantly higher in Cord Blood ( p = 0.039) and for mothers at 3 mo Postpartum ( p = 0.031) in the mm or ifa groups compared to Fa group (table 4).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 0, 'FA'), ('CHEBI_30751', 'formic acid', 4, 'Folic Acid'), ('CHEBI_24870', 'ion', 21, 'Iron'), ('CHEBI_30751', 'formic acid', 30, 'Folic Acid'), ('CHEBI_6956', 'Mitragynine', 55, 'Micronutrient'), ('GO_0007565', 'female pregnancy', 94, 'preconception'), ('CHEBI_33341', 'titanium atom', 108, 'supplements'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 288, 'cord'), ('UBERON_0000178', 'blood', 293, 'blood'), ('GO_0007565', 'female pregnancy', 336, 'postpartum'), ('CHEBI_30751', 'formic acid', 396, 'FA')]
PMC5137891	12/2016	S112-PMC5137891	['there was also no evidence of effect modification by maternal nutrition status (low bmi vs. normal bmi) for hematological indicators either Prenatally or during the post-Partum Period (results not shown).10.1371/journal.pone.0167416.t004\n\ncaption (table-wrap): table 4\nhematological indicators from Preconception to Postpartum by intervention group among women who consumed the Supplements for at least 26 weeks (per protocol analysis)1.variablemmifafa(n = 244)(n = 237)(n = 260) hemoglobin (g/dl) Prenatal at 1sttrimester (<14 wks)12.14 ± 1.5212.00 ± 1.2211.97 ± 1.32prenatal at 2ndtrimester (14–27.9 wks)11.25 ± 1.2711.24 ± 1.3411.24 ± 1.14prenatal at 3rdtrimester (≥28 wks)11.44 ± 1.0811.41 ± 1.3311.44± 1.27postpartum (3 mo)- mothers12.26 ± 1.2112.37 ± 1.2612.41 ± 1.38postpartum (3 mo)- children10.86 ± 1.2010.59 ± 1.0710.74 ± 1.27 anemia (%)2prenatal at 1sttrimester (<14 wks)20.4822.8517.25prenatal at 2ndtrimester (14–27.9 wks)36.7339.6141.81prenatal at 3rdtrimester (≥28 wks)33.6733.7533.23postpartum (3 mo)- mothers40.4440.4532.34postpartum (3 mo)- children (< 10.5)33.8943.4336.73 Plasma Ferritin3(μg/l) Prenatal92.79 (86.33, 99.74)97.79 (90.96, 105.14)90.92 (85.03, 97.21)Postpartum (3 mo)118.15a(109.27, 127.75)117.78a(108.60, 127.74)101.52b(93.97, 109.67)Cord Blood184.27a(176.05, 192.88)189.93a(181.56, 198.26)175.09b(167.87, 182.62) Plasma Transferrin receptor (μg/l) Prenatal3.52a± 1.053.33b± 1.043.42a,b± 1.00postpartum (3 mo)4.98 ± 1.314.92 ± 1.324.83 ± 1.30cord Blood8.10 ± 3.237.38 ± 3.237.77 ± 3.23\n1values are mean ± sd for hemoglobin, and Transferrin receptor, percentages for anemia and geometric mean and 95% ci for ferritin.']	N/A	N/A	[('GO_0019230', 'proprioception', 140, 'prenatally'), ('GO_0007567', 'parturition', 170, 'partum'), ('UBERON_0001699', 'sensory root of facial nerve', 170, 'partum period'), ('GO_0007565', 'female pregnancy', 299, 'preconception'), ('GO_0007565', 'female pregnancy', 316, 'postpartum'), ('CHEBI_33341', 'titanium atom', 378, 'supplements'), ('GO_0007565', 'female pregnancy', 498, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 1092, 'Plasma'), ('PR_000007447', 'follicular dendritic cell secreted peptide', 1099, 'Ferritin3'), ('GO_0051262', 'protein tetramerization', 1115, 'Prenatal92'), ('GO_0007567', 'parturition', 1184, 'Postpartum'), ('UBERON_0000948', 'heart', 1269, 'Cord'), ('UBERON_0003061', 'blood island', 1274, 'blood184'), ('UBERON_0001969', 'blood plasma', 1349, 'Plasma'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 1356, 'transferrin'), ('GO_0019230', 'proprioception', 1384, 'Prenatal3'), ('UBERON_0000178', 'blood', 1482, 'blood8'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 1563, 'transferrin')]
PMC5137891	12/2016	S126-PMC5137891	['furthermore, there were significant increases in Plasma ferritin in Cord Blood and in mothers at 3 months Postpartum among women who consumed the mm or ifa supplement for at least 26 weeks, compared to Fa.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 49, 'plasma'), ('UBERON_0002240', 'spinal cord', 68, 'cord'), ('UBERON_0000178', 'blood', 73, 'blood'), ('GO_0007565', 'female pregnancy', 106, 'postpartum'), ('CHEBI_30751', 'formic acid', 202, 'FA')]
PMC5137972	6/2016	S39-PMC5137972	['in that study, the researchers took Blood samples from both Adults and newborns, and tested for the Unmetabolized form of Folic Acid.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0007023', 'adult organism', 60, 'adults'), ('GO_0031319', 'detection of cAMP', 100, 'unmetabolized'), ('CHEBI_30751', 'formic acid', 122, 'folic acid')]
PMC5139761	4/2011	S28-PMC5139761	['on admission, the patient’s Blood pressure was 113/65 mm hg, her Pulse was 120/min and Respiratory rate was 30/min, her temperature was 37.0 °c.']	N/A	N/A	[('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_0014756', 'Wulst', 65, 'pulse'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory')]
PMC5142354	12/2016	S4-PMC5142354	['Blood lead was measured in 31 women who worked in jobs where lead is used (exposed group) and 268 who did not work in those places (control group).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5142354	12/2016	S5-PMC5142354	['chi-square test was applied to compare exposed and control groups with regard to Blood lead levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 81, 'blood')]
PMC5142354	12/2016	S7-PMC5142354	['multivariable regression analysis was applied to determine significant predictors of Blood lead concentrations in the exposed group.']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood')]
PMC5142354	12/2016	S8-PMC5142354	['results\nexposed women had higher Blood lead levels than those in the control group (4.00\u2009±\u20094.08\xa0μg/dl vs 2.65\u2009±\u20091.75\xa0μg/dl, p \u2009=\u20090.002).']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood')]
PMC5142354	12/2016	S24-PMC5142354	['elevated Blood lead levels (blls) in children cause Learning and behavioral deficits [4,5].']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007612', 'learning', 52, 'learning')]
PMC5142354	12/2016	S31-PMC5142354	['this leads to increased bone turnover, with a consequential release of lead from bone and increased Blood lead levels [15,16].']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood')]
PMC5142354	12/2016	S62-PMC5142354	['Blood lead measurement\nBlood samples were collected using lead-free tubes containing edta.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 23, 'Blood')]
PMC5142354	12/2016	S67-PMC5142354	['Bovine Blood obtained from the national institute of standards and technology (nist) was used as standard reference material.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Bovine'), ('UBERON_0000178', 'blood', 7, 'blood')]
PMC5142354	12/2016	S74-PMC5142354	['chi-square test was applied to compare exposed and control groups regarding Blood lead levels (blls\u2009≥\u20095\xa0μg/dl vs blls\u2009<\u20095\xa0μg/dl).']	N/A	N/A	[('UBERON_0000178', 'blood', 76, 'blood')]
PMC5142354	12/2016	S79-PMC5142354	['student t -test was also used to compare Blood lead levels according to some protection habits in the exposed group.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC5142354	12/2016	S81-PMC5142354	['finally, backward stepwise multivariable regression analysis was applied to determine significant predictors of Blood lead concentrations in the exposed group.']	N/A	N/A	[('UBERON_0000178', 'blood', 112, 'blood')]
PMC5142354	12/2016	S86-PMC5142354	['results\nthe mean Blood lead concentration in the study population was 2.79\xa0μg/dl (sd 2.14), geometric mean 2.38\xa0μg/dl, 95% ci (2.25 – 2.54).']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood')]
PMC5142354	12/2016	S88-PMC5142354	['results of multiple linear regression on association between Blood lead levels and risk factors are shown in table\xa02.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood')]
PMC5142354	12/2016	S92-PMC5142354	['caption (table-wrap): table 1\n\ngeneral information and Blood lead levels of study population ( n \u2009=\u2009299)variablespercentmean (sd)age (years)24.32 (6.71)Gestational age (weeks)24.07 (8.68)Pregnancies2.0 (1.0)body mass index (kg/m2)27.23 (5.63)hemoglobin (g/dl)12.55 (1.34)monthly income per Person, usd140.95 (144.73)working in places where lead is used\u2003yes10.4\u2003no89.6blood lead levels (μg/dl)2.79 (2.14)geometric mean (95% ci)2.38 (2.25 – 2.54)\n\ncaption (table-wrap): table 2\n\nresults from the multiple linear regression analysis on the association between Blood lead and risk factorsrisk factorcoefficient β95% ci p washing the workwear together with other Clothes0.106- 0.018 – 0.2290.093use of lead glazed pottery0.033- 0.102 – 0.1680.634dyeing Hair- 0.016- 0.147 – 0.1150.813living near workplaces where lead is used- 0.021- 0.197 – 0.1560.818living near mining zone0.2370.006 – 0.4680.044living near battery workshop- 0.016- 0.209 – 0.1770.869living near junkyard- 0.079- 0.284 – 0.1270.452living near rubbish dump0.141- 0.060 – 0.3420.169living near straightening and painting workshop0.023- 0.172 – 0.2180.819pica behavior0.115- 0.032 – 0.2610.124living with someone who works with lead0.056- 0.071 – 0.1830.387living near painting store0.081- 0.167 – 0.3290.521living near printing office- 0.120- 0.441 – 0.2010.461working in places where lead is used0.3060.103 – 0.5090.003\nr2\u2009=\u20090.082\ntable\xa03summarizes the main characteristics of both groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('GO_0007565', 'female pregnancy', 152, 'Gestational'), ('GO_0006412', 'translation', 187, 'Pregnancies2'), ('NCBITaxon_10088', 'Mus <genus>', 290, 'person'), ('UBERON_0000178', 'blood', 557, 'blood'), ('UBERON_0013491', 'cervical fascia', 658, 'clothes0'), ('UBERON_0001037', 'strand of hair', 748, 'hair')]
PMC5142354	12/2016	S95-PMC5142354	['caption (table-wrap): table 3\n\ngeneral information and Blood lead levels of the exposed subjects and control groupavariableexposed group ( n \u2009=\u200931)control group ( n \u2009=\u2009268) p value*age (years)26.03 (6.17)24.13 (6.76)0.135gestational age (weeks)22.71 (8.06)24.22 (8.75)0.358number of Pregnancies2.55 (1.38)2.23 (1.47)0.253body mass index (kg/m2)28.81 (4.79)27.04 (5.70)0.098hemoglobin (g/dl)12.97 (1.11)12.50 (1.36)0.065monthly income per Person, usd165.62 (130.59)138.00 (146.28)0.316blood lead levels (μg/dl)4.00 (4.08)2.65 (1.75)0.002**\navalues shown as mean (standard deviation)\n*p value was calculated from student t -test\n**p value from log bll\nfrequency of blls\u2009≥\u20095\xa0μg/dl is depicted in table\xa04.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('GO_0006412', 'translation', 283, 'pregnancies2'), ('NCBITaxon_10088', 'Mus <genus>', 438, 'person')]
PMC5142354	12/2016	S102-PMC5142354	['Blood lead levels were significantly higher in women who did not wear special workwear ( p \u2009=\u20090.028) and in those who did not have the habit of changing clothes after work ( p \u2009=\u20090.025).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5146866	12/2016	S32-PMC5146866	['samples proceed and testing procedure\nleftover samples in lavender top edta (Ethylenediaminetetraacetic Acid) tubes from routine collection of cb for identification of Blood type in all infants born in the hospital were used to test for Vitamin D levels.']	N/A	N/A	[('CHEBI_42191', 'ethylenediaminetetraacetic acid', 77, 'ethylenediaminetetraacetic acid'), ('UBERON_0000178', 'blood', 168, 'blood'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5146866	12/2016	S57-PMC5146866	['characteristics of Umbilical Cord Blood Vitamin D status\ncb levels of Vitamin D were classified as deficient, insufficient, and sufficient in 95 (38.9%, 95%ci 33.0–44.8), 79 (29.8%, 95%ci 24.3–35.3), and 91 (34.3%, 95%ci 28.6–40) infants, respectively.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 19, 'umbilical cord'), ('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5146866	12/2016	S64-PMC5146866	['1\n\nCord Blood 25(Oh)D status and maternal race/ethnicity.']	N/A	N/A	[('UBERON_0000948', 'heart', 3, 'Cord'), ('UBERON_0000178', 'blood', 8, 'blood'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D')]
PMC5153572	11/2016	S20-PMC5153572	['Tbg which is one of the numerous protein that transport th in the Blood with high affinity for thyroxine (T4) increases in Serum a few weeks after Conception and ranges a plateau during mid-Gestational period.']	N/A	N/A	[('PR_000016131', 'TANK-binding kinase 1-binding protein 1', 0, 'TBG'), ('UBERON_0000178', 'blood', 66, 'blood'), ('PR_000016190', 'trichohyalin-like protein 1', 106, 'T4'), ('UBERON_0001977', 'blood serum', 123, 'serum'), ('GO_0007620', 'copulation', 147, 'conception'), ('GO_0007565', 'female pregnancy', 190, 'gestational')]
PMC5153572	11/2016	S32-PMC5153572	['during this time, Blood levels of tsh become suppressed.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC5155676	12/2016	S33-PMC5155676	['a screening Blood sample was obtained and analyzed on the local nhs platform (all 3 laboratories [southampton, oxford, and sheffield] participate in Vitamin D external quality assessment scheme Vitamin D quality assurance system [http://www.deqas.org/]).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_28384', 'vitamin K', 149, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 149, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC5155676	12/2016	S45-PMC5155676	['assessment of 25(Oh)D status\non the day that the study Medication was dispensed and at 34 weeks of Gestation, a nonfasted Venous Blood sample was obtained, and Serum was stored at −80°c.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 14, '25 ... OH ... D'), ('CHEBI_60211', 'compound Z', 55, 'medication'), ('GO_0007565', 'female pregnancy', 99, 'gestation'), ('UBERON_0001638', 'vein', 122, 'venous'), ('UBERON_0000178', 'blood', 129, 'blood'), ('UBERON_0001977', 'blood serum', 160, 'serum')]
PMC5155676	12/2016	S58-PMC5155676	['finally, in sensitivity analysis, we excluded women who reported having taken any additional Vitamin D-containing Supplements within 90 days of the late Pregnancy Blood sampling.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 114, 'supplements'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('UBERON_0000178', 'blood', 163, 'blood')]
PMC5161647	8/2016	S88-PMC5161647	['specifically, Igf2 Dna Methylation scores were residualized for estimated proportions of cells in whole Blood (proportion of Cd8+ T Cells, Cd4+ T Cells, natural Killer [Nk] Cells, B Cells, and Monocytes).']	N/A	N/A	[('PR_000008989', 'interleukin-1 family member 7', 14, 'IGF2'), ('GO_0006306', 'DNA methylation', 19, 'DNA methylation'), ('UBERON_0000178', 'blood', 104, 'blood'), ('CL_0000820', 'B-1a B cell', 125, 'CD8 ...'), ('PR_000005170', 'CD37 molecule', 125, 'CD8'), ('CL_0000084', 'T cell', 130, 'T cells'), ('CL_0000476', 'thyrotroph', 139, 'CD4 ...'), ('PR_000001204', 'C-C chemokine receptor type 8', 139, 'CD4'), ('CL_0000084', 'T cell', 144, 'T cells'), ('CL_0011107', 'Muller cell', 161, 'killer ...'), ('CL_0002280', 'type N enteroendocrine cell', 169, 'NK ... cells'), ('GO_0005634', 'nucleus', 169, 'NK'), ('CL_0000236', 'B cell', 180, 'B cells'), ('CL_0000576', 'monocyte', 193, 'monocytes')]
PMC5165167	12/2016	S57-PMC5165167	['all Blood samples were obtained from the Tail Vein, and the Plasma was used to measure the Glucose concentration by the Glucose oxidase method.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0003481', 'tail vein', 41, 'tail vein'), ('UBERON_0001969', 'blood plasma', 60, 'plasma'), ('CHEBI_17234', 'glucose', 91, 'glucose'), ('CHEBI_17234', 'glucose', 120, 'glucose')]
PMC5165167	12/2016	S62-PMC5165167	['all Blood samples were obtained and the Plasma Glucose concentration was measured as described above.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0001969', 'blood plasma', 40, 'plasma'), ('CHEBI_17234', 'glucose', 47, 'glucose')]
PMC5165167	12/2016	S118-PMC5165167	['once in early age the Blood-Brain Barrier is not yet completed, the obesity-induction is promoted in neonatal rodents by partial destruction of the Hypothalamus Arcuate Nucleus that contains Neuronal Circuitry Controlling body weight and energy Metabolism, as classically and long reported [13,14,32].']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000052', 'fornix of brain', 28, 'brain barrier'), ('UBERON_0004752', 'palatoquadrate cartilage', 148, 'hypothalamus arcuate'), ('GO_0005634', 'nucleus', 169, 'nucleus'), ('UBERON_0000390', 'lens nucleus', 169, 'nucleus'), ('CL_0000540', 'neuron', 191, 'neuronal'), ('UBERON_0023879', 'neural system', 191, 'neuronal circuitry'), ('GO_0065007', 'biological regulation', 210, 'controlling'), ('GO_0008152', 'metabolic process', 245, 'metabolism')]
PMC5183755	12/2016	S40-PMC5183755	['public Dna Methylation datasets\nall Genome-wide Human methylation datasets from Cord Blood available in public data repositories at the time of analysis were used.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 7, 'DNA Methylation'), ('SO_0001026', 'genome', 36, 'genome'), ('NCBITaxon_9606', 'Homo sapiens', 48, 'human'), ('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC5183755	12/2016	S45-PMC5183755	['datasets 1–5 consisting of Cord Bloods from 502 newborns were measured on the illumina 27k array, and datasets 6–10 from 111 term Born neonates were measured on illumina 450k array.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 27, 'cord'), ('UBERON_0000178', 'blood', 32, 'bloods'), ('GO_0007567', 'parturition', 130, 'born')]
PMC5183755	12/2016	S51-PMC5183755	['in dataset 4 [10], Prenatal smoke exposure status was assessed by two categories according to the Cord Blood Cotinine levels: low cotinine and high cotinine.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('UBERON_0002240', 'spinal cord', 98, 'cord'), ('UBERON_0000178', 'blood', 103, 'blood'), ('CHEBI_18123', 'N-methylnicotinate', 109, 'cotinine')]
PMC5183755	12/2016	S55-PMC5183755	["in dataset 9 [15], tobacco exposure in utero was assessed by Cotinine determination in the infants' Umbilical Cord Blood: higher than 10\u2009ng/ml was qualified as exposed to in utero tobacco and lower than 1\u2009ng/ml was considered as nonexposed to in utero tobacco."]	N/A	N/A	[('CHEBI_18123', 'N-methylnicotinate', 61, 'cotinine'), ('UBERON_0002331', 'umbilical cord', 100, 'umbilical cord'), ('UBERON_0000178', 'blood', 115, 'blood')]
PMC5183755	12/2016	S57-PMC5183755	['[16] randomly selected Umbilical Cord Blood from 24 male and 24 female children from the 1st (<1.74\u2009ng/dl) and 4th (>3.77\u2009ng/dl) quartiles of pb levels.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 23, 'umbilical cord'), ('UBERON_0000178', 'blood', 38, 'blood')]
PMC5183755	12/2016	S61-PMC5183755	['estimated Blood Cell percentages and Naïve T Cell abundance\nin five illumina 450k datasets (datasets 6–10), we also considered the proportions of Cd8 T Cells, cd4 T Cells, Natural Killer Cells, and B Cells, and the abundance of defined different subtypes of T Cells: Naive T Cells = Cd45Ra+Ccr7+ and Memory T Cells = cd45ro+.']	N/A	N/A	[('CL_0000081', 'blood cell', 10, 'Blood Cell'), ('UBERON_0000178', 'blood', 10, 'Blood'), ('CL_0000898', 'naive T cell', 37, 'Naïve T cell'), ('CL_0000920', 'CD8-positive, CD28-negative, alpha-beta regulatory T cell', 146, 'CD8 T cells'), ('CL_0000084', 'T cell', 163, 'T cells'), ('CL_0000623', 'natural killer cell', 172, 'natural killer cells'), ('CL_0000236', 'B cell', 198, 'B cells'), ('CL_0000084', 'T cell', 258, 'T cells'), ('CL_0000898', 'naive T cell', 267, 'naive T cells'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 283, 'CD45RA'), ('PR_000001204', 'C-C chemokine receptor type 8', 290, 'CCR7'), ('CL_0000813', 'memory T cell', 300, 'memory T cells'), ('GO_0007613', 'memory', 300, 'memory')]
PMC5183755	12/2016	S73-PMC5183755	['Umbilical Cord Blood samples were obtained from the clamped Umbilical Cord immediately after Delivery.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0002331', 'umbilical cord', 60, 'umbilical cord'), ('GO_0007567', 'parturition', 93, 'delivery')]
PMC5183755	12/2016	S75-PMC5183755	['Cotinine concentrations\nthe Cotinine level in Serum from Cord Blood was analyzed by the method described by xie et al.']	N/A	N/A	[('CHEBI_27965', 'conessine', 0, 'Cotinine'), ('CHEBI_18123', 'N-methylnicotinate', 28, 'cotinine'), ('UBERON_0001977', 'blood serum', 46, 'serum'), ('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC5183755	12/2016	S81-PMC5183755	["Lymphocyte characterization\nLymphocyte subsets in Cord Blood were measured on the bd facscalibur flow cytometer and analyzed using matching cell quest software according to the manufacturer's instructions."]	N/A	N/A	[('CL_0000824', 'mature natural killer cell', 0, 'Lymphocyte'), ('CL_0000824', 'mature natural killer cell', 28, 'Lymphocyte'), ('UBERON_0002240', 'spinal cord', 50, 'cord'), ('UBERON_0000178', 'blood', 55, 'blood')]
PMC5183755	12/2016	S100-PMC5183755	['altered methylation age among newborns and Birth prevalence of fast Aging\nmethylation age was calculated from a total of 613 Cord Blood samples profiled with the illumina infinium 450k ( n = 111) and 27k ( n = 502) arrays (table 1).']	N/A	N/A	[('GO_0007567', 'parturition', 43, 'Birth'), ('GO_0007568', 'aging', 68, 'Aging'), ('UBERON_0002240', 'spinal cord', 125, 'cord'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC5183755	12/2016	S185-PMC5183755	["figure s2: non smoking and smoking mother's newborns Lymphocyte subpopulation of their Cord Blood samples data were analyzed and no significant difference were detected."]	N/A	N/A	[('CL_0000542', 'lymphocyte', 53, 'lymphocyte'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC5187359	12/2016	S84-PMC5187359	['Blood samples were briefly collected into tubes containing edta (6%) and centrifuged (1500 g for 10 min at 4°c).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC520832	9/2004	S43-PMC520832	['study questionnaires\nwomen who agreed to participate in the study were mailed the appropriate questionnaires and Blood requisitions.']	N/A	N/A	[('UBERON_0000178', 'blood', 113, 'blood')]
PMC520832	9/2004	S49-PMC520832	['laboratory analysis\ntotal Plasma Homocysteine, Red Blood Cell Folate, and Serum Folate were determined using established methodology [18,19].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 26, 'plasma'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 33, 'homocysteine'), ('CL_0000232', 'erythrocyte', 47, 'red blood cell'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 62, 'folate'), ('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 80, 'folate')]
PMC520832	9/2004	S52-PMC520832	['dna was extracted from whole Blood and c677t mthfr genotyping was performed using previously established methodology [11,20,21].']	N/A	N/A	[('UBERON_0000178', 'blood', 29, 'blood')]
PMC520832	9/2004	S86-PMC520832	['none of the women were deficient in either Serum Folate (defined as <7.0 nmol/l) or Red Blood Cell Folate (defined as <430 nmol/l Rbc).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_30863', '5-azaorotic acid', 49, 'folate'), ('CL_0000232', 'erythrocyte', 84, 'red blood cell'), ('UBERON_0000178', 'blood', 88, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 99, 'folate'), ('CL_0000232', 'erythrocyte', 130, 'RBC')]
PMC5216258	12/2016	S78-PMC5216258	['informational and emotional support of parents of cshcn\nparents of children newly diagnosed with diabetes reported feeling incompetent, stressed, and anxious, and having low confidence when faced with Learning how to administer home Insulin injections, Blood tests, and other care in a short period of time [17].']	N/A	N/A	[('GO_0007612', 'learning', 201, 'learning'), ('PR_000045358', 'insulin family protein', 233, 'insulin'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC5216338	1/2017	S206-PMC5216338	['Blood samples were taken and Plasma samples were separated and stored at −20\u2009°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 29, 'plasma')]
PMC5219667	1/2017	S130-PMC5219667	['they will take a Blood test anyway, and then they will do all these exams....i don’t mind.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood')]
PMC5240436	1/2017	S43-PMC5240436	['rdt at 32 gw was assessed from Finger prick Blood samples whereas pcr at 36 gw and rdt and pcr at Delivery were assessed from Venous Blood samples.']	N/A	N/A	[('UBERON_0002389', 'manual digit', 31, 'finger'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0007567', 'parturition', 98, 'delivery'), ('UBERON_0001638', 'vein', 126, 'venous'), ('UBERON_0000178', 'blood', 133, 'blood')]
PMC5240436	1/2017	S45-PMC5240436	['we conducted pcr testing for p. falciparum on dried Blood spot samples collected from whole Blood, which were tested in a real-time pcr assay targeting the P. falciparum Lactate dehydrogenase ( pfldh ) Gene [31].']	N/A	N/A	[('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0000178', 'blood', 92, 'blood'), ('28', 'ABO (human)', 156, 'P'), ('CHEBI_24996', 'lactate', 170, 'lactate'), ('SO_0000704', 'gene', 202, 'gene')]
PMC5240436	1/2017	S70-PMC5240436	['caption (table-wrap): table 1\n\nbaseline characteristics of the participating women at enrolment, by intervention groupcharacteristicifammnlnsnumber of participants463466462mean (sd) maternal age, years25 (6)25 (6)25 (6)mean (sd) maternal education, completed years3.9 (3.4)4.1 (3.4)4.1 (3.6)proportion with severely Food insecure households34.7%37.5%35.8%mean (sd) Gestational age at enrolment, weeks16.8 (2.1)16.8 (2.2)16.9 (2.2)mean (sd) number of previous Pregnancies2.1 (1.8)2.1 (1.8)2.2 (1.7)proportion of nulliparous women20.4%23.0%22.1%mean (sd) height, cm156.1 (5.7)156.0 (5.6)156.1 (5.7)mean (sd) weight, kg53.9 (7.4)54.0 (8.1)54.3 (8.4)mean (sd) muac, cm26.4 (2.4)26.3 (2.8)26.5 (2.7)mean (sd) bmi, kg/m222.1 (2.6)22.2 (2.9)22.2 (3.0)proportion of women with a bmi\u2009<\u200918.5\xa0kg/m25.9%4.6%5.7%mean (sd) Blood haemoglobin concentration, g/l111 (17)111 (16)112 (16)proportion of anaemic women (hb\u2009<\u2009100\xa0g/l)21.0%19.8%21.2%proportion of women with a positive hiv test15.6%11.1%14.4%proportion of women with a positive p. falciparum test (rdt)22.7%24.1%22.8%\nifa Iron and Folic Acid, lns Lipid based Nutrient supplement, mmn multiple Micronutrients, muac mid-upper Arm circumference, rdt rapid diagnostic test\nfollow up data for p. falciparum parasitaemia were available from 79.6% of the women at 32 gw, 76.9% at 36 gw, and from 81.4 and 78.7% at Delivery by rdt and pcr respectively.']	N/A	N/A	[('CHEBI_33290', 'food', 316, 'food'), ('GO_0007565', 'female pregnancy', 365, 'gestational'), ('GO_0006412', 'translation', 459, 'pregnancies2'), ('UBERON_0000178', 'blood', 809, 'blood'), ('CHEBI_24870', 'ion', 1065, 'iron'), ('CHEBI_30751', 'formic acid', 1074, 'folic acid'), ('CHEBI_18059', 'lipid', 1090, 'lipid'), ('CHEBI_33284', 'nutrient', 1102, 'nutrient'), ('CHEBI_33839', 'macromolecule', 1136, 'micronutrients'), ('UBERON_0001460', 'arm', 1167, 'arm'), ('GO_0007567', 'parturition', 1350, 'delivery')]
PMC5240907	1/2017	S3-PMC5240907	['one hundred children aged 5 and 14 years had anthropometric parameters, body composition and Blood pressure levels determined.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'blood')]
PMC5240907	1/2017	S35-PMC5240907	['on the second day, anthropometric measures, Blood pressure, and hrv were evaluated.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood')]
PMC5240907	1/2017	S37-PMC5240907	['all participants sat still for at least 5 minutes to assess Blood pressure and Heart rate at rest.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0000948', 'heart', 79, 'heart')]
PMC5240907	1/2017	S52-PMC5240907	['hemodynamic variables and Heart rate variability (hrv)\nBlood pressure (bp) levels were measured twice in the right Arm with the child in a seated position using an automated oscillometric device (omron hem907xl; omron healthcare; usa) with an appropriate cuff size.']	N/A	N/A	[('UBERON_0000948', 'heart', 26, 'Heart'), ('UBERON_0000178', 'blood', 55, 'Blood'), ('UBERON_0001460', 'arm', 115, 'arm')]
PMC5240907	1/2017	S53-PMC5240907	['the Blood pressure value was the average of three measurements made at 2-min intervals [26].']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC5240907	1/2017	S80-PMC5240907	['bmi—body mass index; wc—waist circumference; hp—hip circumference; bf—body fat; sbp—systolic Blood pressure; dbp—diastolic Blood; hr—Heart rate; sdnn—standard deviation normal-to-normal intervals; rmssd—root mean square of successive differences; pnn50—percentage of differences between adjacent normal-to-normal intervals that is greater than 50 milliseconds; lf (n.u.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'Blood'), ('UBERON_0000178', 'blood', 123, 'Blood'), ('UBERON_0000948', 'heart', 133, 'Heart')]
PMC5241768	1/2017	S247-PMC5241768	['b\nconsider initiating Insulin therapy (with or without additional Agents) in patients with newly diagnosed type 2 diabetes who are symptomatic and/or have an a1c ≥10% (86 mmol/mol) and/or Blood Glucose levels ≥300 mg/dl (16.7 mmol/l).']	N/A	N/A	[('CHEBI_66075', 'inflexin', 22, 'insulin'), ('PR_000045358', 'insulin family protein', 22, 'insulin'), ('CHEBI_33250', 'atom', 66, 'agents'), ('UBERON_0000178', 'blood', 188, 'blood'), ('CHEBI_17234', 'glucose', 194, 'glucose')]
PMC5241768	1/2017	S280-PMC5241768	['a\nan Ace Inhibitor or an Angiotensin Receptor Blocker (arb) at the maximum tolerated dose indicated for Blood pressure treatment is the recomended first-line treatment for Hyperytension in patients with diabetes and Urine albumin–to–creatinine ratio (uacr) ≥300 mg/g creatinine a or uacr 30–299 mg/g creatinine.']	N/A	N/A	[('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 5, 'ACE inhibitor'), ('CHEBI_51325', '2-vinylnaphthalene', 25, 'angiotensin receptor blocker'), ('UBERON_0000178', 'blood', 104, 'blood'), ('GO_0042742', 'defense response to bacterium', 172, 'hyperytension'), ('UBERON_0001088', 'urine', 216, 'urine')]
PMC5241768	1/2017	S283-PMC5241768	['b\nfor patients with Blood pressure >120/80 mmhg, lifestyle intervention consists of weight loss, if overweight or obese; a dash-style dietary pattern, including reduced sodium and increased potassium Intake; moderation of Alcohol Intake; and increased physical activity.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('GO_0007631', 'feeding behavior', 200, 'intake'), ('CHEBI_30879', 'alcohol', 222, 'alcohol'), ('GO_0007631', 'feeding behavior', 230, 'intake')]
PMC5241768	1/2017	S297-PMC5241768	['ascvd risk factors include ldl Cholesterol ≥ 100 mg/dl (2.6 mmol/l), high Blood pressure, smoking, chronic Kidney disease, albuminuria, and family history of premature ascvd .']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 31, 'cholesterol'), ('UBERON_0000178', 'blood', 74, 'blood'), ('UBERON_0002113', 'kidney', 107, 'kidney')]
PMC5264377	7/2016	S44-PMC5264377	['in order to obtain a pure, single Follicular Fluid sample, without the contamination of Blood or Fluid from other follicles during aspiration, the aspiration procedure was initiated in the first follicle measuring more than 17mm.']	N/A	N/A	[('UBERON_0000038', 'follicular fluid', 34, 'follicular fluid'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0006314', 'bodily fluid', 97, 'fluid')]
PMC5273824	1/2017	S51-PMC5273824	['patients were divided into two groups, Vitamin D Supplement Intake group (intervention) or control group, based on whether Vitamin D Supplement was take or not before Blood test.']	N/A	N/A	[('CHEBI_10124', 'zolmitriptan', 39, 'Vitamin D supplement'), ('GO_0007631', 'feeding behavior', 60, 'intake'), ('CHEBI_10124', 'zolmitriptan', 123, 'Vitamin D supplement'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC5273824	1/2017	S54-PMC5273824	['measurement of Serum 25-Oh Vitamin D\nBlood was collected after overnight fasting and Serum 25-Oh Vitamin D2 (molecular weight 412.66) and d3 (molecular weight 400.63) levels were measured by using lc-ms/ms (waters uplc, ab sciex 4000qtrp), and then total 25-Oh Vitamin D level was calculated.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 15, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 21, '25-OH'), ('CHEBI_28384', 'vitamin K', 27, 'Vitamin D'), ('UBERON_0000178', 'blood', 37, 'Blood'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 91, '25-OH'), ('CHEBI_28934', 'vitamin D2', 97, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 97, 'Vitamin D2'), ('CHEBI_17792', 'organohalogen compound', 258, 'OH'), ('CHEBI_28384', 'vitamin K', 261, 'Vitamin D')]
PMC5273824	1/2017	S70-PMC5273824	['caption (table-wrap): table 2\n\nSerum 25-Oh Vitamin D levels in intervention and control groups25-Oh vitd2 (nmol/l)25-oh vitd2 detection rate25-oh vitd3 (nmol/l)total25-oh vitd (nmol/l)deficiency rate (%)intervention ( n \u2009=\u200984)11.61\u2009±\u20096.7122.6%71.77\u2009±\u200926.7874.35\u2009±\u200926.13*17.9%control ( n \u2009=\u200914)00060.45\u2009±\u200923.6335.7%\nnote: *compared with control group, p \u2009<\u20090.05\n\nseasonal changes of 25-Oh Vitamin D in Pregnant women with gdm\nBlood samples were taken between october 2013 and july 2015, twenty-one cases were collected in winter, forty-three cases in spring, twenty two cases in summer, and twelve cases in autumn.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 31, 'Serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 37, '25-OH'), ('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('CHEBI_86030', 'O-(hydroxyhexadecanoyl)carnitine', 96, '-OH'), ('CHEBI_37972', 'phosphorus-32 atom', 114, '25'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 382, '25-OH'), ('CHEBI_28384', 'vitamin K', 388, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 401, 'pregnant'), ('UBERON_0000178', 'blood', 425, 'Blood')]
PMC5279975	12/2016	S156-PMC5279975	['additionally, 613 women (61.5%) had records of diabetes in their family, 309 women (31.1%) were Pregnant several times, 581 women (58.2%) were older than 30 years old, 690 women (69.1%) suffered from obesity, and 582 women (58.2%) suffered from high Blood pressure and risk factors of Gestational diabetes (15).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('UBERON_0000178', 'blood', 250, 'blood'), ('GO_0007565', 'female pregnancy', 285, 'gestational')]
PMC5279975	12/2016	S212-PMC5279975	['in addition, emotional support was helpful in performing daily health care, keeping the diet, measuring Blood Sugar, and doing exercise.']	N/A	N/A	[('UBERON_0000178', 'blood', 104, 'blood'), ('CHEBI_24870', 'ion', 110, 'sugar')]
PMC5291080	1/2017	S90-PMC5291080	['caption (table-wrap): table 3\n\nperceived causes of neonatal jaundice among respondents.characteristicsyes/noall participantschwscbas pn % n % n %disparity between Blood groupsno34582.119585.915077.70.029yes7517.93214.14322.3sepsisno28868.615267.013670.50.441yes13231.47533.05729.5malariano7918.83515.44422.80.054yes34181.219284.614977.2mosquito biteno36286.219887.216485.00.505yes5813.82912.82915.0breast Milk or germs in the Breastno40796.922398.218495.30.087yes133.141.894.7prematurityno37789.820891.616987.60.171yes4310.2198.42412.4g6pd defficiencyno39794.521393.818495.30.500yes275.5146.294.7haemolysis in newbornno40596.421896.018796.90.638yes153.694.063.1\nG6Pd, Glucose-6-Phosphate dehydrogenase; chw, community health workers; cbas, community Birth attendants.']	N/A	N/A	[('UBERON_0000178', 'blood', 163, 'blood'), ('UBERON_0001913', 'milk', 405, 'milk'), ('UBERON_0001348', 'brown adipose tissue', 426, 'breastNo40796'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 662, 'G6PD'), ('CHEBI_14314', 'D-glucose 6-phosphate', 668, 'Glucose-6-Phosphate'), ('GO_0007567', 'parturition', 750, 'birth')]
PMC5291080	1/2017	S91-PMC5291080	['caption (table-wrap): table 4\n\nperceived effective treatment for neonatal jaundice stated by respondents.characteristicsyes/noall participantschwscbas pn % n % n %exposure to sunlightno14033.35825.68242.50.000yes28066.716974.411157.5glucose Waterno13832.97432.66433.20.903yes28267.115367.412966.8phototherapyno34882.918179.716786.50.066yes7217.14620.32613.5exchange Blood transfusionno37589.319284.618394.80.001yes4510.73515.4105.2unripe Paw-pawno36687.120188.516585.50.351yes5412.92611.52814.5\nchw, community health workers; cbas, community Birth attendants.']	N/A	N/A	[('CHEBI_52453', 'xenon-129 atom', 241, 'waterNo13832'), ('UBERON_0000178', 'blood', 366, 'blood'), ('UBERON_0009856', 'sac', 438, 'paw'), ('GO_0007567', 'parturition', 542, 'birth')]
PMC5291557	1/2016	S26-PMC5291557	["a total of 1751 Pregnant women were enrolled from may 2006 to december 2010 according to previously described study protocols.15the study subjects were restricted to those in whom Prenatal maternal Blood lead level was assessed, and Postnatal children's Neurodevelopment measurements were performed at 6, 12, 24, and 36 months of age."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnant'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('UBERON_0000178', 'blood', 198, 'blood'), ('GO_0007567', 'parturition', 233, 'postnatal'), ('GO_0007399', 'nervous system development', 254, 'neurodevelopment')]
PMC5291557	1/2016	S39-PMC5291557	['Maternal and Cord Blood lead measurements\nwhole Blood samples were obtained in metal-free tubes at enrollment before Gestation week 20 and at Delivery, as being representative of the early and late Gestational period, respectively and Umbilical Cord Blood at Birth.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000948', 'heart', 13, 'Cord'), ('UBERON_0000178', 'blood', 18, 'Blood'), ('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007567', 'parturition', 142, 'delivery'), ('GO_0007565', 'female pregnancy', 198, 'gestational'), ('UBERON_0002331', 'umbilical cord', 235, 'umbilical cord'), ('UBERON_0000178', 'blood', 250, 'blood'), ('GO_0007567', 'parturition', 259, 'birth')]
PMC5291557	1/2016	S40-PMC5291557	['the Blood samples were frozen and stored at −70oc.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood')]
PMC5291557	1/2016	S42-PMC5291557	['in total, 0.1\u200aml of Blood was diluted with 0.1% Triton x-100.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_29236', 'protium atom', 48, 'Triton')]
PMC5291557	1/2016	S45-PMC5291557	['for internal quality assurance and control purposes, commercial reference materials were obtained from bio-rad (lyphocheks whole Blood metals control, bio-rad, hercules, ca).']	N/A	N/A	[('UBERON_0000178', 'blood', 129, 'Blood')]
PMC5291557	1/2016	S57-PMC5291557	['Blood lead concentrations were log transformed due to a non-normal distribution.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5291557	1/2016	S82-PMC5291557	['we did not find significant associations between mdi or pdi, and maternal early Pregnancy or Cord Blood lead (supplementary table s3).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC5291557	1/2016	S84-PMC5291557	['also, no significant difference in the maternal Blood lead levels across the strata by iron intake was observed.']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood')]
PMC5291557	1/2016	S85-PMC5291557	['caption (fig): figure 2\n\nassociation between late Pregnancy Blood lead, mdi, and pdi at 6 months by maternal dietary iron intake group.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('UBERON_0000178', 'blood', 60, 'blood')]
PMC5291557	1/2016	S90-PMC5291557	['no significant association was seen in analysis stratified by Maternal iron Intake in lead level in maternal early Pregnancy or Cord Blood and mdi or pdi (supplementary table s4).']	N/A	N/A	[('GO_0007618', 'mating', 62, 'maternal'), ('GO_0007631', 'feeding behavior', 76, 'intake'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('UBERON_0000970', 'eye', 115, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 128, 'cord'), ('UBERON_0000178', 'blood', 133, 'blood')]
PMC5295046	12/2016	S27-PMC5295046	['to be eligible, the Pregnant women had to be singapore citizens or permanent residents of homogeneous ethnic background (chinese, malay, or indian) and between 18 and 50 years old, to agree to donate Cord Blood, Cord, and Placenta, and intending to Deliver in kkh and nuh and to reside in singapore for the next 5 years.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('UBERON_0002240', 'spinal cord', 200, 'cord'), ('UBERON_0000178', 'blood', 205, 'blood'), ('UBERON_0002240', 'spinal cord', 212, 'cord'), ('UBERON_0001987', 'placenta', 222, 'placenta'), ('GO_0007567', 'parturition', 249, 'deliver')]
PMC5295046	12/2016	S63-PMC5295046	['at the same clinic visit, maternal cigarette smoking, alcohol drinking, and physical activities were assessed using a questionnaire while maternal Blood was collected for analysis of plasma Vitamin D and Folate concentrations.']	N/A	N/A	[('UBERON_0000178', 'blood', 147, 'blood'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5295525	6/2015	S26-PMC5295525	['with impending Cardiac tamponade, the patient underwent Pericardiocentesis and 800 ml of Blood-stained Fluid was removed.']	N/A	N/A	[('GO_0007614', 'short-term memory', 15, 'cardiac'), ('UBERON_0000948', 'heart', 15, 'cardiac'), ('UBERON_0008909', 'perichordal bone', 56, 'pericardiocentesis'), ('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0006314', 'bodily fluid', 103, 'fluid')]
PMC5295525	6/2015	S78-PMC5295525	['initially, she developed a picture of impending Cardiac tamponade that was relieved by Pericardiocentesis of Blood-stained Fluid.']	N/A	N/A	[('UBERON_0000948', 'heart', 48, 'cardiac'), ('UBERON_0008909', 'perichordal bone', 87, 'pericardiocentesis'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0006314', 'bodily fluid', 123, 'fluid')]
PMC5298530	12/2016	S18-PMC5298530	['during Prenatal obstetric appointments, the patient’s noninvasive Blood pressure (nibp) ranged from 112/71 mm hg (mean Arterial pressure [map] 85 mm hg) to 137/101 mm hg (map 113 mm hg).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'prenatal'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001637', 'artery', 119, 'arterial')]
PMC5298530	12/2016	S31-PMC5298530	['as the patient became more uncomfortable during the second stage of Labor, the infusion was increased to 12 ml/h to allow for adequate pain and Blood pressure control.']	N/A	N/A	[('GO_0007612', 'learning', 68, 'labor'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC5298530	12/2016	S45-PMC5298530	['the patient did not require any Medication or fluid boluses to maintain her Blood pressure after neuraxial Analgesic administration.']	N/A	N/A	[('CHEBI_60211', 'compound Z', 32, 'medication'), ('UBERON_0000178', 'blood', 76, 'blood'), ('CHEBI_35480', 'analgesic', 107, 'analgesic')]
PMC5303734	2/2017	S173-PMC5303734	['in the developing Brain, substantially high energy demand increases the need for Glucose, oxygen and Cerebral Blood flow (hagberg et al.,2014).']	N/A	N/A	[('UBERON_0000955', 'brain', 18, 'brain'), ('CHEBI_17234', 'glucose', 81, 'glucose'), ('UBERON_0001893', 'telencephalon', 101, 'cerebral'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC5307851	2/2017	S121-PMC5307851	['caption (table-wrap): table 3\n\nparticipant schedule of eventsenrollmenttreatmentdeliverypostpartum f/upbaseline visitenroll f/uprefill contactsmid-Pregnancypre-Deliveryhospital visitdelivery f/uptimeline12 to <20\xa0weeks gaup to14 days after enrollment~ every 6\xa0weeks after Supplement dispensed28–36 weeks gaprn as edd nearsduring hospital admission30\xa0days after Deliveryainformed consent✓verify inclusion/exclusion criteria✓health history✓✓dietary supplement intake✓✓Dha ffq✓Dhq-Ii ffq✓measure maternal height✓maternal Blood draw✓✓maternal Urine sample✓✓33–36 weeks garandomization and dispense Supplement bottles✓start Supplements day after enrollmentcontinue daily intake until deliveryreview of maternal medical records✓✓✓telephone contact✓✓✓✓✓mail investigational supplement✓return investigational supplement✓✓bdelivery information (if needed, Blood kits)✓review of infant medical records✓Cord Blood collection✓roi forms✓✓participant compensation✓✓adverse events✓record as they occur after enrollment\nadelivery follow-up contact will be made 30\xa0days after Delivery or after mom and baby have been discharged from the hospital if later than 30\xa0days\nbinvestigational pharmacy will mail participant envelope to return all study Capsules after Delivery\n\nrandomization and implementation\na maximum number of Pregnant women nmax\u2009=\u20091200 (we plan for 1355 enrollments due to expected dropout) will be randomized to one of two arms, either Algal oil as a source of Dha (800\xa0mg Dha in two capsules) or placebo oil (two capsules of half Soybean oil and half corn oil, without Dha).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 147, 'PregnancyPre'), ('GO_0007567', 'parturition', 160, 'deliveryHospital'), ('CHEBI_16158', 'steroid sulfate', 272, 'supplement'), ('GO_0016045', 'detection of bacterium', 361, 'deliveryaInformed'), ('CHEBI_17874', 'dihydrozeatin', 466, 'DHA'), ('PR_000006477', 'protein diaphanous homolog 3', 474, 'DHQ-II'), ('UBERON_0000178', 'blood', 518, 'Blood'), ('UBERON_0001088', 'urine', 539, 'Urine'), ('CHEBI_16158', 'steroid sulfate', 594, 'supplement'), ('CHEBI_33341', 'titanium atom', 619, 'supplements'), ('UBERON_0000178', 'blood', 847, 'Blood'), ('UBERON_0000948', 'heart', 892, 'Cord'), ('UBERON_0000178', 'blood', 897, 'Blood'), ('GO_0007567', 'parturition', 1059, 'delivery'), ('CHEBI_23042', 'carotene', 1228, 'capsules'), ('GO_0007567', 'parturition', 1243, 'delivery'), ('GO_0007565', 'female pregnancy', 1306, 'pregnant'), ('CHEBI_59776', 'D-glyceraldehyde 3-phosphate(2-)', 1434, 'algal'), ('CHEBI_17874', 'dihydrozeatin', 1459, 'DHA'), ('CHEBI_17874', 'dihydrozeatin', 1471, 'DHA'), ('CHEBI_36933', 'oxygen-19 atom', 1529, 'soybean'), ('CHEBI_17874', 'dihydrozeatin', 1568, 'DHA')]
PMC5307851	2/2017	S154-PMC5307851	['Blood collection\nmaternal Blood samples will be collected at enrollment and the morning following Delivery by venipuncture.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 26, 'blood'), ('GO_0007567', 'parturition', 98, 'delivery')]
PMC5307851	2/2017	S160-PMC5307851	['Fatty Acid analysis\nFatty Acid content in Red Blood Cells (Rbc) will be analyzed by gas chromatography.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('CHEBI_35366', 'fatty acid', 20, 'Fatty acid'), ('CL_0000232', 'erythrocyte', 42, 'red blood cells'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CL_0000232', 'erythrocyte', 59, 'RBC')]
PMC5307888	2/2017	S4-PMC5307888	['maternal whole Venous Blood was collected at trial entry (mean 14\xa0weeks Gestation; non-fasting), at 28\xa0weeks Gestation (fasting), and at 36\xa0weeks Gestation (non-fasting).']	N/A	N/A	[('UBERON_0001638', 'vein', 15, 'venous'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0007565', 'female pregnancy', 72, 'gestation'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('GO_0007565', 'female pregnancy', 146, 'gestation')]
PMC5307888	2/2017	S5-PMC5307888	['Cord Blood was collected after Birth and prior to the Delivery Of the Placenta.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 31, 'birth'), ('GO_0008218', 'bioluminescence', 54, 'delivery of'), ('GO_0007565', 'female pregnancy', 70, 'placenta'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5307888	2/2017	S8-PMC5307888	['results\none or more biological specimens were available from 1951 women (989 lifestyle advice and 962 standard care), with Cord Blood from 1174 infants (596 lifestyle advice and 578 standard care).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood')]
PMC5307888	2/2017	S52-PMC5307888	['maternal whole Venous Blood was collected at the time of trial entry (mean 14\xa0weeks Gestation; non-fasting), at 28\xa0weeks Gestation (fasting), and at 36\xa0weeks Gestation (non-fasting).']	N/A	N/A	[('UBERON_0001638', 'vein', 15, 'venous'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0007565', 'female pregnancy', 84, 'gestation'), ('GO_0007565', 'female pregnancy', 121, 'gestation'), ('GO_0007565', 'female pregnancy', 158, 'gestation')]
PMC5307888	2/2017	S53-PMC5307888	['Cord Blood was collected after Birth and prior to the Delivery Of the Placenta.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 31, 'birth'), ('GO_0008218', 'bioluminescence', 54, 'delivery of'), ('GO_0007565', 'female pregnancy', 70, 'placenta'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5307888	2/2017	S66-PMC5307888	['maternal biomarkers (trial entry, 28\xa0weeks, and 36\xa0weeks Gestation) were modelled separately to Cord Blood measures.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 57, 'gestation'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC5307888	2/2017	S87-PMC5307888	['Cord Blood was available from 1183 infants (601 lifestyle advice and 582 standard care).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC5307888	2/2017	S91-PMC5307888	['1\n\nflow of participants through the trial\n\ncaption (table-wrap): table 1\n\nbaseline characteristics of participants contributing one or more biological specimenscharacteristiclifestyle advice group n \u2009=\u2009992standard care group n \u2009=\u2009969total n \u2009=\u20091961maternal age (years), mean (sd)29.3 (5.5)29.6 (5.6)29.5 (5.5)Gestational age at entry (weeks), median (iqr)14.0 (11.9–16.9)14.1 (11.9–17.0)14.1 (11.9–17.0)body mass index (kg/m2), median (iqr)31.2 (28.1–35.9)31.1 (27.8–35.8)31.1 (28.0–35.9)body mass index category, n (%)\u200325.0–29.9409 (41.2)408 (42.1)817 (41.7)\u200330.0–34.9290 (29.2)286 (29.5)576 (29.4)\u200335.0–39.9184 (18.5)159 (16.4)343 (17.5)\u2003≥40.0109 (11.0)116 (12.0)225 (11.5)\u2003public patient, n (%)974 (98.2)944 (97.4)1918 (97.8)\u2003weight (kg), mean (sd)88.7 (17.3)88.5 (17.6)88.6 (17.4)\u2003height (m), mean (sd)1.6 (0.1)1.6 (0.1)1.6 (0.1)race: n (%)\u2003caucasian899 (90.6)885 (91.3)1784 (91.0)\u2003asian21 (2.1)30 (3.1)51 (2.6)\u2003other72 (7.3)54 (5.6)126 (6.4)\u2003smoker, n (%)142 (14.3)116 (12.0)258 (13.2)\u2003nulliparous, n (%)407 (41.0)389 (40.1)796 (40.6)index of socio-economic disadvantage, n (%)\u2003unknown1 (0.1)1 (0.1)2 (0.1)\u2003quintile 1 (most disadvantaged)308 (31.0)284 (29.3)592 (30.2)\u2003quintile 2242 (24.4)238 (24.6)480 (24.5)\u2003quintile 3156 (15.7)149 (15.4)305 (15.6)\u2003quintile 4133 (13.4)154 (15.9)287 (14.6)\u2003quintile 5 (least disadvantaged)152 (15.3)143 (14.8)295 (15.0)\n\ncardiometabolic markers\nmean concentrations of cardiometabolic markers across Pregnancy (table\xa02) and in infant Cord Blood (table\xa03) were similar between the two treatment groups.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 309, 'Gestational'), ('GO_0007565', 'female pregnancy', 1439, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 1473, 'cord'), ('UBERON_0000178', 'blood', 1478, 'blood')]
PMC5307888	2/2017	S120-PMC5307888	['the reasons for missing maternal and Cord Blood data are largely independent of treatment or participant characteristics.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 37, 'cord'), ('UBERON_0000178', 'blood', 42, 'blood')]
PMC5307888	2/2017	S121-PMC5307888	['more than 90% of women in the limit study consented to provide Blood and Cord Blood samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 63, 'blood'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC5307888	2/2017	S142-PMC5307888	['no statistically significant differences were identified between the two treatment groups in Cord Blood Glucose, Insulin and crp [47].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('PR_000045358', 'insulin family protein', 113, 'insulin')]
PMC5318550	2/2017	S58-PMC5318550	['these sd scores were constructed based on distributions in the generation r cohort.17\n\nassessment of Vitamin D status in maternal mid-Pregnancy and Cord Blood Plasma samples\ntotal Vitamin D was reported as the sum of 25-Hydroxyvitamin D2 (25ohd2) and 25-Hydroxyvitamin D3 (25ohd3) species measured in maternal Plasma and Cord Blood samples using a modification of a method previously described.18in mid-Pregnancy (mean 20.6\u2005weeks; sd 1.0, iqr 1.14), Venous Blood samples were collected and directly after Delivery (mean Gestational duration 39.8\u2005weeks; sd 1.8, iqr 2.0), midwives or obstetricians collected Cord Blood from the Umbilical Vein.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0000178', 'blood', 153, 'blood'), ('UBERON_0001969', 'blood plasma', 159, 'plasma'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_86319', '25-hydroxyvitamin D2', 217, '25-hydroxyvitamin D2'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 235, 'D2'), ('CHEBI_63991', '15-epi-lipoxin B4', 251, '25-hydroxyvitamin D3'), ('UBERON_0001969', 'blood plasma', 310, 'plasma'), ('UBERON_0002240', 'spinal cord', 321, 'cord'), ('UBERON_0000178', 'blood', 326, 'blood'), ('GO_0007565', 'female pregnancy', 403, 'pregnancy'), ('UBERON_0001638', 'vein', 450, 'venous'), ('UBERON_0000178', 'blood', 457, 'blood'), ('GO_0007567', 'parturition', 505, 'delivery'), ('GO_0007565', 'female pregnancy', 520, 'gestational'), ('UBERON_0002240', 'spinal cord', 607, 'cord'), ('UBERON_0000178', 'blood', 612, 'blood'), ('UBERON_0002066', 'umbilical vein', 627, 'umbilical vein')]
PMC5318550	2/2017	S85-PMC5318550	['next, the following variables were added stepwise to this basic model; (2) sociodemographic factors and maternal iq; (3) child Birth weight and Gestational duration; (4) maternal mid-Pregnancy and Cord Blood Vitamin D Plasma concentrations; (5) maternal nutritional intake; (6) maternal exposure to fever during Pregnancy; and (7) child relative age in class.']	N/A	N/A	[('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 144, 'gestational'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 197, 'cord'), ('UBERON_0000178', 'blood', 202, 'blood'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 218, 'plasma'), ('GO_0007565', 'female pregnancy', 312, 'pregnancy')]
PMC5322422	2/2017	S33-PMC5322422	['a complete Blood count and coagulopathy studies were significant for anemia (hgb 8.4, hct 24.2, normal range hgb 10.5–14.8\u2009g/dl, hct 30.0–40.9%), mildly low Platelets (143,000, normal range 150–500 103/ μ l), a markedly abnormal prothrombin time (greater than 80, normal range 13.2–16.5 seconds), a profoundly abnormal partial thromboplastin time (greater than 250, normal range 29–48 seconds), and a normal Fibrinogen (376, normal range 150–400\u2009mgs/dl).']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('CL_0000233', 'platelet', 157, 'platelets'), ('GO_0005577', 'fibrinogen complex', 408, 'fibrinogen')]
PMC5322422	2/2017	S35-PMC5322422	['the patient received three iv doses of Vitamin K, packed Red Blood Cells (60\u2009ml/kg total), fresh frozen Plasma (15\u2009ml/kg), and Platelets (15\u2009ml/kg).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 39, 'vitamin K'), ('CL_0000232', 'erythrocyte', 57, 'red blood cells'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0001969', 'blood plasma', 104, 'plasma'), ('CL_0000233', 'platelet', 127, 'platelets')]
PMC5322422	2/2017	S49-PMC5322422	['many Red Blood Cells were noted in the Tissue sample, and the biopsy specimen was grossly bloody as noted by the proceduralist.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 5, 'red blood cells'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000479', 'tissue', 39, 'tissue')]
PMC5325607	2/2017	S45-PMC5325607	['the Animals were euthanized with Isoflurane and Peripheral Blood was taken by Cardiac puncture.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animals'), ('CHEBI_6015', 'isoflurane', 33, 'isoflurane'), ('UBERON_0012101', 'perinatal stage', 48, 'peripheral'), ('UBERON_0000178', 'blood', 59, 'blood'), ('UBERON_0000948', 'heart', 78, 'cardiac')]
PMC5325607	2/2017	S65-PMC5325607	['following oral Glucose application by gavage (2 mg Glucose/g body weight), Glucose concentrations were measured in Tail Vein whole Blood by contourxt Glucose sensor (bayer ag, leverkusen, germany) before Glucose application and 15, 30, 60, 120, and 240 min after gavage.']	N/A	N/A	[('CHEBI_17234', 'glucose', 15, 'glucose'), ('CHEBI_17234', 'glucose', 51, 'glucose'), ('CHEBI_17234', 'glucose', 75, 'glucose'), ('UBERON_0003481', 'tail vein', 115, 'tail vein'), ('UBERON_0000178', 'blood', 131, 'blood'), ('CHEBI_17234', 'glucose', 150, 'glucose'), ('CHEBI_17234', 'glucose', 204, 'glucose')]
PMC5325607	2/2017	S187-PMC5325607	['(a) Glucose tolerance, (b) Insulin sensitivity, (c) Pancreas Insulin content and (d) basal Blood Glucose concentration.']	N/A	N/A	[('CHEBI_17234', 'glucose', 4, 'glucose'), ('PR_000045358', 'insulin family protein', 27, 'insulin'), ('UBERON_0001264', 'pancreas', 52, 'pancreas'), ('PR_000045358', 'insulin family protein', 61, 'insulin'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_17234', 'glucose', 97, 'glucose')]
PMC5328737	8/2016	S16-PMC5328737	['of these participants, 186 had a Blood sample taken before the ffq at 8–14 weeks of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('GO_0007565', 'female pregnancy', 84, 'gestation')]
PMC5328737	8/2016	S19-PMC5328737	['of these participants, 153 had a Blood sample taken before the ffq at 20–30 weeks of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('GO_0007565', 'female pregnancy', 85, 'gestation')]
PMC5328737	8/2016	S32-PMC5328737	['energy and lc-Pufa intakes were calculated using the standard tables of Food composition in japan (2010 edition).22\n\nSerum Phospholipid levels\nnon-fasting Blood samples were obtained from each participant at enrollment and late Pregnancy between 26 and 35 weeks of Gestation.']	N/A	N/A	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 14, 'PUFA'), ('CHEBI_33290', 'food', 72, 'Food'), ('UBERON_0001977', 'blood serum', 117, 'Serum'), ('CHEBI_16247', 'phospholipid', 123, 'phospholipid'), ('UBERON_0000178', 'blood', 155, 'blood'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0007565', 'female pregnancy', 265, 'gestation')]
PMC5328737	8/2016	S33-PMC5328737	["Blood samples were separated by centrifugation for 5 min at 3,000 rpm immediately after venipuncture and stored at −40 °c in the ncchd's hospital laboratory."]	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5332195	8/2016	S60-PMC5332195	['Human sample processing\ndna was extracted from polyester swabs stored in surepath preservative (bd diagnostics, durham, nc) using the qiaamp dna Blood mini kit (qiagen).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0000178', 'blood', 145, 'blood')]
PMC5332602	3/2017	S142-PMC5332602	['Mncs were isolated from the Spleen, Blood, Ileum, and Duodenum of Piglets in the four experimental groups at pid14.']	N/A	N/A	[('CL_0000485', 'mucosal type mast cell', 0, 'MNCs'), ('GO_0005622', 'intracellular anatomical structure', 0, 'MNCs'), ('UBERON_0002106', 'spleen', 28, 'spleen'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002116', 'ileum', 43, 'ileum'), ('UBERON_0002114', 'duodenum', 54, 'duodenum'), ('NCBITaxon_33208', 'Metazoa', 66, 'piglets')]
PMC5332602	3/2017	S232-PMC5332602	['Blood, Duodenum, Ileum, and Spleen Tissues were collected to isolate Mncs as described previously (55).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002114', 'duodenum', 7, 'duodenum'), ('UBERON_0002116', 'ileum', 17, 'ileum'), ('UBERON_0002106', 'spleen', 28, 'spleen'), ('UBERON_0000479', 'tissue', 35, 'tissues'), ('CL_0000485', 'mucosal type mast cell', 69, 'MNCs')]
PMC5337314	2/2017	S72-PMC5337314	['she had dried Blood around her left Naris with no evidence of active bleeding from either Nostril.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('UBERON_0000003', 'naris', 36, 'naris'), ('UBERON_0005928', 'external naris', 90, 'nostril')]
PMC5337314	2/2017	S111-PMC5337314	["pfa-100 ct measures the time required for Platelets from the patient's Blood sample to form a Platelet Plug in response to collagen and Platelet agonists."]	N/A	N/A	[('CL_0000233', 'platelet', 42, 'platelets'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CL_0000233', 'platelet', 94, 'platelet'), ('UBERON_0010148', 'mating plug', 103, 'plug'), ('CL_0000233', 'platelet', 136, 'platelet')]
PMC5337314	2/2017	S117-PMC5337314	['this tool measures the change in light transmission through a sample of Platelet-rich Plasma when aggregation agonists are added or measures the increase in resistance to the passage of electric current through a whole Blood sample with the addition of an agonist [15].']	N/A	N/A	[('CL_0000233', 'platelet', 72, 'platelet'), ('UBERON_0001969', 'blood plasma', 86, 'plasma'), ('UBERON_0000178', 'blood', 219, 'blood')]
PMC5337401	12/2016	S39-PMC5337401	['procedures\nBlood and Urine samples were collected at approximately 12, 20, and 35 weeks of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'Blood'), ('UBERON_0001088', 'urine', 21, 'urine'), ('GO_0007565', 'female pregnancy', 91, 'gestation')]
PMC5338078	3/2017	S4-PMC5338078	['women were tested for hiv, hepatitis b, syphilis, and bacterial vaginosis along with random Blood sugar, Urine albumin, and anemia.']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0001088', 'urine', 105, 'urine')]
PMC5338078	3/2017	S46-PMC5338078	['sociodemographic, medical, and obstetric history were collected using an interviewer-administered survey in the local language of kannada , and all women provided Urine, Blood, and Vaginal samples for laboratory assessment of infections (table\xa01).']	N/A	N/A	[('UBERON_0001088', 'urine', 163, 'urine'), ('UBERON_0000178', 'blood', 170, 'blood'), ('UBERON_0001987', 'placenta', 181, 'vaginal')]
PMC5338078	3/2017	S51-PMC5338078	['caption (table-wrap): table 1\n\ndata collected from the kisalaya and saving children, improving lives mobile clinic projects, mysore, india, 2008-2014surveys collected\u2003social\u2003\u2003sociodemographics\u2003\u2003partner characteristics\u2003\u2003work and\xa0economic status\u2003\u2003sexual history\u2003\u2003knowledge of hiv/aids\u2003\u2003history of domestic\xa0violence\u2003\u2003history of sexually Transmitted infections\u2003clinical\u2003\u2003past medical history\u2003\u2003obstetric history\u2003\u2003general health\u2003\u2003physical exam\u2003\u2003factors associated with\xa0institutional Delivery\u2003\u2003history of Antenatal depressionclinical samples\u2003vitals\u2003Blood was tested for:\u2003\u2003Blood type\u2003\u2003random Blood sugar\u2003\u2003hiv\u2003\u2003hepatitis b\u2003\u2003syphilis\u2003\u2003anemia\u2003\u2003malariaa\u2003Urine was tested for:\u2003\u2003Blood sugar\u2003\u2003albumin\u2003Vaginal samples were\xa0tested for:\u2003\u2003bacterial vaginosis\u2003Stool samplesawere tested for:\u2003\u2003helminthic infectionsinterviews and samples collected during the mobile clinic projects in mysore district, indiaaonly tested in a small random sample of the scil cohort\n\nsaving children, improving Lives (scil) project (2011–2014)\n\nprogram design and updated methods\nthe scil project focused on continuing education and mobile health clinics for rural Pregnant women, while updating protocols by applying lessons learned from the kisalaya project.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 334, 'transmitted'), ('GO_0007567', 'parturition', 477, 'delivery'), ('GO_0007567', 'parturition', 498, 'antenatal'), ('UBERON_0000178', 'blood', 542, 'Blood'), ('UBERON_0000178', 'blood', 565, 'Blood'), ('UBERON_0000178', 'blood', 584, 'blood'), ('UBERON_0001088', 'urine', 642, 'Urine'), ('UBERON_0000178', 'blood', 665, 'Blood'), ('UBERON_0000970', 'eye', 686, 'Vaginal'), ('UBERON_0001988', 'feces', 740, 'Stool'), ('UBERON_0000104', 'life cycle', 970, 'Lives'), ('GO_0007565', 'female pregnancy', 1124, 'pregnant')]
PMC5338078	3/2017	S62-PMC5338078	['Urine, Blood, Vaginal, and Stool samples were collected as a part of Antenatal care for screening for infections.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001987', 'placenta', 14, 'vaginal'), ('UBERON_0001988', 'feces', 27, 'stool'), ('GO_0007567', 'parturition', 69, 'antenatal')]
PMC5340372	3/2017	S4-PMC5340372	['Maternal and Cord Blood were collected for determining the 25(Oh)D level.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 65, 'D')]
PMC5343397	3/2017	S55-PMC5343397	['this includes Pregnancy outcomes (including Gestational diabetes, pre-eclampsia, and hypertension, pre-term Birth, Gestational weight gain); and Birth outcomes (including induction of labour, mode of Birth, estimated Blood loss).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnancy'), ('GO_0007565', 'female pregnancy', 44, 'gestational'), ('GO_0007567', 'parturition', 108, 'birth'), ('GO_0007565', 'female pregnancy', 115, 'gestational'), ('GO_0007567', 'parturition', 145, 'birth'), ('GO_0007567', 'parturition', 200, 'birth'), ('UBERON_0000178', 'blood', 217, 'blood')]
PMC5343397	3/2017	S61-PMC5343397	['outcome variables will include height, weight, bmi, Skinfold thickness measurements, calculated percentage body fat and fat-free mass, dietary and physical activity patterns, Blood pressure, quality of Life and emotional wellbeing, and general health (table\xa02).']	N/A	N/A	[('UBERON_0009007', 'superficial inguinal lymph node', 52, 'skinfold'), ('UBERON_0000178', 'blood', 175, 'blood'), ('UBERON_0000104', 'life cycle', 202, 'life')]
PMC5343397	3/2017	S65-PMC5343397	['outcome variables will include height, weight, bmi, Skinfold thickness measurements, calculated percentage body fat and fat-free mass, dietary and physical activity patterns, Blood pressure, Neurodevelopmental outcome domains, and general health (table\xa03).']	N/A	N/A	[('UBERON_0009007', 'superficial inguinal lymph node', 52, 'skinfold'), ('UBERON_0000178', 'blood', 175, 'blood'), ('GO_0007399', 'nervous system development', 191, 'neurodevelopmental')]
PMC5343397	3/2017	S66-PMC5343397	['caption (table-wrap): table 3\n\navailable child outcomestrial namelimit [55–57]upbeat [58]rolo [59]lip [60–63]belgian flanders [64]nelli [65]the top study [66]investigatorsdodd, grivell, owenspostonmcauliffevinter, tanvig, jensenbogaerts, devliegerluotorenaulttiming assessment6\xa0months, 18\xa0months, 3\xa0years6\xa0months, 3\xa0years6\xa0months, 5\xa0years6\xa0months, 3\xa0years6\xa0months, 3\xa0years6\xa0months, 3\xa0years6\xa0months, 9\xa0months, 18\xa0months, 3\xa0yearsheight✓✓✓✓✓✓✓weight✓✓✓✓✓✓✓bmi✓✓✓✓✓✓✓Head circumference✓✓✓✓Neck circumference✓✓Arm circumference✓✓✓✓Chest circumference✓✓Abdominal circumference✓✓✓✓✓✓Thigh circumference✓✓Hip circumference✓✓✓✓Biceps sftm✓✓✓✓Triceps sftm✓✓✓✓✓Subscapular sftm✓✓✓✓Suprailiac sftm✓✓Abdominal sftm✓Thigh sftm✓✓✓fat mass (calculated)✓✓✓✓✓✓dexa✓✓✓bod-pod✓✓Blood pressure✓✓✓✓✓Cardiovascular function✓✓Breast Feeding✓✓✓✓✓✓✓dietary patterns✓✓✓✓✓physical activity✓✓✓✓✓✓sedentary behaviours✓✓✓✓✓sleep time✓✓✓✓general health✓✓✓✓✓✓ages and stages✓✓✓✓✓Cognitive Development✓✓✓✓✓smoking environment✓✓✓✓✓✓Blood specimen✓✓✓✓Salivary specimen✓✓✓\n\nestablishment of outcome measures\nto determine primary and secondary maternal and child outcomes, we conducted a delphi survey.']	N/A	N/A	[('UBERON_0000033', 'head', 463, 'Head'), ('UBERON_0002551', 'interstitial nucleus of Cajal', 485, 'Neck'), ('UBERON_0002362', 'arachnoid mater', 505, 'Arm'), ('UBERON_0012131', 'centrale', 526, 'Chest'), ('UBERON_0000916', 'abdomen', 547, 'Abdominal'), ('UBERON_0000376', 'hindlimb stylopod', 576, 'Thigh'), ('UBERON_0006337', 'distal early tubule', 597, 'Hip'), ('UBERON_0001530', 'common carotid artery plus branches', 618, 'Biceps'), ('UBERON_0001509', 'triceps brachii', 633, 'Triceps'), ('UBERON_0004029', 'canal of Schlemm', 650, 'Subscapular'), ('UBERON_0010402', 'epidermis suprabasal layer', 670, 'Suprailiac'), ('UBERON_0000916', 'abdomen', 687, 'Abdominal'), ('UBERON_0000376', 'hindlimb stylopod', 702, 'Thigh'), ('UBERON_0000178', 'blood', 758, 'Blood'), ('UBERON_0004535', 'cardiovascular system', 777, 'Cardiovascular'), ('UBERON_0000310', 'breast', 802, 'Breast'), ('GO_0007631', 'feeding behavior', 809, 'feeding'), ('GO_0034209', 'sterol acetylation', 816, '✓✓✓✓✓✓✓'), ('GO_0048208', 'COPII vesicle coating', 946, 'Cognitive development✓✓✓✓✓'), ('UBERON_0000178', 'blood', 997, 'Blood'), ('UBERON_0001836', 'saliva', 1015, 'Salivary')]
PMC5347102	3/2017	S115-PMC5347102	['reductions in fetal Pancreatic Β Cell mass and Insulin Production were coupled to increased Catecholamines and decreased amino acids (including leucine) in fetal Blood.']	N/A	N/A	[('CL_0005019', 'pancreatic epsilon cell', 20, 'pancreatic β cell'), ('UBERON_0001264', 'pancreas', 20, 'pancreatic'), ('GO_0032601', 'connective tissue growth factor production', 47, 'insulin production'), ('PR_000045358', 'insulin family protein', 47, 'insulin'), ('CHEBI_33567', 'catecholamine', 92, 'catecholamines'), ('UBERON_0000178', 'blood', 162, 'blood')]
PMC5350159	3/2017	S65-PMC5350159	['complete Blood counts\nBlood samples from offspring were collected at 10\xa0weeks of age and complete Blood counts were performed with an automated hemavet 950 system (drew scientific, miami lakes, fl).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000178', 'blood', 22, 'Blood'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC5350159	3/2017	S210-PMC5350159	['3) or complete Blood counts (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood')]
PMC5351166	3/2017	S130-PMC5351166	['also taken from prophetic tradition, this is a method whereby Blood is drawn by vacuum from a small skin incision for therapeutic purposes.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood')]
PMC5351212	3/2017	S52-PMC5351212	['for cytokine studies, a separate cohort of 18 gd9 Pregnant dams received the appropriate Solution and were decapitated 4\xa0h after injection in order to collect dam Blood and fetal Brains for cytokine measurements (see below).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('CHEBI_75958', 'solution', 89, 'solution'), ('UBERON_0000178', 'blood', 163, 'blood'), ('UBERON_0000955', 'brain', 179, 'brains')]
PMC5351212	3/2017	S130-PMC5351212	['they were killed by decapitation 4\xa0h post-treatment to collect maternal Blood and fetal Brains.']	N/A	N/A	[('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0000955', 'brain', 88, 'brains')]
PMC5351212	3/2017	S132-PMC5351212	['Trunk Blood was collected into edta-containing tubes after decapitation.']	N/A	N/A	[('UBERON_0002100', 'trunk', 0, 'Trunk'), ('UBERON_0000178', 'blood', 6, 'blood')]
PMC5351212	3/2017	S133-PMC5351212	['tubes were gently inverted in order to mix Blood with the edta.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood')]
PMC5351212	3/2017	S143-PMC5351212	['Vitamin D Metabolite levels\ntwo Vitamin D Metabolites 24,25ohd3 and 25ohd3 were examined in the same maternal Blood in which cytokines were analyzed using a liquid chromatography/tandem mass spectrometry method [46].']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_39382', 'flufenoxuron', 10, 'metabolite'), ('CHEBI_26871', 'terpene alkaloid', 32, 'vitamin D metabolites'), ('UBERON_0000178', 'blood', 110, 'blood')]
PMC5351212	3/2017	S149-PMC5351212	['cytokines in the Plasma of dams and in the fetal Brain Tissue and Vitamin D Metabolites in maternal Blood were analyzed using a 2\u2009×\u20092 (mia\u2009×\u2009vitdtreatment) anova as well.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 17, 'plasma'), ('UBERON_0000955', 'brain', 49, 'brain'), ('UBERON_0000479', 'tissue', 55, 'tissue'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_25212', 'metabolite', 76, 'metabolites'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC5351212	3/2017	S213-PMC5351212	['5\n\ncytokine levels in maternal Blood and fetal Brain 4\xa0h post poly(I:c) exposure.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood'), ('UBERON_0000955', 'brain', 47, 'brain'), ('CHEBI_51686', 'haematoxylin', 67, 'I')]
PMC5357333	3/2017	S48-PMC5357333	['there was no prior Blood transfusion, hepatitis, or Urinary Tract infection.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001553', 'medial tarsal artery', 52, 'urinary tract')]
PMC5357333	3/2017	S80-PMC5357333	['two treatments were applied with confirmation of complete cessation of Blood flow in the Cord with no Cardiac activity.']	N/A	N/A	[('UBERON_0000178', 'blood', 71, 'blood'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000948', 'heart', 102, 'cardiac')]
PMC5359891	3/2017	S9-PMC5359891	['Blood, Urine/Stool, Hair and Cheek swabs will be collected from the mothers for Genetic, epigenetic, hormone, Nutrient and Metabolite measurements, and assessments of the mother’s body composition, anthropometry, health, diet and lifestyle will be made.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0001988', 'feces', 13, 'stool'), ('UBERON_0001037', 'strand of hair', 20, 'hair'), ('UBERON_0007376', 'outer epithelium', 29, 'cheek'), ('SO_0000704', 'gene', 80, 'genetic'), ('CHEBI_33284', 'nutrient', 110, 'nutrient'), ('CHEBI_39382', 'flufenoxuron', 123, 'metabolite')]
PMC5359891	3/2017	S28-PMC5359891	['Placental Nutrient Transfer is determined by the concentration gradient, Blood flow and the operation of active and facilitated transporters [17].']	N/A	N/A	[('GO_0001525', 'angiogenesis', 0, 'Placental nutrient transfer'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_33284', 'nutrient', 10, 'nutrient'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5359891	3/2017	S36-PMC5359891	['higher Blood Glucose levels in Pregnancy carry risk of Cardiovascular disease for both the mother as well as the child, a risk which increases with each Pregnancy [31].']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood'), ('CHEBI_17234', 'glucose', 13, 'glucose'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 55, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC5359891	3/2017	S71-PMC5359891	['at Birth, offspring Cord Blood, Umbilical Cord and Placental samples will be collected.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002331', 'umbilical cord', 32, 'umbilical cord'), ('UBERON_0001987', 'placenta', 51, 'placental')]
PMC5359891	3/2017	S79-PMC5359891	['abbreviations: pcv Preconception visit, pc Preconception, pgv Pregnancy visit, pdv post-Delivery visit, bia bioelectrical impedance analysis, bp Blood pressure, dm diabetes mellitus, dxa dual-energy x-ray absorptiometry, gdm Gestational diabetes, hiv , human immunodeficiency virus, ifg impaired fasting Glucose, igt impaired Glucose tolerance, ngt normal Glucose tolerance, ogtt oral Glucose tolerance test, uss, ultrasound scan.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'preconception'), ('GO_0007565', 'female pregnancy', 43, 'preconception'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('GO_0007567', 'parturition', 88, 'delivery'), ('UBERON_0000178', 'blood', 145, 'blood'), ('GO_0007565', 'female pregnancy', 225, 'gestational'), ('CHEBI_17234', 'glucose', 304, 'glucose'), ('CHEBI_17234', 'glucose', 326, 'glucose'), ('CHEBI_17234', 'glucose', 356, 'glucose'), ('CHEBI_17234', 'glucose', 385, 'glucose')]
PMC5359891	3/2017	S81-PMC5359891	['biosampling: #\u2009=\u2009Blood, ♥\u2009=\u2009Breast Milk, $\u2009=\u2009Buccal swabs, *\u2009=\u2009Epithelial swabs, @\u2009=\u2009Hair, ^ = Stool, ~ = Urine\n\nrecruitment\nrecruitment will be via self-referral of interested women who hear about the study via one or more of the following: (1) local site advertisements in social (e.g.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 28, 'breast milk'), ('UBERON_0001567', 'cheek', 45, 'buccal'), ('UBERON_0000483', 'epithelium', 63, 'epithelial'), ('UBERON_0001037', 'strand of hair', 85, 'hair'), ('UBERON_0001988', 'feces', 95, 'stool'), ('UBERON_0001088', 'urine', 106, 'urine')]
PMC5369775	3/2017	S50-PMC5369775	['we performed Uterine Artery Blood flow measurements by doppler ultrasound for all participants at 12+0to 13+6weeks of Gestation.']	N/A	N/A	[('UBERON_0002493', 'uterine artery', 13, 'uterine artery'), ('UBERON_0000178', 'blood', 28, 'blood'), ('GO_0007565', 'female pregnancy', 118, 'gestation')]
PMC5369775	3/2017	S59-PMC5369775	['the clinical characteristics of the study groups are presented intable 2.10.1371/journal.pone.0174399.t002\n\ncaption (table-wrap): table 2\nbaseline and Pregnancy characteristics.characteristics mean (sd)controls with no risk factors for preeclampsia n = 110one or more risk factors, no preeclampsia n = 817preeclampsia n = 86early and/or severe preeclampsia n = 36late nonsevere preeclampsia n = 50age, years30.0 (4.3)*32.6 (6.0)*31.6 (5.4)32.5 (5.3)31.0 (5.4)weight before Pregnancy, kg62.9 (8.3)*°76.6 (18.4)*79.2 (19.7)°77.6(19.1)80.4 (20.2)weight in the end of Pregnancy, kg77.6 (10.0)*°89.7(17.9)*93.1 (19.6)°91.7 (19.7)94.0 (19.7)bmi before Pregnancy, kg/m222.6 (2.7)27.8 (6.5)28.6 (6.7)28.6(7.1)28.9 (6.8)bmi at the end of Pregnancy, kg/m227.8 (2.9)32.5 (6.3)33.6 (6.9)33.9 (7.7)33.8 (6.5)bmi change, kg/m25.3 (1.6)4.6 (2.1)4.9 (1.8)4.8(2.1)4.9(1.9)nulliparous60%*°31%*31%(1.0)°42%22.%Blood pressure systolic highest, mmhg126.2 (13.1)135.6 (17.0)169.2 (19.7)182.3(17.0)#159.9 (15.0)#Blood pressure diastolic highest, mmhg81.2 (7.8)88.4 (11.6)105.0 (10.1)110.2 (9.8)#101.3 (8.7)#proteinuria highest, g/24 hour--2.3 (3.0)3.6 (4.1)#1.3 (1.2)#Gestational age, weeks40.1 (1.4)*39.8 (1.6)€37.6 (3.3)*€35.7 (3.9)#39.0 (1.7)#Birthweight, g3463 (411)*3578(550)3058 (932)*2420 (921)#3519 (621)#relative birthweight, sd-0.2 (0.8)0.05 (1.1)€-0.5 (1.4)€-1.2 (1.0)#0.1 (1.4)#Placental weight, g584 (108)*619 (133)*€560 (170)€464(146)#626 (155)#Uterine Artery pulsatility index mean1.45 (0.38)*1.51 (0.44)€1.68 (0.47)*€1.74 (0.45)1.64(0.52)mother’s birthweight, g3513 (488)3406 (522)3338 (636)3410 (598)3298 (656)\ndifferences between subjects were calculated by independent-sample t-test for continuous variables and chi-square test for categorical values.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 473, 'pregnancy'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0007565', 'female pregnancy', 646, 'pregnancy'), ('GO_0007565', 'female pregnancy', 729, 'pregnancy'), ('UBERON_0000178', 'blood', 891, 'Blood'), ('UBERON_0000178', 'blood', 989, 'Blood'), ('GO_0007565', 'female pregnancy', 1145, 'Gestational'), ('GO_0007608', 'sensory perception of smell', 1223, 'Birthweight'), ('UBERON_0001987', 'placenta', 1367, 'Placental'), ('UBERON_0002493', 'uterine artery', 1436, 'Uterine artery')]
PMC5369775	3/2017	S61-PMC5369775	['symbols for statistically significant difference (p<0.05):\n* between controls without risk factors and risk women without Preeclampsia,\n° between controls without risk factors and women with preeclampsia,\n€between risk women without preeclampsia and women with preeclampsia,\n#between early/severe preeclampsia and late nonsevere preeclampsia,\n\noutcomes\nprimary outcomes in the study were preeclampsia (Blood pressure ≥ 140/90 mmhg in two consecutive measurements and proteinuria ≥ 0.3 g/24hours) [18], Gestational hypertension (new onset hypertension after 20 weeks of Gestation, without proteinuria), and Birth weight standard deviation (sd) score as a continuous variable calculated according to finnish standards [19].']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 122, 'preeclampsia'), ('UBERON_0000178', 'blood', 402, 'blood'), ('GO_0007565', 'female pregnancy', 502, 'gestational'), ('GO_0007565', 'female pregnancy', 569, 'gestation'), ('GO_0007567', 'parturition', 606, 'birth')]
PMC5369775	3/2017	S62-PMC5369775	['secondary outcomes were early-onset preeclampsia (Delivery before 34+0weeks of Gestation), late-onset preeclampsia (Delivery at or after 34+0weeks of Gestation), preterm preeclampsia (Delivery before 37+0weeks of Gestation), term preeclampsia (Delivery at or after 37+0weeks of Gestation), intermediate preeclampsia (Delivery between 34+0–36+6weeks of Gestation), severe preeclampsia (Blood pressure ≥160 mmhg systolic and/or ≥110 mmhg diastolic and/or proteinuria ≥ 5 g/24hours), small for Gestational age (sga) (Birthweight <-2sd), Gestational diabetes (diet or insulin treated), chronic hypertension (≥140/90 mmhg or Medication for hypertension before 20 weeks of Gestation), hellp syndrome (hemolysis, elevated Liver enzymes, low Platelets) and fetal demise (fetal death after 22thgestational week or over 500g weight).']	N/A	N/A	[('GO_0007567', 'parturition', 50, 'delivery'), ('GO_0007565', 'female pregnancy', 79, 'gestation'), ('GO_0007567', 'parturition', 116, 'delivery'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0007567', 'parturition', 184, 'delivery'), ('GO_0007565', 'female pregnancy', 213, 'gestation'), ('GO_0007567', 'parturition', 244, 'delivery'), ('GO_0007565', 'female pregnancy', 278, 'gestation'), ('GO_0007567', 'parturition', 317, 'delivery'), ('GO_0007565', 'female pregnancy', 352, 'gestation'), ('UBERON_0000178', 'blood', 385, 'blood'), ('GO_0007565', 'female pregnancy', 491, 'gestational'), ('GO_0007596', 'blood coagulation', 514, 'birthweight'), ('GO_0007565', 'female pregnancy', 534, 'gestational'), ('CHEBI_60211', 'compound Z', 620, 'medication'), ('GO_0007565', 'female pregnancy', 667, 'gestation'), ('UBERON_0002107', 'liver', 715, 'liver'), ('CL_0000233', 'platelet', 734, 'platelets')]
PMC5369775	3/2017	S92-PMC5369775	["if the risk factor is inside brackets, only a portion of women in the cluster had that risk factor.end diagnosis, rr (95%ci)risk factors and clusterspre-eclampsia (total)severe pre-eclampsiaearly pre-eclampsiaterm pre-eclampsiaintermed pre-eclampsiapreterm pre-eclampsiabmi over 30 kg/m (c1)2.1 (1.1, 3.6)5.2 (2.1, 10.5)2.2 (0.1, 12.2)2.3 (1.1, 4.2)1.2 (0.02, 6.4)1.5 (0.2, 5.4)pre-eclampsia (c2)8.1 (5.6, 11.2)7.2 (2.7, 15.4)7.2 (0.9, 25.7)9.2 (6.0, 13.0)5.7 (1.2, 16.4)5.0 (1.4, 12.5)age over 40 years (c3)0.4 (0.01, 2.1)0.0 (0.0, 5.9)0.0 (0.0, 17.8)0.5 (0.0, 2.8)0.0 (0.0, 9.3)0.0 (0.0, 6.1)chronic hypertension (c4)5.3 (2.4, 9.8)22.2 (9.9, 41.0)16.7 (2.0, 57.6)2.6 (0.5, 7.3)13.2 (2.7, 36.6)14.4 (4.8, 31.7)small fo Gestational age (age >40) (c5)1.4 (0.2, 4.8)5.8 (0.7, 20.2)17.5 (2.1, 60.5)0.0 (0.0, 3.3)0.0 (0.0, 16.5)6.1 (0.7, 20.9)Gestational diabetes mellitus (sga, ch) (c6)1.1 (0.03, 5.8)0.0 (0.0, 16.2)0.0 (0.0, 48.7)1.5 (0.04, 7.6)0.0 (0.0, 25.6)0.0 (0.0, 16.8)chronic hypertension and bmi over 30 (c7)5.2 (1.5, 11.9)5.4 (0.1, 27.8)0.0 (0.0, 56.1)5.1 (1.1, 13.6)8.5 (0.2, 44.0)5.6 (0.1, 28.8)age under 20 (bmi) (c8)2.8 (0.3, 9.1)5.7 (0.1, 29.6)17.2 (0.4, 88.8)1.8 (0.1, 9.4)0.0 (0.0, 31.4)5.9 (0.2, 30.6)Fetus Mortus (pe,sga, ch) (c9)3.1 (0.4, 10.1)6.4 (0.2, 32.7)0.0 (0.0, 66.1)4.0 (0.5, 13.2)0.0 (0.0, 34.8)0.0 (0.0, 22.8)gdm and bmi over 30 (ch) (c10)0.0 (0.0, 5.7)0.0 (0.0, 23.7)0.0 (0.0, 71.2)0.0 (0.0, 7.5)0.0 (0.0, 37.5)0.0 (0.0, 24.6)pre-eclampsia and sga (bmi) (c11)7.6 (2.2, 16.8)23.8 (5.1, 60.6)0.0 (0.0, 80.5)5.0 (0.6, 16.0)25.1 (3.1, 79.9)16.4 (2.0, 52.4)pre-eclampsia and bmi>30 (c12)11.4 (4.5, 20.9)0.0 (0.0, 26.9)0.0 (0.0, 80.5)10.0 (2.9, 22.1)25.1 (3.1, 79.9)16.4 (2.0, 52.4)diabetes mellitus type1 (c13)11.8 (4.1, 22.4)19.6 (2.4, 60.7)58.8 (7.3, 182.2)3.1 (0.1, 15.1)31.0 (3.8, 95.9)40.6 (11.7, 86.0)sjögren's syndrome (c14)0.0 (0.0, 9.9)0.0 (0.0, 41.2)0.0 (0.0, 123.5)0.0 (0.0, 13.0)0.0 (0.0, 65.0)0.0 (0.0, 42.6)bmi and age >40 (c15)3.1 (0.1, 14.4)12.8 (0.3, 60.1)0.0 (0.0, 123.5)0.0 (0.0, 13.0)20.2 (0.5, 94.8)13.3 (0.3, 62.1)gdm and age >40 (c16)0.0 (0.0, 10.6)0.0 (0.0, 44.1)0.0 (0.0, 132.3)0.0 (0.0, 13.9)0.0 (0.0, 69.6)0.0 (0.0, 45.6)pre-eclampsia, gdm(diet), bmi>30 (c17)10.0 (2.2, 22.9)0.0 (0.0, 44.1)0.0 (0.0, 132.3)8.8 (1.1, 25.5)21.9 (0.6, 101.3)14.4 (0.4, 66.3)pre-eclampsia, ch, bmi>30 (c18)7.3 (0.9, 20.7)15.2 (0.4, 68.8)0.0 (0.0, 142.5)4.8 (0.1, 21.7)23.9 (0.6, 108.6)15.7 (0.4, 71.2)gdm Insulin treated (pe, ch, bmi)(c19)7.3 (0.9, 20.7)0.0 (0.0, 47.5)0.0 (0.0, 142.5)9.6 (1.2, 27.3)0.0 (0.0, 75.0)0.0 (0.0, 49.1)\nsevere pre-eclampsia = Blood pressure ≥160 mmhg systolic and/or ≥110 mmhg diastolic and/or proteinuria ≥ 5 g/24hours, early pre-eclampsia = Delivery before 34+0 weeks of Gestation, term pre-eclampsia = Delivery at or after 37+0 weeks of Gestation, intermediate pre-eclampsia = Delivery between 34+0–36+6 weeks of Gestation, preterm pre-eclampsia = Delivery before 37+0 weeks of Gestation."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 720, 'gestational'), ('GO_0007565', 'female pregnancy', 839, 'Gestational'), ('NCBITaxon_10088', 'Mus <genus>', 1216, 'Fetus'), ('UBERON_0002185', 'bronchus', 1222, 'mortus'), ('PR_000045358', 'insulin family protein', 2434, 'insulin'), ('UBERON_0000178', 'blood', 2583, 'blood'), ('GO_0007567', 'parturition', 2700, 'delivery'), ('GO_0007565', 'female pregnancy', 2730, 'gestation'), ('GO_0007567', 'parturition', 2762, 'delivery'), ('GO_0007565', 'female pregnancy', 2797, 'gestation'), ('GO_0007567', 'parturition', 2837, 'delivery'), ('GO_0007565', 'female pregnancy', 2873, 'gestation'), ('GO_0007567', 'parturition', 2908, 'delivery'), ('GO_0007565', 'female pregnancy', 2938, 'gestation')]
PMC5371275	3/2017	S30-PMC5371275	['maternal weight gain include growth of body fat mass (fm), fat free mass (ffm), total body Water (tbw), Red Blood Cells mass, the fetus, Placenta, Amniotic Fluid, and other products of Conception [11].']	N/A	N/A	[('CHEBI_15377', 'water', 91, 'water'), ('CL_0000232', 'erythrocyte', 104, 'red blood cells'), ('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placenta'), ('UBERON_0000173', 'amniotic fluid', 147, 'amniotic fluid'), ('GO_0007620', 'copulation', 185, 'conception')]
PMC5371292	3/2017	S7-PMC5371292	['pylori infection on behavior, iron Metabolism, Red Blood Cell indices, and behavioral outcomes following comorbid h .']	N/A	N/A	[('GO_0008152', 'metabolic process', 35, 'metabolism'), ('CL_0000232', 'erythrocyte', 47, 'red blood cell'), ('UBERON_0000178', 'blood', 51, 'blood')]
PMC5371292	3/2017	S45-PMC5371292	['pylori infection, Gastrointestinal Blood loss, and enhanced Uptake and Sequestration Of Iron by h .']	N/A	N/A	[('UBERON_0005409', 'alimentary part of gastrointestinal system', 18, 'gastrointestinal'), ('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0043052', 'thermotaxis', 60, 'uptake ...'), ('GO_0051458', 'corticotropin secretion', 71, 'sequestration of iron'), ('CHEBI_24870', 'ion', 88, 'iron')]
PMC5371292	3/2017	S59-PMC5371292	['pylori infection and marginal dietary iron on systemic Iron Homeostasis and Red Blood Cell indices.']	N/A	N/A	[('GO_0055090', 'acylglycerol homeostasis', 55, 'iron homeostasis'), ('CL_0000232', 'erythrocyte', 76, 'red blood cell'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC5371292	3/2017	S89-PMC5371292	['complete Blood count\nserial Blood samples (< 200μl) were collected at 2, 3, 6, &10 months of age via Submandibular venipuncture, and immediately placed into 1 ml edta-coated Anticoagulant Blood collection tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0000178', 'blood', 28, 'blood'), ('UBERON_3010657', 'subhyoideus', 101, 'submandibular'), ('CHEBI_50249', 'anticoagulant', 174, 'anticoagulant'), ('UBERON_0000178', 'blood', 188, 'blood')]
PMC5371292	3/2017	S91-PMC5371292	['whole Blood samples (1 ml) were collected at necropsy from anesthetized Mice via Cardiac puncture, and immediately placed into 1 ml edta-coated Anticoagulant Blood collection tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('UBERON_0000948', 'heart', 81, 'cardiac'), ('CHEBI_50249', 'anticoagulant', 144, 'anticoagulant'), ('UBERON_0000178', 'blood', 158, 'blood')]
PMC5371292	3/2017	S93-PMC5371292	['complete Blood count (cbc) analysis was performed on a heska hematrue veterinary analyzer (loveland, co), using an impedance-based method for counting white Blood Cells, Red Blood Cells, and Platelets.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'Blood'), ('UBERON_0000178', 'blood', 157, 'blood'), ('CL_0000573', 'retinal cone cell', 163, 'cells'), ('CL_0000232', 'erythrocyte', 170, 'red blood cells'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CL_0000233', 'platelet', 191, 'platelets')]
PMC5371292	3/2017	S226-PMC5371292	['pylori- Infection and moderate dietary id decreased mean cellular volume of Erythrocytes and increased Red Blood Cell distribution width in Mice at 12 months postinfection\nmean cellular volume (mcv) is a measurement of Rbc size; Red Cells with reduced mcv are commonly noted on Peripheral Blood smears and/or complete Blood counts as a result of iron deficient Erythropoiesis.']	N/A	N/A	[('GO_0007586', 'digestion', 8, 'infection'), ('CL_0000232', 'erythrocyte', 76, 'erythrocytes'), ('CL_0000232', 'erythrocyte', 103, 'red blood cell'), ('UBERON_0000178', 'blood', 107, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 140, 'mice'), ('CL_0000232', 'erythrocyte', 219, 'RBC'), ('CL_0000232', 'erythrocyte', 229, 'red cells'), ('UBERON_0012101', 'perinatal stage', 278, 'peripheral'), ('UBERON_0000178', 'blood', 289, 'blood'), ('UBERON_0000178', 'blood', 318, 'blood'), ('GO_0030218', 'erythrocyte differentiation', 361, 'erythropoiesis')]
PMC5371292	3/2017	S235-PMC5371292	['Red Cell distribution width (rdw) is a parameter that measures variation in Red Blood Cell size [36].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 0, 'Red cell'), ('CL_0000232', 'erythrocyte', 76, 'red blood cell'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC5371292	3/2017	S333-PMC5371292	['pylori -infected gerbils had higher Gastric ph, higher incidence of Gastric ulceration, and higher incidence of Fecal occult Blood loss, in addition to lower hgb and mcv than uninfected Animals [55].']	N/A	N/A	[('UBERON_0001844', 'cochlea', 36, 'gastric'), ('UBERON_0001844', 'cochlea', 68, 'gastric'), ('UBERON_0000922', 'embryo', 112, 'fecal'), ('UBERON_0000178', 'blood', 125, 'blood'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]
PMC5371292	3/2017	S342-PMC5371292	['pylori infection, id, and Red Blood Cell Homeostasis in Mice.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 26, 'red blood cell'), ('GO_0034101', 'erythrocyte homeostasis', 26, 'red blood cell homeostasis'), ('UBERON_0000178', 'blood', 30, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 56, 'mice')]
PMC5372136	3/2017	S11-PMC5372136	['low Glycemic index (gi) Foods produce lower Postprandial Blood Glucose spikes compared to high gi Foods.']	N/A	N/A	[('GO_0006096', 'glycolytic process', 4, 'glycemic'), ('CHEBI_33290', 'food', 24, 'foods'), ('GO_0007567', 'parturition', 44, 'postprandial'), ('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('CHEBI_33290', 'food', 98, 'foods')]
PMC5372136	3/2017	S35-PMC5372136	["the monitors were calibrated four times a day against capillary Blood Glucose measurements, using Blood Glucose meters (accu-check performa; roche) as per the manufacturer's instructions."]	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_17234', 'glucose', 70, 'glucose'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_17234', 'glucose', 104, 'glucose')]
PMC5372327	3/2017	S92-PMC5372327	['follow-up visits for the children are arranged at 6, 12 and 24\xa0months of age at which Blood samples are taken.']	N/A	N/A	[('UBERON_0000178', 'blood', 86, 'blood')]
PMC5372327	3/2017	S113-PMC5372327	['in brief, the parameters used for the assessment of primary outcomes are as follows: bone parameters assessed with pqct at 12 and 24\xa0months of age, daily infection diary filled in by parents from 2\xa0weeks to 24\xa0months of age, and s-25-Ohd at Birth (Cord Blood) and at 12 and 24\xa0months of age.']	N/A	N/A	[('CHEBI_72765', 'verruculogen', 231, '25-OHD'), ('GO_0007567', 'parturition', 241, 'birth'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC5372879	3/2017	S43-PMC5372879	['Blood samples were drawn into vacutainer tubes in a sitting position, from all study participants.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5372933	3/2017	S32-PMC5372933	['at 8 weeks Postpartum, non-fasting Venous Blood samples were collected from mothers and infants into Trace Element-free evacuated tubes (vacutainer, becton dickinson, mississauga, on, canada).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'postpartum'), ('UBERON_0001638', 'vein', 35, 'venous'), ('UBERON_0000178', 'blood', 42, 'blood'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 101, 'trace element')]
PMC5372933	3/2017	S43-PMC5372933	['between 3–27 weeks Postpartum (in april 2015), trained phlebotomists collected non-fasting Venous Blood samples from mothers and their infants into edta-coated tubes (vacutainer, becton dickinson).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'postpartum'), ('UBERON_0001638', 'vein', 91, 'venous'), ('UBERON_0000178', 'blood', 98, 'blood')]
PMC5372933	3/2017	S47-PMC5372933	['Breast Milk samples were placed on ice and transported to the niph laboratory with the Blood samples.']	N/A	N/A	[('UBERON_0000310', 'breast', 0, 'Breast'), ('UBERON_0001913', 'milk', 7, 'milk'), ('UBERON_0000178', 'blood', 87, 'blood')]
PMC5372933	3/2017	S49-PMC5372933	['both Blood and Breast Milk samples were shipped on dry ice to the university of british columbia in vancouver, canada, for storage at −80 °c until being shipped to other laboratories for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 15, 'breast milk')]
PMC5372933	3/2017	S120-PMC5372933	['anthropometric measures were not assessed at the time of Blood and Milk collection in either group.']	N/A	N/A	[('UBERON_0000178', 'blood', 57, 'blood'), ('UBERON_0001913', 'milk', 67, 'milk')]
PMC5380514	11/2016	S41-PMC5380514	['fasted (≥8 h) maternal Venous Blood and a mid-Feed hm sample were collected.']	N/A	N/A	[('UBERON_0001638', 'vein', 23, 'venous'), ('UBERON_0000178', 'blood', 30, 'blood'), ('GO_0007631', 'feeding behavior', 46, 'feed')]
PMC5380514	11/2016	S58-PMC5380514	['Human Rbc Lipid extraction\nmaternal Blood samples were collected into edta tubes and spun at 10,000 × g to separate Plasma from Rbcs.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CL_0000232', 'erythrocyte', 6, 'RBC'), ('CHEBI_18059', 'lipid', 10, 'lipid'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001969', 'blood plasma', 116, 'plasma'), ('CL_0000232', 'erythrocyte', 128, 'RBCs')]
PMC5384134	4/2017	S151-PMC5384134	['suboptimal breastfeeding (rank 19), iron deficiency (rank 18), high Blood pressure (rank 1), and high Sodium intake (rank 11) were addressed by between 5 and 10% of the 176 reviews (table\xa05).']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_52632', 'potassium-39 atom', 102, 'sodium')]
PMC5385335	4/2017	S62-PMC5385335	['Portal Blood sample was collected in edta-containing tubes (coveto, montaigu, france).']	N/A	N/A	[('UBERON_0001988', 'feces', 0, 'Portal'), ('UBERON_0000178', 'blood', 7, 'blood')]
PMC5385335	4/2017	S63-PMC5385335	['to preserve active form of Gastrointestinal peptides, Portal Blood (200\u2009µl) was collected in less than 30\u2009s and directly flushed within edta tubes containing a mix of protease Inhibitors including Dipeptidyl Peptidase Iv Inhibitor (Diprotin A 100\u2009µm, sigma, saint louis, mo, usa), serine protease inhibitors (aprotinin, approx.']	N/A	N/A	[('UBERON_0005409', 'alimentary part of gastrointestinal system', 27, 'gastrointestinal'), ('UBERON_0001851', 'cortex', 54, 'portal'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_35222', 'inhibitor', 176, 'inhibitors'), ('CHEBI_63266', '4-deoxy-Delta(4)-beta-D-GlcpA-(1->3)-beta-D-GalpNAc6S', 197, 'dipeptidyl peptidase IV inhibitor'), ('CHEBI_76192', 'quadrangularin A', 232, 'diprotin A')]
PMC5385335	4/2017	S71-PMC5385335	['concomitantly, Blood was collected from the Tail Vein in edta-containing tubes (microvette cb300 edta 3k, sarstedt, marnay, france) at 0 (15\u2009min before refeeding), 15, 30, 60, 90, and 150\u2009min after the beginning of the meal.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0003481', 'tail vein', 44, 'tail vein')]
PMC5385921	4/2017	S16-PMC5385921	['mid-Gestation samples were collected from maternal Sera and neonatal Sera collected from Cord Blood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'gestation'), ('UBERON_0001977', 'blood serum', 51, 'sera'), ('UBERON_0001977', 'blood serum', 69, 'sera'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC5385921	4/2017	S37-PMC5385921	['the second sample was collected at Birth, from neonatal Cord Blood (mean (s.d.)']	N/A	N/A	[('GO_0007567', 'parturition', 35, 'birth'), ('UBERON_0002240', 'spinal cord', 56, 'cord'), ('UBERON_0000178', 'blood', 61, 'blood')]
PMC5385921	4/2017	S88-PMC5385921	['in total, 4334 children and their mothers were available with measures of Vitamin D concentrations drawn from maternal Blood at mid-Gestation or drawn from Cord Blood at time of Birth as well as data on the srs and asd status.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0000178', 'blood', 119, 'blood'), ('GO_0007565', 'female pregnancy', 132, 'gestation'), ('UBERON_0002240', 'spinal cord', 156, 'cord'), ('UBERON_0000178', 'blood', 161, 'blood'), ('GO_0007567', 'parturition', 178, 'birth')]
PMC5385921	4/2017	S90-PMC5385921	['on average, 25Ohd concentrations from Cord Blood were lower compared with concentrations at mid-Gestation (mean 25Ohd concentration in maternal Serum at mid-Gestation: 58.6 nmol/l; mean 25Ohd concentration in Cord Blood: 35.9 nmol/l; t =35.8, p<001).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 12, '25OHD'), ('UBERON_0002240', 'spinal cord', 38, 'cord'), ('UBERON_0000178', 'blood', 43, 'blood'), ('GO_0007565', 'female pregnancy', 96, 'gestation'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 112, '25OHD'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('GO_0007565', 'female pregnancy', 157, 'gestation'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 186, '25OHD'), ('UBERON_0002240', 'spinal cord', 209, 'cord'), ('UBERON_0000178', 'blood', 214, 'blood')]
PMC5385921	4/2017	S92-PMC5385921	['table 1summarises the prevalence of 25Ohd deficiency in mid-Gestation and Cord Blood stratified by asd diagnosis.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 36, '25OHD'), ('GO_0007565', 'female pregnancy', 60, 'gestation'), ('UBERON_0002240', 'spinal cord', 74, 'cord'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC5385921	4/2017	S98-PMC5385921	['caption (table-wrap): table 2\nassociation between mid-Gestation and Cord 25Ohd deficiency and clinical autism case–control statusn or (95% ci)χ2(1) p maternal Serum, mid-Gestation: deficient v. sufficient27702.42 (1.09–5.07)4.640.03*maternal Serum, mid-Gestation: insufficient v. sufficient31030.86 (0.43–1.62)0.210.64cord Blood, at Birth: deficient v. sufficient16730.94 (0.36–2.42)0.020.90cord Blood, at Birth: insufficient v. sufficient17611.25 (0.61–2.69)0.370.54\nsignificant at alpha of 0.05.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 54, 'gestation'), ('UBERON_0002240', 'spinal cord', 68, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 73, '25OHD'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('UBERON_0001977', 'blood serum', 242, 'serum'), ('GO_0007565', 'female pregnancy', 253, 'gestation'), ('UBERON_0000178', 'blood', 323, 'blood'), ('GO_0007567', 'parturition', 333, 'birth'), ('UBERON_0000178', 'blood', 396, 'blood'), ('GO_0007567', 'parturition', 406, 'birth')]
PMC5385921	4/2017	S111-PMC5385921	['the number of cases with asd in the analysis of Cord Blood was 46 of whom 30% were 25ohd deficient at time of Birth, compared with 36% of the non-asd children.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('GO_0007567', 'parturition', 110, 'birth')]
PMC5387697	2/2017	S67-PMC5387697	['the study included 339 healthy women without pre-existing diabetes who were evaluated at 24-28 and 32-35 weeks of Gestation and the Cord Blood (foetal compartment) assessed at Birth (50).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 114, 'gestation'), ('UBERON_0002240', 'spinal cord', 132, 'cord'), ('UBERON_0000178', 'blood', 137, 'blood'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC5387697	2/2017	S132-PMC5387697	['one well-characterized definition requires the presence of three or more factors which can be age-adjusted to define hyperinsulinaemia: overweight, high systolic Blood pressure, hypertriglyceridemia, low hdl-Cholesterol and impaired fasting Plasma Glucose (84).']	N/A	N/A	[('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_16113', 'cholesterol', 208, 'cholesterol'), ('UBERON_0001969', 'blood plasma', 241, 'plasma'), ('CHEBI_17234', 'glucose', 248, 'glucose')]
PMC5391584	4/2017	S98-PMC5391584	['the most preferred method of dna collection, voted as the first choice, was Buccal Swab collection (57.8%), followed by Saliva collection (25.4%), dried Blood spot (15%), and the least preferred method being taking a Blood sample (1.2%) (additional file2: figure s1).']	N/A	N/A	[('UBERON_4300123', 'pre-axial region', 76, 'buccal swab'), ('UBERON_0004339', 'vault of skull', 120, 'saliva'), ('UBERON_0000178', 'blood', 153, 'blood'), ('UBERON_0000178', 'blood', 217, 'blood')]
PMC5392925	4/2017	S7-PMC5392925	['fasting Blood draw, Urine collection, anthropometric measurements, and questionnaires on health history and lifestyle are completed at baseline and follow-up clinic visits with targeted windows of 10–13 and 16–19 weeks of Gestation, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001088', 'urine', 20, 'urine'), ('GO_0007565', 'female pregnancy', 222, 'gestation')]
PMC5392925	4/2017	S31-PMC5392925	['fasting Blood draw, Urine collection, and questionnaires are completed at enrollment and follow-up with targeted windows of 10–13 and 16–19 weeks of Gestation, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0001088', 'urine', 20, 'urine'), ('GO_0007565', 'female pregnancy', 149, 'gestation')]
PMC5392925	4/2017	S39-PMC5392925	['study Blood draw and Urine collection are performed at the clinical laboratory within the medical centers.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001088', 'urine', 21, 'urine')]
PMC5392925	4/2017	S43-PMC5392925	['if eligible, the research assistant calls to schedule the baseline clinic visit and sends a packet containing a consent form, questionnaires, Blood collection instructions, facility map, and a reminder letter by mail or email, upon ascertaining participant’s preferred modality.']	N/A	N/A	[('UBERON_0000178', 'blood', 142, 'blood')]
PMC5392925	4/2017	S47-PMC5392925	['data collection and clinic visits\nupon participants’ consent, the research assistant places an order in healthconnect (kpnc’s integrative electronic health record management system) for a Urine collection and a fasting Blood draw at the baseline clinic visit (10–13 weeks of Gestation).']	N/A	N/A	[('UBERON_0001088', 'urine', 188, 'urine'), ('UBERON_0000178', 'blood', 219, 'blood'), ('GO_0007565', 'female pregnancy', 275, 'gestation')]
PMC5392925	4/2017	S48-PMC5392925	['women are instructed to fast for 8\xa0h prior to the Blood draw and the duration since last time Eating/drinking (except Water) is recorded at each visit.']	N/A	N/A	[('UBERON_0000178', 'blood', 50, 'blood'), ('GO_0051318', 'G1 phase', 94, 'eating'), ('CHEBI_15377', 'water', 118, 'water')]
PMC5392925	4/2017	S51-PMC5392925	['the baseline study clinic visit includes Urine specimen collection, fasting Blood draw, anthropometric measurements, and several self-administered questionnaires if not completed prior to the visit (either online or on paper).']	N/A	N/A	[('UBERON_0001088', 'urine', 41, 'urine'), ('UBERON_0000178', 'blood', 76, 'blood')]
PMC5392925	4/2017	S52-PMC5392925	['similarly, the second study clinic visit is targeted at 16–19 weeks of Gestation (at least 6\xa0weeks apart from the baseline study clinic visit), at which time Urine and fasting Blood samples and a survey assessing environmental exposures to Phenols are obtained.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 71, 'gestation'), ('UBERON_0001088', 'urine', 158, 'urine'), ('UBERON_0000178', 'blood', 176, 'blood'), ('CHEBI_33853', 'phenols', 240, 'phenols')]
PMC5392925	4/2017	S53-PMC5392925	['Urine and Blood specimens are transferred by couriers in the standard climate controlled containers along with the biospecimen samples collected for routine clinical care to the kpnc clinical regional laboratory and then to the kaiser permanente research bank (kprb) biorepository.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 10, 'blood')]
PMC5392925	4/2017	S54-PMC5392925	['Blood collection and storage\nat both clinic visits, fasting Blood samples are collected in one 8.5\xa0ml Serum separator tube (sst) and two 6.0\xa0ml Ethylenediaminetetraacetic Acid (edta) tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 144, 'ethylenediaminetetraacetic acid')]
PMC5392925	4/2017	S55-PMC5392925	['the sst is centrifuged within 30\xa0min of Blood collection at the medical center’s clinical laboratory.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood')]
PMC5392925	4/2017	S60-PMC5392925	['1\n\nPrenatal Blood processing protocol for petals.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'Prenatal'), ('UBERON_0000178', 'blood', 12, 'blood')]
PMC5392925	4/2017	S157-PMC5392925	['first, it will include a large and racially/ethnically diverse cohort of 3,350 Pregnant women who will provide Urine and Blood specimens, as well as data on behavioral/lifestyle factors.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 79, 'pregnant'), ('UBERON_0001088', 'urine', 111, 'urine'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC5392925	4/2017	S170-PMC5392925	['in summary, the ongoing petals collects, processes, and stores Urine and Blood specimens from Pregnant women during the first and second Trimesters, which will be linked to extensive data from questionnaires, clinical measurements, and the ehr.']	N/A	N/A	[('UBERON_0001088', 'urine', 63, 'urine'), ('UBERON_0000178', 'blood', 73, 'blood'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('GO_0043033', 'isoamylase complex', 137, 'trimesters')]
PMC5405075	4/2017	S59-PMC5405075	['(73)uk 2007180 mother–child pairs4 ethnic groups: asian, middle eastern, black and white not blinded women: no treatment ( n \u2009=\u200960)800\u2009iu ( n \u2009=\u200960) Ergocalciferol daily200,000\u2009iu ( n \u2009=\u200960) Cholecalciferol single bolus oral dose158/3\u2009yearsmothers: 27\u2009weeks of Gestation to Deliveryhigher in Cord Blood of supplementary arm (control 6.8, daily dose 10.4, single dose 10 p \u2009<\u20090.001) blinded wheezing, eczema, Food allergy, rhinitis, atopy, urti, lrti, inhaled Bronchodilator or Steroidsno significant difference between groups in risk of wheezing at 3\u2009years of age (rr: 0.86, 95% ci 0.49–1.50 p \u2009=\u20090.69)no significant difference between groups pertaining to rest secondary outcomesgrant et al.']	N/A	N/A	[('CHEBI_4910', 'etomidate', 149, 'ergocalciferol'), ('CHEBI_52550', 'theopalauamide', 191, 'cholecalciferol'), ('GO_0007565', 'female pregnancy', 261, 'gestation'), ('GO_0001889', 'liver development', 274, 'deliveryHigher'), ('UBERON_0002240', 'spinal cord', 292, 'cord'), ('UBERON_0000178', 'blood', 297, 'blood'), ('CHEBI_33290', 'food', 408, 'food'), ('CHEBI_60874', 'phenylacetylglycine(1-)', 459, 'bronchodilator'), ('CHEBI_32155', 'stigmatellin A', 477, 'steroidsNo')]
PMC5405075	4/2017	S60-PMC5405075	['(74)new zealand 2010–2011260 mother–child pairs double-blinded women/infant: placebo/placebo1,000/400\u2009iu2,000/800\u2009iu185/18\u2009monthsmothers: 27\u2009weeks of Gestation to Deliveryoff springs: Birth to 6\u2009months enrollment : 25\u2009→\u2009no difference ( p \u2009=\u20090.19) Cord Blood : 27 vs 15\u2009→\u2009higher in both supplemented groups than in placebo 6\u2009months of age : 40 vs 30\u2009→\u2009higher vit d group had the highest and Placebo group the lowest concentrations 18\u2009months of age : 24.4\u2009→\u2009no difference ( p \u2009=\u20090.30)secondary outcomessensitization to airborne Allergensprimary health care visits for Respiratory illnessesdecreased proportion of children sensitized to four Mites Antigensstudy group differences in the proportion of children with primary care visits of doctor-diagnosed asthma (11, 0, and 4%, p \u2009=\u20090.002)chawes et al.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0008218', 'bioluminescence', 163, 'deliveryOff'), ('GO_0007567', 'parturition', 184, 'birth'), ('UBERON_0000948', 'heart', 247, 'Cord'), ('UBERON_0000178', 'blood', 252, 'blood'), ('CHEBI_26130', 'biological pigment', 390, 'placebo'), ('CHEBI_36047', 'antibacterial drug', 526, 'allergensPrimary'), ('UBERON_0001004', 'respiratory system', 566, 'respiratory'), ('NCBITaxon_10088', 'Mus <genus>', 639, 'mites'), ('CHEBI_46682', 'anthophyllite asbestos', 645, 'antigensStudy')]
PMC5405075	4/2017	S62-PMC5405075	['(76) (vdaart)usa 2009–2011876 mothers at high risk of having child with asthma double-blinded Placebo\u2009+\u2009400\u2009Iu ( n \u2009=\u2009436)4,000\u2009+\u2009400\u2009iu ( n \u2009=\u2009440)748/3\u2009yearsmothers: between 10 and 18\u2009weeks of Gestation to Delivery third trimester : higher in supplemented group vs control (39.2 vs 26.8, mean difference 12.4; 95% ci 10.5–14.3, p \u2009<\u20090.001) Cord Blood : significant difference preserved 1 and 3\u2009years Postpartum : no differencewheezing or asthma, eczema with rash, lrti, mean total Ige.']	N/A	N/A	[('CHEBI_8246', 'Pirbuterol acetate', 94, 'Placebo'), ('CHEBI_17883', 'hydrogen chloride', 108, 'IU'), ('GO_0007565', 'female pregnancy', 195, 'gestation'), ('GO_0007567', 'parturition', 208, 'delivery'), ('UBERON_0000948', 'heart', 342, 'Cord'), ('UBERON_0000178', 'blood', 347, 'blood'), ('GO_0007565', 'female pregnancy', 402, 'postpartum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 483, 'IgE')]
PMC5408281	4/2017	S37-PMC5408281	['after an overnight fast, the subjects reported to the clinical research center at 0800\xa0h. after phlebotomy and several non‐invasive vascular tests including endopat (which utilizes a balloon‐filled probe on the Index Finger to detect pulse) and sphygmocor (which utilizes non‐invasive tonometry at the Radial Artery in conjunction with the Brachial Blood pressure to predict central Blood pressure) followed by a light snack of juice and crackers, the echocardiographic study was started at 1200\xa0h.\n\nechocardiography\nechocardiograms were obtained in the left lateral decubitus position with an ie33 (philips, the netherlands) equipped with a broadband s5‐1 transducer (frequency transmitted 1.7\xa0mhz, received 3.4\xa0mhz).']	N/A	N/A	[('UBERON_0002389', 'manual digit', 211, 'index finger'), ('UBERON_0001404', 'radial artery', 302, 'radial artery'), ('UBERON_0001460', 'arm', 340, 'brachial'), ('UBERON_0000178', 'blood', 349, 'blood'), ('UBERON_0000178', 'blood', 383, 'blood')]
PMC5408281	4/2017	S74-PMC5408281	['caption (table-wrap): table 2\n\nsubject demographic and clinical characteristics\xa0 countmean\xa0±\xa0serangeage (year) at baseline1032.5\xa0±\xa02.0124.08–44.5age (year) at Pregnancy1032.8\xa0±\xa01.9624.82–44.58weight (kg)1068\xa0±\xa06.544.9–115.4weight (lbs)10150\xa0±\xa014.398.99–254.4bmi1025\xa0±\xa02.3617.6–43.1systolic Blood pressure at Delivery (mmhg)10128\xa0±\xa02117–139diastolic Blood pressure at Delivery (mmhg)1071.7\xa0±\xa0357.7–86.5birth weight (g)103419\xa0±\xa01632574–4145race/ethnicitywhite, non‐hispanic or non‐latino10smoking statusyes1 (only at baseline)no9gravida/parityg0p06g1p12g2p01g3p11baby sexfemale6male4apgar score (1′, 5′; scale 1–9)9,948,951,91john wiley & sons, ltd\n\ncomparison of methods for determining Cardiac output\n\nvti methods\nthere was no significant difference in absolute estimated Cardiac output among the various vti methods used (table \xa0 3 , fig.']	N/A	N/A	[('GO_0033576', 'protein glycosylation in cytosol', 159, 'pregnancy1032'), ('UBERON_0000178', 'blood', 290, 'blood'), ('GO_0007567', 'parturition', 308, 'delivery'), ('UBERON_0000178', 'blood', 349, 'blood'), ('GO_0007567', 'parturition', 367, 'delivery'), ('UBERON_0000948', 'heart', 686, 'cardiac'), ('UBERON_0000948', 'heart', 772, 'cardiac')]
PMC5409656	3/2017	S43-PMC5409656	['biochemical analysis\nparticipants were asked to provide a non-fasting Blood sample, from which Plasma was extracted and subsequently stored at −80 °c until further analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'blood'), ('UBERON_0001969', 'blood plasma', 95, 'plasma')]
PMC5418719	5/2017	S3-PMC5418719	['we examined 25-Hydroxyvitamin-D (25[Oh]D) levels from Cord Blood at Birth and Serum at 32 and 36\xa0weeks of Postmenstrual age.']	N/A	N/A	[('CHEBI_67320', 'majusculamide A', 12, '25-hydroxyvitamin-D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 33, '25[OH]D'), ('UBERON_0002240', 'spinal cord', 54, 'cord'), ('UBERON_0000178', 'blood', 59, 'blood'), ('GO_0007567', 'parturition', 68, 'birth'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('GO_0008283', 'cell proliferation', 106, 'postmenstrual')]
PMC5418719	5/2017	S4-PMC5418719	['results\nthe study Infants were divided by Cord-Blood levels of 25(Oh)D at Birth into 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml ( n \u2009=\u200920) or\u2009≥\u200910\xa0ng/ml ( n \u2009=\u200929).']	N/A	N/A	[('UBERON_0002397', 'maxilla', 18, 'infants'), ('UBERON_0002240', 'spinal cord', 42, 'cord'), ('UBERON_0000178', 'blood', 47, 'blood'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('GO_0007567', 'parturition', 74, 'birth'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
PMC5418719	5/2017	S24-PMC5418719	['study protocol\nat Birth, Serum calcium, phosphorus, alkaline phosphatase and 25(Oh)D concentrations were obtained from Cord Blood samples before Vitamin D supplementation was started.']	N/A	N/A	[('GO_0007567', 'parturition', 18, 'birth'), ('UBERON_0001977', 'blood serum', 25, 'serum'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 119, 'cord'), ('UBERON_0000178', 'blood', 124, 'blood'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5418719	5/2017	S31-PMC5418719	['we measured 25(Oh)D levels from Cord Blood at Birth and Serum at 32 and 36\xa0weeks pma.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 12, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 32, 'cord'), ('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0007567', 'parturition', 46, 'birth'), ('UBERON_0001977', 'blood serum', 56, 'serum')]
PMC5418719	5/2017	S32-PMC5418719	['eligible infants were stratified by Cord-Blood levels of 25(Oh)D into two groups, < 10\xa0ng/ml and\u2009≥\u200910\xa0ng/ml.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 57, '25(OH ... D')]
PMC5418719	5/2017	S65-PMC5418719	['we classified patients into two groups based on Cord Blood 25(Oh)D levels.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 59, '25(OH)D')]
PMC5418719	5/2017	S66-PMC5418719	['a total of 52 infants were eligible but the study groups was divided and analyzed by Cord Blood 25(Oh)D levels from Cord Blood in 49 infants, excluding 3 infants who is missing cord 25(Oh)D assessment at Birth.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 96, '25(OH ... D'), ('UBERON_0002240', 'spinal cord', 116, 'cord'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 182, '25(OH)D'), ('GO_0007567', 'parturition', 204, 'birth')]
PMC5420136	5/2017	S137-PMC5420136	['Blood samples (~0.1\xa0ml) were obtained from the Ear Vein of each gilt at d 110 of Gestation at 2\xa0h after Feeding for analysis of Metabolites in Plasma [131].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001650', 'hypoglossal nerve', 47, 'ear vein'), ('GO_0007565', 'female pregnancy', 81, 'gestation'), ('GO_0007631', 'feeding behavior', 104, 'feeding'), ('CHEBI_25212', 'metabolite', 128, 'metabolites'), ('UBERON_0001969', 'blood plasma', 143, 'plasma')]
PMC5420151	5/2017	S185-PMC5420151	['hiv status was determined via capillary Blood draws obtained from Finger pricks.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002389', 'manual digit', 66, 'finger')]
PMC5420151	5/2017	S192-PMC5420151	['a sample of whole Blood was collected and stored in microtainers and laboratory tested.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC5421133	5/2017	S60-PMC5421133	['the pups younger than 8 weeks old were decapitated to collect the Blood; and the Blood from the pups at the age of 8 weeks and older were collected via the caudal Vein.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0001638', 'vein', 163, 'vein')]
PMC5424401	10/2015	S99-PMC5424401	['produced primarily by the syncytiotrophoblast in the Placenta, Β-Hcg is detectable in the Blood by the second week of Pregnancy until a peak at 10–12 weeks [72].']	N/A	N/A	[('UBERON_0001987', 'placenta', 53, 'placenta'), ('PR_000000035', 'BMP receptor type-1A', 63, 'β-hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 65, 'hCG'), ('UBERON_0000178', 'blood', 90, 'blood'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC5424401	10/2015	S229-PMC5424401	['safety labs (complete Blood count, bun, creatinine, ast, alt)2.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC5424401	10/2015	S231-PMC5424401	['Blood type and Antibody screenactiongive Mtx (50\xa0mg/m2 of body surface area im)no actionβ-Hcg decline\u2009<15\xa0% from day 4 to day 7: mtx, return to day 1 of protocol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 41, 'MTX'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 90, 'hCG'), ('PR_000006060', 'CWF19-like protein 1', 90, 'hCG')]
PMC5424401	10/2015	S240-PMC5424401	['safety labs (complete Blood count, bun, creatinine, ast, alt)2.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC5424401	10/2015	S243-PMC5424401	['Blood type and Antibody screenactiongive Mtx (50\xa0mg/m2 of body surface area im)give Mtx (50\xa0mg/m2 of body surface area im)Β-Hcg decline\u2009<15\xa0% from day 4 to day 7: give Mtxβ-hcg decline\u2009<15\xa0% from day 7 to day 11: give Mtxβ-hcg decline\u2009<15\xa0% from day 11 to day 14: refer for surgeryβ-hcg decline\u2009>15\xa0% from day 4 to day 7: check β-hcg at 1 week intervals until zero.β-hcg decline\u2009>15\xa0% from day 7 to day 11: check β-hcg at 1 week intervals until zero.β-hcg decline\u2009>15\xa0% from day 11 to day 14: check β-hcg at 1 week intervals until zero.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 41, 'MTX'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 84, 'MTX'), ('PR_000000035', 'BMP receptor type-1A', 122, 'β-hCG'), ('PR_000010717', 'metal regulatory transcription factor 1', 168, 'MTXβ'), ('PR_000010717', 'metal regulatory transcription factor 1', 218, 'MTXβ')]
PMC5424401	10/2015	S249-PMC5424401	['safety labs (complete Blood count, bun, creatinine, ast, alt)3.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood')]
PMC5424401	10/2015	S250-PMC5424401	['Blood type and Antibody screenactionmtx (1\xa0mg/kg, im)leu (0.1\xa0mg/kg, im)Β-Hcg decline\u2009<15\xa0% from day 1 to day 3: give mtxleuβ-hcg decline\u2009<15\xa0% from day 3 to day 5: give mtxleuβ-hcg decline\u2009<15\xa0% from day 5 to day 7: give mtxleuβ-hcg decline\u2009>15\xa0% from day 1 to day 3: check β-hcg at one week intervals until zero.β-hcg decline\u2009>15\xa0% from day 3 to day 5: check β-hcg at one week intervals until zero.β-Hcg decline\u2009>15\xa0% from day 5 to day 7: check β-Hcg at one week intervals until zero.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('PR_000000035', 'BMP receptor type-1A', 72, 'β-hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 74, 'hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 402, 'hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 449, 'hCG')]
PMC5434919	3/2017	S204-PMC5434919	['maternal exposure to hfd results in increased bodyweight at weaning and in Adulthood along with increased adiposity, Blood Lipid levels and hyperinsulinaemia in both male and female offspring.']	N/A	N/A	[('UBERON_0000113', 'post-juvenile adult stage', 75, 'adulthood'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_18059', 'lipid', 123, 'lipid')]
PMC5437202	5/2017	S62-PMC5437202	['during monthly home visits, the comadronas practice counseling the mother about tetanus vaccines, measuring Blood pressure, using a fetal doppler, and correctly estimating Delivery date.']	N/A	N/A	[('UBERON_0000178', 'blood', 108, 'blood'), ('GO_0007567', 'parturition', 172, 'delivery')]
PMC5437202	5/2017	S64-PMC5437202	['caption (table-wrap): table 1\n\nthe school of powher curriculum overview .topic week 1 day 1an overview of maternal-infant careday 2the role of the Birth attendant, health care resources, and the emergency plan week 2 day 3sexual Organs, Sexual Desire, and Menstruation, Ovulation, and Fertilizationday 4the natural development of Pregnancy week 3 day 5the Choice Of Motherhood, the importance of Prenatal Care—part 1day 6the importance of Prenatal Care—part 2 week 4 day 7pregnancy complications, part 1day 8pregnancy complications, part 2 week 5 day 9signs and symptoms of danger during Pregnancyday 10case studies on Prenatal care, exam 1 week 6 day 11review exam 1day 12tetanus vaccine, introduction to stages of labor week 7 day 13uncomplicated labor: stage one and twoday 14uncomplicated labor: stage two and three week 8 day 15review of stages of labor, basic care of the newbornday 16complications during Labor and Delivery week 9 day 17when to refer during laborday 18neonatal resuscitation, immediate post-partum care, maternal lactation week 10 day 19maternal lactation review, post-partum care: day 1 & 4day 20review of normal and complicated labor, exam 2 week 11 day 21medicinal plants, sharing of experiences during laborday 22infection prevention and management, sterilization of Birth tools week 12 day 23family planning methodsday 24case studies: Family Planning, self Breast exam week 13 day 25vaginal infections and stisday 26nutrition and Malnutrition week 14 day 27complicated laborday 28cumulative review, final exam\neach woman that completes the school of powher training program receives a stethoscope, Blood pressure equipment, a fetal doppler, Prenatal Vitamins, and safe Birthing kits funded by international grants and private donations.']	N/A	N/A	[('GO_0007567', 'parturition', 147, 'Birth'), ('UBERON_0000033', 'head', 229, 'Organs'), ('GO_0007530', 'sex determination', 237, 'Sexual Desire'), ('GO_0042703', 'menstruation', 256, 'Menstruation'), ('GO_0030728', 'ovulation', 270, 'Ovulation'), ('GO_0023003', 'nuclear migration to the embryo sac center', 285, 'FertilizationDay'), ('GO_0007565', 'female pregnancy', 330, 'Pregnancy'), ('GO_0050817', 'coagulation', 356, 'Choice of Motherhood'), ('GO_0019230', 'proprioception', 396, 'Prenatal Care'), ('GO_0019230', 'proprioception', 439, 'Prenatal Care'), ('GO_0019653', 'anaerobic purine nucleobase catabolic process', 588, 'PregnancyDay'), ('GO_0007565', 'female pregnancy', 619, 'Prenatal'), ('GO_0040011', 'locomotion', 912, 'Labor'), ('GO_0007586', 'digestion', 922, 'Delivery'), ('GO_0007567', 'parturition', 1295, 'Birth'), ('GO_0006437', 'tyrosyl-tRNA aminoacylation', 1364, 'Family Planning'), ('UBERON_0000310', 'breast', 1386, 'Breast'), ('GO_0009563', 'synergid differentiation', 1459, 'Malnutrition'), ('UBERON_0000178', 'blood', 1627, 'blood'), ('GO_0007565', 'female pregnancy', 1670, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 1679, 'vitamins'), ('GO_0007567', 'parturition', 1698, 'birthing')]
PMC5437202	5/2017	S118-PMC5437202	['additionally, three Comadronas were identified to be consistently taking Blood pressure incorrectly and were appropriately retrained.']	N/A	N/A	[('UBERON_0009971', 'principal gastric gland', 20, 'comadronas'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5437650	5/2017	S71-PMC5437650	['further, women access the it platform during their Prenatal visit to track their own health metrics (e.g., weight, Blood pressure, visit attendance).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('UBERON_0000178', 'blood', 115, 'blood')]
PMC5437650	5/2017	S76-PMC5437650	['personalized profiles allow patients to log vital signs (i.e., Blood pressure, weight) during Prenatal visits and to view their own weight trajectory across pregnancy.']	N/A	N/A	[('UBERON_0000178', 'blood', 63, 'blood'), ('GO_0007565', 'female pregnancy', 94, 'prenatal')]
PMC5437650	5/2017	S171-PMC5437650	['data collected will include medical and Reproductive health history, Prenatal visit attendance and vital signs (e.g., weight and Blood pressure), Pregnancy complications and outcomes, Delivery information, Birth outcomes (e.g., Gestational age, Birth weight), any neonatal intensive care admission/length of stay, and Postpartum healthcare.']	N/A	N/A	[('GO_0000003', 'reproduction', 40, 'reproductive'), ('GO_0007565', 'female pregnancy', 69, 'prenatal'), ('UBERON_0000178', 'blood', 129, 'blood'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007567', 'parturition', 184, 'delivery'), ('GO_0007567', 'parturition', 206, 'birth'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007567', 'parturition', 245, 'birth'), ('GO_0007565', 'female pregnancy', 318, 'postpartum')]
PMC5439533	5/2017	S33-PMC5439533	['questionnaire\nthe questionnaire included demographic information (age, race, living environment, education level, type of fuel used for Cooking, number of persons in the household, Delivery hospital), Antenatal care (number of Antenatal visits, vaccinations received during Pregnancy, consumption of Antenatal Supplements), presence of medical conditions prior to Pregnancy (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), any complications during Pregnancy (hospitalization for any specific complication such as Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection, or influenza-like illness), other risk factors for adverse Pregnancy outcomes (Alcohol consumption and smoking before and during Pregnancy), obstetric characteristics of the mother (number of Parturitions, number of abortions, number of Livebirths and stillbirths, type of Delivery), and characteristics of the offspring (sex, weight, Gestational age at Delivery).']	N/A	N/A	[('GO_0065007', 'biological regulation', 136, 'cooking'), ('GO_0007567', 'parturition', 181, 'delivery'), ('GO_0007567', 'parturition', 201, 'antenatal'), ('GO_0007567', 'parturition', 227, 'antenatal'), ('GO_0007565', 'female pregnancy', 274, 'pregnancy'), ('GO_0007567', 'parturition', 300, 'antenatal'), ('CHEBI_33341', 'titanium atom', 310, 'supplements'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('UBERON_0002113', 'kidney', 402, 'renal'), ('UBERON_0002107', 'liver', 417, 'liver'), ('UBERON_0000178', 'blood', 432, 'blood'), ('UBERON_0001016', 'nervous system', 447, 'neurologic'), ('GO_0007565', 'female pregnancy', 493, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 558, 'preeclampsia'), ('UBERON_0001088', 'urine', 603, 'urinary'), ('UBERON_0001004', 'respiratory system', 645, 'respiratory'), ('GO_0007565', 'female pregnancy', 727, 'pregnancy'), ('CHEBI_30879', 'alcohol', 747, 'alcohol'), ('GO_0007565', 'female pregnancy', 797, 'pregnancy'), ('GO_0018989', 'apolysis', 860, 'parturitions'), ('GO_0008610', 'lipid biosynthetic process', 905, 'livebirths'), ('GO_0007567', 'parturition', 941, 'delivery'), ('GO_0007565', 'female pregnancy', 1003, 'gestational'), ('GO_0007567', 'parturition', 1022, 'delivery')]
PMC5439533	5/2017	S53-PMC5439533	['variables included in the psm model that could explain probability of receiving vaccination were selected a priori (age, race, education level, number of Antenatal visits, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and because of a crude association with vaccination and/or Birth outcomes (type of fuel used for cooking, number of People in the household, reporting receiving at least one tetanus vaccine, iron and Vitamin B12 consumption during Pregnancy, Albendazole consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) calculated from height and weight measurements taken at first Antenatal visit, number of Parturitions).']	N/A	N/A	[('GO_0007567', 'parturition', 154, 'antenatal'), ('UBERON_0002113', 'kidney', 241, 'renal'), ('UBERON_0002107', 'liver', 256, 'liver'), ('UBERON_0000178', 'blood', 271, 'blood'), ('UBERON_0001016', 'nervous system', 286, 'neurologic'), ('GO_0007567', 'parturition', 365, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 422, 'people'), ('CHEBI_33279', 'vitamin D5', 506, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 506, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 537, 'pregnancy'), ('CHEBI_16664', 'albendazole', 548, 'albendazole'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 617, 'pregnancy'), ('CHEBI_2904', 'atenolol', 628, 'aspirin'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_30879', 'alcohol', 666, 'alcohol'), ('GO_0007565', 'female pregnancy', 693, 'pregnancy'), ('GO_0007567', 'parturition', 788, 'antenatal'), ('GO_0018989', 'apolysis', 815, 'parturitions')]
PMC5439533	5/2017	S82-PMC5439533	['at least one chronic condition of the following: obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 76, 'renal'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0000178', 'blood', 106, 'blood'), ('UBERON_0001016', 'nervous system', 121, 'neurologic')]
PMC5439533	5/2017	S91-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, race, calcium, Iron, and Folic Acid Consumption during Pregnancy, education level, number of Parturitions, body mass index (bmi) at first Antenatal visit, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_24870', 'ion', 174, 'iron'), ('CHEBI_30751', 'formic acid', 184, 'folic acid'), ('GO_0007631', 'feeding behavior', 195, 'consumption'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0018989', 'apolysis', 252, 'parturitions'), ('GO_0007567', 'parturition', 297, 'antenatal')]
PMC5439533	5/2017	S92-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, Albendazol and Aspirin consumption during Pregnancy, hospitalization during Pregnancy for any specific complication (Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection), Delivery hospital, number of Parturitions, body mass index (bmi) at first Antenatal visit, Alcohol consumption before Pregnancy, number of Antenatal visits, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_31181', 'aklavinone', 159, 'albendazol'), ('CHEBI_2904', 'atenolol', 174, 'aspirin'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 276, 'preeclampsia'), ('UBERON_0001088', 'urine', 321, 'urinary'), ('UBERON_0001004', 'respiratory system', 363, 'respiratory'), ('GO_0007567', 'parturition', 387, 'delivery'), ('GO_0018989', 'apolysis', 416, 'parturitions'), ('GO_0007567', 'parturition', 461, 'antenatal'), ('CHEBI_30879', 'alcohol', 478, 'alcohol'), ('GO_0007565', 'female pregnancy', 505, 'pregnancy'), ('GO_0007567', 'parturition', 526, 'antenatal')]
PMC5439533	5/2017	S94-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5439533	5/2017	S105-PMC5439533	['models adjusted for race, education level, Iron and Folic Acid Consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits and sex of the baby for mothers vaccinated in the first trimester; age, race, education level, Iron and Folic Acid consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits, number of People in the household and sex of the baby for mothers vaccinated in the second trimester; number of Parturitions, body mass index (bmi) at first Antenatal visit, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and sex of the baby for mothers vaccinated in the third trimester.']	N/A	N/A	[('CHEBI_24870', 'ion', 43, 'iron'), ('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('GO_0007631', 'feeding behavior', 63, 'consumption'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0018989', 'apolysis', 103, 'parturitions'), ('GO_0007567', 'parturition', 148, 'antenatal'), ('GO_0007567', 'parturition', 175, 'antenatal'), ('CHEBI_24870', 'ion', 287, 'iron'), ('CHEBI_30751', 'formic acid', 296, 'folic acid'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('GO_0018989', 'apolysis', 347, 'parturitions'), ('GO_0007567', 'parturition', 392, 'antenatal'), ('GO_0007567', 'parturition', 419, 'antenatal'), ('NCBITaxon_10088', 'Mus <genus>', 447, 'people'), ('GO_0018989', 'apolysis', 549, 'parturitions'), ('GO_0007567', 'parturition', 594, 'antenatal'), ('UBERON_0002113', 'kidney', 680, 'renal'), ('UBERON_0002107', 'liver', 695, 'liver'), ('UBERON_0000178', 'blood', 710, 'blood'), ('UBERON_0001016', 'nervous system', 725, 'neurologic')]
PMC5439533	5/2017	S109-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5441441	4/2017	S2-PMC5441441	['the anthropometric, Blood Lipid, and other laboratory test results of the study subjects were analyzed.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_18059', 'lipid', 26, 'lipid')]
PMC5441441	4/2017	S39-PMC5441441	['none of them was using Lipid-lowering medication when the Blood sample was taken.']	N/A	N/A	[('CHEBI_18059', 'lipid', 23, 'lipid'), ('UBERON_0000178', 'blood', 58, 'blood')]
PMC5441441	4/2017	S40-PMC5441441	['for dyslipidemia analysis, 2 ml of Venous Blood was collected from the selected subjects.']	N/A	N/A	[('UBERON_0001638', 'vein', 35, 'venous'), ('UBERON_0000178', 'blood', 42, 'blood')]
PMC5441441	4/2017	S51-PMC5441441	['Blood Lipids and lipoproteins were measured from samples obtained after an overnight fast.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_18059', 'lipid', 6, 'lipids')]
PMC5441441	4/2017	S52-PMC5441441	['Blood samples were collected in edta-containing tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5441441	4/2017	S57-PMC5441441	['diagnostic criteria\ndyslipidemia was diagnosed according to the criteria of the national Cholesterol education program (1992) for tc and Ldl-C and us national institutes of health Heart, Lung, and Blood institute (expert panel on integrated guidelines for Cardiovascular health and risk reduction in children and adolescents, 2011) for Hdl-C and tag.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 89, 'Cholesterol'), ('PR_000009780', 'legumain', 137, 'LDL-C'), ('UBERON_0000948', 'heart', 180, 'Heart'), ('UBERON_0002048', 'lung', 187, 'Lung'), ('UBERON_0000178', 'blood', 197, 'Blood'), ('UBERON_0004535', 'cardiovascular system', 256, 'Cardiovascular'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 336, 'HDL-C')]
PMC5441441	4/2017	S70-PMC5441441	['ethics issue\nparents of the study subject were asked for their agreement with the statement written by the national institute of nutrition, which clearly stated that Blood samples would be used for research purposes.']	N/A	N/A	[('UBERON_0000178', 'blood', 166, 'blood')]
PMC5441441	4/2017	S75-PMC5441441	['there were no differences in systolic Blood pressure, tc, and Ldl-C between two groups.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('PR_000009780', 'legumain', 62, 'LDL-C')]
PMC5441441	4/2017	S76-PMC5441441	['obese children had significantly higher weight, height, bmi, wc, hc, diastolic Blood pressure, and Tag than normal ones.']	N/A	N/A	[('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_17855', 'triglyceride', 99, 'TAG')]
PMC5441441	4/2017	S113-PMC5441441	['in this study, we were unable to check for the presence of adipokines in the Blood of subjects or to investigate their fat Tissues.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0000479', 'tissue', 123, 'tissues')]
PMC5442204	5/2017	S8-PMC5442204	['three-dimensional ultrasound power doppler imaging visualized the disappearance of main Blood flows in the fetal Brain.']	N/A	N/A	[('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0000955', 'brain', 113, 'brain')]
PMC5442204	5/2017	S50-PMC5442204	['one hundred b-mode images were stored at 50 frame/s, wherein each captured cineloop duration was 2 s. moreover, before and after the ischemia/reperfusion treatment, three-dimensional (3d) ultrasound power doppler imaging was performed to visualize concomitant Blood flow in the area.']	N/A	N/A	[('UBERON_0000178', 'blood', 260, 'blood')]
PMC5442204	5/2017	S56-PMC5442204	['image analysis\nchanges of Blood flow in fetal Brains were quantified based on image intensity of ultrasound b-mode images.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('UBERON_0000955', 'brain', 46, 'brains')]
PMC5442204	5/2017	S79-PMC5442204	['this achievement enabled us to quantify changes in Blood flow by intensity analysis of the sequential images described later with figures3b–d.']	N/A	N/A	[('UBERON_0000178', 'blood', 51, 'blood')]
PMC5442204	5/2017	S89-PMC5442204	['Blood flow in n and lp fetal Brains before and after the ischemia/reperfusion treatments are demonstrated in 3d ultrasound power doppler images of figure4.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000955', 'brain', 29, 'brains')]
PMC5442204	5/2017	S93-PMC5442204	['intensity analysis findings\nchanges in Blood flow within the fetal Brain were evaluated by intensity quantification of ultrasound b-mode images with each five n and lp Mice.']	N/A	N/A	[('UBERON_0000178', 'blood', 39, 'blood'), ('UBERON_0000955', 'brain', 67, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'mice')]
PMC5442204	5/2017	S107-PMC5442204	['hypoxic condition was created by occluding the Uterine and Ovarian Arteries and holding Blood at the Placenta.']	N/A	N/A	[('UBERON_0000995', 'uterus', 47, 'uterine'), ('UBERON_0001171', 'portal lobule', 59, 'ovarian arteries'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC5442204	5/2017	S113-PMC5442204	['in all rois, the Blood flow in the n fetus retained or rather slightly increased during ischemia period.']	N/A	N/A	[('UBERON_0000178', 'blood', 17, 'blood')]
PMC5442204	5/2017	S114-PMC5442204	['this implies that the n fetus has Cerebrovascular Autoregulation to maintain a constant Blood supply to the fetal Brain during the ischemia/reperfusion.']	N/A	N/A	[('UBERON_0004086', 'brain ventricle', 34, 'cerebrovascular'), ('GO_0051458', 'corticotropin secretion', 50, 'autoregulation'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0000955', 'brain', 114, 'brain')]
PMC5442204	5/2017	S118-PMC5442204	['in 3d ultrasound power doppler imaging of an lp fetal Brain (figure4), decreased Blood flow in a large tributary of the Anterior Cerebral Artery was clearly recognized (dorr et al.,2007).']	N/A	N/A	[('UBERON_0000955', 'brain', 54, 'brain'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0002355', 'pelvic region of trunk', 120, 'anterior'), ('UBERON_0004449', 'cerebral artery', 129, 'cerebral artery')]
PMC5443512	5/2017	S82-PMC5443512	['Blood samples\nat 45 days of Life, Serum Insulin values were measured in 5 μl Serum samples using an elisa test (crystal chem, downers grove, il, usa) (fig 1c).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000104', 'life cycle', 28, 'life'), ('UBERON_0001977', 'blood serum', 34, 'serum'), ('PR_000045358', 'insulin family protein', 40, 'insulin'), ('UBERON_0001977', 'blood serum', 77, 'serum')]
PMC5445052	4/2017	S40-PMC5445052	['heparinized Blood samples were collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC5445501	5/2017	S75-PMC5445501	['the kalenjin have a common staple diet: kimyet (ugali) (a paste of cooked Maize or Millet flour sometimes mixed with sorghum flour), native vegetables and Mursik (sour Milk mixed with charcoal dust, sometimes mixed with Cow’s Blood), supplemented with roast meat (usually beef or goat).']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 74, 'maize'), ('NCBITaxon_10088', 'Mus <genus>', 83, 'millet'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'mursik'), ('UBERON_0001913', 'milk', 168, 'milk'), ('NCBITaxon_33208', 'Metazoa', 220, 'cow'), ('UBERON_0000178', 'blood', 226, 'blood')]
PMC5445501	5/2017	S192-PMC5445501	['it can also make the baby fat (making the Birth difficult), and cause high Blood pressure and malaria in the mother:\n“the Food that has a lot of oil for example eggs, ‘kangumu,’ ‘mandazi’, or fatty meat, you should not eat much.']	N/A	N/A	[('GO_0007567', 'parturition', 42, 'birth'), ('UBERON_0000178', 'blood', 75, 'blood'), ('CHEBI_33290', 'food', 122, 'food')]
PMC5445501	5/2017	S246-PMC5445501	['no oil is added but a few mentioned enriching it by adding Animal Blood when cooking.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 59, 'animal'), ('UBERON_0000178', 'blood', 66, 'blood')]
PMC5445501	5/2017	S251-PMC5445501	['to boost its nutritional value, Milk is mixed with raw Blood extracted from a healthy bull or collected from the slaughterhouse.']	N/A	N/A	[('UBERON_0001913', 'milk', 32, 'milk'), ('UBERON_0000178', 'blood', 55, 'blood')]
PMC5445501	5/2017	S254-PMC5445501	['it helps your Blood volume to increase fast.” (130707_003-104)\nAnimal Blood can also be Consumed without milk.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('NCBITaxon_33208', 'Metazoa', 63, 'Animal'), ('UBERON_0000178', 'blood', 70, 'blood'), ('GO_0007631', 'feeding behavior', 88, 'consumed')]
PMC5445501	5/2017	S256-PMC5445501	['the consumption of Blood is a prominent kalenjin custom of the past as explained by a key informant.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood')]
PMC5445501	5/2017	S259-PMC5445501	['the commonly reported fruit known to increase Blood were the tamarillo (solanum betaceum) and oranges ( citrus sinensis ).']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood')]
PMC5445501	5/2017	S318-PMC5445501	['consumption of Cow’s Blood, sour Milk and much Water, as well as vomiting after a heavy meal, is also practised by the maasai women in kenya, also aiming to keep the baby small at Birth to facilitate Delivery [29].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 15, 'cow'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001913', 'milk', 33, 'milk'), ('CHEBI_15377', 'water', 47, 'water'), ('GO_0007567', 'parturition', 180, 'birth'), ('GO_0007567', 'parturition', 200, 'delivery')]
PMC5445501	5/2017	S327-PMC5445501	['fewer Blood reserves make a woman weak.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood')]
PMC5445501	5/2017	S329-PMC5445501	['according to many respondents, the prominent way of ensuring enough Blood is Consuming plenty of traditional vegetables, Liver, Animal Blood, fruits, Milk, beans, red Soil/stones and fish during the Pregnancy period.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007631', 'feeding behavior', 77, 'consuming'), ('UBERON_0002107', 'liver', 121, 'liver'), ('NCBITaxon_33208', 'Metazoa', 128, 'animal'), ('UBERON_0000178', 'blood', 135, 'blood'), ('UBERON_0001913', 'milk', 150, 'milk'), ('UBERON_0001913', 'milk', 167, 'soil'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC544881	12/2004	S6-PMC544881	['the level of Gemfibrozil, as the active Metabolite, in the Venous and Arterial Fetal Cord Blood was within the expected therapeutic range for Adults.']	N/A	N/A	[('CHEBI_5374', 'Glaucolide A', 13, 'gemfibrozil'), ('CHEBI_39382', 'flufenoxuron', 40, 'metabolite'), ('UBERON_0001593', 'venous plexus', 59, 'venous ...'), ('UBERON_0001637', 'artery', 70, 'arterial'), ('UBERON_0005397', 'brain arachnoid mater', 79, 'fetal cord'), ('UBERON_0000178', 'blood', 90, 'blood'), ('UBERON_0007023', 'adult organism', 142, 'adults')]
PMC544881	12/2004	S70-PMC544881	['immediately Postpartum, Placental fetal Blood and maternal Plasma was obtained for total Fatty Acid analysis (figure3).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'postpartum'), ('UBERON_0001987', 'placenta', 24, 'placental'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_35366', 'fatty acid', 89, 'fatty acid')]
PMC544881	12/2004	S80-PMC544881	['caption (fig): figure 4\n\nGemfibrozil Metabolite iii levels in the fetal Cord Blood*ref.']	N/A	N/A	[('CHEBI_5296', 'gemfibrozil', 25, 'Gemfibrozil'), ('CHEBI_39382', 'flufenoxuron', 37, 'metabolite'), ('UBERON_0002240', 'spinal cord', 72, 'cord'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC5452160	4/2017	S4-PMC5452160	['Capillary and Venous Blood samples ( n = 770) were analyzed for hemoglobin (hb) and Plasma ferritin, soluble Transferrin Receptor (Stfr), zinc (pzn), Retinol Binding Protein (Rbp), Folate and Vitamin B12.']	N/A	N/A	[('UBERON_0001982', 'capillary', 0, 'Capillary'), ('UBERON_0001638', 'vein', 14, 'venous'), ('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001969', 'blood plasma', 84, 'plasma'), ('PR_000001679', 'trace amine-associated receptor 5', 109, 'transferrin receptor'), ('PR_000015619', 'sorcin', 131, 'sTfR'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 150, 'retinol binding protein'), ('PR_000013830', 'calcipressin-2', 175, 'RBP'), ('CHEBI_30863', '5-azaorotic acid', 181, 'folate'), ('CHEBI_33279', 'vitamin D5', 192, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 192, 'vitamin B12')]
PMC5452160	4/2017	S65-PMC5452160	['biochemical assessments\nCapillary Blood samples were collected at visit 2 for the measurement of hb in all women.']	N/A	N/A	[('UBERON_0001982', 'capillary', 24, 'Capillary'), ('UBERON_0000178', 'blood', 34, 'blood')]
PMC5452160	4/2017	S66-PMC5452160	['in a sub-set of women, 7.5 ml Venous Blood samples were collected at the same time point for measurement of Plasma ferritin, soluble Transferrin receptor (Stfr), zinc (pzn), Retinol Binding Protein (Rbp), α-1-Acid Glycoprotein (agp), C-Reactive Protein (Crp), Vitamin B12, Folate and Histidine-Rich Protein Ii (Hrp2) concentrations.']	N/A	N/A	[('UBERON_0001638', 'vein', 30, 'venous'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0001969', 'blood plasma', 108, 'plasma'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 133, 'transferrin'), ('PR_000015619', 'sorcin', 155, 'sTfR'), ('CHEBI_26536', 'retinoic acid', 174, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 174, 'retinol binding protein'), ('PR_000013830', 'calcipressin-2', 199, 'RBP'), ('CHEBI_17697', 'N-acetylserotonin', 207, '1-acid glycoprotein'), ('PR_000005890', 'crooked neck-like protein 1', 234, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 254, 'CRP'), ('CHEBI_33279', 'vitamin D5', 260, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 273, 'folate'), ('PR_000008809', 'heat shock 70 kDa protein 4L', 284, 'histidine-rich protein II'), ('PR_000008794', 'heat shock factor protein 5', 311, 'HRP2')]
PMC5452160	4/2017	S67-PMC5452160	['according to procedures recommended by the international Zinc nutrition consultative group (izincg) [25,26], Blood was drawn from the Antecubital Vein and collected in an evacuated, trace Element free Polyethylene tube containing lithium Heparin (sarstedt ag & co., numbrecht, germany).']	N/A	N/A	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 57, 'Zinc'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0002386', 'forelimb zeugopod', 134, 'antecubital'), ('UBERON_0001638', 'vein', 146, 'vein'), ('CHEBI_23888', 'drug', 188, 'element'), ('CHEBI_53551', 'poly(methylene)', 201, 'polyethylene'), ('CHEBI_28304', 'heparin', 238, 'heparin')]
PMC5452160	4/2017	S69-PMC5452160	['Plasma was separated from heparinized Blood at the regional hospital of zinder ≤8 h from collection, by centrifuging at 3000 rpm for 10 min.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 38, 'blood')]
PMC5452160	4/2017	S71-PMC5452160	['hb concentration was measured immediately after capillary Blood collection with a hemocue 201+ photometer (hemocue ab, angelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood')]
PMC5452160	4/2017	S79-PMC5452160	['Venous Blood for assessment of mn concentrations was collected from all eligible Pregnant women participating in visit 2 of the nimanu project until the required sample size was obtained.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('GO_0007565', 'female pregnancy', 81, 'pregnant')]
PMC5457543	6/2017	S7-PMC5457543	['results\nBlood samples from 557 (91.9%) women were analyzed.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'Blood')]
PMC5457543	6/2017	S36-PMC5457543	['the protocol was modified to include a lower age limit of 18\xa0years and to allow randomisation after initial questionnaires and Blood tests were completed, in order to assure that participants were sufficiently motivated and avoid missing data.']	N/A	N/A	[('UBERON_0000178', 'blood', 127, 'blood')]
PMC5457543	6/2017	S40-PMC5457543	['Blood tests were collected after fasting and two hours after Glucose challenge at 30\xa0weeks of Gestation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 61, 'glucose'), ('GO_0007565', 'female pregnancy', 94, 'gestation')]
PMC5457543	6/2017	S41-PMC5457543	['of 606 women randomized, 557 (91.9%) provided Blood samples for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood')]
PMC5457543	6/2017	S47-PMC5457543	['randomisation and blinding\nafter receiving signed consent forms and confirming that Blood tests and questionnaires were completed, a research nurse assigned participants consecutively to the intervention or control arm of the study utilizing a computer-generated list with 1:1 allocation ratio and blocks of 20.']	N/A	N/A	[('UBERON_0000178', 'blood', 84, 'blood')]
PMC5457543	6/2017	S48-PMC5457543	['all examinations, Blood test evaluations and scoring of questionnaires were performed by assessors blinded to group allocation.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC5457543	6/2017	S76-PMC5457543	['prior to randomisation, fasting Blood tests were assessed for evidence of pre-existing diabetes (defined as Glucose ≥7.0\xa0mmol/l) [22].']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_17234', 'glucose', 108, 'glucose')]
PMC5468564	5/2017	S44-PMC5468564	['we found none of the Pregnant mothers that attended anc in the previous months had weight and height recorded in the same anc visit, none had muac measurement as well, 30% had Blood pressure (bp) measurements, and 10% had their hemoglobin level estimated.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('UBERON_0000178', 'blood', 176, 'blood')]
PMC5468564	5/2017	S55-PMC5468564	['data on nutritional indices (weight, height, and muac), Blood pressure (bp), and hemoglobin level estimates were abstracted for all Pregnant mothers that attended anc between january and march 2015 in april 2015.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('GO_0007565', 'female pregnancy', 132, 'pregnant')]
PMC5471716	1/2017	S126-PMC5471716	['they lost weight and their Glucose tolerance, Insulin sensitivity, Blood Lipids, and Blood pressure all improved (table\xa03).']	N/A	N/A	[('CHEBI_17234', 'glucose', 27, 'glucose'), ('PR_000045358', 'insulin family protein', 46, 'insulin'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_18059', 'lipid', 73, 'lipids'), ('UBERON_0000178', 'blood', 85, 'blood')]
PMC5472316	6/2017	S40-PMC5472316	['the measurement of total alkaline phosphatase (tap) activity in Blood Serum was performed to assess Osteoblastic activity.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('CL_0000062', 'osteoblast', 100, 'osteoblastic')]
PMC5472316	6/2017	S129-PMC5472316	['the Animal Blood was collected using standard venepuncture; next, after clotting at room temperature, it was centrifuged and frozen at -80°c for further analysis.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animal'), ('UBERON_0000178', 'blood', 11, 'blood')]
PMC5472316	6/2017	S158-PMC5472316	['Blood Serum biochemical analyses\nthe Blood Serum immediately separated by centrifugation was stored at -25°c for further analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 6, 'serum'), ('UBERON_0000178', 'blood', 37, 'blood'), ('UBERON_0001977', 'blood serum', 43, 'serum')]
PMC5472316	6/2017	S167-PMC5472316	['biochemical analysis\nthe concentration of Phosphorus, ionized calcium, and total calcium in Blood Serum decreased after the maternal Hmb treatment irrespective of the sex of the Piglets.']	N/A	N/A	[('CHEBI_35885', 'secondary phosphine', 42, 'phosphorus'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_17883', 'hydrogen chloride', 133, 'HMB'), ('NCBITaxon_33208', 'Metazoa', 178, 'piglets')]
PMC5473979	6/2017	S69-PMC5473979	['biochemical indicators of Micronutrient status:\na Finger-prick Capillary Blood sample was obtained to measure hemoglobin (hb) concentrations using a b-hemoglobin analyzer (hemocue).']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 26, 'micronutrient'), ('UBERON_0002389', 'manual digit', 50, 'finger'), ('UBERON_0001982', 'capillary', 63, 'capillary'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5473979	6/2017	S70-PMC5473979	['Venous Blood samples were collected after overnight fasting at baseline, first Prenatal visit and 3\xa0months post-Partum to measure iron store (Plasma ferritin) using the sandwich elisa technique [28].']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('GO_0007565', 'female pregnancy', 79, 'prenatal'), ('GO_0007567', 'parturition', 112, 'partum'), ('UBERON_0001969', 'blood plasma', 142, 'plasma')]
PMC5483961	7/2017	S5-PMC5483961	['in a subgroup of ∼300 mother-infant pairs, we measured maternal iron status, mrna levels of Genes encoding for Placental iron and zinc Transport proteins, and Cord Blood iron levels.']	N/A	N/A	[('SO_0000704', 'gene', 92, 'genes'), ('UBERON_0001987', 'placenta', 111, 'placental'), ('GO_0006809', 'nitric oxide biosynthetic process', 135, 'transport'), ('UBERON_0002240', 'spinal cord', 159, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5483961	7/2017	S8-PMC5483961	['ferritin in infant Cord Blood was 18–22% lower in the Lns groups ( p< 0.024).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('UBERON_0000029', 'lymph node', 54, 'LNS')]
PMC5483961	7/2017	S57-PMC5483961	['data and Blood sample collection during Pregnancy\nat enrollment (“booking”) and at 20 and 30 wk of Gestation, women attended the medical research council (mrc) keneba clinic for a detailed Antenatal assessment.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007565', 'female pregnancy', 99, 'gestation'), ('GO_0007567', 'parturition', 189, 'antenatal')]
PMC5483961	7/2017	S58-PMC5483961	['a standard Antenatal check, including Blood pressure measurement and hemoglobin and Urine analyses, was performed at each visit.']	N/A	N/A	[('GO_0007567', 'parturition', 11, 'antenatal'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0001088', 'urine', 84, 'urine')]
PMC5483961	7/2017	S62-PMC5483961	['at each visit, after an overnight fast, a sample of Venous Blood (20 ml) was collected in Trace Element–free tubes (sarstedt ag & co), and aliquots of Plasma were prepared and stored for subsequent analysis.']	N/A	N/A	[('UBERON_0001638', 'vein', 52, 'venous'), ('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 90, 'trace element'), ('UBERON_0001969', 'blood plasma', 151, 'plasma')]
PMC5483961	7/2017	S65-PMC5483961	['for home Deliveries, field assistants residing in the village attended the Delivery to collect Cord Blood and the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'deliveries'), ('GO_0007567', 'parturition', 75, 'delivery'), ('UBERON_0002240', 'spinal cord', 95, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('UBERON_0001987', 'placenta', 114, 'placenta')]
PMC5483961	7/2017	S67-PMC5483961	['the Placenta was then sealed in a sterile plastic bag and transported on ice, with the Cord Blood, to the mrc keneba laboratory for processing (20).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC5483961	7/2017	S70-PMC5483961	['whole-Blood samples collected from the women at booking and 20 and 30 wk of Gestation were used to assess hemoglobin concentration using a medonic hematology analyzer (clinical diagnostic solutions, inc.).']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('GO_0007565', 'female pregnancy', 76, 'gestation')]
PMC5483961	7/2017	S75-PMC5483961	['Cord Blood samples were analyzed for only hemoglobin, iron, and ferritin.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC5483961	7/2017	S76-PMC5483961	['only maternal Blood samples collected at 30 wk of Gestation were analyzed for Plasma zinc, using an inductively coupled Plasma mass spectrometer (7700 series; agilent technologies).']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007565', 'female pregnancy', 50, 'gestation'), ('UBERON_0001969', 'blood plasma', 78, 'plasma'), ('UBERON_0001969', 'blood plasma', 120, 'plasma')]
PMC5483961	7/2017	S87-PMC5483961	['four small sections (∼1–2 mm) of the Placental Tissues were dissected from the maternal side and washed in sterile cold (4°c) pbs to remove excess Blood.']	N/A	N/A	[('UBERON_0001987', 'placenta', 37, 'placental'), ('UBERON_0000479', 'tissue', 47, 'tissues'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC5483961	7/2017	S199-PMC5483961	['mean Cord Blood hemoglobin and iron concentrations were not different between the intervention arms ( p> 0.098) ( figure 6a, b ).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 5, 'cord'), ('UBERON_0000178', 'blood', 10, 'blood')]
PMC5483961	7/2017	S201-PMC5483961	['caption (fig): figure 6\n\nCord Blood concentrations of hb (a), iron (b), and ferritin (c), by intervention arm.']	N/A	N/A	[('UBERON_0000948', 'heart', 25, 'Cord'), ('UBERON_0000178', 'blood', 30, 'blood')]
PMC5484502	6/2017	S25-PMC5484502	['like in other Tissues, Placental Sert mediates the removal of 5Ht, a potent vasoconstrictor, from the Extracellular Space, thereby contributing to the Regulation of Uteroplacental Blood flow.']	N/A	N/A	[('UBERON_0000479', 'tissue', 14, 'tissues'), ('UBERON_0001987', 'placenta', 23, 'placental'), ('PR_000014740', 'splicing factor 4', 33, 'SERT'), ('CHEBI_16039', 'ITP', 62, '5HT'), ('GO_0005615', 'extracellular space', 102, 'extracellular space'), ('GO_0065007', 'biological regulation', 151, 'regulation'), ('UBERON_0012469', 'external anal region', 165, 'uteroplacental'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC5484502	6/2017	S130-PMC5484502	['hence, average Dna Methylation across the seven Cpg Sites (referred to as Slc6A4 methylation) was calculated for each Placental sample and used in further analyses as previously applied for Blood Cell Dna Methylation of the respective Slc6A4 region [16,21,22,41].']	N/A	N/A	[('GO_0006306', 'DNA methylation', 15, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 48, 'CpG sites'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 74, 'SLC6A4'), ('UBERON_0001987', 'placenta', 118, 'placental'), ('CL_0000081', 'blood cell', 190, 'blood cell'), ('UBERON_0000178', 'blood', 190, 'blood'), ('GO_0006306', 'DNA methylation', 201, 'DNA methylation'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 235, 'SLC6A4')]
PMC5485024	3/2017	S33-PMC5485024	['clinical examinations including Blood sampling were performed at age 4, 8 and 16 years.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood')]
PMC5485024	3/2017	S34-PMC5485024	['Blood samples were analysed for specific Ige Antibodies with immunocap (phadia ab, uppsala, sweden) to common inhalant Allergens using the phadiatop®‐Mix (cat, Dog, Horse, Birch, Timothy, mugwort, dermatophagoides pteronyssinus and cladosporium )9.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 41, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 45, 'antibodies'), ('CHEBI_33663', 'cyclic hydrocarbon', 119, 'allergens'), ('CHEBI_60004', 'mixture', 150, 'mix'), ('NCBITaxon_33208', 'Metazoa', 160, 'dog'), ('NCBITaxon_1', 'root', 165, 'horse'), ('NCBITaxon_33208', 'Metazoa', 172, 'birch'), ('NCBITaxon_10088', 'Mus <genus>', 179, 'timothy')]
PMC5485039	3/2017	S22-PMC5485039	['manifestations of Folate deficiency include Neural Tube defects, Haematological abnormalities and impaired immunity.']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 18, 'folate'), ('UBERON_0001049', 'neural tube', 44, 'neural tube'), ('UBERON_0000178', 'blood', 65, 'haematological')]
PMC5485039	3/2017	S37-PMC5485039	['absorption of Folate polyglutamates is rapid, with Blood concentrations of 5‐Methyl‐Thf increasing within 15–20\xa0min of Ingestion (pietrzik et\xa0al ,2010).']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 14, 'folate'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_46882', 'primary amino group', 75, '5‐methyl'), ('CHEBI_17038', 'fecosterol', 84, 'THF'), ('GO_0007631', 'feeding behavior', 119, 'ingestion')]
PMC5485039	3/2017	S78-PMC5485039	['the disease is characterized by Erythrocytes with an abnormal, rigid sickle shape that block small Blood Vessels, impair Blood flow and reduce Erythrocyte survival.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 32, 'erythrocytes'), ('UBERON_0001981', 'blood vessel', 99, 'blood vessels'), ('UBERON_0000178', 'blood', 121, 'blood'), ('CL_0000232', 'erythrocyte', 143, 'erythrocyte')]
PMC5485170	3/2017	S129-PMC5485170	['primary outcome, defined by histopathological examination and polymerase chain reaction (pcr) analysis of Placental biopsies (etheredge et\xa0al ,2015) or 1 or more positive results for (i) the presence of parasite Lactate dehydrogenase (pldh) or Histidine‐Rich Protein Ii (Hrp2) in Plasma, or (ii) by Placental histopathology, or (iii) p.\xa0falciparum dna in maternal Erythrocytes from Venous or Placental Blood by pcr test (mwangi et\xa0al ,2015).']	N/A	N/A	[('UBERON_0001987', 'placenta', 106, 'placental'), ('CHEBI_24996', 'lactate', 212, 'lactate'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 212, 'lactate'), ('PR_000008820', 'heat shock protein beta-8', 244, 'histidine‐rich protein II'), ('PR_000008794', 'heat shock factor protein 5', 271, 'HRP2'), ('UBERON_0001969', 'blood plasma', 280, 'plasma'), ('UBERON_0001987', 'placenta', 299, 'placental'), ('CL_0000232', 'erythrocyte', 364, 'erythrocytes'), ('UBERON_0001638', 'vein', 382, 'venous'), ('UBERON_0001987', 'placenta', 392, 'placental'), ('UBERON_0000178', 'blood', 402, 'blood')]
PMC5486026	6/2017	S124-PMC5486026	['sampling\nat recruitment and during Labor, 10 ml of maternal Blood were collected.']	N/A	N/A	[('GO_0007612', 'learning', 35, 'labor'), ('UBERON_0000178', 'blood', 60, 'blood')]
PMC5486026	6/2017	S125-PMC5486026	['the Blood samples at recruitment were collected under fasting, but not at Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('GO_0007567', 'parturition', 74, 'delivery')]
PMC5486026	6/2017	S126-PMC5486026	['we also collected 2 ml of Venous Cord Blood.']	N/A	N/A	[('UBERON_0005487', 'vitelline vein', 26, 'venous cord'), ('UBERON_0000178', 'blood', 38, 'blood')]
PMC5486026	6/2017	S127-PMC5486026	['Blood Serum was separated within 1 h by centrifugation at 1000× g for 5 min.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 6, 'serum')]
PMC5486996	9/2016	S79-PMC5486996	['women are followed through Pregnancy and until 1-year Postpartum, along with their infants from Birth to 1 year, with collection of anthropometrics, Blood, Stool, and Urine specimens, previous and current medical and demographic information, and Dietary Intake and Eating and physical activity behaviors.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'pregnancy'), ('GO_0007565', 'female pregnancy', 54, 'postpartum'), ('GO_0007567', 'parturition', 96, 'birth'), ('UBERON_0000178', 'blood', 149, 'blood'), ('UBERON_0001988', 'feces', 156, 'stool'), ('UBERON_0001088', 'urine', 167, 'urine'), ('GO_0050923', 'regulation of negative chemotaxis', 246, 'dietary intake'), ('GO_0051318', 'G1 phase', 265, 'eating')]
PMC5486996	9/2016	S104-PMC5486996	['biospecimens collected include maternal Blood, Urine, Rectal swab, Cord Blood and child Rectal swab.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0001088', 'urine', 47, 'urine'), ('UBERON_0001052', 'rectum', 54, 'rectal'), ('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0001052', 'rectum', 88, 'rectal')]
PMC5487839	3/2016	S219-PMC5487839	['favourable prognostic factors are normal Blood pressure and gfr equal to or above 70\xa0ml/min before Conception [60,181–186].']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0007620', 'copulation', 99, 'conception')]
PMC5489519	6/2017	S118-PMC5489519	['all subjects were taking a Prenatal Vitamin with 400\u2009iu of Vitamin D. Blood samples were collected by venipuncture at the time of the study visit; then placed in a Serum separator tube, centrifuged, and Serum stored at −20\u2009°c until later analysis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 36, 'vitamin'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0000178', 'blood', 70, 'Blood'), ('UBERON_0001977', 'blood serum', 164, 'serum'), ('UBERON_0001977', 'blood serum', 203, 'serum')]
PMC5489519	6/2017	S123-PMC5489519	['total circulating Serum 25(Oh)D concentration was measured in duplicate within the month the Blood sample was obtained.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 24, '25(OH)D'), ('UBERON_0000178', 'blood', 93, 'blood')]
PMC5513133	7/2017	S75-PMC5513133	['in pe, circulating Serum angiotensin i, angiotensin ii and Aldosterone are lower compared to normotensive women, while Plasma active renin levels and Autoantibodies to the angiotensin ii type 1 receptor, which stimulate receptor signaling to increase systemic Blood pressure, are higher [62–64].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('CHEBI_27584', 'aldosterone', 59, 'aldosterone'), ('UBERON_0001969', 'blood plasma', 119, 'plasma'), ('GO_0044308', 'axonal spine', 150, 'autoantibodies'), ('UBERON_0000178', 'blood', 260, 'blood')]
PMC5513133	7/2017	S192-PMC5513133	['25(Oh)D levels were assessed from stored Blood samples drawn between 15 and 21\xa0weeks Gestation for multiple marker screening.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 0, '25(OH ... D'), ('UBERON_0000178', 'blood', 41, 'blood'), ('GO_0007565', 'female pregnancy', 85, 'gestation')]
PMC5513591	7/2017	S43-PMC5513591	['this allowed us to select the time at which Blood could be sampled to determine the Tracer dilution and accurately calculate maternal total body Water.']	N/A	N/A	[('UBERON_0000178', 'blood', 44, 'blood'), ('CHEBI_35204', 'tracer', 84, 'tracer'), ('CHEBI_15377', 'water', 145, 'water')]
PMC5513591	7/2017	S50-PMC5513591	['syringes of D2O were weighed before and after injection with a precision scale of 0.1 mg.\nthree-hundred μl of Blood were collected from mothers at 3 h, 24 h, 48 h and 72 h after D2O injection, and 200 μl of a pool of Urine was collected from pups at 24 h, 48 h, 72 h and 96 h after D2O injection.']	N/A	N/A	[('CHEBI_18320', '1,4-dithiothreitol', 12, 'D2O'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_18320', '1,4-dithiothreitol', 178, 'D2O'), ('UBERON_0001088', 'urine', 217, 'urine'), ('CHEBI_18320', '1,4-dithiothreitol', 282, 'D2O')]
PMC5513591	7/2017	S51-PMC5513591	['dams’ Blood samples were obtained by Tail snip after 5 min-Isoflurane anesthesia, collected in vacuum tube containing Ethylenediamine Tetraacetate, and centrifuged at 1050 g and 4°c for 10 min.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0002415', 'tail', 37, 'tail'), ('CHEBI_6015', 'isoflurane', 59, 'isoflurane'), ('CHEBI_63877', 'diethanolammonium nitrate', 118, 'ethylenediamine tetraacetate')]
PMC5514114	7/2017	S20-PMC5514114	['in Rodent Pregnancy, Insulin resistance is readily induced by a high-fat diet rich in saturated fat16–18, which also leads to an offspring phenotype of leptin resistance with hyperphagia19,20, increased body weight and adiposity16,17,20, reduced Insulin sensitivity16,20, dyslipidaemia20, and elevated Blood pressure17,20.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 3, 'rodent'), ('GO_0007565', 'female pregnancy', 10, 'pregnancy'), ('PR_000045358', 'insulin family protein', 21, 'insulin'), ('PR_000045358', 'insulin family protein', 246, 'insulin'), ('UBERON_0000178', 'blood', 302, 'blood')]
PMC5514114	7/2017	S64-PMC5514114	['pups not allocated to litters were killed by decapitation, when Plasma, Red Blood Cells, Liver, and Heart were collected.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CL_0000232', 'erythrocyte', 72, 'red blood cells'), ('UBERON_0000178', 'blood', 76, 'blood'), ('UBERON_0002107', 'liver', 89, 'liver'), ('UBERON_0000948', 'heart', 100, 'heart')]
PMC5514114	7/2017	S69-PMC5514114	['systolic Blood pressure was analysed at 95 days of age by Tail cuff plethysmography (model 179 with an automatic cuff inflation pump (nw20), iitc, life science, woodland hills, ca), according to the manufacturer’s instructions as previously described33.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0002415', 'tail', 58, 'tail')]
PMC5514114	7/2017	S70-PMC5514114	['Adult offspring were warmed using a heat lamp and acclimatised to the restraint tube for 15\u2009minutes prior to Blood pressure recordings.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('UBERON_0000178', 'blood', 109, 'blood')]
PMC5514114	7/2017	S71-PMC5514114	['three clear pressure recordings were taken per Animal (cv\u2009<\u20095%) and mean Blood pressure calculated.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 47, 'animal'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5514114	7/2017	S73-PMC5514114	['after collection of Tail Blood (at t0), a Glucose load (1\u2009g/kg of body weight) was given by gavage.']	N/A	N/A	[('UBERON_0002415', 'tail', 20, 'tail'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_17234', 'glucose', 42, 'glucose')]
PMC5514114	7/2017	S74-PMC5514114	['Blood was collected from the Tail at t30, t60, t90 and t120 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002415', 'tail', 29, 'tail')]
PMC5514114	7/2017	S81-PMC5514114	['Blood was collected in edta tubes and stored on ice until centrifugation and removal of Plasma for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 88, 'plasma')]
PMC5514114	7/2017	S83-PMC5514114	['assays\nduring the oral Glucose tolerance test, Glucose concentration was measured by glucometer (optium xceed; abbott laboratories) from Tail whole Blood, at the time samples were taken.']	N/A	N/A	[('CHEBI_17234', 'glucose', 23, 'glucose'), ('CHEBI_17234', 'glucose', 47, 'glucose'), ('UBERON_0002415', 'tail', 137, 'tail'), ('UBERON_0000178', 'blood', 148, 'blood')]
PMC5514114	7/2017	S118-PMC5514114	['caption (table-wrap): table 5\n\nstudy outcomes among Adult male offspring according to the maternal diet (control or high-fat), and gavage treatment during Pregnancy [Fish oil or control (Water)].maternal control dietmaternal high-fat dietcontrolfish oilcontrolfish oiln12121212glucose Homeostasis\xa0\xa0matsuda index1.35\u2009±\u20090.171.27\u2009±\u20090.250.84\u2009±\u20090.09†1.55\u2009±\u20090.26*\xa0\xa0Homa-Ir3.02\u2009±\u20090.413.89\u2009±\u20090.634.57\u2009±\u20090.54†2.66\u2009±\u20090.42*\xa0\xa0fasting Glucose (mmol/l)4.96\u2009±\u20090.145.46\u2009±\u20090.215.03\u2009±\u20090.115.03\u2009±\u20090.21\xa0\xa0Glucose auc (min.mmol/l)847\u2009±\u200925841\u2009±\u200928866\u2009±\u200931818\u2009±\u200929\xa0\xa0fasting Insulin (pmol/l)497\u2009±\u200963556\u2009±\u200974732\u2009±\u200979434\u2009±\u200971*\xa0\xa0Insulin auc (x103\u2009min.pmol/l)76\u2009±\u2009982\u2009±\u200911124\u2009±\u200914†81\u2009±\u20099liver function\xa0\xa0alp (u/l)79\u2009±\u2009466\u2009±\u2009376\u2009±\u2009582\u2009±\u20096\xa0\xa0ast (u/l)144\u2009±\u200913133\u2009±\u20095171\u2009±\u20099160\u2009±\u200914\xa0\xa0alt (u/l)36\u2009±\u2009235\u2009±\u2009238\u2009±\u2009438\u2009±\u20092lipids\xa0\xa0free Fatty Acids (mmol/l)0.83\u2009±\u20090.090.79\u2009±\u20090.070.95\u2009±\u20090.120.83\u2009±\u20090.08\xa0\xa0total Cholesterol (mmol/l)1.70\u2009±\u20090.131.94\u2009±\u20090.111.96\u2009±\u20090.151.81\u2009±\u20090.09\xa0\xa0hdl-c (mmol/l)1.21\u2009±\u20090.091.46\u2009±\u20090.081.37\u2009±\u20090.101.39\u2009±\u20090.06\xa0\xa0ldl-c (mmol/l)0.29\u2009±\u20090.030.25\u2009±\u20090.030.25\u2009±\u20090.020.25\u2009±\u20090.03\xa0\xa0Triglycerides (mmol/l)0.68\u2009±\u20090.070.94\u2009±\u20090.091.23\u2009±\u20090.15†0.87\u2009±\u20090.11other\xa0\xa0Uric Acid (µmol/l)71\u2009±\u2009575\u2009±\u2009273\u2009±\u2009369\u2009±\u20096\xa0\xa0leptin (ng/ml)1.6\u2009±\u20090.34.2\u2009±\u20091.3*5.7\u2009±\u20091.3††4.0\u2009±\u20090.9\xa0\xa0systolic Blood pressure (mmhg)124\u2009±\u20091125\u2009±\u20091136\u2009±\u20091††††135\u2009±\u20091\ndata are means\u2009±\u2009standard errors.†p\u2009<\u20090.05,††p\u2009<\u20090.01, and††††p\u2009<\u20090.0001 for a maternal diet effect among the offspring of dams that received control gavage; *p\u2009<\u20090.05 and **p\u2009<\u20090.01 for an effect of the gavage treatment between groups exposed to the same maternal diet.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 52, 'adult'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 166, 'fish'), ('CHEBI_15377', 'water', 187, 'water'), ('GO_0042592', 'homeostatic process', 285, 'homeostasis'), ('PR_000008680', 'homer protein homolog 3', 359, 'HOMA-IR3'), ('CHEBI_17234', 'glucose', 422, 'glucose'), ('CHEBI_17234', 'glucose', 484, 'Glucose'), ('PR_000045358', 'insulin family protein', 550, 'insulin'), ('PR_000045358', 'insulin family protein', 601, 'Insulin'), ('CHEBI_35366', 'fatty acid', 796, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 868, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 1054, 'Triglycerides'), ('CHEBI_28895', "3'-UMP", 1128, 'Uric acid'), ('UBERON_0000178', 'blood', 1236, 'blood')]
PMC5514114	7/2017	S130-PMC5514114	['effects of supplemental Fish Oil in control diet\nthere were no differences between the con-fo and the con-con group in terms of Food Consumption, body weight, adiposity, Insulin sensitivity, Lipid profile, or systolic Blood pressure (tables\xa04and5).']	N/A	N/A	[('CHEBI_34766', 'Furamizole', 24, 'fish oil'), ('CHEBI_33290', 'food', 128, 'food'), ('GO_0007631', 'feeding behavior', 128, 'food consumption'), ('PR_000045358', 'insulin family protein', 170, 'insulin'), ('CHEBI_18059', 'lipid', 191, 'lipid'), ('UBERON_0000178', 'blood', 218, 'blood')]
PMC5523023	7/2017	S102-PMC5523023	['we studied the markers of oxidative stress in exhaled Breath [exhaled Carbon Monoxide (eco), Nitric Oxide] and in the peripheral Blood (concentration of free Thiol Groups as a marker of protein oxidation and concentration of Tbars as a marker of Lipid peroxidation) and also analyzed the selected Single Nucleotide Polymorphisms in the Genes for two important antioxidant enzymes, such as polymorphisms of two important antioxidant enzymes, theta Isoform of Glutathione transferase (Gene Gst-T1 ) and catalase (Gene cat ).']	N/A	N/A	[('UBERON_0000310', 'breast', 54, 'breath'), ('CHEBI_17245', 'carbon monoxide', 70, 'carbon monoxide'), ('CHEBI_16480', 'nitric oxide', 93, 'nitric oxide'), ('UBERON_0000178', 'blood', 129, 'blood'), ('CHEBI_29917', 'thiol group', 158, 'thiol'), ('CHEBI_24433', 'group', 164, 'groups'), ('CHEBI_17855', 'triglyceride', 225, 'TBARS'), ('CHEBI_18059', 'lipid', 246, 'lipid'), ('SO_0000694', 'SNP', 297, 'single nucleotide polymorphisms'), ('SO_0000704', 'gene', 336, 'genes'), ('SO_0001060', 'sequence_variant', 447, 'isoform'), ('CHEBI_16856', 'glutathione', 458, 'glutathione'), ('SO_0000704', 'gene', 483, 'gene'), ('PR_000008295', 'glutathione S-transferase A2', 488, 'GST-T1'), ('SO_0000704', 'gene', 511, 'gene')]
PMC5526786	8/2017	S20-PMC5526786	['increased Renal Blood flow leads to an increase in Renal size of 1–1.5\xa0cm[67],[68].activation of the Renin-angiotensin system (ras) leads to increased Plasma levels of both Renin and aldosterone and subsequent Salt and Water retention in the Distal Tubule and Collecting Duct.']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0002113', 'kidney', 51, 'renal'), ('PR_000014368', 'RuvB-like 1', 101, 'renin'), ('UBERON_0001969', 'blood plasma', 151, 'plasma'), ('PR_000014368', 'RuvB-like 1', 173, 'renin'), ('CHEBI_24866', 'salt', 210, 'salt'), ('CHEBI_15377', 'water', 219, 'water'), ('UBERON_0004135', 'distal tubule', 242, 'distal tubule'), ('UBERON_0001232', 'collecting duct of renal tubule', 260, 'collecting duct')]
PMC5526786	8/2017	S56-PMC5526786	['the potent vasodilator activity of Nitric Oxide produced in this manner acts to compensate Blood pressure following a high Salt diet.']	N/A	N/A	[('CHEBI_16480', 'nitric oxide', 35, 'nitric oxide'), ('UBERON_0000178', 'blood', 91, 'blood'), ('CHEBI_24866', 'salt', 123, 'salt')]
PMC5526786	8/2017	S65-PMC5526786	['furthermore the ability of Salt to alter Blood pressure varies between Individuals and is referred to as salt-sensitivity.']	N/A	N/A	[('CHEBI_24866', 'salt', 27, 'salt'), ('UBERON_0000178', 'blood', 41, 'blood'), ('NCBITaxon_1', 'root', 71, 'individuals')]
PMC5526786	8/2017	S70-PMC5526786	['the way in which eo is able to Regulate Blood pressure is due to its ability to function as a Na+pump inhibitor thereby preventing Renal Na+reabsorption, to enhance vascular tone and Regulate Ca2+Signalling in Myocytes, Endothelial Cells and Neurons[37],[38],[39].']	N/A	N/A	[('GO_0065007', 'biological regulation', 31, 'regulate'), ('UBERON_0000178', 'blood', 40, 'blood'), ('CHEBI_29101', 'sodium(1+)', 94, 'Na+'), ('UBERON_0002113', 'kidney', 131, 'renal'), ('CHEBI_29101', 'sodium(1+)', 137, 'Na+'), ('GO_0065007', 'biological regulation', 183, 'regulate'), ('CHEBI_29108', 'calcium(2+)', 192, 'Ca2+'), ('GO_0019722', 'calcium-mediated signaling', 192, 'Ca2+signalling'), ('CL_0000187', 'muscle cell', 210, 'myocytes'), ('CL_0000115', 'endothelial cell', 220, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 220, 'endothelial'), ('CL_0000540', 'neuron', 242, 'neurons')]
PMC5526786	8/2017	S72-PMC5526786	['in patients with essential hypertension eo is found to accumulate in those Tissues responsible for Blood Pressure Regulation (e.g Kidneys, Hypothalamus and Posterior Pituitary).']	N/A	N/A	[('UBERON_0000479', 'tissue', 75, 'tissues'), ('GO_0008217', 'regulation of blood pressure', 99, 'blood pressure regulation'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0002113', 'kidney', 130, 'kidneys'), ('UBERON_0001898', 'hypothalamus', 139, 'hypothalamus'), ('UBERON_0002198', 'neurohypophysis', 156, 'posterior pituitary')]
PMC5526786	8/2017	S120-PMC5526786	['this was combined with the increased occurrence of rising Blood pressure in the high Salt diet supplementation non-Pregnant group.']	N/A	N/A	[('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_24866', 'salt', 85, 'salt'), ('GO_0007565', 'female pregnancy', 115, 'pregnant')]
PMC5526786	8/2017	S128-PMC5526786	['when these same Mice are given a 5% Nacl diet foetal weight is increased and Blood pressure falls.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 16, 'mice'), ('CHEBI_26710', 'sodium chloride', 36, 'NaCl'), ('UBERON_0000178', 'blood', 77, 'blood')]
PMC5526977	7/2017	S112-PMC5526977	['there was no effect of maternal hfd on terminal Blood Triglycerides (non-fasted) (data not shown).']	N/A	N/A	[('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_17855', 'triglyceride', 54, 'triglycerides')]
PMC5526977	7/2017	S318-PMC5526977	['Tail Blood samples were collected at 15, 30, 60, 90, 120, and 180\u2009min post-injection.']	N/A	N/A	[('UBERON_0002415', 'tail', 0, 'Tail'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC5526977	7/2017	S321-PMC5526977	['Blood samples were collected from the Tail in individual cages at 15, 30, 60, 90, and 120\u2009min post-injection.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002415', 'tail', 38, 'tail')]
PMC5526977	7/2017	S323-PMC5526977	['Brain and body dissections\nafter sufficient recovery from the itt (~1 week), females were decapitated after sedation with Ketamine (100\u2009µl of 100\u2009mg/ml, ip) at 1000\u2009h. Trunk Blood was collected in a k+edta collection tube and analyzed for Triglyceride levels using a cardiochek (polymer technology systems, indianapolis, in, usa).']	N/A	N/A	[('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_6121', 'ketamine', 122, 'ketamine'), ('UBERON_0002100', 'trunk', 168, 'Trunk'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_17855', 'triglyceride', 239, 'triglyceride')]
PMC5531500	7/2017	S3-PMC5531500	['First Trimester fasting Blood Glucose was also obtained from ob women.']	N/A	N/A	[('GO_0046897', 'N-terminal peptidyl-tyrosine methylation', 0, 'First trimester'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_17234', 'glucose', 30, 'glucose')]
PMC5531500	7/2017	S37-PMC5531500	['bodyweight, Blood pressure and proteinuria (assessed by a dipstick test) were recorded.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood')]
PMC5531500	7/2017	S44-PMC5531500	['Pregnancy induced hypertension was defined as systolic Blood pressure >140 mm hg and diastolic Blood pressure > 90 mm hg.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC5531500	7/2017	S75-PMC5531500	['homa-ir was calculated using the following formula: homa-i = (fasting Plasma Insulin (mui/l) ×fasting Blood Glucose (mmol/l))/22.5.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 70, 'plasma'), ('PR_000045358', 'insulin family protein', 77, 'insulin'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_17234', 'glucose', 108, 'glucose')]
PMC5531500	7/2017	S76-PMC5531500	['on admission to the Delivery suite, maternal Blood was collected for hba1c and hormones assays.']	N/A	N/A	[('GO_0007567', 'parturition', 20, 'delivery'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC5531500	7/2017	S78-PMC5531500	['after Delivery, glycemia was measured immediately in Cord Blood, Serum aliquots were stored immediately at -80°c until leptin and c-peptide assays were performed.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0001977', 'blood serum', 65, 'serum')]
PMC5531500	7/2017	S92-PMC5531500	['18.5≤ bmi<25 kg/m2bmi≥30 kg/m2maternal characteristicsn = 222n = 226p-valueage (years)30.9 [4]30.8 [4.7]0.7 primiparity n (%) 82 (36.9)89 (39.4)0.6 Gestational age at inclusion (wks)14.8 [2.1]14.8 [2.3]0.9 bmi (kg/m2)before Pregnancy 21.3 [1.7]34.7 [4.6]<0.0001at inclusion 22.4 [1.9]35.5 [4.4]<0.0001education n(%)<0.001 no diploma8 (3.6)26 (11.6)secondary school18 (8.2)44 (19.6)high school diploma25 (11.4)50 (22.2)higher education169 (76.8)105 (46.7) ethnicity n (%)<0.001 white european154 (69.7)76 (33.9)northern africa18 (8.1)52 (23.2)sub saharan africa31 (14)89 (39.7)other18 (8.1)7 (3.1) Gestational hypertension n (%) 2 (0.9)14 (6.3) 0.002caesarian section n (%) 36 (16.3)102 (45.1) <0.001smoking during Pregnancy n (%) 22 (10.1)22 (9.8)0.9 Alcohol use n (%) 9 (4.1)5 (2.2)0.3 Gestational weight gain (kg) 13.5 [4.2]8.2 [7.4]<0.0001 within recommended range n (%)90 (42.7)56 (26.5) <0.01 more than recommended n (%)52 (24.6)96 (45.5)less than recommended n (%)69 (32.7)59 (28.0) Gestational diabetes n (%) 41 (20)99 (45.2) <0.0001 Insulin treatment8 (21.1)49 (52.1)Gestational age at diagnosis n (%)< 18 weeks4 (9.8)49 (49.5)24–28 weeks13 (31.7)36 (36.4)32 weeks24 (58.5)14 (14.1) maternal biological data glycaemia at 37 weeks (mmol/l)4.1 [0.5]4.3 [0.5]<0.01 insulinemia at 37 weeks (mu/ml)10.7 [8.4]19.6 [11.6]<0.0001 homa-ir at 37 weeks2.0 [1.8]3.8 [2.6]<0.0001 hba1c at Delivery (%)5.4 [0.3]5.5 [0.4]<0.0001 leptin at Delivery (ng/ml)23.0 [14.2]48.7 [25.3]<0.0001 adiponectin at delivery (μg/ml)6.0 [2.32]5.0 [2.5]<0.0001neonatal characteristicsn = 222n = 226 Gestational age (weeks)39.8 [1.1]39.6 [1.1]0.09boys n (%)117 (53)103 (45)0.13 Birthweight (g) boys3456 [433]3392 [463]0.24girls3316 [402]3391[408]0.43weight z-score0.01 [0.95]0.08 [0.96]0.4ponderal index (g/cm3)2.75 [0.24]2.78 [0.28]0.2sum of Skinfolds (mm)17.9 [3.3]19.4 [3.9]<0.0001cord Blood biological data glycemia (mmol/l)4.2 [0.92]4.2 [1.0]0.5leptin (ng/ml)9.7 [8.8]12.6 [10.1]<0.01 c-peptide (ng/ml)0.77 [0.7]0.96 [0.7]0.04boys sum of Skinfolds (mm)18.1 [3.5]18.8 [4.2]0.20leptin (ng/ml)8.4 [8]8.9 [6.5]0.7placenta weight (g)570 [132]602 [150]0.21 girls sum of Skinfolds (mm)17.8 [3.1]19.9 [3.6]<0.0001 leptin (ng/ml)11.1 [9.4]15.6 [11.34]<0.01 Placenta weight (g)549 [122]609 [126]<0.01 10.1371/journal.pone.0181307.t002\n\ncaption (table-wrap): table 2\nmaternal and neonatal characteristics according to maternal bmi and to diabetic status.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 148, 'Gestational'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007565', 'female pregnancy', 597, 'Gestational'), ('GO_0007565', 'female pregnancy', 714, 'pregnancy'), ('CHEBI_30879', 'alcohol', 751, 'Alcohol'), ('GO_0007565', 'female pregnancy', 787, 'Gestational'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('PR_000045358', 'insulin family protein', 1041, 'Insulin'), ('GO_0007565', 'female pregnancy', 1075, 'Gestational'), ('GO_0007567', 'parturition', 1384, 'delivery'), ('GO_0007567', 'parturition', 1432, 'delivery'), ('GO_0007565', 'female pregnancy', 1574, 'Gestational'), ('GO_0007608', 'sensory perception of smell', 1652, 'Birthweight'), ('UBERON_0009007', 'superficial inguinal lymph node', 1817, 'skinfolds'), ('UBERON_0000178', 'blood', 1863, 'blood'), ('UBERON_0009007', 'superficial inguinal lymph node', 2017, 'skinfolds'), ('UBERON_0009007', 'superficial inguinal lymph node', 2143, 'skinfolds'), ('UBERON_0001987', 'placenta', 2227, 'Placenta')]
PMC5537904	7/2017	S7-PMC5537904	['Cord Blood 25(Oh)D was not associated with offspring size or body composition at 5 months.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_71657', 'versiconol acetate', 11, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 11, '25(OH ... D')]
PMC5537904	7/2017	S70-PMC5537904	['assessment of 25(Oh)D\nUmbilical Cord Blood samples were obtained at Delivery and processed by the colorado clinical and translational science institute core laboratory.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 14, '25(OH)D'), ('UBERON_0002331', 'umbilical cord', 22, 'Umbilical cord'), ('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0007567', 'parturition', 68, 'delivery')]
PMC5537904	7/2017	S94-PMC5537904	['mother-offspring dyads were eligible for the analyses if offspring were Born ≥37 weeks Gestation, had 25(Oh)D measured in Cord Blood, and had at least one of the following: complete data on maternal Intake of Vitamin D during Pregnancy from Food and dietary supplements, body composition measured at Birth, or body composition measured Postnatally.']	N/A	N/A	[('GO_0007567', 'parturition', 72, 'born'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 102, '25(OH ... D'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('GO_0007631', 'feeding behavior', 199, 'intake'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('CHEBI_33290', 'food', 241, 'food'), ('GO_0007567', 'parturition', 300, 'birth'), ('GO_0007565', 'female pregnancy', 336, 'postnatally')]
PMC5537904	7/2017	S142-PMC5537904	['there was no evidence of an association between Cord Blood 25(Oh)D and infant body size or composition at 5 months of age.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 59, '25(OH)D')]
PMC5537904	7/2017	S167-PMC5537904	['for every 100 iu/day increase in Vitamin D from Food sources or dietary supplements, we observed a 0.6 nmol/l increase in Cord Blood 25(Oh)D. this is a substantially smaller increase than the 2.5 nmol/l increase per 100 iu/day benchmark that has been used to guide Vitamin D supplementation [62].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33290', 'food', 48, 'food'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC5538262	5/2017	S114-PMC5538262	['the Placenta, Cord Blood, and other samples were collected and frozen at Birth and the children were followed until a diagnosis of autism or td was obtained at age 36 months by adi-r in addition to other assessments.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002240', 'spinal cord', 14, 'cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('GO_0007567', 'parturition', 73, 'birth')]
PMC5538262	5/2017	S146-PMC5538262	['maternal mthfr 677 genotype from taqman assays in maternal Blood dna and dietary Folate equivalents calculated from block Food frequencies completed by mothers for the first half and second half of Pregnancy were also examined in bivariate analyses (tables 1,3,s2).']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 81, 'folate'), ('CHEBI_33290', 'food', 122, 'food'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC5539663	7/2017	S41-PMC5539663	['at zero time (baseline), Blood sample was drawn; then, the participants were given 75 g of Glucose in Solution to drink within a 5 min time frame.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_17234', 'glucose', 91, 'glucose'), ('CHEBI_75958', 'solution', 102, 'solution')]
PMC5539663	7/2017	S50-PMC5539663	['normal result for the Glucose screening test was fasting Blood Sugar between 100 and 120 mg/dl.']	N/A	N/A	[('CHEBI_17234', 'glucose', 22, 'glucose'), ('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_24870', 'ion', 63, 'sugar')]
PMC5539754	8/2017	S54-PMC5539754	['fasting Serum Blood samples were collected at the first Antenatal visit (early Pregnancy) and at the 28-week Gestation visit (late Pregnancy) for the measurement of Insulin and 25Ohd.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007567', 'parturition', 56, 'antenatal'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('PR_000045358', 'insulin family protein', 165, 'insulin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD')]
PMC5541627	6/2017	S56-PMC5541627	['anthropometric, body fat composition and Blood pressure measurements were also taken at the baseline interview.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC5543438	8/2017	S77-PMC5543438	['dietitians), Food insecurity - increased access to specialist services through telehealth and allied health outreach visits resulted in enhanced local health professionals’ knowledge.- establishment of nutrition in Pregnancy working group resulted in the development of nutrition education resources.- partnership activities resulted in midwives taking on the role of commencing Blood Glucose Monitoring with the women.']	N/A	N/A	[('CHEBI_33290', 'food', 13, 'food'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0002026', 'regulation of the force of heart contraction', 379, 'blood glucose monitoring'), ('UBERON_0000178', 'blood', 379, 'blood'), ('CHEBI_17234', 'glucose', 385, 'glucose')]
PMC5543438	8/2017	S78-PMC5543438	['all nt diabetes services are now able to provide home Blood Glucose Monitoring equipment to women.']	N/A	N/A	[('GO_0002026', 'regulation of the force of heart contraction', 54, 'blood glucose monitoring'), ('UBERON_0000178', 'blood', 54, 'blood'), ('CHEBI_17234', 'glucose', 60, 'glucose')]
PMC5546866	8/2017	S36-PMC5546866	['a screening Blood sample was obtained and analyzed on the local nhs platform [all three laboratories (southampton, oxford, and sheffield) participate in the Vitamin D external quality assessment scheme (http://www.deqas.org/)].']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_28384', 'vitamin K', 157, 'Vitamin D')]
PMC5546866	8/2017	S48-PMC5546866	['assessment of 25(Oh)D\non the day that the study Medication was dispensed and at 34 weeks of Gestation, a nonfasted Venous Blood sample was obtained and Serum stored at −80°c.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 14, '25(OH)D'), ('CHEBI_60211', 'compound Z', 48, 'medication'), ('GO_0007565', 'female pregnancy', 92, 'gestation'), ('UBERON_0001638', 'vein', 115, 'venous'), ('UBERON_0000178', 'blood', 122, 'blood'), ('UBERON_0001977', 'blood serum', 152, 'serum')]
PMC5546866	8/2017	S71-PMC5546866	['we also undertook sensitivity analysis in which women who reported having taken any additional Vitamin D–containing Supplements within 90 days of the late-Pregnancy Blood sampling were excluded.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 116, 'supplements'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy'), ('UBERON_0000178', 'blood', 165, 'blood')]
PMC5546866	8/2017	S88-PMC5546866	['this association persisted in multivariate analysis adjusting for maternal age, bmi, smoking status, physical activity, educational achievement and season of Blood sampling [ β = 3.1 nmol/l per t Allele; 95% confidence interval (ci), 1.0 to 5.2 nmol/l; p = 0.016].']	N/A	N/A	[('UBERON_0000178', 'blood', 158, 'blood'), ('SO_0001023', 'allele', 196, 'allele')]
PMC5546866	8/2017	S92-PMC5546866	['adjusted for age, bmi, smoking status (yes/no), physical activity (strenuous activity more than once per week, yes/no), educational achievement (a levels or higher, yes/no), and season of Blood sampling (winter, spring, summer, autumn).']	N/A	N/A	[('UBERON_0000178', 'blood', 188, 'blood')]
PMC5546866	8/2017	S104-PMC5546866	['adjusted for age, Pregnancy weight gain, smoking status (yes/no), physical activity (strenuous activity more than once per week, yes/no), educational achievement (a levels or higher, yes/no), season of Blood sampling (winter, spring, summer, autumn), compliance with study protocol, and baseline 25(Oh)D.\nbonferroni-corrected p values.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'pregnancy'), ('UBERON_0000178', 'blood', 202, 'blood'), ('CHEBI_71657', 'versiconol acetate', 296, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 296, '25(OH)D')]
PMC5546866	8/2017	S115-PMC5546866	['models were adjusted for age, physical activity, smoking status, educational attainment, season of Blood sampling, compliance, and Pregnancy weight gain.']	N/A	N/A	[('UBERON_0000178', 'blood', 99, 'blood'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5547508	8/2017	S108-PMC5547508	['chws in the sc will refer all mothers to local clinics for hiv, Blood Sugar, and Pregnancy testing.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_24870', 'ion', 70, 'sugar'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC5551222	7/2017	S3-PMC5551222	['spearman correlation coefficients were calculated comparing log Blood hg and n-3 Pufas to Seafood Consumption, then stratified by Pregnancy status.']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_86926', 'S a S b S', 81, 'PUFAs'), ('CHEBI_34973', 'Selfotel', 90, 'seafood'), ('GO_0007631', 'feeding behavior', 98, 'consumption'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy')]
PMC5551222	7/2017	S38-PMC5551222	['during recruitment, women completed an in-person questionnaire and were asked to provide Saliva and Blood samples.']	N/A	N/A	[('UBERON_0004339', 'vault of skull', 89, 'saliva'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC5551222	7/2017	S39-PMC5551222	['of the 1788 women who were recruited, 634 women provided a Blood sample; the most common reason for not obtaining a Blood sample was not wanting to undergo a needle stick.']	N/A	N/A	[('UBERON_0000178', 'blood', 59, 'blood'), ('UBERON_0000178', 'blood', 116, 'blood')]
PMC5551222	7/2017	S40-PMC5551222	['a metal-free (blue top) tube was used for Blood collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 42, 'blood')]
PMC5551222	7/2017	S46-PMC5551222	['biomarkers\nnon-fasting Blood samples were taken from participants at the time of recruitment.']	N/A	N/A	[('UBERON_0000178', 'blood', 23, 'blood')]
PMC5551222	7/2017	S47-PMC5551222	['Mercury (Hg) and N-3 Pufa were estimated from Blood samples.']	N/A	N/A	[('CHEBI_39378', 'homopteran inhibitor of chitin biosynthesis', 0, 'Mercury'), ('CHEBI_15377', 'water', 9, 'Hg'), ('CHEBI_80445', '9,10-EOT', 17, 'n-3 PUFA'), ('UBERON_0000178', 'blood', 46, 'blood')]
PMC5551222	7/2017	S48-PMC5551222	['Serum Blood levels of N-3 Fatty Acids were obtained by determining Serum Alpha-Linolenic Acid (ala, 18:3n-3c), Erythrocyte Eicosapentaenoic Acid (Epa, 20:5n-3c), Docosapentaenoic Acid (Dpa, 22:5n-3c), and Docosahexaenoic Acid (Dha, 22:6-3c).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_35418', 'N-acetylneuraminate', 22, 'n-3 fatty acids'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('CHEBI_27432', 'alpha-linolenic acid', 73, 'alpha-linolenic acid'), ('CL_0000232', 'erythrocyte', 111, 'erythrocyte'), ('CHEBI_36003', 'decenoic acid', 123, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 146, 'EPA'), ('CHEBI_61205', 'docosatetraenoic acid', 162, 'docosapentaenoic acid'), ('CHEBI_49168', 'dopa', 185, 'DPA'), ('CHEBI_36003', 'decenoic acid', 205, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 227, 'DHA')]
PMC5551222	7/2017	S58-PMC5551222	['Blood samples were analyzed for hg by two methods, both of which employed atomic absorption for the detection the cold vapor Atomic absorption spectroscopy (cvaas) and the direct mercury analysis (dma) or thermal decomposition method.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_33250', 'atom', 125, 'atomic')]
PMC5551222	7/2017	S73-PMC5551222	['statistical analysis\nbecause hg Blood levels and n-3 Pufas were not distributed normally, logarithmic values were calculated for each of these measurements.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('CHEBI_86926', 'S a S b S', 53, 'PUFAs')]
PMC5551222	7/2017	S76-PMC5551222	['linear regression models were also created with Seafood Consumption predicting Blood hg levels, each N-3 Pufa individually, and total n-3 pufa.']	N/A	N/A	[('CHEBI_34973', 'Selfotel', 48, 'seafood'), ('GO_0007631', 'feeding behavior', 56, 'consumption'), ('UBERON_0000178', 'blood', 79, 'blood'), ('CHEBI_30256', 'thiocarbonyl group', 101, 'n-3'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 105, 'PUFA')]
PMC5551222	7/2017	S84-PMC5551222	['the median Blood hg levels were 1.66 μ/ml, and the median N-3 Pufa level was 3.66% of total Fatty Acids Consumed.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood'), ('CHEBI_30256', 'thiocarbonyl group', 58, 'n-3'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 62, 'PUFA'), ('CHEBI_35366', 'fatty acid', 92, 'fatty acids'), ('GO_0007631', 'feeding behavior', 104, 'consumed')]
PMC5551222	7/2017	S95-PMC5551222	['total Blood levels N-3 Pufa or ala was not found to be significantly associated with Seafood Consumption of N-3 Pufa-containing Seafood.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_80445', '9,10-EOT', 19, 'n-3 PUFA'), ('CHEBI_34973', 'Selfotel', 85, 'seafood'), ('GO_0007631', 'feeding behavior', 93, 'consumption'), ('CHEBI_80445', '9,10-EOT', 108, 'n-3 PUFA'), ('CHEBI_34973', 'Selfotel', 128, 'seafood')]
PMC5551222	7/2017	S136-PMC5551222	['limitations\nBlood samples and answers to ffqs were recorded cross-sectionally.']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'Blood')]
PMC555773	9/2004	S17-PMC555773	['No, synthesized in Neurons Of the Central Nervous System, acts as a neuromediator with many physiological functions, including the formation of Memory, coordination between Neuronal activity and Blood Flow, and modulation of pain [6].']	N/A	N/A	[('CHEBI_16382', 'iodide', 0, 'NO'), ('CL_0002421', 'nucleated reticulocyte', 19, 'neurons of ... central nervous system'), ('UBERON_0001017', 'central nervous system', 34, 'central nervous system'), ('GO_0007613', 'memory', 144, 'memory'), ('CL_0000540', 'neuron', 173, 'neuronal'), ('UBERON_0000178', 'blood', 195, 'blood'), ('GO_0007601', 'visual perception', 201, 'flow')]
PMC555773	9/2004	S83-PMC555773	['the Enos is Expressed constitutively in Endothelial Cells and synthesizes the No needed for Regulation Of Blood Pressure.']	N/A	N/A	[('PR_000007020', 'ETS-related transcription factor Elf-1', 4, 'eNOS'), ('GO_0010467', 'gene expression', 12, 'expressed'), ('CL_0000115', 'endothelial cell', 40, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 40, 'endothelial'), ('CHEBI_16382', 'iodide', 78, 'NO'), ('GO_0008217', 'regulation of blood pressure', 92, 'regulation of blood pressure'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC555773	9/2004	S114-PMC555773	['this Cgmp lowers the Intracellular Ca2+and relaxes the Muscles, dilating the Vessel and lowering Blood pressure.']	N/A	N/A	[('CHEBI_17361', "cytidine 5'-monophosphate", 5, 'cGMP'), ('GO_0005622', 'intracellular anatomical structure', 21, 'intracellular'), ('CHEBI_29108', 'calcium(2+)', 35, 'Ca2+'), ('UBERON_0005090', 'muscle structure', 55, 'muscles'), ('UBERON_0000055', 'vessel', 77, 'vessel'), ('UBERON_0000178', 'blood', 97, 'blood')]
PMC555773	9/2004	S233-PMC555773	['systemic Blood pressure and Coronary perfusion remained unaffected.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0005985', 'coronary vessel', 28, 'coronary')]
PMC5580292	9/2017	S34-PMC5580292	['individual Blood samples were collected at slaughter during exsanguinations.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood')]
PMC5580292	9/2017	S35-PMC5580292	['after collection of Blood, samples were kept at room temperature for 2\xa0h and then centrifuged for 10\xa0min at 3000×g at 4\xa0°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood')]
PMC5603094	9/2017	S21-PMC5603094	['it is a rapidly progressive condition characterized by elevated Blood pressure and protein in the Urine [1].']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('UBERON_0001088', 'urine', 98, 'urine')]
PMC5603094	9/2017	S43-PMC5603094	['inclusion criteria\nthe cases were women with Blood pressure\xa0≥\xa0140\xa0mmhg systolic or ≥90\xa0mmhg diastolic on two separate readings taken at least four hours apart with previously normal Blood pressure and when proteinuria is greater than or equal to 300\xa0mg per 24-h Urine collection or dipstick reading of 1+ after 28\xa0weeks’ Gestation [1].']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0000178', 'blood', 182, 'blood'), ('UBERON_0001088', 'urine', 262, 'urine'), ('GO_0007565', 'female pregnancy', 321, 'gestation')]
PMC5612564	7/2017	S82-PMC5612564	['Blood pressure monitor, saturation probe, and fetal Heart monitor have been applied and the monitor is beside the patient.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 52, 'heart')]
PMC5612564	7/2017	S101-PMC5612564	['the ob/gyn resident takes a history, orders initial investigations, and orders Labetalol or Hydralazine to decrease the patient’s Blood pressure.']	N/A	N/A	[('CHEBI_31764', 'Laudanosoline', 79, 'labetalol'), ('CHEBI_5775', 'hydralazine', 92, 'hydralazine'), ('UBERON_0000178', 'blood', 130, 'blood')]
PMC5612564	7/2017	S113-PMC5612564	['caption (table-wrap): table 2\nflow of the scenario\nbp: Blood pressure; fhr: fetal Heart rate; pvcs: premature Ventricular contractions; nicu: Neonatal Intensive Care team;\xa0instructor notes – changes and case branch pointsintervention / time pointchange in caseadditional information if the team mistakenly diagnoses the patient with Pregnancy induced hypertension or any other hypertensive disorder of Pregnancy \xa0 they will be allowed to continue managing according to their differential diagnosis.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0000948', 'heart', 82, 'heart'), ('UBERON_0002082', 'cardiac ventricle', 110, 'ventricular'), ('UBERON_0001759', 'vagus nerve', 142, 'neonatal'), ('UBERON_0001007', 'digestive system', 151, 'intensive care'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy')]
PMC5612564	7/2017	S114-PMC5612564	['their management will be ineffective and the patient and fetus will continue to deteriorateif the nurse or the ob/gyn resident want to move the patient from triage to an inpatient room \xa0 they will be told that a room is being prepared for the patient but this will take five to ten minutestwo minutes into the case \xa0 patient will volunteer that she is paraplegic if this information has not already been elicitedhusband will say “we were told at the pre anesthesia clinic that she needs an Epidural as soon as she goes into labour”if Labetalol ordered or givendecrease in bp to 168/95hr 60 \xa0 if Hydralazine ordered or givendecrease in bp to 168/95hr unchanged \xa0 five minutes into the case or immediately following the Pelvic exambp 190/115hr 50fhr decreases to 60 bpmif not recognized by participants within 30 seconds, patient will ask “is my baby ok?”once transferred to the operating roombp 200/115hr 50fhr recovers to 110if team does not recognize recovery in fhr, patient will ask “is my baby ok?”orconfederate nurse will prompt the team to look at the monitor by saying “the fhr has changed”15 minutesfetal Heart rate drops to 60if not recognized by the team, confederate nurse will prompt the team to look at the monitor by saying “the fhr has changed”if general anesthesia is inducedbp 185/105hr 55patient loses consciousness \xa0 if Succinylcholine is used during induction of anesthesiapatient develops pvcs and runs of Ventricular tachycardiathe patient’s Blood pressure will remain unchanged.']	N/A	N/A	[('UBERON_2000660', 'epural', 490, 'epidural'), ('CHEBI_31764', 'Laudanosoline', 534, 'labetalol'), ('CHEBI_5775', 'hydralazine', 595, 'hydralazine'), ('UBERON_0002108', 'small intestine', 718, 'pelvic'), ('UBERON_0000948', 'heart', 1113, 'heart'), ('CHEBI_45652', 'succinylcholine', 1339, 'succinylcholine'), ('UBERON_0002082', 'cardiac ventricle', 1427, 'ventricular'), ('UBERON_0000178', 'blood', 1464, 'blood')]
PMC5612564	7/2017	S115-PMC5612564	['if the anesthesiologist calls for help \xa0 confederate Respiratory therapist or anesthesia assistant will enterif the team calls for nicu \xa0 confederate nurse will say “nicu is on their way”if the team requests more help \xa0 confederate nurse will say “i’ve called the front desk but the other team is in the next case room performing another caesarean section and they cannot leave”if the team requests results of the Blood work they sent in triage \xa0 the confederate nurse will provide them to the team once in the operating room.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000178', 'blood', 414, 'blood')]
PMC5612564	7/2017	S118-PMC5612564	['the ob/gyn resident assesses the patient in triage, orders initial investigations (complete Blood count (cbc), electrolytes, Liver function tests, Coagulation tests, Urinalysis).']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0002107', 'liver', 125, 'liver'), ('GO_0050817', 'coagulation', 147, 'coagulation'), ('GO_0006281', 'DNA repair', 166, 'urinalysis')]
PMC5612564	7/2017	S119-PMC5612564	['they order Medications to treat the patient’s Blood pressure including labetalol or Hydralazine.']	N/A	N/A	[('CHEBI_25441', 'mycothiols', 11, 'medications'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_5775', 'hydralazine', 84, 'hydralazine')]
PMC5621069	9/2017	S32-PMC5621069	['when it is orally administered, it is Metabolized in the Liver and loses its potency, entailing irregular Blood concentration and more frequent side effects.']	N/A	N/A	[('GO_0008152', 'metabolic process', 38, 'metabolized'), ('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC5621970	7/2017	S8-PMC5621970	['serial complete Blood counts at the time of treatment would allow for early detection and timely management of the patient.']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'blood')]
PMC5621970	7/2017	S25-PMC5621970	['maternal Blood type was o positive.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC5621970	7/2017	S35-PMC5621970	['the complete Blood counts (cbcs) were checked daily.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood')]
PMC5621970	7/2017	S36-PMC5621970	['Chest x-ray and Blood cultures were negative.']	N/A	N/A	[('UBERON_0012131', 'centrale', 0, 'Chest'), ('UBERON_0000178', 'blood', 16, 'blood')]
PMC5621970	7/2017	S55-PMC5621970	['cbc, complete Blood count; ivig, intravenous immunoglobulin; wga, weeks Gestational age.']	N/A	N/A	[('UBERON_0000178', 'blood', 14, 'blood'), ('GO_0007565', 'female pregnancy', 72, 'gestational')]
PMC5621970	7/2017	S72-PMC5621970	['risk reduction mechanisms involve increasing infusion time and decreasing the maximum daily dosage.6hemolytic anemia is caused by the transfer of anti-a and anti-b Antibodies.9risk factors include higher cumulative ivig dose, non-o recipient Blood type, and recipient female gender.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 164, 'antibodies'), ('UBERON_0000178', 'blood', 242, 'blood')]
PMC5623322	9/2017	S54-PMC5623322	['laboratory outcomes\nchildren had Blood collected at 6 and 36 months of age by local phlebotomists from the provincial paediatric hospital.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood')]
PMC5623322	9/2017	S55-PMC5623322	['hb (g/dl) was measured using a portable photometer (hemocue hemoglobin systems), and 1 ml of Venous Blood was collected for ferritin and Vitamin B12 concentrations.']	N/A	N/A	[('UBERON_0001638', 'vein', 93, 'venous'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_33279', 'vitamin D5', 137, 'vitamin B12')]
PMC5623491	9/2017	S81-PMC5623491	['Pregnancy and labour outcomes including Gestational diabetes, Pregnancy-induced hypertension, pre-eclampsia, eclampsia, maternal use of Antibiotics, caesarean section, estimated Blood loss at Birth and Postpartum haemorrhage.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 40, 'gestational'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 136, 'antibiotics'), ('UBERON_0000178', 'blood', 178, 'blood'), ('GO_0007567', 'parturition', 192, 'birth'), ('GO_0007565', 'female pregnancy', 202, 'postpartum')]
PMC5623491	9/2017	S86-PMC5623491	['at enrolment, following informed consent and prior to commencement of study treatment, research personnel will collect a Finger prick Blood sample for baseline Fatty Acid status.']	N/A	N/A	[('UBERON_0002389', 'manual digit', 121, 'finger'), ('UBERON_0000178', 'blood', 134, 'blood'), ('CHEBI_35366', 'fatty acid', 160, 'fatty acid')]
PMC5623491	9/2017	S89-PMC5623491	['at 34 weeks’ Gestation, participating women will attend a clinic appointment for collection of a Finger prick Blood sample for Fatty Acid analysis and unused capsules are returned and counted.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0002389', 'manual digit', 97, 'finger'), ('UBERON_0000178', 'blood', 110, 'blood'), ('CHEBI_35366', 'fatty acid', 127, 'fatty acid')]
PMC5638722	8/2017	S36-PMC5638722	['Cord Blood was collected by an experienced nurse who was not responsible for the primary care and possible resuscitation of the baby, in the delivery room, right after the Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 172, 'delivery')]
PMC5638722	8/2017	S37-PMC5638722	['the obtained 2-ml Cord-Blood was put into tubes containing Ethylenediaminetetraacetic Acid (edta).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 18, 'cord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 59, 'Ethylenediaminetetraacetic acid')]
PMC5638722	8/2017	S40-PMC5638722	['the level of Cord Blood Vitamin D was measured by using a direct competitive chemiluminescent immunoassay (elecsys; roche diagnostics, mannheim, germany).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5638722	8/2017	S44-PMC5638722	['the preterm infants were categorized according to their Cord Blood Vitamin D levels.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 56, 'cord'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5638722	8/2017	S53-PMC5638722	['Venous Blood samples were put into tubes with edta (vacuette tubes, greiner bio-one, monroe, nc, usa).']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood')]
PMC5638722	8/2017	S54-PMC5638722	['complete Blood counts were done by the automatic measurement devices with lh-780 system (beckman coulter diagnostics, image 8000, brea, ca, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC5638722	8/2017	S55-PMC5638722	['for the crp analysis, 0.5 ml of Blood from a Peripheral Vein was drawn into a commercial Blood sample tube without any Additives.']	N/A	N/A	[('UBERON_0000178', 'blood', 32, 'blood'), ('UBERON_0001546', 'posterior tibial vein', 45, 'peripheral vein'), ('UBERON_0000178', 'blood', 89, 'blood'), ('CHEBI_48372', 'anilinyl', 119, 'additives')]
PMC5638722	8/2017	S57-PMC5638722	['for the quantitative Il-6 analysis, 0.5 ml of Venous Blood was drawn into an edta-containing neonatal Blood tube and analyzed using the immuliter 1000 system (siemens, munich, germany) using an immuliter 1000 Il-6 kit (siemens).']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 21, 'IL-6'), ('UBERON_0001638', 'vein', 46, 'venous'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000178', 'blood', 102, 'blood'), ('PR_000001470', 'interleukin-28B', 209, 'IL-6')]
PMC5638722	8/2017	S58-PMC5638722	['approximately 1 ml of Blood samples for Blood cultures are obtained by venipuncture after cleaning the skin with Iodine-Alcohol Solutions and are cultivated in bactec (peti-bact Blood culture, organon teknika corp., durham, nc, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000178', 'blood', 40, 'blood'), ('CHEBI_24859', 'iodine atom', 113, 'iodine'), ('CHEBI_30879', 'alcohol', 120, 'alcohol'), ('CHEBI_75958', 'solution', 128, 'solutions'), ('UBERON_0000178', 'blood', 178, 'Blood')]
PMC5638722	8/2017	S62-PMC5638722	['using variables significant on univariate analyses, (Gestational age at Birth, Birth weight, cord-Blood Vitamin D level) multivariable logistic regression analysis was done for determining the risk of eos and los.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'gestational'), ('GO_0007567', 'parturition', 72, 'birth'), ('GO_0007567', 'parturition', 79, 'birth'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5638722	8/2017	S82-PMC5638722	['two infants with eos had positive Blood cultures indicating gram-negative sepsis ( E. Coli , n=2) and 5 with los had positive Blood cultures ( staphylococcus epidermidis n=2, klebsiella n=2, pseudomonas n=1).']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 83, 'E. coli'), ('UBERON_0000178', 'blood', 126, 'blood')]
PMC5638722	8/2017	S86-PMC5638722	['using variables significant on univariate analyses, (Gestational age at Birth, Birth weight, cord-Blood Vitamin D level) multivariable logistic regression analysis was done for determining the risk of eos and los.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'gestational'), ('GO_0007567', 'parturition', 72, 'birth'), ('GO_0007567', 'parturition', 79, 'birth'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5638722	8/2017	S87-PMC5638722	['low Cord-Blood 25(Oh)D levels as <5 ng/ml was not associated with the occurrence of both eos and los in the model (relative risk [rr], 0.87; 95% confidence interval [ci], 0.73–1.03; p =0.11 and rr, 1.01; 95% ci, 0.86–1.19; p =0.84) (tables 3,4).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 15, '25(OH ... D')]
PMC5646153	10/2017	S48-PMC5646153	['the who defines anemia in Pregnany as low Blood hemoglobin concentration, below 11\xa0g/dl or hematocrit level less than 33% [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 26, 'pregnany'), ('UBERON_0000178', 'blood', 42, 'blood')]
PMC5648128	10/2017	S71-PMC5648128	['Blood pressure was measured with an adequate Armlet when the participants had been seated for 10 minutes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001437', 'epiphysis', 45, 'armlet')]
PMC5648128	10/2017	S72-PMC5648128	['biochemical variables\nBlood was drawn between 08.00 and 09.00 a.m., after an overnight fast.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'Blood')]
PMC5648128	10/2017	S77-PMC5648128	['maternal outcomes\nPregnancy-induced hypertension (≥140mmhg systolic Blood pressure ‒sbp‒/90 mmhg diastolic Blood pressure ‒dbp‒ after 20 gw); Preeclampsia(≥140mmhg systolic/90 mmhg diastolic with proteinuria ≥300 mg in 24-h after 20 gw; albuminuria (proteinuria ≥300 mg in 24-h with sbp <140 mm hg and dbp <90 mm hg).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'Pregnancy'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0000178', 'blood', 107, 'blood'), ('GO_0007128', 'meiotic prophase I', 142, 'preeclampsia')]
PMC5648128	10/2017	S116-PMC5648128	['four hundred forty were allocated to the cg and 434 to the ig (table 1).10.1371/journal.pone.0185873.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the clinical trial randomized population by groups.control groupintervention groupalln = 500n = 500 age (years) 32.7 ± 5.333.2 ± 5.0 race/ethnicitycaucasian 339 (67.8)345 (69.0) hispanic 142 (28.4)143 (28.6) others 19 (3.8)12 (2.4) family history oftype 2 diabetes 118 (23.6)134 (26.8) mets (>2 components) 93 (18.6)118 (23.6) previous history of gdm 14 (2.8)14 (2.8) previous history of Miscarriages 160 (32.2)163(32.6) educational statuselementary education 54(10.8)34 (6.8) secondary school 188 (37.6)210 (42.0) university degree 251 (50.2)252 (50.4) unk 7 (1.4)4 (0.8) employment 376 (75.2)390 (78.0) number of Pregnanciesprimiparous 211 (42.2)232 (46.4) second Pregnancy 160 (32.0)160 (32.0) >2 Pregnancies 129 (25.8)108 (21.6) smokernever 274 (54.8)260 (52.0) current 40 (8.0)43 (8.6) Gestational age (weeks) at baseline 12.1 ± 0.612.0 ± 0.3 body weight (kg)Prepregnancy 61.7 ± 11.660.4 ± 10.4 at baseline 63.9 ± 11.962.5 ± 10.5 weigth gain 2.1 ± 3.22.0 ± 2.7 bmi (kg/m2)Prepregnancy 23.3 ± 4.022.9 ± 3.6 at baseline 24.1 ± 4.123.7 ± 3.8 systolic bp(mm hg) 107 ± 10107 ± 11 diastolic bp (mm hg) 65 ± 1166 ± 9 fasting Blood Glucose (mg/dl) 81.7 ± 6.180.0 ± 6.1 Tsh mcui/ml 1.9 ± 1.22.0 ± 1.4 medas score 4.9 ± 1.75.0 ± 1.8 nutrition score 0.5 ± 3.20.2 ± 3.2 physical activity score -1.7 ± 1.0-1.0 ± 1.0\ndata are mean ± sd or number (%) mets, Metabolic syndrome.']	N/A	N/A	[('GO_0042706', 'eye photoreceptor cell fate commitment', 544, 'miscarriages'), ('GO_0035777', 'pronephric distal tubule development', 771, 'pregnanciesPrimiparous'), ('GO_0007565', 'female pregnancy', 822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 856, 'pregnancies'), ('GO_0007565', 'female pregnancy', 947, 'Gestational'), ('GO_0007565', 'female pregnancy', 1020, 'Prepregnancy'), ('GO_0007565', 'female pregnancy', 1133, 'Prepregnancy'), ('UBERON_0000178', 'blood', 1279, 'Blood'), ('CHEBI_17234', 'glucose', 1285, 'Glucose'), ('CHEBI_17855', 'triglyceride', 1322, 'TSH'), ('GO_0008152', 'metabolic process', 1503, 'Metabolic')]
PMC5648128	10/2017	S118-PMC5648128	['bmi, body mass index; bp, Blood pressure; medas score, 14-point mediterranean diet adherence screener (medas)18.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood')]
PMC5648128	10/2017	S139-PMC5648128	['there was also a significant decrease in the ig in the episodes of uti (p = 0.001), emer-cs (p = 0.001), Perineal trauma (p = 0.001) as well as a significant reduction in the rates of Prematurity (p = 0.023), newborns lga (p = 0.006) and sga (p = 0.001), (table 3).10.1371/journal.pone.0185873.t003\n\ncaption (table-wrap): table 3\nmaternal Pregnancy and neonatal outcomes.control group (n = 440)intervention group (n = 434)p maternal outcomesgdm 103 (23.4)74 (17.1)0.012 75g-ogtt 24–28 gwfasting Blood Glucose (mg/dl) 85.7 ± 6.684.1 ± 6.60.001 1 h Blood Glucose (mg/dl) 123.7 ± 32.0123.5 ± 30.20.912 2 h Blood Glucose (mg/dl) 110.0 ± 26.3106.3 ± 23.80.042 hba1c (%) 24–28 gw 5.1 ± 0.34.9 ± 0.30.001 hba1c (%) 36–38 gw 5.3 ± 0.35.2 ± 0.20.001 fasting Blood Glucose 36–38 gw (mg/dl) 77.1 ± 7.474 ± 7.70.003 fasting Serum Insulin (mcui/ml)24–28 gw 9.4 ± 5.79.1 ± 6.80.061 36–38 gw 10.5 ± 9.610.0 ± 9.90.085 homa-ir24–28 gw 2.2 ± 2.62.0 ± 1.40.045 36–38 gw 2.3 ± 2.72.0 ± 2.30.055 treatment of gdmnutritional 70 (65.4)60 (81.0) Insulin (total) 33 (32.0)14 (19.0)0.037 bolus 6 (5.8)1 (1.4) basal 23 (22.3)12 (16.2) basal/bolus 4 (3.9)1 (1.4)0.003 weight gain (kg) 12 gw to 24–28 gw 5.6 ± 2.85.2 ± 2.50.052 bmi<25 kg.m-2(330/329) 5.8 ± 2.75.4 ± 2.20.003 25–29.9 (88/85) 5.1 ± 3.04.7 ± 3.40.076 ≥ 30 (22/20) 4.2 ± 3.54.0 ± 4.50.770 weight gain (kg) 12 gw to 36–38 gw 9.4 ± 4.39.9 ± 4.70.116 bmi<25 kg.m-29.9 ± 3.910.6 ± 4.00.096 25–29.9 8.8 ± 4.58.3 ± 6.50.066 ≥ 30 5.6 ± 5.67.2 ± 4.70.583 systolic bp (mm hg) 24–28 gw 105 ± 11105 ± 110.189 diastolic bp (mm hg) 24–28 gw 63 ± 963 ± 100.819 systolic bp (mm hg) 36–38 gw 112 ± 13112 ± 110.193 diastolic bp (mm hg) 36–38 gw 72 ± 973 ± 90.316 Pregnancy-induced hypertension 19 (4.3)13 (3.0)0.195 preeclampsia 11 (2.5)7 (1.6)0.247 albuminuria 6 (1.4)2 (0.5)0.298 Urinary Tract infection 60 (13.6)24 (5.5)0.001 Deliveryvaginal 312 (70.9)316 (75.1) instrumental 68 (15.5)58 (11.1) cesarean section 60 (13.6)60 (13.8)0.678 emergency 31 (51.7)9 (15)0.001 Perineal trauma 48 (10.9)14 (3.2)0.001 neonatal outcomesshoulder dystocia 10n.a.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 105, 'perineal'), ('GO_0007565', 'female pregnancy', 184, 'prematurity'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy'), ('UBERON_0000178', 'blood', 495, 'Blood'), ('CHEBI_17234', 'glucose', 501, 'Glucose'), ('UBERON_0000178', 'blood', 547, 'Blood'), ('CHEBI_17234', 'glucose', 553, 'Glucose'), ('UBERON_0000178', 'blood', 603, 'Blood'), ('CHEBI_17234', 'glucose', 609, 'Glucose'), ('UBERON_0000178', 'blood', 749, 'Blood'), ('CHEBI_17234', 'glucose', 755, 'Glucose'), ('UBERON_0001977', 'blood serum', 812, 'Serum'), ('PR_000045358', 'insulin family protein', 818, 'Insulin'), ('PR_000045358', 'insulin family protein', 1023, 'Insulin'), ('GO_0007565', 'female pregnancy', 1681, 'Pregnancy'), ('UBERON_0001502', 'interosseous muscle of manus', 1800, 'Urinary Tract'), ('GO_0006308', 'DNA catabolic process', 1847, 'DeliveryVaginal'), ('UBERON_0001987', 'placenta', 1988, 'Perineal')]
PMC5648128	10/2017	S142-PMC5648128	['sga <10 percentile 25 (5.7)5 (1.2)0.001 Ph Cord Blood 7.27 ± 0.167.28 ± 0.070.714 ph Cord Blood ≤7 2 (0.5)1 (0.2)n.a.']	N/A	N/A	[('UBERON_0003123', 'pharyngeal arch artery 6', 40, 'Ph'), ('UBERON_0000948', 'heart', 43, 'Cord'), ('UBERON_0000178', 'blood', 48, 'Blood'), ('UBERON_0000948', 'heart', 85, 'Cord'), ('UBERON_0000178', 'blood', 90, 'Blood')]
PMC5648128	10/2017	S145-PMC5648128	['hypoglycemia 9 (2.0)3 (0.7)0.075 respiratory distress 4 (0.9)3 (0.7)0.508 hiperbilurrubinemia 31 (7.9)22 (5.1)0.140 Nicu 14 (3.2)8 (1.8)0.147\ngdm, Gestational diabetes mellitus; bp, Blood pressure.']	N/A	N/A	[('UBERON_2001053', 'future internal carotid artery', 116, 'NICU'), ('GO_0007565', 'female pregnancy', 147, 'Gestational'), ('UBERON_0000178', 'blood', 182, 'Blood')]
PMC5651398	9/2017	S56-PMC5651398	['on p8, half of dams ( n\xa0 = \xa0 8–11/diet) underwent behavioral assessments in elevated zero maze (ezm) (shepherd, grewal, fletcher, bill, & dourish,1994), open field test (Oft) (gould, dao, & kovacsics,2009), and porsolt forced‐Swim test (fst) (castagné, moser, roux, & porsolt,2011), Blood draws, and sacrifice to obtain Brain Tissue for analysis.']	N/A	N/A	[('UBERON_0004145', 'outflow tract', 170, 'OFT'), ('GO_0036268', 'swimming', 226, 'swim'), ('UBERON_0000178', 'blood', 283, 'blood'), ('UBERON_0000955', 'brain', 320, 'brain'), ('UBERON_0000479', 'tissue', 326, 'tissue')]
PMC5651398	9/2017	S57-PMC5651398	['for remaining dams ( n\xa0 = \xa0 8–9/diet), pups were weaned on p28, and immediately afterward dams underwent behavioral assessments, Blood draws, and sacrifice for Brain Tissue analysis (see figure\xa01for timeline schematic).']	N/A	N/A	[('UBERON_0000178', 'blood', 129, 'blood'), ('UBERON_0000955', 'brain', 160, 'brain'), ('UBERON_0000479', 'tissue', 166, 'tissue')]
PMC5651398	9/2017	S58-PMC5651398	['females not Pregnant after 3\xa0weeks with males were tested after 13\xa0weeks on diet (to mirror the time Pregnant females remained on diet prior to sacrifice) in ezm, Oft, and fst, and sacrificed to collect Blood and Brain samples for later analysis ( n\xa0 = \xa0 6–15/group; Pregnancy rates varied nonsignificantly by group).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('GO_0007565', 'female pregnancy', 101, 'pregnant'), ('UBERON_0004145', 'outflow tract', 163, 'OFT'), ('UBERON_0000178', 'blood', 203, 'blood'), ('UBERON_0000955', 'brain', 213, 'brain'), ('GO_0007565', 'female pregnancy', 267, 'pregnancy')]
PMC5651398	9/2017	S63-PMC5651398	['eight days after Parturition, half of the dams ( n\xa0 = \xa0 8–11/diet group) underwent behavioral assessments in elevated zero maze (ezm), open field test (Oft), and porsolt Forced‐Swim test (fst), Blood draws, and sacrifice to obtain Brain Tissue for analysis.']	N/A	N/A	[('GO_0019230', 'proprioception', 17, 'parturition'), ('UBERON_0004145', 'outflow tract', 152, 'OFT'), ('GO_0007631', 'feeding behavior', 170, 'forced‐swim'), ('UBERON_0000178', 'blood', 194, 'blood'), ('UBERON_0000955', 'brain', 231, 'brain'), ('UBERON_0000479', 'tissue', 237, 'tissue')]
PMC5651398	9/2017	S64-PMC5651398	['for the remaining dams ( n\xa0 = \xa0 8–9/diet group), pups were weaned on p28, and immediately afterward dams underwent behavioral assessments, Blood draws, and sacrifice for Brain Tissue analysis as at p8\n\nbehavioral assessments\n\nmaternal care\nmaternal care was assessed on days p2–p8 for 3 hr each day, twice during the light phase (0900–1000, 1500–1600\xa0hr) and once during the dark phase (2100–2200\xa0hr).']	N/A	N/A	[('UBERON_0000178', 'blood', 139, 'blood'), ('UBERON_0000955', 'brain', 170, 'brain'), ('UBERON_0000479', 'tissue', 176, 'tissue')]
PMC5651398	9/2017	S84-PMC5651398	['Blood and Brain collection\nBlood (100–150\xa0μl) was drawn via the Facial Maxillary Gland using a 5‐mm lancet and collected into microcentrifuge tubes containing edta.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000955', 'brain', 10, 'brain'), ('UBERON_0000178', 'blood', 27, 'Blood'), ('UBERON_0001736', 'submandibular gland', 64, 'facial maxillary gland')]
PMC5651398	9/2017	S85-PMC5651398	['whole‐Blood Glucose was assessed using a Glucometer (true2go; cvs pharmacy, inc., woonsocket, ri, usa).']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('CHEBI_17234', 'glucose', 12, 'glucose'), ('CHEBI_24321', 'glutamo group', 41, 'glucometer')]
PMC5651398	9/2017	S89-PMC5651398	['Blood was centrifuged at 1,200\xa0 g at 4°c for 10\xa0minutes, and Plasma was removed and stored along with Brain Tissue at −80°c until assayed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 61, 'plasma'), ('UBERON_0000955', 'brain', 102, 'brain'), ('UBERON_0000479', 'tissue', 108, 'tissue')]
PMC5651398	9/2017	S110-PMC5651398	['exclusion criteria included current or recent (within the last 6\xa0months) smoker, inability to read and understand english, and complications of Delivery that would increase risk of Blood draw (e.g., dehydration, anemia).']	N/A	N/A	[('GO_0007567', 'parturition', 144, 'delivery'), ('UBERON_0000178', 'blood', 181, 'blood')]
PMC5651398	9/2017	S112-PMC5651398	['Blood samples\na fasting (≥8\xa0hr) 60‐ml Blood sample was obtained by antecubetal venipuncture within 48\xa0hr of Delivery and prior to hospital discharge.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007567', 'parturition', 108, 'delivery')]
PMC5651398	9/2017	S140-PMC5651398	['(e)Bcaasupplementation, and particularly the combination ofhfdandbcaa, resulted in increased fasting Blood Glucose at p8.']	N/A	N/A	[('CHEBI_76730', 'EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor', 3, 'BCAAsupplementation'), ('UBERON_0000178', 'blood', 101, 'blood'), ('CHEBI_17234', 'glucose', 107, 'glucose')]
PMC5651398	9/2017	S243-PMC5651398	['when availability of Bcaa increases as a function of normal Pregnancy and excess dietary Consumption, there is a subsequent decreased uptake of the amino acid precursors to mood‐altering Neurotransmitters, including Histamine, Dopamine, and Serotonin, via their common transporter, Lat‐1, through the Blood–Brain barrier.']	N/A	N/A	[('CHEBI_22918', 'branched-chain amino acid', 21, 'BCAA'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0007631', 'feeding behavior', 89, 'consumption'), ('CHEBI_25512', 'neurotransmitter', 187, 'neurotransmitters'), ('CHEBI_18295', 'histamine', 216, 'histamine'), ('CHEBI_18243', 'dopamine', 227, 'dopamine'), ('CHEBI_28790', 'serotonin', 241, 'serotonin'), ('PR_000009651', 'laminin subunit alpha-2', 282, 'LAT‐1'), ('UBERON_0000178', 'blood', 301, 'blood'), ('UBERON_0000955', 'brain', 307, 'brain')]
PMC5652542	10/2017	S3-PMC5652542	['maternal lifestyle and demographic data will be collected throughout the Pregnancy, as well as biological samples (eg, Blood, Hair, Urine, Buccal smear, cord Blood, Cord and Placenta samples).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0001037', 'strand of hair', 126, 'hair'), ('UBERON_0001088', 'urine', 132, 'urine'), ('UBERON_0001567', 'cheek', 139, 'buccal'), ('UBERON_0000178', 'blood', 158, 'blood'), ('UBERON_0002240', 'spinal cord', 165, 'cord'), ('UBERON_0001987', 'placenta', 174, 'placenta')]
PMC5652542	10/2017	S30-PMC5652542	['caption (table-wrap): table 2\n\nmaternal measures and samples during Pregnancydata collectedclinic visit12311–14\u2009weeks22–28\u2009weeks32–34\u2009weeksabdominal ultrasound√√√lifestyle information√√nutritional assessment—Food frequency questionnaire√√nutritional assessment—24\u2009hours Food recall√√√maternal anthropometry√√√Bloods√√√Urine*√√Hair sample*√√Buccal smear†√√oral glucose tolerance test√paternal Buccal smear† (optional)√√√\n*for identification of Metabolomic biomarkers.']	N/A	N/A	[('GO_0006412', 'translation', 68, 'pregnancyData'), ('CHEBI_33290', 'food', 208, 'food'), ('CHEBI_33290', 'food', 270, 'food'), ('UBERON_0000178', 'blood', 309, 'Bloods'), ('UBERON_0001088', 'urine', 318, 'Urine'), ('UBERON_0001037', 'strand of hair', 326, 'Hair'), ('UBERON_0001567', 'cheek', 340, 'Buccal'), ('UBERON_0001567', 'cheek', 392, 'buccal'), ('CHEBI_6751', 'mepanipyrim', 443, 'metabolomic')]
PMC5652542	10/2017	S73-PMC5652542	['data collection and analysis\n\nmeasures and samples\nthe primary maternal outcome is\xa0Serum complex Lipid levels\xa0(eg, ga determined by ultra performance liquid chromatography–tandem mass spectrometer) in maternal Blood.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 83, 'serum'), ('CHEBI_18059', 'lipid', 97, 'lipid'), ('UBERON_0000178', 'blood', 210, 'blood')]
PMC5652542	10/2017	S74-PMC5652542	['the secondary maternal outcomes are maternal nutritional status (eg, Blood routine, Micronutrient status in Blood), clinical indicators of maternal health (eg, Blood pressure, Glucose tolerance), Gestational\xa0weight gain and outcomes of Pregnancy, including complications\xa0(eg, Gestational diabetes mellitus, Gestational hypertension).']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0000178', 'blood', 160, 'blood'), ('CHEBI_17234', 'glucose', 176, 'glucose'), ('GO_0007565', 'female pregnancy', 196, 'gestational'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('GO_0007565', 'female pregnancy', 276, 'gestational'), ('GO_0007565', 'female pregnancy', 307, 'gestational')]
PMC5652542	10/2017	S87-PMC5652542	['Blood and/or Serum samples will be collected and prepared by employees of the institution and stored in a regulated −80°c freezer.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001977', 'blood serum', 13, 'serum')]
PMC5658906	10/2017	S4-PMC5658906	['Edc concentrations were quantified in Blood and Urine samples collected at 16 and 26 weeks Gestation.']	N/A	N/A	[('CHEBI_86606', 'Dehydrodiveratric acid', 0, 'EDC'), ('CL_0002364', 'cortical thymic epithelial cell', 0, 'EDC'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0001088', 'urine', 48, 'urine'), ('GO_0007565', 'female pregnancy', 91, 'gestation')]
PMC5658906	10/2017	S11-PMC5658906	['because they are widely distributed in the environment, the majority of Pregnant women in the united states have detectable levels of multiple Edcs in their Blood or Urine [6,7].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CL_0002364', 'cortical thymic epithelial cell', 143, 'EDCs'), ('UBERON_0000178', 'blood', 157, 'blood'), ('UBERON_0001088', 'urine', 166, 'urine')]
PMC5658906	10/2017	S52-PMC5658906	['biomarkers of Gestational Edc exposure\nBlood and Urine samples were collected from participants at approximately 16 weeks and 26 weeks Gestation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('CHEBI_86606', 'Dehydrodiveratric acid', 26, 'EDC'), ('UBERON_0000178', 'blood', 39, 'Blood'), ('UBERON_0001088', 'urine', 49, 'urine'), ('GO_0007565', 'female pregnancy', 135, 'gestation')]
PMC5658906	10/2017	S61-PMC5658906	['if a woman provided multiple Urine or Blood samples at both 16 and 26 weeks Gestation, then the sample concentrations were averaged following log10transformation and treated as continuous variables [34,37].']	N/A	N/A	[('UBERON_0001088', 'urine', 29, 'urine'), ('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007565', 'female pregnancy', 76, 'gestation')]
PMC5659017	10/2017	S4-PMC5659017	['we compared Cord Blood Dna Methylation in offspring of women with active ed ( n \xa0=\xa021), past ed ( n \xa0=\xa043) and age- and social class-matched controls ( n \xa0=\xa0126) as part of the avon longitudinal study of parents and children.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0006306', 'DNA methylation', 23, 'DNA methylation')]
PMC5659017	10/2017	S32-PMC5659017	['we selected women whose offspring had available Dna Methylation data from Cord Blood ( n \xa0=\xa01018) as part of the accessible resource for integrated epigenomic studies (aries; for details, seehttp://www.ariesepigenomics.org.uk/), a representative sub-set of alspac [18–20].']	N/A	N/A	[('GO_0006306', 'DNA methylation', 48, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 74, 'cord'), ('UBERON_0000178', 'blood', 79, 'blood')]
PMC5659017	10/2017	S81-PMC5659017	['Cord Blood of offspring of women with active ed had the lowest methylation level (49.1%; 95% confidence intervals 50.5–47.7%); offspring of controls had the highest global methylation levels (52.4%; 95% ci 53.0–51.0%).']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood')]
PMC5659017	10/2017	S104-PMC5659017	['caption (table-wrap): table 3\n\nwhole-Genome Cord Blood methylation levels in offspring of women across ed types and controls: adjusted linear regressioned type ß (se) p value r2, p valuerestrictive ed ( n \xa0=\xa039)−\u20090.011 (0.008)0.150.84, 2.7\xa0×\xa010−15binge purge ed ( n \xa0=\xa013)−\u20090.009 (0.012)0.42purging ed ( n \xa0=\xa07)−\u20090.026 (0.015)0.08covariates:smoking0.01 (0.007)0.14gender−\u20090.002 (0.006)0.67\nadjusted for maternal smoking in Pregnancy, child gender, cell count and Bisulfite conversion batch\n\npost-hoc analyses\nas the restrictive ed group was the largest, we were able to also explore differences in whole-Genome methylation amongst women with active restrictive-type ed and past restrictive-type ed.']	N/A	N/A	[('SO_0001026', 'genome', 37, 'genome'), ('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('GO_0007565', 'female pregnancy', 423, 'pregnancy'), ('CHEBI_29874', 'bromine dioxide', 463, 'bisulfite'), ('SO_0001026', 'genome', 604, 'genome')]
PMC5659017	10/2017	S144-PMC5659017	['Cord Blood Methylation.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 0, 'cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0032258', 'cytoplasm to vacuole transport by the Cvt pathway', 11, 'methylation')]
PMC5659017	10/2017	S149-PMC5659017	['whole-Genome Cord Blood Methylation in offspring of active ed, past ed, and control women.']	N/A	N/A	[('SO_0001026', 'genome', 6, 'genome'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('GO_0007596', 'blood coagulation', 18, 'blood methylation'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC5659017	10/2017	S151-PMC5659017	['qq and manhattan plots: association between ed and offspring Cord Blood Dna Methylation1.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 61, 'cord'), ('UBERON_0000178', 'blood', 66, 'blood'), ('GO_0006323', 'DNA packaging', 72, 'DNA methylation1')]
PMC5659607	10/2017	S32-PMC5659607	['Blood was drawn from the mothers at entry to the trial and at the 3rdtrimester visit (32 to 38 weeks of Gestation) for measurement of circulating levels of 25(Oh)D, determined by using the diasorin liaison® chemiluminescence immunoassay[13].']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 104, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC5664622	9/2017	S2-PMC5664622	['pre-Delivery maternal Venous Blood and neonatal Cord Blood samples were collected and total 25(Oh)D concentration was measured.']	N/A	N/A	[('GO_0007567', 'parturition', 4, 'delivery'), ('UBERON_0001638', 'vein', 22, 'venous'), ('UBERON_0000178', 'blood', 29, 'blood'), ('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 92, '25(OH ... D')]
PMC5664622	9/2017	S4-PMC5664622	['both, maternal and Umbilical Cord Blood concentrations of Vitamin D were higher in the summer group as compared to the winter group (mean 22.2 ± 6.5 ng/ml vs. 16.5 ± 8.2 ng/ml ( p< 0.001), respectively for the mothers and 31.3 ± 9.4 ng/ml vs. 22.7 ± 11.0 ng/ml ( p< 0.0001), respectively for the neonates).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 19, 'umbilical cord'), ('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5664622	9/2017	S26-PMC5664622	['after informed consent was obtained, maternal Blood was drawn, followed by Cord Blood at Delivery, to form a “mother-infant Blood set”.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007567', 'parturition', 89, 'delivery'), ('UBERON_0000178', 'blood', 124, 'blood')]
PMC5664622	9/2017	S29-PMC5664622	['laboratory analysis and data collection\nTotal 25(Oh)D concentration was measured in the Blood using immunological tests (liaison).']	N/A	N/A	[('PR_000016642', 'E3 ubiquitin-protein ligase TRIM11', 40, 'Total'), ('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 46, '25(OH ... D'), ('UBERON_0000178', 'blood', 88, 'blood')]
PMC5664622	9/2017	S40-PMC5664622	['simple linear regression was used to analyze Venous versus Cord Blood Vitamin D concentration.']	N/A	N/A	[('UBERON_0001638', 'vein', 45, 'venous'), ('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5664622	9/2017	S53-PMC5664622	['Umbilical Cord Blood by season\nmean Umbilical Cord Blood Vitamin D concentration was 27.0 ± 11.1 ng/ml, and was lower among neonates born in winter as compared to summer (22.7 ± 11.2 ng/ml vs. 31.3 ± 9.4 ng/ml, respectively) ( p< 0.0001).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 15, 'Blood'), ('UBERON_0002331', 'umbilical cord', 36, 'umbilical cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5664622	9/2017	S60-PMC5664622	['maternal vs. Umbilical Cord Blood\nUmbilical Cord Blood Vitamin D concentration was higher as compared to maternal levels in all of the investigated cases (figure 2).']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 13, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 28, 'Blood'), ('UBERON_0002331', 'umbilical cord', 34, 'Umbilical cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5664622	9/2017	S66-PMC5664622	['mean concentration among women who supplemented their diet with single-component Vitamin D preparations (mean content: 25 µg) increased by 6.3 ng/ml (95% ci = [1.77, 10.84]) as compared to non-users of Supplements ( p< 0.01), while Cord Blood levels were higher by 12.1 ng/ml (95% ci = [6.06, 18.19]) ( p< 0.001).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 202, 'supplements'), ('UBERON_0002240', 'spinal cord', 232, 'cord'), ('UBERON_0000178', 'blood', 237, 'blood')]
PMC5664622	9/2017	S71-PMC5664622	['dietary intake of Vitamin D (without supplementation) by Pregnant women was significantly below recommendations (median 2.1 µg/day) and was not significantly associated with Blood Vitamin D levels.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC5678092	11/2017	S73-PMC5678092	['baseline Blood Glucose was measured by Tail nick at time 0.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_17234', 'glucose', 15, 'glucose'), ('UBERON_0002415', 'tail', 39, 'tail')]
PMC5678092	11/2017	S76-PMC5678092	['Blood Glucose was measured using accu-chekh Glucose meter (roche diagnostics).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_17234', 'glucose', 44, 'glucose')]
PMC5678092	11/2017	S80-PMC5678092	['a Blood sample was collected by Cardiac puncture and Plasma collected after centrifugation (2000\u2009g 10\u2009mins).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('UBERON_0000948', 'heart', 32, 'cardiac'), ('UBERON_0001969', 'blood plasma', 53, 'plasma')]
PMC5679631	11/2017	S35-PMC5679631	['beginning in january 2002, consent was also requested to obtain a maternal Blood sample at approximately the 36thweek of Gestation and an infant Fecal sample at one month of age for microbial analyses.']	N/A	N/A	[('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007565', 'female pregnancy', 121, 'gestation'), ('UBERON_0000922', 'embryo', 145, 'fecal')]
PMC5679631	11/2017	S46-PMC5679631	['maternal Plasma 25(Oh)D concentration\nBlood samples were immediately centrifuged, transported at 4°c and stored at -80°c in a biobank until further analysis.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 16, '25(OH)D'), ('UBERON_0000178', 'blood', 38, 'Blood')]
PMC5679631	11/2017	S86-PMC5679631	['finally, there was an expected difference among the quintiles in terms of season of Blood sampling in that the higher quintiles included a lower percentage of mothers giving blood during the winter season and a higher percentage in the summer.10.1371/journal.pone.0188011.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the study population (n = 913).maternal multivitamin supplementation containing Vitamin D (n = 913)maternal Plasma 25(Oh)D nmol/l (n = 892)infant Vitamin D supplementation§(n = 616)none< 10 μg≥ 10 μgq 1q 2q 3q 4q 5yesno7.7–27.3#27.4–37.3#37.4–47.8#47.9–59.9#60.0–126.4#n = 350n = 144n = 41921.4 (4.3)&32.3 (2.9)&43.0 (3.2)&53.3 (3.5)&71.9 (10.9)&n = 441n = 165n (%)n (%)n (%)n (%)n (%)n (%)n (%)n (%)n (%)n (%) mode and place of Delivery Vaginal / home171 (48.9)71 (49.3)188 (44.9)80 (44.9)87 (48.6)80 (44.7)92 (51.7)78 (43.8)245 (55.6)93 (56.3)Vaginal / hospital137 (39.1)56 (38.9)174 (41.5)68 (38.2)74 (41.3)77 (43.0)63 (35.4)78 (43.8)157 (35.6)58 (35.2)c-section / hospital36 (10.3)12 (8.3)47 (11.2)21 (11.8)15 (8.4)19 (10.6)21 (11.8)18 (10.1)39 (8.8)14 (8.5)missing6 (1.7)5 (3.5)10 (2.4)9 (5.1)3 (1.7)3 (1.7)2 (1.1)4 (2.2)00 number of siblings none130 (37.1)68 (47.2)166 (39.6)71 (39.9)71 (39.7)73 (40.8)83 (46.7)61 (34.3)185 (42)46 (27.9)1153 (43.7)51 (35.4)197 (47.0)79 (44.4)79 (44.1)82 (45.8)72 (40.4)77 (43.2)189 (42.8)76 (46.1)2 or more66 (18.9)25 (17.4)56 (13.4)28 (15.7)28 (15.6)24 (13.4)23 (12.9)40 (22.5)66 (15)43 (26)missing1 (0.3)0001 (0.6)0001 (0.2)0 recruitment group conventional233 (66.6)66 (45.8)322 (76.8)114 (64)117 (65.4)121 (67.6)129 (72.5)132 (74.2)298 (67.6)54 (32.7)alternative117 (33.4)78 (54.2)97 (23.2)64 (36)62 (34.6)58 (32.4)49 (27.5)46 (25.8)143 (32.4)111 (67.3) maternal Vitamin D quintile 1104 (29.7)30 (20.8)44 (10.5)64 (14.5)40 (24.2)283 (23.7)30 (20.8)66 (15.8)87 (19.7)38 (23)359 (16.9)25 (17.4)95 (22.7)88 (20)24 (14.5)460 (17.1)22 (15.3)96 (22.9)98 (22.2)28 (17)538 (10.9)30 (20.8)110 (26.2)96 (21.8)29 (17.7)missing6 (1.7)7 (4.9)8 (1.9)8 (1.8)6 (3.6) sex male196 (56)63 (43.8)200 (47.7)102 (57.3)87 (48.6)93 (52)78 (43.8)89 (50)219 (49.7)81 (49.1)female154 (44)81 (56.2)219 (52.3)76 (42.7)92 (51.4)86 (48)100 (56.2)89 (50)222 (50.3)84 (50.9) vaginitis (last month of Pregnancy) no319 (91.2)123 (85.4)372 (88.8)156 (87.6)161 (89.9)163 (91)162 (91)153 (86)409 (92.7)143 (86.7)yes25 (7.1)16 (11.1)37 (8.8)13 (7.3)15 (8.4)13 (7.3)14 (7.9)21 (11.8)32 (7.3)22 (13.3)missing6 (1.7)5 (3.5)10 (2.4)9 (5.1)3 (1.7)3 (1.7)2 (1.1)4 (2.2)00 mode of infant Feeding Breast Feeding243 (69.4)105 (72.9)268 (64.0)107 (60.1)125 (69.8)114 (63.7)128 (71.9)128 (71.9)bottle feeding80 (22.9)25 (17.4)103 (24.6)52 (29.2)39 (21.8)50 (27.9)29 (16.3)34 (19.1)combination feeding26 (7.4)14 (9.7)47 (11.2)19 (10.7)15 (8.4)15 (8.4)21 (11.8)15 (8.4)missing1 (0.3)01 (0.2)00001 (0.6) season of maternal Blood sampling winter89 (50)69 (38.6)49 (27.4)41 (23)22 (12.4)spring54 (30.3)51 (28.5)46 (25.7)31 (17.4)16 (8.9)summer8 (4.5)23 (12.8)40 (22.3)66 (37.1)82 (46.1)autumn27 (15.2)36 (20.1)44 (24.6)40 (22.5)58 (32.6)\n§only Breast Fed children;\n#range;\n&mean (sd)\n\nmaternal 25(Oh)D and use of multivitamin supplements containing Vitamin D\nmaternal 25(Oh)D concentrations of the entire group ranged from 7.7 to 126.3 nmol/l with a mean of 44.3, sd 18.3 nmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 442, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 442, '25(OH ... D'), ('CHEBI_28384', 'vitamin K', 473, 'Vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 481, 'D'), ('GO_0007586', 'digestion', 756, 'Delivery'), ('UBERON_0000970', 'eye', 765, 'Vaginal'), ('UBERON_0000970', 'eye', 872, 'Vaginal'), ('CHEBI_28384', 'vitamin K', 1733, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 2237, 'Pregnancy'), ('GO_0007631', 'feeding behavior', 2512, 'Feeding'), ('UBERON_0000310', 'breast', 2520, 'Breast'), ('GO_0070479', "nuclear-transcribed mRNA catabolic process, 5'-3' exonucleolytic nonsense-mediated decay", 2527, 'Feeding243'), ('UBERON_0000178', 'blood', 2840, 'Blood'), ('GO_0007567', 'parturition', 3059, 'breast'), ('UBERON_0000310', 'breast', 3059, 'breast'), ('GO_0007631', 'feeding behavior', 3066, 'fed'), ('CHEBI_71657', 'versiconol acetate', 3109, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 3109, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 3164, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 3183, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 3189, 'D')]
PMC5680205	11/2017	S8-PMC5680205	['decreased map within the zinc-deficient dams implies reduced Blood flow and Nutrient Delivery To the Placenta.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_33284', 'nutrient', 76, 'nutrient'), ('GO_0007567', 'parturition', 85, 'delivery to'), ('GO_0007565', 'female pregnancy', 101, 'placenta'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC5680205	11/2017	S80-PMC5680205	['double labelling immunohistochemistry was used to identify the Fetal Capillaries (fc), Trophoblasts (tb) and maternal Blood space (Mbs) within the Labyrinth Zone ( c ).']	N/A	N/A	[('UBERON_0000922', 'embryo', 63, 'fetal'), ('UBERON_0001982', 'capillary', 69, 'capillaries'), ('UBERON_0000088', 'trophoblast', 87, 'trophoblasts'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001448', 'metatarsal bone', 131, 'MBS'), ('UBERON_0003957', "Bruch's membrane", 147, 'labyrinth zone')]
PMC5680205	11/2017	S150-PMC5680205	['caption (fig): figure 6\n\nmaternal zinc deficiency changed the Blood and Pulse pressure profiles of dams before\xa0Pregnancy, during Pregnancy and in\xa0Lactation.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0014756', 'Wulst', 72, 'pulse'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007595', 'lactation', 146, 'lactation')]
PMC5680205	11/2017	S155-PMC5680205	['( b ) pulse pressure, which is the difference between systolic and diastolic Blood pressures, was significantly lower in the zinc deficient Animals across the whole experimental period.']	N/A	N/A	[('UBERON_0000178', 'blood', 77, 'blood'), ('NCBITaxon_33208', 'Metazoa', 140, 'animals')]
PMC5680205	11/2017	S161-PMC5680205	['in particular, a 16% reduction in Kidney Expression of angiotensin converting enzyme ( Ace ) ( p \u2009=\u20090.031) and a 44% reduction in Inositol 1,4,5-Triphosphate Receptor Type 2 ( Itpr2 ) ( p \u2009=\u20090.05) in the zinc-deficient dams occurred in association with reduced Blood pressure observed at gd18.5 in Mice implanted with Blood Pressure monitors.']	N/A	N/A	[('UBERON_0002113', 'kidney', 34, 'kidney'), ('GO_0010467', 'gene expression', 41, 'expression'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 87, 'Ace'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 130, 'inositol 1,4,5-triphosphate receptor type 2'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 176, 'Itpr2'), ('UBERON_0000178', 'blood', 261, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 298, 'mice'), ('UBERON_0013756', 'venous blood', 318, 'blood pressure')]
PMC5680205	11/2017	S269-PMC5680205	['radio-telemetry surgery, Blood pressure monitoring and Kidney analysis\ndams in cohort 1 were anaesthetised (2.5% Isofluorane and 1\u2009l/minute O2, then maintained at 1.5% Isofluorane and ½ l/minute O2; Attanetmisoflurane, bomac ) and a radio-telemetry probe (pac10, data sciences international ) was inserted into the left Carotid Artery.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002113', 'kidney', 55, 'kidney'), ('CHEBI_6015', 'isoflurane', 113, 'isofluorane'), ('CHEBI_15379', 'dioxygen', 140, 'O2'), ('CHEBI_6015', 'isoflurane', 168, 'isofluorane'), ('CHEBI_15379', 'dioxygen', 195, 'O2'), ('CHEBI_29545', 'Avermectin B2b monosaccharide', 199, 'AttaneTMIsoflurane'), ('UBERON_0005396', 'carotid artery segment', 320, 'carotid artery')]
PMC5682055	10/2017	S33-PMC5682055	['initial Vital Signs on arrival were Blood pressure of 104/77, Heart rate of 65, temperature of 98.4, and Respiratory rate of 15 with 100% saturation.']	N/A	N/A	[('UBERON_0010210', 'blood clot', 8, 'vital signs'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000948', 'heart', 62, 'heart'), ('UBERON_0001004', 'respiratory system', 105, 'respiratory')]
PMC5682869	11/2017	S42-PMC5682869	['in a Rat model, protein deficiency in Pregnancy results in decreased Birth weight, decreased Heart weight, increased Heart rate and increased systolic Blood pressure [2].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 5, 'rat'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007567', 'parturition', 69, 'birth'), ('UBERON_0000948', 'heart', 93, 'heart'), ('UBERON_0000948', 'heart', 117, 'heart'), ('UBERON_0000178', 'blood', 151, 'blood')]
PMC5684580	10/2017	S23-PMC5684580	['twenty women, recruited from canterbury district health board (dhb) in the south island, were using less tight Glycaemic treatment targets (fasting Blood Glucose\u2009<\u20095.5\u2009mmol/l, 1 hour postprandial\u2009<\u20098.0\u2009mmol/l, and 2 hours postprandial\u2009<\u20097.0\u2009mmol/l).']	N/A	N/A	[('GO_0006096', 'glycolytic process', 111, 'glycaemic'), ('UBERON_0000178', 'blood', 148, 'blood'), ('CHEBI_17234', 'glucose', 154, 'glucose')]
PMC5684580	10/2017	S54-PMC5684580	['at the time of the survey, participants had been checking their daily capillary blood Glucose for an average of 6.8\u2009±\u20092.3 weeks (table 1), with just over half checking their Blood Glucose four times a day (32, 53%) and the other participants six times a day (28, 47%).']	N/A	N/A	[('CHEBI_17234', 'glucose', 86, 'glucose'), ('UBERON_0000178', 'blood', 174, 'blood'), ('CHEBI_17234', 'glucose', 180, 'glucose')]
PMC5684580	10/2017	S69-PMC5684580	['all 60 (100%) women indicated that having a health professional to demonstrate the collection of capillary Blood Glucose on themselves and then watch the participant perform it was helpful (table 3).']	N/A	N/A	[('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_17234', 'glucose', 113, 'glucose')]
PMC5688482	11/2017	S82-PMC5688482	['just as health professionals distribute clean needles so that intravenous Drug users do not contract Blood-borne diseases, in Abortion counseling health professionals provide women with complete information for inducing Abortion safely using Misoprostol, so that if women choose to abort, they are able to do so safely.']	N/A	N/A	[('CHEBI_23888', 'drug', 74, 'drug'), ('UBERON_0000178', 'blood', 101, 'blood'), ('GO_0007569', 'cell aging', 126, 'abortion'), ('GO_0007569', 'cell aging', 220, 'abortion'), ('CHEBI_63610', 'misoprostol', 242, 'misoprostol')]
PMC5690443	12/2015	S29-PMC5690443	['Placental transport of magnesium\nthe levels of total ca, ionized ca, and mg are higher in fetal circulation than in maternal Blood[21].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 125, 'blood')]
PMC5690443	12/2015	S62-PMC5690443	['(a) Intracellular mg and small for Gestational age\nby using a fluorescent probe, mag-fura-2, we examined [Mg2+]iof Platelets in the Cord Blood of infants with sga and with aga[36].']	N/A	N/A	[('GO_0005622', 'intracellular anatomical structure', 4, 'Intracellular'), ('GO_0007565', 'female pregnancy', 35, 'gestational'), ('PR_000000164', 'BMP2', 89, '-2'), ('CHEBI_6636', 'magnesium dichloride', 106, 'Mg2+]'), ('CL_0000233', 'platelet', 115, 'platelets'), ('UBERON_0002240', 'spinal cord', 132, 'cord'), ('UBERON_0000178', 'blood', 137, 'blood')]
PMC5690467	9/2017	S80-PMC5690467	['awake, breathing spontaneously with standard monitors: non-invasive Blood pressure cuff (nibp), fetal Heart rate monitor, and pulse oximeter connected.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0000948', 'heart', 102, 'heart')]
PMC5703566	11/2017	S35-PMC5703566	['after providing informed consent and completing initial Blood tests and questionnaires, the participants were individually randomized to either the intervention (n = 303) or the control group (n = 303).']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood')]
PMC5704156	11/2017	S119-PMC5704156	['Blood samples from the mother were obtained within 72 h of Delivery, and later, the total level of Plasma Folate was obtained.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007567', 'parturition', 59, 'delivery'), ('UBERON_0001969', 'blood plasma', 99, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 106, 'folate')]
PMC5704156	11/2017	S120-PMC5704156	['specifically, the predictor variable was Blood measures of Folate measured at the time of Birth, and the outcome of interest was a subsequent diagnosis of autism in the offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 59, 'folate'), ('GO_0007567', 'parturition', 90, 'birth')]
PMC5704156	11/2017	S165-PMC5704156	['for example, since an earlier nhanes study (conducted between 1988 and 1994), the average Blood levels increased from 12.5 nmol/l to 32.2 nmol/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 90, 'blood')]
PMC5706533	11/2017	S39-PMC5706533	['for example, for pre-eclampsia we required evidence that participants were scheduled to undergo routine Blood pressure monitoring and Urinary protein testing (the latter being undertaken at least among women with hypertension).']	N/A	N/A	[('UBERON_0000178', 'blood', 104, 'blood'), ('UBERON_0001088', 'urine', 134, 'urinary')]
PMC5708048	11/2017	S34-PMC5708048	['inclusion criteria were having the intention to Deliver in the two major study hospitals in singapore, agree to donate Placenta, Cord, and Cord Blood at Delivery, and spouse had homogenous parental background of chinese, malaysian, or indian descent.']	N/A	N/A	[('GO_0007567', 'parturition', 48, 'deliver'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0002240', 'spinal cord', 129, 'cord'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('GO_0007567', 'parturition', 153, 'delivery')]
PMC5708673	11/2017	S46-PMC5708673	['maternal Blood samples were collected via venipuncture at the time of the interview.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood')]
PMC5708673	11/2017	S47-PMC5708673	['Blood samples were transported to dhaka within one day of collection in an insulated container, and stored at −20°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5708673	11/2017	S48-PMC5708673	['Plasma from the centrifuged Blood samples was collected into microcentrifuge tubes and stored at −20°c.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 28, 'blood')]
PMC5708673	11/2017	S49-PMC5708673	['Blood/Plasma samples were shipped to harvard school of public health on dry ice.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 6, 'plasma')]
PMC5716389	9/2017	S54-PMC5716389	['mainly, it is present in Blood as Hemoglobulin, in Muscles as myoglobulin and in Heme, Iron Sulfur and other iron containing enzymes [39].']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0043657', 'host cell', 34, 'hemoglobulin'), ('UBERON_0005090', 'muscle structure', 51, 'muscles'), ('CHEBI_30413', 'heme', 81, 'heme'), ('CHEBI_33473', 'hydrocarbylidene group', 87, 'iron sulfur')]
PMC5716389	9/2017	S55-PMC5716389	['normal Blood levels of iron are needed in several biochemical Processes including oxygen binding, transport, storage and sensing; protein, Lipids and some other Nutrients Metabolism; integrated Electron transport; Dna Synthesis; mounting of Immune Response; and Antioxidative Reactions [11].']	N/A	N/A	[('UBERON_0000178', 'blood', 7, 'blood'), ('GO_0007565', 'female pregnancy', 62, 'processes'), ('CHEBI_18059', 'lipid', 139, 'lipids'), ('CHEBI_33284', 'nutrient', 161, 'nutrients'), ('GO_0008152', 'metabolic process', 171, 'metabolism'), ('CHEBI_10545', 'electron', 194, 'electron'), ('GO_0071897', 'DNA biosynthetic process', 214, 'DNA synthesis'), ('GO_0006955', 'immune response', 241, 'immune response'), ('UBERON_0002405', 'immune system', 241, 'immune'), ('GO_0019985', 'translesion synthesis', 262, 'antioxidative reactions')]
PMC5724168	8/2017	S7-PMC5724168	['Blood samples are collected from a small subsample of 50 mothers for a substudy about stress during Pregnancy (babi-stress study).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
PMC5724168	8/2017	S60-PMC5724168	['Blood samples were collected from a subsample of 50 Pregnant women for a satellite study on stress during Pregnancy (babi-stress study, funded by the deutsche forschungsgemeinschaft ).']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC5727393	12/2017	S117-PMC5727393	['i125-labeled Oxytocin was detected robustly within the Blood and Olfactory Bulbs, and was distributed throughout the Brain, including Anterior Olfactory Nucleus, Anterior Cingulate Cortex (Acc), Nucleus Accumbens, Amygdala, and Hypothalamus (table\xa01).']	N/A	N/A	[('CHEBI_7872', 'oxytocin', 13, 'oxytocin'), ('UBERON_0000178', 'blood', 55, 'blood'), ('GO_0007608', 'sensory perception of smell', 65, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 65, 'olfactory bulbs'), ('UBERON_0000955', 'brain', 117, 'brain'), ('UBERON_0002870', 'dorsal motor nucleus of vagus nerve', 134, 'anterior olfactory nucleus'), ('GO_0007608', 'sensory perception of smell', 143, 'olfactory'), ('UBERON_0009835', 'anterior cingulate cortex', 162, 'anterior cingulate cortex'), ('UBERON_2005026', 'primary head sinus', 189, 'ACC'), ('UBERON_0001882', 'nucleus accumbens', 195, 'nucleus accumbens'), ('UBERON_0001876', 'amygdala', 214, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 228, 'hypothalamus')]
PMC5727393	12/2017	S290-PMC5727393	['samples contaminated with Blood were discarded.']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood')]
PMC5727393	12/2017	S300-PMC5727393	['30\u2009min following administration, Mice were killed, Blood collected, and perfused through the Descending Aorta with 20\u2009ml of 0.9% Sodium Chloride, followed by 120\u2009ml of 4% paraformaldehyde in 0.1\u2009m sorenson’s phosphate buffer (10\u2009ml/min).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 33, 'mice'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0001514', 'descending aorta', 93, 'descending aorta'), ('CHEBI_26710', 'sodium chloride', 129, 'sodium chloride')]
PMC5732382	12/2017	S42-PMC5732382	['the kalenjin have a common staple diet: kimyet (ugali) (a paste of cooked Millet flour), native vegetables and mursik (sour Milk mixed with charcoal dust, sometimes mixed with Cow’s Blood), supplemented with roast meat (usually beef or goat).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 74, 'millet'), ('UBERON_0001913', 'milk', 124, 'milk'), ('NCBITaxon_33208', 'Metazoa', 176, 'cow'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC5732382	12/2017	S131-PMC5732382	['“when your Blood is less, it will only help you to get a baby, thereafter, you will bleed until your body dries up and you die”.']	N/A	N/A	[('UBERON_0000178', 'blood', 11, 'blood')]
PMC5732382	12/2017	S137-PMC5732382	['every time we come for clinic they always ask to check Blood levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 55, 'blood')]
PMC5732382	12/2017	S144-PMC5732382	['“ during the 7th month Pregnancy of my other girl that this child follows, my Blood was four points (Hb4).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('UBERON_0000178', 'blood', 78, 'blood'), ('PR_000008533', 'homogentisate 1,2-dioxygenase', 101, 'Hb4')]
PMC5732382	12/2017	S146-PMC5732382	['… fortunately, by the time i was due, my Blood had risen to 8 points.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'blood')]
PMC5732382	12/2017	S192-PMC5732382	['it was also stated that having enough Blood makes a woman strong during Pregnancy and at Birth.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007567', 'parturition', 89, 'birth')]
PMC5732382	12/2017	S196-PMC5732382	['other items believed to increase Blood, as mentioned by various respondents, include Liver, fruits, Animal Blood, Milk, red beans, porridge prepared by flour of Finger Millet mixed with sorghum, iron supplements (issued at the anc clinic), herbs and red Soil/stones.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0002107', 'liver', 85, 'liver'), ('NCBITaxon_33208', 'Metazoa', 100, 'animal'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0001913', 'milk', 114, 'milk'), ('UBERON_0002389', 'manual digit', 161, 'finger'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'millet'), ('UBERON_0001913', 'milk', 254, 'soil')]
PMC5732382	12/2017	S278-PMC5732382	['furthermore, rural health facilities, which are easily accessible, are not equipped with Blood Transfusion kits in case of an emergency Blood Transfusion incident [28].']	N/A	N/A	[('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0009294', 'DNA mediated transformation', 95, 'transfusion'), ('GO_0007596', 'blood coagulation', 136, 'blood transfusion'), ('UBERON_0000178', 'blood', 136, 'blood')]
PMC5732505	12/2017	S6-PMC5732505	['maternal 25(Oh)D was determined on average at 11\xa0weeks of Gestation in Pregnancy and in Umbilical Cord Blood (Ucb) at Birth.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 9, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('UBERON_0002331', 'umbilical cord', 88, 'umbilical cord'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0009845', 'urogenital sinus mesenchyme', 110, 'UCB'), ('GO_0007567', 'parturition', 118, 'birth')]
PMC5732505	12/2017	S42-PMC5732505	['at Birth, Umbilical Cord Blood (ucb) for 25(Oh)D measurement was obtained at Gestational weeks 37 to 42 between january 2013 and may 2014 [hereafter referred to as Ucb 25(Oh)D].']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002331', 'umbilical cord', 10, 'umbilical cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_71657', 'versiconol acetate', 41, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 47, 'D'), ('GO_0007565', 'female pregnancy', 77, 'gestational'), ('PR_000016950', 'ubiquitin-like modifier-activating enzyme 1', 164, 'UCB 25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D')]
PMC5732505	12/2017	S79-PMC5732505	['thus, season at Pregnancy Blood sampling and at Birth was coded using dummy variables (with autumn as a reference) in ancova and used as a covariate.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('UBERON_0000178', 'blood', 26, 'blood'), ('GO_0007567', 'parturition', 48, 'birth')]
PMC5732505	12/2017	S87-PMC5732505	['p -values refer to differences between the groupsmaternal characteristics n non-gdm n gdm p valueage at Delivery (y)64231.4\xa0±\xa04.38132.7\xa0±\xa04.50.018level of educationa6325.0\xa0±\xa01.3794.7\xa0±\xa01.40.051parity6401.5\xa0±\xa00.7811.5\xa0±\xa00.70.275prepregnancy smoking, number of cigarettes daily6251.2\xa0±\xa03.7762.0\xa0±\xa04.60.064alcohol consumption before Pregnancy, portion/wk.6251.9\xa0±\xa02.0782.3\xa0±\xa03.50.755prepregnancy height (cm)642166.3\xa0±\xa06.081165.9\xa0±\xa05.40.398prepregnancy weight (kg)63163.5\xa0±\xa010.28172.1\xa0±\xa013.5<0.001prepregnancy bmi (kg/m2)63923.0\xa0±\xa03.58126.2\xa0±\xa04.8<0.001duration of Gestation at ogtt (wk)32326.3\xa0±\xa04.38025.9\xa0±\xa05.90.774duration of Gestation at Pregnancy Blood sampling (wk)64211.3\xa0±\xa01.98111.2\xa0±\xa02.20.089duration of Gestation at Delivery (wk)64240.2\xa0±\xa01.18140.1\xa0±\xa01.10.410pregnancy 25(Oh)D (nmol/l)64281.9\xa0±\xa019.58180.0\xa0±\xa021.20.417ucb 25(Oh)D (nmol/l)64280.1\xa0±\xa020.08178.4\xa0±\xa018.80.448supplemental Vitamin D intake during Pregnancy ( μ g/d)62115.5\xa0±\xa016.67613.5\xa0±\xa010.80.162cumulative Gestational weight gain atb(kg)0.093\u2003first measurement5801.7\xa0±\xa00.5741.6\xa0±\xa00.5\u200312th Gestational week5803.8\xa0±\xa01.0743.6\xa0±\xa01.1\u200320th Gestational week5806.3\xa0±\xa00.8746.2\xa0±\xa00.8\u200330th Gestational week5809.7\xa0±\xa00.5749.7\xa0±\xa00.4\u2003last measurement58013.8\xa0±\xa00.47413.7\xa0±\xa00.3\ngdm Gestational diabetes mellitus, 25(Oh)D 25-Hydroxy Vitamin D, ucb Umbilical cord Blood\nvalues are means ± sd\nascale from 1\u2009=\u2009lower secondary education to 6\u2009=\u2009first or second stage of tertiary education\nbvalues are adjusted for duration of Gestation\nindependent sample t-tests, mann-whitney u-tests, repeated measures anova or the pearson chi-square test, when appropriate, were applied to compare maternal characteristics between gdm and non-gdm mothers.']	N/A	N/A	[('GO_0007567', 'parturition', 104, 'delivery'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy'), ('GO_0007565', 'female pregnancy', 560, 'gestation'), ('GO_0007565', 'female pregnancy', 624, 'gestation'), ('GO_0007565', 'female pregnancy', 637, 'pregnancy'), ('UBERON_0000178', 'blood', 647, 'blood'), ('GO_0007565', 'female pregnancy', 708, 'gestation'), ('GO_0007567', 'parturition', 721, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 774, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 826, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 832, 'D'), ('CHEBI_27300', 'vitamin D', 887, 'vitamin D'), ('GO_0007565', 'female pregnancy', 911, 'pregnancy'), ('GO_0007565', 'female pregnancy', 972, 'gestational'), ('GO_0007565', 'female pregnancy', 1055, 'gestational'), ('GO_0007565', 'female pregnancy', 1100, 'gestational'), ('GO_0007565', 'female pregnancy', 1145, 'gestational'), ('GO_0007565', 'female pregnancy', 1231, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 1262, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 1270, '25-hydroxy vitamin D'), ('UBERON_0007118', 'umbilicus', 1296, 'umbilical'), ('UBERON_0000178', 'blood', 1311, 'blood'), ('GO_0007565', 'female pregnancy', 1469, 'gestation')]
PMC5732505	12/2017	S128-PMC5732505	['caption (table-wrap): table 2\n\nindependent effect of maternal factors on Birth sizeabirth weight (sds)Birth length (sds)Head circumference (sds)bponderal index (z-score)cmaternal factors np value p value p value p valueprepregnancy bmi 0.020 0.2010.3640.719\u2003underweight19−0.49\u2009±\u20090.17−0.36\u2009±\u20090.19−0.34\u2009±\u20090.22−0.12\u2009±\u20090.23\u2003normal weight494−0.30\u2009±\u20090.03−0.23\u2009±\u20090.04−0.14\u2009±\u20090.04−0.01\u2009±\u20090.05\u2003overweight117−0.13\u2009±\u20090.07−0.12\u2009±\u20090.08−0.04\u2009±\u20090.090.08\u2009±\u20090.09\u2003obese44−0.05\u2009±\u20090.12−0.01\u2009±\u20090.130.03\u2009±\u20090.140.08\u2009±\u20090.16gestational weight gain <0.0010.006 0.1860.505\u2003inadequate164−0.43\u2009±\u20090.06−0.37\u2009±\u20090.07−0.23\u2009±\u20090.07−0.05\u2009±\u20090.08\u2003adequate261−0.28\u2009±\u20090.05−0.20\u2009±\u20090.05−0.11\u2009±\u20090.06−0.02\u2009±\u20090.06\u2003excessive242−0.12\u2009±\u20090.05−0.09\u2009±\u20090.06−0.05\u2009±\u20090.060.07\u2009±\u20090.07prepregnancy smoking 0.021 0.2270.0930.173\u2003yes101−0.43\u2009±\u20090.08−0.30\u2009±\u20090.09−0.27\u2009±\u20090.10−0.13\u2009±\u20090.11\u2003no573−0.23\u2009±\u20090.03−0.18\u2009±\u20090.04−0.09\u2009±\u20090.040.03\u2009±\u20090.04maternal education0.9720.6700.7210.634\u2003higher513−0.26\u2009±\u20090.03−0.19\u2009±\u20090.04−0.11\u2009±\u20090.04−0.00\u2009±\u20090.05\u2003lower161−0.26\u2009±\u20090.06−0.23\u2009±\u20090.07−0.14\u2009±\u20090.080.04\u2009±\u20090.08parity <0.001<0.0010.0070.027 \u2003nullipara431−0.40\u2009±\u20090.04−0.32\u2009±\u20090.04−0.20\u2009±\u20090.05−0.05\u2009±\u20090.05\u2003secundipara185−0.03\u2009±\u20090.05−0.05\u2009±\u20090.06−0.03\u2009±\u20090.070.18\u2009±\u20090.07\u2003multipara580.04\u2009±\u20090.100.22\u2009±\u20090.110.17\u2009±\u20090.12−0.07\u2009±\u20090.13gestational diabetes mellitus0.0630.5590.3510.075\u2003yes76−0.10\u2009±\u20090.09−0.15\u2009±\u20090.10−0.02\u2009±\u20090.110.21\u2009±\u20090.12\u2003no598−0.28\u2009±\u20090.03−0.21\u2009±\u20090.03−0.13\u2009±\u20090.04−0.02\u2009±\u20090.04pregnancy 25(Oh)D concentration 0.010 0.0950.3980.236\u2003suboptimal (<80\xa0nmol/l)333−0.34\u2009±\u20090.04−0.26\u2009±\u20090.05−0.15\u2009±\u20090.05−0.04\u2009±\u20090.06\u2003optimal (≥80\xa0nmol/l)341−0.19\u2009±\u20090.04−0.15\u2009±\u20090.05−0.09\u2009±\u20090.050.05\u2009±\u20090.06ucb 25(Oh)D concentration0.1490.486 0.003 0.234\u2003suboptimal (<80\xa0nmol/l)369−0.22\u2009±\u20090.04−0.18\u2009±\u20090.04−0.02\u2009±\u20090.050.05\u2009±\u20090.05\u2003optimal (≥80\xa0nmol/l)305−0.31\u2009±\u20090.04−0.23\u2009±\u20090.05−0.24\u2009±\u20090.05−0.05\u2009±\u20090.06\n25(Oh)D 25-Hydroxy Vitamin D, ucb Umbilical Cord Blood\nvalues are adjusted mean\u2009±\u2009sem.']	N/A	N/A	[('GO_0007567', 'parturition', 73, 'birth'), ('GO_0007567', 'parturition', 102, 'Birth'), ('UBERON_0000033', 'head', 120, 'Head'), ('CHEBI_71657', 'versiconol acetate', 1405, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1405, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1598, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1791, 'OH)D'), ('CHEBI_43141', '3-hydroxypropoxy group', 1796, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 1822, 'umbilical cord'), ('UBERON_0000178', 'blood', 1837, 'blood')]
PMC5736940	12/2017	S32-PMC5736940	['if the screening test was positive (Blood Glucose greater than 130\u2009mg per ml), diagnostic testing was performed using a 100\u2009g, 3-hour oral Glucose tolerance test (ogtt).']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('CHEBI_17234', 'glucose', 42, 'glucose'), ('CHEBI_17234', 'glucose', 139, 'glucose')]
PMC5741981	12/2018	S39-PMC5741981	['presented Drug classes were Paracetamol, nonsteroidal Anti-Inflammatory Drugs (Nsaids), Vitamins other than Folic Acid and Vitamin D, Drugs against a cold, Acid-suppressive medication, Antibiotics, antifungal medication, Drugs against nausea and vomiting (nvp), Sedatives/anxiolytics, anti-asthma medication, anti-diabetes medication, medication against high Blood pressure, and homeopathic medication.19\nFolic Acid and Vitamin D are Vitamins which are advised in the netherlands during Pregnancy.20therefore, women who only used these Vitamins were categorized as non-medication users.']	N/A	N/A	[('CHEBI_23888', 'drug', 10, 'drug'), ('CHEBI_46195', 'paracetamol', 28, 'paracetamol'), ('CHEBI_35472', 'anti-inflammatory drug', 54, 'anti-inflammatory drugs'), ('CHEBI_16039', 'ITP', 79, 'NSAIDs'), ('CHEBI_33277', 'gamma-tocotrienol', 88, 'vitamins'), ('CHEBI_30751', 'formic acid', 108, 'folic acid'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_23888', 'drug', 134, 'drugs'), ('CHEBI_37527', 'acid', 156, 'acid'), ('CHEBI_33282', 'antibacterial agent', 185, 'antibiotics'), ('CHEBI_23888', 'drug', 221, 'drugs'), ('CHEBI_46670', 'serpentine mineral', 262, 'sedatives'), ('UBERON_0000178', 'blood', 359, 'blood'), ('CHEBI_30751', 'formic acid', 405, 'Folic acid'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 434, 'vitamins'), ('GO_0007565', 'female pregnancy', 487, 'pregnancy'), ('CHEBI_33277', 'gamma-tocotrienol', 536, 'vitamins')]
PMC5758521	1/2018	S84-PMC5758521	['16c−0.11−0.070.010.06\nadata presented are partial correlation coefficients between Vitamins and biomarkers in log-transformed data adjusting for Gestational age at Blood sampling.']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 83, 'vitamins'), ('GO_0007565', 'female pregnancy', 145, 'gestational'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5758844	12/2017	S55-PMC5758844	['fasting Blood samples were collected at baseline and at the time of igb removal, usually following an outpatient clinic review performed within two weeks before/after the igb insertion.']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood')]
PMC5758844	12/2017	S56-PMC5758844	['the following biochemical assays were performed: full Blood count, Liver function tests, Renal function, total Cholesterol, high-density lipoprotein (hdl), low-density lipoprotein (ldl), Triglycerides, Glucose, Insulin, hba1c, Vitamin D, and crp.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0002113', 'kidney', 89, 'renal'), ('CHEBI_16113', 'cholesterol', 111, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 187, 'triglycerides'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('PR_000045358', 'insulin family protein', 211, 'insulin'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5781192	1/2018	S87-PMC5781192	['Agp, Alpha1-Acid Glycoprotein; bia, bioimpedance analysis; Crp, C-Reactive Protein; d, day; hb, haemoglobin; gps, global positioning system; lmp, last Menstrual Period; m, months; muac, mid-upper-Arm-circumference; recipal,\xa0retard de croissance\xa0intra-Uterin et paludisme;\xa0Stfr, soluble Transferrin Receptor; tbs, thick Blood smear.']	N/A	N/A	[('PR_000003830', 'angiogenic factor with G patch and FHA domains 1', 0, 'AGP'), ('PR_000001183', 'alpha-1A adrenergic receptor', 5, 'alpha1-acid glycoprotein'), ('CHEBI_37527', 'acid', 12, 'acid'), ('CHEBI_17089', 'glycoprotein', 17, 'glycoprotein'), ('PR_000005890', 'crooked neck-like protein 1', 59, 'CRP'), ('PR_000005890', 'crooked neck-like protein 1', 64, 'C-reactive protein'), ('GO_0007613', 'memory', 151, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 151, 'menstrual period'), ('UBERON_0001460', 'arm', 196, 'arm'), ('UBERON_0000995', 'uterus', 251, 'uterin'), ('PR_000015619', 'sorcin', 272, 'sTfR'), ('PR_000001679', 'trace amine-associated receptor 5', 286, 'transferrin receptor'), ('UBERON_0000178', 'blood', 319, 'blood')]
PMC5781192	1/2018	S92-PMC5781192	['a sample of Venous Blood was collected in the first and third trimesters for hb, markers of inflammation and lead levels determination.']	N/A	N/A	[('UBERON_0001638', 'vein', 12, 'venous'), ('UBERON_0000178', 'blood', 19, 'blood')]
PMC5781192	1/2018	S93-PMC5781192	['caption (table-wrap): table 2\n\nclinical, nutritional and biological data collected during Pregnancy—the recipal study, 2014–2017ancv 1ancv 2ancv 3ancv 4ancv 5ancv 6ancv 7ancv8delivery clinical and nutritional data Gestational age (weeks), mean (sd)6.8±2.511.6±2.916.7±2.922.1±3.727.6±3.832.7±3.536.2±2.538.4±1.439.1±3.0medical and obstetrical history*†‡§§§§§§§§Alcohol consumption in the last 24\u2009hours‡‡‡‡‡‡‡‡§Iron and Folate intake in the last 24\u2009hours§‡‡‡‡‡‡‡§use of itn the night before the visit‡‡‡‡‡‡‡‡§Axillary temperature, Blood pressure‡‡‡‡‡‡‡‡‡Gestational age (based on lmp or first us)‡‡‡‡‡‡‡‡‡anthropometric measurements\u2003weight‡‡‡‡‡‡‡‡‡\u2003mid-upper-Arm-circumference‡§§‡§‡§§§\u2003skinfold thickness (Bicipital and tricipital)‡§§‡§‡§§§body composition (bioimpendance analysis)‡‡‡‡‡‡‡‡§dietary 24\u2009hours recall§‡§§‡§‡§§ biological data blood and rhesus group‡§§§§§§§§hiv 1 screening‡§§§§§§§§peripheral malaria (tbs, pcr)‡‡‡‡‡‡‡‡‡Placental malaria (tbs, pcr, histology)§§§§§§§§‡Cord Blood malaria (tbs, pcr)§§§§§§§§‡hb level§‡§§§‡§§§Serum Ferritin, stfr, crp, agp, Folic Acid levels§‡§§§‡§§§lead level§‡§§§‡§§§Urinary infection and proteinuria (dipstick test)‡‡‡‡‡‡‡‡§helminthic Intestinal infection (pcr)‡§§§§§§§§Urinary schistosomiasis§§§§§§‡§§Urine storage¶§‡§‡§‡§§§\n*Sickle Cell disease, diabetes or other chronic medical affection; history of Preterm Delivery or hypertensive disorders.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 214, 'Gestational'), ('CHEBI_30879', 'alcohol', 361, 'Alcohol'), ('CHEBI_24870', 'ion', 410, 'Iron'), ('CHEBI_30863', '5-azaorotic acid', 419, 'folate'), ('UBERON_0002397', 'maxilla', 508, 'Axillary'), ('UBERON_0000178', 'blood', 530, 'blood'), ('GO_0007565', 'female pregnancy', 553, 'Gestational'), ('UBERON_0001460', 'arm', 658, 'arm'), ('UBERON_0006378', 'strand of vibrissa hair', 705, 'bicipital'), ('UBERON_0001987', 'placenta', 931, 'Placental'), ('UBERON_0000948', 'heart', 979, 'Cord'), ('UBERON_0000178', 'blood', 984, 'blood'), ('UBERON_0001977', 'blood serum', 1034, 'Serum'), ('CHEBI_5018', 'ferreirin', 1040, 'ferritin'), ('CHEBI_30751', 'formic acid', 1066, 'folic acid'), ('UBERON_0001088', 'urine', 1111, 'Urinary'), ('UBERON_0000160', 'intestine', 1180, 'intestinal'), ('UBERON_0001088', 'urine', 1215, 'Urinary'), ('UBERON_0001088', 'urine', 1247, 'Urine'), ('CL_0000437', 'gonadtroph', 1272, 'Sickle cell'), ('GO_0007565', 'female pregnancy', 1349, 'preterm'), ('GO_0007567', 'parturition', 1357, 'delivery')]
PMC5781192	1/2018	S98-PMC5781192	['Agp, Alpha1-Acid Glycoprotein; ancv, Antenatal care visit; Crp, C-Reactive Protein; hb, haemoglobin; itn, Insecticide-treated bed net; lmp, last Menstrual Period; recipal,\xa0retard de croissance\xa0intra-Uterin et paludisme; Stfr, soluble Transferrin Receptor; tbs, thick Blood smear; us, ultrasound scan.']	N/A	N/A	[('PR_000003830', 'angiogenic factor with G patch and FHA domains 1', 0, 'AGP'), ('PR_000001183', 'alpha-1A adrenergic receptor', 5, 'alpha1-acid glycoprotein'), ('CHEBI_15369', 'actinomycin', 12, 'acid glycoprotein'), ('GO_0007567', 'parturition', 37, 'antenatal'), ('PR_000005890', 'crooked neck-like protein 1', 59, 'CRP'), ('PR_000005890', 'crooked neck-like protein 1', 64, 'C-reactive protein'), ('CHEBI_24852', 'insecticide', 106, 'insecticide'), ('GO_0007613', 'memory', 145, 'menstrual'), ('UBERON_0006505', 'palmar interosseous muscle of manus', 145, 'menstrual period'), ('UBERON_0000995', 'uterus', 199, 'uterin'), ('PR_000015619', 'sorcin', 220, 'sTfR'), ('PR_000001679', 'trace amine-associated receptor 5', 234, 'transferrin receptor'), ('UBERON_0000178', 'blood', 267, 'blood')]
PMC5781192	1/2018	S101-PMC5781192	['malarial screening was performed on maternal Venous Blood, Placental and Cord Blood (table 2).']	N/A	N/A	[('UBERON_0001638', 'vein', 45, 'venous'), ('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0001987', 'placenta', 59, 'placental'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC5781192	1/2018	S105-PMC5781192	['total Blood, Serum, Plasma Urine samples are stored in −20°c or −80°c freezers with a daily monitoring of the temperature.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001977', 'blood serum', 13, 'serum'), ('UBERON_0001969', 'blood plasma', 20, 'plasma'), ('UBERON_0001088', 'urine', 27, 'urine')]
PMC5781192	1/2018	S106-PMC5781192	['caption (table-wrap): table 3\n\nbiological samples stored before Conception, during Pregnancy and at Birth—the recipal study, 2014–2017prepregnancypregnancy*Delivery/Birthplanned analysestotal Blood\u2003total Blood (200\u2009µl)–mother (×2)–Erythrocytic Folic Acid\u2003total Blood (500\u2009µl)–mother (×2)mother–Placenta\xa0Cordmetal level\u2003Blood spot+4°c (50\u2009µl)mother (×1)mother (×8)†mother–Placenta\xa0Cord plasmodium detection (pcr)\u2003Blood spot −20°c (100\u2009µl)mother (×1)mother (×8)†mother–Placenta\xa0Cordimmunological markers\u2003Red Cells (trizol, 100\u2009µl)mother (×1)mother (×8)mother–Placenta\xa0Cord plasmodium phenotyping\u2003Buffy Coat Pax\xa0Gene (300\u2009µl)–mother (×2)mother–Placenta\xa0Cordimmunological markersplasma/Serum\u2003Plasma–20°c‡mother (×1)mother (×2)mother–Placenta\xa0Cordmicro-rnas, cytokines and chemokines\u2003Plasma −80°c‡mother (×1)mother (×2)mother–Placenta\xa0Cordmicro-rnas, cytokines and chemokines\u2003Serum (100\u2009µl)mother (×1)– chlamydia\xa0trachomatis and neisseria\xa0gonorrhoeae detection\u2003Serum (400\u2009µl)–mother (×2)vitamin a\u2003Serum (100\u2009µl)‡mother (×1)mother (×2)–ferritin, crp, stfr, agpurine (1.8\u2009ml)mother (×2)mother (×3)–Pollutant/pesticidestool (−80°c)mother (×1)––helminthic infectionplacenta\u2003biopsy with Formalin––Placentahistopathology for malaria\u2003biopsy −20°c––Placentaimmunological markers\u2003biopsy with rna later––Placentaimmunological markers\nthe frequency of sample collection is indicated in\xa0parentheses.']	N/A	N/A	[('GO_0007620', 'copulation', 64, 'conception'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007586', 'digestion', 156, 'Delivery'), ('GO_0007596', 'blood coagulation', 165, 'birthPlanned'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0000178', 'blood', 204, 'blood'), ('CL_0000232', 'erythrocyte', 231, 'Erythrocytic'), ('CHEBI_30751', 'formic acid', 244, 'folic acid'), ('UBERON_0000178', 'blood', 261, 'blood'), ('UBERON_0001987', 'placenta', 294, 'placenta'), ('UBERON_0001983', 'crypt of Lieberkuhn', 303, 'cordMetal'), ('UBERON_0000178', 'blood', 319, 'Blood'), ('UBERON_0001956', 'cartilage of bronchus', 371, 'placenta cord'), ('UBERON_0000178', 'blood', 412, 'Blood'), ('UBERON_0008335', 'ventrolateral sulcus of medulla oblongata', 467, 'placenta cordImmunological'), ('CL_0000232', 'erythrocyte', 502, 'Red cells'), ('UBERON_0001956', 'cartilage of bronchus', 557, 'placenta cord'), ('UBERON_0010161', 'lumen of blood vessel', 594, 'Buffy coat'), ('PR_000012318', 'paired box protein Pax-6', 605, 'PAX'), ('SO_0000704', 'gene', 609, 'gene'), ('UBERON_0008335', 'ventrolateral sulcus of medulla oblongata', 641, 'placenta cordImmunological'), ('UBERON_0001977', 'blood serum', 682, 'serum'), ('UBERON_0001969', 'blood plasma', 688, 'Plasma'), ('UBERON_0001987', 'placenta', 729, 'placenta'), ('UBERON_0005432', 'aortic sac', 738, 'cordMicro'), ('UBERON_0001969', 'blood plasma', 779, 'Plasma'), ('UBERON_0001987', 'placenta', 821, 'placenta'), ('UBERON_0005432', 'aortic sac', 830, 'cordMicro'), ('UBERON_0001977', 'blood serum', 871, 'Serum'), ('UBERON_0001977', 'blood serum', 956, 'Serum'), ('UBERON_0001977', 'blood serum', 992, 'Serum'), ('CHEBI_75260', 'penicillinate salt', 1091, 'Pollutant'), ('CHEBI_16842', 'formaldehyde', 1177, 'formalin'), ('UBERON_0010005', 'placental labyrinth villous', 1187, 'PlacentaHistopathology'), ('UBERON_0003970', 'placental labyrinth vasculature', 1236, 'PlacentaImmunological'), ('UBERON_0003970', 'placental labyrinth vasculature', 1289, 'PlacentaImmunological')]
PMC5781192	1/2018	S108-PMC5781192	['†in case of unscheduled visit, an additional Blood spot was collected.']	N/A	N/A	[('UBERON_0000178', 'blood', 45, 'blood')]
PMC5781192	1/2018	S111-PMC5781192	['specifics components\n\nmalarial diagnosis\nbefore Conception and during Pregnancy, malarial screening was performed using both microscopy (thick Blood smear) and pcr.']	N/A	N/A	[('GO_0007620', 'copulation', 48, 'conception'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0000178', 'blood', 143, 'blood')]
PMC5781192	1/2018	S112-PMC5781192	['Blood smears were stained with giemsa and parasitaemia was quantified by the lambaréné method.19a molecular diagnostic approach, using a combination of real-time pcr assays comprising Genus-specific Primers and probes for the Gene encoding, the small (18S) plasmodium Rrna and an ultrasensitive plasmodium falciparum -specific detection system20were used to screen samples containing plasmodium parasites.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('NCBITaxon_7955', 'Danio rerio', 184, 'genus'), ('SO_0000112', 'primer', 199, 'primers'), ('SO_0000704', 'gene', 226, 'gene'), ('SO_0000407', 'cytosolic_18S_rRNA', 252, '18S)'), ('SO_0000355', 'haplotype_block', 268, 'rRNA')]
PMC5781192	1/2018	S116-PMC5781192	['following intergrowth-21st methodology, four additional scans were performed for fetal biometry assessment and Uterine and Umbilical Blood flow measurements.22each parameter was measured twice and then averaged; a third measure was performed in case of discrepancy between the two first measurements.']	N/A	N/A	[('UBERON_0000995', 'uterus', 111, 'uterine'), ('UBERON_0007118', 'umbilicus', 123, 'umbilical'), ('UBERON_0000178', 'blood', 133, 'blood')]
PMC5784894	1/2018	S38-PMC5784894	['loading experiments were performed under Isoflurane anaesthesia and Blood sampling was performed following cull as per schedule 1 requirements.']	N/A	N/A	[('CHEBI_6015', 'isoflurane', 41, 'isoflurane'), ('UBERON_0000178', 'blood', 68, 'blood')]
PMC5784894	1/2018	S41-PMC5784894	['Blood was collected by Cardiac puncture following Cervical dislocation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0000948', 'heart', 23, 'cardiac'), ('UBERON_0005434', 'cervical region', 50, 'cervical')]
PMC5789574	2/2018	S26-PMC5789574	['Blood pressure was 120/80, pulls 95/min and systolic murmur.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5789574	2/2018	S30-PMC5789574	['the laboratory analysis were as follows: White Blood Cells 13.66, Red Blood Cells 3.44, hemoglobin 103, hematocrit 0.339, Platelets 155, total protein 51g/l, Albumin 29 g/l, Acid-base balance is normal, some bacteria in Urine, in Coagulation status: hyperfibrinogenemia and the rest of the data was normal.']	N/A	N/A	[('CL_0000738', 'leukocyte', 41, 'white blood cells'), ('UBERON_0000178', 'blood', 47, 'blood'), ('CL_0000232', 'erythrocyte', 66, 'red blood cells'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CL_0000233', 'platelet', 122, 'platelets'), ('PR_000005908', 'alpha-crystallin B chain', 158, 'albumin'), ('CHEBI_37527', 'acid', 174, 'acid'), ('UBERON_0001088', 'urine', 220, 'urine'), ('GO_0050817', 'coagulation', 230, 'coagulation')]
PMC5789574	2/2018	S71-PMC5789574	['the laboratory analysis after the surgery were as follows: White Blood Cells 6,45, Red Blood Cells 3,17, hemoglobin 97, hematocrit 0.296, Platelets 129, ptc: 0.01, Acid-base status: ph: 7,47, Pco2: 4.09 po2: 10.30.']	N/A	N/A	[('CL_0000738', 'leukocyte', 59, 'white blood cells'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CL_0000232', 'erythrocyte', 83, 'red blood cells'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CL_0000233', 'platelet', 138, 'platelets'), ('CHEBI_37527', 'acid', 164, 'acid'), ('CHEBI_15379', 'dioxygen', 192, 'pCO2')]
PMC5792223	1/2018	S96-PMC5792223	['cpg cg08994060 is located in a deoxyribonuclease i ( dnasei ) hypersensitivity cluster in an Intron of Pfkfb3 , a rate-limiting enzyme in Glycolysis, and was associated with Expression of this Gene in whole Blood (table s1).']	N/A	N/A	[('SO_0000188', 'intron', 93, 'intron'), ('PR_000012574', 'prefoldin subunit 4', 103, 'PFKFB3'), ('GO_0006096', 'glycolytic process', 138, 'glycolysis'), ('GO_0010467', 'gene expression', 174, 'expression'), ('SO_0000704', 'gene', 193, 'gene'), ('UBERON_0000178', 'blood', 207, 'blood')]
PMC5792223	1/2018	S98-PMC5792223	['cross-Tissue comparison\nwe measured dnam in whole Blood and do not have specimens from other Tissues available in our cohort ( 24 ).']	N/A	N/A	[('UBERON_0000479', 'tissue', 6, 'tissue'), ('UBERON_0000178', 'blood', 50, 'blood'), ('UBERON_0000479', 'tissue', 93, 'tissues')]
PMC5792223	1/2018	S170-PMC5792223	['a Blood draw was performed at the start of a 75-g Oral Glucose test, and Glucose was quickly assessed in Serum by hexokinase reaction on a modular p800 (roche).']	N/A	N/A	[('UBERON_0000178', 'blood', 2, 'blood'), ('UBERON_0000165', 'mouth', 50, 'oral'), ('CHEBI_17234', 'glucose', 55, 'glucose'), ('CHEBI_17234', 'glucose', 73, 'glucose'), ('UBERON_0001977', 'blood serum', 105, 'serum')]
PMC5792223	1/2018	S184-PMC5792223	['next, we removed a-specific/polymorphic and non-Autosomal probes, probes with <95% success rate, and those probes that were completely methylated or unmethylated in all major cell types in whole Blood.']	N/A	N/A	[('GO_0030849', 'autosome', 48, 'autosomal'), ('UBERON_0000178', 'blood', 195, 'blood')]
PMC5792223	1/2018	S195-PMC5792223	['Gene Expression data\nwe used rna-seq data created from total rna extracted from whole Blood using the truseq v2 library protocol and 2 × 50–Base Pair paired-end sequencing on an illumina hiseq2000 for 2044 of the 3296 Individuals for which we have dnam data from the gonl reference project (likewise under ega accession number egac00001000277).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0000178', 'blood', 86, 'blood'), ('SO_0000028', 'base_pair', 140, 'base pair'), ('NCBITaxon_1', 'root', 218, 'individuals')]
PMC5804088	2/2018	S31-PMC5804088	['at these time points Blood haemoglobin concentration was measured with a hemo-cue®haemoglobinometer from Venous Blood samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0001638', 'vein', 105, 'venous'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC5804088	2/2018	S32-PMC5804088	['malaria parasitaemia was sought by microscopic examination of thick Blood film and by rapid diagnostic test (rdt) using clearview®malaria combo (british biocell international ltd., dundee, uk).']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood')]
PMC5804088	2/2018	S33-PMC5804088	['Plasma samples preparation\nBlood from participants was separated by centrifugation shortly after collection and Plasma was stored at −\xa080\xa0°c before shipment on dry ice to australia.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 27, 'Blood'), ('UBERON_0001969', 'blood plasma', 112, 'plasma')]
PMC5804088	2/2018	S64-PMC5804088	['seroprevalence was defined as the percentage of the cohort having Antibody responses greater than the mean Antibody response plus three standard deviations for negative controls, which were malaria naïve samples from melbourne Blood donors.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibody'), ('UBERON_0000178', 'blood', 227, 'blood')]
PMC5804088	2/2018	S124-PMC5804088	['among senegalese pre-school children, those children who were stunted had lower levels of Igg to schizont extract compared to non-stunted children [45], and papua new guinean children with wasting were reported to have lower levels of specific Igg to Blood stage malaria Antigens [4].']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 90, 'IgG'), ('GO_0071735', 'IgG immunoglobulin complex', 244, 'IgG'), ('UBERON_0000178', 'blood', 251, 'blood'), ('CHEBI_59132', 'antigen', 271, 'antigens')]
PMC5804547	5/2017	S122-PMC5804547	['materials and methods\n\nstudy participants and data collection\nthis study includes mother–infant pairs who had completed a Preconception or first Trimester Food frequency questionnaire (ffq) and who had infant Dna Methylation data available from Cord Blood Leukocytes as part of the newborn epigenetic study (nest).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 122, 'preconception'), ('GO_0009294', 'DNA mediated transformation', 145, 'trimester'), ('CHEBI_33290', 'food', 155, 'Food'), ('GO_0006306', 'DNA methylation', 209, 'DNA methylation'), ('CL_0000132', 'corneal endothelial cell', 245, 'cord blood leukocytes'), ('UBERON_0002240', 'spinal cord', 245, 'cord'), ('UBERON_0000178', 'blood', 250, 'blood')]
PMC5804547	5/2017	S129-PMC5804547	['at Delivery, Birth outcomes were abstracted from medical records and infant Cord Blood specimens were obtained to assess offspring Dna Methylation.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('GO_0007567', 'parturition', 13, 'birth'), ('UBERON_0002240', 'spinal cord', 76, 'cord'), ('UBERON_0000178', 'blood', 81, 'blood'), ('GO_0006306', 'DNA methylation', 131, 'DNA methylation')]
PMC5804547	5/2017	S148-PMC5804547	['specimen handling\ninfant Cord Blood specimens were collected in edta-containing vacutainer tubes and centrifuged using standard protocols to allow for collection of Plasma and buffy coat, with buffy coat used for dna extraction (qiagen; valencia, ca).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 25, 'cord'), ('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0001969', 'blood plasma', 165, 'plasma')]
PMC5812027	2/2018	S51-PMC5812027	['exposure\nmaternal Blood samples were collected from each participant at two time points; before Gestational week 16 (predominantly week 8–12, first trimester, t1) and after Gestational week 31 (predominantly week 32–35, third trimester, t3).']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('GO_0007565', 'female pregnancy', 96, 'gestational'), ('GO_0007565', 'female pregnancy', 173, 'gestational')]
PMC5812027	2/2018	S52-PMC5812027	['non-fasting Venous Blood samples were drawn in gel Serum separating tubes and centrifuged for 10\xa0min within 2 h of sampling.']	N/A	N/A	[('UBERON_0001638', 'vein', 12, 'venous'), ('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 51, 'serum')]
PMC5812027	2/2018	S82-PMC5812027	['results\nin total, 2052 women were included in this study, 2046 with a Blood sample at t1 and 1816 at t3 (fig.1).']	N/A	N/A	[('UBERON_0000178', 'blood', 70, 'blood')]
PMC5812027	2/2018	S92-PMC5812027	['of those who Delivered preterm, 10 Delivered before Gestational week 31 and thus before the t3 Blood sample could be drawn.']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'delivered'), ('GO_0007567', 'parturition', 35, 'delivered'), ('GO_0007565', 'female pregnancy', 52, 'gestational'), ('UBERON_0000178', 'blood', 95, 'blood')]
PMC5827025	2/2018	S31-PMC5827025	['no significant difference on maternal age, family monthly income, Gestational week of Blood sample and parity was observed among three groups (table\xa01).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 66, 'gestational'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC5827025	2/2018	S32-PMC5827025	['there was a significant difference on pre-Pregnancy bmi, season of Blood sample and Periconceptional Multivitamin use among three groups (table\xa01).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0007565', 'female pregnancy', 84, 'periconceptional'), ('CHEBI_7025', 'mupirocin', 101, 'multivitamin')]
PMC5827025	2/2018	S33-PMC5827025	['caption (table-wrap): table 1\n\ndemographic characteristics of 3598 mothers.demographic variablesgestational Vitamin D status1p -value2deficiencyinsufficiencysufficiencypregnant women [n (%)]1397 (38.83)1260 (35.02)941 (26.15)maternal age [years, n (%)]\xa0\xa0<25\xa0\xa025–34\xa0\xa0≥35220 (15.75)1131 (80.96)46 (3.29)194 (15.40)1022 (81.11)44 (3.49)147 (15.62)768 (81.61)26 (2.77)0.909maternal bmi [kg/m2, n (%)]\xa0\xa0underweight (<18.5)\xa0\xa0normal weight (18.5–22.9)\xa0\xa0overweight (≥23.0)333 (23.84)925 (66.21)139 (9.95)271 (21.51)859 (68.17)130 (10.32)168 (17.85)649 (68.97)124 (13.18)0.003season of Blood sample [n (%)]\xa0\xa0spring\xa0\xa0summer\xa0\xa0fall\xa0\xa0winter477 (34.14)311 (22.26)279 (19.97)330 (23.62)468 (37.14)271 (21.51)275 (21.83)246 (19.52)371 (39.43)225 (23.91)193 (20.51)152 (16.15)0.001periconceptional Multivitamin use [n (%)]\xa0\xa0no\xa0\xa0less than one month\xa0\xa0more than one month1220 (87.33)97 (6.94)80 (5.73)1033 (81.98)112 (8.89)115 (9.13)743 (78.96)81 (8.61)117 (12.43)<0.001family monthly income (rmb/yuan) [n (%)]\xa0\xa0low (<2000)\xa0\xa0middle (2000–3999)\xa0\xa0high (≥4000)611 (43.74)590 (42.23)196 (14.03)557 (44.21)516 (40.95)187 (14.84)432 (45.91)372 (39.53)137 (14.56)0.746parity [n(%)]\xa0\xa01 >11345 (96.87)60 (3.13)1238 (96.97)51 (3.03)927 (96.58)37 (3.42)0.854gestational week of Blood sample [w, n (%)]\xa0\xa0first-trimester (<13)\xa0\xa0second-trimester (13–27)519 (37.15)878 (62.85)444 (35.24)816 (64.76)337 (35.81)604 (64.19)0.575\n125(Oh)D < 20\u2009ng/ml for deficiency; 20\u2009≤\u200925(Oh)D < 30\u2009ng/ml for insufficiency; 25(Oh)D ≥ 30\u2009ng/ml for sufficiency.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000178', 'blood', 577, 'blood'), ('CHEBI_7025', 'mupirocin', 781, 'multivitamin'), ('UBERON_0000178', 'blood', 1247, 'blood'), ('CHEBI_84177', '14-HPDHE', 1391, '125(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1432, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1470, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1470, '25(OH)D')]
PMC5827025	2/2018	S36-PMC5827025	['as shown in table\xa02, maternal age, family monthly income, parity and Gestational week of Blood sample, did not influence Gestational Serum 25(Oh)d concentration.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 69, 'gestational'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0007565', 'female pregnancy', 121, 'gestational'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('CHEBI_30778', 'gallic acid', 139, '25(OH)')]
PMC5827025	2/2018	S60-PMC5827025	['caption (table-wrap): table 3\n\nassociation between demographic characteristics and the risk of Gestational Vitamin D deficiency based on multiple logistic regression analyses.parametercrude modelsadjusted models rr (95% ci ) p values rr (95% ci) p valuespre-Pregnancy bmi [kg/m2]1\xa0\xa0<18.51.25 (1.06, 1.47)0.0071.26 (1.07, 1.48)0.006\xa0\xa018.5–22.91.001.00\xa0\xa0≥23.00.84 (0.67, 1.05)0.1160.84 (0.67, 1.06)0.135season of Blood sample2\xa0\xa0spring1.001.00\xa0\xa0summer1.11 (0.93, 1.33)0.2601.12 (0.94, 1.34)0.211\xa0\xa0fall1.06 (0.88, 1.27)0.5551.05 (0.87, 1.27)0.601\xa0\xa0winter1.45 (1.21, 1.74)<0.0011.45 (1.21, 1.74)<0.001periconceptional Multivitamin use3\xa0\xa0no1.001.00\xa0\xa0less than one month0.69 (0.51, 0.94)0.0190.68 (0.50, 0.93)0.016\xa0\xa0more than one month0.72 (0.58, 0.89)0.0020.72 (0.58, 0.90)0.003\n1adjusted for maternal age, periconceptional Multivitamin use, and season of sampling.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 95, 'gestational'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy'), ('UBERON_0000178', 'blood', 411, 'blood'), ('CHEBI_7025', 'mupirocin', 613, 'multivitamin'), ('CHEBI_7025', 'mupirocin', 818, 'multivitamin')]
PMC5827025	2/2018	S140-PMC5827025	['measurement of 25(Oh)D\nmaternal non-fasting Blood samples taken as part of routine Antenatal care were collected and stored at −80\u2009°c, with no further freeze-thaw cycles, until 25(Oh)D measurement.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 15, '25(OH)D'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0007567', 'parturition', 83, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 177, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 183, 'D')]
PMC5837564	4/2017	S76-PMC5837564	['clinical referral criteria were defined to identify urgent referrals (malaria or severe high Blood pressure) observed during the field visit.']	N/A	N/A	[('UBERON_0000178', 'blood', 93, 'blood')]
PMC5837564	4/2017	S78-PMC5837564	['non-urgent referrals (high Glucose level, high Blood pressure, anaemia) are identified via a search function within the Keneba biobank database, and cases are called within a few days for re-testing and clinical evaluation during regular clinics (e.g.']	N/A	N/A	[('CHEBI_17234', 'glucose', 27, 'glucose'), ('UBERON_0000178', 'blood', 47, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'Keneba')]
PMC5837564	4/2017	S87-PMC5837564	['since 1990: most studies include anthropometric measurements, Blood pressure, dietary and lifestyle information and Blood and Urine samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 62, 'blood'), ('UBERON_0000178', 'blood', 116, 'blood'), ('UBERON_0001088', 'urine', 126, 'urine')]
PMC5837564	4/2017	S108-PMC5837564	['data collected in the keneba electronic medical records system (kemres) during each patient encounterdata collection stagegeneral description of data storedreception\ndemographic data retrieved from kwdss on arrival and updated if required\ntype of clinic visit (emergency, self-referred, follow-up, Child welfare clinic, Antenatal, research)triage\nanthropometry data after double entry by trained staff:\n○\u2002weight (all ages)\n○\u2002height/length (once above 25 years)\n○\u2002Head circumference (hc) (< 3 years)\n○\u2002skinfold thickness (sft) (all ages)\n○\u2002muac (< 5 years)\nvital signs and triage assessment data:\n○\u2002Blood pressure, Heart rate, Respiratory rate, temperature, oxygen saturation\n○\u2002glasgow coma score\n○\u2002who emergency signs (tick-boxes)5\n○\u2002who priority signs (tick-boxes)5\nclinical triage (emergency/priority/routine)doctor/nurse\nvaccination record data (either given in the clinic or from infant welfare care)\ndetails of past medical history:\n○\u2002all previous clinic visits since start of kemres\n○\u2002all known medical conditions of importance\n○\u2002Birth history, Drug history, drug allergy history, family history\n○\u2002status of breastfeeding (for all women aged 14-50 years)\npresent complaints (tick boxes for all systems) plus free text for additional information\nphysical examination details (combination of drop-down lists and tick-boxes for each Body system); free text available for any further comments\nrequested investigations—linked to laboratory\ndiagnosis with associated icd-10 code;9free text for specification or if diagnosis not available; tick-boxes for ‘well with complaint’, ‘well without complaint’ or ‘routine child health examination’\ndrug prescriptions: alerts for Drugs presented; Drug doses, frequencies and durations recorded and set according to british national formulary (bnf) guidelines.10restrictions for particular Drugs for certain patient groups, e.g.']	N/A	N/A	[('UBERON_0009746', 'head fold of embryonic disc', 298, 'child'), ('GO_0007567', 'parturition', 320, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 320, 'antenatal'), ('UBERON_0000033', 'head', 463, 'Head'), ('UBERON_0000178', 'blood', 598, 'Blood'), ('UBERON_0000948', 'heart', 614, 'heart'), ('UBERON_0001004', 'respiratory system', 626, 'respiratory'), ('GO_0007567', 'parturition', 1036, 'Birth'), ('CHEBI_23888', 'drug', 1051, 'drug'), ('UBERON_0000997', 'mammalian vulva', 1336, 'body'), ('CHEBI_23888', 'drug', 1671, 'drugs'), ('CHEBI_23888', 'drug', 1688, 'drug'), ('CHEBI_23888', 'drug', 1830, 'drugs')]
PMC5837564	4/2017	S116-PMC5837564	['briefly, agegroup-specific data and samples collected comprise: biological samples (Venous Blood, Urine); questionnaire; anthropometry, body composition based on bioelectrical impedance (using population-specific equations8); and Blood pressure.']	N/A	N/A	[('UBERON_0001638', 'vein', 84, 'venous'), ('UBERON_0000178', 'blood', 91, 'blood'), ('UBERON_0001088', 'urine', 98, 'urine'), ('UBERON_0000178', 'blood', 230, 'blood')]
PMC5837564	4/2017	S118-PMC5837564	['analytical tests conducted comprise fasting Glucose, malaria, zinc Protoporphyrin (discontinued in 2014) and full Blood count.']	N/A	N/A	[('CHEBI_17234', 'glucose', 44, 'glucose'), ('CHEBI_15430', 'protoporphyrin', 67, 'protoporphyrin'), ('UBERON_0000178', 'blood', 114, 'blood')]
PMC5837564	4/2017	S119-PMC5837564	['samples processing involves the separation of Blood fractions (Serum, Plasma, washed Red Blood Cells), treatment of Urine and dna extraction; all samples are split into several aliquots and stored in 2d-barcoded microtubes at −70°c within 2–4\u2009h of collection.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('UBERON_0001969', 'blood plasma', 70, 'plasma'), ('CL_0000232', 'erythrocyte', 85, 'red blood cells'), ('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001088', 'urine', 116, 'urine')]
PMC5837564	4/2017	S121-PMC5837564	['data and samples collected as part of the keneba biobank< 5-year-olds5–18 year olds18-year-oldsquestionnairen/an/aeducation, assets, Medication for diabetes and hypertension received outside the districtphenotypesweight, height, Skinfold thickness, Head circumference, mid upper-Arm circumferenceweight, height, body composition, Blood pressureweight, height, body composition, Blood pressurefield and laboratory analysesmalaria test, znpp, full Blood countznpp, Glucose, Blood pressure, full Blood countznpp, Glucose, Blood pressure, full Blood countbiological samples collectedunfasted Blood (4.0\u2009ml edta, 1.2\u2009ml Serum)fasted Blood (4.9\u2009ml edta, 1.2\u2009ml lh, 4.5\u2009ml Serum) and\u2009∼\u20093\u2009ml Urinefasted Blood (4.9\u2009ml edta, 1.2\u2009ml lh, 4.5\u2009ml Serum) and\u2009∼\u20093\u2009ml Urinebiological sample aliquots bankedwhole Blood, Red Blood Cells, Plasma, Serum, dnawhole Blood, Red Blood Cells, Plasma, Serum, dna; Urine (spun, unspun, Acidified)whole Blood, Red Blood Cells, Plasma, Serum, dna, Urine (spun, unspun, Acidified)\nweight in kg to the nearest 10\u2009g; height, Head circumference and mid upper-Arm circumference (muac) to the nearest 0.1\u2009cm; body composition by tanita bc-418 ma analyser; Blood pressure omron 705-cpii; fasting Glucose accu check (roche diagnostics); malaria rapid test (standard diagnostics); Zinc Protoporphyrin (znpp) by haematoflurometer (aviv biomedical); full Blood count by medonic m-series 3-part haematology analyser (boule medical); acidified Urine samples treated with concentrated Hydrogen Chloride; edta, Ethylenediaminetetraacetic Acid; lh, lithium-Heparin.']	N/A	N/A	[('CHEBI_60211', 'compound Z', 133, 'medication'), ('UBERON_0009007', 'superficial inguinal lymph node', 229, 'skinfold'), ('UBERON_0000033', 'head', 249, 'head'), ('UBERON_0001460', 'arm', 279, 'arm'), ('UBERON_0000178', 'blood', 330, 'blood'), ('UBERON_0000178', 'blood', 378, 'blood'), ('UBERON_0000178', 'blood', 446, 'blood'), ('CHEBI_17234', 'glucose', 463, 'glucose'), ('UBERON_0000178', 'blood', 472, 'blood'), ('UBERON_0000178', 'blood', 493, 'blood'), ('CHEBI_17234', 'glucose', 510, 'glucose'), ('UBERON_0000178', 'blood', 519, 'blood'), ('UBERON_0000178', 'blood', 540, 'blood'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001977', 'blood serum', 615, 'serum'), ('UBERON_0000178', 'blood', 628, 'blood'), ('UBERON_0001977', 'blood serum', 666, 'serum'), ('UBERON_0001286', "Bowman's space", 684, 'urineFasted'), ('UBERON_0000178', 'blood', 696, 'blood'), ('UBERON_0001977', 'blood serum', 734, 'serum'), ('UBERON_0002377', 'muscle of neck', 752, 'urineBiological'), ('UBERON_0000178', 'blood', 796, 'blood'), ('CL_0000232', 'erythrocyte', 803, 'red blood cells'), ('UBERON_0000178', 'blood', 807, 'blood'), ('UBERON_0001969', 'blood plasma', 820, 'plasma'), ('UBERON_0001977', 'blood serum', 828, 'serum'), ('UBERON_0000178', 'blood', 844, 'blood'), ('CL_0000232', 'erythrocyte', 851, 'red blood cells'), ('UBERON_0000178', 'blood', 855, 'blood'), ('UBERON_0001969', 'blood plasma', 868, 'plasma'), ('UBERON_0001977', 'blood serum', 876, 'serum'), ('UBERON_0001088', 'urine', 888, 'urine'), ('CHEBI_34520', 'acephate', 909, 'acidified'), ('UBERON_0000178', 'blood', 925, 'blood'), ('CL_0000232', 'erythrocyte', 932, 'red blood cells'), ('UBERON_0000178', 'blood', 936, 'blood'), ('UBERON_0001969', 'blood plasma', 949, 'plasma'), ('UBERON_0001977', 'blood serum', 957, 'serum'), ('UBERON_0001088', 'urine', 969, 'urine'), ('CHEBI_34520', 'acephate', 990, 'acidified'), ('UBERON_0000033', 'head', 1043, 'head'), ('UBERON_0001460', 'arm', 1076, 'arm'), ('UBERON_0000178', 'blood', 1171, 'blood'), ('CHEBI_17234', 'glucose', 1210, 'glucose'), ('CHEBI_33340', 'zinc group element atom', 1293, 'zinc'), ('CHEBI_15430', 'protoporphyrin', 1298, 'protoporphyrin'), ('UBERON_0000178', 'blood', 1365, 'blood'), ('UBERON_0001088', 'urine', 1452, 'urine'), ('CHEBI_17883', 'hydrogen chloride', 1492, 'hydrogen chloride'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 1517, 'ethylenediaminetetraacetic acid'), ('CHEBI_28304', 'heparin', 1562, 'heparin')]
PMC5838372	3/2018	S42-PMC5838372	['Blood samples for (ca), p, alkaline phosphatase (alp) and 25-Hydroxyvitamin (Oh) D were taken from the mothers within one month, prior to Delivery and from the infants within one week after Delivery.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_63331', '9(R)-HPODE', 58, '25-hydroxyvitamin (OH) D'), ('GO_0007567', 'parturition', 138, 'delivery'), ('GO_0007567', 'parturition', 190, 'delivery')]
PMC5840174	3/2018	S167-PMC5840174	['supplement administration and Blood sampling were performed in accordance with relevant guidelines.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood')]
PMC5840174	3/2018	S179-PMC5840174	['during the morning of the first five days (just prior to any dose) Blood was drawn into Serum separator tubes, mixed by inverting, let stand at room temperature in the dark for 30\u2009min, and then centrifuged at 1200\u2009×\u2009g for 10\u2009min.']	N/A	N/A	[('UBERON_0000178', 'blood', 67, 'blood'), ('UBERON_0001977', 'blood serum', 88, 'serum')]
PMC5840174	3/2018	S181-PMC5840174	['the subjects in groups b and c, and half of those in group a returned on days 12 and 19 for further Blood sampling just prior to that morning’s Folate dose.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_30863', '5-azaorotic acid', 144, 'folate')]
PMC5841533	2/2018	S89-PMC5841533	['caption (table-wrap): table 1\n\ncharacteristics of children retained at 12 years and those lost to follow-up12-year follow-uplost to follow-upcontrolinterventionbefore end of trialafter end of trialn (%)n (%)n (%)n (%)location\u2003urban194 (47%)190 (47%)47 (68%)196 (62%)\u2003rural215 (53%)214 (53%)22 (32%)122 (38%)district\u2003dhanusha339 (83%)325 (80%)59 (86%)265 (83 %)\u2003mahottari70 (17%)75 (19%)10 (14%)51 (16%)\u2003sarlahi02 (0.5%)01 (0.3%)\u2003siraha02 (0.5%)01 (0.3%)main household livelihood\u2003no work47 (11%)46 (11%)1 (1 %)36 (11%)\u2003farming70 (17%)65 (16%)7 (10%)39 (12%)\u2003salaried150 (37%)167 (41%)34 (49%)162 (51%)\u2003small business80 (20%)75 (19%)19 (28%)49 (15%)\u2003waged labour50 (12%)43 (11%)5 (7%)21 (7%)\u2003student7 (2%)4 (1%)3 (4 %)3 (1 %)\u2003out of country5 (1%)4 (1%)08 (3%)mother’s age at enrolment\u2003<20\u2009years118 (29%)124 (31%)20 (29%)99 (31%)\u200320–29\u2009years269 (66%)266 (66%)44 (64%)206 (65%)\u2003≥30\u2009years22 (5%)14 (3%)5 (7%)13 (4%)ethnic origin, n316\u2003dalit plains9 (2%)12 (3%)2 (3%)6 (2%)\u2003muslim21 (5%)29 (7%)8 (12%)19 (6%)\u2003janjati hills7 (2%)9 (2%)2 (3%)14 (4%)\u2003other terai (plains) groups289 (70%)266 (66%)38 (55%)193 (61%)\u2003brahmin chhetri hills23 (6%)21 (5%)6 (9%)22 (7%)\u2003brahmin chhetri plains60 (15%)67 (17%)13 (19%)62 (20%)land ownership\u2003no land19 (5%)23 (6%)6 (9%)20 (6%)\u2003<30\u2009dhur (about 500\u2009m2)281 (69%)280 (69%)45 (65%)219 (69%)\u2003≥30\u2009dhur109 (27%)101 (25%)18 (26%)79 (25%)\u2003appliance score, n68\u2003motor vehicle, tv or refrigerator209 (51%)200 (50%)36 (53%)168 (53%)\u2003sewing machine, cassette player, camera, fan,\xa0bullock cart,\xa0wall clock, radio, iron or bicycle145 (35%)139 (34%)21 (31%)96 (30%)\u2003none of the above55 (13%)65 (16%)11 (16%)54 (17%)maternal education at enrolment\u2003none199 (49%)200 (50%)27 (39%)118 (37%)\u2003primary37 (9%)31 (8%)16 (23%)39 (12%)\u2003secondary or higher173 (42%)173 (43%)26 (38%)161 (51%)\u2003mother’s body mass index at enrolment, n408403\u2003<18.5\u2009kg/m2126 (31%)120 (30%)23 (34%)73 (23%)\u2003≥18.5\u2009kg/m2282 (69%)283 (70%)45 (66%)245 (77%)parity at Birth of index child\u20030179 (44%)175 (43%)33 (48%)153 (48%)\u20031–2176 (43%)196 (49%)28 (40%)137 (43%)\u2003≥354 (13%)33 (8%)8 (12%)28 (9%)Preterm, n8(<37\u2009weeks’ Gestation by ultrasound assessment)25 (6%)25 (6%)3 (38%)48 (15%)place of Birth, n5\u2003hospital212 (52%)246 (60%)–188 (59%)\u2003home187 (46%)156 (39%)3 (60%)116 (36%)\u2003on the way10 (2%)2 (1%)2 (40%)14 (4%)child sex, n407\u2003girl203 (50%)196 (49%)–160 (51%)\u2003boy204 (50%)208 (51%)–152 (49%)total409 (100)404 (100)69 (100)318 (100)\n\ncaption (table-wrap): table 2\n\ncharacteristics of parents, the home environment and children at follow-up, by trial allocation statuscontrol,no (%)intervention,no (%)child’s primary caregiver\u2003mother383 (94%)384 (95%)\u2003father10 (2%)4 (1%)\u2003other16 (4%)16 (4%)mother’s education\u2003none184 (45%)183 (45%)\u2003pre-primary7 (1%)1 (0.3%)\u2003primary39 (10%)47 (12%)\u2003secondary or higher176 (43%)171 (42%)\u2003studied urdu, sanskrit or non-formal education3 (1%)2 (0.5%)mother’s literacy\u2003can read easily or with some difficulty217 (53%)214 (53%)\u2003cannot read191 (47%)190 (47%)mother’s psychological distress (ghq-12)\u2003no\xa0ormild distress (<6)346 (85%)343 (85%)\u2003distress (≥6)63 (15%)61 (15%)father’s education\u2003none84 (21%)80 (20%)\u2003pre-primary–1 (0.3%)\u2003primary38 (9%)36 (9%)\u2003secondary or higher287 (70%)285 (71%)\u2003studied urdu, sanskrit or non-formal education–2 (0.5%)child sex and age\u2003female205 (50%)194 (48%)\u2003male204 (50%)210 (52%)mean (sd) age (years)12.1 (0.4)12.2 (0.4)Child schooling\u2003no schooling13 (3 %)6 (1%)\u2003up to pre-primary level6 (2%)4 (1%)\u2003up to primary level246 (60%)238 (59%)\u2003up to lower secondary level144 (35%)155 (38%)\u2003up to higher secondary level01 (0.3%)\u2003child’s schooling, n344335mean no of years (sd)6.5 (1.6)6.6 (1.5)no of siblings\u2003012 (3 %)13 (3 %)\u20031–2259 (63 %)279 (69%)\u2003≥3138 (34%)112 (28%)screen child anxiety-related disorder\u2003no symptoms of anxiety (<3)203 (50%)209 (52%)\u2003symptoms of anxiety (≥3)206 (50%)195 (48%)\u2003depression self-rating scale\u2003no symptoms of major depression (<14)364 (89%)365 (90%)\u2003symptoms of major depression (≥14)45 (11%)39 (10%)major illness in the past 12\u2009months\u2003yes33 (8%)38 (9%)\u2003no376 (92%)366 (91%)morbidity in the past 7\u2009days\u2003fever40 (10%)42 (10%)\u2003diarrhoea13 (3%)15 (4%)\u2003Blood in stool5 (1%)6 (1%)\u2003pneumonia1 (0.2%)5 (1%)\u2003fast breathing2 (0.4%)7 (2%)\u2003Chest indrawing3 (1%)8 (2%)\u2003cough72 (18%)78 (19%)total409 (100)404 (100)\nGhq-12,\xa012-item general health questionnaire.']	N/A	N/A	[('GO_0007567', 'parturition', 1942, 'birth'), ('GO_0007128', 'meiotic prophase I', 2070, 'Preterm'), ('GO_0007565', 'female pregnancy', 2093, 'gestation'), ('GO_0007567', 'parturition', 2166, 'birth'), ('GO_0007601', 'visual perception', 3356, 'Child'), ('UBERON_0000178', 'blood', 4109, 'Blood'), ('UBERON_0012131', 'centrale', 4189, 'Chest'), ('PR_000007939', 'glial fibrillary acidic protein', 4262, 'GHQ'), ('PR_000003777', 'adiponectin', 4266, '12')]
PMC5906686	4/2018	S36-PMC5906686	['1a), paralleled to reduced concentrations of Glucose, total Cholesterol, Progesterone (prog) and E2 in the Blood (fig.']	N/A	N/A	[('CHEBI_17234', 'glucose', 45, 'glucose'), ('CHEBI_16113', 'cholesterol', 60, 'cholesterol'), ('CHEBI_17026', 'progesterone', 73, 'progesterone'), ('CHEBI_37983', 'sulfur-35 atom', 97, 'E2'), ('PR_000006300', 'lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial', 97, 'E2'), ('UBERON_0000178', 'blood', 107, 'blood')]
PMC5906686	4/2018	S48-PMC5906686	['b – e amount of Glucose, total Cholesterol, Prog and E2 in the Blood of 15.5 dpc Pregnant females in control and starved groups.']	N/A	N/A	[('CHEBI_17234', 'glucose', 16, 'glucose'), ('CHEBI_16113', 'cholesterol', 31, 'cholesterol'), ('PR_000013319', 'neurotrypsin', 44, 'PROG'), ('PR_000006300', 'lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial', 53, 'E2'), ('UBERON_0000178', 'blood', 63, 'blood'), ('GO_0007565', 'female pregnancy', 81, 'pregnant')]
PMC5906686	4/2018	S163-PMC5906686	['the Blood Sugar concentration was determined by collecting Blood samples with the accu-chek®active of roche (roche, germany) and corresponding test strips.']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('CHEBI_24870', 'ion', 10, 'sugar'), ('UBERON_0000178', 'blood', 59, 'blood')]
PMC5924963	4/2018	S85-PMC5924963	['a 3–8\u2009ml baseline Blood sample was collected just prior to the Glucose infusion, half of which was placed in a Sodium Heparin tube and stored on ice.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('CHEBI_28790', 'serotonin', 111, 'sodium heparin')]
PMC5924963	4/2018	S89-PMC5924963	['Blood samples were obtained at baseline and 1, 3, 5, 10, 20, 40, and 60\u2009min after infusion.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5924963	4/2018	S90-PMC5924963	['postprocedure, all heparinized Blood samples were centrifuged at 2400 rpm for 20\u2009min at 4°c.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'blood')]
PMC5924963	4/2018	S110-PMC5924963	['two Adult females were excluded from this measure because their health records indicated they were clinically compromised shortly before or after Blood sample collection.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 4, 'adult'), ('UBERON_0000178', 'blood', 146, 'blood')]
PMC5941617	5/2018	S274-PMC5941617	['newborns from mothers with Serum 25(Oh)D levels <\u200917\xa0ng/ml (median value of the individual means for maternal Blood samples collected during the first Trimester and 2\xa0days Postpartum) had higher Tibia bmc and larger cross-sectional area, as assessed by pqct at 10\xa0days Postpartum.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 27, 'serum'), ('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 33, '25(OH)D'), ('UBERON_0000178', 'blood', 110, 'blood'), ('GO_0009294', 'DNA mediated transformation', 151, 'trimester'), ('GO_0007565', 'female pregnancy', 172, 'postpartum'), ('UBERON_0000979', 'tibia', 195, 'tibia'), ('GO_0007565', 'female pregnancy', 269, 'postpartum')]
PMC5941629	5/2018	S1-PMC5941629	['methods\nin a mexican-american Birth cohort of 241 maternal-infant pairs, Cord Blood samples were measured for repeat element Dna Methylation ( Line-1 and alu ).']	N/A	N/A	[('GO_0007567', 'parturition', 30, 'birth'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0006306', 'DNA methylation', 125, 'DNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 143, 'LINE-1')]
PMC5941629	5/2018	S56-PMC5941629	['Dna Methylation in Cord Blood\nUmbilical Cord Blood samples were collected at the delivery room.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0009472', 'axilla', 19, 'cord blood'), ('UBERON_0002331', 'umbilical cord', 30, 'Umbilical cord'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC5941629	5/2018	S58-PMC5941629	['dna were isolated from clots with a qiaamp Blood dna maxi kit (qiagen, inc., santa clarita, ca, usa) (further details described in holland et al.']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'Blood')]
PMC5941629	5/2018	S81-PMC5941629	['cell types included Cd8T, Cd4T, natural killer, B Lymphocytes, Monocytes, Granulocytes, and Nucleated Red Blood Cells.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 20, 'CD8T'), ('PR_000001200', 'C-C chemokine receptor type 4', 26, 'CD4T'), ('CL_0000236', 'B cell', 48, 'B lymphocytes'), ('CL_0000576', 'monocyte', 63, 'Monocytes'), ('CL_0002062', 'type I pneumocyte', 74, 'Granulocytes'), ('CL_0002242', 'nucleate cell', 92, 'nucleated'), ('GO_0005634', 'nucleus', 92, 'nucleated'), ('CL_0000232', 'erythrocyte', 102, 'red blood cells'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC5952272	5/2018	S27-PMC5952272	['targeted groups and distribution of groups, number of questionnaires, number of samples, and number of tests including total cost of the project.target groupschools or clinicsquestionnairessamplesdata entry figuresteam memberstraining sessionstestscost (us$) millionprimary school88/12008400550503600adolescents16024002400391\u200920055\u2009200pregnant8012001200229\u200920027\u2009600lactating8012001200246\u200900027\u20096001.6children 6-59\u2009mo8012001200238\u200980027\u2009600table salt88/120036002400flour//55550\u20094001665bread88/168050401680total664600010\u2009635117\u2009264055050147\u20093451.6\nsamples of Blood Serum, Blood Plasma, and 24-hour Urine were taken, refrigerated, and kept at −20 to −80°c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 558, 'blood'), ('UBERON_0001977', 'blood serum', 564, 'serum'), ('UBERON_0000178', 'blood', 571, 'blood'), ('UBERON_0001969', 'blood plasma', 577, 'plasma'), ('UBERON_0001088', 'urine', 597, 'urine')]
PMC5952272	5/2018	S145-PMC5952272	['Brains of Individuals with asd display significantly lower concentrations of Serotonin compared with the Brains of non-autistic Individuals.35patrick and ames36proposed that Vitamin D (Calcitriol) activates the transcription of Serotonin-synthesizing Gene Tryptophan Hydroxylase 2 (Tph2) in the Brain and represses the transcription of Tph1 in Tissues outside the Blood-Brain barrier.']	N/A	N/A	[('UBERON_0000955', 'brain', 0, 'Brains'), ('NCBITaxon_1', 'root', 10, 'individuals'), ('CHEBI_28790', 'serotonin', 77, 'serotonin'), ('UBERON_0000955', 'brain', 105, 'brains'), ('NCBITaxon_1', 'root', 128, 'individuals'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 185, 'calcitriol'), ('CHEBI_28790', 'serotonin', 228, 'serotonin'), ('SO_0000704', 'gene', 251, 'gene'), ('PR_000016777', 'tau-tubulin kinase 1', 256, 'tryptophan hydroxylase 2'), ('PR_000016585', 'tripeptidyl-peptidase 1', 282, 'TPH2'), ('UBERON_0000955', 'brain', 295, 'brain'), ('PR_000016585', 'tripeptidyl-peptidase 1', 336, 'TPH1'), ('UBERON_0000479', 'tissue', 344, 'tissues'), ('UBERON_0000178', 'blood', 364, 'blood'), ('UBERON_0000955', 'brain', 370, 'brain')]
PMC5958072	5/2018	S10-PMC5958072	['five well-described ‘trans-species’ Genes include the Major Histocompatibility Complex (Mhc), the abo Blood group, antiviral Genes and auto-Immune related Genes1.']	N/A	N/A	[('SO_0000704', 'gene', 36, 'genes'), ('GO_0042611', 'MHC protein complex', 54, 'major histocompatibility complex'), ('GO_0042611', 'MHC protein complex', 88, 'MHC'), ('UBERON_0000178', 'blood', 102, 'blood'), ('SO_0000704', 'gene', 125, 'genes'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('SO_0000704', 'gene', 155, 'genes1')]
PMC5965027	5/2018	S178-PMC5965027	['they can have sweet Blood [diabetes] or high Blood pressures.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0000178', 'blood', 45, 'blood')]
PMC5991930	4/2018	S86-PMC5991930	['Blood pressure monitor, saturation probe, and foley catheter have been applied and the monitor is next to\xa0the patient.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood')]
PMC5991930	4/2018	S104-PMC5991930	['they will request Blood work.']	N/A	N/A	[('UBERON_0000178', 'blood', 18, 'blood')]
PMC5991930	4/2018	S119-PMC5991930	['the team will request Blood work to assess Blood count, Kidney and Liver function, and electrolytes, including magnesium levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('UBERON_0002107', 'liver', 67, 'liver')]
PMC5995352	6/2018	S4-PMC5995352	['linear regression was stratified by sex a priori and adjusted for maternal ethnicity, pre-Pregnancy body mass index and smoking during Pregnancy, season of Blood sampling and child age.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('UBERON_0000178', 'blood', 156, 'blood')]
PMC5995352	6/2018	S37-PMC5995352	['in the municipality of odense, denmark, s-25Ohd <50 nmol/l was observed in 27.8% of early Pregnant women, in 15.8% of late Pregnant women [25], but in 57.7% of the Cord Blood samples [26].']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 42, '25OHD'), ('GO_0007565', 'female pregnancy', 90, 'pregnant'), ('GO_0007565', 'female pregnancy', 123, 'pregnant'), ('UBERON_0002240', 'spinal cord', 164, 'cord'), ('UBERON_0000178', 'blood', 169, 'blood')]
PMC5995352	6/2018	S44-PMC5995352	['abbreviations: 25Ohd: 25-Hydroxyvitamin D.\n\nassessment of 25Ohd\nBlood samples from early and late Pregnancy (mean Gestational age (ga) 12 and 29 weeks, respectively) and mixed Arterial/Venous Blood from Cord were analysed for Serum 25Ohd concentration by liquid chromatography tandem mass spectrometry (lc-ms/ms) using a thermo scientific tlx1 system attached to a thermo scientific vantage tsq.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 15, '25OHD'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 22, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 58, '25OHD'), ('UBERON_0000178', 'blood', 64, 'Blood'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('UBERON_0001637', 'artery', 176, 'arterial'), ('UBERON_0001638', 'vein', 185, 'venous'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0002240', 'spinal cord', 203, 'cord'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 232, '25OHD')]
PMC6011374	6/2018	S43-PMC6011374	['measurement of Serum 25(Oh)D\nnon-fasting whole Peripheral Blood samples were collected into non-heparinised tubes at 15±1 weeks’ Gestation.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 15, 'serum'), ('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('UBERON_0012101', 'perinatal stage', 47, 'peripheral'), ('UBERON_0000178', 'blood', 58, 'blood'), ('GO_0007565', 'female pregnancy', 129, 'gestation')]
PMC6022422	6/2018	S33-PMC6022422	['weight, Blood pressure, and Heart rate of the fetus were measured by the same Person using a digital scale, digital barometer, and fetal Heart detector (sonicaid).']	N/A	N/A	[('UBERON_0000178', 'blood', 8, 'blood'), ('UBERON_0000948', 'heart', 28, 'heart'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'person'), ('UBERON_0000948', 'heart', 137, 'heart')]
PMC6022422	6/2018	S35-PMC6022422	['the researcher took non-fasting Venous Blood samples from mothers during 6-12 and 15-20 Gestational weeks between 09:00 and 11:00 am.']	N/A	N/A	[('UBERON_0001638', 'vein', 32, 'venous'), ('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0007565', 'female pregnancy', 88, 'gestational')]
PMC6022422	6/2018	S70-PMC6022422	['(13), anthropometric indicators, including weight and height, were measured and Plasma Lipids, Insulin, and adiponectin and visfatin concentrations in the Umbilical Cord Blood of 50 large-for-Gestational age (lga) and 50 appropriate-for-Gestational age (aga) infants Born following complication-free Pregnancies were assessed.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 80, 'plasma'), ('CHEBI_18059', 'lipid', 87, 'lipids'), ('PR_000045358', 'insulin family protein', 95, 'insulin'), ('UBERON_0002331', 'umbilical cord', 155, 'umbilical cord'), ('UBERON_0000178', 'blood', 170, 'blood'), ('GO_0007565', 'female pregnancy', 192, 'gestational'), ('GO_0007565', 'female pregnancy', 237, 'gestational'), ('GO_0007567', 'parturition', 267, 'born'), ('GO_0007565', 'female pregnancy', 300, 'pregnancies')]
PMC6022422	6/2018	S74-PMC6022422	['an increase in maternal Blood Glucose leads to a rise in fetal Blood Glucose, which in turn stimulates fetal Pancreatic Islet Cells, resulting in hyperinsulinemia.']	N/A	N/A	[('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_17234', 'glucose', 30, 'glucose'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_17234', 'glucose', 69, 'glucose'), ('CL_0000083', 'epithelial cell of pancreas', 109, 'pancreatic islet cells'), ('UBERON_0001264', 'pancreas', 109, 'pancreatic')]
PMC6022422	6/2018	S96-PMC6022422	['they examined Milk and Venous Blood samples of 24 healthy breastfeeding women with complication-free physiologic Pregnancies and neonates with appropriate weight for Gestational age at Birth and 180 days after Birth.']	N/A	N/A	[('UBERON_0001913', 'milk', 14, 'milk'), ('UBERON_0001638', 'vein', 23, 'venous'), ('UBERON_0000178', 'blood', 30, 'blood'), ('GO_0007565', 'female pregnancy', 113, 'pregnancies'), ('GO_0007565', 'female pregnancy', 166, 'gestational'), ('GO_0007567', 'parturition', 185, 'birth'), ('GO_0007567', 'parturition', 210, 'birth')]
PMC6022422	6/2018	S97-PMC6022422	['visfatin had been copiously Excreted in mother’s Milk, and Serum visfatin levels were 100 times higher in mothers’ Milk than in their Blood.']	N/A	N/A	[('GO_0007588', 'excretion', 28, 'excreted'), ('UBERON_0001913', 'milk', 49, 'milk'), ('UBERON_0001977', 'blood serum', 59, 'serum'), ('UBERON_0001913', 'milk', 115, 'milk'), ('UBERON_0000178', 'blood', 134, 'blood')]
PMC6039335	7/2018	S199-PMC6039335	['Fat Digestion and absorption\nmany of the Fas generated by Digestion in the Rumen pass into the Small Intestine, where they are absorbed into circulation via the Lymph and Blood.']	N/A	N/A	[('GO_0003153', 'closure of embryonic heart tube', 0, 'Fat digestion'), ('CHEBI_33290', 'food', 41, 'FAs'), ('GO_0007586', 'digestion', 58, 'digestion'), ('UBERON_0007365', 'rumen', 75, 'rumen'), ('UBERON_0002108', 'small intestine', 95, 'small intestine'), ('UBERON_0002391', 'lymph', 161, 'lymph'), ('UBERON_0000178', 'blood', 171, 'blood')]
PMC6043562	7/2018	S173-PMC6043562	['at this visit, we measured Respiratory function and collected Blood.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 27, 'respiratory'), ('UBERON_0000178', 'blood', 62, 'blood')]
PMC6056931	7/2018	S6-PMC6056931	['additional assessments during Pregnancy include anthropometric and Blood pressure measurements, obstetric ultrasound screens, and assessments of Food security, maternal fatigue, Prenatal depression, allergy, immune function, morbidity and Gestational diabetes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_33290', 'food', 145, 'food'), ('GO_0007565', 'female pregnancy', 178, 'prenatal'), ('GO_0007565', 'female pregnancy', 239, 'gestational')]
PMC6056931	7/2018	S7-PMC6056931	['at Birth, maternal and neonatal health is assessed and an Umbilical Cord Blood sample collected.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002331', 'umbilical cord', 58, 'umbilical cord'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC6056931	7/2018	S9-PMC6056931	['follow-up assessments of mothers include anthropometric measures, diet history, Nutrient status, Blood pressure, Breast Milk composition, and measures of Postnatal depression and fatigue.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 80, 'nutrient'), ('UBERON_0000178', 'blood', 97, 'blood'), ('UBERON_0001348', 'brown adipose tissue', 113, 'breast milk'), ('GO_0007567', 'parturition', 154, 'postnatal')]
PMC6056931	7/2018	S117-PMC6056931	['Blood pressure is measured at each Prenatal visit (phases 1 to 3) as well as Postnatally (phases 5, 6 and 8) according to international guidelines [46] using calibrated equipment.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0007565', 'female pregnancy', 77, 'postnatally')]
PMC6056931	7/2018	S186-PMC6056931	['biological sample collection\nVenous Blood (42\xa0ml) is drawn from the participating women into labelled edta-coated, Serum and Trace Element free evacuated tubes at phases 1–4 during Pregnancy and at phase 6 Postnatally.']	N/A	N/A	[('UBERON_0001638', 'vein', 29, 'Venous'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 125, 'trace element'), ('GO_0007565', 'female pregnancy', 181, 'pregnancy'), ('GO_0007565', 'female pregnancy', 206, 'postnatally')]
PMC6056931	7/2018	S187-PMC6056931	['at Birth (phase 4), Umbilical Cord Blood samples are taken immediately after the separation of the newborn from the Umbilical Cord and before Placental Delivery into labelled edta-coated, Serum and trace element free evacuated tubes.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002331', 'umbilical cord', 20, 'umbilical cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('GO_0007565', 'female pregnancy', 142, 'placental'), ('UBERON_0001987', 'placenta', 142, 'placental'), ('GO_0007567', 'parturition', 152, 'delivery'), ('UBERON_0001977', 'blood serum', 188, 'serum')]
PMC6056931	7/2018	S188-PMC6056931	['Venous Blood from the infant (3\xa0ml) is drawn at phases 6, 7 and 8.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood')]
PMC6056931	7/2018	S189-PMC6056931	['dry Blood spots are collected on filter paper cards (whatman, inc) immediately after Blood collection (maternal, Cord and infant).']	N/A	N/A	[('UBERON_0000178', 'blood', 4, 'blood'), ('UBERON_0000178', 'blood', 85, 'blood'), ('UBERON_0002240', 'spinal cord', 113, 'cord')]
PMC6056931	7/2018	S191-PMC6056931	['in case Venous Blood cannot be obtained from the infants, Capillary Blood is being collected by Foot venepuncture.']	N/A	N/A	[('UBERON_0001638', 'vein', 8, 'venous'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0001982', 'capillary', 58, 'capillary'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0002387', 'pes', 96, 'foot')]
PMC6056931	7/2018	S192-PMC6056931	['Venous Blood is processed within 1\xa0h after Blood draw; Plasma/Serum separated and Red Blood Cells washed twice with normal saline.']	N/A	N/A	[('UBERON_0001638', 'vein', 0, 'Venous'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood'), ('UBERON_0001969', 'blood plasma', 55, 'plasma'), ('UBERON_0001977', 'blood serum', 62, 'serum'), ('CL_0000232', 'erythrocyte', 82, 'red blood cells'), ('UBERON_0000178', 'blood', 86, 'blood')]
PMC6056931	7/2018	S203-PMC6056931	['biochemical analyses\nhaemoglobin is determined on site in whole Blood (20\xa0μl) using hemocue (Hb 201+, ängelholm, sweden).']	N/A	N/A	[('UBERON_0000178', 'blood', 64, 'blood'), ('PR_000008609', 'hexokinase-2', 93, 'Hb')]
PMC6056931	7/2018	S209-PMC6056931	['Fatty Acids in Red Blood Cell total Phospholipids are determined using gas chromatography tandem mass spectrometry (gcmsms) [73].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acids'), ('CL_0000232', 'erythrocyte', 15, 'red blood cell'), ('UBERON_0000178', 'blood', 19, 'blood'), ('CHEBI_16247', 'phospholipid', 36, 'phospholipids')]
PMC6056931	7/2018	S211-PMC6056931	['thyroid hormones (Thyroid stimulating hormone, thyroglobulin, total thyroxine) will be determined in whole Blood spots by using electrochemiluminescence immunoassays.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 18, 'thyroid'), ('UBERON_0000178', 'blood', 107, 'blood')]
